PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hayashi, K; Momoi, Y; Tanuma, N; Kishimoto, A; Ogoh, H; Kato, H; Suzuki, M; Sakamoto, Y; Inoue, Y; Nomura, M; Kiyonari, H; Sakayori, M; Fukamachi, K; Kakugawa, Y; Yamashita, Y; Ito, S; Sato, I; Suzuki, A; Nishio, M; Suganuma, M; Watanabe, T; Shima, H				Hayashi, K.; Momoi, Y.; Tanuma, N.; Kishimoto, A.; Ogoh, H.; Kato, H.; Suzuki, M.; Sakamoto, Y.; Inoue, Y.; Nomura, M.; Kiyonari, H.; Sakayori, M.; Fukamachi, K.; Kakugawa, Y.; Yamashita, Y.; Ito, S.; Sato, I.; Suzuki, A.; Nishio, M.; Suganuma, M.; Watanabe, T.; Shima, H.			Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA	ONCOGENE			English	Article							MOUSE SKIN; TNF-ALPHA; KAPPA-B; CANCER DEVELOPMENT; TUMOR PROMOTION; OKADAIC ACID; CYCLIN D1; MICE; PROGRESSION; ACTIVATION	Somatic mutations in the gene encoding the catalytic subunit of protein phosphatase 6 (Ppp6c) have been identified in malignant melanoma and are thought to function as a driver in B-raf-or N-ras-driven tumorigenesis. To assess the role of Ppp6c in carcinogenesis, we generated skin keratinocyte-specific Ppp6c conditional knockout mice and performed two-stage skin carcinogenesis analysis. Ppp6c deficiency induced papilloma formation with 7,12-dimethylbenz (a) anthracene (DMBA) only, and development of those papillomas was significantly accelerated compared with that seen following DMBA/TPA (12-O-tetradecanoylphorbol 13-acetate) treatment of wild-type mice. NF-kappa B activation either by tumor necrosis factor (TNF)-alpha or interleukin (IL)-1 beta was enhanced in Ppp6c-deficient keratinocytes. Overall, we conclude that Ppp6c deficiency predisposes mice to skin carcinogenesis initiated by DMBA. This is the first report showing that such deficiency promotes tumor formation in mice.	[Hayashi, K.; Momoi, Y.; Tanuma, N.; Kato, H.; Sakamoto, Y.; Inoue, Y.; Nomura, M.; Sakayori, M.; Fukamachi, K.; Kakugawa, Y.; Yamashita, Y.; Shima, H.] Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan; [Hayashi, K.; Tanuma, N.; Kato, H.; Shima, H.] Tohoku Univ, Sch Med, Div Canc Mol Biol, Sendai, Miyagi 980, Japan; [Kishimoto, A.; Ogoh, H.; Suzuki, M.; Watanabe, T.] Nara Womens Univ, Dept Biol Sci, Grad Sch Humanities & Sci, Nara 630, Japan; [Kiyonari, H.] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan; [Ito, S.; Sato, I.] Miyagi Canc Ctr, Div Pathol, Natori, Miyagi 9811293, Japan; [Suzuki, A.; Nishio, M.] Kyushu Univ, Med Inst Bioregulat, Div Canc Genet, Fukuoka 812, Japan; [Suganuma, M.] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan	Miyagi Cancer Center; Tohoku University; Nara Womens University; RIKEN; Miyagi Cancer Center; Kyushu University	Shima, H (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, 47-1 Nodayama, Natori, Miyagi 9811293, Japan.	shima@med.tohoku.ac.jp	Kiyonari, Hiroshi/N-7936-2015		JSPS KAKENHI [24591928, 25861168, 22590298]; Women's University Intramural Grant for Project Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Women's University Intramural Grant for Project Research	We thank Dr Hirota Fujiki for critical advice and Dr Yoshikazu Nishino for statistical analyses. We thank Nozomi Sasaki, Kuniko Komuro and Miyuki Ueki for technical assistance. We thank Dr Elise Lamar for English editing. This work was supported by JSPS KAKENHI grant numbers 24591928 to Yoichiro Kakugawa, 25861168 to Kayoko Fukamachi and 22590298 to Hiroshi Shima and by a Nara Women's University Intramural Grant for Project Research to Toshio Watanabe.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Afshar K, 2010, DEVELOPMENT, V137, P237, DOI 10.1242/dev.042754; Ancrile BB, 2008, MOL INTERV, V8, P22, DOI 10.1124/mi.8.1.6; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bastians H, 1996, J CELL SCI, V109, P2865; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Fimmel S, 2007, ANN NY ACAD SCI, V1119, P176, DOI 10.1196/annals.1404.016; Fujiki H, 2011, ANTI-CANCER AGENT ME, V11, P4, DOI 10.2174/187152011794941163; Goshima G, 2003, EMBO J, V22, P2752, DOI 10.1093/emboj/cdg266; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kolar M, 2012, BIOL CELL, V104, P738, DOI 10.1111/boc.201200018; KOMORI A, 1993, CANCER RES, V53, P3462; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Masuda K, 2010, BIOCHEM BIOPH RES CO, V393, P201, DOI 10.1016/j.bbrc.2010.01.097; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Suganuma M, 1999, CANCER RES, V59, P4516; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; Suzuki JS, 2003, CARCINOGENESIS, V24, P1123, DOI 10.1093/carcin/bgg052; TACHIBANA K, 1981, J AM CHEM SOC, V103, P2469, DOI 10.1021/ja00399a082; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Zhang BX, 1998, CANCER RES, V58, P4044	37	20	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4647	4655		10.1038/onc.2014.398	http://dx.doi.org/10.1038/onc.2014.398			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25486434				2022-12-26	WOS:000360189300010
J	Lyu, K; Wang, GC; He, YL; Han, JF; Ye, Q; Qin, CF; Chen, R				Lyu, Ke; Wang, Guang-Chuan; He, Ya-Ling; Han, Jian-Feng; Ye, Qing; Qin, Cheng-Feng; Chen, Rong			Crystal Structures of Enterovirus 71 (EV71) Recombinant Virus Particles Provide Insights into Vaccine Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; MATURATION CLEAVAGE; TYPE-1 POLIOVIRUS; ANTIGENIC HYBRID; IDENTIFICATION; CHIMERA; MORPHOGENESIS; SITE; MECHANISM; PROTEIN	Hand-foot-and-mouth disease (HFMD) remains a major health concern in the Asia-Pacific regions, and its major causative agents include human enterovirus 71 (EV71) and coxsackievirus A16. A desirable vaccine against HFMD would be multivalent and able to elicit protective responses against multiple HFMD causative agents. Previously, we have demonstrated that a thermostable recombinant EV71 vaccine candidate can be produced by the insertion of a foreign peptide into the BC loop of VP1 without affecting viral replication. Here we present crystal structures of two different naturally occurring empty particles, one from a clinical C4 strain EV71 and the other from its recombinant virus containing an insertion in the VP1 BC loop. Crystal structure analysis demonstrated that the inserted foreign peptide is well exposed on the particle surface without significant structural changes in the capsid. Importantly, such insertions do not seem to affect the virus uncoating process as illustrated by the conformational similarity between an uncoating intermediate of another recombinant virus and that of EV71. Especially, at least 18 residues from the N terminus of VP1 are transiently externalized. Altogether, our study provides insights into vaccine development against HFMD.	[Lyu, Ke; He, Ya-Ling; Chen, Rong] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Wang, Guang-Chuan; Han, Jian-Feng; Ye, Qing; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Wang, Guang-Chuan] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310027, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Beijing Institute of Microbiology & Epidemiology; Zhejiang University	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	qincf@bmi.ac.cn; rongchen@ips.ac.cn	Wang, Guangchuan/AAK-6197-2021; Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Guangchuan/0000-0001-5315-1599; Lyu, Ke/0000-0002-2483-2253	Chinese Academy of Sciences; Shanghai Pu-Jiang Career Development Award [09PJ1411400]; 973 Project [2010CB912403]; National Science Foundation of China [31370730, 31070144, 31270195]; Beijing Natural Science Foundation [7122129, 7112108]; Beijing Nova Program of Science and Technology [2010B041]	Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pu-Jiang Career Development Award; 973 Project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program of Science and Technology	This work was supported by 100 Talents' Program of Chinese Academy of Sciences, Shanghai Pu-Jiang Career Development Award Grant 09PJ1411400, 973 Project Grant 2010CB912403, and National Science Foundation of China Grants 31370730 and 31070144 (R. Chen's group) and by Beijing Natural Science Foundation Grants 7122129 and 7112108, National Science Foundation of China Grant 31270195, and Beijing Nova Program of Science and Technology Grant 2010B041 (C. F. Qin's group).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANSARDI DC, 1995, J VIROL, V69, P1540, DOI 10.1128/JVI.69.3.1540-1547.1995; BASAVAPPA R, 1994, PROTEIN SCI, V3, P1651, DOI 10.1002/pro.5560031005; BLONDEL B, 1983, VIROLOGY, V126, P707, DOI 10.1016/S0042-6822(83)80027-0; BURKE KL, 1988, NATURE, V332, P81, DOI 10.1038/332081a0; Cifuente JO, 2013, J VIROL, V87, P7637, DOI 10.1128/JVI.03519-12; COLBEREGARAPIN F, 1988, P NATL ACAD SCI USA, V85, P8668, DOI 10.1073/pnas.85.22.8668; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ding JP, 2002, STRUCTURE, V10, P999, DOI 10.1016/S0969-2126(02)00793-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DJ, 1989, NATURE, V339, P385, DOI 10.1038/339385a0; Foo DGW, 2008, CLIN MICROBIOL INFEC, V14, P286, DOI 10.1111/j.1469-0691.2007.01904.x; FRICKS CE, 1985, J VIROL, V54, P856, DOI 10.1128/JVI.54.3.856-859.1985; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; GUTTMAN N, 1977, J VIROL, V23, P363, DOI 10.1128/JVI.23.2.363-367.1977; JACOBSON MF, 1968, J MOL BIOL, V33, P369, DOI 10.1016/0022-2836(68)90195-2; JENKINS O, 1990, J VIROL, V64, P1201, DOI 10.1128/JVI.64.3.1201-1206.1990; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEBOUVIER GL, 1955, LANCET, V2, P1013; Lin TW, 1996, FOLD DES, V1, P179, DOI 10.1016/S1359-0278(96)00030-2; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Lyu K, 2014, J VIROL, V88, P3114, DOI 10.1128/JVI.03029-13; MARONGIU ME, 1981, J VIROL, V39, P341, DOI 10.1128/JVI.39.2.341-347.1981; MARTIN A, 1988, EMBO J, V7, P2839, DOI 10.1002/j.1460-2075.1988.tb03140.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; MURDIN AD, 1989, J VIROL, V63, P5251, DOI 10.1128/JVI.63.12.5251-5257.1989; MURRAY MG, 1988, P NATL ACAD SCI USA, V85, P3203, DOI 10.1073/pnas.85.9.3203; NUGENT CI, 1995, J VIROL, V69, P13, DOI 10.1128/JVI.69.1.13-22.1995; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Roy MD, 2008, ADV MATER, V20, P1830, DOI 10.1002/adma.200702322; Shingler KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003240; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Wang GC, 2013, P NATL ACAD SCI USA, V110, P7619, DOI 10.1073/pnas.1300233110; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; YEATES TO, 1991, EMBO J, V10, P2331, DOI 10.1002/j.1460-2075.1991.tb07772.x	38	16	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3198	3208		10.1074/jbc.M114.624536	http://dx.doi.org/10.1074/jbc.M114.624536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25492868	hybrid, Green Published			2022-12-26	WOS:000349456000002
J	Ranok, A; Wongsantichon, J; Robinson, RC; Suginta, W				Ranok, Araya; Wongsantichon, Jantana; Robinson, Robert C.; Suginta, Wipa			Structural and Thermodynamic Insights into Chitooligosaccharide Binding to Human Cartilage Chitinase 3-like Protein 2 (CHI3L2 or YKL-39)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomarker; Carbohydrate-binding Protein; Crystal Structure; Glycobiology; Glycoside Hydrolase; Isothermal Titration Calorimetry (ITC); Protein Crystallization	ACIDIC MAMMALIAN CHITINASE; ARTICULAR CHONDROCYTES; HUMAN CHITOTRIOSIDASE; CATALYTIC MECHANISM; SI-CLP; OSTEOARTHRITIS; FAMILY; GENE; IDENTIFICATION; EXPRESSION	Background: Human YKL-39 is currently recognized as a biomarker for osteoarthritis. Results: Crystal structures of YKL-39 reveal that chitooligosaccharide induces local conformational changes to stabilize sugarprotein complexes and that the protein contains five binding subsites for sugars. Conclusion: YKL-39 binds to chitooligosaccharide through enthalpic reactions. Significance: Our findings suggest how YKL-39 interacts with GlcNAc moieties of the natural ligands, which may possibly activate local tissue inflammation. Four crystal structures of human YKL-39 were solved in the absence and presence of chitooligosaccharides. The structure of YKL-39 comprises a major (/)(8) triose-phosphate isomerase barrel domain and a small + insertion domain. Structural analysis demonstrates that YKL-39 interacts with chitooligosaccharides through hydrogen bonds and hydrophobic interactions. The binding of chitin fragments induces local conformational changes that facilitate tight binding. Compared with other GH-18 members, YKL-39 has the least extended chitin-binding cleft, containing five subsites for sugars, namely (-3)(-2)(-1)(+1)(+2), with Trp-360 playing a prominent role in the sugar-protein interactions at the center of the chitin-binding cleft. Evaluation of binding affinities obtained from isothermal titration calorimetry and intrinsic fluorescence spectroscopy suggests that YKL-39 binds to chitooligosaccharides with K-d values in the micromolar concentration range and that the binding energies increase with the chain length. There were no significant differences between the K-d values of chitopentaose and chitohexaose, supporting the structural evidence for the five binding subsite topology. Thermodynamic analysis indicates that binding of chitooligosaccharide to YKL-39 is mainly driven by enthalpy.	[Ranok, Araya; Suginta, Wipa] Suranaree Univ Technol, Inst Sci, Sch Biochem, Biochem Electrochem Res Unit, Nakhon Ratchasima 30000, Thailand; [Wongsantichon, Jantana; Robinson, Robert C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Robinson, Robert C.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	Suranaree University of Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Robinson, RC (corresponding author), Proteos, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	rrobinson@imcb.a-star.edu.sg; wipa@sut.ac.th	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Wongsantichon, Jantana/0000-0002-4134-2248	Office of the Higher Education Commission through CHE333 PhD-THA-SUP Scholarship [CHE500307]; Suranaree University of Technology, Thailand [SUT1-102-57-24-19]; Biomedical Research Council of the Agency for Science, Technology, and Research (A*STAR)	Office of the Higher Education Commission through CHE333 PhD-THA-SUP Scholarship; Suranaree University of Technology, Thailand; Biomedical Research Council of the Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Office of the Higher Education Commission through CHE333 PhD-THA-SUP Scholarship Grant CHE500307 and Suranaree University of Technology, Thailand, Grant SUT1-102-57-24-19.; Supported by the Biomedical Research Council of the Agency for Science, Technology, and Research (A*STAR).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Areshkov PA, 2010, CYTOL GENET+, V44, P1, DOI 10.3103/S0095452710010019; ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; Baban J, 2010, J PHYS CHEM B, V114, P6144, DOI 10.1021/jp909801x; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Brameld KA, 1998, J AM CHEM SOC, V120, P3571, DOI 10.1021/ja972282h; Breedveld FC, 2004, RHEUMATOLOGY, V43, pI4, DOI 10.1093/rheumatology/keh102; De Ceuninck Frederic, 2005, J Biomol Tech, V16, P256; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doyle ML, 1997, CURR OPIN BIOTECH, V8, P31, DOI 10.1016/S0958-1669(97)80154-1; Du H, 2005, RHEUMATOL INT, V26, P35, DOI 10.1007/s00296-004-0497-2; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gratchev A, 2008, BIOMARK INSIGHTS, V3, P39; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Houston DR, 2003, J BIOL CHEM, V278, P30206, DOI 10.1074/jbc.M303371200; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Kavsan V., 2008, SCHOLARLY RES EXCHAN, V2008, P1, DOI DOI 10.3814/2008/814849; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Knorr T, 2003, ANN RHEUM DIS, V62, P995, DOI 10.1136/ard.62.10.995; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Lapensee L, 1997, FERTIL STERIL, V68, P702, DOI 10.1016/S0015-0282(97)00317-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Meng G, 2010, J BIOL CHEM, V285, P39898, DOI 10.1074/jbc.M110.130781; Miyatake K, 2013, BIOCHEM BIOPH RES CO, V431, P52, DOI 10.1016/j.bbrc.2012.12.094; Norberg AL, 2010, FEBS LETT, V584, P4581, DOI 10.1016/j.febslet.2010.10.017; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Ranok Araya, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P317, DOI 10.1089/mab.2013.0016; Sakata M, 2002, CLIN EXP RHEUMATOL, V20, P343; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; Sekine T, 2001, ANN RHEUM DIS, V60, P49, DOI 10.1136/ard.60.1.49; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Steck E, 2002, BIOCHEM BIOPH RES CO, V299, P109, DOI 10.1016/S0006-291X(02)02585-8; Stevens AL, 2008, ARTHRITIS RHEUM-US, V58, P489, DOI 10.1002/art.23120; Takano K, 1999, BIOCHEMISTRY-US, V38, P12698, DOI 10.1021/bi9910169; Tsuruha JI, 2002, J RHEUMATOL, V29, P1459; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798	52	23	29	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2617	2629		10.1074/jbc.M114.588905	http://dx.doi.org/10.1074/jbc.M114.588905			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25477513	Green Published, hybrid			2022-12-26	WOS:000349310700008
J	Schmidpeter, PAM; Schmid, FX				Schmidpeter, Philipp A. M.; Schmid, Franz X.			Prolyl Isomerization as a Molecular Memory in the Allosteric Regulation of the Signal Adapter Protein c-CrkII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Protein; Allosteric Regulation; Biophysics; Protein Folding; Src Homology 3 Domain (SH3 Domain); c-CrkII; Native State Prolyl Isomerization; Sequential Mixing Stopped Flow	TERMINAL SH3 DOMAIN; STRUCTURAL BASIS; PROLINE SWITCH; PRODUCT; C3G	Background: Signaling by chicken c-CrkII (cellular CT10 regulator of kinase) involves native state prolyl isomerization. Results: Dynamic domain interactions are coupled with trans-to-cis isomerization at Pro-238 and down-regulation of chicken c-CrkII. Conclusion: The linkage between protein folding, prolyl isomerization, and function of c-CrkII is explained by a kinetic six-species reaction mechanism. Significance: The linkage with prolyl isomerization attenuates an allosteric transition and provides a molecular memory. c-CrkII is a central signal adapter protein. A domain opening/closing reaction between its N- and C-terminal Src homology 3 domains (SH3N and SH3C, respectively) controls signal propagation from upstream tyrosine kinases to downstream targets. In chicken but not in human c-CrkII, opening/closing is coupled with cis/trans isomerization at Pro-238 in SH3C. Here, we used advanced double-mixing experiments and kinetic simulations to uncover dynamic domain interactions in c-CrkII and to elucidate how they are linked with cis/trans isomerization and how this regulates substrate binding to SH3N. Pro-238 trans cis isomerization is not a simple on/off switch but converts chicken c-CrkII from a high affinity to a low affinity form. We present a double-box model that describes c-CrkII as an allosteric system consisting of an open, high affinity R state and a closed, low affinity T state. Coupling of the T-R transition with an intrinsically slow prolyl isomerization provides c-CrkII with a kinetic memory and possibly functions as a molecular attenuator during signal transduction.	[Schmid, Franz X.] Univ Bayreuth, Biochim Lab, D-95447 Bayreuth, Germany; Univ Bayreuth, Bayreuther Zentrum Mol Biowissenschaften, D-95447 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Schmid, FX (corresponding author), Univ Bayreuth, Biochim Lab, Univ Str 30, D-95447 Bayreuth, Germany.	fx.schmid@unibayreuth.de	Schmidpeter, Philipp/Q-5540-2019	Schmidpeter, Philipp/0000-0003-2871-9706				Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; FELLER SM, 1995, ONCOGENE, V10, P1465; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Jankowski W, 2012, NAT CHEM BIOL, V8, P590, DOI [10.1038/NCHEMBIO.954, 10.1038/nchembio.954]; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; Pace C N, 1986, Methods Enzymol, V131, P266; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Schmidpeter PAM, 2014, ACS CHEM BIOL, V9, P1145, DOI 10.1021/cb500001n; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242	22	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3021	3032		10.1074/jbc.M114.617308	http://dx.doi.org/10.1074/jbc.M114.617308			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25488658	hybrid, Green Published			2022-12-26	WOS:000349310700039
J	Tay, MYF; Saw, WG; Zhaoi, YQ; Chan, KWK; Singh, D; Chong, YW; Forwood, JK; Ooi, EE; Gruber, G; Lescar, J; Luo, DH; Vasudevan, SG				Tay, Moon Y. F.; Saw, Wuan Geok; Zhao, Yongqian; Chan, Kitti W. K.; Singh, Daljit; Chong, Yuwen; Forwood, Jade K.; Ooi, Eng Eong; Grueber, Gerhard; Lescar, Julien; Luo, Dahai; Vasudevan, Subhash G.			The C-terminal 50 Amino Acid Residues of Dengue NS3 Protein Are Important for NS3-NS5 Interaction and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; TYPE-2 NONSTRUCTURAL PROTEIN-3; X-RAY-SCATTERING; VIRUS TYPE-2; CRYSTAL-STRUCTURE; IN-VITRO; STRUCTURAL-CHARACTERIZATION; COMPLEX-FORMATION; ESCHERICHIA-COLI; CATALYTIC DOMAIN	Dengue virus multifunctional proteins NS3 protease/helicase and NS5 methyltransferase/RNA-dependent RNA polymerase form part of the viral replication complex and are involved in viral RNA genome synthesis, methylation of the 5 '-cap of viral genome, and polyprotein processing among other activities. Previous studies have shown that NS5 residue Lys-330 is required for interaction between NS3 and NS5. Here, we show by competitive NS3-NS5 interaction ELISA that the NS3 peptide spanning residues 566-585 disrupts NS3-NS5 interaction but not the null-peptide bearing the N570A mutation. Small angle x-ray scattering study on NS3(172-618) helicase and covalently linked NS3(172-618)-NS5(320-341) reveals a rigid and compact formation of the latter, indicating that peptide NS5(320-341) engages in specific and discrete interaction with NS3. Significantly, NS3: Asn-570 to alanine mutation introduced into an infectious DENV2 cDNA clone did not yield detectable virus by plaque assay even though intracellular double-stranded RNA was detected by immunofluorescence. Detection of increased negative-strand RNA synthesis by real time RT-PCR for the NS3: N570A mutant suggests that NS3-NS5 interaction plays an important role in the balanced synthesis of positive-and negative-strand RNA for robust viral replication. Dengue virus infection has become a global concern, and the lack of safe vaccines or antiviral treatments urgently needs to be addressed. NS3 and NS5 are highly conserved among the four serotypes, and the protein sequence around the pinpointed amino acids from the NS3 and NS5 regions are also conserved. The identification of the functionally essential interaction between the two proteins by biochemical and reverse genetics methods paves the way for rational drug design efforts to inhibit viral RNA synthesis.	[Tay, Moon Y. F.; Zhao, Yongqian; Chan, Kitti W. K.; Singh, Daljit; Chong, Yuwen; Ooi, Eng Eong; Vasudevan, Subhash G.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore; [Saw, Wuan Geok; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Zhao, Yongqian; Vasudevan, Subhash G.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2650, Australia; [Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 138673, Singapore; [Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 138673, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Charles Sturt University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Vasudevan, SG (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.	subhash.vasudevan@duke-nus.edu.sg	Luo, Dahai/J-6022-2012	Luo, Dahai/0000-0001-7637-7275; Forwood, Jade/0000-0003-3267-9997; Tay, Moon/0000-0002-4730-6133; Vasudevan, Subhash/0000-0002-5083-3831; Ooi, Eng Eong/0000-0002-0520-1544	Duke-National University of Singapore Signature Research Program - Ministry of Health, Singapore; National Medical Research Council, Singapore [NMRC/1315/2011, NMRC/TCR/005/2008]; Ministry of Education MOE Tier 3 Grant, Singapore [MOE2012-T3-1-008]	Duke-National University of Singapore Signature Research Program - Ministry of Health, Singapore(Ministry of Health-SingaporeNational University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore); Ministry of Education MOE Tier 3 Grant, Singapore(Ministry of Education, Singapore)	This work was supported by the Duke-National University of Singapore Signature Research Program (funded by the Ministry of Health, Singapore), National Medical Research Council, Singapore, Grants NMRC/1315/2011 and NMRC/TCR/005/2008, and the Ministry of Education MOE Tier 3 Grant MOE2012-T3-1-008, Singapore.	Balakrishna AM, 2010, J BIOENERG BIOMEMBR, V42, P311, DOI 10.1007/s10863-010-9298-3; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bartholomeus A, 1999, J VIRAL HEPATITIS, V6, P261, DOI 10.1046/j.1365-2893.1999.00173.x; BARTHOLOMEUSZ AI, 1993, ARCH VIROL, V128, P111, DOI 10.1007/BF01309792; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Davidson AD, 2014, METHODS MOL BIOL, V1138, P113, DOI 10.1007/978-1-4939-0348-1_8; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Geiss BJ, 2009, FUTURE MED CHEM, V1, P327, DOI 10.4155/FMC.09.27; Gruber A, 2011, INFECT IMMUN, V79, P2880, DOI 10.1128/IAI.01326-10; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Ho CSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053051; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Keller AA, 2013, PHARMACEUTICALS, V6, P184, DOI 10.3390/ph6020184; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lipson H., 1956, ACTA CRYSTALLOGR, V9, P839; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Moreland NJ, 2012, J VIROL METHODS, V179, P97, DOI 10.1016/j.jviromet.2011.10.006; Moreland NJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000881; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Paradkar PN, 2011, BIOSCIENCE REP, V31, P221, DOI 10.1042/BSR20100078; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; Svergun D., 2013, SMALL ANGLE XRAY NEU, P65; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomassini JE, 2003, VIROLOGY, V313, P274, DOI 10.1016/S0042-6822(03)00314-3; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006; ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189	74	88	90	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2379	2394		10.1074/jbc.M114.607341	http://dx.doi.org/10.1074/jbc.M114.607341			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488659	hybrid, Green Published			2022-12-26	WOS:000348588000041
J	de Paula, LCM; Soares, AS; de Lima, TW; Delbem, ACB; Coelho, CJ; Filho, ARG				de Paula, Lauro C. M.; Soares, Anderson S.; de Lima, Telma W.; Delbem, Alexandre C. B.; Coelho, Clarimar J.; Filho, Arlindo R. G.			A GPU-Based Implementation of the Firefly Algorithm for Variable Selection in Multivariate Calibration Problems	PLOS ONE			English	Article							REGRESSION; DESIGN	Several variable selection algorithms in multivariate calibration can be accelerated using Graphics Processing Units (GPU). Among these algorithms, the Firefly Algorithm (FA) is a recent proposed metaheuristic that may be used for variable selection. This paper presents a GPU-based FA (FA-MLR) with multiobjective formulation for variable selection in multivariate calibration problems and compares it with some traditional sequential algorithms in the literature. The advantage of the proposed implementation is demonstrated in an example involving a relatively large number of variables. The results showed that the FA-MLR, in comparison with the traditional algorithms is a more suitable choice and a relevant contribution for the variable selection problem. Additionally, the results also demonstrated that the FA-MLR performed in a GPU can be five times faster than its sequential implementation.	[de Paula, Lauro C. M.; Soares, Anderson S.; de Lima, Telma W.] Fed Univ Goias UFG, Inst Informat, Goiania, Go, Brazil; [Delbem, Alexandre C. B.] Univ Sao Paulo, Inst Math Sci & Comp, Sao Carlos, SP, Brazil; [Coelho, Clarimar J.] Pontifical Catholic Univ Goias PUC Goias, Dept Comp Sci, Goiania, Go, Brazil; [Filho, Arlindo R. G.] Technol Inst Aeronaut ITA, Dept Syst & Control, Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Goias; Universidade de Sao Paulo; Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA)	Soares, AS (corresponding author), Fed Univ Goias UFG, Inst Informat, Goiania, Go, Brazil.	engsoares@gmail.com	da Silva Soares, Anderson/AAU-9878-2020; de Paula, Lauro Cássio Martins/F-5359-2014; Filho, Arlindo Rodrigues Galvão/S-8442-2019; Coelho, Clarimar/C-8044-2019; de Lima, Telma W./B-6172-2013; Delbem, Alexandre C B/A-9287-2008	da Silva Soares, Anderson/0000-0002-2967-6077; de Paula, Lauro Cássio Martins/0000-0002-0546-0685; Filho, Arlindo Rodrigues Galvão/0000-0003-2151-8039; Coelho, Clarimar/0000-0002-5163-2986; Delbem, Alexandre C B/0000-0003-1810-1742; Soares, Telma/0000-0002-4927-2221	research agency CAPES; research agency FAPEG; research agency FAPESP; research agency CNPq	research agency CAPES; research agency FAPEG; research agency FAPESP; research agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	The authors thank the research agencies CAPES, FAPEG, FAPESP and CNPq for the support provided to this research. This is also a contribution of the National Institute of Advanced Analytical Science and Technology (INCTAA) (CNPq - proc. no. 573894/2008-6 and FAPESP proc. no. 2008/57808-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054540; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Anderson da Silva Soares AdS, 2013, COMPUTER TECHNOLOGY, V4, P465; Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Banati H, 2011, INT J COMPUT SCI, V8, P473; Bartoli A, 2009, INT J COMPUT VISION, V85, P133, DOI 10.1007/s11263-009-0253-x; Beebe KR, 1998, WILEY INTERSCIENCE S; Box G.E., 2013, TIME SERIES ANAL FOR; Bradstreet RB, 1965, KJELDAHL METHOD ORGA; BROWN SD, 1994, ANAL CHEM, V66, pR315, DOI 10.1021/ac00084a014; Carbonetto P, 2012, BAYESIAN ANAL, V7, P73, DOI 10.1214/12-BA703; Chau FT, 2004, CHEMOMETRICS BASICS, V234; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; CORTINA JM, 1993, J MANAGE, V19, P915, DOI 10.1016/0149-2063(93)90035-L; CUDA N, 2011, NVIDIA CUDA C PROGR; de Lucena Daniel Vitor, 2012, International Journal of Natural Computing Research, V3, P43, DOI 10.4018/jncr.2012100103; de Lucena DV, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1053; Ferreira MMC, 1999, QUIM NOVA, V22, P724, DOI 10.1590/S0100-40421999000500016; Galvao AR, 2011, J BRAZIL CHEM SOC, V22, P2225, DOI 10.1590/S0103-50532011001100029; Galvao RKH, 2008, CHEMOMETR INTELL LAB, V92, P83, DOI 10.1016/j.chemolab.2007.12.004; Gandomi AH, 2011, COMPUT STRUCT, V89, P2325, DOI 10.1016/j.compstruc.2011.08.002; George EI, 2000, J AM STAT ASSOC, V95, P1304, DOI 10.2307/2669776; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hibon M, 1995, EVALUATING ACCURACY; Husselmann A, 2014, STUDIES COMPUTATIONA, V516, P245, DOI [10.1007/978-3-319-02141-6_12, DOI 10.1007/978-3-319-02141-6_12]; Husselmann AV, 2012, P INT C GEN EV METH, P77; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Lawson CL, 1974, SOLVING LEAST SQUARE; Little J, MATLAB GPU COMPUTING; Liu XW, 2013, LECT NOTES ELECTR EN, V255, P251, DOI 10.1007/978-3-642-38460-8_28; Luebke D, 2007, COMPUTER, V40, P96, DOI 10.1109/MC.2007.59; Lukasik S, 2009, LECT NOTES ARTIF INT, V5796, P97; Martens H., 1989, MULTIVARIATE CALIBRA; MathWorks, MATL GPU COMP SUPP N; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Paula LCM, 2013, INT C PAR DISTR PROC, P737; Reese J, GPU PROGRAMMING MATL; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Soares AS, 2014, ELECTRON LETT, V50, P932, DOI 10.1049/el.2013.3284; Soares AD, 2010, J BRAZIL CHEM SOC, V21, P1626, DOI 10.1590/S0103-50532010000900005; Soares AS, 2013, ELECTRON LETT, V49, P80; Tarpey T, 2000, AM STAT, V54, P116, DOI 10.2307/2686028; Tobias RD., 1995, P 20 ANN SAS US GROU, P1250; Tsuchiyama R., 2010, OPENCL PROGRAMMING B; Westad F, 2000, J NEAR INFRARED SPEC, V8, P117, DOI 10.1255/jnirs.271; Yang X.S., 2013, IJSI, V1, P36, DOI [10.1504/IJSI.2013.055801, DOI 10.1504/IJSI.2013.055801]; Yang X.-S., 2008, NATURE INSPIRED META; Yang XS, 2010, INT J BIO-INSPIR COM, V2, P78, DOI 10.1504/IJBIC.2010.032124; Yang XS, 2009, LECT NOTES COMPUT SC, V5792, P169, DOI 10.1007/978-3-642-04944-6_14	55	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114145	10.1371/journal.pone.0114145	http://dx.doi.org/10.1371/journal.pone.0114145			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493625	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400033
J	Miller, TE; Wang, J; Sukhdeo, K; Horbinski, C; Tesar, PJ; Wechsler-Reya, RJ; Rich, JN				Miller, Tyler E.; Wang, Jun; Sukhdeo, Kumar; Horbinski, Craig; Tesar, Paul J.; Wechsler-Reya, Robert J.; Rich, Jeremy N.			Lgr5 Marks Post-Mitotic, Lineage Restricted Cerebellar Granule Neurons during Postnatal Development	PLOS ONE			English	Article							STEM-CELLS; MOUSE; GENE; PROLIFERATION; RECEPTORS; DIFFERENTIATION; IDENTIFICATION; PROGENITORS; PRECURSORS; COCHLEA	Wnt signaling regulates self-renewal and fate commitment of stem and progenitor cells in development and homeostasis. Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) is a co-receptor for Wnt signaling that marks highly proliferative stem and progenitor cells in many epithelial tissue types. Wnt signaling instructs neural developmental and homeostatic processes; however, Lgr5 expression in the developing and adult brain has not been characterized. Here we report that Lgr5 is expressed in the postnatal cerebellum during the maturation and synaptogenesis of cerebellar granule neurons (CGNs), processes controlled by Wnt signaling. Using a transgenic reporter mouse for in vivo Lgr5 expression analysis and lineage tracing, we reveal that Lgr5 specifically identified CGNs and was restricted temporally to the CGN maturation phase within the internal granule layer, but absent in the adult brain. Cells marked by Lgr5 were lineage restricted, post-mitotic and long-lived. The ligand for Lgr5, R-spondin, was secreted in a paracrine fashion that evolved during the maturation of CGNs, which coincided with the Lgr5 expression pattern. Our findings provide potential new insight into the critical regulation of Wnt signaling in the developing cerebellum and support a novel role for Lgr5 in the regulation of post-mitotic cells.	[Miller, Tyler E.; Sukhdeo, Kumar; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Miller, Tyler E.; Sukhdeo, Kumar] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Jun; Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Horbinski, Craig] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY USA; [Tesar, Paul J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Rich, Jeremy N.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; Sanford Burnham Prebys Medical Discovery Institute; University of Kentucky; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Rich, JN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA.	richj@ccf.org	Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014; Rich, Jeremy/AAM-1445-2021	Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Sukhdeo, Kumar/0000-0001-8725-6081; Miller, Tyler E/0000-0002-1269-1895	National Institutes of Health (NIH) [CA154130, CA169117, CA171652, NS087913, NS089272, CA122759, CA159859]; James S. McDonnell Foundation; NIH [T32 GM007250]; NCI [F30 CA183510, F30 CA165857]; NATIONAL CANCER INSTITUTE [R01CA169117, R01CA159859, R01CA154130, R01CA122759, R01CA171652, F30CA183510, K08CA155764, P30CA177558, F30CA165857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087913, R01NS089272] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was in part funded by National Institutes of Health (NIH) grants: CA154130, CA169117, CA171652, NS087913, NS089272 (JNR), CA122759, CA159859 (RJWR) and the James S. McDonnell Foundation (JNR). TEM and KS were supported in part by NIH grant T32 GM007250 to the CWRU MSTP. TEM was funded by NCI F30 CA183510. KS was funded by NCI F30 CA165857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Institute for BrainScience, 2012, ALL DEV MOUS BRAIN A; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dickins EM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00162; Ding BJ, 2013, J NEUROSCI, V33, P2860, DOI 10.1523/JNEUROSCI.3533-12.2013; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Kilpatrick DL, 2012, CEREBELLUM, V11, P41, DOI 10.1007/s12311-010-0227-0; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lorenz A, 2011, MOL CELL BIOL, V31, P3326, DOI 10.1128/MCB.05718-11; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Sukhdeo K, 2014, EXP EYE RES, V119, P106, DOI 10.1016/j.exer.2013.11.003; ten Donkelaar HJ, 2003, J NEUROL, V250, P1025, DOI 10.1007/s00415-003-0199-9; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	29	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114433	10.1371/journal.pone.0114433	http://dx.doi.org/10.1371/journal.pone.0114433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493560	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400046
J	Bauer, E; Salem, H; Marz, M; Vogel, H; Kaltenpoth, M				Bauer, Eugen; Salem, Hassan; Marz, Manja; Vogel, Heiko; Kaltenpoth, Martin			Transcriptomic Immune Response of the Cotton Stainer Dysdercus fasciatus to Experimental Elimination of Vitamin-Supplementing Intestinal Symbionts	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; MICROBE MUTUALISM; HOST-DEFENSE; WEB SERVER; INSECT; RNA; TRANSMISSION; HEMIPTERA; BACTERIUM; ALIGNMENT	The acquisition and vertical transmission of bacterial symbionts plays an important role in insect evolution and ecology. However, the molecular mechanisms underlying the stable maintenance and control of mutualistic bacteria remain poorly understood. The cotton stainer Dysdercus fasciatus harbours the actinobacterial symbionts Coriobacterium glomerans and Gordonibacter sp. in its midgut. The symbionts supplement limiting B vitamins and thereby significantly contribute to the host's fitness. In this study, we experimentally disrupted the symbionts' vertical transmission route and performed comparative transcriptomic analyses of genes expressed in the gut of aposymbiotic (symbiont-free) and control individuals to study the host immune response in presence and absence of the mutualists. Annotation of assembled cDNA reads identified a considerable number of genes involved in the innate immune system, including different protein isoforms of several immune effector proteins (specifically i-type lysozyme, defensin, hemiptericin, and pyrrhocoricin), suggesting the possibility for a highly differentiated response towards the complex resident microbial community. Gene expression analyses revealed a constitutive expression of transcripts involved in signal transduction of the main insect immune pathways, but differential expression of certain antimicrobial peptide genes. Specifically, qPCRs confirmed the significant down-regulation of c-type lysozyme and up-regulation of hemiptericin in aposymbiotic individuals. The high expression of c-type lysozyme in symbiont-containing bugs may serve to lyse symbiont cells and thereby harvest B-vitamins that are necessary for subsistence on the deficient diet of Malvales seeds. Our findings suggest a sophisticated host response to perturbation of the symbiotic gut microbiota, indicating that the innate immune system not only plays an important role in combating pathogens, but also serves as a communication interface between host and symbionts.	[Bauer, Eugen; Salem, Hassan; Kaltenpoth, Martin] Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, D-07745 Jena, Germany; [Marz, Manja] Univ Jena, Fac Math & Comp Sci, D-07743 Jena, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society; Friedrich Schiller University of Jena; Max Planck Society	Kaltenpoth, M (corresponding author), Max Planck Inst Chem Ecol, Insect Symbiosis Res Grp, D-07745 Jena, Germany.	mkaltenpoth@ice.mpg.de	Kaltenpoth, Martin/M-8475-2014; Bauer, Eugen/L-1837-2019	Kaltenpoth, Martin/0000-0001-9450-0345; Marz, Manja/0000-0003-4783-8823; Salem, Hassan/0000-0002-4135-7407	Max Planck Society; German Science Foundation [MA5082-1/1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG))	This study was funded by the Max Planck Society, www.mpg.de (EB, HS, HV, MK) and the German Science Foundation, MA5082-1/1, www. dfg. de (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; COCIANCICH S, 1994, BIOCHEM J, V300, P567, DOI 10.1042/bj3000567; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2009, FEMS MICROBIOL ECOL, V69, P373, DOI 10.1111/j.1574-6941.2009.00722.x; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kim JK, 2013, APPL ENVIRON MICROB, V79, P7229, DOI 10.1128/AEM.02152-13; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Moran NA, 2006, MOL ECOL, V15, P1251, DOI 10.1111/j.1365-294X.2005.02744.x; Muraille E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003203; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Salem H, P ROY SOC B UNPUB; Salem H, 2013, ENVIRON MICROBIOL, V15, P1956, DOI 10.1111/1462-2920.12001; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	40	12	12	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114865	10.1371/journal.pone.0114865	http://dx.doi.org/10.1371/journal.pone.0114865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490201	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300087
J	Sugimoto, K; Ohkawara, H; Nakamura, Y; Takuwa, Y; Ishibashi, T; Takeishi, Y				Sugimoto, Koichi; Ohkawara, Hiroshi; Nakamura, Yuichi; Takuwa, Yoh; Ishibashi, Toshiyuki; Takeishi, Yasuchika			Receptor for Advanced Glycation End Products - Membrane Type1 Matrix Metalloproteinase Axis Regulates Tissue Factor Expression via RhoA and Rac1 Activation in High-Mobility Group Box-1 Stimulated Endothelial Cells	PLOS ONE			English	Article							KAPPA-B; PROTEIN; ADHESION; BLOCKADE; MT1-MMP; RELEASE; HMGB1	Background: Atherosclerosis is understood to be a blood vessel inflammation. High-mobility group box-1 (HMGB-1) plays a key role in the systemic inflammation. Tissue factor (TF) is known to lead to inflammation which promotes thrombus formation. Membrane type1 matrix metalloprotease (MT1-MMP) associates with advanced glycation endproducts (AGE) triggered-TF protein expression and phosphorylation of NF-kappa B. However, it is still unclear about the correlation of MT1-MMP and HMBG-1-mediated TF expression. In this study, we investigated the molecular mechanisms of TF expression in response to HMGB-1 stimulation and the involvement of MT1-MMP in endothelial cells. Methods and Results: Pull-down assays and Western blotting revealed that HMGB-1 induced RhoA/Rac1 activation and NF-kappa B phosphorylation in cultured human aortic endothelial cells. HMGB-1 increased the activity of MT1-MMP, and inhibition of RAGE or MT1-MMP by siRNA suppressed HMGB-1-induced TF upregulation as well as HMGB-1-triggered RhoA/Rac1 activation and NF-kappa B phosphorylation. Conclusions: The present study showed that RAGE/MT1-MMP axis modified HMBG-1-mediated TF expression through RhoA and Rac1 activation and NF-kappa B phosphorylation in endothelial cells. These results suggested that MT1-MMP was involved in vascular inflammation and might be a good target for treating atherosclerosis.	[Sugimoto, Koichi; Ohkawara, Hiroshi; Nakamura, Yuichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Takuwa, Yoh] Kanazawa Univ, Grad Sch Med, Dept Physiol, Kanazawa, Ishikawa, Japan; [Ishibashi, Toshiyuki] Ohara Gen Hosp, Fukushima, Japan	Fukushima Medical University; Kanazawa University	Sugimoto, K (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.	ksugi@fmu.ac.jp		Ohkawara, Hiroshi/0000-0002-3129-1977	Japan Society for the Promotion of Science [22790718]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (No. 22790718 to KS) (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2011, J ATHEROSCLER THROMB, V18, P762, DOI 10.5551/jat.6783; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Furlani D, 2012, J CELL MOL MED, V16, P1094, DOI 10.1111/j.1582-4934.2011.01381.x; Gregg D, 2003, AM J PHYSIOL-CELL PH, V285, pC723, DOI 10.1152/ajpcell.00230.2003; Ishibashi T, 2003, ARTERIOSCL THROM VAS, V23, P681, DOI 10.1161/01.ATV.0000065194.00822.C7; Kamioka M, 2011, J CELL PHYSIOL, V226, P1554, DOI 10.1002/jcp.22492; Kamioka M, 2010, J ATHEROSCLER THROMB, V17, P590, DOI 10.5551/jat.3624; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lv B, 2009, THROMB HAEMOSTASIS, V102, P352, DOI 10.1160/TH08-11-0759; Meneghini V, 2013, J NEUROSCI, V33, P6047, DOI 10.1523/JNEUROSCI.2052-12.2013; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; Sakamoto T, 2007, ATHEROSCLEROSIS, V193, P44, DOI 10.1016/j.atherosclerosis.2006.08.036; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sugimoto K, 2009, CARDIOVASC RES, V84, P127, DOI 10.1093/cvr/cvp177; Yokoyama K, 2002, CIRCULATION, V105, P962, DOI 10.1161/hc0802.104457	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114429	10.1371/journal.pone.0114429	http://dx.doi.org/10.1371/journal.pone.0114429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490770	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300041
J	Cilli, D; Mirasole, C; Pennisi, R; Pallotta, V; D'Alessandro, A; Antoccia, A; Zolla, L; Ascenzi, P; di Masi, A				Cilli, Domenica; Mirasole, Cristiana; Pennisi, Rosa; Pallotta, Valeria; D'Alessandro, Angelo; Antoccia, Antonio; Zolla, Lello; Ascenzi, Paolo; di Masi, Alessandra			Identification of the Interactors of Human Nibrin (NBN) and of Its 26 kDa and 70 kDa Fragments Arising from the NBN 657del5 Founder Mutation	PLOS ONE			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND-BREAK; DNA-DAMAGE RESPONSE; DISTINCT FUNCTIONAL DOMAINS; DEPENDENT PROTEIN-KINASE; ATAXIA-TELANGIECTASIA; OXIDATIVE STRESS; ATM ACTIVATION; DEFECTIVE RESPONSE; REPAIR PROTEIN	Nibrin (also named NBN or NBS1) is a component of the MRE11/RAD50/NBN complex, which is involved in early steps of DNA double strand breaks sensing and repair. Mutations within the NBN gene are responsible for the Nijmegen breakage syndrome (NBS). The 90% of NBS patients are homozygous for the 657del5 mutation, which determines the synthesis of two truncated proteins of 26 kDa (p26) and 70 kDa (p70). Here, HEK293 cells have been exploited to transiently express either the full-length NBN protein or the p26 or p70 fragments, followed by affinity chromatography enrichment of the eluates. The application of an unsupervised proteomics approach, based upon SDS-PAGE separation and shotgun digestion of protein bands followed by MS/MS protein identification, indicates the occurrence of previously unreported protein interacting partners of the full-length NBN protein and the p26 fragment containing the FHA/BRCT1 domains, especially after cell irradiation. In particular, results obtained shed light on new possible roles of NBN and of the p26 fragment in ROS scavenging, in the DNA damage response, and in protein folding and degradation. In particular, here we show that p26 interacts with PARP1 after irradiation, and this interaction exerts an inhibitory effect on PARP1 activity as measured by NAD+ levels. Furthermore, the p26-PARP1 interaction seems to be responsible for the persistence of ROS, and in turn of DSBs, at 24 h from IR. Since some of the newly identified interactors of the p26 and p70 fragments have not been found to interact with the full-length NBN, these interactions may somehow contribute to the key biological phenomena underpinning NBS.	[Cilli, Domenica; Pennisi, Rosa; Antoccia, Antonio; di Masi, Alessandra] Roma Tre Univ, Dept Sci, Rome, Italy; [Mirasole, Cristiana; Pallotta, Valeria; D'Alessandro, Angelo; Zolla, Lello] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Antoccia, Antonio; Ascenzi, Paolo; di Masi, Alessandra] Consorzio Interuniv, Ist Nazl Biostrut & Biosistemi, Rome, Italy; [Ascenzi, Paolo] Roma Tre Univ, Interdept Lab Electron Microscopy, Rome, Italy	Italfarmaco; Roma Tre University; Tuscia University; Roma Tre University	di Masi, A (corresponding author), Roma Tre Univ, Dept Sci, Rome, Italy.	alessandra.dimasi@uniroma3.it	Pennisi, Rosa/AAQ-7868-2020; di Masi, Alessandra/K-2300-2018; D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Pennisi, Rosa/0000-0001-6542-7898	University Roma Tre (CAL); Italian National Blood Centre (Rome, Italy); Interuniversity Consortium for Biotechnologies (CIB, Italy)	University Roma Tre (CAL); Italian National Blood Centre (Rome, Italy); Interuniversity Consortium for Biotechnologies (CIB, Italy)	Funding: This work was partially supported by grants University Roma Tre (CAL 2012, to AdM). CM, VP, AD and LZ are supported by funds from the Italian National Blood Centre (Rome, Italy). AD acknowledges financial support for a post-doctoral studentship granted by the Interuniversity Consortium for Biotechnologies (CIB, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Antoccia A, 2008, RADIAT RES, V170, P345, DOI 10.1667/RR1357.1; Antoccia A, 2006, GENOME DYN, V1, P191, DOI 10.1159/000092508; Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Bansal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026156; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Becker E, 2006, BIOINFORMATICS, V22, P1289, DOI 10.1093/bioinformatics/btl075; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Brown ML, 2002, P NATL ACAD SCI USA, V99, P4532, DOI 10.1073/pnas.072495299; Burwick N, 2012, BLOOD, V120, P5143, DOI 10.1182/blood-2012-04-420166; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Buscemi G, 2001, MOL CELL BIOL, V21, P5214, DOI 10.1128/MCB.21.15.5214-5222.2001; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti KM, 2000, MUTAGENESIS, V15, P281, DOI 10.1093/mutage/15.3.281; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen WC, 2002, J NEUROSCI RES, V70, P794, DOI 10.1002/jnr.10435; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; di Masi A, 2013, ADV GENOME SCI PROBI, P101; di Masi A, 2012, CURR TOP BIOCH RES, V14, P73; di Masi A, 2008, CURR GENOMICS, V9, P275, DOI 10.2174/138920208784533610; di Masi A, 2008, BIOCHEM BIOPH RES CO, V369, P835, DOI 10.1016/j.bbrc.2008.02.129; di Masi A, 2011, IUBMB LIFE, V63, P503, DOI 10.1002/iub.472; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Dodson GE, 2010, CELL CYCLE, V9, P1516, DOI 10.4161/cc.9.8.11260; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gatei M, 2000, CANCER RES, V60, P3299; Grobelny JV, 2000, J CELL SCI, V113, P4577; Gullotta F, 2010, CURR MED CHEM, V17, P2017, DOI 10.2174/092986710791233698; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hari FJ, 2010, EMBO REP, V11, P387, DOI 10.1038/embor.2010.30; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Iijima K, 2008, J RADIAT RES, V49, P451, DOI 10.1269/jrr.08065; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Kaplan KB, 2012, TRENDS CELL BIOL, V22, P576, DOI 10.1016/j.tcb.2012.08.006; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krenzlin H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002557; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; LEE CG, 1993, J BIOL CHEM, V268, P16822; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li BJ, 2004, GENE DEV, V18, P1824, DOI 10.1101/gad.1223504; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Maselli J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098616; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Melchers A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005423; Mendez G, 2012, IUBMB LIFE, V64, P853, DOI 10.1002/iub.1077; Naka K, 2002, BIOCHEM BIOPH RES CO, V299, P863, DOI 10.1016/S0006-291X(02)02755-9; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Negorev D, 2013, CANCER RES, V73, P4960, DOI 10.1158/0008-5472.CAN-13-1715; Pesciotta EN, 2012, J PROTEOMICS, V76, P194, DOI 10.1016/j.jprot.2012.08.010; Pluth JM, 2008, DNA REPAIR, V7, P108, DOI 10.1016/j.dnarep.2007.08.004; Porcedda P, 2006, DNA REPAIR, V5, P904, DOI 10.1016/j.dnarep.2006.05.002; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Rolli V., 2000, DNA DAMAGE STRESS SI, P35; Rupnik A, 2010, CHROMOSOMA, V119, P115, DOI 10.1007/s00412-009-0242-4; Sagan D, 2009, CARCINOGENESIS, V30, P408, DOI 10.1093/carcin/bgp004; Salewsky B, 2013, GENE, V519, P217, DOI 10.1016/j.gene.2013.02.033; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Seemanova E, 2006, J MED GENET, V43, P218, DOI 10.1136/jmg.2005.035287; Seidman C E, 2001, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0108s37; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stracker TH, 2007, NATURE, V447, P218, DOI 10.1038/nature05740; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wen J, 2013, ONCOGENE, V32, P4448, DOI 10.1038/onc.2012.443; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Yeager TR, 1999, CANCER RES, V59, P4175; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424; Zhao H, 2008, CELL CYCLE, V7, P1490, DOI 10.4161/cc.7.10.5963; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	128	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114651	10.1371/journal.pone.0114651	http://dx.doi.org/10.1371/journal.pone.0114651			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485873	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600082
J	Ezure, T; Nanatani, K; Sato, Y; Suzuki, S; Aizawa, K; Souma, S; Ito, M; Hohsaka, T; von Heijine, G; Utsumi, T; Abe, K; Ando, E; Uozumi, N				Ezure, Toru; Nanatani, Kei; Sato, Yoko; Suzuki, Satomi; Aizawa, Keishi; Souma, Satoshi; Ito, Masaaki; Hohsaka, Takahiro; von Heijine, Gunnar; Utsumi, Toshihiko; Abe, Keietsu; Ando, Eiji; Uozumi, Nobuyuki			A Cell-Free Translocation System Using Extracts of Cultured Insect Cells to Yield Functional Membrane Proteins	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; ASPARTATE-ALANINE ANTIPORTER; NONNATURAL AMINO-ACIDS; FREE TRANSLATION; TETRAGENOCOCCUS-HALOPHILUS; EFFICIENT INCORPORATION; MICROSOMAL-MEMBRANES; MESSENGER-RNA; TOPOLOGY; ASPT	Cell-free protein synthesis is a powerful method to explore the structure and function of membrane proteins and to analyze the targeting and translocation of proteins across the ER membrane. Developing a cell-free system based on cultured cells for the synthesis of membrane proteins could provide a highly reproducible alternative to the use of tissues from living animals. We isolated Sf21 microsomes from cultured insect cells by a simplified isolation procedure and evaluated the performance of the translocation system in combination with a cell-free translation system originating from the same source. The isolated microsomes contained the basic translocation machinery for polytopic membrane proteins including SRP-dependent targeting components, translocation channel (translocon)-dependent translocation, and the apparatus for signal peptide cleavage and N-linked glycosylation. A transporter protein synthesized with the cell-free system could be functionally reconstituted into a lipid bilayer. In addition, single and double labeling with non-natural amino acids could be achieved at both the lumen side and the cytosolic side in this system. Moreover, tail-anchored proteins, which are post-translationally integrated by the guided entry of tail-anchored proteins (GET) machinery, were inserted correctly into the microsomes. These results showed that the newly developed cell-free translocation system derived from cultured insect cells is a practical tool for the biogenesis of properly folded polytopic membrane proteins as well as tail-anchored proteins.	[Nanatani, Kei; Sato, Yoko; Aizawa, Keishi; Souma, Satoshi; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Mol Engn, Sendai, Miyagi 980, Japan; [Ezure, Toru; Ito, Masaaki; Ando, Eiji] Shimadzu Co Ltd, Clin & Biotechnol BU, Kyoto, Japan; [Suzuki, Satomi; Abe, Keietsu] Tohoku Univ, Grad Sch Agr Sci, Dept Microbial Biotechnol, Sendai, Miyagi 980, Japan; [Hohsaka, Takahiro] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa, Japan; [von Heijine, Gunnar] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Utsumi, Toshihiko] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan	Tohoku University; Shimadzu Corporation; Tohoku University; Japan Advanced Institute of Science & Technology (JAIST); Stockholm University; Yamaguchi University	Ezure, T (corresponding author), Shimadzu Co Ltd, Clin & Biotechnol BU, Kyoto, Japan.	ezure@shimadzu.co.jp; uozumi@biophy.che.tohoku.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019	Uozumi, Nobuyuki/0000-0003-4268-1126	Ministry of Education, Culture, Sports, Science, and Technology [24580100, 24246045, 24658090, 25292055]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency [AS2314135E]; Grants-in-Aid for Scientific Research [26450125, 25102006, 13J03082] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (24580100 to KN, 24246045, 24658090 and 25292055 to NU) from the Ministry of Education, Culture, Sports, Science, and Technology, and AS2314135E Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Japan Science and Technology Agency to TE, KN, YS, EA, and NU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; CHEN HZ, 1983, METHOD ENZYMOL, V101, P674; Denic V, 2013, COLD SPRING HARBOR P, V5; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Ezure T, 2007, PROTEOMICS, V7, P4424, DOI 10.1002/pmic.200700774; Ezure T, 2006, BIOTECHNOL PROGR, V22, P1570, DOI 10.1021/bp060110v; GASIOR E, 1979, J BIOL CHEM, V254, P3965; Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Kajihara D, 2006, NAT METHODS, V3, P923, DOI 10.1038/NMETH945; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Moriya K, 2013, PLOS ONE, V8; Nanatani K, 2005, BIOCHEM BIOPH RES CO, V328, P20, DOI 10.1016/j.bbrc.2004.12.133; Nanatani K, 2007, J BACTERIOL, V189, P7089, DOI 10.1128/JB.00088-07; Nanatani K, 2009, J BACTERIOL, V191, P2122, DOI 10.1128/JB.00830-08; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Ota K, 1998, J BIOL CHEM, V273, P28286, DOI 10.1074/jbc.273.43.28286; Sasahara A, 2011, J BIOL CHEM, V286, P29044, DOI 10.1074/jbc.M111.260224; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Sato Y, 2012, J BIOSCI BIOENG, V114, P677, DOI 10.1016/j.jbiosc.2012.06.015; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; SCHEELE G, 1983, METHOD ENZYMOL, V96, P94; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SWERDEL MR, 1989, COMP BIOCHEM PHYS B, V93, P803, DOI 10.1016/0305-0491(89)90049-7; Taki M, 2006, J BIOSCI BIOENG, V102, P511, DOI 10.1263/jbb.102.511; Utsumi T, 2005, FEBS J, V272, P472, DOI 10.1111/j.1742-4658.2004.04487.x; UTSUMI T, 1995, MOL CELL BIOL, V15, P6398; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028	32	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112874	10.1371/journal.pone.0112874	http://dx.doi.org/10.1371/journal.pone.0112874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486605	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600012
J	Hara, K; Shirasuna, K; Usul, F; Karasawa, T; Mizushina, Y; Kimura, H; Kawashima, A; Ohkuchi, A; Matsuyama, S; Kimura, K; Takahashi, M				Hara, Kyoko; Shirasuna, Koumei; Usul, Fumitake; Karasawa, Tadayoshi; Mizushina, Yoshiko; Kimura, Hiroaki; Kawashima, Akira; Ohkuchi, Akihide; Matsuyama, Shuichi; Kimura, Koji; Takahashi, Masafumi			Interferon-Tau Attenuates Uptake of Nanoparticles and Secretion of Interleukin-1 beta in Macrophages	PLOS ONE			English	Article							IFN-TAU; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; MYOCARDIAL-INFARCTION; MICE; ACTIVATION; CELLS; ENCEPHALOMYELITIS; CASPASE-1; CRYSTALS	Background: Type I interferons (IFNs), including IFN-alpha (IFNA) and IFN-beta (IFNB), have anti-inflammatory properties and are used to treat patients with autoimmune and inflammatory disorders. However, little is known of the role of IFN-tau (IFNT), a type I IFN produced by ruminant animals for inflammation. Because IFNB has recently been shown to inhibit nucleotide-binding oligomerization domain-like receptor, pyrin domain-containing 3 (NLRP3) inflammasome activation and subsequent secretion of the potent inflammatory cytokine interleukin (IL)-1 beta, we examined the effects of ruminant IFNT on NLRP3 inflammasome-mediated IL-1 beta secretion in human THP-1 macrophages. Methods and Results: IFNT dose-dependently inhibited IL-1 beta secretion induced by nano-silica, a well-known activators of NLRP3 inflammasomes, in human macrophages primed with lipopolysaccharide (LPS, TLR4 agonist) and Pam3CSK4 (TLR1/2 agonist). IFNT also suppressed phagocytosis of nano-silica and reactive oxygen species (ROS) generation. Western blot analysis showed that IFNT inhibited both pro-IL-1 beta and mature IL-1 beta. In addition, real-time RT-PCR analysis showed that IFNT suppressed IL-1 beta mRNA expression induced by LPS and Pam3CSK4. Although nano-silica particles did not induce IL-10 secretion, IFNT induced IL-10 secretion in a dose-dependent manner. Furthermore, IFNT-suppressed IL-1 beta secretion was restored by anti-IL-10 neutralizing antibody. Conclusions: Ruminant IFNT inhibits NLRP3 inflammasome-driven IL-1 beta secretion in human macrophages via multiple pathways, including the uptake of nano-silica particles, generation of ROS, and IL-10-mediated inhibition of pro-IL-1 beta induction. It may be a therapeutic alternative to IFNA and IFNB.	[Hara, Kyoko; Shirasuna, Koumei; Usul, Fumitake; Karasawa, Tadayoshi; Mizushina, Yoshiko; Kimura, Hiroaki; Kawashima, Akira; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan; [Shirasuna, Koumei] Tokyo Univ Agr, Dept Agr, Lab Anim Reprod, Atsugi, Kanagawa, Japan; [Ohkuchi, Akihide] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Matsuyama, Shuichi; Kimura, Koji] Natl Inst Livestock & Grassland Sci, Anim Feeding & Management Res Div, Nasushiobara, Tochigi, Japan	Jichi Medical University; Tokyo University of Agriculture; Jichi Medical University; National Agriculture & Food Research Organization - Japan	Shirasuna, K (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan.	masafumi2@jichi.ac.jp	Kimura, Hiroaki/E-3224-2010	Kimura, Hiroaki/0000-0002-7441-0382; Karasawa, Tadayoshi/0000-0002-6738-2360	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)''; Council for Science and Technology Policy (CSTP); MEXT; Grants-in-Aid for Scientific Research [25850222] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)''; Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was performed by the grants from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program),'' initiated by the Council for Science and Technology Policy (CSTP) (MT), MEXT-supported program for the Strategic Foundation at Private Universities (MT), Grant-in-Aid for Young Scientists (B) (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexenko AP, 1999, J INTERF CYTOK RES, V19, P1335, DOI 10.1089/107999099312795; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chon TW, 2010, J INTERF CYTOK RES, V30, P477, DOI 10.1089/jir.2009.0089; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Frausto-Del-Rio D, 2012, CYTOKINE, V57, P158, DOI 10.1016/j.cyto.2011.11.008; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Kanno S, 2007, TOXICOL SCI, V97, P398, DOI 10.1093/toxsci/kfm050; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Nakajima A, 2002, J INTERF CYTOK RES, V22, P397, DOI 10.1089/107999002753675839; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rauch Isabella, 2013, JAKSTAT, V2, pe23820, DOI 10.4161/jkst.23820; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Rogez-Kreuz C, 2005, INT IMMUNOL, V17, P1047, DOI 10.1093/intimm/dxh285; Shirasuna K, 2015, NANOTOXICOLOGY, V9, P554, DOI 10.3109/17435390.2014.956156; Soos JM, 2002, J IMMUNOL, V169, P2231, DOI 10.4049/jimmunol.169.5.2231; SOOS JM, 1995, J IMMUNOL, V155, P2747; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takahashi M, 2014, INT HEART J, V55, P101, DOI 10.1536/ihj.13-388; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Usui F, 2012, BIOCHEM BIOPH RES CO, V425, P162, DOI 10.1016/j.bbrc.2012.07.058; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	34	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113974	10.1371/journal.pone.0113974	http://dx.doi.org/10.1371/journal.pone.0113974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486008	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600031
J	Tang, W; Song, LY; Li, D; Qiao, J; Zhao, TT; Zhao, HP				Tang, Wei; Song, Liyan; Li, Dou; Qiao, Jing; Zhao, Tiantao; Zhao, Heping			Production, Characterization, and Flocculation Mechanism of Cation Independent, pH Tolerant, and Thermally Stable Bioflocculant from Enterobacter sp ETH-2	PLOS ONE			English	Article							BACILLUS-LICHENIFORMIS; KLEBSIELLA-PNEUMONIAE; MICROBIAL FLOCCULANT; WATER TREATMENT; POLYSACCHARIDE; BACTERIA; CULTURE	Synthetic high polymer flocculants, frequently utilized for flocculating efficiency and low cost, recently have been discovered as producing increased risk to human health and the environment. Development of a more efficient and environmentally sound alternative flocculant agent is investigated in this paper. Bioflocculants are produced by microorganisms and may exhibit a high rate of flocculation activity. The bioflocculant ETH-2, with high flocculating activity (2849 mg Kaolin particle/mg ETH-2), produced by strain Enterobacter sp. isolated from activated sludge, was systematically investigated with regard to its production, characterization, and flocculation mechanism. Analyses of microscopic observation, zeta potential and ETH-2 structure demonstrates the bridging mechanism, as opposed to charge neutralization, was responsible for flocculation of the ETH-2. ETH-2 retains high molecular weight (603 to 1820 kDa) and multi-functional groups (hydroxyl, amide and carboxyl) that contributed to flocculation. Polysaccharides mainly composed of mannose, glucose, and galactose, with a molar ratio of 1:2.9:9.8 were identified as the active constituents in bioflocculant. The structure of the long backbone with active sites of polysaccharides was determined as a primary basis for the high flocculation activity. Bioflocculant ETH-2 is cation independent, pH tolerant, and thermally stable, suggesting a potential fit for industrial application.	[Tang, Wei; Song, Liyan; Li, Dou; Qiao, Jing] Chinese Acad Sci, Res Ctr Environm Microbiol & Ecol, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Song, Liyan; Li, Dou] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Key Lab Reservoir Aquat Environm, Chongqing 400714, Peoples R China; [Zhao, Tiantao] Chongqing Univ Technol, Sch Chem & Chem Engn, Chongqing 400054, Peoples R China; [Zhao, Heping] Zhejiang Univ, Coll Environm & Resource Sci, Key Lab Environm Remediat & Ecosyst Hlth, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; Chongqing University of Technology; Zhejiang University	Song, LY (corresponding author), Chinese Acad Sci, Res Ctr Environm Microbiol & Ecol, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.	songliyan@cigit.ac.cn	Song, Liyan/J-6609-2016		Science and technology Cooperation Project (Science and Technology office of Guizhou Province) [2013-3]; Science and technology Cooperation Project (The people's Government of Bijie City) [2013-3]; Science and technology Cooperation Project (Kunming Institute of Chinese Academy of Sciences) [2013-3]; National Natural Science Foundation of China [21107091, 21377109]	Science and technology Cooperation Project (Science and Technology office of Guizhou Province); Science and technology Cooperation Project (The people's Government of Bijie City); Science and technology Cooperation Project (Kunming Institute of Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: We thank the Science and technology Cooperation Project (Science and Technology office of Guizhou Province, The people's Government of Bijie City, and Kunming Institute of Chinese Academy of Sciences) (Grant No. 2013-3) and the National Natural Science Foundation of China (Grant No. 21107091, Grant No. 21377109) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljuboori AHR, 2013, BIORESOURCE TECHNOL, V127, P489, DOI 10.1016/j.biortech.2012.09.016; ASPINALL GO, 1982, POLYSACCHARIDES, V1, P35; BENDER J, 1994, APPL ENVIRON MICROB, V60, P2311, DOI 10.1128/AEM.60.7.2311-2315.1994; Elkady MF, 2011, BIORESOURCE TECHNOL, V102, P8143, DOI 10.1016/j.biortech.2011.05.090; Gong WX, 2008, BIORESOURCE TECHNOL, V99, P4668, DOI 10.1016/j.biortech.2007.09.077; He J, 2010, WORLD J MICROB BIOT, V26, P1135, DOI 10.1007/s11274-009-0281-2; KURANE R, 1994, BIOSCI BIOTECH BIOCH, V58, P1589, DOI 10.1271/bbb.58.1589; KURANE R, 1995, BIOSCI BIOTECH BIOCH, V59, P1652, DOI 10.1271/bbb.59.1652; Kwon GS, 1996, BIOTECHNOL LETT, V18, P1459, DOI 10.1007/BF00129355; Li Z, 2009, BIORESOURCE TECHNOL, V100, P3650, DOI 10.1016/j.biortech.2009.02.029; Li Z, 2009, WORLD J MICROB BIOT, V25, P745, DOI 10.1007/s11274-008-9943-8; Liu CS, 2012, ADV MATER RES-SWITZ, V550-553, P1482, DOI 10.4028/www.scientific.net/AMR.550-553.1482; Liu WJ, 2010, BIORESOURCE TECHNOL, V101, P1044, DOI 10.1016/j.biortech.2009.08.108; Lu WY, 2005, BIOCHEM ENG J, V27, P1, DOI 10.1016/j.bej.2005.04.026; Mabinya LV, 2012, INT J MOL SCI, V13, P1054, DOI 10.3390/ijms13011054; MICHAELS AS, 1955, IND ENG CHEM, V47, P1801, DOI 10.1021/ie50549a029; Nakata K, 1999, BIOSCI BIOTECH BIOCH, V63, P2064, DOI 10.1271/bbb.63.2064; Oh HM, 2001, BIOTECHNOL LETT, V23, P1229, DOI 10.1023/A:1010577319771; Prasertsan P, 2006, CARBOHYD POLYM, V66, P289, DOI 10.1016/j.carbpol.2006.03.011; RIES HE, 1968, SCIENCE, V160, P1449, DOI 10.1126/science.160.3835.1449; Salehizadeh H, 2002, BIOTECHNOL LETT, V24, P35, DOI 10.1023/A:1013853115624; Salehizadeh H, 2001, BIOTECHNOL ADV, V19, P371, DOI 10.1016/S0734-9750(01)00071-4; Salehizadeh H, 2000, BIOCHEM ENG J, V5, P39, DOI 10.1016/S1369-703X(99)00066-2; Song LY, 2015, MICROBIOL RES, V170, P105, DOI 10.1016/j.micres.2014.08.008; Sun M, 2012, APPL MICROBIOL BIOT, V96, P1577, DOI 10.1007/s00253-012-4478-1; Swindell SR, 1997, METHODS MOL BIOL, P70; TAKEDA M, 1992, J FERMENT BIOENG, V74, P408, DOI 10.1016/0922-338X(92)90043-T; TOEDA K, 1991, AGR BIOL CHEM TOKYO, V55, P2793, DOI 10.1080/00021369.1991.10857749; Wang LL, 2011, WORLD J MICROB BIOT, V27, P2559, DOI 10.1007/s11274-011-0726-2; Wu HJ, 2010, J IND MICROBIOL BIOT, V37, P1203, DOI 10.1007/s10295-010-0767-9; Xia SQ, 2008, BIORESOURCE TECHNOL, V99, P6520, DOI 10.1016/j.biortech.2007.11.031; Xiong YY, 2010, APPL ENVIRON MICROB, V76, P2778, DOI 10.1128/AEM.02558-09; Yim JH, 2007, BIORESOURCE TECHNOL, V98, P361, DOI 10.1016/j.biortech.2005.12.021; Yokoi H, 1998, BIOTECHNOL TECH, V12, P511, DOI 10.1023/A:1008843228743; Yokoi H, 1997, BIOTECHNOL LETT, V19, P569, DOI 10.1023/A:1018301807009; Yuan SJ, 2011, ENVIRON SCI TECHNOL, V45, P1152, DOI 10.1021/es1030905; ZAJIC JE, 1973, APPL MICROBIOL, V25, P628, DOI 10.1128/AEM.25.4.628-635.1973; Zhang ZQ, 2010, WATER RES, V44, P3087, DOI 10.1016/j.watres.2010.02.033; Zhao HJ, 2013, BIORESOURCE TECHNOL, V137, P226, DOI 10.1016/j.biortech.2013.03.079; Zheng Y, 2008, BIORESOURCE TECHNOL, V99, P7686, DOI 10.1016/j.biortech.2008.01.068	40	52	52	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114591	10.1371/journal.pone.0114591	http://dx.doi.org/10.1371/journal.pone.0114591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485629	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600079
J	Velayati, AA; Farnia, P; Mozafari, M; Malekshahian, D; Seif, S; Rahideh, S; Mirsaeidi, M				Velayati, Ali Akbar; Farnia, Parissa; Mozafari, Mohadese; Malekshahian, Donya; Seif, Shima; Rahideh, Snaz; Mirsaeidi, Mehdi			Molecular Epidemiology of Nontuberculous Mycobacteria Isolates from Clinical and Environmental Sources of a Metropolitan City	PLOS ONE			English	Article							CYSTIC-FIBROSIS; IDENTIFICATION; SIMIAE; INFECTION; DISEASE; GENE; IRAN	Introduction: While NTM infection is mainly acquired from environmental exposure, monitoring of environmental niches for NTM is not a routine practice. This study aimed to find the prevalence of environmental NTM in soil and water in four highly populated suburbs of Tehran, Iran. Material and Methods: A total of 4014 samples from soil and water resources were collected and studied. Sediments of each treated sample were cultured in Lowenstein-Jensen medium and observed twice per week for growth rate, colony morphology, and pigmentation. Colonies were studied with phenotypic tests. Molecular analysis was performed on single colonies derived from subculture of original isolates. Environmental samples were compared with 34 NTM isolates from patients who were residents of the study locations. Results: Out of 4014 samples, mycobacteria were isolated from 862 (21.4%) specimens; 536 (62.1%) belonged to slow growing mycobacteria (SGM) and 326 (37.8%) were rapid growing mycobacteria (RGM). The five most frequent NTM were M. farcinogens (105/862; 12.1%), M. fortuitum (72/862; 8.3%), M. senegalense (58/862; 6.7%), M. kansasii (54/862; 6.2%), and M. simiae (46/862; 5.3%). In total, 62.5% (539/862) of mycobacterial positive samples were isolated from water and only 37.4% (323/862) of them were isolated from soil samples (P<0.05). Out of 5314 positive clinical samples for mycobacteria, 175 (3.2%) isolates were NTM. The trend of NTM isolates increased from 1.2% (13 out of 1078) in 2004 to 3.8% (39 out of 1005) in 2014 (P<0.0001). The major clinical isolates were M. simiae (51; 29.1%), M. kansasii (26; 14.8%), M. chelonae (28; 16%), and M. fortuitum (13; 7.4%). Conclusions: Comparing the distribution pattern of environmental NTM isolates with clinical isolates suggests a possible transmission link, but this does not apply to all environmental NTM species. Our study confirms an increasing trend of NTM isolation from clinical samples that needs further investigation.	[Velayati, Ali Akbar; Farnia, Parissa; Mozafari, Mohadese; Malekshahian, Donya; Seif, Shima; Rahideh, Snaz] Shahid Beheshti Univ Med Sci, NRITLD, Mycobacteriol Res Ctr, Tehran, Iran; [Mirsaeidi, Mehdi] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA	Shahid Beheshti University Medical Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mirsaeidi, M (corresponding author), Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	mmirsae@uic.edu	Velayati, Ali Akbar/H-1448-2017; farnia, parissa/G-7412-2017	farnia, parissa/0000-0003-3676-2018; Mirsaeidi, Mehdi/0000-0001-5298-8442; Velayati, Ali Akbar/0000-0001-9398-5838; Malekshahian, Donya/0000-0003-2727-5488	NIH [5 T32 HL 82547-7]; National Research Institute of Tuberculosis and Lung Disease of Iran for project costs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL082547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Institute of Tuberculosis and Lung Disease of Iran for project costs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mehdi Mirsaeidi MD is supported by NIH grant 5 T32 HL 82547-7. This study was supported by the National Research Institute of Tuberculosis and Lung Disease of Iran for project costs and in the form of salaries for authors Ali Akbar Velayati, Parissa Farnia, Mohadese Mozafari, Donya Malekshahian, Shima Seif, and Snaz Rahideh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghaei P, 2012, J INFECT DEV COUNTR, V6, P23, DOI 10.3855/jidc.1297; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Hamid Mohamed E, 2014, Vet Med Int, V2014, P247906, DOI 10.1155/2014/247906; Hashemi-Shahraki A, 2013, INFECT GENET EVOL, V20, P312, DOI 10.1016/j.meegid.2013.08.027; Hashemi-Shahraki A, 2013, JPN J INFECT DIS, V66, P475, DOI 10.7883/yoken.66.475; Joao ICP, 2014, NT J MYCOBACTERIOL, V3, P144, DOI DOI 10.1016/J.IJMYC0.2014.04.001.[; Kim H, 2005, J MICROBIOL METH, V62, P199, DOI 10.1016/j.mimet.2005.02.010; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; MASSON A M, 1956, Can Med Assoc J, V75, P798; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirsaeidi M, 2014, EUR J INTERN MED; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Mirsaeidi M, 2013, INT J INFECT DIS, V17, pE1000, DOI 10.1016/j.ijid.2013.03.018; Mirsaeidi S M, 2006, Monaldi Arch Chest Dis, V65, P106; Neumann M, 1997, APPL ENVIRON MICROB, V63, P547, DOI 10.1128/AEM.63.2.547-552.1997; PETERS M, 1995, J INFECTION, V31, P39, DOI 10.1016/S0163-4453(95)91333-5; PORTAELS F, 1988, J GEN MICROBIOL, V134, P849; Rahbar M, 2010, AFR J BIOTECHNOL, V9, P3618; Roth A, 2000, J CLIN MICROBIOL, V38, P1094, DOI 10.1128/JCM.38.3.1094-1104.2000; Saifi M, 2013, CLIN MICROBIOL INFEC, V19, P723, DOI 10.1111/j.1469-0691.2012.04005.x; Samra Z, 2005, SCAND J INFECT DIS, V37, P838, DOI 10.1080/00365540500264712; Shitrit D, 2008, RESP MED, V102, P1598, DOI 10.1016/j.rmed.2008.05.004; Tabarsi P, 2009, AM J MED SCI, V337, P182, DOI 10.1097/MAJ.0b013e318185d32f; Tadayon K, 2013, IRAN J MICROBIOL, V5, P1; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Velayati AA, 2014, CHEST; Wong TC, 2005, J ARTHROPLASTY, V20, P684, DOI 10.1016/j.arth.2005.03.001	30	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114428	10.1371/journal.pone.0114428	http://dx.doi.org/10.1371/journal.pone.0114428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485795	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600055
J	Chmielewski, S; Olejnik, A; Sikorski, K; Pelisek, J; Blaszczyk, K; Aoqui, C; Nowicka, H; Zernecke, A; Heemann, U; Wesoly, J; Baumann, M; Bluyssen, HAR				Chmielewski, Stefan; Olejnik, Adam; Sikorski, Krzysztof; Pelisek, Jaroslav; Blaszczyk, Katarzyna; Aoqui, Cristiane; Nowicka, Hanna; Zernecke, Alma; Heemann, Uwe; Wesoly, Joanna; Baumann, Marcus; Bluyssen, Hans A. R.			STAT1-Dependent Signal Integration between IFN gamma and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; TRANSPLANTED MOUSE HEARTS; SMOOTH-MUSCLE-CELLS; INTERFERON-GAMMA; NITRIC-OXIDE; GENE-EXPRESSION; TNF-ALPHA; REDUCES ATHEROSCLEROSIS	Signal integration between IFN gamma and TLRs in immune cells has been associated with the host defense against pathogens and injury, with a predominant role of STAT1. We hypothesize that STAT1-dependent transcriptional changes in vascular cells involved in cross-talk between IFNc and TLR4, reflect pro-atherogenic responses in human atherosclerosis. Genome-wide investigation identified a set of STAT1-dependent genes that were synergistically affected by interactions between IFN gamma and TLR4 in VSMCs. These included the chemokines Cxcl9, Ccl12, Ccl8, Ccrl2, Cxcl10 and Ccl5, adhesion molecules Cd40, Cd74, and antiviral and antibacterial genes Rsad2, Mx1, Oasl1, Gbp5, Nos2, Batf2 and Tnfrsf11a. Among the amplified genes was also Irf8, of which Ccl5 was subsequently identified as a new pro-inflammatory target in VSMCs and ECs. Promoter analysis predicted transcriptional cooperation between STAT1, IRF1, IRF8 and NF kappa B, with the novel role of IRF8 providing an additional layer to the overall complexity. The synergistic interactions between IFN gamma and TLR4 also resulted in increased T-cell migration and impaired aortic contractility in a STAT1-dependent manner. Expression of the chemokines CXCL9 and CXCL10 correlated with STAT1 phosphorylation in vascular cells in plaques from human carotid arteries. Moreover, using data mining of human plaque transcriptomes, expression of a selection of these STAT1-dependent pro-atherogenic genes was found to be increased in coronary artery disease (CAD) and carotid atherosclerosis. Our study provides evidence to suggest that in ECs and VSMCs STAT1 orchestrates a platform for cross-talk between IFN gamma and TLR4, and identifies a STAT1-dependent gene signature that reflects a proatherogenic state in human atherosclerosis.	[Chmielewski, Stefan; Aoqui, Cristiane; Heemann, Uwe; Baumann, Marcus] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, D-80290 Munich, Germany; [Pelisek, Jaroslav; Zernecke, Alma] Tech Univ Munich, Klinikum Rechts Isar, Dept Vasc & Endovasc Surg, D-80290 Munich, Germany; [Chmielewski, Stefan; Olejnik, Adam; Sikorski, Krzysztof; Blaszczyk, Katarzyna; Bluyssen, Hans A. R.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Human Mol Genet, Poznan, Poland; [Nowicka, Hanna; Wesoly, Joanna] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Lab High Throughput Technol, Poznan, Poland; [Zernecke, Alma] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany	Technical University of Munich; Technical University of Munich; Adam Mickiewicz University; Adam Mickiewicz University; German Centre for Cardiovascular Research; Munich Heart Alliance	Bluyssen, HAR (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Human Mol Genet, Poznan, Poland.	h.bluyss@amu.edu.pl		Bluyssen, Hans/0000-0002-4568-6259	Polish Ministry of Science and Higher Education [N N302 016339, N N301 073140, 2012/07/B/NZ1/02710, 0493/IP1/2011/71]; KNOW RNA Research Centre in Poznan [01/KNOW2/2014]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); KNOW RNA Research Centre in Poznan	This publication was supported by grants N N302 016339 (to HB); N N301 073140 (to HB); 2012/07/B/NZ1/02710 (to HB); and 0493/IP1/2011/71 (to KS) from Polish Ministry of Science and Higher Education, and by the KNOW RNA Research Centre in Poznan (No. 01/KNOW2/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Agrawal S, 2007, CIRCULATION, V115, P2939, DOI 10.1161/CIRCULATIONAHA.107.696922; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Doring Y, 2012, ARTERIOSCL THROM VAS, V32, P1613, DOI 10.1161/ATVBAHA.111.236539; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Folkersen L, 2012, MOL MED, V18, P669, DOI 10.2119/molmed.2011.00479; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hiwatashi K, 2011, CANCER LETT, V308, P172, DOI 10.1016/j.canlet.2011.04.024; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; JAHNKE A, 1994, FEBS LETT, V354, P220, DOI 10.1016/0014-5793(94)01130-3; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Martin-Ventura JL, 2009, CARDIOVASC RES, V83, P586, DOI 10.1093/cvr/cvp141; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nagano H, 1997, J CLIN INVEST, V100, P550, DOI 10.1172/JCI119564; Naschberger E, 2004, BIOCHEM J, V379, P409, DOI 10.1042/BJ20031873; Niu XL, 2001, CIRCULATION, V103, P1115, DOI 10.1161/01.CIR.103.8.1115; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; RUSSELL PS, 1994, TRANSPLANTATION, V57, P1367, DOI 10.1097/00007890-199405150-00014; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Sikorski K, 2014, INT J MOL SCI, V15, P14313, DOI 10.3390/ijms150814313; Sikorski Krzysztof, 2012, JAKSTAT, V1, P241, DOI 10.4161/jkst.22469; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	55	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113318	10.1371/journal.pone.0113318	http://dx.doi.org/10.1371/journal.pone.0113318			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478796	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200017
J	Gonzalez-Rojo, S; Fernandez-Diez, C; Guerra, SM; Robles, V; Herraez, MP				Gonzalez-Rojo, Silvia; Fernandez-Diez, Cristina; Guerra, Susana M.; Robles, Vanesa; Herraez, Maria Paz			Differential Gene Susceptibility to Sperm DNA Damage: Analysis of Developmental Key Genes in Trout	PLOS ONE			English	Article							NUCLEAR BASIC-PROTEINS; ONCORHYNCHUS-MYKISS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; EVOLUTION; CHROMATIN; MODEL; CRYOPRESERVATION; FERTILIZATION; DUPLICATION	Sperm chromatin in mammals is packaged in different blocks associated to protamines (PDNA), histones (HDNA), or nuclear matrix proteins. Differential packaging has been related to early or late transcription and also to differential susceptibility to genotoxic damage. Genes located in the more accessible HDNA could be more susceptible to injuries than those located in PDNA, being potential biomarkers of paternal DNA damage. Fish sperm chromatin organization is much diversified, some species lacking protamines and some others totally depleted of histones. Analyzing genotoxic damage in a species homogeneously compacted with some sperm nuclear basic protein type, could help in deciphering the clues of differential susceptibility to damage. In the present study we analyzed in rainbow trout the differential susceptibility of nine genes to UV irradiation and H2O2 treatment. The absence of histones in the sperm nuclei was confirmed by Western blot. The chromatin fractionation in sensitive and resistant regions to PvuII (presumably HDNA-like and PDNA-like, respectively) revealed that the nine genes locate in the same resistant region. The number of lesions promoted was quantified using a qPCR approach. Location of 8-hydroxyguanosine (8-OHdG) was analyzed by immunocytochemistry and confocal microscopy. UV irradiation promoted similar number of lesions in all the analyzed genes and a homogenous distribution of 8-OHdG within the nuclei. 8-OHdG was located in the peripheral area of the nucleus after H2O2 treatment, which promoted a significantly higher number of lesions in developmental-related genes (8.76-10.95 lesions/10 kb) than in rDNA genes (1.05-1.67 lesions/10 kb). We showed for the first time, that differential susceptibility to damage is dependent on the genotoxic mechanism and relies on positional differences between genes. Sensitive genes were also analyzed in cryopreserved sperm showing a lower number of lesions than the previous treatments and a predominant peripheral distribution of oxidative damage (8-OHdG).	[Gonzalez-Rojo, Silvia; Fernandez-Diez, Cristina; Guerra, Susana M.; Robles, Vanesa; Herraez, Maria Paz] Univ Leon, Dept Mol Biol, E-24071 Leon, Spain	Universidad de Leon	Herraez, MP (corresponding author), Univ Leon, Dept Mol Biol, E-24071 Leon, Spain.	paz.herraez@unileon.es	Susana, Susana/L-9204-2015; rodriguez, vanesa robles/N-7508-2015; FERNÁNDEZ, CRISTINA/C-4929-2016; Herraez, Paz/C-6264-2013; González-Rojo, Silvia/C-4703-2016	Susana, Susana/0000-0003-2243-2376; rodriguez, vanesa robles/0000-0002-7917-7700; Herraez, Paz/0000-0002-0028-3616; González-Rojo, Silvia/0000-0002-9630-4468	Junta de Castilla y Leon (Spain) [LE365A11-2, EDU/828/2014]; Spanish Ministry of Economy and Competitiveness [AGL2011-27787]; Fondo Social Europeo	Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by the Junta de Castilla y Leon (Spain) (project LE365A11-2 and EDU/828/2014), the Spanish Ministry of Economy and Competitiveness (project AGL2011-27787) and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1984, MOL BIOL EVOL, V1, P238; Ausio J, 1997, J MOL EVOL, V45, P91, DOI 10.1007/PL00006207; AVRAMOVA Z, 1983, EUR J CELL BIOL, V31, P137; Benhusein GM, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.4637; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Carton-Garcia F, 2013, AQUACULTURE, V402, P106, DOI 10.1016/j.aquaculture.2013.03.034; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dianou GL, 2007, DNA REPAIR, V6, P454, DOI 10.1016/j.dnarep.2006.10.009; Dietrich GJ, 2005, THERIOGENOLOGY, V64, P1809, DOI 10.1016/j.theriogenology.2005.04.010; Durston AJ, 2012, CURR GENOMICS, V13, P300, DOI 10.2174/138920212800793375; Eirin-Lopez JM, 2006, MOL BIOL EVOL, V23, P1304, DOI 10.1093/molbev/msk021; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Frehlick LJ, 2006, J EXP ZOOL PART A, V305A, P277, DOI 10.1002/jez.a.239; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Han Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/825065; HERRAEZ MP, 2008, METHODS REPROD AQUAC, P385; Hiraku Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P205, DOI 10.1562/2006-03-09-IR-840; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4; Koubek P, 2008, THERIOGENOLOGY, V70, P852, DOI 10.1016/j.theriogenology.2008.05.050; Kurtz K, 2009, J EXP ZOOL PART B, V312B, P149, DOI 10.1002/jez.b.21271; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Moghadam HK, 2005, J MOL EVOL, V61, P804, DOI 10.1007/s00239-004-0230-5; Moussa M, 2002, THERIOGENOLOGY, V57, P1695, DOI 10.1016/S0093-691X(02)00682-9; Mungpakdee S, 2008, MOL BIOL EVOL, V25, P1333, DOI 10.1093/molbev/msn097; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Pascual-Anaya J, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-26; Perez-Cerezales S, 2010, THERIOGENOLOGY, V74, P282, DOI 10.1016/j.theriogenology.2010.02.012; Perez-Cerezales S, 2009, THERIOGENOLOGY, V71, P605, DOI 10.1016/j.theriogenology.2008.09.057; Riesco MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067614; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Saperas N, 1997, J MOL EVOL, V44, P422, DOI 10.1007/PL00006162; Schuch AP, 2010, J PHOTOCH PHOTOBIO B, V99, P111, DOI 10.1016/j.jphotobiol.2010.03.004; Shiao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022266; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Speyer BE, 2010, HUM REPROD, V25, P1609, DOI 10.1093/humrep/deq116; Thummel R, 2004, DEV BIOL, V274, P318, DOI 10.1016/j.ydbio.2004.07.018; Valcarce DG, 2013, ANDROLOGY-US, V1, P723, DOI 10.1111/j.2047-2927.2013.00116.x; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Wondrak GT, 2002, PHOTOCH PHOTOBIO SCI, V1, P355, DOI 10.1039/b202732c; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200	46	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114161	10.1371/journal.pone.0114161	http://dx.doi.org/10.1371/journal.pone.0114161			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479606	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200048
J	Indrelid, S; Mathiesen, G; Jacobsen, M; Lea, T; Kleiveland, CR				Indrelid, Stine; Mathiesen, Geir; Jacobsen, Morten; Lea, Tor; Kleiveland, Charlotte R.			Computational and Experimental Analysis of the Secretome of Methylococcus capsulatus (Bath)	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; SIGNAL PEPTIDES; II SECRETION; LOCALIZATION PREDICTION; GLUTAMINE-SYNTHETASE; SURFACE; SYSTEM; BACTERIA; PATHWAY; IDENTIFICATION	The Gram-negative methanotroph Methylococcus capsulatus (Bath) was recently demonstrated to abrogate inflammation in a murine model of inflammatory bowel disease, suggesting interactions with cells involved in maintaining mucosal homeostasis and emphasizing the importance of understanding the many properties of M. capsulatus. Secreted proteins determine how bacteria may interact with their environment, and a comprehensive knowledge of such proteins is therefore vital to understand bacterial physiology and behavior. The aim of this study was to systematically analyze protein secretion in M. capsulatus (Bath) by identifying the secretion systems present and the respective secreted substrates. Computational analysis revealed that in addition to previously recognized type II secretion systems and a type VII secretion system, a type Vb (two-partner) secretion system and putative type I secretion systems are present in M. capsulatus (Bath). In silico analysis suggests that the diverse secretion systems in M. capsulatus transport proteins likely to be involved in adhesion, colonization, nutrient acquisition and homeostasis maintenance. Results of the computational analysis was verified and extended by an experimental approach showing that in addition an uncharacterized protein and putative moonlighting proteins are released to the medium during exponential growth of M. capsulatus (Bath).	[Indrelid, Stine; Jacobsen, Morten; Kleiveland, Charlotte R.] Ostfold Hosp Trust, Fredrikstad, Norway; [Indrelid, Stine; Mathiesen, Geir; Jacobsen, Morten; Lea, Tor; Kleiveland, Charlotte R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Jacobsen, Morten] Univ Oslo, Inst Clin Med, Dept Gastrointestinal & Children Surg, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Indrelid, S (corresponding author), Ostfold Hosp Trust, Fredrikstad, Norway.	stine.indrelid@nmbu.no		Indrelid, Stine/0000-0002-9628-8066				Alm RA, 1996, MOL MICROBIOL, V22, P161; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berven FD, 2006, ARCH MICROBIOL, V184, P362, DOI 10.1007/s00203-005-0055-7; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chatterjee S, 2013, BIOCHEMISTRY-US, V52, P2508, DOI 10.1021/bi400160a; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Fjellbirkeland A, 1997, ARCH MICROBIOL, V168, P128, DOI 10.1007/s002030050478; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; HARTH G, 1994, P NATL ACAD SCI USA, V91, P9342, DOI 10.1073/pnas.91.20.9342; Henderson B, 2013, BIOL REV, V88, P955, DOI 10.1111/brv.12037; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kainulainen V, 2012, J BACTERIOL, V194, P2509, DOI 10.1128/JB.06704-11; Karlsen OA, 2008, MOL MICROBIOL, V70, P15, DOI 10.1111/j.1365-2958.2008.06380.x; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kleiveland CR, 2013, APPL ENVIRON MICROB, V79, P48, DOI 10.1128/AEM.02464-12; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; LIDSTROM ME, 1990, ANNU REV MICROBIOL, V44, P27; LOCHT C, 1993, MOL MICROBIOL, V9, P653, DOI 10.1111/j.1365-2958.1993.tb01725.x; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; MUNRO GKL, 1995, MICROBIOL-UK, V141, P1731, DOI 10.1099/13500872-141-7-1731; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rego AT, 2010, BIOCHEM J, V425, P475, DOI 10.1042/BJ20091518; Romarheim OH, 2011, J NUTR, V141, P124, DOI 10.3945/jn.110.128900; Romine MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S1; Rondelet A, 2013, RES MICROBIOL, V164, P556, DOI 10.1016/j.resmic.2013.03.005; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Schmid G, 2013, EXTREMOPHILES, V17, P921, DOI 10.1007/s00792-013-0574-0; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	60	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114476	10.1371/journal.pone.0114476	http://dx.doi.org/10.1371/journal.pone.0114476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479164	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000346907200092
J	Maruyama, A; Nakamura, K; Yamanaka, H; Kondoh, M; Minamoto, T				Maruyama, Atsushi; Nakamura, Keisuke; Yamanaka, Hiroki; Kondoh, Michio; Minamoto, Toshifumi			The Release Rate of Environmental DNA from Juvenile and Adult Fish	PLOS ONE			English	Article							WATER SAMPLES; EDNA	The environmental DNA (eDNA) technique is expected to become a powerful, non-invasive tool for estimating the distribution and biomass of organisms. This technique was recently shown to be applicable to aquatic vertebrates by collecting extraorganismal DNA floating in the water or absorbed onto suspended particles. However, basic information on eDNA release rate is lacking, despite it being essential for practical applications. In this series of experiments with bluegill sunfish (Lepomis macrochirus), we examined the effect of fish developmental stage on eDNA release rate. eDNA concentration reached equilibrium 3 days after the individual fish were introduced into the separate containers, enabling calculation of the eDNA release rate (copies h(-1)) from individual fish on the assumption that the number of eDNA released from the fish per unit time equals total degradation in the container (copies h(-1)). The eDNA release rate was 3-4 times higher in the adult (body weight: 30-75 g) than in the juvenile group (0.5-2.0 g). Such positive relationship between fish size and eDNA release rate support the possibility of biomass rather than density estimation using eDNA techniques. However, the eDNA release rate per fish body weight (copies h(-1) g(-1)) was slightly higher in the juvenile than the adult group, which is likely because of the ontogenetic reduction in metabolic activity. Therefore, quantitative eDNA data should be carefully interpreted to avoid overestimating biomass when the population is dominated by juveniles, because the age structure of the focal population is often variable and unseen in the field. eDNA degradation rates (copies l(-1) h(-1)), calculated by curve fitting of time-dependent changes in eDNA concentrations after fish removal, were 5.1-15.9% per hour (half-life: 6.3 h). This suggests that quantitative eDNA data should be corrected using a degradation curve attained in the target field.	[Maruyama, Atsushi; Nakamura, Keisuke; Yamanaka, Hiroki; Kondoh, Michio] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 52021, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, Kobe, Hyogo 657, Japan; [Minamoto, Toshifumi] Res Inst Humanity & Nat, Kita Ku, Kyoto, Japan	Ryukoku University; Kobe University; Research Institute for Humanity & Nature (RIHN)	Maruyama, A (corresponding author), Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 52021, Japan.	maruyama@rins.ryukoku.ac.jp	Minamoto, Toshifumi/C-6453-2009; Kondoh, Michio/AAE-4332-2019	Minamoto, Toshifumi/0000-0002-5379-1622; 	JSPS KAKENHI [24657020]; CREST from Japan Science Technology Agency	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from Japan Science Technology Agency	The authors were funded by JSPS KAKENHI Grant Number 24657020 (http://www.jsps.go.jp/) and by CREST from the Japan Science Technology Agency (http://www.jst.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; AZUMA M, 1992, HYDROBIOLOGIA, V243, P269, DOI 10.1007/BF00007042; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Horne A.J., 1994, LIMNOLOGY; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Pilliod D.S., 2013, APPL ENV DNA INVENTO; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Renshaw MA, 2014, MOL ECOL RESOUR; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Winberg GG., 1960, RATE METABOLISM FOOD; Yuma M, 1997, B SHIGA U MED SCI GE, V8, P19	26	166	180	9	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114639	10.1371/journal.pone.0114639	http://dx.doi.org/10.1371/journal.pone.0114639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479160	Green Published, gold			2022-12-26	WOS:000346907200109
J	Pita, S; Panzera, F; Sanchez, A; Panzera, Y; Palomeque, T; Lorite, P				Pita, Sebastian; Panzera, Francisco; Sanchez, Antonio; Panzera, Yanina; Palomeque, Teresa; Lorite, Pedro			Distribution and Evolution of Repeated Sequences in Genomes of Triatominae (Hemiptera-Reduviidae) Inferred from Genomic In Situ Hybridization	PLOS ONE			English	Article							SEX-CHROMOSOME EVOLUTION; DROSOPHILA Y-CHROMOSOME; TRANSPOSABLE ELEMENTS; REPETITIVE DNA; CHAGAS-DISEASE; SATELLITE DNA; HOLOCENTRIC CHROMOSOMES; INFESTANS HETEROPTERA; HORIZONTAL TRANSFER; RIBOSOMAL GENES	The subfamily Triatominae, vectors of Chagas disease, comprises 140 species characterized by a highly homogeneous chromosome number. We analyzed the chromosomal distribution and evolution of repeated sequences in Triatominae genomes by Genomic in situ Hybridization using Triatoma delpontei and Triatoma infestans genomic DNAs as probes. Hybridizations were performed on their own chromosomes and on nine species included in six genera from the two main tribes: Triatomini and Rhodniini. Genomic probes clearly generate two different hybridization patterns, dispersed or accumulated in specific regions or chromosomes. The three used probes generate the same hybridization pattern in each species. However, these patterns are species-specific. In closely related species, the probes strongly hybridized in the autosomal heterochromatic regions, resembling C-banding and DAPI patterns. However, in more distant species these co-localizations are not observed. The heterochromatic Y chromosome is constituted by highly repeated sequences, which is conserved among 10 species of Triatomini tribe suggesting be an ancestral character for this group. However, the Y chromosome in Rhodniini tribe is markedly different, supporting the early evolutionary dichotomy between both tribes. In some species, sex chromosomes and autosomes shared repeated sequences, suggesting meiotic chromatin exchanges among these heterologous chromosomes. Our GISH analyses enabled us to acquire not only reliable information about autosomal repeated sequences distribution but also an insight into sex chromosome evolution in Triatominae. Furthermore, the differentiation obtained by GISH might be a valuable marker to establish phylogenetic relationships and to test the controversial origin of the Triatominae subfamily.	[Pita, Sebastian; Panzera, Francisco; Panzera, Yanina] Univ Republica, Secc Genet Evolutiva, Fac Ciencias, Montevideo, Uruguay; [Sanchez, Antonio; Palomeque, Teresa; Lorite, Pedro] Univ Jaen, Dept Biol Expt, Area Genet, Jaen, Spain	Universidad de la Republica, Uruguay; Universidad de Jaen	Panzera, F (corresponding author), Univ Republica, Secc Genet Evolutiva, Fac Ciencias, Montevideo, Uruguay.	fcopanzera@gmail.com; plorite@ujaen.es	Palomeque, Teresa/H-6365-2015; Martínez, Pedro Lorite/K-6806-2012; Sanchez, Antonio/N-4174-2015; Pita, Sebastián/Z-6090-2019; Panzera, Francisco/M-9884-2015	Palomeque, Teresa/0000-0002-7144-4931; Martínez, Pedro Lorite/0000-0002-9692-5870; Sanchez, Antonio/0000-0002-6715-8158; Pita, Sebastián/0000-0002-4102-5808; Panzera, Francisco/0000-0001-5148-957X	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Spanish Ministerio de Educacion e Innovacion [CGL2011-23841]; European Regional Development Fund; Junta de Andalucia [BIO-220]; PEDECIBA (Programa de Desarrollo de las Ciencias Basicas, Uruguay); CSIC (Comision Sectorial de Investigacion Cientifica, Uruguay); Conserjeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia	"Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Spanish Ministerio de Educacion e Innovacion(Spanish Government); European Regional Development Fund(European Commission); Junta de Andalucia(Junta de Andalucia); PEDECIBA (Programa de Desarrollo de las Ciencias Basicas, Uruguay); CSIC (Comision Sectorial de Investigacion Cientifica, Uruguay); Conserjeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia)	This work has been supported by project grants from the "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay) and by the Spanish Ministerio de Educacion e Innovacion (project CGL2011-23841), co-funded by the European Regional Development Fund and by Junta de Andalucia throughout the program "Ayudas a grupos de investigacion," group BIO-220. S. Pita benefited from funding by PEDECIBA (Programa de Desarrollo de las Ciencias Basicas, Uruguay) and CSIC (Comision Sectorial de Investigacion Cientifica, Uruguay) and by the "Conserjeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia," sponsor of Scholarship Program of Academic Mobility of AUIP (Ibero-American University Postgraduate Association). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MJ, 2008, CHROMOSOME RES, V16, P949, DOI 10.1007/s10577-008-1253-3; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bardella VB, 2014, CYTOGENET GENOME RES, V142, P46, DOI 10.1159/000355214; Bardella VB, 2010, COMP CYTOGENET, V4, P141, DOI 10.3897/compcytogen.v4i2.50; Bardella VB, 2014, INFECT GENET EVOL, V23, P106, DOI 10.1016/j.meegid.2014.01.035; Bressa MJ, 2009, CYTOGENET GENOME RES, V125, P292, DOI 10.1159/000235936; Cabral-de-Mello DC, 2011, GENETICA, V139, P921, DOI 10.1007/s10709-011-9596-7; Carvalho AB, 2009, TRENDS GENET, V25, P270, DOI 10.1016/j.tig.2009.04.002; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; HUGHESSCHRADER S, 1961, CHROMOSOMA, V12, P327, DOI 10.1007/BF00328928; Hwang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045523; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Kaiser VB, 2010, ANNU REV GENET, V44, P91, DOI 10.1146/annurev-genet-102209-163600; Lonnig WE, 2002, ANNU REV GENET, V36, P389, DOI 10.1146/annurev.genet.36.040202.092802; Lorite P, 2012, NATURWISSENSCHAFTEN, V99, P1007, DOI 10.1007/s00114-012-0982-5; Markova M, 2009, CYTOGENET GENOME RES, V126, P368, DOI 10.1159/000275796; Palacios-Gimenez OM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-167; Palomeque T, 2008, HEREDITY, V100, P564, DOI 10.1038/hdy.2008.24; Palomeque T, 2006, GENE, V371, P194, DOI 10.1016/j.gene.2005.11.032; Palomeque T, 2005, CHROMOSOME RES, V13, P795, DOI 10.1007/s10577-005-1013-6; PANZERA F, 1995, CHROMOSOME RES, V3, P143, DOI 10.1007/BF00710707; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2007, AM J TROP MED HYG, V76, P516, DOI 10.4269/ajtmh.2007.76.516; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Panzera Francisco, 1998, P621; Panzera Y, 2012, CYTOGENET GENOME RES, V138, P56, DOI 10.1159/000341888; Papeschi Alba Graciela, 2006, Journal of Biological Research (Thessaloniki), V5, P3; Patterson JS, 2010, MOL PHYLOGENET EVOL, V56, P608, DOI 10.1016/j.ympev.2010.04.038; Paula AS, 2005, MOL PHYLOGENET EVOL, V35, P712; Perez R, 2000, CHROMOSOME RES, V8, P17, DOI 10.1023/A:1009266801160; Pita S, 2013, MEM I OSWALDO CRUZ, V108, P376, DOI 10.1590/S0074-02762013000300017; Sahara K, 2012, CHROMOSOME RES, V20, P83, DOI 10.1007/s10577-011-9262-z; Schofield CJ, 2009, ACTA TROP, V110, P88, DOI 10.1016/j.actatropica.2009.01.010; Singh ND, 2014, MOL BIOL EVOL, V31, P2612, DOI 10.1093/molbev/msu203; SOLARI AJ, 1979, CHROMOSOMA, V72, P225, DOI 10.1007/BF00293236; Ueshima N, 1979, ANIMAL CYTOGENETICS, V3; Weirauch C, 2009, MOL PHYLOGENET EVOL, V53, P287, DOI 10.1016/j.ympev.2009.05.039; WHO, 2014, CHAG DIS AM TRYP; Yoshido Atsuo, 2006, Journal of Insect Biotechnology and Sericology, V75, P147; Zhang HH, 2013, INSECT MOL BIOL, V22, P584, DOI 10.1111/imb.12047	44	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114298	10.1371/journal.pone.0114298	http://dx.doi.org/10.1371/journal.pone.0114298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478792	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200068
J	Suwanpimolkul, G; Grinsdale, JA; Jarlsberg, LG; Higashi, J; Osmond, DH; Hopewell, PC; Kato-Maeda, M				Suwanpimolkul, Gompol; Grinsdale, Jennifer A.; Jarlsberg, Leah G.; Higashi, Julie; Osmond, Dennis H.; Hopewell, Philip C.; Kato-Maeda, Midori			Association between Diabetes Mellitus and Tuberculosis in United States-Born and Foreign-Born Populations in San Francisco	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SOCIOECONOMIC-STATUS; CARE POPULATION; RISK-FACTORS; PREVALENCE	Setting: The impact of diabetes on tuberculosis in United States and foreign-born populations in San Francisco has not been studied. Objective: To determine the characteristics, prevalence and temporal trends of diabetes in US and foreign-born persons attending the San Francisco Tuberculosis Clinic. Design: We analyzed data from individuals seeking medical attention at the San Francisco Tuberculosis Clinic. We included patients with diagnosis of tuberculosis, latent infection, or not infected with Mycobacterium tuberculosis. We assessed the temporal trend and the characteristics of individuals with and without diabetes. Result: Between 2005 and 2012, there were 4371 (19.0%) individuals without evidence of tuberculosis infection, 17,856 (77.6%) with latent tuberculosis, and 791 (3.4%) with tuberculosis. 66% were born in the United States, China, Mexico, and the Philippines. The prevalence of diabetes was the highest among individuals with tuberculosis and increased during the study period. Patients with tuberculosis and diabetes were more likely to be male, older than 45 years and born in the Philippines. There was a disproportionate association of TB and DM relative to LTBI and DM among Filipinos in individuals older than 45 years old. Conclusions: Our data suggest that Filipinos older than 45 years old are more likely to have tuberculosis probably due to a higher prevalence of diabetes. In San Francisco, tuberculosis-screening programs in individuals with diabetes and latent tuberculosis may be beneficial in patients older than 45 years old especially from the Philippines.	[Suwanpimolkul, Gompol; Jarlsberg, Leah G.; Hopewell, Philip C.; Kato-Maeda, Midori] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA; [Suwanpimolkul, Gompol] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Suwanpimolkul, Gompol] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand; [Grinsdale, Jennifer A.; Higashi, Julie] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Osmond, Dennis H.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; San Francisco Department of Public Health; University of California System; University of California San Francisco	Kato-Maeda, M (corresponding author), Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA.	Midori.Kato-Maeda@ucsf.edu		Jarlsberg, Leah/0000-0001-6548-6337	National Institutes of Health [NIH AI034238]; King Chulalongkorn Memorial Hospital, Thai Red Cross Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Chulalongkorn Memorial Hospital, Thai Red Cross Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health http://www.nih.gov/(NIH AI034238) and King Chulalongkorn Memorial Hospital, Thai Red Cross Society http://www.redcross.or.th/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; [Anonymous], 2003, MMWR RECOMM REP; [Anonymous], 2011, NAT DIAB STAT; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Bays HE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-277; CDC, 2013, REP TUB US 2012; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gary He AA, 2005, DIABETES CALIFORNIA; Guozhong He KB, 2009, DIABETES CALIFORNIA; Holland AT, 2013, J DIABETES COMPLICAT, V27, P34, DOI 10.1016/j.jdiacomp.2012.08.006; International Diabetes Federation, 2012, DIAB ATL UPD; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kampoli AM, 2011, CURR PHARM DESIGN, V17, P4147, DOI 10.2174/138161211798764825; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Olson NA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-365; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Park SW, 2012, EUR J CLIN MICROBIOL, V31, P1305, DOI 10.1007/s10096-011-1443-3; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; San Francisco Department of Public Health, 2012, COMM HLTH STAT ASS C; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sicree JS, 2003, GLOBAL BURDEN DIABET; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Suwanpimolkul GJL, 2013, AM J RESP CRIT CARE, pA1647; Suwanpimolkul G, 2013, AM J RESP CRIT CARE, V187, P998, DOI 10.1164/rccm.201212-2239OC; WHO, 2011, COLLABORATIVE FRAMEW; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2011, TUB DIAB; 2000, AM J RESP CRIT CARE, V161, P1376	33	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114442	10.1371/journal.pone.0114442	http://dx.doi.org/10.1371/journal.pone.0114442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478954	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200088
J	Weller, P; Nel, I; Hassenkamp, P; Gauler, T; Schlueter, A; Lang, S; Dountsop, P; Hoffmann, AC; Lehnerdt, G				Weller, Patrick; Nel, Ivonne; Hassenkamp, Philipp; Gauler, Thomas; Schlueter, Anke; Lang, Stephan; Dountsop, Paulette; Hoffmann, Andreas-Claudius; Lehnerdt, Goetz			Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LOCALLY ADVANCED HEAD; PERIPHERAL-BLOOD; BONE-MARROW; CANCER; METASTASIS; EXPRESSION	Background: Since image based diagnostic tools fail to detect early metastasis in head and neck squamous cell carcinoma (HNSCC) it is crucial to develop minimal invasive diagnostic methods. A promising approach is to identify and characterize circulating tumor cells (CTC) in the peripheral blood of HNSCC patients. In this pilot study, we assessed which non-hematopoietic cell types are identifiable and whether their numbers differ in pre- and postoperative blood samples. Methods: 20 ml citrated peripheral blood was taken from 10 HNSCC patients before and after curative resection. CTC were enriched using density gradient centrifugation. CTC presence was verified by multi-immunofluorescence staining against cytokeratin (CK; epithelial), N-cadherin (mesenchymal); CD133 (stem-cell), CD45 (hematopoietic) and DAPI (nucleus). Individual cell type profiles were analyzed. Results: We were able to detect cells with epithelial properties like CK+/N-cadherin-/CD45- and CK+/CD133-/CD45- as well as cells with mesenchymal features such as N-cadherin+/CK-/CD45- and cells with both characteristics like N-cadherin+/CK+/CD45-. We also observed cells showing stem cell-like features like CD133+/CK-/CD45- and cells with both epithelial and stem cell-like features such as CD133+/CK+/CD45-. The number of CK positive cells (p=0.002), N-cadherin positive cells (p=0.002) and CD133 positive cells (p=0.01) decreased significantly after resection. Kaplan-Meier test showed that the survival was significantly shorter when N-cadherin+ cells were present after resection (p=0.04; 474 vs. 235 days; [HR]=3.1). Conclusions: This is - to the best of our knowledge- the first pilot study identifying different CTC populations in peripheral blood of HNSCC patients and showing that these individual cell type profiles may have distinct clinical implications.	[Weller, Patrick; Hassenkamp, Philipp; Schlueter, Anke; Lang, Stephan; Lehnerdt, Goetz] Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany; [Nel, Ivonne; Hassenkamp, Philipp; Gauler, Thomas; Hoffmann, Andreas-Claudius] Univ Duisburg Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany; [Dountsop, Paulette] Evangel Krankenhaus Duesseldorf, Dept Otorhinolaryngol, Dusseldorf, Germany; [Lehnerdt, Goetz] St Anna Klin, Dept Otorhinolaryngol, Wuppertal, Germany	University of Duisburg Essen; University of Duisburg Essen	Weller, P (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Otorhinolaryngol, Essen, Germany.	patrick.weller@yahoo.de			Dr. Werner Jackstadt-Stiftung, Wuppertal/Germany	Dr. Werner Jackstadt-Stiftung, Wuppertal/Germany	The work was supported by the Dr. Werner Jackstadt-Stiftung, Laurentiusstrasse 25, 42103 Wuppertal/Germany, www.jackstaedt-stiftung.de (ACH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balasubramanian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042048; Bozec A, 2013, EUR ARCH OTO-RHINO-L, V270, P2745, DOI 10.1007/s00405-013-2399-y; Buglione M, 2012, EUR J CANCER, V48, P3019, DOI 10.1016/j.ejca.2012.05.007; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chong PP, 2012, J ORTHOP RES, V30, P634, DOI 10.1002/jor.21556; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Gauler TC, 2011, J THORAC ONCOL, V6, pS1114; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Hristozova T, 2011, ANN ONCOL, V22, P1878, DOI 10.1093/annonc/mdr130; Jatana KR, 2010, ARCH OTOLARYNGOL, V136, P1274, DOI 10.1001/archoto.2010.223; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; MOLDENHAUER G, 1987, BRIT J CANCER, V56, P714, DOI 10.1038/bjc.1987.276; Nel I, 2013, BR J CANC; Nel I, 2014, INT J CLIN PHARM TH, V52, P74, DOI 10.5414/CPXCES13EA01; Nel I, 2013, TRANSL ONCOL, V6, P420, DOI 10.1593/tlo.13271; Nguyen PT, 2011, HISTOL HISTOPATHOL, V26, P147, DOI 10.14670/HH-26.147; Nichols AC, 2012, HEAD NECK-J SCI SPEC, V34, P1440, DOI 10.1002/hed.21941; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Winter SC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-424; Yang FC, 1998, BLOOD, V92, P4632, DOI 10.1182/blood.V92.12.4632.424k28_4632_4640; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	31	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113706	10.1371/journal.pone.0113706	http://dx.doi.org/10.1371/journal.pone.0113706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479539	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200029
J	Butschkau, A; Wagner, NM; Genz, B; Vollmar, B				Butschkau, Antje; Wagner, Nana-Maria; Genz, Berit; Vollmar, Brigitte			Protein Z Exerts Pro-Angiogenic Effects and Upregulates CXCR4	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; Z PLASMA-LEVELS; IN-VITRO; INHIBITOR; KINASE; DEFICIENCY; ACTIVATION; PHENOTYPE; CELLS	Objective: Protein Z (PZ) is a vitamin K-dependent coagulation factor without catalytic activity. Evidence points towards PZ as an independent risk factor for the occurrence of human peripheral arterial disease. However, the role of PZ in ischemia-driven angiogenesis and vascular healing processes has not been elucidated so far. Approach: Angiogenic potency of PZ was assessed in established in vitro assays using endothelial cells. PZ-deficient (PZ(-/-)) mice and their wild-type littermates (PZ(+/+)) were subjected to hindlimb ischemia. Furthermore, PZ(-/)-mice were exposed to PZ expressing adenovirus (AdV-PZ) or control adenovirus (AdV-GFP). In an additional set of animals, PZ(-/)-mice were exposed to AdV-PZ and AdV-GFP, each in combination with the CXCR4 antagonist AMD3100. Results: In vitro, PZ stimulated migratory activity and capillary-like tube formation of endothelial cells comparable to SDF-1. PZ(-/)-mice exhibited diminished hypoxia-driven neovascularization and reperfusion in post-ischemic hindlimbs, which was restored by adenoviral gene transfer up to levels seen in PZ+/+ mice. The stimulatory impact of PZ on endothelial cells in vitro was abolished by siRNA targeting against PZ and PZ was not able to restore reduced migration after knockdown of CXCR4. The increased surface expression of CXCR4 on PZ-stimulated endothelial cells and the abrogated restoration of PZ(-/)-mice via AdV-PZ after concomitant treatment with the CXCR4 antagonist AMD3100 supports the idea that PZ mediates angiogenesis via a G-protein coupled pathway and involves the SDF1/ CXCR4 axis. This is underlined by the fact that addition of the G-protein inhibitor PTX to PZ-stimulated endothelial cells abolished the effect of PZ on capillary-like tube formation. Conclusions: The results of the current study reveal a role of PZ in ischemiainduced angiogenesis, which involves a G-protein coupled pathway and a raised	[Butschkau, Antje; Genz, Berit; Vollmar, Brigitte] Univ Hosp Rostock, Inst Expt Surg, Rostock, Germany; [Wagner, Nana-Maria] Univ Hosp Rostock, Clin Anesthesiol & Crit Care Med, Rostock, Germany	University of Rostock; University of Rostock	Butschkau, A (corresponding author), Univ Hosp Rostock, Inst Expt Surg, Rostock, Germany.	antje.butschkau@uni-rostock.de	Wagner, Nana-Maria/AAB-3953-2021; Genz, Berit/AAZ-4230-2020	Wagner, Nana-Maria/0000-0002-4610-6666	Deutsche Forschungsgemeinschaft DFG [VO 450/11-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft DFG (VO 450/11-1). BV received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2004, CIRCULATION, V109, P2761, DOI 10.1161/01.CIR.0000129968.46095.F3; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2001, SCIENCE, V293, P1602, DOI 10.1126/science.1064981; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Fedi S, 2003, THROMB HAEMOSTASIS, V90, P1173, DOI 10.1160/TH03-04-0237; Fujimaki K, 1998, BIOCHEMISTRY-US, V37, P6838, DOI 10.1021/bi972002a; Gramling MW, 2010, EXP CELL RES, V316, P314, DOI 10.1016/j.yexcr.2009.10.024; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044; Ikeda Y, 2012, J BIOL CHEM, V287, P34256, DOI 10.1074/jbc.M112.353532; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; PROWSE CV, 1977, BIOCHEM SOC T, V5, P255, DOI 10.1042/bst0050255; Santacroce R, 2006, J THROMB HAEMOST, V4, P2417, DOI 10.1111/j.1538-7836.2006.02186.x; Sofi F, 2005, J THROMB HAEMOST, V3, P2254, DOI 10.1111/j.1538-7836.2005.01536.x; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; Sofi F, 2007, THROMB HAEMOSTASIS, V98, P1114, DOI 10.1160/TH07-04-0300; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P749, DOI 10.1160/TH09-09-0645; TANABE S, 1991, J BIOCHEM-TOKYO, V109, P924, DOI 10.1093/oxfordjournals.jbchem.a123481; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Vasse M, 2006, THROMB HAEMOSTASIS, V95, P519, DOI 10.1160/TH05-11-0723; Vasse M, 2001, LANCET, V357, P933, DOI 10.1016/S0140-6736(00)04218-5; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Whitmont K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719570; Xue ML, 2011, J BIOL CHEM, V286, P6742, DOI 10.1074/jbc.M110.181388; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113554	10.1371/journal.pone.0113554	http://dx.doi.org/10.1371/journal.pone.0113554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474349	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500085
J	Cusick, KD; Fitzgerald, LA; Pirlo, RK; Cockrell, AL; Petersen, ER; Biffinger, JC				Cusick, Kathleen D.; Fitzgerald, Lisa A.; Pirlo, Russell K.; Cockrell, Allison L.; Petersen, Emily R.; Biffinger, Justin C.			Selection and Evaluation of Reference Genes for Expression Studies with Quantitative PCR in the Model Fungus Neurospora crassa under Different Environmental Conditions in Continuous Culture	PLOS ONE			English	Article							HOUSEKEEPING GENES; QUANTIFICATION; NORMALIZATION; VALIDATION; RNA	Neurospora crassa has served as a model organism for studying circadian pathways and more recently has gained attention in the biofuel industry due to its enhanced capacity for cellulase production. However, in order to optimize N. crassa for biotechnological applications, metabolic pathways during growth under different environmental conditions must be addressed. Reverse-transcription quantitative PCR (RT-qPCR) is a technique that provides a high-throughput platform from which to measure the expression of a large set of genes over time. The selection of a suitable reference gene is critical for gene expression studies using relative quantification, as this strategy is based on normalization of target gene expression to a reference gene whose expression is stable under the experimental conditions. This study evaluated twelve candidate reference genes for use with N. crassa when grown in continuous culture bioreactors under different light and temperature conditions. Based on combined stability values from NormFinder and Best Keeper software packages, the following are the most appropriate reference genes under conditions of: (1) light/dark cycling: btl, asl, and vma1; (2) all-dark growth: btl, tbp, vma1, and vma2; (3) temperature flux: btl, vma1, act, and asl; (4) all conditions combined: vma1, vma2, tbp, and btl. Since N. crassa exists as different cell types (uni- or multi-nucleated), expression changes in a subset of the candidate genes was further assessed using absolute quantification. A strong negative correlation was found to exist between ratio and threshold cycle (C-T) values, demonstrating that C-T changes serve as a reliable reflection of transcript, and not gene copy number, fluctuations. The results of this study identified genes that are appropriate for use as reference genes in RT-qPCR studies with N. crassa and demonstrated that even with the presence of different cell types, relative quantification is an acceptable method for measuring gene expression changes during growth in bioreactors.	[Cusick, Kathleen D.; Cockrell, Allison L.] US Naval Res Lab, Natl Res Council Associateship, Washington, DC 20375 USA; [Fitzgerald, Lisa A.; Pirlo, Russell K.; Petersen, Emily R.; Biffinger, Justin C.] US Naval Res Lab, Div Chem, Washington, DC USA	National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Cusick, KD (corresponding author), US Naval Res Lab, Natl Res Council Associateship, Washington, DC 20375 USA.	Kathleen_cusick.ctr@code6100.nrl.navy.mil	Cusick, Kathleen/AAZ-4174-2020; Pirlo, Russell/AAE-5830-2019	Cusick, Kathleen/0000-0001-7224-3472; Pirlo, Russell/0000-0002-2410-028X; , Lisa/0000-0002-2716-4908	Defense Advanced Research Projects Agency's Biochronicity program [MIPR HR001133889]	Defense Advanced Research Projects Agency's Biochronicity program	This work was funded by the Defense Advanced Research Projects Agency's Biochronicity program MIPR HR001133889. The views expressed are those of the authors and do not reflect the official policy or position of the Department of Defense or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Bistis GN., 2003, FUNGAL GENET NEWSL, V50, P17, DOI [10.4148/1941-4765.1154, DOI 10.4148/1941-4765.1154]; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, P14; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Dogaris I, 2013, APPL MICROBIOL BIOT, V97, P1457, DOI 10.1007/s00253-012-4655-2; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ish-Shalom S, 2010, METHODS MOL BIOL MOL; Kim HK, 2011, PLANT PATHOLOGY J, V27, P301, DOI 10.5423/PPJ.2011.27.4.301; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nevarez L, 2008, MICROBIOL-SGM, V154, P3752, DOI 10.1099/mic.0.2008/021386-0; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Rivetta A, 2013, EUKARYOT CELL, V12, P684, DOI 10.1128/EC.00017-13; Shen GM, 2013, FLA ENTOMOL, V96, P442, DOI 10.1653/024.096.0208; Shen GM, 2012, PEST MANAG SCI, V68, P1553, DOI 10.1002/ps.3340; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Steiger MG, 2010, J BIOTECHNOL, V145, P30, DOI 10.1016/j.jbiotec.2009.10.012; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Tralau T, 2007, FUNGAL GENET BIOL, V44, P754, DOI 10.1016/j.fgb.2006.11.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang Z, 2012, FUNGAL GENET BIOL, V49, P533, DOI 10.1016/j.fgb.2012.05.004; WECHSER MA, 1995, MOL GEN GENET, V249, P317, DOI 10.1007/BF00290533; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	11	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112706	10.1371/journal.pone.0112706	http://dx.doi.org/10.1371/journal.pone.0112706			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474155	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500074
J	Duerksen, SW; Thiemann, GW; Budge, SM; Poulin, M; Niemi, A; Michel, C				Duerksen, Steven W.; Thiemann, Gregory W.; Budge, Suzanne M.; Poulin, Michel; Niemi, Andrea; Michel, Christine			Large, Omega-3 Rich, Pelagic Diatoms under Arctic Sea Ice: Sources and Implications for Food Webs	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; PHYTOPLANKTON BLOOMS; STABLE-ISOTOPES; NORTH-ATLANTIC; SPRING BLOOM; CYCLE; DYNAMICS; GROWTH; ALGAE; OCEAN	Pelagic primary production in Arctic seas has traditionally been viewed as biologically insignificant until after the ice breakup. There is growing evidence however, that under-ice blooms of pelagic phytoplankton may be a recurrent occurrence. During the springs of 2011 and 2012, we found substantial numbers (201-5713 cells m(-3)) of the large centric diatom (diameter >250 mu m) Coscinodiscus centralis under the sea ice in the Canadian Arctic Archipelago near Resolute Bay, Nunavut. The highest numbers of these pelagic diatoms were observed in Barrow Strait. Spatial patterns of fatty acid profiles and stable isotopes indicated two source populations for C. centralis: a western origin with low light conditions and high nutrients, and a northern origin with lower nutrient levels and higher irradiances. Fatty acid analysis revealed that pelagic diatoms had significantly higher levels of polyunsaturated fatty acids (mean +/- SD: 50.3 +/- 8.9%) compared to ice-associated producers (30.6 +/- 10.3%) in our study area. In particular, C. centralis had significantly greater proportions of the long chain omega-3 fatty acid, eicosapentaenoic acid (EPA), than ice algae (24.4 +/- 5.1% versus 13.7 +/- 5.1%, respectively). Thus, C. centralis represented a significantly higher quality food source for local herbivores than ice algae, although feeding experiments did not show clear evidence of copepod grazing on C. centralis. Our results suggest that C. centralis are able to initiate growth under pack ice in this area and provide further evidence that biological productivity in ice-covered seas may be substantially higher than previously recognized.	[Duerksen, Steven W.; Thiemann, Gregory W.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Budge, Suzanne M.] Dalhousie Univ, Dept Proc Engn & Appl Sci, Halifax, NS, Canada; [Poulin, Michel] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Niemi, Andrea; Michel, Christine] Fisheries & Oceans Canada, Winnipeg, MB, Canada	York University - Canada; Dalhousie University; Fisheries & Oceans Canada	Duerksen, SW (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	swd@dal.ca	Thiemann, Gregory/J-9517-2013	Thiemann, Gregory/0000-0002-1888-900X; Budge, Suzanne/0000-0003-4984-7344	Natural Sciences and Engineering Research Council [371739-2009-RGPIN]; Fisheries and Oceans Canada (International Governance Strategy); Natural Resources Canada (Program of Energy Research and Development and Polar Continental Shelf Program) grants; Environment Canada; Northern Scientific Training Program (NSTP); York University Graduate Studies grants; Canadian Museum of Nature; Kenneth Molson Foundation [POLARBR-5167]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fisheries and Oceans Canada (International Governance Strategy); Natural Resources Canada (Program of Energy Research and Development and Polar Continental Shelf Program) grants; Environment Canada(CGIAR); Northern Scientific Training Program (NSTP); York University Graduate Studies grants; Canadian Museum of Nature; Kenneth Molson Foundation	This work was supported by grants from the Natural Sciences and Engineering Research Council (#371739-2009-RGPIN) (http://www.nserc-crsng.gc.ca/) to G.W.T. and C.M., Fisheries and Oceans Canada (International Governance Strategy) and Natural Resources Canada (Program of Energy Research and Development and Polar Continental Shelf Program) grants to C.M., Environment Canada and Kenneth Molson Foundation grants (POLARBR-5167) to G.W.T, Northern Scientific Training Program (NSTP) (http://www.polarcom.gc.ca/eng/content/northernscientific-training-program), and York University Graduate Studies grants (http://www.yorku.ca/grads/money_matters/rfc_fcf.html) to S.D., and by financial support to M.P. from the Canadian Museum of Nature. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt KE, 2005, MAR BIOL, V146, P513, DOI 10.1007/s00227-004-1457-9; ATKINS WRG, 1951, J MAR BIOL ASSOC UK, V29, P609, DOI 10.1017/S0025315400052802; BERARD-THERRIAULT L., 1999, PUBLICATION SPECIALE, V128, P1; Breteler WCMK, 2005, MAR ECOL PROG SER, V291, P125; Brown TA, 2011, POLAR BIOL, V34, P1857, DOI 10.1007/s00300-010-0942-5; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Budge SM, 1999, PHYTOCHEMISTRY, V52, P561, DOI 10.1016/S0031-9422(99)00241-1; Carmack E, 2006, PROG OCEANOGR, V71, P446, DOI 10.1016/j.pocean.2006.10.004; Cleve PT, 1883, J LINNEAN SOC BOT, V20, P313; COTA GF, 1987, J GEOPHYS RES-OCEANS, V92, P1951, DOI 10.1029/JC092iC02p01951; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; GARRISON DL, 1986, POLAR BIOL, V6, P237, DOI 10.1007/BF00443401; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Graeve M, 2005, J EXP MAR BIOL ECOL, V317, P109, DOI 10.1016/j.jembe.2004.11.016; Griffiths MJ, 2010, LIPIDS, V45, P1053, DOI 10.1007/s11745-010-3468-2; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hasle Grethe Rytter, 1992, Diatom Research, V7, P37; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Hobson KA, 1995, MAR ECOL PROG SER, V128, P1, DOI 10.3354/meps128001; HORNER R, 1982, ARCTIC, V35, P485; Husson F, 2013, FACTOMINER MULTIVARI; Katsuki K, 2009, MICROPALEONTOLOGY, V55, P137; Kemp AES, 2000, DEEP-SEA RES PT II, V47, P2129, DOI 10.1016/S0967-0645(00)00019-9; LANGE CB, 1992, SARSIA, V77, P173, DOI 10.1080/00364827.1992.10413503; Leu E, 2006, CAN J FISH AQUAT SCI, V63, P2760, DOI 10.1139/F06-159; Lovejoy C, 2002, DEEP-SEA RES PT II, V49, P5027, DOI 10.1016/S0967-0645(02)00176-5; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Matrai P, 2013, MAR BIOL, V160, P1297, DOI 10.1007/s00227-013-2181-0; Matsuoka A, 2009, ESTUAR COAST SHELF S, V82, P537, DOI 10.1016/j.ecss.2009.02.024; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Michel C, 1996, J GEOPHYS RES-OCEANS, V101, P18345, DOI 10.1029/96JC00045; Mundy CJ, 2014, MAR ECOL PROG SER, V497, P39, DOI 10.3354/meps10587; Mundy CJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038837; Needoba JA, 2004, J PHYCOL, V40, P505, DOI 10.1111/j.1529-8817.2004.03171.x; Niehoff B, 2002, MAR BIOL, V140, P567, DOI 10.1007/s00227-001-0731-3; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PARK PW, 1994, J FOOD SCI, V59, P1262, DOI 10.1111/j.1365-2621.1994.tb14691.x; Parrish CC, 2005, MAR ECOL PROG SER, V286, P57, DOI 10.3354/meps286057; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Peter KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049632; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; PRINSENBERG SJ, 1987, CONT SHELF RES, V7, P913, DOI 10.1016/0278-4343(87)90006-9; R Core Team, 2021, R LANGUAGE ENV STAT; Riedel A, 2003, CAN DATA REP HYDROGR, V159, P1; Sargent J.R., 1993, Coastal and Estuarine Studies, V43, P103; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Strass VH, 1996, POLAR BIOL, V16, P409; THOMPSON PA, 1990, J PHYCOL, V26, P278, DOI 10.1111/j.0022-3646.1990.00278.x; Todorov V, 2009, J STAT SOFTW, V32, P1; Tremblay JE, 2006, LIMNOL OCEANOGR, V51, P900, DOI 10.4319/lo.2006.51.2.0900; von Quillfeldt CH, 2000, BOT MAR, V43, P499, DOI 10.1515/BOT.2000.050	56	15	16	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114070	10.1371/journal.pone.0114070	http://dx.doi.org/10.1371/journal.pone.0114070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473949	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500109
J	Froud, R; Abel, G				Froud, Robert; Abel, Gary			Using ROC Curves to Choose Minimally Important Change Thresholds when Sensitivity and Specificity Are Valued Equally: The Forgotten Lesson of Pythagoras. Theoretical Considerations and an Example Application of Change in Health Status	PLOS ONE			English	Article							LOW-BACK-PAIN; OUTCOME MEASURES; RESPONSIVENESS; INSTRUMENTS; TIME	Background: Receiver Operator Characteristic (ROC) curves are being used to identify Minimally Important Change (MIC) thresholds on scales that measure a change in health status. In quasi-continuous patient reported outcome measures, such as those that measure changes in chronic diseases with variable clinical trajectories, sensitivity and specificity are often valued equally. Notwithstanding methodologists agreeing that these should be valued equally, different approaches have been taken to estimating MIC thresholds using ROC curves. Aims and objectives: We aimed to compare the different approaches used with a new approach, exploring the extent to which the methods choose different thresholds, and considering the effect of differences on conclusions in responder analyses. Methods: Using graphical methods, hypothetical data, and data from a large randomised controlled trial of manual therapy for low back pain, we compared two existing approaches with a new approach that is based on the addition of the sums of squares of 1-sensitivity and 1-specificity. Results: There can be divergence in the thresholds chosen by different estimators. The cut-point selected by different estimators is dependent on the relationship between the cut-points in ROC space and the different contours described by the estimators. In particular, asymmetry and the number of possible cut-points affects threshold selection. Conclusion: Choice of MIC estimator is important. Different methods for choosing cut-points can lead to materially different MIC thresholds and thus affect results of responder analyses and trial conclusions. An estimator based on the smallest sum of squares of 1-sensitivity and 1-specificity is preferable when sensitivity and specificity are valued equally. Unlike other methods currently in use, the cut-point chosen by the sum of squares method always and efficiently chooses the cut-point closest to the top-left corner of ROC space, regardless of the shape of the ROC curve.	[Froud, Robert] Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Froud, Robert] Norge Helsehoyskole, Oslo, Norway; [Abel, Gary] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 1TN, Cambs, England	University of Warwick; University of Cambridge	Froud, R (corresponding author), Univ Warwick, Warwick Med Sch, Clin Trials Unit, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	r.froud@warwick.ac.uk	Froud, Robert/AAQ-2429-2021; Abel, Gary/ABE-1765-2021	Froud, Robert/0000-0002-9193-2297; Abel, Gary/0000-0003-2231-5161				Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Collinson P, 1998, HEART, V80, P215, DOI 10.1136/hrt.80.3.215; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; de Vet HCW., 2018, MEASUREMENT MED, V10th; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; de Vet HCW, 2010, J CLIN EPIDEMIOL, V63, P37, DOI 10.1016/j.jclinepi.2009.03.011; DEYO RA, 1986, J CHRON DIS, V39, P897, DOI 10.1016/0021-9681(86)90038-X; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Froud R, 2014, ROCMIC V2 0 0 STAT M; Froud R, 2010, THESIS QUEEN MARY U; Froud R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X657008; Froud R, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-35; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Lauridsen HH, 2007, PAIN, V131, P112, DOI 10.1016/j.pain.2006.12.023; Muller U, 2004, EUR SPINE J, V13, P301, DOI 10.1007/s00586-003-0665-1; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Terwee CB, 2003, QUAL LIFE RES, V12, P349, DOI 10.1023/A:1023499322593; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; Underwood MR, 1999, SPINE, V24, P1104, DOI 10.1097/00007632-199906010-00010	21	56	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114468	10.1371/journal.pone.0114468	http://dx.doi.org/10.1371/journal.pone.0114468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474472	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500035
J	Lehto, M; Karilainen, T; Rog, T; Cramariuc, O; Vanhala, E; Tornaeus, J; Taberman, H; Janis, J; Alenius, H; Vattulainen, I; Laine, O				Lehto, Maili; Karilainen, Topi; Rog, Tomasz; Cramariuc, Oana; Vanhala, Esa; Tornaeus, Jarkko; Taberman, Helena; Janis, Janne; Alenius, Harri; Vattulainen, Ilpo; Laine, Olli			Co-Exposure with Fullerene May Strengthen Health Effects of Organic Industrial Chemicals	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; IN-VITRO EVALUATION; AQUEOUS SUSPENSIONS; C-60; TOXICITY; NANOPARTICLES; DYNAMICS; EXPOSURE; DISPERSIONS; PARTICLES	In vitro toxicological studies together with atomistic molecular dynamics simulations show that occupational co-exposure with C-60 fullerene may strengthen the health effects of organic industrial chemicals. The chemicals studied are acetophenone, benzaldehyde, benzyl alcohol, m-cresol, and toluene which can be used with fullerene as reagents or solvents in industrial processes. Potential co-exposure scenarios include a fullerene dust and organic chemical vapor, or a fullerene solution aerosolized in workplace air. Unfiltered and filtered mixtures of C-60 and organic chemicals represent different co-exposure scenarios in in vitro studies where acute cytotoxicity and immunotoxicity of C-60 and organic chemicals are tested together and alone by using human THP-1-derived macrophages. Statistically significant co-effects are observed for an unfiltered mixture of benzaldehyde and C-60 that is more cytotoxic than benzaldehyde alone, and for a filtered mixture of m-cresol and C-60 that is slightly less cytotoxic than m-cresol. Hydrophobicity of chemicals correlates with co-effects when secretion of pro-inflammatory cytokines IL-1 beta and TNF-alpha is considered. Complementary atomistic molecular dynamics simulations reveal that C-60 co-aggregates with all chemicals in aqueous environment. Stable aggregates have a fullerene-rich core and a chemical-rich surface layer, and while essentially all C-60 molecules aggregate together, a portion of organic molecules remains in water.	[Lehto, Maili; Vanhala, Esa; Tornaeus, Jarkko; Alenius, Harri; Laine, Olli] Finnish Inst Occupat Hlth, Helsinki, Finland; [Karilainen, Topi; Rog, Tomasz; Cramariuc, Oana; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Taberman, Helena; Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Vattulainen, Ilpo] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark	Finnish Institute of Occupational Health; Tampere University; University of Eastern Finland; University of Southern Denmark	Laine, O (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	olli.laine@ttl.fi	Vattulainen, Ilpo T/G-4224-2014; Rog, Tomasz/ABE-3044-2020; Jänis, Janne/B-7326-2014	Rog, Tomasz/0000-0001-6765-7013; Alenius, Harri/0000-0003-0106-8923; Vattulainen, Ilpo/0000-0001-7408-3214	Finnish Work Environment Fund [110358]; Finnish Academy of Science and Letters; Academy of Finland; European Research Council (Advanced Grant CROWDED-PRO-LIPIDS)	Finnish Work Environment Fund; Finnish Academy of Science and Letters(Academy of Finland); Academy of Finland(Academy of Finland); European Research Council (Advanced Grant CROWDED-PRO-LIPIDS)	OL received funding from the Finnish Work Environment Fund (Project 110358, www.tsr.fi), TK from the Finnish Academy of Science and Letters (Vaisalan rahasto, www.acadsci.fi), OC from the Academy of Finland (www.aka.fi), and TR and IV from the European Research Council (Advanced Grant CROWDED-PRO-LIPIDS, erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alargova RG, 2001, J AM CHEM SOC, V123, P10460, DOI 10.1021/ja010202a; Anilkumar P, 2011, CURR MED CHEM, V18, P2045, DOI 10.2174/092986711795656225; Aschberger K, 2010, REGUL TOXICOL PHARM, V58, P455, DOI 10.1016/j.yrtph.2010.08.017; Costa CLA, 2012, COMP BIOCHEM PHYS C, V155, P206, DOI 10.1016/j.cbpc.2011.08.005; Baun A, 2008, AQUAT TOXICOL, V86, P379, DOI 10.1016/j.aquatox.2007.11.019; Brant JA, 2006, LANGMUIR, V22, P3878, DOI 10.1021/la053293o; Deguchi S, 2001, LANGMUIR, V17, P6013, DOI 10.1021/la010651o; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gangwal S, 2011, ENVIRON HEALTH PERSP, V119, P1539, DOI 10.1289/ehp.1103750; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; GIRIFALCO LA, 1992, J PHYS CHEM-US, V96, P858, DOI 10.1021/j100181a061; Goulaouic S, 2008, J IMMUNOTOXICOL, V5, P337, DOI 10.1080/15476910802371016; Guldi DM, 2009, CHEM SOC REV, V38, P1587, DOI 10.1039/b900402p; Henry TB, 2011, CURR OPIN BIOTECH, V22, P533, DOI 10.1016/j.copbio.2011.05.511; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heymann D, 1996, FULLERENE SCI TECHN, V4, P509, DOI 10.1080/10641229608001567; Holder AL, 2007, CHEMOSPHERE, V70, P13, DOI 10.1016/j.chemosphere.2007.07.036; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horie M, 2010, J BIOCHEM, V148, P289, DOI 10.1093/jb/mvq068; Hu XL, 2008, ENVIRON TOXICOL CHEM, V27, P1868, DOI 10.1897/08-009.1; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnston HJ, 2010, TOXICOL SCI, V114, P162, DOI 10.1093/toxsci/kfp265; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kato H, 2010, MOL BIOSYST, V6, P1238, DOI 10.1039/c002364g; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Lens Marko, 2011, Recent Pat Biotechnol, V5, P67, DOI 10.2174/187220811796365707; Lide D. R., 2009, CRC HDB CHEM PHYS, P6; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Ma XM, 2010, ENVIRON ENG SCI, V27, P989, DOI 10.1089/ees.2010.0141; Mo YQ, 2012, TOXICOL IN VITRO, V26, P295, DOI 10.1016/j.tiv.2011.12.001; Montellano A, 2011, NANOSCALE, V3, P4035, DOI 10.1039/c1nr10783f; Monticelli L, 2012, PHYS CHEM CHEM PHYS, V14, P12526, DOI 10.1039/c2cp41117b; Monticelli L, 2012, J CHEM THEORY COMPUT, V8, P1370, DOI 10.1021/ct3000102; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nyberg M, 1999, PHYS REV B, V60, P7956, DOI 10.1103/PhysRevB.60.7956; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Parish A, 2011, ET113 INN RES PROD; Park JW, 2011, NANOTOXICOLOGY, V5, P406, DOI 10.3109/17435390.2010.525329; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Salonen E, 2008, SMALL, V4, P1986, DOI 10.1002/smll.200701279; Spohn P, 2009, ENVIRON POLLUT, V157, P1134, DOI 10.1016/j.envpol.2008.08.013; Todorovic-Markovic B, 2008, APPL SURF SCI, V255, P3283, DOI 10.1016/j.apsusc.2008.09.043; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Verschueren K, 2001, HDB ENV DATA ORGANIC, P314; Xia XR, 2010, TOXICOL LETT, V197, P128, DOI 10.1016/j.toxlet.2010.05.010; Xia XR, 2010, TOXICOL APPL PHARM, V242, P29, DOI 10.1016/j.taap.2009.09.011; Zhang LL, 2011, ENVIRON SCI TECHNOL, V45, P1341, DOI 10.1021/es102316m	54	8	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114490	10.1371/journal.pone.0114490	http://dx.doi.org/10.1371/journal.pone.0114490			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473947	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500040
J	Sanyal, C; Aprikian, A; Cury, F; Chevalier, S; Dragomir, A				Sanyal, Chiranjeev; Aprikian, Armen; Cury, Fabio; Chevalier, Simone; Dragomir, Alice			Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; RADICAL RETROPUBIC PROSTATECTOMY; ANDROGEN-DEPRIVATION THERAPY; EXTERNAL-BEAM RADIOTHERAPY; DOSE-RATE BRACHYTHERAPY; BIOCHEMICAL RECURRENCE; ACTIVE SURVEILLANCE; FREE SURVIVAL; RISK; MORTALITY	Background: Prostate cancer (PCa) is the most common non-skin cancer among men in developed countries. Several novel treatments have been adopted by healthcare systems to manage PCa. Most of the observational studies and randomized trials on PCa have concurrently evaluated fewer treatments over short follow-up. Further, preceding decision analytic models on PCa management have not evaluated various contemporary management options. Therefore, a contemporary decision analytic model was necessary to address limitations to the literature by synthesizing the evidence on novel treatments thereby forecasting short and long-term clinical outcomes. Objectives: To develop and validate a Markov Monte Carlo model for the contemporary clinical management of PCa, and to assess the clinical burden of the disease from diagnosis to end-of-life. Methods: A Markov Monte Carlo model was developed to simulate the management of PCa in men 65 years and older from diagnosis to end-of-life. Health states modeled were: risk at diagnosis, active surveillance, active treatment, PCa recurrence, PCa recurrence free, metastatic castrate resistant prostate cancer, overall and PCa death. Treatment trajectories were based on state transition probabilities derived from the literature. Validation and sensitivity analyses assessed the accuracy and robustness of model predicted outcomes. Results: Validation indicated model predicted rates were comparable to observed rates in the published literature. The simulated distribution of clinical outcomes for the base case was consistent with sensitivity analyses. Predicted rate of clinical outcomes and mortality varied across risk groups. Life expectancy and health adjusted life expectancy predicted for the simulated cohort was 20.9 years (95% CI 20.5-21.3) and 18.2 years (95% CI 17.9-18.5), respectively. Conclusion: Study findings indicated contemporary management strategies improved survival and quality of life in patients with PCa. This model could be used to compare long-term outcomes and life expectancy conferred of PCa management paradigms.	[Sanyal, Chiranjeev; Aprikian, Armen; Cury, Fabio; Chevalier, Simone; Dragomir, Alice] McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada; [Aprikian, Armen; Chevalier, Simone; Dragomir, Alice] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Cury, Fabio] McGill Univ, Dept Radiat Oncol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University; McGill University	Dragomir, A (corresponding author), McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada.	alice.dragomir@muhc.mcgill.ca	Cury, Fabio L./AAW-5633-2020	Cury, Fabio L./0000-0003-1293-0822	Fonds de recherche du Quebec-Sante (FRQ-S)	Fonds de recherche du Quebec-Sante (FRQ-S)	Chiranjeev Sanyal is a recipient of a doctoral research studentship from ''The Fonds de recherche du Quebec-Sante (FRQ-S)'' (www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2009, RADIOTHER ONCOL, V93, P185, DOI 10.1016/j.radonc.2009.09.001; AlDuhaiby EZ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-18; Alicikus ZA, 2011, CANCER-AM CANCER SOC, V117, P1429, DOI 10.1002/cncr.25467; [Anonymous], 2000, REPORT DEMOGRAPHIC S; [Anonymous], 1999, DEATHS PERCENT TOTAL; Astrom L, 2005, RADIOTHER ONCOL, V74, P157, DOI 10.1016/j.radonc.2004.10.014; Azoulay L, 2011, EUR UROL, V60, P1244, DOI 10.1016/j.eururo.2011.08.041; Bensimon L, 2014, CANCER CAUSE CONTROL, V25, P329, DOI 10.1007/s10552-013-0334-6; Carter H. Ballentine, 2012, Journal of the National Cancer Institute Monographs, P175, DOI 10.1093/jncimonographs/lgs036; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; COWEN ME, 1994, J CLIN EPIDEMIOL, V47, P3, DOI 10.1016/0895-4356(94)90029-9; Crook JM, 2012, NEW ENGL J MED, V367, P895, DOI 10.1056/NEJMoa1201546; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; Deutsch I, 2010, BRACHYTHERAPY, V9, P313, DOI 10.1016/j.brachy.2010.02.196; Dragomir A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-252; Drummond M F, 1992, Int J Technol Assess Health Care, V8, P671; Drummond MF, 2015, METHODS EC EVALUATIO; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Efstathiou JA, 2008, EUR UROL, V54, P816, DOI 10.1016/j.eururo.2008.01.021; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Fleming C, 1993, JAMA, V269, P2650; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Galalae RM, 2004, INT J RADIAT ONCOL, V58, P1048, DOI 10.1016/j.ijrobp.2003.08.003; Grover SA, 2000, CAN MED ASSOC J, V162, P977; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Hogendoorn W, 2014, J VASC SURG, V59, P651, DOI 10.1016/j.jvs.2013.09.026; Hotte SJ, 2010, CURR ONCOL, V17, pS72; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Keegan KA, 2011, CANCER, V118, P3512; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Kotecha R, 2013, BRACHYTHERAPY, V12, P44, DOI 10.1016/j.brachy.2012.05.003; Merino T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-530; Oudard S, 2013, CANCER TREAT REV, V39, P275, DOI 10.1016/j.ctrv.2012.09.005; Pataky R, 2014, INT J CANC; Pierorazio PM, 2013, BJU INT; Prada PJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-31; Rodrigues G, 2012, CUAJ-CAN UROL ASSOC, V6, P121, DOI 10.5489/cuaj.11085; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Saad F, 2013, CUAJ-CAN UROL ASSOC, V7, P231, DOI 10.5489/cuaj.1542; Sathya JR, 2005, J CLIN ONCOL, V23, P1192, DOI 10.1200/JCO.2005.06.154; Siebert U, 2006, EUR J PUBLIC HEALTH, V16, P185, DOI 10.1093/eurpub/cki163; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Smith MR, 2008, J CLIN ONCOL, V26, P4333, DOI 10.1200/JCO.2008.16.5845; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; Spratt DE, 2013, INT J RADIAT ONCOL, V85, P686, DOI 10.1016/j.ijrobp.2012.05.023; Spratt DE, 2014, BJU INT; Statistics Canada, TABL 102 0122 HLTH A; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Stone NN, 2010, INT J RADIAT ONCOL, V76, P355, DOI 10.1016/j.ijrobp.2009.01.078; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; U.S. Population by Age, 2010, NAT TABL TRENDS; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; van den Bergh RCN, 2009, EUR UROL, V55, P1, DOI 10.1016/j.eururo.2008.09.007; van Kempen BJH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-158; Vora SA, 2013, J UROLOGY, V190, P521, DOI 10.1016/j.juro.2013.02.012; Yu O, 2014, J CLIN ONCOL, V32, P5, DOI 10.1200/JCO.2013.49.4757; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029; Zelefsky MJ, 2010, J CLIN ONCOL, V28, P1508, DOI 10.1200/JCO.2009.22.2265	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113432	10.1371/journal.pone.0113432	http://dx.doi.org/10.1371/journal.pone.0113432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474006	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500082
J	Sun, ZL; Wang, HY; Wang, J; Zhou, LM; Yang, PM				Sun, Zhenliang; Wang, Huiyan; Wang, Jing; Zhou, Lianming; Yang, Peiming			Chemical Composition and Anti-Inflammatory, Cytotoxic and Antioxidant Activities of Essential Oil from Leaves of Mentha piperita Grown in China	PLOS ONE			English	Article							DNA-DAMAGE; INFLAMMATION; CONSTITUENTS; SUPPRESSION; APOPTOSIS; OXIDE	The chemical composition, anti- inflammatory, cytotoxic and antioxidant activities of essential oil from leaves of Mentha piperita (MEO) grown in China were investigated. Using GC- MS analysis, the chemical composition of MEO was characterized, showing that it was mainly composed of menthol, menthone and menthy acetate. MEO exhibited potent anti- inflammatory activities in a croton oil-induced mouse ear edema model. It could also effectively inhibit nitric oxide (NO) and prostaglandin E2 (PGE2) production in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. The cytotoxic effect was assessed against four human cancer cells. MEO was found to be significantly active against human lung carcinoma SPC-A1, human leukemia K562 and human gastric cancer SGC-7901 cells, with an IC50 value of 10.89, 16.16 and 38.76 mu g/ml, respectively. In addition, MEO had moderate antioxidant activity. The results of this study may provide an experimental basis for further systematic research, rational development and clinical utilization of peppermint resources.	[Sun, Zhenliang; Yang, Peiming] China State Inst Pharmaceut Ind, Shanghai Inst Pharmaceut Ind, State Key Lab New Drug & Pharmaceut Proc, Shanghai 200040, Peoples R China; [Wang, Huiyan] Ji Lin Med Coll, Changchun 132013, Jilin, Peoples R China; [Wang, Jing; Zhou, Lianming] Southern Med Univ, Fengxian Hosp, Dept Gen Surg, Shanghai 201499, Peoples R China	Southern Medical University - China	Zhou, LM (corresponding author), Southern Med Univ, Fengxian Hosp, Dept Gen Surg, Shanghai 201499, Peoples R China.	lianmingzhou@163.com; qqsohu@163.com						Abbas SR, 2014, FOOD CHEM, V147, P10, DOI 10.1016/j.foodchem.2013.09.113; Chou ST, 2012, FOOD CHEM, V134, P262, DOI 10.1016/j.foodchem.2012.02.131; Duh CY, 1999, J NAT PROD, V62, P1518, DOI 10.1021/np990212d; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; He K, 1997, J NAT PROD, V60, P38, DOI 10.1021/np960513c; Iscan G, 2002, J AGR FOOD CHEM, V50, P3943, DOI 10.1021/jf011476k; Kim JY, 2008, J OLEO SCI, V57, P623, DOI 10.5650/jos.57.623; Lampronti I, 2006, INT J ONCOL, V29, P989; Li LJ, 2011, PHYTOTHER RES, V25, P1095, DOI 10.1002/ptr.3367; Lin CT, 2008, BIORESOURCE TECHNOL, V99, P8783, DOI 10.1016/j.biortech.2008.04.041; Liu J, 2012, J PHARM PHARMACOL, V64, P146, DOI 10.1111/j.2042-7158.2011.01371.x; Liu X, 2012, CARBOHYD POLYM, V90, P1664, DOI 10.1016/j.carbpol.2012.07.047; Lu CG, 2008, J ANHUI AGR SCI, V36, P425; [陆长根 LU Changgen], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P400; Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Menichini F, 2009, FOOD CHEM, V115, P679, DOI 10.1016/j.foodchem.2008.12.067; Mimica-Dukic N, 2003, PLANTA MED, V69, P413, DOI 10.1055/s-2003-39704; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pattrick P, 2008, ESTUAR COAST SHELF S, V79, P251, DOI 10.1016/j.ecss.2008.04.009; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Rashid S, 2013, FOOD CHEM, V138, P693, DOI 10.1016/j.foodchem.2012.10.102; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tung YT, 2008, BIORESOURCE TECHNOL, V99, P3908, DOI 10.1016/j.biortech.2007.07.050; Tyagi AK, 2011, FOOD CONTROL, V22, P1707, DOI 10.1016/j.foodcont.2011.04.002; Xu PengXiang, 2003, Chemistry and Industry of Forest Products, V23, P43; Yadegarinia D, 2006, PHYTOCHEMISTRY, V67, P1249, DOI 10.1016/j.phytochem.2006.04.025; Yu JQ, 2011, FOOD CHEM, V126, P1593, DOI 10.1016/j.foodchem.2010.12.027	28	65	65	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114767	10.1371/journal.pone.0114767	http://dx.doi.org/10.1371/journal.pone.0114767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493616	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400075
J	Aper, SJA; van Spreeuwel, ACC; van Turnhout, MC; van der Linden, AJ; Pieters, PA; van der Zon, NLL; de la Rambelje, SL; Bouten, CVC; Merkx, M				Aper, Stijn J. A.; van Spreeuwel, Ariane C. C.; van Turnhout, Mark C.; van der Linden, Ardjan J.; Pieters, Pascal A.; van der Zon, Nick L. L.; de la Rambelje, Sander L.; Bouten, Carlijn V. C.; Merkx, Maarten			Colorful Protein-Based Fluorescent Probes for Collagen Imaging	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; IN-VIVO; EXTRACELLULAR-MATRIX; TISSUE; MICROSCOPY; BINDING; 3D; AUTOFLUORESCENCE; QUANTIFICATION; VISUALIZATION	Real-time visualization of collagen is important in studies on tissue formation and remodeling in the research fields of developmental biology and tissue engineering. Our group has previously reported on a fluorescent probe for the specific imaging of collagen in live tissue in situ, consisting of the native collagen binding protein CNA35 labeled with fluorescent dye Oregon Green 488 (CNA35-OG488). The CNA35-OG488 probe has become widely used for collagen imaging. To allow for the use of CNA35-based probes in a broader range of applications, we here present a toolbox of six genetically-encoded collagen probes which are fusions of CNA35 to fluorescent proteins that span the visible spectrum: mTurquoise2, EGFP, mAmetrine, LSSmOrange, tdTomato and mCherry. While CNA35-OG488 requires a chemical conjugation step for labeling with the fluorescent dye, these protein-based probes can be easily produced in high yields by expression in E. coli and purified in one step using Ni2+-affinity chromatography. The probes all bind specifically to collagen, both in vitro and in porcine pericardial tissue. Some first applications of the probes are shown in multicolor imaging of engineered tissue and two-photon imaging of collagen in human skin. The fully-genetic encoding of the new probes makes them easily accessible to all scientists interested in collagen formation and remodeling.	[Aper, Stijn J. A.; van der Linden, Ardjan J.; Pieters, Pascal A.; van der Zon, Nick L. L.; de la Rambelje, Sander L.; Merkx, Maarten] Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, Eindhoven, Netherlands; [Aper, Stijn J. A.; van der Linden, Ardjan J.; Pieters, Pascal A.; van der Zon, Nick L. L.; de la Rambelje, Sander L.; Merkx, Maarten] Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands; [van Spreeuwel, Ariane C. C.; van Turnhout, Mark C.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Eindhoven University of Technology	Merkx, M (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, Eindhoven, Netherlands.	m.merkx@tue.nl	Merkx, Maarten/E-7009-2011; Bouten, Carlijn/AAT-5187-2020	Bouten, Carlijn/0000-0003-1035-5094; van der Zon, Nick L L/0000-0003-4198-0634; Pieters, Pascal/0000-0003-2032-0100; van Turnhout, Mark/0000-0002-2465-8427	ERC starting grant [ERC-2011-StG 280255]; Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]	ERC starting grant; Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM)	This work was supported by an ERC starting grant (ERC-2011-StG 280255) and a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant no. FES0908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8; Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Breurken M, 2011, CHEM COMMUN, V47, P7998, DOI 10.1039/c1cc11964h; Breurken M, 2010, CHEMBIOCHEM, V11, P1665, DOI 10.1002/cbic.201000223; Brownfield DG, 2013, CURR BIOL, V23, P703, DOI 10.1016/j.cub.2013.03.032; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chai CK, 2013, J BIOMECH, V46, P1759, DOI 10.1016/j.jbiomech.2013.03.017; Chen JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019097; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; Cox MAJ, 2010, TISSUE ENG PT A, V16, P1527, DOI [10.1089/ten.tea.2009.0263, 10.1089/ten.TEA.2009.0263]; Danila D, 2013, NANOMED-NANOTECHNOL, V9, P1067, DOI 10.1016/j.nano.2013.03.009; de Jonge N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073161; de Jonge N, 2013, ANN BIOMED ENG, V41, P763, DOI 10.1007/s10439-012-0704-3; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/nmeth.1596, 10.1038/NMETH.1596]; Foolen J, 2012, BIOMATERIALS, V33, P7508, DOI 10.1016/j.biomaterials.2012.06.103; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Fritze O, 2010, TISSUE ENG PART C-ME, V16, P705, DOI [10.1089/ten.tec.2009.0309, 10.1089/ten.TEC.2009.0309]; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; GLASSMAN W, 1995, AM J OBSTET GYNECOL, V173, P1550, DOI 10.1016/0002-9378(95)90648-7; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Huyghe JM, 2012, BIOMECH MODEL MECHAN, V11, P161, DOI 10.1007/s10237-011-0300-8; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Klink A, 2011, J AM COLL CARDIOL, V58, P2522, DOI 10.1016/j.jacc.2011.09.017; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li Y, 2013, CURR OPIN CHEM BIOL, V17, P968, DOI 10.1016/j.cbpa.2013.10.018; Mees G, 2012, J NUCL MED, V53, P464, DOI 10.2967/jnumed.111.095794; Megens RTA, 2007, MOL IMAGING, V6, P247, DOI 10.2310/7290.2007.00021; Megens RTA, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2965542; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rubbens MP, 2009, ANN BIOMED ENG, V37, P1263, DOI 10.1007/s10439-009-9698-x; Rubbens MP, 2009, TISSUE ENG PT A, V15, P999, DOI 10.1089/ten.tea.2007.0396; Sanders HMHF, 2009, CONTRAST MEDIA MOL I, V4, P81, DOI 10.1002/cmmi.266; Sanders HMHF, 2011, CHEM COMMUN, V47, P1503, DOI 10.1039/c0cc02901g; Schrauwen JTC, 2012, J STRUCT BIOL, V180, P335, DOI 10.1016/j.jsb.2012.06.007; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; van Bochove GS, 2012, EUR J INORG CHEM, P2115, DOI 10.1002/ejic.201200010; van Spreeuwel AC, 2014, INTEGR BIOL CAMB; Vis PWR, 2012, J CELL MOL MED, V16, P730, DOI 10.1111/j.1582-4934.2011.01351.x; Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Xia ZY, 2011, ACS CHEM BIOL, V6, P1117, DOI 10.1021/cb200135e; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	52	45	45	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114983	10.1371/journal.pone.0114983	http://dx.doi.org/10.1371/journal.pone.0114983			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490719	Green Submitted, gold, Green Published			2022-12-26	WOS:000347515300100
J	Lin, LJ; Liao, MA; Ren, YJ; Luo, L; Zhang, X; Yang, DY; He, J				Lin, Lijin; Liao, Ming'an; Ren, Yajun; Luo, Li; Zhang, Xiao; Yang, Daiyu; He, Jing			Effects of Mulching Tolerant Plant Straw on Soil Surface on Growth and Cadmium Accumulation of Galinsoga parviflora	PLOS ONE			English	Article							HYPERACCUMULATOR; RICE; LEAD; VARIETIES	Pot and field experiments were conducted to study the effects of mulching with straw of cadmium (Cd) tolerant plants (Ranunculus sieboldii, Mazus japonicus, Clinopodium confine and Plantago asiatica) on growth and Cd accumulation of Galinsoga parviflora in Cd-contaminated soil. In the pot experiment, mulching with M. japonicus straw increased the root biomass, stem biomass, leaf biomass, shoot biomass, plant height and activities of antioxidant enzymes (superoxide dismutase, peroxidase and catalase) of G. parviflora compared with the control, whereas mulching with straws of R. sieboldii, C. confine and P. asiatica decreased these parameters. Straws of the four Cd-tolerant plants increased the Cd content in roots of G. parviflora compared with the control. However, only straws of M. japonicus and P. asiatica increased the Cd content in shoots of G. parviflora, reduced the soil pH, and increased the soil exchangeable Cd concentration. Straw of M. japonicus increased the amount of Cd extraction in stems, leaves and shoots of G. parviflora by 21.11%, 29.43% and 24.22%, respectively, compared with the control, whereas straws of the other three Cd-tolerant plants decreased these parameters. In the field experiment, the M. japonicus straw also increased shoot biomass, Cd content in shoots, and amount of Cd extraction in shoots of G. parviflora compared with the control. Therefore, straw of M. japonicus can be used to improve the Cd extraction ability of G. parviflora from Cd-contaminated soil.	[Lin, Lijin; Liao, Ming'an; Ren, Yajun; Luo, Li; Zhang, Xiao; Yang, Daiyu; He, Jing] Sichuan Agr Univ, Coll Hort, Yaan 625014, Sichuan, Peoples R China; [Lin, Lijin] Yaan Soil & Water Conservat Monitoring Substn, Yaan 625000, Sichuan, Peoples R China	Sichuan Agricultural University	Liao, MA (corresponding author), Sichuan Agr Univ, Coll Hort, Yaan 625014, Sichuan, Peoples R China.	lman@sicau.edu.cn						Bao S.D., 2000, AGROCHEMICAL ANAL SO, V3rd ed.; Blanco-Canqui H, 2007, SOIL TILL RES, V95, P240, DOI 10.1016/j.still.2007.01.004; [陈良华 Chen Lianghua], 2012, [四川农业大学学报, Journal of Sichuan Agricultural University], V30, P174; DATTA R, 2004, ENV GEOSCI, V11, P53, DOI DOI 10.1306/eg.08280303014; Du RJ, 2011, INT J PHYTOREMEDIAT, V13, P1024, DOI 10.1080/15226514.2010.549862; Einhellig FA, 1996, AGRON J, V88, P886, DOI 10.2134/agronj1996.00021962003600060007x; Ge Xiao, 2014, Journal of Ecology and Rural Environment, V30, P369; Gong B, 2013, SCI HORTIC-AMSTERDAM, V161, P49, DOI 10.1016/j.scienta.2013.06.027; Hao Z.B., 2004, PLANT PHYSL EXPT; Kulikova ZL, 2010, B ENVIRON CONTAM TOX, V85, P243, DOI 10.1007/s00128-010-0046-5; Li YJ., 2001, ENV PROBLEMS COUNTER; Lin LJ, 2014, ENVIRON TOXICOL CHEM, V33, P2422, DOI 10.1002/etc.2694; Lin LJ, 2014, ENVIRON TOXICOL CHEM, V33, P1950, DOI 10.1002/etc.2626; Liu D, 2007, B ENVIRON CONTAM TOX, V78, P280, DOI 10.1007/s00128-007-9121-y; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042944; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Maestri E, 2010, ENVIRON EXP BOT, V68, P1, DOI 10.1016/j.envexpbot.2009.10.011; Marques APGC, 2009, CRIT REV ENV SCI TEC, V39, P622, DOI 10.1080/10643380701798272; McGrath SP, 2002, ADV AGRON, V75, P1, DOI 10.1016/S0065-2113(02)75002-5; [聂发辉 Nie Fahui], 2005, [生态环境, Ecology and Environment], V14, P136; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Rastmanesh F, 2010, B ENVIRON CONTAM TOX, V85, P515, DOI 10.1007/s00128-010-0149-z; Shan YuHua, 2006, Acta Pedologica Sinica, V43, P941; Tatar E, 1998, MICROCHEM J, V58, P306, DOI 10.1006/mchj.1997.1559; van Asten PJA, 2005, NUTR CYCL AGROECOSYS, V72, P255, DOI 10.1007/s10705-005-3108-z; Wang ME, 2006, ENVIRON POLLUT, V144, P572, DOI 10.1016/j.envpol.2006.01.024; Whitbread A, 2003, AGR ECOSYST ENVIRON, V100, P251, DOI 10.1016/S0167-8809(03)00189-0; Whiting SN, 2001, ENVIRON SCI TECHNOL, V35, P3237, DOI 10.1021/es010644m; Yang YY, 2000, PLANT PHYSIOL, V124, P1019, DOI 10.1104/pp.124.3.1019; Zhang XF, 2011, J HAZARD MATER, V189, P414, DOI 10.1016/j.jhazmat.2011.02.053; Zhao HuaYin, 2011, Journal of Environmental Protection, V2, P932, DOI 10.4236/jep.2011.27106; Zhu HH, 2010, PLANT SOIL, V331, P427, DOI 10.1007/s11104-009-0263-z	32	27	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114957	10.1371/journal.pone.0114957	http://dx.doi.org/10.1371/journal.pone.0114957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490210	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300097
J	Badrinarayan, P; Sastry, GN				Badrinarayan, Preethi; Sastry, G. Narahari			Specificity Rendering 'Hot-Spots' for Aurora Kinase Inhibitor Design: The Role of Non-Covalent Interactions and Conformational Transitions	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; P38 MAP KINASE; CRYSTAL-STRUCTURE; INACTIVE CONFORMATIONS; SECONDARY STRUCTURE; PROTEIN-KINASES; A KINASE; BINDING; POTENT; DATABASE	The present study examines the conformational transitions occurring among the major structural motifs of Aurora kinase (AK) concomitant with the DFG-flip and deciphers the role of non-covalent interactions in rendering specificity. Multiple sequence alignment, docking and structural analysis of a repertoire of 56 crystal structures of AK from Protein Data Bank (PDB) has been carried out. The crystal structures were systematically categorized based on the conformational disposition of the DFG-loop [in (D-I) 42, out (D-O) 5 and out-up (D-OU) 9], G-loop [extended (G(E)) 53 and folded (G(F)) 3] and alpha C-helix [in (C-I) 42 and out (C-O) 14]. The overlapping subsets on categorization show the inter-dependency among structural motifs. Therefore, the four distinct possibilities a) 2W1C (D-I, C-I, G(E)) b) 3E5A (D-I, C-I, G(F)) c) 3DJ6 (D-I, C-O, G(F)) d) 3UNZ (D-OU, C-O, G(F)) along with their co-crystals and apo-forms were subjected to molecular dynamics simulations of 40 ns each to evaluate the variations of individual residues and their impact on forming interactions. The non-covalent interactions formed by the 157 AK co-crystals with different regions of the binding site were initially studied with the docked complexes and structure interaction fingerprints. The frequency of the most prominent interactions was gauged in the AK inhibitors from PDB and the four representative conformations during 40 ns. Based on this study, seven major non-covalent interactions and their complementary sites in AK capable of rendering specificity have been prioritized for the design of different classes of inhibitors.	[Badrinarayan, Preethi; Sastry, G. Narahari] Indian Inst Chem Technol, CSIR, Mol Modeling Grp, Hyderabad 500607, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Sastry, GN (corresponding author), Indian Inst Chem Technol, CSIR, Mol Modeling Grp, Hyderabad 500607, Andhra Pradesh, India.	gnsastry@gmail.com	Badrinarayan, Preethi/D-4442-2014	Badrinarayan, Preethi/0000-0001-6167-1754	CSIR 12th Five Year Project GENESIS [BSC 0121]	CSIR 12th Five Year Project GENESIS	Funding for this work came from the CSIR 12th Five Year Project GENESIS (BSC 0121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2012, XLSTAT 2012 DAT AN S; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CB, 2008, ACS CHEM BIOL, V3, P180, DOI 10.1021/cb700200w; Badrinarayan P, 2013, CURR PHARM DESIGN, V19, P4714, DOI 10.2174/1381612811319260005; Badrinarayan P, 2012, J MOL GRAPH MODEL, V34, P89, DOI 10.1016/j.jmgm.2011.12.009; Badrinarayan P, 2011, COMB CHEM HIGH T SCR, V14, P840, DOI 10.2174/138620711797537102; Badrinarayan P, 2011, J CHEM INF MODEL, V51, P115, DOI 10.1021/ci100340w; Bavetsias V, 2013, J MED CHEM, V56, P9122, DOI 10.1021/jm401115g; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Cancilla MT, 2008, BIOORG MED CHEM LETT, V18, P3978, DOI 10.1016/j.bmcl.2008.06.011; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Dietrich J, 2010, BIOORGAN MED CHEM, V18, P5738, DOI 10.1016/j.bmc.2010.05.063; Dixon SL, 2006, CHEM BIOL DRUG DES, V67, P370, DOI 10.1111/j.1747-0285.2006.00384.x; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Eswar M.A., 2006, CURR PROTOC BIOINF, V15, P561; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Ghose AK, 2008, J MED CHEM, V51, P5149, DOI 10.1021/jm800475y; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Guimaraes CRW, 2011, J CHEM INF MODEL, V51, P1199, DOI 10.1021/ci200153c; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Helms V, 1997, PROTEIN SCI, V6, P2336; Heron NM, 2006, BIOORG MED CHEM LETT, V16, P1320, DOI 10.1016/j.bmcl.2005.11.053; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hyeon C, 2009, P NATL ACAD SCI USA, V106, P3023, DOI 10.1073/pnas.0813266106; Hynes J, 2008, J MED CHEM, V51, P4, DOI 10.1021/jm7009414; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kuglstatter A, 2010, BIOORG MED CHEM LETT, V20, P5217, DOI 10.1016/j.bmcl.2010.06.157; Kulkarni RG, 2006, CURR PHARM DESIGN, V12, P2437, DOI 10.2174/138161206777698945; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Libertini S, 2010, RECENT PAT ANTI-CANC, V5, P219, DOI 10.2174/157489210791760517; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Marcou G, 2007, J CHEM INF MODEL, V47, P195, DOI 10.1021/ci600342e; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin AJM, 2011, BIOINFORMATICS, V27, P2003, DOI 10.1093/bioinformatics/btr191; Martin MP, 2012, ACS CHEM BIOL, V7, P698, DOI 10.1021/cb200508b; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mountzios G, 2008, CANCER TREAT REV, V34, P175, DOI 10.1016/j.ctrv.2007.09.005; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliveira TM, 2011, J PHYS CHEM A, V115, P3895, DOI 10.1021/jp108286r; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Patel RY, 2010, J PROTEOME RES, V9, P4433, DOI 10.1021/pr100662s; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pflug A, 2011, BIOCHEM J, V440, P85, DOI 10.1042/BJ20110592; Pollard JR, 2009, J MED CHEM, V52, P2629, DOI 10.1021/jm8012129; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Reddy AS, 2008, COMPUT BIOL CHEM, V32, P387, DOI 10.1016/j.compbiolchem.2008.03.017; Reddy AS, 2007, PROTEINS, V67, P1179, DOI 10.1002/prot.21202; Seeliger MA, 2009, CANCER RES, V69, P2384, DOI 10.1158/0008-5472.CAN-08-3953; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Solanki S, 2011, J MED CHEM, V54, P1626, DOI 10.1021/jm1011726; Telesco SE, 2011, MOL BIOSYST, V7, P2066, DOI 10.1039/c0mb00345j; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Linden OPJ, 2014, J MED CHEM, V57, P249, DOI 10.1021/jm400378w; Vijay D, 2010, CHEM PHYS LETT, V485, P235, DOI 10.1016/j.cplett.2009.12.012; Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016757; Yan AX, 2011, DRUG DISCOV TODAY, V16, P260, DOI 10.1016/j.drudis.2010.12.003; Yang Y, 2012, MOL BIOSYST, V8, P3049, DOI 10.1039/c2mb25217a; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t; Zhou P, 2012, CURR MED CHEM, V19, P226, DOI 10.2174/092986712803414150; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P2108, DOI 10.1021/ct700166f	87	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113773	10.1371/journal.pone.0113773	http://dx.doi.org/10.1371/journal.pone.0113773			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485544	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600026
J	Lee, SJ; Ritchie, CS; Yaffe, K; Cenzer, IS; Barnes, DE				Lee, Sei J.; Ritchie, Christine S.; Yaffe, Kristine; Cenzer, Irena Stijacic; Barnes, Deborah E.			A Clinical Index to Predict Progression from Mild Cognitive Impairment to Dementia Due to Alzheimer's Disease	PLOS ONE			English	Article							OLDER-ADULTS; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RISK; RECOMMENDATIONS; CLASSIFICATION; VALIDATION; BIOMARKERS; CONVERSION	Background: Mild cognitive impairment is often a precursor to dementia due to Alzheimer's disease, but many patients with mild cognitive impairment never develop dementia. New diagnostic criteria may lead to more patients receiving a diagnosis of mild cognitive impairment. Objective: To develop a prediction index for the 3-year risk of progression from mild cognitive impairment to dementia relying only on information that can be readily obtained in most clinical settings. Design and Participants: 382 participants diagnosed with amnestic mild cognitive impairment enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI), a multi-site, longitudinal, observational study. Main Predictors Measures: Demographics, comorbid conditions, caregiver report of participant symptoms and function, and participant performance on individual items from basic neuropsychological scales. Main Outcome Measure: Progression to probable Alzheimer's disease. Key Results: Subjects had a mean (SD) age of 75 (7) years and 43% progressed to probable Alzheimer's disease within 3 years. Important independent predictors of progression included being female, resisting help, becoming upset when separated from caregiver, difficulty shopping alone, forgetting appointments, number of words recalled from a 10-word list, orientation and difficulty drawing a clock. The final point score could range from 0 to 16 (mean [SD]: 4.2 [2.9]). The optimism-corrected Harrell's c-statistic was 0.71(95% CI: 0.68-0.75). Fourteen percent of subjects with low risk scores (0-2 points, n=124) converted to probable Alzheimer's disease over 3 years, compared to 51% of those with moderate risk scores (3-8 points, n=223) and 91% of those with high risk scores (9-16 points, n=35). Conclusions: An index using factors that can be obtained in most clinical settings can predict progression from amnestic mild cognitive impairment to probable Alzheimer's disease and may help clinicians differentiate between mild cognitive impairment patients at low vs. high risk of progression.	[Lee, Sei J.; Ritchie, Christine S.; Cenzer, Irena Stijacic] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Lee, Sei J.; Ritchie, Christine S.; Yaffe, Kristine; Cenzer, Irena Stijacic; Barnes, Deborah E.] San Francisco VA Med Ctr, San Francisco, CA USA; [Ritchie, Christine S.] Jewish Home San Francisco, San Francisco, CA USA; [Yaffe, Kristine; Barnes, Deborah E.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine; Barnes, Deborah E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lee, SJ (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.	sei.lee@ucsf.edu			S.D. Bechtel, Jr. Foundation; National Institutes of Health [K24-AG031155, R01-DK69406, R01-AG26720]; Veterans Health Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031155, P30AG044281, R01AG026720] Funding Source: NIH RePORTER	S.D. Bechtel, Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SJL was supported by the S.D. Bechtel, Jr. Foundation (http://sdbjrfoundation.org/). KY was supported for this study by the National Institutes of Health (K24-AG031155, R01-DK69406 and R01-AG26720) and the Veterans Health Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahalt C, 2012, J GEN INTERN MED, V27, P568, DOI 10.1007/s11606-011-1933-0; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Brodaty H, 2013, ALZHEIMERS DEMENT, V9, P310, DOI 10.1016/j.jalz.2011.11.010; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Klunk WE, 2011, NEUROBIOL AGING, V32, pS20, DOI 10.1016/j.neurobiolaging.2011.09.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miao Y, 2013, SAS GLOBAL FORUM, P504; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Mohs RC., 1994, ADM SCORING MANUAL A; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Panza F, 2005, AM J GERIAT PSYCHIAT, V13, P633, DOI 10.1176/appi.ajgp.13.8.633; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Robinson L, 2011, INT PSYCHOGERIATR, V23, P1026, DOI 10.1017/S1041610210002437; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Zhou B, 2012, J ALZHEIMERS DIS, V30, P367, DOI 10.3233/JAD-2012-112117	39	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113535	10.1371/journal.pone.0113535	http://dx.doi.org/10.1371/journal.pone.0113535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486250	Green Published, gold			2022-12-26	WOS:000346907600021
J	Walthers, CM; Lee, M; Wu, BM; Dunn, JCY				Walthers, Christopher M.; Lee, Min; Wu, Benjamin M.; Dunn, James C. Y.			Smooth Muscle Strips for Intestinal Tissue Engineering	PLOS ONE			English	Article							COLLAGEN EXPRESSION; INTERSTITIAL-CELLS; SCAFFOLDS; GROWTH; NEUROTRANSMISSION; DIFFERENTIATION; PROLIFERATION; MACROPOROSITY; ARCHITECTURE; TGF-BETA-1	Functionally contracting smooth muscle is an essential part of the engineered intestine that has not been replicated in vitro. The purpose of this study is to produce contracting smooth muscle in culture by maintaining the native smooth muscle organization. We employed intact smooth muscle strips and compared them to dissociated smooth muscle cells in culture for 14 days. Cells isolated by enzymatic digestion quickly lost maturity markers for smooth muscle cells and contained few enteric neural and glial cells. Cultured smooth muscle strips exhibited periodic contraction and maintained neural and glial markers. Smooth muscle strips cultured for 14 days also exhibited regular fluctuation of intracellular calcium, whereas cultured smooth muscle cells did not. After implantation in omentum for 14 days on polycaprolactone scaffolds, smooth muscle strip constructs expressed high levels of smooth muscle maturity markers as well as enteric neural and glial cells. Intact smooth muscle strips may be a useful component for engineered intestinal smooth muscle.	[Walthers, Christopher M.; Wu, Benjamin M.; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Div Adv Prosthodont Biomat, Los Angeles, CA USA; [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Hosp Dent, Los Angeles, CA USA; [Lee, Min; Wu, Benjamin M.] Univ Calif Los Angeles, Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA USA; [Dunn, James C. Y.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dunn, JCY (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	jdunn@mednet.ucla.edu		Wu, Benjamin/0000-0001-5236-8534	National Institutes of Health [R01 DK083119]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an R01 DK083119 from the National Institutes of Health (www.nih.gov) received by JCYD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2001, FASEB J, V15, P1546, DOI 10.1096/fj.00-0756com; Altomare A, 2014, AM J PHYSIOL-GASTR L, V307, pG77, DOI 10.1152/ajpgi.00385.2013; Bines JE, 2009, J GASTROEN HEPATOL, V24, pS86, DOI 10.1111/j.1440-1746.2009.06077.x; Bulick AS, 2009, TISSUE ENG PT A, V15, P815, DOI 10.1089/ten.tea.2008.0179; Cha JM, 2006, ARTIF ORGANS, V30, P704, DOI 10.1111/j.1525-1594.2006.00287.x; de Filippo RE, 2003, TISSUE ENG, V9, P301, DOI 10.1089/107632703764664765; De Philippo RE, 2008, TRANSPLANTATION, V86, P208, DOI 10.1097/TP.0b013e31817f1686; Donohoe CL, 2010, SURG-J R COLL SURG E, V8, P270, DOI 10.1016/j.surge.2010.06.004; GABELLA G, 1981, NEUROSCIENCE, V6, P425, DOI 10.1016/0306-4522(81)90135-4; Gabella Giorgio, 2012, Journal of Smooth Muscle Research, V48, P65; Geisbauer CL, 2012, J SURG RES, V174, P257, DOI 10.1016/j.jss.2010.12.016; Goyal RK, 2010, AM J PHYSIOL-GASTR L, V298, pG10, DOI 10.1152/ajpgi.00426.2009; Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074, DOI 10.1152/ajpgi.1999.277.5.G1074; Guyton AC, 2000, TXB MED PHYSL, P87; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Joshi VS, 2013, J SURG RES, V183, P18, DOI 10.1016/j.jss.2013.01.005; Lee M, 2008, TISSUE ENG PT A, V14, P1395, DOI 10.1089/ten.tea.2007.0232; Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816; Marieb E., 2018, HUMAN ANATOMY PHYSL; Mendoza J, 2006, J SURG RES, V136, P8, DOI 10.1016/j.jss.2006.01.027; Miyasaka EA, 2011, PEDIATR SURG INT, V27, P137, DOI 10.1007/s00383-010-2786-z; Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104; Nair DG, 2011, AM J PHYSIOL-GASTR L, V300, pG903, DOI 10.1152/ajpgi.00528.2010; Nakase Y, 2006, TISSUE ENG, V12, P403, DOI 10.1089/ten.2006.12.403; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ruhl A, 2005, NEUROGASTROENT MOTIL, V17, P777, DOI 10.1111/j.1365-2982.2005.00687.x; Sala FG, 2011, TISSUE ENG PT A, V17, P1841, DOI [10.1089/ten.TEA.2010.0564, 10.1089/ten.tea.2010.0564]; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sarna SK, 2008, AM J PHYSIOL-GASTR L, V294, pG372, DOI 10.1152/ajpgi.00344.2007; Shi XZ, 2013, AM J PHYSIOL-GASTR L, V304, pG337, DOI 10.1152/ajpgi.00369.2012; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Somara S, 2009, GASTROENTEROLOGY, V137, P53, DOI 10.1053/j.gastro.2009.03.036; Stanzel RDP, 2010, AM J PHYSIOL-CELL PH, V299, pC805, DOI 10.1152/ajpcell.00086.2010; TENNYSON VM, 1986, ANAT REC, V215, P267, DOI 10.1002/ar.1092150310; Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7; Tortora GJ, 2008, PRINCIPLES ANATOMY P; Walthers CM, 2014, BIOMATERIALS, V35, P5129, DOI 10.1016/j.biomaterials.2014.03.025; Weih S, 2011, LANGENBECKS ARCH SUR; Yazdani SK, 2009, TISSUE ENG PT A, V15, P827, DOI 10.1089/ten.tea.2008.0092; Zakhem E, 2014, BIOMATERIALS, V35, P1882, DOI 10.1016/j.biomaterials.2013.11.049; Zakhem E, 2012, BIOMATERIALS, V33, P4810, DOI 10.1016/j.biomaterials.2012.03.051	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114850	10.1371/journal.pone.0114850	http://dx.doi.org/10.1371/journal.pone.0114850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486279	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600101
J	Schwarz, H; Schmittner, M; Duschl, A; Horejs-Hoeck, J				Schwarz, Harald; Schmittner, Maria; Duschl, Albert; Horejs-Hoeck, Jutta			Residual Endotoxin Contaminations in Recombinant Proteins Are Sufficient to Activate Human CD1c(+) Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FEEDBACK INHIBITOR; HUMAN MONOCYTES; LIPOPOLYSACCHARIDE; CD14; RECOGNITION; RECEPTOR; TOLL-LIKE-RECEPTOR-4; EXPRESSION; IMMATURE	Many commercially available recombinant proteins are produced in Escherichia coli, and most suppliers guarantee contamination levels of less than 1 endotoxin unit (EU). When we analysed commercially available proteins for their endotoxin content, we found contamination levels in the same range as generally stated in the data sheets, but also some that were higher. To analyse whether these low levels of contamination have an effect on immune cells, we stimulated the monocytic cell line THP-1, primary human monocytes, in vitro differentiated human monocyte-derived dendritic cells, and primary human CD1c(+) dendritic cells (DCs) with very low concentrations of lipopolysaccharide (LPS; ranging from 0.002-2 ng/ml). We show that CD1c(+) DCs especially can be activated by minimal amounts of LPS, equivalent to the levels of endotoxin contamination we detected in some commercially available proteins. Notably, the enhanced endotoxin sensitivity of CD1c(+) DCs was closely correlated with high CD14 expression levels observed in CD1c(+) DCs that had been maintained in cell culture medium for 24 hours. When working with cells that are particularly sensitive to LPS, even low endotoxin contamination may generate erroneous data. We therefore recommend that recombinant proteins be thoroughly screened for endotoxin contamination using the limulus amebocyte lysate test, fluorescence-based assays, or a luciferase based NF-kappa B reporter assay involving highly LPS-sensitive cells overexpressing TLR4, MD-2 and CD14.	[Schwarz, Harald; Schmittner, Maria; Duschl, Albert; Horejs-Hoeck, Jutta] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Horejs-Hoeck, J (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	jutta.horejs_hoeck@sbg.ac.at	Duschl, Albert/E-5872-2011; Horejs-Hoeck, Jutta/AAF-1735-2019; Horejs-Hoeck, Jutta/E-5010-2011	Duschl, Albert/0000-0002-7034-9860; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Schwarz, Harald/0000-0002-2898-7826	Austrian Science Fund (FWF) [P22202, P23933]; Austrian Science Fund (FWF) [P 23933] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), grant numbers P22202 and P23933. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRINK M, 1994, LEUKEMIA, V8, P1579; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dawson ME, 1988, PHARM ENG, V8, P9; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; EGNER W, 1993, ADV EXP MED BIOL, V329, P263; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Heumann D, 2002, CLIN CHIM ACTA, V323, P59, DOI 10.1016/S0009-8981(02)00180-8; Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Patterson S, 2005, J IMMUNOL, V174, P8200, DOI 10.4049/jimmunol.174.12.8200; Perera PY, 1997, J IMMUNOL, V158, P4422; Peters M, 2012, INNATE IMMUN-LONDON, V18, P694, DOI 10.1177/1753425912436590; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Proksch P, 2005, J IMMUNOL, V174, P7075, DOI 10.4049/jimmunol.174.11.7075; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schwarz H, 2013, IMMUNOBIOLOGY, V218, P533, DOI 10.1016/j.imbio.2012.06.007; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; ZIEGLERHEITBROCK HWL, 1986, CANCER RES, V46, P5947	30	100	101	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113840	10.1371/journal.pone.0113840	http://dx.doi.org/10.1371/journal.pone.0113840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478795	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200034
J	Kage-Nakadai, E; Imae, R; Suehiro, Y; Yoshina, S; Hori, S; Mitani, S				Kage-Nakadai, Eriko; Imae, Rieko; Suehiro, Yuji; Yoshina, Sawako; Hori, Sayaka; Mitani, Shohei			A Conditional Knockout Toolkit for Caenorhabditis elegans Based on the Cre/loxP Recombination	PLOS ONE			English	Article							SINGLE/LOW-COPY INTEGRATION; SITE-SPECIFIC RECOMBINATION; GENE-EXPRESSION; C. ELEGANS; GENOME; TRIMETHYLPSORALEN; SYSTEM; ULTRAVIOLET; TRANSGENES; FLP	Conditional knockout (cKO) based on site-specific recombination (SSR) technology is a powerful approach for estimating gene functions in a spatially and temporally specific manner in many model animals. In Caenorhabditis elegans (C. elegans), spatial- and temporal-specific gene functions have been largely determined by mosaic analyses, rescue experiments and feeding RNAi methods. To develop a systematic and stable cKO system in C. elegans, we generated Cre recombinase expression vectors that are driven by various tissue-specific or heat-shock promoters. Validation using Cre-mediated fluorescence protein inactivation or activation systems demonstrated successful Cre-dependent loxP excision. We established a collection of multi-copy Cre transgenic strains for each evaluated vector. To evaluate our Cre/loxP-based cKO system, we generated sid-1 deletion mutants harboring floxed sid-1 single-copy integration (SCI) using ultraviolet trimethylpsoralen (UV/TMP) methods. sid-1 mutants that were rescued by the floxed sid-1 SCI were then crossed with the Pdpy-7:: Cre strain for cKO in the hypodermis. The sid-1 cKO animals were resistant to bli-3 RNAi, which causes the Bli-phenotyple in the hypodermis, but they were sensitive to unc-22 RNAi, which leads to twitching of the body wall muscle. Our system, which is based on the combination of a transgenic Cre collection, pre-existing deletion mutants, and UV/TMP SCI methods, provided a systematic approach for cKO in C. elegans.	[Kage-Nakadai, Eriko; Imae, Rieko; Suehiro, Yuji; Yoshina, Sawako; Hori, Sayaka; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kage-Nakadai, Eriko] Osaka City Univ, OCU Adv Res Inst Nat Sci & Technol, Osaka 558, Japan	Tokyo Women's Medical University; Osaka Metropolitan University	Mitani, S (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan.	mitani.shohei@twmu.ac.jp	Sayaka, Hori/AAU-7866-2020		Japan Society for the promotion of Science (JSPS)	Japan Society for the promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the promotion of Science (JSPS) (to E.K.-N. and S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; BRENNER S, 1974, GENETICS, V77, P71; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Cheng Z, 2013, NAT BIOTECHNOL, V31, P934, DOI 10.1038/nbt.2674; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hoier EF, 2000, GENE DEV, V14, P874; Hubbard EJA, 2014, METHODS, V68, P417, DOI 10.1016/j.ymeth.2014.05.007; Kage-Nakadai E, 2014, METHODS, V68, P397, DOI 10.1016/j.ymeth.2014.02.036; Kage-Nakadai E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-1; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Liu PP, 2014, CELL RES, V24, P886, DOI 10.1038/cr.2014.73; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mello C, 1995, DNA TRANSFORMATION; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Shen Z, 2014, DEV CELL; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Voutev R, 2008, GENETICS, V180, P103, DOI 10.1534/genetics.108.090274	24	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114680	10.1371/journal.pone.0114680	http://dx.doi.org/10.1371/journal.pone.0114680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474529	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500054
J	Kang, HH; Kang, JY; Ha, JH; Lee, J; Kim, SK; Moon, HS; Lee, SH				Kang, Hyeon Hui; Kang, Ji Young; Ha, Jick Hwan; Lee, Jongmin; Kim, Sung Kyoung; Moon, Hwa Sik; Lee, Sang Haak			The Associations between Anthropometric Indices and Obstructive Sleep Apnea in a Korean Population	PLOS ONE			English	Article							NECK CIRCUMFERENCE; METABOLIC SYNDROME; FAT DISTRIBUTION; OBESITY; PREVALENCE; DIAGNOSIS; SEVERITY; WEIGHT	Background: Obesity is a major risk factor for the development of obstructive sleep apnea (OSA). Although clinical and epidemiological studies have shown that OSA and obesity are strongly associated, few Asian studies have examined the associations between anthropometric obesity indices and OSA, especially in the Korean population. The purpose of this study was to evaluate the influence of anthropometric obesity indices on OSA in a Korean population. Methods: Anthropometric indices, including neck circumference, waist circumference, and body mass index, were assessed in 383 consecutive subjects with suspected OSA. Results: Of the 383 subjects assessed, 316 (82.5%) were diagnosed with OSA. Neck circumference (r=0.518), waist circumference (r=0.570), and body mass index (r=0.512) were correlated with the apnea-hypopnea index (p<0.001, for all). After adjusting for age, sex, alcohol consumption, and smoking, a logistic regression model showed that neck circumference [odds ratio (OR), 1.414; p<0.001)], waist circumference (OR, 1.114; p<0.001), and body mass index (OR, 1.364; p<0.001) were associated with OSA. The linear regression model showed that neck circumference (beta=3.748, p<0.001), waist circumference (beta=1.272, p<0.001), and body mass index (beta=3.082, p<0.001) were associated with apnea-hypopnea index. The cut-off values for predicting OSA were determined as 34.5 cm for neck circumference, 76.5 cm for waist circumference, and 23.05 kg/m(2) for body mass index for females, and 38.75 cm for neck circumference, 88.5 cm for waist circumference, and 24.95 kg/m(2) for body mass index for males. Conclusion: Increased anthropometric indices were significantly associated with the presence and severity of OSA in a Korean population. In addition, this study demonstrated the cut-off values for body mass index, waist circumference, and neck circumference for increased OSA risk.	[Kang, Hyeon Hui; Kang, Ji Young; Lee, Jongmin; Kim, Sung Kyoung; Moon, Hwa Sik; Lee, Sang Haak] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Seoul, South Korea	Catholic University of Korea	Lee, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Seoul, South Korea.	mdlee@catholic.ac.kr		Kim, Sung Kyoung/0000-0003-2226-8262				Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chan ASL, 2010, INTERN MED J, V40, P102, DOI 10.1111/j.1445-5994.2009.02069.x; Cizza G, 2014, METAB SYNDR RELAT D, V12, P231, DOI 10.1089/met.2013.0093; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dancey DR, 2003, CHEST, V123, P1544, DOI 10.1378/chest.123.5.1544; Davidson TM, 2008, LARYNGOSCOPE, V118, P339, DOI 10.1097/MLG.0b013e3181587d7c; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Iber C., 2007, AASM MANUAL SCORING; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kagawa M, 2007, ASIA PAC J CLIN NUTR, V16, P31; Kang SG, 2013, KOREAN J BIOL PSYCHI, V20, P55; Lam JCM, 2012, RESPIROLOGY, V17, P223, DOI 10.1111/j.1440-1843.2011.02081.x; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Martins Andrea Barral, 2007, J. bras. pneumol., V33, P93, DOI 10.1590/S1806-37132007000100017; McNicholas Walter T, 2008, Proc Am Thorac Soc, V5, P154, DOI 10.1513/pats.200708-118MG; MILLMAN RP, 1995, CHEST, V107, P362, DOI 10.1378/chest.107.2.362; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Phillips BG, 2000, AM J PHYSIOL-HEART C, V279, pH234, DOI 10.1152/ajpheart.2000.279.1.H234; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; Serafini FM, 2001, OBES SURG, V11, P28, DOI 10.1381/096089201321454079; Sharma SK, 2006, CHEST, V130, P149, DOI 10.1378/chest.130.1.149; Simpson L, 2010, SLEEP, V33, P467, DOI 10.1093/sleep/33.4.467; Soylu AC, 2012, SLEEP BREATH, V16, P1151, DOI 10.1007/s11325-011-0623-9; Subramanian S, 2011, SLEEP BREATH, V15, P711, DOI 10.1007/s11325-010-0426-4; Yamagishi K, 2010, EUR RESPIR J, V36, P379, DOI 10.1183/09031936.00118609; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76	31	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114463	10.1371/journal.pone.0114463	http://dx.doi.org/10.1371/journal.pone.0114463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474257	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500033
J	Yadav, D; Singh, R; Vatsa, M; Noore, A				Yadav, Daksha; Singh, Richa; Vatsa, Mayank; Noore, Afzel			Recognizing Age-Separated Face Images: Humans and Machines	PLOS ONE			English	Article							CLASSIFICATION; RECOGNITION; CLASSIFIERS; INFORMATION; QUALITY; BIAS; SEX	Humans utilize facial appearance, gender, expression, aging pattern, and other ancillary information to recognize individuals. It is interesting to observe how humans perceive facial age. Analyzing these properties can help in understanding the phenomenon of facial aging and incorporating the findings can help in designing effective algorithms. Such a study has two components - facial age estimation and age-separated face recognition. Age estimation involves predicting the age of an individual given his/her facial image. On the other hand, age-separated face recognition consists of recognizing an individual given his/her age-separated images. In this research, we investigate which facial cues are utilized by humans for estimating the age of people belonging to various age groups along with analyzing the effect of one's gender, age, and ethnicity on age estimation skills. We also analyze how various facial regions such as binocular and mouth regions influence age estimation and recognition capabilities. Finally, we propose an age-invariant face recognition algorithm that incorporates the knowledge learned from these observations. Key observations of our research are: (1) the age group of newborns and toddlers is easiest to estimate, (2) gender and ethnicity do not affect the judgment of age group estimation, (3) face as a global feature, is essential to achieve good performance in age-separated face recognition, and (4) the proposed algorithm yields improved recognition performance compared to existing algorithms and also outperforms a commercial system in the young image as probe scenario.	[Yadav, Daksha; Noore, Afzel] W Virginia Univ, Morgantown, WV 26506 USA; [Singh, Richa; Vatsa, Mayank] IIIT Delhi, Delhi, India	West Virginia University; Indraprastha Institute of Information Technology Delhi	Vatsa, M (corresponding author), IIIT Delhi, Delhi, India.	mayank@iiitd.ac.in	Singh, Richa/M-9961-2017; Vatsa, Mayank/AAR-7199-2020; Vatsa, Mayank/I-5050-2013	Singh, Richa/0000-0003-4060-4573; Vatsa, Mayank/0000-0001-5952-2274; Vatsa, Mayank/0000-0001-5952-2274	Department of Information Technology, Government of India	Department of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India)	The research is partly supported through a grant from Department of Information Technology, Government of India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allev TR, 1988, SOCIAL APPL ASPECTS; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; Anzures G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011679; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Carbon CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079164; CROSS JF, 1971, PERCEPT PSYCHOPHYS, V10, P393, DOI 10.3758/BF03210319; Fu Y, 2008, IEEE T MULTIMEDIA, V10, P578, DOI 10.1109/TMM.2008.921847; George PA, 2000, VIS COGN, V7, P485, DOI 10.1080/135062800394621; GEORGE PA, 1995, PERCEPTION, V24, P1059, DOI 10.1068/p241059; George PA, 1998, PERCEPTION, V27, P295, DOI 10.1068/p270295; Guodong Guo, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3392, DOI 10.1109/ICPR.2010.828; JONES G, 1984, J EXP CHILD PSYCHOL, V38, P328, DOI 10.1016/0022-0965(84)90129-2; Kittler J, 1998, PATTERN ANAL APPL, V1, P18, DOI 10.1007/BF01238023; Kwon YH, 1999, COMPUT VIS IMAGE UND, V74, P1, DOI 10.1006/cviu.1997.0549; Lanitis A, 2004, IEEE T SYST MAN CY B, V34, P621, DOI 10.1109/TSMCB.2003.817091; Lanitis A, 2002, IEEE T PATTERN ANAL, V24, P442, DOI 10.1109/34.993553; Lanitis A, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/239480; Li ZF, 2011, IEEE T INF FOREN SEC, V6, P1028, DOI 10.1109/TIFS.2011.2156787; Macmillan N. A., 2004, DETECTION THEORY USE; Mayes AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015270; McNicol D., 2005, PRIMER SIGNAL DETECT; Megreya AM, 2011, ACTA PSYCHOL, V137, P83, DOI 10.1016/j.actpsy.2011.03.003; Megvii I., 2013, FACE RES TOOLKIT; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Norwich K. H., 1993, INFORM SENSATION PER; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Paik M. C., 2013, STAT METHODS RATES P; Patterson E., 2007, 2007 1 IEEE INT C BI, P1; Ramanathan N, 2006, IEEE T IMAGE PROCESS, V15, P3349, DOI 10.1109/TIP.2006.881993; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Ricanek K, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P341; Ross A, 2003, PATTERN RECOGN LETT, V24, P2115, DOI 10.1016/S0167-8655(03)00079-5; Singh M, 2014, IEEE ACCESS, V2, P822, DOI 10.1109/ACCESS.2014.2344667; Tistarelli Massimo, 2013, Age Factors in Biometric Processing, P253, DOI 10.1049/PBSP010E_ch14; Vapnik V., 1998, STAT LEARNING THEORY; Vatsa M, 2007, INT J NEURAL SYST, V17, P343, DOI 10.1142/S0129065707001196; Wolf L., 2008, WORKSH FAC INR LIF I; Yadav D, 2013, IEEE COMPUT SOC CONF, P173, DOI 10.1109/CVPRW.2013.33; Yang ZG, 2007, LECT NOTES COMPUT SC, V4642, P464	43	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112234	10.1371/journal.pone.0112234	http://dx.doi.org/10.1371/journal.pone.0112234			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474200	Green Published, gold			2022-12-26	WOS:000346382500066
J	Singleton, DC; Rouhi, P; Zois, CE; Haider, S; Li, JL; Kessler, BM; Cao, Y; Harris, AL				Singleton, D. C.; Rouhi, P.; Zois, C. E.; Haider, S.; Li, J-L; Kessler, B. M.; Cao, Y.; Harris, A. L.			Hypoxic regulation of RIOK3 is a major mechanism for cancer cell invasion and metastasis	ONCOGENE			English	Article							BREAST-CANCER; MIGRATING CELLS; CYTOPLASMIC MATURATION; ACTIN DYNAMICS; HIF-1-ALPHA; ACTIVATION; CARCINOMA; HIF-2-ALPHA; PHENOTYPE; NETWORKS	Hypoxia is a common feature of locally advanced breast cancers that is associated with increased metastasis and poorer survival. Stabilisation of hypoxia-inducible factor-1 alpha (HIF1 alpha) in tumours causes transcriptional changes in numerous genes that function at distinct stages of the metastatic cascade. We demonstrate that expression of RIOK3 (RIght Open reading frame kinase 3) was increased during hypoxic exposure in an HIF1 alpha-dependent manner. RIOK3 was localised to distinct cytoplasmic aggregates in normoxic cells and underwent redistribution to the leading edge of the cell in hypoxia with a corresponding change in the organisation of the actin cytoskeleton. Depletion of RIOK3 expression caused MDA-MB-231 to become elongated and this morphological change was due to a loss of protraction at the trailing edge of the cell. This phenotypic change resulted in reduced cell migration in two-dimensional cultures and inhibition of cell invasion through three-dimensional extracellular matrix. Proteomic analysis identified interactions of RIOK3 with actin and several actin-binding factors including tropomyosins (TPM3 and TPM4) and tropomodulin 3. Depletion of RIOK3 in cells resulted in fewer and less organised actin filaments. Analysis of these filaments showed reduced association of TPM3, particularly during hypoxia, suggesting that RIOK3 regulates actin filament specialisation. RIOK3 depletion reduced the dissemination of MDA-MB-231 cells in both a zebrafish model of systemic metastasis and a mouse model of pulmonary metastasis. These findings demonstrate that RIOK3 is necessary for maintaining actin cytoskeletal organisation required for migration and invasion, biological processes that are necessary for hypoxia-driven metastasis.	[Singleton, D. C.; Zois, C. E.; Haider, S.; Li, J-L; Harris, A. L.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England; [Rouhi, P.; Cao, Y.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kessler, B. M.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford OX3 9DS, England; [Cao, Y.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Cao, Y.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Cao, Y.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England	University of Oxford; Karolinska Institutet; University of Oxford; Linkoping University; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Harris, AL (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England.	aharris.lab@imm.ox.ac.uk	Harris, Adrian L/ABA-3343-2020; Kessler, Benedikt/AAY-8614-2021	Harris, Adrian L/0000-0003-1376-8409; Kessler, Benedikt/0000-0002-8160-2446	European Commission Metoxia [222741]; British Columbia Cancer Agency Branch; Cancer Research UK; Cancer Research UK [11359, 16466] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	European Commission Metoxia; British Columbia Cancer Agency Branch; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	European Commission Metoxia Grant No. 222741 (D Singleton, P Rouhi, Y Cao, A Harris), Cancer Research UK (A Harris, C Zois, S Haider, J Li), Breast Cancer Research Foundation (A Harris) and Oxford NIHR Biomedical Research Centre (B Kessler). This study makes use of data generated by the Molecular Taxonomy of Breast Cancer International Consortium, which was funded by Cancer Research UK and the British Columbia Cancer Agency Branch.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Alcoser SY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-124; Baumas K, 2012, RNA BIOL, V9, DOI [10.4161/rna.9.2.18810, 10.4161/rna.18810]; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Cramer LP, 2013, CURR OPIN CELL BIOL, V25, P591, DOI 10.1016/j.ceb.2013.05.001; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koch A, 2010, EUR J CELL BIOL, V89, P184, DOI 10.1016/j.ejcb.2009.11.024; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; Mackeen MM, 2010, J PROTEOME RES, V9, P4082, DOI 10.1021/pr100269b; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rouhi P, 2010, NAT PROTOC, V5, P1911, DOI 10.1038/nprot.2010.150; Rundqvist H, 2010, CURR TOP MICROBIOL, V345, P121, DOI 10.1007/82_2010_77; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; Weidemann A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-80; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365	41	32	33	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4713	4722		10.1038/onc.2014.396	http://dx.doi.org/10.1038/onc.2014.396			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25486436	Green Accepted, Green Submitted			2022-12-26	WOS:000360931500005
J	Elimam, H; Papillon, J; Takano, T; Cybulsky, AV				Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.			Calcium-independent Phospholipase A(2)gamma Enhances Activation of the ATF6 Transcription Factor during Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Signaling; Endoplasmic Reticulum (ER); Endoplasmic Reticulum Stress (ER Stress); Phospholipase A; Unfolded Protein Response (UPR)	UNFOLDED PROTEIN RESPONSE; EPITHELIAL-CELL INJURY; ER STRESS; GENETIC ABLATION; LIPID-METABOLISM; MITOCHONDRIAL; DEATH; A(2); EXPRESSION; DIFFERENTIATION	Background: Calcium-independent PLA(2) (iPLA(2)) is a membrane-bound enzyme that localizes at the endoplasmic reticulum (ER). Results: iPLA(2) amplified activation of the ATF6 pathway of the unfolded protein response, resulting in up-regulation of ER chaperones and cytoprotection. Conclusion: iPLA(2) enhances activation of ATF6. Significance: Modulating iPLA(2) activity may provide opportunities for pharmacological intervention in glomerular diseases associated with ER stress. Injury of visceral glomerular epithelial cells (GECs) causes proteinuria in many glomerular diseases. We reported previously that calcium-independent phospholipase A(2) (iPLA(2)) is cytoprotective against complement-mediated GEC injury. Because iPLA(2) is localized at the endoplasmic reticulum (ER), this study addressed whether the cytoprotective effect of iPLA(2) involves the ER stress unfolded protein response (UPR). In cultured rat GECs, overexpression of the full-length iPLA(2), but not a mutant iPLA(2) that fails to associate with the ER, augmented tunicamycin-induced activation of activating transcription factor-6 (ATF6) and induction of the ER chaperones, glucose-regulated protein 94 (GRP94) and glucose-regulated protein 78 (GRP78). Augmented responses were inhibited by the iPLA(2) inhibitor, (R)-bromoenol lactone, but not by the cyclooxygenase inhibitor, indomethacin. Tunicamycin-induced cytotoxicity was reduced in GECs expressing iPLA(2), and the cytoprotection was reversed by dominant-negative ATF6. GECs from iPLA(2) knock-out mice showed blunted ATF6 activation and chaperone up-regulation in response to tunicamycin. Unlike ATF6, the two other UPR pathways, i.e. inositol-requiring enzyme 1 and protein kinase RNA-like ER kinase pathways, were not affected by iPLA(2). Thus, in GECs, iPLA(2) amplified activation of the ATF6 pathway of the UPR, resulting in up-regulation of ER chaperones and cytoprotection. These effects were dependent on iPLA(2) catalytic activity and association with the ER but not on prostanoids. Modulating iPLA(2) activity may provide opportunities for pharmacological intervention in glomerular diseases associated with ER stress.	[Elimam, Hanan; Papillon, Joan; Takano, Tomoko; Cybulsky, Andrey V.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University	Takano, T (corresponding author), McGill Univ, Div Nephrol, 3775 Univ St,Rm 236, Montreal, PQ H3A 2B4, Canada.	tomoko.takano@mcgill.ca; andrey.cybulsky@mcgill.ca	Elimam, Hanan/H-5858-2017; Cybulsky, Andrey V./AAG-8238-2020	Elimam, Hanan/0000-0003-2585-9957; Cybulsky, Andrey V./0000-0003-4348-2348	National Institutes of Health [RO1 HL118639]; Canadian Institutes of Health Research [MOP-53264, MOP-133492, MOP-125988, MOP-53335]; Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Catherine McLaughlin Hakim Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL118639. This work was also supported by Research Grants MOP-53264, MOP-133492, MOP-125988, and MOP-53335 from the Canadian Institutes of Health Research, the Kidney Foundation of Canada, and the Catherine McLaughlin Hakim Chair (to A. V. C.).	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Belmont PJ, 2010, CIRC RES, V106, P307, DOI 10.1161/CIRCRESAHA.109.203901; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Coers W, 1996, EXP NEPHROL, V4, P184; Cohen D, 2008, AM J PHYSIOL-RENAL, V294, pF469, DOI 10.1152/ajprenal.00372.2007; Cummings BS, 2004, J PHARMACOL EXP THER, V308, P921, DOI 10.1124/jpet.103.060541; Cummings BS, 2002, AM J PHYSIOL-RENAL, V283, pF492, DOI 10.1152/ajprenal.00022.2002; Cummings BS, 2000, J PHARMACOL EXP THER, V294, P793; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Cybulsky AV, 2011, AM J PHYSIOL-RENAL, V301, pF496, DOI 10.1152/ajprenal.00728.2010; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; Elimam H, 2013, J BIOL CHEM, V288, P3871, DOI 10.1074/jbc.M112.396614; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, AM J PHYSIOL-RENAL, V292, pF853, DOI 10.1152/ajprenal.00318.2006; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maiuolo J, 2011, P NATL ACAD SCI USA, V108, P7832, DOI 10.1073/pnas.1101379108; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2010, J BIOL CHEM, V285, P36495, DOI 10.1074/jbc.M110.115766; Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Ren GH, 2010, BBA-MOL CELL RES, V1803, P468, DOI 10.1016/j.bbamcr.2010.01.020; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	43	13	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3009	3020		10.1074/jbc.M114.592261	http://dx.doi.org/10.1074/jbc.M114.592261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25492867	Green Published, hybrid			2022-12-26	WOS:000349310700038
J	Ming, M; Sinnett-Smith, J; Wang, J; Soares, HP; Young, SH; Eibl, G; Rozengurt, E				Ming, Ming; Sinnett-Smith, James; Wang, Jia; Soares, Heloisa P.; Young, Steven H.; Eibl, Guido; Rozengurt, Enrique			Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR SIGNALING SYSTEMS; COUPLED RECEPTOR; INSULIN-RECEPTOR; GROWTH; RISK; NEUROTENSIN; GLUCOSE; PHOSPHORYLATION; APOPTOSIS	Natural products represent a rich reservoir of potential small chemical molecules exhibiting anti-proliferative and chemopreventive properties. Here, we show that treatment of pancreatic ductal adenocarcinoma (PDAC) cells (PANC-1, MiaPaCa-2) with the isoquinoline alkaloid berberine (0.3-6 mu M) inhibited DNA synthesis and proliferation of these cells and delay the progression of their cell cycle in G1. Berberine treatment also reduced (by 70%) the growth of MiaPaCa-2 cell growth when implanted into the flanks of nu/nu mice. Mechanistic studies revealed that berberine decreased mitochondrial membrane potential and intracellular ATP levels and induced potent AMPK activation, as shown by phosphorylation of AMPK alpha subunit at Thr-172 and acetyl-CoA carboxylase (ACC) at Ser(79). Furthermore, berberine dose-dependently inhibited mTORC1 (phosphorylation of S6K at Thr(389) and S6 at Ser(240/244)) and ERK activation in PDAC cells stimulated by insulin and neurotensin or fetal bovine serum. Knockdown of alpha(1) and alpha(2) catalytic subunit expression of AMPK reversed the inhibitory effect produced by treatment with low concentrations of berberine on mTORC1, ERK and DNA synthesis in PDAC cells. However, at higher concentrations, berberine inhibited mitogenic signaling (mTORC1 and ERK) and DNA synthesis through an AMPK-independent mechanism. Similar results were obtained with metformin used at doses that induced either modest or pronounced reductions in intracellular ATP levels, which were virtually identical to the decreases in ATP levels obtained in response to berberine. We propose that berberine and metformin inhibit mitogenic signaling in PDAC cells through dose-dependent AMPK-dependent and independent pathways.	[Ming, Ming; Sinnett-Smith, James; Wang, Jia; Young, Steven H.; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Soares, Heloisa P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Eibl, Guido] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Sinnett-Smith, James; Young, Steven H.; Eibl, Guido; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; [Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [P01 CA163200, P30 DK4130, R01 DK100405]; Department of Veterans Affair Grant [1I01BX001473]; Ronald S. Hirschberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100405, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair Grant; Ronald S. Hirschberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants P01 CA163200, P30 DK4130, R01 DK100405, Department of Veterans Affair Grant 1I01BX001473 and funds from the endowed Ronald S. Hirschberg Chair of Pancreatic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat HA, 2007, J AM COLL SURGEONS, V204, P996, DOI 10.1016/j.jamcollsurg.2007.01.067; BANDI HR, 1993, J BIOL CHEM, V268, P4530; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Berker B, 2004, GYNECOL ENDOCRINOL, V19, P125, DOI 10.1080/09513590400007309; Brand Randall E., 1998, Current Opinion in Oncology, V10, P362, DOI 10.1097/00001622-199807000-00014; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ducommun S, 2014, AM J PHYSIOL-ENDOC M, V306, pE688, DOI 10.1152/ajpendo.00672.2013; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Elek J, 2000, ANTICANCER RES, V20, P53; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Goodwin PJ, 2008, CLIN BREAST CANCER, V8, P501, DOI 10.3816/CBC.2008.n.060; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Guha S, 2005, CANCER RES, V65, P2738, DOI 10.1158/0008-5472.CAN-04-3197; Guha S, 2003, CANCER RES, V63, P2379; Guha S, 2002, CANCER RES, V62, P1632; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Heasley LE, 2001, ONCOGENE, V20, P1563, DOI 10.1038/sj.onc.1204183; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kisfalvi K, 2005, J CELL PHYSIOL, V202, P880, DOI 10.1002/jcp.20187; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Larsson SC, 2006, AM J CLIN NUTR, V84, P1171, DOI 10.1093/ajcn/84.5.1171; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Lo T-F, 2013, MICRORNA 21 3P BERBE; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Michaud DS, 2007, CANCER EPIDEM BIOMAR, V16, P2101, DOI 10.1158/1055-9965.EPI-07-0182; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Perrin MC, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-25; Pinto-Garcia L, 2010, PLANTA MED, V76, P1155, DOI 10.1055/s-0030-1249931; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Reubi JC, 1998, GUT, V42, P546, DOI 10.1136/gut.42.4.546; Rizvi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018137; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt E, 2001, ANNU REV PHYSIOL, V63, P49, DOI 10.1146/annurev.physiol.63.1.49; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Ryder NM, 2001, J CELL PHYSIOL, V186, P53, DOI 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sinnett-Smith J, 2000, J BIOL CHEM, V275, P30644, DOI 10.1074/jbc.M003702200; Sinnett-Smith J, 2013, BIOCHEM BIOPH RES CO, V430, P352, DOI 10.1016/j.bbrc.2012.11.010; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Tsilidis KK, 2014, DIABETES CARE, V37, P2522, DOI 10.2337/dc14-0584; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Wang L, 2000, CLIN CANCER RES, V6, P566; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang Y, 2012, MUTAT RES-FUND MOL M, V734, P20, DOI 10.1016/j.mrfmmm.2012.04.005; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xie WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024520; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Young SH, 2010, BIOCHEM BIOPH RES CO, V401, P154, DOI 10.1016/j.bbrc.2010.09.036; Yue W, 2014, CANCER PREV RES, V7, P388, DOI 10.1158/1940-6207.CAPR-13-0337; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhao HL, 2012, DIABETES, V61, P933, DOI 10.2337/db11-1164; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024	88	52	55	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114573	10.1371/journal.pone.0114573	http://dx.doi.org/10.1371/journal.pone.0114573			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493642	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400054
J	Alford, L; Andrade, TO; Georges, R; Burel, F; van Baaren, J				Alford, Lucy; Andrade, Thiago Oliveira; Georges, Romain; Burel, Francoise; van Baaren, Joan			Could Behaviour and Not Physiological Thermal Tolerance Determine Winter Survival of Aphids in Cereal Fields?	PLOS ONE			English	Article							CHILL COMA RECOVERY; COLD-HARDINESS; ACTIVITY THRESHOLDS; SITOBION-AVENAE; INTERSPECIFIC VARIATION; PEA APHIDS; TEMPERATURE; ACCLIMATION; RESISTANCE; POPULATION	Traits of physiological thermotolerance are commonly measured in the laboratory as predictors of the field success of ectotherms at unfavourable temperatures (e. g. during harsh winters, heatwaves, or under conditions of predicted global warming). Due to being more complicated to measure, behavioural thermoregulation is less commonly studied, although both physiology and behaviour interact to explain the survival of ectotherms. The aphids Metopolophium dirhodum, Rhopalosiphum padi and Sitobion avenae are commercially important pests of temperate cereal crops. Although coexisting, these species markedly differ in winter success, with R. padi being the most abundant species during cold winters, followed by S. avenae and lastly M. dirhodum. To better understand the thermal physiology and behavioural factors contributing to differential winter success, the lethal temperature (physiological thermotolerance) and the behaviour of aphids in a declining temperature regime (behavioural thermotolerance) of these three species were investigated. Physiological thermotolerance significantly differed between the three species, with R. padi consistently the least cold tolerant and S. avenae the most cold tolerant. However, although the least cold tolerant of the study species, significantly more R. padi remained attached to the host plant at extreme sub-zero temperatures than S. avenae and M. dirhodum. Given the success of anholocyclic R. padi in harsh winters compared to its anholocyclic counterparts, this study illustrates that behavioural differences could be more important than physiological thermotolerance in explaining resistance to extreme temperatures. Furthermore it highlights that there is a danger to studying physiological thermotolerance in isolation when ascertaining risks of ectotherm invasions, the establishment potential of exotic species in glasshouses, or predicting species impacts under climate change scenarios.	[Alford, Lucy; Andrade, Thiago Oliveira; Georges, Romain; Burel, Francoise; van Baaren, Joan] Univ Rennes 1, UMR ECOBIO 6553, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Alford, L (corresponding author), Univ Rennes 1, UMR ECOBIO 6553, Rennes, France.	l.alford.02@cantab.net		Alford, Lucy/0000-0002-2967-4274; Georges, Romain/0000-0002-0566-3060; van baaren, joan/0000-0002-8552-9645	Marie Curie Intra-European Fellowship [FP7-PEOPLE-2010-IEF-326943]	Marie Curie Intra-European Fellowship(European Commission)	This work was funded by a Marie Curie Intra-European Fellowship (FP7-PEOPLE-2010-IEF-326943) awarded to L Alford, F Burel and J van Baaren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford L, 2012, J APPL ENTOMOL, V135, P332, DOI 10.1111/j.1439-0418.2011.01658.x; Alford L, 2012, AGR FOREST ENTOMOL, V14, P69, DOI 10.1111/j.1461-9563.2011.00553.x; Andersen JL, 2013, J INSECT PHYSIOL, V59, P1041, DOI 10.1016/j.jinsphys.2013.07.008; Andrade T, 2013, THESIS U RENNES 1; Andrade TO, 2013, ENTOMOL EXP APPL, V147, P167, DOI 10.1111/eea.12055; BALE JS, 1988, ECOL ENTOMOL, V13, P121, DOI 10.1111/j.1365-2311.1988.tb00340.x; BALE JS, 1987, J INSECT PHYSIOL, V33, P899, DOI 10.1016/0022-1910(87)90001-1; Blackman R. L, 1989, APHIDS WORLDS CROPS; Burgi LP, 2012, J INSECT PHYSIOL, V58, P1184, DOI 10.1016/j.jinsphys.2012.05.017; Butts RA, 1997, ECOL ENTOMOL, V22, P26, DOI 10.1046/j.1365-2311.1997.00027.x; CLOUGH MS, 1990, ANN APPL BIOL, V116, P1, DOI 10.1111/j.1744-7348.1990.tb06581.x; Cocu N, 2005, J BIOGEOGR, V32, P615, DOI 10.1111/j.1365-2699.2005.01190.x; Colinet H, 2013, J EXP BIOL, V216, P253, DOI 10.1242/jeb.076216; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Coombs MR, 2013, EXP APPL ACAROL, V59, P435, DOI 10.1007/s10493-012-9619-9; Costanzo JP, 2001, PHYSIOL BIOCHEM ZOOL, V74, P510, DOI 10.1086/322161; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; Everatt MJ, 2013, J INSECT PHYSIOL, V59, P1057, DOI 10.1016/j.jinsphys.2013.08.003; Fabre F, 2006, ECOL MODEL, V193, P457, DOI 10.1016/j.ecolmodel.2005.08.021; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Formby JP, 2013, FLA ENTOMOL, V96, P1530, DOI 10.1653/024.096.0435; HARRINGTON R, 1990, ACTA PHYTOPATHOL HUN, V25, P423; HARRINGTON R, 1990, J ANIM ECOL, V59, P1177, DOI 10.2307/5039; Hart AJ, 2002, PHYSIOL ENTOMOL, V27, P112, DOI 10.1046/j.1365-3032.2002.00276.x; Hazell SP, 2011, J INSECT PHYSIOL, V57, P1085, DOI 10.1016/j.jinsphys.2011.04.004; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Hill MP, 2013, GLOBAL ECOL BIOGEOGR, V22, P942, DOI 10.1111/geb.12059; HONEK A, 1985, Z ANGEW ENTOMOL, V100, P309; Hughes GE, 2011, BIOCONTROL, V56, P19, DOI 10.1007/s10526-010-9314-x; Hughes GE, 2010, PHYSIOL ENTOMOL, V35, P373, DOI 10.1111/j.1365-3032.2010.00754.x; Hughes GE, 2010, BIOCONTROL, V55, P493, DOI 10.1007/s10526-010-9267-0; Hughes GE, 2009, BIOCONTROL, V54, P785, DOI 10.1007/s10526-009-9230-0; HUTCHINSON LA, 1994, J APPL ECOL, V31, P102, DOI 10.2307/2404603; Jarosik Vojtech, 2003, Plant Protection Science, V39, P61; Jones SR, 1997, J MED ENTOMOL, V34, P426, DOI 10.1093/jmedent/34.4.426; Klok CJ, 2003, BIOL J LINN SOC, V78, P401, DOI 10.1046/j.1095-8312.2003.00154.x; KNIGHT JD, 1986, ECOL ENTOMOL, V11, P189, DOI 10.1111/j.1365-2311.1986.tb00294.x; Krespi L, 1997, ENVIRON ENTOMOL, V26, P545, DOI 10.1093/ee/26.3.545; Le Lann C, 2011, PHYSIOL ENTOMOL, V36, P21, DOI 10.1111/j.1365-3032.2010.00758.x; Le Ralec A, 2010, CR BIOL, V333, P554, DOI 10.1016/j.crvi.2010.03.010; LEATHER SR, 1989, B ENTOMOL RES, V79, P345, DOI 10.1017/S0007485300018344; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Macdonald SS, 2004, J INSECT PHYSIOL, V50, P695, DOI 10.1016/j.jinsphys.2004.05.004; McConnachie S, 2007, J THERM BIOL, V32, P66, DOI 10.1016/j.jtherbio.2006.10.002; Modlmeier AP, 2012, NATURWISSENSCHAFTEN, V99, P811, DOI 10.1007/s00114-012-0963-8; MONTGOMERY ME, 1977, ENTOMOL EXP APPL, V22, P236, DOI 10.1007/BF00302860; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Navas CA, 1996, J HERPETOL, V30, P478, DOI 10.2307/1565690; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029409; PONS X, 1993, ENVIRON ENTOMOL, V22, P381, DOI 10.1093/ee/22.2.381; Powell SJ, 2008, ECOL ENTOMOL, V33, P95, DOI 10.1111/j.1365-2311.2007.00947.x; Powell SJ, 2006, PHYSIOL ENTOMOL, V31, P348, DOI 10.1111/j.1365-3032.2006.00527.x; Powell SJ, 2005, J EXP BIOL, V208, P2615, DOI 10.1242/jeb.01685; Powell SJ, 2004, J INSECT PHYSIOL, V50, P277, DOI 10.1016/j.jinsphys.2004.01.003; Renault D, 2012, PHYSIOL ENTOMOL, V37, P354, DOI 10.1111/j.1365-3032.2012.00851.x; ROITBERG BD, 1979, CAN ENTOMOL, V111, P515, DOI 10.4039/Ent111515-4; Sinclair BJ, 2006, PHYSIOL ENTOMOL, V31, P98, DOI 10.1111/j.1365-3032.2005.00481.x; STRATHDEE AT, 1995, J INSECT PHYSIOL, V41, P653, DOI 10.1016/0022-1910(95)00029-T; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2005, J INSECT PHYSIOL, V51, P1013, DOI 10.1016/j.jinsphys.2005.04.016; WALTERS KFA, 1986, J APPL ECOL, V23, P905, DOI 10.2307/2403943; Williams C. T., 1980, Bulletin SROP, V3, P63; WINDER L, 1990, ECOL ENTOMOL, V15, P105, DOI 10.1111/j.1365-2311.1990.tb00789.x	69	22	23	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114982	10.1371/journal.pone.0114982	http://dx.doi.org/10.1371/journal.pone.0114982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490555	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000347515300099
J	Matsuyama, S; Moriuchi, M; Suico, MA; Yano, S; Morino-Koga, S; Shuto, T; Yamanaka, K; Kondo, T; Araki, E; Kai, H				Matsuyama, Shingo; Moriuchi, Masataka; Suico, Mary Ann; Yano, Shuichiro; Morino-Koga, Saori; Shuto, Tsuyoshi; Yamanaka, Kunitoshi; Kondo, Tatsuya; Araki, Eiichi; Kai, Hirofumi			Mild Electrical Stimulation Increases Stress Resistance and Suppresses Fat Accumulation via Activation of LKB1-AMPK Signaling Pathway in C. elegans	PLOS ONE			English	Article							PROTEIN-KINASE AAK-2; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; DIETARY RESTRICTION; INSULIN-RESISTANCE; ENERGY SENSOR; AMPK; LONGEVITY; CELLS; LKB1	Electrical current at physiological strength has been applied as a therapeutic approach for various diseases. Several of our works showed that mild electrical stimulation (MES) at 0.1-ms pulse width has positive impact on organisms. But despite the growing evidence of the beneficial effects of MES, its effects on individual animals and the molecular underpinnings are poorly understood and rarely studied. Here, we examined the effects of MES on individual animal and its mechanisms by mainly using Caenorhabditis elegans, a powerful genetic model organism. Interestingly, MES increased stress resistance and suppressed excess fat accumulation in wild-type N2 worms but not in AMPK/AAK-2 and LKB1/PAR-4 mutant worms. MES promoted the nuclear localization of transcription factors DAF-16 and SKN-1 and consequently increased the expression of anti-stress genes, whereas MES inhibited the nuclear localization of SBP-1 and suppressed the expression of lipogenic genes. Moreover, we found that MES induced the activation of LKB1/PAR4-AMPK/AAK2 pathway in C. elegans and in several mammalian cell lines. The mitochondrial membrane potential and cellular ATP level were slightly and transiently decreased by MES leading to the activation of LKB1-AMPK signaling pathway. Together, we firstly and genetically demonstrated that MES exerts beneficial effects such as stress resistance and suppression of excess fat accumulation, via activation of LKB1-AMPK signaling pathway.	[Matsuyama, Shingo; Moriuchi, Masataka; Suico, Mary Ann; Yano, Shuichiro; Morino-Koga, Saori; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan; [Yamanaka, Kunitoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto, Japan; [Kondo, Tatsuya] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Japan.	hirokai@gpo.kumamoto-u.ac.jp		Suico, Mary Ann/0000-0002-6751-8352; Kondo, Tatsuya/0000-0003-4830-8955; Shuto, Tsuyoshi/0000-0003-1275-4988	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19390045]; Japan Society for the Promotion of Science (JSPS) Program of Japan; Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented), MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented), MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to H. Kai (#19390045); Japan Society for the Promotion of Science (JSPS) Program (Research Fellowships for Young Scientists) of Japan; Program for Leading Graduate Schools "HIGO (Health life science: Interdisciplinary and Glocal Oriented), MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Balakatounis Konstantine C, 2008, Eplasty, V8, pe28; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; BASSETT CAL, 1993, J CELL BIOCHEM, V51, P387, DOI 10.1002/jcb.2400510402; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Fukuda R, 2013, J BIOL CHEM, V288, P16117, DOI 10.1074/jbc.M112.442442; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Kondo T, 2014, DIABETES METAB J, V38, P100, DOI 10.4093/dmj.2014.38.2.100; Kondo T, 2012, DIABETES, V61, P838, DOI 10.2337/db11-1098; Kondo T, 2010, OBES RES CLIN PRACT, V4, pE101, DOI 10.1016/j.orcp.2009.09.007; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Martins I, 2011, AGING-US, V3, P821, DOI 10.18632/aging.100380; Do MT, 2013, FOOD CHEM, V136, P415, DOI 10.1016/j.foodchem.2012.09.012; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Morino-Koga S, 2013, J CELL PHYSIOL, V228, P439, DOI 10.1002/jcp.24149; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Possik E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004273; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Taura M, 2010, CANCER SCI, V101, P1610, DOI 10.1111/j.1349-7006.2010.01567.x; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093	46	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114690	10.1371/journal.pone.0114690	http://dx.doi.org/10.1371/journal.pone.0114690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490091	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300066
J	Stanojevic, B; Saenko, V; Todorovic, L; Petrovic, N; Nikolic, D; Zivaljevic, V; Paunovic, I; Nakashima, M; Yamashita, S; Dzodic, R				Stanojevic, Boban; Saenko, Vladimir; Todorovic, Lidija; Petrovic, Nina; Nikolic, Dragan; Zivaljevic, Vladan; Paunovic, Ivan; Nakashima, Masahiro; Yamashita, Shunichi; Dzodic, Radan			Low VHL mRNA Expression is Associated with More Aggressive Tumor Features of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							HIPPEL-LINDAU-DISEASE; RENAL-CELL CARCINOMA; SUPPRESSOR GENE; GERMLINE MUTATIONS; CONSECUTIVE PATIENTS; METHYLATION STATUS; SIGNALING PATHWAY; PROGNOSTIC VALUE; HIGH PREVALENCE; BRAF MUTATIONS	Alterations of the von Hippel-Lindau (VHL) tumor suppressor gene can cause different hereditary tumors associated with VHL syndrome, but the potential role of the VHL gene in papillary thyroid carcinoma (PTC) has not been characterized. This study set out to investigate the relationship of VHL expression level with clinicopathological features of PTC in an ethnically and geographically homogenous group of 264 patients from Serbia, for the first time. Multivariate logistic regression analysis showed a strong correlation between low level of VHL expression and advanced clinical stage (OR=5.78, 95% CI 3.17-10.53, P<0.0001), classical papillary morphology of the tumor (OR=2.92, 95% CI 1.33-6.44, P=0.008) and multifocality (OR=1.96, 95% CI 1.06-3.62, P=0.031). In disease-free survival analysis, low VHL expression had marginal significance (P=0.0502 by the log-rank test) but did not appear to be an independent predictor of the risk for chance of faster recurrence in a proportion hazards model. No somatic mutations or evidence of VHL downregulation via promoter hypermethylation in PTC were found. The results indicate that the decrease of VHL expression associates with tumor progression but the mechanism of downregulation remains to be elucidated.	[Stanojevic, Boban; Saenko, Vladimir; Nakashima, Masahiro; Yamashita, Shunichi] Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Stanojevic, Boban; Todorovic, Lidija; Petrovic, Nina] Univ Belgrade, Vinca Inst Nucl Sci, Lab Radiobiol & Mol Genet, Belgrade, Serbia; [Nikolic, Dragan; Zivaljevic, Vladan; Paunovic, Ivan; Dzodic, Radan] Univ Belgrade, Sch Med, Belgrade, Serbia; [Zivaljevic, Vladan; Paunovic, Ivan] Clin Ctr Serbia, Clin Endocrinol, Ctr Endocrine Surg, Belgrade, Serbia; [Dzodic, Radan] Inst Oncol & Radiol Serbia, Dept Surg Oncol, Belgrade, Serbia	Nagasaki University; University of Belgrade; University of Belgrade; Clinical Centre of Serbia; Institute for Oncology & Radiology of Serbia (IORS)	Stanojevic, B (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Nagasaki 852, Japan.	boban.stanojevic27@gmail.com	Yamashita, Shunichi/GVS-9508-2022; Todorovic, Lidija/Q-6759-2016; Todorovic, Lidija/CAJ-5290-2022; Nikolic, Dragan/AAC-8023-2021	Todorovic, Lidija/0000-0003-0672-0693; Todorovic, Lidija/0000-0003-0672-0693; Nikolic, Dragan/0000-0001-5919-1575; Dzodic, Radan/0000-0002-3041-7339; Stanojevic, Boban/0000-0002-4674-0384; Yamashita, Shunichi/0000-0001-6399-6261; Petrovic, Nina/0000-0003-2503-1228	Nagasaki University Global COE Program; Ministry of Education, Science and Technological Development of the Republic of Serbia [173049, 145094D]; Grants-in-Aid for Scientific Research [26293222] Funding Source: KAKEN	Nagasaki University Global COE Program; Ministry of Education, Science and Technological Development of the Republic of Serbia; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Nagasaki University Global COE Program; Ministry of Education, Science and Technological Development of the Republic of Serbia, Contracts No. 173049 and 145094D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RE, 2004, TRENDS MOL MED, V10, P466, DOI 10.1016/j.molmed.2004.07.008; Benetatos L, 2008, LEUKEMIA, V22, P1293, DOI 10.1038/sj.leu.2405053; Bindra RS, 2002, CANCER RES, V62, P3014; Bluyssen HAR, 2004, FEBS LETT, V556, P137, DOI 10.1016/S0014-5793(03)01392-9; Carta C, 2006, CLIN ENDOCRINOL, V64, P105, DOI 10.1111/j.1365-2265.2005.02401.x; Chen CB, 2011, J BONE JOINT SURG AM, V93A, P1833, DOI 10.2106/JBJS.I.01553; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Corless CL, 1997, HUM PATHOL, V28, P459, DOI 10.1016/S0046-8177(97)90035-6; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; De Lellies RA, 2004, PATHOLOGY GENETICS T; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Espinosa AV, 2007, BRIT J CANCER, V96, P16, DOI 10.1038/sj.bjc.6603520; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; Gallou C, 2004, HUM MUTAT, V24, P215, DOI 10.1002/humu.20082; Grebe SKG, 1997, J CLIN ENDOCR METAB, V82, P3684, DOI 10.1210/jc.82.11.3684; Guo Y, 2009, ONCOGENE, V28, P1864, DOI 10.1038/onc.2009.35; Hatzimichael E, 2009, CLIN LYMPHOMA MYELOM, V9, P239, DOI 10.3816/CLM.2009.n.047; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hes FJ, 2003, J CLIN ENDOCR METAB, V88, P969, DOI 10.1210/jc.2002-021466; Hinze R, 2000, ENDOCR PATHOL, V11, P145, DOI 10.1385/EP:11:2:145; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Hoebeeck J, 2006, INT J CANCER, V119, P624, DOI 10.1002/ijc.21888; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hoque MO, 2005, J CLIN ENDOCR METAB, V90, P4011, DOI 10.1210/jc.2005-0313; Hu SY, 2006, J CLIN ENDOCR METAB, V91, P98, DOI 10.1210/jc.2005-1810; IIDA F, 1969, CANCER, V24, P764, DOI 10.1002/1097-0142(196910)24:4<764::AID-CNCR2820240416>3.0.CO;2-S; KATOH R, 1992, CANCER-AM CANCER SOC, V70, P1585, DOI 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kimura ET, 2003, CANCER RES, V63, P1454; Koch CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-131; Kogan E. A., 2006, Arkhiv Patologii, V68, P8; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Kuzmin I, 1999, ONCOGENE, V18, P5672, DOI 10.1038/sj.onc.1202959; Lazzereschi D, 1997, J EXP CLIN CANC RES, V16, P325; Lida F, 1969, CANCER, V24, P764; Liu T, 2014, INT J MOL MED, V33, P1236, DOI 10.3892/ijmm.2014.1661; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Martinez A, 2001, J CLIN PATHOL-MOL PA, V54, P300, DOI 10.1136/mp.54.5.300; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; McCarthy RP, 2006, CLIN CANCER RES, V12, P2414, DOI 10.1158/1078-0432.CCR-05-2818; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Migdalska-Sek M, 2011, WSPOLCZESNA ONKOL, V15, P191, DOI 10.5114/wo.201124312; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Park SY, 2006, CANCER-AM CANCER SOC, V107, P1831, DOI 10.1002/cncr.22218; Pasquali D, 2011, THYROID, V21, P391, DOI 10.1089/thy.2010.0168; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; Qi H, 2003, CANCER RES, V63, P7076; Ries LAG, 2007, SEER CANC STAT REV 1; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Sakashita N, 1999, HISTOCHEM J, V31, P133, DOI 10.1023/A:1003554712386; SANTORO M, 1994, ONCOGENE, V9, P509; Sgambati MT, 2000, AM J HUM GENET, V66, P84, DOI 10.1086/302726; Shattuck TM, 2005, NEW ENGL J MED, V352, P2406, DOI 10.1056/NEJMoa044190; Siironen P, 2005, TUMOR BIOL, V26, P57, DOI 10.1159/000085586; Stanojevic B, 2011, ENDOCR J, V58, P381, DOI 10.1507/endocrj.K11E-054; Sugg SL, 1998, J CLIN ENDOCR METAB, V83, P4116, DOI 10.1210/jc.83.11.4116; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Valera VA, 2011, J CANCER, V2, P515, DOI 10.7150/jca.2.515; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Xing MZ, 2007, ENDOCRINOLOGY, V148, P948, DOI 10.1210/en.2006-0927; Zatyka M, 2002, CANCER RES, V62, P3803; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3; Zia MK, 2007, INT J MOL MED, V20, P605	71	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114511	10.1371/journal.pone.0114511	http://dx.doi.org/10.1371/journal.pone.0114511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490036	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300045
J	Best, NB; Hartwig, T; Budka, JS; Bishop, BJ; Brown, E; Potluri, DPV; Cooper, BR; Premachandra, GS; Johnston, CT; Schulz, B				Best, Norman B.; Hartwig, Thomas; Budka, Joshua S.; Bishop, Brandon J.; Brown, Elliot; Potluri, Devi P. V.; Cooper, Bruce R.; Premachandra, Gnanasiri S.; Johnston, Cliff T.; Schulz, Burkhard			Soilless Plant Growth Media Influence the Efficacy of Phytohormones and Phytohormone Inhibitors	PLOS ONE			English	Article							BRASSINOSTEROID BIOSYNTHESIS; FUNGICIDE PROPICONAZOLE; TRIAZOLE FUNGICIDES; PHYSICAL-PROPERTIES; PACLOBUTRAZOL; UNICONAZOLE; SORPTION; DRENCH; BRASSINOLIDE; DEGRADATION	Plant growth regulators, such as hormones and their respective biosynthesis inhibitors, are effective tools to elucidate the physiological function of phytohormones in plants. A problem of chemical treatments, however, is the potential for interaction of the active compound with the growth media substrate. We studied the interaction and efficacy of propiconazole, a potent and specific inhibitor of brassinosteroid biosynthesis, with common soilless greenhouse growth media for rice, sorghum, and maize. Many of the tested growth media interacted with propiconazole reducing its efficacy up to a hundred fold. To determine the molecular interaction of inhibitors with media substrates, Fourier Transform Infrared Spectroscopy and sorption isotherm analysis was applied. While mica clay substrates absorbed up to 1.3 mg of propiconazole per g substrate, calcined clays bound up to 12 mg of propiconazole per g substrate. The efficacy of the gibberellic acid biosynthesis inhibitor, uniconazole, and the most active brassinosteroid, brassinolide, was impacted similarly by the respective substrates. Conversely, gibberellic acid showed no distinct growth response in different media. Our results suggest that the reduction in efficacy of propiconazole, uniconazole, and brassinolide in bioassays when grown in calcined clay is caused by hydrophobic interactions between the plant growth regulators and the growth media. This was further confirmed by experiments using methanol-water solvent mixes with higher hydrophobicity values, which reduce the interaction of propiconazole and calcined clay.	[Best, Norman B.; Hartwig, Thomas; Budka, Joshua S.; Bishop, Brandon J.; Brown, Elliot; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Hartwig, Thomas] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Budka, Joshua S.] USDA ARS, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Potluri, Devi P. V.] Chicago State Univ, Dept Biol, Chicago, IL USA; [Cooper, Bruce R.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Premachandra, Gnanasiri S.; Johnston, Cliff T.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Institution for Science; United States Department of Agriculture (USDA); Chicago State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Schulz, B (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	bschulz1@umd.edu	Johnston, Cliff T/B-2215-2009; Johnston, Cliff T/A-1331-2015; Best, Norman B/G-1969-2015	Johnston, Cliff T/0000-0002-8462-9724; Johnston, Cliff T/0000-0002-8462-9724; Best, Norman B/0000-0002-6572-5999	National Science Foundation CAREER Integrative Organismal Systems Grant [1054918]	National Science Foundation CAREER Integrative Organismal Systems Grant(National Science Foundation (NSF))	National Science Foundation CAREER Integrative Organismal Systems Grant 1054918 to BS (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen JW, 2006, TOXICOL PATHOL, V34, P853, DOI 10.1080/01926230601047816; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; BANKO T J, 1988, Journal of Environmental Horticulture, V6, P124; Barrett J. E., 1989, Acta Horticulturae, P275; BARRETT JE, 1994, HORTSCIENCE, V29, P893, DOI 10.21273/HORTSCI.29.8.893; Battaglin WA, 2011, WATER AIR SOIL POLL, V218, P307, DOI 10.1007/s11270-010-0643-2; Boyd SA, 2011, WILEY-IUPAC SER BIOP, P51; BRIAN PW, 1955, PHYSIOL PLANTARUM, V8, P669, DOI 10.1111/j.1399-3054.1955.tb07760.x; Bromilow RH, 1999, PESTIC SCI, V55, P1129, DOI 10.1002/(SICI)1096-9063(199912)55:12&lt;1129::AID-; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; Clouse Steven D, 2011, Arabidopsis Book, V9, pe0151, DOI 10.1199/tab.0151; Currey CJ, 2010, HORTTECHNOLOGY, V20, P863, DOI 10.21273/HORTTECH.20.5.863; Evans MR, 2007, HORTTECHNOLOGY, V17, P312, DOI 10.21273/HORTTECH.17.3.312; EVANS MMS, 1995, PLANT PHYSIOL, V108, P475, DOI 10.1104/pp.108.2.475; Faust JE, 2001, HORTTECHNOLOGY, V11, P557, DOI 10.21273/HORTTECH.11.4.557; FELDMANN KA, 1989, SCIENCE, V243, P1351, DOI 10.1126/science.243.4896.1351; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; FLETCHER RA, 1986, PHYSIOL PLANTARUM, V66, P197, DOI 10.1111/j.1399-3054.1986.tb02408.x; FONTENO WC, 1990, J AM SOC HORTIC SCI, V115, P375, DOI 10.21273/JASHS.115.3.375; Garrison AW, 2011, INT J ENV RES PUB HE, V8, P3453, DOI 10.3390/ijerph8083453; Gent MPN, 2000, PLANT GROWTH REGULAT, P89; Ghosh MK, 2012, J PHYS CHEM B, V116, P14254, DOI 10.1021/jp308936g; GROSSMANN K, 1990, PHYSIOL PLANTARUM, V78, P640, DOI 10.1111/j.1399-3054.1990.tb05254.x; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hartwig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036625; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hewitt, 1998, FUNGICIDES CROP PROT; Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; Idowu OS, 2007, J AOAC INT, V90, P291; JIAO J, 1990, HORTSCIENCE, V25, P1244, DOI 10.21273/HORTSCI.25.10.1244; Kim IS, 2003, PEST MANAG SCI, V59, P324, DOI 10.1002/ps.642; Kim IS, 2002, PLANT SOIL, V239, P321, DOI 10.1023/A:1015000328350; Lee JK, 2004, LANGMUIR, V20, P3844, DOI 10.1021/la049748b; Levine SL, 1999, ENVIRON TOXICOL CHEM, V18, P2565, DOI [10.1002/etc.5620181125, 10.1897/1551-5028(1999)018&lt;2565:MOCEIR&gt;2.3.CO;2]; Li H, 2003, SOIL SCI SOC AM J, V67, P122, DOI 10.2136/sssaj2003.0122; Million JB, 1999, HORTSCIENCE, V34, P1099, DOI 10.21273/HORTSCI.34.6.1099; Million JB, 1998, HORTSCIENCE, V33, P852, DOI 10.21273/HORTSCI.33.5.852; Million JB, 1998, HORTSCIENCE, V33, P1030, DOI 10.21273/HORTSCI.33.6.1030; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myers N, 1999, CURR SCI INDIA, V76, P507; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; Ogutu RA, 2009, HORTSCIENCE, V44, P431, DOI 10.21273/HORTSCI.44.2.431; Orozco R., 1995, Acta Horticulturae, P137; Pardos M, 2005, HORTSCIENCE, V40, P1773, DOI 10.21273/HORTSCI.40.6.1773; Pasian CC, 1999, SCI HORTIC-AMSTERDAM, V80, P277, DOI 10.1016/S0304-4238(98)00248-9; PHINNEY BO, 1956, P NATL ACAD SCI USA, V42, P185, DOI 10.1073/pnas.42.4.185; Rademacher W., 2020, PLANT BIOCH REGULATO, P169; Raviv M., 1986, The role of organic matter in modern agriculture, P257; Riise G, 2001, WATER AIR SOIL POLL, V129, P245, DOI 10.1023/A:1010353209449; Roberts T.R., 1999, METABOLIC PATHWAYS 2, P1080; Sannino A, 2004, J AOAC INT, V87, P991; Schoonheydt RA, 2012, HDB CLAY SCI; Schulz B, 1995, PLANT MOL BIOL MAN K, VK3, P1; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Singh N, 2005, PEST MANAG SCI, V61, P191, DOI 10.1002/ps.973; Sopher CR, 1999, CAN J BOT, V77, P279, DOI 10.1139/cjb-77-2-279; STARMAN TW, 1990, HORTSCIENCE, V25, P935, DOI 10.21273/HORTSCI.25.8.935; Sun GB, 2005, TOXICOL LETT, V155, P277, DOI 10.1016/j.toxlet.2004.10.006; Thorstensen CW, 2001, J ENVIRON QUAL, V30, P2046, DOI 10.2134/jeq2001.2046; Vriet C, 2013, MOL PLANT, V6, P1738, DOI 10.1093/mp/sst096; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; Wang C, 2011, J AGR FOOD CHEM, V59, P8507, DOI 10.1021/jf200970s; WANG YT, 1991, HORTSCIENCE, V26, P148, DOI 10.21273/HORTSCI.26.2.148; WARREN S L, 1990, Journal of Environmental Horticulture, V8, P151; WARREN S L, 1991, Journal of Environmental Horticulture, V9, P163; Watson Gary W., 2001, Journal of Environmental Horticulture, V19, P119; Watson JT, 2009, PROC FL STATE HORTIC, V122, P370; WEATHERS PJ, 1988, IN VITRO CELL DEV B, V24, P727, DOI 10.1007/BF02623612; Whipker B. E., 1997, HortTechnology, V7, P269; WIGGINS TE, 1984, PESTIC SCI, V15, P206, DOI 10.1002/ps.2780150212; Yabuta T., 1938, J AGR CHEM SOC JAPAN, V14, P1526, DOI DOI 10.1271/NOGEIKAGAKU1924.14.12_1526; Yadav R. K., 2005, Agricultural Reviews, V26, P124; YOSHIDA Y, 1991, BIOCHEM SOC T, V19, P778, DOI 10.1042/bst0190778; Zar JH., 2010, BIOSTAT ANAL, V5th	78	4	4	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e107689	10.1371/journal.pone.0107689	http://dx.doi.org/10.1371/journal.pone.0107689			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485677	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600002
J	Perales, H; Golicher, D				Perales, Hugo; Golicher, Duncan			Mapping the Diversity of Maize Races in Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHIAPAS; LANDRACES; GERMPLASM; BENEFITS	Traditional landraces of maize are cultivated throughout more than one-half of Mexico's cropland. Efforts to organize in situ conservation of this important genetic resource have been limited by the lack of knowledge of regional diversity patterns. We used recent and historic collections of maize classified for race type to determine biogeographic regions and centers of landrace diversity. We also analyzed how diversity has changed over the last sixty years. Based on racial composition of maize we found that Mexico can be divided into 11 biogeographic regions. Six of these biogeographic regions are in the center and west of the country and contain more than 90% of the reported samples for 38 of the 47 races studied; these six regions are also the most diverse. We found no evidence of rapid overall decline in landrace diversity for this period. However, several races are now less frequently reported and two regions seem to support lower diversity than in previous collection periods. Our results are consistent with a previous hypothesis for diversification centers and for migration routes of original maize populations merging in western central Mexico. We provide maps of regional diversity patterns and landrace based biogeographic regions that may guide efforts to conserve maize genetic resources.	[Perales, Hugo] El Colegio Frontera Sur, Grp Agroecol, San Cristobal, Chiapas, Mexico; [Golicher, Duncan] El Colegio Frontera Sur, Grp Conservac & Restaurac Bosques, San Cristobal, Chiapas, Mexico; [Golicher, Duncan] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR); Bournemouth University	Perales, H (corresponding author), El Colegio Frontera Sur, Grp Agroecol, Carretera Panamericana & Periferico S-N, San Cristobal, Chiapas, Mexico.	hperales@ecosur.mx	Perales, Hugo/F-6193-2010; Golicher, Duncan/B-4240-2009	Perales, Hugo/0000-0003-3431-5759; 	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO)	Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO)	Funding: Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO) collected the original data and supported the work. CONABIO had no role in the study design, analysis, decision to publish, or preparation of the manuscript.	Almanza H, 2012, RETHINK DEV INEQUALI, V1, P17; Anderson E., 1942, ANN MISSOURI BOT GARD, V29, P69, DOI 10.2307/2394331; Anderson E., 1946, ANN MO BOT GARD, V33, P147, DOI [10.2307/2394428, DOI 10.2307/2394428]; Anderson Edgar, 1947, ANN MISSOURI BOT GARD, V34, P433, DOI 10.2307/2394775; Angeles Arrieta H. H., 2000, Agricultura Tecnica en Mexico, V26, P31; [Anonymous], 1988, ASA MONOGRAPH, DOI DOI 10.2134/AGR0NM0N0GR18.3ED.C2; [Anonymous], 2009, ORIGEN DIVERSIFICACI; Aragon-Cuevas F., 2006, LIBRO TECNICO N 6; Arias LM., 2007, U CIENCIA, V23, P69; Arslan A, 2009, AM J AGR ECON, V91, P956, DOI 10.1111/j.1467-8276.2009.01323.x; Bellon MR, 2006, WORLD DEV, V34, P113, DOI 10.1016/j.worlddev.2005.05.012; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; Benz BF, 1986, THESIS U WISCONSIN M; BIRD RM, 1980, BIOTROPICA, V12, P30, DOI 10.2307/2387771; BRETTING PK, 1990, AM J BOT, V77, P211, DOI 10.2307/2444643; Brickell C.D., 2004, ACTA HORTIC, V647, P1; Brush SB, 2007, AGR ECOSYST ENVIRON, V121, P211, DOI 10.1016/j.agee.2006.12.018; CONABIO, 2014, REC GEN ACT AN INF A; de Candolle A., 1884, ORIGIN CULTIVATED PL; Eakin H, 2014, DEV CHANGE, V45, P133, DOI 10.1111/dech.12074; Espinosa D., 2008, CAPITAL NATURAL MEXI, VI, P33, DOI DOI 10.32800/ABC.2019.42.0187; Golicher D, 2007, METHODOLOGY FLEXIBLE; Guarino L., 2002, P387, DOI 10.1079/9780851995229.0387; Hartkamp A.D., 2000, MAIZE PRODUCTION ENV; Hernandez-Xolocotzi E, 1970, AGROCIENCIA, V5, P3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; INEGI website, 2014, SUBPR FIS; International Maize and Wheat Improvement Center (CIMMYT), 2001, CIMMYT 1999 2000 WOR; KATO TA, 1984, EVOL BIOL, V17, P219; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Leclerc C., 2011, DIVERSITY, V4, P1, DOI [DOI 10.3390/D4010001, 10.3390/d4010001]; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; MANGELSDORF P. C., 1956, Botanical Museum Leaflet, Harvard University, Cambridge, Mass., V17, P151; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mercer K, 2008, EVOL APPL, V1, P489, DOI 10.1111/j.1752-4571.2008.00038.x; Morrone Juan J., 2005, Rev. Mex. Biodiv., V76, P207; Ort DR, 2014, SCIENCE, V344, P483, DOI 10.1126/science.1253884; Ortega PR, 1991, AVANCES ESTUDIO RECU, P161; Parra J. Ron, 2006, SCI CUCBA, V8, P1; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pressoir G, 2004, HEREDITY, V92, P95, DOI 10.1038/sj.hdy.6800388; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reif J, 2006, THEOR APPL GENET, V113, P177, DOI 10.1007/s00122-006-0283-5; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; SANCHEZ GJJ, 1992, ECON BOT, V46, P72, DOI 10.1007/BF02985256; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Sanchez-Gonzalez JJ, 1989, THESIS N CAROLINA ST; Sturtevant E. L, 1894, B TORREY BOT CLUB, V21, P319, DOI DOI 10.2307/2477991; Ureta C, 2012, GLOBAL CHANGE BIOL, V18, P1073, DOI 10.1111/j.1365-2486.2011.02607.x; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; van Heerwaarden J, 2009, THEOR APPL GENET, V119, P875, DOI 10.1007/s00122-009-1096-0; Vavilov NI, 1992, ORIGIN GEOGRAPHY CUL, P207; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Villa Tania Carolina Camacho, 2005, Plant Genetic Resources Characterization and Utilization, V3, P373, DOI 10.1079/PGR200591; Wellhausen EJ., 1952, RACES MAIZE MEXICO; Wellhausen EJ, 1957, PUBLICATION NAS NRC, V511; XOLOCOTZI EH, 1985, ECON BOT, V39, P416, DOI 10.1007/BF02858749; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170; Zhao W, 2006, NUCLEIC ACIDS RES, V34, pD752, DOI 10.1093/nar/gkj011	61	58	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114657	10.1371/journal.pone.0114657	http://dx.doi.org/10.1371/journal.pone.0114657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486121	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000346907600085
J	Xie, CP; Chen, YP; Sun, WW; Ding, J; Zhou, LZ; Wang, SH; Wang, SQ; Zhang, YL; Zhu, DS; Wen, XB; Hu, SN; Li, SK				Xie, Chuping; Chen, Yaping; Sun, Wanwei; Ding, Jun; Zhou, Lizhen; Wang, Shasha; Wang, Shuqi; Zhang, Yueling; Zhu, Dashi; Wen, Xiaobo; Hu, Songnian; Li, Shengkang			Transcriptome and Expression Profiling Analysis of the Hemocytes Reveals a Large Number of Immune-Related Genes in Mud Crab Scylla paramamosain during Vibrio parahaemolyticus Infection	PLOS ONE			English	Article							SHRIMP LITOPENAEUS-VANNAMEI; MOLECULAR-CLONING; WHITE SHRIMP; CDNA; IDENTIFICATION; DROSOPHILA; GENERATION; LIVER; HEPATOPANCREAS; ACTIVATION	Background: Mud crab Scylla paramamosain is an economically important marine species in China. However, frequent outbreaks of infectious diseases caused by marine bacteria, such as Vibrio parahaemolyticus, result in great economic losses. Methodology/Principal Findings: Comparative de novo transcriptome analysis of S. paramamosain infected with V. parahaemolyticus was carried out to investigate the molecular mechanisms underlying the immune response to pathogenic bacteria by using the Illumina paired-end sequencing platform. A total of 52,934,042 clean reads from the hemocytes of V. parahaemolyticus-infected mud crabs and controls were obtained and assembled into 186,193 contigs. 59,120 unigenes were identified from 81,709 consensus sequences of mud crabs and 48,934 unigenes were matched proteins in the Nr or Swissprot databases. Among these, 10,566 unigenes belong to 3 categories of Gene Ontology, 25,349 to 30 categories of KEGG, and 15,191 to 25 categories of COG database, covering almost all functional categories. By using the Solexa/Illumina's DGE platform, 1213 differentially expressed genes (P<0.05), including 538 significantly up-regulated and 675 down-regulated, were detected in V. parahaemolyticus-infected crabs as compared to that in the controls. Transcript levels of randomly-chosen genes were further measured by quantitative real-time PCR to confirm the expression profiles. Many differentially expressed genes are involved in various immune processes, including stimulation of the Toll pathway, Immune Deficiency (IMD) pathway, Ras-regulated endocytosis, and proPO-activating system. Conclusions/Significance: Analysis of the expression profile of crabs under infection provides invaluable new data for biological research in S. paramamosain, such as the identification of novel genes in the hemocytes during V. parahaemolyticus infection. These results will facilitate our comprehensive understanding of the mechanisms involved in the immune response to bacterial infection and will be helpful for diseases prevention in crab aquaculture.	[Xie, Chuping; Sun, Wanwei; Ding, Jun; Zhou, Lizhen; Wang, Shasha; Wang, Shuqi; Zhang, Yueling; Zhu, Dashi; Wen, Xiaobo; Li, Shengkang] Shantou Univ, Guangdong Prov Key Lab Marine Biol, Shantou, Peoples R China; [Xie, Chuping; Sun, Wanwei; Ding, Jun; Zhou, Lizhen; Wang, Shasha; Wang, Shuqi; Zhang, Yueling; Zhu, Dashi; Li, Shengkang] Shantou Univ, Inst Marine Biol, Shantou, Peoples R China; [Chen, Yaping; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Shantou University; Shantou University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Li, SK (corresponding author), Shantou Univ, Guangdong Prov Key Lab Marine Biol, Shantou, Peoples R China.	lisk@stu.edu.cn	Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [41376176, 41176103]; Guangdong provincial project of Science and Technology [2012B020308007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong provincial project of Science and Technology	Funding: The work was supported by grants from National Natural Science Foundation of China (41376176, 41176103), Guangdong provincial project of Science and Technology (2012B020308007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; Bayne CJ, 2006, COMP BIOCHEM PHYS D, V1, P396, DOI 10.1016/j.cbd.2006.10.001; Boswell MG, 2009, COMP BIOCHEM PHYS C, V149, P258, DOI 10.1016/j.cbpc.2008.11.005; Cao D, 2001, ANIM GENET, V32, P169, DOI 10.1046/j.1365-2052.2001.00753.x; Cao JS, 2013, FISH SHELLFISH IMMUN, V34, P129, DOI 10.1016/j.fsi.2012.10.018; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Du ZQ, 2013, MOL BIOL REP, V40, P6873, DOI 10.1007/s11033-013-2805-y; Ekert PG, 1997, BRIT MED BULL, V53, P591; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Gao WH, 2012, AQUACULTURE, V364, P186, DOI 10.1016/j.aquaculture.2012.08.024; Gaston JSH, 2002, CLIN EXP IMMUNOL, V127, P1, DOI 10.1046/j.1365-2249.2002.01759.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He NH, 2004, FISH SHELLFISH IMMUN, V17, P121, DOI 10.1016/j.fsi.2003.11.008; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Li S, 2012, J APPL MICROBIOL, V113, P1341, DOI 10.1111/jam.12008; Li SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073392; Li SK, 2012, FISH SHELLFISH IMMUN, V32, P503, DOI 10.1016/j.fsi.2011.12.002; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Li XC, 2013, DEV COMP IMMUNOL, V39, P313, DOI 10.1016/j.dci.2012.11.011; Liu HP, 2010, FISH SHELLFISH IMMUN, V28, P862, DOI 10.1016/j.fsi.2010.02.008; Liu J, 2009, FISH SHELLFISH IMMUN, V26, P422, DOI 10.1016/j.fsi.2009.01.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102668; Ma THT, 2007, FISH SHELLFISH IMMUN, V23, P430, DOI 10.1016/j.fsi.2006.12.005; Mangkalanan S, 2014, DEV COMP IMMUNOL, V44, P116, DOI 10.1016/j.dci.2013.11.018; Martin SA, 2002, BIOCHEM BIOPH RES CO, V293, P578, DOI 10.1016/S0006-291X(02)00263-2; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mu Y, 2013, BMC GENOMICS, V11, P506; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Sanchez CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-626; Schlenke TA, 2005, INSECT MOL BIOL, V14, P175, DOI 10.1111/j.1365-2583.2004.00543.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Taboada X, 2012, GENE, V492, P250, DOI 10.1016/j.gene.2011.10.020; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Vuylsteke M, 2006, PLANT J, V45, P439, DOI 10.1111/j.1365-313X.2005.02630.x; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yan F, 2011, FISH SHELLFISH IMMUN, V30, P354, DOI 10.1016/j.fsi.2010.11.004; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang QX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063787; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093452; Zhu L, 2014, FISH SHELLFISH IMMUN, V36, P172, DOI 10.1016/j.fsi.2013.10.023; Zou ZH, 2011, COMP BIOCHEM PHYS D, V6, P150, DOI 10.1016/j.cbd.2010.12.003	58	28	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114500	10.1371/journal.pone.0114500	http://dx.doi.org/10.1371/journal.pone.0114500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486443	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600062
J	Abe, C; Johansson, E; Allzen, E; Savic, I				Abe, Christoph; Johansson, Emilia; Allzen, Elin; Savic, Ivanka			Sexual Orientation Related Differences in Cortical Thickness in Male Individuals	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; SURFACE-BASED ANALYSIS; HUMAN BRAIN; WORKING-MEMORY; PUTATIVE PHEROMONES; GENDER IDENTITY; HOMOSEXUAL-MEN; VISUAL-CORTEX; ADULTS	Previous neuroimaging studies demonstrated sex and also sexual orientation related structural and functional differences in the human brain. Genetic information and effects of sex hormones are assumed to contribute to the male/female differentiation of the brain, and similar effects could play a role in processes influencing human's sexual orientation. However, questions about the origin and development of a person's sexual orientation remain unanswered, and research on sexual orientation related neurobiological characteristics is still very limited. To contribute to a better understanding of the neurobiology of sexual orientation, we used magnetic resonance imaging (MRI) in order to compare regional cortical thickness (Cth) and subcortical volumes of homosexual men (hoM), heterosexual men (heM) and heterosexual women (heW). hoM (and heW) had thinner cortices primarily in visual areas and smaller thalamus volumes than heM, in which hoM and heW did not differ. Our results support previous studies, which suggest cerebral differences between hoM and heM in regions, where sex differences have been reported, which are frequently proposed to underlie biological mechanisms. Thus, our results contribute to a better understanding of the neurobiology of sexual orientation.	[Abe, Christoph; Johansson, Emilia] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Allzen, Elin] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Savic, Ivanka] Karolinska Hosp, Neurol Clin, Div Pediat Neurol, Dept Womens & Childrens Hlth, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Abe, C (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	christoph.abe@ki.se		Abe, Christoph/0000-0002-1680-8480	Swedish Medical Research Council; Stockholm Brain Institutet; KI (Karolisnka Institutet) foundation; AFA insurance fund; FORTE research fund	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm Brain Institutet; KI (Karolisnka Institutet) foundation; AFA insurance fund; FORTE research fund	This work was supported by the Swedish Medical Research Council, Stockholm Brain Institutet, KI (Karolisnka Institutet) foundation and by the use of resources and facilities at the Karolinska Institutet, Stockholm. Collection of control data was funded by the AFA insurance fund and the FORTE research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Bluhm RL, 2011, HUM BRAIN MAPP, V32, P1029, DOI 10.1002/hbm.21090; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Dickerson BC, 2012, NEUROLOGY, V78, P84, DOI 10.1212/WNL.0b013e31823efc6c; Durazzo TC, 2013, ADDICT BIOL, V18, P379, DOI 10.1111/j.1369-1600.2011.00407.x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Garcia-Falgueras A, 2010, ENDOCR DEV, V17, P22, DOI 10.1159/000262525; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gooren LJG, 2002, MOL CELL ENDOCRINOL, V198, P31, DOI 10.1016/S0303-7207(02)00366-0; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Hofer P, 2013, EUR NEUROPSYCHOPHARM, V23, P79, DOI 10.1016/j.euroneuro.2012.04.013; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Hu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059426; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Keogh R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029221; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Lentini E, 2013, CEREB CORTEX, V23, P2322, DOI 10.1093/cercor/bhs222; Luders E, 2006, CEREB CORTEX, V16, P1232, DOI 10.1093/cercor/bhj064; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Manning JT, 2003, MED HYPOTHESES, V61, P303, DOI 10.1016/S0306-9877(03)00184-1; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Michels L, 2008, NEUROIMAGE, V40, P1296, DOI 10.1016/j.neuroimage.2007.12.048; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Peper JS, 2011, NEUROSCIENCE, V191, P28, DOI 10.1016/j.neuroscience.2011.02.014; Peper JS, 2011, PSYCHONEUROENDOCRINO, V36, P1101, DOI 10.1016/j.psyneuen.2011.05.004; Ponseti J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000762; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002; Rahman Q, 2003, PERS INDIV DIFFER, V34, P1337, DOI 10.1016/S0191-8869(02)00140-X; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2013, SEX DIFFERENCES CORT; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Savic I, 2010, PROG BRAIN RES, V186, P41, DOI 10.1016/B978-0-444-53630-3.00004-X; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Swaab DF, 2009, FUNCT NEUROL, V24, P17; Tanabe J, 2013, AM J NEURORADIOL, V34, P1150, DOI 10.3174/ajnr.A3347; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Ventre-Dominey J, 2005, COGNITIVE BRAIN RES, V25, P747, DOI 10.1016/j.cogbrainres.2005.09.004; Walhovd KB, 2006, NEUROIMAGE, V31, P1343, DOI 10.1016/j.neuroimage.2006.01.011; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028	57	30	30	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114721	10.1371/journal.pone.0114721	http://dx.doi.org/10.1371/journal.pone.0114721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479554	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200115
J	Ericson, VR; Spilker, KA; Tugizova, MS; Shen, K				Ericson, Vivian R.; Spilker, Kerri A.; Tugizova, Madina S.; Shen, Kang			MTM-6, a Phosphoinositide Phosphatase, is Required to Promote Synapse Formation in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MYOTUBULAR MYOPATHY; NERVOUS-SYSTEM; POSTSYNAPTIC DIFFERENTIATION; ALZHEIMERS-DISEASE; WNT SIGNALS; DROSOPHILA; NEURONS; FAMILY	Forming the proper number of synapses is crucial for normal neuronal development. We found that loss of function of the phosphoinositide phosphatase mtm-6 results in a reduction in the number of synaptic puncta. The reduction in synapses is partially the result of MTM-6 regulation of the secretion of the Wnt ligand EGL-20 from cells in the tail and partially the result of neuronal action. MTM-6 shows relative specificity for EGL-20 over the other Wnt ligands. We suggest that the ability of MTM-6 to regulate EGL-20 secretion is a function of its expression pattern. We conclude that regulation of secretion of different Wnt ligands can use different components. Additionally, we present a novel neuronal function for MTM-6.	[Ericson, Vivian R.; Spilker, Kerri A.; Tugizova, Madina S.; Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu	Tugizova, Madina/GPC-4412-2022		Howard Hughes Medical Institute; National Science Foundation; Stanford Graduate Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University)	Funding was provided by Investigator Award, Howard Hughes Medical Institute, No Grant Number, http://www.hhmi.org/; National Science Foundation Graduate Fellowship, National Science Foundation, http://www.nsf.gov/; Stanford Graduate Fellowship, http://sgf.stanford.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2012, REV NEUROSCIENCE, V23, P29, DOI [10.1515/RNS.2011.057, 10.1515/rns.2011.057]; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; Baulac S, 2008, ARCH NEUROL-CHICAGO, V65, P943, DOI 10.1001/archneur.65.7.943; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bolis A, 2007, MOL NEUROBIOL, V35, P308, DOI 10.1007/s12035-007-0031-0; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee HW, 2010, J NEUROSCI, V30, P5508, DOI 10.1523/JNEUROSCI.4283-09.2010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Mei J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004979; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Mizumoto K, 2013, CELL REP, V5, P389, DOI 10.1016/j.celrep.2013.09.011; Mizumoto K, 2013, NEURON, V77, P655, DOI 10.1016/j.neuron.2012.12.031; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Neukomm LJ, 2011, DEVELOPMENT, V138, P2003, DOI 10.1242/dev.060012; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Razidlo GL, 2011, J BIOL CHEM, V286, P20005, DOI 10.1074/jbc.M110.197749; Robinson FL, 2008, P NATL ACAD SCI USA, V105, P4916, DOI 10.1073/pnas.0800742105; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sanchez-Juan P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.011; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200; Zou W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000679	67	1	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114501	10.1371/journal.pone.0114501	http://dx.doi.org/10.1371/journal.pone.0114501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479419	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200096
J	Nikolic, N; Bocker, R; Kostic-Kravljanac, L; Nikolic, M				Nikolic, Nina; Boecker, Reinhard; Kostic-Kravljanac, Ljiljana; Nikolic, Miroslav			Assembly Processes under Severe Abiotic Filtering: Adaptation Mechanisms of Weed Vegetation to the Gradient of Soil Constraints	PLOS ONE			English	Article							NUTRIENT-ACQUISITION STRATEGIES; ENVIRONMENTAL GRADIENT; ECOSYSTEMS; DIVERSITY; ABUNDANCE; COPPER; PLANTS; WHEAT	Questions: Effects of soil on vegetation patterns are commonly obscured by other environmental factors; clear and general relationships are difficult to find. How would community assembly processes be affected by a substantial change in soil characteristics when all other relevant factors are held constant? In particular, can we identify some functional adaptations which would underpin such soil-induced vegetation response? Location: Eastern Serbia: fields partially damaged by long-term and large-scale fluvial deposition of sulphidic waste from a Cu mine; subcontinental/submediterranean climate. Methods: We analysed the multivariate response of cereal weed assemblages (including biomass and foliar analyses) to a strong man-made soil gradient (from highly calcareous to highly acidic, nutrient-poor soils) over short distances (field scale). Results: The soil gradient favoured a substitution of calcicoles by calcifuges, and an increase in abundance of pseudometallophytes, with preferences for Atlantic climate, broad geographical distribution, hemicryptophytic life form, adapted to low-nutrient and acidic soils, with lower concentrations of Ca, and very narrow range of Cu concentrations in leaves. The trends of abundance of the different ecological groups of indicator species along the soil gradient were systematically reflected in the maintenance of leaf P concentrations, and strong homeostasis in biomass N:P ratio. Conclusion: Using annual weed vegetation at the field scale as a fairly simple model, we demonstrated links between gradients in soil properties (pH, nutrient availability) and floristic composition that are normally encountered over large geographic distances. We showed that leaf nutrient status, in particular the maintenance of leaf P concentrations and strong homeostasis of biomass N:P ratio, underpinned a clear functional response of vegetation to mineral stress. These findings can help to understand assembly processes leading to unusual, novel combinations of species which are typically observed as a consequence of strong environmental filtering, as for instance on sites affected by industrial activities.	[Nikolic, Nina; Kostic-Kravljanac, Ljiljana; Nikolic, Miroslav] Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia; [Boecker, Reinhard] Univ Hohenheim, Stuttgart, Germany	University of Belgrade; University Hohenheim	Nikolic, N (corresponding author), Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia.	nina@imsi.bg.ac.rs	Nikolic, Nina/AAB-9448-2021; Nikolic, Miroslav/H-8657-2014; Kravljanac, Ljiljana Kostic/AAT-7315-2020	Nikolic, Nina/0000-0002-4214-3291; Nikolic, Miroslav/0000-0001-9643-138X; Kravljanac, Ljiljana Kostic/0000-0003-2586-0739	Serbian Ministry of Education, Science and Technological Development [173028]	Serbian Ministry of Education, Science and Technological Development	This work was supported by the Serbian Ministry of Education, Science and Technological Development Grant #173028 to MN (http://www.mpn.gov.rs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S.E., 1974, CHEM ANAL ECOLOGICAL; ALVAREZ H, 1974, AM MIDL NAT, V92, P1, DOI 10.2307/2424198; Austin M. P., 2005, VEGETATION ECOLOGY, P52; AUSTIN MP, 1994, J VEG SCI, V5, P215, DOI 10.2307/3236154; BAKER AJM, 1987, NEW PHYTOL, V106, P93; Barker AV, 2007, HDB PLANT NUTR, P22; Becker T, 2007, FOLIA GEOBOT, V42, P11, DOI 10.1007/BF02835100; Bergmann W, 1986, EMAHRUNGSSTORUNGEN B; BROWN G, 1994, VEGETATIO, V115, P77; Cimalova S, 2009, PLANT ECOL, V203, P45, DOI 10.1007/s11258-008-9503-1; CLARK RK, 1981, NEW PHYTOL, V87, P799, DOI 10.1111/j.1469-8137.1981.tb01715.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; Ellenberg H, 1988, VEGETATION ECOLOGY C, P621; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Fageria NK, 2001, COMMUN SOIL SCI PLAN, V32, P1659, DOI 10.1081/CSS-100104220; Fried G, 2008, AGR ECOSYST ENVIRON, V128, P68, DOI 10.1016/j.agee.2008.05.003; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Hallett Lauren M., 2013, P16; Hayes P, 2014, J ECOL, V102, P396, DOI 10.1111/1365-2745.12196; HilleRisLambers J, 2013, OIKOS, V122, P1649, DOI 10.1111/j.1600-0706.2013.00698.x; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; HOLZNER W, 1978, VEGETATIO, V38, P13, DOI 10.1007/BF00141295; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lee JA, 1999, ADV BOT RES, V29, P1; Lososova Z, 2008, J BIOGEOGR, V35, P177, DOI 10.1111/j.1365-2699.2007.01778.x; Lososova Z, 2006, FOLIA GEOBOT, V41, P259, DOI 10.1007/BF02904941; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mielke P. W., 2001, PERMUTATION METHODS; MILIJIC S, 1980, ARH POLJOPR NAUKE, V41, P201; Misic V., 1997, VEGETATION SERBIA, P311; Nagy L, 1997, NEW PHYTOL, V137, P267, DOI 10.1046/j.1469-8137.1997.00799.x; Nikolic N, 2012, SCI TOTAL ENVIRON, V425, P146, DOI 10.1016/j.scitotenv.2012.02.076; Nikolic N, 2011, PLANT SOIL, V339, P485, DOI 10.1007/s11104-010-0605-x; NORVELL WA, 1984, SOIL SCI SOC AM J, V48, P1285, DOI 10.2136/sssaj1984.03615995004800060017x; Petit S, 2012, J VEG SCI, V23, P1137, DOI 10.1111/j.1654-1103.2012.01421.x; Sanchez C., 2007, HDB PLANT NUTR, P51; SMITH RAH, 1979, J APPL ECOL, V16, P595, DOI 10.2307/2402534; THOMPSON J, 1983, NEW PHYTOL, V94, P297, DOI 10.1111/j.1469-8137.1983.tb04502.x; Thompson K, 1997, NEW PHYTOL, V136, P679, DOI 10.1046/j.1469-8137.1997.00787.x; Tischew S, 2014, APPL VEG SCI, V17, P288, DOI 10.1111/avsc.12078; van der Maarel E, 2007, J VEG SCI, V18, P767, DOI 10.1111/j.1654-1103.2007.tb02592.x; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wiegleb G, 2001, ECOL ENG, V17, P199, DOI 10.1016/S0925-8574(00)00159-2	54	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114290	10.1371/journal.pone.0114290	http://dx.doi.org/10.1371/journal.pone.0114290			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474688	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500011
J	Pelle, DW; Peacock, JD; Schmidt, CL; Kampfschulte, K; Scholten, DJ; Russo, SS; Easton, KJ; Steensma, MR				Pelle, Dominic W.; Peacock, Jacqueline D.; Schmidt, Courtney L.; Kampfschulte, Kevin; Scholten, Donald J., II; Russo, Scott S.; Easton, Kenneth J.; Steensma, Matthew R.			Genetic and Functional Studies of the Intervertebral Disc: A Novel Murine Intervertebral Disc Model	PLOS ONE			English	Article							EARLY DEGENERATIVE CHANGES; NUCLEUS PULPOSUS CELLS; ORGAN-CULTURE SYSTEM; MOUSE MODELS; EXPRESSION; RECEPTOR; POLYMORPHISMS; PREVALENCE; ACTIVATION; INDUCTION	Intervertebral disc (IVD) homeostasis is mediated through a combination of micro-environmental and biomechanical factors, all of which are subject to genetic influences. The aim of this study is to develop and characterize a genetically tractable, ex vivo organ culture model that can be used to further elucidate mechanisms of intervertebral disc disease. Specifically, we demonstrate that IVD disc explants (1) maintain their native phenotype in prolonged culture, (2) are responsive to exogenous stimuli, and (3) that relevant homeostatic regulatory mechanisms can be modulated through ex-vivo genetic recombination. We present a novel technique for isolation of murine IVD explants with demonstration of explant viability (CMFDA/propidium iodide staining), disc anatomy (H&E), maintenance of extracellular matrix (ECM) (Alcian Blue staining), and native expression profile (qRT-PCR) as well as ex vivo genetic recombination (mT/mG reporter mice; AdCre) following 14 days of culture in DMEM media containing 10% fetal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin. IVD explants maintained their micro-anatomic integrity, ECM proteoglycan content, viability, and gene expression profile consistent with a homeostatic drive in culture. Treatment of genetically engineered explants with cre-expressing adenovirus efficaciously induced ex vivo genetic recombination in a variety of genetically engineered mouse models. Exogenous administration of IL-1 beta and TGF-beta 3 resulted in predicted catabolic and anabolic responses, respectively. Genetic recombination of TGFBR1(fl/fl) explants resulted in constitutively active TGF-beta signaling that matched that of exogenously administered TGF-beta 3. Our results illustrate the utility of the murine intervertebral disc explant to investigate mechanisms of intervertebral disc degeneration.	[Pelle, Dominic W.; Peacock, Jacqueline D.; Schmidt, Courtney L.; Kampfschulte, Kevin; Scholten, Donald J., II; Steensma, Matthew R.] Van Andel Inst, Lab Musculoskeletal Oncol, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI 49503 USA; [Pelle, Dominic W.] Grand Rapids Med Educ Partners, Dept Orthopaed Surg, Grand Rapids, MI USA; [Scholten, Donald J., II; Steensma, Matthew R.] Michigan State Univ, Coll Human Med, Dept Surg, Grand Rapids, MI USA; [Russo, Scott S.; Easton, Kenneth J.] Orthopaed Associates Michigan, Sect Spine Surg, Grand Rapids, MI USA; [Steensma, Matthew R.] Helen DeVos Childrens Hosp, Spectrum Hlth Med Grp, Dept Surg, Grand Rapids, MI USA	Van Andel Institute; Michigan State University; Michigan State University College of Human Medicine; Spectrum Health Medical Group	Pelle, DW (corresponding author), Van Andel Inst, Lab Musculoskeletal Oncol, Ctr Skeletal Dis & Tumor Metastasis, Grand Rapids, MI 49503 USA.	dominic.pelle@vai.org			Jay and Betty Van Andel Foundation	Jay and Betty Van Andel Foundation	This work was supported by the Jay and Betty Van Andel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Chan SCW, 2012, JOVE-J VIS EXP, DOI 10.3791/3490; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chiba K, 1998, SPINE, V23, P1821, DOI 10.1097/00007632-199809010-00002; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Eser B, 2010, GENET TEST MOL BIOMA, V14, P313, DOI 10.1089/gtmb.2009.0202; Fosang AJ, 2008, NAT CLIN PRACT RHEUM, V4, P420, DOI 10.1038/ncprheum0841; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Haschtmann D, 2006, SPINE, V31, P2918, DOI 10.1097/01.brs.0000247954.69438.ae; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Huang K, 2011, MOL BIOL REP, V38, P3569, DOI 10.1007/s11033-010-0467-6; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jin HT, 2011, FEBS LETT, V585, P1209, DOI 10.1016/j.febslet.2011.03.034; Kepler CK, 2013, SPINE, V38, P873, DOI 10.1097/BRS.0b013e318285ae08; Korecki CL, 2007, EUR SPINE J, V16, P1029, DOI 10.1007/s00586-007-0327-9; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Markova DZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4301; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Mayer JE, 2013, SPINE J, V13, P299, DOI 10.1016/j.spinee.2013.01.041; Muders MH, 2009, CANCER RES, V69, P6042, DOI 10.1158/0008-5472.CAN-09-0552; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Parolin M, 2010, Evid Based Spine Care J, V1, P67, DOI 10.1055/s-0028-1100919; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Ponnappan RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3494; Reitmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069610; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, SPINE, V31, P884, DOI 10.1097/01.brs.0000209335.57767.b5; Roberts S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-24; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sambrook PN, 1999, ARTHRITIS RHEUM-US, V42, P366, DOI 10.1002/1529-0131(199902)42:2<366::AID-ANR20>3.0.CO;2-6; Seol D, 2013, J ORTHOP RES, V31, P838, DOI 10.1002/jor.22285; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Vo NV, 2013, SPINE J, V13, P331, DOI 10.1016/j.spinee.2012.02.027; Wang JR, 2013, ARTHRITIS RHEUM-US, V65, P832, DOI 10.1002/art.37819; Wang MN, 2012, ARTHRITIS RHEUM-US, V64, P2611, DOI 10.1002/art.34469; Wang WX, 2011, HUM MOL GENET, V20, P3910, DOI 10.1093/hmg/ddr310; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Wuertz K, 2012, EUR CELLS MATER, V23, P103; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhu Y, 2013, J ORTHOP RES, V31, P1144, DOI 10.1002/jor.22337	47	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112454	10.1371/journal.pone.0112454	http://dx.doi.org/10.1371/journal.pone.0112454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474689	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500071
J	Li, CT; Chen, YN; Chang, CH; Tsai, KH				Li, Chun-Ting; Chen, Yen-Nien; Chang, Chih-Han; Tsai, Kuen-Horng			The Effects of Backward Adjustable Thoracic Support in Wheelchair on Spinal Curvature and Back Muscle Activation for Elderly People	PLOS ONE			English	Article							HIP FLEXION; SITTING POSTURES; BODY-COMPOSITION; LUMBAR SUPPORT; CORD-INJURY; RELIABILITY; PRESSURE; POSITION; SYSTEM; HEALTH	Objectives: To investigate the effects of backward adjustable thoracic support on spinal curvature and back muscle activation during wheelchair sitting. Methods: Twenty elderly people were recruited for this study. The backward adjustable thoracic support sitting posture was compared with the slumped, normal, and lumbar support sitting postures. Spinal curvatures (pelvic, lumbar, and thoracic angles) and muscle activations of 4 back muscles on both sides (maximal voluntary isometric contraction of the lumbar multifidus, lumbar erector spinae, iliocostalis lumborum pars thoracis, and thoracic erector spinae at T9) were measured and compared between the different sitting postures using one-way analysis of variance with repeated measures. Results: The backward adjustable thoracic support sitting posture showed a relatively neutral pelvic tilt (-0.32 +/- 4.80 degrees) when compared with the slumped (22.84 +/- 5.27 degrees) and lumbar support (-8.97 +/- 3.31 degrees) sitting postures (P<0.001), and showed relatively higher lumbar lordosis (-23.38 +/- 6.50 degrees) when compared with the slumped (14.77 +/- 7.83 degrees), normal (0.44 +/- 7.47 degrees), and lumbar support (-16.76 +/- 4.77 degrees) sitting postures (P<0.05). It also showed relatively lower back muscle activity when compared with the normal and lumbar support sitting postures (P<0.05). Conclusions: The backward adjustable thoracic support sitting concept was suggested because it maintains a more neutral pelvic tilt, higher lumbar lordosis, and lower back muscle activation, which may help maintain a better sitting posture and reduce the risk of back pain.	[Li, Chun-Ting; Chen, Yen-Nien; Chang, Chih-Han] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Chen, Yen-Nien] Met Ind Res & Dev Ctr, Kaohsiung, Taiwan; [Tsai, Kuen-Horng] Natl Univ Tainan, Grad Inst Mechatron Syst Engn, Tainan, Taiwan	National Cheng Kung University; National University Tainan	Chang, CH (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	cchang@mail.bme.ncku.edu.tw; khnutn@gmail.com		Chen, Yennien/0000-0002-3047-0797; Tsai, Kuen-Horng/0000-0002-4360-3712	National Science Council, Taiwan [NSC 101-2320-B-024-001-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant no. NSC 101-2320-B-024-001-MY2 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSC website: http://web1.nsc.gov.tw/mp.aspx?mp=7.	Adams M, 2002, BIOMECHANICS BACK PA; ANDERSSON BJ, 1974, SCAND J REHABIL MED, V6, P115; ANDERSSON G B J, 1979, Spine, V4, P52, DOI 10.1097/00007632-197901000-00009; Barrett E, 2014, MANUAL THER, V19, P10, DOI 10.1016/j.math.2013.09.003; BENNETT DL, 1989, PHYS THER, V69, P902, DOI 10.1093/ptj/69.11.902; BRIDGER RS, 1989, HUM FACTORS, V31, P679, DOI 10.1177/001872088903100604; Callaghan JP, 2002, CLIN BIOMECH, V17, P353, DOI 10.1016/S0268-0033(02)00023-2; Congdon R, 2005, CLIN BIOMECH, V20, P947, DOI 10.1016/j.clinbiomech.2005.03.011; Cooper R. A., 1998, WHEELCHAIR SELECTION; Dankaerts W, 2004, J ELECTROMYOGR KINES, V14, P333, DOI 10.1016/j.jelekin.2003.07.001; Danneels LA, 2001, MANUAL THER, V6, P145, DOI 10.1054/math.2001.0396; De Carvalho DE, 2012, APPL ERGON, V43, P876, DOI 10.1016/j.apergo.2011.12.007; DEFOA JL, 1989, J ANAT, V163, P243; Dewberry MJ, 2003, CLIN BIOMECH, V18, P494, DOI 10.1016/S0268-0033(03)00096-2; Folsch C, 2012, PM&R, V4, P335, DOI 10.1016/j.pmrj.2012.01.009; Guimond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037450; Hastings JD, 2003, ARCH PHYS MED REHAB, V84, P528, DOI 10.1053/apmr.2003.50036; Huang HC, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-40; Janssen-Potten YJ, 2001, ARCH PHYS MED REHAB, V82, P1393, DOI 10.1053/apmr.2001.25989; Kasahara S, 2008, GAIT POSTURE, V28, P251, DOI 10.1016/j.gaitpost.2007.12.004; Lin F, 2006, ARCH PHYS MED REHAB, V87, P504, DOI 10.1016/j.apmr.2005.11.031; Makhsous M, 2003, SPINE, V28, P1113, DOI 10.1097/00007632-200306010-00006; Makhsous M, 2007, ARCH PHYS MED REHAB, V88, P862, DOI 10.1016/j.apmr.2007.03.017; Makhsous M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-17; May LA, 2004, ARCH PHYS MED REHAB, V85, P1146, DOI 10.1016/j.apmr.2003.08.105; Moutzouri M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-131; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; Nordin M., 2001, BASIC BIOMECHANICS M; O'Sullivan PB, 2006, SPINE, V31, pE707, DOI 10.1097/01.brs.0000234735.98075.50; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Poole DC, 1997, AM J PHYSIOL-HEART C, V272, pH2107, DOI 10.1152/ajpheart.1997.272.5.H2107; Pope MH, 2002, ANNU REV BIOMED ENG, V4, P49, DOI 10.1146/annurev.bioeng.4.092101.122107; Reed MP, 1996, SAE TECHNICAL PAPER, P19; Sabol TP, 2006, CLIN GERIATR MED, V22, P355, DOI 10.1016/j.cger.2005.12.013; Samuelsson K, 2001, DISABIL REHABIL, V23, P677; Solberg G., 2008, POSTURAL DISORDERS M, V2n; Stojadinovic O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069223; Toosizadeh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048625; Uritani D, 2013, J PHYS THER SCI, V25, P1181, DOI 10.1589/jpts.25.1181; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Welsh DG, 1996, CIRC RES, V79, P551, DOI 10.1161/01.RES.79.3.551; Zacharkow D, 1988, POSTURE SITTING STAN	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113644	10.1371/journal.pone.0113644	http://dx.doi.org/10.1371/journal.pone.0113644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25480152	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400072
J	Qu, C; Bonar, SL; Hickman-Brecks, CL; Abu-Amer, S; McGeough, MD; Pena, CA; Broderick, L; Yang, C; Grimston, SK; Kading, J; Abu-Amer, Y; Novack, DV; Hoffman, HM; Civitelli, R; Mbalaviele, G				Qu, Chao; Bonar, Sheri L.; Hickman-Brecks, Cynthia L.; Abu-Amer, Samer; McGeough, Matthew D.; Pena, Carla A.; Broderick, Lori; Yang, Chang; Grimston, Susan K.; Kading, Jacqueline; Abu-Amer, Yousef; Novack, Deborah V.; Hoffman, Hal M.; Civitelli, Roberto; Mbalaviele, Gabriel			NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms	FASEB JOURNAL			English	Article						osteoclasts; IL-1 beta; PARP1; NOMID; cryopyrinopathies	POLY(ADP-RIBOSE) POLYMERASE-1; ACTIVATION; INFLAMMASOMES; TARGET; CELLS	Activating-mutations in NOD-like receptor (NLR) family, pyrin domain-containing 3 (NLRP3) cause neonatal-onset multisystem inflammatory disease. However, the ontogeny of skeletal anomalies in this disorder is poorly understood. Mice globally expressing the D301N mutation in Nlrp3 (D303N in human) model the human phenotype, including systemic inflammation and skeletal deformities. To gain insights into the skeletal manifestations, we generated mice in which the expression of D301N Nlrp3 (Nlrp3(D301N)) is restricted to myeloid cells. These mice exhibit systemic inflammation and severe osteopenia (similar to 60% lower bone mass) similar to mice globally expressing the knock-in mutation, consistent with the paradigm of innate immune-driven cryopyrinopathies. Because systemic inflammation may indirectly affect bone homeostasis, we engineered mice in which Nlrp3(D301N) is expressed specifically in osteoclasts, the cells that resorb bone. These mice also develop similar to 50% lower bone mass due to increased osteolysis, but there is no systemic inflammation and no change in osteoclast number. Mechanistically, aside from its role in IL-1 beta maturation, Nlrp3(D301N) expression enhances osteoclast bone resorbing ability through reorganization of actin cytoskeleton while promoting the degradation of poly(ADP-ribose) polymerase 1, an inhibitor of osteoclastogenesis. Thus, NLRP3 inflammasome activation is not restricted to the production of proinflammatory mediators but also leads to cytokine-autonomous responses.	[Qu, Chao; Bonar, Sheri L.; Hickman-Brecks, Cynthia L.; Abu-Amer, Samer; Yang, Chang; Grimston, Susan K.; Kading, Jacqueline; Novack, Deborah V.; Civitelli, Roberto; Mbalaviele, Gabriel] Washington Univ, Sch Med, Div Bone & Mineral Dis, 660 South Euclid Ave,Campus Box 8301, St Louis, MO 63110 USA; [McGeough, Matthew D.; Pena, Carla A.; Broderick, Lori; Hoffman, Hal M.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Abu-Amer, Yousef] Univ Calif San Diego, Div Allergy Immunol & Rheumatol, La Jolla, CA 92093 USA	Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Diego	Mbalaviele, G (corresponding author), Washington Univ, Sch Med, Div Bone & Mineral Dis, 660 South Euclid Ave,Campus Box 8301, St Louis, MO 63110 USA.	gmbalavi@dom.wustl.edu	Civitelli, Roberto/AAA-8260-2019	Civitelli, Roberto/0000-0003-4076-4315; Novack, Deborah/0000-0001-7101-5582	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [R01-AR064755]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [5 P30 AR057235, R01-AR054326]; NIH/Core Center for Musculoskeletal Biology and Medicine; Shriners Hospital for Children Grant [85600]; Pfizer, Inc.; Amgen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075830] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054326, R01AR064755, P30AR057235, R01AR052705] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; NIH/Core Center for Musculoskeletal Biology and Medicine; Shriners Hospital for Children Grant; Pfizer, Inc.(Pfizer); Amgen(Amgen); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Marcus Watkins and Rong Zeng for technical assistance and Sung Yeop Jeong for maintaining mouse colonies. The authors also thank Susanna Brydges, James Mueller, and Daniel Kastner for their role in generating the Nlrp3<SUP>fl(D301N)/+</SUP> mice, and the Musculoskeletal Histology and Morphometry Core as well as the Structure and Strength Core at Washington University in St. Louis. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR064755 (to G.M.), NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 5 P30 AR057235, NIH/Core Center for Musculoskeletal Biology and Medicine (to G.M.), and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR054326 and Shriners Hospital for Children Grant 85600 (to Y.A.). G.M. is cofounder of Confluence Life Sciences. R.C. receives research support from Pfizer, Inc. and Amgen and holds stock of Amgen, Eli-Lilly, and Merck & Co. H.M.H. is consultant for Regeneron and is a consultant and speaker for Novartis and Sobi. All other authors report no conflicts of interest.	Beranger GE, 2008, J BONE MINER RES, V23, P564, DOI 10.1359/JBMR.071111; Bonar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035979; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Castri P, 2014, BBA-MOL CELL RES, V1843, P640, DOI 10.1016/j.bbamcr.2013.12.005; Chen JF, 2010, J BIOL CHEM, V285, P36315, DOI 10.1074/jbc.M110.157743; Erener S, 2012, MOL CELL, V46, P200, DOI 10.1016/j.molcel.2012.02.016; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hill SC, 2007, PEDIATR RADIOL, V37, P145, DOI 10.1007/s00247-006-0358-0; Hirai T, 2013, J IMMUNOL, V190, P4805, DOI 10.4049/jimmunol.1200901; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hottiger MO, 2011, FEBS LETT, V585, P1595, DOI 10.1016/j.febslet.2011.03.031; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Kharkwal G, 2012, J MOL ENDOCRINOL, V48, P261, DOI 10.1530/JME-11-0061; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Malireddi RKS, 2010, J IMMUNOL, V185, P3127, DOI 10.4049/jimmunol.1001512; Petrilli V, 2004, J CLIN INVEST, V114, P1072, DOI 10.1172/JCI200421854; Rigante D, 2011, RHEUMATOL INT, V31, P1661, DOI 10.1007/s00296-010-1787-5; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Sibley CH, 2012, ARTHRITIS RHEUM-US, V64, P2375, DOI 10.1002/art.34409; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Verheugd P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2672; Weber FA, 2013, STEM CELLS, V31, P2364, DOI 10.1002/stem.1507; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	29	43	46	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1269	1279		10.1096/fj.14-264804	http://dx.doi.org/10.1096/fj.14-264804			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25477279	Green Published			2022-12-26	WOS:000354115000015
J	Morrow, GP; MacMillan, L; Lamarre, SG; Young, SK; MacFarlane, AJ; Brosnan, ME; Brosnan, JT				Morrow, Gregory P.; MacMillan, Luke; Lamarre, Simon G.; Young, Sara K.; MacFarlane, Amanda J.; Brosnan, Margaret E.; Brosnan, John T.			In Vivo Kinetics of Formate Metabolism in Folate-deficient and Folate-replete Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; HOMOCYSTEINE REMETHYLATION; NEURAL-TUBE; SERINE; LIVER; ASSAY; MICE; HUMANS; TRANSSULFURATION; NUTRITION	It is now established that the mitochondrial production of formate is a major process in the endogenous generation of folate-linked one-carbon groups. We have developed an in vivo approach involving the constant infusion of [C-13] formate until isotopic steady state is attained to measure the rate of endogenous formate production in rats fed on either a folate-replete or folate-deficient diet. Formate was produced at a rate of 76 mu mol.h(-1).100 g of body weight(-1) in the folate-replete rats, and this was decreased by 44% in folate-deficient rats. This decreased formate production was confirmed in isolated rat liver mitochondria where formate production from serine, the principal precursor of one-carbon groups, was decreased by 85%, although formate production from sarcosine and dimethylglycine (choline metabolites) was significantly increased. We attribute this unexpected result to the demonstrated production of formaldehyde by sarcosine dehydrogenase and dimethylglycine dehydrogenase from their respective substrates in the absence of tetrahydrofolate and subsequent formation of formate by formaldehyde dehydrogenase. Comparison of formate production with the ingestion of dietary formate precursors (serine, glycine, tryptophan, histidine, methionine, and choline) showed that similar to 75% of these precursors were converted to formate, indicating that formate is a significant, although under-appreciated end product of choline and amino acid oxidation. Ingestion of a high protein diet did not result in increased production of formate, suggesting a regulation of the conversion of these precursors at the mitochondrial level to formate.	[Morrow, Gregory P.; MacMillan, Luke; Young, Sara K.; Brosnan, Margaret E.; Brosnan, John T.] Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada; [Lamarre, Simon G.] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [MacFarlane, Amanda J.] Hlth Canada, Nutr Res Div, Ottawa, ON K1A 0K9, Canada	Memorial University Newfoundland; University of Moncton; Health Canada	Brosnan, JT (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada.	jbrosnan@mun.ca	Lamarre, Simon/A-5674-2008	Lamarre, Simon/0000-0001-7038-4626	Canadian Institutes of Health Research; Research Development Corporation; School of Graduate Studies, Memorial University of Newfoundland; Research Development Corp.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Development Corporation; School of Graduate Studies, Memorial University of Newfoundland; Research Development Corp.	This work was supported, in whole or in part, by grants from the Canadian Institutes of Health Research and the Research Development Corporation (to J. T. B. and M. E. B.). We also acknowledge support by graduate fellowships from the School of Graduate Studies, Memorial University of Newfoundland (to G. P. M. and to L. M.), and Canadian Institutes of Health Research and Research Development Corp. (to L. M.).	ANNISON EF, 1962, BIOCHEM J, V84, P552, DOI 10.1042/bj0840552; BARLOWE C K, 1988, Biofactors, V1, P171; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BILLS ND, 1992, BLOOD, V79, P2273; BROSNAN JT, 1983, AM J PHYSIOL, V244, pE151, DOI 10.1152/ajpendo.1983.244.2.E151; Damian P, 1996, TOXICOL APPL PHARM, V139, P22, DOI 10.1006/taap.1996.0139; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; FERRELL CL, 1986, J NUTR, V116, P2525, DOI 10.1093/jn/116.12.2525; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; GRADY S, 1986, J ANAL TOXICOL, V10, P1; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; HORNE DW, 1988, CLIN CHEM, V34, P2357; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; KREBS HA, 1976, BIOCHEM J, V158, P341, DOI 10.1042/bj1580341; Lamarre SG, 2014, AMINO ACIDS, V46, P1885, DOI 10.1007/s00726-014-1738-7; Lamarre SG, 2013, CLIN CHEM LAB MED, V51, P571, DOI 10.1515/cclm-2012-0552; Lamarre SG, 2012, AM J PHYSIOL-ENDOC M, V302, pE61, DOI 10.1152/ajpendo.00345.2011; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Narisawa A, 2012, HUM MOL GENET, V21, P1496, DOI 10.1093/hmg/ddr585; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Qian DL, 1996, BIOCHEM J, V313, P479, DOI 10.1042/bj3130479; RAFECAS I, 1994, BRIT J NUTR, V72, P199, DOI 10.1079/BJN19940024; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SONNE JC, 1948, J BIOL CHEM, V173, P69; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; WAYDHAS C, 1978, EUR J BIOCHEM, V89, P143, DOI 10.1111/j.1432-1033.1978.tb20906.x; Wolfe R. R., 1992, RADIOACTIVE AND STAB, P258; WOLFE RR, 1982, J APPL PHYSIOL, V52, P458, DOI 10.1152/jappl.1982.52.2.458	31	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2244	2250		10.1074/jbc.M114.600718	http://dx.doi.org/10.1074/jbc.M114.600718			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480787	hybrid, Green Published			2022-12-26	WOS:000348588000028
J	Krska, D; Ravulapalli, R; Fieldhouse, RJ; Lugo, MR; Merrill, AR				Krska, Daniel; Ravulapalli, Ravikiran; Fieldhouse, Robert J.; Lugo, Miguel R.; Merrill, A. Rod			C3larvin Toxin, an ADP-ribosyltransferase from Paenibacillus larvae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERUGINOSA EXOTOXIN-A; PSEUDOMONAS-AERUGINOSA; CLOSTRIDIUM-LIMOSUM; RIBOSYLATING TOXINS; BACILLUS-CEREUS; INHIBITORS; EXOENZYME; COMPLEX; MIMICRY; NAD(+)	C3larvin toxin was identified by a bioinformatic strategy as a putative mono-ADP-ribosyltransferase and a possible virulence factor from Paenibacillus larvae, which is the causative agent of American Foulbrood in honey bees. C3larvin targets RhoA as a substrate for its transferase reaction, and kinetics for both the NAD(+) (K-m = 34 +/- 12 mu M) and RhoA (K-m = 17 +/- 3 mu M) substrates were characterized for this enzyme from the mono-ADP-ribosyltransferase C3 toxin subgroup. C3larvin is toxic to yeast when expressed in the cytoplasm, and catalytic variants of the enzyme lost the ability to kill the yeast host, indicating that the toxin exerts its lethality through its enzyme activity. A small molecule inhibitor of C3larvin enzymatic activity was discovered called M3 (K-i = 11 +/- 2 mu M), and to our knowledge, is the first inhibitor of transferase activity of the C3 toxin family. C3larvin was crystallized, and its crystal structure (apoenzyme) was solved to 2.3 angstrom resolution. C3larvin was also shown to have a different mechanism of cell entry from other C3 toxins.	[Krska, Daniel; Ravulapalli, Ravikiran; Lugo, Miguel R.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Fieldhouse, Robert J.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Fieldhouse, Robert J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Guelph; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Merrill, Rod/M-8313-2014		Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported by the Canadian Institutes of Health Research (to A. R. M.). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong S, 2002, J ENZYM INHIB MED CH, V17, P235, DOI 10.1080/1475636021000010914; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Bohmer J, 1996, BIOCHEMISTRY-US, V35, P282, DOI 10.1021/bi951784+; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahrer J, 2010, CELL MICROBIOL, V12, P233, DOI 10.1111/j.1462-5822.2009.01393.x; Fieldhouse RJ, 2012, J BIOL CHEM, V287, P21176, DOI 10.1074/jbc.M111.337311; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Funfhaus A, 2013, ENVIRON MICROBIOL, V15, P2951, DOI 10.1111/1462-2920.12229; Genersch E., 2010, PAENIBACILLUS LARVAE, V103, pS10; Goblirsch MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069831; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, EMBO REP, V9, P802, DOI 10.1038/embor.2008.90; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Rieg S, 2010, EMERG INFECT DIS, V16, P487, DOI 10.3201/eid1603.091457; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Swann SL, 2011, J MED CHEM, V54, P1223, DOI 10.1021/jm1013677; Tautzenberger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085695; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Turgeon Z, 2009, FEMS MICROBIOL LETT, V300, P97, DOI 10.1111/j.1574-6968.2009.01777.x; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; Vogelsgesang M, 2006, BIOCHEMISTRY-US, V45, P1017, DOI 10.1021/bi052253g; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wilde C, 2003, BIOCHEMISTRY-US, V42, P9694, DOI 10.1021/bi034583b; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Yates SP, 2005, ANAL BIOCHEM, V340, P41, DOI 10.1016/j.ab.2005.01.051	36	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1639	1653		10.1074/jbc.M114.589846	http://dx.doi.org/10.1074/jbc.M114.589846			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477523	hybrid, Green Published			2022-12-26	WOS:000348056400031
J	An, HK; Kim, KS; Lee, JW; Park, MH; Moon, HI; Park, SJ; Baik, JS; Kim, CH; Lee, YC				An, Hyun-Kyu; Kim, Kyoung-Sook; Lee, Ji-Won; Park, Mi-Hyun; Moon, Hyung-In; Park, Shin-Ji; Baik, Ji-Sue; Kim, Cheorl-Ho; Lee, Young-Choon			Mimulone-Induced Autophagy through p53-Mediated AMPK/mTOR Pathway Increases Caspase-Mediated Apoptotic Cell Death in A549 Human Lung Cancer Cells	PLOS ONE			English	Article							PAULOWNIA-TOMENTOSA FRUITS; C-GERANYL COMPOUNDS; INHIBITS PROLIFERATION; NCI-H460 CELLS; FLAVANONES; P53; ACTIVATION; GROWTH; MECHANISMS; AGENTS	Anticancer properties and mechanisms of mimulone (MML), C-geranylflavonoid isolated from the Paulownia tomentosa fruits, were firstly elucidated in this study. MML prevented cell proliferation in a dose-and time-dependent way and triggered apoptosis through the extrinsic pathway in A549 human lung adenocarcinoma cells. Furthermore, MML-treated cells displayed autophagic features, such as the formation of autophagic vacuoles, a primary morphological feature of autophagy, and the accumulation of microtubule-associated protein 1 light chain 3 (LC3) puncta, another typical maker of autophagy, as determined by FITC-conjugated immunostaining and monodansylcadaverine (MDC) staining, respectively. The expression levels of LC3-I and LC3-II, specific markers of autophagy, were also augmented by MML treatment. Autophagy inhibition by 3-methyladenine (3-MA), pharmacological autophagy inhibitor, and shRNA knockdown of Beclin-1 reduced apoptotic cell death induced by MML. Autophagic flux was not significantly affected by MML treatment and lysosomal inhibitor, chloroquine (CQ) suppressed MML-induced autophagy and apoptosis. MML-induced autophagy was promoted by decreases in p53 and p-mTOR levels and increase of p-AMPK. Moreover, inhibition of p53 transactivation by pifithrin-alpha (PFT-alpha) and knockdown of p53 enhanced induction of autophagy and finally promoted apoptotic cell death. Overall, the results demonstrate that autophagy contributes to the cytotoxicity of MML in cancer cells harboring wild-type p53. This study strongly suggests that MML is a potential candidate for an anticancer agent targeting both autophagy and apoptotic cell death in human lung cancer. Moreover, co-treatment of MML and p53 inhibitor would be more effective in human lung cancer therapy.	[An, Hyun-Kyu; Kim, Kyoung-Sook; Lee, Ji-Won; Park, Mi-Hyun; Moon, Hyung-In; Park, Shin-Ji; Baik, Ji-Sue; Lee, Young-Choon] Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea; [Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Unit, Suwon 440746, South Korea	Dong A University; Sungkyunkwan University (SKKU)	Lee, YC (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea.	yclee@dau.ac.kr	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714	Dong-A University research fund	Dong-A University research fund	This work was supported by the Dong-A University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aredia Francesca, 2012, Cells, V1, P520, DOI 10.3390/cells1030520; Asai T, 2008, PHYTOCHEMISTRY, V69, P1234, DOI 10.1016/j.phytochem.2007.11.011; Avisetti DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087050; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chang WA, 2014, MOL MED REP, V9, P1653, DOI 10.3892/mmr.2014.2015; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hsu HF, 2008, FOOD CHEM TOXICOL, V46, P3785, DOI 10.1016/j.fct.2008.09.068; Huang RY, 2014, CELL PHYSIOL BIOCHEM, V33, P375, DOI 10.1159/000356677; Hung JY, 2009, J AGR FOOD CHEM, V57, P9809, DOI 10.1021/jf902315e; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Kaewpiboon C, 2014, INT J ONCOL, V44, P1233, DOI 10.3892/ijo.2014.2297; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SK, 2010, PHYTOTHER RES, V24, P1898, DOI 10.1002/ptr.3277; Kollar P, 2011, BRIT J PHARMACOL, V162, P1534, DOI 10.1111/j.1476-5381.2010.01171.x; Lee JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083611; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; Navratilova A, 2013, PHYTOCHEMISTRY, V89, P104, DOI 10.1016/j.phytochem.2013.01.002; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Schneiderova K, 2013, NAT PROD RES, V27, P613, DOI 10.1080/14786419.2012.683002; Smejkal K, 2008, PLANTA MED, V74, P1488, DOI 10.1055/s-2008-1081339; Smejkal K, 2007, J NAT PROD, V70, P1244, DOI 10.1021/np070063w; Smejkal K, 2007, MOLECULES, V12, P1210, DOI 10.3390/12061210; Smejkal K, 2010, J NAT PROD, V73, P568, DOI 10.1021/np900681y; Song J, 2014, BIOORG MED CHEM LETT, V24, P1188, DOI 10.1016/j.bmcl.2013.12.111; Tan W, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-27; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Warin RF, 2014, J AGR FOOD CHEM, V62, P1352, DOI 10.1021/jf405573e; Wu SH, 2010, ANTICANCER RES, V30, P2125; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x; Zhang XJ, 2013, ACTA PHARMACOL SIN, V34, P595, DOI 10.1038/aps.2012.184; Zhang YS, 2014, ONCOL LETT, V7, P295, DOI 10.3892/ol.2013.1696	48	33	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114607	10.1371/journal.pone.0114607	http://dx.doi.org/10.1371/journal.pone.0114607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490748	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300060
J	Moens, B; Muller, C; van Noorden, L; Franek, M; Celie, B; Boone, J; Bourgois, J; Leman, M				Moens, Bart; Muller, Chris; van Noorden, Leon; Franek, Marek; Celie, Bert; Boone, Jan; Bourgois, Jan; Leman, Marc			Encouraging Spontaneous Synchronisation with D-Jogger, an Adaptive Music Player That Aligns Movement and Music	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; PHASE-TRANSITIONS; SYNCHRONOUS MUSIC; PHYSICAL-ACTIVITY; EXERCISE DOMAIN; AUDITORY CUES; GAIT; WALKING; BEAT; VARIABILITY	In this study we explore how music can entrain human walkers to synchronise to the musical beat without being instructed to do so. For this, we use an interactive music player, called D-Jogger, that senses the user's walking tempo and phase. D-Jogger aligns the music by manipulating the timing difference between beats and footfalls. Experiments are reported that led to the development and optimisation of four alignment strategies. The first strategy matched the music's tempo continuously to the runner's pace. The second strategy matched the music's tempo at the beginning of a song to the runner's pace, keeping the tempo constant for the remainder of the song. The third alignment starts a song in perfect phase synchrony and continues to adjust the tempo to match the runner's pace. The fourth and last strategy additionally adjusts the phase of the music so each beat matches a footfall. The first two strategies resulted in a minor increase of steps in phase synchrony with the main beat when compared to a random playlist, the last two strategies resulted in a strong increase in synchronised steps. These results may be explained in terms of phase-error correction mechanisms and motor prediction schemes. Finding the phase-lock is difficult due to fluctuations in the interaction, whereas strategies that automatically align the phase between movement and music solve the problem of finding the phase-locking. Moreover, the data show that once the phase-lock is found, alignment can be easily maintained, suggesting that less entrainment effort is needed to keep the phase-lock, than to find the phase-lock. The different alignment strategies of D-Jogger can be applied in different domains such as sports, physical rehabilitation and assistive technologies for movement performance.	[Moens, Bart; Muller, Chris; van Noorden, Leon; Leman, Marc] Univ Ghent, Inst Psychoacoust & Elect Mus, Dept Musicol, B-9000 Ghent, Belgium; [Franek, Marek] Univ Hradec Kralove, Dept Management, Hradec Kralove, Czech Republic; [Celie, Bert; Boone, Jan; Bourgois, Jan] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	Ghent University; University of Hradec Kralove; Ghent University	Leman, M (corresponding author), Univ Ghent, Inst Psychoacoust & Elect Mus, Dept Musicol, B-9000 Ghent, Belgium.	marc.leman@ugent.be	Boone, Jan/AAC-9748-2020; Franěk, Marek/P-7670-2016	Franěk, Marek/0000-0002-9228-5319; Moens, Bart/0000-0002-1281-9406	Flemish Government, Belgium; COST Action on Sonic Interaction Design (SID) by the European Science Foundation [IC 0601]	Flemish Government, Belgium; COST Action on Sonic Interaction Design (SID) by the European Science Foundation	This work was supported by funding by a Methusalem grant from the Flemish Government, Belgium. Several step frequency and gait phase detection methods were developed using funding by the COST IC 0601 Action on Sonic Interaction Design (SID) by the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJNE B, 1968, BIOMETRIKA, V55, P343, DOI 10.1093/biomet/55.2.343; Bacon CJ, 2012, J SPORT MED PHYS FIT, V52, P359; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Chaiwanichsiri D, 2011, ASIAN BIOMED, V5, P649, DOI 10.5372/1905-7415.0505.086; de Bruin N, 2010, PARKINSONS DIS, V2010, P483; Dixon S, 2007, J NEW MUSIC RES, V36, P39, DOI 10.1080/09298210701653310; Fairhurst MT, 2013, CEREB CORTEX, V23, P2592, DOI 10.1093/cercor/bhs243; Fisher N., 1995, STAT ANAL CIRCULAR D; Fritz TH, 2013, P NATL ACAD SCI USA, V110, P17784, DOI 10.1073/pnas.1217252110; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hausdorff J, 2009, CHAOS INTERDISCIPLIN, V19, P026; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hockman J, 2009, P INT C NEW INT MUS, P90; Hoffmann CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045206; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Lane AM, 2011, J SPORT SCI MED, V10, P400; Large EW, 2009, ANN NY ACAD SCI, V1169, P46, DOI 10.1111/j.1749-6632.2009.04550.x; Leman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067932; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2014, ACTA PSYCHOL, V147, P10, DOI 10.1016/j.actpsy.2013.10.002; Masahiro N., 2008, P 2008 INT C MUS INF, P193; Mendonca C, 2014, HUM MOVEMENT SCI, V33, P33, DOI 10.1016/j.humov.2013.11.006; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Moens B, 2010, P 7 SOUND MUS COMP C, P451; Moens B, 2010, SENSOR EVALUATION RE; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nowicki L., 2013, PSYCHOMUSICOLOGY, V23, P6, DOI [10.1037/a0032039, DOI 10.1037/A0032039]; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Papetti S, 2011, P INT C NEW INT MUS, P473; Pappas IPI, 2001, IEEE T NEUR SYS REH, V9, P113, DOI 10.1109/7333.928571; Phillips-Silver J, 2011, NEUROPSYCHOLOGIA, V49, P961, DOI 10.1016/j.neuropsychologia.2011.02.002; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Styns F, 2007, HUM MOVEMENT SCI, V26, P769, DOI 10.1016/j.humov.2007.07.007; Terry PC, 2012, J SCI MED SPORT, V15, P52, DOI 10.1016/j.jsams.2011.06.003; WILKIE D, 1983, J R STAT SOC C-APPL, V32, P311; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Ying H, 2007, IFMBE PROC, V13, P80; Zar JH, 1999, BIOSTATISTICAL ANAL; Zplanede, 2002, EL TIM STRETCH PITCH	55	48	48	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114234	10.1371/journal.pone.0114234	http://dx.doi.org/10.1371/journal.pone.0114234			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AY3YM	25489742	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300022
J	Takahashi, Y; Kondo, K; Miyaji, A; Watanabe, Y; Fan, QH; Honma, T; Tanaka, K				Takahashi, Yoshio; Kondo, Kazuhiro; Miyaji, Asami; Watanabe, Yusuke; Fan, Qiaohui; Honma, Tetsuo; Tanaka, Kazuya			Recovery and Separation of Rare Earth Elements Using Salmon Milt	PLOS ONE			English	Article							HEAVY-METAL IONS; MULTIPLE-SCATTERING; AQUEOUS-SOLUTIONS; DNA; COMPLEXES; EXTRACTION; COLUMNS; REMOVAL; MATRIX	Recycling rare earth elements (REEs) used in advanced materials such as Nd magnets is important for the efficient use of REE resources when the supply of several REEs is limited. In this work, the feasibility of using salmon milt for REE recovery and separation was examined, along with the identification of the binding site of REEs in salmon milt. Results showed that (i) salmon milt has a sufficiently high affinity to adsorb REEs and (ii) the adsorption capacity of the milt is 1.04 mEq/g, which is comparable with that of commercial cation exchange resin. Heavier REEs have higher affinity for milt. A comparison of stability constants and adsorption patterns of REEs discussed in the literature suggests that the phosphate is responsible for the adsorption of REE in milt. The results were supported by dysprosium (Dy) and lutetium (Lu) L-III-edge extended x-ray absorption fine structure (EXAFS) spectroscopy. The REE-P shell was identified for the second neighboring atom, which shows the importance of the phosphate site as REE binding sites. The comparison of REE adsorption pattern and EXAFS results between the milt system and other adsorbent systems (cellulose phosphate, Ln-resin, bacteria, and DNA-filter hybrid) revealed that the coordination number of phosphate is correlated with the slope of the REE pattern. The separation column loaded with milt was tested to separate REE for the practical use of salmon milt for the recovery and separation of REE. However, water did not flow through the column possibly because of the hydrophobicity of the milt. Thus, sequential adsorption-desorption approach using a batch-type method was applied for the separation of REE. As an example of the practical applications of REE separation, Nd and Fe(III) were successfully separated from a synthetic solution of Nd magnet waste by a batch-type method using salmon milt.	[Takahashi, Yoshio; Watanabe, Yusuke; Fan, Qiaohui] Univ Tokyo, Dept Earth & Planetary Sci, Bukyo Ku, Tokyo 1138654, Japan; [Takahashi, Yoshio; Miyaji, Asami] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima, Hiroshima 7398526, Japan; [Kondo, Kazuhiro] Aisin Cosmos R&D Co LTD, Kisarazu, Chiba 2920818, Japan; [Honma, Tetsuo] Japan Synchrotron Radiat Res Inst JASRI, SPring 8, Sayo, Hyogo 6795198, Japan; [Tanaka, Kazuya] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Hiroshima 7398530, Japan	University of Tokyo; Hiroshima University; Aisin Seiki; Japan Synchrotron Radiation Research Institute; Hiroshima University	Takahashi, Y (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bukyo Ku, Hongo 7-3-1, Tokyo 1138654, Japan.	ytakaha@hiroshima-u.ac.jp	Takahashi, Yoshio/F-6733-2011	Takahashi, Yoshio/0000-0001-7860-2341; KONDO, Kazuhiro/0000-0002-3731-6258	Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [22224011] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, CONTINENTAL CRUST; Bunker G., 2010, INTRO XAFS PRACTICAL; BYRNE RH, 1990, GEOCHIM COSMOCHIM AC, V54, P2645, DOI 10.1016/0016-7037(90)90002-3; Du XY, 2011, J IND ECOL, V15, P836, DOI 10.1111/j.1530-9290.2011.00362.x; Eliseeva SV, 2011, NEW J CHEM, V35, P1165, DOI 10.1039/c0nj00969e; Gupta C. K., 2004, EXTRACTIVE METALLURG; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hokkaido Bureau of Economy, TRAD IND; Hopkins BS, 1933, P NATL ACAD SCI USA, V19, P64, DOI 10.1073/pnas.19.1.64; Liao BQ, 2005, SEPAR SCI TECHNOL, V40, P1685, DOI 10.1081/SS-200059604; Matsuura Takanori, 2006, Membrane, V31, P281; Murakami H, 2006, CARBONATITE RELATED, P197; Nebel-Jacobsen Y, 2005, CHEM GEOL, V220, P105, DOI 10.1016/j.chemgeo.2005.03.009; NI YX, 1995, AM MINERAL, V80, P21; ODAY PA, 1994, J AM CHEM SOC, V116, P2938, DOI 10.1021/ja00086a026; Sakai H, 2009, COLLOID SURFACE A, V347, P210, DOI 10.1016/j.colsurfa.2009.04.031; Sigg L., 1992, CHEM SOLID WATER INT, P369; SMITH RM, 1987, SCI TOTAL ENVIRON, V64, P125, DOI 10.1016/0048-9697(87)90127-6; Takahashi Y, 2005, CHEM GEOL, V219, P53, DOI 10.1016/j.chemgeo.2005.02.009; Takahashi Y, 2004, ANAL SCI, V20, P1301, DOI 10.2116/analsci.20.1301; Takahashi Y, 2007, CHEM GEOL, V244, P569, DOI 10.1016/j.chemgeo.2007.07.005; Takahashi Y, 2012, ANAL SCI, V28, P985, DOI 10.2116/analsci.28.985; Takahashi Y, 2010, GEOCHIM COSMOCHIM AC, V74, P5443, DOI 10.1016/j.gca.2010.07.001; Takeshima T, 2014, POLYM J, V46, P36, DOI 10.1038/pj.2013.58; Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086; Yamada M, 2002, B CHEM SOC JPN, V75, P1627, DOI 10.1246/bcsj.75.1627; Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r; Yamamoto Y, 2010, GEOCHEM J, V44, P39, DOI 10.2343/geochemj.1.0041; Yan CH, 1999, J RARE EARTH, V17, P58; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zinchenko AA, 2009, J HAZARD MATER, V168, P38, DOI 10.1016/j.jhazmat.2009.01.121	31	24	24	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114858	10.1371/journal.pone.0114858	http://dx.doi.org/10.1371/journal.pone.0114858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490035	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300085
J	Gabriel, F; Accoceberry, I; Bessoule, JJ; Salin, B; Lucas-Guerin, M; Manon, S; Dementhon, K; Noel, T				Gabriel, Frederic; Accoceberry, Isabelle; Bessoule, Jean-Jacques; Salin, Benedicte; Lucas-Guerin, Marine; Manon, Stephen; Dementhon, Karine; Noel, Thierry			A Fox2-Dependent Fatty Acid beta-Oxidation Pathway Coexists Both in Peroxisomes and Mitochondria of the Ascomycete Yeast Candida lusitaniae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GLYOXYLATE CYCLE; NEUROSPORA-CRASSA; MOLECULAR-CLONING; PROTEIN; ALBICANS; IDENTIFICATION; DEHYDROGENASE; PURIFICATION; TROPICALIS	It is generally admitted that the ascomycete yeasts of the subphylum Saccharomycotina possess a single fatty acid beta-oxidation pathway located exclusively in peroxisomes, and that they lost mitochondrial beta-oxidation early during evolution. In this work, we showed that mutants of the opportunistic pathogenic yeast Candida lusitaniae which lack the multifunctional enzyme Fox2p, a key enzyme of the beta-oxidation pathway, were still able to grow on fatty acids as the sole carbon source, suggesting that C. lusitaniae harbored an alternative pathway for fatty acid catabolism. By assaying C-14(alpha)-palmitoyl-CoA consumption, we demonstrated that fatty acid catabolism takes place in both peroxisomal and mitochondrial subcellular fractions. We then observed that a fox2 Delta null mutant was unable to catabolize fatty acids in the mitochondrial fraction, thus indicating that the mitochondrial pathway was Fox2p-dependent. This finding was confirmed by the immunodetection of Fox2p in protein extracts obtained from purified peroxisomal and mitochondrial fractions. Finally, immunoelectron microscopy provided evidence that Fox2p was localized in both peroxisomes and mitochondria. This work constitutes the first demonstration of the existence of a Fox2p-dependent mitochondrial beta-oxidation pathway in an ascomycetous yeast, C. lusitaniae. It also points to the existence of an alternative fatty acid catabolism pathway, probably located in peroxisomes, and functioning in a Fox2p-independent manner.	[Gabriel, Frederic; Accoceberry, Isabelle; Lucas-Guerin, Marine; Dementhon, Karine; Noel, Thierry] Univ Bordeaux, UMR 5234, F-33000 Bordeaux, France; [Gabriel, Frederic; Accoceberry, Isabelle; Lucas-Guerin, Marine; Dementhon, Karine; Noel, Thierry] CNRS, UMR 5234, F-33000 Bordeaux, France; [Bessoule, Jean-Jacques] Univ Bordeaux, Lab Biogenese Membranaire, UMR 5200, Bordeaux, France; [Bessoule, Jean-Jacques] CNRS, Lab Biogenese Membranaire, UMR 5200, F-33000 Bordeaux, France; [Salin, Benedicte; Manon, Stephen] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France; [Salin, Benedicte; Manon, Stephen] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Gabriel, F (corresponding author), Univ Bordeaux, UMR 5234, F-33000 Bordeaux, France.	thierry.noel@u-bordeaux2.fr	Manon, Stéphen/C-7088-2017	Noel, Thierry/0000-0003-0320-1126; Manon, Stephen/0000-0002-5792-1084; DEMENTHON, Karine/0000-0003-0974-3663	University of Bordeaux; Centre National de la Recherche Scientifique	University of Bordeaux; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Funding: This work was supported by grants from the University of Bordeaux and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ast J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00297; Baltazar MF, 1999, MICROBIOL-UK, V145, P271, DOI 10.1099/13500872-145-1-271; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Boisnard S, 2009, FUNGAL GENET BIOL, V46, P55, DOI 10.1016/j.fgb.2008.10.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Camougrand N, 2008, METHOD ENZYMOL, V451, P89, DOI 10.1016/S0076-6879(08)03208-4; Cheng Q, 2005, BBA-MOL CELL BIOL L, V1735, P192, DOI 10.1016/j.bbalip.2005.06.006; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; DELAGARZA MM, 1985, EUR J BIOCHEM, V148, P285, DOI 10.1111/j.1432-1033.1985.tb08837.x; Dementhon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032621; Distel Ben, 2006, Methods Mol Biol, V313, P21; DOMMES P, 1983, J BIOL CHEM, V258, P846; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; El-Kirat-Chatel S, 2011, YEAST, V28, P321, DOI 10.1002/yea.1836; Favel A, 2003, DIAGN MICR INFEC DIS, V47, P331, DOI 10.1016/S0732-8893(03)00094-4; Ferdinandusse S, 2004, J LIPID RES, V45, P1104, DOI 10.1194/jlr.M300512-JLR200; Feron G, 2005, FEMS MICROBIOL LETT, V250, P63, DOI 10.1016/j.femsle.2005.06.045; FOSSA A, 1995, MOL GEN GENET, V247, P95, DOI 10.1007/BF00425825; Foulon V, 1999, P NATL ACAD SCI USA, V96, P10039, DOI 10.1073/pnas.96.18.10039; Francois F, 2004, YEAST, V21, P95, DOI 10.1002/yea.1059; Francois F, 2001, J CLIN MICROBIOL, V39, P3906, DOI 10.1128/JCM.39.11.3906-3914.2001; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; HILTUNEN JK, 1992, J BIOL CHEM, V267, P6646; Jansen GA, 2006, BBA-MOL CELL RES, V1763, P1403, DOI 10.1016/j.bbamcr.2006.07.012; KAMIRYO T, 1982, J BACTERIOL, V152, P269; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; KURIHARA T, 1992, J BIOCHEM-TOKYO, V111, P783, DOI 10.1093/oxfordjournals.jbchem.a123836; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Maggio-Hall LA, 2008, FUNGAL GENET BIOL, V45, P180, DOI 10.1016/j.fgb.2007.06.004; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Pauly Diana, 2011, J Vis Exp, DOI 10.3791/3084; Pereira C, 2010, MOL MICROBIOL, V76, P1398, DOI 10.1111/j.1365-2958.2010.07122.x; PICATAGGIO S, 1992, BIO-TECHNOL, V10, P894, DOI 10.1038/nbt0892-894; Piekarska K, 2008, MICROBIOL-SGM, V154, P3061, DOI 10.1099/mic.0.2008/020289-0; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; POLAKIS ES, 1964, BIOCHEM J, V90, P369, DOI 10.1042/bj0900369; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; Ramirez MA, 2007, EUKARYOT CELL, V6, P280, DOI 10.1128/EC.00372-06; Refsum S, 1947, JAMA-J AM MED ASSOC, V133, P1319, DOI [10.1001/jama.1947.02880170065026, DOI 10.1001/JAMA.1947.02880170065026]; RODRIGUESDEMIRANDA L, 1979, A VAN LEEUW J MICROB, V45, P479, DOI 10.1007/BF00443285; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; SCHERER S, 1987, J CLIN MICROBIOL, V25, P675, DOI 10.1128/JCM.25.4.675-679.1987; Schmidt G, 1996, MICROBIOL-SGM, V142, P419, DOI 10.1099/13500872-142-2-419; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; Shen YQ, 2009, NUCLEIC ACIDS RES, V37, P5619, DOI 10.1093/nar/gkp566; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Smith JJ, 2000, J BIOL CHEM, V275, P20168, DOI 10.1074/jbc.M909285199; Strijbis K, 2010, EUKARYOT CELL, V9, P1809, DOI 10.1128/EC.00172-10; THIERINGER R, 1991, J BIOL CHEM, V266, P13118; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANDERS RJA, 1991, J INHERIT METAB DIS, V14, P349, DOI 10.1007/BF01811700; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004	66	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114531	10.1371/journal.pone.0114531	http://dx.doi.org/10.1371/journal.pone.0114531			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486052	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600071
J	Zagorskaite, E; Sasnauskas, G				Zagorskaite, Evelina; Sasnauskas, Giedrius			Chemical Display of Pyrimidine Bases Flipped Out by Modification-Dependent Restriction Endonucleases of MspJI and PvuRts1I Families	PLOS ONE			English	Article							HEMI-METHYLATED DNA; CPG BINDING DOMAIN; STRUCTURAL BASIS; SRA DOMAIN; RECOGNITION; PROTEIN; RESIDUES; 5-METHYLCYTOSINE; PERMANGANATE; UHRF1	The epigenetic DNA modifications 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) in eukaryotes are recognized either in the context of double-stranded DNA (e.g., by the methyl-CpG binding domain of MeCP2), or in the flipped-out state (e.g., by the SRA domain of UHRF1). The SRA-like domains and the base-flipping mechanism for 5(h)mC recognition are also shared by the recently discovered prokaryotic modification-dependent endonucleases of the MspJI and PvuRts1I families. Since the mechanism of modified cytosine recognition by many potential eukaryotic and prokaryotic 5(h) mC "readers" is still unknown, a fast solution based method for the detection of extrahelical 5(h) mC would be very useful. In the present study we tested base-flipping by MspJI- and PvuRts1I-like restriction enzymes using several solution-based methods, including fluorescence measurements of the cytosine analog pyrrolocytosine and chemical modification of extrahelical pyrimidines with chloroacetaldehyde and KMnO4. We find that only KMnO4 proved an efficient probe for the positive display of flipped out pyrimidines, albeit the method required either non-physiological pH (4.3) or a substitution of the target cytosine with thymine. Our results imply that DNA recognition mechanism of 5(h) mC binding proteins should be tested using a combination of all available methods, as the lack of a positive signal in some assays does not exclude the base flipping mechanism.	[Zagorskaite, Evelina; Sasnauskas, Giedrius] Vilnius State Univ, Inst Biotechnol, Dept Prot DNA Interact, Vilnius, Lithuania	Vilnius University	Sasnauskas, G (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Prot DNA Interact, Vilnius, Lithuania.	gsasnaus@ibt.lt	Sasnauskas, Giedrius/AAE-8191-2019		Research Council of Lithuania [MIP-027/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	Funding: This work was supported by the Research Council of Lithuania (Grant MIP-027/2012 to GS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Berry DA, 2004, TETRAHEDRON LETT, V45, P2457, DOI 10.1016/j.tetlet.2004.01.108; Bischerour J, 2007, NUCLEIC ACIDS RES, V35, P2584, DOI 10.1093/nar/gkm186; Bochtler M, 2006, EMBO J, V25, P2219, DOI 10.1038/sj.emboj.7601096; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Daujotyte D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn200; FRITZSCHE E, 1987, NUCLEIC ACIDS RES, V15, P5517, DOI 10.1093/nar/15.14.5517; GOGOS JA, 1990, NUCLEIC ACIDS RES, V18, P6807, DOI 10.1093/nar/18.23.6807; Hahn MA, 2014, GENOMICS, V104, P314, DOI 10.1016/j.ygeno.2014.08.015; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; HAYATSU H, 1967, BIOCHEM BIOPH RES CO, V29, P556, DOI 10.1016/0006-291X(67)90521-9; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P12092, DOI 10.1093/nar/gku871; Horton JR, 2014, NUCLEIC ACIDS RES, V42, P7947, DOI 10.1093/nar/gku497; Horton JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep04246; Horton JR, 2012, NUCLEIC ACIDS RES, V40, P9763, DOI 10.1093/nar/gks719; Huang XJ, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-56; Irier HA, 2012, DNA CELL BIOL, V31, pS42, DOI 10.1089/dna.2011.1565; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Kazrani AA, 2014, NUCLEIC ACIDS RES, V42, P5929, DOI 10.1093/nar/gku186; Klimasauskas S, 2009, DNA RNA MODIFICATION, P37; KUSMIEREK JT, 1982, BIOCHEMISTRY-US, V21, P5717, DOI 10.1021/bi00265a050; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Oakeley EJ, 1999, BIOTECHNIQUES, V27, P744, DOI 10.2144/99274st05; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Rajakumara E, 2011, GENE DEV, V25, P137, DOI 10.1101/gad.1980311; Reddy YVR, 2000, J MOL BIOL, V298, P597, DOI 10.1006/jmbi.2000.3673; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sasnauskas G, 2003, P NATL ACAD SCI USA, V100, P6410, DOI 10.1073/pnas.1131003100; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Serva S, 1998, NUCLEIC ACIDS RES, V26, P3473, DOI 10.1093/nar/26.15.3473; Shao C, 2014, ACTA CRYSTALLOGR D, V70, P2477, DOI 10.1107/S139900471401606X; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Sun ZY, 2013, CELL REP, V3, P567, DOI 10.1016/j.celrep.2013.01.001; Szwagierczak A, 2011, NUCLEIC ACIDS RES, V39, P5149, DOI 10.1093/nar/gkr118; Tamulaitis G, 2002, FEBS LETT, V518, P17, DOI 10.1016/S0014-5793(02)02621-2; Wang H, 2011, NUCLEIC ACIDS RES, V39, P9294, DOI 10.1093/nar/gkr607; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Zhou T, 2014, MOL CELL, V54, P879, DOI 10.1016/j.molcel.2014.04.003	46	4	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114580	10.1371/journal.pone.0114580	http://dx.doi.org/10.1371/journal.pone.0114580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486533	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600077
J	Zhang, XY; Wang, JX; Zhang, M; Qin, GH; Li, DQ; Zhu, KY; Ma, EB; Zhang, JZ				Zhang, Xueyao; Wang, Jianxin; Zhang, Min; Qin, Guohua; Li, Daqi; Zhu, Kun Yan; Ma, Enbo; Zhang, Jianzhen			Molecular Cloning, Characterization and Positively Selected Sites of the Glutathione S-Transferase Family from Locusta migratoria	PLOS ONE			English	Article							EXPRESSION; EVOLUTION; SYNTHASE; IDENTIFICATION; PROTECTION	Glutathione S-transferases (GSTs) are multifunctional enzymes that are involved in the metabolism of endogenous and exogenous compounds and are related to insecticide resistance. The purpose of this study was to provide new information on the molecular characteristics and the positive selection of locust GSTs. Based on the transcriptome database, we sequenced 28 cytosolic GSTs and 4 microsomal GSTs from the migratory locust (Locusta migratoria). We assigned the 28 cytosolic GSTs into 6 classes-sigma, epsilon, delta, theta, omega and zeta, and the 4 microsomal GSTs into 2 subclasses-insect and MGST3. The tissue-and stage-expression patterns of the GSTs differed at the mRNA level. Further, the substrate specificities and kinetic constants of the cytosolic GSTs differed markedly at the protein level. The results of likelihood ratio tests provided strong evidence for positive selection in the delta class. The result of Bayes Empirical Bayes analysis identified 4 amino acid sites in the delta class as positive selection sites. These sites were located on the protein surface. Our findings will facilitate the elucidation of the molecular characteristics and evolutionary aspects of insect GST-superfamily.	[Zhang, Xueyao; Wang, Jianxin; Zhang, Min; Qin, Guohua; Li, Daqi; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Shanxi University; Kansas State University	Ma, EB (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi, Peoples R China.	maenbo2003@sxu.edu.cn; zjz@sxu.edu.cn		Zhu, Kun Yan/0000-0001-9372-8030	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [31320103921]; National Natural Science Foundation of China [31101463, 31201545, 31201548]; Research Fund for the Doctoral Program of Higher Education of China [20111401120009, 20111401110006]; Shanxi Province Science Foundation for Youths [2012021027-1]	Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Province Science Foundation for Youths	This research was supported by the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (31320103921), the National Natural Science Foundation of China (Grant No. 31101463, 31201545, 31201548), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20111401120009, 20111401110006). Shanxi Province Science Foundation for Youths (Grant No. 2012021027-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-13; Board PG, 2011, DRUG METAB REV, V43, P215, DOI 10.3109/03602532.2010.549132; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Espinoza HM, 2013, BIOCHEM PHARMACOL, V85, P839, DOI 10.1016/j.bcp.2012.11.018; Eswar N., 2001, CURRENT PROTOCOLS PR; Flanagan JU, 2011, DRUG METAB REV, V43, P194, DOI 10.3109/03602532.2011.560157; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Johansson K, 2010, FREE RADICAL BIO MED, V49, P1638, DOI 10.1016/j.freeradbiomed.2010.08.013; Kojima F, 2005, FUND CLIN PHARMACOL, V19, P255, DOI 10.1111/j.1472-8206.2005.00316.x; Lan T, 2013, J BIOL CHEM, V288, P24441, DOI 10.1074/jbc.M113.456863; Li XW, 2009, INSECT BIOCHEM MOLEC, V39, P745, DOI 10.1016/j.ibmb.2009.08.010; Mounsey KE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-43; Osorio DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-167; Qin GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058410; Qin GH, 2012, J INSECT PHYSIOL, V58, P220, DOI 10.1016/j.jinsphys.2011.10.011; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ren HL, 2009, DEV COMP IMMUNOL, V33, P980, DOI 10.1016/j.dci.2009.04.003; Schroder O, 2003, BIOCHEM BIOPH RES CO, V312, P271, DOI 10.1016/j.bbrc.2003.10.115; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-39; Shi DS, 2007, PROTEIN SCI, V16, P1689, DOI 10.1110/ps.072919907; Siritantikorn A, 2007, BIOCHEM BIOPH RES CO, V355, P592, DOI 10.1016/j.bbrc.2007.02.018; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Yamada T, 2007, BIOCHEMISTRY-US, V46, P8414, DOI 10.1021/bi700605m; Yang YQ, 2009, HYPERTENSION, V54, P1360, DOI 10.1161/HYPERTENSIONAHA.109.139428; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yong ML, 2009, ARCH INSECT BIOCHEM, V71, P3, DOI 10.1002/arch.20254; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Yu XL, 2012, COMP BIOCHEM PHYS B, V161, P356, DOI 10.1016/j.cbpb.2011.12.009; Zhang XY, 2012, ARCH INSECT BIOCHEM, V80, P77, DOI 10.1002/arch.21025; Zhou HX, 1997, P NATL ACAD SCI USA, V94, P12372, DOI 10.1073/pnas.94.23.12372	36	8	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114776	10.1371/journal.pone.0114776	http://dx.doi.org/10.1371/journal.pone.0114776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486043	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600097
J	Fujie, Y; Fusaki, N; Katayama, T; Hamasaki, M; Soejima, Y; Soga, M; Ban, H; Hasegawa, M; Yamashita, S; Kimura, S; Suzuki, S; Matsuzawa, T; Akari, H; Era, T				Fujie, Yasumitsu; Fusaki, Noemi; Katayama, Tomohiko; Hamasaki, Makoto; Soejima, Yumi; Soga, Minami; Ban, Hiroshi; Hasegawa, Mamoru; Yamashita, Satoshi; Kimura, Shigemi; Suzuki, Saori; Matsuzawa, Tetsuro; Akari, Hirofumi; Era, Takumi			New Type of Sendai Virus Vector Provides Transgene-Free iPS Cells Derived from Chimpanzee Blood	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; EFFICIENT; FIBROBLASTS; MOUSE; DERIVATION; INDUCTION; EVOLUTION; PATTERNS; PRIMATES	Induced pluripotent stem cells (iPSCs) are potentially valuable cell sources for disease models and future therapeutic applications; however, inefficient generation and the presence of integrated transgenes remain as problems limiting their current use. Here, we developed a new Sendai virus vector, TS12KOS, which has improved efficiency, does not integrate into the cellular DNA, and can be easily eliminated. TS12KOS carries KLF4, OCT3/4, and SOX2 in a single vector and can easily generate iPSCs from human blood cells. Using TS12KOS, we established iPSC lines from chimpanzee blood, and used DNA array analysis to show that the global gene-expression pattern of chimpanzee iPSCs is similar to those of human embryonic stem cell and iPSC lines. These results demonstrated that our new vector is useful for generating iPSCs from the blood cells of both human and chimpanzee. In addition, the chimpanzee iPSCs are expected to facilitate unique studies into human physiology and disease.	[Fujie, Yasumitsu; Katayama, Tomohiko; Hamasaki, Makoto; Soejima, Yumi; Soga, Minami; Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, Kumamoto 8600811, Japan; [Fusaki, Noemi; Ban, Hiroshi; Hasegawa, Mamoru] DNAVEC Corp, Tsukuba, Ibaraki 3002611, Japan; [Fusaki, Noemi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Yamashita, Satoshi] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Chuo Ku, Kumamoto 8608556, Japan; [Kimura, Shigemi] Kumamoto Univ, Grad Sch Med Sci, Dept Child Dev, Chuo Ku, Kumamoto 8608556, Japan; [Suzuki, Saori; Akari, Hirofumi] Kyoto Univ, Primate Res Inst, Ctr Human Evolut Modeling Res, Sect Comparat Microbiol & Immunol, Inuyama, Aichi 4848506, Japan; [Matsuzawa, Tetsuro] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Inuyama, Aichi 4848506, Japan; [Akari, Hirofumi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Lab Evolut Virol, Kyoto 6068507, Japan	Kumamoto University; DNAVEC Corporation; Japan Science & Technology Agency (JST); Kumamoto University; Kumamoto University; Kyoto University; Kyoto University; Kyoto University	Era, T (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	tera@kumamoto-u.ac.jp	Fusaki, Noemi/U-1628-2019; AKARI, Hirofumi/AGR-4616-2022; Hamasaki, Makoto/AAO-2229-2020; Matsuzawa, Tetsuro/ABE-9654-2021	Matsuzawa, Tetsuro/0000-0002-8147-2725; Akari, Hirofumi/0000-0003-2166-6015; Yamashita, Satoshi/0000-0001-9315-3492	Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST), Japan Science and Project of the Primate Research Institute, Kyoto University; DNAVEC Corporation; JST grant (PRESTO); Grants-in-Aid for Scientific Research [24615005] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO); Core Research for Evolutional Science and Technology (CREST), Japan Science and Project of the Primate Research Institute, Kyoto University; DNAVEC Corporation; JST grant (PRESTO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan, Precursory Research for Embryonic Science and Technology (PRESTO), and Core Research for Evolutional Science and Technology (CREST), Japan Science and Project of the Primate Research Institute, Kyoto University. DNAVEC Corporation provided support in the form of salaries for authors MH & HB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NF was provided with salary by JST grant (PRESTO). The specific roles of these authors are articulated in the 'author contributions' section.	Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Fusaki N BH, 2014, INDUCTION HUMAN PLUR, P171; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gonzalez JP, 2013, CURR TOP MICROBIOL, V365, P337, DOI 10.1007/82_2012_304; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hamasaki M, 2012, STEM CELLS, V30, P2437, DOI 10.1002/stem.1221; Hankowski KE, 2011, LAB INVEST, V91, P972, DOI 10.1038/labinvest.2011.85; Kitagawa M, 2012, J BIOL CHEM, V287, P27983, DOI 10.1074/jbc.M112.350074; Langerak AW, 1999, LEUKEMIA, V13, P965, DOI 10.1038/sj.leu.2401427; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mubiru JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094522; Nagai Y, 2011, BIOLOGY OF PARAMYXOVIRUSES, P115; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; REARDEN A, 1986, J IMMUNOL, V136, P2504; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sasaki K, 2005, GENE THER, V12, P203, DOI 10.1038/sj.gt.3302409; Sawatzki HK, 2007, HUM MUTAT, V28, P99, DOI 10.1002/humu.20420; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	40	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113052	10.1371/journal.pone.0113052	http://dx.doi.org/10.1371/journal.pone.0113052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479600	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200014
J	Huang, X; Tan, H; Li, X; Zhou, SJ; Wen, SW; Luo, ML				Huang, Xin; Tan, Hongzhuan; Li, Xun; Zhou, Shujin; Wen, Shi Wu; Luo, Meiling			Maternal Chronic HBV Infection Would Not Increase the Risk of Pregnancy-Induced Hypertension - Results from Pregnancy Cohort in Liuyang Rural China	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CARRIER STATUS; PREECLAMPSIA; PREVENTION; PREVALENCE; MORTALITY; OUTCOMES; WOMEN; EPIDEMIOLOGY; MOTHERS	The relationship between maternal HBV (hepatitis B virus) infection and pregnancy-induced hypertension (PIH) is inconclusive. Few studies have been conducted in rural areas of China. In order to examine the association between maternal chronic HBV infection and risk of PIH in Liuyang rural area China, we enrolled 6,195 eligible pregnant women in 2010-2011 in selected 14 towns of Liuyang on their first prenatal visit to local maternity care unit. A total of 461 subjects (7.44% (95%CI: 6.79%, 8.10%)) were identified with positive HBsAg status (exposed group) and 5734 were non-HBV carriers (unexposed group). Multivariate log-binomial regression models were used to estimate the risk of PIH, gestational hypertension (GH), and preeclampsia (PE) in relation to maternal chronic HBV infection. There are total of 455 subjects diagnosed with PIH (7.34% (95% CI: 6.70%, 7.99%)), including 371 GH (5.99% (95% CI: 5.40%, 6.58%)) and 81 PE (1.31% (95% CI: 1.07%, 1.64%)). The crude risk ratio between PIH, GH, PE and maternal HBV infection were 1.20 (95% CI: 0.88, 1.64), 1.30(95% CI: 0.93, 1.81) and 0.79 (95% CI: 0.32, 1.93), respectively. After adjustment for gravidity history, abortion history, family history of Diabetes Mellitus (DM) and family history of hypertension, positive HBsAg status was still not significantly associated with PIH (RR=1.18, 95% CI: 0.87, 1.62), GH (RR=1.27, 95% CI: 0.91, 1.78) or PE (RR=0.79, 95% CI: 0.32, 1.95). Additional adjustment for maternal age, marital status, parity history, family history of DM, Body Mass Index at first antenatal visit, folic acid supplementation, smoking status during pregnancy and economic status of living area, multivariate analysis provided similar results. In conclusion, our study found that maternal chronic HBV infection prevalence rate is 7.4% among Liuyang rural area and there is no significant association between maternal HBV infection and the risk of PIH, GH or PE.	[Huang, Xin; Tan, Hongzhuan; Li, Xun; Wen, Shi Wu; Luo, Meiling] Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Zhou, Shujin] Liuyang Municipal Hosp Maternal & Child Hlth, Liuyang, Hunan, Peoples R China; [Wen, Shi Wu] Univ Ottawa, OMNI Res Grp, Dept Obstet & Gynaecol, Ottawa, ON, Canada	Central South University; University of Ottawa	Tan, H (corresponding author), Cent S Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China.	tanhz99@qq.com		Huang, Xin/0000-0002-4874-3626	Canadian Institute of Health Research [CIHR MOP 115183, CIHR MOP 86562]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	HT and SWW received funding from the Canadian Institute of Health Research (grants CIHR MOP 115183, CIHR MOP 86562) to do this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Brown DW, 2006, STROKE, V37, P1055, DOI 10.1161/01.STR.0000206284.96739.ee; Changsha City Bureau of Statistics National Bureau of Changsha Survey Organization, 2010, CHANGSH STAT YB 2010, P417; Chen XK, 2006, BJOG-INT J OBSTET GY, V113, P544, DOI 10.1111/j.1471-0528.2006.00898.x; Connell LE, 2011, LIVER INT, V31, P1163, DOI 10.1111/j.1478-3231.2011.02556.x; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hudu SA, 2014, CURR ISSUES MOL BIOL, V16, P69; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Ishizaka N, 2002, CIRCULATION, V105, P1028, DOI 10.1161/hc0902.105718; Ji ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097474; Lao TT, 2013, J VIRAL HEPATITIS, V20, P343, DOI 10.1111/jvh.12037; Lao TT, 2007, J HEPATOL, V47, P46, DOI 10.1016/j.jhep.2007.02.014; Li F, 2012, VACCINE, V30, P7118, DOI 10.1016/j.vaccine.2012.09.031; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lobstein S, 2011, DIGESTION, V83, P76, DOI 10.1159/000320455; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Rao AK, 2006, AM J OBSTET GYNECOL, V195, P834, DOI 10.1016/j.ajog.2006.06.079; Reddick KLB, 2011, J VIRAL HEPATITIS, V18, pE394, DOI 10.1111/j.1365-2893.2011.01436.x; Safir A, 2010, LIVER INT, V30, P765, DOI 10.1111/j.1478-3231.2010.02218.x; Saleh-Gargari S, 2009, HEPAT MON, V9, P180; Sarin SK, 2009, CLIN GASTROENT-SER, P185, DOI 10.1007/978-1-59745-565-7_7; Sirilert S, 2014, INT J GYNECOL OBSTET, V126, P106, DOI 10.1016/j.ijgo.2014.02.019; Sung J, 2007, STROKE, V38, P1436, DOI 10.1161/STROKEAHA.106.466268; To WWK, 2003, AUST NZ J OBSTET GYN, V43, P119, DOI 10.1046/j.0004-8666.2003.00029.x; Tse KY, 2005, J HEPATOL, V43, P771, DOI 10.1016/j.jhep.2005.05.023; Wong SF, 1999, AM J PERINAT, V16, P485, DOI 10.1055/s-1999-6802; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002; Zhang Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-25	32	14	14	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114248	10.1371/journal.pone.0114248	http://dx.doi.org/10.1371/journal.pone.0114248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479003	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200055
J	Li, QL; Pratt, CH; Dionne, LA; Fairfield, H; Karst, SY; Sundberg, JP; Uitto, J				Li, Qiaoli; Pratt, C. Herbert; Dionne, Louise A.; Fairfield, Heather; Karst, Son Yong; Sundberg, John P.; Uitto, Jouni			Spontaneous asj-2J Mutant Mouse as a Model for Generalized Arterial Calcification of Infancy: A Large Deletion/Insertion Mutation in the Enpp1 Gene	PLOS ONE			English	Article							CONNECTIVE-TISSUE MINERALIZATION; PSEUDOXANTHOMA ELASTICUM; VASCULAR CALCIFICATION; ECTOPIC MINERALIZATION; MICE; PYROPHOSPHATE; LESSONS; PLASMA	Generalized arterial calcification of infancy (GACI), an autosomal recessive disorder caused by mutations in the ENPP1 gene, manifests with extensive mineralization of the cardiovascular system. The affected individuals in most cases die within the first year of life, and there is currently no effective treatment for this disorder. In this study, we characterized a spontaneous mutant mouse, asj-2J, as a model for GACI. These mice were identified as part of a phenotypic deviant search in a large-scale production colony of BALB/cJ mice at The Jackson Laboratory. They demonstrated a characteristic gait due to stiffening of the joints, with phenotypic similarity to a previously characterized asj ("ages with stiffened joints'') mouse, caused by a missense mutation in the Enpp1 gene. Complementation testing indicated that asj-2J and asj were allelic. PCR-based mutation detection strategy revealed in asj-2J mice a large, 40,035 bp, deletion spanning from intron 1 to the 3 '-untranslated region of the Enpp1 gene, coupled with a 74 bp insertion. This was accompanied with a significant reduction in the plasma PPi concentration and reduced PPi/P-i ratio. As a consequence, extensive aberrant mineralization affecting the arterial vasculature, a number of internal organs, and the dermal sheath of vibrissae, a progressive biomarker of the ectopic mineralization process, was demonstrated by a combination of micro computed tomography, histopathology with calcium-specific stains, and direct chemical assay of calcium. Comparison of the asj and asj-2J mice demonstrated that the latter ones, particularly when placed on an acceleration diet high in phosphate and low in magnesium, had more extensive mineralization. Thus, the asj-2J mouse serves as a novel model for GACI, a currently intractable disorder.	[Li, Qiaoli; Uitto, Jouni] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Pratt, C. Herbert; Dionne, Louise A.; Fairfield, Heather; Karst, Son Yong; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Jefferson University; Jackson Laboratory	Uitto, J (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.	Jouni.Uitto@jefferson.edu		Li, Qiaoli/0000-0002-8495-7103; Pratt, Herb/0000-0002-4964-8292	National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01 AR064766, R21 AR063781, R01 AR28450]; NIH/National Center for Research Resources/Office of Research Infrastructure Programs [OK010972-35, OD011163-02, RR001183, RR032339]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063781, R01AR028450, K01AR064766] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972, R21OD011163] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/National Center for Research Resources/Office of Research Infrastructure Programs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) grants K01 AR064766 (to QL), R21 AR063781 (to JPS), and R01 AR28450 (to JU). This work was also supported by NIH/National Center for Research Resources/Office of Research Infrastructure Programs grants OK010972-35, OD011163-02, RR001183, and RR032339 (The Jackson Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apschner A, 2014, DIS MODEL MECH, V7, P811, DOI 10.1242/dmm.015693; Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Berndt A, 2013, J INVEST DERMATOL, V133, P833, DOI 10.1038/jid.2012.340; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Edouard T, 2011, EUR J PEDIATR, V170, P1585, DOI 10.1007/s00431-011-1572-9; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jiang QJ, 2012, EXP DERMATOL, V21, P694, DOI 10.1111/j.1600-0625.2012.01553.x; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Le Corre Y, 2012, AM J PATHOL, V180, P2208, DOI 10.1016/j.ajpath.2012.02.007; Li QL, 2008, J INVEST DERMATOL, V128, P1160, DOI 10.1038/sj.jid.5701145; Li QL, 2014, CELL CYCLE, V13, P2609, DOI 10.4161/15384101.2014.943567; Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Li QL, 2013, AM J PATHOL, V183, P10, DOI 10.1016/j.ajpath.2013.03.002; Li QL, 2010, J MOL MED, V88, P173, DOI 10.1007/s00109-009-0522-8; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Mackenzie NCW, 2012, BONE, V51, P961, DOI 10.1016/j.bone.2012.07.014; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Nitschke Yvonne, 2012, Frontiers in Genetics, V3, P302, DOI 10.3389/fgene.2012.00302; Nitschke Y, 2012, TRENDS CARDIOVAS MED, V22, P145, DOI 10.1016/j.tcm.2012.07.011; O'Neill WC, 2010, NEPHROL DIAL TRANSPL, V25, P187, DOI 10.1093/ndt/gfp362; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Otero JE, 2013, J BONE MINER RES, V28, P419, DOI 10.1002/jbmr.1752; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2011, CIRC RES, V109, P578, DOI 10.1161/CIRCRESAHA.111.247965; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Silva K, 2012, LAB MOUSE, P779; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Takabayashi S, 2014, EXP ANIM TOKYO, V63, P193, DOI 10.1538/expanim.63.193; Tolouian R, 2012, CLIN LAB, V58, P1129, DOI 10.7754/Clin.Lab.2012.111101; Zaka R, 2006, CURR OPIN RHEUMATOL, V18, P181, DOI 10.1097/01.bor.0000209432.36355.6e	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113542	10.1371/journal.pone.0113542	http://dx.doi.org/10.1371/journal.pone.0113542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479107	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200023
J	Pearce, CW; Young, PG				Pearce, Christopher W.; Young, Philippe G.			On the Pressure Response in the Brain due to Short Duration Blunt Impacts	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; HEAD-INJURY; BIOMECHANICS	When the head is subject to non-penetrating (blunt) impact, contusion-type injuries are commonly identified beneath the impact site (the coup) and, in some instances, at the opposite pole (the contre-coup). This pattern of injury has long eluded satisfactory explanation and blunt head injury mechanisms in general remain poorly understood. There are only a small number of studies in the open literature investigating the head's response to short duration impacts, which can occur in collisions with light projectiles. As such, the head impact literature to date has focussed almost exclusively on impact scenarios which lead to a quasi-static pressure response in the brain. In order to investigate the response of the head to a wide range of impact durations, parametric numerical studies were performed on a highly bio-fidelic finite element model of the human head created from in vivo magnetic resonance imaging (MRI) scan data with non-linear tissue material properties. We demonstrate that short duration head impacts can lead to potentially deleterious transients of positive and negative intra-cranial pressure over an order of magnitude larger than those observed in the quasi-static regime despite reduced impact force and energy. The onset of this phenomenon is shown to be effectively predicted by the ratio of impact duration to the period of oscillation of the first ovalling mode of the system. These findings point to dramatically different pressure distributions in the brain and hence different patterns of injury depending on projectile mass, and provide a potential explanation for dual coup/contre-coup injuries observed clinically.	[Pearce, Christopher W.; Young, Philippe G.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England	University of Exeter	Young, PG (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Harrison Bldg,North Pk Rd, Exeter EX4 4QF, Devon, England.	philippe.g.young@exeter.ac.uk						Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; Bhateja A, 2009, INDIAN J NEUROTRAUM, V6, P115, DOI 10.1016/S0973-0508(09)80004-X; Bradshaw D., 2001, P 17 INT TECHN C ENH, P1; Brennen CE, 2003, P 5 INT S CAV OS JAP; Cifu D.X., 2010, TRAUMATIC BRAIN INJU; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ENGIN AE, 1969, J BIOMECH, V2, P325, DOI 10.1016/0021-9290(69)90089-X; Gadd C. W., 1970, P 14 STAPP CAR CRASH, P356; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Johnsen E, 2009, P 7 INT S CAV MICH U; KABO JM, 1983, J BIOMECH, V16, P313, DOI 10.1016/0021-9290(83)90015-5; KENNER VH, 1973, J BIOMECH, V6, P1, DOI 10.1016/0021-9290(73)90032-8; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Maruoka K, 2001, MAT SCI SPORTS S, V7514, P145; Mathai KI, 2009, INDIAN J NEUROTRAUM, V6, P17; Nahum A.M., 1977, 21 STAPP CAR CRASH C; NASA, 1995, MAN SYST INT STAND, V1; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; R&A Rules Ltd, 2008, IN VEL TEST PROC; Roberts J., 2001, SPORTS ENG, V4, P191, DOI [10.1046/j.1460-2687.2001.00084.x, DOI 10.1046/J.1460-2687.2001.00084.X]; Sauren A, 1993, INT IRCOBI C BIOM IM, P241; Suh CM, 2005, J MECH SCI TECHNOL, V19, P1424, DOI 10.1007/BF03023901; US Centers for Disease Control and Prevention, 2010, GET STATS TRAUM BRAI; WAHI KK, 1977, ANN BIOMED ENG, V5, P303, DOI 10.1007/BF02367311; Ward C., 1980, SAE TECHNICAL PAPER; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090; Young PG, 2003, J SOUND VIB, V267, P1107, DOI 10.1016/S0022-460X(03)00200-1; Young PG, 1998, IRCOBI C GOT SEPT, P391; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015	35	10	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114292	10.1371/journal.pone.0114292	http://dx.doi.org/10.1371/journal.pone.0114292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478695	Green Published, gold			2022-12-26	WOS:000346907200067
J	Wright, FL; Gamboni, F; Moore, EE; Nydam, TL; Mitra, S; Silliman, CC; Banerjee, A				Wright, Franklin L.; Gamboni, Fabia; Moore, Ernest E.; Nydam, Trevor L.; Mitra, Sanchayita; Silliman, Christopher C.; Banerjee, Anirban			Hyperosmolarity Invokes Distinct Anti-Inflammatory Mechanisms in Pulmonary Epithelial Cells: Evidence from Signaling and Transcription Layers	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; HYPERTONIC SALINE RESUSCITATION; ALVEOLAR MACROPHAGE ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; HEMORRHAGIC-SHOCK; ENDOTHELIAL-CELLS; TNF-ALPHA; CYSTIC-FIBROSIS; EXPRESSION	Hypertonic saline (HTS) has been used intravenously to reduce organ dysfunction following injury and as an inhaled therapy for cystic fibrosis lung disease. The role and mechanism of HTS inhibition was explored in the TNF alpha and IL-1 beta stimulation of pulmonary epithelial cells. Hyperosmolar (HOsm) media (400 mOsm) inhibited the production of select cytokines stimulated by TNF alpha and IL-1 beta at the level of mRNA translation, synthesis and release. In TNF alpha stimulated A549 cells, HOsm media inhibited I-kappa B alpha phosphorylation, NF-kappa B translocation into the nucleus and NF-kappa B nuclear binding. In IL-1 beta stimulated cells HOsm inhibited I-kappa B alpha phosphorylation without affecting NF-kappa B translocation or nuclear binding. Incubation in HOsm conditions inhibited both TNF alpha and IL-1 beta stimulated nuclear localization of interferon response factor 1 (IRF-1). Additional transcription factors such as AP-1, Erk-1/2, JNK and STAT-1 were unaffected by HOsm. HTS and sorbitol supplemented media produced comparable outcomes in all experiments, indicating that the effects of HTS were mediated by osmolarity, not by sodium. While not affecting MAPK modules discernibly in A549 cells, both HOsm conditions inhibit IRF-1 against TNF alpha or IL-1 beta, but inhibit p65 NF-kappa B translocation only against TNF alpha but not IL-1 beta. Thus, anti-inflammatory mechanisms of HTS/HOsm appear to disrupt cytokine signals at distinct intracellular steps.	[Wright, Franklin L.; Gamboni, Fabia; Nydam, Trevor L.; Mitra, Sanchayita; Banerjee, Anirban] Univ Colorado Denver, Dept Surg, Trauma Res Ctr, Aurora, CO 80045 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Silliman, Christopher C.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Banerjee, A (corresponding author), Univ Colorado Denver, Dept Surg, Trauma Res Ctr, Aurora, CO 80045 USA.	Anirban.Banerjee@ucdenver.edu		Wright, Franklin/0000-0002-4433-5385	National Institute of General Medical Sciences of the National Institutes of Health [P50 GM049222, T32 GM008315]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM049222, T32GM008315] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by National Institute of General Medical Sciences of the National Institutes of Health under Award Number P50 GM049222 and T32 GM008315. The content is solely the responsibility of the authors and does not necessarily represent the office views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Ananko EA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-56; Banerjee A, 2013, SHOCK, V39, P366, DOI 10.1097/SHK.0b013e3182894016; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Ciesla DJ, 2001, SURGERY, V129, P567, DOI 10.1067/msy.2001.113286; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Cuschieri J, 2002, J IMMUNOL, V168, P1389, DOI 10.4049/jimmunol.168.3.1389; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; Eckels PC, 2009, AM J PHYSL CELL PHYS; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Gundersen Y, 2010, SHOCK, V34, P450, DOI 10.1097/SHK.0b013e3181e68649; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; Henriquet C, 2007, LUNG CANCER, V56, P167, DOI 10.1016/j.lungcan.2006.12.003; Jarrar D, 2002, AM J PHYSIOL-LUNG C, V283, pL799, DOI 10.1152/ajplung.00465.2001; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Levitt JE, 2009, J INTENSIVE CARE MED; Li W, 2007, PEPTIDES, V28, P1252, DOI 10.1016/j.peptides.2007.03.021; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; Matthay Michael A, 2008, Proc Am Thorac Soc, V5, P297, DOI 10.1513/pats.200708-141DR; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Ochi H, 2002, EUR J IMMUNOL, V32, P1821, DOI 10.1002/1521-4141(200207)32:7<1821::AID-IMMU1821>3.0.CO;2-A; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Powers KA, 2005, SURGERY, V137, P66, DOI 10.1016/j.surg.2004.05.051; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Sato H, 2008, MED SCI MONITOR, V14, pBR79; Shapiro L, 1997, EXP CELL RES, V231, P354, DOI 10.1006/excr.1997.3476; Shukla A, 2004, SHOCK, V21, P391, DOI 10.1097/00024382-200405000-00001; Shultz DB, 2009, J INTERF CYTOK RES, V29, P817, DOI 10.1089/jir.2009.0034; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Tarran R, 2007, SEMIN RESP CRIT CARE, V28, P295, DOI 10.1055/s-2007-981650; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Werner T, 2003, FASEB J, V17, P1228, DOI 10.1096/fj.02-0955rev; Wohlauer M, 2012, CRIT CARE MED, V40, P2647, DOI 10.1097/CCM.0b013e3182592006; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Ziegler Elizabeth C, 2005, Sci STKE, V2005, pre6, DOI 10.1126/stke.2842005re6	52	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114129	10.1371/journal.pone.0114129	http://dx.doi.org/10.1371/journal.pone.0114129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479425	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907200045
J	Frostegard, AG; Su, J; Hua, X; Vikstrom, M; de Faire, U; Frostegard, J				Frostegard, Anna G.; Su, Jun; Hua, Xiang; Vikstrom, Max; de Faire, Ulf; Frostegard, Johan			Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ANTIPHOSPHOLIPID ANTIBODIES; CARDIOVASCULAR-DISEASE; EUROPEAN LACIDIPINE; PROTECTIVE FACTORS; APOPTOTIC CELLS; EXTERNALIZATION; HYPERTENSION; RECOGNITION; CLEARANCE	Background: Antibodies against cardiolipin and phosphatidylserine (anti-CL and anti-PS) are associated with thrombosis. In contrast, we determined that IgM antibodies against oxidized CL and PS (OxCL and OxPS) and phosphorylcholine (anti-PC) could be protection markers for cardiovascular disease (CVD). Methods: 226 individuals with established hypertension (diastolic pressure >95 mmHg) from the European Lacidipine Study on Atherosclerosis. Antibodies were tested by ELISA. As a surrogate measure of atherosclerosis, the mean of the maximum intima-media thicknesses (IMT) in the far walls of common carotids and bifurcations was determined by ultrasonography at the time of inclusion and 4 years following inclusion. Results: Increases in IMT measures at follow-up were significantly less common in subjects which at baseline had high IgM anti-OxPS and anti-PC at above 75th percentile: OR 0,45, CI (0,23-0,86) and OR 0.37, CI (0,19-0,71), p=0.0137 respectively and above 90th percentile: OR 0.32, CI (0,12-0,84) and OR 0.39, CI (0,15-1.00), p=0.050 and OR 0,22, CI (0,08-0,59) p=0,0029. IgM anti-OxCL was negatively associated with IMT increases (OR, 0.32, CI (0,12-0,84), p=0231). There were no associations for IgM anti-PS or anti-CL. Anti-PC, as determined herein by a commercial ELISA, was strongly associated with data from our previously published in house ELISA (R=0,87; p=0,0001).) Anti-PC was also a risk marker at low levels (below 25th percentile; OR=2,37 (1,16-4,82), p=0,0177). Conclusions: High levels of IgM anti-OxPS and anti-OxCL, but not traditional antiphospholipid antibodies (anti-PS and anti-CL), are associated with protection against atherosclerosis development. In addition, low IgM anti-PC was a risk marker but high a protection marker.	[Frostegard, Anna G.; Su, Jun; Hua, Xiang; Frostegard, Johan] Karolinska Inst, Inst Environm Med, Unit Immunol & Chron Dis, S-10401 Stockholm, Sweden; [Vikstrom, Max; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Cardiovasc Epidemiol Unit, S-10401 Stockholm, Sweden; [Frostegard, Johan] Karolinska Univ Hosp, Dept Acute Internal Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Frostegard, AG (corresponding author), Karolinska Inst, Inst Environm Med, Unit Immunol & Chron Dis, S-10401 Stockholm, Sweden.	anna.frostegard@ki.se		Frostegard, Johan/0000-0002-3569-3367	Stockholm County Council; Karolinska Institutet; Swedish Science Fund; King Gustav V 80th year's foundation; Swedish Heart Lung foundation; Swedish Rheumatism Association; CIDaT, Vinnova; Torsten Soderberg Foundation; 6th Framework Program of the European Union, Priority 1: Life sciences, genomics and biotechnology for health (CVDIMMUNE) [LSHM-CT-2006-037227]	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Science Fund; King Gustav V 80th year's foundation; Swedish Heart Lung foundation(Swedish Heart-Lung Foundation); Swedish Rheumatism Association; CIDaT, Vinnova(Vinnova); Torsten Soderberg Foundation; 6th Framework Program of the European Union, Priority 1: Life sciences, genomics and biotechnology for health (CVDIMMUNE)	This study was supported by (1) (JF) The regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet; (2) (JF) the Swedish Science Fund, the King Gustav V 80th year's foundation; (3) (JF/uDF) The Swedish Heart Lung foundation; (4) (JF) The Swedish Rheumatism Association; (5) (JF) CIDaT, Vinnova; (6) (JF) Torsten Soderberg Foundation; and (7) (JF/udF)6th Framework Program of the European Union, Priority 1: Life sciences, genomics and biotechnology for health (grant LSHM-CT-2006-037227 CVDIMMUNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Caidahl K, 2013, INT J CARDIOL, V167, P464, DOI 10.1016/j.ijcard.2012.01.018; Cederholm A, 2005, ARTERIOSCL THROM VAS, V25, P198, DOI 10.1161/01.ATV.0000150415.18759.36; Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106; Fiskesund Roland, 2012, Results Immunol, V2, P13, DOI 10.1016/j.rinim.2012.01.001; Fiskesund R, 2010, STROKE, V41, P607, DOI 10.1161/STROKEAHA.109.558742; Frostegard AG, 2013, CLIN EXPT IMMUNOLOGY; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Frostegard J, 2005, ARTERIOSCL THROM VAS, V25, P1776, DOI 10.1161/01.ATV.0000174800.78362.ec; Frostegard J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-117; Geller BJ, 2013, J THROMB THROMBOLYSI; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Horkko S, 1997, P NATL ACAD SCI USA, V94, P10356, DOI 10.1073/pnas.94.19.10356; Horkko S, 1996, J CLIN INVEST, V98, P815, DOI 10.1172/JCI118854; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Jitkaew S, 2009, J LEUKOCYTE BIOL, V85, P427, DOI 10.1189/jlb.0408232; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; NISHINARITA S, 1990, MED MICROBIOL IMMUN, V179, P205; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Sobel M, 2013, J VASC SURG, V58, P997, DOI 10.1016/j.jvs.2013.04.042; Su J, 2008, RHEUMATOLOGY, V47, P1144, DOI 10.1093/rheumatology/ken120; Su J, 2013, J RHEUMATOLOGY; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Su J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-1; Tuominen A, 2006, ARTERIOSCL THROM VAS, V26, P2096, DOI 10.1161/01.ATV.0000233333.07991.4a; Zanchetti A, 1998, J HYPERTENS, V16, P949, DOI 10.1097/00004872-199816070-00008; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	30	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111764	10.1371/journal.pone.0111764	http://dx.doi.org/10.1371/journal.pone.0111764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473948	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500064
J	Kapetanakis, VV; Rudnicka, AR; Wathern, AK; Lennon, L; Papacosta, O; Cook, DG; Wannamethee, SG; Whincup, PH; Owen, CG				Kapetanakis, Venediktos V.; Rudnicka, Alicja R.; Wathern, Andrea K.; Lennon, Lucy; Papacosta, Olia; Cook, Derek G.; Wannamethee, S. Goya; Whincup, Peter H.; Owen, Christopher G.			Adiposity in Early, Middle and Later Adult Life and Cardiometabolic Risk Markers in Later Life; Findings from the British Regional Heart Study	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; COHORT PROFILE; WEIGHT CHANGE; BIRTH-WEIGHT; OBESITY; OVERWEIGHT; MORTALITY	Objectives: This research investigates the associations between body mass index (BMI) at 21, 40-59, 60-79 years of age on cardiometabolic risk markers at 60-79 years. Methods: A prospective study of 3464 British men with BMI measured at 40-59 and 60-79 years, when cardiometabolic risk was assessed. BMI at 21 years was ascertained from military records, or recalled from middle-age (adjusted for reporting bias); associations between BMI at different ages and later cardiometabolic risk markers were examined using linear regression. Sensitive period, accumulation and mobility life course models were devised for high BMI (defined as BMI >= 75th centile) and compared with a saturated BMI trajectory model. Results: At ages 21, 40-59 and 60-79 years, prevalences of overweight (BMI >= 25 kg/m(2)) were 12%, 53%, 70%, and obesity (>= 30 kg/m(2)) 1.6%, 6.6%, and 17.6%, respectively. BMI at 21 years was positively associated with serum insulin, blood glucose, and HbA1c at 60-79 years, with increases of 1.5% (95% CI 0.8,2.3%), 0.4% (0.1,0.6%), 0.3% (0.1,0.4%) per 1 kg/m(2), respectively, but showed no associations with blood pressure or blood cholesterol. However, these associations were modest compared to those between BMI at 60-79 years and serum insulin, blood glucose and HbA1c at 60-79 years, with increases of 8.6% (8.0,9.2%), 0.7% (0.5,0.9%), and 0.5% (0.4,0.7%) per 1 kg/m(2), respectively. BMI at 60-79 years was also associated with total cholesterol and blood pressure. Associations for BMI at 40-59 years were mainly consistent with those of BMI at 60-79 years. None of the life course models fitted the data as well as the saturated model for serum insulin. A sensitive period at 50 years for glucose and HbA1c and sensitive period at 70 years for blood pressure were identified. Conclusions: In this cohort of men who were thin compared to more contemporary cohorts, BMI in later life was the dominant influence on cardiovascular and diabetes risk. BMI in early adult life may have a small long-term effect on diabetes risk.	[Kapetanakis, Venediktos V.; Rudnicka, Alicja R.; Wathern, Andrea K.; Cook, Derek G.; Whincup, Peter H.; Owen, Christopher G.] Univ London, Populat Hlth Res Inst, London, England; [Lennon, Lucy; Papacosta, Olia; Wannamethee, S. Goya] UCL, Sch Med, London W1N 8AA, England	University of London; University of London; University College London; UCL Medical School	Kapetanakis, VV (corresponding author), Univ London, Populat Hlth Res Inst, Cranmer Terrace, London, England.	vkapetan@sgul.ac.uk	Lennon, Lucy/AFT-1973-2022; Cook, Derek G/C-3271-2008; Lennon, Lucy/ABB-9433-2020	Lennon, Lucy/0000-0002-1738-1351; Cook, Derek/0000-0002-9723-5759; Papacosta, Olia/0000-0001-8781-6747; Owen, Christopher/0000-0003-1135-5977; Whincup, Peter/0000-0002-5589-4107; Rudnicka, Alicja R/0000-0003-0369-8574	British Heart Foundation [PG/10/030/28330, RG/08/013/25942]; British Heart Foundation [PG/10/30/28330, RG/13/16/30528] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This research was supported by a project grant from the British Heart Foundation (PG/10/030/28330) [http://www.bhf.org.uk]. The British Regional Heart Study is supported by a British Heart Foundation Programme Grant (RG/08/013/25942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; [Anonymous], 2004, LIFE COURSE APPROACH; BRUCE NG, 1990, J HYPERTENS, V8, pS11; Bynner JM, 1996, 1970 BRIT COHORT STU; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Houston DK, 2009, AM J EPIDEMIOL, V169, P927, DOI 10.1093/aje/kwp007; Hypponen E, 2003, DIABETES CARE, V26, P2512, DOI 10.2337/diacare.26.9.2512; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Li L, 2007, J HYPERTENS, V25, P1215, DOI 10.1097/HJH.0b013e3280f3c01a; Lloyd LJ, 2009, INT J OBES LOND; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Organization WH, 2009, GLOB HLTH RISKS MORT; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Pereira SMP, 2013, EUR HEART J, V34, P1215, DOI 10.1093/eurheartj/ehs333; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Sabia S, 2009, AM J CLIN NUTR, V89, P601, DOI 10.3945/ajcn.2008.26482; Schmidt M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002698; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tu YK, 2005, AM J EPIDEMIOL, V161, P27, DOI 10.1093/aje/kwi002; Vistisen D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001602; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Walker M, 2004, INT J EPIDEMIOL, V33, P1185, DOI 10.1093/ije/dyh295; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Wannamethee SG, 1999, DIABETES CARE, V22, P1266, DOI 10.2337/diacare.22.8.1266; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651; WHINCUP PH, 1992, J EPIDEMIOL COMMUN H, V46, P164, DOI 10.1136/jech.46.2.164; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yang X, 2007, INT J OBESITY, V31, P521, DOI 10.1038/sj.ijo.0803459	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114289	10.1371/journal.pone.0114289	http://dx.doi.org/10.1371/journal.pone.0114289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474626	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000346382500010
J	Kim, YK; Choi, HJ; Jeoung, JW; Park, KH; Kim, DM				Kim, Young Kook; Choi, Hyuk Jin; Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung			Five-Year Incidence of Primary Open-Angle Glaucoma and Rate of Progression in Health Center-Based Korean Population: The Gangnam Eye Study	PLOS ONE			English	Article							ANGELES LATINO EYE; OCULAR HYPERTENSION; INTRAOCULAR-PRESSURE; RISK-FACTORS; LIFE-STYLE; PREVALENCE; ROTTERDAM; ASSOCIATION; JAPANESE; TAJIMI	Objective: To investigate the 5-year incidence and progression rate of primary open-angle glaucoma (POAG) in a health-center-based Korean population. Methods: The study population comprised 5,021 subjects who participated in standardized health screening (including non-contact tonometry and fundus photography) at the Gangnam Healthcare Center during the period from January 2005 to December 2006 and again from January 2010 to December 2011. Among these subjects, 948 (18.9%) with findings suggestive of glaucoma were subjected to a comprehensive glaucoma evaluation, which included applanation tonometry and standard automated perimetry. Based on the results, the subjects were diagnosed as POAG suspect or definite POAG. Results: The 5-year incidences of POAG suspect and definite POAG were 0.84% (42 subjects) and 0.72% (36 subjects), respectively. The rate of progression from POAG suspect to definite POAG was 4.75% per year. In subjects with a baseline intraocular pressure (IOP) >21 mmHg, the incidence of POAG suspect or definite POAG was significantly higher than in those with a baseline IOP <= 21 mmHg (32% vs. 1.05%; P<0.001). A multivariate analysis showed that the progression from POAG suspect to definite POAG was significantly associated with older age (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.03-1.10), higher baseline IOP (OR, 1.10; 95% CI, 1.01-1.24), higher body mass index (BMI) (OR, 1.15; 95% CI, 1.03-1.31), higher education level (OR, 1.57; 95% CI, 1.05-2.17), and higher hematocrit level (OR, 1.22; 95% CI, 1.08-1.43). Conclusions: In the health-center-based Korean population, the 5-year incidence of POAG was 0.72%, and the rate of progression from POAG suspect to definite POAG was 4.75% per year. This study identified old age, high baseline IOP, high BMI, high level of education, and high hematocrit level as significant risk factors for incident POAG.	[Kim, Young Kook] Jeju Natl Univ Hosp, Dept Ophthalmol, Cheju, South Korea; [Choi, Hyuk Jin; Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Choi, Hyuk Jin] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea; [Jeoung, Jin Wook; Park, Ki Ho; Kim, Dong Myung] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea	Jeju National University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeoung, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	neuroprotect@gmail.com		Jeoung, Jin Wook/0000-0002-1690-1239; Kim, Young Kook/0000-0002-6037-8449				da Silva TM, 2012, GENE, V502, P142, DOI 10.1016/j.gene.2012.04.047; de Voogd S, 2005, OPHTHALMOLOGY, V112, P1487, DOI 10.1016/j.ophtha.2005.04.018; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Ekstrom C, 2008, ACTA OPHTHALMOL, V86, P747, DOI 10.1111/j.1755-3768.2008.01244.x; FRAME PS, 1989, J FAM PRACTICE, V29, P150; Higginbotham EJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1185, DOI 10.1001/archopht.124.8.1185; Hong C, 1987, Korean J Ophthalmol, V1, P41; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P247, DOI 10.1111/j.1755-3768.2008.01385.x; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Lee EJ, 2009, INVEST OPHTH VIS SCI, V50, P662, DOI 10.1167/iovs.08-1682; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; LEYDHECKER W, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V133, P662; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; Mukesh BN, 2002, OPHTHALMOLOGY, V109, P1047, DOI 10.1016/S0161-6420(02)01040-0; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, ARCH OPHTHALMOL-CHIC, V129, P767, DOI 10.1001/archophthalmol.2010.373; Sekeroglu MA, 2011, ACTA OPHTHALMOL, V89, P429, DOI 10.1111/j.1755-3768.2009.01713.x; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; Varma R, 2012, AM J OPHTHALMOL, V154, P315, DOI 10.1016/j.ajo.2012.02.014; Wu SY, 2001, AM J EPIDEMIOL, V153, P184, DOI 10.1093/aje/153.2.184; Wu Z J, 1993, Zhonghua Yan Ke Za Zhi, V29, P353; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5	29	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114058	10.1371/journal.pone.0114058	http://dx.doi.org/10.1371/journal.pone.0114058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474589	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500106
J	Krentz, NAJ; Nian, CL; Lynn, FC				Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.			TALEN/CRISPR-Mediated eGFP Knock-In Add-On at the OCT4 Locus Does Not Impact Differentiation of Human Embryonic Stem Cells towards Endoderm	PLOS ONE			English	Article							PANCREATIC PROGENITOR CELLS; GREEN FLUORESCENT PROTEIN; SELF-RENEWAL; PLURIPOTENCY; EFFICIENT; ESTABLISHMENT; EXPRESSION; LINES; MAINTENANCE; INDUCTION	Human embryonic stem cells (hESCs) have great promise as a source of unlimited transplantable cells for regenerative medicine. However, current progress on producing the desired cell type for disease treatment has been limited due to an insufficient understanding of the developmental processes that govern their differentiation, as well as a paucity of tools to systematically study differentiation in the lab. In order to overcome these limitations, cell-type reporter hESC lines will be required. Here we outline two strategies using Transcription Activator Like Effector Nucleases (TALENs) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-Associated protein (Cas) to create OCT4-eGFP knock-in add-on hESC lines. Thirty-one and forty-seven percent of clones were correctly modified using the TALEN and CRISPR-Cas9 systems, respectively. Further analysis of three correctly targeted clones demonstrated that the insertion of eGFP in-frame with OCT4 neither significantly impacted expression from the wild type allele nor did the fusion protein have a dramatically different biological stability. Importantly, the OCT4-eGFP fusion was easily detected using microscopy, flow cytometry and western blotting. The OCT4 reporter lines remained equally competent at producing CXCR4+ definitive endoderm that expressed a panel of endodermal genes. Moreover, the genomic modification did not impact the formation of NKX6.1+/SOX9+ pancreatic progenitor cells following directed differentiation. In conclusion, these findings demonstrate for the first time that CRISPR-Cas9 can be used to modify OCT4 and highlight the feasibility of creating cell-type specific reporter hESC lines utilizing genome-editing tools that facilitate homologous recombination.	[Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.] Child & Family Res Inst, Diabet Res Program, Vancouver, BC, Canada; [Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Krentz, Nicole A. J.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; University of British Columbia	Lynn, FC (corresponding author), Child & Family Res Inst, Diabet Res Program, Vancouver, BC, Canada.	francis.lynn@ubc.ca		Lynn, Francis/0000-0001-9318-1063; Krentz, Nicole/0000-0003-3622-2652	Michael Smith Foundation; Canadian Diabetes Association; Child and Family Research Institute; Canadian Institute of Health Research-BC Transplantation Trainee Fellowship; Child and Family Research Institute Sue Carruthers Graduate Studentship; University of British Columbia Four Year Fellowship; Juvenile Diabetes Research Foundation [2-2011-91]; Canadian Institutes of Health Research [RMF-111626]; Child and Family Research Institute Canucks for Kids Fund	Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Diabetes Association; Child and Family Research Institute; Canadian Institute of Health Research-BC Transplantation Trainee Fellowship; Child and Family Research Institute Sue Carruthers Graduate Studentship; University of British Columbia Four Year Fellowship; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute Canucks for Kids Fund	FCL salary support provided by the Michael Smith Foundation for Health Research, the Canadian Diabetes Association, and the Child and Family Research Institute. NAJK is a recipient of the Canadian Institute of Health Research-BC Transplantation Trainee Fellowship, Child and Family Research Institute Sue Carruthers Graduate Studentship, and University of British Columbia Four Year Fellowship. FCL received the following grants in support of this work: Juvenile Diabetes Research Foundation 2-2011-91; Canadian Institutes of Health Research RMF-111626; Child and Family Research Institute Canucks for Kids Fund 2014. The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Aksoy I, 2013, EMBO J, V32, P938, DOI 10.1038/emboj.2013.31; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Jauch R, 2011, STEM CELLS, V29, P940, DOI 10.1002/stem.639; Lakshmipathy U, 2004, STEM CELLS, V22, P531, DOI 10.1634/stemcells.22-4-531; Leavitt AD, 2011, CTS-CLIN TRANSL SCI, V4, P298, DOI 10.1111/j.1752-8062.2011.00281.x; Liu YP, 2004, STEM CELLS DEV, V13, P636, DOI 10.1089/scd.2004.13.636; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; MacArthur CC, 2012, STEM CELLS DEV, V21, P191, DOI 10.1089/scd.2011.0163; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McDonald E, 2012, INT J BIOCHEM CELL B, V44, P72, DOI 10.1016/j.biocel.2011.09.008; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; McKnight KD, 2010, CELL STEM CELL, V6, P300, DOI 10.1016/j.stem.2010.03.003; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; PETERS DT, 2013, GENOME EDITING HUMAN, DOI DOI 10.3824/STEMBOOK.1.94.1; Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Ren CP, 2005, ACTA BIOCH BIOPH SIN, V37, P68, DOI 10.1093/abbs/37.1.68; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rodriguez RT, 2007, EXP BIOL MED, V232, P1368, DOI 10.3181/0703-RM-63; Sander M, 2000, DEVELOPMENT, V127, P5533; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Seymour PA, 2012, DEVELOPMENT, V139, P3363, DOI 10.1242/dev.078733; Siemen H, 2005, STEM CELLS DEV, V14, P378, DOI 10.1089/scd.2005.14.378; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Wei CX, 2013, J GENET GENOMICS, V40, P281, DOI 10.1016/j.jgg.2013.03.013; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393	55	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114275	10.1371/journal.pone.0114275	http://dx.doi.org/10.1371/journal.pone.0114275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474420	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500008
J	Xia, Y; Wang, L; Jiang, YX; Dai, Q; Li, XY; Li, WB				Xia, Yu; Wang, Liang; Jiang, Yuxin; Dai, Qing; Li, Xiaoyi; Li, Wenbo			Sonographic Appearance of Primary Thyroid Lymphoma-Preliminary Experience	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; HASHIMOTOS-THYROIDITIS; DIAGNOSIS	Objective: Primary thyroid lymphoma (PTL) is an uncommon thyroid malignancy. Despite the rarity of PTL, it is important to recognize PTL promptly because its management differs from that of all the other thyroid neoplasms. This study was designed to investigate the sonographic features of PTL. Methods: Twenty-seven pathologically confirmed PTLs were categorized into diffuse and non-diffuse type. Sonographic features including thyroid size, thyroid background echotexture, lesion size, echogenecity, calcification, vascularity, cervical lymphadenopathy of each type were retrospectively analyzed. Results: All 27 PTLs were diffuse large B-cell lymphomas and were accompanied by diffuse Hashimoto's thyroiditis. Ten were diffuse type and seventeen were non-diffuse type sonographically. The observations in diffuse group included goiter (10/10, 100.0%), marked echogenesity (10/10, 100.0%), heterogeneous echotexture (10/10, 100.0%), and cervical lymphadenopathy (4/10, 40.0%). The observations in non-diffuse group included marked hypoechogenicity (17/17, 100.0%), heterogeneous background thyroid gland (17/17, 100.0%), goiter (15/17, 88.2%), increased vascularity (8/13, 61.5%), mulifocality (10/17, 58.8%), and cervical lymphadenopathy (7/17, 41.2%). Conclusions: Although some common features were found, the sonographic appearance of PTL is unspecific, especially for the diffuse type. Therefore, interventional diagnostic procedures should be warranted in the clinical settings when PTL is suspected.	[Xia, Yu; Wang, Liang; Jiang, Yuxin; Dai, Qing; Li, Wenbo] Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China; [Xia, Yu; Wang, Liang; Jiang, Yuxin; Dai, Qing; Li, Xiaoyi; Li, Wenbo] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Li, Xiaoyi] Chinese Acad Med Sci, Dept Gen Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Jiang, YX (corresponding author), Chinese Acad Med Sci, Dept Ultrasound, Beijing 100730, Peoples R China.	yxjiangpumch@gmail.com	li, wenbo/GZM-8930-2022	Jiang, Yuxin/0000-0002-8388-7262; Xia, Yu/0000-0001-5248-9870	Peking Union Medical College Hospital	Peking Union Medical College Hospital	This study was supported by a grant from Peking Union Medical College Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SM, 1999, SEMIN ONCOL, V26, P316; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; FRIEDBERG MH, 1994, SURGERY, V116, P1061; HAMBURGER JI, 1983, ANN INTERN MED, V99, P685, DOI 10.7326/0003-4819-99-5-685; HYJEK E, 1988, HUM PATHOL, V19, P1315, DOI 10.1016/S0046-8177(88)80287-9; Ishikawa Hitoshi, 2002, Radiat Med, V20, P9; King AD, 1997, POSTGRAD MED J, V73, P412, DOI 10.1136/pgmj.73.861.412; Mack LA, 2007, WORLD J SURG, V31, P978, DOI 10.1007/s00268-005-0768-z; MATSUZUKA F, 1993, THYROID, V3, P93, DOI 10.1089/thy.1993.3.93; Nam M, 2012, J ULTRAS MED, V31, P589, DOI 10.7863/jum.2012.31.4.589; Ota H, 2006, THYROID, V16, P983, DOI 10.1089/thy.2006.16.983; Podoloff DA, 1996, AM J ROENTGENOL, V167, P1337, DOI 10.2214/ajr.167.5.8911208; Sakorafas GH, 2010, SURG ONCOL, V19, pE124, DOI 10.1016/j.suronc.2010.06.002; Sasai K, 1996, ACTA ONCOL, V35, P457, DOI 10.3109/02841869609109922; TAKASHIMA S, 1989, RADIOLOGY, V171, P439, DOI 10.1148/radiology.171.2.2649921; Takashima S, 1997, J CLIN ULTRASOUND, V25, P279, DOI 10.1002/(SICI)1097-0096(199706)25:5<279::AID-JCU11>3.0.CO;2-E	16	19	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114080	10.1371/journal.pone.0114080	http://dx.doi.org/10.1371/journal.pone.0114080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474402	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500113
J	Tian, YF; Gawlak, G; Shah, AS; Higginbotham, K; Tian, XY; Kawasaki, Y; Akiyama, T; Sacks, DB; Birukova, AA				Tian, Yufeng; Gawlak, Grzegorz; Shah, Alok S.; Higginbotham, Katherine; Tian, Xinyong; Kawasaki, Yoshihiro; Akiyama, Tetsu; Sacks, David B.; Birukova, Anna A.			Hepatocyte Growth Factor-induced Asef-IQGAP1 Complex Controls Cytoskeletal Remodeling and Endothelial Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED PHOSPHOLIPIDS; ACTIN-FILAMENTS; SCATTER FACTOR; BETA-CATENIN; RHO GTPASES; C-MET; IQGAP1; RAC; CDC42; PERMEABILITY	Hepatocyte growth factor (HGF) attenuates agonist-induced endothelial cell (EC) permeability and increases pulmonary endothelial barrier function via Rac-dependent enhancement of the peripheral actin cytoskeleton. However, the precise mechanisms of HGF effects on the peripheral cytoskeleton are not well understood. This study evaluated a role for Rac/Cdc42-specific guanine nucleotide exchange factor Asef and the multifunctional Rac effector, IQGAP1, in the mechanism of HGF-induced EC barrier enhancement. HGF induced Asef and IQGAP1 co-localization at the cell cortical area and stimulated formation of an Asef-IQGAP1 functional protein complex. siRNA-induced knockdown of Asef or IQGAP1 attenuated HGF-induced EC barrier enhancement. Asef knockdown attenuated HGF-induced Rac activation and Rac association with IQGAP1, and it abolished both IQGAP1 accumulation at the cell cortical layer and IQGAP1 interaction with actin cytoskeletal regulators cortactin and Arp3. Asef activation state was essential for Asef interaction with IQGAP1 and protein complex accumulation at the cell periphery. In addition to the previously reported role of the IQGAP1 RasGAP-related domain in the Rac-dependent IQGAP1 activation and interaction with its targets, we show that the IQGAP1 C-terminal domain is essential for HGF-induced IQGAP1/Asef interaction and Asef-Rac-dependent activation leading to IQGAP1 interaction with Arp3 and cortactin as a positive feedback mechanism of IQGAP1 activation. These results demonstrate a novel feedback mechanism of HGF-induced endothelial barrier enhancement via Asef/IQGAP1 interactions, which regulate the level of HGF-induced Rac activation and promote cortical cytoskeletal remodeling via IQGAP1Arp3/cortactin interactions.	[Tian, Yufeng; Gawlak, Grzegorz; Shah, Alok S.; Higginbotham, Katherine; Tian, Xinyong; Birukova, Anna A.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Chicago, IL 60637 USA; [Kawasaki, Yoshihiro; Akiyama, Tetsu] Univ Tokyo, Lab Mol & Genet Informat, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	University of Chicago; University of Tokyo; National Institutes of Health (NIH) - USA	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave,MC-6026, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu		Sacks, David/0000-0003-3100-0735	National Institutes of Health from NHLBI [HL89257, HL107920]; Intramural Research Program of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R56HL107920, R01HL107920] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health Grants HL89257 and HL107920 from NHLBI and by the Intramural Research Program of the National Institutes of Health.	Aoki M, 2000, J Atheroscler Thromb, V7, P71; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kawasaki Y, 2009, J BIOL CHEM, V284, P22436, DOI 10.1074/jbc.M109.020768; Kouklis P, 2004, CIRC RES, V94, P159, DOI 10.1161/01.RES.0000110418.38500.31; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rosen EM, 1995, ADV CANCER RES, V67, P257, DOI 10.1016/S0065-230X(08)60715-0; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tian YF, 2014, MOL CELL BIOL, V34, P3546, DOI 10.1128/MCB.00248-14; Tomita N, 2000, J Atheroscler Thromb, V7, P1; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Waheed F, 2013, MOL BIOL CELL, V24, P1068, DOI 10.1091/mbc.E12-09-0661; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Zhang LL, 2000, J NEUROSCI RES, V59, P489, DOI 10.1002/(SICI)1097-4547(20000215)59:4<489::AID-JNR3>3.0.CO;2-9; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	54	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4097	4109		10.1074/jbc.M114.620377	http://dx.doi.org/10.1074/jbc.M114.620377			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25492863	hybrid, Green Published			2022-12-26	WOS:000349458400021
J	Arribas-Gonzalez, E; de Juan-Sanz, J; Aragon, C; Lopez-Corcuera, B				Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz			Molecular Basis of the Dominant Negative Effect of a Glycine Transporter 2 Mutation Associated with Hyperekplexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; NEUROTRANSMITTER TRANSPORTERS; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; SLC6 TRANSPORTERS; STARTLE DISEASE; GLYT2; DYSFUNCTION; TRAFFICKING; MECHANISMS	Hyperekplexia or startle disease is a rare clinical syndrome characterized by an exaggerated startle in response to trivial tactile or acoustic stimuli. This neurological disorder can have serious consequences in neonates, provoking brain damage and/or sudden death due to apnea episodes and cardiorespiratory failure. Hyperekplexia is caused by defective inhibitory glycinergic neurotransmission. Mutations in the human SLC6A5 gene encoding the neuronal GlyT2 glycine transporter are responsible for the presynaptic form of the disease. GlyT2 mediates synaptic glycine recycling, which constitutes the main source of releasable transmitter at glycinergic synapses. Although the majority of GlyT2 mutations detected so far are recessive, a dominant negative mutant that affects GlyT2 trafficking does exist. In this study, we explore the properties and structural alterations of the S512R mutation in GlyT2. We analyze its dominant negative effect that retains wild-type GlyT2 in the endoplasmic reticulum (ER), preventing surface expression. We show that the presence of an arginine rather than serine 512 provoked transporter misfolding, enhanced association to the ER-chaperone calnexin, altered association with the coat-protein complex II component Sec24D, and thereby impeded ER exit. The S512R mutant formed oligomers with wild-type GlyT2 causing its retention in the ER. Overexpression of calnexin rescued wild-type GlyT2 from the dominant negative effect of the mutant, increasing the amount of transporter that reached the plasma membrane and dampening the interaction between the wild-type and mutant GlyT2. The ability of chemical chaperones to overcome the dominant negative effect of the disease mutation on the wild-type transporter was demonstrated in heterologous cells and primary neurons.	[Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, Dept Biol Mol, CSIC, E-28049 Madrid, Spain; [Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Madrid 28029, Spain; [Arribas-Gonzalez, Esther; de Juan-Sanz, Jaime; Aragon, Carmen; Lopez-Corcuera, Beatriz] Univ Autonoma Madrid, IdiPAZ Hosp Univ La Paz, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario La Paz	Lopez-Corcuera, B (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	blopez@cbm.csic.es	Corcuera, Beatriz López/D-5188-2009; Aragon, Carmen/K-9783-2014; de Juan-Sanz, Jaime/L-7990-2017	Corcuera, Beatriz López/0000-0002-0383-4241; Aragon, Carmen/0000-0001-8287-9386; de Juan-Sanz, Jaime/0000-0002-1212-5623; Arribas Gonzalez, Esther/0000-0001-6579-3396	Spanish "Ministerio de Economia y Competitividad" [SAF2011-28674]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Fundacion Ramon Areces	Spanish "Ministerio de Economia y Competitividad"; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Fundacion Ramon Areces	This work was supported by Spanish "Ministerio de Economia y Competitividad" Grant SAF2011-28674, by the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), and by an institutional grant from the "Fundacion Ramon Areces."	Apostolides PF, 2013, J NEUROSCI, V33, P4768, DOI 10.1523/JNEUROSCI.5555-12.2013; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Arribas-Gonzalez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063230; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Chiba P, 2014, PHARMACOL RES, V83, P63, DOI 10.1016/j.phrs.2013.11.009; Conn PM, 2009, TRENDS PHARMACOL SCI, V30, P228, DOI 10.1016/j.tips.2009.02.002; de Juan-Sanz J, 2013, J NEUROSCI, V33, P14269, DOI 10.1523/JNEUROSCI.1532-13.2013; de Juan-Sanz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058863; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Fujiwara M, 2013, J PHARMACOL SCI, V122, P71, DOI 10.1254/jphs.12194FP; Geerlings A, 2002, J NEUROCHEM, V82, P58, DOI 10.1046/j.1471-4159.2002.00930.x; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Harvey RJ, 2013, NAT REV DRUG DISCOV, V12, P866, DOI 10.1038/nrd3893; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Leidenheimer NJ, 2014, PHARMACOL RES, V83, P10, DOI 10.1016/j.phrs.2014.01.005; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; LIU QR, 1993, J BIOL CHEM, V268, P22802; LOPEZCORCUERA B, 1991, J BIOL CHEM, V266, P24809; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Perez-Siles G, 2012, BIOCHEM J, V442, P323, DOI 10.1042/BJ20110247; Pettit RS, 2012, ANN PHARMACOTHER, V46, P1065, DOI 10.1345/aph.1R076; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Rudnick G, 2014, PFLUG ARCH EUR J PHY, V466, P25, DOI 10.1007/s00424-013-1410-1; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x	50	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2150	2165		10.1074/jbc.M114.587055	http://dx.doi.org/10.1074/jbc.M114.587055			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480793	Green Published, hybrid			2022-12-26	WOS:000348588000020
J	Kim, D; Dai, J; Fai, LY; Yao, H; Son, YO; Wang, L; Pratheeshkumar, P; Kondo, K; Shi, XL; Zhang, Z				Kim, Donghern; Dai, Jin; Fai, Leonard Yenwong; Yao, Hua; Son, Young-Ok; Wang, Lei; Pratheeshkumar, Poyil; Kondo, Kazuya; Shi, Xianglin; Zhang, Zhuo			Constitutive Activation of Epidermal Growth Factor Receptor Promotes Tumorigenesis of Cr(VI)-transformed Cells through Decreased Reactive Oxygen Species and Apoptosis Resistance Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HEXAVALENT CHROMIUM; SIGNALING PATHWAY; EGFR MUTATIONS; CANCER-CELLS; TUMOR-CELLS; DNA-DAMAGE; PHOSPHORYLATION; TRANSFORMATION; MECHANISMS	Hexavalent chromium (Cr(VI)) compounds are well-established lung carcinogens. Epidermal growth factor receptor (EGFR) is a tyrosine kinase transmembrane receptor that regulates cell survival, tumor invasion, and angiogenesis. Our results show that chronic exposure of human bronchial epithelial (BEAS-2B) cells to Cr(VI) is able to cause malignant cell transformation. These transformed cells exhibit apoptosis resistance with reduced poly ADP-ribose polymerase cleavage (C-PARP) and Bax expression and enhanced expressions of Bcl-2 and Bcl-xL. These transformed cells also exhibit reduced capacity of reactive oxygen species (ROS) generation along with elevated expression of antioxidant manganese superoxide dismutase 2 (SOD2). The expression of this antioxidant was also elevated in lung tumor tissue from a worker exposed to Cr(VI) for 19 years. EGFR was activated in Cr(VI)-transformed BEAS-2B cells, lung tissue from animals exposed to Cr(VI) particles, and human lung tumor tissue. Further study indicates that constitutive activation of EGFR in Cr(VI)-transformed cells was due to increased binding to its ligand amphiregulin (AREG). Inhibition of EGFR or AREG increased Bax expression and reduced Bcl-2 expression, resulting in reduced apoptosis resistance. Furthermore, inhibition of AREG or EGFR restored capacity of ROS generation and decreased SOD2 expression. PI3K/AKT was activated, which depended on EGFR in Cr(VI)-transformed BEAS-2B cells. Inhibition of PI3K/AKT increased ROS generation and reduced SOD2 expression, resulting in reduced apoptosis resistance with commitment increase in Bax expression and reduction of Bcl-2 expression. Xenograft mouse tumor study further demonstrates the essential role of EGFR in tumorigenesis of Cr(VI)-transformed cells. In summary, the present study suggests that ligand-dependent constitutive activation of EGFR causes reduced ROS generation and increased antioxidant expression, leading to development of apoptosis resistance, contributing to Cr(VI)-induced tumorigenesis.	[Kim, Donghern; Dai, Jin; Fai, Leonard Yenwong; Zhang, Zhuo] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Son, Young-Ok; Wang, Lei; Pratheeshkumar, Poyil; Shi, Xianglin] Univ Kentucky, Ctr Res Environm Dis, Lexington, KY 40536 USA; [Yao, Hua] Zhejiang Univ, Affiliated Hosp 1, Dept Stomatol, Hangzhou 310003, Zhejiang, Peoples R China; [Kondo, Kazuya] Univ Tokushima, Inst Hlth Biosci, Dept Oncol Med Serv, Grad Sch, Tokushima 7708509, Japan	University of Kentucky; University of Kentucky; Zhejiang University; Tokushima University	Zhang, Z (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	zhuo.zhang@uky.edu	Kondo, Kazuya/J-9163-2012; Son, Youngok/AAB-1380-2021; Shi, Xianglin/B-8588-2012; Zhang, Zhuo/B-8601-2012; Son, Young-Ok/P-3675-2015	Son, Youngok/0000-0003-0154-4061	National Institutes of Health/NIEHS [R01ES018883]; National Institutes of Health/NCI [R03CA171604]; NATIONAL CANCER INSTITUTE [P30CA177558, R03CA171604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021771, R01ES018883] Funding Source: NIH RePORTER	National Institutes of Health/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by National Institutes of Health/NIEHS R01ES018883 and National Institutes of Health/NCI R03CA171604 (to Z. Z.).	[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V49, P1; Beaver L. M., 2010, ENV HLTH PERSPEC, V117, P1898; Chen CH, 2006, MOL PHARMACOL, V69, P1347, DOI 10.1124/mol.105.017558; Chen F, 2001, MOL CELL BIOCHEM, V222, P183, DOI 10.1023/A:1017970330982; Chiarugi P, 2007, ANTIOXID REDOX SIGN, V9, P1, DOI 10.1089/ars.2007.9.1; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hill R, 2008, DNA REPAIR, V7, P239, DOI 10.1016/j.dnarep.2007.10.001; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Ivanova D, 2013, ADV CLIN EXP MED, V22, P899; Kagan V., 1990, MEMBRANE LIPID OXIDA, V3, P192; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Lee DH, 2009, J CELL BIOCHEM, V106, P1113, DOI 10.1002/jcb.22098; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Marinov M, 2009, CLIN CANCER RES, V15, P1277, DOI 10.1158/1078-0432.CCR-08-2166; Medan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037045; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Orcutt KP, 2011, CANCER RES, V71, P3932, DOI 10.1158/0008-5472.CAN-10-3425; Paletta-Silva R, 2013, INT J MOL SCI, V14, P3683, DOI 10.3390/ijms14023683; Pellerin C, 2000, ENVIRON HEALTH PERSP, V108, pA402, DOI 10.2307/3434980; Peus D, 2000, PHOTOCHEM PHOTOBIOL, V72, P135, DOI 10.1562/0031-8655(2000)072<0135:UIEGFR>2.0.CO;2; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rodrigues CFD, 2009, MUTAT RES-FUND MOL M, V670, P42, DOI 10.1016/j.mrfmmm.2009.07.004; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Scagliotti GV, 2004, CLIN CANCER RES, V10, p4227S, DOI 10.1158/1078-0432.CCR-040007; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; SHI XL, 1989, BIOCHEM BIOPH RES CO, V163, P627, DOI 10.1016/0006-291X(89)92183-9; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Wang BJ, 2010, TOXICOL LETT, V198, P216, DOI 10.1016/j.toxlet.2010.06.024; Wang X, 2011, TOXICOL SCI, V123, P399, DOI 10.1093/toxsci/kfr180; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wyllie AH, 1999, BRIT J CANCER, V80, P34; Yao H, 2008, J ENVIRON PATHOL TOX, V27, P77, DOI 10.1615/JEnvironPatholToxicolOncol.v27.i2.10; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ye JP, 1999, J BIOL CHEM, V274, P34974, DOI 10.1074/jbc.274.49.34974; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zhou CL, 2006, INT J ONCOL, V29, P269; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	51	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2213	2224		10.1074/jbc.M114.619783	http://dx.doi.org/10.1074/jbc.M114.619783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477514	Green Published, hybrid			2022-12-26	WOS:000348588000025
J	Fan, AL; Zocher, G; Stec, E; Stehle, T; Li, SM				Fan, Aili; Zocher, Georg; Stec, Edyta; Stehle, Thilo; Li, Shu-Ming			Site-directed Mutagenesis Switching a Dimethylallyl Tryptophan Synthase to a Specific Tyrosine C-3-Prenylating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-FUMIGATUS; INDOLE PRENYLTRANSFERASES; BIOCHEMICAL-CHARACTERIZATION; PRENYLATION; DERIVATIVES; CATALYZES; HYDROXYNAPHTHALENES; OVERPRODUCTION; REARRANGEMENT; BIOSYNTHESIS	The tryptophan prenyltransferases FgaPT2 and 7-DMATS (7-dimethylallyl tryptophan synthase) from Aspergillus fumigatus catalyze C-4- and C-7-prenylation of the indole ring, respectively. 7-DMATS was found to accept L-tyrosine as substrate as well and converted it to an O-prenylated derivative. An acceptance of L-tyrosine by FgaPT2 was also observed in this study. Interestingly, isolation and structure elucidation revealed the identification of a C-3-prenylated L-tyrosine as enzyme product. Molecular modeling and site-directed mutagenesis led to creation of a mutant FgaPT2_K174F, which showed much higher specificity toward L-tyrosine than L-tryptophan. Its catalytic efficiency toward L-tyrosine was found to be 4.9-fold in comparison with that of non-mutated FgaPT2, whereas the activity toward L-tryptophan was less than 0.4% of that of the wild-type. To the best of our knowledge, this is the first report on an enzymatic C-prenylation of L-tyrosine as free amino acid and altering the substrate preference of a prenyltransferase by mutagenesis.	[Fan, Aili; Stec, Edyta; Li, Shu-Ming] Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany; [Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany	Philipps University Marburg; Eberhard Karls University of Tubingen	Li, SM (corresponding author), Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany.	shuming.li@staff.uni-marburg.de	Fan, Aili/X-3185-2019	Fan, Aili/0000-0003-4738-0517	Deutsche Forschungsgemeinschaft [Li844/4-1, SFB766]; China Scholarship Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); China Scholarship Council(China Scholarship Council)	This work was supported in part by Deutsche Forschungsgemeinschaft Grants Li844/4-1 (to S.-M. L.) and SFB766 (to G. Z. and T. S.).; Recipient of a scholarship from the China Scholarship Council.	Ahmed F, 2008, J NAT PROD, V71, P1963, DOI 10.1021/np8004248; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; El-Seedi HR, 2009, CURR MED CHEM, V16, P2581, DOI 10.2174/092986709788682056; Fan AL, 2014, APPL MICROBIOL BIOT, V98, P10119, DOI 10.1007/s00253-014-5872-7; Fan AL, 2014, TETRAHEDRON LETT, V55, P5199, DOI 10.1016/j.tetlet.2014.07.080; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Jain HD, 2008, BIOORGAN MED CHEM, V16, P4626, DOI 10.1016/j.bmc.2008.02.050; Jost M, 2010, J AM CHEM SOC, V132, P17849, DOI 10.1021/ja106817c; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Kremer A, 2007, MICROBIOL-SGM, V153, P3409, DOI 10.1099/mic.0.2007/009019-0; Kremer A, 2010, MICROBIOL-SGM, V156, P278, DOI 10.1099/mic.0.033886-0; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Liebhold M, 2013, ORG LETT, V15, P5834, DOI 10.1021/ol4029012; Liebhold M, 2012, ORG LETT, V14, P4882, DOI 10.1021/ol302207r; Lindel T, 2012, TOP CURR CHEM, V309, P67, DOI 10.1007/128_2011_204; Lu YP, 2009, BIOCHEM BIOPH RES CO, V379, P351, DOI 10.1016/j.bbrc.2008.12.061; Luk LYP, 2011, J AM CHEM SOC, V133, P12342, DOI 10.1021/ja2034969; Luk LYP, 2009, J AM CHEM SOC, V131, P13932, DOI 10.1021/ja906485u; Majmudar JD, 2011, CHEMBIOCHEM, V12, P2723, DOI 10.1002/cbic.201100612; McIntosh JA, 2013, ACS CHEM BIOL, V8, P877, DOI 10.1021/cb300614c; McIntosh JA, 2011, J AM CHEM SOC, V133, P13698, DOI 10.1021/ja205458h; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pockrandt D, 2014, APPL MICROBIOL BIOT, V98, P4987, DOI 10.1007/s00253-014-5509-x; Pockrandt D, 2012, CHEMBIOCHEM, V13, P2764, DOI 10.1002/cbic.201200545; Rudolf JD, 2013, ACS CHEM BIOL, V8, P2707, DOI 10.1021/cb400691z; Stec E, 2008, CHEMBIOCHEM, V9, P2055, DOI 10.1002/cbic.200800237; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Tarcz S, 2014, CHEMBIOCHEM, V15, P108, DOI 10.1002/cbic.201300610; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Wallwey C, 2011, NAT PROD REP, V28, P496, DOI 10.1039/c0np00060d; Wessjohann LA, 2013, CURR OPIN CHEM BIOL, V17, P229, DOI 10.1016/j.cbpa.2013.02.016; Williams RM, 2000, TOP CURR CHEM, V209, P97; Winkelblech J, 2014, CHEMBIOCHEM, V15, P1030, DOI 10.1002/cbic.201400046; Wollinsky B, 2012, BIOORG MED CHEM LETT, V22, P3866, DOI 10.1016/j.bmcl.2012.04.119; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin WB, 2013, J AM CHEM SOC, V135, P2064, DOI 10.1021/ja311145n; Yu X, 2012, METHOD ENZYMOL, V516, P259, DOI 10.1016/B978-0-12-394291-3.00005-8; Yu X, 2012, J BIOL CHEM, V287, P1371, DOI 10.1074/jbc.M111.317982; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Yu X, 2011, APPL MICROBIOL BIOT, V92, P737, DOI 10.1007/s00253-011-3351-y; Zou HX, 2011, APPL MICROBIOL BIOT, V89, P1443, DOI 10.1007/s00253-010-2956-x	48	15	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1364	1373		10.1074/jbc.M114.623413	http://dx.doi.org/10.1074/jbc.M114.623413			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477507	Green Published, hybrid			2022-12-26	WOS:000348056400006
J	Kuroda, S; Kubota, T; Aoyama, K; Kikuchi, S; Tazawa, H; Nishizaki, M; Kagawa, S; Fujiwara, T				Kuroda, Shinji; Kubota, Tetsushi; Aoyama, Katsuyuki; Kikuchi, Satoru; Tazawa, Hiroshi; Nishizaki, Masahiko; Kagawa, Shunsuke; Fujiwara, Toshiyoshi			Establishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse Model	PLOS ONE			English	Article							EXPRESSION; METASTASES; CARCINOMA; INVASION	Orthotopic models of various types of tumors are widely used in anti-tumor therapeutic experiments in preclinical studies. However, there are few ways to appropriately monitor therapeutic effect in orthotopic tumor models, especially for tumors invisible from the outside. In this study we aimed to establish a non-invasive semi-quantitative bioluminescent imaging method of monitoring an orthotopic esophageal cancer mouse model. We confirmed that the TE8 esophageal cancer cell line implanted orthotopically into the abdominal esophagus of nu/nu mice (n=5) developed not only a main tumor at the implanted site, but also local lymph node metastases and peritoneal disseminations within 6 weeks after inoculation. We established a TE8 cell line that stably expressed the firefly luciferase gene (TE8-Luc). We showed that TE8-Luc cells implanted subcutaneously into nu/nu mice (n=5) grew over time until 5 weeks after inoculation. Tumor volume was strongly correlated with luminescent intensity emitted from the tumor, which was quantified using the IVIS imaging system. We then showed that TE8-Luc cells implanted orthotopically into the mouse abdominal esophagus (n=8) also formed a tumor and that the luminescent intensity of such a tumor, as detected by IVIS, increased over time until 7 weeks after inoculation and was therefore likely to reflect tumor progression. We therefore propose that this orthotopic esophageal cancer model, monitored using the non-invasive semi-quantitative IVIS imaging system, will be useful for in vivo therapeutic experiments against esophageal cancer. This experimental setting is expected to contribute to the development of novel therapeutic technologies for esophageal cancer in preclinical studies.	[Kuroda, Shinji; Kubota, Tetsushi; Aoyama, Katsuyuki; Kikuchi, Satoru; Nishizaki, Masahiko; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan	Okayama University; Okayama University	Kuroda, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan.	shinkuro@okayama-u.ac.jp	Kagawa, Shunsuke/B-2189-2011; TAZAWA, Hiroshi/B-2247-2011	TAZAWA, Hiroshi/0000-0003-4658-1050; Kagawa, Shunsuke/0000-0002-3610-8211; Kikuchi, Satoru/0000-0002-7671-0696	Ministry of Education, Culture, Sports and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports and Technology, Japan (TF) and Grants from the Ministry of Health, Labour and Welfare, Japan (TF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Chishima T, 1997, CANCER RES, V57, P2042; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Furihata T, 2001, INT J ONCOL, V19, P903; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Gros SJ, 2010, INT J CANCER, V126, P2671, DOI 10.1002/ijc.24980; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kawamata H, 2003, CANCER SCI, V94, P699, DOI 10.1111/j.1349-7006.2003.tb01505.x; Kuroda S, 2010, CANCER RES, V70, P9339, DOI 10.1158/0008-5472.CAN-10-2333; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Ohara T, 2010, CANCER LETT, V293, P207, DOI 10.1016/j.canlet.2010.01.017; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Quatromoni JG, 2014, J IMMUNOTHER, V37, P283, DOI 10.1097/CJI.0000000000000038; Sakaeda T, 2009, ADV DRUG DELIVER REV, V61, P388, DOI 10.1016/j.addr.2008.10.005; Samkoe KS, 2010, INT J RADIAT ONCOL, V76, P251, DOI 10.1016/j.ijrobp.2009.08.041; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Tuli R, 2012, TRANSL ONCOL, V5, P77, DOI 10.1593/tlo.11316; Zhao S, 1999, EUR J NUCL MED, V26, P231, DOI 10.1007/s002590050382	20	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114562	10.1371/journal.pone.0114562	http://dx.doi.org/10.1371/journal.pone.0114562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493557	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400053
J	LeRiche, K; Eagle, SHC; Crease, TJ				LeRiche, Kaitlynn; Eagle, Shannon H. C.; Crease, Teresa J.			Copy Number of the Transposon, Pokey, in rDNA Is Positively Correlated with rDNA Copy Number in Daphnia obtusa	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; EPIGENETIC REGULATION; DNA; EVOLUTION; ELEMENTS; CRUSTACEA; GENOME; RECOMBINATION; SEQUENCE; PULEX	Pokey is a class II DNA transposon that inserts into 28S ribosomal RNA (rRNA) genes and other genomic regions of species in the subgenus, Daphnia. Two divergent lineages, PokeyA and PokeyB have been identified. Recombination between misaligned rRNA genes changes their number and the number of Pokey elements. We used quantitative PCR (qPCR) to estimate rRNA gene and Pokey number in isolates from natural populations of Daphnia obtusa, and in clonally-propagated mutation accumulation lines (MAL) initiated from a single D. obtusa female. The change in direction and magnitude of Pokey and rRNA gene number did not show a consistent pattern across similar to 87 generations in the MAL; however, Pokey and rRNA gene number changed in concert. PokeyA and 28S gene number were positively correlated in the isolates from both natural populations and the MAL. PokeyB number was much lower than PokeyA in both MAL and natural population isolates, and showed no correlation with 28S gene number. Preliminary analysis did not detect PokeyB outside rDNA in any isolates and detected only 0 to 4 copies of PokeyA outside rDNA indicating that Pokey may be primarily an rDNA element in D. obtusa. The recombination rate in this species is high and the average size of the rDNA locus is about twice as large as that in other Daphnia species such as D. pulicaria and D. pulex, which may have facilitated expansion of PokeyA to much higher numbers in D. obtusa rDNA than these other species.	[LeRiche, Kaitlynn; Eagle, Shannon H. C.; Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Crease, TJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	tcrease@uoguelph.ca	Crease, Teresa/E-2932-2015	Crease, Teresa/0000-0001-8074-8024; Eagle, Shannon/0000-0002-6643-8799	Natural Sciences and Engineering Research Council (NSERC) of Canada; Ontario Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship in Science and Technology	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc.ca) of Canada to TJC, an Ontario Graduate Scholarship in Science and Technology to SHCE (http://osap.gov.on.ca), and a Undergraduate Summer Research Assistantship from NSERC to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-13; Averbeck KT, 2005, GENETICS, V171, P1837, DOI 10.1534/genetics.105.047670; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; CREASE TJ, 1991, MOL BIOL EVOL, V8, P620; Crease TJ, 1998, J MOL EVOL, V46, P307, DOI 10.1007/PL00006307; CREASE TJ, 1995, GENETICS, V141, P1327; Doyle J. J., 1987, PHYTOCHEM B, P11; Eagle SHC, 2012, MOBILE DNA, V3, pe4; Eagle SHC, 2013, THESIS U GUELPH; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Elliott TA, 2011, THESIS U GUELPH; Elliott TA, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-20; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Glass SK, 2008, GENOME, V51, P988, DOI 10.1139/G08-092; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kojima KK, 2003, MOL BIOL EVOL, V20, P351, DOI 10.1093/molbev/msg031; Linquist S, 2013, BIOL REV, V88, P573, DOI 10.1111/brv.12017; Louis EJ, 2002, GENOME BIOL, V3; McTaggart S, 2007, GENETICS, V175, P311, DOI 10.1534/genetics.105.050229; Omilian AR, 2001, MOL BIOL EVOL, V18, P2201, DOI 10.1093/oxfordjournals.molbev.a003767; Penton EH, 2004, MOL BIOL EVOL, V21, P1727, DOI 10.1093/molbev/msh189; Penton EH, 2002, J MOL EVOL, V55, P664, DOI 10.1007/s00239-002-2362-9; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Sullender BW, 2001, J MOL EVOL, V53, P63, DOI 10.1007/s002390010193; Valizadeh P, 2008, J MOL EVOL, V66, P643, DOI 10.1007/s00239-008-9118-0; Xu HF, 2006, MOL GENET GENOMICS, V276, P31, DOI 10.1007/s00438-006-0124-x; Zhang X, 2008, GENETICS, V180, P1617, DOI 10.1534/genetics.108.093716; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179	37	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114773	10.1371/journal.pone.0114773	http://dx.doi.org/10.1371/journal.pone.0114773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490398	Green Submitted, gold, Green Published			2022-12-26	WOS:000347515300078
J	Gonzalez-Hunt, CP; Leung, MCK; Bodhicharla, RK; McKeever, MG; Arrant, AE; Margillo, KM; Ryde, IT; Cyr, DD; Kosmaczewski, SG; Hammarlund, M; Meyer, JN				Gonzalez-Hunt, Claudia P.; Leung, Maxwell C. K.; Bodhicharla, Rakesh K.; McKeever, Madeline G.; Arrant, Andrew E.; Margillo, Kathleen M.; Ryde, Ian T.; Cyr, Derek D.; Kosmaczewski, Sara G.; Hammarlund, Marc; Meyer, Joel N.			Exposure to Mitochondrial Genotoxins and Dopaminergic Neurodegeneration in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEAR-DNA DAMAGE; ENVIRONMENTAL RISK-FACTORS; PARKINSONS-DISEASE; CALORIC RESTRICTION; OXIDATIVE DAMAGE; COMPLEX-I; REPAIR; MECHANISMS; BRAIN; NEURONS	Neurodegeneration has been correlated with mitochondrial DNA (mtDNA) damage and exposure to environmental toxins, but causation is unclear. We investigated the ability of several known environmental genotoxins and neurotoxins to cause mtDNA damage, mtDNA depletion, and neurodegeneration in Caenorhabditis elegans. We found that paraquat, cadmium chloride and aflatoxin B-1 caused more mitochondrial than nuclear DNA damage, and paraquat and aflatoxin B-1 also caused dopaminergic neurodegeneration. 6-hydroxydopamine (6-OHDA) caused similar levels of mitochondrial and nuclear DNA damage. To further test whether the neurodegeneration could be attributed to the observed mtDNA damage, C. elegans were exposed to repeated low-dose ultraviolet C radiation (UVC) that resulted in persistent mtDNA damage; this exposure also resulted in dopaminergic neurodegeneration. Damage to GABAergic neurons and pharyngeal muscle cells was not detected. We also found that fasting at the first larval stage was protective in dopaminergic neurons against 6-OHDA-induced neurodegeneration. Finally, we found that dopaminergic neurons in C. elegans are capable of regeneration after laser surgery. Our findings are consistent with a causal role for mitochondrial DNA damage in neurodegeneration, but also support non mtDNA-mediated mechanisms.	[Gonzalez-Hunt, Claudia P.; Leung, Maxwell C. K.; Bodhicharla, Rakesh K.; McKeever, Madeline G.; Margillo, Kathleen M.; Ryde, Ian T.; Meyer, Joel N.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Arrant, Andrew E.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Cyr, Derek D.] Duke Univ, Ctr Appl Genom & Technol, Durham, NC USA; [Kosmaczewski, Sara G.; Hammarlund, Marc] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Genet, New Haven, CT USA	Duke University; Duke University; Duke University; Yale University	Meyer, JN (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	joel.meyer@duke.edu	; Meyer, Joel/G-9836-2017	Arrant, Andrew/0000-0003-4706-9411; Bodhicharla, Rakesh/0000-0002-2344-6318; Gonzalez-Hunt, Claudia/0000-0002-2736-0001; Susco, Sara/0000-0001-9470-0689; Leung, Maxwell/0000-0003-1530-3306; Meyer, Joel/0000-0003-1219-0983	Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods; American Foundation of Aging Research GlaxoSmithKline Foundation Award; RJR-Duke Leon Golberg Toxicology Training Program; National Institute of Neurological Disorders and Stroke [R21 NS065468]; National Institute of Environmental Health Sciences [R01-ES017540-01A2]; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065468] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods; American Foundation of Aging Research GlaxoSmithKline Foundation Award; RJR-Duke Leon Golberg Toxicology Training Program; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by the Society of Toxicology Colgate-Palmolive Award for Student Research Training in Alternative Methods (MCKL), American Foundation of Aging Research GlaxoSmithKline Foundation Award (MCKL), RJR-Duke Leon Golberg Toxicology Training Program (JNM and RB), National Institute of Neurological Disorders and Stroke (R21 NS065468 to JNM), and National Institute of Environmental Health Sciences (R01-ES017540-01A2 to JNM). Some strains were provided by the CGC, which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; BACKER JM, 1982, CANCER RES, V42, P2764; Barlow BK, 2007, REPROD TOXICOL, V23, P457, DOI 10.1016/j.reprotox.2007.01.007; Bedard LL, 2006, CANCER LETT, V241, P174, DOI 10.1016/j.canlet.2005.11.018; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Bess A.S, 2012, NUCL ACIDS RES; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boamah EK, 2010, CHEM RES TOXICOL, V23, P1151, DOI 10.1021/tx900420k; Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7; Boyd WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007024; Brar SS, 2012, AM J PHYSL LUNG CELL; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Bronstein J, 2008, ENV HLTH PERSPECT, V117; Bronstein J, 2009, ENVIRON HEALTH PERSP, V117, P117, DOI 10.1289/ehp.11702; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Byrne AB, 2011, IN VIVO LASER AXOTOM, pe2707; Cannino G, 2009, MITOCHONDRION, V9, P377, DOI 10.1016/j.mito.2009.08.009; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cline SD, 2010, NUCLEIC ACIDS RES, V38, P7546, DOI 10.1093/nar/gkq656; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cohen BH, 2010, DEV DISABIL RES REV, V16, P189, DOI 10.1002/ddrr.106; Cover C, 2005, J PHARMACOL EXP THER, V315, P879, DOI 10.1124/jpet.105.088898; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Drechsel DA, 2009, METHOD ENZYMOL, V456, P381, DOI 10.1016/S0076-6879(08)04421-2; Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002; El Bejjani R, 2012, ANNU REV GENET, V46, P499, DOI 10.1146/annurev-genet-110711-155550; Ergun E, 2006, DEUT TIERARZTL WOCH, V113, P363; Franco R, 2010, CHEM-BIOL INTERACT, V188, P289, DOI 10.1016/j.cbi.2010.06.003; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Furda Amy M, 2012, Methods Mol Biol, V920, P111, DOI 10.1007/978-1-61779-998-3_9; GAINES G, 1984, J MOL BIOL, V172, P451, DOI 10.1016/S0022-2836(84)80017-0; Gomez C, 2007, FRONT BIOSCI-LANDMRK, V12, P1079, DOI 10.2741/2128; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; Groopman JD, 2005, TOXICOL APPL PHARM, V206, P131, DOI 10.1016/j.taap.2004.09.020; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hollins DL, 2006, FREE RADICAL BIO MED, V40, P1220, DOI 10.1016/j.freeradbiomed.2005.11.011; Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012; Hunter SE, 2012, DNA REPAIR, V11, P857, DOI 10.1016/j.dnarep.2012.08.002; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Ishiguro H, 2001, IUBMB LIFE, V51, P263, DOI 10.1080/152165401753311816; Jones GM, 2000, J TOXICOL-CLIN TOXIC, V38, P123, DOI 10.1081/CLT-100100926; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Kobayashi H, 2008, FREE RADICAL RES, V42, P651, DOI 10.1080/10715760802270334; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Korr H, 2001, CHEM-BIOL INTERACT, V134, P217, DOI 10.1016/S0009-2797(01)00154-5; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kurochkin IO, 2011, AM J PHYSIOL-REG I, V300, pR21, DOI 10.1152/ajpregu.00279.2010; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Larosche I, 2010, J PHARMACOL EXP THER, V332, P886, DOI 10.1124/jpet.109.160879; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9; Leung MCK, 2010, TOXICOL SCI, V118, P444, DOI 10.1093/toxsci/kfq295; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Loft S, 1998, FREE RADICAL RES, V29, P525, DOI 10.1080/10715769800300571; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Melrose HL, 2006, EXP BRAIN RES, V173, P196, DOI 10.1007/s00221-006-0461-3; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; Miller DB, 2008, METABOLISM, V57, pS44, DOI 10.1016/j.metabol.2008.07.011; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; NASS R, 2007, CURRENT PROTOCOLS TO; Negga R, 2011, NEUROTOXICOLOGY, V32, P331, DOI 10.1016/j.neuro.2011.02.002; NIRANJAN BG, 1986, CANCER RES, V46, P3637; NIRANJAN BG, 1982, SCIENCE, V215, P73, DOI 10.1126/science.6797067; Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011; Pinto M, 2013, BIOCH BIOPHYSICA ACT; Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Rooney JP, 2014, EXP GERONTOL; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; SACHS C, 1975, BIOCHEM PHARMACOL, V24, P1, DOI 10.1016/0006-2952(75)90304-4; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sajan M P, 1996, J Biochem Toxicol, V11, P235; Sajan M. P., 1997, Indian Journal of Experimental Biology, V35, P1187; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Samokhvalov V, 2008, AUTOPHAGY, V4, P1034, DOI 10.4161/auto.6994; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schmidt CW, 2010, ENV HLTH PERSPECT, V118; Shaughnessy DT, 2010, MITOCHONDRION, V10, P579, DOI 10.1016/j.mito.2010.02.001; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; SUZUKI J, 1995, FREE RADICAL BIO MED, V18, P431, DOI 10.1016/0891-5849(94)00152-A; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tokunaga I, 1997, BIOCHEM MOL BIOL INT, V43, P73; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; WUNDERLI.V, 1970, BIOCHEM J, V118, P99, DOI 10.1042/bj1180099; WUNDERLICH V, 1971, CHEM-BIOL INTERACT, V4, P81, DOI 10.1016/0009-2797(72)90001-4; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Yu BP, 2001, ANN NY ACAD SCI, V928, P39; Yumino K, 2002, J BIOCHEM, V131, P565, DOI 10.1093/oxfordjournals.jbchem.a003135; Zhou Shaoyu, 2013, Int J Biochem Mol Biol, V4, P191	127	39	40	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114459	10.1371/journal.pone.0114459	http://dx.doi.org/10.1371/journal.pone.0114459			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486066	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600058
J	McDonnell, MD; Yaveroglu, ON; Schmerl, BA; Iannella, N; Ward, LM				McDonnell, Mark D.; Yaveroglu, Omer Nebll; Schmerl, Brett A.; Iannella, Nicolangelo; Ward, Lawrence M.			Motif-Role-Fingerprints: The Building-Blocks of Motifs, Clustering-Coefficients and Transitivities in Directed Networks	PLOS ONE			English	Article							COMPLEX NETWORKS	Complex networks are frequently characterized by metrics for which particular subgraphs are counted. One statistic from this category, which we refer to as motif-role fingerprints, differs from global subgraph counts in that the number of subgraphs in which each node participates is counted. As with global subgraph counts, it can be important to distinguish between motif-role fingerprints that are 'structural' (induced subgraphs) and 'functional' (partial subgraphs). Here we show mathematically that a vector of all functional motif-role fingerprints can readily be obtained from an arbitrary directed adjacency matrix, and then converted to structural motif-role fingerprints by multiplying that vector by a specific invertible conversion matrix. This result demonstrates that a unique structural motif-role fingerprint exists for any given functional motif-role fingerprint. We demonstrate a similar result for the cases of functional and structural motif-fingerprints without node roles, and global subgraph counts that form the basis of standard motif analysis. We also explicitly highlight that motif-role fingerprints are elemental to several popular metrics for quantifying the subgraph structure of directed complex networks, including motif distributions, directed clustering coefficient, and transitivity. The relationships between each of these metrics and motif-role fingerprints also suggest new subtypes of directed clustering coefficients and transitivities. Our results have potential utility in analyzing directed synaptic networks constructed from neuronal connectome data, such as in terms of centrality. Other potential applications include anomaly detection in networks, identification of similar networks and identification of similar nodes within networks. Matlab code for calculating all stated metrics following calculation of functional motif-role fingerprints is provided as S1 Matlab File.	[McDonnell, Mark D.; Schmerl, Brett A.; Iannella, Nicolangelo] Univ S Australia, Inst Telecommun Res, Computat & Theoret Neurosci Lab, Mawson Lakes, SA, Australia; [Yaveroglu, Omer Nebll] Univ Calif Irvine, Calif Inst Telecommun & Informat Technol Calit2, Irvine, CA USA; [McDonnell, Mark D.; Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [McDonnell, Mark D.; Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of South Australia; University of California System; University of California Irvine; University of British Columbia; University of British Columbia	McDonnell, MD (corresponding author), Univ S Australia, Inst Telecommun Res, Computat & Theoret Neurosci Lab, Mawson Lakes, SA, Australia.	mark.mcdonnell@unisa.edu.au	Iannella, Nicolangelo/A-1026-2009; Schmerl, Brett A/O-1054-2018; McDonnell, Mark/A-8374-2008	Iannella, Nicolangelo/0000-0002-1983-9071; Schmerl, Brett A/0000-0003-3611-9065; McDonnell, Mark/0000-0002-7009-3869; Ward, Lawrence/0000-0003-4431-5015	Australian Research Fellowship from Australian Research Council [DP1093425]; Australian Government; National Health and Medical Research Council (NHMRC) of Australia [APP1050832]; Natural Sciences and Engineering Research Council (NSERC) of Canada; United States of America National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) [OIA-1028394]	Australian Research Fellowship from Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States of America National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI)(National Science Foundation (NSF))	Funding: Mark D. McDonnell's contribution was by supported by an Australian Research Fellowship from the Australian Research Council (project number DP1093425) (www.arc.gov.au), an Endeavour Award from the Australian Government (http://www.innovation.gov.au/InternationalEducation/EndeavourAwards/) and the National Health and Medical Research Council (NHMRC) of Australia (project grant, APP1050832) (www.nhrmc.gov.au). Lawrence M. Ward's contribution was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (www.nserc-crsng.gc.ca). Omer Nebil Yaverolu's contribution was supported by the United States of America National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) grant OIA-1028394. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036112; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cook SA, 1971, P 3 ANN ACM S THEOR, P151, DOI DOI 10.1145/800157.805047; Dong CY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-23; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Henderson Keith, 2012, P 18 ACM SIGKDD INT, P1231, DOI DOI 10.1145/2339530.2339723; Itzkovitz S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.058102; Itzkovitz S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026117; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kashtan N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031909; Koschutzki D, 2007, J THEOR BIOL, V248, P471, DOI 10.1016/j.jtbi.2007.05.038; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Marx V, 2012, NATURE, V490, P293, DOI 10.1038/490293a; Mayo M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00357; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088254; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Prettejohn BJ, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00011; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Qian JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017013; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106132; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wong E, 2012, BRIEF BIOINFORM, V13, P202, DOI 10.1093/bib/bbr033; Yaveroglu ON, 2014, SCI REP-UK, V4, DOI 10.1038/srep04547	38	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114503	10.1371/journal.pone.0114503	http://dx.doi.org/10.1371/journal.pone.0114503			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486535	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600063
J	Qiu, Y; Li, WH; Zhang, HQ; Liu, Y; Tian, XX; Fang, WG				Qiu, Ying; Li, Wei-hua; Zhang, Hong-quan; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang			P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells	PLOS ONE			English	Article							P2X(7) RECEPTOR EXPRESSION; EXTRACELLULAR ATP; IN-VITRO; PURINERGIC RECEPTORS; METASTASIS; PROLIFERATION; INTERLEUKIN-8; CALCIUM; GROWTH; VIVO	The ATP-gated P2X7 has been shown to play an important role in invasiveness and metastasis of some tumors. However, the possible links and underlying mechanisms between P2X7 and prostate cancer have not been elucidated. Here, we demonstrated that P2X7 was highly expressed in some prostate cancer cells. Down-regulation of P2X7 by siRNA significantly attenuated ATP- or BzATP-driven migration and invasion of prostate cancer cells in vitro, and inhibited tumor invasiveness and metastases in nude mice. In addition, silencing of P2X7 remarkably attenuated ATP- or BzATP-driven expression changes of EMT/invasion-related genes Snail, E-cadherin, Claudin-1, IL-8 and MMP-3, and weakened the phosphorylation of PI3K/AKT and ERK1/2 in vitro. Similar effects were observed in nude mice. These data indicate that P2X7 stimulates cell invasion and metastasis in prostate cancer cells via some EMT/invasion-related genes, as well as PI3K/AKT and ERK1/2 signaling pathways. P2X7 could be a promising therapeutic target for prostate cancer.	[Qiu, Ying; Li, Wei-hua; Zhang, Hong-quan; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China; [Qiu, Ying; Li, Wei-hua; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100191, Peoples R China; [Zhang, Hong-quan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100191, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81321003, 30971152]; Ministry of Science and Technology of China [2010CB529402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants to WGF from National Natural Science Foundation of China (81321003, 30971152), and 973 Program (2010CB529402) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adinolfi E, 2012, CANCER RES, V72, P2957, DOI 10.1158/0008-5472.CAN-11-1947; ALBINI A, 1987, CANCER RES, V47, P3239; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Chen L, 2004, CANCER LETT, V215, P239, DOI 10.1016/j.canlet.2004.05.023; Deli T, 2007, INT J CANCER, V121, P55, DOI 10.1002/ijc.22621; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Ghalali A, 2014, CARCINOGENESIS; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Janssens R, 2001, BRIT J PHARMACOL, V132, P536, DOI 10.1038/sj.bjp.0703833; Jantaratnotai N, 2011, NEUROSCI LETT, V497, P80, DOI 10.1016/j.neulet.2011.04.034; Jelassi B, 2011, P2X 7 RECEPTOR ACTIV; Kim SJ, 2001, NEOPLASIA, V3, P33, DOI 10.1038/sj.neo.7900124; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Liu YX, 2001, CHINESE MED J-PEKING, V114, P35; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Mutini C, 1999, J IMMUNOL, V163, P1958; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Ren SY, 2010, CELL BIOL INT, V34, P1205, DOI 10.1042/CBI20090428; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; SILINSKY EM, 1975, J PHYSIOL-LONDON, V247, P145, DOI 10.1113/jphysiol.1975.sp010925; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Stebbing J, 2013, ONCOGENE, V32, P4871, DOI 10.1038/onc.2012.591; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; White N, 2005, CANCER LETT, V224, P81, DOI 10.1016/j.canlet.2004.11.027; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Zhang XJ, 2004, LEUKEMIA RES, V28, P1313, DOI 10.1016/j.leukres.2004.04.001; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	44	83	88	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114371	10.1371/journal.pone.0114371	http://dx.doi.org/10.1371/journal.pone.0114371			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486274	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600048
J	Roquer, J; Rodriguez-Campello, A; Cuadrado-Godia, E; Giralt-Steinhauer, E; Jimenez-Conde, J; Soriano, C; Ois, A				Roquer, Jaume; Rodriguez-Campello, Ana; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Jimenez-Conde, Jordi; Soriano, Carol; Ois, Angel			The Role of HbA1c Determination in Detecting Unknown Glucose Disturbances in Ischemic Stroke	PLOS ONE			English	Article							ADMISSION HYPERGLYCEMIA; BLOOD-GLUCOSE; PREVALENCE; METABOLISM; RISK; ASSOCIATION; POPULATION; HEMOGLOBIN; PROGNOSIS; MORTALITY	Objectives: To evaluate the usefulness of hemoglobin A1c (HbA1c) determinations during the acute ischemic stroke (IS) to identify undiagnosed glucose disturbances in a prospective series of patients with first-ever IS. Methods: Retrospective analysis of a prospective series of first-ever IS patients. Patients with previous diagnosis of diabetes mellitus (DM) were excluded from the study. Patients were classified as non-DM (HbA1c<5.7% and no previous evidence of 2 or more fasting blood glucose>=126 mg/dL), prediabetes (HbA1c from 5.7% to 6.4%), and new suspected DM (HbA1c>=6.5% independently of current blood glucose). Medical charts from hospital discharge to July 2014 of all suspected DM patients were reviewed to confirm the DM diagnosis. Results: The initial cohort included 1283 patients, of which 393 were excluded because of previous DM diagnosis and 136 because HbA1c during acute stroke phase was not available. No demographic differences were observed between patients with and without HbA1c determinations. The final cohort was composed of 754 patients with first-ever IS and unknown DM history. HbA1c determination suggested new DM in 87 cases (11.5%) and detected 273 patients with prediabetes (36.2%). New DM cases were identified in all etiological stroke subtypes. After discharge, DM diagnosis was confirmed in 80.2% of patients with available follow-up. Conclusions: HbA1c determination detected both undiagnosed DM and prediabetes in IS patients without taking into account the blood glucose values during admission, and independently of etiological stroke subtype. HbA1c determination should be included in the systematic screening of all IS patients.	[Roquer, Jaume; Cuadrado-Godia, Elisa] Univ Pompeu Fabra, IMIM Hosp Mar, DCEXS, Serv Neurol, Barcelona, Spain; [Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel] Univ Autonoma Barcelona, IMIM Hosp Mar, Dept Med, Serv Neurol, E-08193 Barcelona, Spain; [Giralt-Steinhauer, Eva; Soriano, Carol] IMIM Hosp Mar, Serv Neurol, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Roquer, J (corresponding author), Univ Pompeu Fabra, IMIM Hosp Mar, DCEXS, Serv Neurol, Barcelona, Spain.	jroquer@hospitaldelmar.cat	JIMENEZ-CONDE, JORDI/C-1941-2012; TARRAGA, CAROLINA SORIANO/AAG-8777-2019; Roquer, Jaume/G-8919-2017; Campello, Ana Rodriguez/AAP-7757-2021; Ois, A/AAE-7583-2022; Ois, A/X-2922-2019	Roquer, Jaume/0000-0001-5992-2606; Campello, Ana Rodriguez/0000-0001-8621-1420; Ois, A/0000-0002-1375-5950; Ois, A/0000-0002-1375-5950; Cuadrado-Godia, Elisa/0000-0002-9147-875X; Giralt Steinhauer, Eva/0000-0002-7463-0983; Soriano Tarraga, Carolina/0000-0002-5635-273X	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III FEDER) [RD12/0042/0020]	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III FEDER)	This work was supported in part by Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III FEDER, RD12/0042/0020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilleira S, 2008, GAC SANIT, V22, P565, DOI 10.1016/S0213-9111(08)75355-X; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; CANDELISE L, 1985, ARCH NEUROL-CHICAGO, V42, P661, DOI 10.1001/archneur.1985.04060070051014; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carson AP, 2012, DIABETES CARE, V35, P1845, DOI 10.2337/dc11-2140; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Dave JA, 2010, QJM-INT J MED, V103, P495, DOI 10.1093/qjmed/hcq062; Fonville S, 2013, CEREBROVASC DIS, V36, P283, DOI 10.1159/000353677; Gentile NT, 2006, ACAD EMERG MED, V13, P174, DOI 10.1197/j.aem.2005.08.009; Goldstein LB, 1997, STROKE, V28, P307, DOI 10.1161/01.STR.28.2.307; Huisa BN, 2013, J STROKE CEREBROVASC, V22, pE564, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.023; JAMROZIK K, 1994, STROKE, V25, P51, DOI 10.1161/01.STR.25.1.51; Jia Q, 2012, STROKE, V43, P650, DOI 10.1161/STROKEAHA.111.633784; Picon MJ, 2012, DIABETES CARE, V35, P1648, DOI 10.2337/dc11-2111; Karapanayiotides T, 2004, NEUROLOGY, V62, P1558, DOI 10.1212/01.WNL.0000123252.55688.05; Kernan WN, 2013, CEREBROVASC DIS, V36, P290, DOI 10.1159/000355142; Kernan WN, 2005, ARCH INTERN MED, V165, P227, DOI 10.1001/archinte.165.2.227; Khoury JC, 2013, STROKE, V44, P1500, DOI 10.1161/STROKEAHA.113.001318; Li YF, 2013, MMWR-MORBID MORTAL W, V62, P209; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Matz K, 2006, DIABETES CARE, V29, P792, DOI 10.2337/diacare.29.04.06.dc05-1818; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Roquer J, 2008, J NEUROL, V255, P1012, DOI 10.1007/s00415-008-0820-z; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Sung J, 2009, CIRCULATION, V119, P812, DOI 10.1161/CIRCULATIONAHA.108.776989; Urabe T, 2009, STROKE, V40, P1289, DOI 10.1161/STROKEAHA.108.522557; Williams LS, 2002, NEUROLOGY, V59, P67, DOI 10.1212/WNL.59.1.67	30	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e109960	10.1371/journal.pone.0109960	http://dx.doi.org/10.1371/journal.pone.0109960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485761	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600003
J	Gao, W; Cai, LT; Xu, XD; Fan, JX; Xue, XL; Yan, XJ; Qu, QR; Wang, XH; Zhang, C; Wu, GQ				Gao, Wei; Cai, Liting; Xu, Xudong; Fan, Juxiang; Xue, Xiulei; Yan, Xuejiao; Qu, Qinrong; Wang, Xihua; Zhang, Chen; Wu, Guoqiu			Anti-CTGF Single-Chain Variable Fragment Dimers Inhibit Human Airway Smooth Muscle (ASM) Cell Proliferation by Down-Regulating p-Akt and p-mTOR Levels	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; EXTRACELLULAR-MATRIX; FACTOR-BETA; CCN FAMILY; EXPRESSION; HYPERPLASIA; MECHANISMS; REVEALS; DOMAINS	Connective tissue growth factor (CTGF) contributes to airway smooth muscle (ASM) cell hyperplasia in asthma. Humanized single-chain variable fragment antibody (scFv) was well characterized as a CTGF antagonist in the differentiation of fibroblast into myofibroblast and pulmonary fibrosis in our previous studies. To further improve the bioactivity of scFv, we constructed a plasmid to express scFv-linker-matrilin-6xHis fusion proteins that could self-assemble into the scFv dimers by disulfide bonds in matrilin under non-reducing conditions. An immunoreactivity assay demonstrated that the scFv dimer could highly bind to CTGF in a concentration-dependent manner. The MTT and EdU assay results revealed that CTGF (>= 10 ng/mL) promoted the proliferation of ASM cells, and this effect was inhibited when the cells were treated with anti-CTGF scFv dimer. The western blot analysis results showed that increased phosphorylation of Akt and mTOR induced by CTGF could be suppressed by this scFv dimer. Based on these findings, anti-CTGF scFv dimer may be a potential agent for the prevention of airway remodeling in asthma.	[Gao, Wei; Cai, Liting; Fan, Juxiang; Xue, Xiulei; Yan, Xuejiao; Qu, Qinrong] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China; [Xu, Xudong] Southeast Univ, Dept Biol Engn, Nanjing 210009, Peoples R China; [Wang, Xihua] Southeast Univ, Zhongda Hosp, Dept Respirat, Nanjing 210009, Peoples R China; [Zhang, Chen; Wu, Guoqiu] Southeast Univ, Zhongda Hosp, Ctr Clin Lab Med, Nanjing 210009, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China	Wu, GQ (corresponding author), Southeast Univ, Zhongda Hosp, Ctr Clin Lab Med, Nanjing 210009, Peoples R China.	nationball@163.com	Wu, Guoqiu/D-6558-2015	Wu, Guoqiu/0000-0002-6825-8716	National Natural Science Foundation of China [30970809, 81271636]; Natural Science Foundation of Jiangsu Province [BK2009274]; Special Fund of Clinical Medicine, Jiangsu Province, China [BL2012063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Special Fund of Clinical Medicine, Jiangsu Province, China	The authors thank the National Natural Science Foundation of China (No. 30970809, 81271636), the Natural Science Foundation of Jiangsu Province (No. BK2009274) and the Special Fund of Clinical Medicine, Jiangsu Province, China (No. BL2012063) for the financial support to this work.	Blalock TD, 2012, INVEST OPHTH VIS SCI, V53, P3387, DOI 10.1167/iovs.12-9425; Bosse Y, 2006, AM J RESP CELL MOL, V34, P746, DOI 10.1165/rcmb.2005-0309OC; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Burgess JK, 2005, CLIN EXP PHARMACOL P, V32, P988, DOI 10.1111/j.1440-1681.2005.04296.x; Burgess JK, 2003, AM J RESP CRIT CARE, V167, P71, DOI 10.1164/rccm.200205-416OC; Cohen P, 2000, AM J PHYSIOL-LUNG C, V278, pL545, DOI 10.1152/ajplung.2000.278.3.L545; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hackett TL, 2012, CURR OPIN ALLERGY CL, V12, P53, DOI 10.1097/ACI.0b013e32834ec6eb; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; James A, 2000, EUR RESPIR J, V15, P782, DOI 10.1034/j.1399-3003.2000.15d25.x; James A, 2012, AM J RESP CRIT CARE, V186, P568, DOI 10.1164/ajrccm.186.6.568; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kudo M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00263; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Prakash YS, 2009, AM J RESP CELL MOL, V41, P603, DOI 10.1165/rcmb.2008-0151OC; Puthalapattu S, 2014, J INVEST MED, V62, P665, DOI 10.2310/JIM.0000000000000065; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Wang G, 2013, PLOS ONE, V8; Wang XH, 2011, RESPIROLOGY, V16, P500, DOI 10.1111/j.1440-1843.2011.01938.x; Weisser NE, 2009, BIOTECHNOL ADV, V27, P502, DOI 10.1016/j.biotechadv.2009.04.004; Wu GQ, 2012, APPL MICROBIOL BIOT, V93, P2475, DOI 10.1007/s00253-011-3755-8; Wu GQ, 2010, BIOTECHNOL APPL BIOC, V56, P95, DOI 10.1042/BA20100031; Xie SP, 2007, AM J PHYSIOL-LUNG C, V293, pL245, DOI 10.1152/ajplung.00068.2007; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2003, SCIENCE, V301, P1334, DOI 10.1126/science.1089553; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200	37	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113980	10.1371/journal.pone.0113980	http://dx.doi.org/10.1371/journal.pone.0113980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478966	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200037
J	Hu, YQ; Chan, KH; He, XX; Ho, MKC; Wong, YH				Hu, Yueqing; Chan, King H.; He, Xixin; Ho, Maurice K. C.; Wong, Yung H.			Synthesis and Functional Characterization of Substituted Isoquinolinones as MT2-Selective Melatoninergic Ligands	PLOS ONE			English	Article							RECEPTOR ANTAGONISTS; ACETIC-ACID; IN-VITRO; MT1; AFFINITY; AGONISTS; CELLS; BIOAVAILABILITY; DERIVATIVES; RESPONSES	A series of substituted isoquinolinones were synthesized and their binding affinities and functional activities towards human melatonin MT1 and MT2 receptors were evaluated. Structure-activity relationship analysis revealed that substituted isoquinolinones bearing a 3-methoxybenzyloxyl group at C5, C6 or C7 position respectively (C5 > C6 > C7 in terms of their potency) conferred effective binding and selectivity toward the MT2 receptor, with 15b as the most potent compound. Most of the tested compounds were MT2-selective agonists as revealed in receptormediated cAMP inhibition, intracellular Ca2+ mobilization and phosphorylation of extracellular signal-regulated protein kinases. Intriguingly, compounds 7e and 7f bearing a 4-methoxybenzyloxyl group or 4-methylbenzyloxyl at C6 behaved as weak MT2-selective antagonists. These results suggest that substituted isoquinolinones represent a novel family of MT2-selective melatonin ligands. The position of the substituted benzyloxyl group, and the substituents on the benzyl ring appeared to dictate the functional characteristics of these compounds.	[Hu, Yueqing; Chan, King H.; He, Xixin; Ho, Maurice K. C.; Wong, Yung H.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Hu, Yueqing; Chan, King H.; He, Xixin; Ho, Maurice K. C.; Wong, Yung H.] Hong Kong Univ Sci & Technol, Biotechnol Res Inst, Kowloon, Hong Kong, Peoples R China; [Wong, Yung H.] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wong, Yung H.] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Wong, YH (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	boyung@hkust.hk	Ho, Maurice K/A-5993-2010	Ho, Maurice K/0000-0002-1211-2347; Wong, Yung Hou/0000-0002-0123-7697	National Key Basic Research Program of China [2013CB530900]; Research Grant Council [HKUST 660108]; University Grant Council of Hong Kong [T13-607/12R]; Hong Kong Jockey Club Charities Trust	National Key Basic Research Program of China(National Basic Research Program of China); Research Grant Council(Hong Kong Research Grants Council); University Grant Council of Hong Kong; Hong Kong Jockey Club Charities Trust	This work was supported in part by the National Key Basic Research Program of China (2013CB530900), Research Grant Council (HKUST 660108), University Grant Council of Hong Kong (T13-607/12R), and the Hong Kong Jockey Club Charities Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the authors confirm that this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arendt J, 2006, CHRONOBIOL INT, V23, P21, DOI 10.1080/07420520500464361; Conway S, 2001, BIOCHEM BIOPH RES CO, V282, P1229, DOI 10.1006/bbrc.2001.4722; Doolen S, 1998, EUR J PHARMACOL, V345, P67, DOI 10.1016/S0014-2999(98)00064-8; Drazen DL, 2001, NEUROENDOCRINOLOGY, V74, P178, DOI 10.1159/000054684; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Dubocovich ML, 1997, N-S ARCH PHARMACOL, V355, P365, DOI 10.1007/PL00004956; EBISAWA T, 1994, P NATL ACAD SCI USA, V91, P6133, DOI 10.1073/pnas.91.13.6133; Farce A, 2008, EUR J MED CHEM, V43, P1926, DOI 10.1016/j.ejmech.2007.12.001; Faust R, 2000, J MED CHEM, V43, P1050, DOI 10.1021/jm980684+; Frungieri NB, 2005, ENDOCRINOLOGY, V146, P1541, DOI 10.1210/en.2004-0990; Gerdin MJ, 2003, BIOCHEM PHARMACOL, V66, P315, DOI 10.1016/S0006-2952(03)00239-9; Hogan MV, 2001, J PINEAL RES, V30, P87, DOI 10.1034/j.1600-079X.2001.300204.x; Hu YQ, 2010, BIOORG MED CHEM LETT, V20, P2582, DOI 10.1016/j.bmcl.2010.02.084; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; Karageorge GN, 2004, BIOORG MED CHEM LETT, V14, P5881, DOI 10.1016/j.bmcl.2004.09.024; LEE AWM, 1992, J CHEM SOC PERK T 1, P309, DOI 10.1039/p19920000309; Liu AMF, 2004, J BIOL CHEM, V279, P53196, DOI 10.1074/jbc.M410196200; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Mody SM, 2000, MOL PHARMACOL, V57, P13; Mor M, 2001, BIOORGAN MED CHEM, V9, P1045, DOI 10.1016/S0968-0896(00)00322-9; New DC, 2004, ASSAY DRUG DEV TECHN, V2, P269, DOI 10.1089/1540658041410641; Nonno R, 1999, BRIT J PHARMACOL, V127, P1288, DOI 10.1038/sj.bjp.0702658; Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x; Podda MV, 2003, NEUROSCI LETT, V341, P209, DOI 10.1016/S0304-3940(03)00209-X; Pummerer R, 1910, BER DTSCH CHEM GES, V43, P1401, DOI 10.1002/cber.19100430241; Pummerer R, 1909, BER DTSCH CHEM GES, V42, P2282, DOI 10.1002/cber.190904202126; Ram PT, 2002, CANCER LETT, V179, P141, DOI 10.1016/S0304-3835(01)00873-4; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Rivara S, 2005, J MED CHEM, V48, P4049, DOI 10.1021/jm048956y; Rivara S, 2008, CURR TOP MED CHEM, V8, P954, DOI 10.2174/156802608784936719; Slominski R.M., 2012, MOL CELL ENDOCRINOL; SPADONI G, 1993, J MED CHEM, V36, P4069, DOI 10.1021/jm00077a010; TETSUO M, 1980, LIFE SCI, V27, P105, DOI 10.1016/0024-3205(80)90450-6; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; WALDHAUSER F, 1984, NEUROENDOCRINOLOGY, V39, P307, DOI 10.1159/000123997; Wallez V, 2002, J MED CHEM, V45, P2788, DOI 10.1021/jm0005252; WONG YH, 1994, METHOD ENZYMOL, V238, P81; Zhu J, 2012, XENOBIOTICA, V42, P1138, DOI 10.3109/00498254.2012.691186; Zlotos DP, 2012, CURR MED CHEM, V19, P3532	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113638	10.1371/journal.pone.0113638	http://dx.doi.org/10.1371/journal.pone.0113638			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479338	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200026
J	Gonzalez-Rodriguez, PJ; Li, Y; Martinez, F; Zhang, LB				Gonzalez-Rodriguez, Pablo J.; Li, Yong; Martinez, Fabian; Zhang, Lubo			Dexamethasone Protects Neonatal Hypoxic-Ischemic Brain Injury via L-PGDS-Dependent PGD(2)-DP1-pERK Signaling Pathway	PLOS ONE			English	Article							PROSTAGLANDIN-D SYNTHASE; ALLERGIC INFLAMMATION; RECEPTOR; PHOSPHORYLATION; GLUCOCORTICOIDS; D-2; PREVENTION; STRESS; FETAL; TRACE	Background and Purpose: Glucocorticoids pretreatment confers protection against neonatal hypoxic-ischemic (HI) brain injury. However, the molecular mechanism remains poorly elucidated. We tested the hypothesis that glucocorticoids protect against HI brain injury in neonatal rat by stimulation of lipocalin-type prostaglandin D synthase (L-PGDS)-induced prostaglandin D-2 (PGD(2))-DP1-pERK mediated signaling pathway. Methods: Dexamethasone and inhibitors were administered via intracerebroventricular (i.c.v) injections into 10-day-old rat brains. Levels of L-PGD(2), D prostanoid (DP1) receptor, pERK1/2 and PGD(2) were determined by Western immunoblotting and ELISA, respectively. Brain injury was evaluated 48 hours after conduction of HI in 10-day-old rat pups. Results: Dexamethasone pretreatment significantly upregulated L-PGDS expression and the biosynthesis of PGD(2). Dexamethasone also selectively increased isoform pERK-44 level in the neonatal rat brains. Inhibitors of L-PGDS (SeCl4), DP1 (MK-0524) and MAPK (PD98059) abrogated dexamethasone-induced increases in pERK-44 level, respectively. Of importance, these inhibitors also blocked dexamethasone-mediated neuroprotective effects against HI brain injury in neonatal rat brains. Conclusion: Interaction of glucocorticoids-GR signaling and L-PGDS-PGD(2)-DP1-pERK mediated pathway underlies the neuroprotective effects of dexamethasone pretreatment in neonatal HI brain injury.	[Gonzalez-Rodriguez, Pablo J.; Li, Yong; Martinez, Fabian; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92350 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92350 USA.	lzhang@llu.edu		Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a National Institutes of Health grant HL118861 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham IM, 2001, J NEUROENDOCRINOL, V13, P749, DOI 10.1046/j.1365-2826.2001.00705.x; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Arnold Walter, 2012, P531; Feng YZ, 2008, PEDIATR RES, V64, P370, DOI 10.1203/PDR.0b013e318180ebe6; Feng YZ, 2008, BRAIN RES BULL, V76, P102, DOI 10.1016/j.brainresbull.2008.01.012; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Flavin MP, 1996, EXP NEUROL, V139, P34, DOI 10.1006/exnr.1996.0078; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Garcia-Fernandez LF, 2000, J NEUROCHEM, V75, P460, DOI 10.1046/j.1471-4159.2000.0750460.x; HERTTING G, 1989, ANN NY ACAD SCI, V559, P84; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Katsumata Y, 2014, HYPERTENSION, V63, P80, DOI 10.1161/HYPERTENSIONAHA.113.01639; KAUFFMAN KS, 1994, PEDIATR RES, V35, P515, DOI 10.1203/00006450-199405000-00001; Li Y, 2013, NEUROBIOL DIS, V60, P32, DOI 10.1016/j.nbd.2013.08.011; Li Y, 2012, STROKE, V43, P2483, DOI 10.1161/STROKEAHA.112.664698; Li Y, 2012, PROG NEUROBIOL, V98, P145, DOI 10.1016/j.pneurobio.2012.05.010; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Revest JM, 2014, MOL PSYCHIATR, V19, P1001, DOI 10.1038/mp.2013.134; Saleem S, 2009, NEUROSCIENCE, V160, P248, DOI 10.1016/j.neuroscience.2009.02.039; Saleem S, 2007, EUR J NEUROSCI, V26, P73, DOI 10.1111/j.1460-9568.2007.05627.x; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Taniguchi H, 2007, NEUROSCI LETT, V420, P39, DOI 10.1016/j.neulet.2007.04.016; Taniguchi H, 2007, J NEUROSCI, V27, P4303, DOI 10.1523/JNEUROSCI.0321-07.2007; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; TOMBAUGH GC, 1992, J NEUROCHEM, V59, P137, DOI 10.1111/j.1471-4159.1992.tb08884.x; Tuor UI, 1997, NEUROSCI BIOBEHAV R, V21, P175, DOI 10.1016/S0149-7634(96)00007-3; Tuor UI, 1995, ANN NY ACAD SCI, V765, P179, DOI 10.1111/j.1749-6632.1995.tb16574.x; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Verklan MT, 2009, J PERINAT NEONAT NUR, V23, P59, DOI 10.1097/01.JPN.0000346221.48202.7e; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154	42	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114470	10.1371/journal.pone.0114470	http://dx.doi.org/10.1371/journal.pone.0114470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474649	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500037
J	Homburger, H; Schneider, MK; Hilfiker, S; Luscher, A				Homburger, Hermel; Schneider, Manuel K.; Hilfiker, Sandra; Luescher, Andreas			Inferring Behavioral States of Grazing Livestock from High-Frequency Position Data Alone	PLOS ONE			English	Article							ANIMAL MOVEMENT; SPACE MODELS; CATTLE; GPS; VEGETATION; INFERENCE; SELECTION; PASTURES	Studies of animal behavior are crucial to understanding animal-ecosystem interactions, but require substantial efforts in visual observation or sensor measurement. We investigated how classifying behavioral states of grazing livestock using global positioning data alone depends on the classification approach, the preselection of training data, and the number and type of movement metrics. Positions of grazing cows were collected at intervals of 20 seconds in six upland areas in Switzerland along with visual observations of animal behavior for comparison. A total of 87 linear and cumulative distance metrics and 15 turning angle metrics across multiple time steps were used to classify position data into the behavioral states of walking, grazing, and resting. Five random forest classification models, a linear discriminant analysis, a support vector machine, and a state-space model were evaluated. The most accurate classification of the observed behavioral states in an independent validation dataset was 83%, obtained using random forest with all available movement metrics. However, the state-specific accuracy was highly unequal (walking: 36%, grazing: 95%, resting: 58%). Random undersampling led to a prediction accuracy of 77%, with more balanced state-specific accuracies (walking: 68%, grazing: 82%, resting: 68%). The other evaluated machine-learning approaches had lower classification accuracies. The state-space model, based on distance to the preceding position and turning angle, produced a relatively low accuracy of 64%, slightly lower than a random forest model with the same predictor variables. Given the successful classification of behavioral states, our study promotes the more frequent use of global positioning data alone for animal behavior studies under the condition that data is collected at high frequency and complemented by context-specific behavioral observations. Machine-learning algorithms, notably random forest, were found very useful for classification and easy to implement. Moreover, the use of measures across multiple time steps is clearly necessary for a satisfactory classification.	[Homburger, Hermel; Schneider, Manuel K.; Hilfiker, Sandra; Luescher, Andreas] Agroscope, Inst Sustainabil Sci, CH-8046 Zurich, Switzerland; [Homburger, Hermel] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	Swiss Federal Research Station Agroscope; University of Freiburg	Schneider, MK (corresponding author), Agroscope, Inst Sustainabil Sci, Reckenholzstr 191, CH-8046 Zurich, Switzerland.	manuel.schneider@agroscope.admin.ch	Schneider, Manuel K./O-2308-2015; Lüscher, Andreas/E-2944-2018	Schneider, Manuel K./0000-0002-3842-2618; Andreas, Luescher/0000-0001-8158-1721	Fondation Sur-la-Croix; Canton of Grisons within the AlpFUTUR joint research program	Fondation Sur-la-Croix; Canton of Grisons within the AlpFUTUR joint research program	This research was supported by grants from the Fondation Sur-la-Croix (http://www.fondation-sur-la-croix.ch/) and the Canton of Grisons within the AlpFUTUR joint research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Aharoni Y, 2013, J ANIM SCI, V91, P1381, DOI 10.2527/jas.2012-5400; Anderson DM, 2012, RANGELAND J, V34, P149, DOI 10.1071/RJ11062; Bailey DW, 2006, RANGELAND ECOL MANAG, V59, P351, DOI 10.2111/04-165R2.1; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Beyer HL, 2013, METHODS ECOL EVOL, V4, P433, DOI 10.1111/2041-210X.12026; Braun U, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-164; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buho H, 2011, ADV SPACE RES, V48, P43, DOI 10.1016/j.asr.2011.02.015; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen C., 2004, USING RANDOM FOREST, V110, P24; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Davis JD, 2011, APPL ENG AGRIC, V27, P143; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; GANSKOPP D, 1987, NORTHWEST SCI, V61, P74; Ganskopp D, 2001, APPL ANIM BEHAV SCI, V73, P251, DOI 10.1016/S0168-1591(01)00148-4; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geremia C, 2014, ECOL APPL, V24, P346, DOI 10.1890/13-0137.1; Hapfelmeier A, 2013, COMPUT STAT DATA AN, V60, P50, DOI 10.1016/j.csda.2012.09.020; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Jewell PL, 2007, AGR ECOSYST ENVIRON, V122, P377, DOI 10.1016/j.agee.2007.02.012; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Karatzoglou A., 2004, R J STAT SOFTW, V11, P1; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Laporte I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011954; MATCHES AG, 1992, J PROD AGRIC, V5, P1; Mellone U, 2011, INT J BIOMETEOROL, V55, P463, DOI 10.1007/s00484-010-0368-3; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Naes T, 2001, J CHEMOMETR, V15, P413, DOI 10.1002/cem.676; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Plummer M., 2003, P 3 INT WORKSHOP DIS; Postlethwaite CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057640; R Core Team, 2021, R LANGUAGE ENV STAT; Ripley B.D., 2005, PATTERN RECOGNITION; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Schlecht E, 2004, APPL ANIM BEHAV SCI, V85, P185, DOI 10.1016/j.applanim.2003.11.003; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Torgo L., 2010, DATA MINING R LEARNI; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935, DOI [10.1145/1273496.1273614, DOI 10.1145/1273496.1273614]; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Witte TH, 2005, J BIOMECH, V38, P1717, DOI 10.1016/j.jbiomech.2004.07.028	45	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114522	10.1371/journal.pone.0114522	http://dx.doi.org/10.1371/journal.pone.0114522			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474315	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500043
J	Gawish, R; Martins, R; Bohm, B; Wimberger, T; Sharif, O; Lakovits, K; Schmidt, M; Knapp, S				Gawish, Riem; Martins, Rui; Bohm, Benedikta; Wimberger, Terje; Sharif, Omar; Lakovits, Karin; Schmidt, Mariane; Knapp, Sylvia			Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis	FASEB JOURNAL			English	Article						peritonitis; inflammation; macrophages; Negative regulator	ESCHERICHIA-COLI PERITONITIS; CUTTING EDGE; OSTEOCLAST DIFFERENTIATION; PNEUMOCOCCAL PNEUMONIA; PATTERN-RECOGNITION; N-GLYCOSYLATION; DENDRITIC CELLS; INNATE IMMUNITY; HOST-DEFENSE; IN-VIVO	During infections, TLR-mediated responses require tight regulation to allow for pathogen removal, while preventing overwhelming inflammation and immunopathology. The triggering receptor expressed on myeloid cells (TREM)-2 negatively regulates inflammation by macrophages and impacts on phagocytosis, but the function of endogenous TREM-2 during infections is poorly understood. We investigated TREM-2's role in regulating TLR4-mediated inflammation by studying wild-type and TREM-2(-/-) mice challenged with LPS and found TREM-2 to dampen early inflammation. Augmented early inflammation in TREM-2(-/-) animals was followed by an accelerated resolution and ultimately improved survival, associated with the induction of the negative regulator A20. Upon infection with Escherichia coli, the otherwise beneficial effect of an exaggerated early immune response in TREM-2(-/-) animals was counteracted by a 50% reduction in bacterial phagocytosis. In line with this, TREM-2(-/-) peritoneal macrophages (PMs) exhibited augmented inflammation following TLR4 stimulation, demonstrating the presence and negative regulatory functionality of TREM-2 on primary PMs. Significantly, we identified a high turnover rate because TREM-2 RNA is 25-fold down-regulated and the protein proteasomally degraded upon LPS encounter, thus ensuring a tightly regulated and versatile system that modulates inflammation. Our results illustrate TREM-2's effects on infection-triggered inflammation and identify TREM-2 as a potential target to prevent overwhelming inflammation while preserving antibacterial-effector functions.	[Gawish, Riem; Martins, Rui; Bohm, Benedikta; Wimberger, Terje; Sharif, Omar; Knapp, Sylvia] Austrian Acad Sci, Ctr Mol Med, Ce M M, A-1010 Vienna, Austria; [Gawish, Riem; Martins, Rui; Bohm, Benedikta; Wimberger, Terje; Sharif, Omar; Lakovits, Karin; Knapp, Sylvia] Med Univ Vienna, Lab Infect Biol, Dept Med 1, A-1090 Vienna, Austria; [Schmidt, Mariane] Tech Univ Denmark, Natl Food Inst, Div Epidemiol & Microbial Gen, DK-2800 Lyngby, Denmark	Austrian Academy of Sciences; Medical University of Vienna; Technical University of Denmark	Knapp, S (corresponding author), Med Univ Vienna, Austrian Acad Sci, Dept Med 1, Lab Infect Biol,Ce M M,Ctr Mol Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	sylvia.knapp@meduniwien.ac.at	Knapp, Sylvia/J-3973-2013; Gawish, Riem/AAZ-2302-2020; Martins, Rui/M-9606-2016	Knapp, Sylvia/0000-0001-9016-5244; Gawish, Riem/0000-0003-4267-2131; Martins, Rui/0000-0001-8106-6324; Sharif, Omar/0000-0001-7899-2343	Austrian Science Fund FWF [W1205]; FWF; Medical University of Vienna; European Union [261382]; Austrian Science Fund (FWF) [P 25801] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Medical University of Vienna; European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank L. Riki Cheever for her valuable comments and intellectual contributions to this paper. This work was funded by the Austrian Science Fund FWF (W1205). R.G. is a member of the Doctoral Program "Cell Communication in Health and Disease" [cofinanced by FWF and the Medical University of Vienna (to S.K.)]. The research leading to these results has received funding from the European Union Seventh Framework Program (FP7/2007-2013) under Grant Agreement 261382 (to M.S.). The authors declare no conflicts of interest.	Anwar MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.28; Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Broche F, 2001, Curr Opin Crit Care, V7, P105, DOI 10.1097/00075198-200104000-00009; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Chen LC, 2008, EXP MOL PATHOL, V84, P145, DOI 10.1016/j.yexmp.2007.11.004; Chen QX, 2013, AM J RESP CRIT CARE, V188, P201, DOI 10.1164/rccm.201211-1967OC; Colonna M, 2007, ADV EXP MED BIOL, V602, P97; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Correale C, 2013, GASTROENTEROLOGY, V144, P346, DOI [10.1053/j.gastro.2012.10.040, 10.1053/j.gastro.2012.12.016]; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; HAKOLA HPA, 1970, ACTA NEUROL SCAND, V46, P79; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hamerman Jessica A, 2006, Sci STKE, V2006, pre1, DOI 10.1126/stke.3202006re1; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Holmes C J, 1996, Perit Dial Int, V16 Suppl 1, pS124; HOLZHEIMER RG, 1991, INFECTION, V19, P447, DOI 10.1007/BF01726463; Hoogerwerf JJ, 2010, AM J RESP CELL MOL, V42, P349, DOI 10.1165/rcmb.2008-0362OC; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Knapp S, 2004, J IMMUNOL, V173, P7131, DOI 10.4049/jimmunol.173.12.7131; Knapp S, 2003, INFECT IMMUN, V71, P6747, DOI 10.1128/IAI.71.12.6747-6753.2003; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lagler H, 2009, J IMMUNOL, V183, P2027, DOI 10.4049/jimmunol.0803862; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Matt U, 2013, J CLIN INVEST, V123, P3014, DOI 10.1172/JCI60681; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; PAREKH RB, 1989, BIOCHEMISTRY-US, V28, P7644, DOI 10.1021/bi00445a021; Park-Min KH, 2009, J IMMUNOL, V183, P2444, DOI 10.4049/jimmunol.0804165; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Peng QS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003801; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Sharif O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004167; Sharif O, 2013, J IMMUNOL, V190, P5640, DOI 10.4049/jimmunol.1202270; Sun MX, 2013, INVEST OPHTH VIS SCI, V54, P3451, DOI 10.1167/iovs.12-10938; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; van Westerloo DJ, 2005, CRIT CARE MED, V33, P1036, DOI 10.1097/01.CCM.0000162684.11375.85; van 't Veer C, 2011, J BIOL CHEM, V286, P36603, DOI 10.1074/jbc.M110.189126; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Zeck A, 2011, J PROTEOME RES, V10, P3031, DOI 10.1021/pr1012653; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	64	41	52	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1247	1257		10.1096/fj.14-260067	http://dx.doi.org/10.1096/fj.14-260067			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25477281	Green Accepted			2022-12-26	WOS:000354115000013
J	Sim, CB; Ziemann, M; Kaspi, A; Harikrishnan, KN; Ooi, J; Khurana, I; Chang, L; Hudson, JE; El-Osta, A; Porrello, ER				Sim, Choon Boon; Ziemann, Mark; Kaspi, Antony; Harikrishnan, K. N.; Ooi, Jenny; Khurana, Ishant; Chang, Lisa; Hudson, James E.; El-Osta, Assam; Porrello, Enzo R.			Dynamic changes in the cardiac methylome during postnatal development	FASEB JOURNAL			English	Article						DNA methylation; cardiomyocyte proliferation; binucleation; neonatal heart; epigenetics	DNA METHYLATION; TGF-BETA; EPIGENETIC REGULATION; EXPRESSION; HEART; DEMETHYLATION; MECHANISMS; ENRICHMENT; ARREST; DAMAGE	Relatively little is known about the epigenetic control mechanisms that guide postnatal organ maturation. The goal of this study was to determine whether DNA methylation plays an important role in guiding transcriptional changes during the first 2 wk of mouse heart development, which is an important period for cardiomyocyte maturation, loss of proliferative capacity and loss of regenerative potential. Gene expression profiling (RNA-seq) and genome-wide sequencing of methylated DNA (MBD-seq) identified dynamic changes in the cardiac methylome during postnatal development [2545 differentially methylated regions (DMRs) from P1 to P14 in the mouse]. The vast majority (similar to 80%) of DMRs were hypermethylated between P1 and P14, and these hypermethylated regions were associated with transcriptional shut down of important developmental signaling pathways, including Hedgehog, bone morphogenetic protein, TGF-beta, fibroblast growth factor, and Wnt/beta-catenin signaling. Postnatal inhibition of DNA methylation with 5-aza-2'-deoxycytidine induced a marked increase (similar to 3-fold) in cardiomyocyte proliferation and similar to 50% reduction in the percentage of binucleated cardiomyocytes compared with saline-treated controls. This study provides novel evidence for widespread alterations in DNA methylation during postnatal heart maturation and suggests that cardiomyocyte cell cycle arrest during the neonatal period is subject to regulation by DNA methylation.	[Sim, Choon Boon; Hudson, James E.; Porrello, Enzo R.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ziemann, Mark; Kaspi, Antony; Harikrishnan, K. N.; Ooi, Jenny; Khurana, Ishant; Chang, Lisa; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 3004, Australia	University of Queensland; Baker Heart and Diabetes Institute	El-Osta, A (corresponding author), Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 3004, Australia.	assam.el-osta@bakeridi.edu.au; e.porrello@uq.edu.au	Hudson, James/AAE-1605-2019; Hudson, James E/O-1775-2013; Ziemann, Mark Daniel/AAE-8466-2019	Hudson, James E/0000-0003-0832-9356; Ooi, Jenny/0000-0002-4800-6124; Khurana, Ishant/0000-0001-9050-2749; El-Osta, Assam/0000-0003-2969-9137; Kaipananickal, Harikrishnan/0000-0002-4662-659X; Kaspi, Antony/0000-0001-6576-5862; El-Osta, Assam/0000-0001-7968-7375; Ziemann, Mark/0000-0002-7688-6974; Porrello, Enzo/0000-0001-6105-7463	Australian Research Council (ARC) Linkage Infrastructure, Equipment and Facilities Funding (LIEF) [LE120100071]; Victorian Government's Operational Infrastructure Support program; National Health and Medical Research Council (Australia); National Heart Foundation of Australia; University of Queensland (UQ) postdoctoral fellowship; UQ International (UQI) PhD scholarship	Australian Research Council (ARC) Linkage Infrastructure, Equipment and Facilities Funding (LIEF)(Australian Research Council); Victorian Government's Operational Infrastructure Support program; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); University of Queensland (UQ) postdoctoral fellowship(University of Queensland); UQ International (UQI) PhD scholarship	The authors thank Prof. Eric Olson (University of Texas Southwestern Medical Center) for provision of tissue samples and for helpful discussions on the manuscript. The authors thank Ms. Sindhu Igoor (University of Queensland) for technical assistance with animal studies and Mr. Gregory Quaife-Ryan (University of Queensland) for advice on bioinformatics analysis methods. The authors also acknowledge Queensland Facility for Advanced Bioinformatics (QFAB) Bioinformatics and funding provided by Australian Research Council (ARC) Linkage Infrastructure, Equipment and Facilities Funding (LIEF) LE120100071 for providing access to the MetaCore program, as well as support, in part, by the Victorian Government's Operational Infrastructure Support program. E.R.P., A.E.-O., and J.E.H. are supported by fellowships and grants from the National Health and Medical Research Council (Australia) and the National Heart Foundation of Australia. E.R.P. is also supported by a University of Queensland (UQ) postdoctoral fellowship. C.B.S. is supported by a UQ International (UQI) PhD scholarship.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chamberlain AA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000976; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Choi WY, 2013, DEVELOPMENT, V140, P660, DOI 10.1242/dev.088526; Felician G, 2014, CIRC RES, V115, P636, DOI 10.1161/CIRCRESAHA.115.304517; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Paradis A, 2014, INT J MED SCI, V11, P373, DOI 10.7150/ijms.7802; Pirola L, 2011, GENOME RES, V21, P1601, DOI 10.1101/gr.116095.110; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Stevens M, 2013, GENOME RES, V23, P1541, DOI 10.1101/gr.152231.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Xiao DL, 2014, CARDIOVASC RES, V101, P373, DOI 10.1093/cvr/cvt264; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	47	50	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1329	1343		10.1096/fj.14-264093	http://dx.doi.org/10.1096/fj.14-264093			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25491312				2022-12-26	WOS:000354115000020
J	Pilgrim, T; Rothenbuhler, M; Kalesan, B; Pulver, C; Stefanini, GG; Zanchin, T; Raber, L; Stortecky, S; Jung, S; Mattle, H; Moschovitis, A; Wenaweser, P; Meier, B; Gsponer, T; Windecker, S; Juni, P				Pilgrim, Thomas; Rothenbuehler, Martina; Kalesan, Bindu; Pulver, Cedric; Stefanini, Giulio G.; Zanchin, Thomas; Raeber, Lorenz; Stortecky, Stefan; Jung, Simon; Mattle, Heinrich; Moschovitis, Aris; Wenaweser, Peter; Meier, Bernhard; Gsponer, Thomas; Windecker, Stephan; Jueni, Peter			Additive Effect of Anemia and Renal Impairment on Long-Term Outcome after Percutaneous Coronary Intervention	PLOS ONE			English	Article							IMPACT; HEMOGLOBIN; MORTALITY	Introduction: Anemia and renal impairment are important co-morbidities among patients with coronary artery disease undergoing Percutaneous Coronary Intervention (PCI). Disease progression to eventual death can be understood as the combined effect of baseline characteristics and intermediate outcomes. Methods: Using data from a prospective cohort study, we investigated clinical pathways reflecting the transitions from PCI through intermediate ischemic or hemorrhagic events to all-cause mortality in a multi-state analysis as a function of anemia (hemoglobin concentration <120 g/l and <130 g/l, for women and men, respectively) and renal impairment (creatinine clearance,60 ml/min) at baseline. Results: Among 6029 patients undergoing PCI, anemia and renal impairment were observed isolated or in combination in 990 (16.4%), 384 (6.4%), and 309 (5.1%) patients, respectively. The most frequent transition was from PCI to death (6.7%, 95% CI 6.1-7.3), followed by ischemic events (4.8%, 95 CI 4.3-5.4) and bleeding (3.4%, 95% CI 3.0-3.9). Among patients with both anemia and renal impairment, the risk of death was increased 4-fold as compared to the reference group (HR 3.9, 95% CI 2.9-5.4) and roughly doubled as compared to patients with either anemia (HR 1.7, 95% CI 1.3-2.2) or renal impairment (HR 2.1, 95% CI 1.5-2.9) alone. Hazard ratios indicated an increased risk of bleeding in all three groups compared to patients with neither anemia nor renal impairment. Conclusions: Applying a multi-state model we found evidence for a gradient of risk for the composite of bleeding, ischemic events, or death as a function of hemoglobin value and estimated glomerular filtration rate at baseline.	[Pilgrim, Thomas; Pulver, Cedric; Stefanini, Giulio G.; Zanchin, Thomas; Raeber, Lorenz; Stortecky, Stefan; Moschovitis, Aris; Wenaweser, Peter; Meier, Bernhard; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland; [Rothenbuehler, Martina; Kalesan, Bindu; Gsponer, Thomas; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Rothenbuehler, Martina; Kalesan, Bindu; Gsponer, Thomas; Jueni, Peter] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Jung, Simon; Mattle, Heinrich] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern	Pilgrim, T (corresponding author), Univ Hosp Bern, Dept Cardiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland.	Thomas.pilgrim@insel.ch	Wenaweser, Peter/AAN-7009-2021; Stortecky, Stefan/AAS-9140-2021; Pilgrim, Thomas/AAS-9120-2021; Stefanini, Giulio G/K-7406-2016; Stefanini, Giulio/GZG-4754-2022; Juni, Peter/Q-8700-2016	Pilgrim, Thomas/0000-0001-8721-4068; Stefanini, Giulio G/0000-0002-3558-6967; Stefanini, Giulio/0000-0002-3558-6967; Juni, Peter/0000-0002-5985-0670; Rothenbuhler, Martina/0000-0001-8009-4104; Stortecky, Stefan/0000-0002-5076-0177				[Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954; Bassand JP, 2010, EUR HEART J, V31, P50, DOI 10.1093/eurheartj/ehp401; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Duncan T, 2004, STAT METHODS GENETIC; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Lee PC, 2004, J AM COLL CARDIOL, V44, P541, DOI 10.1016/j.jacc.2004.04.047; McKechnie RS, 2004, CIRCULATION, V110, P271, DOI 10.1161/01.CIR.0000134964.01697.C7; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Moore RA, 2012, EUR J PAIN, V16, P585, DOI 10.1016/j.ejpain.2011.08.009; Nikolsky E, 2004, AM J CARDIOL, V94, P1023, DOI 10.1016/j.amjcard.2004.06.058; Pilgrim T, 2012, CIRC-CARDIOVASC INTE, V5, P202, DOI 10.1161/CIRCINTERVENTIONS.111.965749; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Reinecke H, 2003, EUR HEART J, V24, P2142, DOI 10.1016/j.ehj.2003.09.008; Richardson DB, 2009, AM J EPIDEMIOL, V169, P756, DOI 10.1093/aje/kwn411; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Sukhija R, 2010, AM J CARDIOL, V105, P293, DOI 10.1016/j.amjcard.2009.09.031; Zhang RY, 2009, INT J CARDIOL, V136, P72, DOI 10.1016/j.ijcard.2008.04.028	19	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114846	10.1371/journal.pone.0114846	http://dx.doi.org/10.1371/journal.pone.0114846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489846	Green Published, gold			2022-12-26	WOS:000347515300083
J	Cao, HD; Ye, H; Sun, ZP; Shen, X; Song, ZW; Wu, XC; He, WC; Dai, CS; Yang, JW				Cao, Hongdi; Ye, Hong; Sun, Zhiping; Shen, Xia; Song, Zongwei; Wu, Xiaochun; He, Weichun; Dai, Chunsun; Yang, Junwei			Circulatory Mitochondrial DNA Is a Pro-Inflammatory Agent in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CELL-FREE DNA; CARDIOVASCULAR RISK; PLASMA; MORTALITY; SURVIVAL; SEPSIS; INJURY; DYSFUNCTION; FAILURE	Chronic inflammation is highly prevalent in maintenance hemodialysis (MHD) patients, and it has been shown to be a strong predictor of morbidity and mortality. Mitochondrial DNA (mtDNA) released into circulation after cell damage can promote inflammation in patients and animal models. However, the role and mechanisms of circulatory mtDNA in chronic inflammation in MHD patients remain unknown. Sixty MHD patients and 20 health controls were enrolled in this study. The circulatory mtDNA was detected by quantitative real-time PCR assay. Plasma interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) were quantitated by ELISA assay. Dialysis systems in MHD patients and in vitro were used to evaluate the effect of different dialysis patterns on circulatory mtDNA. Circulatory mtDNA was elevated in MHD patients comparing to that of health control. Regression analysis demonstrated that plasma mtDNA was positively associated with TNF-a and the product of serum calcium and phosphorus, while negatively associated with hemoglobin and serum albumin in MHD patients. MtDNA induced the secretion of IL-6 and TNF-alpha in the THP-1 cells. Single high-flux hemodialysis (HF-HD) and on line hemodiafiltration (OL-HDF) but not low-flux hemodialysis (LF-HD) could partially reduce plasma mtDNA in MHD patients. In vitro, both HD and hemofiltration (HF) could fractional remove mtDNA. Collectively, circulatory mtDNA is elevated and its level is closely correlated with chronic inflammation in MHD patients. HF-HD and HDF can partially reduce circulatory mtDNA in MHD patients.	[Cao, Hongdi; Ye, Hong; Sun, Zhiping; Shen, Xia; Song, Zongwei; Wu, Xiaochun; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			Jiangsu Province's Science and Technology Programs of Construction; People's Livelihood [BL2013037]; Nanjing Medical University	Jiangsu Province's Science and Technology Programs of Construction; People's Livelihood; Nanjing Medical University	This work was supported by Jiangsu Province's Science and Technology Programs of Construction and the People's Livelihood (BL2013037) to Junwei Yang. Hongdi Cao was supported by the Yong fellowship from the Nanjing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizono K, 2004, BLOOD PURIFICAT, V22, P26, DOI 10.1159/000081870; Atamaniuk J, 2012, NEPHROL DIAL TRANSPL, V27, P902, DOI 10.1093/ndt/gfr695; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Caglar K, 2002, KIDNEY INT, V62, P1408, DOI 10.1111/j.1523-1755.2002.kid556.x; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Hung A, 2008, HEMODIAL INT, V12, P236, DOI 10.1111/j.1542-4758.2008.00260.x; Hung AM, 2011, J AM SOC NEPHROL, V22, P437, DOI 10.1681/ASN.2010070760; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Korabecna M, 2012, EXPERT OPIN BIOL TH, V12, pS27, DOI 10.1517/14712598.2012.676034; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Malaponte G, 2002, NEPHROL DIAL TRANSPL, V17, P1964, DOI 10.1093/ndt/17.11.1964; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nolan CR, 2005, J AM SOC NEPHROL, V16, pS120, DOI 10.1681/ASN.2005060662; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Puskarich MA, 2012, SHOCK, V38, P337, DOI 10.1097/SHK.0b013e318266a169; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Stenvinkel P, 2002, KIDNEY INT, V62, P1791, DOI 10.1046/j.1523-1755.2002.00637.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; Sursal T, 2013, SHOCK, V39, P55, DOI 10.1097/SHK.0b013e318276f4ca; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	34	41	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113179	10.1371/journal.pone.0113179	http://dx.doi.org/10.1371/journal.pone.0113179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485699	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600015
J	Chen, P; Wang, LX; Wang, Y; Li, SM; Shen, LM; Liu, Q; Ni, JZ				Chen, Ping; Wang, Lixiang; Wang, Yong; Li, Shuiming; Shen, Liming; Liu, Qiong; Ni, Jiazuan			Phosphoproteomic Profiling of Selenate-Treated Alzheimer's Disease Model Cells	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; OXIDATIVE STRESS; MOUSE MODEL; TAU HYPERPHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; PHYSIOLOGICAL LEVELS; AEROBIC GLYCOLYSIS; NEURITE OUTGROWTH; HYDROGEN-PEROXIDE; ENERGY-METABOLISM	The reversible phosphorylation of proteins regulates most biological processes, while abnormal phosphorylation is a cause or consequence of many diseases including Alzheimer's disease (AD). One of the hallmarks of AD is the formation of neurofibrillary tangles (NFTs), which is composed of hyperphosphorylated tau proteins. Sodium selenate has been recently found to reduce tau hyperphosphorylation and NFTs formation, and to improve spatial learning and motor performance in AD mice. In the current study, the phosphoproteomics of N2aSW cells treated with selenate were investigated. To avoid missing low-abundance phosphoproteins, both the total proteins of cells and the phosphor-enriched proteins were extracted and subjected to the two-dimensional gel electrophoresis with Pro-Q diamond staining and then LC-MS/MS analysis. A total of 65 proteins were altered in phosphorylation level, of which 39 were up-regulated and 26 were down-regulated. All identified phosphoproteins were bioinformatically annotated according to their physiochemical features, subcellular location, and biological function. Most of these significantly changed phosphoproteins are involved in crucial neural processes such as protesome activity, oxidative stress, cysteine and methionine metabolism, and energy metabolism. Furthermore, decreases were found in homocysteine, phosphortau and amyloid beta upon selenate treatment. Our results suggest that selenate may intervene in the pathological process of AD by altering the phosphorylation of some key proteins involved in oxidative stress, energy metabolism and protein degradation, thus play important roles in maintaining redox homeostasis, generating ATP, and clearing misfolded proteins and aggregates. The present paper provides some new clues to the mechanism of selenate in AD prevention.	[Chen, Ping; Wang, Yong; Shen, Liming; Ni, Jiazuan] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Peoples R China; [Wang, Lixiang; Li, Shuiming; Liu, Qiong; Ni, Jiazuan] Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Shenzhen 518060, Peoples R China; [Chen, Ping] Shenzhen Univ, Coll Optoelect Engn, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Shenzhen 518060, Peoples R China	Shenzhen University; Shenzhen University; Shenzhen University	Liu, Q (corresponding author), Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Shenzhen 518060, Peoples R China.	liuqiong@szu.edu.cn; jzni@szu.edu.cn	Liu, Qiong/AAK-1556-2021	Shen, Liming/0000-0003-0074-8556	National Natural Science Foundation of China [21271131, 21301120]; Shenzhen Bureau of Science, Technology and Information [JCYJ20120817163755064, JCYJ20130408172946974]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science, Technology and Information	This work was financially supported by the National Natural Science Foundation of China (No. 21271131, 21301120), and the Shenzhen Bureau of Science, Technology and Information (No. JCYJ20120817163755064 & JCYJ20130408172946974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly NT, 2007, EPIDEMIOLOGY, V18, P52, DOI 10.1097/01.ede.0000248202.83695.4e; Arias C, 2002, EXP NEUROL, V176, P163, DOI 10.1006/exnr.2002.7912; Berr C, 2012, BIOFACTORS, V38, P139, DOI 10.1002/biof.1003; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Ceccatelli S, 2007, PHYSIOL BEHAV, V92, P87, DOI 10.1016/j.physbeh.2007.05.048; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066384; Cheng Yibin, 2010, Wei Sheng Yan Jiu, V39, P483; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; De Simoni S, 2008, NEUROSCI LETT, V433, P219, DOI 10.1016/j.neulet.2007.12.068; Di Domenico F, 2011, J PROTEOMICS, V74, P1091, DOI 10.1016/j.jprot.2011.03.033; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Gao SJ, 2007, AM J EPIDEMIOL, V165, P955, DOI 10.1093/aje/kwk073; Garcia L, 2004, J NEUROSCI RES, V77, P292, DOI 10.1002/jnr.20140; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Golji J, 2012, BIOPHYS J, V102, P2022, DOI 10.1016/j.bpj.2012.01.062; Golji J, 2010, BIOPHYS J, V99, P1073, DOI 10.1016/j.bpj.2010.05.024; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; HALEGOUA S, 1987, DEV BIOL, V121, P97, DOI 10.1016/0012-1606(87)90142-4; Hetz C, 2003, CELL MOL LIFE SCI, V60, P133, DOI 10.1007/s000180300009; Horecker BL, 2002, J BIOL CHEM, V277, P47965, DOI 10.1074/jbc.X200007200; Ishrat T, 2009, BRAIN RES, V1281, P117, DOI 10.1016/j.brainres.2009.04.010; Jin CM, 2013, J CANCER, V4, P662, DOI 10.7150/jca.6641; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Li JG, 2014, ANN NEUROL, V75, P851, DOI 10.1002/ana.24145; Liu GP, 2013, MOL THER, V21, P2247, DOI 10.1038/mt.2013.189; Loef M, 2011, J ALZHEIMERS DIS, V26, P81, DOI 10.3233/JAD-2011-110414; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Morris MS, 2003, LANCET NEUROL, V2, P425, DOI 10.1016/S1474-4422(03)00438-1; Nagamine S, 2010, NEUROCHEM INT, V57, P102, DOI 10.1016/j.neuint.2010.04.015; Nakamura M, 2006, BBA-MOL CELL RES, V1763, P977, DOI 10.1016/j.bbamcr.2006.07.008; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Palmer AM, 1999, J NEURAL TRANSM, V106, P317, DOI 10.1007/s007020050161; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pillai R, 2014, IUBMB LIFE, V66, P229, DOI 10.1002/iub.1262; Rahaman H, 2012, FASEB J, V26; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Song GL, 2014, J ALZHEIMERS DIS, V41, P85, DOI 10.3233/JAD-131805; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Stone JR, 2002, J BIOL CHEM, V277, P15621, DOI 10.1074/jbc.M112153200; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tiwari V, 2014, J ALZHEIMERS DIS, V41, P387, DOI 10.3233/JAD-122449; Tolbert CE, 2013, CELL ADHES MIGR, V7, P219, DOI 10.4161/cam.23184; Tung YT, 2008, NEUROSCI LETT, V440, P38, DOI 10.1016/j.neulet.2008.05.048; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Wang YP, 2006, J NEURAL TRANSM, V113, P1723, DOI 10.1007/s00702-006-0507-5; Wang ZF, 2006, J NEUROCHEM, V98, P1167, DOI 10.1111/j.1471-4159.2006.03956.x; Xiang TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029783; Xiong SL, 2007, ANTIOXID REDOX SIGN, V9, P457, DOI 10.1089/ars.2006.1363; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yin YY, 2010, J ALZHEIMERS DIS, V19, P735, DOI 10.3233/JAD-2010-1272; Zetterberg M, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-11; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264; Zhao ZB, 2014, NEUROSCIENCE, V275, P232, DOI 10.1016/j.neuroscience.2014.06.013	75	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113307	10.1371/journal.pone.0113307	http://dx.doi.org/10.1371/journal.pone.0113307			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485856	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600017
J	Rial, D; Castro, AA; Machado, N; Garcao, P; Goncalves, FQ; Silva, HB; Tome, AR; Kofalvi, A; Corti, O; Raisman-Vozari, R; Cunha, RA; Prediger, RD				Rial, Daniel; Castro, Adalberto A.; Machado, Nuno; Garcao, Pedro; Goncalves, Francisco Q.; Silva, Henrique B.; Tome, Angelo R.; Koefalvi, Attila; Corti, Olga; Raisman-Vozari, Rita; Cunha, Rodrigo A.; Prediger, Rui D.			Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; 2-TRIAL MEMORY TASK; DOPAMINERGIC-NEURONS; MOUSE MODELS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; SYNAPTIC PLASTICITY; SPATIAL MEMORY; RAT MODEL; GENE; IMPAIRMENTS	There is considerable evidence showing that the neurodegenerative processes that lead to sporadic Parkinson's disease (PD) begin many years before the appearance of the characteristic motor symptoms. Neuropsychiatric, sensorial and cognitive deficits are recognized as early non-motor manifestations of PD, and are not attenuated by the current anti-parkinsonian therapy. Although loss-of-function mutations in the parkin gene cause early-onset familial PD, Parkin-deficient mice do not display spontaneous degeneration of the nigrostriatal pathway or enhanced vulnerability to dopaminergic neurotoxins such as 6-OHDA and MPTP. Here, we employed adult homozygous C57BL/6 mice with parkin gene deletion on exon 3 (parkin(-/-)) to further investigate the relevance of Parkin in the regulation of non-motor features, namely olfactory, emotional, cognitive and hippocampal synaptic plasticity. Parkin(-/-) mice displayed normal performance on behavioral tests evaluating olfaction (olfactory discrimination), anxiety (elevated plus-maze), depressive-like behavior (forced swimming and tail suspension) and motor function (rotarod, grasping strength and pole). However, parkin(-/-) mice displayed a poor performance in the open field habituation, object location and modified Y-maze tasks suggestive of procedural and short-term spatial memory deficits. These behavioral impairments were accompanied by impaired hippocampal long-term potentiation (LTP). These findings indicate that the genetic deletion of parkin causes deficiencies in hippocampal synaptic plasticity, resulting in memory deficits with no major olfactory, emotional or motor impairments. Therefore, parkin(-/-) mice may represent a promising animal model to study the early stages of PD and for testing new therapeutic strategies to restore learning and memory and synaptic plasticity impairments in PD.	[Rial, Daniel; Castro, Adalberto A.; Prediger, Rui D.] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, BR-88049900 Florianopolis, SC, Brazil; [Rial, Daniel; Machado, Nuno; Garcao, Pedro; Goncalves, Francisco Q.; Silva, Henrique B.; Tome, Angelo R.; Koefalvi, Attila; Cunha, Rodrigo A.] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Corti, Olga; Raisman-Vozari, Rita] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere, CRICM, Hop Salpetriere Batiment,ICM,CNRS UMR 7225, F-75651 Paris, France; [Tome, Angelo R.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3000456 Coimbra, Portugal; [Cunha, Rodrigo A.] Univ Coimbra, Fac Med, P-3005504 Coimbra, Portugal	Universidade Federal de Santa Catarina (UFSC); Universidade de Coimbra; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universidade de Coimbra; Universidade de Coimbra	Prediger, RD (corresponding author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, BR-88049900 Florianopolis, SC, Brazil.	ruidsp@hotmail.com	Prediger, Rui D/C-4036-2013; Rial, Daniel/C-3595-2013; Rial, Daniel/D-3219-2009; Corti, Olga/I-4981-2016; Corti, Olga/AAC-3160-2019; Prediger, Rui Daniel/AAV-3419-2020; Prediger, Rui/CAG-4328-2022; Kofalvi, Attila/O-9815-2017; DE CASTRO, ADALBERTO ALVES/F-7387-2012; Cunha, Rodrigo A/E-7475-2015; da silva, Henrique Bernardo/AAY-4358-2020; Tome, Angelo Jose Ribeiro/AAL-1963-2020; de Jesus Machado, Nuno Miguel/C-3771-2013	Prediger, Rui D/0000-0002-7547-6463; Rial, Daniel/0000-0002-2079-7331; Corti, Olga/0000-0003-2093-7389; Prediger, Rui Daniel/0000-0002-7547-6463; Prediger, Rui/0000-0001-5102-0296; Kofalvi, Attila/0000-0001-6910-9707; DE CASTRO, ADALBERTO ALVES/0000-0002-9828-4894; Cunha, Rodrigo A/0000-0003-2550-6422; da silva, Henrique Bernardo/0000-0002-7234-3411; Tome, Angelo Jose Ribeiro/0000-0001-8671-989X; de Jesus Machado, Nuno Miguel/0000-0001-5097-4231; Queiroz Goncalves, Francisco/0000-0001-8042-0221	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES-COFECUB 681-10]; Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC); QREN [CENTRO-07-ST24-FEDER-002006]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); QREN	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-COFECUB 681-10), Programa de Apoio aos Nucleos de Excelencia (PRONEX - Project NENASC), Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC), QREN (CENTRO-07-ST24-FEDER-002006). DR and AAC received scholarships from CNPq. RDP is supported by a research fellowship from CNPq. RRV and RAC are supported by Visitant Research fellowships from CNPq (Ciencia sem Fronteiras). The authors have no financial or personal conflicts of interest related to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AS, 2013, NEUROTOX RES, V24, P280, DOI 10.1007/s12640-013-9389-0; Anders S, 2012, BRAIN, V135, P1128, DOI 10.1093/brain/aws040; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Assini FL, 2009, BEHAV BRAIN RES, V204, P206, DOI 10.1016/j.bbr.2009.06.005; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Bjorklund A, 2010, PROG BRAIN RES, V184, P325, DOI 10.1016/S0079-6123(10)84017-8; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Da Cunha C, 2002, CELL MOL NEUROBIOL, V22, P227, DOI 10.1023/A:1020736131907; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Lau LML, 2006, ARCH NEUROL-CHICAGO, V63, P362, DOI 10.1001/archneur.63.3.noc50312; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Ferreira SG, 2012, NEUROCHEM INT, V61, P219, DOI 10.1016/j.neuint.2012.05.009; Ferreira SG, 2009, NEUROPHARMACOLOGY, V56, P676, DOI 10.1016/j.neuropharm.2008.12.001; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Moreira ELG, 2012, J ALZHEIMERS DIS, V32, P495, DOI 10.3233/JAD-2012-120541; Hanson JE, 2010, NEUROMOL MED, V12, P270, DOI 10.1007/s12017-010-8113-y; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kahle PJ, 2004, EMBO REP, V5, P681, DOI 10.1038/sj.embor.7400188; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koles L, 2013, BRAIN RES BULL, V97, P126, DOI 10.1016/j.brainresbull.2013.06.007; Kurtenbach S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077509; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCLAMB RL, 1988, NEUROSCI LETT, V94, P338, DOI 10.1016/0304-3940(88)90041-9; Moreira ELG, 2010, J NEURAL TRANSM, V117, P1337, DOI 10.1007/s00702-010-0464-x; Muller A, 2002, J CLIN NEUROSCI, V9, P521, DOI 10.1054/jocn.2001.1071; Niu L, 2009, HIPPOCAMPUS, V19, P649, DOI 10.1002/hipo.20540; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Petit GH, 2011, EUR NEUROPSYCHOPHARM, V21, P211, DOI 10.1016/j.euroneuro.2010.09.010; Pinna A, 2014, NEUROTOX RES, V25, P392, DOI 10.1007/s12640-013-9446-8; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Prediger RD, 2009, NEUROTOX RES; Prediger RDS, 2012, NEUROPHARMACOLOGY, V62, P115, DOI 10.1016/j.neuropharm.2011.08.039; Prediger RDS, 2011, J NEURAL TRANSM, V118, P1215, DOI 10.1007/s00702-010-0568-3; Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Saleewong T, 2012, J INTEGR NEUROSCI, V11, P243, DOI 10.1142/S0219635212500173; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; Scullin CS, 2012, BRAIN RES, V1431, P1, DOI 10.1016/j.brainres.2011.10.035; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Soares E, 2013, NEUROSCIENCE, V250, P565, DOI 10.1016/j.neuroscience.2013.07.055; Stebbins GT, 1999, NEUROPSYCHOLOGIA, V37, P503, DOI 10.1016/S0028-3932(98)00068-2; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Taylor TN, 2010, BEHAV BRAIN RES, V211, P1, DOI 10.1016/j.bbr.2010.03.004; Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007; Vieira C, 2008, NEUROSCI LETT, V445, P170, DOI 10.1016/j.neulet.2008.09.001; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Zhu XR, 2007, EUR J NEUROSCI, V26, P1902, DOI 10.1111/j.1460-9568.2007.05812.x	69	75	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e0114216	10.1371/journal.pone.0114216	http://dx.doi.org/10.1371/journal.pone.0114216			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486126	Green Published, gold			2022-12-26	WOS:000346907600046
J	Scheibe, A; Gleixner, G				Scheibe, Andrea; Gleixner, Gerd			Influence of Litter Diversity on Dissolved Organic Matter Release and Soil Carbon Formation in a Mixed Beech Forest	PLOS ONE			English	Article							TEMPERATE DECIDUOUS FOREST; RATIO MASS-SPECTROMETRY; STABLE-ISOTOPE ANALYSIS; FAGUS-SYLVATICA L.; LEAF-LITTER; DECOMPOSITION DYNAMICS; NUTRIENT STOCKS; LIGNIN CONTROL; FOLIAR LITTER; NITROGEN	We investigated the effect of leaf litter on below ground carbon export and soil carbon formation in order to understand how litter diversity affects carbon cycling in forest ecosystems. C-13 labeled and unlabeled leaf litter of beech (Fagus sylvatica) and ash (Fraxinus excelsior), characterized by low and high decomposability, were used in a litter exchange experiment in the Hainich National Park (Thuringia, Germany). Litter was added in pure and mixed treatments with either beech or ash labeled with C-13. We collected soil water in 5 cm mineral soil depth below each treatment biweekly and determined dissolved organic carbon (DOC), delta C-13 values and anion contents. In addition, we measured carbon concentrations and delta C-13 values in the organic and mineral soil (collected in 1 cm increments) up to 5 cm soil depth at the end of the experiment. Litter-derived C contributes less than 1% to dissolved organic matter (DOM) collected in 5 cm mineral soil depth. Better decomposable ash litter released significantly more (0.50 +/- 0.17%) litter carbon than beech litter (0.17 +/- 0.07%). All soil layers held in total around 30% of litter-derived carbon, indicating the large retention potential of litter-derived C in the top soil. Interestingly, in mixed (ash and beech litter) treatments we did not find a higher contribution of better decomposable ash-derived carbon in DOM, O horizon or mineral soil. This suggest that the known selective decomposition of better decomposable litter by soil fauna has no or only minor effects on the release and formation of litter-derived DOM and soil organic matter. Overall our experiment showed that 1) litter-derived carbon is of low importance for dissolved organic carbon release and 2) litter of higher decomposability is faster decomposed, but litter diversity does not influence the carbon flow.	[Scheibe, Andrea; Gleixner, Gerd] Max Planck Inst Biogeochem, D-07745 Jena, Germany	Max Planck Society	Gleixner, G (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	gerd.gleixner@bgc-jena.mpg.de	Gleixner, Gerd/O-4215-2019; Gleixner, Gerd/M-8519-2017	Gleixner, Gerd/0000-0002-4616-0953; Gleixner, Gerd/0000-0002-4616-0953	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work within the Graduate School 1086 was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberic P, 2011, RAPID COMMUN MASS SP, V25, P3012, DOI 10.1002/rcm.5212; [Anonymous], 2011, EUROPEAN HUMUS FORMS; Anthoni PM, 2004, AGR FOREST METEOROL, V121, P55, DOI 10.1016/S0168-1923(03)00162-X; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Dittman JA, 2007, ECOLOGY, V88, P1153, DOI 10.1890/06-0834; Don A, 2005, SOIL BIOL BIOCHEM, V37, P2171, DOI 10.1016/j.soilbio.2005.03.019; Eissfeller V, 2013, THESIS GEORG AUGUST; Fahey TJ, 2011, ECOSYSTEMS, V14, P326, DOI 10.1007/s10021-011-9414-1; Feinstein LM, 2013, MOL ECOL, V22, P1171, DOI 10.1111/mec.12160; Feinstein LM, 2012, ENVIRON MICROBIOL, V14, P1488, DOI 10.1111/j.1462-2920.2012.02737.x; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Froberg M, 2007, EUR J SOIL SCI, V58, P108, DOI 10.1111/j.1365-2389.2006.00812.x; Froberg M, 2006, BIOGEOCHEMISTRY, V77, P1, DOI 10.1007/s10533-004-0564-5; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Gleixner G, 2013, ECOL RES, V28, P683, DOI 10.1007/s11284-012-1022-9; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; GUGGENBERGER G, 1994, ORG GEOCHEM, V21, P51, DOI 10.1016/0146-6380(94)90087-6; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hattenschwiler S, 2005, P NATL ACAD SCI USA, V102, P1519, DOI 10.1073/pnas.0404977102; Hettmann E, 2007, RAPID COMMUN MASS SP, V21, P4135, DOI 10.1002/rcm.3304; Holzwarth FM, 2011, J PLANT NUTR SOIL SC, V174, P799, DOI 10.1002/jpln.201000369; Hongve D, 2000, EUR J SOIL SCI, V51, P667, DOI 10.1046/j.1365-2389.2000.00339.x; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Kaiser K, 2001, BIOGEOCHEMISTRY, V55, P103, DOI 10.1023/A:1010694032121; Kalbitz K, 2006, EUR J SOIL SCI, V57, P504, DOI 10.1111/j.1365-2389.2006.00797.x; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Kammer A, 2011, BIOGEOSCIENCES, V8, P2195, DOI 10.5194/bg-8-2195-2011; Kammer A, 2012, BIOGEOCHEMISTRY, V108, P395, DOI 10.1007/s10533-011-9607-x; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Kramer C, 2010, SOIL BIOL BIOCHEM, V42, P1028, DOI 10.1016/j.soilbio.2010.02.021; Langenbruch C, 2014, J PLANT NUTR SOIL SC, V177, P178, DOI 10.1002/jpln.201200643; LIECHTY HO, 1995, J ENVIRON QUAL, V24, P927, DOI 10.2134/jeq1995.00472425002400050021x; Malik A, 2013, FEMS MICROBIOL ECOL, V86, P139, DOI 10.1111/1574-6941.12182; Malik A, 2012, ENVIRON SCI TECHNOL, V46, P10123, DOI 10.1021/es302467y; McDowell WH, 2003, GEODERMA, V113, P179, DOI 10.1016/S0016-7061(02)00360-9; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Michalzik B, 1999, EUR J SOIL SCI, V50, P579, DOI 10.1046/j.1365-2389.1999.00267.x; Michalzik B, 2001, BIOGEOCHEMISTRY, V52, P173, DOI 10.1023/A:1006441620810; Moller J, 1999, SOIL BIOL BIOCHEM, V31, P367, DOI 10.1016/S0038-0717(98)00138-2; Muller M, 2009, SOIL BIOL BIOCHEM, V41, P1066, DOI 10.1016/j.soilbio.2009.02.007; Ngao J, 2005, GLOBAL CHANGE BIOL, V11, P1768, DOI 10.1111/j.1365-2486.2004.01014.x; Scheibe A, 2012, RAPID COMMUN MASS SP, V26, P173, DOI 10.1002/rcm.5311; Scheu S, 2005, ECOL STUD-ANAL SYNTH, V176, P211; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Steinbeiss S, 2008, SOIL BIOL BIOCHEM, V40, P2634, DOI 10.1016/j.soilbio.2008.07.007; TIETEMA A, 1994, BIOL FERT SOILS, V18, P49, DOI 10.1007/BF00336444; Toosi ER, 2012, SOIL BIOL BIOCHEM, V50, P12, DOI 10.1016/j.soilbio.2012.02.033; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002	56	13	15	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114040	10.1371/journal.pone.0114040	http://dx.doi.org/10.1371/journal.pone.0114040			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486628	Green Published, gold			2022-12-26	WOS:000346907600038
J	Borruel, S; Molto, JF; Alpanes, M; Fernandez-Duran, E; Alvarez-Blasco, F; Luque-Ramirez, M; Escobar-Morreale, HF				Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.			Surrogate Markers of Visceral Adiposity in Young Adults: Waist Circumference and Body Mass Index Are More Accurate than Waist Hip Ratio, Model of Adipose Distribution and Visceral Adiposity Index	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; FAT THICKNESS; RISK-FACTORS; OBESITY; ULTRASONOGRAPHY; WOMEN; TISSUE	Surrogate indexes of visceral adiposity, a major risk factor for metabolic and cardiovascular disorders, are routinely used in clinical practice because objective measurements of visceral adiposity are expensive, may involve exposure to radiation, and their availability is limited. We compared several surrogate indexes of visceral adiposity with ultrasound assessment of subcutaneous and visceral adipose tissue depots in 99 young Caucasian adults, including 20 women without androgen excess, 53 women with polycystic ovary syndrome, and 26 men. Obesity was present in 7, 21, and 7 subjects, respectively. We obtained body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), model of adipose distribution (MOAD), visceral adiposity index (VAI), and ultrasound measurements of subcutaneous and visceral adipose tissue depots and hepatic steatosis. WC and BMI showed the strongest correlations with ultrasound measurements of visceral adiposity. Only WHR correlated with sex hormones. Linear stepwise regression models including VAI were only slightly stronger than models including BMI or WC in explaining the variability in the insulin sensitivity index (yet BMI and WC had higher individual standardized coefficients of regression), and these models were superior to those including WHR and MOAD. WC showed 0.94 (95% confidence interval 0.88-0.99) and BMI showed 0.91 (0.85-0.98) probability of identifying the presence of hepatic steatosis according to receiver operating characteristic curve analysis. In conclusion, WC and BMI not only the simplest to obtain, but are also the most accurate surrogate markers of visceral adiposity in young adults, and are good indicators of insulin resistance and powerful predictors of the presence of hepatic steatosis.	[Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Univ Alcala, Dept Endocrinol & Nutr, Madrid, Spain; [Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Hosp Univ Ramo & Cajal, Madrid, Spain; [Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Borruel, Susana; Molto, Jose F.; Alpanes, Macarena; Fernandez-Duran, Elena; Alvarez-Blasco, Francisco; Luque-Ramirez, Manuel; Escobar-Morreale, Hector F.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Borruel, Susana; Molto, Jose F.] Hosp Univ 12 Octubre, Dept Radiol, Madrid, Spain	Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitario 12 de Octubre	Escobar-Morreale, HF (corresponding author), Univ Alcala, Dept Endocrinol & Nutr, Madrid, Spain.	hectorfrancisco.escobar@salud.madrid.org	Ramírez, Manuel Luque/G-5037-2015; Luque-Ramírez, Manuel/AAG-4264-2019; Escobar-Morreale, Héctor F/G-5468-2010; Ramírez, Manuel Luque/AAN-6775-2021	Ramírez, Manuel Luque/0000-0002-6002-4237; Luque-Ramírez, Manuel/0000-0002-6002-4237; Escobar-Morreale, Héctor F/0000-0002-6890-1644; 	Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness [FIS PI080944, PI1100357]; Direccion General de Farmacia, Spanish Ministry of Health, Social Services and Equality, Spain [EC10-096]	Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness(Spanish Government); Direccion General de Farmacia, Spanish Ministry of Health, Social Services and Equality, Spain	This study was supported by grants FIS PI080944 & PI1100357 from Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, and grant EC10-096 from Direccion General de Farmacia, Spanish Ministry of Health, Social Services and Equality, Spain. The sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Ahn SG, 2008, HEART, V94, DOI 10.1136/hrt.2007.118471; Al-Daghri NM, 2013, EUR J CLIN INVEST, V43, P183, DOI 10.1111/eci.12030; Al-Daghri NM, 2013, PEDIAT RES; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Bjorntorp P, 1993, Obes Res, V1, P206; Borruel S, 2013, J CLIN ENDOCR METAB, V98, P1254, DOI 10.1210/jc.2012-3698; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Corona G, 2011, J ENDOCRINOL INVEST, V34, P557, DOI 10.3275/7806; Du T, 2013, INT J OBES; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Escobar-Morreale HF, 2008, J CLIN ENDOCR METAB, V93, P527, DOI 10.1210/jc.2007-2053; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Escobar-Morreale HF, 2000, FERTIL STERIL, V74, P816, DOI 10.1016/S0015-0282(00)00718-4; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Ferrannini E, 2008, EUR HEART J SUPPL, V10, pB4, DOI 10.1093/eurheartj/sum042; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Kim SK, 2004, AM J CLIN NUTR, V79, P593; KISSEBAH AH, 1991, INT J OBESITY, V15, P109; Lee M, 2007, AM J CARDIOL, V99, p68B, DOI 10.1016/j.amjcard.2006.11.007; LEMIEUX S, 1994, DIABETES METAB, V20, P375; Liu KH, 2003, INT J OBESITY, V27, P1267, DOI 10.1038/sj.ijo.0802398; Luyckx FH, 2000, DIABETES METAB, V26, P98; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mazzuca E, 2013, J SLEEP RES; Mohammadreza B, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-20; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Ribeiro FF, 2001, HYPERTENSION, V38, P713, DOI 10.1161/01.HYP.38.3.713; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Vongsuvanh R, 2012, J HEPATOL, V57, P392, DOI 10.1016/j.jhep.2012.03.013; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	37	62	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114112	10.1371/journal.pone.0114112	http://dx.doi.org/10.1371/journal.pone.0114112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479351	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200043
J	Flowers, BM; Rusnak, LE; Wong, KE; Banks, DA; Munyikwa, MR; McFarland, AG; Hinton, SD				Flowers, Brittany M.; Rusnak, Lauren E.; Wong, Kristen E.; Banks, Dallas A.; Munyikwa, Michelle R.; McFarland, Alexander G.; Hinton, Shanta D.			The Pseudophosphatase MK-STYX Induces Neurite-Like Outgrowths in PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; DUAL-SPECIFICITY PHOSPHATASE; SIGNAL-REGULATED KINASE; RNA-BINDING-PROTEIN; MAP KINASE; NEURONAL DIFFERENTIATION; ACTIN DYNAMICS; MESSENGER-RNA; PC-12 CELLS	The rat pheochromocytoma PC12 cell line is a widely used system to study neuronal differentiation for which sustained activation of the extracellular signaling related kinase (ERK) pathway is required. Here, we investigate the function of MK-STYX [MAPK (mitogen-activated protein kinase) phosphoserine/threonine/tyrosine-binding protein] in neuronal differentiation. MK-STYX is a member of the MAPK phosphatase (MKP) family, which is generally responsible for dephosphorylating the ERKs. However, MK-STYX lacks catalytic activity due to the absence of the nucleophilic cysteine in the active site signature motif HC(X-5)R that is essential for phosphatase activity. Despite being catalytically inactive, MK-STYX has been shown to play a role in important cellular pathways, including stress responses. Here we show that PC12 cells endogenously express MK-STYX. In addition, MK-STYX, but not its catalytically active mutant, induced neurite-like outgrowths in PC12 cells. Furthermore, MK-STYX dramatically increased the number of cells with neurite extensions in response to nerve growth factor (NGF), whereas the catalytically active mutant did not. MK-STYX continued to induce neurites in the presence of a MEK (MAP kinase kinase) inhibitor suggesting that MK-STYX does not act through the Ras-ERK/MAPK pathway but is involved in another pathway whose inactivation leads to neuronal differentiation. RhoA activity assays indicated that MK-STYX induced extensions through the Rho signaling pathway. MK-STYX decreased RhoA activation, whereas RhoA activation increased when MK-STYX was down-regulated. Furthermore, MK-STYX affected downstream players of RhoA such as the actin binding protein cofilin. The presence of MK-STYX decreased the phosphorylation of cofilin in non NGF stimulated cells, but increased its phosphorylation in NGF stimulated cells, whereas knocking down MK-STYX caused an opposite effect. Taken together our data suggest that MK-STYX may be a regulator of RhoA signaling, and implicate this pseudophosphatase as a regulator of neuronal differentiation.	[Flowers, Brittany M.; Rusnak, Lauren E.; Wong, Kristen E.; Banks, Dallas A.; Munyikwa, Michelle R.; McFarland, Alexander G.; Hinton, Shanta D.] Coll William & Mary, Dept Biol, Integrated Sci Ctr, Williamsburg, VA 23185 USA	William & Mary	Hinton, SD (corresponding author), Coll William & Mary, Dept Biol, Integrated Sci Ctr, Williamsburg, VA 23185 USA.	sdhinton@wm.edu	Flowers, Brittany/AAK-3757-2021	Wong, Kristen/0000-0002-7497-9835; Banks, Dallas/0000-0002-1873-2387; Munyikwa, Michelle/0000-0003-0794-1754	National Science Foundation Grant (NSF) [MCB1113167]; Women in Scientific Education grant from NSF; James Monroe Scholars Program at the College of William and Mary; Howard Hughes Medical Research Institute grant through the Undergraduate Science Education Program	National Science Foundation Grant (NSF)(National Science Foundation (NSF)); Women in Scientific Education grant from NSF; James Monroe Scholars Program at the College of William and Mary; Howard Hughes Medical Research Institute grant through the Undergraduate Science Education Program	This work was supported by the National Science Foundation Grant (NSF) MCB1113167 to S.D.H., a Women in Scientific Education grant from NSF awarded to the College of William and Mary, Graduate Research Scholarship to L.E.R., James Monroe Scholars Program at the College of William and Mary to K.E.W., and by a Howard Hughes Medical Research Institute grant through the Undergraduate Science Education Program to the College of William and Mary to D.A.B., B.M.F., A.G.M., M.R.M, and K.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Barr JE, 2013, FEBS J, V280, P273, DOI 10.1111/febs.12068; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bluthgen N, 2009, FEBS J, V276, P1024, DOI 10.1111/j.1742-4658.2008.06846.x; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; Dixon SJ, 2006, BBA-MOL CELL RES, V1763, P366, DOI 10.1016/j.bbamcr.2006.02.009; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Easton JB, 2006, J NEUROCHEM, V97, P834, DOI 10.1111/j.1471-4159.2006.03789.x; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hinton SD, 2010, BIOCHEM J, V427, P349, DOI 10.1042/BJ20091383; Ho WC, 2001, EXP CELL RES, V263, P254, DOI 10.1006/excr.2000.5112; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Jeon CY, 2010, EXP MOL MED, V42, P335, DOI 10.3858/emm.2010.42.5.035; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Keegan K, 1993, Curr Opin Neurobiol, V3, P14, DOI 10.1016/0959-4388(93)90029-X; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KONDRATYEV AD, 1990, FEBS LETT, V264, P75, DOI 10.1016/0014-5793(90)80768-E; Liu RY, 2002, MOL CELL NEUROSCI, V20, P2, DOI 10.1006/mcne.2002.1107; Martin S, 2013, J NEUROCHEM; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Niemi NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093896; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pazman C, 2000, DEVELOPMENT, V127, P1715; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; Reiterer V, 2014, TRENDS CELL BIOL; Reiterer V, 2013, P NATL ACAD SCI USA, V110, pE2934, DOI 10.1073/pnas.1301985110; Samstag Y, 2013, IMMUNOL REV, V256, P30, DOI 10.1111/imr.12115; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Siligan C, 2005, ONCOGENE, V24, P2512, DOI 10.1038/sj.onc.1208455; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Talens-Visconti R, 2010, J NEUROCHEM, V112, P1074, DOI 10.1111/j.1471-4159.2009.06526.x; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Tonks NK, 2009, CELL, V139, P464, DOI 10.1016/j.cell.2009.10.008; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; WISHART MJ, 1995, J BIOL CHEM, V270, P26782, DOI 10.1074/jbc.270.45.26782; Wishart MJ, 2002, P NATL ACAD SCI USA, V99, P2112, DOI 10.1073/pnas.251686198; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang H, 2007, AM J PHYSIOL-RENAL, V293, pF148, DOI 10.1152/ajprenal.00294.2006; Zhang Z, 2006, CELL MOL BIOL LETT, V11, P12, DOI 10.2478/s11658-006-0002-x	68	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114535	10.1371/journal.pone.0114535	http://dx.doi.org/10.1371/journal.pone.0114535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479605	gold, Green Published			2022-12-26	WOS:000346907200099
J	Rahmandad, H				Rahmandad, Hazhir			Human Growth and Body Weight Dynamics: An Integrative Systems Model	PLOS ONE			English	Article							RESTING METABOLIC-RATE; PHYSICAL-ACTIVITY LEVEL; CATCH-UP GROWTH; ENERGY-EXPENDITURE; FAT DISTRIBUTION; REFERENCE CHILD; OBESITY; MASS; REQUIREMENTS; OVERWEIGHT	Quantifying human weight and height dynamics due to growth, aging, and energy balance can inform clinical practice and policy analysis. This paper presents the first mechanism-based model spanning full individual life and capturing changes in body weight, composition and height. Integrating previous empirical and modeling findings and validated against several additional empirical studies, the model replicates key trends in human growth including A) Changes in energy requirements from birth to old ages. B) Short and long-term dynamics of body weight and composition. C) Stunted growth with chronic malnutrition and potential for catch up growth. From obesity policy analysis to treating malnutrition and tracking growth trajectories, the model can address diverse policy questions. For example I find that even without further rise in obesity, the gap between healthy and actual Body Mass Indexes (BMIs) has embedded, for different population groups, a surplus of 14%-24% in energy intake which will be a source of significant inertia in obesity trends. In another analysis, energy deficit percentage needed to reduce BMI by one unit is found to be relatively constant across ages. Accompanying documented and freely available simulation model facilitates diverse applications customized to different sub-populations.	[Rahmandad, Hazhir] Virginia Tech, Ind & Syst Engn Dept, Falls Church, VA 22043 USA; [Rahmandad, Hazhir] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Rahmandad, H (corresponding author), Virginia Tech, Ind & Syst Engn Dept, Falls Church, VA 22043 USA.	hazhir@vt.edu	Rahmandad, Hazhir/B-4474-2013	Rahmandad, Hazhir/0000-0002-2784-9042	National Institutes of Health, Office of Behavioral and Social Science Research [HHSN276201000004C, 1R21HL113680-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL113680] Funding Source: NIH RePORTER	National Institutes of Health, Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this project was provided through National Institutes of Health, Office of Behavioral and Social Science Research contract HHSN276201000004C and 1R21HL113680-01. The author received no other funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN PHILIP L., 1962; Boersma B, 1997, ENDOCR REV, V18, P646, DOI 10.1210/er.18.5.646; Brady I, 2014, OBESITY, V22, P1939, DOI 10.1002/oby.20804; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Butte NF, 2000, PEDIATR RES, V47, P578, DOI 10.1203/00006450-200005000-00004; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P953, DOI 10.1079/PHN2005790; Carberry AE, 2010, PEDIATR RES, V68, P84, DOI [10.1203/PDR.0b013e3181df5421, 10.1203/00006450-201011001-00161]; CDC, 2013, NAT HLTH NUTR EX SUR; Christiansen E, 2005, J THEOR BIOL, V234, P99, DOI 10.1016/j.jtbi.2004.11.012; Doucet E, 2001, BRIT J NUTR, V85, P715, DOI 10.1079/BJN2001348; Ellis KJ, 2000, ANN NY ACAD SCI, V904, P374; Fields DA, 2009, GENDER MED, V6, P369, DOI 10.1016/j.genm.2009.07.003; Flatt JP, 2004, OBES RES, V12, P2013, DOI 10.1038/oby.2004.252; FORBES GB, 1987, NUTR REV, V45, P225; Gobel B, 2014, OBESITY, V22, P2105, DOI 10.1002/oby.20813; Gutierrez RG, 2003, STATA J, V3, P412; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2013, LANCET DIABETES ENDO, V1, P97, DOI 10.1016/S2213-8587(13)70051-2; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Kuczmarski R J, 2000, Adv Data, P1; Luhrmann PM, 2001, METABOLISM, V50, P972, DOI 10.1053/meta.2001.24871; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; POEHLMAN ET, 1992, METABOLISM, V41, P915, DOI 10.1016/0026-0495(92)90177-C; POEHLMAN ET, 1993, AM J PHYSIOL, V264, pE450, DOI 10.1152/ajpendo.1993.264.3.E450; Rahmandad H, 2012, RES SOC SCI INT SYST; Salbe AD, 2002, PEDIATRICS, V110, P307, DOI 10.1542/peds.110.2.307; Spadano JL, 2005, AM J CLIN NUTR, V81, P1102; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Talbot FB, 1938, AM J DIS CHILD, V55, P455; Tennefors C, 2003, EUR J CLIN NUTR, V57, P647, DOI 10.1038/sj.ejcn.1601591; Torun B, 2005, PUBLIC HEALTH NUTR, V8, P968, DOI 10.1079/PHN2005791; VISSER M, 1995, AM J CLIN NUTR, V61, P772, DOI 10.1093/ajcn/61.4.772; WADDINGTON C. H., 1957, The strategy of the genes. A discussion of some aspects of theoretical biology. With an appendix by H. Kacser.; WALKER SP, 1988, EUR J CLIN NUTR, V42, P395; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZM, 2012, AM J HUM BIOL, V24, P460, DOI 10.1002/ajhb.22246; Wang ZM, 2005, AM J CLIN NUTR, V81, P799, DOI 10.1093/ajcn/81.4.799; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Wells JCK, 2012, AM J CLIN NUTR, V96, P1316, DOI 10.3945/ajcn.112.036970; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229	43	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114609	10.1371/journal.pone.0114609	http://dx.doi.org/10.1371/journal.pone.0114609			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479101	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907200108
J	Vergetaki, A; Jeschke, U; Vrekoussis, T; Taliouri, E; Sabatini, L; Papakonstanti, EA; Makrigiannakis, A				Vergetaki, Aikaterini; Jeschke, Udo; Vrekoussis, Thomas; Taliouri, Eirini; Sabatini, Luca; Papakonstanti, Evangelia A.; Makrigiannakis, Antonis			Galectin-1 Overexpression in Endometriosis and Its Regulation by Neuropeptides (CRH, UCN) Indicating Its Important Role in Reproduction and Inflammation	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; UROCORTIN MESSENGER-RNA; BLASTOCYST IMPLANTATION; STROMAL CELLS; IN-VITRO; EXPRESSION; PROGESTERONE; TOLERANCE; RECEPTOR; DECIDUALIZATION	Endometriosis is an inflammatory disease of women of reproductive age featured by the presence of ectopic endometrium and is strongly related to infertility. Galectins, carbonhydrate-binding proteins, have been found to have pro- or anti-inflammatory roles in the reproductive tract and in pathological conditions concerning infertility. Galectin-1, which is expressed at endometrium and decidua, plays a major role in implantation and trophoblast invasion. Also, the neuropeptides, corticotropin releasing hormone (CRH) and urocortin (UCN) and their receptors are expressed in eutopic and ectopic endometrium showing a differential expression pattern in endometriotic women compared to healthy ones. The aim of this study was to examine the galectin-1 expression in endometriotic lesions and compare its expression in eutopic endometrium of endometriotic and healthy women. Furthermore, we examined the effect of CRH and UCN in galectin-1 expression in Ishikawa cell line and macrophages and investigated the implication of CRHR1 in these responses. Eutopic and ectopic endometrium specimens, Ishikawa cell line and mice macrophages were used. Immunohistochemistry and western blot analysis were performed in order to identify galectin-1 expression in ectopic and eutopic endometrium of women with and without endometriosis and the regulatory effect of CRH and UCN on galectin-1 expression. This study presents for the first time that galectin-1 is overexpressed in endometriotic lesions compared to eutopic endometrium of endometriotic women and is more abundantly expressed in eutopic endometrium of disease women compared to healthy ones. Furthermore, it is shown that CRH and UCN upregulate galectin-1 expression in Ishikawa cell line and macrophages and this effect is mediated through CRHR1. These results suggest that galectin-1 might play an important role in endometriosis pathology and infertility profile of women suffering from endometriosis by being at the same time regulated by CRH and UCN interfering in the immune disequilibrium which characterizes this pathological condition.	[Vergetaki, Aikaterini; Taliouri, Eirini; Makrigiannakis, Antonis] Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece; [Jeschke, Udo] Univ Munich, Dept Obstet & Gynecol, Munich, Germany; [Vrekoussis, Thomas] Univ Ioannina, Sch Med, Dept Obstet & Gynecol, GR-45110 Ioannina, Greece; [Sabatini, Luca] St Bartholomews Hosp, Ctr Reprod Med, London, England; [Papakonstanti, Evangelia A.] Univ Crete, Sch Med, Dept Biochem, Iraklion, Greece	University of Crete; University of Munich; University of Ioannina; University of London; Queen Mary University London; University of Crete	Makrigiannakis, A (corresponding author), Univ Crete, Sch Med, Dept Obstet & Gynecol, Iraklion, Greece.	makrigia@med.uoc.gr	Jeschke, Udo/A-6643-2009	Jeschke, Udo/0000-0003-2623-3235; Makrigiannakis, Antonis/0000-0002-8475-1500; Papakonstanti, Evangelia/0000-0002-7119-6026	University Laboratory of Human Reproduction [KA 2920]; Research Committee of the University of Crete [KA 3001]	University Laboratory of Human Reproduction; Research Committee of the University of Crete	This work was supported by the University Laboratory of Human Reproduction (KA 2920) (in the laboratory of A.M.) and by the Research Committee of the University of Crete (KA 3001) (in the laboratory of E.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Bamberger AM, 2006, AM J PATHOL, V168, P141, DOI 10.2353/ajpath.2006.050167; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Braun DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Choe YS, 1997, MOL REPROD DEV, V48, P261, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;261::AID-MRD14&gt;3.0.CO;2-0; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Chrousos GP, 1999, AM J OBSTET GYNECOL, V180, pS249, DOI 10.1016/S0002-9378(99)70710-6; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; de Ziegler D, 1998, J REPROD IMMUNOL, V39, P149, DOI 10.1016/S0165-0378(98)00019-9; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; DiBlasio AM, 1997, J CLIN ENDOCR METAB, V82, P1594, DOI 10.1210/jc.82.5.1594; Florio P, 2004, PEPTIDES, V25, P1751, DOI 10.1016/j.peptides.2004.05.026; Florio P, 2002, J ENDOCRINOL, V173, pR9, DOI 10.1677/joe.0.173R009; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Gravanis Achille, 2002, Hormones (Athens), V1, P139; Harada T, 2001, FERTIL STERIL, V76, P1, DOI 10.1016/S0015-0282(01)01816-7; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Jeschke U, 2010, J REPROD IMMUNOL, V85, P99, DOI 10.1016/j.jri.2009.10.012; Kabir-Salmani M, 2008, MOL ENDOCRINOL, V22, P707, DOI 10.1210/me.2007-0243; Kalantaridou SN, 2007, CRIT REV CL LAB SCI, V44, P461, DOI 10.1080/10408360701548468; Kempuraj D, 2004, AM J REPROD IMMUNOL, V52, P267, DOI 10.1111/j.1600-0897.2004.00224.x; KLIMAN HJ, 1990, PLACENTA, V11, P349, DOI 10.1016/S0143-4004(05)80226-7; Kolundzic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028514; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Makrigiannakis A, 1997, ANN NY ACAD SCI, V816, P116, DOI 10.1111/j.1749-6632.1997.tb52135.x; Makrigiannakis A, 2001, NAT IMMUNOL, V2, P1018, DOI 10.1038/ni719; Makrigiannakis A, 1996, NEUROENDOCRINOLOGY, V64, P85, DOI 10.1159/000127103; Makrigiannakis A, 1999, NEUROENDOCRINOLOGY, V70, P451, DOI 10.1159/000054507; Makrigiannakis A, 1999, MOL HUM REPROD, V5, P789, DOI 10.1093/molehr/5.9.789; Minas V, 2005, REPROD BIOMED ONLINE, V10, P205, DOI 10.1016/S1472-6483(10)60942-X; Minici F, 2007, GYNECOL ENDOCRINOL, V23, P574, DOI 10.1080/09513590701581721; Noel JC, 2011, APPL IMMUNOHISTO M M, V19, P253, DOI 10.1097/PAI.0b013e3181f5a05e; Nothnick WB, 2001, FERTIL STERIL, V76, P223, DOI 10.1016/S0015-0282(01)01878-7; Novembri R, 2011, J CLIN ENDOCR METAB, V96, P1145, DOI 10.1210/jc.2010-2263; Paclik D, 2011, CELL IMMUNOL, V271, P97, DOI 10.1016/j.cellimm.2011.06.003; PALMER R., 1950, ANN ENDOCRINOL, V11, P183; PETRAGLIA F, 1992, J CLIN ENDOCR METAB, V74, P1427, DOI 10.1210/jc.74.6.1427; Rabinovich GA, 1997, J BIOCHEM-TOKYO, V122, P365; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sampson JA, 1927, AM J PATHOL, V3, P93; Shimizu Y, 2008, ENDOCR J, V55, P879, DOI 10.1507/endocrj.K08E-111; Tariverdian N, 2007, SEMIN IMMUNOPATHOL, V29, P193, DOI 10.1007/s00281-007-0077-0; Tariverdian N, 2010, J MOL MED, V88, P267, DOI 10.1007/s00109-009-0559-8; Than NG, 2008, J MATERN-FETAL NEO M, V21, P429, DOI 10.1080/14767050802041961; Tirado-Gonzalez I, 2013, MOL HUM REPROD, V19, P43, DOI 10.1093/molehr/gas043; Torricelli M, 2007, HUM REPROD, V22, P92, DOI 10.1093/humrep/del331; Vergetaki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062313; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Webster EL, 1996, ENDOCRINOLOGY, V137, P5747, DOI 10.1210/en.137.12.5747; Zoumakis E, 2000, MOL HUM REPROD, V6, P344, DOI 10.1093/molehr/6.4.344	57	17	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114229	10.1371/journal.pone.0114229	http://dx.doi.org/10.1371/journal.pone.0114229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473847	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500003
J	Asuthkar, S; Demirkhanyan, L; Sun, XH; Elustondo, PA; Krishnan, V; Baskaran, P; Velpula, KK; Thyagarajan, B; Pavlov, EV; Zakharian, E				Asuthkar, Swapna; Demirkhanyan, Lusine; Sun, Xiaohui; Elustondo, Pia A.; Krishnan, Vivek; Baskaran, Padmamalini; Velpula, Kiran Kumar; Thyagarajan, Baskaran; Pavlov, Evgeny V.; Zakharian, Eleonora			The TRPM8 Protein Is a Testosterone Receptor II. FUNCTIONAL EVIDENCE FOR AN IONOTROPIC EFFECT OF TESTOSTERONE ON TRPM8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen; Androgen Receptor; Calcium Channel; Ion Channel; Testosterone; Transient Receptor Potential Channels (TRP Channels); Cold and Menthol Receptor TRPM8	PROSTATE-CANCER; ANDROGEN RECEPTOR; STEROID-HORMONES; EPITHELIAL-CELLS; NONGENOMIC ACTIONS; SKELETAL-MUSCLE; T-CELLS; CHANNELS; COLD; ACTIVATION	Background: TRPM8 channels are highly expressed in prostate tissues, where the role of this cold receptor is not well understood. Results: Testosterone activates TRPM8 in various cellular systems and in the planar lipid bilayers. Conclusion: TRPM8 is an ionotropic testosterone receptor. Significance: TRPM8 channels may be implicated in various physiological processes regulated by androgens. Testosterone is a key steroid hormone in the development of male reproductive tissues and the regulation of the central nervous system. The rapid signaling mechanism induced by testosterone affects numerous behavioral traits, including sexual drive, aggressiveness, and fear conditioning. However, the currently identified testosterone receptor(s) is not believed to underlie the fast signaling, suggesting an orphan pathway. Here we report that an ion channel from the transient receptor potential family, TRPM8, commonly known as the cold and menthol receptor is the major component of testosterone-induced rapid actions. Using cultured and primary cell lines along with the purified TRPM8 protein, we demonstrate that testosterone directly activates TRPM8 channel at low picomolar range. Specifically, testosterone induced TRPM8 responses in primary human prostate cells, PC3 prostate cancer cells, dorsal root ganglion neurons, and hippocampal neurons. Picomolar concentrations of testosterone resulted in full openings of the purified TRPM8 channel in planar lipid bilayers. Furthermore, acute applications of testosterone on human skin elicited a cooling sensation. Our data conclusively demonstrate that testosterone is an endogenous and highly potent agonist of TRPM8, suggesting a role of TRPM8 channels well beyond their well established function in somatosensory neurons. This discovery may further imply TRPM8 channel function in testosterone-dependent behavioral traits.	[Asuthkar, Swapna; Demirkhanyan, Lusine; Sun, Xiaohui; Velpula, Kiran Kumar; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Elustondo, Pia A.; Pavlov, Evgeny V.] Dalhousie Univ, Halifax, NS B3H 4R2, Canada; [Krishnan, Vivek; Baskaran, Padmamalini; Thyagarajan, Baskaran] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY 82071 USA; [Pavlov, Evgeny V.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA	University of Illinois System; University of Illinois Peoria; Dalhousie University; University of Wyoming; New York University	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	zakharel@uic.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855; Baskaran, Padmamalini/0000-0001-8851-1486	National Institutes of Health [R01GM098052]; Heart and Stroke Foundation of Canada [G-13-00030008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM098052 (to E. Z.). This work was also supported by Grant G-13-00030008 from the Heart and Stroke Foundation of Canada (to E. P.).	Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Asuthkar S, 2015, J BIOL CHEM, V290, P2659, DOI 10.1074/jbc.M114.610824; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Benten WPM, 1997, FEBS LETT, V407, P211, DOI 10.1016/S0014-5793(97)00346-3; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Estrada M, 2000, AM J PHYSIOL-ENDOC M, V279, pE132, DOI 10.1152/ajpendo.2000.279.1.E132; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Jones RD, 2003, BRIT J PHARMACOL, V138, P733, DOI 10.1038/sj.bjp.0705141; KOENIG H, 1989, CIRC RES, V64, P415, DOI 10.1161/01.RES.64.3.415; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Lyng FM, 2000, BIOL REPROD, V63, P736, DOI 10.1095/biolreprod63.3.736; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MICHEL G, 1980, ENDOCRINOLOGY, V107, P2088, DOI 10.1210/endo-107-6-2088; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Zakharian Eleonora, 2013, Methods Mol Biol, V998, P109, DOI 10.1007/978-1-62703-351-0_8; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	37	71	73	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2670	2688		10.1074/jbc.M114.610873	http://dx.doi.org/10.1074/jbc.M114.610873			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25480785	Green Published, hybrid			2022-12-26	WOS:000349310700012
J	Sun, XJ; Dang, FB; Zhang, DY; Yuan, Y; Zhang, C; Wu, YT; Wang, YG; Liu, Y				Sun, Xiujie; Dang, Fabin; Zhang, Deyi; Yuan, Yuan; Zhang, Cui; Wu, Yuting; Wang, Yiguo; Liu, Yi			Glucagon-CREB/CRTC2 Signaling Cascade Regulates Hepatic BMAL1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB COACTIVATOR TORC2; REV-ERB-ALPHA; CIRCADIAN CLOCK; MODULATES GLUCONEOGENESIS; PERIPHERAL-TISSUES; GENE-EXPRESSION; MAMMALIAN CLOCK; KEY REGULATOR; LIVER; TRANSCRIPTION	Energy metabolism follows a diurnal pattern responding to the cycles of light and food exposures. Although food availability is a potent synchronizer of peripheral circadian clock in mammals, the underlying mechanism remains elusive. Here, we found that the temporal signals of fasting and refeeding hormones regulate the transcription of Bmal1, a key transcription activator of molecular clock, in the liver. During fasting, glucagon, a major fasting hormone, activates CREB/CRTC2 transcriptional complex that is recruited to Bmal1 promoter to induce its expression. Furthermore, we showed that CRTC2 is required for basal transcriptional regulation of Bmal1 by experiments using either adenovirus-mediated CRTC2 RNAi knockdown or primary Crtc2 null hepatocytes. On the other hand, insulin suppresses fasting-induced Bmal1 expression by inhibiting CRTC2 activity after refeeding. Taken together, our results indicate CRTC2 as a key component of the circadian oscillator that integrates the mammalian clock and energy metabolism.	[Sun, Xiujie; Dang, Fabin; Zhang, Deyi; Yuan, Yuan; Zhang, Cui; Wu, Yuting; Liu, Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Sun, Xiujie; Dang, Fabin; Zhang, Deyi; Yuan, Yuan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Yiguo] Tsinghua Univ, Minist Educ, Key Lab Bioinformat, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing 700084, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Liu, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	liuyi@sibs.ac.cn	Sun, Xiujie/L-1244-2017	Sun, Xiujie/0000-0003-3814-7406; Zhang, Deyi/0000-0002-1581-2357	National Basic Research 973 (NBR973) Program [2014CB910500]; National Natural Science Foundation of China [81390351, 31222028]; NBR973 [2012CB524900]; Chinese Academy of Sciences [KSCX2-EW-R-09, 2010OHTP08]; Shanghai Pujiang Program [10PJ1411200]	National Basic Research 973 (NBR973) Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NBR973(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from the National Basic Research 973 (NBR973) Program (2014CB910500), National Natural Science Foundation of China (81390351 and 31222028), NBR973 (2012CB524900), the Chinese Academy of Sciences (KSCX2-EW-R-09 and 2010OHTP08), and Shanghai Pujiang Program (10PJ1411200).	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froy O, 2009, MECH AGEING DEV, V130, P154, DOI 10.1016/j.mad.2008.10.006; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107	35	47	52	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2189	2197		10.1074/jbc.M114.612358	http://dx.doi.org/10.1074/jbc.M114.612358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480789	Green Published, hybrid			2022-12-26	WOS:000348588000023
J	San Roman, AK; Aronson, BE; Krasinski, SD; Shivdasani, RA; Verzi, MP				San Roman, Adrianna K.; Aronson, Boaz E.; Krasinski, Stephen D.; Shivdasani, Ramesh A.; Verzi, Michael P.			Transcription Factors GATA4 and HNF4A Control Distinct Aspects of Intestinal Homeostasis in Conjunction with Transcription Factor CDX2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEIN; GENE-EXPRESSION; INSULIN GENE; MOUSE COLON; ADULT; DIFFERENTIATION; EPITHELIUM; MAINTENANCE; PROMOTER; MICE	Distinct groups of transcription factors (TFs) assemble at tissue- specific cis-regulatory sites, implying that different TF combinations may control different genes and cellular functions. Within such combinations, TFs that specify or maintain a lineage and are therefore considered master regulators may play a key role. Gene enhancers often attract these tissue-restricted TFs, as well as TFs that are expressed more broadly. However, the contributions of the individual TFs to combinatorial regulatory activity have not been examined critically in many cases in vivo. We address this question using a genetic approach in mice to inactivate the intestine-specifying and intestine-restricted factor CDX2 alone or in combination with its more broadly expressed partner factors, GATA4 and HNF4A. Compared with single mutants, each combination produced significantly greater defects and rapid lethality through distinct anomalies. Intestines lacking Gata4 and Cdx2 were deficient in crypt cell replication, whereas combined loss of Hnf4a and Cdx2 specifically impaired viability and maturation of villus enterocytes. Integrated analysis of TF binding and of transcripts affected in Hnf4a; Cdx2 compound-mutant intestines indicated that this TF pair controls genes required to construct the apical brush border and absorb nutrients, including dietary lipids. This study thus defines combinatorial TF activities, their specific requirements during tissue homeostasis, and modules of transcriptional targets in intestinal epithelial cells in vivo.	[San Roman, Adrianna K.; Shivdasani, Ramesh A.; Verzi, Michael P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [San Roman, Adrianna K.; Shivdasani, Ramesh A.; Verzi, Michael P.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [San Roman, Adrianna K.] Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA; [Aronson, Boaz E.; Krasinski, Stephen D.] Boston Childrens Hosp, Div Pediat Gastroenterol & Nutr, Dept Med, Boston, MA 02115 USA; [Aronson, Boaz E.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Verzi, Michael P.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu; verzi@biology.rutgers.edu	San Roman, Adrianna K/K-7245-2019	San Roman, Adrianna K/0000-0003-4511-3052	National Institutes of Health [R01DK08229, R01DK061382, F31CA180784, K01DK088868]; National Science Foundation; Human Genetics Institute of New Jersey; Nutricia Research Foundation; European Society for Pediatric Research; KWF Kankerbestrijding; Prins Bernhard Cultuurfonds; Specialized Program of Research Excellence in Gastrointestinal Cancer Award from the NCI, National Institutes of Health [P50CA127003]; NATIONAL CANCER INSTITUTE [F31CA180784, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK088868, R01DK061382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Genetics Institute of New Jersey; Nutricia Research Foundation(Danone Nutricia); European Society for Pediatric Research; KWF Kankerbestrijding(KWF Kankerbestrijding); Prins Bernhard Cultuurfonds; Specialized Program of Research Excellence in Gastrointestinal Cancer Award from the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK08229 (to R. A. S.) and R01DK061382 (to S. D. K.) and Fellowships F31CA180784 (to A. K. S. R.) and K01DK088868 (to M. P. V.). This work was also supported by a National Science Foundation graduate research fellowship (to A. K. S. R.); the Human Genetics Institute of New Jersey (to M. P. V.); the Nutricia Research Foundation, the European Society for Pediatric Research, KWF Kankerbestrijding, and Prins Bernhard Cultuurfonds (to B. E. A.); and Specialized Program of Research Excellence in Gastrointestinal Cancer Award P50CA127003 from the NCI, National Institutes of Health.	Aronson BE, 2014, BBA-GENE REGUL MECH, V1839, P1273, DOI 10.1016/j.bbagrm.2014.05.018; Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Beuling E, 2012, MOL CELL BIOL, V32, P3392, DOI 10.1128/MCB.00070-12; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gregory PA, 2004, MOL PHARMACOL, V65, P953, DOI 10.1124/mol.65.4.953; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hryniuk A, 2012, DEV BIOL, V363, P426, DOI 10.1016/j.ydbio.2012.01.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JAMES R, 1991, J BIOL CHEM, V266, P3246; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jin TR, 1996, MOL CELL BIOL, V16, P19; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitchelmore C, 2000, BIOCHEM J, V346, P529, DOI 10.1042/0264-6021:3460529; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Roberts LR, 2009, TXB GASTROENTEROLOGY, V2, P2386; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sodhi CP, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-19; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Wering HM, 2004, AM J PHYSIOL-GASTR L, V287, pG899, DOI 10.1152/ajpgi.00150.2004; Verzi MP, 2013, MOL CELL BIOL, V33, P281, DOI 10.1128/MCB.01185-12; Verzi MP, 2011, MOL CELL BIOL, V31, P2026, DOI 10.1128/MCB.01250-10; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	45	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1850	1860		10.1074/jbc.M114.620211	http://dx.doi.org/10.1074/jbc.M114.620211			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25488664	Green Published, hybrid			2022-12-26	WOS:000348056400049
J	Crame, JA; Beu, AG; Ineson, JR; Francis, JE; Whittle, RJ; Bowman, VC				Crame, J. Alistair; Beu, Alan G.; Ineson, Jon R.; Francis, Jane E.; Whittle, Rowan J.; Bowman, Vanessa C.			The Early Origin of the Antarctic Marine Fauna and Its Evolutionary Implications	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; MARAMBIO SEYMOUR ISLAND; LA MESETA FORMATION; NICHE CONSERVATISM; PLANT DIVERSITY; EOCENE CLIMATE; GLOBAL DIVERSITY; TEMPERATURES; EXTINCTION; PALEOGENE	The extensive Late Cretaceous - Early Paleogene sedimentary succession of Seymour Island, N.E. Antarctic Peninsula offers an unparalleled opportunity to examine the evolutionary origins of a modern polar marine fauna. Some 38 modern Southern Ocean molluscan genera (26 gastropods and 12 bivalves), representing approximately 18% of the total modern benthic molluscan fauna, can now be traced back through at least part of this sequence. As noted elsewhere in the world, the balance of the molluscan fauna changes sharply across the Cretaceous Paleogene (K/Pg) boundary, with gastropods subsequently becoming more diverse than bivalves. A major reason for this is a significant radiation of the Neogastropoda, which today forms one of the most diverse clades in the sea. Buccinoidea is the dominant neogastropod superfamily in both the Paleocene Sobral Formation (SF) (56% of neogastropod genera) and Early - Middle Eocene La Meseta Formation (LMF) (47%), with the Conoidea (25%) being prominent for the first time in the latter. This radiation of Neogastropoda is linked to a significant pulse of global warming that reached at least 65 degrees S, and terminates abruptly in the upper LMF in an extinction event that most likely heralds the onset of global cooling. It is also possible that the marked Early Paleogene expansion of neogastropods in Antarctica is in part due to a global increase in rates of origination following the K/ Pg mass extinction event. The radiation of this and other clades at,65 degrees S indicates that Antarctica was not necessarily an evolutionary refugium, or sink, in the Early Middle Eocene. Evolutionary source - sink dynamics may have been significantly different between the Paleogene greenhouse and Neogene icehouse worlds.	[Crame, J. Alistair; Francis, Jane E.; Whittle, Rowan J.; Bowman, Vanessa C.] British Antarctic Survey, NERC, Cambridge, England; [Beu, Alan G.] GNS Sci, Lower Hutt, New Zealand; [Ineson, Jon R.] Geol Survey Denmark & Greenland, Copenhagen, Denmark	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; GNS Science - New Zealand; Geological Survey Of Denmark & Greenland	Crame, JA (corresponding author), British Antarctic Survey, NERC, Cambridge, England.	jacr@bas.ac.uk	Ineson, Jon R/G-9800-2018	Ineson, Jon R/0000-0003-0017-3705; Bowman, Vanessa/0000-0002-4887-3949	Natural Environment Research Council [NE/I005803/1, NE/C506399/1]; NERC [NE/I005803/1, NE/I00582X/2] Funding Source: UKRI; Natural Environment Research Council [NE/I00582X/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support was received from the Natural Environment Research Council (http://www. nerc.ac.uk): Research grants NE/I005803/1 and NE/C506399/1, and core funds to the BAS programme 'Environmental Change and Evolution'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERHAN M, 1994, PALAIOS, V9, P516, DOI 10.2307/3515126; ADAMS CG, 1990, PALAEOGEOGR PALAEOCL, V77, P289; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; [Anonymous], MONOGRAPHIE COMPLETE; Archibald SB, 2010, PALEOBIOLOGY, V36, P374, DOI 10.1666/09021.1; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Berggren WA, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P1; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bona P, 2010, ANTARCT SCI, V22, P531, DOI 10.1017/S0954102010000362; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bouchet P, 2010, MALACOLOGIA, V52, P4; Bowman VC, 2013, GEOLOGY, V41, P1227, DOI 10.1130/G34891.1; Bowman VC, 2012, REV PALAEOBOT PALYNO, V171, P40, DOI 10.1016/j.revpalbo.2011.11.004; Casadio S, 2001, AMEGHINIANA, V38, P321; Case JA, 2007, 20071047 USGS; Case Judd A., 1992, Antarctic Research Series, V56, P119; Collinson ME, 2001, PALAEOBIOLOGY, VII, P112; Crame JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054139; Crame JA, 2004, CRETACEOUS RES, V25, P411, DOI 10.1016/j.cretres.2004.02.002; Dingle RV, 1998, PALAEOGEOGR PALAEOCL, V141, P215, DOI 10.1016/S0031-0182(98)00056-X; Dingle RV, 1998, J S AM EARTH SCI, V11, P571, DOI 10.1016/S0895-9811(98)00035-2; Douglas PMJ, 2014, P NATL ACAD SCI USA, V111, P6582, DOI 10.1073/pnas.1321441111; Dutton AL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000593; Dzik J, 2001, PALAEOGEOGR PALAEOCL, V172, P297, DOI 10.1016/S0031-0182(01)00304-2; Eberle JJ, 2012, GEOL SOC AM BULL, V124, P3, DOI 10.1130/B30571.1; Elliot D.H., 1982, ANTARCT GEOSCI, P287; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; Erwin DH, 2009, CURR BIOL, V19, pR575, DOI 10.1016/j.cub.2009.05.047; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Feldmann RM, 1988, GEOL SOC AM MEM, V169; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Francis J. E., 2008, ANTARCTICA KEYSTONE, P19, DOI [10.3133/of2007-1047, DOI 10.3133/OF2007-1047]; Francis JE, 2002, PALAEOGEOGR PALAEOCL, V182, P47, DOI 10.1016/S0031-0182(01)00452-7; Francis JE, 2006, GEOL SOC LOND SPEC P, V258; Goldberg EE, 2005, AM NAT, V165, P623, DOI 10.1086/430012; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; HANSEN TA, 1988, PALEOBIOLOGY, V14, P37, DOI 10.1017/S0094837300011787; Harasewych MG, 2009, J PALEONTOL, V83, P750, DOI 10.1666/09-004.1; Hathway B, 2000, J GEOL SOC LONDON, V157, P417, DOI 10.1144/jgs.157.2.417; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hayami I, 1975, B U MUS U TOKYO, V10; Heinberg C, 1999, PALAEOGEOGR PALAEOCL, V154, P87, DOI 10.1016/S0031-0182(99)00088-7; Hollis CJ, 2009, GEOLOGY, V37, P99, DOI 10.1130/G25200A.1; Huber B.T., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V119, P427, DOI 10.2973/odp.proc.sr.119.142.1991; Ivany LC, 2007, 20071047 USGS; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2008, P NATL ACAD SCI USA, V105, P11528, DOI 10.1073/pnas.0801919105; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Jansson R, 2013, EVOLUTION, V67, P1741, DOI 10.1111/evo.12089; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Keating-Bitonti CR, 2011, GEOLOGY, V39, P771, DOI 10.1130/G32054.1; Kemp DB, 2014, GEOLOGY, V42, P583, DOI 10.1130/G35512.1; Koch CF, 1998, ADEQUACY OF THE FOSSIL RECORD, P189; Kosnik MA, 2005, PALEOBIOLOGY, V31, P459, DOI 10.1666/0094-8373(2005)031[0459:CILCTB]2.0.CO;2; Lockwood R, 2003, P NATL ACAD SCI USA, V100, P2478, DOI 10.1073/pnas.0535132100; Mannion PD, 2014, TRENDS ECOL EVOL, V29, P42; Marenssi SA, 1998, ASOC PAL ARGENT PUBL, P137; Marenssi S, 2012, ANDEAN GEOL, V39, P67, DOI 10.5027/andgeoV39N1-a04; Marenssi SA, 2006, GEOL SOC SPEC PUBL, V258, P125, DOI 10.1144/GSL.SP.2006.258.01.09; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Oleinik AE, 1996, J PALEONTOL, V70, P923, DOI 10.1017/S0022336000038610; OLIVER PG, 1981, MALACOLOGIA, V21, P61; Patzkowsky ME, 2012, STRATIGRAPHIC PALEOB; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pirrie D, 1991, INT ASS SEDIMENTOLOG, V12, P293; Pross J, 2012, NATURE, V488, P73, DOI 10.1038/nature11300; Reguero Marcelo A, 2012, Rev. peru biol., V19, P275; Ricklefs Robert E., 1993, P350; Rinaldi C. A., 1978, CONTRIBUCION I ANTAR, V217, P1; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Sadler P. M, 1988, GEOLOGY PALEONTOLOGY, V169, P303, DOI DOI 10.1130/MEM169-P303; Schweitzer C.E., 2009, Scripta Geologica (Leiden), V138, P1; Sepkoski Jr JJ, 2002, B AM PALEONT, V363; Sluijs A, 2006, NATURE, V441, P610, DOI 10.1038/nature04668; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Sohl N.F., 1983, US GEOLOGICAL SURVEY, V83-451, P1, DOI [10.3133/ofr83451, DOI 10.3133/OFR83451]; Sohl N.F., 1984, US GEOL SURV OPEN FI, V83, P1; SOHL NF, 1992, J PALEONTOL, V66, P414, DOI 10.1017/S0022336000033977; SOHL NF, 1987, US GEOL SURV OPEN FI, V87, P1; STEHLI FG, 1969, SCIENCE, V164, P947, DOI 10.1126/science.164.3882.947; Stilwell JD, 2003, CRETACEOUS RES, V24, P111, DOI 10.1016/S0195-6671(03)00035-1; Stilwell JD, 2002, J PALEONTOL, V76, P1102, DOI 10.1666/0022-3360(2002)076<1102:ANLAGM>2.0.CO;2; Stilwell JD, 1992, ANT RES SER, V55; Stilwell Jeffrey D., 2004, Bulletins of American Paleontology, V367, P1; Stott L.D., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P849, DOI 10.2973/odp.proc.sr.113.187.1990; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tobin TS, 2012, PALAEOGEOGR PALAEOCL, V350, P180, DOI 10.1016/j.palaeo.2012.06.029; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Valentine J. W., 1969, Palaeontology, V12, P684; Valentine JW, 2013, PALEOBIOLOGY, V39, P1, DOI 10.1666/0094-8373-39.1.1; VERMEIJ G J, 1977, Paleobiology, V3, P245; Wallace CC, 2008, J PALEONTOL, V82, P313, DOI 10.1666/06-091.1; Weijers JWH, 2007, EARTH PLANET SC LETT, V261, P230, DOI 10.1016/j.epsl.2007.06.033; Whittle RJ, 2011, PALAEONTOLOGY, V54, P935, DOI 10.1111/j.1475-4983.2011.01061.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wolfe JA, 1985, AGU GEOPHYS MONOGR S, V32; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; Zelaya DG, 2009, MALACOLOGIA, V51, P271, DOI 10.4002/040.051.0204; Zinsmeister W.J., 1988, Geological Society of America Memoir, V169, P253; ZINSMEISTER WJ, 1989, J PALEONTOL, V63, P731, DOI 10.1017/S0022336000036453; Zinsmeister WJ, 2001, J GEOL, V109, P213, DOI 10.1086/319239; ZINSMEISTER WJ, 1980, J PALEONTOL, V54, P1; ZINSMEISTER WJ, 1982, J GEOL SOC LONDON, V139, P779, DOI 10.1144/gsjgs.139.6.0779	118	25	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114743	10.1371/journal.pone.0114743	http://dx.doi.org/10.1371/journal.pone.0114743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493546	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000346611400074
J	Kuan, CS; Yee, YH; Too, WCS; Few, LL				Kuan, Chee Sian; Yee, Yoke Hiang; Too, Wei Cun See; Few, Ling Ling			Ets and GATA Transcription Factors Play a Critical Role in PMA-Mediated Repression of the ck beta Promoter via the Protein Kinase C Signaling Pathway	PLOS ONE			English	Article							GH3 PITUITARY-CELLS; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; PHOSPHATIDYLCHOLINE SYNTHESIS; DOWN-REGULATION; CPG ISLANDS; CHOLINE; DIFFERENTIATION; 13-ACETATE; SEQUENCE	Background: Choline kinase is the most upstream enzyme in the CDP-choline pathway. It catalyzes the phosphorylation of choline to phosphorylcholine in the presence of ATP and Mg2+ during the biosynthesis of phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. In humans, choline kinase (CK) is encoded by two separate genes, ck alpha and ck beta, which produce three isoforms, CK alpha 1, CK alpha 2, and CK beta. Previous studies have associated ck beta with muscle development; however, the molecular mechanism underlying the transcriptional regulation of ck beta has never been elucidated. Methodology/Principal Findings: In this report, the distal promoter region of the ck beta gene was characterized. Mutational analysis of the promoter sequence and electrophoretic mobility shift assays (EMSA) showed that Ets and GATA transcription factors were essential for the repression of ck beta promoter activity. Supershift and chromatin immunoprecipitation (ChIP) assays further identified that GATA3 but not GATA2 was bound to the GATA site of ck beta promoter. In addition, phorbol-12-myristate-13-acetate (PMA) decreased ck beta promoter activity through Ets and GATA elements. PMA also decreased the ck beta mRNA and protein levels about 12 hours after the promoter activity was down-regulated. EMSA further revealed that PMA treatment increased the binding of both Ets and GATA transcription factors to their respective DNA elements. The PMA-mediated repressive effect was abolished by chronic PMA treatment and by treatment with the PKC inhibitor PKC412, but not the PKC inhibitor Go 6983, suggesting PKC epsilon or PKC eta as the PKC isozyme involved in the PMA-mediated repression of ck beta promoter. Further confirmation by using PKC isozyme specific inhibitors identified PKC epsilon as the isozyme that mediated the PMA repression of ck beta promoter. Conclusion/Significance: These results demonstrate the participation of the PKC signaling pathway in the regulation of ck beta gene transcription by Ets and GATA transcription factors.	[Kuan, Chee Sian; Yee, Yoke Hiang; Too, Wei Cun See; Few, Ling Ling] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian 16150, Kelantan, Malaysia	Universiti Sains Malaysia	Few, LL (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	fewling@usm.my	Few, Ling Ling/E-1964-2012; See Too, Wei Cun/C-9382-2016	Few, Ling Ling/0000-0001-8296-8135; See Too, Wei Cun/0000-0003-1933-3107	Universiti Sains Malaysia Research University [1001/PPSK/813034, 1001/PPSK/815101]	Universiti Sains Malaysia Research University(Universiti Sains Malaysia)	This work was supported by Universiti Sains Malaysia Research University Grants 1001/PPSK/813034 and 1001/PPSK/815101. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1390, P1, DOI 10.1016/S0005-2760(97)00177-X; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Batarseh A, 2008, BIOCHEMISTRY-US, V47, P12886, DOI 10.1021/bi8012643; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chua SL, 2011, CYTOTECHNOLOGY, V63, P645, DOI 10.1007/s10616-011-9383-4; Clement SA, 2002, FREE RADICAL BIO MED, V32, P341, DOI 10.1016/S0891-5849(01)00802-4; CROSSLEY M, 1995, MOL CELL BIOL, V15, P2448; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gilles C, 1997, CLIN EXP METASTAS, V15, P519, DOI 10.1023/A:1018427027270; Gruber J, 2012, FEBS J, V279, P1915, DOI 10.1111/j.1742-4658.2012.08573.x; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kim Taehyun, 2011, Int J Alzheimers Dis, V2011, P857368, DOI 10.4061/2011/857368; Kiss Z, 1996, ARCH BIOCHEM BIOPHYS, V335, P191, DOI 10.1006/abbi.1996.0497; Kobayashi M, 2001, J NEUROCHEM, V76, P361, DOI 10.1046/j.1471-4159.2001.00007.x; KOLESNICK RN, 1987, J BIOL CHEM, V262, P14525; KOLESNICK RN, 1987, J BIOL CHEM, V262, P9204; Li CY, 2008, BBA-GENE REGUL MECH, V1779, P606, DOI 10.1016/j.bbagrm.2008.06.004; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Monks DE, 1996, PLANT PHYSIOL, V110, P1197, DOI 10.1104/pp.110.4.1197; Naito S, 1998, AM J PHYSIOL-CELL PH, V274, pC472, DOI 10.1152/ajpcell.1998.274.2.C472; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ORKIN SH, 1992, BLOOD, V80, P575; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; SLACK BE, 1995, BIOCHEM J, V305, P621, DOI 10.1042/bj3050621; Takai Daiya, 2003, In Silico Biology, V3, P235; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; WITTENBERG J, 1953, J BIOL CHEM, V202, P431; WOOTEN MW, 1994, CELL GROWTH DIFFER, V5, P395; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Yee Y H., 2011, HLTH ENV J, V1, P12; Zheng WH, 2000, J BIOL CHEM, V275, P13377, DOI 10.1074/jbc.275.18.13377	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113485	10.1371/journal.pone.0113485	http://dx.doi.org/10.1371/journal.pone.0113485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490397	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300008
J	Sato, K; Ishiai, M; Takata, M; Kurumizaka, H				Sato, Koichi; Ishiai, Masamichi; Takata, Minoru; Kurumizaka, Hitoshi			Defective FANCI Binding by a Fanconi Anemia-Related FANCD2 Mutant	PLOS ONE			English	Article							CROSS-LINK REPAIR; CORE-COMPLEX PROTEIN; DNA-REPAIR; GENE; IDENTIFICATION; INTERACTS; NUCLEASE; PATHWAY; FAAP20; MONOUBIQUITINATION	FANCD2 is a product of one of the genes associated with Fanconi anemia (FA), a rare recessive disease characterized by bone marrow failure, skeletal malformations, developmental defects, and cancer predisposition. FANCD2 forms a complex with FANCI (ID complex) and is monoubiquitinated, which facilitates the downstream interstrand crosslink (ICL) repair steps, such as ICL unhooking and nucleolytic end resection. In the present study, we focused on the chicken FANCD2 (cFANCD2) mutant harboring the Leu234 to Arg (L234R) substitution. cFANCD2 L234R corresponds to the human FANCD2 L231R mutation identified in an FA patient. We found that cFANCD2 L234R did not complement the defective ICL repair in FANCD2(-/-) DT40 cells. Purified cFANCD2 L234R did not bind to chicken FANCI, and its monoubiquitination was significantly deficient, probably due to the abnormal ID complex formation. In addition, the histone chaperone activity of cFANCD2 L234R was also defective. These findings may explain some aspects of Fanconi anemia pathogenesis by a FANCD2 missense mutation.	[Sato, Koichi; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan; [Ishiai, Masamichi; Takata, Minoru] Kyoto Univ, Ctr Radiat Biol, Lab DNA Damage Signaling, Dept Late Effects Studies, Kyoto 606, Japan	Waseda University; Kyoto University	Kurumizaka, H (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan.	kurumizaka@waseda.jp		Takata, Minoru/0000-0002-4926-3675; Sato, Koichi/0000-0002-0574-774X; Kurumizaka, Hitoshi/0000-0001-7412-3722	JSPS KAKENHI [25250023, 24310042, 26281021, 26830128]; MEXT KAKENHI [25116002, 23114010, 25131706]; Waseda Research Institute for Science and Engineering; Waseda University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Waseda Research Institute for Science and Engineering; Waseda University	This work was supported in part by JSPS KAKENHI Grant Numbers 25250023 [to H. K.], 24310042 [to M. T.], 26281021 [to M. I.], and 26830128 [to K. S.], and by MEXT KAKENHI Grant Numbers 25116002 [to H. K.], 23114010 [to M. T.], and 25131706 [to M. I]. H. K. was also supported by the Waseda Research Institute for Science and Engineering and Waseda University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Blom E, 2004, DNA REPAIR, V3, P77, DOI 10.1016/j.dnarep.2003.09.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandrasekharappa SC, 2013, BLOOD, V121, pE138, DOI 10.1182/blood-2012-12-474585; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Douwel DK, 2014, MOL CELL, V54, P460, DOI 10.1016/j.molcel.2014.03.015; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Hemphill AW, 2009, CYTOGENET GENOME RES, V125, P165, DOI 10.1159/000230001; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Kook H, 2005, HEMATOLOGY, V10, P108, DOI 10.1080/10245330512331390096; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kruyt FAE, 1999, J BIOL CHEM, V274, P34212, DOI 10.1074/jbc.274.48.34212; Lachaud C, 2014, J CELL SCI, V127, P2811, DOI 10.1242/jcs.146167; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Leveille F, 2004, J BIOL CHEM, V279, P39421, DOI 10.1074/jbc.M407034200; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Mouw KW, 2014, DNA REPAIR, V19, P130, DOI 10.1016/j.dnarep.2014.03.019; Murina O, 2014, CELL REP, V7, P1030, DOI 10.1016/j.celrep.2014.03.069; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Reuter T, 2000, BLOOD, V95, P719, DOI 10.1182/blood.V95.2.719; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tachiwana H, 2011, ACTA CRYSTALLOGR D, V67, P578, DOI 10.1107/S0907444911014818; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yuan FH, 2009, J BIOL CHEM, V284, P24443, DOI 10.1074/jbc.M109.016006; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018	63	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114752	10.1371/journal.pone.0114752	http://dx.doi.org/10.1371/journal.pone.0114752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489943	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300074
J	Vargas, L; Brigida, ABS; Mota, JP; de Carvalho, TG; Rojas, CA; Vaneechoutte, D; Van Bel, M; Farrinelli, L; Ferreira, PCG; Vandepoele, K; Hemerly, AS				Vargas, Livia; Santa Brigida, Ailton B.; Mota Filho, Jose P.; de Carvalho, Thais G.; Rojas, Cristian A.; Vaneechoutte, Dries; Van Bel, Michiel; Farrinelli, Laurent; Ferreira, Paulo C. G.; Vandepoele, Klaas; Hemerly, Adriana S.			Drought Tolerance Conferred to Sugarcane by Association with Gluconacetobacter diazotrophicus: A Transcriptomic View of Hormone Pathways	PLOS ONE			English	Article							ABSCISIC-ACID; ABIOTIC STRESS; NITROGEN-FIXATION; SIGNALING PATHWAYS; PLANT-RESPONSES; GENE FAMILY; ARABIDOPSIS; EXPRESSION; ETHYLENE; GROWTH	Sugarcane interacts with particular types of beneficial nitrogen-fixing bacteria that provide fixed-nitrogen and plant growth hormones to host plants, promoting an increase in plant biomass. Other benefits, as enhanced tolerance to abiotic stresses have been reported to some diazotrophs. Here we aim to study the effects of the association between the diazotroph Gluconacetobacter diazotrophicus PAL5 and sugarcane cv. SP70-1143 during water depletion by characterizing differential transcriptome profiles of sugarcane. RNA-seq libraries were generated from roots and shoots of sugarcane plants free of endophytes that were inoculated with G. diazotrophicus and subjected to water depletion for 3 days. A sugarcane reference transcriptome was constructed and used for the identification of differentially expressed transcripts. The differential profile of non-inoculated SP70-1143 suggests that it responds to water deficit stress by the activation of drought-responsive markers and hormone pathways, as ABA and Ethylene. qRT-PCR revealed that root samples had higher levels of G. diazotrophicus 3 days after water deficit, compared to roots of inoculated plants watered normally. With prolonged drought only inoculated plants survived, indicating that SP70-1143 plants colonized with G. diazotrophicus become more tolerant to drought stress than non-inoculated plants. Strengthening this hypothesis, several gene expression responses to drought were inactivated or regulated in an opposite manner, especially in roots, when plants were colonized by the bacteria. The data suggests that colonized roots would not be suffering from stress in the same way as non-inoculated plants. On the other hand, shoots specifically activate ABA-dependent signaling genes, which could act as key elements in the drought resistance conferred by G. diazotrophicus to SP70-1143. This work reports for the first time the involvement of G. diazotrophicus in the promotion of drought-tolerance to sugarcane cv. SP70-1143, and it describes the initial molecular events that may trigger the increased drought tolerance in the host plant.	[Vargas, Livia; Santa Brigida, Ailton B.; Mota Filho, Jose P.; de Carvalho, Thais G.; Rojas, Cristian A.; Ferreira, Paulo C. G.; Hemerly, Adriana S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Biol Mol Plantas, Rio De Janeiro, RJ, Brazil; [Rojas, Cristian A.] Univ Fed Integracao Latino Americana, Foz Do Iguacu, PR, Brazil; [Vaneechoutte, Dries; Van Bel, Michiel; Vandepoele, Klaas] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Vaneechoutte, Dries; Van Bel, Michiel; Vandepoele, Klaas] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Farrinelli, Laurent] Fasteris SA, Plan Les Ouates, Switzerland	Universidade Federal do Rio de Janeiro; Universidade Federal da Integracao Latino-Americana; Flanders Institute for Biotechnology (VIB); Ghent University	Hemerly, AS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Biol Mol Plantas, Cidade Univ, Rio De Janeiro, RJ, Brazil.	hemerly@bioqmed.ufrj.br	Ferreira, Paulo C G/I-2836-2015; Vandepoele, Klaas/E-7514-2010; Rojas, Cristian/X-1027-2018	Ferreira, Paulo C G/0000-0002-5510-999X; Vandepoele, Klaas/0000-0003-4790-2725; Rojas, Cristian/0000-0002-9085-6261; Van Bel, Michiel/0000-0002-1873-2563	Instituto Nacional de Ciencia de Tecnologia (INCT) in Biological Nitrogen Fixation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; Ghent University [01MR0310W]; CNPq	Instituto Nacional de Ciencia de Tecnologia (INCT) in Biological Nitrogen Fixation; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ghent University(Ghent University); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research was supported by Instituto Nacional de Ciencia de Tecnologia (INCT) in Biological Nitrogen Fixation, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeic, oamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). LV is indebted to CAPES for graduate fellowships. KV acknowledges the Multidisciplinary Research Partnership "Bioinformatics: from nucleotides to networks" Project (no 01MR0310W) of Ghent University. ASH and PCGF receive support from CNPq research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto MK, 2012, PLANT SCI, V182, P19, DOI 10.1016/j.plantsci.2011.08.009; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Arencibia AD, 2006, PLANT SIGNAL BEHAV, V1, P265, DOI 10.4161/psb.1.5.3390; Arzanesh M. H., 2009, International Journal of Botany, V5, P244; Babak B, 2013, DNA RES, V20, P315, DOI 10.1093/dnares/dst012; Baldani JI, 1997, SOIL BIOL BIOCHEM, V29, P911, DOI 10.1016/S0038-0717(96)00218-0; Bertalan M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-450; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Bhattacharjee RB, 2008, APPL MICROBIOL BIOT, V80, P199, DOI 10.1007/s00253-008-1567-2; Blanco Y, 2005, J BIOSCI BIOENG, V99, P366, DOI 10.1263/jbb.99.366; BODDEY RM, 1995, PLANT SOIL, V174, P195, DOI 10.1007/BF00032247; Brechenmacher L, 2010, PLANT PHYSIOL, V153, P1808, DOI 10.1104/pp.110.157800; Chandna R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P181, DOI 10.1007/978-1-4614-0634-1_10; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen CN, 2002, PLANT MOL BIOL, V49, P633, DOI 10.1023/A:1015593715144; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Creus CM, 2004, CAN J BOT, V82, P273, DOI [10.1139/b03-119, 10.1139/B03-119]; Davies WJ, 2005, J PLANT GROWTH REGUL, V24, P285, DOI 10.1007/s00344-005-0103-1; Dimkpa C, 2009, PLANT CELL ENVIRON, V32, P1682, DOI 10.1111/j.1365-3040.2009.02028.x; Dominguez-Nunez JA, 2012, FOREST SYST, V21, P364, DOI 10.5424/fs/2012213-02135; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hsiao TC, 2000, J EXP BOT, V51, P1595, DOI 10.1093/jexbot/51.350.1595; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; James EK, 1998, CRIT REV PLANT SCI, V17, P77, DOI 10.1016/S0735-2689(98)00357-8; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Ma N, 2006, J EXP BOT, V57, P2763, DOI 10.1093/jxb/erl033; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Matsuoka S, 2009, IN VITRO CELL DEV-PL, V45, P372, DOI 10.1007/s11627-009-9220-z; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Muthukumarasamy R, 2000, CURR SCI INDIA, V78, P1063; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Oliveira ALM, 2002, PLANT SOIL, V242, P205, DOI 10.1023/A:1016249704336; OLIVEIRA ALM, 2003, BRAZ J MICROBIOL, V34, P59; Pedraza RO, 2008, INT J FOOD MICROBIOL, V125, P25, DOI 10.1016/j.ijfoodmicro.2007.11.079; Polizel AM, 2011, GENET MOL RES, V10, P3641, DOI 10.4238/2011.October.21.4; Ravikumar G, 2014, TRANSGENIC RES, V23, P421, DOI 10.1007/s11248-013-9776-6; Reis RR, 2014, PLANT SCI, V221, P59, DOI 10.1016/j.plantsci.2014.02.003; Rodriguez-Salazar J, 2009, FEMS MICROBIOL LETT, V296, P52, DOI 10.1111/j.1574-6968.2009.01614.x; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Roychoudhury A, 2013, PLANT CELL REP, V32, P985, DOI 10.1007/s00299-013-1414-5; Ruiz-Sanchez M, 2011, J PLANT PHYSIOL, V168, P1031, DOI 10.1016/j.jplph.2010.12.019; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun S, 2008, J BIOL CHEM, V283, P6261, DOI 10.1074/jbc.M706800200; Taji T, 1999, PLANT CELL PHYSIOL, V40, P119, DOI 10.1093/oxfordjournals.pcp.a029469; Tammisola Jussi, 2010, GM Crops, V1, P181, DOI 10.4161/gmcr.1.4.13173; Rudorff BFT, 2010, REMOTE SENS-BASEL, V2, P1057, DOI 10.3390/rs2041057; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; URQUIAGA S, 1992, SOIL SCI SOC AM J, V56, P105, DOI 10.2136/sssaj1992.03615995005600010017x; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Van Bel M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r134; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Vargas L, 2012, PLANT SOIL, V356, P127, DOI 10.1007/s11104-012-1274-8; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xie ZJ, 2003, PLANT GROWTH REGUL, V41, P117, DOI 10.1023/A:1027371906349; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yang W, 2011, PLANTA, V233, P219, DOI 10.1007/s00425-010-1279-6; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803	102	60	60	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114744	10.1371/journal.pone.0114744	http://dx.doi.org/10.1371/journal.pone.0114744			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489849	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300073
J	Li, CL; Yang, JG; Lin, D; Zhao, YS; Liu, S; Xing, SN; Zhao, S; Chen, CQ; Jiang, ZM; Pu, FF; Cao, JP; Ma, DC				Li, Chang-Ling; Yang, Jin-Gang; Lin, Di; Zhao, Yong-Shan; Liu, Shuo; Xing, Si-Ning; Zhao, Song; Chen, Cong-Qin; Jiang, Zhi-Ming; Pu, Fei-Fei; Cao, Jian-Ping; Ma, Dong-Chu			Phosphorylation of Ribosomal Protein S6 Kinase 1 at Thr421/Ser424 and Dephosphorylation at Thr389 Regulates SP600125-Induced Polyploidization of Megakaryocytic Cell Lines	PLOS ONE			English	Article							JNK INHIBITOR SP600125; MEGAKARYOBLASTIC LEUKEMIA; MUSCLE-CELLS; DAMI CELL; MTOR; ACTIVATION; ENDOMITOSIS; PLOIDY; ESTABLISHMENT; LOCALIZATION	Megakaryocytes (MKs) are one of the few cell types that become polyploid; however, the mechanisms by which these cells are designated to become polyploid are not fully understood. In this investigation, we successfully established two relatively synchronous polyploid cell models by inducing Dami and CMK cells with SP600125. We found that SP600125 induced the polyploidization of Dami and CMK cells, concomitant with the phosphorylation of ribosomal protein S6 kinase 1 (S6K1) at Thr421/Ser424 and dephosphorylation at Thr389. The polyploidization was partially blocked by H-89, a cAMP-dependent protein kinase (PKA) inhibitor, through direct binding to S6K1, leading to dephosphorylation at Thr421/Ser424 and phosphorylation at Thr389, independent of PKA. Overexpression of a rapamycinresistant mutant of S6K1 further enhanced the inhibitory effect of LY294002 on the SP600125-induced polyploidization of Dami and CMK cells. SP600125 also induced the polyploidization of Meg-01 cells, which are derived from a patient with chronic myelogenous leukemia, without causing a significant change in S6K1 phosphorylation. Additionally, SP600125 induced the polyploidization of HEL cells, which are derived from a patient with erythroleukemia, and phosphorylation at Thr389 of S6K1 was detected. However, the polyploidization of both Meg-01 cells and HEL cells as a result of SP600125 treatment was lower than that of SP600125-induced Dami and CMK cells, and it was not blocked by H-89 despite the increased phosphorylation of S6K1 at Thr389 in both cell lines in response to H-89. Given that the Dami and CMK cell lines were derived from patients with acute megakaryocytic leukemia (AMKL) and expressed high levels of platelet-specific antigens, our data suggested that SP600125-induced polyploidization is cell-type specific, that these cell lines were more differentiated, and that phosphorylation at Thr421/Ser424 and dephosphorylation at Thr389 of S6K1 may play an important role in the SP600125-induced polyploidization of these cell lines synergistically with other signaling pathways.	[Li, Chang-Ling; Yang, Jin-Gang; Lin, Di; Liu, Shuo; Xing, Si-Ning; Zhao, Song; Jiang, Zhi-Ming; Pu, Fei-Fei; Cao, Jian-Ping; Ma, Dong-Chu] Shenyang Mil Area Command, Gen Hosp, Dept Expt Med, Shenyang, Liaoning, Peoples R China; [Zhao, Yong-Shan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Liaoning, Peoples R China; [Chen, Cong-Qin] Shenyang Pharmaceut Univ, Shenyang, Liaoning, Peoples R China	Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Ma, DC (corresponding author), Shenyang Mil Area Command, Gen Hosp, Dept Expt Med, Shenyang, Liaoning, Peoples R China.	mdc580819@sina.com		Ma, Dongchu/0000-0002-3229-9719; Yang, Jingang/0000-0003-3719-9853	Fundation of the State Key Lab of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences [2013-001]; National natural science foundation of China [61302003]; Natural Science Foundation of Liaoning Province [20062079]	Fundation of the State Key Lab of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences; National natural science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was funded by the Fundation of the State Key Lab of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences (2013-001), National natural science foundation of China (61302003) and Natural Science Foundation of Liaoning Province (20062079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Bluteau D, 2009, J THROMB HAEMOST, V7, P227, DOI 10.1111/j.1538-7836.2009.03398.x; Carow CE, 2001, J CELL PHYSIOL, V188, P291, DOI 10.1002/jcp.1120; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; GREENBERG SM, 1988, BLOOD, V72, P1968; Guerriero R, 2006, J CELL SCI, V119, P744, DOI 10.1242/jcs.02784; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; Kim JA, 2010, ONCOGENE, V29, P1702, DOI 10.1038/onc.2009.464; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; Ma DC, 1996, EUR J HAEMATOL, V57, P121; Ma Dong-Chu, 2001, Shengli Xuebao, V53, P296; Ma DC, 2009, J CELL PHYSIOL, V219, P31, DOI 10.1002/jcp.21647; MacLeod RAF, 1997, BLOOD, V90, P2850, DOI 10.1182/blood.V90.7.2850.2850_2850_2850; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; McCrann DJ, 2010, BLOOD, V116, P2192, DOI 10.1182/blood-2010-04-280420; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Miyamoto-Yamasaki Y, 2007, CELL BIOL INT, V31, P1501, DOI 10.1016/j.cellbi.2007.07.002; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; OGURA M, 1985, BLOOD, V66, P1384; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raslova H, 2006, BLOOD, V107, P2303, DOI 10.1182/blood-2005-07-3005; Rosner M, 2012, AMINO ACIDS, V42; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Vitrat N, 1998, BLOOD, V91, P3711; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; WANG ZY, 1995, BLOOD, V86, P3783, DOI 10.1182/blood.V86.10.3783.bloodjournal86103783; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Wen Q, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002043; Zhang Y, 2004, BLOOD, V103, P3717, DOI 10.1182/blood-2003-09-3365	42	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114389	10.1371/journal.pone.0114389	http://dx.doi.org/10.1371/journal.pone.0114389			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486532	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600051
J	Pauksch, L; Hartmann, S; Szalay, G; Alt, V; Lips, KS				Pauksch, Linda; Hartmann, Sonja; Szalay, Gabor; Alt, Volker; Lips, Katrin S.			In Vitro Assessment of Nanosilver-Functionalized PMMA Bone Cement on Primary Human Mesenchymal Stem Cells and Osteoblasts	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTIONS; SILVER NANOPARTICLES; ESCHERICHIA-COLI; ANTIBACTERIAL; DIFFERENTIATION; GENTAMICIN; IONS; BIOCOMPATIBILITY; CYTOTOXICITY; EFFICACY	Peri-prosthetic infections caused by multidrug resistant bacteria have become a serious problem in surgery and orthopedics. The aim is to introduce biomaterials that avoid implant-related infections caused by multiresistant bacteria. The efficacy of silver nanoparticles (AgNP) against a broad spectrum of bacteria and against multiresistant pathogens has been repeatedly described. In the present study polymethylmethacrylate (PMMA) bone cement functionalized with AgNP and/or gentamicin were tested regarding their biocompatibility with bone forming cells. Therefore, influences on viability, cell number and differentiation of primary human mesenchymal stem cells (MSCs) and MSCs cultured in osteogenic differentiation media (MSC-OM) caused by the implant materials were studied. Furthermore, the growth behavior and the morphology of the cells on the testing material were observed. Finally, we examined the induction of cell stress, regarding antioxidative defense and endoplasmatic reticulum stress. We demonstrated similar cytocompatibility of PMMA loaded with AgNP compared to plain PMMA or PMMA loaded with gentamicin. There was no decrease in cell number, viability and osteogenic differentiation and no induction of cell stress for all three PMMA variants after 21 days. Addition of gentamicin to AgNP-loaded PMMA led to a slight decrease in osteogenic differentiation. Also an increase in cell stress was detectable for PMMA loaded with gentamicin and AgNP. In conclusion, supplementation of PMMA bone cement with gentamicin, AgNP, and both results in bone implants with an antibacterial potency and suitable cytocompatibility in MSCs and MSC-OM.	[Pauksch, Linda; Hartmann, Sonja; Lips, Katrin S.] Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany; [Szalay, Gabor; Alt, Volker] Univ Hosp Giessen & Marburg, Dept Trauma Surg, Giessen, Germany	Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Lips, KS (corresponding author), Univ Giessen, Lab Expt Trauma Surg, D-35390 Giessen, Germany.	Katrin.S.Lips@chiru.med.uni-giessen.de			Federal Ministry of Education and Research [03X0103D]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding: This work was financially supported by the Federal Ministry of Education and Research [03X0103D]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; Ahamed MIN, 2015, INT J BIOL MACROMOL, V72, P680, DOI 10.1016/j.ijbiomac.2014.08.055; Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538; Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078; [Anonymous], 2011, JRC SCI TECHNICAL RE; Arora M, 2013, WORLD J ORTHOP, V4, P67, DOI 10.5312/wjo.v4.i2.67; Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Chang Y, 2013, BONE JOINT RES, V2, P220, DOI 10.1302/2046-3758.210.2000188; Chang YH, 2006, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000229324.75911.c7; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Darwiche H, 2010, CLIN ORTHOP RELAT R, V468, P2392, DOI 10.1007/s11999-010-1325-5; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Galvez-Lopez R, 2014, DIAGN MICR INFEC DIS, V78, P70, DOI 10.1016/j.diagmicrobio.2013.09.014; GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576, DOI 10.2106/00004623-199510000-00015; Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1; GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; Hanssen A D, 1999, Instr Course Lect, V48, P111; Ince A, 2007, INT ORTHOP, V31, P223, DOI 10.1007/s00264-006-0144-5; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; Lentino Joseph R, 2004, Curr Infect Dis Rep, V6, P388, DOI 10.1007/s11908-004-0038-x; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Liu XJ, 2014, J BIOMED NANOTECHNOL, V10, P1277, DOI 10.1166/jbn.2014.1824; Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001; Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046; Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Okafor F, 2013, INT J ENV RES PUB HE, V10, P5221, DOI 10.3390/ijerph10105221; Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037; Qin H, 2014, INT J NANOMED, V9, P2469, DOI 10.2147/IJN.S59753; Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343; Renaud A, 2012, CAN J SURG, V55, P394, DOI 10.1503/cjs.033610; Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/nnm.12.18, 10.2217/NNM.12.18]; Samberg ME, 2011, NANOTOXICOLOGY, V5, P244, DOI 10.3109/17435390.2010.525669; Singh RP, 2012, TOXICOL LETT, V213, P249, DOI 10.1016/j.toxlet.2012.07.009; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Teodoro JS, 2011, TOXICOL IN VITRO, V25, P664, DOI 10.1016/j.tiv.2011.01.004; Trampuz A, 2005, SWISS MED WKLY, V135, P243; van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557; Wright JB, 1998, AM J INFECT CONTROL, V26, P572, DOI 10.1053/ic.1998.v26.a93527; Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	53	16	16	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114740	10.1371/journal.pone.0114740	http://dx.doi.org/10.1371/journal.pone.0114740			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485700	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600093
J	Xu, Y; Luo, Q; Lin, T; Zeng, ZP; Wang, GH; Zeng, DQ; Ding, R; Sun, CL; Zhang, XK; Chen, HF				Xu, Yang; Luo, Qiang; Lin, Ting; Zeng, Zhiping; Wang, Guanghui; Zeng, Dequan; Ding, Rong; Sun, Cuiling; Zhang, Xiao-kun; Chen, Haifeng			U12, a UDCA Derivative, Acts as an Anti-Hepatoma Drug Lead and Inhibits the mTOR/S6K1 and Cyclin/CDK Complex Pathways	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID UDCA; COLON-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; MTOR INHIBITOR; MITOCHONDRIAL DYSFUNCTION; INDUCE APOPTOSIS; BINDING-PROTEIN; LIVER; GROWTH; EXPRESSION	U12, one of 20 derivatives synthesized from ursodeoxycholic acid (UDCA), has been found to have anticancer effects in liver cancer cell lines (SMMC-7721 and HepG2) and to protect normal liver cells from deoxycholic acid (DCA) damage (QSG-7701). Its anticancer mechanism was investigated using computer-aided network pharmacology and comparative proteomics. Results showed that its anti-malignancy activities were activated by mTOR/S6K1, cyclinD1/CDK2/4 and caspase-dependent apoptotic signaling pathways in hepatocellular carcinoma cells (HCC). The action of U12 may be similar to that of rapamycin. Animal testing confirmed that U12 exerted better anti-tumor activity than UDCA and had less severe side effects than fluorouracil (5-Fu). These observations indicate that U12 differs from UDCA and other derivatives and may be a suitable lead for the development of compounds useful in the treatment of HCC.	[Xu, Yang; Luo, Qiang; Lin, Ting; Zeng, Zhiping; Wang, Guanghui; Zeng, Dequan; Ding, Rong; Sun, Cuiling; Zhang, Xiao-kun; Chen, Haifeng] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China; [Zhang, Xiao-kun] Sanford Burnham Med Res Inst, La Jolla, CA USA	Xiamen University; Sanford Burnham Prebys Medical Discovery Institute	Zhang, XK (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China.	xzhang@burnham.org; haifeng@xmu.edu.cn			Fundamental Research Funds for the Central Universities [2010121100, 2011121055]; National Natural Science Foundation of China [81202419, 81202956]; Xiamen Science and Technology Key program grant [3502Z20100006]; Natural Science Foundation of Fujian Province of China [2011 J05098]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology Key program grant; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	Funding was provided by Fundamental Research Funds for the Central Universities (No. 2010121100, 2011121055), the Grants from the National Natural Science Foundation of China (No. 81202419, 81202956), Xiamen Science and Technology Key program grant (No. 3502Z20100006) and the Natural Science Foundation of Fujian Province of China (No. 2011 J05098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts DS, 2005, J NATL CANCER I, V97, P846, DOI 10.1093/jnci/dji144; Amadori S, 2012, BRIT J HAEMATOL, V156, P205, DOI 10.1111/j.1365-2141.2011.08940.x; Amaral JD, 2007, J BIOL CHEM, V282, P34250, DOI 10.1074/jbc.M704075200; Amaral JD, 2009, TRENDS MOL MED, V15, P531, DOI 10.1016/j.molmed.2009.09.005; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Aravalli RN, 2012, ARCH TOXICOL; Asciutti S, 2009, ANTICANCER RES, V29, P4971; Barilli A, 2008, CARDIOVASC RES, V78, P563, DOI 10.1093/cvr/cvn024; Chen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020729; Choi YH, 2003, CANCER LETT, V199, P157, DOI 10.1016/S0304-3835(03)00351-3; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Endo M, 2012, CLIN CANC RES; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fiorucci S, 2004, BRIT J PHARMACOL, V143, P33, DOI 10.1038/sj.bjp.0705780; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P8897, DOI 10.1073/pnas.151136298; Grewe M, 1999, CANCER RES, V59, P3581; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Im E, 2005, CANCER LETT, V229, P49, DOI 10.1016/j.canlet.2004.11.055; Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483; Im EO, 2001, CANCER LETT, V163, P83, DOI 10.1016/S0304-3835(00)00671-6; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Kappler M, 2012, ALIMENT PHARM THER; Khare S, 2008, NUTR CANCER, V60, P389, DOI 10.1080/01635580701883003; Kudo M, 2011, DIGEST DIS, V29, P310, DOI 10.1159/000327565; Li YF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-329; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Nojiri S, 2009, HEPATOL RES, V39, P21, DOI 10.1111/j.1872-034X.2008.00406.x; Paolini M, 2002, HEPATOLOGY, V36, P305, DOI 10.1053/jhep.2002.34939; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Rabenhorst U, 2009, HEPATOLOGY, V50, P1121, DOI 10.1002/hep.23098; Saito K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049456; Sola S, 2003, J BIOL CHEM, V278, P48831, DOI 10.1074/jbc.M300468200; Xu Y, 2009, J PROTEOME RES, V8, P1585, DOI 10.1021/pr801001j; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X	39	8	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113479	10.1371/journal.pone.0113479	http://dx.doi.org/10.1371/journal.pone.0113479			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486097	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600020
J	Zutkis, AA; Anbalagan, S; Chaussee, MS; Dmitriev, AV				Zutkis, Anastasia A.; Anbalagan, Srivishnupriya; Chaussee, Michael S.; Dmitriev, Alexander V.			Inactivation of the Rgg2 Transcriptional Regulator Ablates the Virulence of Streptococcus pyogenes	PLOS ONE			English	Article							BIOFILM FORMATION; EXPRESSION; COMPETENCE; METABOLISM; STRAIN; GENE	Streptococcus pyogenes adapts to different niches encountered in the human host via the activity of numerous regulatory proteins including the Rgg family of transcriptional regulators. The S. pyogenes chromosome encodes four Rgg paralogues designated Rgg1 (RopB), Rgg2 (MutR), Rgg3, and Rgg4 (ComR). In order to understand the role of the Rgg2 protein in the regulation of metabolic and virulence-associated properties of S. pyogenes, the rgg2 gene was inactivated in the M1 serotype strain SF370. Inactivation of rgg2 increased the growth yield of S. pyogenes in THY broth, increased biofilm formation, and increased production of SIC, which is an important virulence factor that inhibits complement mediated lysis. To identify Rgg2-regulated genes, the transcriptomes of SF370 and the rgg2 mutant strains were compared in the middle-exponential and post-exponential phases of growth. Rgg2 was found to control the expression of dozens of genes primarily in the exponential phase of growth, including genes associated with virulence (sse, scpA, slo, nga, mf-3), DNA transformation, and nucleotide metabolism. Inactivation of rgg2 decreased the ability of S. pyogenes to adhere to epithelial cells. In addition, the mutant strain was more sensitive to killing when incubated with human blood and avirulent in a murine bacteremia model. Finally, inoculation of mice with the avirulent rgg2 mutant of S. pyogenes SF370 conferred complete protection to mice subsequently challenged with the wild-type strain. Restoration of an intact rgg2 gene in mutant strain restored the wild-type phenotypes. Overall, the results demonstrate that Rgg2 is an important regulatory protein in S. pyogenes involved in controlling genes associated with both metabolism and virulence.	[Zutkis, Anastasia A.; Dmitriev, Alexander V.] Russian Acad Med Sci, Dept Mol Microbiol, Inst Expt Med, St Petersburg, Russia; [Anbalagan, Srivishnupriya; Chaussee, Michael S.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA; [Dmitriev, Alexander V.] St Petersburg State Univ, St Petersburg 199034, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; University of South Dakota; Saint Petersburg State University	Dmitriev, AV (corresponding author), Russian Acad Med Sci, Dept Mol Microbiol, Inst Expt Med, St Petersburg, Russia.	admitriev10@yandex.ru						Anbalagan S, 2011, J BACTERIOL, V193, P4933, DOI 10.1128/JB.00429-11; Bortoni ME, 2009, MICROBIOL-SGM, V155, P4123, DOI 10.1099/mic.0.028282-0; BRIKO NI, 2014, ZH MIKROBIO IN PRESS; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Dmitriev AV, 2008, FEMS MICROBIOL LETT, V284, P43, DOI 10.1111/j.1574-6968.2008.01171.x; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; MALKE H, 1994, FEMS MICROBIOL LETT, V116, P107; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Morrison DA, 2013, J BACTERIOL, V195, P2612, DOI 10.1128/JB.00230-13; [Полякова Екатерина Михайловна Polyakova E.M.], 2010, [Медицинский академический журнал, Medical Academic Journal, Meditsinskii akademicheskii zhurnal], V10, P39; Ricker A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23419; Santiago AE, 2009, VACCINE, V27, P2426, DOI 10.1016/j.vaccine.2009.02.073; Wang JY, 2001, INFECT IMMUN, V69, P4734, DOI 10.1128/IAI.69.8.4734-4741.2001; Watson ME, 2013, INFECT IMMUN, V81, P1606, DOI 10.1128/IAI.00021-13	28	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114784	10.1371/journal.pone.0114784	http://dx.doi.org/10.1371/journal.pone.0114784			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486272	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600100
J	Ren, P; Chaturvedi, V; Chaturvedi, S				Ren, Ping; Chaturvedi, Vishnu; Chaturvedi, Sudha			Carbon Dioxide is a Powerful Inducer of Monokaryotic Hyphae and Spore Development in Cryptococcus gattii and Carbonic Anhydrase Activity is Dispensable in This Dimorphic Transition	PLOS ONE			English	Article							NEOFORMANS VAR.-GATTII; FUNGAL PATHOGEN CRYPTOCOCCUS; BRITISH-COLUMBIA; VANCOUVER-ISLAND; MATING-TYPE; PACIFIC-NORTHWEST; DISTINCT ROLES; SEXUAL CYCLE; VIRULENCE; CANADA	Cryptococcus gattii is unique among human pathogenic fungi with specialized ecological niche on trees. Since leaves concentrate CO2, we investigated the role of this gaseous molecule in C. gattii biology and virulence. We focused on the genetic analyses of beta-carbonic anhydrase (beta-CA) encoded by C. gattii CAN1 and CAN2 as later is critical for CO2 sensing in a closely related pathogen C. neoformans. High CO2 conditions induced robust development of monokaryotic hyphae and spores in C. gattii. Conversely, high CO2 completely repressed hyphae development in sexual mating. Both CAN1 and CAN2 were dispensable for CO2 induced morphogenetic transitions. However, C. gattii CAN2 was essential for growth in ambient air similar to its reported role in C. neoformans. Both can1 and can2 mutants retained full pathogenic potential in vitro and in vivo. These results provide insight into C. gattii adaptation for arboreal growth and production of infectious propagules by b-CA independent mechanism(s).	[Ren, Ping; Chaturvedi, Vishnu; Chaturvedi, Sudha] New York State Dept Hlth, Mycol Lab, Wadsworth Ctr, Albany, NY 12208 USA; [Chaturvedi, Vishnu; Chaturvedi, Sudha] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Chaturvedi, S (corresponding author), New York State Dept Hlth, Mycol Lab, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.	Sudha.Chaturvedi@health.ny.gov		Ren, Ping/0000-0002-4022-6667; Chaturvedi, Vishnu/0000-0002-3922-9676	NIAID [AI05887702]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIAID AI05887702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; Callejas A, 1998, MED MYCOL, V36, P341, DOI 10.1080/02681219880000531; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; FISHER D, 1993, AUST NZ J MED, V23, P678, DOI 10.1111/j.1445-5994.1993.tb04726.x; Fortes ST, 2001, MYCOSES, V44, P137, DOI 10.1046/j.1439-0507.2001.00651.x; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fu JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003335; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; Granados DP, 2005, MICROB ECOL, V49, P282, DOI 10.1007/s00248-004-0236-y; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Halliday CL, 2003, J CLIN MICROBIOL, V41, P703, DOI 10.1128/JCM.41.2.703-711.2003; HATCH MD, 1992, PLANT CELL PHYSIOL, V33, P333; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Kidd SE, 2007, EMERG INFECT DIS, V13, P51, DOI 10.3201/eid1301.060823; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kurtzman CP, 2007, INT J SYST EVOL MICR, V57, P1154, DOI 10.1099/ijs.0.64847-0; Lazera MS, 2000, MED MYCOL, V38, P379, DOI 10.1080/714030957; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Mogensen EG, 2006, EUKARYOT CELL, V5, P103, DOI 10.1128/EC.5.1.103-111.2006; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Stephen C, 2002, CAN VET J, V43, P792; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	40	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113147	10.1371/journal.pone.0113147	http://dx.doi.org/10.1371/journal.pone.0113147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478697	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200016
J	Wang, WJ; Du, ZY; Yan, JQ; Ma, D; Shi, MM; Zhang, MJ; Peng, CH; Li, HW				Wang, Weijie; Du, Zhiyong; Yan, Jiqi; Ma, Di; Shi, Minmin; Zhang, Mingjun; Peng, Chenghong; Li, Hongwei			Mesenchymal Stem Cells Promote Liver Regeneration and Prolong Survival in Small-For-Size Liver Grafts: Involvement of C-Jun N-Terminal Kinase, Cyclin D1, and NF-kappa B	PLOS ONE			English	Article							IN-VITRO; HEPATOCYTE PROLIFERATION; ISCHEMIA-REPERFUSION; TRANSPLANTATION; INJURY; HEPATECTOMY; MECHANISMS; FIBROSIS; THERAPY	Background: The therapeutic potential of mesenchymal stem cells (MSCs) has been highlighted recently for treatment of acute or chronic liver injury, by possibly differentiating into hepatocyte-like cells, reducing inflammation, and enhancing tissue repair. Despite recent progress, exact mechanisms of action are not clearly elucidated. In this study, we attempted to explore whether and how MSCs protected hepatocytes and stimulated allograft regeneration in small-for-size liver transplantation (SFSLT). Methods: SFSLT model was established with a 30% partial liver transplantation (30PLT) in rats. The differentiation potential and characteristics of bone marrow derived MSCs were explored in vitro. MSCs were infused transvenously immediately after graft implantation in therapy group. Expressions of apoptosis-, inflammatory-, anti-inflammatory-, and growth factor-related genes were measured by RT-PCR, activities of transcription factors AP-1 and NF-kappa B were analyzed by EMSA, and proliferative responses of the hepatic graft were evaluated by immunohistochemistry and western blot. Results: MSCs were successfully induced into hepatocyte-like cells, osteoblasts and adipocytes in vitro. MSCs therapy could not only alleviate ischemia reperfusion injury and acute inflammation to promote liver regeneration, but also profoundly improve one week survival rate. It markedly up-regulated the mRNA expressions of HGF, Bcl-2, Bcl-XL, IL-6, IL-10, IP-10, and CXCR2, however, down-regulated TNF-alpha. Increased activities of AP-1 and NF-kappa B, as well as elevated expressions of p-c-Jun, cyclin D1, and proliferating cell nuclear antigen (PCNA), were also found in MSCs therapy group. Conclusion: These data suggest that MSCs therapy promotes hepatocyte proliferation and prolongs survival in SFSLT by reducing ischemia reperfusion injury and acute inflammation, and sustaining early increased expressions of c-Jun N-terminal Kinase, Cyclin D1, and NF-kappa B.	[Wang, Weijie; Yan, Jiqi; Ma, Di; Shi, Minmin; Zhang, Mingjun; Peng, Chenghong; Li, Hongwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Wang, Weijie] Zhengzhou Univ, Sch Med, Affiliated Hosp 1, Dept Surg, Zhengzhou 450052, Henan Province, Peoples R China; [Du, Zhiyong] Cent Hosp Wuhan, Dept Hepatobiliary Surg, Wuhan, Hubei Province, Peoples R China	Shanghai Jiao Tong University; Zhengzhou University	Yan, JQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	jiqiyan@yahoo.com		Peng, Chenghong/0000-0002-5573-7873	National Natural Science Foundation of China [81070358]; Municipal Natural Science Foundation of Shanghai Municipality [09ZR1418600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Natural Science Foundation of Shanghai Municipality	This study was supported by grants from The National Natural Science Foundation of China (81070358) and Municipal Natural Science Foundation of Shanghai Municipality (09ZR1418600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich I, 2007, GUT, V56, P405, DOI 10.1136/gut.2005.090050; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bishi DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092397; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Du ZY, 2013, J SURG RES, V183, P907, DOI 10.1016/j.jss.2013.02.009; Fouraschen SMG, 2012, STEM CELLS DEV, V21, P2410, DOI 10.1089/scd.2011.0560; Fu WY, 2013, HEPATOL RES, V43, P300, DOI 10.1111/j.1872-034X.2012.01071.x; Holden NS, 2011, J PHARMACOL TOX MET, V63, P7, DOI 10.1016/j.vascn.2010.03.002; Jeon H, 2010, CURR OPIN ORGAN TRAN, V15, P283, DOI 10.1097/MOT.0b013e32833983ee; Jiang SM, 2009, LIVER TRANSPLANT, V15, P1043, DOI 10.1002/lt.21797; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; KAMADA N, 1983, SURGERY, V93, P64; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Kubo N, 2012, J GASTROEN HEPATOL, V27, P165, DOI 10.1111/j.1440-1746.2011.06798.x; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Ma T, 2012, AM J TRANSPLANT, V12, P620, DOI 10.1111/j.1600-6143.2011.03870.x; Malato Y, 2012, GASTROENTEROLOGY, V143, P1597, DOI 10.1053/j.gastro.2012.08.030; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011; Nesher E, 2011, TRANSPL P, V43, P1736, DOI 10.1016/j.transproceed.2010.11.031; Niu J, 2014, CLIN EXP IMMUNOL, V176, P473, DOI 10.1111/cei.12283; Njoku DB, 2009, J AUTOIMMUN, V32, P52, DOI 10.1016/j.jaut.2008.11.003; Pan GZ, 2012, J SURG RES, V178, P935, DOI 10.1016/j.jss.2012.04.070; Pan QW, 2011, LIVER TRANSPLANT, V17, P596, DOI 10.1002/lt.22260; Puglisi MA, 2011, J BIOMED BIOTECHNOL, V2011, P1; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Salomone F, 2013, STEM CELL RES, V11, P1037, DOI 10.1016/j.scr.2013.07.003; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Seki T, 2012, J SURG RES, V178, P63, DOI 10.1016/j.jss.2012.02.014; Shao CH, 2014, J SURG RES, V186, P408, DOI 10.1016/j.jss.2013.08.016; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; Tiberio L, 2006, CYTOKINE, V34, P131, DOI 10.1016/j.cyto.2006.04.009; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Wang WJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083908, 10.1371/journal.pone.0084654]; Xia XF, 2012, LIVER TRANSPLANT, V18, P696, DOI 10.1002/lt.23414; Yang ZF, 2007, LIVER TRANSPLANT, V13, P558, DOI 10.1002/lt.21094; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Yu Y, 2010, STEM CELLS DEV, V19, P903, DOI 10.1089/scd.2009.0254; Zhang HY, 2012, TRANSFUS MED REV, V26, P129, DOI 10.1016/j.tmrv.2011.09.002; Zhao W, 2012, WORLD J GASTROENTERO, V18, P1048, DOI 10.3748/wjg.v18.i10.1048; Zhong Z, 2006, TRANSPLANTATION, V82, P241, DOI 10.1097/01.tp.0000228867.98158.d2	44	34	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112532	10.1371/journal.pone.0112532	http://dx.doi.org/10.1371/journal.pone.0112532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479410	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200011
J	Burke, JF; Langa, KM; Hayward, RA; Albin, RL				Burke, James F.; Langa, Kenneth M.; Hayward, Rodney A.; Albin, Roger L.			Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease	PLOS ONE			English	Article							HYPOTHETICAL MODEL; COST-EFFECTIVENESS; HEART-DISEASE; ASPIRIN; RISK; DIAGNOSIS; TRIALS	Objectives: In this study, we developed a model of presymptomatic treatment of Alzheimer disease (AD) after a screening diagnostic evaluation and explored the circumstances required for an AD prevention treatment to produce aggregate net population benefit. Methods: Monte Carlo simulation methods were used to estimate outcomes in a simulated population derived from data on AD incidence and mortality. A wide variety of treatment parameters were explored. Net population benefit was estimated in aggregated QALYs. Sensitivity analyses were performed by individually varying the primary parameters. Findings: In the base-case scenario, treatment effects were uniformly positive, and net benefits increased with increasing age at screening. A highly efficacious treatment (i.e. relative risk 0.6) modeled in the base-case is estimated to save 20 QALYs per 1000 patients screened and 221 QALYs per 1000 patients treated. Conclusions: Highly efficacious presymptomatic screen and treat strategies for AD are likely to produce substantial aggregate population benefits that are likely greater than the benefits of aspirin in primary prevention of moderate risk cardiovascular disease (28 QALYS per 1000 patients treated), even in the context of an imperfect treatment delivery environment.	[Burke, James F.; Albin, Roger L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Burke, James F.; Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Burke, James F.; Langa, Kenneth M.; Hayward, Rodney A.] VAAAHS, Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Albin, Roger L.] VAAAHS, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA; [Albin, Roger L.] VAAAHS, Neurol Serv, Ann Arbor, MI USA; [Albin, Roger L.] Univ Michigan, Michigan Alzheimer Dis Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Burke, JF (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	jamesbur@umich.edu		Langa, Kenneth/0000-0002-2798-1836	NINDS [K08 NS082597, R01 MD008879]; NIH [P50 NS091856]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS091856, K08NS082597] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD008879] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by NINDS K08 NS082597, R01 MD008879 (JFB) and NIH P50 NS091856 (RLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2007, FORECASTING GLOBAL B, P1; Centers for Disease Control and Prevention, US LIF TABL 1999 200; Cohen JT, 2008, ALZHEIMERS DEMENT, V4, P212, DOI 10.1016/j.jalz.2008.02.003; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Howdey LM, 2010, AGE SEX COMPOSITION; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Koerkamp BG, 2010, MED DECIS MAKING, V30, P194, DOI 10.1177/0272989X09342277; McMahon PM, 2000, RADIOLOGY, V217, P58, DOI 10.1148/radiology.217.1.r00se1358; McMahon PM, 2003, RADIOLOGY, V228, P515, DOI 10.1148/radiol.2282020915; Parfit Derek., 1986, REASONS PERSONS; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Spackman DE, 2011, CURR ALZHEIMER RES; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290; Sussman JB, 2011, CIRC-CARDIOVASC QUAL, V4, P268, DOI 10.1161/CIRCOUTCOMES.110.959239; World Health Organization, DEMENTIA PUBLIC HLTH	28	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114339	10.1371/journal.pone.0114339	http://dx.doi.org/10.1371/journal.pone.0114339			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474698	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500020
J	Li, JQ; Tseng, KK; Hsieh, ZY; Yang, CW; Huang, HN				Li, Jiaqian; Tseng, Kuo-Kun; Hsieh, Zu Yi; Yang, Ching Wen; Huang, Huang-Nan			Staining Pattern Classification of Antinuclear Autoantibodies Based on Block Segmentation in Indirect Immunofluorescence Images	PLOS ONE			English	Article								Indirect immunofluorescence based on HEp-2 cell substrate is the most commonly used staining method for antinuclear autoantibodies associated with different types of autoimmune pathologies. The aim of this paper is to design an automatic system to identify the staining patterns based on block segmentation compared to the cell segmentation most used in previous research. Various feature descriptors and classifiers are tested and compared in the classification of the staining pattern of blocks and it is found that the technique of the combination of the local binary pattern and the k-nearest neighbor algorithm achieve the best performance. Relying on the results of block pattern classification, experiments on the whole images show that classifier fusion rules are able to identify the staining patterns of the whole well (specimen image) with a total accuracy of about 94.62%.	[Li, Jiaqian; Tseng, Kuo-Kun] Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China; [Hsieh, Zu Yi] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Ching Wen] Taichung Vet Gen Hosp, Comp & Commun Ctr, Taichung, Taiwan; [Huang, Huang-Nan] Tunghai Univ, Dept Math, Taichung 40704, Taiwan	Harbin Institute of Technology; University Town of Shenzhen; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Tunghai University	Tseng, KK (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Dept Comp Sci & Technol, Shenzhen, Peoples R China.	kktseng@foxmail.com	Li, Jiaqian/HGE-4168-2022	Li, Jiaqian/0000-0001-6655-6069; Huang, Huang-Nan/0000-0001-7387-0427				Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Cheng CC, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-S1-S5; Cordella LP, 1999, PATTERN ANAL APPL, V2, P205, DOI 10.1007/s100440050029; Cordelli E., 2011, INT S COMP BAS MED S, P1; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Creemers C, 2011, P 4 INT S APPL SCI B, P28; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Di Cataldo S, 2012, INT C PATT RECOG, P3349; Ersoy I, 2012, INT C PATT RECOG, P3362; FUKUNAGA K, 1975, IEEE T COMPUT, VC 24, P750, DOI 10.1109/T-C.1975.224297; Ghosh S, 2012, INT C PATT RECOG, P174; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hsieh T., 2009, INT C INF COMM SIGN, P1; Huang YC, 2012, LECT NOTES ARTIF INT, V7197, P529, DOI 10.1007/978-3-642-28490-8_55; Iannello G, 2012, P 25 INT S COMP BAS, P1; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Li K, 2012, INT C PATT RECOG, P170; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Rigon A, 2007, CYTOM PART B-CLIN CY, V72B, P472, DOI 10.1002/cyto.b.20356; Sahoolizadeh AH, 2008, INT J COMPUTER SCI E, V2, P218; Snell V, 2012, INT C PATT RECOG, P3750; Soares F, 2004, INT C PATT RECOG, P604, DOI 10.1109/ICPR.2004.1334215; Soda P, 2006, WORLD ACAD SCI ENG T, V2, P829; Soda P, 2007, ICIAP 2007 P, P685; Soda P, 2006, COMP MED SY, P219, DOI 10.1109/CBMS.2006.21; Soda P, 2009, PATTERN ANAL APPL, V12, P215, DOI 10.1007/s10044-008-0116-z; Soda P, 2009, IEEE T INF TECHNOL B, V13, P322, DOI 10.1109/TITB.2008.2010855; Sorwar G, 2001, 10TH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P545, DOI 10.1109/FUZZ.2001.1009012; Strandmark P, 2012, INT C PATT RECOG, P33; Thibault G, 2012, INT C PATT RECOG, P2440; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Wang HX, 2011, 2011 TENTH INTERNATIONAL SYMPOSIUM ON DISTRIBUTED COMPUTING AND APPLICATIONS TO BUSINESS, ENGINEERING AND SCIENCE (DCABES), P175, DOI 10.1109/DCABES.2011.62; Wiliem A, 2013, ARXIV13041262; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Worman HJ, 2003, AUTOIMMUN REV, V2, P211, DOI 10.1016/S1568-9972(03)00013-2; Yang Y, 2013, IEEE IMAGE PROC, P733, DOI 10.1109/ICIP.2013.6738151; Yu-Len Huang, 2008, 2008 IEEE International Conference on Sensor Networks, Ubiquitous, and Trustworthy Computing (SUTC '08), P423; Yu-Len Huang, 2008, 2008 IEEE International Conference on Sensor Networks, Ubiquitous, and Trustworthy Computing (SUTC '08), P418, DOI 10.1109/SUTC.2008.73; Zhang D., 2011, BIOMETRIC IMAGE DISC, P41, DOI [10.4018/9781591408307.ch003, DOI 10.4018/9781591408307.CH003]	42	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113132	10.1371/journal.pone.0113132	http://dx.doi.org/10.1371/journal.pone.0113132			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474260	Green Published, gold			2022-12-26	WOS:000346382500075
J	Xie, RJ; Li, YJ; He, SL; Zheng, YQ; Yi, SL; Lv, Q; Deng, L				Xie, Rangjin; Li, Yongjie; He, Shaolan; Zheng, Yongqiang; Yi, Shilai; Lv, Qiang; Deng, Lie			Genome-Wide Analysis of Citrus R2R3MYB Genes and Their Spatiotemporal Expression under Stresses and Hormone Treatments	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENE; GAMYB-LIKE GENES; FACTOR SUPERFAMILY; FLAVONOL SYNTHESIS; OVER-EXPRESSION; ARABIDOPSIS; R2R3-MYB; CELL; ACID; BIOSYNTHESIS	The R2R3MYB proteins represent one of the largest families of transcription factors, which play important roles in plant growth and development. Although genome-wide analysis of this family has been conducted in many species, little is known about R2R3MYB genes in citrus, In this study, 101 R2R3MYB genes has been identified in the citrus (Citrus sinesis and Citrus clementina) genomes, which are almost equal to the number of rice. Phylogenetic analysis revealed that they could be subdivided into 21 subgroups. The evolutionary relationships and the intro-exon organizations were also analyzed, revealing strong gene conservation but also the expansions of particular functional genes during the plant evolution. Tissue-specific expression profiles showed that 95 citrus R2R3MYB genes were expressed in at least one tissue and the other 6 genes showed very low expression in all tissues tested, suggesting that citrus R2R3MYB genes play important roles in the development of all citrus organs. The transcript abundance level analysis during abiotic conditions (NaCl, abscisic acid, jasmonic acid, drought and low temperature) identified a group of R2R3MYB genes that responded to one or multiple treatments, which showed a promising for improving citrus adaptation to stresses. Our results provided an essential foundation for the future selection of the citrus R2R3MYB genes for cloning and functional dissection with an aim of uncovering their roles in citrus growth and development.	[Xie, Rangjin; Li, Yongjie; He, Shaolan; Zheng, Yongqiang; Yi, Shilai; Lv, Qiang; Deng, Lie] Southwest Univ, Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China	Chinese Academy of Agricultural Sciences; Southwest University - China	Deng, L (corresponding author), Southwest Univ, Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China.	niwodouhao@126.com	li, yong/HDN-3885-2022	Zheng, Yongqiang/0000-0002-5513-057X	Chongqing fundamental and advanced research projects [cstc2013jcyjA80036]; southwest university basic scientific research business expenses special funds [XDJK2013C052]; National Natural Science Foundation of China [31301743]	Chongqing fundamental and advanced research projects; southwest university basic scientific research business expenses special funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Chongqing fundamental and advanced research projects (cstc2013jcyjA80036), southwest university basic scientific research business expenses special funds (XDJK2013C052) and National Natural Science Foundation of China (31301743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Borg M, 2011, PLANT CELL, V23, P534, DOI 10.1105/tpc.110.081059; Brownfield L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000430; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chai GH, 2014, J EXP BOT, V65, P4255, DOI 10.1093/jxb/eru196; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; Cultrone A, 2010, TREE GENET GENOMES, V6, P101, DOI 10.1007/s11295-009-0232-y; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; De Vos M, 2006, PLANT SIGNAL BEHAV, V1, P305, DOI 10.4161/psb.1.6.3512; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Gibbs DJ, 2014, NEW PHYTOL, V203, P1194, DOI 10.1111/nph.12879; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; He YA, 2012, J EXP BOT, V63, P1511, DOI 10.1093/jxb/err389; Huang ZA, 2012, J GENET GENOMICS, V39, P149, DOI 10.1016/j.jgg.2012.01.007; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047576; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Oh JE, 2011, PLANT MOL BIOL, V77, P91, DOI 10.1007/s11103-011-9796-7; Omer S, 2013, PLANT CELL REP, V32, P161, DOI 10.1007/s00299-012-1350-9; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Seo JS, 2012, MOL BREEDING, V29, P601, DOI 10.1007/s11032-011-9576-8; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shan H, 2012, MOL BIOTECHNOL, V51, P160, DOI 10.1007/s12033-011-9451-1; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Zhang LC, 2012, GENE, V505, P100, DOI 10.1016/j.gene.2012.05.033; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhu LH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054028, 10.1371/journal.pone.0065680]; Zou BH, 2013, FUNCT PLANT BIOL, V40, P304, DOI 10.1071/FP12253	55	13	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113971	10.1371/journal.pone.0113971	http://dx.doi.org/10.1371/journal.pone.0113971			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473954	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500100
J	Yu, JL; Zheng, J; Zhao, XX; Liu, JX; Mao, ZC; Ling, YN; Chen, DN; Chen, C; Hui, LL; Cui, LM; Chen, Y; Jiang, PP; Guan, MX				Yu, Jialing; Zheng, Jing; Zhao, Xiaoxu; Liu, Junxia; Mao, Zhuochao; Ling, Yining; Chen, Danni; Chen, Chao; Hui, Lanlan; Cui, Limei; Chen, Ye; Jiang, Pingping; Guan, Min-Xin			Aminoglycoside Stress Together with the 12S rRNA 1494C > T Mutation Leads to Mitophagy	PLOS ONE			English	Article							SYNDROMIC HEARING-LOSS; HAIR CELL-DEATH; MITOCHONDRIAL-DNA; NONSYNDROMIC DEAFNESS; C1494T MUTATION; QUALITY-CONTROL; A-SITE; OTOTOXICITY; AUTOPHAGY; TRANSCRIPTION	`Aminoglycosides as modifying factors modulated the phenotypic manifestation of mitochondrial rRNA mutations and the incomplete penetrance of hearing loss. In this report, using cybrids harboring the m. 1494C> T mutation, we showed that gentamycin aggravated mitochondrial dysfunction in a combination of the m. 1494C> T mutation. The m. 1494C> T mutation was responsible for the dramatic reduction in three mtDNA-encoded proteins of H-strand, with the average of 39% reduction, except of the MT-ND6 protein, accompanied with 21% reduction of ATP production and increase in mitochondrial reactive oxygen species, compared with those of control cybrids. After exposure to gentamycin, 35% reduction of mitochondrial ATP production was observed in mutant cybrids with a marked decrease of the mitochondrial membrane potential. More excessive cellular reactive oxygen species was detected with stimulus of gentamycin than those in mutant cells. Under gentamycin and m. 1494C> T stress together, more dysfunctional mitochondria were forced to fuse and exhibited mitophagy via upregulated LC3-B, as a compensatory protective response to try to optimize mitochondrial function, rather than undergo apoptosis. These findings may provide valuable information to further understand of mechanistic link between mitochondrial rRNA mutation, toxicity of AGs and hearing loss.	[Yu, Jialing; Zheng, Jing; Zhao, Xiaoxu; Liu, Junxia; Chen, Danni; Chen, Chao; Hui, Lanlan; Cui, Limei; Chen, Ye; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Ye; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Mao, Zhuochao] Zhejiang Univ, Sch Basic Med Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Ling, Yining] Zhejiang Univ, Sch Agr & Biotechonl, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University	Jiang, PP (corresponding author), Zhejiang Univ, Inst Genet, Hangzhou 310003, Zhejiang, Peoples R China.	ppjiang@zju.edu.cn	Chen, Ye/D-1164-2015	Chen, Ye/0000-0003-3671-2504; Guan, Min-Xin/0000-0001-5067-6736	973 Program from the Ministry of Science and Technology of China (GMX) [2014CB541704]; Key project from National Natural Science Foundation of China (GMX) [81330024]	973 Program from the Ministry of Science and Technology of China (GMX); Key project from National Natural Science Foundation of China (GMX)	This work was supported by the 973 Program (2014CB541704) from the Ministry of Science and Technology of China (GMX) and Key project (81330024) from National Natural Science Foundation of China (GMX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Chen JF, 2007, GENE, V401, P4, DOI 10.1016/j.gene.2007.06.009; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Darrouzet J, 1974, Rev Laryngol Otol Rhinol (Bord), V95, P601; Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fischel-Ghodsian N, 2005, PHARMACOGENOMICS, V6, P27, DOI 10.1517/14622416.6.1.27; Fischel-Ghodsian N, 2003, EAR HEARING, V24, P303, DOI 10.1097/01.AUD.0000079802.82344.B5; Fourmy D, 1998, J MOL BIOL, V277, P347, DOI 10.1006/jmbi.1997.1552; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Guan MX, 2000, HUM MOL GENET, V9, P1787, DOI 10.1093/hmg/9.12.1787; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Pye D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl516; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Rodriguez-Ballesteros M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.042440; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Schacht J, 2012, ANAT REC, V295, P1837, DOI 10.1002/ar.22578; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tono T, 2001, ORL-J OTO-RHIN-LARYN, V63, P25, DOI 10.1159/000055702; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Ylikoski J, 2002, HEARING RES, V163, P71, DOI 10.1016/S0378-5955(01)00380-X; Yu JL, 2014, MITOCHONDRION, V14, P18, DOI 10.1016/j.mito.2013.12.004; Zavodszky E, 2013, FEBS LETT, V587, P1988, DOI 10.1016/j.febslet.2013.04.025; Zhao H, 2005, NUCLEIC ACIDS RES, V33, P1132, DOI 10.1093/nar/gki262; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	44	11	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114650	10.1371/journal.pone.0114650	http://dx.doi.org/10.1371/journal.pone.0114650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474306	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500052
J	McGrail, DJ; Mezencev, R; Kieu, QMN; McDonald, JF; Dawson, MR				McGrail, Daniel J.; Mezencev, Roman; Kieu, Quang Minh N.; McDonald, John F.; Dawson, Michelle R.			SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression	FASEB JOURNAL			English	Article						physical oncology; metastasis; motility; cell mechanics	DOWN-REGULATION; CELL-MIGRATION; SOLID STRESS; CANCER; STIFFNESS; DEFORMATION; PROGRESSION; MICROSCOPY; GELSOLIN; FORCE	A growing body of evidence suggests that the developmental process of epithelial-to-mesenchymal transition (EMT) is co-opted by cancer cells to metasta-size to distant sites. This transition is associated with morphologic elongation and loss of cell-cell adhesions, though little is known about how it alters cell biophysical properties critical for migration. Here, we use multiple-particle tracking (MPT) microrheology and traction force cytometry to probe how genetic induction of EMT in epithelial MCF7 breast cancer cells changes their intracellular stiffness and extracellular force exertion, respectively, relative to an empty vector control. This analysis demonstrated that EMT alone was sufficient to produce dramatic cytoskeletal softening coupled with increases in cell-exerted traction forces. Microarray analysis revealed that these changes corresponded with down-regulation of genes associated with actin cross-linking and up-regulation of genes associated with actomyosin contraction. Finally, we show that this loss of structural integrity to expedite migration could inhibit mesenchymal cell proliferation in a secondary tumor as it accumulates solid stress. This work demonstrates that not only does EMT enable escape from the primary tumor through loss of cell adhesions but it also induces a concerted series of biophysical changes enabling enhanced migration of cancer cells after detachment from the primary tumor.	[McGrail, Daniel J.; Kieu, Quang Minh N.; Dawson, Michelle R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Mezencev, Roman; McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Dawson, Michelle R.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Dawson, MR (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, 311 Ferst Dr NW, Atlanta, GA 30332 USA.	mdawson@gatech.edu	Dawson, Michelle R/Q-7217-2019; Jain, Rakesh K/I-1384-2017; Mezencev, Roman/O-8489-2019; Mezencev, Roman/A-8573-2009; McGrail, Daniel/F-3967-2014	Dawson, Michelle R/0000-0002-2122-4711; Jain, Rakesh K/0000-0001-7571-3548; Mezencev, Roman/0000-0003-4361-7628; McGrail, Daniel/0000-0002-6669-6069	U.S. National Science Foundation (NSF) [1032527]; Georgia Tech and Emory Center for Regenerative Medicine (NSF) [1411304]; Ovarian Cancer Institute, Atlanta, GA, USA; Georgia Tech's Presidential Undergraduate Research Award; NSF [DGE-0965945]	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Georgia Tech and Emory Center for Regenerative Medicine (NSF); Ovarian Cancer Institute, Atlanta, GA, USA; Georgia Tech's Presidential Undergraduate Research Award; NSF(National Science Foundation (NSF))	This work was funded by the U.S. National Science Foundation (NSF; 1032527), Georgia Tech and Emory Center for Regenerative Medicine (NSF; 1411304), and the Ovarian Cancer Institute, Atlanta, GA, USA. Additional funding was provided by Georgia Tech's Presidential Undergraduate Research Award (Q.K.), and by NSF Grant DGE-0965945 (D.M.). The authors declare no conflicts of interest.	Asch HL, 1996, CANCER RES, V56, P4841; Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Khatau SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036689; Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee MH, 2012, BIOPHYS J, V102, P2731, DOI 10.1016/j.bpj.2012.05.005; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; McGrail DJ, 2014, J CELL SCI, V127, P2621, DOI 10.1242/jcs.144378; McGrail DJ, 2013, EXP CELL RES, V319, P684, DOI 10.1016/j.yexcr.2012.11.017; McGrail DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033248; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Shi W, 2010, PHARMACOGENOMICS J, V10, P310, DOI 10.1038/tpj.2010.35; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Spagnol ST, 2014, INTEGR BIOL-UK, V6, P523, DOI 10.1039/c3ib40226f; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Taube JH, 2010, P NATL ACAD SCI USA, V107, P19132, DOI 10.1073/pnas.1015095107; The Physical Sciences-Oncology Centers Network, 2013, SCI REPORTS, V3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wu PH, 2012, NAT PROTOC, V7, P155, DOI 10.1038/nprot.2011.436; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	49	41	44	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1280	1289		10.1096/fj.14-257345	http://dx.doi.org/10.1096/fj.14-257345			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25491311				2022-12-26	WOS:000354115000016
J	Espinosa, S; Branch, LC; Cueva, R				Espinosa, Santiago; Branch, Lyn C.; Cueva, Ruben			Road Development and the Geography of Hunting by an Amazonian Indigenous Group: Consequences for Wildlife Conservation	PLOS ONE			English	Article							SOURCE-SINK SYSTEMS; PROTECTED AREAS; RESOURCE USE; FOREST; MODEL; SUSTAINABILITY; EXTRACTION; IMPACTS; GAME; DEFORESTATION	Protected areas are essential for conservation of wildlife populations. However, in the tropics there are two important factors that may interact to threaten this objective: 1) road development associated with large-scale resource extraction near or within protected areas; and 2) historical occupancy by traditional or indigenous groups that depend on wildlife for their survival. To manage wildlife populations in the tropics, it is critical to understand the effects of roads on the spatial extent of hunting and how wildlife is used. A geographical analysis can help us answer questions such as: How do roads affect spatial extent of hunting? How does market vicinity relate to local consumption and trade of bushmeat? How does vicinity to markets influence choice of game? A geographical analysis also can help evaluate the consequences of increased accessibility in landscapes that function as source-sink systems. We applied spatial analyses to evaluate the effects of increased landscape and market accessibility by road development on spatial extent of harvested areas and wildlife use by indigenous hunters. Our study was conducted in Yasuni Biosphere Reserve, Ecuador, which is impacted by road development for oil extraction, and inhabited by the Waorani indigenous group. Hunting activities were self-reported for 12-14 months and each kill was georeferenced. Presence of roads was associated with a two-fold increase of the extraction area. Rates of bushmeat extraction and trade were higher closer to markets than further away. Hunters located closer to markets concentrated their effort on large-bodied species. Our results clearly demonstrate that placing roads within protected areas can seriously reduce their capacity to sustain wildlife populations and potentially threaten livelihoods of indigenous groups who depend on these resources for their survival. Our results critically inform current policy debates regarding resource extraction and road building near or within protected areas.	[Espinosa, Santiago; Branch, Lyn C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Espinosa, Santiago] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Quito, Ecuador; [Cueva, Ruben] Wildlife Conservat Soc, Ecuador Program, Quito, Ecuador	State University System of Florida; University of Florida; Pontificia Universidad Catolica del Ecuador	Espinosa, S (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	srespinosa@puce.edu.ec	Espinosa, Santiago/M-4751-2019	Espinosa, Santiago/0000-0002-7416-7167	University of Florida; World Wildlife Fund; Wildlife Conservation Society	University of Florida(University of Florida); World Wildlife Fund; Wildlife Conservation Society	This work was supported by the University of Florida (Department of Wildlife Ecology and Conservation, Tropical Conservation and Development Program, and Amazon Leadership Conservation initiative), the World Wildlife Fund (Russel E. Train Education for Nature Program) and the Wildlife Conservation Society (Research Fellowship Program and WCS-Ecuador Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert B, 2007, CURR ANTHROPOL, V48, P584, DOI 10.1086/519914; Alers M, 2007, REDUCING THREATS PRO; Asquith NM, 1997, ECOLOGY, V78, P941, DOI 10.1890/0012-9658(1997)078[0941:DMCCCR]2.0.CO;2; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Beck H, 2010, J TROP ECOL, V26, P407, DOI 10.1017/S0266467410000106; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett EL, 2000, BIOL RESOURCE MANAGE, P1; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Brandon K., 1998, PARKS PERIL PEOPLE P; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brugiere D, 2009, AFR J ECOL, V47, P630, DOI 10.1111/j.1365-2028.2008.01013.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Damania R, 2005, P ROY SOC B-BIOL SCI, V272, P259, DOI 10.1098/rspb.2004.2945; De Souza-Mazurek RR, 2000, BIODIVERS CONSERV, V9, P579, DOI 10.1023/A:1008999201747; Espinosa S, 2012, THESIS U FLORIDA GAI; Fahrig L, 2009, ECOL SOC, V14; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finer M., 2014, HIGH RESOLUTION SATE; Finer M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014012; Finer M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034005; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; FRANZEN M, 2005, THESIS U CALIFORNIA; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; GODOY R, 1995, HUM ECOL, V23, P29, DOI 10.1007/BF01190097; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HAMES RB, 1979, HUM ECOL, V7, P219, DOI 10.1007/BF00889493; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Hill, ADAPTIVE RESPONSES N, P139; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; JOSHI NV, 1991, THEOR POPUL BIOL, V40, P211, DOI 10.1016/0040-5809(91)90053-I; Kauffman R. G., 2001, MEAT SCI APPL, V1, P1; Laurance WF, 2005, TRENDS ECOL EVOL, V20, P645, DOI 10.1016/j.tree.2005.10.009; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2008, CONSERV BIOL, V22, P721, DOI 10.1111/j.1523-1739.2008.00917.x; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Levi T, 2011, EVOL ECOL RES, V13, P171; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; McCullough DR, 1996, J WILDLIFE MANAGE, V60, P1, DOI 10.2307/3802033; Mena P, 2000, BIOL RESOURCE MANAGE, P57; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Naranjo EJ, 2007, BIOL CONSERV, V138, P412, DOI 10.1016/j.biocon.2007.05.010; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Novaro AJ, 2005, J APPL ECOL, V42, P910, DOI 10.1111/j.1365-2664.2005.01067.x; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 1996, BIOL CONSERV, V77, P115, DOI 10.1016/0006-3207(96)00010-9; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; RAISG, 2012, AM 2012 PROT AR IND; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; Rival Laura, 1996, HIJOS SOL PADRES JAG; Robinson J.G., 1991, P415; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; ROSS EB, 1978, CURR ANTHROPOL, V19, P1, DOI 10.1086/201999; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; Sierra R, 1999, ECOL ECON, V30, P107, DOI 10.1016/S0921-8009(98)00101-3; Silverman B.W., 1986, DENSITY ESTIMATION S; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Smith DA, 2008, BIOL CONSERV, V141, P925, DOI 10.1016/j.biocon.2007.12.021; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Sunquist M., 2002, WILDCATS WORLD; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; USHER MB, 1988, BIOL CONSERV, V44, P119, DOI 10.1016/0006-3207(88)90007-9; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warriss P.D, 2000, MEAT SCI INTRO TEXT; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; WILKIE DS, 1992, CONSERV BIOL, V6, P570, DOI 10.1046/j.1523-1739.1992.06040570.x; Wilkie DS, 2000, SCIENCE, V287, P975; Yost JA, 1983, ADAPTIVE RESPONSES N, P198	87	54	58	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114916	10.1371/journal.pone.0114916	http://dx.doi.org/10.1371/journal.pone.0114916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489954	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300094
J	Fiory, F; Parrillo, L; Raciti, GA; Zatterale, F; Nigro, C; Mirra, P; Falco, R; Ulianich, L; Di Jeso, B; Formisano, P; Miele, C; Beguinot, F				Fiory, Francesca; Parrillo, Luca; Raciti, Gregory Alexander; Zatterale, Federica; Nigro, Cecilia; Mirra, Paola; Falco, Roberta; Ulianich, Luca; Di Jeso, Bruno; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco			PED/PEA-15 Inhibits Hydrogen Peroxide-Induced Apoptosis in Ins-1E Pancreatic Beta-Cells via PLD-1	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; PHOSPHOLIPASE-D ISOZYMES; SKELETAL-MUSCLE CELLS; PHOSPHATIDIC-ACID; GLUCOSE-TRANSPORT; GLIOMA-CELLS; PKC-ZETA; DEATH; KINASE; ACTIVATION	The small scaffold protein PED/PEA-15 is involved in several different physiologic and pathologic processes, such as cell proliferation and survival, diabetes and cancer. PED/PEA-15 exerts an anti-apoptotic function due to its ability to interfere with both extrinsic and intrinsic apoptotic pathways in different cell types. Recent evidence shows that mice overexpressing PED/PEA-15 present larger pancreatic islets and increased beta-cells mass. In the present work we investigated PED/PEA-15 role in hydrogen peroxide-induced apoptosis in Ins-1E beta-cells. In pancreatic islets isolated from TgPED/PEA-15 mice hydrogen peroxide-induced DNA fragmentation was lower compared to WT islets. TUNEL analysis showed that PED/PEA-15 overexpression increases the viability of Ins-1E beta-cells and enhances their resistance to apoptosis induced by hydrogen peroxide exposure. The activity of caspase-3 and the cleavage of PARP-1 were markedly reduced in Ins-1E cells overexpressing PED/PEA-15 (Ins-1EPED/PEA-15). In parallel, we observed a decrease of the mRNA levels of pro-apoptotic genes Bcl-xS and Bad. In contrast, the expression of the anti-apoptotic gene Bcl-xL was enhanced. Accordingly, DNA fragmentation was higher in control cells compared to Ins-1EPED/PEA-15 cells. Interestingly, the preincubation with propranolol, an inhibitor of the pathway of PLD-1, a known interactor of PED/PEA-15, responsible for its deleterious effects on glucose tolerance, abolishes the antiapoptotic effects of PED/PEA-15 overexpression in Ins-1E beta-cells. The same results have been obtained by inhibiting PED/PEA-15 interaction with PLD-1 in Ins-1EPED/PEA-15. These results show that PED/PEA-15 overexpression is sufficient to block hydrogen peroxide-induced apoptosis in Ins-1E cells through a PLD-1 mediated mechanism.	[Fiory, Francesca; Parrillo, Luca; Raciti, Gregory Alexander; Zatterale, Federica; Nigro, Cecilia; Mirra, Paola; Falco, Roberta; Ulianich, Luca; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco] Univ Naples Federico II, Dipartimento Sci Med & Traslaz, Naples, Italy; [Fiory, Francesca; Parrillo, Luca; Zatterale, Federica; Nigro, Cecilia; Mirra, Paola; Falco, Roberta; Ulianich, Luca; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, URT, I-80125 Naples, Italy; [Di Jeso, Bruno] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Salento	Miele, C (corresponding author), Univ Naples Federico II, Dipartimento Sci Med & Traslaz, Naples, Italy.	c.miele@ieos.cnr.it; beguino@unina.it	Nigro, Cecilia/K-7338-2016; Formisano, Pietro/J-4237-2018; Parrillo, Luca/AIA-1186-2022; Ulianich, Luca/ABD-2530-2020; Luca, Parrillo/Q-3874-2018; NIGRO, Cecilia/AAB-9189-2019; Zatterale, Federica/AAU-5898-2020	NIGRO, Cecilia/0000-0001-8924-9731; Zatterale, Federica/0000-0002-1653-8652; RACITI, GREGORYALEXANDER/0000-0003-2742-5634; Parrillo, Luca/0000-0001-9801-9778; di jeso, bruno/0000-0001-8713-5984; Formisano, Pietro/0000-0001-7020-6870	European Foundation; Associazione Italiana per la Ricerca sul cancro (AIRC); Ministero dell'Universita e della Ricerca Scientifica [PON 01_02460, FIRB-MERIT]; Societa Italiana di Diabetologia (SID-FO.DI.RI); P.O.R. Campania FSE , Project CREMe	European Foundation(European Science Foundation (ESF)); Associazione Italiana per la Ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Societa Italiana di Diabetologia (SID-FO.DI.RI); P.O.R. Campania FSE , Project CREMe(Regione Campania)	This work has been supported by: the European Foundation for the Study of Diabetes (EFSD), the Associazione Italiana per la Ricerca sul cancro (AIRC), the Ministero dell'Universita e della Ricerca Scientifica (grants PRIN and FIRB-MERIT, and PON 01_02460) and the Societa Italiana di Diabetologia (SID-FO.DI.RI). This work was also supported by the P.O.R. Campania FSE 2007-2013, Project CREMe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D, 2008, J LEUKOCYTE BIOL, V83, P1019, DOI 10.1189/jlb.0807531; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DANZIGER N, 1995, J NEUROCHEM, V64, P1016; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Fagman H, 2011, DEV BIOL, V359, P163, DOI 10.1016/j.ydbio.2011.08.015; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Hao CH, 2001, CANCER RES, V61, P1162; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Jang JH, 2004, REDOX REP, V9, P343, DOI 10.1179/135100004225006858; Jang YH, 2008, CELL SIGNAL, V20, P2198, DOI 10.1016/j.cellsig.2008.07.010; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim KO, 2003, EXP MOL MED, V35, P38, DOI 10.1038/emm.2003.6; Kim R, 2005, ONCOL REP, V14, P595; Lombardi A, 2012, DIABETOLOGIA, V55, P141, DOI 10.1007/s00125-011-2315-1; Ma WN, 2010, EXP MOL MED, V42, P456, DOI 10.3858/emm.2010.42.6.047; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Mohanty S, 2005, CLIN CANCER RES, V11, P6730, DOI 10.1158/1078-0432.CCR-05-0450; Peng YH, 2007, J GASTROINTEST SURG, V11, P1712, DOI 10.1007/s11605-007-0314-9; Renault F, 2003, BIOCHEM PHARMACOL, V66, P1581, DOI 10.1016/S0006-2952(03)00514-8; Sampson SR, 2010, APOPTOSIS, V15, P1165, DOI 10.1007/s10495-010-0517-5; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Singh M, 2007, MITOCHONDRION, V7, P367, DOI 10.1016/j.mito.2007.07.003; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Stassi G, 2005, CANCER RES, V65, P6668, DOI 10.1158/0008-5472.CAN-04-4009; Sulzmaier Florian, 2012, Small GTPases, V3, P173, DOI 10.4161/sgtp.20021; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Tsukamoto T, 2000, CANCER LETT, V149, P105, DOI 10.1016/S0304-3835(99)00350-X; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; Valks DM, 2003, J BIOL CHEM, V278, P25542, DOI 10.1074/jbc.M303760200; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Yamada M, 2004, BIOCHEM J, V378, P649, DOI 10.1042/BJ20031398	45	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113655	10.1371/journal.pone.0113655	http://dx.doi.org/10.1371/journal.pone.0113655			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489735	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300012
J	Ho, TW; Tsai, YJ; Ruan, SY; Huang, CT; Lai, FP; Yu, CJ				Ho, Te-Wei; Tsai, Yi-Ju; Ruan, Sheng-Yuan; Huang, Chun-Ta; Lai, Feipei; Yu, Chong-Jen		HINT Study Grp	In-Hospital and One-Year Mortality and Their Predictors in Patients Hospitalized for First-Ever Chronic Obstructive Pulmonary Disease Exacerbations: A Nationwide Population-Based Study	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; QUALITY-OF-LIFE; BETA-BLOCKERS; STATIN USE; COPD; MORBIDITY; RISK; OUTCOMES; SYSTEM; ASTHMA	Introduction: Natural history of chronic obstructive pulmonary disease (COPD) is punctuated by exacerbations; however, little is known about prognosis of the first-ever COPD exacerbation and variables predicting its outcomes. Materials and Methods: A population-based cohort study among COPD patients with their first-ever exacerbations requiring hospitalizations was conducted. Main outcomes were in-hospital mortality and one-year mortality after discharge. Demographics, comorbidities, medications and in-hospital events were obtained to explore outcome predictors. Results: The cohort comprised 4204 hospitalized COPD patients, of whom 175 (4%) died during the hospitalization. In-hospital mortality was related to higher age (odds ratio [OR]: 1.05 per year; 95% confidence interval [CI]: 1.03-1.06) and Charlson comorbidity index score (OR: 1.08 per point; 95% CI: 1.01-1.15); angiotensin II receptor blockers (OR: 0.61; 95% CI: 0.38-0.98) and beta blockers (OR: 0.63; 95% CI: 0.41-0.95) conferred a survival benefit. At one year after discharge, 22% (871/4029) of hospital survivors were dead. On multivariate Cox regression analysis, age and Charlson comorbidity index remained independent predictors of one-year mortality. Longer hospital stay (hazard ratio [HR] 1.01 per day; 95% CI:1.01-1.01) and ICU admission (HR: 1.33; 95% CI: 1.03-1.73) during the hospitalization were associated with higher mortality risks. Prescription of beta blockers (HR: 0.79; 95% CI: 0.67-0.93) and statins (HR: 0.66; 95% CI: 0.47-0.91) on hospital discharge were protective against one-year mortality. Conclusions: Even the first-ever severe COPD exacerbation signifies poor prognosis in COPD patients. Comorbidities play a crucial role in determining outcomes and should be carefully assessed. Angiotensin II receptor blockers, b blockers and statins may, in theory, have dual cardiopulmonary protective properties and probably alter prognosis of COPD patients. Nevertheless, the limitations inherent to a claims database study, such as the diagnostic accuracy of COPD and its exacerbation, should be born in mind.	[Ho, Te-Wei; Lai, Feipei] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Ruan, Sheng-Yuan; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Lai, Feipei] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Lai, Feipei] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan; [HINT Study Grp] Hospitalist Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	huangct@ntu.edu.twv	Ho, Te-Wei/F-1309-2015	Ho, Te-Wei/0000-0002-4371-6936; RUAN, SHENG-YUAN/0000-0002-7949-7253; HUANG, CHUN-TA/0000-0002-5234-4986; Yu, Chong-Jen/0000-0001-5664-9392	National Science Council [NSC101c7905-2]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, grant number: NSC101c7905-2 (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Andreas S, 2006, EUR RESPIR J, V27, P972, DOI 10.1183/09031936.06.00098105; Andreas S, 2005, CHEST, V128, P3618, DOI 10.1378/chest.128.5.3618; [Anonymous], TAIW 2012 PUBL HLTH; Casanova C, 2005, AM J RESP CRIT CARE, V171, P591, DOI 10.1164/rccm.200407-867OC; Chandra Divay, 2007, Indian J Chest Dis Allied Sci, V49, P13; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-359; Chua AP, 2005, CHEST, V128, P518, DOI 10.1378/chest.128.2.518; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; Donaldson GC, 2005, AM J RESP CRIT CARE, V171, P446, DOI 10.1164/rccm.200408-1054OC; Dransfield MT, 2008, THORAX, V63, P301, DOI 10.1136/thx.2007.081893; Egred M, 2005, QJM-INT J MED, V98, P493, DOI 10.1093/qjmed/hci080; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fairman K., 2000, J MANAGE CARE PHARM, V6, P499, DOI [10.18553/jmcp.2000.6.6.499, DOI 10.18553/JMCP.2000.6.6.499]; Fragoso CAV, 2012, EUR RESPIR J, V40, P37, DOI 10.1183/09031936.00128711; Gil A, 2006, HUM VACCINES, V2, P181, DOI 10.4161/hv.2.4.3104; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kaparianos A, 2011, CURR MED CHEM, V18, P3506, DOI 10.2174/092986711796642562; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lieberman D, 2002, CHEST, V122, P1264, DOI 10.1378/chest.122.4.1264; Lipworth BJ, 2009, LANCET, V373, P104, DOI 10.1016/S0140-6736(09)60018-0; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; Mohan Alladi, 2006, BMC Pulm Med, V6, P27, DOI 10.1186/1471-2466-6-27; National Health Institutes, TAIW INTR NAT HLTH I; Patil SP, 2003, ARCH INTERN MED, V163, P1180, DOI 10.1001/archinte.163.10.1180; Ranieri P, 2008, J AM GERIATR SOC, V56, P909, DOI 10.1111/j.1532-5415.2008.01683.x; Rivera-Fernandez R, 2006, CRIT CARE MED, V34, P2317, DOI 10.1097/01.CCM.0000233859.01815.38; Roche N, 2008, EUR RESPIR J, V32, P953, DOI 10.1183/09031936.00129507; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Shrikrishna D, 2012, CLIN SCI, V123, P487, DOI 10.1042/CS20120081; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Steer J, 2010, QJM-INT J MED, V103, P817, DOI 10.1093/qjmed/hcq126; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang MT, 2013, AM J MED, V126, P598, DOI 10.1016/j.amjmed.2013.01.036; Ward A, 2006, CLIN THER, V28, P1912, DOI 10.1016/j.clinthera.2006.11.002; Wildman MJ, 2009, QJM-INT J MED, V102, P389, DOI 10.1093/qjmed/hcp036; Wong MH, 2012, AM J RESP CELL MOL, V46, P641, DOI 10.1165/rcmb.2011-0289OC; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137; Young RP, 2009, POSTGRAD MED J, V85, P414, DOI 10.1136/pgmj.2008.078477	48	63	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114866	10.1371/journal.pone.0114866	http://dx.doi.org/10.1371/journal.pone.0114866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490399	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300088
J	Idelevich, EA; Grunewald, CM; Wullenweber, J; Becker, K				Idelevich, Evgeny A.; Grunewald, Camilla M.; Wuellenweber, Joerg; Becker, Karsten			Rapid Identification and Susceptibility Testing of Candida spp. from Positive Blood Cultures by Combination of Direct MALDI-TOF Mass Spectrometry and Direct Inoculation of Vitek 2	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MICRODILUTION REFERENCE METHOD; STREAM INFECTIONS; ANTIFUNGAL SUSCEPTIBILITY; INVASIVE CANDIDIASIS; BIOTYPER SYSTEM; AMPHOTERICIN-B; SEPTIC SHOCK; YEAST; MS	Fungaemia is associated with high mortality rates and early appropriate antifungal therapy is essential for patient management. However, classical diagnostic workflow takes up to several days due to the slow growth of yeasts. Therefore, an approach for direct species identification and direct antifungal susceptibility testing (AFST) without prior time-consuming sub-culturing of yeasts from positive blood cultures (BCs) is urgently needed. Yeast cell pellets prepared using Sepsityper kit were used for direct identification by MALDI-TOF mass spectrometry (MS) and for direct inoculation of Vitek 2 AST-YS07 card for AFST. For comparison, MALDI-TOF MS and Vitek 2 testing were performed from yeast subculture. A total of twenty four positive BCs including twelve C. glabrata, nine C. albicans, two C. dubliniensis and one C. krusei isolate were processed. Applying modified thresholds for species identification (score >= 1.5 with two identical consecutive propositions), 62.5% of BCs were identified by direct MALDI-TOF MS. AFST results were generated for 72.7% of BCs directly tested by Vitek 2 and for 100% of standardized suspensions from 24 h cultures. Thus, AFST comparison was possible for 70 isolate-antifungal combinations. Essential agreement (minimum inhibitory concentration difference <= 1 double dilution step) was 88.6%. Very major errors (VMEs) (false-susceptibility), major errors (false-resistance) and minor errors (false categorization involving intermediate result) amounted to 33.3% (of resistant isolates), 1.9% (of susceptible isolates) and 1.4% providing 90.0% categorical agreement. All VMEs were due to fluconazole or voriconazole. This direct method saved on average 23.5 h for identification and 15.1 h for AFST, compared to routine procedures. However, performance for azole susceptibility testing was suboptimal and testing from subculture remains indispensable to validate the direct finding.	[Idelevich, Evgeny A.; Grunewald, Camilla M.; Wuellenweber, Joerg; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	University of Munster	Idelevich, EA (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	evgeny.idelevich@ukmuenster.de	Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341				[Anonymous], 2007, ISOFDIS 20776 22007; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; bioMerieux SA, 2010, VITEK 2 SYSTEMS PROD, V410791; Buchan BW, 2013, J CLIN MICROBIOL, V51, P1359, DOI 10.1128/JCM.03105-12; Buchan BW, 2012, J CLIN MICROBIOL, V50, P346, DOI 10.1128/JCM.05021-11; Cassagne C, 2013, MED MYCOL, V51, P371, DOI 10.3109/13693786.2012.720720; Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10; Drancourt M, 2010, CLIN MICROBIOL INFEC, V16, P1620, DOI 10.1111/j.1469-0691.2010.03290.x; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gorton RL, 2014, MYCOSES, V57, P592, DOI 10.1111/myc.12205; Hamprecht A, 2014, MED MICROBIOL IMMUN, V203, P93, DOI 10.1007/s00430-013-0319-9; Idelevich EA, 2014, CLIN MICROBIOL INFEC, V20, P1001, DOI 10.1111/1469-0691.12640; Idelevich EA, 2014, J CLIN MICROBIOL, V52, P4058, DOI 10.1128/JCM.02400-14; Iriart X, 2012, J CLIN MICROBIOL, V50, P2107, DOI 10.1128/JCM.06713-11; Jamal W, 2013, DIAGN MICR INFEC DIS, V76, P404, DOI 10.1016/j.diagmicrobio.2013.04.013; Kerremans JJ, 2004, EUR J CLIN MICROBIOL, V23, P892, DOI 10.1007/s10096-004-1247-9; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Lavergne RA, 2013, MED MYCOL, V51, P652, DOI 10.3109/13693786.2012.762607; Ling TKW, 2003, J CLIN MICROBIOL, V41, P4705, DOI 10.1128/JCM.41.10.4705-4707.2003; Machen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087870; Marinach-Patrice C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008862; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; Nonnemann B, 2013, APMIS, V121, P871, DOI 10.1111/apm.12050; Peterson JF, 2011, J CLIN MICROBIOL, V49, P1765, DOI 10.1128/JCM.02517-10; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P3522, DOI 10.1128/JCM.00403-07; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P796, DOI 10.1128/JCM.01986-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Pinto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025712; Schmalreck AF, 2014, ANTIMICROB AGENTS CH, V58, P1575, DOI 10.1128/AAC.01799-13; Schmalreck AF, 2012, MYCOSES, V55, pe124, DOI 10.1111/j.1439-0507.2011.02165.x; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Theel ES, 2012, J CLIN MICROBIOL, V50, P3093, DOI 10.1128/JCM.01045-12; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y; U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health, 2009, GUID IND FDA CLASS 2; Van Herendael BH, 2012, EUR J CLIN MICROBIOL, V31, P841, DOI 10.1007/s10096-011-1383-y; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yan YJ, 2011, J CLIN MICROBIOL, V49, P2528, DOI 10.1128/JCM.00339-11	43	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114834	10.1371/journal.pone.0114834	http://dx.doi.org/10.1371/journal.pone.0114834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489741	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300082
J	Macher, HC; Suarez-Artacho, G; Guerrero, JM; Gomez-Bravo, MA; Alvarez-Gomez, S; Bernal-Bellido, C; Dominguez-Pascual, I; Rubio, A				Macher, Hada C.; Suarez-Artacho, Gonzalo; Guerrero, Juan M.; Gomez-Bravo, Miguel A.; Alvarez-Gomez, Sara; Bernal-Bellido, Carmen; Dominguez-Pascual, Inmaculada; Rubio, Amalia			Monitoring of Transplanted Liver Health by Quantification of Organ-Specific Genomic Marker in Circulating DNA from Receptor	PLOS ONE			English	Article							CELL-FREE DNA; ACUTE REJECTION; RENAL-TRANSPLANTATION; GRAFT-REJECTION; DONOR DNA; RECIPIENTS; PLASMA; KIDNEY; PCR; ORIGIN	Background: Health assessment of the transplanted organ is very important due to the relationship of long-term survival of organ transplant recipients and health organ maintenance. Nowadays, the measurement of cell-free DNA from grafts in the circulation of transplant recipients has been considered a potential biomarker of organ rejection or transplant associated complications in an attempt to replace or reduce liver biopsy. However, methods developed to date are expensive and extremely time-consuming. Our approach was to measure the SRY gene, as a male organ biomarker, in a setting of sex-mismatched female recipients of male donor organs. Methods: Cell-free DNA quantization of the SRY gene was performed by real-time quantitative PCR beforehand, at the moment of transplantation during reperfusion (day 0) and during the stay at the intensive care unit. Beta-globin cell-free DNA levels, a general cellular damage marker, were also quantified. Results: Beta-globin mean values of patients, who accepted the graft without any complications during the first week after surgery, diminished from day 0 until patient stabilization. This decrease was not so evident in patients who suffered some kind of post-transplantation complications. All patients showed an increase in SRY levels at day 0, which decreased during hospitalization. Different complications that did not compromise donated organs showed increased beta-globin levels but no SRY gene levels. However, when a donated organ was damaged the patients exhibited high levels of both genes. Conclusion: Determination of a SRY gene in a female recipient's serum is a clear and specific biomarker of donated organs and may give us important information about graft health in a short period of time by a non-expensive technique. This approach may permit clinicians to maintain a close follow up of the transplanted patient.	[Macher, Hada C.; Guerrero, Juan M.; Alvarez-Gomez, Sara; Dominguez-Pascual, Inmaculada; Rubio, Amalia] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS,Dept Clin Biochem, Seville, Spain; [Suarez-Artacho, Gonzalo; Gomez-Bravo, Miguel A.; Bernal-Bellido, Carmen] Virgen Rocio Univ Hosp, Hepatobiliary & Liver Transplantat Unit, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Rubio, A (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS,Dept Clin Biochem, Seville, Spain.	amaliarubio@us.es	Guerrero, Josep M./D-5519-2014; IBIS, NEUROINMUNO/O-9306-2015; Bernal-Bellido, Carmen/F-5802-2016; Rubio, Amalia/L-1992-2017; Guerrero, Josep M./Y-2929-2019	Guerrero, Josep M./0000-0001-5236-4592; Rubio, Amalia/0000-0002-5905-0534; Guerrero, Juan Miguel/0000-0001-7553-0119; Suarez Artacho, Gonzalo/0000-0003-4710-2488; Macher, Hada/0000-0002-8622-1175; Bernal-Bellido, Carmen/0000-0001-8940-3452; GOMEZ BRAVO, MIGUEL ANGEL/0000-0002-5155-3508	Red tematica de investigacion cooperativa en envejecimiento y fragilidad [RETICEF RD06/00130001]; Ayuda para la Consolidacion de Grupos de Investigacion y Desarrollo Tecnologico de la Comunidad Autonoma Andaluza [P06-CTS-0160]	Red tematica de investigacion cooperativa en envejecimiento y fragilidad; Ayuda para la Consolidacion de Grupos de Investigacion y Desarrollo Tecnologico de la Comunidad Autonoma Andaluza	The work was supported by "Red tematica de investigacion cooperativa en envejecimiento y fragilidad'' (RETICEF RD06/00130001), and by "Ayuda para la Consolidacion de Grupos de Investigacion y Desarrollo Tecnologico de la Comunidad Autonoma Andaluza'' (P06-CTS-0160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2013, ANN SURG, V258, P409, DOI 10.1097/SLA.0b013e3182a15db4; Beck J, 2013, CLIN CHEM, V59, P1732, DOI 10.1373/clinchem.2013.210328; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gadi VK, 2006, CLIN CHEM, V52, P379, DOI 10.1373/clinchem.2005.058974; Moreira VG, 2009, CLIN CHEM, V55, P1958, DOI 10.1373/clinchem.2009.129072; Grant A., 1999, Gut, V45, pIV1; Lo YMD, 2011, CLIN CHEM, V57, P941, DOI 10.1373/clinchem.2011.166686; Lo YMD, 1998, LANCET, V351, P1329, DOI 10.1016/S0140-6736(05)79055-3; Lui YYN, 2003, CLIN CHEM, V49, P495, DOI 10.1373/49.3.495; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Macher HC, 2012, CLIN CHIM ACTA, V413, P490, DOI 10.1016/j.cca.2011.11.004; Millan O, 2013, CYTOKINE, V61, P556, DOI 10.1016/j.cyto.2012.10.026; Mortarino M, 2011, HAEMOPHILIA, V17, P952, DOI 10.1111/j.1365-2516.2011.02537.x; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Vivarelli M, 1995, EUR J GASTROEN HEPAT, V7, P1215; Yu SC, 2014, P NATL ACAD SCI US; Yu SCY, 2013, CLIN CHEM, V59, P1228, DOI 10.1373/clinchem.2013.203679; Zhang J, 1999, CLIN CHEM, V45, P1741; Zhang ZH, 2003, CHINESE MED J-PEKING, V116, P191; Zhong XY, 2001, ANN NY ACAD SCI, V945, P250	22	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113987	10.1371/journal.pone.0113987	http://dx.doi.org/10.1371/journal.pone.0113987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489845	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300013
J	Gao, H; Li, L; Rao, SQ; Shen, GQ; Xi, QS; Chen, SH; Zhang, Z; Wang, K; Ellis, SG; Chen, QY; Topol, EJ; Wang, QK				Gao, Hanxiang; Li, Lin; Rao, Shaoqi; Shen, Gongqing; Xi, Quansheng; Chen, Shenghan; Zhang, Zheng; Wang, Kai; Ellis, Stephen G.; Chen, Qiuyun; Topol, Eric J.; Wang, Qing K.			Genome-Wide Linkage Scan Identifies Two Novel Genetic Loci for Coronary Artery Disease: In GeneQuest Families	PLOS ONE			English	Article							HEART-DISEASE; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; HAPLOTYPE ASSOCIATION; PARENTAL HISTORY; RISK; METAANALYSIS; POLYMORPHISM; DEATH; CAD	Coronary artery disease (CAD) is the leading cause of death worldwide. Recent genome-wide association studies (GWAS) identified >50 common variants associated with CAD or its complication myocardial infarction (MI), but collectively they account for <20% of heritability, generating a phenomena of "missing heritability''. Rare variants with large effects may account for a large portion of missing heritability. Genome-wide linkage studies of large families and follow-up fine mapping and deep sequencing are particularly effective in identifying rare variants with large effects. Here we show results from a genome-wide linkage scan for CAD in multiplex GeneQuest families with early onset CAD and MI. Whole genome genotyping was carried out with 408 markers that span the human genome by every 10 cM and linkage analyses were performed using the affected relative pair analysis implemented in GENEHUNTER. Affected only nonparametric linkage (NPL) analysis identified two novel CAD loci with highly significant evidence of linkage on chromosome 3p25.1 (peak NPL =5.49) and 3q29 (NPL =6.84). We also identified four loci with suggestive linkage on 9q22.33, 9q34.11, 17p12, and 21q22.3 (NPL = 3.18-4.07). These results identify novel loci for CAD and provide a framework for fine mapping and deep sequencing to identify new susceptibility genes and novel variants associated with risk of CAD.	[Gao, Hanxiang; Zhang, Zheng] Lanzhou Univ, Affiliated Hosp 1, Ctr Heart, Lanzhou 730000, Gansu, Peoples R China; [Gao, Hanxiang; Li, Lin; Rao, Shaoqi; Shen, Gongqing; Xi, Quansheng; Chen, Shenghan; Chen, Qiuyun; Wang, Qing K.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med,Dept Mol Med, Ctr Cardiovasc Genet,Lerner Res Inst,Dept Mol Car, Cleveland, OH 44106 USA; [Rao, Shaoqi] Guangdong Med Coll, Inst Med Syst Biol, Dongguan 523808, Guangdong, Peoples R China; [Rao, Shaoqi] Guangdong Med Coll, Inst Sch Publ Hlth, Dongguan 523808, Guangdong, Peoples R China; [Wang, Kai; Ellis, Stephen G.; Wang, Qing K.] Cleveland Clin, Sydell & Arnold Miller Family Heart & Vasc Inst, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH USA; [Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, Scripps Clin, La Jolla, CA 92037 USA; [Wang, Qing K.] Cleveland Clin, Ctr Sleep Med, Neurol Inst, Cleveland, OH 44106 USA; [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44195 USA; [Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China; [Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430074, Peoples R China	Lanzhou University; Case Western Reserve University; Cleveland Clinic Foundation; Guangdong Medical University; Guangdong Medical University; Cleveland Clinic Foundation; Scripps Research Institute; Cleveland Clinic Foundation; Case Western Reserve University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Topol, EJ (corresponding author), Scripps Res Inst, Scripps Translat Sci Inst, Scripps Clin, La Jolla, CA 92037 USA.	etopol@scripps.edu; wangq2@ccf.org		Zhang, Zheng/0000-0002-7917-7057; Rao, Shaoqi/0000-0001-7809-3700	National Institute of Health grants [R01 HL121358, R01 HL094498, P50 HL77107]; American Heart Association grants [0630193N, 11SDG5510001, 11IRG5570046]; National Natural Science Foundation of China [31071166, 81373085]; Science and Technology Planning Project of Guangdong Province [2009A030301004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107, R01HL121358, R01HL094498] Funding Source: NIH RePORTER	National Institute of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grants(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health grants (R01 HL121358, R01 HL094498 and P50 HL77107), the American Heart Association grants (0630193N, 11SDG5510001 and 11IRG5570046), the National Natural Science Foundation of China (grant nos. 31071166, 81373085 to SR) and Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004 to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Banerjee A, 2012, INT J CLIN PRACT, V66, P536, DOI 10.1111/j.1742-1241.2012.02908.x; Chiodini BD, 2003, ARTERIOSCL THROM VAS, V23, P1863, DOI 10.1161/01.ATV.0000093281.10213.DB; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COLDITZ GA, 1991, AM J CARDIOL, V67, P933, DOI 10.1016/0002-9149(91)90163-F; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Di Cara F, 2013, J CELL SCI, V126, P4769, DOI 10.1242/jcs.133306; Ding SD, 2012, WIEN KLIN WOCHENSCHR, V124, P671, DOI 10.1007/s00508-012-0223-0; Engert JC, 2008, EUR J HUM GENET, V16, P105, DOI 10.1038/sj.ejhg.5201920; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Girelli D, 2009, SEMIN THROMB HEMOST, V35, P671, DOI 10.1055/s-0029-1242721; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1996, NAT GENET, V14, P132, DOI 10.1038/ng1096-132; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Ouwehand WH, 2009, J THROMB HAEMOST, V7, P305, DOI 10.1111/j.1538-7836.2009.03441.x; Pandey AK, 2014, ATHEROSCLEROSIS, V232, P369, DOI 10.1016/j.atherosclerosis.2013.11.042; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; S.A.G.E, 2006, STAT AN GEN EP 5 3 C; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samani NJ, 2005, AM J HUM GENET, V77, P1011; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seidelmann SB, 2008, J LIPID RES, V49, P1034, DOI 10.1194/jlr.M700576-JLR200; Shalata A, 2013, AM J HUM GENET, V93, P1061, DOI 10.1016/j.ajhg.2013.10.025; Shen GQ, 2007, AM J HUM GENET, V81, P780, DOI 10.1086/521581; Shen GQ, 2013, GENE, V521, P78, DOI 10.1016/j.gene.2013.03.022; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Wienke A, 2001, Twin Res, V4, P266, DOI 10.1375/twin.4.4.266; Yang R, 2010, J LIPID RES, V51, P1442, DOI 10.1194/jlr.M004325; Yip AG, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S100; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113935	10.1371/journal.pone.0113935	http://dx.doi.org/10.1371/journal.pone.0113935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485937	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600030
J	So, KS; Kim, CH; Rho, JK; Kim, SY; Choi, YJ; Song, JS; Kim, WS; Choi, CM; Chun, YJ; Lee, JC				So, Kwang Sup; Kim, Cheol Hyeon; Rho, Jin Kyung; Kim, Sun Ye; Choi, Yun Jung; Song, Joon Seon; Kim, Woo Sung; Choi, Chang Min; Chun, Young Jin; Lee, Jae Cheol			Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							PROTEIN-KINASE CK2; GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; MUTATION; GEFITINIB; ERLOTINIB; APOPTOSIS; SURVIVAL; CHEMOTHERAPY; CHAPERONE	Protein kinase CK2 has diverse functions promoting and maintaining cancer phenotypes. We investigated the effect of CK2 inhibition in lung cancer cells with T790M-mediated resistance to the EGFR-TK inhibitor. Resistant sublines of PC-9 to gefitinib (PC-9/GR) and erlotinib (PC-9/ER) were established by previous study, and T790M secondary mutation was found in both resistant sublines. A decrease of EGFR by siRNA treatment effectively controlled the growth of resistant cells, thus suggesting that they still have EGFR-dependency. CX-4945, a potent and selective CK2 inhibitor, induced autophagy in PC-9/GR and PC-9/ER, and which was supported by the induction of autophagic vacuoles and microtubule-associated protein 1 light chain 3 (LC3) expression, and the increase of punctate fluorescent signals in resistant cells pre-transfected with green fluorescent protein (GFP)tagged LC3. However, the withdrawal of CX-4945 led to the recovery of cancer cells with autophagy. We found that the induction of autophagy by CX-4945 in both resistant cells was CK2 dependent by using small interfering RNA against CK2. The treatment with CX-4945 alone induced a minimal growth inhibition in resistant cells. However, combined treatment of CX-4945 and EGFR-TKI effectively inhibited cancer-cell proliferation and induced apoptosis. CX-4945 increased the translocation of EGFR from the cell surface into the autophagosome, subsequently leading to the decrease of EGFR while inhibition of autophagy by 3MA or Atg7-targeted siRNA pretreatment reduced the decrease of EGFR by CX-4945. Accordingly, apoptosis by a combination of CX-4945 and EGFR-TKI was suppressed by 3MA or Atg7-targeted siRNA pretreatment, thus suggesting that autophagosome-mediated EGFR down-regulation would have an important role regarding apoptotic cell death by EGFR-TKI. Combined treatment of the CK2 inhibitor and EGFR-TKI may be a promising strategy for overcoming T790M-mediated resistance.	[So, Kwang Sup; Rho, Jin Kyung; Kim, Sun Ye; Choi, Yun Jung; Kim, Woo Sung; Choi, Chang Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Song, Joon Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Choi, Chang Min; Lee, Jae Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Rho, Jin Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [So, Kwang Sup; Chun, Young Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Kim, Cheol Hyeon] Korea Canc Ctr Hosptial, Dept Internal Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Chung Ang University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	yjchun@cau.ac.kr; jclee@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021		Korean Health Technology R&D Project, Ministry of Health Welfare [HI12C1146000013]; Asan Institute for Life Science, Seoul, Republic of Korea [2011-0529]	Korean Health Technology R&D Project, Ministry of Health Welfare; Asan Institute for Life Science, Seoul, Republic of Korea	This work was funded by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI12C1146000013) and a grant (2011-0529) from Asan Institute for Life Science, Seoul, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2007, MOL CANCER THER, V6, P1006, DOI 10.1158/1535-7163.MCT-06-0491; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Berardi R, 2013, ONCOTARGETS THER, V6, P563, DOI 10.2147/OTT.S28155; Chen G, 2013, BIOCHEM BIOPH RES CO, V431, P623, DOI 10.1016/j.bbrc.2012.12.070; Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Hessenauer A, 2011, CELL SIGNAL, V23, P145, DOI 10.1016/j.cellsig.2010.08.014; Homma MK, 2008, MOL CELL BIOCHEM, V316, P49, DOI 10.1007/s11010-008-9823-4; Ihle NT, 2005, MOL CANCER THER, V4, P1349, DOI 10.1158/1535-7163.MCT-05-0149; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Kwak E, 2011, ONCOLOGIST, V16, P1498, DOI 10.1634/theoncologist.2011-0087; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Miyata Y, 2004, ANN NY ACAD SCI, V1030, P150, DOI 10.1196/annals.1329.019; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Moreira-Leite FF, 2010, J THORAC ONCOL, V5, P765, DOI 10.1097/JTO.0b013e3181d95d93; Olsen BB, 2012, INT J ONCOL, V41, P1967, DOI 10.3892/ijo.2012.1635; Ou SHI, 2012, CRIT REV ONCOL HEMAT, V83, P407, DOI 10.1016/j.critrevonc.2011.11.010; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Paz-Ares L, 2010, J CELL MOL MED, V14, P51, DOI 10.1111/j.1582-4934.2009.00991.x; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sakuma Y, 2013, LAB INVEST, V93, P1137, DOI 10.1038/labinvest.2013.102; Sequist LV, 2013, J CLIN ONCOL, V31; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Unger GM, 2004, CURR CANCER DRUG TAR, V4, P77, DOI 10.2174/1568009043481687; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	45	26	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114000	10.1371/journal.pone.0114000	http://dx.doi.org/10.1371/journal.pone.0114000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486409	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600035
J	Wahl, M; Al Sofyani, A; Saha, M; Kruse, I; Lenz, M; Sawall, Y				Wahl, Martin; Al Sofyani, Abdulmohsin; Saha, Mahasweta; Kruse, Inken; Lenz, Mark; Sawall, Yvonne			Large Scale Patterns of Antimicrofouling Defenses in the Hard Coral Pocillopora verrucosa in an Environmental Gradient along the Saudi Arabian Coast of the Red Sea	PLOS ONE			English	Article							SEASONAL-VARIATION; ANTIMICROBIAL ACTIVITY; ANTIFOULING ACTIVITY; GEOGRAPHIC-VARIATION; TEMPORAL DYNAMICS; RESISTANCE; MUCUS; BACTERIA; VARIABILITY; POPULATIONS	Large scale patterns of ecologically relevant traits may help identify drivers of their variability and conditions beneficial or adverse to the expression of these traits. Antimicrofouling defenses in scleractinian corals regulate the establishment of the associated biofilm as well as the risks of infection. The Saudi Arabian Red Sea coast features a pronounced thermal and nutritional gradient including regions and seasons with potentially stressful conditions to corals. Assessing the patterns of antimicrofouling defenses across the Red Sea may hint at the susceptibility of corals to global change. We investigated microfouling pressure as well as the relative strength of 2 alternative antimicrofouling defenses (chemical antisettlement activity, mucus release) along the pronounced environmental gradient along the Saudi Arabian Red Sea coast in 2 successive years. Microfouling pressure was exceptionally low along most of the coast but sharply increased at the southernmost sites. Mucus release correlated with temperature. Chemical defense tended to anti-correlate with mucus release. As a result, the combined action of mucus release and chemical antimicrofouling defense seemed to warrant sufficient defense against microbes along the entire coast. In the future, however, we expect enhanced energetic strain on corals when warming and/or eutrophication lead to higher bacterial fouling pressure and a shift towards putatively more costly defense by mucus release.	[Wahl, Martin; Saha, Mahasweta; Kruse, Inken; Lenz, Mark; Sawall, Yvonne] GEOMAR Helmholtz Ctr Ocean Res, Dept Benth Ecol, Kiel, Germany; [Al Sofyani, Abdulmohsin] King Abdulaziz Univ, Dept Marine Biol, Jeddah 21413, Saudi Arabia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; King Abdulaziz University	Wahl, M (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Dept Benth Ecol, Kiel, Germany.	mwahl@geomar.de	Kruse, Inken/E-4207-2014; Kruse, Inken/B-5949-2016; Lenz, Mark/AAG-1734-2021; Wahl, Martin/D-2038-2016; Saha, Mahasweta/K-4867-2014	Wahl, Martin/0000-0001-8703-3857; Kruse, Inken/0000-0001-7176-6300; Saha, Mahasweta/0000-0001-9308-1054	KAU, Jeddah, Saudi Arabia [T-065/430-DSR]	KAU, Jeddah, Saudi Arabia	This collaboration of the Jeddah Transect Project between King Abdulaziz University (KAU) and Helmholtz-Center for Ocean Research GEOMAR was funded by KAU, Jeddah, Saudi Arabia, under grant no. T-065/430-DSR. Further support was given by GEOMAR and King Abdullah University for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Dube D, 2002, MAR ECOL PROG SER, V231, P139, DOI 10.3354/meps231139; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Fischer M, 2013, SEA TECHNOL, V54, P49; Flothe CR, 2013, J PHYCOL, V49, P468, DOI 10.1111/jpy.12059; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Harder T., 2008, MARINE IND BIOFOULIN; Heindl H, 2010, SYST APPL MICROBIOL, V33, P94, DOI 10.1016/j.syapm.2009.12.002; Hellio C, 2004, MAR BIOTECHNOL, V6, P67, DOI 10.1007/s10126-003-0020-x; Henrikson AA, 1998, BIOFOULING, V12, P245, DOI 10.1080/08927019809378357; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Kuerten B, 2014, J SEA RES, V85, P379, DOI 10.1016/j.seares.2013.07.008; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Lenihan HS, 2010, MAR ECOL PROG SER, V409, P51, DOI 10.3354/meps08595; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Long JD, 2007, MAR ECOL PROG SER, V333, P75, DOI 10.3354/meps333075; Lyons DA, 2007, MAR BIOL, V153, P179, DOI 10.1007/s00227-007-0795-9; MAIDA M, 1993, J CHEM ECOL, V19, P2285, DOI 10.1007/BF00979664; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Marechal JP, 2004, J EXP MAR BIOL ECOL, V313, P47, DOI 10.1016/j.jembe.2004.07.016; Marti R, 2005, SCI MAR, V69, P485; McConnell O., 1989, BIOORG MAR CHEM, V3, P86; Muscatine L, 1973, NUTR CORALS; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Page M, 2005, J CHEM ECOL, V31, P1161, DOI 10.1007/s10886-005-4254-0; Plouguerne E, 2010, J APPL PHYCOL, V22, P717, DOI 10.1007/s10811-010-9511-0; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ridgway T, 2001, MAR BIOL, V139, P175; RIEGL B, 1995, J EXP MAR BIOL ECOL, V186, P259, DOI 10.1016/0022-0981(94)00164-9; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez-Troncoso AP, 2010, CIENC MAR, V36, P91, DOI 10.7773/cm.v36i1.1701; Rohde S, 2008, J EXP MAR BIOL ECOL, V367, P227, DOI 10.1016/j.jembe.2008.10.003; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Saha M, 2013, BIOFOULING, V29, P661, DOI 10.1080/08927014.2013.795953; Sawall Y., 2014, J ECOL ECOGR, VS4, P003, DOI DOI 10.4172/2157-7625.S4-003; Sawall Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103179; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Slattery M, 2001, MAR BIOL, V138, P1183; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; STEINBERG PD, 1995, OECOLOGIA, V102, P169, DOI 10.1007/BF00333248; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; Veron J.E.N., 2000, CORALS WORLD, V1-3; WAHL M, 1994, MAR ECOL PROG SER, V110, P45, DOI 10.3354/meps110045; Wahl M, 1998, BIOFOULING, V12, P205, DOI 10.1080/08927019809378355; Wahl M, 2008, BIOFOULING, V24, P427, DOI 10.1080/08927010802339772; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310	60	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e106573	10.1371/journal.pone.0106573	http://dx.doi.org/10.1371/journal.pone.0106573			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485603	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600001
J	Wang, YF; Ma, SR; Wang, WM; Huang, CF; Zhao, ZL; Liu, B; Zhang, WF; Zhao, YF; Zhang, L; Sun, ZJ				Wang, Yu-Fan; Ma, Si-Rui; Wang, Wei-Ming; Huang, Cong-Fa; Zhao, Zhi-Li; Liu, Bing; Zhang, Wen-Feng; Zhao, Yi-Fang; Zhang, Lu; Sun, Zhi-Jun			Inhibition of Survivin Reduces HIF-1 alpha, TGF-beta 1 and TFE3 in Salivary Adenoid Cystic Carcinoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; TARGETING SURVIVIN; LACRIMAL GLAND; FACTOR PATHWAY	In the present study, we explored the expression and correlation of survivin with HIF-1 alpha, TGF-beta 1 and TFE3 in adenoid cystic carcinoma (AdCC). The expression of survivin, HIF-1 alpha, TGF-beta 1 and TFE3 was assessed by immunohistochemical staining of a tissue microarray containing tissue samples of normal salivary gland (NSG), pleomorphic adenoma (PA) and AdCC. Correlation analysis of these proteins revealed that increased survivin expression was associated with the overexpression of HIF-1 alpha (P<0.001, r=0.5599), TGF-beta 1 (P<0.001, r=0.6616) and TFE3 (P<0.001, r=0.7747). The expression of survivin, HIF-1 alpha, TGF-beta 1 and TFE3 was not correlated with the pathological type of human AdCC (P>0.05). Selective inhibition of survivin by YM155 and siRNA significantly reduced human SACC-83 cell proliferation, with the corresponding decrease in expression of HIF-1 alpha, TGF-beta 1 and TFE3. The data indicate that the overexpression of survivin in AdCC is related to HIF-1 alpha, TGF-beta 1 and TFE3. We hypothesize from these findings that the inhibition of survivin may be a novel strategy for neoadjuvant chemotherapeutic and radiosensitive treatment of AdCC.	[Wang, Yu-Fan; Ma, Si-Rui; Wang, Wei-Ming; Huang, Cong-Fa; Zhao, Zhi-Li; Zhang, Lu; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Wang, Yu-Fan; Ma, Si-Rui; Wang, Wei-Ming; Huang, Cong-Fa; Zhao, Zhi-Li; Zhang, Lu; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Liu, Bing; Zhang, Wen-Feng; Zhao, Yi-Fang; Sun, Zhi-Jun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Head Neck Oncol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhang, L (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China.	luzhang2012@whu.edu.cn; zhijundejia@163.com	Sun, Zhi-Jun/AAD-8791-2022; zhao, zhili/F-4137-2016	Sun, Zhi-Jun/0000-0003-0932-8013; zhao, zhili/0000-0002-9030-1979	National Natural Science Foundation of China [81072203, 81272963, 81371106, 81272946, 81170977]; program for new century excellent talents in university, ministry of education of China [NCET-13-0439]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for new century excellent talents in university, ministry of education of China(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China)	This work was funded by National Natural Science Foundation of China (81072203, 81272963) to Z.-J. Sun, (81371106) to L. Zhang, (81272946) to W.-F. Zhang, and (81170977) to Y.-F. Zhao. Z.-J. Sun supported by program for new century excellent talents in university (NCET-13-0439), ministry of education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Arlt A, 2013, CANCER LETT, V332, P346, DOI 10.1016/j.canlet.2010.10.015; BARNES L, 2005, WHO CLASSIFICATION T, P221; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bian Y, 2012, ONCOGENE, V31, P3322, DOI 10.1038/onc.2011.494; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Chen YQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-29; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Costa AF, 2012, HISTOPATHOLOGY, V60, P816, DOI 10.1111/j.1365-2559.2011.04128.x; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Dong L, 2013, ORAL ONCOL, V49, P1051, DOI 10.1016/j.oraloncology.2013.07.012; Dresang LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080543; Ellington CL, 2012, CANCER-AM CANCER SOC, V118, P4444, DOI 10.1002/cncr.27408; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; Ge XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101207; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hanna C, 2013, AM J PHYSIOL-RENAL, V305, pF1323, DOI 10.1152/ajprenal.00155.2013; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Helbig L, 2014, INT J RADIAT ONCOL, V88, P159, DOI 10.1016/j.ijrobp.2013.09.047; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Huang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083479; Hung SP, 2013, CELL TRANSPLANT, V22, P1869, DOI 10.3727/096368912X657954; Ikeguchi M, 2005, J EXP CLIN CANC RES, V24, P415; Jia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051549; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Ko YH, 2007, JPN J CLIN ONCOL, V37, P805, DOI 10.1093/jjco/hym119; Ko YH, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-30; Lamers F, 2012, EUR J CANCER, V48, P763, DOI 10.1016/j.ejca.2011.10.012; Laurie SA, 2011, LANCET ONCOL, V12, P815, DOI 10.1016/S1470-2045(10)70245-X; Liao YC, 2009, EXP EYE RES, V88, P4, DOI 10.1016/j.exer.2008.09.015; Mulay K, 2013, HISTOPATHOLOGY, V62, P840, DOI 10.1111/his.12073; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Poh Y. W., 2012, Experimental Oncology, V34, P85; Pollard P, 2005, J PATHOL, V205, P41, DOI 10.1002/path.1686; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schlette EJ, 2004, J CLIN ONCOL, V22, P1682, DOI 10.1200/JCO.2004.10.172; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Song K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061896; Sun ZJ, 2012, CLIN CANCER RES, V18, P5304, DOI 10.1158/1078-0432.CCR-12-1371; Sun ZJ, 2010, J PHARMACOL EXP THER, V334, P500, DOI 10.1124/jpet.110.167692; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Tang YL, 2014, ONCOTARGET, V5, P1491, DOI 10.18632/oncotarget.1606; Thavaraj S, 2005, J PATHOL, V205, P14, DOI 10.1002/path.1683; Veekony H, 2007, CLIN CANCER RES, V13, P3133, DOI 10.1158/1078-0432.CCR-06-2555; Wang L, 2013, ONCOL REP, V30, P207, DOI 10.3892/or.2013.2460; Wang YF, 2014, APOPTOSIS, V19, P748, DOI 10.1007/s10495-013-0960-1; Zhang L, 2013, CANCER LETT, V331, P230, DOI 10.1016/j.canlet.2013.01.003	51	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114051	10.1371/journal.pone.0114051	http://dx.doi.org/10.1371/journal.pone.0114051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485635	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600040
J	Drexler, N; Miller, M; Gerding, J; Todd, S; Adams, L; Dahlgren, FS; Bryant, N; Weis, E; Herrick, K; Francies, J; Komatsu, K; Piontkowski, S; Velascosoltero, J; Shelhamer, T; Hamilton, B; Eribes, C; Brock, A; Sneezy, P; Goseyun, C; Bendle, H; Hovet, R; Williams, V; Massung, R; McQuiston, JH				Drexler, Naomi; Miller, Mark; Gerding, Justin; Todd, Suzanne; Adams, Laura; Dahlgren, F. Scott; Bryant, Nelva; Weis, Erica; Herrick, Kristen; Francies, Jessica; Komatsu, Kenneth; Piontkowski, Stephen; Velascosoltero, Jose; Shelhamer, Timothy; Hamilton, Brian; Eribes, Carmen; Brock, Anita; Sneezy, Patsy; Goseyun, Cye; Bendle, Harty; Hovet, Regina; Williams, Velda; Massung, Robert; McQuiston, Jennifer H.			Community-Based Control of the Brown Dog Tick in a Region with High Rates of Rocky Mountain Spotted Fever, 2012-2013	PLOS ONE			English	Article							RHIPICEPHALUS-SANGUINEUS TICKS; RICKETTSIA-RICKETTSII; EASTERN ARIZONA; LYME-DISEASE; PREVENTION; IXODIDAE; ACARI; PREVALENCE; EXPOSURE	Rocky Mountain spotted fever (RMSF) transmitted by the brown dog tick (Rhipicephalus sanguineus sensu lato) has emerged as a significant public health risk on American Indian reservations in eastern Arizona. During 2003-2012, more than 250 RMSF cases and 19 deaths were documented among Arizona's American Indian population. The high case fatality rate makes community-level interventions aimed at rapid and sustained reduction of ticks urgent. Beginning in 2012, a two year pilot integrated tick prevention campaign called the RMSF Rodeo was launched in a, similar to 600-home tribal community with high rates of RMSF. During year one, long-acting tick collars were placed on all dogs in the community, environmental acaricides were applied to yards monthly, and animal care practices such as spay and neuter and proper tethering procedures were encouraged. Tick levels, indicated by visible inspection of dogs, tick traps and homeowner reports were used to monitor tick presence and evaluate the efficacy of interventions throughout the project. By the end of year one, <1% of dogs in the RMSF Rodeo community had visible tick infestations five months after the project was started, compared to 64% of dogs in Non-Rodeo communities, and environmental tick levels were reduced below detectable levels. The second year of the project focused on use of the long-acting collar alone and achieved sustained tick control with fewer than 3% of dogs in the RMSF Rodeo community with visible tick infestations by the end of the second year. Homeowner reports of tick activity in the domestic and peridomestic setting showed similar decreases in tick activity compared to the non-project communities. Expansion of this successful project to other areas with Rhipicephalus-transmitted RMSF has the potential to reduce brown dog tick infestations and save human lives.	[Drexler, Naomi; Todd, Suzanne; Dahlgren, F. Scott; Bryant, Nelva; Massung, Robert; McQuiston, Jennifer H.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Miller, Mark; Gerding, Justin] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Todd, Suzanne; Adams, Laura] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Adams, Laura; Weis, Erica; Herrick, Kristen; Francies, Jessica; Komatsu, Kenneth] Arizona Dept Hlth Serv, Dept Publ Hlth Serv, Phoenix, AZ 85007 USA; [Weis, Erica] Intertribal Council Arizona Inc, Tribal Epidemiol Ctr, Phoenix, AZ USA; [Piontkowski, Stephen; Velascosoltero, Jose; Shelhamer, Timothy] Indian Hlth Serv, Off Environm Hlth & Engn, Phoenix Area Unit, Phoenix, AZ USA; [Hamilton, Brian] Indian Hlth Serv, Phoenix Area Unit, Phoenix, AZ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Arizona Department of Health Services	Drexler, N (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	isj3@cdc.gov	Dahlgren, Fredrick Scott/AAW-4396-2021	Dahlgren, Fredrick Scott/0000-0003-1790-2804; Drexler, Naomi/0000-0001-6998-5520	CDC Emerging Infections funds; PetSmart Charities; Indian Health Service and Housing and Urban Development; Centers for Disease Control and Prevention; Arizona Department of Health Services; Intertribal Council of Arizona Inc.; U.S. Department of Agriculture; Indian Health Service; Tribe B. Students and staff at North Carolina State University; Virginia-Maryland Regional College of Veterinary Medicine	CDC Emerging Infections funds; PetSmart Charities; Indian Health Service and Housing and Urban Development; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Arizona Department of Health Services; Intertribal Council of Arizona Inc.; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Indian Health Service(United States Department of Health & Human Services); Tribe B. Students and staff at North Carolina State University; Virginia-Maryland Regional College of Veterinary Medicine	Parts of this project were funded with CDC Emerging Infections funds. Spay and neuter services were partially provided through a grant from PetSmart Charities (http://www.petsmartcharities.org/pro/grants/spay-neuter) managed by the CDC Foundation. Bayer Healthcare donated Seresto collars and Bayer Advanced acaricidal spray that were used during the project. Funding provided by Indian Health Service and Housing and Urban Development permitted purchase of collars and product and spay-neuter services in 2013. Additionally, financial and personnel contributions have been provided by the Centers for Disease Control and Prevention, the Arizona Department of Health Services, Intertribal Council of Arizona Inc., U.S. Department of Agriculture, Indian Health Service, and Tribe B. Students and staff at North Carolina State University and the Virginia-Maryland Regional College of Veterinary Medicine donated their time in 2012 to help provide free spay and neuter capabilities to the tribe. Grantors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizona Department of Health Services, 2012, ROCK MOUNT SPOTT FEV; BURGDORFER W, 1975, J MED ENTOMOL, V12, P269, DOI 10.1093/jmedent/12.3.269; Centers for Disease Control and Prevention, 2014, MMWR SURVEILL SUMM, V61, P102; Chapman AS, 2006, MMWR RECOMM REP, V55, P19; Clark RP, 2008, INFECT DIS CLIN N AM, V22, P381, DOI 10.1016/j.idc.2008.03.007; Council of State and Territorial Epidemiologists, 2009, PUBL HLTH REP NAT NO; Cruz-Vazquez C, 1999, EXP APPL ACAROL, V23, P277, DOI 10.1023/A:1006075232455; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Dantas-Torres F, 2011, PARASITOLOGY, V138, P527, DOI 10.1017/S0031182010001502; Demma LJ, 2006, VECTOR-BORNE ZOONOT, V6, P423, DOI 10.1089/vbz.2006.6.423; Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043; Diniz PPVP, 2010, VECTOR-BORNE ZOONOT, V10, P117, DOI 10.1089/vbz.2008.0184; Fritz CL, 2012, ZOONOSES PUBLIC HLTH, V59, P4, DOI 10.1111/j.1863-2378.2011.01414.x; HATTWICK MAW, 1978, JAMA-J AM MED ASSOC, V240, P1499; IBM SPSS Data Collection Remote Interviewing Software, 2008, MRINTERVIEW 5 6; KOCH HG, 1986, ANN ENTOMOL SOC AM, V79, P11, DOI 10.1093/aesa/79.1.11; KOCH HG, 1982, J MED ENTOMOL, V19, P293, DOI 10.1093/jmedent/19.3.293; Marshall GS, 2003, ARCH PEDIAT ADOL MED, V157, P443, DOI 10.1001/archpedi.157.5.443; McQuiston JH, 2011, ZOONOSES PUBLIC HLTH, V58, P85, DOI 10.1111/j.1863-2378.2009.01300.x; Nicholson WL, 2006, ANN NY ACAD SCI, V1078, P338, DOI 10.1196/annals.1374.065; Nicholson WL, 2006, ANN NY ACAD SCI, V1078, P519, DOI 10.1196/annals.1374.102; NORMENT BR, 1984, AM J VET RES, V45, P1706; Openshaw JJ, 2010, AM J TROP MED HYG, V83, P174, DOI 10.4269/ajtmh.2010.09-0752; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Range B., 2001, LEVEL 3 ECOREGIONS A, P175; SAS Institute Inc, 2011, SAS STAT STAT SOFTW; SPACH DH, 1993, NEW ENGL J MED, V329, P936, DOI 10.1056/NEJM199309233291308; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-102; Tinoco-Gracia L, 2009, VET REC, V164, P59, DOI 10.1136/vr.164.2.59; U.S. Census Bureau, 2010, PROF GEN POP HOUS CH; U.S. Department of Commerce, 2014, 1981 2010 STAT NORM; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wilson ME, 2002, MED CLIN N AM, V86, P219, DOI 10.1016/S0025-7125(03)00084-1; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	35	43	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112368	10.1371/journal.pone.0112368	http://dx.doi.org/10.1371/journal.pone.0112368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479289	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907200009
J	Kolb, D; Pritz, E; Steinecker-Frohnwieser, B; Lohberger, B; Deutsch, A; Kroneis, T; El-Heliebi, A; Dohr, G; Meditz, K; Wagner, K; Koefeler, H; Leitinger, G; Leithner, A; Liegl-Atzwanger, B; Zweytick, D; Rinner, B				Kolb, Dagmar; Pritz, Elisabeth; Steinecker-Frohnwieser, Bibiane; Lohberger, Birgit; Deutsch, Alexander; Kroneis, Thomas; El-Heliebi, Amin; Dohr, Gottfried; Meditz, Katharina; Wagner, Karin; Koefeler, Harald; Leitinger, Gerd; Leithner, Andreas; Liegl-Atzwanger, Bernadette; Zweytick, Dagmar; Rinner, Beate			Extended Ultrastructural Characterization of Chordoma Cells: The Link to New Therapeutic Options	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; GLUCOSYLCERAMIDE SYNTHASE; ION CHANNELS; CANCER; CA2+; MITOCHONDRIA; SPHINGOLIPIDS; APOPTOSIS; SURVIVAL; TUMOR	Chordomas are rare bone tumors, developed from the notochord and largely resistant to chemotherapy. A special feature of this tumor is the heterogeneity of its cells. By combining high pressure freezing (HPF) with electron tomography we were able to illustrate the connections within the cells, the cell-cell interface, and the mitochondria-associated endoplasmic reticulum membrane complex that appears to play a special role among the characteristics of chordoma. These lipid raft-like regions are responsible for lipid syntheses and for calcium signaling. Compared to other tumor cells, chordoma cells show a close connection of rough endoplasmic reticulum and mitochondria, which may influence the sphingolipid metabolism and calcium release. We quantified levels of ceramide and glycosylceramide species by the methyl tert-butyl ether extraction method and we assessed the intracellular calcium concentration with the ratiometric fluorescent dye Fura-2(AM). Measurements of the changes in the intracellular calcium concentration revealed an increase in calcium due to the application of acetylcholine. With regard to lipid synthesis, glucosylceramide levels in the chordoma cell line were significantly higher than those in normal healthy cells. The accumulation of glycosylceramide in drug resistant cancer cells has been confirmed in many types of cancer and may also account for drug resistance in chordoma. This study aimed to provide a deep morphological description of chordoma cells, it demonstrated that HPF analysis is useful in elucidating detailed structural information. Furthermore we demonstrate how an accumulation of glycosylceramide in chordoma provides links to drug resistance and opens up the field for new research options.	[Kolb, Dagmar; Meditz, Katharina; Wagner, Karin; Koefeler, Harald; Rinner, Beate] Med Univ Graz, Med Res Ctr, Graz, Austria; [Kolb, Dagmar; Pritz, Elisabeth; Kroneis, Thomas; El-Heliebi, Amin; Dohr, Gottfried; Leitinger, Gerd] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Steinecker-Frohnwieser, Bibiane] Ludwig Boltzmann Cluster Rheumatol Balneol & Reha, Ludwig Boltzmann Inst Rehabil Internal Dis, Saalfelden, Austria; [Lohberger, Birgit; Leithner, Andreas] Med Univ Graz, Dept Orthopaed Surg, Graz, Austria; [Deutsch, Alexander] Med Univ Graz, Div Hematol, Dept Internal Med, Graz, Austria; [Liegl-Atzwanger, Bernadette] Med Univ Graz, Inst Pathol, Graz, Austria; [Zweytick, Dagmar] Graz Univ, Div Biophys, Inst Mol Biosci, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Rinner, B (corresponding author), Med Univ Graz, Med Res Ctr, Graz, Austria.	beate.rinner@medunigraz.at	Kroneis, Thomas/D-1373-2011; Dohr, Gottfried/E-8070-2010; Deutsch, Alexander AJ/F-2168-2010	Kroneis, Thomas/0000-0002-4761-9340; Deutsch, Alexander AJ/0000-0003-0914-2809; Rinner, Beate/0000-0002-6340-4905; Zweytick, Dagmar/0000-0002-4766-7713; Steinecker-Frohnwieser, Bibiane/0000-0001-6852-4466; Leitinger, Gerd/0000-0002-5281-9830; Kofeler, Harald/0000-0002-2725-9616	Medical University of Graz	Medical University of Graz	Financial support from the Medical University of Graz is gratefully acknowledged. No commercial benefits of any kind have been or will be received from institutions related directly or indirectly to the subject of the manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Casali PG, 2007, CURR OPIN ONCOL, V19, P367, DOI 10.1097/CCO.0b013e3281214448; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Don AS, 2014, BIOMOLECULES, V4, P315, DOI 10.3390/biom4010315; El-Heliebi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087663; ERLANDSON RA, 1968, CANCER RES, V28, P2115; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Kok JW, 2000, INT J CANCER, V87, P172, DOI 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Liu Ying, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1727; Lucci A, 1998, ANTICANCER RES, V18, P475; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; MORTON DL, 1994, PROG BRAIN RES, V101, P251; Muro Kenji, 2007, Expert Rev Neurother, V7, P1295, DOI 10.1586/14737175.7.10.1295; Nibu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826435; Nicholson KM, 1999, BRIT J CANCER, V81, P423, DOI 10.1038/sj.bjc.6690711; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Rinner B, 2012, INT J ONCOL, V40, P443, DOI 10.3892/ijo.2011.1235; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Sciubba DM, 2008, NEUROSURG CLIN N AM, V19, P5, DOI 10.1016/j.nec.2007.09.006; Sietsma H, 2001, J MEMBRANE BIOL, V181, P153, DOI 10.1007/s00232-001-0033-1; Smoll NR, 2013, CANCER-AM CANCER SOC, V119, P2029, DOI 10.1002/cncr.28032; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; THURIN J, 1986, FEBS LETT, V208, P17, DOI 10.1016/0014-5793(86)81522-8; Vance JE, 2013, BIOCHIM BIOPHYS ACTA, V1841, P595; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; Williams BJ, 2013, J NATL COMPR CANC NE, V11, P726, DOI 10.6004/jnccn.2013.0089; Yamaguchi T, 2005, MODERN PATHOL, V18, P1005, DOI 10.1038/modpathol.3800378	45	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114251	10.1371/journal.pone.0114251	http://dx.doi.org/10.1371/journal.pone.0114251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479055	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200056
J	Melendreras, SG; Martinez-Camblor, P; Menendez, A; Bravo-Mendoza, C; Gonzalez-Vidal, A; Coto, E; Diaz-Corte, C; Ruiz-Ortega, M; Lopez-Larrea, C; Suarez-Alvarez, B				Melendreras, Susana G.; Martinez-Camblor, Pablo; Menendez, Aurora; Bravo-Mendoza, Cristina; Gonzalez-Vidal, Ana; Coto, Eliecer; Diaz-Corte, Carmen; Ruiz-Ortega, Marta; Lopez-Larrea, Carlos; Suarez-Alvarez, Beatriz			Soluble Co-Signaling Molecules Predict Long-Term Graft Outcome in Kidney-Transplanted Patients	PLOS ONE			English	Article							ANTI-CD40 MONOCLONAL-ANTIBODY; T-CELL-ACTIVATION; COSTIMULATORY MOLECULES; ACUTE REJECTION; RENAL-DISEASE; CD30 LEVELS; LIGAND; 4-1BB; PROLIFERATION; INFLAMMATION	Co-signaling molecules are responsible for full T-cell activation after solid organ transplantation. Their increased expression can lead to the release of a soluble form that can modulate the immune response post-transplantation. We analyzed the presence of co-signaling molecules (sCD30, sCD40, sCD137, sCTLA-4, sCD80, sCD28, sCD40L, sPD-1, and sPD-L1) in serum from kidney-transplanted patients (n=59) obtained at different times (before transplantation, and 15 days, 3 months and 1 year post-transplantation) and their contribution to graft outcome was evaluated using principal component analysis. Before transplantation, high levels of soluble co-signaling molecules (mainly sCD30, sCD137 and sCD40) were detected in all patients. These molecules were modulated soon after receiving an allograft but never attained similar levels to those of healthy controls. A signature based on the determination of six soluble co-stimulatory (sCD30, sCD40, sCD137 and sCD40L) and co-inhibitory (sPD-1 and sPD-L1) molecules at 3 months post-transplantation allowed a group of patients to be identified (27.12%) with a worse long-term graft outcome. Patients with high levels of soluble molecules showed a progressive and gradual deterioration of kidney function (increased creatinine and proteinuria levels and decreased estimated glomerular filtration rate) over time and a higher risk of graft loss at 6 years post-transplantation than patients with low levels of these molecules (62.55% versus 5.14%, p<0.001). Thus, our data show an aberrant expression of soluble co-signaling molecules in kidney-transplanted patients whose quantification at 3 months post-transplantation might be a useful biomarker of immune status and help to predict long-term graft evolution.	[Melendreras, Susana G.; Diaz-Corte, Carmen] Hosp Univ Cent Asturias, Dept Nephrol, Oviedo, Spain; [Melendreras, Susana G.] Hosp Son Llatzer, Dept Nephrol, Palma De Mallorca, Spain; [Martinez-Camblor, Pablo; Gonzalez-Vidal, Ana] Oficina Invest Biosanitaria Asturias OIB FICYT, Oviedo, Spain; [Martinez-Camblor, Pablo] Univ Autonoma Chile, Santiago, Chile; [Menendez, Aurora; Bravo-Mendoza, Cristina; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Coto, Eliecer] Hosp Univ Cent Asturias, Genet Mol Lab Med, Oviedo, Spain; [Ruiz-Ortega, Marta; Suarez-Alvarez, Beatriz] Univ Autonoma Madrid, Fdn Jimenez Diaz, Inst Invest Sanitaria, Cellular Biol Renal Dis Lab, Madrid, Spain; [Coto, Eliecer; Diaz-Corte, Carmen; Ruiz-Ortega, Marta; Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain	Central University Hospital Asturias; Hospital Universitari Son Llatzer; Universidad Autonoma de Chile; Central University Hospital Asturias; Central University Hospital Asturias; Autonomous University of Madrid; Fundacion Jimenez Diaz	Lopez-Larrea, C (corresponding author), Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain.	inmuno@hca.es; beatriz.suarez@fjd.es	Stefanadis, Christodoulos/ABH-2232-2020; Ruiz-Ortega, Marta/D-3584-2012; Camblor, Pablo Martinez/Z-4834-2019; Ortega, Marta Ruiz/AAN-2136-2020; Martinez-Camblor, Pablo/Q-1715-2015; RG, SMABSS/N-3322-2018; ruiz-ortega, marta/D-3584-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Ruiz-Ortega, Marta/0000-0002-1495-6535; Camblor, Pablo Martinez/0000-0001-7845-3905; Ortega, Marta Ruiz/0000-0002-1495-6535; RG, SMABSS/0000-0001-9944-3861; ruiz-ortega, marta/0000-0002-1403-2690; Lopez-Larrea, Carlos/0000-0001-9988-1730; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Plan Nacional de I+D+I; Fondo de Investigaciones Sanitaria-Fondos (FIS); FEDER European Union [PI12/02587]; Red de Investigacion Renal REDinREN [RD06/0016/1006, RD12/0021]; Institute Carlos III, Spain [002, 012, 018, 021]	Plan Nacional de I+D+I; Fondo de Investigaciones Sanitaria-Fondos (FIS); FEDER European Union(European Commission); Red de Investigacion Renal REDinREN; Institute Carlos III, Spain	This work was supported by Plan Nacional de I+D+I 2008-2011, Spanish grants from the Fondo de Investigaciones Sanitaria-Fondos (FIS), FEDER European Union (PI12/02587), and the Red de Investigacion Renal REDinREN RD06/0016/1006 and RD12/0021 (groups 002, 012, 018 and 021) from the Institute Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Boenisch O, 2010, J IMMUNOL, V185, P5806, DOI 10.4049/jimmunol.0903435; Cao J, 2012, INT IMMUNOPHARMACOL, V14, P585, DOI 10.1016/j.intimp.2012.08.004; Capece D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/926321; Cervelli C, 2009, TRANSPL P, V41, P1159, DOI 10.1016/j.transproceed.2009.03.077; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen YL, 2012, TRANSPLANTATION, V94, P911, DOI 10.1097/TP.0b013e31826784ad; Contin C, 2003, IMMUNOLOGY, V110, P131, DOI 10.1046/j.1365-2567.2003.01716.x; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; D'Addio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060391; D'Addio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053797; D'Addio F, 2011, J IMMUNOL, V187, P4530, DOI 10.4049/jimmunol.1002031; Domingues EMFL, 2010, CLIN TRANSPLANT, V24, P821, DOI 10.1111/j.1399-0012.2009.01182.x; Esposito P, 2012, CELL IMMUNOL, V278, P10, DOI 10.1016/j.cellimm.2012.06.007; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Grinyo JM, 2013, EXPERT OPIN DRUG SAF, V12, P111, DOI 10.1517/14740338.2013.748747; Her M, 2009, LUPUS, V18, P501, DOI 10.1177/0961203308099176; Huang JP, 2013, J IMMUNOL, V190, P6250, DOI 10.4049/jimmunol.1300022; Huang JP, 2012, BLOOD, V120, P3030, DOI 10.1182/blood-2012-05-427799; Kamali K, 2009, EXP CLIN TRANSPLANT, V7, P237; Kashizuka H, 2005, TRANSPLANTATION, V79, P1045, DOI 10.1097/01.TP.0000161665.35243.21; Kennedy MK, 2006, IMMUNOLOGY, V118, P143, DOI 10.1111/j.1365-2567.2006.02354.x; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Kovac J, 2010, TRANSPL P, V42, P4043, DOI 10.1016/j.transproceed.2010.09.050; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lisowska KA, 2012, J CLIN IMMUNOL, V32, P189, DOI 10.1007/s10875-011-9603-x; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; Meijers RWJ, 2014, TRANSPL INT, V27, P1272, DOI 10.1111/tri.12416; Meijers RWJ, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-19; Pelzl S, 2002, TRANSPLANTATION, V73, P3, DOI 10.1097/00007890-200201150-00002; Rajakariar R, 2005, AM J TRANSPLANT, V5, P1922, DOI 10.1111/j.1600-6143.2005.00966.x; Riella LV, 2011, KIDNEY INT SUPPL, V1, P25, DOI 10.1038/kisup.2011.8; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rodriguez LM, 2007, HUM IMMUNOL, V68, P652, DOI 10.1016/j.humimm.2007.05.004; Rostaing L, 2013, AM J TRANSPLANT, V13, P2875, DOI 10.1111/ajt.12460; Sayegh MH, 1998, NEW ENGL J MED, V338, P1813, DOI 10.1056/NEJM199806183382506; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Song MY, 2011, J IMMUNOTHER, V34, P297, DOI 10.1097/CJI.0b013e318210ed0e; Steward-Tharp SM, 2010, ANN NY ACAD SCI, V1183, P123, DOI 10.1111/j.1749-6632.2009.05124.x; Susal C, 2011, TRANSPLANTATION, V91, P1364, DOI 10.1097/TP.0b013e31821aba74; Tanaka K, 2007, J IMMUNOL, V179, P5204, DOI 10.4049/jimmunol.179.8.5204; Velasquez SY, 2013, TRANSPLANTATION, V96, P154, DOI 10.1097/TP.0b013e318296fd69; Vinay DS, 2011, CELL MOL IMMUNOL, V8, P281, DOI 10.1038/cmi.2010.82; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Watanabe M, 2013, AM J TRANSPLANT, V13, P1976, DOI 10.1111/ajt.12330; Wong CK, 2008, J CLIN IMMUNOL, V28, P36, DOI 10.1007/s10875-007-9137-4; Wu YL, 2012, INT J BIOL SCI, V8, P1420, DOI 10.7150/ijbs.5273; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Yeung MY, 2011, AM J TRANSPLANT, V11, P2012, DOI 10.1111/j.1600-6143.2011.03727.x; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910	52	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113396	10.1371/journal.pone.0113396	http://dx.doi.org/10.1371/journal.pone.0113396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478957	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200020
J	Petryk, N; Zhou, YF; Sybirna, K; Mucchielli, MH; Guiard, B; Bao, WG; Stasyk, OV; Stasyk, OG; Krasovska, OS; Budin, K; Reymond, N; Imbeaud, S; Coudouel, S; Delacroix, H; Sibirny, A; Bolotin-Fukuhara, M				Petryk, Nataliya; Zhou, You-Fang; Sybirna, Kateryna; Mucchielli, Marie-Helene; Guiard, Bernard; Bao, Wei-Guo; Stasyk, Oleh V.; Stasyk, Olena G.; Krasovska, Olena S.; Budin, Karine; Reymond, Nancie; Imbeaud, Sandrine; Coudouel, Sophie; Delacroix, Herve; Sibirny, Andriy; Bolotin-Fukuhara, Monique			Functional Study of the Hap4-Like Genes Suggests That the Key Regulators of Carbon Metabolism HAP4 and Oxidative Stress Response YAP1 in Yeast Diverged from a Common Ancestor	PLOS ONE			English	Article							CCAAT-BINDING COMPLEX; SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; IRON-DEFICIENCY; FACTOR PHP4; EXPRESSION; PROTEIN; OVEREXPRESSION; EVOLUTION; CONTAINS	The transcriptional regulator HAP4, induced by respiratory substrates, is involved in the balance between fermentation and respiration in S. cerevisiae. We identified putative orthologues of the Hap4 protein in all ascomycetes, based only on a conserved sixteen amino acid-long motif. In addition to this motif, some of these proteins contain a DNA-binding motif of the bZIP type, while being nonetheless globally highly divergent. The genome of the yeast Hansenula polymorpha contains two HAP4-like genes encoding the protein HpHap4-A which, like ScHap4, is devoid of a bZIP motif, and HpHap4-B which contains it. This species has been chosen for a detailed examination of their respective properties. Based mostly on global gene expression studies performed in the S. cerevisiae HAP4 disruption mutant (Sc Delta hap4), we show here that HpHap4-A is functionally equivalent to ScHap4, whereas HpHap4-B is not. Moreover HpHAP4-B is able to complement the H2O2 hypersensitivity of the ScYap1 deletant, YAP1 being, in S. cerevisiae, the main regulator of oxidative stress. Finally, a transcriptomic analysis performed in theSc Delta yap1 strain overexpressing HpHAP4-B shows that HpHap4-B acts both on oxidative stress response and carbohydrate metabolism in a manner different from both ScYap1 and ScHap4. Deletion of these two genes in their natural host, H. polymorpha, confirms that HpHAP4-A participates in the control of the fermentation/respiration balance, while HpHAP4-B is involved in oxidative stress since its deletion leads to hypersensitivity to H2O2. These data, placed in an evolutionary context, raise new questions concerning the evolution of the HAP4 transcriptional regulation function and suggest that Yap1 and Hap4 have diverged from a unique regulatory protein in the fungal ancestor.	[Petryk, Nataliya; Zhou, You-Fang; Sybirna, Kateryna; Bao, Wei-Guo; Budin, Karine; Bolotin-Fukuhara, Monique] Univ Paris 11, Inst Genet & Microbiol, IFR Genome 115, F-91405 Orsay, France; [Petryk, Nataliya; Zhou, You-Fang; Sybirna, Kateryna; Bao, Wei-Guo; Budin, Karine; Bolotin-Fukuhara, Monique] CNRS, F-91405 Orsay, France; [Petryk, Nataliya; Stasyk, Oleh V.; Stasyk, Olena G.; Krasovska, Olena S.; Sibirny, Andriy] Natl Acad Sci, Inst Cell Biol, Lvov, Ukraine; [Mucchielli, Marie-Helene; Budin, Karine; Reymond, Nancie; Imbeaud, Sandrine; Coudouel, Sophie; Delacroix, Herve] Gif Orsay DNA MicroArray Platform, Gif Sur Yvette, France; [Petryk, Nataliya; Mucchielli, Marie-Helene; Guiard, Bernard; Reymond, Nancie; Delacroix, Herve] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Stasyk, Olena G.] Ivan Franko Lviv Natl Univ, Dept Biochem, Lvov, Ukraine; [Sibirny, Andriy] Univ Rzeszow, Rzeszow, Poland	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); National Academy of Sciences Ukraine; Institute of Cell Biology of NASU; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv; University of Rzeszow	Bolotin-Fukuhara, M (corresponding author), Univ Paris 11, Inst Genet & Microbiol, IFR Genome 115, F-91405 Orsay, France.	monique.bolotin@u-psud.fr	Stasyk, Oleh/E-9496-2019; Stasyk, Olena/K-9254-2017; Imbeaud, Sandrine/P-8780-2017	Stasyk, Oleh/0000-0001-8135-6102; Stasyk, Olena/0000-0002-0253-2372; Imbeaud, Sandrine/0000-0001-8439-6732; Sibirny, Andriy/0000-0001-8579-1566; Bolotin-Fukuhara, Monique/0000-0002-5285-5006; Petryk, Nataliya/0000-0001-8629-1475	CNRS [UMR8621]; EC [GARNISH QLK3-2000-174]; French government; bilateral CNRS-Ukrainian NAS program; Ile de France; FEBS collaborative experimental Scholarship for Central and Eastern Europe; INTAS [05-109-4177]	CNRS(Centre National de la Recherche Scientifique (CNRS)); EC(European CommissionEuropean Commission Joint Research Centre); French government; bilateral CNRS-Ukrainian NAS program; Ile de France; FEBS collaborative experimental Scholarship for Central and Eastern Europe; INTAS(INTASEuropean Commission)	Experiments were funded by recurrent national fundings (CNRS and University) to the IGM (UMR8621). The EC contract GARNISH QLK3-2000-174 to MBF contributed to the start of this work. NP was supported by a French government fellowship for joint PhD, a bilateral CNRS-Ukrainian NAS program and a regional support from Ile de France grant for joint PhD. KS was supported by a FEBS collaborative experimental Scholarship for Central and Eastern Europe and an INTAS fellowship grant for young Scientist (05-109-4177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoutzias GD, 2004, COMP FUNCT GENOM, V5, P79, DOI 10.1002/cfg.365; Bao WG, 2008, EUKARYOT CELL, V7, P1895, DOI 10.1128/EC.00018-08; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; BOSSIER P, 1993, J BIOL CHEM, V268, P23640; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x; Brakhage AA, 1999, FUNGAL GENET BIOL, V27, P243, DOI 10.1006/fgbi.1999.1136; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Delahodde A, 2001, MOL MICROBIOL, V39, P304, DOI 10.1046/j.1365-2958.2001.02182.x; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Dumond H, 2000, MOL MICROBIOL, V36, P830, DOI 10.1046/j.1365-2958.2000.01845.x; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464; Goffeau A, 2000, FEBS LETT, V480, P37, DOI 10.1016/S0014-5793(00)01775-0; HOEFNAGEL MHN, 1995, EUR J BIOCHEM, V233, P531, DOI 10.1111/j.1432-1033.1995.531_2.x; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Kaniuga Z, 1969, INHIBITORS TOOLS CEL, P282; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lascaris R, 2004, MICROBIOL-SGM, V150, P929, DOI 10.1099/mic.0.26742-0; Lascaris R, 2003, GENOME BIOL, V4; Lelandais G, 2011, CR BIOL, V334, P655, DOI 10.1016/j.crvi.2011.05.014; LEVINE DW, 1973, APPL MICROBIOL, V26, P982, DOI 10.1128/AEM.26.6.982-990.1973; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marisa L, 2007, BIOINFORMATICS, V23, P2339, DOI 10.1093/bioinformatics/btm321; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; OLESEN JT, 1991, MOL CELL BIOL, V11, P611, DOI 10.1128/MCB.11.2.611; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; SUDBERY PE, 1988, BIOCHEM SOC T, V16, P1081; Sybirna K, 2005, CURR GENET, V47, P172, DOI 10.1007/s00294-004-0556-y; Sybirna K, 2010, YEAST, V27, P941, DOI 10.1002/yea.1802; TAN XQ, 1995, J CELL BIOL, V128, P307, DOI 10.1083/jcb.128.3.307; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Veiga A, 2003, FEMS YEAST RES, V3, P141, DOI 10.1016/S1567-1356(02)00189-7; Voronovsky AY, 2005, FEMS YEAST RES, V5, P1055, DOI 10.1016/j.femsyr.2005.09.001	54	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112263	10.1371/journal.pone.0112263	http://dx.doi.org/10.1371/journal.pone.0112263			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479159	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200007
J	Prahm, KP; Witting, N; Vissing, J				Prahm, Kira P.; Witting, Nanna; Vissing, John			Decreased Variability of the 6-Minute Walk Test by Heart Rate Correction in Patients with Neuromuscular Disease	PLOS ONE			English	Article							RELIABILITY	Objective: The 6-minute walk test is widely used to assess functional status in neurological disorders. However, the test is subject to great inter-test variability due to fluctuating motivation, fatigue and learning effects. We investigated whether inter-test variability of the 6MWT can be reduced by heart rate correction. Methods: Sixteen patients with neuromuscular diseases, including Facioscapulohumeral muscular dystrophy, Limb-girdle muscular dystrophy, Charcot-Marie-Tooths, Dystrophia Myotonica and Congenital Myopathy and 12 healthy subjects were studied. Patients were excluded if they had cardiac arrhythmias, if they received drug treatment for hypertension or any other medical conditions that could interfere with the interpretation of the heart rate and walking capability. All completed three 6-minute walk tests on three different test-days. Heart rate was measured continuously. Results: Successive standard 6-minute walk tests showed considerable learning effects between Tests 1 and 2 (4.9%; P=0.026), and Tests 2 and 3 (4.5%; P=0.020) in patients. The same was seen in controls between Tests 1 and 2 (8.1%; P=0.039)). Heart rate correction abolished this learning effect. Conclusion: A modified 6-minute walk test, by correcting walking distance with average heart rate during walking, decreases the variability among repeated 6-minute walk tests, and should be considered as an alternative outcome measure to the standard 6-minute walk test in future clinical follow-up and treatment trials.	[Prahm, Kira P.; Witting, Nanna; Vissing, John] Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Dept Neurol, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Vissing, J (corresponding author), Univ Copenhagen, Rigshosp, Neuromuscular Res Unit, Dept Neurol, DK-1168 Copenhagen, Denmark.	john.vissing@regionh.dk		Witting, Nanna/0000-0002-0664-0709				[Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; ASTRAND PO, 1986, TXB WORK PHYSL PHYSL, P354; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Camarri B, 2006, RESP MED, V100, P658, DOI 10.1016/j.rmed.2005.08.003; Guyton A.C., 2006, TXB MED PHYSL, P1062; Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003; Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010; Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1097/00005768-200301000-00025; Kierkegaard M, 2007, NEUROMUSCULAR DISORD, V17, P943, DOI 10.1016/j.nmd.2007.08.003; KNOX AJ, 1988, THORAX, V43, P388, DOI 10.1136/thx.43.5.388; Wu G, 2003, AM HEART J, V146, P129, DOI 10.1016/S0002-8703(03)00119-4	11	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114273	10.1371/journal.pone.0114273	http://dx.doi.org/10.1371/journal.pone.0114273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479403	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200062
J	Fu, F; Li, B; Dai, M; Hu, SJ; Li, X; Xu, CH; Wang, B; Yang, B; Tang, MX; Dong, XZ; Fei, Z; Shi, XT				Fu, Feng; Li, Bing; Dai, Meng; Hu, Shi-Jie; Li, Xia; Xu, Can-Hua; Wang, Bing; Yang, Bin; Tang, Meng-Xing; Dong, Xiu-Zhen; Fei, Zhou; Shi, Xue-Tao			Use of Electrical Impedance Tomography to Monitor Regional Cerebral Edema during Clinical Dehydration Treatment	PLOS ONE			English	Article							BRAIN; MANNITOL; HEMORRHAGE; PRESSURE; THERAPY; INJURY; MODEL; HEAD	Objective: Variations of conductive fluid content in brain tissue (e. g. cerebral edema) change tissue impedance and can potentially be measured by Electrical Impedance Tomography (EIT), an emerging medical imaging technique. The objective of this work is to establish the feasibility of using EIT as an imaging tool for monitoring brain fluid content. Design: a prospective study. Setting: In this study EIT was used, for the first time, to monitor variations in cerebral fluid content in a clinical model with patients undergoing clinical dehydration treatment. The EIT system was developed in house and its imaging sensitivity and spatial resolution were evaluated on a saline-filled tank. Patients: 23 patients with brain edema. Interventions: The patients were continuously imaged by EIT for two hours after initiation of dehydration treatment using 0.5 g/kg intravenous infusion of mannitol for 20 minutes. Measurement and Main Results: Overall impedance across the brain increased significantly before and after mannitol dehydration treatment (p=0.0027). Of the all 23 patients, 14 showed high-level impedance increase and maintained this around 4 hours after the dehydration treatment whereas the other 9 also showed great impedance gain during the treatment but it gradually decreased after the treatment. Further analysis of the regions of interest in the EIT images revealed that diseased regions, identified on corresponding CT images, showed significantly less impedance changes than normal regions during the monitoring period, indicating variations in different patients' responses to such treatment. Conclusions: EIT shows potential promise as an imaging tool for real-time and non-invasive monitoring of brain edema patients.	[Fu, Feng; Dai, Meng; Xu, Can-Hua; Yang, Bin; Dong, Xiu-Zhen; Shi, Xue-Tao] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Li, Bing; Hu, Shi-Jie; Li, Xia; Wang, Bing; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Neurosurg Unit, Xian 710032, Peoples R China; [Tang, Meng-Xing] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Air Force Military Medical University; Air Force Military Medical University; Imperial College London	Dong, XZ (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.	dongxiuzhen@fmmu.edu.cn; feizhou@fmmu.edu.cn; shixuetao@fmmu.edu.cn		Yang, Bin/0000-0001-9687-5968; Fu, Feng/0000-0002-4286-5227	National Key Technology R&D Program of China [2011BAI08B13, 2012BAI20B02]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work is partially supported by National Key Technology R&D Program of China under grant No. 2011BAI08B13 and 2012BAI20B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellani G, 2012, CURR OPIN CRIT CARE, V18, P29, DOI 10.1097/MCC.0b013e32834eb47d; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; BOONE K, 1994, PHYSIOL MEAS, V15, pA189, DOI 10.1088/0967-3334/15/2A/024; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Burgess A, 2014, J CONTROL RELEASE, V192, P243, DOI 10.1016/j.jconrel.2014.07.051; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Dai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055020; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Frerichs I, 2013, PHYSIOL MEAS, V34, P567, DOI 10.1088/0967-3334/34/6/567; Gibson A, 2000, PHYSIOL MEAS, V21, P45, DOI 10.1088/0967-3334/21/1/306; Gilad O, 2009, NEUROIMAGE, V47, P514, DOI 10.1016/j.neuroimage.2009.04.085; Gregson BA, 2001, J NEUROL NEUROSUR PS, V70, P138; Harting MT, 2010, J SURG RES, V159, P557, DOI 10.1016/j.jss.2008.10.014; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; Ho ML, 2012, AM J ROENTGENOL, V199, pW258, DOI 10.2214/AJR.11.8081; Holder DS, 1996, PHYSIOL MEAS, V17, pA179, DOI 10.1088/0967-3334/17/4A/022; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Li JB, 2014, IEEE T BIO-MED ENG, V61, P254, DOI 10.1109/TBME.2013.2288133; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; Marmarou A, 2003, ACT NEUR S, V86, P7; Nguyen GT, 2013, NEUROIMAGE-CLIN, V2, P658, DOI 10.1016/j.nicl.2013.04.004; On NH, 2011, PHARM RES-DORDR, V28, P2505, DOI 10.1007/s11095-011-0478-6; Sadleir RJ, 2001, IEEE T BIO-MED ENG, V48, P484, DOI 10.1109/10.915715; Shi XT, 2005, P ANN INT IEEE EMBS, P1492, DOI 10.1109/IEMBS.2005.1616714; Tang T, 2010, ANN BIOMED ENG, V38, P2733, DOI 10.1007/s10439-010-0003-9; Tidswell T, 2001, NEUROIMAGE, V13, P283, DOI 10.1006/nimg.2000.0698; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Wang K, 2009, CHINESE MED J-PEKING, V122, P1501, DOI 10.3760/cma.j.issn.0366-6999.2009.13.005; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu CH, 2011, PHYSIOL MEAS, V32, P585, DOI 10.1088/0967-3334/32/5/007	32	33	37	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113202	10.1371/journal.pone.0113202	http://dx.doi.org/10.1371/journal.pone.0113202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474474	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500077
J	Wang, X; Xu, J; Zhu, YX; Li, JK; Zhou, S; Tian, SL; Xiang, YC; Liu, XM; Zheng, Y; Pan, T				Wang, Xi; Xu, Jing; Zhu, Yuexing; Li, Jiukun; Zhou, Si; Tian, Shunliang; Xiang, Yucheng; Liu, Xingmo; Zheng, Ying; Pan, Tao			Biomechanical Analysis of a Newly Developed Shape Memory Alloy Hook in a Transforaminal Lumbar Interbody Fusion (TLIF) In Vitro Model	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; CORROSION BEHAVIOR; SPINAL-FUSION; POSTERIOR; COMPLICATIONS; STABILITY; SEGMENTS	Objective: The objective of this biomechanical study was to evaluate the stability provided by a newly developed shape memory alloy hook (SMAH) in a cadaveric transforaminal lumbar interbody fusion (TLIF) model. Methods: Six human cadaveric spines (L1-S2) were tested in an in vitro flexibility experiment by applying pure moments of +/- 8 Nm in flexion/extension, left/right lateral bending, and left/right axial rotation. After intact testing, a TLIF was performed at L4-5. Each specimen was tested for the following constructs: unilateral SMAH (USMAH); bilateral SMAH (BSMAH); unilateral pedicle screws and rods (UPS); and bilateral pedicle screws and rods (BPS). The L3-L4, L4-L5, and L5-S1 range of motion (ROM) were recorded by a Motion Analysis System. Results: Compared to the other constructs, the BPS provided the most stability. The UPS significantly reduced the ROM in extension/flexion and lateral bending; the BSMAH significantly reduced the ROM in extension/flexion, lateral bending, and axial rotation; and the USMAH significantly reduced the ROM in flexion and left lateral bending compared with the intact spine (p<0.05). The USMAH slightly reduced the ROM in extension, right lateral bending and axial rotation (p<0.05). Stability provided by the USMAH compared with the UPS was not significantly different. ROMs of adjacent segments increased in all fixed constructs (p. 0.05). Conclusions: Bilateral SMAH fixation can achieve immediate stability after L4-5 TLIF in vitro. Further studies are required to determine whether the SMAH can achieve fusion in vivo and alleviate adjacent segment degeneration.	[Wang, Xi; Xu, Jing; Zhu, Yuexing; Li, Jiukun; Xiang, Yucheng; Liu, Xingmo; Pan, Tao] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Si; Tian, Shunliang] Guilin Med Coll, Dept Anat, Guilin, Peoples R China; [Zheng, Ying] Guangdong Gen Hosp, Dept Nutr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guilin Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Pan, T (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China.	Pantao_sysu@163.com			International Program of Project 985, Sun Yat-Sen University	International Program of Project 985, Sun Yat-Sen University	This works was supported by the International Program of Project 985, Sun Yat-Sen University, http://202.116.66.140/Item/4433.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad M, 2002, BIO-MED MATER ENG, V12, P225; BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603; Cakir B, 2009, SPINE, V34, P1287, DOI 10.1097/BRS.0b013e3181a136ab; Carroll WM, 2003, J BIOMED MATER RES A, V67A, P1123, DOI 10.1002/jbm.a.10099; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Cho TK, 2014, J NEUROL SURG PART A, V75, P270, DOI 10.1055/s-0033-1349331; Chrastil J, 2012, J AM ACAD ORTHOP SUR, V20, P283, DOI 10.5435/JAAOS-20-05-283; Christensen A, 2014, EUR SPINE J, V23, P1137, DOI 10.1007/s00586-014-3238-6; CLOSKEY RF, 1993, SPINE, V18, P1011, DOI 10.1097/00007632-199306150-00010; Cole CD, 2009, CURR REV MUSCULOSKE, V2, P118, DOI 10.1007/s12178-009-9053-8; Driscoll M, 2011, MED BIOL ENG COMPUT, V49, P1437, DOI 10.1007/s11517-011-0801-8; Faundez AA, 2008, J SPINAL DISORD TECH, V21, P175, DOI 10.1097/BSD.0b013e318074bb7d; Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2; Fu LJ, 2014, SPINE, V39, P805, DOI 10.1097/BRS.0000000000000283; Harms J G, 1998, Oper Orthop Traumatol, V10, P90, DOI 10.1007/s00064-006-0112-7; Hatakeyama S, 2011, INT J NEPHROL, V2011; Humphreys SC, 2001, SPINE, V26, P567; Javernick Matthew A, 2003, Am J Orthop (Belle Mead NJ), V32, P344; Kawakita Eiji, 2012, Open Orthop J, V6, P239, DOI 10.2174/1874325001206010239; Lau D, 2011, J CLIN NEUROSCI, V18, P624, DOI 10.1016/j.jocn.2010.09.004; Li HF, 2014, J MATER SCI-MATER M, V25, P1249, DOI 10.1007/s10856-014-5158-8; Lowe TG, 2002, J SPINAL DISORD TECH, V15, P31, DOI 10.1097/00024720-200202000-00005; Mavrogenis AF, 2014, EUR J ORTHOP SURG TR, V1, P111, DOI DOI 10.1007/s00590-014-1421-4; Niesche M, 2014, CLIN NEUROL NEUROSUR, V124, P25, DOI 10.1016/j.clineuro.2014.06.020; Rohlmann A, 2007, EUR SPINE J, V16, P1223, DOI 10.1007/s00586-006-0292-8; Ryhanen J, 1997, J BIOMED MATER RES, V35, P451; Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0; Schmoelz W, 2003, J SPINAL DISORD TECH, V16, P418, DOI 10.1097/00024720-200308000-00015; Sengupta D, 2013, ADV ORTHOP, V2013, DOI 10.1155/2013/738252; Sethi A, 2011, SPINE J, V11, P863, DOI 10.1016/j.spinee.2011.06.015; Sim HB, 2010, J NEUROSURG-SPINE, V12, P700, DOI 10.3171/2009.12.SPINE09123; Soh J, 2013, ASIAN SPINE J, V7, P273, DOI 10.4184/asj.2013.7.4.273; Suk KS, 2000, SPINE, V25, P1843; Tormenti MJ, 2012, J NEUROSURG-SPINE, V16, P44, DOI 10.3171/2011.9.SPINE11373; Tsitsopoulos PP, 2012, J SPINAL DISORD TECH, V25, pE240, DOI 10.1097/BSD.0b013e31824c820c; Wang Y, 2010, EUR SPINE J, V19, P394, DOI 10.1007/s00586-009-1207-2; Xie YZ, 2012, ORTHOPEDICS, V35, pE1517, DOI 10.3928/01477447-20120919-22; Xu H, 2013, NEUROSURGERY, V73, P198, DOI 10.1227/01.neu.0000430320.39870.f7; Xue HM, 2012, SPINE J, V12, P209, DOI 10.1016/j.spinee.2012.01.010; Yan DL, 2008, EUR SPINE J, V17, P1311, DOI 10.1007/s00586-008-0739-1; YANG PJ, 1992, CHINESE MED J-PEKING, V105, P312; YANG SW, 1986, SPINE, V11, P937; Zhang Hui, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P1128	43	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114326	10.1371/journal.pone.0114326	http://dx.doi.org/10.1371/journal.pone.0114326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474112	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500014
J	Badiola, KA; Quan, DH; Triccas, JA; Todd, MH				Badiola, Katrina A.; Quan, Diana H.; Triccas, James A.; Todd, Matthew H.			Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science	PLOS ONE			English	Article							SOURCE DRUG DISCOVERY; MYCOBACTERIUM-TUBERCULOSIS; MEMBRANE; MMPL3; LEADS	Tuberculosis afflicts an estimated 2 billion people worldwide and causes 1.3 million deaths annually. Chemotherapeutic solutions rely on drugs developed many years ago, with only one new therapeutic having been approved in the last 40 years. Given the rise of drug-resistant strains, there is an urgent need for the development of a more robust drug development pipeline. GlaxoSmithKline recently placed the structures and activities of 177 novel anti-tubercular leads in the public domain, as well as the results of ongoing optimisation of some of the series. Since many of the compounds arose from screening campaigns, their provenance was unclear and synthetic routes were in many cases not reported. Here we present the efficient synthesis of several novel analogues of one family of the GSK compounds-termed "Spiros''-using an oxa-Pictet-Spengler reaction. The new compounds are attractive from a medicinal chemistry standpoint and some were potent against the virulent strain, suggesting this class is worthy of further study. The research was carried out using open source methodology, providing the community with full access to all raw experimental data in real time.	[Badiola, Katrina A.; Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Quan, Diana H.; Triccas, James A.] Univ Sydney, Dept Infect Dis & Immunol, Microbial Pathogenesis & Immun Grp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Todd, MH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au	Triccas, Jamie/AAD-7629-2020; Todd, Matthew/S-2678-2018	Todd, Matthew/0000-0001-7096-4751; Quan, Diana/0000-0002-7341-8921; Triccas, James/0000-0003-3730-2339	University of Sydney; National Health and Medical Research Council Centre of Research Excellence on Tuberculosis Control [APP1043225]	University of Sydney(University of Sydney); National Health and Medical Research Council Centre of Research Excellence on Tuberculosis Control	This work was supported by the University of Sydney (KAB, MHT) and the National Health and Medical Research Council Centre of Research Excellence on Tuberculosis Control (APP1043225)(JAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelMagid AF, 1996, J ORG CHEM, V61, P3849, DOI 10.1021/jo960057x; [Anonymous], 2012, INT GUID US BED TREA; [Anonymous], 2008, Clinical Trial, Patent No. [WO 2008155132 A1, 2008155132, NCT01218217]; Badiola K, 2013, ELECT LAB NOTEBOOK S; Badiola K, 2013, NMR DATA SYNTHESIS S; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Bouguerne B, 2010, SYNTHETIC COMMUN, V40, P915, DOI 10.1080/00397910903026715; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lun SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3907; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; MCCALLUM C, 1975, ELECTROCHIM ACTA, V20, P815, DOI 10.1016/0013-4686(75)87002-2; OLOFSON RA, 1984, J ORG CHEM, V49, P2081, DOI 10.1021/jo00185a072; OLOFSON RA, 1988, PURE APPL CHEM, V60, P1715, DOI 10.1351/pac198860111715; RAM S, 1987, SYNTHETIC COMMUN, V17, P415, DOI 10.1080/00397918708063919; Remuinan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060933; Robertson MN, 2014, PARASITOLOGY, V141, P148, DOI 10.1017/S0031182013001121; Shao L., 2011, Preparation of Thienopyranylmethanamine Derivatives and Analogs for Use as Nervous System Agents, Patent No. [WO2011069063A2, 2011069063]; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; WHO, 2013, WORLD HLTH ORG GLOB; Woelfle M, 2011, NAT CHEM, V3, P745, DOI 10.1038/nchem.1149; Zumia A, 2013, NAT REV DRUG DISCOV, V12, P388	24	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111782	10.1371/journal.pone.0111782	http://dx.doi.org/10.1371/journal.pone.0111782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493550	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400004
J	Miccoli, L; Delgado, R; Rodriguez-Ruiz, S; Guerra, P; Garcia-Marmol, E; Fernandez-Santaella, MC				Miccoli, Laura; Delgado, Rafael; Rodriguez-Ruiz, Sonia; Guerra, Pedro; Garcia-Marmol, Eduardo; Carmen Fernandez-Santaella, M.			Meet OLAF, a Good Friend of the IAPS! The Open Library of Affective Foods: A Tool to Investigate the Emotional Impact of Food in Adolescents	PLOS ONE			English	Article							AFFECTIVE PICTURE SYSTEM; EATING-DISORDERS; BRAIN RESPONSES; IMAGE DATABASE; HIGH-CALORIE; STIMULI; PREFERENCES; VALIDATION; ACTIVATION; PSYCHOLOGY	In the last decades, food pictures have been repeatedly employed to investigate the emotional impact of food on healthy participants as well as individuals who suffer from eating disorders and obesity. However, despite their widespread use, food pictures are typically selected according to each researcher's personal criteria, which make it difficult to reliably select food images and to compare results across different studies and laboratories. Therefore, to study affective reactions to food, it becomes pivotal to identify the emotional impact of specific food images based on wider samples of individuals. In the present paper we introduce the Open Library of Affective Foods (OLAF), which is a set of original food pictures created to reliably select food pictures based on the emotions they prompt, as indicated by affective ratings of valence, arousal, and dominance and by an additional food craving scale. OLAF images were designed to allow simultaneous use with affective images from the International Affective Picture System (IAPS), which is a well-known instrument to investigate emotional reactions in the laboratory. The ultimate goal of the OLAF is to contribute to understanding how food is emotionally processed in healthy individuals and in patients who suffer from eating and weight-related disorders. The present normative data, which was based on a large sample of an adolescent population, indicate that when viewing affective non-food IAPS images, valence, arousal, and dominance ratings were in line with expected patterns based on previous emotion research. Moreover, when viewing food pictures, affective and food craving ratings were consistent with research on food cue processing. As a whole, the data supported the methodological and theoretical reliability of the OLAF ratings, therefore providing researchers with a standardized tool to reliably investigate the emotional and motivational significance of food. The OLAF database is publicly available at zenodo.org.	[Miccoli, Laura; Delgado, Rafael; Rodriguez-Ruiz, Sonia; Guerra, Pedro; Carmen Fernandez-Santaella, M.] Univ Granada, Dept Personal, Granada, Spain; [Garcia-Marmol, Eduardo] Univ Granada, Dept Phys Educ & Sports, Granada, Spain	University of Granada; University of Granada	Miccoli, L (corresponding author), Univ Granada, Dept Personal, Granada, Spain.	lauramiccoli@ugr.es	Delgado Rodríguez, Rafael F./L-5176-2018; Guerra, Pedro/ABH-1639-2020; Guerra, Pedro/ABF-1291-2020; Fernández, María Carmen/H-5469-2011; Garcia-Marmol, Eduardo/AAS-7475-2021	Delgado Rodríguez, Rafael F./0000-0003-4971-6643; Guerra, Pedro/0000-0003-0614-629X; Fernández, María Carmen/0000-0001-7094-1138; Garcia-Marmol, Eduardo/0000-0001-9746-6859; Miccoli, Laura/0000-0002-2523-3746	Junta de Andalucia (Spain) [P12.SEJ.391]	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission)	This research was funded by a grant from Junta de Andalucia (Spain) to MCFS (grant code P12.SEJ.391). (http://www.juntadeandalucia.es/servicios/ayudas/detalle/69962.html; Convocatoria 2012. Resolucion de concesion de incentivos para proyectos de investigacion de excelencia (Resoluciones y anexos, zip); ANEXO III DE RESOLUCION PERSONAL-firmada.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Munoz MA, 2010, MOTIV EMOTION, V34, P93, DOI 10.1007/s11031-009-9145-1; [Anonymous], 2004, SOCIAL THEORY HLTH, DOI DOI 10.1057/PALGRAVE.STH.8700030; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Berridge KC, 2009, INQUIRY, V52, P378, DOI 10.1080/00201740903087359; BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Blechert J, 2011, PSYCHOSOM MED, V73, P415, DOI 10.1097/PSY.0b013e318211b871; Blechert J, 2010, APPETITE, V54, P262, DOI 10.1016/j.appet.2009.11.007; Bradley M.M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; Bradley MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00493; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Cepeda-Benito A, 2000, BEHAV THER, V31, P151, DOI 10.1016/S0005-7894(00)80009-X; Datta R, 2006, LECT NOTES COMPUT SC, V3953, P288, DOI 10.1007/11744078_23; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Echeburua E., 1995, EVALUACION TRATAMIEN; Foroni F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00051; Giel KE, 2011, INT J EAT DISORDER, V44, P105, DOI 10.1002/eat.20785; Hamm AO, 1997, PSYCHOPHYSIOLOGY, V34, P97, DOI 10.1111/j.1469-8986.1997.tb02420.x; Hill AJ, 2007, P NUTR SOC, V66, P277, DOI 10.1017/S0029665107005502; HOLM S, 1979, SCAND J STAT, V6, P65; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Lang P.J., 2008, A8 U FLOR; Mauler BI, 2006, J ABNORM PSYCHOL, V115, P567, DOI 10.1037/0021-843X.115.3.567; McCaffery JM, 2009, AM J CLIN NUTR, V90, P928, DOI 10.3945/ajcn.2009.27924; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; Molto J, 2013, AN PSICOL-SPAIN, V29, P965, DOI 10.6018/analesps.29.3.153591; Munoz MA, 2013, TOB CONTROL, V22, P123, DOI 10.1136/tobaccocontrol-2011-050070; Neumark-Sztainer D, 2009, J ADOLESCENT HEALTH, V44, P206, DOI 10.1016/j.jadohealth.2008.11.005; Nijs IMT, 2012, CURR OBES REP, V1, P106, DOI 10.1007/s13679-012-0011-1; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nijs Ilse M T, 2008, Eat Behav, V9, P462, DOI 10.1016/j.eatbeh.2008.07.009; Ortega-Roldan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102595; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Rodriguez S, 2007, EUR EAT DISORD REV, V15, P231, DOI 10.1002/erv.724; Rodriguez-Ruiz S, 2012, J PSYCHOPHYSIOL, V26, P10, DOI 10.1027/0269-8803/a000064; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Smeets PAM, 2012, P NUTR SOC, V71, P511, DOI 10.1017/S0029665112000808; StaSoft Inc, 2008, STAT DATA ANAL SOFTW; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Stockburger J, 2009, NEUROIMAGE, V47, P1819, DOI 10.1016/j.neuroimage.2009.04.071; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Versace F, 2012, ADDICT BIOL, V17, P991, DOI 10.1111/j.1369-1600.2011.00372.x; Verschuere B, 2001, PSYCHOL BELG, V41, P205; Vila J., 2001, REV PSICOLOG A GEN A, V54, P635, DOI DOI 10.6018/analesps.29.3.153591; World Health Organization, 1986, YOUNG PEOPL HTH CHAL	56	39	39	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114515	10.1371/journal.pone.0114515	http://dx.doi.org/10.1371/journal.pone.0114515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490404	Green Published, gold			2022-12-26	WOS:000347515300048
J	Levin, A; Neufeldt, CJ; Pang, D; Wilson, K; Loewen-Dobler, D; Joyce, MA; Wozniak, RW; Tyrrell, DLJ				Levin, Aviad; Neufeldt, Christopher J.; Pang, Daniel; Wilson, Kristen; Loewen-Dobler, Darci; Joyce, Michael A.; Wozniak, Richard W.; Tyrrell, D. Lorne J.			Functional Characterization of Nuclear Localization and Export Signals in Hepatitis C Virus Proteins and Their Role in the Membranous Web	PLOS ONE			English	Article							RNA REPLICATION; CORE PROTEIN; HIV-1 INTEGRASE; ENTRY; INFECTION; CELLS; DETERMINANTS; RECEPTOR; BIOLOGY; REV	The hepatitis C virus (HCV) is a positive strand RNA virus of the Flavivirus family that replicates in the cytoplasm of infected hepatocytes. Previously, several nuclear localization signals (NLS) and nuclear export signals (NES) have been identified in HCV proteins, however, there is little evidence that these proteins travel into the nucleus during infection. We have recently shown that nuclear pore complex (NPC) proteins (termed nucleoporins or Nups) are present in the membranous web and are required during HCV infection. In this study, we identify a total of 11 NLS and NES sequences in various HCV proteins. We show direct interactions between HCV proteins and importin alpha 5 (IPOA5/kap alpha 1), importin beta 3 (IPO5/kap beta 3), and exportin 1 (XPO1/CRM1) both in-vitro and in cell culture. These interactions can be disrupted using peptides containing the specific NLS or NES sequences of HCV proteins. Moreover, using a synchronized infection system, we show that these peptides inhibit HCV infection during distinct phases of the HCV life cycle. The inhibitory effects of these peptides place them in two groups. The first group binds IPOA5 and inhibits infection during the replication stage of HCV life cycle. The second group binds IPO5 and is active during both early replication and early assembly. This work delineates the entire life cycle of HCV and the active involvement of NLS sequences during HCV replication and assembly. Given the abundance of NLS sequences within HCV proteins, our previous finding that Nups play a role in HCV infection, and the relocation of the NLS double-GFP reporter in HCV infected cells, this work supports our previous hypothesis that NPC-like structures and nuclear transport factors function in the membranous web to create an environment conducive to viral replication.	[Levin, Aviad; Pang, Daniel; Wilson, Kristen; Joyce, Michael A.; Tyrrell, D. Lorne J.] Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Levin, Aviad; Neufeldt, Christopher J.; Wozniak, Richard W.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Levin, A (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	aviad@ualberta.ca; rwozniak@ualberta.ca; lorne.tyrrell@ualberta.ca	Neufeldt, Christopher/AAD-1702-2019	Neufeldt, Christopher/0000-0002-4551-1811	Canadian institute of Health Research [MOP 130404, MOP 106502, MOP 97566]; Alberta Innovates Health Solutions [SIF 200900863]; Li Ka Shing Institute of Virology; Banting Postdoctoral Fellowship Program; AIHS Postdoctoral Fellowship; Alberta Innovates [201201140] Funding Source: researchfish	Canadian institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Li Ka Shing Institute of Virology; Banting Postdoctoral Fellowship Program; AIHS Postdoctoral Fellowship; Alberta Innovates	Funding: Funds for this work were provided by the Canadian institute of Health Research to RWW (MOP 130404 and MOP 106502) and DLJT (MOP 97566) (http://www.cihr-irsc.gc.ca/e/193.html), Alberta Innovates Health Solutions (SIF 200900863) (http://www.aihealthsolutions.ca/), and the Li Ka Shing Institute of Virology (http://likashingvirology.med.ualberta.ca/). AL is supported by the Banting Postdoctoral Fellowship Program, administered by the Government of Canada and by AIHS Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Bird G, 2008, J VIROL, V82, P9848, DOI 10.1128/JVI.01221-08; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cerutti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025854; CHANG SC, 1994, BIOCHEM BIOPH RES CO, V205, P1284, DOI 10.1006/bbrc.1994.2804; Chang SJ, 2007, CLIN CHEM LAB MED, V45, P1219, DOI 10.1515/CCLM.2007.263; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chung KM, 2000, J VIROL, V74, P5233, DOI 10.1128/JVI.74.11.5233-5241.2000; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Diaz A, 2010, P NATL ACAD SCI USA, V107, P16291, DOI 10.1073/pnas.1011105107; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Ferraris P, 2013, CELL MOL LIFE SCI, V70, P1297, DOI 10.1007/s00018-012-1213-0; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Germain MA, 2014, MOL CELL PROTEOMICS, V13, P184, DOI 10.1074/mcp.M113.030155; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Huang YP, 2005, WORLD J GASTROENTERO, V11, P4709, DOI 10.3748/wjg.v11.i30.4709; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Joyce MA, 2010, MICROBES INFECT, V12, P263, DOI 10.1016/j.micinf.2009.12.012; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Katta SS, 2014, TRENDS CELL BIOL, V24, P221, DOI 10.1016/j.tcb.2013.10.006; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Levin A, 2010, VIRUS GENES, V40, P341, DOI 10.1007/s11262-010-0458-7; Levin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004155; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Miller DJ, 2003, J VIROL, V77, P12193, DOI 10.1128/JVI.77.22.12193-12202.2003; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Muramatsu S, 1997, J VIROL, V71, P4954, DOI 10.1128/JVI.71.7.4954-4961.1997; Neufeldt CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003744; Overby AK, 2011, VIRULENCE, V2, P238, DOI 10.4161/viru.2.3.16162; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosenbluh J, 2007, J BIOL CHEM, V282, P15743, DOI 10.1074/jbc.M609864200; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Song J, 2000, VIRUS RES, V69, P109, DOI 10.1016/S0168-1702(00)00206-9; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898	81	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114629	10.1371/journal.pone.0114629	http://dx.doi.org/10.1371/journal.pone.0114629			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485706	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600080
J	Liu, J; Fordham, DA; Cooke, BD; Cox, T; Mutze, G; Strive, T				Liu, June; Fordham, Damien A.; Cooke, Brian D.; Cox, Tarnya; Mutze, Greg; Strive, Tanja			Distribution and Prevalence of the Australian Non-Pathogenic Rabbit Calicivirus Is Correlated with Rainfall and Temperature	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE VIRUS; PARTIAL CROSS-PROTECTION; SOUTH-WESTERN AUSTRALIA; RHDV-LIKE VIRUS; WILD RABBITS; ORYCTOLAGUS-CUNICULUS; SEROLOGICAL EVIDENCE; BIOLOGICAL-CONTROL; POPULATIONS; IMPACT	Background: Australia relies heavily on rabbit haemorrhagic disease virus (RHDV) for the biological control of introduced European wild rabbits Oryctolagus cuniculus, which are significant economic and environmental pests. An endemic nonpathogenic rabbit calicivirus termed RCV-A1 also occurs in wild rabbits in Australian and provides partial protection against lethal RHDV infection, thus interfering with effective rabbit control. Despite its obvious importance for rabbit population management, little is known about the epidemiology of this benign rabbit calicivirus. Methods: We determined the continent-wide distribution and prevalence of RCV-A1 by analysing 1,805 serum samples from wild rabbit populations at 78 sites across Australia for the presence of antibodies to RCV-A1 using a serological test that specifically detects RCV-A1 antibodies and does not cross-react with co-occurring RHDV antibodies. We also investigated possible correlation between climate variables and prevalence of RCV-A1 by using generalised linear mixed effect models. Results: Antibodies to RCV-A1 were predominantly detected in rabbit populations in cool, high rainfall areas of the south-east and south-west of the continent. There was strong support for modelling RCV-A1 prevalence as a function of average annual rainfall and minimum temperature. The best ranked model explained 26% of the model structural deviance. According to this model, distribution and prevalence of RCV-A1 is positively correlated with periods of above average rainfall and negatively correlated with periods of drought. Implications: Our statistical model of RCV-A1 prevalence will greatly increase our understanding of RCV-A1 epidemiology and its interaction with RHDV in Australia. By defining the environmental conditions associated with the prevalence of RCV-A1, it also contributes towards understanding the distribution of similar viruses in New Zealand and Europe.	[Liu, June; Strive, Tanja] Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Canberra, ACT 2601, Australia; [Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Fordham, Damien A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Cooke, Brian D.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Liu, June; Cooke, Brian D.; Cox, Tarnya; Strive, Tanja] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia; [Cox, Tarnya] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Orange, NSW 2800, Australia; [Mutze, Greg] Dept Water Land & Biodivers Conservat, Nat Resources Management Biosecur Unit, Adelaide, SA 5001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; University of Adelaide; University of Canberra; University of Canberra; NSW Department of Primary Industries	Strive, T (corresponding author), Commonwealth Sci & Ind Res Org, Ecosyst Sci Div, Canberra, ACT 2601, Australia.	tanja.strive@csiro.au	Strive, Tanja/C-1486-2008; Fordham, Damien A/E-9255-2013; Cox, Tarnya/L-8213-2019; Liu, June/C-7871-2009	Fordham, Damien A/0000-0003-2137-5592; Cox, Tarnya/0000-0001-9581-9227; 	Wildlife Pests and Diseases Preparedness Program (WEDPP), Australian Bureau of Agriculture and Resource Economics and Sciences (ABARES) of the Australian Department of Agriculture, Fisheries and Forestry; ARC Linkage Grant [LP12020024]; Super Science Fellowship [FS110200051]	Wildlife Pests and Diseases Preparedness Program (WEDPP), Australian Bureau of Agriculture and Resource Economics and Sciences (ABARES) of the Australian Department of Agriculture, Fisheries and Forestry; ARC Linkage Grant(Australian Research Council); Super Science Fellowship	This project was partially funded by grants from the Wildlife Pests and Diseases Preparedness Program (WEDPP), Australian Bureau of Agriculture and Resource Economics and Sciences (ABARES) of the Australian Department of Agriculture, Fisheries and Forestry. D.A.F. was supported by an ARC Linkage Grant (LP12020024) and Super Science Fellowship (FS110200051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 1998, VIRUS RES, V54, P123, DOI 10.1016/S0168-1702(98)00017-3; Barnes S. L., 1964, J APPL METEOROLOGY, V3, P395; Bates BC, 2008, CLIMATIC CHANGE, V89, P339, DOI 10.1007/s10584-007-9390-9; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowen Z, 1998, WILDLIFE RES, V25, P655, DOI 10.1071/WR98004; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Bruce JS, 2004, WILDLIFE RES, V31, P605, DOI 10.1071/WR04009; Bruce JS, 2004, WILDLIFE RES, V31, P31, DOI 10.1071/WR02069; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Capucci L, 1996, J VIROL, V70, P8614, DOI 10.1128/JVI.70.12.8614-8623.1996; Cooke BD, 2002, WILDLIFE RES, V29, P673, DOI 10.1071/WR00092; Cooke B, 2013, AUST ECON HIST REV, V53, P91, DOI 10.1111/aehr.12000; Cooke BD, 2012, WILDLIFE RES, V39, P279, DOI 10.1071/WR11166; Davison AC, 1997, BOOTSTRAP METHODS TH; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elsworth P, 2014, VIROLOGY, V464, P415, DOI 10.1016/j.virol.2014.06.037; FENNER F, 1953, J HYG-CAMBRIDGE, V51, P225, DOI 10.1017/S0022172400015655; Forrester NL, 2009, VIROLOGY, V393, P42, DOI 10.1016/j.virol.2009.07.008; Fouchet D, 2008, J THEOR BIOL, V250, P593, DOI 10.1016/j.jtbi.2007.10.037; Gall A, 2007, VET MICROBIOL, V120, P17, DOI 10.1016/j.vetmic.2006.10.006; GILBERT N, 1987, AUST WILDLIFE RES, V14, P491; Henzell RP, 2002, WILDLIFE RES, V29, P523, DOI 10.1071/WR00083; Jahnke M, 2010, J VIROL, V84, P12397, DOI 10.1128/JVI.00777-10; Kerr PJ, 2012, ANTIVIR RES, V93, P387, DOI 10.1016/j.antiviral.2012.01.009; Kovaliski J, 1998, J WILDLIFE DIS, V34, P421, DOI 10.7589/0090-3558-34.3.421; Kovaliski J, 2014, MOL ECOL, V23, P408, DOI 10.1111/mec.12596; Le Gall-Recule G, 2011, VIROLOGY, V410, P395, DOI 10.1016/j.virol.2010.12.001; Lees AC, 2008, MAMMAL REV, V38, P304, DOI 10.1111/j.1365-2907.2008.00116.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lenghaus C, 1994, RABBIT HAEMORRHAGIC, P104; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Liu JE, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-182; Liu JN, 2012, VET MICROBIOL, V157, P345, DOI 10.1016/j.vetmic.2012.01.018; McColl KA, 2002, EPIDEMIOL INFECT, V129, P655, DOI 10.1017/S0950268802007756; McPhee SR, 2010, WILDLIFE RES, V37, P68, DOI 10.1071/WR09103; McPhee SR, 2009, WILDLIFE RES, V36, P447, DOI 10.1071/WR08137; Mutze G, 1998, J WILDLIFE DIS, V34, P221, DOI 10.7589/0090-3558-34.2.221; Mutze G, 2008, LAGOMORPH BIOL EVOLU, P179; Mutze G, 2010, WILDLIFE RES, V37, P311, DOI 10.1071/WR09162; Nagesha HS, 2000, ARCH VIROL, V145, P749, DOI 10.1007/s007050050668; O'Keefe JS, 1999, VET MICROBIOL, V66, P29, DOI 10.1016/S0378-1135(98)00307-1; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson BJ, 2007, WILDLIFE RES, V34, P398, DOI 10.1071/WR06117; Robinson AJ, 2002, WILDLIFE RES, V29, P663, DOI 10.1071/WR00119; Robinson AJ, 2002, WILDLIFE RES, V29, P655, DOI 10.1071/WR00096; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Strive T, 2009, VIROLOGY, V384, P97, DOI 10.1016/j.virol.2008.11.004; Strive T, 2010, VIROLOGY, V398, P125, DOI 10.1016/j.virol.2009.11.045; Strive T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-51	52	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113976	10.1371/journal.pone.0113976	http://dx.doi.org/10.1371/journal.pone.0113976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486092	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600032
J	Shahrin, L; Leung, DT; Matin, N; Pervez, MM; Azim, T; Bardhan, PK; Heffelfinger, JD; Chisti, MJ				Shahrin, Lubaba; Leung, Daniel T.; Matin, Nashaba; Pervez, Mohammed Moshtaq; Azim, Tasnim; Bardhan, Pradip Kumar; Heffelfinger, James D.; Chisti, Mohammod Jobayer			Characteristics and Predictors of Death among Hospitalized HIV-Infected Patients in a Low HIV Prevalence Country: Bangladesh	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; MORTALITY; AIDS; MIGRATION; ADULTS; HEALTH; HAART; MEN	Background: Predictors of death in hospitalized HIV-infected patients have not been previously reported in Bangladesh. Objective: The primary aim of this study was to determine predictors of death among hospitalized HIV-infected patients at a large urban hospital in Bangladesh. Methods: A study was conducted in the HIV in-patient unit (Jagori Ward) of icddr,b's Dhaka Hospital. Characteristics of patients who died during hospitalization were compared to those of patients discharged from the ward. Bivariate analysis was performed to determine associations between potential risk factors and death. Multivariable logistic regression was used to identify factors independently associated with death. Results: Of 293 patients admitted to the Jagori Ward, 57 died during hospitalization. Most hospitalized patients (67%) were male and the median age was 35 (interquartile range: 2-65) years. Overall, 153 (52%) patients were diagnosed with HIV within 6 months of hospitalization. The most common presumptive opportunistic infections (OIs) identified were tuberculosis (32%), oesophageal candidiasis (9%), Pneumocystis jirovecii pneumonia (PJP) (8%), and histoplasmosis (7%). On multivariable analysis, independent predictors of mortality were CD4 count <= 200 cells/mm(3) (adjusted odds ratio [aOR]: 16.6, 95% confidence interval [CI]: 3.7-74.4), PJP (aOR: 18.5, 95% CI: 4.68-73.3), oesophageal candidiasis (aOR: 27.5, 95% CI: 5.5-136.9), malignancy (aOR: 15.2, 95% CI: 2.3-99.4), and bacteriuria (aOR: 7.9, 95% CI: 1.2-50.5). Being on antiretroviral therapy prior to hospitalization (aOR: 0.2, 95% CI: 0.06-0.5) was associated with decreased mortality. Conclusion: This study showed that most patients who died during hospitalization on the Jagori Ward had HIV-related illnesses which could have been averted with earlier diagnosis of HIV and proper management of OIs. It is prudent to develop a national HIV screening programme to facilitate early identification of HIV.	[Shahrin, Lubaba; Pervez, Mohammed Moshtaq; Bardhan, Pradip Kumar; Chisti, Mohammod Jobayer] Dhaka Hosp, Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Shahrin, Lubaba; Pervez, Mohammed Moshtaq; Chisti, Mohammod Jobayer] Int Ctr Diarrheal Dis Res, CNFS, Dhaka, Bangladesh; [Shahrin, Lubaba; Leung, Daniel T.; Pervez, Mohammed Moshtaq; Azim, Tasnim] Int Ctr Diarrheal Dis Res, Ctr HIV AIDS CHIV, Dhaka, Bangladesh; [Leung, Daniel T.] Int Ctr Diarrheal Dis Res, CVS, Dhaka, Bangladesh; [Matin, Nashaba] Royal London Hosp, Barts Hlth NHS Trust, London E1 1BB, England; [Heffelfinger, James D.] Ctr Dis Control & Prevent CDC, Global Dis Detect Branch, Div Global Hlth Promot, Ctr Global Hlth, Atlanta, GA USA	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); Barts Health NHS Trust; Royal London Hospital; Centers for Disease Control & Prevention - USA	Shahrin, L (corresponding author), Dhaka Hosp, Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.	lubabashahrin@icddrb.org	Chisti, Mohammod J/A-7216-2018; Shahrin, Lubaba/AAF-1019-2020	Shahrin, Lubaba/0000-0002-5676-3280; Leung, Daniel/0000-0001-8401-0801	icddr,b; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI100923] Funding Source: NIH RePORTER	icddr,b; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research protocol was funded by the icddr,b and its donors who provide unrestricted support to this organization for its infrastructure (such as Dhaka Hospital) and research. Current donors providing unrestricted support include the following: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency, Embassy of the Kingdom of Netherlands, Swedish International Development Cooperation Agency, Swiss Agency for Development and Cooperation and Department for International Development, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaba PA, 2011, J INFECT DEV COUNTR, V5, P377, DOI 10.3855/jidc.1096; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Azim T, 2008, INT J STD AIDS, V19, P327, DOI 10.1258/ijsa.2007.007269; Azim T, 2009, 20 YEARS HIV BANGLAD, V2009, P1; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Charles BHEL, 2003, REV HUMAN IMMUNODEFI, P652; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Dhaka Tribune, 2013, WORLD AIDS DAY OBS 3; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; HOEPELMAN AIM, 1992, AIDS, V6, P179, DOI 10.1097/00002030-199202000-00006; International Organization for Migration (IOM), 2013, SIT AN MIGR HIV BANG, P1; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV AS PAC UNAIDS RE; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Kumarasamy N, 2003, CLIN INFECT DIS, V36, P79, DOI 10.1086/344756; Mamtaz A, 1999, J Prev Soc Med, V18, P74; Matin N, 2011, J HEALTH POPUL NUTR, V29, P14; Mercer A, 2007, SEX TRANSM DIS, V34, P265, DOI 10.1097/01.olq.0000240384.61924.65; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Pervez MM, 2013, HLTH SCI B, V11, P15; Pinho Ana Maria Felix De, 1994, Genitourinary Medicine, V70, P30; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Sani MU, 2006, J NATL MED ASSOC, V98, P862; Schneider M, 2005, NATURAL HIST MORTALI; UNAIDS, 2021, PREV HIV INF TIM NEW; Weine SM, 2012, AIDS BEHAV, V16, P1605, DOI 10.1007/s10461-012-0183-4; World Bank, 2016, HLTH RISKS PART MATT, P1; World Health Organization, 2013, POCK BOOK HOSP CAR C	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113095	10.1371/journal.pone.0113095	http://dx.doi.org/10.1371/journal.pone.0113095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485634	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600014
J	Agarwal, R; Denning, DW; Chakrabarti, A				Agarwal, Ritesh; Denning, David W.; Chakrabarti, Arunaloke			Estimation of the Burden of Chronic and Allergic Pulmonary Aspergillosis in India	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BRONCHOPULMONARY ASPERGILLOSIS; SEVERE ASTHMA; RESPIRATORY SYMPTOMS; FUNGAL SENSITIZATION; ANTIFUNGAL TREATMENT; GLOBAL BURDEN; HEALTH SURVEY; PREVALENCE; TUBERCULOSIS	Background and Objectives: It would be of considerable interest to clinicians if the burden of chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA) in India were known. Herein, we estimate the burden of CPA following pulmonary tuberculosis (PTB), and ABPA (and severe asthma with fungal sensitization [SAFS]) complicating asthma. Methods: We used the population estimates for India from the 2011 census data. The burden of asthma was estimated using three different methods (Global Initiative against Asthma [GINA] report statement, World Health Survey [WHS] estimates, Indian study on the epidemiology of asthma and chronic bronchitis [INSEARCH]). Global and India-specific figures were used for calculating the prevalence of ABPA and SAFS. The World Health Organization estimates were used for calculating PTB rates while the frequency of CPA was assessed from a previously published scoping review. Sensitivity analysis was performed to determine the burden in various scenarios. Results: The total Indian population in 2011 was 1.2 billion. The asthma prevalence in adults was estimated at about 27.6 (range, 17-30) million. The burden of ABPA ranged from 0.12-6.09 million with different assumptions (best estimate, 1.38 [range, 0.86-1.52] million). The prevalence of SAFS was approximated at about 0.52-1.21 million (best estimate, 0.96 [range, 0.6-1.06] million). The incident TB cases were about 2.1 million while the annual incidence of CPA varied 27,000-0.17 million cases, with different estimates. If the mortality of CPA is estimated as 15% annually, the 5-year prevalence of CPA was placed at 290,147 cases with 5-year prevalence rate being 24 per 100,000. Conclusion: There is a significant burden of ABPA, SAFS and CPA in India. Prospective community-based studies are required to accurately determine the prevalence of these disorders.	[Agarwal, Ritesh] PGIMER, Dept Pulm Med, Chandigarh, India; [Denning, David W.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester M23 9LT, Lancs, England; [Chakrabarti, Arunaloke] PGIMER, Dept Med Microbiol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), PGIMER, Dept Pulm Med, Chandigarh, India.	agarwal.ritesh@live.com	Denning, David/AAC-6931-2019; Agarwal, Ritesh/A-3063-2009	Denning, David/0000-0001-5626-2251; Agarwal, Ritesh/0000-0003-2547-7668	National Institute of Allergy and Infectious Diseases, National Institute of Health Research; European Union; AstraZeneca; Astellas; GSK; Gilead; Pfizer	National Institute of Allergy and Infectious Diseases, National Institute of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)National Institute for Health Research (NIHR)); European Union(European Commission); AstraZeneca(AstraZeneca); Astellas(Astellas Pharmaceuticals); GSK(GlaxoSmithKline); Gilead(Gilead Sciences); Pfizer(Pfizer)	Dr. Denning holds founder shares in F2G Ltd a University of Manchester spin-out company and has current grant support from the National Institute of Allergy and Infectious Diseases, National Institute of Health Research, the European Union and AstraZeneca. He acts as a consultant to Trinity group, T2 Biosystems, GSK, as well as other companies over the last 5 years including Pfizer, Schering Plough (now Merck), Astellas and Gilead. In the last 3 years, he has been paid for talks on behalf of Astellas, GSK, Gilead and Pfizer. The other authors have no competing interests to report. The competing interests do not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2007, CHEST, V132, P1183, DOI 10.1378/chest.07-0808; Agarwal R, 2013, FUTURE MICROBIOL, V8, P1463, DOI 10.2217/fmb.13.116; Agarwal R, 2013, MYCOSES, V56, P559, DOI 10.1111/myc.12075; Agarwal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061105; Agarwal R, 2012, EXPERT REV RESP MED, V6, P363, DOI [10.1586/ers.12.35, 10.1586/ERS.12.35]; Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; Agarwal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015346; Agarwal R, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P707, DOI 10.1007/978-90-481-2408-4_42; Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Agbetile J, 2013, J ALLERGY CLIN IMMUN; Al-shair K, 2013, CLIN INFECT DIS, V57, P828, DOI 10.1093/cid/cit411; [Anonymous], 1970, Tubercle, V51, P227; [Anonymous], 1968, TUBERCLE, V49, P1; Beasley R., GLOBAL BURDEN ASTHMA; Bombarda Sidney, 2003, Sao Paulo Med. J., V121, P198, DOI 10.1590/S1516-31802003000500004; Chowgule RV, 1998, AM J RESP CRIT CARE, V158, P547, DOI 10.1164/ajrccm.158.2.9708064; Denning DW, 2013, EUR RESPIR J, V41, P621, DOI 10.1183/09031936.00226911; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; Denning DW, 2009, AM J RESP CRIT CARE, V179, P11, DOI 10.1164/rccm.200805-737OC; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Dhooria S, 2014, INT J TUBERC LUNG D, V18, P850, DOI 10.5588/ijtld.13.0838; Ghosh Tapashi, 2010, J Indian Med Assoc, V108, P863; Global tuberculosis database, INC MORT PERC PULM T; Hogan C, 2011, SEMIN RESP CRIT CARE, V32, P682, DOI 10.1055/s-0031-1295716; Jindal SK, 2012, INT J TUBERC LUNG D, V16, P1270, DOI 10.5588/ijtld.12.0005; KHAN ZU, 1976, SCAND J RESPIR DIS, V57, P73; Kurhade A M, 2002, Indian J Med Microbiol, V20, P141; Maurya V, 2005, CHEST, V127, P1252, DOI 10.1378/chest.127.4.1252; Shahid M, 2001, Indian J Med Microbiol, V19, P201; Smith NL, 2011, EUR RESPIR J, V37, P865, DOI 10.1183/09031936.00054810; TB India, 2013, RNTCP ANN STAT REP; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204	36	63	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114745	10.1371/journal.pone.0114745	http://dx.doi.org/10.1371/journal.pone.0114745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478929	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200121
J	Baig, MH; Sudhakar, DR; Kalaiarasan, P; Subbarao, N; Wadhawa, G; Lohani, M; Khan, MKA; Khan, AU				Baig, Mohd Hassan; Sudhakar, D. Raja; Kalaiarasan, Ponnusamy; Subbarao, Naidu; Wadhawa, Gulshan; Lohani, Mohtashim; Khan, M. Kalim A.; Khan, Asad U.			Insight into the Effect of Inhibitor Resistant S130G Mutant on Physico-Chemical Properties of SHV Type Beta-Lactamase: A Molecular Dynamics Study	PLOS ONE			English	Article							PROTEIN STABILITY; ESCHERICHIA-COLI; CLAVULANIC ACID; TEM-1; CONSEQUENCES; INACTIVATION; COMBINATIONS; PERTURBATION; MUTAGENESIS; TAZOBACTAM	Bacterial resistance is a serious threat to human health. The production of beta-lactamase, which inactivates beta-lactams is most common cause of resistance to the beta-lactam antibiotics. The Class A enzymes are most frequently encountered among the four beta-lactamases in the clinic isolates. Mutations in class A beta-lactamases play a crucial role in substrate and inhibitor specificity. SHV and TEM type are known to be most common class A beta-lactamases. In the present study, we have analyzed the effect of inhibitor resistant S130G point mutation of SHV type Class-A beta-lactamase using molecular dynamics and other in silico approaches. Our study involved the use of different in silico methods to investigate the affect of S130G point mutation on the major physico-chemical properties of SHV type class A beta-lactamase. We have used molecular dynamics approach to compare the dynamic behaviour of native and S130G mutant form of SHV beta-lactamase by analyzing different properties like root mean square deviation (RMSD), H-bond, Radius of gyration (Rg) and RMS fluctuation of mutation. The results clearly suggest notable loss in the stability of S130G mutant that may further lead to decrease in substrate specificity of SHV. Molecular docking further indicates that S130G mutation decreases the binding affinity of all the three inhibitors in clinical practice.	[Baig, Mohd Hassan; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Baig, Mohd Hassan; Lohani, Mohtashim; Khan, M. Kalim A.] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India; [Sudhakar, D. Raja; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Kalaiarasan, Ponnusamy] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Wadhawa, Gulshan] Govt India, Dept Biotechnol, New Delhi, India	Aligarh Muslim University; Integral University; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	Subbarao, Prof Naidu/AAZ-1832-2020; Khan, Asad U/K-8157-2013; Lohani, Mohtashim/AAR-3394-2021; Ahmad Khan, Mohammad Kalim/AAA-2751-2022	Subbarao, Prof Naidu/0000-0002-1720-2165; Khan, Asad U/0000-0001-9191-9423; Ahmad Khan, Mohammad Kalim/0000-0002-8004-1448; Lohani, Mohtashim/0000-0001-9414-4539; Baig, Mohd Hassan/0000-0001-8227-4838	Department of Biotechnology [BT/PR11610/BRB/10/669/2008, BT/PR11453/BID/07/296/2009]; Indian Council of Medical Research, New Delhi, India [BIC/11(06)/2013]	Department of Biotechnology; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by Department of Biotechnology, grants no. BT/PR11610/BRB/10/669/2008 and BT/PR11453/BID/07/296/2009 to AUK. Indian Council of Medical Research, New Delhi, India provided a Senior Research Fellowship to Mohd Hassan Baig (BIC/11(06)/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasov BP, 2000, P NATL ACAD SCI USA, V97, P3160, DOI 10.1073/pnas.060027897; Aumeran C, 2003, ANTIMICROB AGENTS CH, V47, P2958, DOI 10.1128/AAC.47.9.2958-2961.2003; Baig MH, 2012, BIOINFORMATION, V8, P1225, DOI 10.6026/97320630081225; Barry GH, 2005, J ANTIMICROB CHEMOTH, V55, P1050; BUSH K, 1988, Clinical Microbiology Reviews, V1, P109; Buynak JD, 2006, BIOCHEM PHARMACOL, V71, P930, DOI 10.1016/j.bcp.2005.11.012; Danishuddin Mohd, 2011, In Silico Biology, V11, P273, DOI 10.3233/ISB-2012-0443; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Gong SS, 2009, BIOCHEM SOC T, V37, P727, DOI 10.1042/BST0370727; Helfand MS, 2005, CURR OPIN PHARMACOL, V5, P452, DOI 10.1016/j.coph.2005.04.013; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; IMTIAZ U, 1994, BIOCHEMISTRY-US, V33, P5728, DOI 10.1021/bi00185a009; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kumar KR, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/151273; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; Lee N, 2003, DRUGS, V63, P1511, DOI 10.2165/00003495-200363140-00006; Leflon-Guibout W, 2002, J ANTIMICROB CHEMOTH, V49, P367, DOI 10.1093/jac/49.2.367; Meroueh SO, 2002, J AM CHEM SOC, V124, P9422, DOI 10.1021/ja026547q; Nisius L, 2012, NAT CHEM, V4, P711, DOI [10.1038/NCHEM.1396, 10.1038/nchem.1396]; Page MGF, 2000, DRUG RESIST UPDATE, V3, P109, DOI 10.1054/drup.2000.0137; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Ripoll A, 2011, ANTIMICROB AGENTS CH, V55, P4530, DOI 10.1128/AAC.00178-11; SANDERS CC, 1988, ANTIMICROB AGENTS CH, V32, P1365, DOI 10.1128/AAC.32.9.1365; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Thomas VL, 2005, BIOCHEMISTRY-US, V44, P9330, DOI 10.1021/bi0502700; Vakulenko SB, 1998, ANTIMICROB AGENTS CH, V42, P1542, DOI 10.1128/AAC.42.7.1542; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang L, 1998, PROTEINS, V32, P438, DOI 10.1002/(SICI)1097-0134(19980901)32:4<438::AID-PROT4>3.0.CO;2-C; Wang XJ, 2002, J BIOL CHEM, V277, P32149, DOI 10.1074/jbc.M204212200; Williams DH, 2004, ANGEW CHEM INT EDIT, V43, P6596, DOI 10.1002/anie.200300644; Williams JD, 1999, INT J ANTIMICROB AG, V12, pS3, DOI 10.1016/S0924-8579(99)00085-0	37	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112456	10.1371/journal.pone.0112456	http://dx.doi.org/10.1371/journal.pone.0112456			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479359	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200010
J	Herbert, AD; Carr, AM; Hoffmann, E				Herbert, Alex D.; Carr, Antony M.; Hoffmann, Eva			FindFoci: A Focus Detection Algorithm with Automated Parameter Training That Closely Matches Human Assignments, Reduces Human Inconsistencies and Increases Speed of Analysis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IMAGE-ANALYSIS; GAMMA-H2AX FOCI; SUBCELLULAR LOCATION; CELLS; PROTEIN; MEIOSIS; REPAIR; IDENTIFICATION; RECOMBINATION	Accurate and reproducible quantification of the accumulation of proteins into foci in cells is essential for data interpretation and for biological inferences. To improve reproducibility, much emphasis has been placed on the preparation of samples, but less attention has been given to reporting and standardizing the quantification of foci. The current standard to quantitate foci in open-source software is to manually determine a range of parameters based on the outcome of one or a few representative images and then apply the parameter combination to the analysis of a larger dataset. Here, we demonstrate the power and utility of using machine learning to train a new algorithm (FindFoci) to determine optimal parameters. FindFoci closely matches human assignments and allows rapid automated exploration of parameter space. Thus, individuals can train the algorithm to mirror their own assignments and then automate focus counting using the same parameters across a large number of images. Using the training algorithm to match human assignments of foci, we demonstrate that applying an optimal parameter combination from a single image is not broadly applicable to analysis of other images scored by the same experimenter or by other experimenters. Our analysis thus reveals wide variation in human assignment of foci and their quantification. To overcome this, we developed training on multiple images, which reduces the inconsistency of using a single or a few images to set parameters for focus detection. FindFoci is provided as an open-source plugin for ImageJ.	[Herbert, Alex D.; Carr, Antony M.; Hoffmann, Eva] Univ Sussex, Sch Life Sci, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Herbert, AD (corresponding author), Univ Sussex, Sch Life Sci, MRC Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	a.herbert@sussex.ac.uk	hoffmann, eva/AAM-6594-2020	hoffmann, eva/0000-0002-2588-0652; Herbert, Alex/0000-0002-9843-9980; Carr, Antony Michael/0000-0002-2028-2389	Medical Research Council [G1100074]; Medical Research Council, UK [G0902043]; Medical Research Council [G0902043] Funding Source: researchfish; MRC [G1100074, G0902043] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AMC was funded by Medical Research Council grant G1100074. ERH was funded by a Senior Research Nonclinical Fellowship G0902043 from the Medical Research Council, UK (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Bergman A, 2014, CELL ADHES MIGR, V8, P1; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; Chakravorty R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083251; Copsey A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004071; Das DK, 2013, MICRON, V45, P97, DOI 10.1016/j.micron.2012.11.002; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Gonzalez JE, 2012, ANAL QUANT CYTOL, V34, P66; Firsanov DV, 2011, CLIN EPIGENETICS, V2, P283, DOI 10.1007/s13148-011-0044-4; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Herold J, 2010, J BIOTECHNOL, V149, P299, DOI 10.1016/j.jbiotec.2010.03.004; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jakob B, 2012, RADIAT RES, V177, P524, DOI 10.1667/RR2452.1; Jucha A, 2010, MUTAT RES-GEN TOX EN, V696, P16, DOI 10.1016/j.mrgentox.2009.12.004; Kneitz B, 2000, GENE DEV, V14, P1085; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Ma LY, 2012, IEEE ACM T COMPUT BI, V9, P228, DOI 10.1109/TCBB.2011.52; Martin OA, 2013, DNA REPAIR, V12, P844, DOI 10.1016/j.dnarep.2013.07.002; Murphy RF, 2008, I S BIOMED IMAGING, P308, DOI 10.1109/ISBI.2008.4540994; Narayanaswamy R, 2009, J PROTEOME RES, V8, P6, DOI 10.1021/pr800524g; Newnham L, 2010, P NATL ACAD SCI USA, V107, P781, DOI 10.1073/pnas.0913435107; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sanders WS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sheng JJ, 2011, DRUG METAB DISPOS, V39, P1334, DOI 10.1124/dmd.111.039537; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Slattery SD, 2012, ASSAY DRUG DEV TECHN, V10, P161, DOI 10.1089/adt.2011.0397; Smith K, 2014, J BIOMOL SCREEN, V19, P685, DOI 10.1177/1087057114527313; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Sundstrom A, 2012, IEEE T INF TECHNOL B, V16, P1200, DOI 10.1109/TITB.2012.2206819; Svensson CM, 2014, CYTOM PART A, V85A, P501, DOI 10.1002/cyto.a.22471; Svetlanov A, 2004, EXP CELL RES, V296, P71, DOI 10.1016/j.yexcr.2004.03.020; Toyoda T, 2013, J TOXICOL PATHOL, V26, P215, DOI 10.1293/tox.26.215; Vizcaino C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000824; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095265; Wheeler RE, 2010, MULTRESP IMPERM; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wikswo JP, 2013, IEEE T BIO-MED ENG, V60, P682, DOI 10.1109/TBME.2013.2244891	46	61	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114749	10.1371/journal.pone.0114749	http://dx.doi.org/10.1371/journal.pone.0114749			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478967	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000346907200122
J	McKinney, GJ; Varian, A; Scardina, J; Nichols, KM				McKinney, Garrett J.; Varian, Anna; Scardina, Julie; Nichols, Krista M.			Genetic and Morphological Divergence in Three Strains of Brook Trout Salvelinus fontinalis Commonly Stocked in Lake Superior	PLOS ONE			English	Article							NATURAL-SELECTION; LOCAL ADAPTATION; LIFE-HISTORY; NIPIGON BAY; HABITAT USE; CHARR; POPULATIONS; EVOLUTION; TRAITS; WILD	Fitness related traits often show spatial variation across populations of widely distributed species. Comparisons of genetic variation among populations in putatively neutral DNA markers and in phenotypic traits susceptible to selection (Q(ST) F-ST analysis) can be used to determine to what degree differentiation among populations can be attributed to selection or genetic drift. Traditionally, Q(ST) F-ST analyses require a large number of populations to achieve sufficient statistical power; however, new methods have been developed that allow Q(ST) F-ST comparisons to be conducted on as few as two populations if their pedigrees are informative. This study compared genetic and morphological divergence in three strains of brook trout Salvelinus fontinalis that were historically or currently used for stocking in the Lake Superior Basin. Herein we examined if morphological divergence among populations showed temporal variation, and if divergence could be attributed to selection or was indistinguishable from genetic drift. Multivariate Q(ST) F-ST analysis showed evidence for divergent selection between populations. Univariate analyses suggests that the pattern observed in the multivariate analyses was largely driven by divergent selection for length and weight, and moreover by divergence between the Assinica strain and each of the Iron River and Siskiwit strains rather than divergent selection between each population pair. While it could not be determined if divergence was due to natural selection or inadvertent artificial selection in hatcheries, selected differences were consistent with patterns of domestication commonly found in salmonids.	[McKinney, Garrett J.; Scardina, Julie; Nichols, Krista M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Varian, Anna] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nichols, KM (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.	krista.nichols@noaa.gov			Purdue University	Purdue University	Funding was provided by Purdue University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 1995, J FISH BIOL, V47, P177, DOI 10.1111/j.1095-8649.1995.tb06054.x; Boula D, 2002, ENVIRON BIOL FISH, V64, P229, DOI 10.1023/A:1016054119783; Bourke P, 1997, J FISH BIOL, V51, P783, DOI 10.1111/j.1095-8649.1997.tb01999.x; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; COCKERHAM CC, 1969, EVOLUTION, V23, P72, DOI 10.1111/j.1558-5646.1969.tb03496.x; COCKERHAM CC, 1973, GENETICS, V74, P679; Cooper AM, 2010, CONSERV GENET, V11, P1087, DOI 10.1007/s10592-009-9841-0; D'Amelio S, 2008, N AM J FISH MANAGE, V28, P1343, DOI 10.1577/M05-193.1; D'Amelio S, 2008, T AM FISH SOC, V137, P1213, DOI 10.1577/T05-275.1; FLICK WA, 1977, NAT CAN, V104, P353; Fraser DJ, 2005, EVOLUTION, V59, P611; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HOAR WS, 1976, J FISH RES BOARD CAN, V33, P1233, DOI 10.1139/f76-158; Huckins CJ, 2008, N AM J FISH MANAGE, V28, P1321, DOI 10.1577/M05-191.1; Huckins CJ, 2008, T AM FISH SOC, V137, P1229, DOI 10.1577/T05-274.1; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Karhunen M, 2013, MOL ECOL RESOUR, V13, P746, DOI 10.1111/1755-0998.12111; KARHUNEN M, 2013, RAFM REFERENCE MANUA; Kostow KE, 2003, T AM FISH SOC, V132, P780, DOI 10.1577/T02-051; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LEIDER SA, 1990, AQUACULTURE, V88, P239, DOI 10.1016/0044-8486(90)90151-C; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leonard JBK, 2013, N AM J FISH MANAGE, V33, P359, DOI 10.1080/02755947.2012.754801; Mavarez J, 2009, J EVOLUTION BIOL, V22, P1708, DOI 10.1111/j.1420-9101.2009.01785.x; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Mucha JM, 2008, T AM FISH SOC, V137, P1203, DOI 10.1577/T05-273.1; MUCHA JM, 2003, THESIS; Newman L.E., 2003, GREAT LAKES FISHERY; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; O'Hara RB, 2005, GENETICS, V171, P1331, DOI 10.1534/genetics.105.044545; Ovaskainen O, 2011, GENETICS, V189, P621, DOI 10.1534/genetics.111.129387; PLUMMER M, 2012, CODA REFERENCE MANUA; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; Rohlf FJ, 2007, TPSRELW RELATIVE WAR; Seamons TR, 2012, EVOL APPL, V5, P705, DOI 10.1111/j.1752-4571.2012.00247.x; Sutton TM, 2002, N AM J AQUACULT, V64, P188, DOI 10.1577/1548-8454(2002)064&lt;0188:HPAONA&gt;2.0.CO;2; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Theriault V, 2003, J FISH BIOL, V63, P1144, DOI 10.1046/j.1095-8649.2003.00233.x; Van Offelen Henry K., 1993, North American Journal of Fisheries Management, V13, P86, DOI 10.1577/1548-8675(1993)013<0086:SGMADO>2.3.CO;2; Varian A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012950; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Wilson CC, 2008, N AM J FISH MANAGE, V28, P1307, DOI 10.1577/M05-190.1; Wright S, 1931, GENETICS, V16, P0097	45	9	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113809	10.1371/journal.pone.0113809	http://dx.doi.org/10.1371/journal.pone.0113809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479612	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200031
J	Pandith, AH; Islam, N				Pandith, Altaf Hussain; Islam, Nasarul			Electron Transport and Nonlinear Optical Properties of Substituted Aryldimesityl Boranes: A DFT Study	PLOS ONE			English	Article							AMORPHOUS MOLECULAR MATERIALS; OXIDATION-REDUCTION REACTIONS; BAND-STRUCTURE; HYPERPOLARIZABILITIES; STATE; POLYMERIZATION; APPROXIMATION; CHEMOSENSOR; COPOLYMERS; OLIGOMERS	A comprehensive theoretical study was carried out on a series of aryldimesityl borane (DMB) derivatives using Density Functional theory. Optimized geometries and electronic parameters like electron affinity, reorganization energy, frontiers molecular contours, polarizability and hyperpolarizability have been calculated by employing B3PW91/6-311++G (d, p) level of theory. Our results show that the Hammett function and geometrical parameters correlates well with the reorganization energies and hyperpolarizability for the series of DMB derivatives studied in this work. The orbital energy study reveals that the electron releasing substituents increase the LUMO energies and electron withdrawing substituents decrease the LUMO energies, reflecting the electron transport character of aryldimesityl borane derivatives. From frontier molecular orbitals diagram it is evident that mesityl rings act as the donor, while the phenylene and Boron atom appear as acceptors in these systems. The calculated hyperpolarizability of secondary amine derivative of DMB is 40 times higher than DMB (1). The electronic excitation contributions to the hyperpolarizability studied by using TDDFT calculation shows that hyperpolarizability correlates well with dipole moment in ground and excited state and excitation energy in terms of the two-level model. Thus the results of these calculations can be helpful in designing the DMB derivatives for efficient electron transport and nonlinear optical material by appropriate substitution with electron releasing or withdrawing substituents on phenyl ring of DMB system.	[Pandith, Altaf Hussain; Islam, Nasarul] Univ Kashmir, Dept Chem, Srinagar 190006, Kashmir, India	University of Kashmir	Pandith, AH (corresponding author), Univ Kashmir, Dept Chem, Srinagar 190006, Kashmir, India.	altafpandit23@gmail.com	Islam, Nasarul/I-3442-2012	Islam, Nasarul/0000-0002-5719-0795; Pandith, Altaf/0000-0002-2601-5580				Bauernschmitt R, 1996, CHEM PHYS LETT, V256, P454, DOI 10.1016/0009-2614(96)00440-X; BINKLEY JS, 1980, J AM CHEM SOC, V102, P939, DOI 10.1021/ja00523a008; Chen EYX, 2000, CHEM REV, V100, P1391, DOI 10.1021/cr980462j; Cheng YC, 2003, J CHEM PHYS, V118, P3764, DOI 10.1063/1.1539090; Dagani R, 1996, CHEM ENG NEWS, V74, P22, DOI 10.1021/cen-v074n004.p022; Datta A, 2006, CHEM SOC REV, V35, P1305, DOI 10.1039/b605478a; Doi H, 2003, CHEM MATER, V15, P1080, DOI 10.1021/cm020948n; Entwistle CD, 2004, CHEM MATER, V16, P4574, DOI 10.1021/cm0495717; Entwistle CD, 2002, ANGEW CHEM INT EDIT, V41, P2927, DOI 10.1002/1521-3773(20020816)41:16<2927::AID-ANIE2927>3.0.CO;2-L; Erker G, 2005, DALTON T, P1883, DOI 10.1039/b503688g; Ervin KM, 2003, J PHYS CHEM A, V107, P8521, DOI 10.1021/jp0357323; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fu YW, 2008, MACROMOL THEOR SIMUL, V17, P385, DOI 10.1002/mats.200800041; Gao HZ, 2011, J PHYS CHEM A, V115, P9259, DOI 10.1021/jp202976m; Garcia G, 2011, J PHYS CHEM C, V115, P6922, DOI 10.1021/jp112165r; GLOGOWSKI ME, 1981, J ORGANOMET CHEM, V218, P137, DOI 10.1016/S0022-328X(00)86094-5; Huh JO, 2010, CHEM COMMUN, V46, P1138, DOI 10.1039/b918263b; Islam N, 2014, SPECTROCHIM ACTA A, V131, P461, DOI 10.1016/j.saa.2014.04.089; Jakle F, 2006, COORDIN CHEM REV, V250, P1107, DOI 10.1016/j.ccr.2006.01.007; Jia WL, 2004, CHEM-EUR J, V10, P994, DOI 10.1002/chem.200305579; KANIS DR, 1992, J AM CHEM SOC, V114, P10338, DOI 10.1021/ja00052a035; Kinoshita M, 2002, ADV FUNCT MATER, V12, P780, DOI 10.1002/adfm.200290007; Kubo Y, 2003, ANGEW CHEM INT EDIT, V42, P2036, DOI 10.1002/anie.200250788; Lam ST, 2009, INORG CHEM, V48, P9664, DOI 10.1021/ic900803a; Leffler JE., 1989, RATES EQUILIBRIA ORG; Lewis G. N., 1923, VALENCE STRUCTURE AT; Li X, 2012, CHINESE SCI BULL, V57, P1772, DOI 10.1007/s11434-012-5059-5; Lin BC, 2005, J AM CHEM SOC, V127, P66, DOI 10.1021/ja045087t; Lin BC, 2003, J PHYS CHEM A, V107, P5241, DOI 10.1021/jp0304529; Lindsay GA, 1995, POLYM 2 ORDER NONLIN; Liu CG, 2009, INORG CHEM, V48, P6548, DOI 10.1021/ic9004906; Liu Y, 2009, INORG CHEM, V48, P10018, DOI 10.1021/ic9002675; MARCUS RA, 1957, J CHEM PHYS, V26, P872, DOI 10.1063/1.1743424; MARCUS RA, 1957, J CHEM PHYS, V26, P867, DOI 10.1063/1.1743423; Matsumi N, 1999, MACROMOLECULES, V32, P4467, DOI 10.1021/ma980785h; Naka S, 2000, SYNTHETIC MET, V111, P331, DOI 10.1016/S0379-6779(99)00358-6; Noda T, 2000, J LUMIN, V87-9, P1168, DOI 10.1016/S0022-2313(99)00583-9; OUDAR JL, 1977, J CHEM PHYS, V66, P2664, DOI 10.1063/1.434213; Parab K, 2006, J AM CHEM SOC, V128, P12879, DOI 10.1021/ja063302v; Parisel O, 1996, CHEM PHYS LETT, V250, P178, DOI 10.1016/0009-2614(96)00016-4; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Persoons A, 2011, OPT MATER EXPRESS, V1, P5, DOI 10.1364/OME.1.000005; Piers WE, 2005, ADV ORGANOMET CHEM, V52, P1, DOI 10.1016/S0065-3055(04)52001-4; Qin Y, 2005, MACROMOLECULES, V38, P8987, DOI 10.1021/ma051615p; Qin Y, 2002, J AM CHEM SOC, V124, P12672, DOI 10.1021/ja020773i; Sakuda E, 2005, J PHYS CHEM B, V109, P22326, DOI 10.1021/jp054601u; Sakuda E, 2010, J PHYS CHEM A, V114, P9144, DOI 10.1021/jp1057463; Shirota Y, 2000, J AM CHEM SOC, V122, P11021, DOI 10.1021/ja0023332; Spassova M, 2007, CHEM PHYS LETT, V439, P213, DOI 10.1016/j.cplett.2007.03.055; Sun Y, 2010, INORG CHEM, V49, P4394, DOI 10.1021/ic1004159; Sundaraganesan N, 2009, SPECTROCHIM ACTA A, V73, P11, DOI 10.1016/j.saa.2009.01.007; Uchida M, 2001, J PHOTOPOLYM SCI TEC, V4, P301; ULMAN A, 1988, J PHYS CHEM-US, V92, P2385, DOI 10.1021/j100319a056; Yamada T, 2011, ORG ELECTRON, V12, P169, DOI 10.1016/j.orgel.2010.10.022; Yamada T, 2010, ORG ELECTRON, V11, P255, DOI 10.1016/j.orgel.2009.11.003; Yamaguchi S, 2001, J AM CHEM SOC, V123, P11372, DOI 10.1021/ja015957w; Yang YT, 2006, J PHYS CHEM B, V110, P3180, DOI 10.1021/jp0540252; Zhang R, 2010, SPECTROCHIM ACTA A, V75, P1115, DOI 10.1016/j.saa.2009.12.067; Zhao Q, 2008, INORG CHEM, V47, P9256, DOI 10.1021/ic800500c	59	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114125	10.1371/journal.pone.0114125	http://dx.doi.org/10.1371/journal.pone.0114125			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479382	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200044
J	Berenbaum, F; Chauvin, P; Hudry, C; Mathoret-Philibert, F; Poussiere, M; De Chalus, T; Dreuillet, C; Russo-Marie, F; Joubert, JM; Saraux, A				Berenbaum, Francis; Chauvin, Pierre; Hudry, Christophe; Mathoret-Philibert, Florence; Poussiere, Maud; De Chalus, Thibault; Dreuillet, Caroline; Russo-Marie, Francoise; Joubert, Jean-Michel; Saraux, Alain			Fears and Beliefs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; META-ETHNOGRAPHY; DISEASE STATUS; DIAGNOSIS; INTERVENTIONS; PERCEPTIONS; PREVALENCE; VALIDATION; FRANCE	Objectives: To explore beliefs and apprehensions about disease and its treatment in patients with rheumatoid arthritis and spondyloarthritis. Methods: 25 patients with rheumatoid arthritis and 25 with spondyloarthritis participated in semi-structured interviews about their disease and its treatment. The interviews were performed by trained interviewers in participants' homes. The interviews were recorded and the main themes identified by content analysis. Results: Patients differentiated between the underlying cause of the disease, which was most frequently identified as a hereditary or individual predisposition. In patients with rheumatoid arthritis, the most frequently cited triggering factor for disease onset was a psychological factor or life-event, whereas patients with spondyloarthritis tended to focus more on an intrinsic vulnerability to disease. Stress and overexertion were considered important triggering factors for exacerbations, and relaxation techniques were frequently cited strategies to manage exacerbations. The unpredictability of the disease course was a common source of anxiety. Beliefs about the disease and apprehensions about the future tended to evolve over the course of the disease, as did treatment expectations. Conclusions: Patients with rheumatoid arthritis and spondyloarthritis hold a core set of beliefs and apprehensions that reflect their level of information about their disease and are not necessarily appropriate. The physician can initiate discussion of these beliefs in order to dispel misconceptions, align treatment expectations, provide reassurance to the patient and readjust disease management. Such a dialogue would help improve standards of care in these chronic and incapacitating diseases.	[Berenbaum, Francis] Sorbonne Univ, Univ Paris 06, Hop St Antoine, AP HP,Dept Rheumatol, Paris, France; [Chauvin, Pierre] Sorbonne Univ, Univ Paris 06, INSERM,UMR S 1136, Pierre Louis Inst Epidemiol & Publ Hlth,Dept Soci, Paris, France; [Hudry, Christophe] Hop La Pitie Salpetriere, AP HP, Dept Rheumatol, Paris, France; [Mathoret-Philibert, Florence] Hop Cochin, AP HP, Dept Clin Psychol, F-75674 Paris, France; [De Chalus, Thibault; Joubert, Jean-Michel] UCB Labs, Colombes, France; [Dreuillet, Caroline; Russo-Marie, Francoise] Arthrit Fdn Courtin, Neuilly Sur Seine, France; [Saraux, Alain] CHU La Cavale Blanche, Dept Rheumatol, Brest, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest	Berenbaum, F (corresponding author), Sorbonne Univ, Univ Paris 06, Hop St Antoine, AP HP,Dept Rheumatol, Paris, France.	francis.berenbaum@sat.aphp.fr	Berenbaum, Francis/AAO-5690-2020; Chauvin, Pierre/S-2981-2019	Berenbaum, Francis/0000-0001-8252-7815; Chauvin, Pierre/0000-0002-9183-6406; Hudry, Christophe/0000-0002-1036-3660	Arthritis Fundation; French charitable organisation; UCB Pharma	Arthritis Fundation; French charitable organisation; UCB Pharma(UCB Pharma SA)	The work was jointly funded and supported by Arthritis Fundation, a French charitable organisation dedicated to the promotion and support of biomedical research on severe joint diseases, and UCB Pharma. The funder provided support in the form of salaries for authors TDC, CD, FR-M and JMJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Berry D, 2004, RHEUMATOLOGY, V43, P901, DOI 10.1093/rheumatology/keh196; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Campbell R, 2011, HEALTH TECHNOL ASSES, V15, pIII, DOI 10.3310/hta15430; Daker-White G, 2014, DISABIL REHABIL, V36, P1061, DOI 10.3109/09638288.2013.829531; de Thurah A, 2010, RHEUMATOL INT, V30, P1441, DOI 10.1007/s00296-009-1160-8; Dissanayake RK, 2010, INT J RHEUM DIS, V13, P324, DOI 10.1111/j.1756-185X.2010.01563.x; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gettings L, 2010, MUSCULOSKELET CARE, V8, P99, DOI 10.1002/msc.171; Goodacre LJ, 2004, RHEUMATOLOGY, V43, P583, DOI 10.1093/rheumatology/keh116; Gossec L, 2011, ANN RHEUM DIS, V70, P935, DOI 10.1136/ard.2010.142901; Gossec L, 2012, REV RHUM, V79, pA133; Groarke A, 2004, RHEUMATOLOGY, V43, P1142, DOI 10.1093/rheumatology/keh262; Guillemin F, 2005, ANN RHEUM DIS, V64, P1427, DOI 10.1136/ard.2004.029199; HAWLEY DJ, 1995, BAILLIERE CLIN RHEUM, V9, P803, DOI 10.1016/S0950-3579(05)80315-2; Haywood KL, 2010, J RHEUMATOL, V37, P2100, DOI 10.3899/jrheum.091359; Kataria RK, 2004, AM FAM PHYSICIAN, V69, P2853; Lin WC, 2011, J NURS RES, V19, P1, DOI 10.1097/JNR.0b013e31820b0f8c; Lutze U, 2007, SCAND J CARING SCI, V21, P64, DOI 10.1111/j.1471-6712.2007.00443.x; McLeod K, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/197454; Pouchot J, 2007, JOINT BONE SPINE, V74, P622, DOI 10.1016/j.jbspin.2006.11.024; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Reveille JD, 2005, J RHEUMATOL, V32, P10; Rindfleisch JA, 2005, AM FAM PHYSICIAN, V72, P1037; Rudwaleit M, 2012, NAT REV RHEUMATOL, V8, P262, DOI 10.1038/nrrheum.2012.39; Salminen E, 2002, PREV MED, V34, P529, DOI 10.1006/pmed.2002.1015; Saraux A, 2005, ANN RHEUM DIS, V64, P1431, DOI 10.1136/ard.2004.029207; Sokka T, 2009, CURR OPIN RHEUMATOL, V21, P284, DOI 10.1097/BOR.0b013e32832a2f02; Stack RJ, 2013, ARTHRIT CARE RES, V65, P1916, DOI 10.1002/acr.22097; Stack RJ, 2012, ANN RHEUM DIS, V71, P493, DOI 10.1136/ard.2011.155416; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	31	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114350	10.1371/journal.pone.0114350	http://dx.doi.org/10.1371/journal.pone.0114350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474157	Green Published, gold			2022-12-26	WOS:000346382500023
J	Scala, G; Affinito, O; Miele, G; Monticelli, A; Cocozza, S				Scala, Giovanni; Affinito, Ornella; Miele, Gennaro; Monticelli, Antonella; Cocozza, Sergio			Evidence for Evolutionary and Nonevolutionary Forces Shaping the Distribution of Human Genetic Variants near Transcription Start Sites	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; INDUCED DNA LESIONS; HUMAN GENOME; CPG ISLANDS; GC-CONTENT; MAMMALIAN EVOLUTION; HOUSEKEEPING GENES; CHROMATIN; ORGANIZATION; REPLICATION	The regions surrounding transcription start sites (TSSs) of genes play a critical role in the regulation of gene expression. At the same time, current evidence indicates that these regions are particularly stressed by transcription-related mutagenic phenomena. In this work we performed a genome-wide analysis of the distribution of single nucleotide polymorphisms (SNPs) inside the 10 kb region flanking human TSSs by dividing SNPs into four classes according to their frequency (rare, two intermediate classes, and common). We found that, in this 10 kb region, the distribution of variants depends on their frequency and on their localization relative to the TSS. We found that the distribution of variants is generally different for TSSs located inside or outside of CpG islands. We found a significant relationship between the distribution of rare variants and nucleosome occupancy scores. Furthermore, our analysis suggests that evolutionary (purifying selection) and nonevolutionary (biased gene conversion) forces both play a role in determining the relative SNP frequency around TSSs. Finally, we analyzed the potential pathogenicity of each class of variant using the Combined Annotation Dependent Depletion score. In conclusion, this study provides a novel and detailed view of the distribution of genomic variants around TSSs, providing insight into the forces that instigate and maintain variability in such critical regions.	[Scala, Giovanni; Affinito, Ornella; Miele, Gennaro; Monticelli, Antonella; Cocozza, Sergio] Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy; [Scala, Giovanni; Miele, Gennaro] Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [Scala, Giovanni; Miele, Gennaro] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Affinito, Ornella; Cocozza, Sergio] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Affinito, Ornella; Monticelli, Antonella] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy	University of Naples Federico II; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Scala, G (corresponding author), Univ Naples Federico II, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy.	gscala@na.infn.it	Cocozza, Sergio/F-6488-2010; Miele, Gennaro/F-3628-2010; Affinito, Ornella/AAC-1003-2019; Miele, Gennaro/AAG-6782-2020	Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578; SCALA, GIOVANNI/0000-0002-9037-1782; , Ornella/0000-0002-8355-9509	Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples; Epigenomic Flagship Project-Epigen; CNR; POR Campania FSE; CREME	Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples; Epigenomic Flagship Project-Epigen; CNR(Consiglio Nazionale delle Ricerche (CNR)); POR Campania FSE(Regione Campania); CREME	GS and OA are recipients of a doctoral fellowship from the Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples. This work was partially supported by the Epigenomic Flagship Project-Epigen, CNR and by POR Campania FSE 2007-2013, Project CREME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Basak S, 2005, BIOCHEM BIOPH RES CO, V330, P629, DOI 10.1016/j.bbrc.2005.02.134; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Capra JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003684; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cui Peng, 2012, Genomics Proteomics & Bioinformatics, V10, P11, DOI 10.1016/S1672-0229(11)60029-6; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Gontijo AM, 2003, BIOCHIMIE, V85, P1133; De Maio N, 2013, MOL BIOL EVOL, V30, P2249, DOI 10.1093/molbev/mst131; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Frith MC, 2006, GENOME RES, V16, P713, DOI 10.1101/gr.5031006; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guo YJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-140; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Higasa K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-66; Hinz JM, 2010, ENVIRON MOL MUTAGEN, V51, P582, DOI 10.1002/em.20577; Hurst LD, 2000, GENE, V261, P107, DOI 10.1016/S0378-1119(00)00489-3; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; Kimura M, 1985, NEUTRAL THEORY MOL E; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; Necsulea A, 2009, MOL BIOL EVOL, V26, P729, DOI 10.1093/molbev/msn303; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Polak P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-187; Polak P, 2009, GENOME BIOL EVOL, V1, P189, DOI 10.1093/gbe/evp024; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	62	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114432	10.1371/journal.pone.0114432	http://dx.doi.org/10.1371/journal.pone.0114432			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474578	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500027
J	Qu, Y; Chakrabarty, R; Iran, HT; Kwon, EJG; Kwon, M; Nguyen, TD; Ro, DK				Qu, Yang; Chakrabarty, Romit; Iran, Hue T.; Kwon, Eun-Joo G.; Kwon, Moonhyuk; Nguyen, Trinh-Don; Ro, Dae-Kyun			A Lettuce (Lactuca sativa) Homolog of Human Nogo-B Receptor Interacts with cis-Prenyltransferase and Is Necessary for Natural Rubber Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHATE SYNTHASE; GERANYL DIPHOSPHATE; DOLICHOL SYNTHESIS; OIL BODIES; PROTEIN LOCALIZATION; ALTERNATIVE SOURCES; CRYSTAL-STRUCTURE; BUDDING YEAST; KEY ENZYME; EXPRESSION	Natural rubber (cis-1,4-polyisoprene) is an indispensable biopolymer used to manufacture diverse consumer products. Although a major source of natural rubber is the rubber tree (Hevea brasiliensis), lettuce (Lactuca sativa) is also known to synthesize natural rubber. Here, we report that an unusual cisprenyltransferase- like 2 (CPTL2) that lacks the conserved motifs of conventional cis-prenyltransferase is required for natural rubber biosynthesis in lettuce. CPTL2, identified from the lettuce rubber particle proteome, displays homology to a human NogoB receptor and is predominantly expressed in latex. Multiple transgenic lettuces expressing CPTL2-RNAi constructs showed that a decrease of CPTL2 transcripts (3-15% CPTL2 expression relative to controls) coincided with the reduction of natural rubber as low as 5%. We also identified a conventional cis-prenyltransferase 3 (CPT3), exclusively expressed in latex. In subcellular localization studies using fluorescent proteins, cytosolic CPT3 was relocalized to endoplasmic reticulum by co-occurrence of CPTL2 in tobacco and yeast at the log phase. Furthermore, yeast two-hybrid data showed that CPTL2 and CPT3 interact. Yeast microsomes containing CPTL2/CPT3 showed enhanced synthesis of short cis-polyisoprenes, but natural rubber could not be synthesized in vitro. Intriguingly, a homologous pair CPTL1/CPT1, which displays ubiquitous expressions in lettuce, showed a potent dolichol biosynthetic activity in vitro. Taken together, our data suggest that CPTL2 is a scaffolding protein that tethers CPT3 on endoplasmic reticulum and is necessary for natural rubber biosynthesis in planta, but yeast-expressed CPTL2 and CPT3 alone could not synthesize high molecular weight natural rubber in vitro.	[Qu, Yang; Chakrabarty, Romit; Iran, Hue T.; Kwon, Eun-Joo G.; Kwon, Moonhyuk; Nguyen, Trinh-Don; Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Ro, DK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	daekyun.ro@ucalgary.ca	Ro, Dae-Kyun/G-9289-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Qu, Yang/0000-0002-0847-7212; Nguyen, Trinh-Don/0000-0002-2759-5791	Alberta Ingenuity New Faculty Award from Alberta Innovates Technology Future; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair; Next-Generation BioGreen 21 Program SSAC Grant from the Korean Rural Development Administration [PJ009549032014]	Alberta Ingenuity New Faculty Award from Alberta Innovates Technology Future; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Next-Generation BioGreen 21 Program SSAC Grant from the Korean Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by funds from the Alberta Ingenuity New Faculty Award from Alberta Innovates Technology Future, the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chair (to D. K. R.).; Supported by Next-Generation BioGreen 21 Program SSAC Grant PJ009549032014 from the Korean Rural Development Administration.	Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Asawatreratanakul K, 2003, EUR J BIOCHEM, V270, P4671, DOI 10.1046/j.1432-1033.2003.03863.x; Burke C, 2002, J BIOL CHEM, V277, P3141, DOI 10.1074/jbc.M105900200; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; Bushman BS, 2006, PHYTOCHEMISTRY, V67, P2590, DOI 10.1016/j.phytochem.2006.09.012; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Cornish K, 1999, PLANTA, V210, P85, DOI 10.1007/s004250050657; Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8; Cornish K, 2001, NAT PROD REP, V18, P182, DOI 10.1039/a902191d; Fehrenbacher KL, 2002, MOL BIOL CELL, V13, P854, DOI 10.1091/mbc.01-04-0184; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Golemis E. A., 2008, CURR PROTOC MOL BIOL; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Hillebrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041874; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kato JI, 1999, J BACTERIOL, V181, P2733, DOI 10.1128/JB.181.9.2733-2738.1999; Kera K, 2012, FEBS J, V279, P3813, DOI 10.1111/j.1742-4658.2012.08742.x; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627; Park EJ, 2014, CELL METAB, V20, P448, DOI 10.1016/j.cmet.2014.06.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Sasaki D, 2011, J BIOL CHEM, V286, P3729, DOI 10.1074/jbc.M110.147991; Sato M, 2001, GENES CELLS, V6, P495, DOI 10.1046/j.1365-2443.2001.00438.x; Sato M, 1999, MOL CELL BIOL, V19, P471; Schmidt T, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-11; SEILER GJ, 1991, ECON BOT, V45, P4, DOI 10.1007/BF02860045; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; SWANSON CL, 1979, J APPL POLYM SCI, V23, P743, DOI 10.1002/app.1979.070230309; Takahashi S, 2006, CHEM REC, V6, P194, DOI 10.1002/tcr.20083; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Teng KH, 2012, BIOORG CHEM, V43, P51, DOI 10.1016/j.bioorg.2011.09.004; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; van Beilen JB, 2007, CRIT REV BIOTECHNOL, V27, P217, DOI 10.1080/07388550701775927; van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200	46	54	56	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1898	1914		10.1074/jbc.M114.616920	http://dx.doi.org/10.1074/jbc.M114.616920			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477521	Green Published, hybrid			2022-12-26	WOS:000348588000001
J	Rodriguez, E; Nan, R; Li, KY; Gor, J; Perkins, SJ				Rodriguez, Elizabeth; Nan, Ruodan; Li, Keying; Gor, Jayesh; Perkins, Stephen J.			A Revised Mechanism for the Activation of Complement C3 to C3b A MOLECULAR EXPLANATION OF A DISEASE-ASSOCIATED POLYMORPHISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-SCATTERING; FACTOR-H; X-RAY; SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; COMPONENT C3; REVEALS; ULTRACENTRIFUGATION; FRAGMENTS; PROTEINS	The solution structure of complement C3b is crucial for the understanding of complement activation and regulation. C3b is generated by the removal of C3a from C3. Hydrolysis of the C3 thioester produces C3u, an analog of C3b. C3b cleavage results in C3c and C3d (thioester-containing domain; TED). To resolve functional questions in relation to C3b and C3u, analytical ultracentrifugation and x-ray and neutron scattering studies were used with C3, C3b, C3u, C3c, and C3d, using the wild-type allotype with Arg(102). In 50 mM NaCl buffer, atomistic scattering modeling showed that both C3b and C3u adopted a compact structure, similar to the C3b crystal structure in which its TED and macroglobulin 1 (MG1) domains were connected through the Arg(102)-Glu(1032) salt bridge. In physiological 137 mM NaCl, scattering modeling showed that C3b and C3u were both extended in structure, with the TED and MG1 domains now separated by up to 6 nm. The importance of the Arg(102)-Glu(1032) salt bridge was determined using surface plasmon resonance to monitor the binding of wild-type C3d(E1032) and mutant C3d(A1032) to immobilized C3c. The mutant did not bind, whereas the wild-type form did. The high conformational variability of TED in C3b in physiological buffer showed that C3b is more reactive than previously thought. Because the Arg(102)-Glu(1032) salt bridge is essential for the C3b-Factor H complex during the regulatory control of C3b, the known clinical associations of the major C3S (Arg(102)) and disease-linked C3F (Gly(102)) allotypes of C3b were experimentally explained for the first time.	[Rodriguez, Elizabeth; Nan, Ruodan; Li, Keying; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England	University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk			Centre for Molecular Structures and Dynamics of the Science and Technology Facilities Council; Engineering and Physical Sciences Research Council; CCP-SAS, a joint Engineering and Physical Sciences Research Council [EP/K039121/1]; National Science Foundation [CHE-1265821]; EPSRC [EP/K039121/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K039121/1] Funding Source: researchfish	Centre for Molecular Structures and Dynamics of the Science and Technology Facilities Council; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CCP-SAS, a joint Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Centre for Molecular Structures and Dynamics of the Science and Technology Facilities Council and the Engineering and Physical Sciences Research Council. Support for this work was also provided in part by the CCP-SAS project, a joint Engineering and Physical Sciences Research Council (EP/K039121/1) and National Science Foundation (CHE-1265821) grant. The work described here won an award for Best Oral Presentation at the XXVth International Complement Workshop in Rio de Janeiro, September 14 - 18, 2014.	Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; ARVILOMMI H, 1975, J IMMUNOL METHODS, V8, P345, DOI 10.1016/0022-1759(75)90056-3; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Delanghe JR, 2014, PATHOLOGY, V46, P1, DOI 10.1097/PAT.0000000000000042; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Hadders MA, 2012, CELL REP, V1, P200, DOI 10.1016/j.celrep.2012.02.003; HARDY RC, 1949, J RES NAT BUR STAND, V42, P573, DOI 10.6028/jres.042.049; HASE S, 1985, J BIOCHEM-TOKYO, V98, P863, DOI 10.1093/oxfordjournals.jbchem.a135366; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Heurich M, 2011, P NATL ACAD SCI USA, V108, P8761, DOI 10.1073/pnas.1019338108; HIRANI S, 1986, BIOCHEM J, V233, P613, DOI 10.1042/bj2330613; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Law S.K.A., 1995, COMPLEMENT; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Li KY, 2010, BIOCHEM J, V431, P63, DOI 10.1042/BJ20100759; LINDNER P, 1992, PHYSICA B, V180, P967, DOI 10.1016/0921-4526(92)90524-V; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; PERKINS SJ, 1990, BIOCHEMISTRY-US, V29, P1175, DOI 10.1021/bi00457a012; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2011, METHODS, V54, P181, DOI 10.1016/j.ymeth.2011.01.004; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Winters MS, 2005, J IMMUNOL, V174, P3469, DOI 10.4049/jimmunol.174.6.3469; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	49	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2334	2350		10.1074/jbc.M114.605691	http://dx.doi.org/10.1074/jbc.M114.605691			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488663	Green Published, hybrid			2022-12-26	WOS:000348588000038
J	Li, J; Diaz, J; Wang, X; Tsang, SH; You, JX				Li, Jing; Diaz, Jason; Wang, Xin; Tsang, Sabrina H.; You, Jianxin			Phosphorylation of Merkel Cell Polyomavirus Large Tumor Antigen at Serine 816 by ATM Kinase Induces Apoptosis in Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE T-ANTIGEN; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; RETINOBLASTOMA FAMILY; SUPPRESSOR PROTEINS; CYCLE CHECKPOINT; VIRUS T; CARCINOMA; SIMIAN-VIRUS-40; REPLICATION	Merkel cell carcinoma is a highly aggressive form of skin cancer. Merkel cell polyomavirus (MCV) infection and DNA integration into the host genome correlate with 80% of all Merkel cell carcinoma cases. Integration of the MCV genome frequently results in mutations in the large tumor antigen (LT), leading to expression of a truncated LT that retains pRB binding but with a deletion of the C-terminal domain. Studies from our laboratory and others have shown that the MCV LT C-terminal helicase domain contains growth-inhibiting properties. Additionally, we have shown that host DNA damage response factors are recruited to viral replication centers. In this study, we identified a novel MCV LT phosphorylation site at Ser-816 in the C-terminal domain. We demonstrate that activation of the ATM pathway stimulated MCV LT phosphorylation at Ser-816, whereas inhibition of ATM kinase activity prevented LT phosphorylation at this site. In vitro phosphorylation experiments confirmed that ATM kinase is responsible for phosphorylating MCV LT at Ser-816. Finally, we show that ATM kinase-mediated MCV LT Ser-816 phosphorylation may contribute to the anti-tumorigenic properties of the MCV LT C-terminal domain.	[Li, Jing] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Diaz, Jason; Tsang, Sabrina H.; You, Jianxin] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wang, Xin] Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44295 USA	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation	You, JX (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, 201C Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu			National Institutes of Health [R01CA148768, R01CA142723, 3R01CA142723-05S1]; NATIONAL CANCER INSTITUTE [R01CA187718, T32CA115299, R01CA148768, R01CA142723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA148768, R01CA142723, and 3R01CA142723-05S1.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Agelli M, 2003, J AM ACAD DERMATOL, V49, P832, DOI 10.1016/S0190-9622(03)02108-X; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Bichakjian CK, 2007, CANCER-AM CANCER SOC, V110, P1, DOI 10.1002/cncr.22765; Bollag B, 2000, VIROLOGY, V274, P165, DOI 10.1006/viro.2000.0451; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Carter JJ, 2013, P NATL ACAD SCI USA, V110, P12744, DOI 10.1073/pnas.1303526110; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; D'Amours D, 2001, J CELL SCI, V114, P3771; Demetriou SK, 2012, INT J CANCER, V131, P1818, DOI 10.1002/ijc.27440; Diaz J, 2014, CANCERS, V6, P1464, DOI 10.3390/cancers6031464; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022468; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Fradet-Turcotte A, 2007, J VIROL, V81, P9162, DOI 10.1128/JVI.00384-07; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harris KF, 1996, J VIROL, V70, P2378, DOI 10.1128/JVI.70.4.2378-2386.1996; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katunuma N, 2001, ADV ENZYME REGUL, V41, P237, DOI 10.1016/S0065-2571(00)00018-2; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Li J, 2013, J VIROL, V87, P9173, DOI 10.1128/JVI.01216-13; Li Peng, 2004, Cell, VS116, pS57, DOI 10.1016/S0092-8674(04)00031-5; McVey D, 1996, J VIROL, V70, P3887, DOI 10.1128/JVI.70.6.3887-3893.1996; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; PRIVES C, 1990, CELL, V61, P735, DOI 10.1016/0092-8674(90)90179-I; Salvesen GS, 2002, CELL DEATH DIFFER, V9, P3, DOI 10.1038/sj.cdd.4400963; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Schrama D, 2012, CURR OPIN ONCOL, V24, P141, DOI 10.1097/CCO.0b013e32834fc9fe; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Shimazu T, 2006, ONCOGENE, V25, P7391, DOI 10.1038/sj.onc.1209731; Shivakumar CV, 1996, ONCOGENE, V13, P323; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Tsang SH, 2014, J VIROL, V88, P3285, DOI 10.1128/JVI.03656-13; Wang X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003021; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1874	1884		10.1074/jbc.M114.594895	http://dx.doi.org/10.1074/jbc.M114.594895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25480786	Green Published, hybrid			2022-12-26	WOS:000348056400051
J	Caceres, O; Rastogi, N; Bartra, C; Couvin, D; Galarza, M; Asencios, L; Mendoza-Ticona, A				Caceres, Omar; Rastogi, Nalin; Bartra, Carlos; Couvin, David; Galarza, Marco; Asencios, Luis; Mendoza-Ticona, Alberto			Characterization of the Genetic Diversity of Extensively-Drug Resistant Mycobacterium tuberculosis Clinical Isolates from Pulmonary Tuberculosis Patients in Peru	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SOUTH-AMERICA; COMPLEX; SPOLIGOTYPES; STRAINS; MUTATIONS; SEQUENCES; DATABASE; TOOL; TB	Background: Peru holds the fourth highest burden of tuberculosis in the Americas. Despite an apparently well-functioning DOTS control program, the prevalence of multidrug resistant tuberculosis (MDR-TB) continues to increase. To worsen this situation, cases of extensively drug resistance tuberculosis (XDR-TB) have been detected. Little information exists about the genetic diversity of drug-susceptible vs. MDR-TB and XDR-TB. Methods: Cryopreserved samples of XDR strains from 2007 to 2009 (second semester), were identified and collected. Starting from 227 frozen samples, a total of 142 XDR-TB strains of Mycobacterium tuberculosis complex (MTBC; 1 isolate per patient) were retained for this study. Each strain DNA was analyzed by spoligotyping and the 15-loci Mycobacterial Interspersed Repetitive Unit (MIRU-15). Results: Among the 142 isolates analyzed, only 2 samples (1.41%) could not be matched to any lineage. The most prevalent sublineage was Haarlem (43.66%), followed by T (27.46%), LAM (16.2%), Beijing (9.15%), and X clade (1.41%). Spoligotype analysis identified clustering for 128/142 (90.1%) isolates vs. 49/142 (34.5%) with MIRUs. Of the samples, 90.85% belonged to retreated patients. The drug resistant profile demonstrated that 62.67% showed resistance to injectable drugs capreomycin (CAP) and kanamycin (KAN) vs. 15.5% to CAP alone and 21.8% to KAN alone. The SIT219/T1 and SIT50/H3 were the most prevalent patterns in our study. The spoligoforest analysis showed that SIT53/T1 was at the origin of many of the T lineage strains as well as a big proportion of Haarlem lineage strains (SIT50/H3, followed by SIT47/H1, SIT49/H3, and SIT2375/H1), as opposed to the SIT1/Beijing strains that did not appear to evolve into minor Beijing sublineages among the XDR-TB strains. Conclusion: In contrast with other Latin-American countries where LAM sublineage is the most predominant, we found the Haarlem to be the most common followed by T sublineage among the XDR-TB strains.	[Caceres, Omar; Galarza, Marco] Inst Nacl Salud, Biotechnol & Mol Biol Lab, Lima, Peru; [Rastogi, Nalin; Couvin, David] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Les Abymes, Guadeloupe, France; [Bartra, Carlos; Asencios, Luis] Inst Nacl Salud, Mycobacterias Natl Reference Lab, Lima, Peru; [Mendoza-Ticona, Alberto] Minist Salud MINSA, Lima, Peru	Instituto Nacional de Salud - Peru; Instituto Nacional de Salud - Peru	Caceres, O (corresponding author), Inst Nacl Salud, Biotechnol & Mol Biol Lab, Lima, Peru.	caceresreyomar@gmail.com	RASTOGI, NALIN/AAP-1958-2020; Galarza, Marco/L-3632-2017	RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023; Caceres, Omar/0000-0003-1529-2475; Galarza, Marco/0000-0002-6547-2354; Bartra More, Carlos Arturo/0000-0003-4760-8972	International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru; International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru	International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru; International Association of National Public Health Institutes (IANPHI) Research Seed Grant; Instituto Nacional de Salud, Peru	AM and OC were supported by International Association of National Public Health Institutes (IANPHI) Research Seed Grant (www.ianphi.org) and Instituto Nacional de Salud, Peru (www.ins.gob.pe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Alonso-Rodriguez N, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-34; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Barletta F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-397; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; Del Castillo Hernán, 2009, Rev. perú. med. exp. salud publica, V26, P380; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Driscoll JR, 2002, EMERG INFECT DIS, V8, P1306, DOI 10.3201/eid0811.020174; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent P. T, 1995, PUBLIC HLTH MYCOBACT; Nieto LM, 2012, J CLIN MICROBIOL, V50, P4185, DOI 10.1128/JCM.01946-12; Mendoza-Ticona Alberto, 2007, Rev. perú. med. exp. salud publica, V24, P313; Ministerio de Salud, DIR SAL LIM CIUD AN; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Olano J, 2007, TUBERCULOSIS, V87, P502, DOI 10.1016/j.tube.2007.05.011; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rosales S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-208; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585	33	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e112789	10.1371/journal.pone.0112789	http://dx.doi.org/10.1371/journal.pone.0112789			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489950	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300004
J	Da Silva, S; Moreira, B; Da Costa, N				Da Silva, Sergio; Moreira, Bruno; Da Costa, Newton, Jr.			2D:4D Digit Ratio Predicts Delay of Gratification in Preschoolers	PLOS ONE			English	Article							TESTOSTERONE; CHILDREN; 2ND	We replicate the Stanford marshmallow experiment with a sample of 141 preschoolers and find a correlation between lack of self-control and 2D:4D digit ratio. Children with low 2D:4D digit ratio are less likely to delay gratification. Low 2D:4D digit ratio may indicate high fetal testosterone. If this hypothesis is true, our finding means high fetal testosterone children are less likely to delay gratification.	[Da Silva, Sergio; Da Costa, Newton, Jr.] Univ Fed Santa Catarina, Grad Program Econ, BR-88049970 Florianopolis, SC, Brazil; [Moreira, Bruno] Fed Inst Minas Gerais, BR-35570000 Formiga, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG)	Da Silva, S (corresponding author), Univ Fed Santa Catarina, Grad Program Econ, BR-88049970 Florianopolis, SC, Brazil.	professorsergiodasilva@gmail.com	da Costa Jr., Newton C. A./AAZ-4155-2020; Da Silva, Sergio/A-2477-2008	da Costa Jr., Newton C. A./0000-0001-7723-2676; Da Silva, Sergio/0000-0002-7987-4098	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [304342/2009-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by: BM: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) PhD scholarship, www.capes.gov.br. NDC.J: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), www.cnpq.br. Grant Number: 304342/2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1532; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Da Silva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109520; Hampson E, 2012, EVOL HUM BEHAV, V33, P557, DOI 10.1016/j.evolhumbehav.2012.02.003; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Honekopp Johannes, 2013, Front Endocrinol (Lausanne), V4, P185, DOI 10.3389/fendo.2013.00185; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Johnston DW, 2009, DEMOGRAPHY, V46, P281, DOI 10.1353/dem.0.0053; Llaurens V, 2009, PHILOS T R SOC B, V364, P881, DOI 10.1098/rstb.2008.0235; Manning J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00009; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; McCabe LA, 2007, INFANT MENT HEALTH J, V28, P584, DOI 10.1002/imhj.20155; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; Moreira B, 2010, J ECON PSYCHOL, V31, P794, DOI 10.1016/j.joep.2010.03.005; NISAN M, 1976, CHILD DEV, V47, P195; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; PHELPS VR, 1952, AM J HUM GENET, V4, P72; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Voracek M, 2009, PSYCHOL REP, V104, P922, DOI 10.2466/PR0.104.3.922-956; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	22	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114394	10.1371/journal.pone.0114394	http://dx.doi.org/10.1371/journal.pone.0114394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490040	gold, Green Published			2022-12-26	WOS:000347515300035
J	Lobo, MR; Wang, XY; Gillespie, GY; Woltjer, RL; Pike, MM				Lobo, Merryl R.; Wang, Xiaoyan; Gillespie, G. Yancey; Woltjer, Randall L.; Pike, Martin M.			Combined Efficacy of Cediranib and Quinacrine in Glioma Is Enhanced by Hypoxia and Causally Linked to Autophagic Vacuole Accumulation	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TYROSINE KINASE INHIBITOR; CELL-DEATH; TARGETED THERAPIES; INDUCED APOPTOSIS; TUMOR HYPOXIA; GROWTH; GLIOBLASTOMA; VASCULATURE; RESISTANCE	We have previously reported that the in vivo anti-glioma efficacy of the anti-angiogenic receptor tyrosine kinase inhibitor cediranib is substantially enhanced via combination with the late-stage autophagy inhibitor quinacrine. The current study investigates the role of hypoxia and autophagy in combined cediranib/quinacrine efficacy. EF5 immunostaining revealed a prevalence of hypoxia in mouse intracranial 4C8 glioma, consistent with high-grade glioma. MTS cell viability assays using 4C8 glioma cells revealed that hypoxia potentiated the efficacy of combined cediranib/quinacrine: cell viability reductions induced by 1 mu M cediranib +2.5 mu M quinacrine were 78 +/- 7% (hypoxia) vs. 31 +/- 3% (normoxia), p<0.05. Apoptosis was markedly increased for cediranib/quinacrine/hypoxia versus all other groups. Autophagic vacuole biomarker LC3-II increased robustly in response to cediranib, quinacrine, or hypoxia. Combined cediranib/quinacrine increased LC3-II further, with the largest increases occurring with combined cediranib/quinacrine/ hypoxia. Early stage autophagy inhibitor 3-MA prevented LC3-II accumulation with combined cediranib/quinacrine/hypoxia and substantially attenuated the associated reduction in cell viability. Combined efficacy of cediranib with bafilomycin A1, another late-stage autophagy inhibitor, was additive but lacked substantial potentiation by hypoxia. Substantially lower LC3-II accumulation was observed with bafilomycin A1 in comparison to quinacrine. Cediranib and quinacrine each strongly inhibited Akt phosphoryation, while bafilomycin A1 had no effect. Our results provide compelling evidence that autophagic vacuole accumulation plays a causal role in the anti-glioma cytotoxic efficacy of combined cediranib/quinacrine. Such accumulation is likely related to stimulation of autophagosome induction by hypoxia, which is prevalent in the glioma tumor microenvironment, as well as Akt signaling inhibition from both cediranib and quinacrine. Quinacrine's unique ability to inhibit both Akt and autophagic vacuole degradation may enhance its ability to drive cytotoxic autophagic vacuole accumulation. These findings provide a rationale for a clinical evaluation of combined cediranib/quinacrine therapy for malignant glioma.	[Lobo, Merryl R.; Pike, Martin M.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Lobo, Merryl R.; Pike, Martin M.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Wang, Xiaoyan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Alabama System; University of Alabama Birmingham	Pike, MM (corresponding author), Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA.	pikema@ohsu.edu		Gillespie, George/0000-0001-6436-9542	National Institutes of Health, National Cancer Institute [1R21 CA167302-01]; NATIONAL CANCER INSTITUTE [R21CA167302] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the National Institutes of Health, National Cancer Institute (#1R21 CA167302-01, MMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi R, 2009, CANCER BIOL THER, V8, P130, DOI DOI 10.4161/CBT.8.21.10416; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Calvo E, 2009, ONCOTARGETS THER, V2, P135; Chiavarina B, 2010, CELL CYCLE, V9, P3534, DOI 10.4161/cc.9.17.12908; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DYER CA, 1995, J NEUROPATH EXP NEUR, V54, P852, DOI 10.1097/00005072-199511000-00012; Ehsanian R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-13; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Guo C, 2009, ONCOGENE, V28, P1151, DOI 10.1038/onc.2008.460; Guo CH, 2011, P NATL ACAD SCI USA, V108, P7968, DOI 10.1073/pnas.1105369108; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jordan BF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00094; Joshi AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044372; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kaza N, 2012, BRAIN PATHOL, V22, P89, DOI 10.1111/j.1750-3639.2011.00544.x; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lindberg N, 2012, UPSALA J MED SCI, V117, P92, DOI 10.3109/03009734.2012.654860; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Marceau F, 2009, DRUG METAB DISPOS, V37, P2271, DOI 10.1124/dmd.109.028480; Martinho O, 2013, TRANSL ONCOL, V6, P187, DOI 10.1593/tlo.12400; Mercer RW, 2009, BIODRUGS, V23, P25, DOI 10.2165/00063030-200923010-00003; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Nazarenko I, 2012, UPSALA J MED SCI, V117, P99, DOI 10.3109/03009734.2012.665097; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rahman R, 2010, J ONCOL, V2010, DOI 10.1155/2010/251231; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rouschop KMA, 2009, CURR MOL MED, V9, P417, DOI 10.2174/156652409788167131; Selvakumaran M, 2013, CLIN CANCER RES, V19, P2995, DOI 10.1158/1078-0432.CCR-12-1542; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Thaker NG, 2009, EXPERT REV NEUROTHER, V9, P1815, DOI 10.1586/ERN.09.116; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Weinmann M, 2004, ONCOGENE, V23, P3757, DOI 10.1038/sj.onc.1207481; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yung L, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-53; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang RG, 2011, CANCER BIOTHER RADIO, V26, P335, DOI 10.1089/cbr.2010.0814	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114110	10.1371/journal.pone.0114110	http://dx.doi.org/10.1371/journal.pone.0114110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490024	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300015
J	Merz, WM; Leufgen, C; Fimmers, R; Stoffel-Wagner, B; Gembruch, U				Merz, Waltraut M.; Leufgen, Christina; Fimmers, Rolf; Stoffel-Wagner, Birgit; Gembruch, Ulrich			Reference Intervals for N-Terminal Pro-B-Type Natriuretic Peptide in Amniotic Fluid between 10 and 34 Weeks of Gestation	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; BNP MEASUREMENTS USEFUL; CORD BLOOD; UMBILICAL ARTERY; FETAL ANEMIA; DIAGNOSIS; VOLUME; MANAGEMENT; FETUSES; CIRCULATION	Background: In adult and pediatric cardiology, n-terminal pro-B-type natriuretic peptide (nt-proBNP) serves as biomarker in the diagnosis and management of cardiovascular dysfunction. Elevated levels of circulating nt-proBNP are present in fetal conditions associated with myocardial pressure or volume load. Compared to fetal blood sampling, amniocentesis is technically easier and can be performed from early pregnancy onwards. We aimed to investigate amniotic fluid (AF) nt-proBNP concentrations in normal pregnancies between 10 and 34 weeks of gestation. Methods: Nt-proBNP and total protein (TP) was measured in AF by chemiluminescence assay (photometry, respectively). To adjust for a potential dilutional effect, the AF-nt-proBNP/AF-TP ratio was analyzed. Reference intervals were constructed by regression modeling across gestational age. Results: 132 samples were analyzed. A negative correlation between AF-nt-proBNP/AF-TP ratio and gestational age was observed. Curves for the mean and the 5% and 95% reference interval between 10 and 34 weeks of gestation were established. Conclusion: In normal pregnancy, nt-proBNP is present in AF and decreases during gestation. Our data provide the basis for research on AF-nt-proBNP as biomarker in fetal medicine.	[Merz, Waltraut M.; Leufgen, Christina; Gembruch, Ulrich] Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Sch Med, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Sch Med, Inst Clin Chem & Pharmacol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Merz, WM (corresponding author), Univ Bonn, Sch Med, Dept Obstet & Prenatal Med, Bonn, Germany.	waltraut.merz@ukb.uni-bonn.de	Sánchez-Margalet, Victor/AAB-9986-2021; Gembruch, Ulrich/Q-8228-2017	Sánchez-Margalet, Victor/0000-0001-8638-8680; Gembruch, Ulrich/0000-0001-8284-4669				Anderson DF, 2013, AM J PHYSIOL-REG I, V305, pR506, DOI 10.1152/ajpregu.00175.2013; Bahlmann F, 2011, J PERINAT MED, V39, P529, DOI [10.1515/JPM.2011.065, 10.1515/jpm.2011.065]; Bar-Oz B, 2005, CLIN CHEM, V51, P926, DOI 10.1373/clinchem.2005.048892; Brace RA, 2004, AM J OBSTET GYNECOL, V191, P837, DOI 10.1016/j.ajog.2004.01.048; BRACE RA, 1995, PLACENTA, V16, P1, DOI 10.1016/0143-4004(95)90077-2; Carvajal JA, 2009, REPROD SCI, V16, P32, DOI 10.1177/1933719108324137; Clerico A, 2004, CLIN CHEM, V50, P33, DOI 10.1373/clinchem.2003.024760; Delabaere A, 2010, ULTRASOUND OBST GYN, V35, P620, DOI 10.1002/uog.7579; Deprest JA, 2010, PRENATAL DIAG, V30, P653, DOI 10.1002/pd.2571; Desai AS, 2013, CIRCULATION, V127, P509, DOI 10.1161/CIRCULATIONAHA.112.120493; Girsen A, 2007, ULTRASOUND OBST GYN, V29, P296, DOI 10.1002/uog.3934; Godfrey ME, 2012, ULTRASOUND OBST GYN, V39, P131, DOI 10.1002/uog.9064; Habli M, 2010, AM J OBSTET GYNECOL, V203; Hammerer-Lercher A, 2005, CLIN CHEM, V51, P913, DOI 10.1373/clinchem.2004.046557; Hunt SA, 2005, CIRCULATION, V112, P1825, DOI 10.1016/j.jacc.2005.08.023; ITOH H, 1993, J CLIN ENDOCR METAB, V76, P907, DOI 10.1210/jc.76.4.907; Januzzi JL, 2013, CIRCULATION, V127, P500, DOI 10.1161/CIRCULATIONAHA.112.120485; Kocylowski RD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.009; Lechner E, 2009, PEDIATR RES, V66, P466, DOI 10.1203/PDR.0b013e3181b3aee4; Luterek K, 2011, NEUROENDOCRINOL LETT, V32, P657; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Matsumoto LC, 2000, AM J OBSTET GYNECOL, V182, P699, DOI 10.1067/mob.2000.104226; McElhinney DB, 2010, CIRCULATION, V121, P1256, DOI 10.1161/CIRCULATIONAHA.109.870246; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Merz WM, 2014, ULTRASOUND OBST GYN, V44, P377, DOI 10.1002/uog.13443; Merz WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063664; Merz WM, 2012, PEDIATR RES, V72, P174, DOI 10.1038/pr.2012.53; Merz WM, 2012, CLIN RES CARDIOL, V101, P73, DOI 10.1007/s00392-011-0366-4; Merz WM, 2010, CLIN BIOCHEM, V43, P519, DOI 10.1016/j.clinbiochem.2009.11.012; Michielsen ECHJ, 2008, ANN CLIN BIOCHEM, V45, P389, DOI 10.1258/acb.2007.007069; Moriichi A, 2013, J PERINATOL, V33, P182, DOI 10.1038/jp.2012.94; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Ng LL, 2004, CLIN SCI, V106, P129, DOI 10.1042/CS20030234; Ogawa T, 2014, NATRIURETIC PEPTIDES, P1; Ross M G, 2001, J Matern Fetal Med, V10, P2, DOI 10.1080/714904292; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Tosse V, 2012, NEONATOLOGY, V101, P260, DOI 10.1159/000334826; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090; Tutschek B, 2011, SEMIN FETAL NEONAT M, V16, P13, DOI 10.1016/j.siny.2010.09.005; van Mieghem T, 2012, BEST PRACT RES CL OB, V26, P711, DOI 10.1016/j.bpobgyn.2012.03.005; Van Mieghem T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.013	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114416	10.1371/journal.pone.0114416	http://dx.doi.org/10.1371/journal.pone.0114416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490554	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300039
J	You, YA; Park, YJ; Kwon, WS; Yoon, SJ; Ryu, BY; Kim, YJ; Pang, MG				You, Young-Ah; Park, Yoo-Jin; Kwon, Woo-Sung; Yoon, Sung-Jae; Ryu, Buom-Yong; Kim, Young Ju; Pang, Myung-Geol			Increased Frequency of Aneuploidy in Long-Lived Spermatozoa	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; INTRACYTOPLASMIC SPERM INJECTION; NUMERICAL CHROMOSOME-ABNORMALITIES; MULTICOLOR FISH; HEALTHY-MEN; HUMANS; AGE; ETIOLOGY; ORIGIN	Aneuploidy commonly causes spontaneous abortions, stillbirths, and aneuploid births in humans. Notably, the majority of sex chromosome aneuploidies in live births have a paternal origin. An increased frequency of aneuploidy is also associated with male infertility. However, the dynamics and behavior of aneuploid spermatozoa during fertilization in humans have not been studied in detail. Therefore, we compared the frequency of aneuploidy and euploidy in live spermatozoa from normozoospermic men over a 3-day period. To assess the dynamics and behavior of aneuploid spermatozoa, we simultaneously evaluated sperm viability using the hypo-osmotic swelling test and sperm aneuploidy using fluorescence in situ hybridization. Whereas the frequency of viable euploid spermatozoa significantly decreased over 3 days, the frequency of viable spermatozoa with aneuploidy interestingly showed a time-dependent increase. In addition, spermatozoa with abnormal sex chromosomes survived longer. To compared with spermatozoa with other swelling patterns, those with tail-tip swelling patterns had a lower frequency of aneuploidy at all time points. This study revealed the novel finding that the frequency of aneuploid spermatozoa with fertilization capability significantly increased compared to that of euploid spermatozoa over 3 days, suggesting that aneuploid spermatozoa can survive longer than euploid spermatozoa and have a greater chance of fertilizing oocytes.	[You, Young-Ah; Park, Yoo-Jin; Kwon, Woo-Sung; Yoon, Sung-Jae; Ryu, Buom-Yong; Pang, Myung-Geol] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea; [Kim, Young Ju] Ewha Womans Univ, Dept Obstet & Gynecol, Seoul 158710, South Korea	Chung Ang University; Ewha Womans University	Pang, MG (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, Gyeonggi Do, South Korea.	mgpang@cau.ac.kr	Kwon, Woo-Sung/J-6731-2019; Pang, Myung-Geol/AAV-2014-2021	Kwon, Woo-Sung/0000-0002-0848-7189; Pang, Myung-Geol/0000-0003-2019-3789; You, Younag-Ah/0000-0001-6714-7144	Ministry of Food and Drug Safety, Republic of Korea [14162MFDS661]	Ministry of Food and Drug Safety, Republic of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a 2014 grant (14162MFDS661) from the Ministry of Food and Drug Safety, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRUZZO MA, 1995, ENVIRON MOL MUTAGEN, V25, P38, DOI 10.1002/em.2850250608; Bernardini L, 1997, MOL HUM REPROD, V3, P431, DOI 10.1093/molehr/3.5.431; Collodel G, 2007, ARCH ANDROLOGY, V53, P229, DOI 10.1080/01485010701426471; Demaliaj E, 2012, ANEUPLOIDY HLTH DIS, P121; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; HOEGERMAN SF, 1995, LANCET, V346, P1095; Hook E B, 1985, Basic Life Sci, V36, P7; Hossain AM, 1998, HUM REPROD, V13, P1578, DOI 10.1093/humrep/13.6.1578; Hossain AM, 2008, FERTIL STERIL, V89, P237, DOI 10.1016/j.fertnstert.2007.01.170; Jacobs PA, 1995, ADV GENET, V33, P101, DOI 10.1016/S0065-2660(08)60332-6; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Johnson MD, 1998, FERTIL STERIL, V70, P397, DOI 10.1016/S0015-0282(98)00209-X; MARTIN RH, 1995, AM J HUM GENET, V57, P1395; Martin RH, 1987, AM J HUM GENET, V84, P179; Martini AC, 2006, FERTIL STERIL, V85, P1840, DOI 10.1016/j.fertnstert.2005.11.048; McAuliffe ME, 2012, ENVIRON HEALTH PERSP, V120, P535, DOI 10.1289/ehp.1104017; Meschede D, 1997, HUM REPROD, V12, P1913, DOI 10.1093/humrep/12.9.1913; 유영아, 2009, Clinical and Experimental Reproductive Medicine, V36, P45; Mohamed EA, 2012, ANEUPLOIDY ETIOLOGY, P123; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Olson SB, 1988, PREFERENTIAL PATERNA, P583; Pang MG, 1999, HUM REPROD, V14, P1266, DOI 10.1093/humrep/14.5.1266; Pang MG, 2010, FERTIL STERIL, V94, P1012, DOI 10.1016/j.fertnstert.2009.04.043; Pehlivan T, 2003, Reprod Biomed Online, V6, P232; Pfeffer J, 1999, FERTIL STERIL, V72, P472, DOI 10.1016/S0015-0282(99)00279-4; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; Robbins WA, 1997, ENVIRON MOL MUTAGEN, V30, P175, DOI 10.1002/(SICI)1098-2280(1997)30:2<175::AID-EM10>3.0.CO;2-A; Rodrigo L, 2004, HUM REPROD, V19, P118, DOI 10.1093/humrep/deh012; Shi Q, 2000, CYTOGENET CELL GENET, V90, P79, DOI 10.1159/000015668; Silber S, 2003, FERTIL STERIL, V79, P30, DOI 10.1016/S0015-0282(02)04407-2; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Sloter ED, 2000, AM J HUM GENET, V67, P862, DOI 10.1086/303088; Templado C, 2005, CYTOGENET GENOME RES, V111, P199, DOI 10.1159/000086890; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Vegetti W, 2000, HUM REPROD, V15, P351, DOI 10.1093/humrep/15.2.351; Vera M, 2012, ANEUPLOIDY HLTH DIS, P141; Verheyen G, 1997, HUM REPROD UPDATE, V3, P195, DOI 10.1093/humupd/3.3.195; WRAMSBY H, 1987, NEW ENGL J MED, V316, P121, DOI 10.1056/NEJM198701153160301; Wyrobek AJ, 2000, NATO SCI SERIES, V313, P134	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114600	10.1371/journal.pone.0114600	http://dx.doi.org/10.1371/journal.pone.0114600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490252	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300057
J	Ozdemir, BC; Hensel, J; Secondini, C; Wetterwald, A; Schwaninger, R; Fleischmann, A; Raffelsberger, W; Poch, O; Delorenzi, M; Temanni, R; Mills, IG; van der Pluijm, G; Thalmann, GN; Cecchini, MG				Oezdemir, Berna C.; Hensel, Janine; Secondini, Chiara; Wetterwald, Antoinette; Schwaninger, Ruth; Fleischmann, Achim; Raffelsberger, Wolfgang; Poch, Olivier; Delorenzi, Mauro; Temanni, Ramzi; Mills, Ian G.; van der Pluijm, Gabri; Thalmann, George N.; Cecchini, Marco G.			The Molecular Signature of the Stroma Response in Prostate Cancer-Induced Osteoblastic Bone Metastasis Highlights Expansion of Hematopoietic and Prostate Epithelial Stem Cell Niches	PLOS ONE			English	Article							VEGF-INDUCED ANGIOGENESIS; GENE-EXPRESSION; TUMOR MICROENVIRONMENT; STIMULATING FACTOR-1; N-CADHERIN; MARROW; ADHESION; GROWTH; PROGRESSION; ACTIVATION	The reciprocal interaction between cancer cells and the tissue-specific stroma is critical for primary and metastatic tumor growth progression. Prostate cancer cells colonize preferentially bone (osteotropism), where they alter the physiological balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption, and elicit prevalently an osteoblastic response (osteoinduction). The molecular cues provided by osteoblasts for the survival and growth of bone metastatic prostate cancer cells are largely unknown. We exploited the sufficient divergence between human and mouse RNA sequences together with redefinition of highly species-specific gene arrays by computer-aided and experimental exclusion of cross-hybridizing oligonucleotide probes. This strategy allowed the dissection of the stroma (mouse) from the cancer cell (human) transcriptome in bone metastasis xenograft models of human osteoinductive prostate cancer cells (VCaP and C4-2B). As a result, we generated the osteoblastic bone metastasis-associated stroma transcriptome (OB-BMST). Subtraction of genes shared by inflammation, wound healing and desmoplastic responses, and by the tissue type-independent stroma responses to a variety of non-osteotropic and osteotropic primary cancers generated a curated gene signature ("Core" OB-BMST) putatively representing the bone marrow/bone-specific stroma response to prostate cancer-induced, osteoblastic bone metastasis. The expression pattern of three representative Core OB-BMST genes (PTN, EPHA3 and FSCN1) seems to confirm the bone specificity of this response. A robust induction of genes involved in osteogenesis and angiogenesis dominates both the OB-BMST and Core OB-BMST. This translates in an amplification of hematopoietic and, remarkably, prostate epithelial stem cell niche components that may function as a self-reinforcing bone metastatic niche providing a growth support specific for osteoinductive prostate cancer cells. The induction of this combinatorial stem cell niche is a novel mechanism that may also explain cancer cell osteotropism and local interference with hematopoiesis (myelophthisis). Accordingly, these stem cell niche components may represent innovative therapeutic targets and/or serum biomarkers in osteoblastic bone metastasis.	[Oezdemir, Berna C.; Hensel, Janine; Secondini, Chiara; Wetterwald, Antoinette; Schwaninger, Ruth; Thalmann, George N.; Cecchini, Marco G.] Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland; [Fleischmann, Achim] Univ Bern, Dept Clin Res, Bern, Switzerland; [Raffelsberger, Wolfgang] Univ Bern, Inst Pathol, Bern, Switzerland; [Poch, Olivier] IGBMC, Strasbourg, France; [Delorenzi, Mauro] Univ Strasbourg, ICube, UMR7357, Strasbourg, France; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Dept Oncol, Lausanne, Switzerland; [Temanni, Ramzi] SIB, Lausanne, Switzerland; [Mills, Ian G.] Sidra Med & Res Ctr, Biomed Informat Div, Doha, Qatar; [van der Pluijm, Gabri] Univ Oslo, NCMM, Prostate Canc Res Grp, Oslo, Norway; [Temanni, Ramzi] LUMC, Dept Urol, Leiden, Netherlands	University of Bern; University of Bern; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne; Swiss Institute of Bioinformatics; Sidra Medical & Research Center; University of Oslo; Leiden University; Leiden University Medical Center (LUMC)	Cecchini, MG (corresponding author), Univ Bern, Dept Urol, Urol Res Lab, Bern, Switzerland.	marco.cecchini@dkf.unibe.ch	Özdemir, Berna C./ABY-1073-2022; Mills, Ian/AAK-9292-2020	Özdemir, Berna C./0000-0002-7380-0055; Mills, Ian/0000-0001-5347-5083; TEMANNI, Mohamed Ramzi/0000-0001-9125-1136; van der Pluijm, Gabri/0000-0002-1351-1884	European Commission [CANCURE-2006-020970, ITN PRO-NEST-238278]; Swiss National Foundation [3100A0-116237]; OncoSuisse MD/PhD Scholarship [323630-128865/1]; Department of Clinical Research, University of Bern, Switzerland	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Foundation(Swiss National Science Foundation (SNSF)); OncoSuisse MD/PhD Scholarship; Department of Clinical Research, University of Bern, Switzerland	Funding: This work was supported by grants from the European Commission (CANCURE-2006-020970 and FP7 Marie Curie ITN PRO-NEST-238278) and from the Swiss National Foundation (3100A0-116237). B.C.O. received funding from the OncoSuisse MD/PhD Scholarship (323630-128865/1). Part of the costs for the microarray hybridization was supported by the Department of Clinical Research, University of Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Amali AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058857; Arai F, 2012, ANN NY ACAD SCI, V1266, P72, DOI 10.1111/j.1749-6632.2012.06576.x; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Blum R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013024; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charbord P, 2005, ANN NY ACAD SCI, V1044, P159, DOI 10.1196/annals.1349.020; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Contie S, 2011, INT J CANCER, V128, P352, DOI 10.1002/ijc.25591; Cooper CR, 2003, CANCER-AM CANCER SOC, V97, P739, DOI 10.1002/cncr.11181; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fokas E, 2007, CANCER METAST REV, V26, P705, DOI 10.1007/s10555-007-9088-5; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Genander M, 2012, CELL ADHES MIGR, V6, P126, DOI 10.4161/cam.18932; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kitagawa Y, 2005, CANCER RES, V65, P10921, DOI 10.1158/0008-5472.CAN-05-1809; Koeneman KS, 1999, PROSTATE, V39, P246; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Korenchuk S, 2001, IN VIVO, V15, P163; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Laderach DJ, 2013, CANCER RES, V73, P86, DOI 10.1158/0008-5472.CAN-12-1260; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Makoni SN, 2004, AM J HEMATOL, V76, P92, DOI 10.1002/ajh.20046; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martin TJ, 2010, ADV EXP MED BIOL, V658, P51, DOI 10.1007/978-1-4419-1050-9_6; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miles FL, 2014, MOL CANCER RES, V12, P297, DOI 10.1158/1541-7786.MCR-13-0535; Mohamedali KA, 2011, CLIN CANCER RES, V17, P2328, DOI 10.1158/1078-0432.CCR-10-2943; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104; Nakayoshi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092626; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; ORR B, 2010, PROSTATE, V71, P305, DOI DOI 10.1002/PR0S.21244; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pennisi A, 2009, BLOOD, V114, P1803, DOI 10.1182/blood-2009-01-201954; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Pitteri SJ, 2011, CANCER RES, V71, P5090, DOI 10.1158/0008-5472.CAN-11-0568; Planche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018640; Raffelsberger W, 2008, BIOINFORMATICS, V24, P276, DOI 10.1093/bioinformatics/btm556; Richardson AM, 2007, DIAGN MOL PATHOL, V16, P189, DOI 10.1097/PDM.0b013e3180de20ac; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sadler NM, 2013, AM J BLOOD RES, V3, P271; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Shiozawa Y, 2011, CLIN CANCER RES, V17, P5553, DOI 10.1158/1078-0432.CCR-10-2505; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sleeman JP, 2012, CANCER METAST REV, V31, P429, DOI 10.1007/s10555-012-9373-9; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tan VY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-52; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; THALMANN GN, 1994, CANCER RES, V54, P2577; Ting MJ, 2010, EXP HEMATOL, V38, P1087, DOI 10.1016/j.exphem.2010.07.007; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiesner C, 2008, NEOPLASIA, V10, P996, DOI 10.1593/neo.08618; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	95	20	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114530	10.1371/journal.pone.0114530	http://dx.doi.org/10.1371/journal.pone.0114530			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485970	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600070
J	Parameswaran, S; Sharma, RK				Parameswaran, Sreejit; Sharma, Rajendra K.			Ischemia and Reperfusion Induce Differential Expression of Calpastatin and Its Homologue High Molecular Weight Calmodulin-Binding Protein in Murine Cardiomyocytes	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; ALTERED EXPRESSION; CARDIAC-MUSCLE; RAT-HEART; CALPAIN; CALCIUM; INJURY; APOPTOSIS; CALCINEURIN; CULTURE	In the heart, calpastatin (Calp) and its homologue high molecular weight calmodulin-binding protein (HMWCaMBP) regulate calpains (Calpn) by inhibition. A rise in intracellular myocardial Ca2+ during cardiac ischemia activates Calpn thereby causing damage to myocardial proteins, which leads to myocyte death and consequently to loss of myocardial structure and function. The present study aims to elucidate expression of Calp and HMWCaMBP with respect to Calpn during induced ischemia and reperfusion in primary murine cardiomyocyte cultures. Ischemia and subsequently reperfusion was induced in similar to 80% confluent cultures of neonatal murine cardiomyocytes (NMCC). Flow cytometric analysis (FACS) has been used for analyzing protein expression concurrently with viability. Confocal fluorescent microscopy was used to observe protein localization. We observed that ischemia induces increased expression of Calp, HMWCaMBP and Calpn. Calpn expressing NMCC on co-expressing Calp survived ischemic induction compared to NMCC co-expressing HMWCaMBP. Similarly, living cells expressed Calp in contrast to dead cells which expressed HMWCaMBP following reperfusion. A significant difference in the expression of Calp and its homologue HMWCaMBP was observed in localization studies during ischemia. The current study adds to the existing knowledge that HMWCaMBP could be a putative isoform of Calp. NMCC on co-expressing Calp and Calpn-1 survived ischemic and reperfusion inductions compared to NMCC co-expressing HMWCaMBP and Calpn-1. A significant difference in expression of Calp and HMWCaMBP was observed in localization studies during ischemia.	[Parameswaran, Sreejit; Sharma, Rajendra K.] Univ Saskatchewan, Coll Med, Dept Pathol & Lab Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Sharma, RK (corresponding author), Univ Saskatchewan, Coll Med, Dept Pathol & Lab Med, Saskatoon, SK S7N 0W0, Canada.	rajendra.sharma@usask.ca			Heart and Stroke Foundation of Saskatchewan, Canada [411894]	Heart and Stroke Foundation of Saskatchewan, Canada	Funding: This work was supported by the Heart and Stroke Foundation of Saskatchewan, Canada (Grant number - 411894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Gedik N, 2013, ARCH MED SCI, V9, P968, DOI 10.5114/aoms.2013.38175; Haas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031669; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heidrich FM, 2009, CIRC RES, V104, pE19, DOI 10.1161/CIRCRESAHA.108.191072; Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232; Kakkar R, 2001, CELL CALCIUM, V29, P59, DOI 10.1054/ceca.2000.0157; Kakkar R, 1997, MOL CELL BIOCHEM, V177, P215, DOI 10.1023/A:1006886111569; Kakkar R, 2000, J PATHOL, V191, P208, DOI 10.1002/(SICI)1096-9896(200006)191:2<208::AID-PATH618>3.0.CO;2-6; Kakkar R, 1997, BIOCHEMISTRY-US, V36, P11550, DOI 10.1021/bi9711083; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Kleinbongard P, 2014, BR J PHARM; Li HZ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-18; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parameswaran S, 2014, BIOCHEM BIOPH RES CO, V443, P604, DOI 10.1016/j.bbrc.2013.12.019; Parameswaran S, 2013, CAN J PHYSIOL PHARM, V91, P985, DOI 10.1139/cjpp-2013-0161; Parameswaran S, 2012, CARDIOVASC DRUG THER, V26, P321, DOI 10.1007/s10557-012-6399-8; Pikkarainen S, 2009, J BIOL CHEM, V284, P27195, DOI 10.1074/jbc.M109.037887; Saucerman JJ, 2012, J MOL CELL CARDIOL, V52, P312, DOI 10.1016/j.yjmcc.2011.06.005; SHARMA RK, 1990, J BIOL CHEM, V265, P1152; Singh N, 2008, BIOCHEM BIOPH RES CO, V373, P387, DOI 10.1016/j.bbrc.2008.06.040; Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; Wu HY, 2007, ACTA MED OKAYAMA, V61, P123; YOSHIDA K, 1995, JPN CIRC J, V59, P40	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114653	10.1371/journal.pone.0114653	http://dx.doi.org/10.1371/journal.pone.0114653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486053	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600084
J	Chen, TJ; Sun, LP; He, CY; Gong, YH; Xu, Q; Yuan, Y				Chen, Tiejun; Sun, Liping; He, Caiyun; Gong, Yuehua; Xu, Qian; Yuan, Yuan			Serum OPN Expression for Identification of Gastric Cancer and Atrophic Gastritis and Its Influencing Factors	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PLASMA OSTEOPONTIN LEVELS; BONE-MINERAL DENSITY; INTESTINAL METAPLASIA; POSTMENOPAUSAL WOMEN; PROGRESSION; INVASION; RECEPTOR; METASTASIS; CARCINOMA	Background: Most studies have found that osteopontin (OPN) expression level is related to the poor prognosis of gastric cancer. However, few studies have examined the relationship between OPN expression and gastric precancerous diseases, and the potential role of OPN in the formation and development of GC. We investigated the relationships between serum OPN levels and the risks of gastric cancer (GC) and its precancerous disease, to explore the diagnostic efficacy of serum OPN level for GC and atrophic gastritis and its influencing factors. Methods: A total of 1,452 patients were enrolled, including 609 with mild superficial gastritis (SG), 594 with atrophic gastritis (AG) and 249 with GC. The levels of serum OPN and serum Helicobacter pylori IgG antibody were detected by enzyme-linked immunosorbent assay. Results: Serum OPN levels increased from mild SG (1.99 +/- 1.91 ng/ml) to AG (2.37 +/- 2.27 ng/ml) to GC (5.94 +/- 4.52 ng/ml) (P <= 0.002), along with increasing severity of gastric disease. OPN levels were significantly higher in patients with GC compared with the non-cancer population (2.17 +/- 2.10, P < 0.0001). Serum OPN level was positively correlated with age and was higher in men than women, but was not correlated with H. pylori infection status. The area under the receiver operating characteristic curve was 0.805, the optimal cutoff was 2.56 ng/ml and the sensitivity and specificity were 74.3% and 71.8%, respectively, for the ability of serum OPN to discriminate GC. Conclusions: Serum OPN expression was closely related to the risks of GC and AG, and it might be a useful marker for the discrimination of GC. OPN level was positively correlated with age and male sex, but was not affected by H. pylori infection, and it was promoted by smoking and drinking, in patients with mild SG.	[Chen, Tiejun; Sun, Liping; He, Caiyun; Gong, Yuehua; Xu, Qian; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang 110001, Peoples R China; [Chen, Tiejun; Sun, Liping; He, Caiyun; Gong, Yuehua; Xu, Qian; Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang 110001, Peoples R China; [Chen, Tiejun] Benxi Cent Hosp, Dept Med Oncol, Benxi, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Canc Inst & Gen Surg, Tumor Etiol & Screening Dept, Shenyang 110001, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; Science Technology Project in Liaoning Province [2011225002]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Science Technology Project in Liaoning Province	This work is supported by grants from the National Key Basic Research Program of China (973 Program Ref No. 2010CB529304), and the Science Technology Project in Liaoning Province (Ref No. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; [Anonymous], GENES CHROMOSOMES CA, V49, P28; Banerjee A, 2009, TOXICOL PATHOL, V37, P492, DOI 10.1177/0192623309335633; Blasberg JD, 2010, J CLIN ONCOL, V28, P936, DOI 10.1200/JCO.2009.25.5711; Cao ZM, 2002, EXP NEPHROL, V10, P19; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7; Chang WL, 2011, HELICOBACTER, V16, P217, DOI 10.1111/j.1523-5378.2011.00832.x; Chen YJ, 2009, J AM ACAD DERMATOL, V60, P225, DOI 10.1016/j.jaad.2008.09.046; Cho EH, 2013, J KOREAN MED SCI, V28, P1496, DOI 10.3346/jkms.2013.28.10.1496; Cristaudo A, 2010, INT J BIOL MARKER, V25, P164, DOI 10.1177/172460081002500307; Dai N, 2007, ONCOLOGY-BASEL, V72, P89, DOI 10.1159/000111108; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; Dirnu R, 2012, ROM J MORPHOL EMBRYO, V53, P293; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Farr JN, 2012, J CLIN ENDOCR METAB, V97, P4219, DOI 10.1210/jc.2012-2381; Fodor D, 2013, J INVEST MED, V61, P15, DOI 10.2310/JIM.0b013e3182761264; Gong Yue-hua, 2006, Zhonghua Zhongliu Zazhi, V28, P691; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Higashiyama M, 2007, ANN SURG ONCOL, V14, P3419, DOI 10.1245/s10434-007-9564-8; Hillas G, 2013, CYTOKINE, V61, P251, DOI 10.1016/j.cyto.2012.10.002; Imano M, 2010, AM SURGEON, V76, P91; Imano M, 2009, J GASTROINTEST SURG, V13, P1577, DOI 10.1007/s11605-009-0955-y; Kong Ling-bo, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P207; Miyajima Jiro, 2010, Kurume Medical Journal, V57, P73, DOI 10.2739/kurumemedj.57.73; Negrini R, 1996, GASTROENTEROLOGY, V111, P655, DOI 10.1053/gast.1996.v111.pm8780570; Paliwal P, 2012, AGING-US, V4, P553, DOI 10.18632/aging.100477; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Ribeiro-Silva A, 2008, INT J BIOL MARKER, V23, P154, DOI 10.1177/172460080802300304; Sakaki N, 2002, ALIMENT PHARM THERAP, V16, P198, DOI 10.1046/j.1365-2036.16.s2.13.x; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Shimoyama T, 2001, J CLIN PATHOL, V54, P332, DOI 10.1136/jcp.54.4.332; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Sullivan J, 2011, HISTOL HISTOPATHOL, V26, P893, DOI 10.14670/HH-26.893; Sun Xian-jun, 2005, Zhonghua Zhongliu Zazhi, V27, P292; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Tang HW, 2008, CANCER INVEST, V26, P60, DOI 10.1080/07357900701519279; Wasilewska A, 2011, ADV MED SCI-POLAND, V56, P193, DOI 10.2478/v10039-011-0034-y; Wijkstrom H, 2000, SCAND J UROL NEPHROL, V34, P116, DOI 10.1080/00365590050509878; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Yuan Yuan, 2013, Cancer Biology Medicine, V10, P72, DOI 10.7497/j.issn.2095-3941.2013.02.002; Zhang X, 2009, ONCOL REP, V21, P609, DOI 10.3892/or_00000263; Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114	45	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114005	10.1371/journal.pone.0114005	http://dx.doi.org/10.1371/journal.pone.0114005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479069	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200039
J	Larson, BA; Lembela-Bwalya, D; Bonawitz, R; Hammond, EE; Thea, DM; Herlihy, J				Larson, Bruce A.; Lembela-Bwalya, Deophine; Bonawitz, Rachael; Hammond, Emily E.; Thea, Donald M.; Herlihy, Julie			Finding a Needle in the Haystack: The Costs and Cost-Effectiveness of Syphilis Diagnosis and Treatment during Pregnancy to Prevent Congenital Syphilis in Kalomo District of Zambia	PLOS ONE			English	Article							CLINICAL-IMPLICATIONS; OUTCOMES; KENYA	Background: In March 2012, The Elizabeth Glaser Pediatric AIDS Foundation trained maternal and child health workers in Southern Province of Zambia to use a new rapid syphilis test (RST) during routine antenatal care. A recent study by Bonawitz et al. (2014) evaluated the impact of this roll out in Kalomo District. This paper estimates the costs and cost-effectiveness from the provider's perspective under the actual conditions observed during the first year of the RST roll out. Methods: Information on materials used and costs were extracted from program records. A decision-analytic model was used to evaluate the costs (2012 USD) and cost-effectiveness. Basic parameters needed for the model were based on the results from the evaluation study. Results: During the evaluation study, 62% of patients received a RST, and 2.8% of patients tested were positive (and 10.4% of these were treated). Even with very high RST sensitivity and specificity (98%), true prevalence of active syphilis would be substantially less (estimated at < 0.7%). For 1,000 new ANC patients, costs of screening and treatment were estimated at $2,136, and the cost per avoided disability-adjusted-life year lost (DALY) was estimated at $628. Costs change little if all positives are treated (because prevalence is low and treatment costs are small), but the cost-per-DALY avoided falls to just $66. With full adherence to guidelines, costs increase to $3,174 per 1,000 patients and the cost-per-DALY avoided falls to $60. Conclusions: Screening for syphilis is only useful for reducing adverse birth outcomes if patients testing positive are actually treated. Even with very low prevalence of syphilis (a needle in the haystack), cost effectiveness improves dramatically if those found positive are treated; additional treatment costs little but DALYs avoided are substantial. Without treatment, the needle is essentially found and thrown back into the haystack.	[Larson, Bruce A.; Bonawitz, Rachael; Hammond, Emily E.; Thea, Donald M.; Herlihy, Julie] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Lembela-Bwalya, Deophine] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Bonawitz, Rachael; Herlihy, Julie] Boston Med Ctr, Dept Pediat, Boston, MA USA	Boston University; University of Zambia; Boston Medical Center	Larson, BA (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	blarson@bu.edu		White, Emily/0000-0003-2698-7002; Larson, Bruce/0000-0002-9322-2387; Thea, Donald/0000-0002-6933-1030	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001418-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (5U2GPS001418-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonawitz RE, 2014, INTRO RAPID IN PRESS; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; [Government of Zambia Health Mo], 2014, NAT AIDS STRAT FRAM; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Larson Bruce A, 2013, Cost Eff Resour Alloc, V11, P18, DOI 10.1186/1478-7547-11-18; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Scott CA, 2013, PLOS ONE IN PRESS; Scott CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072444; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; World Health Organization, 2012, INV CAS EL MOTH TO C; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	16	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113868	10.1371/journal.pone.0113868	http://dx.doi.org/10.1371/journal.pone.0113868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478877	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200035
J	Moriuchi, T; Iso, N; Sagari, A; Ogahara, K; Kitajima, E; Tanaka, K; Tabira, T; Higashi, T				Moriuchi, Takefumi; Iso, Naoki; Sagari, Akira; Ogahara, Kakuya; Kitajima, Eiji; Tanaka, Koji; Tabira, Takayuki; Higashi, Toshio			Excitability of the Primary Motor Cortex Increases More Strongly with Slow- than with Normal-Speed Presentation of Actions	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; VENTRAL PREMOTOR CORTEX; CORTICOSPINAL EXCITABILITY; CORTICAL INTERACTIONS; GRASPING MOVEMENTS; CLINICAL-RELEVANCE; ACTION RECOGNITION; HAND MOVEMENTS; MODULATION	Introduction: The aim of the present study was to investigate how the speed of observed action affects the excitability of the primary motor cortex (M1), as assessed by the size of motor evoked potentials (MEPs) induced by transcranial magnetic stimulation (TMS). Methods: Eighteen healthy subjects watched a video clip of a person catching a ball, played at three different speeds (normal-, half-, and quarter-speed). MEPs were induced by TMS when the model's hand had opened to the widest extent just before catching the ball ("open") and when the model had just caught the ball ("catch"). These two events were locked to specific frames of the video clip ("phases"), rather than occurring at specific absolute times, so that they could easily be compared across different speeds. MEPs were recorded from the thenar (TH) and abductor digiti minimi (ADM) muscles of the right hand. Results: The MEP amplitudes were higher when the subjects watched the video clip at low speed than when they watched the clip at normal speed. A repeated-measures ANOVA, with the factor VIDEO-SPEED, showed significant main effects. Bonferroni's post hoc test showed that the following MEP amplitude differences were significant: TH, normal vs. quarter; ADM, normal vs. half; and ADM, normal vs. quarter. Paired t-tests showed that the significant MEP amplitude differences between TMS phases under each speed condition were TH, "catch" higher than "open" at quarter speed; ADM, "catch" higher than "open" at half speed. Conclusions: These results indicate that the excitability of M1 was higher when the observed action was played at low speed. Our findings suggest that the action observation system became more active when the subjects observed the video clip at low speed, because the subjects could then recognize the elements of action and intention in others.	[Moriuchi, Takefumi; Iso, Naoki; Sagari, Akira; Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Nagasaki 852, Japan; [Moriuchi, Takefumi; Iso, Naoki] Tojinkai Miharadai Hosp, Med Corp, Nagasaki, Japan; [Sagari, Akira] Nagasaki Genbaku Hosp, Japanese Red Cross Soc, Nagasaki, Japan; [Ogahara, Kakuya] Kanagawa Univ Human Serv, Fac Hlth & Social Work, Sch Rehabil, Kanagawa, Japan; [Kitajima, Eiji] Nagasaki Univ, Ctr Ind, Univ & Govt Cooperat, Nagasaki 852, Japan; [Tanaka, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Unit Phys & Occupat Therapy, Nagasaki 852, Japan; [Tabira, Takayuki] Nishikyushu Univ, Fac Rehabil Sci, Saga, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Higashi, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Nagasaki 852, Japan.	higashi-t@nagasaki-u.ac.jp	Tabira, takayuki/AAS-4222-2021; TANAKA, KOJI/ABC-4601-2021	TANAKA, KOJI/0000-0002-7932-8601				Abdollahi RO, 2013, CEREB CORTEX, V23, P2734, DOI 10.1093/cercor/bhs264; Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; Baldissera F, 2001, EUR J NEUROSCI, V13, P190, DOI 10.1046/j.0953-816x.2000.01368.x; Bang DH, 2013, CLIN REHABIL, V27, P1118, DOI 10.1177/0269215513501528; BARKER AT, 1985, LANCET, V1, P1106; Biagi L, 2010, BRAIN RES BULL, V81, P434, DOI 10.1016/j.brainresbull.2009.12.002; Borroni P, 2008, SOC NEUROSCI-UK, V3, P276, DOI 10.1080/17470910701515269; Bucchioni G, 2013, BRAIN COGNITION, V81, P176, DOI 10.1016/j.bandc.2012.11.001; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Candidi M, 2010, CEREB CORTEX, V20, P2832, DOI 10.1093/cercor/bhq033; Castiello U, 2009, NEUROPSYCHOLOGIA, V47, P835, DOI 10.1016/j.neuropsychologia.2008.12.016; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Davare M, 2008, J PHYSIOL-LONDON, V586, P2735, DOI 10.1113/jphysiol.2008.152603; Davare M, 2009, CORTEX, V45, P1050, DOI 10.1016/j.cortex.2009.02.011; Enticott PG, 2011, BRAIN RES BULL, V85, P89, DOI 10.1016/j.brainresbull.2011.03.018; Enticott PG, 2010, NEUROPSYCHOLOGIA, V48, P2675, DOI 10.1016/j.neuropsychologia.2010.05.014; Ertelt D, 2007, NEUROIMAGE, V36, pT164, DOI 10.1016/j.neuroimage.2007.03.043; Ertelt D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-42; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franceschini M, 2012, NEUROREHAB NEURAL RE, V26, P456, DOI 10.1177/1545968311427406; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Koch G, 2010, NEUROPSYCHOLOGIA, V48, P3513, DOI 10.1016/j.neuropsychologia.2010.07.037; Lago A, 2010, NEUROPSYCHOLOGIA, V48, P1802, DOI 10.1016/j.neuropsychologia.2010.02.030; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Maeda F., 2002, INT C SERIES, V1232, P889, DOI [10.1016/S0531-5131(01)00729-4, DOI 10.1016/S0531-5131(01)00729-4]; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Ogawa K, 2012, EXP BRAIN RES, V216, P61, DOI 10.1007/s00221-011-2908-4; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sartori L, 2013, SOC COGN AFFECT NEUR, V8, P662, DOI 10.1093/scan/nss044; Sartori L, 2013, NEUROREPORT, V24, P63, DOI 10.1097/WNR.0b013e32835c6e6a; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; Senot P, 2011, EXP BRAIN RES, V211, P161, DOI 10.1007/s00221-011-2635-x; Small SL, 2012, DEV PSYCHOBIOL, V54, P293, DOI 10.1002/dev.20504; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Turella L, 2009, NEUROIMAGE, V46, P844, DOI 10.1016/j.neuroimage.2009.03.002; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Winter D. A., 2005, BIOMECHANICS MOTOR C, P36	65	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114355	10.1371/journal.pone.0114355	http://dx.doi.org/10.1371/journal.pone.0114355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479161	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200075
J	Le, QV; Isbell, LA; Matsumoto, J; Le, VQ; Hori, E; Tran, AH; Maior, RS; Tomaz, C; Ono, T; Nishijo, H				Quan Van Le; Isbell, Lynne A.; Matsumoto, Jumpei; Van Quang Le; Hori, Etsuro; Anh Hai Tran; Maior, Rafael S.; Tomaz, Carlos; Ono, Taketoshi; Nishijo, Hisao			Monkey Pulvinar Neurons Fire Differentially to Snake Postures	PLOS ONE			English	Article							RAPID DETECTION; RESPONSES; AMYGDALA; STIMULI; THREAT; ATTENTION; DISTANCE; BEHAVIOR; GRASS; FEAR	There is growing evidence from both behavioral and neurophysiological approaches that primates are able to rapidly discriminate visually between snakes and innocuous stimuli. Recent behavioral evidence suggests that primates are also able to discriminate the level of threat posed by snakes, by responding more intensely to a snake model poised to strike than to snake models in coiled or sinusoidal postures (Etting and Isbell 2014). In the present study, we examine the potential for an underlying neurological basis for this ability. Previous research indicated that the pulvinar is highly sensitive to snake images. We thus recorded pulvinar neurons in Japanese macaques (Macaca fuscata) while they viewed photos of snakes in striking and non-striking postures in a delayed non-matching to sample (DNMS) task. Of 821 neurons recorded, 78 visually responsive neurons were tested with the all snake images. We found that pulvinar neurons in the medial and dorsolateral pulvinar responded more strongly to snakes in threat displays poised to strike than snakes in non-threat-displaying postures with no significant difference in response latencies. A multidimensional scaling analysis of the 78 visually responsive neurons indicated that threat-displaying and non-threat-displaying snakes were separated into two different clusters in the first epoch of 50 ms after stimulus onset, suggesting bottom-up visual information processing. These results indicate that pulvinar neurons in primates discriminate between poised to strike from those in non-threat-displaying postures. This neuronal ability likely facilitates behavioral discrimination and has clear adaptive value. Our results are thus consistent with the Snake Detection Theory, which posits that snakes were instrumental in the evolution of primate visual systems.	[Quan Van Le; Matsumoto, Jumpei; Van Quang Le; Hori, Etsuro; Anh Hai Tran; Ono, Taketoshi; Nishijo, Hisao] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Isbell, Lynne A.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Ctr Primate, Brasilia, DF, Brazil; [Maior, Rafael S.; Tomaz, Carlos] Univ Brasilia, Inst Biol, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil	University of Toyama; University of California System; University of California Davis; Universidade de Brasilia; Universidade de Brasilia	Nishijo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	nishijo@med.u-toyama.ac.jp	Maior, Rafael S./F-3994-2012; Tomaz, Carlos A B/F-8626-2012	Maior, Rafael S./0000-0001-7219-8675; Matsumoto, Jumpei/0000-0003-4729-2816	Japan Society for the Promotion of Science Asian Core Program; Ministry of Education, Science, Sports and Culture [25290005]; National Bio-Resource Project "Japanese Monkeys" of the MEXT, Japan	Japan Society for the Promotion of Science Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Bio-Resource Project "Japanese Monkeys" of the MEXT, Japan	This work was supported partly by the Japan Society for the Promotion of Science Asian Core Program; the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (25290005); National Bio-Resource Project "Japanese Monkeys" of the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1984, ANIM BEHAV, V32, P1108, DOI 10.1016/S0003-3472(84)80227-4; Asahi T, 2003, NEUROSCI RES, V47, P255, DOI 10.1016/S0168-0102(03)00202-5; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; DELLOMO G, 1994, PHYSIOL BEHAV, V55, P125, DOI 10.1016/0031-9384(94)90019-1; Etting SF, 2014, ETHOLOGY IN PRESS; Etting SF, 2014, AM J PRIMATOL, V76, P135, DOI 10.1002/ajp.22216; Greene H.W., 1988, Biology of Reptilia, V16, P1; Greene H. W., 1997, SNAKES EVOLUTION MYS; Hayakawa S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00080; Isbell L. A., 2009, FRUIT TREE SERPENT W; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kusama T., 1970, STEREOTAXIC ATLAS BR; LEVINE S, 1993, BEHAV NEURAL BIOL, V60, P225, DOI 10.1016/0163-1047(93)90428-K; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lobue V, 2008, PSYCHOL SCI, V19, P284, DOI 10.1111/j.1467-9280.2008.02081.x; LoBue V, 2011, VIS COGN, V19, P129, DOI 10.1080/13506285.2010.522216; LoBue V, 2010, DEVELOPMENTAL SCI, V13, P221, DOI 10.1111/j.1467-7687.2009.00872.x; Maior RS, 2011, NEUROSCI LETT, V504, P257, DOI 10.1016/j.neulet.2011.09.042; Maior RS, 2010, BEHAV BRAIN RES, V215, P129, DOI 10.1016/j.bbr.2010.07.009; Masataka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015122; Matsuda K., 1996, NEUROSCI RES, V25, pS270, DOI [10.1016/0168-0102(96)89315-1, DOI 10.1016/0168-0102(96)89315-1]; Nguyen MN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00085; Nguyen MN, 2013, EUR J NEUROSCI, V37, P35, DOI 10.1111/ejn.12020; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Nelson EE, 2003, EMOTION, V3, P3, DOI 10.1037/1528-3542.3.1.3; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Ohman A, 2012, J COGN PSYCHOL, V24, P17, DOI 10.1080/20445911.2011.629603; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; Penkunas MJ, 2013, DEVELOPMENTAL SCI, V16, P1; RANDALL JA, 1995, BEHAV ECOL SOCIOBIOL, V36, P243, DOI 10.1007/s002650050146; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Shibasaki M, 2009, J COMP PSYCHOL, V123, P131, DOI 10.1037/a0015095; Soares SC, 2012, EVOL PSYCHOL-US, V10, P187, DOI 10.1177/147470491201000202; Tazumi T, 2010, NEUROSCIENCE, V169, P287, DOI 10.1016/j.neuroscience.2010.04.028; Van Le Q, 2013, P NATL ACAD SCI USA, V110, P19000, DOI 10.1073/pnas.1312648110; Ward R, 2005, CURR BIOL, V15, P571, DOI 10.1016/j.cub.2005.01.056; WIENER SG, 1992, DEV PSYCHOBIOL, V25, P127, DOI 10.1002/dev.420250205; Young F.W., 1987, MULTIDIMENSIONAL SCA	44	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114258	10.1371/journal.pone.0114258	http://dx.doi.org/10.1371/journal.pone.0114258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479158	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200058
J	Wooliver, R; Senior, JK; Schweitzer, JA; O'Reilly-Wapstra, JM; Langley, JA; Chapman, SK; Bailey, JK				Wooliver, Rachel; Senior, John K.; Schweitzer, Jennifer A.; O'Reilly-Wapstra, Julianne M.; Langley, J. Adam; Chapman, Samantha K.; Bailey, Joseph K.			Evolutionary History and Novel Biotic Interactions Determine Plant Responses to Elevated CO2 and Nitrogen Fertilization	PLOS ONE			English	Article							PHYLOGENETIC NICHE CONSERVATISM; ECOSYSTEM RESPONSE; DIVERSITY; GROWTH; DEPOSITION; TRAITS; BIODIVERSITY; PLANTATIONS; ADAPTATION; LIMITATION	A major frontier in global change research is predicting how multiple agents of global change will alter plant productivity, a critical component of the carbon cycle. Recent research has shown that plant responses to climate change are phylogenetically conserved such that species within some lineages are more productive than those within other lineages in changing environments. However, it remains unclear how phylogenetic patterns in plant responses to changing abiotic conditions may be altered by another agent of global change, the introduction of non-native species. Using a system of 28 native Tasmanian Eucalyptus species belonging to two subgenera, Symphyomyrtus and Eucalyptus, we hypothesized that productivity responses to abiotic agents of global change (elevated CO2 and increased soil N) are unique to lineages, but that novel interactions with a non-native species mediate these responses. We tested this hypothesis by examining productivity of 1) native species monocultures and 2) mixtures of native species with an introduced hardwood plantation species, Eucalyptus nitens, to experimentally manipulated soil N and atmospheric CO2. Consistent with past research, we found that N limits productivity overall, especially in elevated CO2 conditions. However, monocultures of species within the Symphyomyrtus subgenus showed the strongest response to N (gained 127% more total biomass) in elevated CO2 conditions, whereas those within the Eucalyptus subgenus did not respond to N. Root: shoot ratio (an indicator of resource use) was on average greater in species pairs containing Symphyomyrtus species, suggesting that functional traits important for resource uptake are phylogenetically conserved and explaining the phylogenetic pattern in plant response to changing environmental conditions. Yet, native species mixtures with E. nitens exhibited responses to CO2 and N that differed from those of monocultures, supporting our hypothesis and highlighting that both plant evolutionary history and introduced species will shape community productivity in a changing world.	[Wooliver, Rachel; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Senior, John K.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [O'Reilly-Wapstra, Julianne M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia; [Langley, J. Adam; Chapman, Samantha K.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tasmania; University of Tasmania; Villanova University	Wooliver, R (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	rwoolive@utk.edu	O'Reilly-Wapstra, Julianne M/J-7275-2014	O'Reilly-Wapstra, Julianne M/0000-0003-4801-4412; Wooliver, Rachel/0000-0002-7723-437X				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Aiken L. S., 1991, MULTIPLE REGRESSION; Amr A, 2001, J FOOD COMPOS ANAL, V14, P59, DOI 10.1006/jfca.2000.0950; Anekonda TS, 1999, FUNCT ECOL, V13, P675, DOI 10.1046/j.1365-2435.1999.00367.x; Barbour RC, 2010, FOREST ECOL MANAG, V260, P2079, DOI 10.1016/j.foreco.2010.08.049; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Burns JH, 2006, BIOL INVASIONS, V8, P797, DOI 10.1007/s10530-005-3838-5; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Churkina G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003291; Cleland EE, 2010, ANN NY ACAD SCI, V1195, P46, DOI 10.1111/j.1749-6632.2010.05458.x; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; Davis CC, 2010, PHILOS T R SOC B, V365, P3201, DOI 10.1098/rstb.2010.0130; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dimarco RD, 2013, ECOL ENTOMOL, V38, P535, DOI 10.1111/een.12046; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Felker-Quinn E, 2011, ECOLOGY, V92, P1208, DOI 10.1890/10-1370.1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Genung MA, 2014, PEERJ, V2, DOI 10.7717/peerj.288; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harpole WS, 2011, OECOLOGIA, V166, P197, DOI 10.1007/s00442-010-1808-9; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Judd TS, 1996, FOREST ECOL MANAG, V82, P87, DOI 10.1016/0378-1127(95)03693-8; Kembel SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019992; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kulmatiski A, 2007, CAN J FOREST RES, V37, P1574, DOI 10.1139/X07-040; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lankau RA, 2013, ECOLOGY, V94, P32, DOI 10.1890/12-0675.1; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; May B, 2009, REV FERTILISER USE A; McKinnon GE, 2008, AM J BOT, V95, P368, DOI 10.3732/ajb.95.3.368; NOBLE IR, 1989, AUST J BOT, V37, P207, DOI 10.1071/BT9890207; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Nunez MA, 2009, ECOLOGY, V90, P2352, DOI 10.1890/08-2139.1; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schweitzer JA, 1999, J TORREY BOT SOC, V126, P15, DOI 10.2307/2997251; Senior JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060088; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Strauss Sharon Y, 2006, Ecol Lett, V9, P357, DOI 10.1111/j.1461-0248.2005.00874.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallis IR, 2010, FOREST ECOL MANAG, V260, P814, DOI 10.1016/j.foreco.2010.05.040; Warren CR, 2002, TREE PHYSIOL, V22, P11, DOI 10.1093/treephys/22.1.11; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams K. J., 1996, Tasforests, V8, P39; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100	64	3	3	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114596	10.1371/journal.pone.0114596	http://dx.doi.org/10.1371/journal.pone.0114596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479056	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907200107
J	Albrechtova, K; Papousek, I; De Nys, H; Pauly, M; Anoh, E; Mossoun, A; Dolejska, M; Masarikova, M; Metzger, S; Couacy-Hymann, E; Akoua-Koffi, C; Wittig, RM; Klimes, J; Cizek, A; Leendertz, FH; Literak, I				Albrechtova, Katerina; Papousek, Ivo; De Nys, Helene; Pauly, Maude; Anoh, Etile; Mossoun, Arsene; Dolejska, Monika; Masarikova, Martina; Metzger, Sonya; Couacy-Hymann, Emmanuel; Akoua-Koffi, Chantal; Wittig, Roman M.; Klimes, Jiri; Cizek, Alois; Leendertz, Fabian H.; Literak, Ivan			Low Rates of Antimicrobial-Resistant Enterobacteriaceae in Wildlife in Tai National Park, Cote d'Ivoire, Surrounded by Villages with High Prevalence of Multiresistant ESBL-Producing Escherichia coli in People and Domestic Animals	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; MEDIATED QUINOLONE RESISTANCE; TRANSMISSION; GENES; IDENTIFICATION; HUMANS; EPIDEMIOLOGY; CARRIAGE; PLASMIDS; BACTERIA	Antimicrobial resistance genes can be found in all ecosystems, including those where antibiotic selective pressure has never been exerted. We investigated resistance genes in a collection of faecal samples of wildlife (non-human primates, mice), people and domestic animals (dogs, cats) in Cote d'Ivoire; in the chimpanzee research area of Tai "National Park (TNP) and adjacent villages. Single bacteria isolates were collected from antibiotic-containing agar plates and subjected to molecular analysis to detect Enterobacteriaceae isolates with plasmidmediated genes of extended-spectrum beta-lactamases (ESBLs) and plasmidmediated quinolone resistance (PMQR). While the prevalence of ESBL-producing E. coli in the villages was 27% in people (n=77) and 32% in dogs (n=38), no ESBL-producer was found in wildlife of TNP (n575). PMQR genes, mainly represented by qnrS1, were also present in human-and dog-originating isolates from the villages (36% and 42% in people and dogs, respectively), but no qnrS has been found in the park. In TNP, different variants of qnrB were detected in Citrobacter freundii isolates originating non-human primates and mice. In conclusion, ESBL and PMQR genes frequently found in humans and domestic animals in the villages were rather exceptional in wildlife living in the protected area. Although people enter the park, the strict biosecurity levels they are obliged to follow probably impede transmission of bacteria between them and wildlife.	[Albrechtova, Katerina; Papousek, Ivo; Dolejska, Monika; Klimes, Jiri; Literak, Ivan] Univ Vet & Pharmaceut Sci, Dept Biol & Wildlife Dis, Fac Vet Hyg & Ecol, Brno, Czech Republic; [De Nys, Helene; Metzger, Sonya; Leendertz, Fabian H.] Robert Koch Inst, Project Grp Epidemiol Highly Pathogen Microorgani, Berlin, Germany; [De Nys, Helene; Pauly, Maude; Metzger, Sonya; Wittig, Roman M.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Anoh, Etile; Akoua-Koffi, Chantal] Alassane Ouattara Univ, Univ Teaching Hosp Bouake, Res Dev Ctr, Bouake, Cote Ivoire; [Mossoun, Arsene; Couacy-Hymann, Emmanuel] Lab Natl Pathol Anim, LANADA, Bingerville, Cote Ivoire; [Dolejska, Monika; Masarikova, Martina; Cizek, Alois; Literak, Ivan] Univ Vet & Pharmaceut Sci, CEITEC VFU, Brno, Czech Republic; [Masarikova, Martina; Cizek, Alois] Univ Vet & Pharmaceut Sci, Fac Vet Med, Inst Microbiol & Infect Dis, Brno, Czech Republic; [Wittig, Roman M.] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire	University of Veterinary Sciences Brno; Robert Koch Institute; Max Planck Society; University of Veterinary Sciences Brno; University of Veterinary Sciences Brno	Albrechtova, K (corresponding author), Univ Vet & Pharmaceut Sci, Dept Biol & Wildlife Dis, Fac Vet Hyg & Ecol, Brno, Czech Republic.	albkat@seznam.cz; leendertzf@rki.de	Cizek, Alois/G-8833-2014; Leendertz, Fabian Hubertus/H-8902-2019; Papoušek, Ivo/C-6641-2013; De Nys, Helene/P-6384-2016; Masarikova, Martina/G-9690-2014	Cizek, Alois/0000-0001-5706-4601; Papoušek, Ivo/0000-0003-0172-4134; De Nys, Helene/0000-0002-2942-4531; AKOUA KOFFI, Chantal/0000-0003-0975-6632; Masarikova, Martina/0000-0002-9673-1021	European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; European Social Fund [CZ.1.07/2.3.00/30.0014]	European Regional Development Fund(European Commission); European Social Fund(European Social Fund (ESF))	This study was funded by the project 'CEITEC - Central European Institute of Technology' (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. MD and IP were supported by the Operational Programme ''Education for Competitiveness'' (CZ.1.07/2.3.00/30.0014) from the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup F, 2008, ANTIMICROBIAL RESIST; Albrechtova K, 2012, ANTIMICROB AGENTS CH, V56, P4013, DOI 10.1128/AAC.05859-11; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P67, DOI 10.1111/j.1469-0691.2012.03860.x; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Benavides JA, 2012, APPL ENVIRON MICROB, V78, P4281, DOI 10.1128/AEM.07593-11; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boesch C, 2000, CHIMPANZEES TAI FORE; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Canton R, 2011, CURR OPIN PHARMACOL, V11, P477, DOI 10.1016/j.coph.2011.07.007; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carlos C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-161; *CDC, 2004, STAND MOL SUBT FOODB; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; *CLSI, 2008, PERF STAND ANT SUSC; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Galan JC, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00009; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Jacoby GA, 2011, ANTIMICROB AGENTS CH, V55, P4979, DOI 10.1128/AAC.05187-11; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Kariuki S., 2011, SITUATION ANAL ANTIB; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; KLIEBE C, 1985, ANTIMICROB AGENTS CH, V28, P302, DOI 10.1128/AAC.28.2.302; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Li B, 2010, APPL ENVIRON MICROB, V76, P6680; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Literak I, 2012, MICROB DRUG RESIST, V18, P567, DOI 10.1089/mdr.2012.0075; Lonchel CM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-53; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Ma L, 1998, ANTIMICROB AGENTS CH, V42, P1181, DOI 10.1128/AAC.42.5.1181; Macpherson CNL., 2000, DOGS ZOONOSES PUBLIC; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Perez F, 2013, ANTIMICROB AGENTS CH, V57, P4602, DOI 10.1128/AAC.00725-13; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pesapane R, 2013, ECOHEALTH, V10, P115, DOI 10.1007/s10393-013-0838-2; Poirel L, 2002, J ANTIMICROB CHEMOTH, V50, P1031, DOI 10.1093/jac/dkf240; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09	50	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113548	10.1371/journal.pone.0113548	http://dx.doi.org/10.1371/journal.pone.0113548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474243	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500084
J	Cardone, M; Dzutsev, AK; Li, HC; Riteau, N; Gerosa, F; Shenderov, K; Winkler-Pickett, R; Provezza, L; Riboldi, E; Leighty, RM; Orr, SJ; Steinhagen, F; Wewers, MD; Sher, A; Anderson, SK; Goldszmid, R; McVicar, DW; Lyakh, L; Trinchieri, G				Cardone, Marco; Dzutsev, Amiran K.; Li, Hongchuan; Riteau, Nicolas; Gerosa, Franca; Shenderov, Kevin; Winkler-Pickett, Robin; Provezza, Lisa; Riboldi, Elena; Leighty, Robert M.; Orr, Selinda J.; Steinhagen, Folkert; Wewers, Mark D.; Sher, Alan; Anderson, Stephen K.; Goldszmid, Romina; McVicar, Daniel W.; Lyakh, Lyudmila; Trinchieri, Giorgio			Interleukin-1 and Interferon-gamma Orchestrate beta-Glucan-Activated Human Dendritic Cell Programming via I kappa B-zeta Modulation	PLOS ONE			English	Article							INDUCIBLE NUCLEAR-PROTEIN; T-HELPER-CELLS; NLRP3 INFLAMMASOME; HUMAN MACROPHAGES; CANDIDA-ALBICANS; HOST-DEFENSE; IFN-GAMMA; DIFFERENTIAL REQUIREMENT; IL-1-BETA PRODUCTION; RECEPTOR DECTIN-1	Recognition of microbial components via innate receptors including the C-type lectin receptor Dectin-1, together with the inflammatory environment, programs dendritic cells (DCs) to orchestrate the magnitude and type of adaptive immune responses. The exposure to beta-glucan, a known Dectin-1 agonist and component of fungi, yeasts, and certain immune support supplements, activates DCs to induce T helper (Th)17 cells that are essential against fungal pathogens and extracellular bacteria but may trigger inflammatory pathology or autoimmune diseases. However, the exact mechanisms of DC programming by beta-glucan have not yet been fully elucidated. Using a gene expression/perturbation approach, we demonstrate that in human DCs beta-glucan transcriptionally activates via an interleukin (IL)-1- and inflammasome-mediated positive feedback late-induced genes that bridge innate and adaptive immunity. We report that in addition to its known ability to directly prime T cells toward the Th17 lineage, IL-1 by promoting the transcriptional cofactor inhibitor of kappa B-zeta (I kappa B-zeta) also programs beta-glucan-exposed DCs to express cell adhesion and migration mediators, antimicrobial molecules, and Th17-polarizing factors. Interferon (IFN)-gamma interferes with the IL-1/I kappa B-zeta axis in beta-glucan-activated DCs and promotes T cell- mediated immune responses with increased release of IFN-gamma and IL-22, and diminished production of IL-17. Thus, our results identify IL-1 and IFN-gamma as regulators of DC programming by beta-glucan. These molecular networks provide new insights into the regulation of the Th17 response as well as new targets for the modulation of immune responses to beta-glucancontaining microorganisms.	[Cardone, Marco; Dzutsev, Amiran K.; Li, Hongchuan; Winkler-Pickett, Robin; Riboldi, Elena; Orr, Selinda J.; Steinhagen, Folkert; Anderson, Stephen K.; Goldszmid, Romina; McVicar, Daniel W.; Lyakh, Lyudmila; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Dzutsev, Amiran K.; Li, Hongchuan; Anderson, Stephen K.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD USA; [Riteau, Nicolas; Shenderov, Kevin; Sher, Alan] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Gerosa, Franca; Provezza, Lisa] Univ Verona, Dept Pathol, I-37100 Verona, Italy; [Leighty, Robert M.] Data Management Serv Inc, Frederick Natl Lab Canc Res, Frederick, MD USA; [Wewers, Mark D.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Trinchieri, Giorgio] Trans NIH Ctr Human Immunol, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Verona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University	Trinchieri, G (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA.	trinchig@mail.nih.gov	Anderson, Stephen K/B-1727-2012; Wewers, Mark/AAB-6202-2021; Riteau, Nicolas/ABC-1764-2020; McVicar, Daniel/G-1970-2015; Trinchieri, Giorgio/F-9369-2015	Anderson, Stephen K/0000-0002-7856-4266; Riteau, Nicolas/0000-0003-1306-6466; Trinchieri, Giorgio/0000-0001-5892-7464; Shenderov, Kevin/0000-0002-5255-6815; McVicar, Daniel/0000-0002-1112-5111; Orr, Selinda/0000-0001-8539-7825	Intramural Research Program of the National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was fully supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, in part through the contract HHSN261200800001E to the Frederick National Laboratory for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biondo C, 2011, EUR J IMMUNOL, V41, P1969, DOI 10.1002/eji.201141490; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cardone M, 2014, J LEUKOCYTE BIOL, V95, P161, DOI 10.1189/jlb.0313168; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; de Castro CP, 2012, J IMMUNOL, V189, P4144, DOI 10.4049/jimmunol.1201946; del Fresno C, 2013, IMMUNITY, V38, P1176, DOI 10.1016/j.immuni.2013.05.010; Eigenbrod T, 2013, J IMMUNOL, V190, P6533, DOI 10.4049/jimmunol.1300324; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; GHEZZI P, 1988, J IMMUNOL, V140, P4238; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hildebrand DG, 2013, J IMMUNOL, V190, P4812, DOI 10.4049/jimmunol.1300089; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Steinhagen F, 2012, J LEUKOCYTE BIOL, V92, P775, DOI 10.1189/jlb.1011522; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Voronov E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00177; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; ZIAI MR, 1986, CANCER RES, V46, P6187; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	64	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114516	10.1371/journal.pone.0114516	http://dx.doi.org/10.1371/journal.pone.0114516			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474109	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500041
J	Galabova, G; Brunner, S; Winsauer, G; Juno, C; Wanko, B; Mairhofer, A; Luhrs, P; Schneeberger, A; von Bonin, A; Mattner, F; Schmidt, W; Staffler, G				Galabova, Gergana; Brunner, Sylvia; Winsauer, Gabriele; Juno, Claudia; Wanko, Bettina; Mairhofer, Andreas; Luehrs, Petra; Schneeberger, Achim; von Bonin, Arne; Mattner, Frank; Schmidt, Walter; Staffler, Guenther			Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCLONAL-ANTIBODY; PCSK9; CHOLESTEROL; IMMUNIZATION; HYPERCHOLESTEROLEMIA; MUTATIONS; STATIN; GENE; MICE	Background: Low Density Lipoprotein (LDL) hypercholesterolemia, and its associated cardiovascular diseases, are some of the leading causes of death worldwide. The ability of proprotein convertase subtilisin/kexin 9 (PCSK9) to modulate circulating LDL cholesterol (LDLc) concentrations made it a very attractive target for LDLc management. To date, the most advanced approaches for PCSK9 inhibition are monoclonal antibody (mAb) therapies. Although shown to lower LDLc significantly, mAbs face functional limitations because of their relatively short in vivo half-lives necessitating frequent administration. Here, we evaluated the long-term efficacy and safety of PCSK9-specific active vaccines in different preclinical models. Methods and Finding: PCSK9 peptide-based vaccines were successfully selected by our proprietary technology. To test their efficacy, wild-type (wt) mice, Ldlr(+/-) mice, and rats were immunized with highly immunogenic vaccine candidates. Vaccines induced generation of high-affine PCSK9-specific antibodies in all species. Group mean total cholesterol (TC) concentration was reduced by up to 30%, and LDLc up to 50% in treated animals. Moreover, the PCSK9 vaccine-induced humoral immune response persisted for up to one year in mice, and reduced cholesterol levels significantly throughout the study. Finally, the vaccines were well tolerated in all species tested. Conclusions: Peptide-based anti-PCSK9 vaccines induce the generation of antibodies that are persistent, high-affine, and functional for up to one year. They are powerful and safe tools for long-term LDLc management, and thus may represent a novel therapeutic approach for the prevention and/or treatment of LDL hypercholesterolemia-related cardiovascular diseases in humans.	[Galabova, Gergana; Brunner, Sylvia; Winsauer, Gabriele; Juno, Claudia; Wanko, Bettina; Mairhofer, Andreas; Luehrs, Petra; Schneeberger, Achim; von Bonin, Arne; Mattner, Frank; Schmidt, Walter; Staffler, Guenther] AFFiRiS AG, A-1030 Vienna, Austria		Galabova, G (corresponding author), AFFiRiS AG, Karl Farkas Gasse 22, A-1030 Vienna, Austria.	Gergana.Galabova@affiris.com; Guenther.Staffler@affiris.com						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chong PH, 2000, DRUGS, V60, P55, DOI 10.2165/00003495-200060010-00005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; Do RQ, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0345-z; Fattori E, 2012, J LIPID RES, V53, P1654, DOI 10.1194/jlr.M028340; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Lu X, ATHEROSCLEROSIS, V225, P56; Marais DA, 2012, CURR OPIN LIPIDOL, V23, P511, DOI 10.1097/MOL.0b013e3283587563; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Ryan US, 2006, VASC PHARMACOL, V45, P253, DOI 10.1016/j.vph.2006.08.004; Schneeberger A, 2009, J NUTR HEALTH AGING, V13, P264, DOI 10.1007/s12603-009-0070-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang LW, 2012, INT J BIOL SCI, V8, P310, DOI 10.7150/ijbs.3524	27	90	92	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114469	10.1371/journal.pone.0114469	http://dx.doi.org/10.1371/journal.pone.0114469			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474576	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500036
J	Haralalka, S; Shelton, C; Cartwright, HN; Guo, FL; Trimble, R; Kumar, RP; Abmayr, SM				Haralalka, Shruti; Shelton, Claude; Cartwright, Heather N.; Guo, Fengli; Trimble, Rhonda; Kumar, Ram P.; Abmayr, Susan M.			Live Imaging Provides New Insights on Dynamic F-Actin Filopodia and Differential Endocytosis during Myoblast Fusion in Drosophila	PLOS ONE			English	Article							ROLLING-PEBBLES; ARP2/3 COMPLEX; IMMUNOGLOBULIN SUPERFAMILY; MUSCLE TYPES; BLOWN-FUSE; PROTEIN; WASP; SNS; POLYMERIZATION; ADHESION	The process of myogenesis includes the recognition, adhesion, and fusion of committed myoblasts into multinucleate syncytia. In the larval body wall muscles of Drosophila, this elaborate process is initiated by Founder Cells and Fusion-Competent Myoblasts (FCMs), and cell adhesion molecules Kin-of-IrreC (Kirre) and Sticks-and-stones (Sns) on their respective surfaces. The FCMs appear to provide the driving force for fusion, via the assembly of protrusions associated with branched F-actin and the WASp, SCAR and Arp2/3 pathways. In the present study, we utilize the dorsal pharyngeal musculature that forms in the Drosophila embryo as a model to explore myoblast fusion and visualize the fusion process in live embryos. These muscles rely on the same cell types and genes as the body wall muscles, but are amenable to live imaging since they do not undergo extensive morphogenetic movement during formation. Time-lapse imaging with F-actin and membrane markers revealed dynamic FCM-associated actin-enriched protrusions that rapidly extend and retract into the myotube from different sites within the actin focus. Ultrastructural analysis of this actin-enriched area showed that they have two morphologically distinct structures: wider invasions and/or narrow filopodia that contain long linear filaments. Consistent with this, formin Diaphanous (Dia) and branched actin nucleator, Arp3, are found decorating the filopodia or enriched at the actin focus, respectively, indicating that linear actin is present along with branched actin at sites of fusion in the FCM. Gain-of-function Dia and loss-of-function Arp3 both lead to fusion defects, a decrease of F-actin foci and prominent filopodia from the FCMs. We also observed differential endocytosis of cell surface components at sites of fusion, with actin reorganizing factors, WASp and SCAR, and Kirre remaining on the myotube surface and Sns preferentially taken up with other membrane proteins into early endosomes and lysosomes in the myotube.	[Haralalka, Shruti; Shelton, Claude; Cartwright, Heather N.; Guo, Fengli; Trimble, Rhonda; Kumar, Ram P.; Abmayr, Susan M.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Abmayr, Susan M.] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Abmayr, SM (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	sma@stowers.org		Cartwright, Heather/0000-0001-6639-5808	NIH [R01-AR44274]; Stowers Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044274] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by NIH, grant number: R01-AR44274 (www.nih.gov) and the Stowers Institute for Medical Research (www.stowers.org). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Afshar K, 2000, DEVELOPMENT, V127, P1887; Artero RD, 2001, DEVELOPMENT, V128, P4251; Berger S, 2008, J CELL SCI, V121, P1303, DOI 10.1242/jcs.022269; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bothe I, 2014, DEVELOPMENT, V141, P2289, DOI 10.1242/dev.100743; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bour BA, 2000, GENE DEV, V14, P1498; Charrasse S, 2013, MOL BIOL CELL, V24, P234, DOI 10.1091/mbc.E12-02-0167; de Joussineau C, 2012, CURR TOP DEV BIOL, V98, P277, DOI 10.1016/B978-0-12-386499-4.00011-2; de Velasco B, 2006, DEV GENES EVOL, V216, P39, DOI 10.1007/s00427-005-0029-4; Dottermusch-Heidel C, 2012, DEV BIOL, V368, P18, DOI 10.1016/j.ydbio.2012.04.031; Duan R, 2012, J CELL BIOL, V199, P169, DOI 10.1083/jcb.201204065; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Gildor B, 2009, EMBO REP, V10, P1043, DOI 10.1038/embor.2009.129; Goncalves-Pimentel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018340; GREIG S, 1993, NATURE, V362, P630, DOI 10.1038/362630a0; Haralalka S, 2012, METHODS, V56, P55, DOI 10.1016/j.ymeth.2011.08.008; Haralalka S, 2011, DEVELOPMENT, V138, P1551, DOI 10.1242/dev.057653; Haralalka S, 2010, EXP CELL RES, V316, P3007, DOI 10.1016/j.yexcr.2010.05.018; Homem CCF, 2009, MOL BIOL CELL, V20, P5138, DOI 10.1091/mbc.E09-02-0144; Hummel T, 2000, GENE DEV, V14, P863; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Kaipa BR, 2013, J CELL SCI, V126, P360, DOI 10.1242/jcs.113860; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kocherlakota KS, 2008, GENETICS, V178, P1371, DOI 10.1534/genetics.107.083808; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Nose A, 1998, DEVELOPMENT, V125, P215; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Ranganayakulu G, 1998, DEVELOPMENT, V125, P3037; Rau A, 2001, DEVELOPMENT, V128, P5061; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Roy S, 2012, CURR BIOL, V22, pR63, DOI 10.1016/j.cub.2011.12.031; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schafer G, 2007, DEV BIOL, V304, P664, DOI 10.1016/j.ydbio.2007.01.015; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Stevenson V, 2002, CURR BIOL, V12, P705, DOI 10.1016/S0960-9822(02)00807-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	62	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114126	10.1371/journal.pone.0114126	http://dx.doi.org/10.1371/journal.pone.0114126			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474591	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500115
J	Li, YJ; Cai, M; Cao, L; Qin, X; Zheng, TT; Xu, XH; Sandvick, TM; Hutchinson, K; Wold, LE; Hu, KL; Sun, QH; Thomas, DP; Ren, J; He, GL				Li, Yuanjing; Cai, Ming; Cao, Li; Qin, Xing; Zheng, Tiantian; Xu, Xiaohua; Sandvick, Taylor M.; Hutchinson, Kirk; Wold, Loren E.; Hu, Keli; Sun, Qinghua; Thomas, D. Paul; Ren, Jun; He, Guanglong			Endurance Exercise Accelerates Myocardial Tissue Oxygenation Recovery and Reduces Ischemia Reperfusion Injury in Mice	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; K-ATP CHANNEL; IN-VIVO; BLOOD-FLOW; CARDIOPROTECTION; MITOCHONDRIAL; REFLOW; EPIDEMIOLOGY; HYPERTENSION; CONSUMPTION	Exercise training offers cardioprotection against ischemia and reperfusion (I/R) injury. However, few essential signals have been identified to underscore the protection from injury. In the present study, we hypothesized that exercise-induced acceleration of myocardial tissue oxygenation recovery contributes to this protection. C57BL/6 mice (4 weeks old) were trained on treadmills for 45 min/day at a treading rate of 15 m/min for 8 weeks. At the end of 8-week exercise training, mice underwent 30-min left anterior descending coronary artery occlusion followed by 60-min or 24-h reperfusion. Electron paramagnetic resonance oximetry was performed to measure myocardial tissue oxygenation. Western immunoblotting analyses, gene transfection, and myography were examined. The oximetry study demonstrated that exercise markedly shortened myocardial tissue oxygenation recovery time following reperfusion. Exercise training up-regulated Kir6.1 protein expression (a subunit of ATP-sensitive K+ channel on vascular smooth muscle cells, VSMC sarc-KATP) and protected the heart from I/R injury. In vivo gene transfer of dominant negative Kir6.1AAA prolonged the recovery time and enlarged infarct size. In addition, transfection of Kir6.1AAA increased the stiffness and reduced the relaxation capacity in the vasculature. Together, our study demonstrated that exercise training up-regulated Kir6.1, improved tissue oxygenation recovery, and protected the heart against I/R injury. This exercise-induced cardioprotective mechanism may provide a potential therapeutic intervention targeting VSMC sarc-K-ATP channels and reperfusion recovery.	[Cao, Li; Qin, Xing; Zheng, Tiantian; Sandvick, Taylor M.; Ren, Jun; He, Guanglong] Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA; [Thomas, D. Paul] Univ Wyoming, Dept Kinesiol & Hlth, Laramie, WY 82071 USA; [Wold, Loren E.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Xu, Xiaohua; Sun, Qinghua] Ohio State Univ, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Hu, Keli] Ohio State Univ, Div Pharmacol, Columbus, OH 43210 USA; [Hutchinson, Kirk] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Li, Yuanjing] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China; [Cai, Ming] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China; [Cao, Li] Soochow Univ, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Qin, Xing] Fourth Mil Med Univ, Dept Cardiol, Xian 710032, Peoples R China	University of Wyoming; University of Wyoming; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Arizona; Chongqing Medical University; Chongqing Medical University; Soochow University - China; Air Force Military Medical University	He, GL (corresponding author), Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA.	Ghe@uwyo.edu	Li, Yuan/GXV-1310-2022; Ren, Jun/ACG-5366-2022; Wold, Loren E/E-4320-2011	Ren, Jun/0000-0002-0275-0783; Hu, Keli/0000-0002-6955-5261	National Heart, Lung and Blood Institute [HL081630]; National Institute of Environmental Health Sciences [ES016588, ES018900]; National Institute of General Medical Sciences at the National Institutes of Health [P20GM103432]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES018900, K01ES016588, R01ES019923, R01ES018900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103432] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Heart, Lung and Blood Institute HL081630, National Institute of Environmental Health Sciences ES016588, National Institute of Environmental Health Sciences ES018900, and National Institute of General Medical Sciences (P20GM103432) at the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman Ulf, 2003, Med Sci Monit, V9, pCR389; Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005; Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1; Belabbas H, 2008, AM J PHYSIOL-REG I, V295, pR1512, DOI 10.1152/ajpregu.00014.2008; Brown DA, 2005, J PHYSIOL-LONDON, V569, P913, DOI 10.1113/jphysiol.2005.095729; Cai M, 2011, AM J PHYSIOL-HEART C, V300, pH1069, DOI 10.1152/ajpheart.00694.2010; Davidson SM, 2009, PHARMACOL REP, V61, P172, DOI 10.1016/S1734-1140(09)70019-2; Demirel HA, 2001, J APPL PHYSIOL, V91, P2205, DOI 10.1152/jappl.2001.91.5.2205; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Hamilton KL, 2004, FREE RADICAL BIO MED, V37, P1360, DOI 10.1016/j.freeradbiomed.2004.07.025; Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Katz PS, 2011, BASIC RES CARDIOL, V106, P1123, DOI 10.1007/s00395-011-0201-0; Lawrence KM, 2002, CIRCULATION, V106, P1556, DOI 10.1161/01.CIR.0000028424.02525.AE; Libonati JR, 1997, MED SCI SPORT EXER, V29, P509, DOI 10.1097/00005768-199704000-00013; Magro M, 2010, NAT REV CARDIOL, V7, P480, DOI 10.1038/nrcardio.2010.117; Meilhac O, 2001, ARTERIOSCL THROM VAS, V21, P1681, DOI 10.1161/hq1001.097106; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Niemann B, 2011, BASIC RES CARDIOL; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Ramachandran S, 2005, ATHEROSCLEROSIS, V178, P33, DOI 10.1016/j.atherosclerosis.2004.08.010; Rezkalla SH, 2010, J INTERV CARDIOL, V23, P429, DOI 10.1111/j.1540-8183.2010.00561.x; Shern-Brewer R, 1998, ARTERIOSCL THROM VAS, V18, P1181, DOI 10.1161/01.ATV.18.7.1181; Shinozaki N, 2007, INT HEART J, V48, P423, DOI 10.1536/ihj.48.423; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Tavazzi L, 1999, AM HEART J, V138, pS48, DOI 10.1016/S0002-8703(99)70320-0; Thakker GD, 2008, OBESITY, V16, P2593, DOI 10.1038/oby.2008.414; Weir RAP, 2006, AM J CARDIOL, V97, p13F, DOI 10.1016/j.amjcard.2006.03.005; Xu X, 2011, AM J PHYSL REGUL INT; Xu Y, 2008, J PHARMACOL EXP THER, V327, P402, DOI 10.1124/jpet.108.142372; Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; Zhu XH, 2007, AM J PHYSIOL-HEART C, V293, pH1442, DOI 10.1152/ajpheart.00256.2007; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114205	10.1371/journal.pone.0114205	http://dx.doi.org/10.1371/journal.pone.0114205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474642	Green Published, gold			2022-12-26	WOS:000346382500001
J	Lin, J; Han, ZH; Li, XY; Ochs, T; Zhao, J; Zhang, X; Yang, JY; Liu, P; Xiong, ZY; Gai, Y; Tang, CS; Du, JB; Jin, HF				Lin, Jing; Han, Zhenhui; Li, Xueying; Ochs, Todd; Zhao, Juan; Zhang, Xi; Yang, Jinyan; Liu, Ping; Xiong, Zhenyu; Gai, Yong; Tang, Chaoshu; Du, Junbao; Jin, Hongfang			Risk Factors for Postural Tachycardia Syndrome in Children and Adolescents	PLOS ONE			English	Article							ORTHOSTATIC INTOLERANCE; WATER DRINKING; MIDODRINE HYDROCHLORIDE; SYNDROME POTS; THERAPEUTIC EFFECTIVENESS; AUTONOMIC DYSFUNCTION; SLEEP DISTURBANCES; PLASMA COPEPTIN; SYNCOPE; HYPOVOLEMIA	Background: Postural tachycardia syndrome (POTS) is prevalent in children and adolescents and has a great impact on health. But its risk factors have not been fully understood. This study aimed to explore possible risk factors for children and adolescents with POTS. Methods and Findings: 600 children and adolescents (test group) aged 7-18 (11.9 +/- 3.0) years old, 259 males and 341 females, were recruited for identifying its risk factors. Another 197 subjects aged from 7 to 18 (11.3 +/- 2.3) years old were enrolled in the validation group. Heart rate (HR) and blood pressure (BP) were monitored during upright test. Risk factors were analyzed and sensitivity and specificity for predicting POTS were tested via receiver operating characteristic curve. Among 600 subjects, 41 were confirmed with POTS patients (6.8%) based on clinical manifestation and upright test. The results showed a significant difference in daily water intake, the daily sleeping hours, supine HR, HR increment and maximum HR during upright test between POTS and the unaffected children (P<0.05). Likelihood of POTS would increase by 1.583 times if supine HR was increased by 10 beats/min (95%CI 1.184 to 2.116, P<0.01), by 3.877 times if a child's water intake was less than 800 ml/day (95%CI 1.937 to 7.760, P<0.001), or by 5.905 times (95%CI 2.972 to 11.733, P<0.001) if sleeping hours were less than 8 hours/day. Supine HR, daily water intake and sleeping hours showed the capability of predicting POTS in children and adolescents with an AUC of 83.9% (95% CI: 78.6%-89.1%), sensitivity of 80.5% and specificity of 75%. Furthermore, in validation group, predictive sensitivity and specificity were 73.3% and 72.5%. Conclusion: Faster supine HR, less water intake and shorter sleeping hours were identified as risk factors for POTS.	[Lin, Jing; Zhao, Juan; Yang, Jinyan; Liu, Ping; Du, Junbao; Jin, Hongfang] Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China; [Han, Zhenhui; Zhang, Xi; Xiong, Zhenyu; Gai, Yong] Childrens Hosp Kaifeng, Dept Pediat, Zhengzhou, Henan, Peoples R China; [Li, Xueying] Peking Univ, Dept Med Stat, Hosp 1, Beijing 100871, Peoples R China; [Ochs, Todd] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tang, Chaoshu] Peking Univ, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Du, Junbao] Minist Educ, Key Lab Mol Cardiol, Beijing, Peoples R China	Peking University; Peking University; Northwestern University; Feinberg School of Medicine; Peking University	Du, JB (corresponding author), Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China.	Junbaodu1@126.com; jinhongfang51@126.com	Gai, Yongkang/AAF-3308-2019	Gai, Yongkang/0000-0001-6766-5240; Jin, Hongfang/0000-0002-1606-8988	National Twelfth Five-Year Plan for Science & Technology Support [2012BAI03B03]; Ministry of Science and Technology, P.R. China; Major Basic Research Project of China [2012CB517806, 2011CB503904]; National Natural Science Foundation of China [81121061]; National Natural Science Foundation of China	National Twelfth Five-Year Plan for Science & Technology Support; Ministry of Science and Technology, P.R. China(Ministry of Science and Technology, China); Major Basic Research Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by: 1) National Twelfth Five-Year Plan for Science & Technology Support [2012BAI03B03], Ministry of Science and Technology, P.R. China to HJ [HTTP://WWW.MOST.GOV.CN]; 2) Major Basic Research Project of China [2012CB517806, 2011CB503904], Ministry of Science and Technology, P.R. China to JD [HTTP://WWW.MOST.GOV.CN]; 3) National Natural Science Foundation of China [81121061], National Natural Science Foundation of China to JD [http://www.nsfc.gov.cn]. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagai K, 2013, AUTON NEUROSCI-BASIC, V177, P260, DOI 10.1016/j.autneu.2013.02.021; Bagai K, 2011, J CLIN SLEEP MED, V7, P204; Chen L, 2013, CARDIOL YOUNG, V18, P1; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; FOLLENIUS M, 1992, SLEEP, V15, P21, DOI 10.1093/sleep/15.1.21; Garland EM, 2007, NEUROLOGY, V69, P790, DOI 10.1212/01.wnl.0000267663.05398.40; [黄玉娟 HUANG Yujuan], 2007, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V22, P442; Irwin M, 2003, BRAIN BEHAV IMMUN, V17, P365, DOI 10.1016/S0889-1591(03)00031-X; Jacob G, 1997, AM J MED, V103, P128, DOI 10.1016/S0002-9343(97)00133-2; Jarhour IT, 2013, SEMIN PEDIAT NEUROL, V20, P18; Jimenez-Cohl P, 2012, REV MED CHILE, V140, P145, DOI 10.4067/S0034-98872012000200001; Johnson JN, 2010, PEDIATR NEUROL, V42, P77, DOI 10.1016/j.pediatrneurol.2009.07.002; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; Kanjwal K, 2010, INT J MED SCI, V7, P62; Kuchel O, 1998, CLIN AUTON RES, V8, P341, DOI 10.1007/BF02309625; Liao Y, 2013, AM J CARDIOL, V112, P816, DOI 10.1016/j.amjcard.2013.05.008; LOW PA, 1995, NEUROLOGY, V45, pS19; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Lu CC, 2003, CIRCULATION, V108, P2660, DOI 10.1161/01.CIR.0000101966.24899.CB; Mack KJ, 2010, SEMIN PEDIATR NEUROL, V17, P109, DOI 10.1016/j.spen.2010.04.006; Mathias CJ, 2012, NAT REV NEUROL, V8, P22, DOI 10.1038/nrneurol.2011.187; Mathias CJ, 2004, EUR J NEUROL, V11, P613, DOI 10.1111/j.1468-1331.2004.00840.x; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Olatunji L A, 2011, Niger J Physiol Sci, V26, P11; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Raj SR, 2013, CIRCULATION, V127, P2336, DOI 10.1161/CIRCULATIONAHA.112.144501; Raj SR, 2005, CIRCULATION, V111, P1574, DOI 10.1161/01.CIR.0000160356.97313.5D; Schroeder C, 2002, CIRCULATION, V106, P2806, DOI 10.1161/01.CIR.0000038921.64575.D0; Shannon JR, 2002, AM J MED, V112, P355, DOI 10.1016/S0002-9343(02)01025-2; Skinner JE, 2010, J CHILD NEUROL, V25, P1210, DOI 10.1177/0883073809359539; Stewart JM, 1999, J PEDIATR-US, V135, P218, DOI 10.1016/S0022-3476(99)70025-9; Winker R, 2004, WIEN KLIN WOCHENSCHR, V116, P40; Yang JY, 2013, J PEDIATR-US, V163, P1169, DOI 10.1016/j.jpeds.2013.04.039; Z'Graggen WJ, 2010, EUR J NEUROL, V17, P1370, DOI 10.1111/j.1468-1331.2010.03030.x; Zhang QY, 2012, J PEDIATR-US, V161, P281, DOI 10.1016/j.jpeds.2012.01.054; Zhao J, 2014, AM J CARDIOL, V114, P601, DOI 10.1016/j.amjcard.2014.05.039; Zhao J, 2014, J PEDIATR-US, V165, P290, DOI 10.1016/j.jpeds.2014.04.032	37	29	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113625	10.1371/journal.pone.0113625	http://dx.doi.org/10.1371/journal.pone.0113625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474569	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500087
J	Sales, KU; Friis, S; Abusleme, L; Moutsopoulos, NM; Bugge, TH				Sales, K. U.; Friis, S.; Abusleme, L.; Moutsopoulos, N. M.; Bugge, T. H.			Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; TRANSMEMBRANE SERINE-PROTEASE; FACTOR ACTIVATOR INHIBITOR-2; GENE-EXPRESSION; PROSTATE; CANCER; RAS; POTENT; OVEREXPRESSION; PROGNOSIS	Deregulation of matriptase is a consistent feature of human epithelial cancers and correlates with poor disease outcome. We have previously shown that matriptase promotes multi-stage squamous cell carcinogenesis in transgenic mice through dual activation of pro-hepatocyte growth factor-cMet-Akt-mTor proliferation/survival signaling and PAR-2-Gai-NF kappa B inflammatory signaling. Matriptase was congenitally and constitutively deregulated in our prior studies, and therefore it was unclear if aberrant matriptase signaling supports only initiation of tumor formation or if it is also critical for the progression of established tumors. To determine this, we here have generated triple-transgenic mice with constitutive deregulation of matriptase and simultaneous inducible expression of the cognate matriptase inhibitor, hepatocyte growth factor inhibitor (HAI)-2. As expected, constitutive expression of HAI-2 suppressed the formation of matriptase-dependent tumors in 7,12-Dimethylbenz(a)anthracene-treated mouse skin. Interestingly, however, the induction of HAI-2 expression in already established tumors markedly impaired malignant progression and caused regression of individual tumors. Tumor regression correlated with reduced accumulation of tumor-associated inflammatory cells, likely caused by diminished expression of pro-tumorigenic inflammatory cytokines. The data suggest that matriptase-dependent signaling may be a therapeutic target for both squamous cell carcinoma chemoprevention and for the treatment of established tumors.	[Sales, K. U.; Friis, S.; Abusleme, L.; Moutsopoulos, N. M.; Bugge, T. H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Sales, K. U.] Natl Inst Dent & Craniofacial Res, Clin Res Core, NIH, Bethesda, MD 20892 USA; [Sales, K. U.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil; [Friis, S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Universidade de Sao Paulo; University of Copenhagen	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Room 211,30 Convent Dr, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	Moutsopoulos, Niki/A-9538-2019; sales, katiuchia u/J-4880-2012	sales, katiuchia/0000-0002-3768-5790; Abusleme, Loreto/0000-0002-7210-1236	NIDCR Intramural Research Program; Sao Paulo Research Foundation [2014/14311-0]; Harboe Foundation; Lundbeck Foundation;  [17.12.1981]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr Mary Jo Danton and Dr J Silvio Gutkind for critically reviewing this manuscript. We also thank Andrew Cho and Dr Ashok Kulkarni, NIDCR Gene Targeting Facility, for generation of transgenic mice. Histology was performed by Histoserv, Inc., Germantown, MD, USA. The study was supported by the NIDCR Intramural Research Program (THB), Sao Paulo Research Foundation 2014/14311-0 (KUS), The Harboe Foundation, The Foundation of 17.12.1981 and the Lundbeck Foundation (SF).	Baba T, 2012, J PATHOL, V228, P181, DOI 10.1002/path.3993; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BALMAIN A, 1985, BRIT J CANCER, V51, P1, DOI 10.1038/bjc.1985.1; Bergum C, 2010, PROSTATE, V70, P1422, DOI 10.1002/pros.21177; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Bocheva G, 2009, J INVEST DERMATOL, V129, P1816, DOI 10.1038/jid.2008.449; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Cheng MF, 2014, HISTOPATHOLOGY, V65, P24, DOI 10.1111/his.12361; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Enyedy IJ, 2001, J MED CHEM, V44, P1349, DOI 10.1021/jm000395x; Forbs D, 2005, INT J ONCOL, V27, P1061; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gray K, 2014, THROMB HAEMOSTASIS, V112, P402, DOI 10.1160/TH13-11-0895; Ha SY, 2014, VIRCHOWS ARCH, V464, P19, DOI 10.1007/s00428-013-1504-3; Hoang CD, 2004, CHEST, V125, P1843, DOI 10.1378/chest.125.5.1843; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jin JS, 2007, HISTOL HISTOPATHOL, V22, P305, DOI 10.14670/HH-22.305; Jin JS, 2006, MODERN PATHOL, V19, P447, DOI 10.1038/modpathol.3800495; Kang JY, 2003, CANCER RES; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Nakamura K, 2009, ANN ONCOL, V20, P63, DOI 10.1093/annonc/mdn556; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Sun J, 2003, BIOCHEMISTRY-US, V42, P892, DOI 10.1021/bi026878f; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228; Ye JJ, 2014, CANCER SCI, V105, P44, DOI 10.1111/cas.12306; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	47	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4664	4672		10.1038/onc.2014.391	http://dx.doi.org/10.1038/onc.2014.391			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25486433	Green Accepted			2022-12-26	WOS:000360189300012
J	Tanaka, N; Takahashi, S; Matsubara, T; Jiang, CT; Sakamoto, W; Chanturiya, T; Teng, RF; Gavrilova, O; Gonzalez, FJ				Tanaka, Naoki; Takahashi, Shogo; Matsubara, Tsutomu; Jiang, Changtao; Sakamoto, Wataru; Chanturiya, Tatyana; Teng, Ruifeng; Gavrilova, Oksana; Gonzalez, Frank J.			Adipocyte-specific Disruption of Fat-specific Protein 27 Causes Hepatosteatosis and Insulin Resistance in High-fat Diet-fed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Diabetes; Hepatocyte; Insulin Resistance; Lipid; Mouse	HEPATIC STEATOSIS; LIPID DROPLETS; GENERALIZED LIPODYSTROPHY; METABOLIC DISEASE; DEFICIENT MICE; FSP27; LIVER; SENSITIVITY; STORAGE; GENE	Background: FSP27 contributes to unilocular lipid droplet formation in adipocytes. Results: Adipocyte-specific FSP27 disruption in mice produced small white adipose mass, hepatosteatosis, and insulin resistance upon high-fat diet feeding. Conclusion: Adipose FSP27 plays a critical role in minimizing ectopic fat accumulation. Significance: This mouse model is useful for understanding the significance of fat storage in adipose tissue. White adipose tissue (WAT) functions as an energy reservoir where excess circulating fatty acids are transported to WAT, converted to triglycerides, and stored as unilocular lipid droplets. Fat-specific protein 27 (FSP27, CIDEC in humans) is a lipid-coating protein highly expressed in mature white adipocytes that contributes to unilocular lipid droplet formation. However, the influence of FSP27 in adipose tissue on whole-body energy homeostasis remains unclear. Mice with adipocyte-specific disruption of the Fsp27 gene (Fsp27(Ad)) were generated using an aP2-Cre transgene with the Cre/LoxP system. Upon high-fat diet feeding, Fsp27(Ad) mice were resistant to weight gain. In the small WAT of these mice, small adipocytes containing multilocular lipid droplets were dispersed. The expression levels of the genes associated with mitochondrial abundance and brown adipocyte identity were increased, and basal lipolytic activities were significantly augmented in adipocytes isolated from Fsp27(Ad) mice compared with the Fsp27(F/F) counterparts. The impaired fat-storing function in Fsp27(Ad) adipocytes and the resultant lipid overflow from WAT led to marked hepatosteatosis, dyslipidemia, and systemic insulin resistance in high-fat diet-treated Fsp27(Ad) mice. These results demonstrate a critical role for FSP27 in the storage of excess fat in WAT with minimizing ectopic fat accumulation that causes insulin-resistant diabetes and non-alcoholic fatty liver disease. This mouse model may be useful for understanding the significance of fat-storing properties of white adipocytes and the role of local FSP27 in whole-body metabolism and estimating the pathogenesis of human partial lipodystrophy caused by CIDEC mutations.	[Tanaka, Naoki; Takahashi, Shogo; Matsubara, Tsutomu; Jiang, Changtao; Gonzalez, Frank J.] NCI, Ctr Canc Res, Lab Metab, NIH, Bethesda, MD 20892 USA; [Sakamoto, Wataru] NIDDK, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA; [Chanturiya, Tatyana; Teng, Ruifeng; Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gonzalez, FJ (corresponding author), NCI, Ctr Canc Res, Lab Metab, NIH, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov	Teng, Ruifeng/U-8318-2019; Takahashi, Shogo/GVS-9010-2022	Takahashi, Shogo/0000-0002-3831-5353; Tanaka, Naoki/0000-0002-3212-3836; Jiang, Changtao/0000-0002-5206-2372	National Institutes of Health Intramural Research Program (NCI) [U54 ES16015]; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NCI) and Grant U54 ES16015 (to F. J. G.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka N, 2014, BBA-MOL CELL BIOL L, V1841, P1596, DOI 10.1016/j.bbalip.2014.08.015; Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; You Y, 1998, MAMM GENOME, V9, P232, DOI 10.1007/s003359900731; Zadeh ES, 2013, J HEPATOL, V59, P131, DOI 10.1016/j.jhep.2013.02.007; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611	31	64	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3092	3105		10.1074/jbc.M114.605980	http://dx.doi.org/10.1074/jbc.M114.605980			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25477509	Green Published, hybrid			2022-12-26	WOS:000349310700045
J	Doi, Y; Takaya, N				Doi, Yuki; Takaya, Naoki			A Novel A3 Group Aconitase Tolerates Oxidation and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI ACONITASE; MUTATIONAL ANALYSIS; IRON; PEROXYNITRITE; INACTIVATION; DEHYDRATASE; SUPEROXIDE; PROPIONATE; BACTERIAL; CLUSTERS	Achromobacter denitrificans YD35 is an NO2--tolerant bacterium that expresses the aconitase genes acnA3, acnA4, and acnB, of which acnA3 is essential for growth tolerance against 100 mM NO2-. Atmospheric oxygen inactivated AcnA3 at a rate of 1.6 x 10(-3) min(-1), which was 2.7- and 37-fold lower compared with AcnA4 and AcnB, respectively. Stoichiometric titration showed that the [4Fe-4S](2+) cluster of AcnA3 was more stable against oxidative inactivation by ferricyanide than that of AcnA4. Aconitase activity of AcnA3 persisted against high NO2- levels that generate reactive nitrogen species with an inactivation rate constant of k = 7.8 x 10(-3) min(-1), which was 1.6- and 7.8-fold lower than those for AcnA4 and AcnB, respectively. When exposed to NO2-, the acnA3 mutant (AcnA3Tn) accumulated higher levels of cellular citrate compared with the other aconitase mutants, indicating that AcnA3 is a major producer of cellular aconitase activity. The extreme resistance of AcnA3 against oxidation and reactive nitrogen species apparently contributes to bacterial NO2- tolerance. AcnA3Tn accumulated less cellular NADH and ATP compared with YD35 under our culture conditions. The accumulation of more NO by AcnA3Tn suggested that NADH-dependent enzymes detoxify NO for survival in a high NO2- milieu. This novel aconitase is distributed in Alcaligenaceae bacteria, including pathogens and denitrifiers, and it appears to contribute to a novel NO2- tolerance mechanism in this strain.	[Doi, Yuki; Takaya, Naoki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	takaya.naoki.ge@u.tsukuba.ac.jp			Ministry of Education, Science, Culture and Sports of Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Culture and Sports of Japan.	Baothman OAS, 2013, MICROBIOL-SGM, V159, P1209, DOI 10.1099/mic.0.067934-0; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Blank L, 2002, MICROBIOL-SGM, V148, P133, DOI 10.1099/00221287-148-1-133; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Claes WA, 2002, J BACTERIOL, V184, P2728, DOI 10.1128/JB.184.10.2728-2739.2002; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; Doi Y, 2014, APPL ENVIRON MICROB, V80, P1910, DOI 10.1128/AEM.03316-13; Doi Y, 2009, APPL ENVIRON MICROB, V75, P5186, DOI 10.1128/AEM.00604-09; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Hughes MN, 1999, BBA-BIOENERGETICS, V1411, P263, DOI 10.1016/S0005-2728(99)00019-5; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Keyer K, 1997, J BIOL CHEM, V272, P27652, DOI 10.1074/jbc.272.44.27652; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin JT, 1998, ADV MICROB PHYSIOL, V39, P1; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Tang Y, 2005, MOL MICROBIOL, V56, P1149, DOI 10.1111/j.1365-2958.2005.04610.x; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; ZHENG L, 1992, J BIOL CHEM, V267, P7895; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	39	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1412	1421		10.1074/jbc.M114.614164	http://dx.doi.org/10.1074/jbc.M114.614164			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477516	hybrid, Green Published			2022-12-26	WOS:000348056400011
J	Fujinaga, K; Luo, ZP; Schaufele, F; Peterlin, BM				Fujinaga, Koh; Luo, Zeping; Schaufele, Fred; Peterlin, B. Matija			Visualization of Positive Transcription Elongation Factor b (P-TEFb) Activation in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; EMBRYONIC STEM-CELLS; C-TERMINAL DOMAIN; 7SK SNRNA; HIV TRANSCRIPTION; PRIMORDIAL DWARFISM; GENE-EXPRESSION; CYCLIN T1; HEXIM1	Regulation of transcription elongation by positive transcription elongation factor b (P-TEFb) plays a central role in determining the state of cell activation, proliferation, and differentiation. In cells, P-TEFb exists in active and inactive forms. Its release from the inactive 7SK small nuclear ribonucleoprotein complex is a critical step for P-TEFb to activate transcription elongation. However, no good method exists to analyze this P-TEFb equilibrium in living cells. Only inaccurate and labor-intensive cell-free biochemical assays are currently available. In this study, we present the first experimental system to monitor P-TEFb activation in living cells. We created a bimolecular fluorescence complementation assay to detect interactions between P-TEFb and its substrate, the C-terminal domain of RNA polymerase II. When cells were treated with suberoylanilide hydroxamic acid, which releases P-TEFb from the 7SK small nuclear ribonucleoprotein, they turned green. Other known P-TEFb-releasing agents, including histone deacetylase inhibitors, bromodomain and extraterminal bromodomain inhibitors, and protein kinase C agonists, also scored positive in this assay. Finally, we identified 5'-azacytidine as a new P-TEFb-releasing agent. This release of P-TEFb correlated directly with activation of human HIV and HEXIM1 transcription. Thus, our visualization of P-TEFb activation by fluorescent complementation assay could be used to find new P-TEFb-releasing agents, compare different classes of agents, and assess their efficacy singly and/or in combination.	[Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Fujinaga, Koh; Luo, Zeping; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Schaufele, Fred] Univ Calif San Francisco, Diabet & Endocrinol Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu			National Institutes of Health CARE Center [U19 AI096113]; HARC Center [P50 GM082250, AI1049104]; American Foundation of AIDS Research Grant [108241-51-RGRL]; California HIV/AIDS Research Program [ID13-SF-558]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health CARE Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HARC Center; American Foundation of AIDS Research Grant; California HIV/AIDS Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health CARE Center Grant U19 AI096113 and HARC Center Grants P50 GM082250 and AI1049104 (to B. M. P.). This work was also supported by American Foundation of AIDS Research Grant 108241-51-RGRL and California HIV/AIDS Research Program Grant ID13-SF-558 (to K. F.).	Alazami AM, 2012, HUM MUTAT, V33, P1429, DOI 10.1002/humu.22175; Aune GJ, 2008, CLIN CANCER RES, V14, P6449, DOI 10.1158/1078-0432.CCR-08-0730; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Castelo-Branco G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r98; Cheng YL, 2012, LAB INVEST, V92, P1013, DOI 10.1038/labinvest.2012.59; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Dai Q, 2014, CELL REP, V7, P735, DOI 10.1016/j.celrep.2014.03.053; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fernandez G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-266; Fujinaga K, 2002, J VIROL, V76, P10873, DOI 10.1128/JVI.76.21.10873-10881.2002; Fujinaga K, 2014, J BIOL CHEM, V289, P21181, DOI 10.1074/jbc.M114.557751; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hsin JP, 2014, MOL CELL BIOL, V34, P2488, DOI 10.1128/MCB.00181-14; Hu Chang-Deng, 2006, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2103s29; Izeddin I, 2014, ELIFE, V3, DOI 10.7554/eLife.02230; Jeeninga RE, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-37; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Napolitano G, 2002, J CELL PHYSIOL, V192, P209, DOI 10.1002/jcp.10130; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Okamura D, 2012, GENE DEV, V26, P2477, DOI 10.1101/gad.202242.112; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Peterlin BM, 2010, CELL CYCLE, V9, P2933, DOI 10.4161/cc.9.15.12698; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Ramakrishnan Rajesh, 2012, Biology (Basel), V1, P94, DOI 10.3390/biology1010094; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	50	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1829	1836		10.1074/jbc.M114.605816	http://dx.doi.org/10.1074/jbc.M114.605816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25492871	Green Published, hybrid			2022-12-26	WOS:000348056400047
J	Kuwabara, H; Heishman, SJ; Brasic, JR; Contoreggi, C; Cascella, N; Mackowick, KM; Taylor, R; Rousset, O; Willis, W; Huestis, MA; Concheiro, M; Wand, G; Wong, DF; Volkow, ND				Kuwabara, Hiroto; Heishman, Stephen J.; Brasic, James R.; Contoreggi, Carlo; Cascella, Nicola; Mackowick, Kristen M.; Taylor, Richard; Rousset, Olivier; Willis, William; Huestis, Marilyn A.; Concheiro, Marta; Wand, Gary; Wong, Dean F.; Volkow, Nora D.			Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STRIATAL DOPAMINE RELEASE; WITHDRAWAL SYMPTOMS; SMOKING; FMRI; QUANTIFICATION; REPLACEMENT; MODULATION; OCCUPANCY; RESPONSES	The rewarding effects of nicotine are associated with activation of nicotine receptors. However, there is increasing evidence that the endogenous opioid system is involved in nicotine's rewarding effects. We employed PET imaging with [C-11] carfentanil to test the hypotheses that acute cigarette smoking increases release of endogenous opioids in the human brain and that smokers have an upregulation of mu opioid receptors (MORs) when compared to nonsmokers. We found no significant changes in binding potential (BPND) of [C-11] carfentanil between the placebo and the active cigarette sessions, nor did we observe differences in MOR binding between smokers and nonsmokers. Interestingly, we showed that in smokers MOR availability in bilateral superior temporal cortices during the placebo condition was negatively correlated with scores on the Fagerstrom Test for Nicotine Dependence (FTND). Also in smokers, smoking-induced decreases in [C-11] carfentanil binding in frontal cortical regions were associated with self-reports of cigarette liking and wanting. Although we did not show differences between smokers and nonsmokers, the negative correlation with FTND corroborates the role of MORs in superior temporal cortices in nicotine addiction and provides preliminary evidence of a role of endogenous opioid signaling in frontal cortex in nicotine reward.	[Kuwabara, Hiroto; Brasic, James R.; Rousset, Olivier; Willis, William; Wong, Dean F.] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Heishman, Stephen J.; Cascella, Nicola; Wong, Dean F.] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA; [Wand, Gary] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Wong, Dean F.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; [Heishman, Stephen J.; Contoreggi, Carlo; Mackowick, Kristen M.; Taylor, Richard; Huestis, Marilyn A.; Concheiro, Marta] NIDA, Intramural Res Program, Baltimore, MD USA; [Volkow, Nora D.] NIDA, Rockville, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Kuwabara, H (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	hkuwaba1@jhmi.edu	Concheiro, Marta/A-6360-2011; Rousset, Olivier G/J-6053-2012	Concheiro, Marta/0000-0002-3858-1280; Rousset, Olivier G/0000-0003-4414-149X	NIH, National Institute on Drug Abuse; NIDA [K24 DA000412]; Radiology Internal Funds; National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH) [UL1 TR 001079]; NIH Roadmap for Medical Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000413, K24DA000412] Funding Source: NIH RePORTER	NIH, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Radiology Internal Funds; National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was provided by the Intramural Research Program of NIH, National Institute on Drug Abuse (SH, CC, KM, RT), and an award from NIDA, K24 DA000412 (DFW), as well as Radiology Internal Funds (DFW). All authors declare no conflicts of interest. Additionally, resources were provided by the Johns Hopkins Institute for Clinical and Translational Research (ICTR), which is funded in part by grant number UL1 TR 001079 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J., 2003, HUMAN BRAIN FUNCTION, V2nd, P635, DOI DOI 10.1016/B978-012264841-0/50034-2; Balfour DJK, 1996, PHARMACOL THERAPEUT, V72, P51, DOI 10.1016/S0163-7258(96)00099-X; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Baumann B, 1999, J NEUROPSYCH CLIN N, V11, P71, DOI 10.1176/jnp.11.1.71; Berrendero F, 2002, J NEUROSCI, V22, P10935; Brody AL, 2009, INT J NEUROPSYCHOPH, V12, P305, DOI 10.1017/S146114570800922X; Brody AL, 2009, NEUROPSYCHOPHARMACOL, V34, P282, DOI 10.1038/npp.2008.87; Buchhalter AR, 2005, ADDICTION, V100, P550, DOI 10.1111/j.1360-0443.2005.01030.x; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1124; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Colasanti A, 2012, BIOL PSYCHIAT, V72, P371, DOI 10.1016/j.biopsych.2012.01.027; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; DANNALS RF, 1985, INT J APPL RADIAT IS, V36, P303, DOI 10.1016/0020-708X(85)90089-4; DHATT RK, 1995, J NEUROCHEM, V64, P1878; Donny EC, 2007, ADDICTION, V102, P324, DOI 10.1111/j.1360-0443.2006.01670.x; Endres CJ, 2003, NUCL MED BIOL, V30, P177, DOI 10.1016/S0969-8051(02)00411-0; Esterlis I, 2010, J NUCL MED, V51, P1226, DOI 10.2967/jnumed.109.072447; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Hadjiconstantinou M, 2011, NEUROPHARMACOLOGY, V60, P1209, DOI 10.1016/j.neuropharm.2010.11.010; Hahn B, 2013, BIOL PSYCHIAT, V74, P436, DOI 10.1016/j.biopsych.2013.03.017; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heishman SJ, 2008, NICOTINE TOB RES, V10, P643, DOI 10.1080/14622200801908174; Hughes J, 1998, TOB CONTROL, V7, P92, DOI 10.1136/tc.7.1.92a; Hughes JR, 2006, NICOTINE TOB RES, V8, P153, DOI 10.1080/14622200500494856; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Krishnan-Sarin S, 1999, ARCH GEN PSYCHIAT, V56, P663, DOI 10.1001/archpsyc.56.7.663; Kuwabara H, 2012, J NUCL MED, V53, P805, DOI 10.2967/jnumed.111.098186; Lee JH, 2005, APPL PSYCHOPHYS BIOF, V30, P195, DOI 10.1007/s10484-005-6377-z; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MALIN DH, 1993, PSYCHOPHARMACOLOGY, V112, P339, DOI 10.1007/BF02244930; Martin-Soelch C, 2003, EUR J NEUROSCI, V18, P680, DOI 10.1046/j.1460-9568.2003.02791.x; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Rahmim A, 2005, PHYS MED BIOL, V50, P4887, DOI 10.1088/0031-9155/50/20/010; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Scott DJ, 2007, NEUROPSYCHOPHARMACOL, V32, P450, DOI 10.1038/sj.npp.1301238; Sossi V, 2005, IEEE NUCL SCI CONF R, P2195; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Weerts EM, 2013, INT J NEUROPSYCHOPH, V16, P47, DOI 10.1017/S146114571200017X; Weerts EM, 2011, ALCOHOL CLIN EXP RES, V35, P2162, DOI 10.1111/j.1530-0277.2011.01565.x; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	49	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e113694	10.1371/journal.pone.0113694	http://dx.doi.org/10.1371/journal.pone.0113694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493427	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400017
J	Gastardelo, TS; Cunha, BR; Raposo, LS; Maniglia, JV; Cury, PM; Lisoni, FCR; Tajara, EH; Oliani, SM				Gastardelo, Thais Santana; Cunha, Bianca Rodrigues; Raposo, Luis Sergio; Maniglia, Jose Victor; Cury, Patricia Maluf; Rodrigues Lisoni, Flavia Cristina; Tajara, Eloiza Helena; Oliani, Sonia Maria			Inflammation and Cancer: Role of Annexin A1 and FPR2/ALX in Proliferation and Metastasis in Human Laryngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTORS; MAST-CELLS; DIFFERENTIAL EXPRESSION; PANCREATIC-CANCER; TUMOR; NEUTROPHILS; MECHANISMS; ANGIOGENESIS; POLARIZATION; GALECTIN-1	The anti-inflammatory protein annexin A1 (ANXA1) has been associated with cancer progression and metastasis, suggesting its role in regulating tumor cell proliferation. We investigated the mechanism of ANXA1 interaction with formylated peptide receptor 2 (FPR2/ALX) in control, peritumoral and tumor larynx tissue samples from 20 patients, to quantitate the neutrophils and mast cells, and to evaluate the protein expression and co-localization of ANXA1/FPR2 in these inflammatory cells and laryngeal squamous cells by immunocytochemistry. In addition, we performed in vitro experiments to further investigate the functional role of ANXA1/FPR2 in the proliferation and metastasis of Hep-2 cells, a cell line from larynx epidermoid carcinoma, after treatment with ANXA1(2-26) (annexin A1 N-terminal-derived peptide), Boc2 (antagonist of FPR) and/or dexamethasone. Under these treatments, the level of Hep-2 cell proliferation, pro-inflammatory cytokines, ANXA1/FPR2 co-localization, and the prostaglandin signalling were analyzed using ELISA, immunocytochemistry and real-time PCR. An influx of neutrophils and degranulated mast cells was detected in tumor samples. In these inflammatory cells of peritumoral and tumor samples, ANXA1/FPR2 expression was markedly exacerbated, however, in laryngeal carcinoma cells, this expression was downregulated. ANXA1(2-26) treatment reduced the proliferation of the Hep-2 cells, an effect that was blocked by Boc2, and up-regulated ANXA1/FPR2 expression. ANXA1(2-26) treatment also reduced the levels of pro-inflammatory cytokines and affected the expression of metalloproteinases and EP receptors, which are involved in the prostaglandin signalling. Overall, this study identified potential roles for the molecular mechanism of the ANXA1/FPR2 interaction in laryngeal cancer, including its relationship with the prostaglandin pathway, providing promising starting points for future research. ANXA1 may contribute to the regulation of tumor growth and metastasis through paracrine mechanisms that are mediated by FPR2/ALX. These data may lead to new biological targets for therapeutic intervention in human laryngeal cancer.	[Gastardelo, Thais Santana; Oliani, Sonia Maria] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Sao Paulo, Brazil; [Cunha, Bianca Rodrigues; Tajara, Eloiza Helena] Fac Med FAMERP, Dept Mol Biol, Sao Jose Do Rio Preto, SP, Brazil; [Raposo, Luis Sergio; Maniglia, Jose Victor] Fac Med FAMERP, Dept Otorhinolaringol, Sao Jose Do Rio Preto, SP, Brazil; [Cury, Patricia Maluf] Fac Med FAMERP, Dept Pathol, Sao Jose Do Rio Preto, SP, Brazil; [Rodrigues Lisoni, Flavia Cristina] Sao Paulo State Univ UNESP, Dept Biol & Zoot, Ilha Solteira, SP, Brazil; [Tajara, Eloiza Helena] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil; [Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Dept Biol, Inst Biociencias Letras & Ciencias Exatas IBILCE, Saa Jose Do Rio Preto, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Oliani, SM (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med EPM, Sao Paulo, Brazil.	smoliani@ibilce.unesp.br	Maniglia, José V/K-3129-2016; Oliani, Sonia Maria/E-3476-2012; Tajara, Eloiza H/G-7586-2012; Rodrigues-Lisoni, Flavia Cristina/P-2447-2015; Cury, Patricia/GRX-5489-2022; Bizotto, Thaís Santana Gastardelo/I-9056-2012	Maniglia, José V/0000-0002-9765-2659; Oliani, Sonia Maria/0000-0003-0918-2130; Tajara, Eloiza H/0000-0002-2603-2057; Rodrigues-Lisoni, Flavia Cristina/0000-0002-8855-9049; Bizotto, Thaís Santana Gastardelo/0000-0002-0627-8631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/08187-4, 2008/01655-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [302768/2010-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (grants 2008/08187-4 to SMO and 2008/01655-2 to TSG) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (grant 302768/2010-6 to SMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao AC, 2010, ORAL ONCOL, V46, P880, DOI 10.1016/j.oraloncology.2010.09.005; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045639; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Conti P, 2007, ANN CLIN LAB SCI, V37, P315; Cooray SN, 2013, P NATL ACAD SCI US; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dansky Ullmann C, 2012, CANCER; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Esteban F, 2009, HISTOPATHOLOGY, V54, P258, DOI 10.1111/j.1365-2559.2008.03193.x; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Galli J, 2006, Acta Otorhinolaryngol Ital, V26, P260; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatae N, 2002, J BIOCHEM, V131, P781, DOI 10.1093/oxfordjournals.jbchem.a003165; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; John CD, 2007, FASEB J, V21, P1037, DOI 10.1096/fj.06-7299com; Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860; Kankkunen JP, 1997, INT J CANCER, V72, P385, DOI 10.1002/(SICI)1097-0215(19970729)72:3<385::AID-IJC1>3.0.CO;2-L; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Lin CY, 2008, J SURG ONCOL, V97, P544, DOI 10.1002/jso.20992; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marusawa H, 2013, CANC LETT; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1053/jhep.1996.v24.pm0008707286; Mendes RA, 2009, ORAL ONCOL, V45, pE124, DOI 10.1016/j.oraloncology.2009.03.016; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Paweletz CP, 2000, CANCER RES, V60, P6293; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pimentel TA, 2011, LAB INVEST, V91, P33, DOI 10.1038/labinvest.2010.140; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Remedi MM, 2009, INT J EXP PATHOL, V90, P44, DOI 10.1111/j.1365-2613.2008.00628.x; Ribatti D, 2009, INT REV CEL MOL BIO, V275, P89, DOI 10.1016/S1937-6448(09)75004-X; Rodrigues-Lisoni FC, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-14; Sansone P, 2011, CURR OPIN GENET DEV, V21, P80, DOI 10.1016/j.gde.2010.11.001; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Sawatsubashi M, 2000, VIRCHOWS ARCH, V436, P243, DOI 10.1007/s004280050037; Sena AAS, 2006, CLIN EXP ALLERGY, V36, P1260, DOI 10.1111/j.1365-2222.2006.02570.x; Sena A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076969; Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Vokes EE, 2003, NEW ENGL J MED, V349, P2087, DOI 10.1056/NEJMp038171; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Xia SH, 2002, ONCOGENE, V21, P6641, DOI 10.1038/sj.onc.1205818; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	69	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e111317	10.1371/journal.pone.0111317	http://dx.doi.org/10.1371/journal.pone.0111317			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490767	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300001
J	Sos-Hegedus, A; Juhasz, Z; Poor, P; Kondrak, M; Antal, F; Tari, I; Mauch-Mani, B; Banfalvi, Z				Sos-Hegedus, Anita; Juhasz, Zsofia; Poor, Peter; Kondrak, Mihaly; Antal, Ferenc; Tari, Irma; Mauch-Mani, Brigitte; Banfalvi, Zsofia			Soil Drench Treatment with beta-Aminobutyric Acid Increases Drought Tolerance of Potato	PLOS ONE			English	Article							INDUCED RESISTANCE; NITRIC-OXIDE; ARABIDOPSIS; GENE; GROWTH; LEAVES; PLANTS	The non-protein amino acid beta-aminobutyric acid (BABA) is known to be a priming agent for a more efficient activation of cellular defence responses and a potent inducer of resistance against biotic and abiotic stresses in plants. Nevertheless, most of the studies on priming have been carried out in Arabidopsis. In potato, the effect of BABA was demonstrated only on biotic stress tolerance. We investigated the effect of BABA on the drought tolerance of potato and found that soil drenched with BABA at a final concentration of 0.3 mM improves the drought tolerance of potato. Water loss from the leaves of the primed plants is attenuated and the yield is increased compared to the unprimed drought-stressed plants. The metabolite composition of the tubers of the BABA-treated plants is less affected by drought than the tuber composition of the non-treated plants. Nitric oxide and ROS (reactive oxygen species) production is increased in the BABA-treated roots but not in the leaves. In the leaves of the BABA-treated plants, the expression of the drought-inducible gene StDS2 is delayed, but the expression of ETR1, encoding an ethylene receptor, is maintained for a longer period under the drought conditions than in the leaves of the non-treated, drought-stressed control plants. This result suggests that the ethylene-inducible gene expression remains suppressed in primed plants leading to a longer leaf life and increased tuber yield compared to the non-treated, drought-stressed plants. The priming effect of BABA in potato, however, is transient and reverts to an unprimed state within a few weeks.	[Sos-Hegedus, Anita; Juhasz, Zsofia; Kondrak, Mihaly; Antal, Ferenc; Banfalvi, Zsofia] NARIC, Agr Biotechnol Inst, H-2101 Godollo, Hungary; [Poor, Peter; Tari, Irma] Univ Szeged, Dept Plant Biol, H-6701 Szeged, Hungary; [Mauch-Mani, Brigitte] Univ Neuchatel, Fac Sci, CH-2000 Neuchatel, Switzerland	Szeged University; University of Neuchatel	Sos-Hegedus, A (corresponding author), NARIC, Agr Biotechnol Inst, POB 411, H-2101 Godollo, Hungary.	banfalvi@abc.hu	Mauch-Mani, Brigitte/O-2387-2014; Poór, Péter/C-9466-2012; Bánfalvi, Zsófia/D-3494-2012	Poór, Péter/0000-0002-4539-6358; Mauch-Mani, Brigitte/0000-0002-6743-8520	Swiss National Science Foundation; Nemzeti Innovacios Hivatal	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nemzeti Innovacios Hivatal	This work was supported by the Swiss National Science Foundation (nfp.snf.ch/E/international/europe/scopes to ASH, ZJ, MK, FA, BMM, ZB), and Nemzeti Innovacios Hivatal (http://www.nih.gov.hu to ASH, ZJ, MK, FA, ZB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Arasimowicz-Jelonek M, 2013, PLANT SCI, V198, P83, DOI 10.1016/j.plantsci.2012.10.004; Baudouin E, 2011, PLANT BIOLOGY, V13, P233, DOI 10.1111/j.1438-8677.2010.00403.x; Capone R, 2004, PLANT PHYSIOL BIOCH, V42, P425, DOI 10.1016/j.plaphy.2004.03.005; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Doczi R, 2002, PLANT CELL ENVIRON, V25, P1197, DOI 10.1046/j.1365-3040.2002.00904.x; Fernie AR, 2011, PLANT CELL, V23, P2477, DOI 10.1105/tpc.111.086272; Floryszak-Wieczorek J, 2012, MOL PLANT MICROBE IN, V25, P1469, DOI 10.1094/MPMI-02-12-0044-R; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Kolbert Zsuzsanna, 2012, Acta Biologica Szegediensis, V56, P37; Maggio A, 2008, EUR J AGRON, V28, P343, DOI 10.1016/j.eja.2007.10.003; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Sani E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r59; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; STIEKEMA WJ, 1988, PLANT MOL BIOL, V11, P255, DOI 10.1007/BF00027383; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; VANLOON CD, 1981, AM POTATO J, V58, P51, DOI 10.1007/BF02855380; Wang FF, 2013, PLANT CELL REP, V32, P1099, DOI 10.1007/s00299-013-1421-6; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zimmerli L, 2008, PLANT J, V53, P144, DOI 10.1111/j.1365-313X.2007.03343.x	33	22	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114297	10.1371/journal.pone.0114297	http://dx.doi.org/10.1371/journal.pone.0114297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489951	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000347515300024
J	Davis, JS; He, V; Anstey, NM; Condon, JR				Davis, Joshua S.; He, Vincent; Anstey, Nicholas M.; Condon, John R.			Long Term Outcomes Following Hospital Admission for Sepsis Using Relative Survival Analysis: A Prospective Cohort Study of 1,092 Patients with 5 Year Follow Up	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ENDOTHELIAL DYSFUNCTION; ORGAN DYSFUNCTION; IMMUNOSUPPRESSION; RESUSCITATION; EPIDEMIOLOGY; INFLAMMATION; MULTICENTER; PNEUMONIA; EFFICACY	Background: Sepsis is a leading cause of death in intensive care units and is increasing in incidence. Current trials of novel therapeutic approaches for sepsis focus on 28-day mortality as the primary outcome measure, but excess mortality may extend well beyond this time period. Methods: We used relative survival analysis to examine excess mortality in a cohort of 1,028 patients admitted to a tertiary referral hospital with sepsis during 2007-2008, over the first 5 years of follow up. Expected survival was estimated using the Ederer II method, using Australian life tables as the reference population. Cumulative and interval specific relative survival were estimated by age group, sex, sepsis severity and Indigenous status. Results: Patients were followed for a median of 4.5 years (range 0-5.2). Of the 1028 patients, the mean age was 46.9 years, 52% were male, 228 (22.2%) had severe sepsis and 218 (21%) died during the follow up period. Mortality based on cumulative relative survival exceeded that of the reference population for the first 2 years post admission in the whole cohort and for the first 3 years in the subgroup with severe sepsis. Independent predictors of mortality over the whole follow up period were male sex, Indigenous Australian ethnicity, older age, higher Charlson Comorbidity Index, and sepsis-related organ dysfunction at presentation. Conclusions: The mortality rate of patients hospitalised with sepsis exceeds that of the general population until 2 years post admission. Efforts to improve outcomes from sepsis should examine longer term outcomes than the traditional primary endpoints of 28-day and 90-day mortality.	[Davis, Joshua S.; He, Vincent; Anstey, Nicholas M.; Condon, John R.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Davis, Joshua S.; Anstey, Nicholas M.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research	Davis, JS (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Joshua.Davis@menzies.edu.au	Condon, John R/N-2281-2013; Davis, Joshua/N-2288-2013	Condon, John R/0000-0003-4952-0990; Davis, Joshua/0000-0001-9864-5699	National Health and Medical Research Council [1013411, 1042072, 496600]; University Postgraduate Research Scholarship from Charles Darwin University	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University Postgraduate Research Scholarship from Charles Darwin University	The study was supported by the National Health and Medical Research Council: Early Career Fellowship # 1013411 to JSD and Practitioner Fellowship(1042072) and Program Grant (496600) to NMA. VH was supported by University Postgraduate Research Scholarship from Charles Darwin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alberti C, 2003, AM J RESP CRIT CARE, V168, P77, DOI 10.1164/rccm.200208-785OC; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Baker C H, 1994, J Fla Med Assoc, V81, P119; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Davis JS, 2011, MED J AUSTRALIA, V194, P519, DOI 10.5694/j.1326-5377.2011.tb03088.x; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; Dent OF, 2009, ANN SURG, V249, P402, DOI 10.1097/SLA.0b013e31819a0469; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Dickman PW, 2009, STATA J; Eerola H, 2001, INT J CANCER, V93, P368, DOI 10.1002/ijc.1341; Esteban A, 2007, CRIT CARE MED, V35, P1284, DOI 10.1097/01.CCM.0000260960.94300.DE; Feigin VL, 2002, CEREBROVASC DIS, V13, P219, DOI 10.1159/000057846; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Ghelani D, 2009, J EVAL CLIN PRACT, V15, P425, DOI 10.1111/j.1365-2753.2008.01030.x; Hack CE, 2001, CRIT CARE MED, V29, pS21, DOI 10.1097/00003246-200107001-00011; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HOLLENBERG SM, 1994, J CRIT CARE, V9, P262, DOI 10.1016/0883-9441(94)90006-X; Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Lemay AC, 2013, AM J MED SCI; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Peake SL, 2009, RESUSCITATION, V80, P811, DOI 10.1016/j.resuscitation.2009.03.008; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Scoll BJ, 2009, J UROLOGY, V181, P506, DOI 10.1016/j.juro.2008.10.026; Storgaard M, 2013, SCAND J INFECT DIS; Vincent JL, 2004, CRIT CARE MED, V32, pS209, DOI 10.1097/01.CCM.0000126124.41743.86; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	39	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112224	10.1371/journal.pone.0112224	http://dx.doi.org/10.1371/journal.pone.0112224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486241	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600008
J	Garcia-Quintanilla, M; Pulido, MR; Pachon, J; McConnell, MJ				Garcia-Quintanilla, Meritxell; Pulido, Marina R.; Pachon, Jeronimo; McConnell, Michael J.			Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection	PLOS ONE			English	Article							MULTIDRUG-RESISTANT ACINETOBACTER; NEISSERIA-MENINGITIDIS; VACCINE CANDIDATE; PNEUMONIA; MUTANT; MICE	The increasing clinical importance of infections caused by multidrug resistant Acinetobacter baumannii warrants the development of novel approaches for prevention and treatment. In this context, vaccination of certain patient populations may contribute to reducing the morbidity and mortality caused by this pathogen. Vaccines against Gram-negative bacteria based on inactivated bacterial cells are highly immunogenic and have been shown to produce protective immunity against a number of bacterial species. However, the high endotoxin levels present in these vaccines due to the presence of lipopolysaccharide complicates their use in human vaccination. In the present study, we used a laboratory-derived strain of A. baumannii that completely lacks lipopolysaccharide due to a mutation in the lpxD gene (IB010), one of the genes involved in the first steps of lipopolysaccharide biosynthesis, for vaccination. We demonstrate that IB010 has greatly reduced endotoxin content (<1.0 endotoxin unit/10(6) cells) compared to wild type cells. Immunization with formalin inactivated IB010 produced a robust antibody response consisting of both IgG1 and IgG2c subtypes. Mice immunized with IB010 had significantly lower post-infection tissue bacterial loads and significantly lower serum levels of the pro-inflammatory cytokines IL-1 beta, TNF-alpha and IL-6 compared to control mice in a mouse model of disseminated A. baumannii infection. Importantly, immunized mice were protected from infection with the ATCC 19606 strain and an A. baumannii clinical isolate. These data suggest that immunization with inactivated A. baumannii whole cells deficient in lipopolysaccharide could serve as the basis for a vaccine for the prevention of infection caused by A. baumannii.	[Garcia-Quintanilla, Meritxell; Pulido, Marina R.; Pachon, Jeronimo; McConnell, Michael J.] Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	McConnell, MJ (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	mcconnell.mike75@gmail.com	Pulido, Marina/J-3176-2018; Quintanilla, Meritxell/AAB-4069-2019; Pachon, Jeronimo/M-4337-2014	Garcia-Quintanilla, Meritxell/0000-0003-1889-1377; McConnell, Michael/0000-0003-1028-381X; Pulido, Marina Rosa/0000-0003-1633-4294; Pachon, Jeronimo/0000-0002-8166-5308	Ministerio de Economia y Competitividad of Spain [RD06/0008/0000, PI-0046-2011, CP11/00314]	Ministerio de Economia y Competitividad of Spain(Spanish Government)	Support was provided by REIPI REIPI RD06/0008/0000 Consejeria de Salud de la Junta de Andalucia (PI-0046-2011) Subprograma Miguel Servet from the Ministerio de Economia y Competitividad of Spain (CP11/00314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATSON HC, 1950, J EXP MED, V91, P219, DOI 10.1084/jem.91.2.219; BAUMANN P, 1968, J BACTERIOL, V96, P39, DOI 10.1002/path.1700960105; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004; Fernandez-Cuenca F, 2004, ENFERM INFEC MICR CL, V22, P267, DOI 10.1016/S0213-005X(04)73085-2; Garcia-Quintanilla M, 2013, CURR PHARM IN PRESS; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Ho PL, 2009, CHEST, V136, P1119, DOI 10.1378/chest.09-0285; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; McConnell MJ, 2006, INFECT IMMUN, V74, P1009, DOI 10.1128/IAI.74.2.1009-1015.2006; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Ong CWM, 2009, RESPIROLOGY, V14, P1200, DOI 10.1111/j.1440-1843.2009.01630.x; Pachon J, 2014, VACCINE IN PRESS; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Rodriguez-Hernandez MJ, 2000, J ANTIMICROB CHEMOTH, V45, P493, DOI 10.1093/jac/45.4.493; Steeghs L, 1999, INFECT IMMUN, V67, P4988, DOI 10.1128/IAI.67.10.4988-4993.1999; Tasbakan MS, 2009, MIKROBIYOL BUL, V43, P61; TONG MJ, 1972, J AMER MED ASSOC, V219, P1044, DOI 10.1001/jama.219.8.1044; Valencia R, 2009, INFECT CONT HOSP EP, V30, P257, DOI 10.1086/595977; van der Ley P, 2003, J ENDOTOXIN RES, V9, P124, DOI 10.1179/096805103125001522; Vila J, 2008, EXPERT OPIN PHARMACO, V9, P587, DOI 10.1517/14656566.9.4.587; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509	33	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114410	10.1371/journal.pone.0114410	http://dx.doi.org/10.1371/journal.pone.0114410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485716	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600054
J	Wang, ZG; Jin, X; Bao, XG; Li, XF; Zhao, JH; Sun, JH; Christie, P; Li, L				Wang, Zhi-Gang; Jin, Xin; Bao, Xing-Guo; Li, Xiao-Fei; Zhao, Jian-Hua; Sun, Jian-Hao; Christie, Peter; Li, Long			Intercropping Enhances Productivity and Maintains the Most Soil Fertility Properties Relative to Sole Cropping	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; WHEAT TRITICUM-AESTIVUM; INTERSPECIFIC INTERACTIONS; NITROGEN-FIXATION; RESOURCE CAPTURE; N-2 FIXATION; WHITE LUPIN; PHOSPHORUS; SYSTEMS; MAIZE	Yield and nutrient acquisition advantages are frequently found in intercropping systems. However, there are few published reports on soil fertility in intercropping relative to monocultures. A field experiment was therefore established in 2009 in Gansu province, northwest China. The treatments comprised maize/faba bean, maize/soybean, maize/chickpea and maize/turnip intercropping, and their correspoding monocropping. In 2011 (the 3rd year) and 2012 (the 4th year) the yields and some soil chemical properties and enzyme activities were examined after all crop species were harvested or at later growth stages. Both grain yields and nutrient acquisition were significantly greater in all four intercropping systems than corresponding monocropping over two years. Generally, soil organic matter (OM) did not differ significantly from monocropping but did increase in maize/chickpea in 2012 and maize/turnip in both years. Soil total N (TN) did not differ between intercropping and monocropping in either year with the sole exception of maize/faba bean intercropping receiving 80 kg P ha(-1) in 2011. Intercropping significantly reduced soil Olsen-P only in 2012, soil exchangeable K in both years, soil cation exchangeable capacity (CEC) in 2012, and soil pH in 2012. In the majority of cases soil enzyme activities did not differ across all the cropping systems at different P application rates compared to monocrops, with the exception of soil acid phosphatase activity which was higher in maize/legume intercropping than in the corresponding monocrops at 40 kg ha(-1) P in 2011. P fertilization can alleviate the decline in soil Olsen-P and in soil CEC to some extent. In summary, intercropping enhanced productivity and maintained the majority of soil fertility properties for at least three to four years, especially at suitable P application rates.The results indicate that maize-based intercropping may be an efficient cropping system for sustainable agriculture with carefully managed fertilizer inputs.	[Wang, Zhi-Gang; Jin, Xin; Li, Xiao-Fei; Christie, Peter; Li, Long] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Minist Educ, Beijing 100193, Peoples R China; [Bao, Xing-Guo; Zhao, Jian-Hua; Sun, Jian-Hao] Gansu Acad Agr Sci, Inst Soils Fertilizers & Water Saving Agr, Lanzhou 730070, Peoples R China	China Agricultural University	Li, L (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Minist Educ, Beijing 100193, Peoples R China.	lilong@cau.edu.cn	Li, xiaofei/GXF-7187-2022; Christie, Peter/B-7919-2008; Li, Long/A-4998-2013; Li, Xiaofei/ABB-4458-2022	Christie, Peter/0000-0002-1939-7277; Li, Long/0000-0003-0523-3308; 	National Basic Research Program of China [2011CB100405]; Chinese Ministry of Science and Technology [2012BAD14B04, 2012BAD14B10]	National Basic Research Program of China(National Basic Research Program of China); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	The study was supported financially by the National Basic Research Program of China (Project No. 2011CB100405) and Chinese Ministry of Science and Technology (Project Nos. 2012BAD14B04 and 2012BAD14B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AE N, 1990, SCIENCE, V248, P477, DOI 10.1126/science.248.4954.477; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Andrade JF, 2012, AGRON J, V104, P1049, DOI 10.2134/agronj2012.0051; Antonious GF, 2003, J ENVIRON SCI HEAL B, V38, P479, DOI 10.1081/PFC-120021667; Batjes NH, 1997, SOIL USE MANAGE, V13, P9, DOI 10.1111/j.1475-2743.1997.tb00550.x; Beedy TL, 2010, AGR ECOSYST ENVIRON, V138, P139, DOI 10.1016/j.agee.2010.04.008; Conn C, 2000, SOIL BIOL BIOCHEM, V32, P489, DOI 10.1016/S0038-0717(99)00178-9; Dalal R. C., 1977, Advances in Agronomy, V29, P83; de Carvalho LM, 2009, HORTIC BRAS, V27, P458, DOI 10.1590/S0102-05362009000400010; Dick WA, 2000, SOIL BIOL BIOCHEM, V32, P1915, DOI 10.1016/S0038-0717(00)00166-8; Doran JW, 2002, AGR ECOSYST ENVIRON, V88, P119, DOI 10.1016/S0167-8809(01)00246-8; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Eskandari H, 2011, AFR J BIOTECHNOL, V10, P17755, DOI 10.5897/AJB11.2250; FAO, 1988, SOILS MAP WORLD REV; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; GARDNER WK, 1983, PLANT SOIL, V70, P391, DOI 10.1007/BF02374894; GILLER KE, 1994, SOIL SCIENCE AND SUSTAINABLE LAND MANAGEMENT IN THE TROPICS, P173; GILLER KE, 1995, PLANT SOIL, V174, P255, DOI 10.1007/BF00032251; Gu Y, 2009, EUR J SOIL BIOL, V45, P436, DOI 10.1016/j.ejsobi.2009.06.003; Guan S.Y, 1986, SOIL ENZYME RES METH; Gunes A, 2007, J PLANT NUTR, V30, P1555, DOI 10.1080/01904160701615467; Hauggaard-Nielsen H, 2001, FIELD CROP RES, V72, P185, DOI 10.1016/S0378-4290(01)00176-9; Haynes RJ, 1999, BIOL FERT SOILS, V28, P253, DOI 10.1007/s003740050490; He ZQ, 2010, J FOOD AGRIC ENVIRON, V8, P1112; HOGBERG P, 1986, CAN J FOREST RES, V16, P1165, DOI 10.1139/x86-207; HORST WJ, 1987, Z PFLANZ BODENKUNDE, V150, P1, DOI 10.1002/jpln.19871500102; Ilany T, 2010, AGROFOREST SYST, V80, P399, DOI 10.1007/s10457-010-9317-8; Inal A, 2007, PLANT PHYSIOL BIOCH, V45, P350, DOI 10.1016/j.plaphy.2007.03.016; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Jensen ES, 1996, PLANT SOIL, V182, P25, DOI 10.1007/BF00010992; Jensen ES, 2003, PLANT SOIL, V252, P177, DOI 10.1023/A:1024189029226; Karlen DL, 1997, SOIL SCI SOC AM J, V61, P4, DOI 10.2136/sssaj1997.03615995006100010001x; Klose S, 2000, BIOL FERT SOILS, V31, P191, DOI 10.1007/s003740050645; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Kumar BM, 1998, AGROFOREST SYST, V42, P81, DOI 10.1023/A:1006199910985; Li L, 2001, FIELD CROP RES, V71, P173, DOI 10.1016/S0378-4290(01)00157-5; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Li L, 2013, ENCY BIODIVERSITY, P382, DOI [10.1016/B978-0-12-384719-5.00363-4, DOI 10.1016/B978-0-12-384719-5.00363-4]; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Li QZ, 2011, PLANT SOIL, V339, P147, DOI 10.1007/s11104-010-0561-5; Li SM, 2004, ANN BOT-LONDON, V94, P297, DOI 10.1093/aob/mch140; Li WX, 2003, J PLANT NUTR, V26, P629, DOI 10.1081/PLN-120017670; Li YY, 2009, PLANT SOIL, V323, P295, DOI 10.1007/s11104-009-9938-8; Lopez-Bellido L, 2006, FIELD CROP RES, V98, P253, DOI 10.1016/j.fcr.2006.03.001; Lyman JK, 1986, MULTIPLE CROPPING SY; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mei PP, 2012, FIELD CROP RES, V130, P19, DOI 10.1016/j.fcr.2012.02.007; MORRIS RA, 1993, FIELD CROP RES, V34, P303, DOI 10.1016/0378-4290(93)90119-8; MORRIS RA, 1993, FIELD CROP RES, V34, P319, DOI 10.1016/0378-4290(93)90120-C; Mucheru-Muna M, 2010, FIELD CROP RES, V115, P132, DOI 10.1016/j.fcr.2009.10.013; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Ouma G., 2009, THE J, V1, P13; Pellegrino E, 2011, AGR ECOSYST ENVIRON, V140, P245, DOI 10.1016/j.agee.2010.12.011; Radulov I., 2011, Research Journal of Agricultural Science, V43, P160; Raghothama KG, 2005, PLANT SOIL, V274, P37, DOI 10.1007/s11104-004-2005-6; ROSS DJ, 1983, SOIL BIOL BIOCHEM, V15, P287, DOI 10.1016/0038-0717(83)90073-1; Rusinamhodzi L, 2012, FIELD CROP RES, V136, P12, DOI 10.1016/j.fcr.2012.07.014; Saikh H, 1998, PLANT SOIL, V204, P175, DOI 10.1023/A:1004323426199; Sardans J, 2008, EUR J SOIL BIOL, V44, P509, DOI 10.1016/j.ejsobi.2008.09.011; SEARLE PGE, 1981, FIELD CROP RES, V4, P133, DOI 10.1016/0378-4290(81)90063-0; Singh DK, 2008, CHEMOSPHERE, V71, P412, DOI 10.1016/j.chemosphere.2007.11.005; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; STEPHENS BD, 1983, PLANT PHYSIOL, V71, P731, DOI 10.1104/pp.71.4.731; Sultani MI, 2007, INT J ENVIRON SCI TE, V4, P109, DOI 10.1007/BF03325968; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tang C, 1997, AUST J EXP AGR, V37, P563, DOI 10.1071/EA96151; Thevathasan NV, 2004, AGROFOREST SYST, V61-2, P257, DOI 10.1023/B:AGFO.0000029003.00933.6d; TRENBATH BR, 1993, FIELD CROP RES, V34, P381, DOI 10.1016/0378-4290(93)90123-5; Vandermeer J.H., 1992, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Vanlauwe B, 1998, EUR J SOIL SCI, V49, P417, DOI 10.1046/j.1365-2389.1998.4930417.x; Velmourougane K, 2013, GEODERMA, V197, P186, DOI 10.1016/j.geoderma.2013.01.011; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Willey R. W., 1979, Field Crop Abstracts, V32, P1; Xia HY, 2013, FIELD CROP RES, V154, P53, DOI 10.1016/j.fcr.2013.07.011; Yang WT, 2013, FIELD CROP RES, V146, P44, DOI 10.1016/j.fcr.2013.03.008; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhiping Q, 2004, J SUSTAIN AGR, V23, P39, DOI 10.1300/J064v23n04_05; Zhou XG, 2011, EUR J SOIL BIOL, V47, P279, DOI 10.1016/j.ejsobi.2011.07.001; Zomer RJ, 2009, 89 ICRAF WORLD AGR C	80	34	39	7	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113984	10.1371/journal.pone.0113984	http://dx.doi.org/10.1371/journal.pone.0113984			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486249	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600033
J	Grell, AS; Thigarajah, R; Edvinsson, L; Samraj, AK				Grell, Anne-Sofie; Thigarajah, Rushani; Edvinsson, Lars; Samraj, Ajoy Kumar			Regulatory Mechanism of Endothelin Receptor B in the Cerebral Arteries after Focal Cerebral Ischemia	PLOS ONE			English	Article							SP1 PHOSPHORYLATION; UP-REGULATION; IN-VITRO; MITHRAMYCIN; BINDING; CHROMOMYCIN; ANTAGONIST; EXPRESSION; INHIBITOR; OCCLUSION	Background and Purpose: Increased expression of endothelin receptor type B (ETBR), a vasoactive receptor, has recently been implied in the reduced cerebral blood flow and exacerbated neuronal damage after ischemia-reperfusion (I/R). The study explores the regulatory mechanisms of ETBR to identify drug targets to restore normal cerebral artery contractile function as part of successful neuroprotective therapy. Methods: We have employed in vitro methods on human and rat cerebral arteries to study the regulatory mechanisms and the efficacy of target selective inhibitor, Mithramycin A (MitA), to block the ETBR mediated contractile properties. Later, middle cerebral artery occluded (MCAO) rats were used to substantiate the observations. Quantative PCR, immunohistochemistry, western blot and wire myograph methods were employed to study the expression and contractile properties of cerebral arteries. Results: Increased expression of specificity protein (Sp1) was observed in human and rat cerebral arteries after organ culture, strongly correlating with the ETBR upregulation. Similar observations were made in MCAO rats. Treatment with MitA, a Sp1 specific inhibitor, significantly downregulated the ETBR mRNA and protein levels. It also significantly reduced the ETBR mediated cerebrovascular contractility. Detailed analysis indicated that ERK1/2 mediated phosphorylation of Sp1 might be essential for ETBR transcription. Conclusion: Transcription factor Sp1 regulates the ETBR mediated vasoconstriction in focal cerebral ischemia via MEK-ERK signaling, which is also conserved in humans. The results show that MitA can effectively be used to block ETBR mediated vasoconstriction as a supplement to an existing ischemic stroke therapy.	[Grell, Anne-Sofie; Edvinsson, Lars; Samraj, Ajoy Kumar] Univ Copenhagen, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Thigarajah, Rushani; Edvinsson, Lars] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden	University of Copenhagen; Lund University	Samraj, AK (corresponding author), Univ Copenhagen, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	aksamraj@gmail.com		Edvinsson, Lars/0000-0002-1805-1346	Lundbeck foundation for Centre of Excellence grant, Denmark; Swedish Heart and Lung foundation; Swedish Research council [5958]	Lundbeck foundation for Centre of Excellence grant, Denmark; Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Swedish Research council(Swedish Research CouncilEuropean Commission)	Lundbeck foundation for Centre of Excellence grant, Denmark, and the Swedish Heart and Lung foundation, and the Swedish Research council (grant no. 5958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnstedt H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-5; Ansar S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-12; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71.abs; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DORLEANSJUSTE P, 1993, BRIT J PHARMACOL, V110, P687, DOI 10.1111/j.1476-5381.1993.tb13866.x; Dutcher JP, 1997, LEUKEMIA RES, V21, P375, DOI 10.1016/S0145-2126(96)00108-7; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; EHRENREICH H, 1995, CLEV CLIN J MED, V62, P105, DOI 10.3949/ccjm.62.2.105; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Henriksson M, 2004, BRIT J PHARMACOL, V142, P1155, DOI 10.1038/sj.bjp.0705803; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041852; KENNEDY BJ, 1995, MED PEDIATR ONCOL, V24, P327, DOI 10.1002/mpo.2950240511; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Maddahi A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-56; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; MEMEZAWA H, 1992, EXP BRAIN RES, V89, P67; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; NISHIGAYA K, 1991, STROKE, V22, P635, DOI 10.1161/01.STR.22.5.635; Povlsen GK, 2012, EXP BRAIN RES, V219, P507, DOI 10.1007/s00221-012-3108-6; ROUBERT P, 1991, J CARDIOVASC PHARM, V17, pS104, DOI 10.1097/00005344-199100177-00027; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Zhang RL, 2008, STROKE, V39, P2830, DOI 10.1161/STROKEAHA.108.515684	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113624	10.1371/journal.pone.0113624	http://dx.doi.org/10.1371/journal.pone.0113624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479176	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200024
J	Lerma, LL; Benomar, N; Knapp, CW; Galeote, DC; Galvez, A; Abriouel, H				Lerma, Leyre Lavilla; Benomar, Nabil; Knapp, Charles W.; Galeote, David Correa; Galvez, Antonio; Abriouel, Hikmate			Diversity, Distribution and Quantification of Antibiotic Resistance Genes in Goat and Lamb Slaughterhouse Surfaces and Meat Products	PLOS ONE			English	Article							ESCHERICHIA-COLI; TETRACYCLINE RESISTANCE; SULFONAMIDE RESISTANCE; ANTIMICROBIAL RESISTANCE; HEALTHY HUMANS; SALMONELLA; PREVALENCE; BACTERIA; POULTRY; STRAINS	The distribution and quantification of tetracycline, sulfonamide and beta-lactam resistance genes were assessed in slaughterhouse zones throughout meat chain production and the meat products; this study represents the first to report quantitatively monitor antibiotic resistance genes (ARG) in goat and lamb slaughterhouse using a culture independent approach, since most studies focused on individual bacterial species and their specific resistance types. Quantitative PCR (qPCR) revealed a high prevalence of tetracycline resistance genes tetA and tetB in almost all slaughterhouse zones. Sulfonamide resistance genes were largely distributed, while beta-lactam resistance genes were less predominant. Statistical analysis revealed that resistant bacteria, in most cases, were spread by the same route in almost all slaughterhouse zones, except for tetB, bla(CTX) and bla(TEM) genes, which occurred in few zones as isolated 'hot spots.' The sum of all analyzed ARG indicated that slaughterhouse surfaces and end products act as reservoirs of ARG, mainly tet genes, which were more prevalent in slaughtering room (SR), cutting room (CR) and commercial meat products (MP). Resistance gene patterns suggest they were disseminated throughout slaughterhouse zones being also detected in commercial meat products, with significant correlations between different sampling zones/end products and total resistance in SR, CR and white room (WR) zones, and also refrigerator 4 (F4) and MP were observed. Strategically controlling key zones in slaughterhouse (SR, CR and WR) by adequate disinfection methods could strategically reduce the risks of ARG transmission and minimize the issues of food safety and environment contamination.	[Lerma, Leyre Lavilla; Benomar, Nabil; Galvez, Antonio; Abriouel, Hikmate] Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen 23071, Spain; [Knapp, Charles W.] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland; [Galeote, David Correa] Agencia CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain	Universidad de Jaen; University of Strathclyde; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Abriouel, H (corresponding author), Univ Jaen, Area Microbiol, Dept Ciencias Salud, Fac Ciencias Expt, Jaen 23071, Spain.	hikmate@ujaen.es	Correa-Galeote, David/I-8336-2017; Correa-Galeote, David/A-9780-2019; Abriouel, Hikmate/K-9769-2017; Knapp, Charles W/D-3373-2009; Galvez, Antonio/M-2359-2014	Correa-Galeote, David/0000-0002-9776-8424; Correa-Galeote, David/0000-0002-9776-8424; Knapp, Charles W/0000-0001-7997-8543; Galvez, Antonio/0000-0002-5894-5029; Lavilla- Lerma, Maria Leyre/0000-0002-1295-1968; Abriouel, Hikmate/0000-0002-0666-3978; Benomar El Bakali, Nabil/0000-0002-7297-6171	Ministerio de Innovacion y Ciencia [AGL2009-08921]; Junta de Andalucia [P08-AGR-4295]; Plan propio de la Universidad de Jaen; Campus de Excelencia Internacional Agroalimentario CeiA3; Spanish Ministry of Education and Science	Ministerio de Innovacion y Ciencia(Spanish Government); Junta de Andalucia(Junta de Andalucia); Plan propio de la Universidad de Jaen; Campus de Excelencia Internacional Agroalimentario CeiA3; Spanish Ministry of Education and Science(Spanish Government)	This work was supported by grants AGL2009-08921 (Ministerio de Innovacion y Ciencia), P08-AGR-4295 (Junta de Andalucia), Plan propio de la Universidad de Jaen, and Campus de Excelencia Internacional Agroalimentario CeiA3. Leyre Lavilla Lerma was beneficiary of a fellowship from Spanish Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Antunes P, 2005, ANTIMICROB AGENTS CH, V49, P836, DOI 10.1128/AAC.49.2.836-839.2005; Aradhye A. A., 2014, African Journal of Microbiology Research, V8, P277; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Barza M, 2002, CLIN INFECT DIS, V34, pS71, DOI 10.1086/340241; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; Brtkova A, 2009, J FOOD NUTR RES-SLOV, V48, P121; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dancey C., 2004, STAT MATHS PSYCHOL U; DELOSREYESGAVILAN CG, 1992, APPL ENVIRON MICROB, V58, P3429; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Florez AB, 2008, INT J FOOD MICROBIOL, V121, P189, DOI 10.1016/j.ijfoodmicro.2007.11.029; Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07; Gregova G, 2012, ANN AGR ENV MED, V19, P75; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Hammerum AM, 2006, INT J FOOD MICROBIOL, V106, P235, DOI 10.1016/j.ijfoodmicro.2005.06.023; HOLMBERG SD, 1984, NEW ENGL J MED, V311, P617, DOI 10.1056/NEJM198409063111001; HUMMEL R, 1986, J BASIC MICROB, V26, P461, DOI 10.1002/jobm.3620260806; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Lerma LL, 2013, INT J FOOD MICROBIOL, V161, P97, DOI 10.1016/j.ijfoodmicro.2012.11.028; LEVY SB, 1976, NEW ENGL J MED, V295, P583, DOI 10.1056/NEJM197609092951103; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Sambrook J., 2002, MOL CLONING LAB MANU; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; Skockova A, 2012, J MICROB BIOTEC FOOD, V1, P777; Smith DeWaal C, 2013, ANTIBIOTIC RESISTANC, P1; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Sunde M, 2006, J ANTIMICROB CHEMOTH, V58, P741, DOI 10.1093/jac/dkl294; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Trobos M, 2008, INT J ANTIMICROB AG, V32, P367, DOI 10.1016/j.ijantimicag.2008.04.021; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	44	15	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114252	10.1371/journal.pone.0114252	http://dx.doi.org/10.1371/journal.pone.0114252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479100	Green Published, Green Accepted, gold			2022-12-26	WOS:000346907200057
J	Xie, ZL; Yi, HG; Chandrasekaran, B				Xie, Zilong; Yi, Han-Gyol; Chandrasekaran, Bharath			Nonnative Audiovisual Speech Perception in Noise: Dissociable Effects of the Speaker and Listener	PLOS ONE			English	Article							SENTENCE RECOGNITION; VISUAL ENHANCEMENT; ADVERSE CONDITIONS; NORMAL-HEARING; INTELLIGIBILITY; EXPERIENCE; INTEGRATION; LANGUAGE; CUES	Nonnative speech poses a challenge to speech perception, especially in challenging listening environments. Audiovisual (AV) cues are known to improve native speech perception in noise. The extent to which AV cues benefit nonnative speech perception in noise, however, is much less well-understood. Here, we examined native American English-speaking and native Korean-speaking listeners' perception of English sentences produced by a native American English speaker and a native Korean speaker across a range of signal-to-noise ratios (SNRs; -4 to -20 dB) in audio-only and audiovisual conditions. We employed psychometric function analyses to characterize the pattern of AV benefit across SNRs. For native English speech, the largest AV benefit occurred at intermediate SNR (i.e. -12 dB); but for nonnative English speech, the largest AV benefit occurred at a higher SNR (-4 dB). The psychometric function analyses demonstrated that the AV benefit patterns were different between native and nonnative English speech. The nativeness of the listener exerted negligible effects on the AV benefit across SNRs. However, the nonnative listeners' ability to gain AV benefit in native English speech was related to their proficiency in English. These findings suggest that the native language background of both the speaker and listener clearly modulate the optimal use of AV cues in speech recognition.	[Xie, Zilong; Yi, Han-Gyol; Chandrasekaran, Bharath] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Chandrasekaran, Bharath] Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Chandrasekaran, B (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.	bchandra@utexas.edu		Xie, Zilong/0000-0002-6851-7554; Yi, Han Gyol/0000-0001-7152-3712; Chandrasekaran, Bharath/0000-0002-3673-9435	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R01DC013315]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013315] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (https://www.nidcd.nih.gov/Pages/default.aspx) under Award Number R01DC013315 awarded to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audacity Developer Team, 2008, AUD VERS 1 2 6 COMP; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baker W, 2010, BILING-LANG COGN, V13, P263, DOI 10.1017/S136672890999006X; Bates D., 2012, IME4 LINEAR MIXED EF; Bent T, 2003, J ACOUST SOC AM, V114, P1600, DOI 10.1121/1.1603234; Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; Boersma P., 2010, PRAAT DOING PHONETIC; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Calandruccio L, 2012, J SPEECH LANG HEAR R, V55, P1342, DOI 10.1044/1092-4388(2012/11-0260); Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Chen T, 1998, P IEEE, V86, P837, DOI 10.1109/5.664274; ERBER NP, 1969, J SPEECH HEAR RES, V12, P423, DOI 10.1044/jshr.1202.423; FISHER CG, 1968, J SPEECH HEAR RES, V11, P796, DOI 10.1044/jshr.1104.796; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Hazan V, 2006, J ACOUST SOC AM, V119, P1740, DOI 10.1121/1.2166611; Hazan V, 2010, SPEECH COMMUN, V52, P996, DOI 10.1016/j.specom.2010.05.003; Helfer KS, 2005, J ACOUST SOC AM, V117, P842, DOI 10.1121/1.1836832; Irwin A, 2011, SPEECH COMMUN, V53, P807, DOI 10.1016/j.specom.2011.01.010; Ma WJ, 2009, PLOS ONE, P4; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; MILLER GA, 1951, J EXP PSYCHOL, V41, P329, DOI 10.1037/h0062491; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Ross LA, 2007, SCHIZOPHR RES, V97, P173, DOI 10.1016/j.schres.2007.08.008; Ross LA, 2011, EUR J NEUROSCI, V33, P2329, DOI 10.1111/j.1460-9568.2011.07685.x; Schneider W., 2002, E PRIME VERSION 20 C; Seidl A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00448, 10.3389/fpsyg.2012.00479]; Sommers MS, 2005, EAR HEARING, V26, P263, DOI 10.1097/00003446-200506000-00003; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; US Census Bureau, 2001, PROF FOR BORN POP US; Van Engen KJ, J SPEECH LANGUAGE HE; Wang Y, 2008, J ACOUST SOC AM, V124, P1716, DOI 10.1121/1.2956483; Yi HG, 2013, J ACOUST SOC AM, V134, pEL387, DOI 10.1121/1.4822320	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114439	10.1371/journal.pone.0114439	http://dx.doi.org/10.1371/journal.pone.0114439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474650	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500028
J	Bae, WK; Kang, K; Yu, JH; Yoo, KH; Factor, VM; Kaji, K; Matter, M; Thorgeirsson, S; Hennighausen, L				Bae, Woo Kyun; Kang, Keunsoo; Yu, Ji Hoon; Yoo, Kyung Hyun; Factor, Valentina M.; Kaji, Kosuke; Matter, Matthias; Thorgeirsson, Snorri; Hennighausen, Lothar			The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration	FASEB JOURNAL			English	Article						H3-K27 trimethylation; liver regeneration; fibrosis	STEM-CELLS; GROUP PROTEINS; POLYCOMB; COMPLEX; CANCER; LIVER; PROLIFERATION; METHYLATION; MEMORY; BMI-1	To investigate the role of enhancer of zeste homolog (EZH) 1 and EZH2 in liver homeostasis, mice were generated that carried Ezh1(-/-) and EZH2(fl/fl) alleles and an Alb-Cre transgene. Only the combined loss of EZH1 and EZH2 in mouse hepatocytes caused a depletion of global trimethylation on Lys 27 of histone H3 (H3K27me3) marks and the specific loss of over similar to 1900 genes at 3 mo of age. Ezh1(-/-),Ezh2(fl/fl)Alb-Cre mice exhibited progressive liver abnormalities manifested by the development of regenerative nodules and concomitant periportal fibrosis, inflammatory infiltration, and activation of A6-positive hepatic progenitor cells at 8 mo of age. In response to chronic treatment with carbon tetrachloride, all experimental mice, but none of the controls (n = 27 each), showed increased hepatic degeneration associated with liver dysfunction and reduced ability to proliferate. After two-thirds partial hepatectomy, mutant mice (n = 5) displayed increased liver injury and a blunted regenerative response. Genome-wide analyses at 3 mo of age identified 51 genes that had lost H3K27me3 marks, and their expression was significantly increased. These genes were involved in regulation of cell survival, fibrosis, and proliferation. H3K27me3 levels and liver physiology were unaffected in mice lacking either EZH1 globally or EZH2 specifically in hepatocytes. This work demonstrates a critical redundancy of EZH1 and EZH2 in maintaining hepatic homeostasis and regeneration.	[Bae, Woo Kyun; Kang, Keunsoo; Yu, Ji Hoon; Yoo, Kyung Hyun; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, Bethesda, MD 20892 USA; [Factor, Valentina M.; Kaji, Kosuke; Matter, Matthias; Thorgeirsson, Snorri] NCI, Ctr Canc Res, Expt Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; [Bae, Woo Kyun] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Kang, Keunsoo] Dankook Univ, Dept Microbiol, Cheonan, South Korea; [Yu, Ji Hoon] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Taegu, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chonnam National University; Dankook University	Bae, WK (corresponding author), NIDDK, Lab Genet & Physiol, NIH, 8 Ctr Dri,Room 101, Bethesda, MD 20892 USA.	drwookyun@chonnam.ac.kr; lotharh@mail.nih.gov		Matter, Matthias/0000-0002-2005-5266; Hennighausen, Lothar/0000-0001-8319-9841	NIH NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075030, ZICDK071001, ZIADK061000] Funding Source: NIH RePORTER	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Harold Smith [U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases' (NIDDK) genomics core] for conducting next-generation sequencing. Alexander Tarakhovsky (Rockefeller University, New York, NY, USA) provided Ezh2 floxed mice. Ezh1 mutant mice were generated at the Research Institute of Molecular Pathology (Vienna, Austria) by Donal O'Carroll (laboratory of Thomas Jenuwein) with the help of Maria Sibilia (Laboratory of Erwin Wagner). The research was supported by the Intramural Research Program of the NIH NIDDK. The authors declare no conflicts of interest.	Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bardot ES, 2013, EMBO J, V32, P1990, DOI 10.1038/emboj.2013.110; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; FACTOR VM, 1994, AM J PATHOL, V145, P409; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JM, 2012, MOL CELL, V48, P572, DOI 10.1016/j.molcel.2012.09.004; Lin T, 2013, HEPATOLOGY, V58, P2176, DOI 10.1002/hep.26600; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	28	35	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1653	1662		10.1096/fj.14-261537	http://dx.doi.org/10.1096/fj.14-261537			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25477280	Green Published			2022-12-26	WOS:000354114600005
J	Mlih, M; Host, L; Martin, S; Niederhoffer, N; Monassier, L; Terrand, J; Messaddeq, N; Radke, M; Gotthardt, M; Bruban, V; Kober, F; Bernard, M; Canet-Soulas, E; Abt-Jijon, F; Boucher, P; Matz, RL				Mlih, Mohamed; Host, Lionel; Martin, Sophie; Niederhoffer, Nathalie; Monassier, Laurent; Terrand, Jerome; Messaddeq, Nadia; Radke, Michael; Gotthardt, Michael; Bruban, Veronique; Kober, Frank; Bernard, Monique; Canet-Soulas, Emmanuelle; Abt-Jijon, Francisco; Boucher, Philippe; Matz, Rachel L.			The Src Homology and Collagen A (ShcA) Adaptor Protein Is Required for the Spatial Organization of the Costamere/Z-disk Network during Heart Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; SMOOTH-MUSCLE; CARDIAC-HYPERTROPHY; NEBULETTE MUTATIONS; MOUSE HEART; TITIN; MICE; ERBB2; CAVEOLIN-1; DISEASE	Src homology and collagen A (ShcA) is an adaptor protein that binds to tyrosine kinase receptors. Its germ line deletion is embryonic lethal with abnormal cardiovascular system formation, and its role in cardiovascular development is unknown. To investigate its functional role in cardiovascular development in mice, ShcA was deleted in cardiomyocytes and vascular smooth muscle cells by crossing ShcA flox mice with SM22a-Cre transgenic mice. Conditional mutant mice developed signs of severe dilated cardiomyopathy, myocardial infarctions, and premature death. No evidence of a vascular contribution to the phenotype was observed. Histological analysis of the heart revealed aberrant sarcomeric Z-disk and M-band structures, and misalignments of T-tubules with Z-disks. We find that not only the ErbB3/Neuregulin signaling pathway but also the baroreceptor reflex response, which have been functionally associated, are altered in the mutant mice. We further demonstrate that ShcA interacts with Caveolin-1 and the costameric protein plasma membrane Ca2+/calmodulin-dependent ATPase (PMCA), and that its deletion leads to abnormal dystrophin signaling. Collectively, these results demonstrate that ShcA interacts with crucial proteins and pathways that link Z-disk and costamere.	[Mlih, Mohamed; Host, Lionel; Martin, Sophie; Terrand, Jerome; Bruban, Veronique; Abt-Jijon, Francisco; Boucher, Philippe; Matz, Rachel L.] Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France; [Niederhoffer, Nathalie; Monassier, Laurent] Univ Strasbourg, Lab Neurobiol, F-67000 Strasbourg, France; [Niederhoffer, Nathalie; Monassier, Laurent] Univ Strasbourg, Cardiovasc Pharmacol Dept, EA 7296, F-67000 Strasbourg, France; [Messaddeq, Nadia] Univ Strasbourg, CNRS, IGBMC, INSERM,U964,UMR 7104, F-67401 Illkirch Graffenstaden, France; [Radke, Michael; Gotthardt, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Radke, Michael; Gotthardt, Michael] German Ctr Cardiovasc Res, DZHK, D-13347 Berlin, Germany; [Kober, Frank; Bernard, Monique] Univ Aix Marseille, CNRS, UMR 7339, CRMBM, F-13385 Marseille, France; [Canet-Soulas, Emmanuelle] CNRS, INSERM, U630, CREATIS,LRMN,UMR 5220, F-69621 Villeurbanne, France; [Canet-Soulas, Emmanuelle] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Boucher, P (corresponding author), Univ Strasbourg, CNRS, UMR 7213, F-67401 Illkirch Graffenstaden, France.	philippe.boucher@unistra.fr; rachel.matz-westphal@unistra.fr	Gotthardt, Michael/ABE-8274-2021; Bernard, Monique/Q-7254-2017; Kober, Frank/L-8737-2013; Niederhoffer, Nathalie/AAF-1343-2020; Mlih, Mohamed/O-4834-2019; Carmen, Team3/Y-7384-2019; martin, sophie/AAP-3498-2021	Gotthardt, Michael/0000-0003-1788-3172; Bernard, Monique/0000-0002-3179-8698; Kober, Frank/0000-0002-7869-3615; Mlih, Mohamed/0000-0003-3491-9616; Carmen, Team3/0000-0002-3614-0924; MATZ, Rachel/0000-0001-5832-7063; Lab, Carmen/0000-0002-5935-3236; Terrand, jerome/0000-0002-8169-7713; Radke, Michael/0000-0003-0112-9917; Martin, Sophie/0000-0002-2907-7445; Boucher, Philippe/0000-0002-3928-9812	Fondation de France; Fondation pour la Recherche Medicale (FRM); Agence Nationale de la Recherche [ANR-06-Physio-032-01, ANR-09-BLAN-0121-01]	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Fondation de France, Fondation pour la Recherche Medicale (FRM), and Agence Nationale de la Recherche Grants ANR-06-Physio-032-01 and ANR-09-BLAN-0121-01.	Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Camprecios G, 2011, J CELL PHYSIOL, V226, P450, DOI 10.1002/jcp.22354; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Das M, 2014, BBA-BIOMEMBRANES, V1838, P579, DOI 10.1016/j.bbamem.2013.07.017; Epstein ND, 2003, CELL, V112, P147, DOI 10.1016/S0092-8674(03)00037-0; Erickson SL, 1997, DEVELOPMENT, V124, P4999; GARDIN JM, 1995, CIRC RES, V76, P907, DOI 10.1161/01.RES.76.5.907; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Gautel M, 1996, J CELL SCI, V109, P2747; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Jacquier A, 2011, NMR BIOMED, V24, P1047, DOI 10.1002/nbm.1645; Jakobsen CJ, 2006, EUR J CARDIO-THORAC, V29, P978, DOI 10.1016/j.ejcts.2006.02.014; Jiang Zhenggang, 2010, Curr Heart Fail Rep, V7, P42, DOI 10.1007/s11897-010-0003-y; KAUFMAN MH, 1981, J ANAT, V133, P235; Kober F, 2005, MAGNET RESON MED, V53, P601, DOI 10.1002/mrm.20373; Lai KMV, 2000, GENE DEV, V14, P1132; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Maiellaro-Rafferty K, 2013, J MOL CELL CARDIOL, V60, P151, DOI 10.1016/j.yjmcc.2013.04.021; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; MANNING WJ, 1994, AM J PHYSIOL, V266, pH1672, DOI 10.1152/ajpheart.1994.266.4.H1672; Matz RL, 2000, BRIT J PHARMACOL, V131, P303, DOI 10.1038/sj.bjp.0703568; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pellegrini M, 2007, CELL DEATH DIFFER, V14, P338, DOI 10.1038/sj.cdd.4401997; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Sawyer DB, 2011, J MOL CELL CARDIOL, V51, P501, DOI 10.1016/j.yjmcc.2011.06.016; SEBESTYEN MG, 1995, J CELL SCI, V108, P3029; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Sharma P, 2010, J CELL SCI, V123, P3061, DOI 10.1242/jcs.066712; Shen ZX, 2012, BIOCHEM BIOPH RES CO, V422, P639, DOI 10.1016/j.bbrc.2012.05.041; Stevenson LE, 1999, CELL GROWTH DIFFER, V10, P61; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Vanderlaan RD, 2011, CIRC RES, V108, P184, DOI 10.1161/CIRCRESAHA.110.233924; Vasti Cecilia, 2012, ISRN Cardiol, V2012, P745185, DOI 10.5402/2012/745185; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; Woldt E, 2011, J BIOL CHEM, V286, P16775, DOI 10.1074/jbc.M110.212878; Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693; Yajnik V, 1998, METH MOL B, V84, P223; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	60	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2419	2430		10.1074/jbc.M114.597377	http://dx.doi.org/10.1074/jbc.M114.597377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488665	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000348588000044
J	Brandl, HB; van Dongen, WFD; Darolova, A; Kristofik, J; Majtan, J; Hoi, H				Brandl, Hanja B.; van Dongen, Wouter F. D.; Darolova, Alzbeta; Kristofik, Jan; Majtan, Juraj; Hoi, Herbert			Composition of Bacterial Assemblages in Different Components of Reed Warbler Nests and a Possible Role of Egg Incubation in Pathogen Regulation	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; ANTIMICROBIAL PROPERTIES; CLOACAL BACTERIA; GUT MICROBIOTA; EGGSHELL; WILD; TRANSMISSION; COMMUNITIES; INFECTION; GROWTH	Bacteria play a central role in animal health. Yet, little is known about the acquisition of bacteria and the extent to which bacteria are acquired from different environmental sources. For example, bird nests host diverse bacteria associated with the eggs, nestlings and nesting material, but previous research has typically focussed on only a limited number of nest components at a time. It therefore remains unknown to what extent bacteria are transmitted between these components. Using both molecular and culture techniques, we characterised nest-associated bacterial assemblages throughout the entire nesting cycle of reed warblers by sampling bacteria on eggs before and during incubation, within nestling faeces, and on the nesting material of post-breeding nests. We found that bacterial assemblages clustered by nest component. Yet some overlap existed between nest components, suggesting that bacterial transmission across components is likely to occur. Eggs and nestlings from the same nest harboured more similar bacteria than expected by chance, suggesting an influence of environment or genetics on bacterial assemblages. Bacterial loads were not lower on incubated eggs. Instead, incubation was associated with a change in the structure of assemblages, including a decrease in potentially-harmful Gram-negative bacteria. In addition we show for the first time, that incubation is associated with the complete extinction of harmful haemolytic bacteria. Overall, our study appears to be the first to demonstrate differences in bacterial assemblages between bird nest components. In addition, we highlight the complexity of nest bacterial assemblages and provide new insights into the benefits of incubation.	[Brandl, Hanja B.; van Dongen, Wouter F. D.; Hoi, Herbert] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, A-1160 Vienna, Austria; [Darolova, Alzbeta; Kristofik, Jan; Majtan, Juraj] Slovak Acad Sci, Inst Zool, Bratislava 84506, Slovakia	University of Veterinary Medicine Vienna; Slovak Academy of Sciences	Brandl, HB (corresponding author), Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Savoyenstr 1a, A-1160 Vienna, Austria.	hanja.b@gmx.net	Majtan, Juraj/N-5841-2018; Brandl, Hanja/M-9233-2019	Majtan, Juraj/0000-0002-7268-1584; Brandl, Hanja/0000-0001-6972-5403; Darolova, Alzbeta/0000-0002-3269-2895	VEGA - Scientific grant agency of the Ministry of Education of the Slovak Republic; Slovak Academy of Sciences [VEGA 2/0034/15]	VEGA - Scientific grant agency of the Ministry of Education of the Slovak Republic(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Slovak Academy of Sciences(Slovak Academy of Sciences)	This study was financially supported by VEGA - Scientific grant agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences (VEGA 2/0034/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WILDLIFE REHAB; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Baltag E, 2011, NORTH-WEST J ZOOL, V7, P176; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bojesen AM, 2003, AVIAN PATHOL, V32, P503, DOI 10.1080/0307945031000154107; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; CARLSON HC, 1968, AVIAN DIS, V12, P297, DOI 10.2307/1588229; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Christensen H, 2003, INT J SYST EVOL MICR, V53, P275, DOI 10.1099/ijs.0.02330-0; CLARK L, 1990, PARASITOL TODAY, V6, P358, DOI 10.1016/0169-4758(90)90415-Z; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Corrigan A, 2011, APPL ENVIRON MICROB, V77, P6653, DOI 10.1128/AEM.05028-11; D'Alba L, 2014, J EXP BIOL, V217, P1116, DOI 10.1242/jeb.098343; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; De Reu K, 2008, WORLD POULTRY SCI J, V64, P5, DOI 10.1017/S0043933907001687; De Reu K, 2005, BRIT POULTRY SCI, V46, P149, DOI 10.1080/00071660500065359; De Vylder J, 2009, POULTRY SCI, V88, P2491, DOI 10.3382/ps.2009-00203; Ibanez-Alamo JD, 2014, J AVIAN BIOL, V45, P354, DOI 10.1111/jav.00353; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Duchesne P, 2006, MOL ECOL NOTES, V6, P965, DOI 10.1111/j.1471-8286.2006.01414.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flint JF, 2009, J APPL POULTRY RES, V18, P367, DOI 10.3382/japr.2008-00133; Glunder G, 2002, DEUT TIERARZTL WOCH, V109, P266; Glutz von Blotzheim U., 1991, HDB VOGEL MITTELEURO; Gomis SM, 1997, AVIAN DIS, V41, P234, DOI 10.2307/1592464; Gonzalez-Braojos S, 2012, ACTA ORNITHOL, V47, P119, DOI 10.3161/000164512X662223; Gonzalez-Braojos S, 2012, J ORNITHOL, V153, P181, DOI 10.1007/s10336-011-0725-y; Goodenough AE, 2012, MICROB ECOL, V63, P986, DOI 10.1007/s00248-011-9992-7; Gorley C.K., 2006, GETTING STARTED PRIM; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; Gross W. B., 1959, Avian Diseases, V3, P370, DOI 10.2307/1587575; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gunderson AR, 2009, J AVIAN BIOL, V40, P440, DOI 10.1111/j.1600-048X.2008.04650.x; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Kilgas P, 2012, J ORNITHOL, V153, P833, DOI 10.1007/s10336-011-0801-3; Knarreborg A, 2002, APPL ENVIRON MICROB, V68, P5918, DOI 10.1128/AEM.68.12.5918-5924.2002; Koller H, 2006, J MAR BIOL ASSOC UK, V86, P1113, DOI 10.1017/S0025315406014093; Kovacs A, 2010, RES MICROBIOL, V161, P192, DOI 10.1016/j.resmic.2010.01.006; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; LIN MY, 1993, AVIAN DIS, V37, P6, DOI 10.2307/1591450; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Lopes M, 2013, POULTRY SCI, V92, P638, DOI 10.3382/ps.2012-02700; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Mills TK, 1999, AUK, V116, P947; Moreno J, 2003, AUK, V120, P784, DOI 10.1642/0004-8038(2003)120[0784:BEOCBO]2.0.CO;2; Morishita TY, 1997, J AVIAN MED SURG, V11, P77; Or A, 2013, RES MICROBIOL, V164, P262, DOI 10.1016/j.resmic.2012.12.004; PECKHAM MC, 1966, AVIAN DIS, V10, P413, DOI 10.2307/1588248; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Ruiz-de-Castaneda R, 2012, CONDOR, V114, P203, DOI 10.1525/cond.2011.100230; Ruiz-Rodriguez M, 2009, BIOL J LINN SOC, V96, P406, DOI 10.1111/j.1095-8312.2008.01127.x; Saag P, 2011, MICROB ECOL, V61, P740, DOI 10.1007/s00248-010-9789-0; SATO GIHEI., 1960, JAPANESE JOUR VET RES, V8, P285; Schottner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055505; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Slovak Hydrometeorological Institute, 2012, ANN BOOK CLIM OBS 20; Soler JJ, 2012, J EVOLUTION BIOL, V25, P1779, DOI 10.1111/j.1420-9101.2012.02561.x; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Wang JM, 2011, ECOLOGY, V92, P1137, DOI 10.1890/i0012-9658-92-5-1137; Wellman-Labadie O, 2010, J AGR FOOD CHEM, V58, P10156, DOI 10.1021/jf101954g; White J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022339; White J, 2010, ECOL LETT, V13, P1515, DOI 10.1111/j.1461-0248.2010.01542.x; Wienemann T, 2011, SYST APPL MICROBIOL, V34, P542, DOI 10.1016/j.syapm.2011.06.003; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	82	38	39	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114861	10.1371/journal.pone.0114861	http://dx.doi.org/10.1371/journal.pone.0114861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493434	gold, Green Published			2022-12-26	WOS:000346611400080
J	Iguchi, Y; Kosugi, S; Nishikawa, H; Lin, ZQ; Minabe, Y; Toda, S				Iguchi, Yoshio; Kosugi, Sakurako; Nishikawa, Hiromi; Lin, Ziqiao; Minabe, Yoshio; Toda, Shigenobu			Repeated Exposure of Adult Rats to Transient Oxidative Stress Induces Various Long-Lasting Alterations in Cognitive and Behavioral Functions	PLOS ONE			English	Article							TRANSPORTER KNOCKOUT MICE; INDUCED LOCOMOTOR-ACTIVITY; TERM SPATIAL MEMORY; CHRONIC MILD STRESS; GLUTATHIONE DEPLETION; DOPAMINE-TRANSPORTER; ANIMAL-MODEL; HYPERDOPAMINERGIC MICE; NUCLEUS ACCUMBENS; HABIT FORMATION	Exposure of neonates to oxidative stress may increase the risk of psychiatric disorders such as schizophrenia in adulthood. However, the effects of moderate oxidative stress on the adult brain are not completely understood. To address this issue, we systemically administrated 2-cyclohexen-1-one (CHX) to adult rats to transiently reduce glutathione levels. Repeated administration of CHX did not affect the acquisition or motivation of an appetitive instrumental behavior (lever pressing) rewarded by a food outcome under a progressive ratio schedule. In addition, response discrimination and reversal learning were not affected. However, acute CHX administration blunted the sensitivity of the instrumental performance to outcome devaluation, and this effect was prolonged in rats with a history of repeated CHX exposure, representing pro-depression-like phenotypes. On the other hand, repeated CHX administration reduced immobility in forced swimming tests and blunted acute cocaine-induced behaviors, implicating antidepressant-like effects. Multivariate analyses segregated a characteristic group of behavioral variables influenced by repeated CHX administration. Taken together, these findings suggest that repeated administration of CHX to adult rats did not cause a specific mental disorder, but it induced long-term alterations in behavioral and cognitive functions, possibly related to specific neural correlates.	[Iguchi, Yoshio; Kosugi, Sakurako; Nishikawa, Hiromi; Lin, Ziqiao; Minabe, Yoshio; Toda, Shigenobu] Kanazawa Univ, Sch Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9808641, Japan	Kanazawa University	Toda, S (corresponding author), Kanazawa Univ, Sch Med, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa 9808641, Japan.	yiguchi@med.kanazawa-u.ac.jp	Iguchi, Yoshio/R-3318-2019	Iguchi, Yoshio/0000-0001-8240-3345	Ministry of Education, Culture, Sports and Technology, Japan [20452097, 25860994, 24791208, 26860920, 25461727, 25116510, 26120712]; Eli Lilly; Japan Foundation for Neuroscience and Mental Health; Takeda Research Foundation; Matsubara Saburoh Memorial Research Foundation for Psychiatry	Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eli Lilly(Eli Lilly); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Takeda Research Foundation(Takeda Science Foundation (TSF)); Matsubara Saburoh Memorial Research Foundation for Psychiatry	This study was supported by Grants-in-Aids from the Ministry of Education, Culture, Sports and Technology, Japan (20452097 and 25860994 to YI; 24791208 to SK; 26860920 to HN; 25461727, 25116510, and 26120712 to ST), Eli Lilly (to YI), Japan Foundation for Neuroscience and Mental Health (to YI), Takeda Research Foundation (to ST) and Matsubara Saburoh Memorial Research Foundation for Psychiatry (to SK, ZL and YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; ASHER IM, 1974, BRAIN RES, V82, P1, DOI 10.1016/0006-8993(74)90888-9; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Castagne V, 2004, NEUROSCIENCE, V123, P821, DOI 10.1016/j.neuroscience.2003.11.012; Choy KHC, 2010, EUR J PHARMACOL, V649, P224, DOI 10.1016/j.ejphar.2010.09.035; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; CREESE I, 1975, BRAIN RES, V83, P419, DOI 10.1016/0006-8993(75)90834-3; Cruz-Aguado R, 2001, BRAIN RES BULL, V55, P327, DOI 10.1016/S0361-9230(01)00484-1; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Dean O, 2009, BEHAV BRAIN RES, V198, P258, DOI 10.1016/j.bbr.2008.11.017; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Garcia-Fuster MJ, 2010, EUR J NEUROSCI, V31, P79, DOI 10.1111/j.1460-9568.2009.07045.x; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groppetti A, 1974, BIOCH PHARM S1, V23, P756; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; Hilario MRF, 2008, FRONT NEUROSCI-SWITZ, V2, P208, DOI 10.3389/neuro.01.030.2008; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Johnson AW, 2013, P NATL ACAD SCI USA, V110, P12462, DOI 10.1073/pnas.1307925110; Kalivas PW, 2003, METH MOLEC MED, V79, P3; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Kulak A, 2012, BEHAV BRAIN RES, V226, P563, DOI 10.1016/j.bbr.2011.10.020; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lu RZ, 2009, NEUROCHEM INT, V55, P552, DOI 10.1016/j.neuint.2009.05.009; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; MASUKAWA T, 1989, LIFE SCI, V44, P417, DOI 10.1016/0024-3205(89)90266-X; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Perona MTG, 2008, BEHAV PHARMACOL, V19, P566, DOI 10.1097/FBP.0b013e32830cd80f; PIJNENBURG AJJ, 1975, PSYCHOPHARMACOLOGIA, V41, P87, DOI 10.1007/BF00421062; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prasad BM, 1995, ANN NY ACAD SCI, V771, P617, DOI 10.1111/j.1749-6632.1995.tb44714.x; R Core Team, 2012, R LANG ENV STAT COMP; Ramadan E, 2012, INT J NEUROSCI, V122, P373, DOI 10.3109/00207454.2012.665972; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Roberts D.C.S., 1992, ANIMAL MODELS DRUG A, P233, DOI [10.1385/0-89603-217-5:233, DOI 10.1385/0-89603-217-5:233]; Sasaoka T, 2012, CLIN EXP PHARMACOL P, V39, P597, DOI 10.1111/j.1440-1681.2012.05723.x; Schiavone S, 2013, ANTIOXID REDOX SIGN, V18, P1475, DOI 10.1089/ars.2012.4720; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2010, PSYCHONEUROENDOCRINO, V35, P977, DOI 10.1016/j.psyneuen.2009.12.010; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Shukitt-Hale B, 1998, FREE RADICAL BIO MED, V24, P1149, DOI 10.1016/S0891-5849(97)00399-7; Simeone A, 2011, MOL NEUROBIOL, V43, P107, DOI 10.1007/s12035-010-8148-y; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Suo L, 2013, NEUROPSYCHOPHARMACOL, V38, P1387, DOI 10.1038/npp.2013.67; Szumlinski KK, 2003, PSYCHOPHARMACOLOGY, V165, P329, DOI 10.1007/s00213-002-1274-0; Tagliari B, 2010, J NEURAL TRANSM, V117, P1067, DOI 10.1007/s00702-010-0445-0; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; WEST AP, 1990, PROG NEURO-PSYCHOPH, V14, P863, DOI 10.1016/0278-5846(90)90073-P; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	68	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114024	10.1371/journal.pone.0114024	http://dx.doi.org/10.1371/journal.pone.0114024			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489939	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300014
J	Liu, HL; Huang, CY; Chen, JY; Wang, HYJ; Chen, PY; Wei, KC				Liu, Hao-Li; Huang, Chiung-Yin; Chen, Ju-Yu; Wang, Hay-Yan Jack; Chen, Pin-Yuan; Wei, Kuo-Chen			Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma Treatment	PLOS ONE			English	Article							ANTITUMOR AGENT TEMOZOLOMIDE; GLIOBLASTOMA-MULTIFORME; HUMAN PLASMA; ADJUVANT TEMOZOLOMIDE; PHASE-III; RAT; DISRUPTION; RADIATION; TUMOR; DRUG	Focused ultrasound (FUS) exposure with the presence of microbubbles has been shown to transiently open the blood-brain barrier (BBB), and thus has potential to enhance the delivery of various kinds of therapeutic agents into brain tumors. The purpose of this study was to assess the preclinical therapeutic efficacy of FUS-BBB opening for enhanced temozolomide (TMZ) delivery in glioma treatment. FUS exposure with microbubbles was delivered to open the BBB of nude mice that were either normal or implanted with U87 human glioma cells. Different TMZ dose regimens were tested, ranging from 2.5 to 25 mg/kg. Plasma and brain samples were obtained at different time-points ranging from 0.5 to 4 hours, and the TMZ concentration within samples was quantitated via a developed LC-MS/MS procedure. Tumor progression was followed with T2-MRI, and animal survival and brain tissue histology were conducted. Results demonstrated that FUS-BBB opening caused the local TMZ accumulation in the brain to increase from 6.98 to 19 ng/mg. TMZ degradation time in the tumor core was found to increase from 1.02 to 1.56 hours. Improved tumor progression and animal survival were found at different TMZ doses (up to 15% and 30%, respectively). In conclusion, this study provides preclinical evidence that FUS-BBB opening increases the local concentration of TMZ to improve the control of tumor progression and animal survival, suggesting the potential for clinical application to improve current brain tumor treatment.	[Liu, Hao-Li; Chen, Ju-Yu] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Huang, Chiung-Yin; Chen, Pin-Yuan; Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Wang, Hay-Yan Jack] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Liu, Hao-Li] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; National Sun Yat Sen University; Chang Gung University	Liu, HL (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.	haoliliu@mail.cgu.edu.tw; kuochenwei@adm.cgmh.org.tw		Chen, Ju-Yu/0000-0001-8064-9392; Wei, Kuochen/0000-0003-3505-2196	Ministry of Science and Technology, Taiwan [101-2221-E-182-002-MY3, 102-2221-E-182-020-MY3, 103-2622-B-182A-001, 103-2325-B-182A-007]; Chang-Gung Memorial Hospital, Taiwan [CMRPD2A0031-33, CMRPG380041]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang-Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This research was supported by the Ministry of Science and Technology, Taiwan, grant nos. 101-2221-E-182-002-MY3, 102-2221-E-182-020-MY3, 103-2622-B-182A-001, 103-2325-B-182A-007, and Chang-Gung Memorial Hospital, Taiwan, grant nos. CMRPD2A0031-33 and CMRPG380041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SD, 1999, CLIN CANCER RES, V5, P309; BURGER PC, 1987, MAYO CLIN PROC, V62, P527, DOI 10.1016/S0025-6196(12)65479-2; Chowdhury SK, 1999, J PHARMACEUT BIOMED, V19, P659, DOI 10.1016/S0731-7085(98)00198-8; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Galanis E, 2000, BRIT J CANCER, V82, P1371, DOI 10.1054/bjoc.1999.1075; GROOTHUIS DR, 1982, J NEUROPATH EXP NEUR, V41, P164, DOI 10.1097/00005072-198203000-00006; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Grossman SA, 2003, J CLIN ONCOL, V21, P1485, DOI 10.1200/JCO.2003.10.035; Gupta Vinay, 2006, Neurosurg Focus, V20, pE20, DOI 10.3171/foc.2006.20.4.13; HALPERIN EC, 1988, INT J RADIAT ONCOL, V15, P505, DOI 10.1016/S0360-3016(98)90036-0; Hammond LA, 1999, J CLIN ONCOL, V17, P2604, DOI 10.1200/JCO.1999.17.8.2604; Hassouna I, 2008, INT J RADIAT ONCOL, V72, P927, DOI 10.1016/j.ijrobp.2008.06.1923; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2003, ACT NEUR S, V86, P555; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Kim H, 2001, J PHARMACEUT BIOMED, V24, P461, DOI 10.1016/S0731-7085(00)00466-0; Kim HK, 1997, J CHROMATOGR B, V703, P225, DOI 10.1016/S0378-4347(97)00431-3; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; NEUWELT EA, 1982, P NATL ACAD SCI-BIOL, V79, P4420, DOI 10.1073/pnas.79.14.4420; NEUWELT EA, 1986, NEUROSURGERY, V19, P573, DOI 10.1227/00006123-198610000-00011; NEUWELT EA, 1985, CANCER RES, V45, P2827; NEUWELT EA, 1986, CANCER, V58, P1609, DOI 10.1002/1097-0142(19861015)58:8<1609::AID-CNCR2820580805>3.0.CO;2-7; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Reyderman L, 2004, XENOBIOTICA, V34, P487, DOI 10.1080/00498250410001685737; SHEN F, 1995, J CHROMATOGR B, V667, P291, DOI 10.1016/0378-4347(95)00040-P; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; STEVENS MFG, 1987, CANCER RES, V47, P5846; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tralins KS, 2002, J NUCL MED, V43, P1667; Von Hoff DD, 2004, HDB ANTICANCER PHARM, P57992; Wei KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058995	35	63	65	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114311	10.1371/journal.pone.0114311	http://dx.doi.org/10.1371/journal.pone.0114311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490097	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300026
J	Qin, M; Liu, XY; Tang, XM; Suo, JX; Tao, GR; Suo, X				Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun			Transfection of Eimeria mitis with Yellow Fluorescent Protein as Reporter and the Endogenous Development of the Transgenic Parasite	PLOS ONE			English	Article							TOXOPLASMA-GONDII; TRANSIENT TRANSFECTION; STABLE TRANSFECTION; VACCINE DEVELOPMENT; FINE-STRUCTURE; TENELLA; EXPRESSION; COCCIDIOSIS; CHICKENS; MICROGAMETOGENESIS	Background: Advancements have been made in the genetic manipulation of apicomplexan parasites. Both the in vitro transient and in vivo stable transfection of Eimeria tenella have been developed successfully. Herein, we report the transient and stable transfection of Eimeria mitis. Methods and Findings: Sporozoites of E. mitis transfected with enhanced yellow fluorescent protein (EYFP) expression plasmid were inoculated into chickens via the cloacal route. The recovered fluorescent oocysts were sorted by fluorescence activated cell sorting (FACS) and then passaged 6 generations successively in chickens. The resulting population was analyzed by genome walking and Western blot. The endogenous development of the transgenic E. mitis was observed and its reproduction potential was tested. The stable transfection of E. mitis was developed. Genome walking confirmed the random integration of plasmid DNA into the genome; while Western blot analysis demonstrated the expression of foreign proteins. Constitutive expression of EYFP was observed in all stages of merogony, gametogony and sporogony. The peak of the transgenic oocyst output was delayed by 24 h and the total oocyst reproduction was reduced by 7-fold when compared to the parental strain. Conclusion: Stable transfection of E. mitis was successfully developed. The expression of foreign antigens in the transgenic parasites will facilitate the development of transgenic E. mitis as a vaccine vector.	[Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China; [Qin, Mei; Liu, Xian Yong; Tang, Xin Ming; Suo, Jing Xia; Tao, Ge Ru; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Liu, Xian Yong; Suo, Xun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Suo, X (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn		Tang, Xinming/0000-0003-0127-1235; LIU, XIANYONG/0000-0001-9425-6784	National Natural Science Foundation of China [31330076, 31001060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Key project, 31330076; 31001060).	Blake DP, 2014, TRENDS PARASITOL, V30, P12, DOI 10.1016/j.pt.2013.10.003; CHEN H, 2013, J PARASITOL RES, V2013, DOI DOI 10.1155/2013/591520; Clark JD, 2008, MOL BIOCHEM PARASIT, V162, P77, DOI 10.1016/j.molbiopara.2008.07.006; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; COLLEY FC, 1967, J PROTOZOOL, V14, P663, DOI 10.1111/j.1550-7408.1967.tb02059.x; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; FERGUSON DJP, 1977, ACTA PATH MICRO IM B, V85, P67; FERNANDO MA, 1973, Z PARASITENKD, V43, P33, DOI 10.1007/BF00329535; Fitz-Coy S, 1991, AVIAN DIS, V36, P44; FITZCOY SH, 1992, AVIAN DIS, V36, P718, DOI 10.2307/1591771; GOONEWARDENE R, 1993, P NATL ACAD SCI USA, V90, P5234, DOI 10.1073/pnas.90.11.5234; Hao LL, 2007, MOL BIOCHEM PARASIT, V153, P213, DOI 10.1016/j.molbiopara.2007.02.005; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Huang XX, 2011, J IMMUNOL, V187, P3595, DOI 10.4049/jimmunol.1100043; Jenkins M, 2010, AVIAN DIS, V54, P1002, DOI 10.1637/9137-111109-Reg.1; JOYNER LP, 1958, PARASITOLOGY, V48, P101, DOI 10.1017/S0031182000021090; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kelleher M, 1998, MOL BIOCHEM PARASIT, V97, P21, DOI 10.1016/S0166-6851(98)00128-5; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Lee SH, 2007, POULTRY SCI, V86, P63, DOI 10.1093/ps/86.1.63; Liu XY, 2008, MOL BIOCHEM PARASIT, V161, P72, DOI 10.1016/j.molbiopara.2008.06.006; Liu XY, 2013, VET PARASITOL, V193, P1, DOI 10.1016/j.vetpar.2012.12.019; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; MEHLHORN H, 1972, Z PARASITENK, V40, P151, DOI 10.1007/BF00329150; Michels MG, 2011, VET PARASITOL, V177, P55, DOI 10.1016/j.vetpar.2010.11.022; RUFF MD, 1982, AM J VET RES, V43, P507; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; SCHOLTYSECK E, 1972, Z PARASITENK, V38, P95, DOI 10.1007/BF00329023; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; SPEER CA, 1972, SCIENCE, V178, P763, DOI 10.1126/science.178.4062.763; Tyzzer EE, 1929, AM J HYG, V10, P0269, DOI 10.1093/oxfordjournals.aje.a112759; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013; Yin GW, 2013, PARASITOL RES, V112, P2105, DOI 10.1007/s00436-013-3307-5; Yin GW, 2011, INT J PARASITOL, V41, P813, DOI 10.1016/j.ijpara.2011.04.001; Zou J, 2009, INT J PARASITOL, V39, P1189, DOI 10.1016/j.ijpara.2009.03.006	39	17	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114188	10.1371/journal.pone.0114188	http://dx.doi.org/10.1371/journal.pone.0114188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490541	gold, Green Submitted, Green Published			2022-12-26	WOS:000347515300019
J	Tran, CH; Sugimoto, JD; Pulliam, JRC; Ryan, KA; Myers, PD; Castleman, JB; Doty, R; Johnson, J; Stringfellow, J; Kovacevich, N; Brew, J; Cheung, LL; Caron, B; Lipori, G; Harle, CA; Alexander, C; Yang, Y; Longini, IM; Halloran, ME; Morris, JG; Small, PA				Tran, Cuc H.; Sugimoto, Jonathan D.; Pulliam, Juliet R. C.; Ryan, Kathleen A.; Myers, Paul D.; Castleman, Joan B.; Doty, Randell; Johnson, Jackie; Stringfellow, Jim; Kovacevich, Nadia; Brew, Joe; Cheung, Lai Ling; Caron, Brad; Lipori, Gloria; Harle, Christopher A.; Alexander, Charles; Yang, Yang; Longini, Ira M., Jr.; Halloran, M. Elizabeth; Morris, J. Glenn, Jr.; Small, Parker A., Jr.			School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SCHOOLCHILDREN; CHILDREN; TECUMSEH; OUTBREAK	Background: School-located influenza vaccination (SLIV) programs can substantially enhance the sub-optimal coverage achieved under existing delivery strategies. Randomized SLIV trials have shown these programs reduce laboratory-confirmed influenza among both vaccinated and unvaccinated children. This work explores the effectiveness of a SLIV program in reducing the community risk of influenza and influenza-like illness (ILI) associated emergency care visits. Methods: For the 2011/12 and 2012/13 influenza seasons, we estimated age-group specific attack rates (AR) for ILI from routine surveillance and census data. Age-group specific SLIV program effectiveness was estimated as one minus the AR ratio for Alachua County versus two comparison regions: the 12 county region surrounding Alachua County, and all non-Alachua counties in Florida. Results: Vaccination of,50% of 5-17 year-olds in Alachua reduced their risk of ILI-associated visits, compared to the rest of Florida, by 79% (95% confidence interval: 70, 85) in 2011/12 and 71% (63, 77) in 2012/13. The greatest indirect effectiveness was observed among 0-4 year-olds, reducing AR by 89% (84, 93) in 2011/12 and 84% (79, 88) in 2012/13. Among all non-school age residents, the estimated indirect effectiveness was 60% (54, 65) and 36% (31, 41) for 2011/12 and 2012/13. The overall effectiveness among all age-groups was 65% (61, 70) and 46% (42, 50) for 2011/12 and 2012/13. Conclusion: Wider implementation of SLIV programs can significantly reduce the influenza-associated public health burden in communities.	[Tran, Cuc H.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Tran, Cuc H.; Sugimoto, Jonathan D.; Pulliam, Juliet R. C.; Ryan, Kathleen A.; Cheung, Lai Ling; Yang, Yang; Longini, Ira M., Jr.; Morris, J. Glenn, Jr.; Small, Parker A., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Tran, Cuc H.; Harle, Christopher A.] Univ Florida, Clin Translat Sci Inst, Gainesville, FL USA; [Sugimoto, Jonathan D.; Brew, Joe] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Sugimoto, Jonathan D.; Brew, Joe] Univ Florida, Coll Med, Dept Epidemiol, Gainesville, FL USA; [Sugimoto, Jonathan D.; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Pulliam, Juliet R. C.; Harle, Christopher A.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL USA; [Pulliam, Juliet R. C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Ryan, Kathleen A.; Small, Parker A., Jr.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Myers, Paul D.; Kovacevich, Nadia; Brew, Joe; Caron, Brad] Florida Dept Hlth Alachua Cty, Gainesville, FL USA; [Castleman, Joan B.] Univ Florida, Coll Nursing, Gainesville, FL 32611 USA; [Doty, Randell] Univ Florida, Coll Pharm, Gainesville, FL USA; [Johnson, Jackie] Alachua Cty Publ Sch, Gainesville, FL USA; [Stringfellow, Jim] Partnership Strong Families, Gainesville, FL USA; [Lipori, Gloria] Univ Florida Hlth Integrated Data Repository, UF Hlth, Gainesville, FL USA; [Harle, Christopher A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Alexander, Charles] Florida Dept Hlth, Tallahassee, FL USA; [Yang, Yang; Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Yang, Yang; Longini, Ira M., Jr.] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Small, Parker A., Jr.] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); State University System of Florida; University of Florida; Florida Department of Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Florida Department of Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	JGMorris@epi.ufl.edu	Brew, Joe R/K-6654-2017; Pulliam, Juliet RC/A-6516-2008	Brew, Joe R/0000-0002-4119-0117; Pulliam, Juliet RC/0000-0003-3314-8223; Sugimoto, Jonathan/0000-0002-1761-328X; Tran, Cuc/0000-0003-4798-8039	University of Florida Emerging Pathogens Institute; National Institutes of Health [NIH R37 AI032042, NIH U01 GM070749, NIH U54 GM111274, UL1 TR000064, TL1TR000066, KL2TR000065]; Alachua County Board of Commissioners Community Health Offering Innovative Care & Educational Services (CHOICES); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000065, TL1TR000066, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749, U54GM111274] Funding Source: NIH RePORTER	University of Florida Emerging Pathogens Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alachua County Board of Commissioners Community Health Offering Innovative Care & Educational Services (CHOICES); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by internal funding from the University of Florida Emerging Pathogens Institute and funding from the National Institutes of Health (NIH R37 AI032042, NIH U01 GM070749, NIH U54 GM111274 to J.D.S., Y.Y, I.M.L., M.E.H), (UL1 TR000064 & TL1TR000066 to C.H.T), (UL1 TR000064 & KL2TR000065 to C.A.H). The Alachua County School-located Influenza Vaccination program (Florida Department of Health in Alachua County) is supported by the Alachua County Board of Commissioners Community Health Offering Innovative Care & Educational Services (CHOICES), and vaccine reimbursement from private health insurance and Medicaid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONOVA E, 2014, VACCINE; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; *BUR EP FL DEP HLT, 2013, FLOR FLU REV 2012 20; *CDCP, 2013, MMWR RECOMM REP, V2013, P1; *CDCP, 2013, FLUVIEW WEB PORT NAT; Ding H., 2010, Morbidity and Mortality Weekly Report, V59, P477; Furlow Carolyn, 2011, Morbidity and Mortality Weekly Report, V60, P737; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Glezen WP, 2010, J INFECT DIS, V202, P1626, DOI 10.1086/657089; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Grijalva Carlos G, 2010, PLoS One, V5, pe15097, DOI 10.1371/journal.pone.0015097; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Halloran ME., 2010, DESIGN ANAL VACCINE; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2010, VACCINE, V28, P7737, DOI 10.1016/j.vaccine.2010.09.064; Kjos SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072243; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lu PJ, 2013, MMWR SURVEILL SUMM, V62, P1; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Pannaraj PS, 2014, CLIN INFECT DIS, V59, P325, DOI 10.1093/cid/ciu340; PEBODY R, 2014, EURO SURVEILL, V19; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; R Core Team, 2021, R LANGUAGE ENV STAT; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Stevenson M., 2014, EPIR R PACKAGE ANAL; Tran CH, 2010, BIOSECUR BIOTERROR, V8, P331, DOI 10.1089/bsp.2010.0029; *UK DEP HLTH JOINT, 2012, JVCI STAT ROUT ANN I; *US CENS BUR, 2010, CENS POP HOUS DEM PR, V1; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	33	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114479	10.1371/journal.pone.0114479	http://dx.doi.org/10.1371/journal.pone.0114479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489850	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300043
J	Cazamea-Catalan, D; Besseau, L; Falcon, J; Magnanou, E				Cazamea-Catalan, Damien; Besseau, Laurence; Falcon, Jack; Magnanou, Elodie			The Timing of Timezyme Diversification in Vertebrates	PLOS ONE			English	Article							ARYLALKYLAMINE N-ACETYLTRANSFERASE; WHOLE-GENOME DUPLICATION; MELATONIN SYNTHESIS; PINEAL ORGAN; PROVIDES EVIDENCE; CIRCADIAN CLOCKS; EC 2.3.1.87; EVOLUTION; AANAT; EXPRESSION	All biological functions in vertebrates are synchronized with daily and seasonal changes in the environment by the time keeping hormone melatonin. Its nocturnal surge is primarily due to the rhythmic activity of the arylalkylamine N-acetyl transferase AANAT, which thus became the focus of many investigations regarding its evolution and function. Various vertebrate isoforms have been reported from cartilaginous fish to mammals but their origin has not been clearly established. Using phylogeny and synteny, we took advantage of the increasing number of available genomes in order to test whether the various rounds of vertebrate whole genome duplications were responsible for the diversification of AANAT. We highlight a gene secondary loss of the AANAT2 in the Sarcopterygii, revealing for the first time that the AAANAT1/2 duplication occurred before the divergence between Actinopterygii (bony fish) and Sarcopterygii (tetrapods, lobe-finned fish, and lungfish). We hypothesize the teleost-specific whole genome duplication (WDG) generated the appearance of the AANAT1a/1b and the AANAT2/2'paralogs, the 2' isoform being rapidly lost in the teleost common ancestor (ray-finned fish). We also demonstrate the secondary loss of the AANAT1a in a Paracantopterygii (Atlantic cod) and of the 1b in some Ostariophysi (zebrafish and cave fish). Salmonids present an even more diverse set of AANATs that may be due to their specific WGD followed by secondary losses. We propose that vertebrate AANAT diversity resulted from 3 rounds of WGD followed by previously uncharacterized secondary losses. Extant isoforms show subfunctionalized localizations, enzyme activities and affinities that have increased with time since their emergence.	[Cazamea-Catalan, Damien; Besseau, Laurence; Falcon, Jack; Magnanou, Elodie] Univ Paris 06, Sorbonne Univ, Observ Oceanol, BIOM,UMR 7232, Banyuls Sur Mer, France; [Cazamea-Catalan, Damien; Besseau, Laurence; Falcon, Jack; Magnanou, Elodie] CNRS, BIOM, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Magnanou, E (corresponding author), Univ Paris 06, Sorbonne Univ, Observ Oceanol, BIOM,UMR 7232, Banyuls Sur Mer, France.	elodie.magnanou@obs-banyuls.fr	Besseau, Laurence/O-9942-2015	Besseau, Laurence/0000-0002-9617-8190; Magnanou, Elodie/0000-0002-8375-9682	Agence Nationale de la Recherche [ANR 07-BLAN-0097-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	Agence Nationale de la Recherche (grant number: ANR 07-BLAN-0097-01), JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allendorf F.W., 1984, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartell PA, 2007, J BIOL RHYTHM, V22, P515, DOI 10.1177/0748730407308167; Begay V, 1998, ENDOCRINOLOGY, V139, P905, DOI 10.1210/en.139.3.905; Benyassi A, 2000, NEUROREPORT, V11, P255, DOI 10.1097/00001756-200002070-00006; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Canestro C, 2013, SEMIN CELL DEV BIOL, V24, P83, DOI 10.1016/j.semcdb.2012.12.008; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cazamea-Catalan D, 2013, J EXP BIOL, V216, P1938, DOI 10.1242/jeb.080960; Cazamea-Catalan D, 2012, MOL ECOL, V21, P5027, DOI 10.1111/j.1365-294X.2012.05725.x; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; COLLIN JP, 1988, RECHERCHE, V19, P1154; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 1999, J BIOL CHEM, V274, P9076, DOI 10.1074/jbc.274.13.9076; Coon SL, 2001, J BIOL CHEM, V276, P24097, DOI 10.1074/jbc.M011298200; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Davies WL, 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a9780470022890, DOI 10.1002/9780470015902.A9780470022890]; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Drummond AJ, 2010, GENEIOUS V5 3; Ekstrom P, 2003, PHILOS T R SOC B, V358, P1679, DOI 10.1098/rstb.2003.1303; Falcon J, 1996, PFLUG ARCH EUR J PHY, V432, P386, DOI 10.1007/s004240050149; Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Falcon Jack, 2007, Journal de la Societe de Biologie, V201, P21, DOI 10.1051/jbio:2007003; Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002; Falcon J, 2014, P NATL ACAD SCI USA, V111, P314, DOI 10.1073/pnas.1312634110; Falcon J, 2009, ANN NY ACAD SCI, V1163, P101, DOI 10.1111/j.1749-6632.2009.04435.x; Ferry G, 2004, PROTEIN EXPRES PURIF, V38, P84, DOI 10.1016/j.pep.2004.07.004; Ferry G, 2000, J BIOL CHEM, V275, P8794, DOI 10.1074/jbc.275.12.8794; Froschauer A, 2006, CURR GENOMICS, V7, P43, DOI 10.2174/138920206776389766; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Isorna E, 2006, MOL CELL ENDOCRINOL, V252, P11, DOI 10.1016/j.mce.2006.03.032; Isorna E, 2011, J PINEAL RES, V51, P434, DOI 10.1111/j.1600-079X.2011.00907.x; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Iuvone PM, 2002, INVEST OPHTH VIS SCI, V43, P564; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Koop BF, 2008, GENOMICS GENOME DUPL, P77; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Opazo JC, 2013, MOL BIOL EVOL, V30, P140, DOI 10.1093/molbev/mss212; REITER RJ, 1991, ADV EXP MED BIOL, V294, P149; Ribelayga C, 2004, J PHYSIOL-LONDON, V554, P467, DOI 10.1113/jphysiol.2003.053710; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Shi Q, 2004, GEN COMP ENDOCR, V136, P311, DOI 10.1016/j.ygcen.2004.01.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosini G, 2012, EXP EYE RES, V103, P82, DOI 10.1016/j.exer.2012.08.009; VOISIN P, 1984, J BIOL CHEM, V259, P913; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Zilberman-Peled B, 2006, BRAIN RES, V1073, P220, DOI 10.1016/j.brainres.2005.12.028; Zilberman-Peled B, 2004, GEN COMP ENDOCR, V138, P139, DOI 10.1016/j.ygcen.2004.05.007; Zilberman-Peled B, 2011, MAR DRUGS, V9, P906, DOI 10.3390/md9050906	66	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112380	10.1371/journal.pone.0112380	http://dx.doi.org/10.1371/journal.pone.0112380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486407	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600010
J	De Vos, L; Steenkamp, ET; Martin, SH; Santana, QC; Fourie, G; van der Merwe, NA; Wingfield, MJ; Wingfield, BD				De Vos, Lieschen; Steenkamp, Emma T.; Martin, Simon H.; Santana, Quentin C.; Fourie, Gerda; van der Merwe, Nicolaas A.; Wingfield, Michael J.; Wingfield, Brenda D.			Genome-Wide Macrosynteny among Fusarium Species in the Gibberella fujikuroi Complex Revealed by Amplified Fragment Length Polymorphisms	PLOS ONE			English	Article							SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; MATING POPULATION; GENETIC-MAP; GRAMINEARUM; MAIZE; EVOLUTION; AFLP	The Gibberella fujikuroi complex includes many Fusarium species that cause significant losses in yield and quality of agricultural and forestry crops. Due to their economic importance, whole-genome sequence information has rapidly become available for species including Fusarium circinatum, Fusarium fujikuroi and Fusarium verticillioides, each of which represent one of the three main clades known in this complex. However, no previous studies have explored the genomic commonalities and differences among these fungi. In this study, a previously completed genetic linkage map for an interspecific cross between Fusarium temperatum and F. circinatum, together with genomic sequence data, was utilized to consider the level of synteny between the three Fusarium genomes. Regions that are homologous amongst the Fusarium genomes examined were identified using in silico and pyrosequenced amplified fragment length polymorphism (AFLP) fragment analyses. Homology was determined using BLAST analysis of the sequences, with 777 homologous regions aligned to F. fujikuroi and F. verticillioides. This also made it possible to assign the linkage groups from the interspecific cross to their corresponding chromosomes in F. verticillioides and F. fujikuroi, as well as to assign two previously unmapped supercontigs of F. verticillioides to probable chromosomal locations. We further found evidence of a reciprocal translocation between the distal ends of chromosome 8 and 11, which apparently originated before the divergence of F. circinatum and F. temperatum. Overall, a remarkable level of macrosynteny was observed among the three Fusarium genomes, when comparing AFLP fragments. This study not only demonstrates how in silico AFLPs can aid in the integration of a genetic linkage map to the physical genome, but it also highlights the benefits of using this tool to study genomic synteny and architecture.	[De Vos, Lieschen; Martin, Simon H.; Santana, Quentin C.; van der Merwe, Nicolaas A.; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, FABI, Dept Genet, ZA-0002 Pretoria, South Africa; [Steenkamp, Emma T.; Fourie, Gerda] Univ Pretoria, FABI, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	De Vos, L (corresponding author), Univ Pretoria, FABI, Dept Genet, Private Bag X20, ZA-0002 Pretoria, South Africa.	lieschen.bahlmann@up.ac.za	Steenkamp, Emma T/B-7958-2009; Wingfield, Michael J/A-9473-2008; Wingfield, Brenda D./B-1376-2008; Santana, Quentin C/D-4969-2009; De Vos, Lieschen/G-2328-2016; Martin, Simon H/H-4400-2019; Van der Merwe, Nicolaas A/A-9096-2008; Martin, Simon Henry/D-1410-2011	Steenkamp, Emma T/0000-0003-0217-8219; Wingfield, Brenda D./0000-0002-6189-1519; Santana, Quentin C/0000-0002-1178-2533; De Vos, Lieschen/0000-0001-9824-9768; van der Merwe, Albe/0000-0003-3185-348X; Fourie, Gerda/0000-0003-2650-5448; Martin, Simon Henry/0000-0002-0747-7456	University of Pretoria; Tree Protection Cooperative Program (TPCP); Mellon Foundation; National Research Foundation (NRF)/Department of Science and Technology (DST); Centre of Excellence in Tree Health Biotechnology (CTHB); THRIP initiative of the Department of Trade and Industry (DTI) in South Africa; National Research Foundation of South Africa [(UID) 83924]; NRF	University of Pretoria; Tree Protection Cooperative Program (TPCP); Mellon Foundation; National Research Foundation (NRF)/Department of Science and Technology (DST)(Department of Science & Technology (India)); Centre of Excellence in Tree Health Biotechnology (CTHB); THRIP initiative of the Department of Trade and Industry (DTI) in South Africa; National Research Foundation of South Africa(National Research Foundation - South Africa); NRF	Funding: The authors thank the University of Pretoria, members of the Tree Protection Cooperative Program (TPCP), the Mellon Foundation, the National Research Foundation (NRF)/Department of Science and Technology (DST), Centre of Excellence in Tree Health Biotechnology (CTHB) and the THRIP initiative of the Department of Trade and Industry (DTI) in South Africa for financial assistance. This work was based on the research supported in part by a number of grants from the National Research Foundation of South Africa (includes Grant specific unique reference number (UID) 83924). The Grant holders acknowledge that opinions, findings and conclusions or recommendations expressed in any publication generated by the NRF supported research are that of the author(s), and that the NRF accepts no liability whatsoever in this regard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BLACKWELL PUB PROF; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; De Vos L, 2007, FUNGAL GENET BIOL, V44, P701, DOI 10.1016/j.fgb.2007.02.007; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Desjardins AE, 2000, MYCOL RES, V104, P865, DOI 10.1017/S0953756299002002; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hane JK, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r45; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; Jurgenson JE, 2002, APPL ENVIRON MICROB, V68, P1972, DOI 10.1128/AEM.68.4.1972-1979.2002; Kvas M, 2009, FUNGAL DIVERS, V34, P1; Lee J, 2008, APPL ENVIRON MICROB, V74, P2349, DOI 10.1128/AEM.01866-07; Lind M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048347; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morrow CA, 2012, MBIO, V3, DOI 10.1128/mBio.00310-11; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Parkin IAP, 2002, GENOME, V45, P356, DOI 10.1139/G01-160; Peters JL, 2001, PLANT PHYSIOL, V127, P1579, DOI 10.1104/pp.010504; Revanna KV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-316; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rombauts S, 2003, BIOINFORMATICS, V19, P776, DOI 10.1093/bioinformatics/btg090; Scauflaire J, 2011, MYCOLOGIA, V103, P586, DOI 10.3852/10-135; Singh PK, 2010, J BIOSCIENCES, V35, P539, DOI 10.1007/s12038-010-0062-y; Steenkamp ET, 2001, MOL PLANT PATHOL, V2, P215, DOI 10.1046/j.1464-6722.2001.00072.x; Steenkamp ET, 2002, MYCOLOGIA, V94, P1032, DOI 10.2307/3761868; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wingfield BD, 2012, S AFR J SCI, V108, P104, DOI 10.4102/sajs.v108i1/2.537; Xu JR, 1996, GENETICS, V143, P175; XU JR, 1995, MOL PLANT MICROBE IN, V8, P74, DOI 10.1094/MPMI-8-0074	37	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114682	10.1371/journal.pone.0114682	http://dx.doi.org/10.1371/journal.pone.0114682			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486277	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600087
J	Li, Y; Rivera, CM; Ishll, H; Jin, FL; Selvaraj, S; Lee, AY; Dixon, JR; Ren, B				Li, Yan; Rivera, Chloe M.; Ishll, Haruhiko; Jin, Fulai; Selvaraj, Siddarth; Lee, Ah Young; Dixon, Jesse R.; Ren, Bing			CRISPR Reveals a Distal Super-Enhancer Required for Sox2 Expression in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							MASTER TRANSCRIPTION FACTORS; DEVELOPMENTAL REGULATORS; POLYCOMB; INTERACTOME; SEQUENCES; IDENTITY; DOMAINS; GENOMES; MAP	The pluripotency of embryonic stem cells (ESCs) is maintained by a small group of master transcription factors including Oct4, Sox2 and Nanog. These core factors form a regulatory circuit controlling the transcription of a number of pluripotency factors including themselves. Although previous studies have identified transcriptional regulators of this core network, the cis-regulatory DNA sequences required for the transcription of these key pluripotency factors remain to be defined. We analyzed epigenomic data within the 1.5 Mb gene-desert regions around the Sox2 gene and identified a 13kb-long super-enhancer (SE) located 100kb downstream of Sox2 in mouse ESCs. This SE is occupied by Oct4, Sox2, Nanog, and the mediator complex, and physically interacts with the Sox2 locus via DNA looping. Using a simple and highly efficient double-CRISPR genome editing strategy we deleted the entire 13-kb SE and characterized transcriptional defects in the resulting monoallelic and biallelic deletion clones with RNA-seq. We showed that the SE is responsible for over 90% of Sox2 expression, and Sox2 is the only target gene along the chromosome. Our results support the functional significance of a SE in maintaining the pluripotency transcription program in mouse ESCs.	[Li, Yan; Rivera, Chloe M.; Ishll, Haruhiko; Jin, Fulai; Selvaraj, Siddarth; Lee, Ah Young; Dixon, Jesse R.; Ren, Bing] Ludwig Inst Canc Res, San Diego, CA USA; [Rivera, Chloe M.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, San Diego, CA 92103 USA; [Dixon, Jesse R.] Univ Calif San Diego, Sch Med, Med Scientist Training Program, San Diego, CA 92103 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Cellular & Mol Med,Inst Genome Med, San Diego, CA 92103 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, San Diego, CA USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Jin, Fulai/0000-0003-0025-4337; Ishii, Haruhiko/0000-0002-1593-096X	Ludwig Institute for Cancer Research; US National Institutes of Health [U54 HG006997]; UCSD Genetics Training Program through National Institute of General Medical Sciences [T32 GM008666]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666, T32GM007198] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Genetics Training Program through National Institute of General Medical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work is supported by funds from the Ludwig Institute for Cancer Research, and US National Institutes of Health (U54 HG006997) to BR. CMR was supported in part by the UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences, T32 GM008666. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gribnau J, 2003, GENE DEV, V17, P759, DOI 10.1101/gad.1059603; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jin FL, 2011, TRANSCR-AUSTIN, V2, P226, DOI 10.4161/trns.2.5.17712; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zappone MV, 2000, DEVELOPMENT, V127, P2367	40	71	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114485	10.1371/journal.pone.0114485	http://dx.doi.org/10.1371/journal.pone.0114485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486255	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600060
J	Lee, S; Bountziouka, V; Lum, S; Stocks, J; Bonner, R; Naik, M; Fothergill, H; Wells, JCK				Lee, Simon; Bountziouka, Vassiliki; Lum, Sooky; Stocks, Janet; Bonner, Rachel; Naik, Mitesh; Fothergill, Helen; Wells, Jonathan C. K.			Ethnic Variability in Body Size, Proportions and Composition in Children Aged 5 to 11 Years: Is Ethnic-Specific Calibration of Bioelectrical Impedance Required?	PLOS ONE			English	Article							FAT-FREE MASS; PREDICTION EQUATIONS; 4-COMPONENT MODEL; PHYSICAL-ACTIVITY; AFRICAN-AMERICAN; INDEX; WATER; ADOLESCENTS; GIRLS; ANTHROPOMETRY	Background: Bioelectrical Impedance Analysis (BIA) has the potential to be used widely as a method of assessing body fatness and composition, both in clinical and community settings. BIA provides bioelectrical properties, such as whole-body impedance which ideally needs to be calibrated against a gold-standard method in order to provide accurate estimates of fat-free mass. UK studies in older children and adolescents have shown that, when used in multi-ethnic populations, calibration equations need to include ethnic-specific terms, but whether this holds true for younger children remains to be elucidated. The aims of this study were to examine ethnic differences in body size, proportions and composition in children aged 5 to 11 years, and to establish the extent to which such differences could influence BIA calibration. Methods: In a multi-ethnic population of 2171 London primary school-children (47% boys; 34% White, 29% Black African/Caribbean, 25% South Asian, 12% Other) detailed anthropometric measurements were performed and ethnic differences in body size and proportion were assessed. Ethnic differences in fat-free mass, derived by deuterium dilution, were further evaluated in a subsample of the population (n=698). Multiple linear regression models were used to calibrate BIA against deuterium dilution. Results: In children < 11 years of age, Black African/Caribbean children were significantly taller, heavier and had larger body size than children of other ethnicities. They also had larger waist and limb girths and relatively longer legs. Despite these differences, ethnic-specific terms did not contribute significantly to the BIA calibration equation (Fat-free mass=1.12+0.71*(height(2)/impedance)+0.18*weight). Conclusion: Although clear ethnic differences in body size, proportions and composition were evident in this population of young children aged 5 to 11 years, an ethnic-specific BIA calibration equation was not required.	[Lee, Simon; Bountziouka, Vassiliki; Lum, Sooky; Stocks, Janet; Bonner, Rachel] UCL Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, London, England; [Naik, Mitesh] Guys & St Thomas NHS Fdn Trust, London, England; [Fothergill, Helen] North Devon Dist Hosp, Barnstaple, Devon, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Lee, S (corresponding author), UCL Inst Child Hlth, Resp Crit Care & Anaesthesia Sect, London, England.	s.lee@ucl.ac.uk	Bountziouka, Vasiliki/I-6297-2018; Wells, Jonathan/A-4604-2009; Bountziouka, Vasiliki/S-6886-2019	Bountziouka, Vasiliki/0000-0003-2522-1582; Wells, Jonathan/0000-0003-0411-8025; Bountziouka, Vasiliki/0000-0003-2522-1582	Wellcome Trust [WT094129MA]; Asthma UK [10/013]; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network	Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Child Growth Foundation; National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust [WT094129MA], Asthma UK [10/013] and the Child Growth Foundation. The SLIC study team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basterfield L, 2014, J SCI MED SPORT; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Bouthoorn SH, 2014, OBESITY SILVER SPRIN; Bray GA, 2002, AM J CLIN NUTR, V76, P980, DOI 10.1093/ajcn/76.5.980; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Deurenberg P, 2002, EUR J CLIN NUTR, V56, P214, DOI 10.1038/sj.ejcn.1601303; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; Epstein AL, 1978, ETHOS IDENTITY 3 STU; Griffiths LJ, 2011, INT J PEDIATR OBES, V6, pE423, DOI 10.3109/17477166.2010.526221; Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d; Haroun D, 2010, OBESITY, V18, P1252, DOI 10.1038/oby.2009.344; Hattori K, 1997, AM J HUM BIOL, V9, P573, DOI 10.1002/(SICI)1520-6300(1997)9:5<573::AID-AJHB5>3.0.CO;2-V; HATTORI K, 1991, J ANTHROPOL SOC NIP, V99, P141; HOFFER EC, 1969, J APPL PHYSIOL, V27, P531, DOI 10.1152/jappl.1969.27.4.531; Horlick M, 2002, AM J CLIN NUTR, V76, P991, DOI 10.1093/ajcn/76.5.991; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kyle UG, 2003, CURR OPIN CLIN NUTR, V6, P387, DOI 10.1097/01.mco.0000078988.18774.3d; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Lindsay AR, 2014, J NUTR EDUC BEHAV, V46, P43, DOI 10.1016/j.jneb.2013.03.013; Lum S, 2014, EXPLORING ETHNIC DIF; Montagnese C, 2013, EUR J CLIN NUTR, V67, pS34, DOI 10.1038/ejcn.2011.213; National Obesity Observatory, 2009, BOD MASS IND MEAS OB; Newton RL, 2005, INT J OBESITY, V29, P594, DOI 10.1038/sj.ijo.0802968; Nightingale CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076426; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Norgan NG, 2005, PUBLIC HEALTH NUTR, V8, P1108, DOI 10.1079/PHN2005799; ORGAN LW, 1994, J APPL PHYSIOL, V77, P98, DOI 10.1152/jappl.1994.77.1.98; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Ramasubramanian L, 2013, CHILD CARE HLTH DEV, V39, P134, DOI 10.1111/j.1365-2214.2011.01325.x; Ramirez E, 2012, EUR J CLIN NUTR, V66, P1099, DOI 10.1038/ejcn.2012.89; Rush EC, 2003, EUR J CLIN NUTR, V57, P1394, DOI 10.1038/sj.ejcn.1601701; SCRIMGEOUR CM, 1993, BIOL MASS SPECTROM, V22, P383, DOI 10.1002/bms.1200220704; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Wells JCK, 2012, OBES REV, V13, P14, DOI 10.1111/j.1467-789X.2012.01034.x; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2000, INT J OBESITY, V24, P325, DOI 10.1038/sj.ijo.0801132; Wells JCK, 2008, ARCH DIS CHILD, V93, P168, DOI 10.1136/adc.2007.115741; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591; Wells JCK, 2010, AM J CLIN NUTR, V91, P610, DOI 10.3945/ajcn.2009.28428; Whitrow MJ, 2008, AM J RESP CRIT CARE, V177, P1262, DOI 10.1164/rccm.200706-867OC; Wu Y, 2001, J ADOLESCENT HEALTH, V28, P197, DOI 10.1016/S1054-139X(00)00163-4	45	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113883	10.1371/journal.pone.0113883	http://dx.doi.org/10.1371/journal.pone.0113883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478928	Green Published, gold			2022-12-26	WOS:000346907200036
J	Liu, XJ; Wang, BW; Zhao, M; Zhang, C; Chen, YH; Hu, CQ; Zhao, H; Wang, H; Chen, X; Tao, FB; Xu, DX				Liu, Xiao-Jing; Wang, Bi-Wei; Zhao, Mei; Zhang, Cheng; Chen, Yuan-Hua; Hu, Chun-Qiu; Zhao, Hui; Wang, Hua; Chen, Xi; Tao, Fang-Biao; Xu, De-Xiang			Effects of Maternal LPS Exposure during Pregnancy on Metabolic Phenotypes in Female Offspring	PLOS ONE			English	Article							CATCH-UP GROWTH; INTRAUTERINE FETAL-DEATH; FATTY LIVER-DISEASE; FOR-GESTATIONAL-AGE; INCREASED SUSCEPTIBILITY; INSULIN SENSITIVITY; PRETERM DELIVERY; BIRTH-WEIGHT; GLUCOSE-TOLERANCE; N-ACETYLCYSTEINE	It is increasingly recognized that intra-uterine growth restriction (IUGR) is associated with an increased risk of metabolic disorders in late life. Previous studies showed that mice exposed to LPS in late gestation induced fetal IUGR. The present study investigated the effects of maternal LPS exposure during pregnancy on metabolic phenotypes in female adult offspring. Pregnant mice were intraperitoneally injected with LPS (50 mg/kg) daily from gestational day (GD) 15 to GD17. After lactation, female pups were fed with standard-chow diets (SD) or high-fat diets (HFD). Glucose tolerance test (GTT) and insulin tolerance test (ITT) were assessed 8 and 12 weeks after diet intervention. Hepatic triglyceride content was examined 12 weeks after diet intervention. As expected, maternal LPS exposure during pregnancy resulted in fetal IUGR. Although there was an increasing trend on fat mass in female offspring whose dams were exposed to LPS during pregnancy, maternal LPS exposure during pregnancy did not elevate the levels of fasting blood glucose and serum insulin and hepatic triglyceride content in female adult offspring. Moreover, maternal LPS exposure during pregnancy did not alter insulin sensitivity in adipose tissue and liver in female adult offspring. Further analysis showed that maternal LPS exposure during pregnancy did not exacerbate HFD-induced glucose tolerance and insulin resistance in female adult offspring. In addition, maternal LPS exposure during pregnancy did not aggravate HFD-induced elevation of hepatic triglyceride content in female adult offspring. In conclusion, LPS-induced IUGR does not alter metabolic phenotypes in adulthood.	[Liu, Xiao-Jing; Wang, Bi-Wei; Zhang, Cheng; Chen, Yuan-Hua; Hu, Chun-Qiu; Wang, Hua; Xu, De-Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Peoples R China; [Liu, Xiao-Jing; Zhao, Mei; Chen, Yuan-Hua; Wang, Hua; Tao, Fang-Biao; Xu, De-Xiang] Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China; [Liu, Xiao-Jing; Chen, Xi] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China; [Zhao, Hui] Anhui Med Univ, Affiliated Hosp 2, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China.	fbtao@126.com; xudex@126.com			National Natural Science Foundation of China [81172711, 81100449]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by National Natural Science Foundation of China (81172711, 81100449). The funders contributed to study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bol VV, 2009, AM J PHYSIOL-REG I, V297, pR291, DOI 10.1152/ajpregu.90497.2008; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Cao L, 2012, ENDOCRINOLOGY, V153, P4955, DOI 10.1210/en.2012-1349; Chen YH, 2012, J IMMUNOL, V189, P454, DOI 10.4049/jimmunol.1103579; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Crume TL, 2014, OBESITY, V22, P608, DOI 10.1002/oby.20565; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Rubio APD, 2014, J PINEAL RES, V56, P154, DOI 10.1111/jpi.12108; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Guo Y, 2013, TOXICOL LETT, V221, P212, DOI 10.1016/j.toxlet.2013.06.238; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Park SY, 2012, INT J OBESITY, V36, P273, DOI 10.1038/ijo.2011.83; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Rivera DL, 1998, FASEB J, V12, P189, DOI 10.1096/fasebj.12.2.189; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Schmitz T, 2007, J IMMUNOL, V178, P1115, DOI 10.4049/jimmunol.178.2.1115; Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Shen L, 2014, TOXICOL APPL PHARM, V274, P263, DOI 10.1016/j.taap.2013.11.009; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006; Wolf G, 2003, NUTR REV, V61, P176, DOI 10.1301/nr.2003.may.176-179; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; Xu DX, 2006, AM J OBSTET GYNECOL, V195, P1707, DOI 10.1016/j.ajog.2006.03.047; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027; Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082713; Zhao M, 2014, TOXICOL LETT, V224, P201, DOI 10.1016/j.toxlet.2013.10.021; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	50	15	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114780	10.1371/journal.pone.0114780	http://dx.doi.org/10.1371/journal.pone.0114780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479255	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200127
J	Sun, HQ; Guo, DY; Su, YP; Yu, DM; Wang, QL; Wang, T; Zhou, Q; Ran, XZ; Zou, ZM				Sun, Huiqin; Guo, Deyu; Su, Yongping; Yu, Dongmei; Wang, Qingliang; Wang, Tao; Zhou, Qing; Ran, Xinze; Zou, Zhongmin			Hyperplasia of Pericytes Is One of the Main Characteristics of Microvascular Architecture in Malignant Glioma	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TUMOR ANGIOGENESIS; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-FACTOR; CANCER; HETEROGENEITY; GROWTH; PROLIFERATION; TUMORIGENESIS; VASCULATURE	Objectives: To investigate the role of pericytes in constructing the malformed microvessels (MVs) and participating microvascular architecture heterogeneity of glioma. Methods: Forty human glioma tissue samples (WHO grade II-IV) were included in present study. Observation of blood vessel patterns, quantitative analysis of endothelial cells (ECs)-and pericyte-labeled MVs and comparison between malignant grades based on single-or double-immunohistochemical staining. The MV number density (MVND), microvascular pericyte number density (MPND), and microvascular pericyte area density (MPAD) were calculated. The expression of PDGF beta was also scored after immunostaining. Results: In grade II glioma, most of tumor MVs were the thin-wall CD34(+) vessels with near normal morphology. In addition to thin-wall CD34(+) MVs, more thick-wall MVs were found in grade III glioma, which often showed alpha-SMA positive. Most of MVs in grade IV glioma were in the form of plexus, curled cell cords and glomeruloid microvascular proliferation while the alpha-SMA(+) cells were the main components. The MVs usually showed disordered arrangement, loose connection and active cell proliferation as shown by Ki67 and alpha-SMA coexpression. With the increase of glioma grades, the alpha-SMA(+) MVND, CD34(+) MVND and MPND were significantly augmented although the increase of CD34(+) MVND but not MPAD was statistically insignificant between grade III and IV. It was interesting that some vessel-like structures only consist of alpha-SMA(+) cells, assuming the guiding role of pericytes in angiogenesis. The expression level of PDGF beta was upregulated and directly correlated with the MPND in different glioma grades. Conclusion: Hyperplasia of pericytes was one of the significant characteristics of malignant glioma and locally proliferated pericytes were the main constituent of MVs in high grade glioma. The pathological characteristics of pericytes could be used as indexes of malignant grades of glioma.	[Sun, Huiqin; Su, Yongping; Wang, Tao; Zhou, Qing; Ran, Xinze] Third Mil Med Univ, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Coll Prevent Med, Chongqing, Peoples R China; [Sun, Huiqin; Guo, Deyu; Yu, Dongmei; Wang, Qingliang] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Sun, Huiqin; Guo, Deyu; Yu, Dongmei; Wang, Qingliang] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Sun, Huiqin; Guo, Deyu; Yu, Dongmei; Wang, Qingliang] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Zou, Zhongmin] Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Ministry of Education, China; Army Medical University	Sun, HQ (corresponding author), Third Mil Med Univ, Inst Combined Injury, State Key Lab Trauma Burns & Combined Injury, Coll Prevent Med, Chongqing, Peoples R China.	huiqinsun02@163.com; zmzou@tmmu.edu.cn			National Natural Science Foundation, China [30971141]; Medical Research Project of PLA [06H030]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Medical Research Project of PLA	This work was supported by the National Natural Science Foundation, China (URL:http://www.nsfc.gov.cn) (Grant No. 30971141), the Medical Research Project of PLA (06H030) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2008, CURR CANCER DRUG TAR, V8, P447, DOI 10.2174/156800908785699360; Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bian XW, 2006, J NEURO-ONCOL, V80, P211, DOI 10.1007/s11060-006-9167-4; Bian XW, 2004, INT IMMUNOPHARMACOL, V4, P1537, DOI 10.1016/j.intimp.2004.07.017; Cao Y, 2013, CANCER-AM CANCER SOC, V119, P313, DOI 10.1002/cncr.27746; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Eberhard A, 2000, CANCER RES, V60, P1388; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Hida K, 2013, CANCER SCI, V104, P1391, DOI 10.1111/cas.12251; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jouanneau E, 2008, NEUROSURGERY, V62, P31, DOI 10.1227/01.NEU.0000311060.65002.4E; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kalinski T, 2009, PATHOL RES PRACT, V205, P339, DOI 10.1016/j.prp.2008.12.008; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lebelt A, 2008, FOLIA HISTOCHEM CYTO, V46, P69, DOI 10.2478/v10042-008-0009-4; Liu AY, 2013, CURR BIOL, V23, pR565, DOI 10.1016/j.cub.2013.05.023; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mountzios G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054048; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nolte I, 2008, CLIN NEUROL NEUROSUR, V110, P339, DOI 10.1016/j.clineuro.2007.12.008; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Shih AH, 2006, CANCER LETT, V232, P139, DOI 10.1016/j.canlet.2005.02.002; Takeuchi H, 2010, J NEUROSURG, V113, P218, DOI 10.3171/2009.10.JNS08631; Tate MC, 2009, NEUROTHERAPEUTICS, V6, P447, DOI 10.1016/j.nurt.2009.04.001; Virgintino D, 2008, J VASC RES, V45, P129, DOI 10.1159/000109965; Wang CJ, 2009, APPL IMMUNOHISTO M M, V17, P530, DOI 10.1097/PAI.0b013e3181a13bf2; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; WESSELING P, 1995, J NEUROPATH EXP NEUR, V54, P304, DOI 10.1097/00005072-199505000-00003; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Zhong CJ, 2013, J GASTROENTEROL, V48, P601, DOI 10.1007/s00535-012-0689-6	38	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114246	10.1371/journal.pone.0114246	http://dx.doi.org/10.1371/journal.pone.0114246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478951	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200054
J	Tamosiunas, A; Luksiene, D; Baceviciene, M; Bernotiene, G; Radisauskas, R; Malinauskiene, V; Kranciukaite-Butylkiniene, D; Virviciute, D; Peasey, A; Bobak, M				Tamosiunas, Abdonas; Luksiene, Delia; Baceviciene, Migle; Bernotiene, Gailute; Radisauskas, Ricardas; Malinauskiene, Vilija; Kranciukaite-Butylkiniene, Daina; Virviciute, Delia; Peasey, Anne; Bobak, Martin			Health Factors and Risk of All-Cause, Cardiovascular, and Coronary Heart Disease Mortality: Findings from the MONICA and HAPIEE Studies in Lithuania	PLOS ONE			English	Article							LIFE EXPECTANCY; MEN; WOMEN; PROFILE; ASSOCIATION; POPULATION; STROKE; SMOKING; TRENDS; IMPACT	Aims: This study investigated the trends and levels of the prevalence of health factors, and the association of all-cause and cardiovascular (CVD) mortality with healthy levels of combined risk factors among Lithuanian urban population. Methods: Data from five general population surveys in Kaunas, Lithuania, conducted between 1983 and 2008 were used. Healthy factors measured at baseline include non-smoking, normal weight, normal arterial blood pressure, normal level of total serum cholesterol, normal physical activity and normal level of fasting glucose. Among 9,209 men and women aged 45-64 (7,648 were free from coronary heart disease (CHD) and stroke at baseline), 1,219 death cases from any cause, 589 deaths from CVD, and 342 deaths from CHD occurred during follow up. Cox proportional hazards regression was used to estimate the association between health factors and mortality from all causes, CVD and CHD. Results: Between 1983 and 2008, the proportion of subjects with 6 healthy levels of risk factors was higher in 2006-2008 than in 1983-1984 (0.6% vs. 0.2%; p=0.09), although there was a significant increase in fasting glucose and a decline in intermediate physical activity. Men and women with normal or intermediate levels of risk factors had significantly lower all-cause, CVD and CHD mortality risk than persons with high levels of risk factors. Subjects with 5-6 healthy factors had hazard ratio (HR) of CVD mortality 0.35 (95% confidence interval (CI) 0.15-0.83) compared to average risk in the whole population. The hazard ratio for CVD mortality risk was significant in men (HR 0.34, 95% CI 0.12-0.97) but not in women (HR 0.38, 95% CI 0.09-1.67). Conclusions: An inverse association of most healthy levels of cardiovascular risk factors with risk of all-cause and CVD mortality was observed in this urban population-based cohort. A greater number of cardiovascular health factors were related with significantly lower risk of CVD mortality, particularly among men.	[Tamosiunas, Abdonas; Luksiene, Delia; Baceviciene, Migle; Bernotiene, Gailute; Radisauskas, Ricardas; Malinauskiene, Vilija; Kranciukaite-Butylkiniene, Daina; Virviciute, Delia] Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania; [Peasey, Anne; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England	Lithuanian University of Health Sciences; University of London; University College London	Tamosiunas, A (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania.	abdonas.tamosiunas@lsmuni.lt	Tamosiunas, Abdonas/AAD-4274-2021; Baceviciene, Migle/AAG-1246-2020; Radišauskas, Ričardas/AAT-8920-2021	Baceviciene, Migle/0000-0002-9819-2316; Radišauskas, Ričardas/0000-0002-1227-2674; Bobak, Martin/0000-0002-2633-6851; Peasey, Anne/0000-0001-7434-2079	Wellcome Trust [081081/Z/06/Z]; US National Institute on Aging [1R0I AG23522]; MacArthur Foundation (Health and Social Upheaval network); NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation (Health and Social Upheaval network); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HAPIEE study was funded by grants from the Wellcome Trust (grant no. 081081/Z/06/Z), the US National Institute on Aging (grant no. 1R0I AG23522), and by the MacArthur Foundation (Health and Social Upheaval network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, J HLTH WELFARE STAT; [Anonymous], 2013, HLTH BALT COUNTR 201; Artero EG, 2012, MAYO CLIN PROC, V87, P944, DOI 10.1016/j.mayocp.2012.07.015; Baceviciene M, 2012, MEDICINA-LITHUANIA, V48, P632, DOI 10.3390/medicina48120093; Byun W, 2010, MED SCI SPORT EXER, V42, P1632, DOI 10.1249/MSS.0b013e3181d43f29; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Carlsson AC, 2013, INT J CARDIOL, V168, P946, DOI 10.1016/j.ijcard.2012.10.045; Chiuve SE, 2011, JAMA-J AM MED ASSOC, V306, P62, DOI 10.1001/jama.2011.907; Clarke R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3513; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2009, CIRCULATION, V120, P1181, DOI 10.1161/CIRCULATIONAHA.108.835728; Giampaoli S, 2006, AM J EPIDEMIOL, V163, P893, DOI 10.1093/aje/kwj110; Grabauskas V, 2008, MEDICINA-LITHUANIA, V44, P633, DOI 10.3390/medicina44080082; Kurth T, 2006, ARCH INTERN MED, V166, P1403, DOI 10.1001/archinte.166.13.1403; Kuzmickiene I, 2013, CANCER EPIDEMIOL, V37, P133, DOI 10.1016/j.canep.2012.10.001; Lee CD, 2009, ARCH INTERN MED, V169, P2096, DOI 10.1001/archinternmed.2009.414; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Luksiene D, 2012, PREV MED, V55, P299, DOI 10.1016/j.ypmed.2012.08.002; Mendis S, 2011, WHO GLOBAL ATLAS CAR; Mitchell JA, 2010, AM HEART J, V160, P102, DOI 10.1016/j.ahj.2010.05.001; Norkus A., 2000, LITH ENDOCRINOL, V3, P234; Organization WH, 2009, GLOB HLTH RISKS MORT; Palmieri L, 2006, EUR J CARDIOV PREV R, V13, P562, DOI 10.1097/01.hjr.0000221866.27039.4b; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; Yamamoto T, 2008, CIRC J, V72, P545; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zeng Q, 2013, INT J CARDIOL, V167, P2311, DOI 10.1016/j.ijcard.2012.06.022	32	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114283	10.1371/journal.pone.0114283	http://dx.doi.org/10.1371/journal.pone.0114283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479610	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200066
J	Xu, XB; Bai, HQ; Liu, CP; Chen, EY; Chen, QG; Zhuang, JY; Shen, B				Xu, Xiangbin; Bai, Haiqi; Liu, Chaoping; Chen, Eryong; Chen, Qifeng; Zhuang, Jieyun; Shen, Bo			Genome-Wide Analysis of MicroRNAs and Their Target Genes Related to Leaf Senescence of Rice	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; INDUCED CELL-DEATH; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; STRESS RESPONSES; SMALL RNAS; SIGNAL-TRANSDUCTION; REGULATORY NETWORK; SALICYLIC-ACID	Grain production of rice (Oryza sativa L.) is a top priority in ensuring food security for human beings. One of the approaches to increase yield is to delay leaf senescence and to extend the available time for photosynthesis. MicroRNAs (miRNAs) are key regulators of aging and cellular senescence in eukaryotes. Here, to help understand their biological role in rice leaf senescence, we report identification of miRNAs and their putative target genes by deep sequencing of six small RNA libraries, six RNA-seq libraries and two degradome libraries from the leaves of two super hybrid rice, Nei-2-You 6 (N2Y6, age-resistant rice) and Liang-You-Pei 9 (LYP9, age-sensitive rice). In total 372 known miRNAs, 162 miRNA candidates and 1145 targets were identified. Compared with the expression of miRNAs in the leaves of LYP9, the numbers of miRNAs up-regulated and down-regulated in the leaves of N2Y6 were 47 and 30 at early stage of grain-filling, 21 and 17 at the middle stage, and 11 and 37 at the late stage, respectively. Six miRNA families, osa-miR159, osa-miR160 osa-miR164, osa-miR167, osa-miR172 and osa-miR1848, targeting the genes encoding APETALA2 (AP2), zinc finger proteins, salicylic acid-induced protein 19 (SIP19), auxin response factors (ARF) and NAC transcription factors, respectively, were found to be involved in leaf senescence through phytohormone signaling pathways. These results provided valuable information for understanding the miRNA-mediated leaf senescence of rice, and offered an important foundation for rice breeding.	[Xu, Xiangbin; Bai, Haiqi; Liu, Chaoping; Chen, Eryong; Chen, Qifeng; Shen, Bo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhuang, Jieyun] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Zhuang, JY (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	jz1803@hzcnc.com; bshen65@163.com	Zhuang, Jie-Yun/B-4131-2012; SHEN, BO/GOK-2179-2022	Zhuang, Jie-Yun/0000-0002-1439-5061; SHEN, BO/0000-0003-0490-2071	Natural Science Foundation of Zhejiang Province [LY12C06004]; National Key Technology RD Program [2011BAD35B02-03]; Program of Key Technology and Innovation Group of Zhejiang Province [2010R50024-6]; State Key Laboratory of Rice Biology [120124]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key Technology RD Program(National Key Technology R&D Program); Program of Key Technology and Innovation Group of Zhejiang Province; State Key Laboratory of Rice Biology	This work was supported by the Natural Science Foundation of Zhejiang Province (LY12C06004), the National Key Technology R&D Program (2011BAD35B02-03), the Program of Key Technology and Innovation Group of Zhejiang Province (2010R50024-6) and the State Key Laboratory of Rice Biology (120124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Choi DS, 2011, PLANT CELL, V23, P823, DOI 10.1105/tpc.110.082081; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076029; Guilfoyle TJ, 2010, J PLANT GROWTH REGUL, V10, P281; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jones B, 2010, PLANT CELL, V22, P2956, DOI 10.1105/tpc.110.074856; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Lim PO, 2003, TRENDS PLANT SCI, V8, P272, DOI 10.1016/S1360-1385(03)00103-1; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C., 2000, HYBRID RICE, V15, P4; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Masselink H, 2001, CANCER LETT, V171, P87, DOI 10.1016/S0304-3835(01)00631-0; Matsumura K, 2009, SUSTAIN SCI, V4, P301, DOI 10.1007/s11625-009-0077-1; Morcillo F, 2007, PLANTA, V226, P1353, DOI 10.1007/s00425-007-0574-3; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Rao MV, 2002, PLANT J, V32, P447, DOI 10.1046/j.1365-313X.2002.01434.x; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Roberts IN, 2006, PLANTA, V224, P1437, DOI 10.1007/s00425-006-0312-2; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shen Bo, 2007, Agricultural Sciences in China, V6, P17, DOI 10.1016/S1671-2927(07)60012-1; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song JB, 2012, PLANT CELL PHYSIOL, V53, P1283, DOI 10.1093/pcp/pcs080; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Wang RongFu, 2004, Acta Agronomica Sinica, V30, P393; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Xu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070959; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhou ZC, 2005, CHINESE AGR SCI B, V21, P184; Zou YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064770	64	24	32	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114313	10.1371/journal.pone.0114313	http://dx.doi.org/10.1371/journal.pone.0114313			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479006	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200072
J	Fan, DY; Zhu, W; Li, DJ; Ji, D; Wang, P				Fan, Dongyan; Zhu, Wei; Li, Dejun; Ji, De; Wang, Ping			Identification of a Novel Homozygous Mutation, TMPRSS3: c.535G > A, in a Tibetan Family with Autosomal Recessive Non-Syndromic Hearing Loss	PLOS ONE			English	Article							DEAFNESS; GENE; POPULATION; PHENOTYPE; CHINESE; PROTEIN	Different ethnic groups have distinct mutation spectrums associated with inheritable deafness. In order to identify the mutations responsible for congenital hearing loss in the Tibetan population, mutation screening for 98 deafness-related genes by microarray and massively parallel sequencing of captured target exons was conducted in one Tibetan family with familiar hearing loss. A homozygous mutation, TMPRSS3: c.535G>A, was identified in two affected brothers. Both parents are heterozygotes and an unaffected sister carries wild type alleles. The same mutation was not detected in 101 control Tibetan individuals. This missense mutation results in an amino acid change (p.Ala179Thr) at a highly conserved site in the scavenger receptor cysteine rich (SRCR) domain of the TMPRSS3 protein, which is essential for protein-protein interactions. Thus, this mutation likely affects the interactions of this transmembrane protein with extracellular molecules. According to our bioinformatic analyses, the TMPRSS3: c.535G>A mutation might damage protein function and lead to hearing loss. These data suggest that the homozygous mutation TMPRSS3: c.535G>A causes prelingual hearing loss in this Tibetan family. This is the first TMPRSS3 mutation found in the Chinese Tibetan population.	[Fan, Dongyan; Zhu, Wei; Wang, Ping] Jilin Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Changchun 130023, Jilin Province, Peoples R China; [Fan, Dongyan; Ji, De] Tibet Univ, Sch Med, Lhasa, Peoples R China; [Li, Dejun] Jilin Univ, Hosp 1, Ctr Prenatal Diag, Changchun 130023, Jilin Province, Peoples R China	Jilin University; Tibet University; Jilin University	Wang, P (corresponding author), Jilin Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Changchun 130023, Jilin Province, Peoples R China.	wang_ping@jlu.edu.cn			National Science Foundation of China [8116360]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (Grant No. 8116360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Zubair M, 2004, BMC Med Genet, V5, P24, DOI 10.1186/1471-2350-5-24; Ben-Yosef T, 2001, J MED GENET, V38, P396, DOI 10.1136/jmg.38.6.396; Charif M, 2012, BIOCHEM BIOPH RES CO, V419, P643, DOI 10.1016/j.bbrc.2012.02.066; Chung J, 2014, J MOL MED, V92, P651, DOI 10.1007/s00109-014-1128-3; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Eisen MD, 2007, CELL MOL LIFE SCI, V64, P566, DOI 10.1007/s00018-007-6417-3; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Fan D, 2013, CHINESE SCI J HEAR S, V11, P271; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Hutchin T, 2005, CLIN GENET, V68, P506, DOI 10.1111/j.1399-0004.2005.00539.x; Kim HJ, 2010, CLIN EXP OTORHINOLAR, V3, P65, DOI 10.3342/ceo.2010.3.2.65; Lee J, 2013, GENE, V532, P276, DOI 10.1016/j.gene.2013.07.108; Lee K, 2012, CLIN GENET, V82, P56, DOI 10.1111/j.1399-0004.2011.01695.x; Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629; Li Qi, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P893; Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159; Molina L, 2013, HUM MOL GENET, V22, P1289, DOI 10.1093/hmg/dds532; Ouyang XM, 2009, J HUM GENET, V54, P131, DOI 10.1038/jhg.2009.4; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Vozzi D, 2014, GENE, V542, P209, DOI 10.1016/j.gene.2014.03.033; Wattenhofer M, 2005, HUM GENET, V117, P528, DOI 10.1007/s00439-005-1332-x; Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030720	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114136	10.1371/journal.pone.0114136	http://dx.doi.org/10.1371/journal.pone.0114136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474651	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500116
J	Hina, S; Mustafa, M; Hayat, T				Hina, Sadia; Mustafa, Meraj; Hayat, Tasawar			Peristaltic Motion of Johnson-Segalman Fluid in a Curved Channel with Slip Conditions	PLOS ONE			English	Article							INDUCED MAGNETIC-FIELD; WALL PROPERTIES; MASS-TRANSFER; ASYMMETRIC CHANNEL; MAXWELL FLUID; HEAT-TRANSFER; GRADE FLUID; FLOW; TRANSPORT	Slip effects on the peristaltic transport of Johnson-Segalman fluid through a curved channel have been addressed. The influence of wall properties is also analyzed. Long wavelength and low Reynolds number assumptions have been utilized in the mathematical formulation of the problem. The equations so formed have been solved numerically by shooting method through computational software Mathematica 8. In addition the analytic solution for small Weissenberg number (elastic parameter) is computed through a regular perturbation method. An excellent agreement is noticed between the two solutions. The results indicate an increase in the magnitude of velocity with an intensification in the slip effect. Moreover the size and circulation of the trapped boluses increase with an increase in the slip parameter. Unlike the planar channel, the profiles of axial velocity are not symmetric about the central line of the channel.	[Hina, Sadia] Fatima Jinnah Women Univ, Dept Math Sci, Rawalpindi, Pakistan; [Mustafa, Meraj] Natl Univ Sci & Technol, Sch Nat Sci, Islamabad, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Hina, S (corresponding author), Fatima Jinnah Women Univ, Dept Math Sci, Rawalpindi, Pakistan.	quaidan85@yahoo.com	Hina, Sadia/AAE-7053-2019; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Mustafa Hashmi, Meraj/P-1769-2014	Hina, Sadia/0000-0001-8066-0399				Ali N, 2008, PHYS LETT A, V372, P1477, DOI 10.1016/j.physleta.2007.09.061; Ali N, 2010, EUR J MECH B-FLUID, V29, P387, DOI 10.1016/j.euromechflu.2010.04.002; Ali N, 2010, INT J HEAT MASS TRAN, V53, P3319, DOI 10.1016/j.ijheatmasstransfer.2010.02.036; Ali N, 2010, Z NATURFORSCH A, V65, P191, DOI 10.1515/zna-2010-0306; Ali N, 2009, CHAOS SOLITON FRACT, V39, P407, DOI 10.1016/j.chaos.2007.04.010; Davies C, 1997, J FLUID MECH, V352, P205, DOI 10.1017/S0022112097007313; Ebaid A, 2008, PHYS LETT A, V372, P4493, DOI 10.1016/j.physleta.2008.04.031; Ebaid A, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/172590; Elnaby MAA, 2008, COMMUN NONLINEAR SCI, V13, P752, DOI 10.1016/j.cnsns.2006.07.007; Elshahed M, 2005, MATH PROBL ENG, P663, DOI 10.1155/MPE.2005.663; Gad NS, 2011, APPL MATH COMPUT, V217, P4313, DOI 10.1016/j.amc.2010.08.016; Haroun MH, 2006, MATH PROBL ENG, V2006, DOI 10.1155/MPE/2006/61475; Hayat T, 2008, TRANSPORT POROUS MED, V74, P259, DOI 10.1007/s11242-007-9196-2; Hayat T, 2008, PHYS LETT A, V372, P5026, DOI 10.1016/j.physleta.2008.03.065; Hayat T, 2003, MATH PROBL ENG, P1, DOI 10.1155/S1024123X03308014; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P5126, DOI 10.1016/j.ijheatmasstransfer.2011.07.036; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P1615, DOI 10.1016/j.ijheatmasstransfer.2010.11.022; Hayat T, 2010, NONLINEAR ANAL-REAL, V11, P3155, DOI 10.1016/j.nonrwa.2009.11.010; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P1526, DOI 10.1016/j.cnsns.2009.06.032; Hayat T, 2008, MATH COMPUT MODEL, V47, P380, DOI 10.1016/j.mcm.2007.04.012; Hina S, 2014, APPL MATH MECH-ENGL, V35, P73, DOI 10.1007/s10483-014-1773-7; Hina S, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4007433; Hina S, 2012, INT J HEAT MASS TRAN, V55, P3511, DOI 10.1016/j.ijheatmasstransfer.2012.03.014; Hina S, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4026168; Hina S, 2012, NONLINEAR ANAL-MODEL, V17, P297, DOI 10.15388/NA.17.3.14057; JAFFRIN MY, 1971, ANNU REV FLUID MECH, V3, P13, DOI 10.1146/annurev.fl.03.010171.000305; Kothandapani A, 2008, PHYS LETT A, V372, P1265, DOI 10.1016/j.physleta.2007.09.040; Kothandapani M, 2008, PHYS LETT A, V372, P4586, DOI 10.1016/j.physleta.2008.04.050; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Latham T., 1966, THESIS MIT PRESS CAM; Mekheimer KS, 2008, PHYS LETT A, V372, P4271, DOI 10.1016/j.physleta.2008.03.059; Mekheimer KS, 2008, PHYSICA A, V387, P2403, DOI 10.1016/j.physa.2007.12.017; MITTRA TK, 1973, J BIOMECH, V6, P681, DOI 10.1016/0021-9290(73)90024-9; Mustafa M, 2014, MECCANICA, V49, P521, DOI 10.1007/s11012-013-9809-5; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Muthu P, 2008, APPL MATH MODEL, V32, P2019, DOI 10.1016/j.apm.2007.06.034; Nadeem S, 2011, J TAIWAN INST CHEM E, V42, P58, DOI 10.1016/j.jtice.2010.03.006; Radhakrishnamacharya G, 2007, CR MECANIQUE, V335, P369, DOI 10.1016/j.crme.2007.05.002; Rao IJ, 1999, ACTA MECH, V132, P209, DOI 10.1007/BF01186968; Sato H., 2000, T JAPAN SOC MECH ENG, V66, P679; Srinivas S, 2011, COMMUN NONLINEAR SCI, V16, P1845, DOI 10.1016/j.cnsns.2010.08.004; Srinivas S, 2009, COMPUT PHYS COMMUN, V180, P2115, DOI 10.1016/j.cpc.2009.06.015; Srinivas S, 2009, APPL MATH COMPUT, V213, P197, DOI 10.1016/j.amc.2009.02.054; Srivastava VP, 1997, INT J ENG SCI, V35, P1359, DOI 10.1016/S0020-7225(97)00053-0; Wang YQ, 2007, THEOR COMP FLUID DYN, V21, P369, DOI 10.1007/s00162-007-0054-1	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114168	10.1371/journal.pone.0114168	http://dx.doi.org/10.1371/journal.pone.0114168			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474212	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500120
J	Yang, SC; Sung, PJ; Lin, CF; Kuo, J; Chen, CY; Hwang, TL				Yang, Shun-Chin; Sung, Ping-Jyun; Lin, Chwan-Fwu; Kuo, Jimmy; Chen, Chun-Yu; Hwang, Tsong-Long			Anti-Inflammatory Effects of Secondary Metabolites of Marine Pseudomonas sp in Human Neutrophils Are through Inhibiting P38 MAPK, JNK, and Calcium Pathways	PLOS ONE			English	Article							ACTIVATED HUMAN NEUTROPHILS; ELASTASE RELEASE; SUPEROXIDE-PRODUCTION; LUNG INJURY; KINASE; INFLAMMATION; SHOCK; IDENTIFICATION; INNATE; SITES	Activated neutrophils play a significant role in the pathogenesis of many inflammatory diseases. The metabolites of marine microorganisms are increasingly employed as sources for developing new drugs; however, very few marine drugs have been studied in human neutrophils. Herein, we showed that secondary metabolites of marine Pseudomonas sp. (N11) significantly inhibited superoxide anion generation and elastase release in formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-activated human neutrophils, with IC50 values of 0.67 +/- 0.38 mg/ml and 0.84 +/- 0.12 mg/ml, respectively. In cell-free systems, neither superoxide anion-scavenging effect nor inhibition of elastase activity was associated with the suppressive effects of N11. N11 inhibited the phosphorylation of p38 MAP kinase and JNK, but not Erk and Akt, in FMLP-induced human neutrophils. Also, N11 dose-dependently attenuated the transient elevation of intracellular calcium concentration in activated neutrophils. In contrast, N11 failed to alter phorbol myristate acetate-induced superoxide anion generation, and the inhibitory effects of N11 were not reversed by protein kinase A inhibitor. In conclusion, the anti-inflammatory effects of N11 on superoxide anion generation and elastase release in activated human neutrophils are through inhibiting p38 MAP kinase, JNK, and calcium pathways. Our results suggest that N11 has the potential to be developed to treat neutrophil-mediated inflammatory diseases.	[Yang, Shun-Chin] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Yang, Shun-Chin] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Dept Life Sci, Pingtung, Taiwan; [Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Grad Inst Biotechnol, Pingtung, Taiwan; [Lin, Chwan-Fwu] Chang Gung Univ Sci & Technol, Dept Cosmet Sci, Taoyuan, Taiwan; [Lin, Chwan-Fwu] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Kuo, Jimmy] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Chen, Chun-Yu] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Chen, Chun-Yu] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Sch Tradit Med, Coll Med, Taoyuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan	Chang Gung University; Taipei Veterans General Hospital; National Dong Hwa University; National Dong Hwa University; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; National Museum of Marine Biology & Aquarium; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Hwang, TL (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Sch Tradit Med, Coll Med, Taoyuan, Taiwan.	htl@mail.cgu.edu.tw	Hwang, Tsong-Long/AAE-6944-2020; Sung, Ping-Jyun/Z-4162-2019; Poubelle, Patrice E/G-6537-2013	Hwang, Tsong-Long/0000-0002-5780-3977; 	Ministry of Education [EMRPD1D901]; National Science Council [NSC 100-2628-B-182-001-MY3]; Taipei Veterans General Hospital [V103B-029]; Chang Gung Memorial Hospital, Taiwan [CMRPG3C1381, CMRPD1D0281]	Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This research was supported by the grant from the Ministry of Education (EMRPD1D901), National Science Council (NSC 100-2628-B-182-001-MY3), Taipei Veterans General Hospital (V103B-029), and Chang Gung Memorial Hospital (CMRPG3C1381, CMRPD1D0281), Taiwan. The funders had no role in study design, data collection and analysis, decision	Aikawa N, 2011, PULM PHARMACOL THER, V24, P549, DOI 10.1016/j.pupt.2011.03.001; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Chang HL, 2008, EUR J PHARMACOL, V586, P332, DOI 10.1016/j.ejphar.2008.02.041; Chen CY, 2014, FREE RADICAL BIO MED, V72, P222, DOI 10.1016/j.freeradbiomed.2014.04.018; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen YH, 2011, MAR DRUGS, V9, P934, DOI 10.3390/md9060934; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fumagalli L, 2013, J IMMUNOL, V190, P3648, DOI 10.4049/jimmunol.1201951; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Hwang TL, 2012, TOXICOL APPL PHARM, V260, P193, DOI 10.1016/j.taap.2012.02.011; Hwang TL, 2010, BIOCHEM PHARMACOL, V80, P1190, DOI 10.1016/j.bcp.2010.06.028; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kovach MA, 2012, CURR OPIN INFECT DIS, V25, P321, DOI 10.1097/QCO.0b013e3283528c9b; Kugelberg E, 2014, NAT REV IMMUNOL, V14, P430, DOI 10.1038/nri3703; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Li YS, 2013, J MOL MED, V91, P781, DOI 10.1007/s00109-013-1005-5; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Lomas DA, 2012, J CLIN PHARMACOL, V52, P416, DOI 10.1177/0091270010397050; Maaty WS, 2013, J BIOL CHEM, V288, P27042, DOI 10.1074/jbc.M113.484113; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McNamara CE, 2005, J NAT PROD, V68, P1431, DOI 10.1021/np050171n; Menezes GB, 2011, PHARMACOL THERAPEUT, V132, P204, DOI 10.1016/j.pharmthera.2011.07.002; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Pearce AN, 2007, J NAT PROD, V70, P936, DOI 10.1021/np060626o; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Rupesh KR, 2012, TOXICOL IN VITRO, V26, P571, DOI 10.1016/j.tiv.2012.01.023; Sansom CE, 2007, J NAT PROD, V70, P2042, DOI 10.1021/np070436t; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Simard JC, 2010, J LEUKOCYTE BIOL, V87, P905, DOI 10.1189/jlb.1009676; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sung PJ, 2004, CHEM PHARM BULL, V52, P1504, DOI 10.1248/cpb.52.1504; Taori K, 2007, J NAT PROD, V70, P1593, DOI 10.1021/np0702436; Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008; Verhein KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075351; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vinothkumar S, 2013, BIOTECHNOL ADV, V31, P1826, DOI 10.1016/j.biotechadv.2013.02.006; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wei WC, 2013, MAR DRUGS, V11, P4083, DOI 10.3390/md11104083; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Yang SC, 2013, MOLECULES, V18, P6455, DOI 10.3390/molecules18066455; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41; Ye SH, 2012, CARBOHYD POLYM, V87, P764, DOI 10.1016/j.carbpol.2011.08.057; Yu HP, 2011, FREE RADICAL BIO MED, V50, P1737, DOI 10.1016/j.freeradbiomed.2011.03.026; Yu HP, 2009, BIOCHEM PHARMACOL, V78, P983, DOI 10.1016/j.bcp.2009.06.008; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	58	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114761	10.1371/journal.pone.0114761	http://dx.doi.org/10.1371/journal.pone.0114761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474595	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500055
J	Fishel, ML; Wu, X; Devlin, CM; Logsdon, DP; Jiang, YL; Luo, MH; He, Y; Yu, ZS; Tong, Y; Lipking, KP; Maitra, A; Rajeshkumar, NV; Scandura, G; Kelley, MR; Ivan, M				Fishel, Melissa L.; Wu, Xue; Devlin, Cecilia M.; Logsdon, Derek P.; Jiang, Yanlin; Luo, Meihua; He, Ying; Yu, Zhangsheng; Tong, Yan; Lipking, Kelsey P.; Maitra, Anirban; Rajeshkumar, N. V.; Scandura, Glenda; Kelley, Mark R.; Ivan, Mircea			Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 (APE1/Ref-1) Redox Function Negatively Regulates NRF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hypoxia; Nuclear Factor 2 (Erythroid-derived 2-like Factor) (NFE2L2) (Nrf2); Reactive Oxygen Species (ROS); Redox Signaling; Transcription Factor; APE1; Ref-1; HMOX1; Pancreatic Adenocarcinoma	SIGNALING PROTEIN APE1/REF-1; PANCREATIC-CANCER CELLS; OXYGENASE-1 HO-1 INHIBITORS; HEME OXYGENASE-1; DNA-REPAIR; TUMOR-GROWTH; TRANSCRIPTION FACTORS; GENE-EXPRESSION; RESISTANCE; INDUCTION	Background: The redox activity of Ref-1 activates the binding of several transcription factors important in cancer. Results: Repression of Ref-1 potently activates NRF2 resulting in up-regulation of target gene expression. Conclusion: Activation of NRF2 is a potential mechanism of resistance to therapies based on Ref-1 inhibition. Significance: Dual blockade of Ref-1 and NRF2 or the specific downstream target, HMOX-1, represents a strategy for overcoming resistance. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) (henceforth referred to as Ref-1) is a multifunctional protein that in addition to its base excision DNA repair activity exerts redox control of multiple transcription factors, including nuclear factor -light chain enhancer of activated B cells (NF-B), STAT3, activator protein-1 (AP-1), hypoxia-inducible factor-1 (HIF-1), and tumor protein 53 (p53). In recent years, Ref-1 has emerged as a promising therapeutic target in cancer, particularly in pancreatic ductal carcinoma. Although a significant amount of research has centered on Ref-1, no wide-ranging approach had been performed on the effects of Ref-1 inhibition and transcription factor activity perturbation. Starting with a broader approach, we identified a previously unsuspected effect on the nuclear factor erythroid-related factor 2 (NRF2), a critical regulator of cellular defenses against oxidative stress. Based on genetic and small molecule inhibitor-based methodologies, we demonstrated that repression of Ref-1 potently activates NRF2 and its downstream targets in a dose-dependent fashion, and that the redox, rather than the DNA repair function of Ref-1 is critical for this effect. Intriguingly, our results also indicate that this pathway does not involve reactive oxygen species. The link between Ref-1 and NRF2 appears to be present in all cells tested in vitro, noncancerous and cancerous, including patient-derived tumor samples. In particular, we focused on understanding the implications of the novel interaction between these two pathways in primary pancreatic ductal adenocarcinoma tumor cells and provide the first evidence that this mechanism has implications for overcoming the resistance against experimental drugs targeting Ref-1 activity, with clear translational implications.	[Fishel, Melissa L.; Jiang, Yanlin; Luo, Meihua; He, Ying; Kelley, Mark R.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Fishel, Melissa L.; Logsdon, Derek P.; Luo, Meihua; Kelley, Mark R.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Wu, Xue; Ivan, Mircea] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Devlin, Cecilia M.; Scandura, Glenda; Ivan, Mircea] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Yu, Zhangsheng; Tong, Yan] Indiana Univ, Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Lipking, Kelsey P.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Maitra, Anirban; Rajeshkumar, N. V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Maitra, Anirban; Rajeshkumar, N. V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; Johns Hopkins University	Fishel, ML (corresponding author), 1044 W Walnut St,Rm 4-321, Indianapolis, IN 46202 USA.	mfishel@iu.edu; mivan@iu.edu	Fishel, Melissa L./AAH-6608-2020; Wu, Xue/AAJ-9340-2020; Ivan, Mircea/A-8109-2012	Fishel, Melissa L./0000-0002-9436-6382; Wu, Xue/0000-0002-0511-9436; Kelley, Mark/0000-0002-6120-9532; Ivan, Mircea/0000-0003-3424-6642	National Institutes of Health [NCI CA167291, NCI 1R01 CA155332-01, CA121168, CA121168S1, CA167291]; Riley Children's Foundation; Indiana University Simon Cancer Center Indiana Translational Research Acceleration Collaboration (IUSCC ITRAC); Stand Up to Cancer Dream Team Translational Research Grant [SU2C-AACR]; Program of the Entertainment Industry Foundation Grant [SU2C-AACR-DT0509]; NATIONAL CANCER INSTITUTE [R01CA167291, R01CA155332, R01CA121168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; Indiana University Simon Cancer Center Indiana Translational Research Acceleration Collaboration (IUSCC ITRAC); Stand Up to Cancer Dream Team Translational Research Grant; Program of the Entertainment Industry Foundation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants NCI CA167291 (to M. L. F.), NCI 1R01 CA155332-01 (to M. I.), CA121168, CA121168S1, and CA167291, and a grant from the Riley Children's Foundation (to M. R. K.), a grant from the Indiana University Simon Cancer Center Indiana Translational Research Acceleration Collaboration (IUSCC ITRAC) basic science pilot funding mechanism (to M. I. and M. L. F.), Stand Up to Cancer Dream Team Translational Research Grant SU2C-AACR and Program of the Entertainment Industry Foundation Grant SU2C-AACR-DT0509 (to N. V. R.).	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Cardoso AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047462; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Enomoto N, 2002, BIOCHEM BIOPH RES CO, V297, P346, DOI 10.1016/S0006-291X(02)02186-1; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fishel M. L., 2013, DNA BASE EXCISION RE; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2013, DNA REPAIR AND CANCER: FROM BENCH TO CLINIC, P233; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fishel ML, 2010, EXP HEMATOL, V38, P1178, DOI 10.1016/j.exphem.2010.08.011; Higgins LG, 2011, CHEM-BIOL INTERACT, V192, P37, DOI 10.1016/j.cbi.2010.09.025; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; Jiang YL, 2010, CANCER INVEST, V28, P885, DOI 10.3109/07357907.2010.512816; Jiwaji M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050521; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Meng D, 2010, TOXICOL APPL PHARM, V244, P291, DOI 10.1016/j.taap.2010.01.004; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; Pittala V, 2013, CURR MED CHEM, V20, P3711, DOI 10.2174/0929867311320300003; Rensing H, 2001, CRIT CARE MED, V29, P1962, DOI 10.1097/00003246-200110000-00019; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; Salerno L, 2013, BIOORGAN MED CHEM, V21, P5145, DOI 10.1016/j.bmc.2013.06.040; Sengupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068467; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/1381612811319150012; Tkachev VO, 2011, BIOCHEMISTRY-MOSCOW+, V76, P407, DOI 10.1134/S0006297911040031; Wang D, 2004, MOL CANCER THER, V3, P679; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7778; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang J, 2013, BIOCHEMISTRY-US, V52, P2955, DOI 10.1021/bi400179m; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	42	51	51	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3057	3068		10.1074/jbc.M114.621995	http://dx.doi.org/10.1074/jbc.M114.621995			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25492865	Green Published, hybrid			2022-12-26	WOS:000349310700042
J	Davis, AL; Qiao, SX; Lesson, JL; de la Vega, MR; Park, SL; Seanez, CM; Gokhale, V; Cabello, CM; Wondrak, GT				Davis, Angela L.; Qiao, Shuxi; Lesson, Jessica L.; de la Vega, Montserrat Rojo; Park, Sophia L.; Seanez, Carol M.; Gokhale, Vijay; Cabello, Christopher M.; Wondrak, Georg T.			The Quinone Methide Aurin Is a Heat Shock Response Inducer That Causes Proteotoxic Stress and Noxa-dependent Apoptosis in Malignant Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAF INHIBITOR RESISTANCE; HSP90 INHIBITOR; AURINTRICARBOXYLIC ACID; COMBINATION-THERAPY; CANCER; ACTIVATION; AUTOPHAGY; CHAPERONE; PROTEASOME; EXPRESSION	Pharmacological induction of proteotoxic stress is rapidly emerging as a promising strategy for cancer cell-directed chemotherapeutic intervention. Here, we describe the identification of a novel drug-like heat shock response inducer for the therapeutic induction of proteotoxic stress targeting malignant human melanoma cells. Screening a focused library of compounds containing redox-directed electrophilic pharmacophores employing the Stress & Toxicity PathwayFinder (TM) PCR Array technology as a discovery tool, a drug-like triphenylmethane-derivative (aurin; 4-[bis(p-hydroxyphenyl)methylene]-2,5-cyclohexadien-1-one) was identified as an experimental cell stress modulator that causes (i) heat shock factor transcriptional activation, (ii) up-regulation of heat shock response gene expression (HSPA6, HSPA1A, DNAJB4, HMOX1), (iii) early unfolded protein response signaling (phospho-PERK, phospho-eIF2 alpha, CHOP (CCAAT/enhancer-binding protein homologous protein)), (iv) proteasome impairment with increased protein-ubiquitination, and (v) oxidative stress with glutathione depletion. Fluorescence polarization-based experiments revealed that aurin displays activity as a geldanamycin-competitive Hsp90 alpha-antagonist, a finding further substantiated by molecular docking and ATPase inhibition analysis. Aurin exposure caused caspase-dependent cell death in a panel of human malignant melanoma cells (A375, G361, LOX-IMVI) but not in nonmalignant human skin cells (Hs27 fibroblasts, HaCaT keratinocytes, primary melanocytes) undergoing the aurin-induced heat shock response without impairment of viability. Aurin-induced melanoma cell apoptosis depends on Noxa up-regulation as confirmed by siRNA rescue experiments demonstrating that siPMAIP1-based target down-regulation suppresses aurin-induced cell death. Taken together, our data suggest feasibility of apoptotic elimination of malignant melanoma cells using the quinone methide-derived heat shock response inducer aurin.	Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA; [Wondrak, Georg T.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona; Arizona Center Cancer Care; University of Arizona	Wondrak, GT (corresponding author), Univ Arizona, Coll Pharm, 1515 North Campbell Ave, Tucson, AZ 85724 USA.	wondrak@pharmacy.arizona.edu		Park, Sophia L/0000-0002-1615-1749	National Institutes of Health [R01CA122484, R03CA167580, R21CA166926, ES007091, ES006694]; Arizona Cancer Center [CA023074]; NATIONAL CANCER INSTITUTE [R21CA166926, R03CA167580, R01CA122484, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007091, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA122484, R03CA167580, R21CA166926, ES007091, ES006694, and Arizona Cancer Center Support Grant CA023074. Preliminary data from this research were part of an oral presentation at the 19th Annual Meeting of the Society for Free Radical Biology and Medicine, November 17, 2012, San Diego, CA.	Acquaviva J, 2014, MOL CANCER THER, V13, P353, DOI 10.1158/1535-7163.MCT-13-0481; Armstrong JL, 2011, CLIN CANCER RES, V17, P2216, DOI 10.1158/1078-0432.CCR-10-3003; Bair WB, 2010, MELANOMA RES, V20, P85, DOI 10.1097/CMR.0b013e3283364903; Cabello CM, 2012, INVEST NEW DRUG, V30, P1289, DOI 10.1007/s10637-011-9676-7; Cabello CM, 2009, BIOCHEM PHARMACOL, V78, P344, DOI 10.1016/j.bcp.2009.04.016; Cabello CM, 2009, BIOCHEM PHARMACOL, V77, P1125, DOI 10.1016/j.bcp.2008.12.002; Carta F, 2005, MELANOMA RES, V15, P235, DOI 10.1097/00008390-200508000-00002; Catalanotti F, 2012, CLIN CANCER RES, V18, P2420, DOI 10.1158/1078-0432.CCR-12-0626; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Coss RA, 2003, MOL CANCER THER, V2, P383; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Davis AL, 2013, INT J MOL SCI, V14, P4185, DOI 10.3390/ijms14024185; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Deichmann M, 2004, INT J ONCOL, V25, P259; Dobbelstein M, 2014, NAT REV DRUG DISCOV, V13, P179, DOI 10.1038/nrd4201; Flemming A, 2011, NAT REV DRUG DISCOV, V10, P491, DOI 10.1038/nrd3482; Foresti R, 2005, J PHARMACOL EXP THER, V312, P686, DOI 10.1124/jpet.104.074153; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garbe C, 2011, ONCOLOGIST, V16, P5, DOI 10.1634/theoncologist.2010-0190; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Hughes D, 2008, CANCER PREV RES, V1, P485, DOI 10.1158/1940-6207.CAPR-08-0149; Kalogeraki A, 2006, ANTICANCER RES, V26, P3551; Kandela IK, 2002, PHOTOCH PHOTOBIO SCI, V1, P309, DOI 10.1039/b110572h; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Klaic L, 2011, J AM CHEM SOC, V133, P19634, DOI 10.1021/ja208359a; Kudchadkar R, 2012, CANCER J, V18, P124, DOI 10.1097/PPO.0b013e31824b436e; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; Laufenberg LJ, 2014, SHOCK, V41, P420, DOI 10.1097/SHK.0000000000000128; Llauger-Bufi L, 2003, BIOORG MED CHEM LETT, V13, P3975, DOI 10.1016/j.bmcl.2003.08.065; Lu HF, 2008, J NEUROSCI RES, V86, P2925, DOI 10.1002/jnr.21733; Luke JJ, 2013, ONCOLOGIST, V18, P717, DOI 10.1634/theoncologist.2012-0391; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; McCollum AK, 2008, MOL CANCER THER, V7, P3256, DOI 10.1158/1535-7163.MCT-08-0157; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; PHILLIPS MD, 1988, BLOOD, V72, P1898; Qiao SX, 2013, AUTOPHAGY, V9, P2087, DOI 10.4161/auto.26506; Qiao SX, 2012, APOPTOSIS, V17, P1079, DOI 10.1007/s10495-012-0746-x; Qiao SX, 2012, BIOCHEM PHARMACOL, V83, P1229, DOI 10.1016/j.bcp.2012.01.027; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Straume O, 2012, P NATL ACAD SCI USA, V109, P8699, DOI 10.1073/pnas.1017909109; STRONY J, 1990, CIRCULATION, V81, P1106, DOI 10.1161/01.CIR.81.3.1106; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Wondrak GT, 2007, FREE RADICAL BIO MED, V43, P178, DOI 10.1016/j.freeradbiomed.2007.03.035; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Xu WP, 2011, CANCER CELL, V20, P281, DOI 10.1016/j.ccr.2011.08.020; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang X, 2011, FREE RADICAL BIO MED, V50, P811, DOI 10.1016/j.freeradbiomed.2010.12.036; Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052333; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	70	20	22	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1623	1638		10.1074/jbc.M114.592626	http://dx.doi.org/10.1074/jbc.M114.592626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477506	hybrid, Green Published			2022-12-26	WOS:000348056400030
J	Asano, E; Ebara, T; Yamada-Namikawa, C; Kitaori, T; Suzumori, N; Katano, K; Ozaki, Y; Nakanishi, M; Sugiura-Ogasawara, M				Asano, Eriko; Ebara, Takeshi; Yamada-Namikawa, Chisato; Kitaori, Tamao; Suzumori, Nobuhiro; Katano, Kinue; Ozaki, Yasuhiko; Nakanishi, Makoto; Sugiura-Ogasawara, Mayumi			Genotyping Analysis for the 46 C/T Polymorphism of Coagulation Factor XII and the Involvement of Factor XII Activity in Patients with Recurrent Pregnancy Loss	PLOS ONE			English	Article							ASPIRIN PLUS HEPARIN; LUPUS ANTICOAGULANT; ANTIBODIES; GENE; MISCARRIAGE; WOMEN; DEFICIENCY; TRIAL	Background: Established causes of recurrent pregnancy loss (RPL) include antiphospholipid syndrome, uterine anomalies, parental chromosomal abnormalities, particularly translocations and abnormal embryonic karyotype. A systematic review concluded that coagulation factor XII (FXII) deficiency was associated with RPL. However, it could not be established whether the 46 C/T SNP of FXII or low activity of FXII was a risk factor for RPL, because of the small sample size. Methods and Findings: We conducted a cross-sectional and cohort study in 279 patients with two or more unexplained consecutive pregnancy losses and 100 fertile women. The association between the lupus anticoagulant (LA) activity and FXII activity was examined. The frequency of the CC, CT and TT genotypes and the FXII activity were also compared between the patients and controls. Subsequent miscarriage rates among the CC, CT, TT genotypes and according to the FXII activity was examined. LA was associated with reduced FXII activity. The CT, but not the TT, genotype was confirmed to be a risk factor for RPL in the cross-sectional study using multivariate logistic regression analysis (OR, 2.8; 95% CI, 1.37-5.85). The plasma FXII activity in the patients was similar to that in the controls. Neither low FXII activity nor the CT genotype predicted the subsequent pregnancy outcome in the cohort study. On the other hand, and intermediate FXII activity level of 85-101% was predictive of subsequent miscarriage. Conclusions: Low FXII activity was not associated with RPL. The FXII gene was found to be one of the significant susceptibility genes for RPL, similar to the FV Leiden mutation. However, the clinical influence of the CT genotype might be relatively small, because the presence/absence of this genotype did not have any predictive value for the subsequent pregnancy outcome. This was the first study indicating the influence of FXII 46C/T on further pregnancy outcomes.	[Asano, Eriko; Kitaori, Tamao; Suzumori, Nobuhiro; Katano, Kinue; Ozaki, Yasuhiko; Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi, Japan; [Ebara, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Yamada-Namikawa, Chisato; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem 2, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University	Sugiura-Ogasawara, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi, Japan.	og.mym@med.nagoya-cu.ac.jp	Ebara, Takeshi/W-6525-2018	Ebara, Takeshi/0000-0003-3342-1058; Suzumori, Nobuhiro/0000-0001-9003-1289	Ministry of Education, Culture, Sports, Science and Technology of Japan [ID 24592472]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, ID 24592472, (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi M, 2011, J MATERN-FETAL NEO M, V24, P545, DOI 10.3109/14767058.2010.511331; Braat EAM, 1999, EUR J BIOCHEM, V263, P904, DOI 10.1046/j.1432-1327.1999.00593.x; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; COWCHOCK FS, 1992, AM J OBSTET GYNECOL, V166, P1318, DOI 10.1016/0002-9378(92)91596-3; de Laat B, 2006, ANN RHEUM DIS, V65, P1468, DOI 10.1136/ard.2005.045237; Dossenbach-Glaninger A, 2008, FERTIL STERIL, V90, P1155, DOI 10.1016/j.fertnstert.2007.07.1376; FARQUHARSON RG, 1984, LANCET, V2, P228; Gallimore MJ, 1998, THROMB HAEMOSTASIS, V79, P87; Hayashi Y, 2013, FERTIL STERIL, V100, P1018, DOI 10.1016/j.fertnstert.2013.06.020; Iinuma Y, 2002, FERTIL STERIL, V77, P353, DOI 10.1016/S0015-0282(01)02989-2; Johnson CY, 2011, AM J EPIDEMIOL, V173, P136, DOI 10.1093/aje/kwq349; Jones DW, 2000, BRIT J HAEMATOL, V110, P721, DOI 10.1046/j.1365-2141.2000.02251.x; Kaandorp SP, 2010, NEW ENGL J MED, V362, P1586, DOI 10.1056/NEJMoa1000641; Kanaji T, 1998, BLOOD, V91, P2010, DOI 10.1182/blood.V91.6.2010.2010_2010_2014; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; LAMMLE B, 1991, THROMB HAEMOSTASIS, V65, P117; LaRusch GA, 2010, BLOOD, V115, P5111, DOI 10.1182/blood-2009-08-236430; Ogasawara M, 1996, LUPUS, V5, P587, DOI 10.1177/096120339600500605; Ogasawara MS, 2001, FERTIL STERIL, V75, P916, DOI 10.1016/S0015-0282(01)01688-0; Pauer HU, 2003, FERTIL STERIL, V80, P590, DOI 10.1016/S0015-0282(03)00788-X; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Rai R, 1997, BRIT MED J, V314, P253, DOI 10.1136/bmj.314.7076.253; SAMUEL M, 1992, J BIOL CHEM, V267, P19691; Sotiriadis A, 2007, OBSTET GYNECOL, V109, P1146, DOI 10.1097/01.AOG.0000260873.94196.d6; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Sugiura-Ogasawara M, 2004, FERTIL STERIL, V81, P367, DOI 10.1016/j.fertnstert.2003.07.014; Sugiura-Ogasawara M, 2012, HUM REPROD, V27, P2297, DOI 10.1093/humrep/des179; Sugiura-Ogasawara M, 2010, FERTIL STERIL, V93, P1983, DOI 10.1016/j.fertnstert.2008.12.097; Walch K, 2005, BJOG-INT J OBSTET GY, V112, P1434, DOI 10.1111/j.1471-0528.2005.00686.x	30	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114452	10.1371/journal.pone.0114452	http://dx.doi.org/10.1371/journal.pone.0114452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489738	Green Submitted, gold, Green Published			2022-12-26	WOS:000347515300042
J	Franke, M; Kramarczyk, A; Taylan, C; Maintz, D; Hoppe, B; Koerber, F				Franke, Mareike; Kramarczyk, Annette; Taylan, Christina; Maintz, David; Hoppe, Bernd; Koerber, Friederike			Ultrasound-Guided Percutaneous Renal Biopsy in 295 Children and Adolescents: Role of Ultrasound and Analysis of Complications	PLOS ONE			English	Article							ARTERIOVENOUS-FISTULA; NATIVE KIDNEYS; SINGLE-CENTER; SAFETY; EXPERIENCE; DIAGNOSIS	Introduction: Percutaneous renal biopsy (PRB) is a decisive diagnostic procedure for children and adolescents with renal diseases. Aim of this study was to evaluate retrospectively the complication rates of percutaneous kidney biopsies and their therapeutic consequences to assess the role of ultrasound-guidance including Doppler ultrasound examinations in preparation, execution and follow-up care and to present a recommended protocol. Patients and Methods: Institutional review board approved this retrospective study; informed consent was waived. Between 1997 and 2011 a total of 438 ultrasound-guided biopsies were performed in 295 patients, 169 of the biopsies were performed on kidney transplants. Average age of patients was 10.2+/-5.2 years (range of 15 days until age of 23). Before and post biopsy ultrasound examination including Doppler examination was carried out. Biopsy itself was ultrasound monitored. Complications were analysed with regard to age of patient, kidney transplants, year of occurrence, number of punctures, performing physician and time interval of occurrence to develop an optimized protocol for ultrasound-guidance. Results: In 99% of cases successful PRB were performed, i.e. enough kidney parenchyma for histological analysis was obtained. No lethal or major complication that required surgical intervention occurred. Eighteen relevant complications were observed (complication rate: 4.1%). Except in one case in which additional MRI diagnostic was necessary, ultrasound examination after 4 hours post biopsy or even earlier when symptoms occurred, was able to detect complications and determine indications for intervention. Conclusion: Ultrasound-guided PRB is an established and effective method in children and adolescents, but shows a certain rate of complications and therefore should not be indicated without diligence. Ultrasound including Doppler ultrasound is a valuable tool in preparation, guidance of biopsy, detection of complications and in follow-up care. Ultrasound examinations (including Doppler) pre-, during and 4 hours post kidney biopsy and, depending from case, a few days until weeks after biopsy is recommended.	[Franke, Mareike; Maintz, David; Koerber, Friederike] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Kramarczyk, Annette; Taylan, Christina] Univ Hosp Cologne, Dept Pediat, Cologne, Germany; [Hoppe, Bernd] Univ Hosp Bonn, Dept Pediat, Bonn, Germany	University of Cologne; University of Cologne; University of Bonn	Koerber, F (corresponding author), Univ Hosp Cologne, Dept Radiol, Cologne, Germany.	friederike.koerber@uk-koeln.de	Maintz, David/ABG-3220-2020					ALRASHEED SA, 1990, PEDIATR NEPHROL, V4, P600, DOI 10.1007/BF00858632; Bilge I, 1999, NEPHROL DIAL TRANSPL, V14, P2726, DOI 10.1093/ndt/14.11.2726; Cameron JS, 1997, AM J NEPHROL, V17, P347; DAVIS CL, 1995, J AM SOC NEPHROL, V6, P1250; Feneberg R, 1998, NEPHRON, V79, P438, DOI 10.1159/000045090; GAINZA FJ, 1995, CLIN NEPHROL, V43, P303; Heffernan E, 2009, J CLIN ULTRASOUND, V37, P226, DOI 10.1002/jcu.20465; HUBSCH P, 1991, NEPHRON, V59, P482, DOI 10.1159/000186613; Hussain F, 2003, PEDIATR NEPHROL, V18, P53, DOI 10.1007/s00467-002-1003-2; Hussain F, 2010, NEPHROL DIAL TRANSPL, V25, P485, DOI 10.1093/ndt/gfp434; Ishikawa E, 2009, CLIN EXP NEPHROL, V13, P325, DOI 10.1007/s10157-009-0165-7; KARAFIN L, 1970, J UROLOGY, V103, P332, DOI 10.1016/S0022-5347(17)61954-2; MATSELL DG, 1992, PEDIATR NEPHROL, V6, P562, DOI 10.1007/BF00866508; Maya ID, 2009, SEMIN DIALYSIS, V22, P458, DOI 10.1111/j.1525-139X.2009.00609.x; Nammalwar BR, 2006, PEDIATR NEPHROL, V21, P286, DOI 10.1007/s00467-005-2084-5; Okamura T, 1998, UROL INT, V61, P261, DOI 10.1159/000030325; Ozdemir S., 1998, International Urology and Nephrology, V30, P689, DOI 10.1007/BF02564854; Printza N, 2011, HIPPOKRATIA, V15, P258; Riccabona M, 1998, J ULTRAS MED, V17, P505; Schwarz A, 2005, AM J TRANSPLANT, V5, P1992, DOI 10.1111/j.1600-6143.2005.00988.x; Simckes AM, 2000, PEDIATR NEPHROL, V14, P946, DOI 10.1007/s004670000316; Sinha MD, 2006, J NEPHROL, V19, P41; Skalova S, 2010, SINGAP MED J, V51, P481; Stratta P, 2007, EUR J CLIN INVEST, V37, P954, DOI 10.1111/j.1365-2362.2007.01885.x; Sweeney C, 2006, PEDIATR TRANSPLANT, V10, P159, DOI 10.1111/j.1399-3046.2005.00433.x; Tondel C, 2012, CLIN J AM SOC NEPHRO, V7, P1591, DOI 10.2215/CJN.02150212; Munoz AT, 2011, ARCH MED SCI, V7, P823, DOI 10.5114/aoms.2011.25557; Waldo B, 2009, NEPHROL DIAL TRANSPL, V24, P2433, DOI 10.1093/ndt/gfp073; Whittier WL, 2004, CURR OPIN NEPHROL HY, V13, P661, DOI 10.1097/00041552-200411000-00013; ZEIS PM, 1976, J PEDIATR-US, V89, P263, DOI 10.1016/S0022-3476(76)80463-5	30	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114737	10.1371/journal.pone.0114737	http://dx.doi.org/10.1371/journal.pone.0114737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489731	Green Submitted, gold, Green Published			2022-12-26	WOS:000347515300072
J	Novello, C; Pazzaglia, L; Conti, A; Quattrini, I; Pollino, S; Perego, P; Picci, P; Benassi, MS				Novello, Chiara; Pazzaglia, Laura; Conti, Amalia; Quattrini, Irene; Pollino, Serena; Perego, Paola; Picci, Piero; Benassi, Maria Serena			p53-Dependent Activation of microRNA-34a in Response to Etoposide-Induced DNA Damage in Osteosarcoma Cell Lines Not Impaired by Dominant Negative p53 Expression	PLOS ONE			English	Article							GROWTH ARREST; METHYLATION; MIR-34A; APOPTOSIS; MUTATION	Osteosarcoma (OS) is the most common primary malignant bone tumor and prevalently occurs in the second decade of life. Etoposide, a chemotherapeutic agent used in combined treatments of recurrent human OS, belongs to the topoisomerase inhibitor family and causes DNA breakage. In this study we evaluated the cascade of events determined by etoposide-induced DNA damage in OS cell lines with different p53 status focusing on methylation status and expression of miR-34a that modulate tumor cell growth and cell cycle progression. Wild-type p53 U2-OS cells and U2-OS cells expressing dominant-negative form of p53 (U2-OS175) were more sensitive to etoposide than p53-deficient MG63 and Saos-2 cells, showing increased levels of unmethylated miR-34a, reduced expression of CDK4 and cell cycle arrest in G1 phase. In contrast, MG63 and Saos-2 cell lines presented aberrant methylation of miR-34a promoter gene with no miR-34a induction after etoposide treatment, underlining the close connection between p53 expression and miR-34a methylation status. Consistently, in p53siRNA transfected U2-OS cells we observed loss of miR-34a induction after etoposide exposure associated with a partial gain of gene methylation and cell cycle progress towards G2/M phase. Our results suggest that the open and unmethylated conformation of the miR-34a gene may be regulated by p53 able to bind the gene promoter. In conclusion, cell response to etoposide-induced DNA damage was not compromised in cells with dominant-negative p53 expression.	[Novello, Chiara; Pazzaglia, Laura; Conti, Amalia; Quattrini, Irene; Pollino, Serena; Picci, Piero; Benassi, Maria Serena] Rizzoli Orthopaed Inst, Expt Oncol Lab, Bologna, Italy; [Pollino, Serena] Univ Parma, Ctr Mol & Translat Oncol, I-43100 Parma, Italy; [Pollino, Serena] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Perego, Paola] IRCCS, Ist Nazl Tumori, Mol Pharmacol Unit, Milan, Italy	IRCCS Istituto Ortopedico Rizzoli; University of Parma; University of Parma; Fondazione IRCCS Istituto Nazionale Tumori Milan	Benassi, MS (corresponding author), Rizzoli Orthopaed Inst, Expt Oncol Lab, Bologna, Italy.	mariaserena.benassi@ior.it	Quattrini, Irene/C-6672-2019; Perego, Paola/J-7647-2016; Pazzaglia, Laura/C-7918-2019; Conti, Amalia/AAC-5159-2022; Novello, Chiara/K-2569-2016; Picci, Piero/J-5979-2016; Quattrini, Irene/C-6672-2019	Quattrini, Irene/0000-0002-4482-0612; Perego, Paola/0000-0003-2806-7269; Pazzaglia, Laura/0000-0001-5937-4953; Novello, Chiara/0000-0001-5405-0300; Picci, Piero/0000-0002-8519-4101; Quattrini, Irene/0000-0003-2221-3376; Pollino, Serena/0000-0001-6426-5372	Fondazione Umberto Veronesi; FIRC Triennial fellowship "Mario e Valeria Rindi" [13748]; EU Project "Eurosarc"; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); FIRC Triennial fellowship "Mario e Valeria Rindi"(Fondazione AIRC per la ricerca sul cancro); EU Project "Eurosarc"; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from: 5% donation (Italy). Amalia Conti was supported by post-doctoral fellowship "Fondazione Umberto Veronesi", Chiara Novello was supported by FIRC Triennial fellowship "Mario e Valeria Rindi" (Research project n<SUP>o</SUP>13748). The work was supported also by EU Project "Eurosarc". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Bai L, 2006, J CANC MOL, V2, P141; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Chim CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-197; D'Adamo DR, 2011, SEMIN ONCOL, V38, pS19, DOI 10.1053/j.seminoncol.2011.09.004; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; ESMO European Sarcoma Network Work, 2012, ANN ONCOL, V23, P100, DOI 10.1093/annonc/mds254; Ezoe S, 2012, INT J ENV RES PUB HE, V9, P2444, DOI 10.3390/ijerph9072444; Fitzgibbon C, 2013, INVEST NEW DRUG, V31, P1466, DOI 10.1007/s10637-013-0031-z; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gatti L, 2002, CELL DEATH DIFFER, V9, P1352, DOI 10.1038/sj.cdd.4401109; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; He CL, 2009, BIOCHEM BIOPH RES CO, V388, P35, DOI 10.1016/j.bbrc.2009.07.101; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kawabe T, 2004, MOL CANCER THER, V3, P513; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Mikeska T, 2012, EXPERT REV MOL DIAGN, V12, P473, DOI [10.1586/ERM.12.45, 10.1586/erm.12.45]; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsang WP, 2005, INT J CANCER, V114, P331, DOI 10.1002/ijc.20818; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Zhu JJ, 2006, LIFE SCI, V78, P1469, DOI 10.1016/j.lfs.2005.07.044	33	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114757	10.1371/journal.pone.0114757	http://dx.doi.org/10.1371/journal.pone.0114757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490093	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300076
J	Aguila, S; Martinez-Martinez, I; Dichiara, G; Gutierrez-Gallego, R; Navarro-Fernandez, J; Vicente, V; Corral, J				Aguila, Sonia; Martinez-Martinez, Irene; Dichiara, Gilda; Gutierrez-Gallego, Ricardo; Navarro-Fernandez, Jose; Vicente, Vicente; Corral, Javier			Increased N-Glycosylation Efficiency by Generation of an Aromatic Sequon on N135 of Antithrombin	PLOS ONE			English	Article							HIGH-AFFINITY HEPARIN; ENDOPLASMIC-RETICULUM; BETA-ANTITHROMBIN; ALLOSTERIC ACTIVATION; BINDING; MECHANISM; SERPINS; THROMBOSIS; STABILITY; PROTEINS	The inefficient glycosylation of consensus sequence on N135 in antithrombin explains the two glycoforms of this key anticoagulant serpin found in plasma: alpha and beta, with four and three N-glycans, respectively. The lack of this N-glycan increases the heparin affinity of the beta-glycoform. Recent studies have demonstrated that an aromatic sequon (Phe-Y-Asn-X-Thr) in reverse beta-turns enhances N-glycosylation efficiency and stability of different proteins. We evaluated the effect of the aromatic sequon in this defective glycosylation site of antithrombin, despite of being located in a loop between the helix D and the strand 2A. We analyzed the biochemical and functional features of variants generated in a recombinant cell system (HEK-EBNA). Cells transfected with wild-type plasmid (K133-Y-N135-X-S137) generated 50% of alpha and beta-antithrombin. The S137T, as previously reported, K133F, and the double mutant (K133F/S137T) had improved glycosylation efficiency, leading to the secretion of alpha-antithrombin, as shown by electrophoretic and mass analysis. The presence of the aromatic sequon did not significantly affect the stability of this conformationally sensitive serpin, as revealed by thermal denaturation assay. Moreover, the aromatic sequon hindered the activation induced by heparin, in which is involved the helix D. Accordingly, K133F and particularly K133F/S137T mutants had a reduced anticoagulant activity. Our data support that aromatic sequons in a different structural context from reverse turns might also improve the efficiency of N-glycosylation.	[Aguila, Sonia; Martinez-Martinez, Irene; Navarro-Fernandez, Jose; Vicente, Vicente; Corral, Javier] Univ Murcia, Hosp Morales Meseguer, Ctr Reg Hemodonac, IMIB, Murcia, Spain; [Dichiara, Gilda] Univ Navarra, Ctr Appl Med Res, Lab Thrombosis & Haemostasis, Div Cardiovasc Sci, E-31080 Pamplona, Spain; [Gutierrez-Gallego, Ricardo] UPF, Dept Expt & Hlth Sci, IMIM Hosp Mar, Bioanal Grp, Barcelona, Spain; [Gutierrez-Gallego, Ricardo] Anapharm Biotech, Barcelona, Spain	University of Murcia; University of Navarra; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Corral, J (corresponding author), Univ Murcia, Hosp Morales Meseguer, Ctr Reg Hemodonac, IMIB, Murcia, Spain.	javier.corral@carm.es	Vicente, Vicente/L-6185-2019; Martínez-Martínez, Irene/AAM-8862-2020; Aguila, Sonia/Q-2822-2019	Vicente, Vicente/0000-0002-4278-3264; Martínez-Martínez, Irene/0000-0002-1067-6464; Aguila, Sonia/0000-0001-5794-5177; Gutierrez Gallego, Ricardo/0000-0001-9639-2181; Dichiara Rodriguez, Gilda/0000-0003-2374-1787; Corral, Javier/0000-0003-0288-1107	ISCIII [PI12/00657]; FEDER [PI12/00657]; Redes RIC (ISCIII) [RD12/0042/0050, RD12/0042/0009]; Redes RIC (FEDER) [RD12/0042/0050, RD12/0042/0009]; Ministerio de Ciencia e Innovacion	ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); Redes RIC (ISCIII); Redes RIC (FEDER); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Funding: This work has been supported by PI12/00657 (ISCIII, (www.isciii.es) & FEDER), and Redes RIC (RD12/0042/0050 & RD12/0042/0009) (ISCIII & FEDER), S.A is holder of a FPI grant from Ministerio de Ciencia e Innovacion (www.idi.mineco.gob.es), I.M.M. is a Miguel Servet researcher from ISCIII and J.N.F. holders a post-doctoral contract Sara Borrell from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainle FN, 2011, J BIOL CHEM, V286, P1323, DOI 10.1074/jbc.M110.159475; Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200; Brooks AR, 2013, J THROMB HAEMOST, V11, P1699, DOI 10.1111/jth.12300; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Carrell RW, 2003, BIOCHEM SOC SYMP, V70, P163, DOI 10.1042/bss0700163; CHOAY J, 1989, ANN NY ACAD SCI, V556, P61; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hernandez-Espinosa D, 2007, THROMB HAEMOSTASIS, V98, P557, DOI 10.1160/TH07-02-0152; Huntington JA, 2003, J THROMB HAEMOST, V1, P1535, DOI 10.1046/j.1538-7836.2003.00305.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; Liu Y, 2009, BIOTECHNOL PROGR, V25, P1468, DOI 10.1002/btpr.241; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Mushunje A, 2004, J THROMB HAEMOST, V2, P2170, DOI 10.1111/j.1538-7836.2004.01047.x; Ni HY, 2000, THROMB RES, V99, P407, DOI 10.1016/S0049-3848(00)00263-2; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Olson ST, 1997, ARCH BIOCHEM BIOPHYS, V341, P212, DOI 10.1006/abbi.1997.9973; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; PETERSON CB, 1985, J BIOL CHEM, V260, P610; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Preston RJS, 2013, BLOOD, V121, P3801, DOI 10.1182/blood-2012-10-415000; Price JL, 2012, BIOPOLYMERS, V98, P195, DOI 10.1002/bip.22030; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1	42	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114454	10.1371/journal.pone.0114454	http://dx.doi.org/10.1371/journal.pone.0114454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485983	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600057
J	Berdel, HO; Yin, H; Liu, JY; Grochowska, K; Middleton, C; Yanasak, N; Abdelsayed, R; Berdel, WE; Mozaffari, M; Yu, JC; Baban, B				Berdel, Henrik O.; Yin, Hongyu; Liu, Jun Yao; Grochowska, Karolina; Middleton, Christopher; Yanasak, Nathan; Abdelsayed, Rafik; Berdel, Wolfgang E.; Mozaffari, Mahmood; Yu, Jack C.; Baban, Babak			Targeting Serum Glucocorticoid-Regulated Kinase-1 in Squamous Cell Carcinoma of the Head and Neck: A Novel Modality of Local Control	PLOS ONE			English	Article							STEM-LIKE CELLS; ANDROGEN RECEPTOR; PLUS CETUXIMAB; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; PROSTATE-CANCER; UP-REGULATION; CHEMOTHERAPY; EXPRESSION; SGK1	Purpose: The inhibition of serum glucocorticoid-regulated kinase-1 (SGK-1) has been found to decrease growth of colon and prostate cancer cells. The purpose of this study is to evaluate the therapeutic effect of SGK-1 inhibition in head and neck squamous cell carcinoma (SCC). Experimental Design: Human head and neck tumors (HTB41/43) were established in athymic mice. Growth rates between mice treated with vehicle (PBS) injection (group 1, n=5), SGK-1 Inhibitor GSK 650394 (group 2, n=6), systemic cisplatin (group 3, n=6), and a combination of SGK-1 Inhibitor and cisplatin (group 4, n=6) were compared using repeated measures one-way ANOVA with Newman-Keuls Multiple Comparison Test. Tumor cells were subsequently submitted to further analyses. Results: At the end of the experiment mean tumor sizes were 122.33+/-105.86, 76.73+/-36.09, 94.52+/-75.92, and 25.76+/-14.89 mm(2) (mean +/- SD) for groups 1 to 4. Groups 2 and 3 showed decreased tumor growth compared to controls (p<0.001). Group 4 displayed even greater growth suppression (p<0.0001). Importantly, group 4 fared better than group 3 (p<0.001). CD44 expression was reduced in group 2 (p<0.05), and to an even greater extent in groups 3 and 4 (p<0.0025). A trend towards reduction of HER 2 expression was noted in group 4. Conclusions: SGK-1 inhibition suppresses tumor growth, and in combination with systemic cisplatin exceeds the effect of cisplatin alone. Decreased expression of CD44 and HER 2 implies depletion of tumor stem cells, and less tumorigenicity. SGK-1 inhibition represents a potential modality of local control for palliation in advanced cases.	[Berdel, Henrik O.; Yin, Hongyu; Liu, Jun Yao; Grochowska, Karolina; Middleton, Christopher; Yanasak, Nathan; Abdelsayed, Rafik; Mozaffari, Mahmood; Yu, Jack C.; Baban, Babak] Georgia Regents Univ, Augusta, GA 30901 USA; [Berdel, Henrik O.] Univ S Carolina, Sch Med, Palmetto Health, Columbia, SC USA; [Yin, Hongyu] Chinese Acad Med Sci, Plast Surg Hosp, Beijing, Peoples R China; [Yin, Hongyu] Peking Union Med Coll, Beijing, Peoples R China; [Berdel, Wolfgang E.] Univ Hosp Muenster, Dept Med A, Munster, Germany	University System of Georgia; Augusta University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Munster	Baban, B (corresponding author), Georgia Regents Univ, Augusta, GA 30901 USA.	bbaban@gru.edu	Yanasak, Nathan/CAG-5116-2022		Milford B. Hatcher Endowment	Milford B. Hatcher Endowment	This study was supported by institutional funds (provided to BB) and the Milford B. Hatcher Endowment (provided to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-4; ALSARRAF M, 1988, SEMIN ONCOL, V15, P70; Amato R, 2013, ONCOGENE, V32, P4572, DOI 10.1038/onc.2012.470; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Baban B, 2014, AM J HYPERTENS, V27, P846, DOI 10.1093/ajh/hpt269; Baban B, 2013, EXP MOL PATHOL, V95, P288, DOI 10.1016/j.yexmp.2013.09.002; Baban B, 2013, EXP MOL PATHOL, V94, P343, DOI 10.1016/j.yexmp.2012.11.004; Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Bachaud JM, 1996, INT J RADIAT ONCOL, V36, P999, DOI 10.1016/S0360-3016(96)00430-0; Baskin R, 2012, CELL SIGNAL, V24, P435, DOI 10.1016/j.cellsig.2011.09.016; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bloom C, 1998, CAN ASSOC RADIOL J, V49, P370; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Facompre N, 2012, ADV PHARMACOL, V65, P235, DOI 10.1016/B978-0-12-397927-8.00008-7; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Guardiola E, 2004, CANCER, V101, P2028, DOI 10.1002/cncr.20623; Hanna E, 2004, ARCH OTOLARYNGOL, V130, P861, DOI 10.1001/archotol.130.7.861; HAUGHEY BH, 1992, ANN OTO RHINOL LARYN, V101, P105, DOI 10.1177/000348949210100201; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705, DOI 10.1016/0360-3016(92)90642-U; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Masoumy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095720; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Moniz Larissa S, 2013, Biochem J, V452, pe11, DOI 10.1042/BJ20130617; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Polakis P, 2000, GENE DEV, V14, P1837; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schmidt EM, 2012, FEBS J, V279, P1231, DOI 10.1111/j.1742-4658.2012.08515.x; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P156, DOI 10.1038/ncponc0750; Shanmugam I, 2007, CELL DEATH DIFFER, V14, P2085, DOI 10.1038/sj.cdd.4402227; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; Szmulewitz RZ, 2012, PROSTATE, V72, P157, DOI 10.1002/pros.21416; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; Trog D, 2006, PROTEOMICS, V6, P2924, DOI 10.1002/pmic.200500587; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; VOKES EE, 1993, INT J RADIAT ONCOL, V27, P481, DOI 10.1016/0360-3016(93)90263-U; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113795	10.1371/journal.pone.0113795	http://dx.doi.org/10.1371/journal.pone.0113795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485633	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600027
J	See, LC; Kuo, CF; Yu, KH; Luo, SF; Chou, IJ; Ko, YS; Chiou, MJ; Liu, JR				See, Lai-Chu; Kuo, Chang-Fu; Yu, Kuang-Hui; Luo, Shue-Fen; Chou, I-Jun; Ko, Yu-Shien; Chiou, Meng-Jiun; Liu, Jia-Rou			Hyperthyroid and Hypothyroid Status Was Strongly Associated with Gout and Weakly Associated with Hyperuricaemia	PLOS ONE			English	Article							METABOLIC SYNDROME; KIDNEY-FUNCTION; RENAL-FUNCTION; RISK; EPIDEMIOLOGY; HYPERTENSION; POPULATION; PREVALENCE; CREATININE; ARTHRITIS	Objectives: The aim of this study was to estimate the risk of hyperuricaemia and gout in people with hypothyroid or hyperthyroid status. Methods: This study analyzed data from individuals who participated in health screening programs at Chang Gung Memorial Hospital in northern Taiwan (2000-2010). Participants were categorized as having euthyroid, hypothyroid, or hyperthyroid status according to their thyroid-stimulating hormone (TSH) levels. Multinomial logistic regression models were used to calculate the odds ratios (95% CI) for hyperuricaemia and gout in participants with thyroid dysfunction compared to euthyroid participants. Results: A total of 87,813 (euthyroid, 83,502; hypothyroid, 1,460; hyperthyroid, 2,851) participants were included. The prevalence of hyperuricaemia was higher in hyperthyroid subjects (19.4%) than in euthyroid subjects (17.8%) but not in hypothyroid subjects (19.3%). The prevalence of gout was significantly higher in both hypothyroid (6.0%) and hyperthyroid (5.3%) subjects than in euthyroid subjects (4.3%). In men, hypothyroid or hyperthyroid status was not associated with hyperuricaemia. However, hypothyroid or hyperthyroid status was associated with ORs (95% CI) of 1.47 (1.10-1.97) and 1.37 (1.10-1.69), respectively, for gout. In women, hypothyroid status was not associated with hyperuricaemia or gout. However, hyperthyroid status was associated with ORs (95% CI) of 1.42 (1.24-1.62) for hyperuricaemia and 2.13 (1.58-2.87) for gout. Conclusions: Both hyperthyroid and hypothyroid status were significantly associated with gout and weakly associated with hyperuricaemia. A thyroid function test for gout patients may by warranted.	[See, Lai-Chu; Chiou, Meng-Jiun; Liu, Jia-Rou] Chang Gung Univ, Mol Med Res Ctr, Dept Publ Hlth, Taoyuan, Taiwan; [See, Lai-Chu; Chiou, Meng-Jiun; Liu, Jia-Rou] Chang Gung Univ, Mol Med Res Ctr, Biostat Core Lab, Taoyuan, Taiwan; [Kuo, Chang-Fu; Yu, Kuang-Hui; Luo, Shue-Fen] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Kuo, Chang-Fu] Univ Nottingham, Sch Clin Sci, Div Acad Rheumatol, Nottingham NG7 2RD, England; [Chou, I-Jun] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Ko, Yu-Shien] Chang Gung Mem Hosp, Hlth Evaluat Ctr, Taoyuan, Taiwan; [Ko, Yu-Shien] Chang Gung Mem Hosp, Div Cardiol 1, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; University of Nottingham; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yu, KH (corresponding author), Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan.	gout@cgmh.org.tw	Kuo, Chang-Fu/Q-1714-2016	Kuo, Chang-Fu/0000-0002-9770-5730; See, Lai-Chu/0000-0002-1379-8969	Ministry of Education, Taiwan [EMRPD1D0101]; Chang Gung Memorial Hospital [CMRPG390211]	Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Funding: The authors would like to thank the Ministry of Education, Taiwan (EMRPD1D0101) and Chang Gung Memorial Hospital (CMRPG390211) for financially supporting this research in data collection and analysis, and preparation of the manuscript.	ABBOTT RD, 1988, J CLIN EPIDEMIOL, V41, P237, DOI 10.1016/0895-4356(88)90127-8; Arromdee E, 2002, J RHEUMATOL, V29, P2403; Chang HY, 2001, J RHEUMATOL, V28, P1640; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Choi HK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8190; Domrongkitchaiporn S, 2005, J AM SOC NEPHROL, V16, P791, DOI 10.1681/ASN.2004030208; DURWARD WF, 1976, ARTHRITIS RHEUM, V19, P123, DOI 10.1002/art.1780190125; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; ERICKSON AR, 1994, AM J MED, V97, P231, DOI 10.1016/0002-9343(94)90005-1; Giordano N, 2001, CLIN EXP RHEUMATOL, V19, P661; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Kellgren JH, 1963, EPIDEMIOL CHRON, P327; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Kuo CF, 2014, ANN RHEUM DIS; Kuo CF, 2010, RHEUMATOLOGY, V49, P141, DOI 10.1093/rheumatology/kep364; KUZELL W C, 1955, J Chronic Dis, V2, P645, DOI 10.1016/0021-9681(55)90193-4; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LIN HY, 1989, NEW ENGL J MED, V321, P287, DOI 10.1056/NEJM198908033210504; Mariani LH, 2012, J AM SOC NEPHROL, V23, P22, DOI 10.1681/ASN.2010070766; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; MCLAUGHLIN KJ, 1994, NEPHROL DIAL TRANSPL, V9, P1521; Mooraki A, 1998, CLIN NEPHROL, V49, P59; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Raber W, 1999, WIEN KLIN WOCHENSCHR, V111, P326; Saini V, 2012, CLIN BIOCHEM, V45, P212, DOI 10.1016/j.clinbiochem.2011.10.012; SATO A, 1995, METABOLISM, V44, P207, DOI 10.1016/0026-0495(95)90266-X; See LC, 2011, CLIN RHEUMATOL, V30, P323, DOI 10.1007/s10067-010-1461-z; Sheane BJ, 2007, JCR-J CLIN RHEUMATOL, V13, P293, DOI 10.1097/RHU.0b013e3181571119; STEIGER MJ, 1991, J ROY SOC MED, V84, P688; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; YU TF, 1982, AM J MED, V72, P95, DOI 10.1016/0002-9343(82)90593-9; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114579	10.1371/journal.pone.0114579	http://dx.doi.org/10.1371/journal.pone.0114579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486420	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600076
J	Hinrichs, JB; Renne, J; Schoenfeld, C; Gutberlet, M; Haverich, A; Warnecke, G; Welte, T; Wacker, F; Gottlieb, J; Vogel-Claussen, J				Hinrichs, Jan B.; Renne, Julius; Schoenfeld, Christian; Gutberlet, Marcel; Haverich, Axel; Warnecke, Gregor; Welte, Tobias; Wacker, Frank; Gottlieb, Jens; Vogel-Claussen, Jens			Cardiac Mass and Function Decrease in Bronchiolitis Obliterans Syndrome after Lung Transplantation: Relationship to Physical Activity?	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; PULMONARY-HYPERTENSION; PERCENT EMPHYSEMA; HYPERTROPHY; HEART; METAANALYSIS; RECIPIENTS; UPDATE	Rationale: There is a need to expand knowledge on cardio-pulmonary pathophysiology of bronchiolitis obliterans syndrome (BOS) following lung transplantation (LTx). Objectives: The purpose of this study was to assess MRI-derived biventricular cardiac mass and function parameters as well as flow hemodynamics in patients with and without BOS after LTx. Methods: Using 1.5T cardiac MRI, measurements of myocardial structure and function as well as measurements of flow in the main pulmonary artery and ascending aorta were performed in 56 lung transplant patients. The patients were dichotomized into two gender matched groups of comparable age range: one with BOS (BOS stages 1-3) and one without BOS (BOS 0/0p). Measurements and Main Results: Significantly lower biventricular cardiac mass, right and left ventricular end-diastolic volume, biventricular stroke volume, flow hemodynamics and significant higher heart rate but preserved cardiac output were observed in patients with BOS 1-3 compared to the BOS 0/0p group (p<0.05). In a stepwise logistic regression analysis global cardiac mass (p=0.046) and days after LTx (p=0.0001) remained independent parameters to predict BOS. In a second model an indicator for the physical fitness level - walking number of stairs - was added to the logistic regression model. In this second model, time after LTx (p=0.005) and physical fitness (p=0.01) remained independent predictors for BOS. Conclusion: The observed changes in biventricular cardiac mass and function as well as changes in hemodynamic flow parameters in the pulmonary trunk and ascending aorta are likely attributed to the physical fitness level of patients after lung transplantation, which in turn is strongly related to lung function.	[Hinrichs, Jan B.; Renne, Julius; Schoenfeld, Christian; Gutberlet, Marcel; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany; [Welte, Tobias; Gottlieb, Jens] Hannover Med Sch, Clin Pneumol, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany; [Haverich, Axel; Warnecke, Gregor] Hannover Med Sch, Clin Cardiothorac Transplant & Vasc Surg, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de	Vogel-Claussen, Jens/Q-3374-2019; Haverich, Axel/AAC-7552-2022; Renne, Julius/A-8060-2016	Renne, Julius/0000-0003-3727-8180; Vogel-Claussen, Jens/0000-0001-5595-6948; Gottlieb, Prof. Jens/0000-0002-9540-9022	German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302). Funding had no influence on study design, data collection, analysis, decision to publish or preparation of the manuscript.	Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Giles JT, 2010, ARTHRITIS RHEUM-US, V62, P940, DOI 10.1002/art.27349; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Gottlieb Jens, 2008, Ther Adv Respir Dis, V2, P237, DOI 10.1177/1753465808093514; Grau M, 2013, CHEST, V144, P136, DOI 10.1378/chest.12-1779; HACHEM RR, 2005, SEMINARS IN THORACIC, V16, P350, DOI DOI 10.1053/J.SEMTCVS.2004.09.011; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Henk CB, 1998, CHEST, V114, P771, DOI 10.1378/chest.114.3.771; Kasimir MT, 2004, EUR J CARDIO-THORAC, V26, P776, DOI 10.1016/j.ejcts.2004.05.057; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Kotsimbos T, 2012, EUR RESPIR REV, V21, P271, DOI 10.1183/09059180.00006312; Kreitner KF, 2013, CIRC-CARDIOVASC IMAG, V6, P722, DOI 10.1161/CIRCIMAGING.112.000276; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; Meyer KC, 2012, CURR PULMONOL REP, V1, P147, DOI 10.1007/s13665-012-0020-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nathan SD, 2009, RESP MED, V103, P1816, DOI 10.1016/j.rmed.2009.07.011; Paoletti E, 2010, TRANSPL P, V42, pS41, DOI 10.1016/j.transproceed.2010.07.007; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Sandstede J, 2000, EUR RADIOL, V10, P438, DOI 10.1007/s003300050072; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Srichai MB, 2009, AM J ROENTGENOL, V192, P662, DOI 10.2214/AJR.07.3744; Suhling H, 2013, TRANSPLANTATION, V95, P1045, DOI 10.1097/TP.0b013e31828555d0; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Turkbey EB, 2010, HEART, V96, P42, DOI 10.1136/hrt.2009.178426; Vogel-Claussen J, 2011, INVEST RADIOL, V46, P567, DOI 10.1097/RLI.0b013e31821b7041; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Yamamoto H, 1998, SURG TODAY, V28, P900, DOI 10.1007/s005950050250; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	37	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114001	10.1371/journal.pone.0114001	http://dx.doi.org/10.1371/journal.pone.0114001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479016	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200038
J	Lu, X; Long, Y; Lin, L; Sun, RZ; Zhong, S; Cui, ZB				Lu, Xing; Long, Yong; Lin, Li; Sun, Rongze; Zhong, Shan; Cui, Zongbin			Characterization of Zebrafish Abcc4 as an Efflux Transporter of Organochlorine Pesticides	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEINS; DICHLORODIPHENYLTRICHLOROETHANE DDT; DIGESTIVE GLAND; P-GLYCOPROTEIN; GLUTATHIONE; MRP; MRP4/ABCC4; LINDANE; GENE; TRANSFERASES	DDT and lindane are highly toxic organochlorine pesticides and posing adverse effects on the environment and public health due to their frequent usage in developing countries. ABCC4/MRP4 is an organic anion transporter that mediates cellular efflux of a wide range of exogenous and endogenous compounds such as cyclic nucleotides and anti-cancer drugs; however, it remains unclear whether ABCC4 and its orthologs function in the detoxification of organochlorine pesticides. Here, we demonstrated the roles of zebrafish Abcc4 in cellular efflux of DDT and lindane. Zebrafish abcc4 was maternally expressed in the oocytes and its transcripts were detected in the lens, pancreas, gills, liver, intestine and bladder of developing embryos and in adult tissues examined. DDT and lindane were able to induce the expression of abcc4 gene and overexpression of Abcc4 significantly decreased the cytotoxicity and accumulation of DDT and lindane in LLC-PK1 cells and developing embryos. In contrast, overexpression of an Abcc4-G1188D mutant abolished its transporter function without effects on its substrate binding activity, and sensitized LLC-PK1 cells and developing embryos to toxic pesticides. Moreover, glutathione (GSH) was involved in the efflux of cellular pesticides and ATPase activity in developing embryos can be induced by DDT or lindane. Thus, zebrafish Abcc4 plays crucial roles in cellular efflux of organochlorine pesticides and can be used a potential molecular marker for the monitor of DDT and lindane contamination in the aquatic environment.	[Lu, Xing; Lin, Li; Sun, Rongze; Zhong, Shan] Wuhan Univ, Sch Basic Med Sci, Dept Genet, Wuhan 430072, Hubei, Peoples R China; [Long, Yong; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhong, S (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Genet, Wuhan 430072, Hubei, Peoples R China.	zhongshan@whu.edu.cn; zbcui@ihb.ac.cn			National Natural Science Foundation of China [31172395]; Key Technologies Research and Development Program of China [2013BAI12B01-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies Research and Development Program of China(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (grant no. 31172395) and the Key Technologies Research and Development Program of China (grant no. 2013BAI12B01-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali U, 2014, SCI TOTAL ENVIRON, V476, P705, DOI 10.1016/j.scitotenv.2013.12.107; Bai J, 2004, INT J BIOCHEM CELL B, V36, P247, DOI 10.1016/S1357-2725(03)00236-X; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; Chopra AK, 2011, ENVIRON MONIT ASSESS, V173, P905, DOI 10.1007/s10661-010-1433-4; COLE SPC, 1994, CANCER RES, V54, P5902; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Della Torre C, 2012, CHEM-BIOL INTERACT, V198, P9, DOI 10.1016/j.cbi.2012.04.008; Doyotte A, 1997, AQUAT TOXICOL, V39, P93, DOI 10.1016/S0166-445X(97)00024-6; Juan ME, 2010, J NUTR, V140, P489, DOI 10.3945/jn.109.114959; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Fitzpatrick PJ, 1997, BIOMARKERS, V2, P51, DOI 10.1080/135475097231977; FLEMING L, 1994, ANN NEUROL, V36, P100, DOI 10.1002/ana.410360119; Frelet A, 2006, FEBS LETT, V580, P1064, DOI 10.1016/j.febslet.2006.01.024; Frias MM, 2001, J CHROMATOGR B, V760, P1; Furmanski BD, 2013, CLIN CANCER RES, V19, P4359, DOI 10.1158/1078-0432.CCR-13-0980; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Gu QL, 2013, J GENET GENOMICS, V40, P523, DOI 10.1016/j.jgg.2013.06.008; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Huang P, 2012, J GENET GENOMICS, V39, P421, DOI 10.1016/j.jgg.2012.07.004; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; LAGADIC L, 1993, INSECT BIOCHEM MOLEC, V23, P467, DOI 10.1016/0965-1748(93)90054-V; Lai LQ, 2002, BIOCHEM J, V361, P497, DOI 10.1042/0264-6021:3610497; LeDoux M, 2011, J CHROMATOGR A, V1218, P1021, DOI 10.1016/j.chroma.2010.12.097; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2011, MOL BIOL REP, V38, P1703, DOI 10.1007/s11033-010-0283-z; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P381, DOI 10.1016/j.cbpc.2011.01.002; Long Y, 2011, COMP BIOCHEM PHYS C, V153, P310, DOI 10.1016/j.cbpc.2010.12.001; Long Y, 2011, COMP BIOCHEM PHYS B, V158, P46, DOI 10.1016/j.cbpb.2010.09.005; Lu Y, 2010, BIOMED ENVIRON SCI, V23, P230, DOI 10.1016/S0895-3988(10)60057-8; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; MAYEUX PR, 1993, J PHARMACOL EXP THER, V266, P47; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mo SJ, 2010, DEV BIOL, V344, P210, DOI 10.1016/j.ydbio.2010.04.033; Pathak R, 2011, REPROD TOXICOL, V31, P534, DOI 10.1016/j.reprotox.2011.02.007; Ren XQ, 2004, MOL PHARMACOL, V65, P1536, DOI 10.1124/mol.65.6.1536; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Shabbir A, 2005, TOXICOL APPL PHARM, V203, P91, DOI 10.1016/j.taap.2004.07.011; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiemann U, 2008, REPROD TOXICOL, V25, P316, DOI 10.1016/j.reprotox.2008.03.002; Toyoda Y, 2008, XENOBIOTICA, V38, P833, DOI [10.1080/00498250701883514, 10.1080/00498250701883514 ]; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Zamek-Gliszczynski MJ, 2006, J PHARMACOL EXP THER, V319, P1485, DOI 10.1124/jpet.106.110106; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	58	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111664	10.1371/journal.pone.0111664	http://dx.doi.org/10.1371/journal.pone.0111664			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478949	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200003
J	Silva, TMA; Mol, JPS; Winter, MG; Atluri, V; Xavier, MN; Pires, SF; Paixao, TA; Andrade, HM; Santos, RL; Tsolis, RM				Silva, Teane M. A.; Mol, Juliana P. S.; Winter, Maria G.; Atluri, Vidya; Xavier, Mariana N.; Pires, Simone F.; Paixao, Tatiane A.; Andrade, Helida M.; Santos, Renato L.; Tsolis, Renee M.			The Predicted ABC Transporter AbcEDCBA Is Required for Type IV Secretion System Expression and Lysosomal Evasion by Brucella ovis	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; OUTER-MEMBRANE PROPERTIES; INTRACELLULAR SURVIVAL; MURINE MACROPHAGES; OMP25/OMP31 FAMILY; ESCHERICHIA-COLI; VIRB; ABORTUS; VIRULENCE; SUIS	Brucella ovis is a major cause of reproductive failure in rams and it is one of the few well-described Brucella species that is not zoonotic. Previous work showed that a B. ovis mutant lacking a species-specific ABC transporter (Delta abcBA) was attenuated in mice and was unable to survive in macrophages. The aim of this study was to evaluate the role of this ABC transporter during intracellular survival of B. ovis. In HeLa cells, B. ovis WT was able to survive and replicate at later time point (48 hpi), whereas an Delta abcBA mutant was attenuated at 24 hpi. The reduced survival of the DabcBA mutant was associated with a decreased ability to exclude the lysosomal marker LAMP1 from its vacuolar membrane, suggesting a failure to establish a replicative niche. The DabcBA mutant showed a reduced abundance of the Type IV secretion system (T4SS) proteins VirB8 and VirB11 in both rich and acid media, when compared to WT B. ovis. However, mRNA levels of virB1, virB8, hutC, and vjbR were similar in both strains. These results support the notion that the ABC transporter encoded by abcEDCBA or its transported substrate acts at a post-transcriptional level to promote the optimal expression of the B. ovis T4SS within infected host cells.	[Silva, Teane M. A.; Mol, Juliana P. S.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [Winter, Maria G.; Atluri, Vidya; Xavier, Mariana N.; Tsolis, Renee M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Pires, Simone F.; Andrade, Helida M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; University of California System; University of California Davis; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil.	rls@ufmg.br; rmtsolis@ucdavis.edu	Byndloss, Mariana Xavier/ABD-5506-2021; de Lima Santos, Renato/A-1134-2008; Byndloss, Mariana X/D-9890-2014; Gomes, Teane Milagres Augusto/AAP-2686-2021; Paixao, Tatiane/A-2871-2013	Byndloss, Mariana Xavier/0000-0002-2122-4156; de Lima Santos, Renato/0000-0002-4830-0470; Byndloss, Mariana X/0000-0002-2122-4156; Gomes, Teane Milagres Augusto/0000-0002-3752-8613; Paixao, Tatiane/0000-0001-8284-9902; Mol, Juliana/0000-0002-6946-8213; Tsolis, Renee/0000-0001-9131-6657	US PHS [AI050553, AI090387]; CNPq, Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090387, R01AI050553] Funding Source: NIH RePORTER	US PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US PHS grants AI050553 and AI090387 to R.M.T. supported this work. T.M.A.S. was supported by a fellowship from CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; ANDREWS JC, 1985, J BACTERIOL, V161, P484, DOI 10.1128/JB.161.2.484-492.1985; Arocena GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035394; Blasco J. M., 1990, Animal brucellosis., P351; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; BURGESS GW, 1982, VET MICROBIOL, V7, P551, DOI 10.1016/0378-1135(82)90049-9; Caro-Hernandez P, 2007, INFECT IMMUN, V75, P4050, DOI 10.1128/IAI.00486-07; CARPENTER TE, 1987, J AM VET MED ASSOC, V190, P977; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Cloeckaert A, 2002, VET MICROBIOL, V90, P229, DOI 10.1016/S0378-1135(02)00211-0; Copin R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002575; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Edwards RA, 1999, BIOTECHNIQUES, V26, P892, DOI 10.2144/99265st02; Ficapal A, 1998, SMALL RUMINANT RES, V29, P13, DOI 10.1016/S0921-4488(97)00108-9; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Garza E, 2011, WORLD J MICROB BIOT, V27, P449, DOI 10.1007/s11274-010-0451-2; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; GIBSON MM, 1984, J BACTERIOL, V160, P122, DOI 10.1128/JB.160.1.122-130.1984; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9; Jenner DC, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/354649; Jubier-Maurin V, 2001, J BACTERIOL, V183, P426, DOI 10.1128/JB.183.2.426-434.2001; Ko JY, 2000, MICROB PATHOGENESIS, V29, P245, DOI 10.1006/mpat.2000.0389; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Lamontagne J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-300; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; Martin-Martin AI, 2011, VET J, V189, P103, DOI 10.1016/j.tvjl.2010.05.021; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; NAIDER F, 1975, J BACTERIOL, V122, P1208, DOI 10.1128/JB.122.3.1208-1215.1975; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; PLOMMET M, 1991, ZBL BAKT-INT J MED M, V275, P436; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rolan HG, 2007, INFECT IMMUN, V75, P2965, DOI 10.1128/IAI.01896-06; Rosinha GMS, 2002, INFECT IMMUN, V70, P5036, DOI 10.1128/IAI.70.9.5036-5044.2002; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Sa JC, 2012, VET MICROBIOL, V159, P130, DOI 10.1016/j.vetmic.2012.03.029; Sangari FJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-107; Vieira HGS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097526; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2013, FUTURE MICROBIOL, V8, P1193, DOI 10.2217/fmb.13.83; Sieira R, 2010, J BACTERIOL, V192, P217, DOI 10.1128/JB.01124-09; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Thoen C. O., 1993, P236; Tsolis RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005519; Verger JM, 1988, TECHNIQUES BRUCELLOS; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Zhong ZJ, 2009, MICROBIOL-SGM, V155, P3392, DOI 10.1099/mic.0.030619-0	64	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114532	10.1371/journal.pone.0114532	http://dx.doi.org/10.1371/journal.pone.0114532			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474545	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500045
J	Smithline, ZB; Nikonova, AS; Hensley, HH; Cai, KQ; Egleston, BL; Proia, DA; Seeger-Nukpezah, T; Golemis, EA				Smithline, Zachary B.; Nikonova, Anna S.; Hensley, Harvey H.; Cai, Kathy Q.; Egleston, Brian L.; Proia, David A.; Seeger-Nukpezah, Tamina; Golemis, Erica A.			Inhibiting Heat Shock Protein 90 (HSP90) Limits the Formation of Liver Cysts Induced by Conditional Deletion of Pkd1 in Mice	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; GROWTH; GANETESPIB; EVEROLIMUS; MODEL	Polycystic liver disease (PLD) occurs in 75-90% of patients affected by autosomal dominant polycystic kidney disease (ADPKD), which affects 1: 400-1,000 adults and arises from inherited mutations in the PKD1 or PKD2 genes. PLD can lead to bile duct obstructions, infected or bleeding cysts, and hepatomegaly, which can diminish quality of life. At present, no effective, approved therapy exists for ADPKD or PLD. We recently showed that inhibition of the molecular chaperone heat shock protein 90 (HSP90) with a small molecule inhibitor, STA-2842, induced the degradation of multiple HSP90-dependent client proteins that contribute to ADPKD pathogenesis and slowed the progression of renal cystogenesis in mice with conditional deletion of Pkd1. Here, we analyzed the effects of STA-2842 on liver size and cystic burden in Pkd(-/-) mice with established PLD. Using magnetic resonance imaging over time, we demonstrate that ten weeks of STA-2842 treatment significantly reduced both liver mass and cystic index suggesting selective elimination of cystic tissue. Pre-treatment cystic epithelia contain abundant HSP90; the degree of reduction in cysts was accompanied by inhibition of proliferation-associated signaling proteins EGFR and others, and induced cleavage of caspase 8 and PARP1, and correlated with degree of HSP90 inhibition and with inactivation of ERK1/2. Our results suggest that HSP90 inhibition is worth further evaluation as a therapeutic approach for patients with PLD.	[Smithline, Zachary B.] Yale Univ, New Haven, CT 06520 USA; [Smithline, Zachary B.; Nikonova, Anna S.; Hensley, Harvey H.; Cai, Kathy Q.; Egleston, Brian L.; Seeger-Nukpezah, Tamina; Golemis, Erica A.] Fox Chase Canc Ctr, Program Mol Therapeut, Philadelphia, PA 19111 USA; [Proia, David A.] Synta Pharmaceut, Lexington, MA 02421 USA; [Seeger-Nukpezah, Tamina] Univ Hosp Cologne, Ctr Integrated Oncol, Dept Internal Med 1, D-50937 Cologne, Germany	Yale University; Fox Chase Cancer Center; University of Cologne	Seeger-Nukpezah, T (corresponding author), Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	tamina.seeger-nukpezah@uk-koeln.de; Erica.Golemis@fccc.edu	Egleston, Brian L./P-1000-2019	Egleston, Brian L./0000-0002-1633-799X; Golemis, Erica/0000-0003-3618-3673	DOD PRMRP [W81XWH-12-1-0437/PR110518]; German Research Foundation (DFG) [SE2280/1, SE2280/2]; Koln Fortune [252/2013]; National Institutes of Health Core Grant [CA06927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	DOD PRMRP; German Research Foundation (DFG)(German Research Foundation (DFG)); Koln Fortune; National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are very thankful to Catherine and Peter Getchell and the Bucks County Chapter of the Fox Chase Board of Associates for their financial support. This work was further supported by funding from DOD PRMRP W81XWH-12-1-0437/PR110518 (to E.A. G.), from the German Research Foundation (DFG) SE2280/1, SE2280/2 and Koln Fortune 252/2013 (to T.S.-N.) and from the National Institutes of Health Core Grant CA06927 (to Fox Chase Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2014, MTOR INHIBITION POTE; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; Chrispijn M, 2013, J HEPATOL, V59, P153, DOI 10.1016/j.jhep.2013.03.004; DAGATA IDA, 1994, SEMIN LIVER DIS, V14, P215, DOI 10.1055/s-2007-1007313; GRANTHAM JJ, 1990, AM J KIDNEY DIS, V15, P110, DOI 10.1016/S0272-6386(12)80507-5; Kurbegovic A, 2010, HUM MOL GENET, V19, P1174, DOI 10.1093/hmg/ddp588; Liu H, 2013, CLIN CANC RES OFFICI; Liu YM, 2014, TRANSPL P, V46, P66, DOI 10.1016/j.transproceed.2013.10.040; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Proia DA, 2014, CLIN CANCER RES, V20, P413, DOI 10.1158/1078-0432.CCR-13-2166; Ramalingam S, 2013, J CLIN ONCOL, V33, p18s; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2012, J AM SOC NEPHROL, V23, P1674, DOI 10.1681/ASN.2012040367; Spirli C, 2010, HEPATOLOGY, V51, P1778, DOI 10.1002/hep.23511; Spirli C, 2010, GASTROENTEROLOGY, V138, P360, DOI 10.1053/j.gastro.2009.09.005; Strazzabosco M, 2011, GASTROENTEROLOGY, V140, P1855, DOI 10.1053/j.gastro.2011.04.030; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923	27	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114403	10.1371/journal.pone.0114403	http://dx.doi.org/10.1371/journal.pone.0114403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474361	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500025
J	Xu, JG; Huang, CF; Yang, ZF; Jin, MM; Fu, PH; Zhang, N; Luo, J; Li, DL; Liu, MY; Zhou, Y; Zhu, YQ				Xu, Jin-Gen; Huang, Chunfeng; Yang, Zhengfeng; Jin, Mengmeng; Fu, Panhan; Zhang, Ni; Luo, Jian; Li, Dali; Liu, Mingyao; Zhou, Yan; Zhu, Yongqun			Crystal Structure of LGR4-Rspo1 Complex INSIGHTS INTO THE DIVERGENT MECHANISMS OF LIGAND RECOGNITION BY LEUCINE-RICH REPEAT G-PROTEIN-COUPLED RECEPTORS (LGRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; R-SPONDIN RECOGNITION; WNT/BETA-CATENIN; NEGATIVE COOPERATIVITY; EXTRACELLULAR REGION; R-SPONDIN-4 RSPO4; ORPHAN RECEPTORS; WNT RECEPTORS; RELAXIN; ECTODOMAIN	Leucine-rich repeat G-protein-coupled receptors (LGRs) are a unique class of G-protein-coupled receptors characterized by a large extracellular domain to recognize ligands and regulate many important developmental processes. Among the three groups of LGRs, group B members (LGR4-6) recognize R-spondin family proteins (Rspo1-4) to stimulate Wnt signaling. In this study, we successfully utilized the "hybrid leucine-rich repeat technique," which fused LGR4 with the hagfish VLR protein, to obtain two recombinant human LGR4 proteins, LGR4(15) and LGR4(9). We determined the crystal structures of ligand-free LGR415 and the LGR4(9)-Rspo1 complex. LGR4 exhibits a twisted horseshoe-like structure. Rspo1 adopts a flat and beta-fold architecture and is bound in the concave surface of LGR4 in the complex through electrostatic and hydrophobic interactions. All the Rspo1-binding residues are conserved in LGR4-6, suggesting that LGR4-6 bind R-spondins through an identical surface. Structural analysis of our LGR4-Rspo1 complex with the previously determined LGR4 and LGR5 structures revealed that the concave surface of LGR4 is the sole binding site for R-spondins, suggesting a one-site binding model of LGR4-6 in ligand recognition. The molecular mechanism of LGR4-6 is distinct from the two-step mechanism of group A receptors LGR1-3 and the multiple-interface binding model of group C receptors LGR7-8, suggesting LGRs utilize the divergent mechanisms for ligand recognition. Our structures, together with previous reports, provide a comprehensive understanding of the ligand recognition by LGRs.	[Xu, Jin-Gen; Huang, Chunfeng; Jin, Mengmeng; Fu, Panhan; Zhang, Ni; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Jin-Gen; Huang, Chunfeng; Jin, Mengmeng; Fu, Panhan; Zhang, Ni; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Yang, Zhengfeng; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Yang, Zhengfeng; Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	Zhejiang University; Zhejiang University; East China Normal University; East China Normal University	Zhou, Y (corresponding author), Zhejiang Univ, Inst Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhouyanlsi@zju.edu.cn; zhuyonggun@zju.edu.cn	Yang, Zhengfeng/AAA-7014-2020; Luo, Jian/H-3362-2016	Liu, Mingyao/0000-0001-7339-5048; Luo, Jian/0000-0003-3583-0154; Xu, Jingen/0000-0002-2053-6369	China's Fundamental Research Funds for the Central Universities; NSFC [31370722, 81322024]; Natural Science Foundation of Zhejiang Province [LR13C05001]; Zhejiang University K. P. Chao's High Technology Development Foundation [J20130639]	China's Fundamental Research Funds for the Central Universities; NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang University K. P. Chao's High Technology Development Foundation	This work was supported by China's Fundamental Research Funds for the Central Universities, Research Grants 31370722 and 81322024 from the NSFC, Grant LR13C05001 from Natural Science Foundation of Zhejiang Province, and Grant J20130639 from Zhejiang University K. P. Chao's High Technology Development Foundation (to Y. Zhu).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Barker N, 2013, DEVELOPMENT, V140, P2484, DOI 10.1242/dev.083113; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Diepenhorst NA, 2014, J BIOL CHEM, V289, P34938, DOI 10.1074/jbc.M114.600882; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Hsu SYT, 2003, MOL CELL ENDOCRINOL, V202, P165, DOI 10.1016/S0303-7207(03)00078-9; Jiang XL, 2014, J BIOL CHEM, V289, P14273, DOI 10.1074/jbc.M114.549592; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Laskowski AR, 1993, J APPL CRYSTALLOGR, V26, P283; LIMBIRD LE, 1975, BIOCHEM BIOPH RES CO, V64, P1160, DOI 10.1016/0006-291X(75)90815-3; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; RAZ E, 1991, GENETICS, V129, P191; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Svendsen AM, 2009, ANN NY ACAD SCI, V1160, P54, DOI 10.1111/j.1749-6632.2009.03835.x; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	56	16	17	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2455	2465		10.1074/jbc.M114.599134	http://dx.doi.org/10.1074/jbc.M114.599134			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480784	Green Published, hybrid			2022-12-26	WOS:000348588000047
J	Factor-Litvak, P; Insel, B; Calafat, AM; Liu, XH; Perera, F; Rauh, VA; Whyatt, RM				Factor-Litvak, Pam; Insel, Beverly; Calafat, Antonia M.; Liu, Xinhua; Perera, Frederica; Rauh, Virginia A.; Whyatt, Robin M.			Persistent Associations between Maternal Prenatal Exposure to Phthalates on Child IQ at Age 7 Years	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BISPHENOL-A; ENVIRONMENTAL CHEMICALS; TEMPORAL VARIABILITY; NATIONAL-HEALTH; MALE RATS; IN-VITRO; METABOLITES; NEURODEVELOPMENT; INTELLIGENCE	Background: Prior research reports inverse associations between maternal prenatal urinary phthalate metabolite concentrations and mental and motor development in preschoolers. No study evaluated whether these associations persist into school age. Methods: In a follow up of 328 inner-city mothers and their children, we measured prenatal urinary metabolites of di-n-butyl phthalate (DnBP), butylbenzyl phthalate (BBzP), di-isobutyl phthalate (DiBP), di-2-ethylhexyl phthalate and diethyl phthalate in late pregnancy. The Wechsler Intelligence Scale for Children, 4th edition was administered at child age 7 years and evaluates four areas of cognitive function associated with overall intelligence quotient (IQ). Results: Child full-scale IQ was inversely associated with prenatal urinary metabolite concentrations of DnBP and DiBP: b=-22.69 (95% confidence interval [CI] = -4.33, -1.05) and b= -2.69 (95% CI= -4.22, -1.16) per log unit increase. Among children of mothers with the highest versus lowest quartile DnBP and DiBP metabolite concentrations, IQ was 6.7 (95% CI= 1.9, 11.4) and 7.6 (95% CI= 3.2, 12.1) points lower, respectively. Associations were unchanged after control for cognition at age 3 years. Significant inverse associations were also seen between maternal prenatal metabolite concentrations of DnBP and DiBP and child processing speed, perceptual reasoning and working memory; DiBP and child verbal comprehension; and BBzP and child perceptual reasoning. Conclusion: Maternal prenatal urinary metabolite concentrations measured in late pregnancy of DnBP and DiBP are associated with deficits in children's intellectual development at age 7 years. Because phthalate exposures are ubiquitous and concentrations seen here within the range previously observed among general populations, results are of public health significance.	[Factor-Litvak, Pam; Insel, Beverly] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Calafat, Antonia M.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Liu, Xinhua] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Perera, Frederica; Whyatt, Robin M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, Columbia Ctr Childrens Environm Hlth, New York, NY USA; [Rauh, Virginia A.] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA	Columbia University; Centers for Disease Control & Prevention - USA; Columbia University; Columbia University; Columbia University	Factor-Litvak, P (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	prf1@columbia.edu	Calafat, Antonia/GOP-1115-2022; Calafat, Antonia/N-1183-2019	Calafat, Antonia/0000-0002-9796-7482; Perera, Frederica/0000-0002-1364-9250	National Institute of Environmental Health Sciences (NIEHS) [R01ES013543, R01ES014393, R01ES08977]; NIEHS/United States Environmental Protection Agency [P50 ES09600/RD 83214101]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008977, R01ES013543, R01ES014393, P30ES009089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS/United States Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences (NIEHS) grants R01ES013543, R01ES014393, and R01ES08977 and by NIEHS/United States Environmental Protection Agency grant P50 ES09600/RD 83214101. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022; Bellinger DC, 2013, SAF HEALTH WORK-KR, V4, P1, DOI 10.5491/SHAW.2013.4.1.1; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Bouchard MF, 2011, ENVIRON HEALTH PERSP, V119, P1189, DOI 10.1289/ehp.1003185; Braun JM, 2013, CURR OPIN PEDIATR, V25, P247, DOI 10.1097/MOP.0b013e32835e1eb6; Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009; Brown L., 1990, TEST NONVERBAL INTEL; Caldwell B.M., 1979, HOME OBSERVATION MEA; CDC, 4 CDCP; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536; Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Li YF, 2009, J APPL TOXICOL, V29, P603, DOI 10.1002/jat.1447; Matsuda S, 2012, PROG NEURO-PSYCHOPH, V39, P273, DOI 10.1016/j.pnpbp.2012.06.016; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; O'Connor JC, 2002, TOXICOL SCI, V69, P79, DOI 10.1093/toxsci/69.1.79; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330; Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; Wechsler D, 1974, WECHSLER INTELLIGENC; Weiss B, 2012, NEUROTOXICOLOGY, V33, P1410, DOI 10.1016/j.neuro.2012.05.014; Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705; Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	44	103	104	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114003	10.1371/journal.pone.0114003	http://dx.doi.org/10.1371/journal.pone.0114003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493564	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400026
J	Horton, TW; Bierregaard, RO; Zawar-Reza, P; Holdaway, RN; Sagar, P				Horton, Travis W.; Bierregaard, Richard O.; Zawar-Reza, Peyman; Holdaway, Richard N.; Sagar, Paul			Juvenile Osprey Navigation during Trans-Oceanic Migration	PLOS ONE			English	Article							MAGNETIC COMPASS ORIENTATION; WIND DRIFT; GECARCOIDEA-NATALIS; PANDION-HALIAETUS; AVIAN ORIENTATION; COMPENSATION; BEHAVIOR; FIELD; SEA; MAP	To compensate for drift, an animal migrating through air or sea must be able to navigate. Although some species of bird, fish, insect, mammal, and reptile are capable of drift compensation, our understanding of the spatial reference frame, and associated coordinate space, in which these navigational behaviors occur remains limited. Using high resolution satellite-monitored GPS track data, we show that juvenile ospreys (Pandion haliaetus) are capable of non-stop constant course movements over open ocean spanning distances in excess of 1500 km despite the perturbing effects of winds and the lack of obvious landmarks. These results are best explained by extreme navigational precision in an exogenous spatio-temporal reference frame, such as positional orientation relative to Earth's magnetic field and pacing relative to an exogenous mechanism of keeping time. Given the age (< 1 year-old) of these birds and knowledge of their hatching site locations, we were able to transform Enhanced Magnetic Model coordinate locations such that the origin of the magnetic coordinate space corresponded with each bird's nest. Our analyses show that trans-oceanic juvenile osprey movements are consistent with bicoordinate positional orientation in transformed magnetic coordinate or geographic space. Through integration of movement and meteorological data, we propose a new theoretical framework, chord and clock navigation, capable of explaining the precise spatial orientation and temporal pacing performed by juvenile ospreys during their long-distance migrations over open ocean.	[Horton, Travis W.] Univ Canterbury, Dept Geol Sci, Christchurch 1, New Zealand; [Bierregaard, Richard O.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Zawar-Reza, Peyman] Univ Canterbury, Dept Geog, Christchurch 1, New Zealand; [Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Sagar, Paul] Natl Inst Water & Atmospher Res, Christchurch, New Zealand	University of Canterbury; University of North Carolina; University of North Carolina Charlotte; University of Canterbury; University of Canterbury; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Horton, TW (corresponding author), Univ Canterbury, Dept Geol Sci, Christchurch 1, New Zealand.	travis.horton@canterbury.ac.nz		Horton, Travis/0000-0003-0558-2970	tobacco company	tobacco company	The authors thank Public Service of New Hampshire and anonymous donors who funded the transmitters and Massachusetts Audubon who administered the funds for the Massachusetts birds. The anonymous donors do not have any competing interests in relation to this work, nor were their identities relevant to the assessment of the validity of this work. None of the research costs or authors' salaries were funded by a tobacco company. The authors are not aware of any competing interests.	ABLE KP, 1995, CONDOR, V97, P592, DOI 10.2307/1369049; Adamczewska AM, 2001, BIOL BULL, V200, P305, DOI 10.2307/1543512; Akesson S, 1998, J AVIAN BIOL, V29, P618, DOI 10.2307/3677182; Alerstam T., 1990, P331; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; BARLOW JS, 1964, J THEOR BIOL, V6, P76; Batschelet E, 1981, CIRCULAR STAT BIOL; Bierregaard RO, 2014, J RAPTOR RES, V48, P86, DOI 10.3356/JRR-13-00016.1; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; BINGMAN VP, 1982, ANIM BEHAV, V30, P49, DOI 10.1016/S0003-3472(82)80236-4; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bloom Peter H., 2007, P193; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Bostrom JE, 2012, ECOGRAPHY, V35, P1039, DOI 10.1111/j.1600-0587.2012.07507.x; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; DeVries P, 2004, T AM FISH SOC, V133, P1379, DOI 10.1577/T03-173.1; EMLEN ST, 1969, SCIENCE, V165, P716, DOI 10.1126/science.165.3894.716; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Gronroos J, 2013, J ORNITHOL, V154, P385, DOI 10.1007/s10336-012-0902-7; GWINNER E, 1967, NATURWISSENSCHAFTEN, V54, P447, DOI 10.1007/BF00603157; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Hake M, 2001, J AVIAN BIOL, V32, P47, DOI 10.1034/j.1600-048X.2001.320107.x; HICKS JW, 1985, AUST J ZOOL, V33, P127, DOI 10.1071/ZO9850127; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KEETON WT, 1979, ANNU REV PHYSIOL, V41, P353, DOI 10.1146/annurev.ph.41.030179.002033; Kjellen N, 2001, J AVIAN BIOL, V32, P57, DOI 10.1034/j.1600-048X.2001.320108.x; KRAMER G, 1950, NATURWISSENSCHAFTEN, V37, P377, DOI 10.1007/BF00626007; Krupczynski P, 2008, CURR BIOL, V18, P1961, DOI 10.1016/j.cub.2008.10.066; Larkin T., 1978, ANIMAL MIGRATION NAV, DOI [10.1007/978-3-662-11147-5_8, DOI 10.1007/978-3-662-11147-5_8]; Lea MA, 2010, MAR ECOL PROG SER, V419, P233, DOI 10.3354/meps08758; LEDNOR AJ, 1984, J EXP BIOL, V111, P259; LINDAUER M, 1968, Z VERGL PHYSIOL, V60, P219, DOI 10.1007/BF00298600; Liu Xiaofeng, 2012, Chinese Birds, V3, P1; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lohmann KJ, 2012, CURR OPIN NEUROBIOL, V22, P336, DOI 10.1016/j.conb.2011.11.005; Maus S, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003026; McLaren JD, 2012, BEHAV ECOL, V23, P1089, DOI 10.1093/beheco/ars078; MERRIAM JB, 1992, GEOPHYS J INT, V108, P415, DOI 10.1111/j.1365-246X.1992.tb04624.x; Meyer SK, 2000, BEHAVIOUR, V137, P379, DOI 10.1163/156853900502132; Muggeo V.M., 2008, R NEWS, V8, P20; Narazaki T, 2009, J EXP BIOL, V212, P4019, DOI 10.1242/jeb.034637; PAPI F, 1989, ETHOL ECOL EVOL, V1, P219, DOI 10.1080/08927014.1989.9525511; PHILLIPS JB, 1986, J COMP PHYSIOL A, V158, P103, DOI 10.1007/BF00614524; Pinet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027663; PIPER JDA, 1989, PHYS EARTH PLANET IN, V55, P37, DOI 10.1016/0031-9201(89)90232-X; Putman NF, 2013, CURR BIOL, V23, P312, DOI 10.1016/j.cub.2012.12.041; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Rao JS., 2001, TOPICS CIRCULAR STAT; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Safi K, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-4; Sapir N, 2014, J ORNITHOL, V155, P745, DOI 10.1007/s10336-014-1060-x; Schmidt AJ, 2012, ANIM BEHAV, V84, P333, DOI 10.1016/j.anbehav.2012.04.023; SHAMAROCK WC, 2005, NCARTN468STR; Shamoun-Baranes J, 2010, INTEGR COMP BIOL, V50, P280, DOI 10.1093/icb/icq011; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Viguier C., 1882, REV PHILOSOPHIQUE FR, V14, P1; WEHNER R, 1970, EXPERIENTIA, V26, P967, DOI 10.1007/BF02114135; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054; Wiltschko R, 2010, CURR ZOOL, V56, P265, DOI 10.1093/czoolo/56.3.265; Wiltschko W., 1972, ANIMAL ORIENTATION N, P569	71	17	17	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114557	10.1371/journal.pone.0114557	http://dx.doi.org/10.1371/journal.pone.0114557			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493430	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400052
J	Chen, Y; Huang, WN; Peng, B				Chen, Yi; Huang, Weina; Peng, Bei			Determination of Optimal Parameters for Dual-Layer Cathode of Polymer Electrolyte Fuel Cell Using Computational Intelligence-Aided Design	PLOS ONE			English	Article							SERPENTINE FLOW-FIELD; SENSITIVITY EXAMINATION; MODEL; OPTIMIZATION; SIMULATION; PERFORMANCE; VALIDATION; TRANSPORT	Because of the demands for sustainable and renewable energy, fuel cells have become increasingly popular, particularly the polymer electrolyte fuel cell (PEFC). Among the various components, the cathode plays a key role in the operation of a PEFC. In this study, a quantitative dual-layer cathode model was proposed for determining the optimal parameters that minimize the over-potential difference g and improve the efficiency using a newly developed bat swarm algorithm with a variable population embedded in the computational intelligence-aided design. The simulation results were in agreement with previously reported results, suggesting that the proposed technique has potential applications for automating and optimizing the design of PEFCs.	[Chen, Yi; Huang, Weina; Peng, Bei] Univ Elect Sci & Technol China, Sch Mech Engn, Chengdu 611731, Peoples R China; [Chen, Yi; Huang, Weina; Peng, Bei] Univ Elect Sci & Technol China, Robot Res Ctr, Chengdu 611731, Peoples R China; [Chen, Yi] Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Glasgow Caledonian University	Peng, B (corresponding author), Univ Elect Sci & Technol China, Sch Mech Engn, Chengdu 611731, Peoples R China.	beipeng@uestc.edu.cn	Chen, Yi/P-8641-2017	Chen, Yi/0000-0001-7960-8374	National Natural Science Foundation of China [91123023, 51105061]; National Program for Support of Top-Notch Young Professionals	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-Notch Young Professionals	This work was supported by the National Natural Science Foundation of China (No. 91123023 and 51105061) and the National Program for Support of Top-Notch Young Professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMPHLETT JC, 1995, J ELECTROCHEM SOC, V142, P1, DOI 10.1149/1.2043866; Askarzadeh A, 2012, IEEE T IND ELECTRON, V59, P3473, DOI 10.1109/TIE.2011.2172173; Baschuk JJ, 2000, J POWER SOURCES, V86, P181, DOI 10.1016/S0378-7753(99)00426-7; BERNARDI DM, 1992, J ELECTROCHEM SOC, V139, P2477, DOI 10.1149/1.2221251; Bevers D, 1997, J APPL ELECTROCHEM, V27, P1254, DOI 10.1023/A:1018488021355; Chen Y, 2014, SWARMDOLPHIN SWARM D; Chen Y, 2013, SWARMBAT ARTIFICIAL; Chen Y, 2011, J APPL PHYS, V110; Chen Y, 2013, SECFLAB SIMPLE ECONO; Chen Y, 2012, 2012 P 58 ANN REL MA; Chen Y, 2014, APPL THERM ENG, V70, P263, DOI 10.1016/j.applthermaleng.2014.05.004; Chen Y, 2014, J CLEAN PROD, V69, P143, DOI 10.1016/j.jclepro.2014.01.058; Chen Y, 2013, ENERGIES, V6, P3082, DOI 10.3390/en6063082; Chen Y, 2013, INFORM FUSION, V14, P327, DOI 10.1016/j.inffus.2011.12.003; Chen Y, 2013, ENTROPY-SWITZ, V15, P10, DOI 10.3390/e15010010; Chen Y, 2012, J DYN SYST-T ASME, V134, DOI 10.1115/1.4006220; Chen Y, 2012, APPL SOFT COMPUT, V12, P2631, DOI 10.1016/j.asoc.2012.04.014; Chen Y, 2012, EXPERT SYST APPL, V39, P6469, DOI 10.1016/j.eswa.2011.12.060; Chen Y, 2007, IEEE C EVOL COMPUTAT, P987; Feng XH, 2010, ELECTROCHIM ACTA, V55, P4579, DOI 10.1016/j.electacta.2010.03.013; Gao F, 2010, J POWER SOURCES, V195, P7609, DOI 10.1016/j.jpowsour.2010.06.006; Grujicic M, 2004, APPL SURF SCI, V227, P56, DOI 10.1016/j.apsusc.2003.10.035; Jung JH, 2011, IEEE T IND ELECTRON, V58, P4217, DOI 10.1109/TIE.2010.2098365; Khajeh-Hosseini-Dalasm N, 2010, INT J HYDROGEN ENERG, V35, P2417, DOI 10.1016/j.ijhydene.2009.12.111; Kulikovsky AA, 1999, J ELECTROCHEM SOC, V146, P3981, DOI 10.1149/1.1392580; Min CH, 2006, J POWER SOURCES, V160, P374, DOI 10.1016/j.jpowsour.2006.01.080; Molaeimanesh GR, 2014, J POWER SOURCES, V258, P89, DOI 10.1016/j.jpowsour.2014.02.027; Noorkami M, 2014, INT J HYDROGEN ENERG, V39, P1439, DOI 10.1016/j.ijhydene.2013.10.156; Pathak R, 2013, ELECTROCHIM ACTA, V113, P42, DOI 10.1016/j.electacta.2013.08.033; Pathapati PR, 2005, RENEW ENERG, V30, P1, DOI 10.1016/j.renene.2004.05.001; Ramadass P, 2003, J POWER SOURCES, V123, P230, DOI 10.1016/S0378-7753(03)00531-7; Rowe A, 2001, J POWER SOURCES, V102, P82, DOI 10.1016/S0378-7753(01)00798-4; Sayyaadi H, 2013, INT J ENERG RES, V37, P1872, DOI 10.1002/er.3004; Song DT, 2004, J POWER SOURCES, V126, P104, DOI 10.1016/j.jpowsour.2003.08.043; Song JM, 2001, J POWER SOURCES, V94, P78, DOI 10.1016/S0378-7753(00)00629-7; SPRINGER TE, 1991, J ELECTROCHEM SOC, V138, P2334, DOI 10.1149/1.2085971; Tao WQ, 2006, J POWER SOURCES, V160, P359, DOI 10.1016/j.jpowsour.2006.01.078; Wang L, 2003, INT J HYDROGEN ENERG, V28, P1263, DOI 10.1016/S0360-3199(02)00284-7; Wang XD, 2008, J POWER SOURCES, V175, P397, DOI 10.1016/j.jpowsour.2007.09.009; Wang XD, 2014, J TAIWAN INST CHEM E, V45, P1532, DOI 10.1016/j.jtice.2014.03.011; Wang XD, 2012, INT J HYDROGEN ENERG, V37, P15766, DOI 10.1016/j.ijhydene.2012.04.029; Wang XD, 2011, INT J HEAT MASS TRAN, V54, P2375, DOI 10.1016/j.ijheatmasstransfer.2011.02.024; Wang XD, 2010, INT J HYDROGEN ENERG, V35, P4247, DOI 10.1016/j.ijhydene.2010.02.059; Wang Y, 2008, J ELECTROCHEM SOC, V155, pA8; Wang Y, 2011, APPL ENERG, V88, P981, DOI 10.1016/j.apenergy.2010.09.030; Wang Y, 2009, J ELECTROCHEM SOC, V156, pB403, DOI 10.1149/1.3056057; Weber AZ, 2004, CHEM REV, V104, P4679, DOI 10.1021/cr020729l; [徐彦杰 Xu Yanjie], 2012, [中国药学杂志, Chinese Pharmaceutical Journal], V47, P669; Yang XS, 2010, STUD COMPUT INTELL, V284, P65, DOI 10.1007/978-3-642-12538-6_6; Yerramalla S, 2003, J POWER SOURCES, V124, P104, DOI 10.1016/S0378-7753(03)00733-X; 刘晓红, 2012, [中国卫生统计, Chinese Journal of Health Statistics], V29, P846	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114223	10.1371/journal.pone.0114223	http://dx.doi.org/10.1371/journal.pone.0114223			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490761	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300021
J	Fabregat, G; Garcia-de-la-Asuncion, J; Sarria, B; Cortijo, J; De Andres, J; Mata, M; Pastor, E; Belda, FJ				Fabregat, Gustavo; Garcia-de-la-Asuncion, Jose; Sarria, Benjamin; Cortijo, Julio; De Andres, Jose; Mata, Manuel; Pastor, Ernesto; Javier Belda, Francisco			Increased Expression of AQP 1 and AQP 5 in Rat Lungs Ventilated with Low Tidal Volume is Time Dependent	PLOS ONE			English	Article							MECHANICAL VENTILATION; FLUID TRANSPORT; PULMONARY-EDEMA; INJURY; MICE; AQUAPORIN-1; PRESSURE; INFLATION; CYTOKINES; STRATEGY	Background and Goals: Mechanical ventilation (MV) can induce or worsen pulmonary oedema. Aquaporins (AQPs) facilitate the selective and rapid bidirectional movement of water. Their role in the development and resolution of pulmonary oedema is controversial. Our objectives are to determine if prolonged MV causes lung oedema and changes in the expression of AQP 1 and AQP 5 in rats. Methods: 25 male Wistar rats were subjected to MV with a tidal volume of 10 ml/kg, during 2 hours (n=12) and 4 hours (n=13). Degree of oedema was compared with a group of non-ventilated rats (n=5). The expression of AQP 1 and AQP 5 were determined by western immunoblotting, measuring the amount of mRNA (previously amplified by RT-PCR) and immunohistochemical staining of AQPs 1 and 5 in lung samples from all groups. Results: Lung oedema and alveolar-capillary membrane permeability did not change during MV. AQP-5 steady state levels in the western blot were increased (p<0.01) at 2 h and 4 h of MV. But in AQP-1 expression these differences were not found. However, the amount of mRNA for AQP-1 was increased at 2 h and 4 h of MV; and for AQP 5 at 4 h of MV. These findings were corroborated by representative immunohistochemical lung samples. Conclusion: In lungs from rats ventilated with a low tidal volume the expression of AQP 5 increases gradually with MV duration, but does not cause pulmonary oedema or changes in lung permeability. AQPs may have a protective effect against the oedema induced by MV.	[Fabregat, Gustavo] Hosp Gen Univ, Valencia, Spain; [Garcia-de-la-Asuncion, Jose; Pastor, Ernesto] Hosp Clin Univ, Valencia, Spain; [Sarria, Benjamin; Cortijo, Julio] Univ Valencia, Sch Med, Dept Pharmacol, Valencia, Spain; [Cortijo, Julio] Hosp Gen Univ, Res Fdn, Valencia, Spain; [De Andres, Jose; Javier Belda, Francisco] Univ Valencia, Sch Med, Valencia, Spain; [Mata, Manuel] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain; [Javier Belda, Francisco] Hosp Clin Univ, Anaesthesia & Crit Care Dept, Valencia, Spain; [Javier Belda, Francisco] Hosp Clin Univ, Fdn Invest, Inst Invest Clin INCLIVA, Valencia, Spain	Hospital Clinic Universitari de Valencia; Hospital Clinic Universitari de Valencia; University of Valencia; University of Valencia; University of Valencia	Fabregat, G (corresponding author), Hosp Gen Univ, Valencia, Spain.		Morcillo, Esteban/I-1552-2015; De Andres, Jose/AAG-3413-2019; Roig, Manuel Mata/G-4338-2015; Fabregat, Gustavo/AAF-8107-2021; Sarria Chust, Benjamin/D-5900-2016	Morcillo, Esteban/0000-0003-4373-9457; Roig, Manuel Mata/0000-0002-1506-7983; Fabregat, Gustavo/0000-0002-1658-1466; Sarria Chust, Benjamin/0000-0002-8570-7827				Allen GB, 2006, AM J PHYSIOL-LUNG C, V291, pL710, DOI 10.1152/ajplung.00532.2005; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bai CX, 1999, J CLIN INVEST, V103, P555, DOI 10.1172/JCI4138; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bueno PCS, 2002, BRAZ J MED BIOL RES, V35, P191, DOI 10.1590/S0100-879X2002000200007; Cao Chun-shui, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P426; Caruso P, 2003, INTENS CARE MED, V29, P1808, DOI 10.1007/s00134-003-1908-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Dong CL, 2012, RESP PHYSIOL NEUROBI, V181, P21, DOI 10.1016/j.resp.2011.12.008; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Hales CA, 2001, RESP PHYSIOL, V124, P159, DOI 10.1016/S0034-5687(00)00193-6; HEDENSTIERNA G, 1989, EUR RESPIR J, V2, P528; Hegeman MA, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/435236; Jiao GY, 2002, CHINESE MED J-PEKING, V115, P963; Jin LD, 2013, INT IMMUNOPHARMACOL, V16, P288, DOI 10.1016/j.intimp.2013.03.031; KATZENSTEIN ALA, 1976, AM J PATHOL, V85, P210; King LS, 1996, J CLIN INVEST, V97, P2183, DOI 10.1172/JCI118659; Kozono D, 2002, J CLIN INVEST, V109, P1395, DOI 10.1172/JCI200215851; Ma TH, 2000, J CLIN INVEST, V105, P93, DOI 10.1172/JCI8258; Papadimitriou D, 2008, LAB ANIM-UK, V42, P265, DOI 10.1258/la.2007.006035; Plotz FB, 2002, INTENS CARE MED, V28, P486, DOI 10.1007/s00134-002-1216-7; Schmalstieg FC, 2001, ASAIO J, V47, P365, DOI 10.1097/00002480-200107000-00014; Schwarte LA, 2000, BASIC RES CARDIOL, V95, P510, DOI 10.1007/s003950070029; Song YL, 2000, J PHYSIOL-LONDON, V525, P771, DOI 10.1111/j.1469-7793.2000.00771.x; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wang F, 2010, HEPATO-GASTROENTEROL, V57, P1553; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wrigge H, 2000, ANESTHESIOLOGY, V93, P1413, DOI 10.1097/00000542-200012000-00012; Wu XM, 2009, LUNG, V187, P225, DOI 10.1007/s00408-009-9155-5; Yue Dong-Mei, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P147; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	40	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114247	10.1371/journal.pone.0114247	http://dx.doi.org/10.1371/journal.pone.0114247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489856	gold, Green Submitted, Green Published			2022-12-26	WOS:000347515300023
J	Ugarte, JP; Orozco-Duque, A; Tobon, C; Kremen, V; Novak, D; Saiz, J; Oesterlein, T; Schmitt, C; Luik, A; Bustamante, J				Ugarte, Juan P.; Orozco-Duque, Andres; Tobon, Catalina; Kremen, Vaclav; Novak, Daniel; Saiz, Javier; Oesterlein, Tobias; Schmitt, Clauss; Luik, Armin; Bustamante, John			Dynamic Approximate Entropy Electroanatomic Maps Detect Rotors in a Simulated Atrial Fibrillation Model	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; ELECTROGRAM FRACTIONATION; IONIC MECHANISMS; SAMPLE ENTROPY; COMPUTER-MODEL; FOCAL IMPULSE; ABLATION; IRREGULARITY; MORPHOLOGY; HUMANS	There is evidence that rotors could be drivers that maintain atrial fibrillation. Complex fractionated atrial electrograms have been located in rotor tip areas. However, the concept of electrogram fractionation, defined using time intervals, is still controversial as a tool for locating target sites for ablation. We hypothesize that the fractionation phenomenon is better described using non-linear dynamic measures, such as approximate entropy, and that this tool could be used for locating the rotor tip. The aim of this work has been to determine the relationship between approximate entropy and fractionated electrograms, and to develop a new tool for rotor mapping based on fractionation levels. Two episodes of chronic atrial fibrillation were simulated in a 3D human atrial model, in which rotors were observed. Dynamic approximate entropy maps were calculated using unipolar electrogram signals generated over the whole surface of the 3D atrial model. In addition, we optimized the approximate entropy calculation using two real multicenter databases of fractionated electrogram signals, labeled in 4 levels of fractionation. We found that the values of approximate entropy and the levels of fractionation are positively correlated. This allows the dynamic approximate entropy maps to localize the tips from stable and meandering rotors. Furthermore, we assessed the optimized approximate entropy using bipolar electrograms generated over a vicinity enclosing a rotor, achieving rotor detection. Our results suggest that high approximate entropy values are able to detect a high level of fractionation and to locate rotor tips in simulated atrial fibrillation episodes. We suggest that dynamic approximate entropy maps could become a tool for atrial fibrillation rotor mapping.	[Ugarte, Juan P.; Orozco-Duque, Andres; Bustamante, John] Univ Pontificia Bolivariana, Ctr Bioingn, Medellin, Colombia; [Tobon, Catalina] Inst Tecnol Metropolitano, GI2B, Medellin, Colombia; [Kremen, Vaclav; Novak, Daniel] Czech Tech Univ, Czech Inst Informat Robot & Cybernet, CR-16635 Prague, Czech Republic; [Kremen, Vaclav] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Saiz, Javier] Univ Politecn Valencia, I3BH, E-46071 Valencia, Spain; [Oesterlein, Tobias] Karlsruhe Inst Technol, Inst Biomed Engn, D-76021 Karlsruhe, Germany; [Schmitt, Clauss; Luik, Armin] Staedt Klinikum Karlsruhe, Med Klin 4, Karlsruhe, Germany	Universidad Pontificia Bolivariana; Czech Technical University Prague; Czech Technical University Prague; Universitat Politecnica de Valencia; Helmholtz Association; Karlsruhe Institute of Technology; Municipal Hospital Karlsruhe	Ugarte, JP (corresponding author), Univ Pontificia Bolivariana, Ctr Bioingn, Medellin, Colombia.	juan.ugartem@alfa.upb.edu.co	Ugarte, Juan Pablo/R-2624-2019; Saiz, Javier/I-1295-2015; Novak, Daniel/G-9231-2014; Bustamante, John/D-1372-2012; Orozco-Duque, Andres/M-8332-2014; Luik, Armin/ABE-0996-2022; Kremen, Vaclav/G-7612-2017; Ugarte, Juan Pablo/HCI-9870-2022	Ugarte, Juan Pablo/0000-0001-8008-3528; Saiz, Javier/0000-0002-9850-0825; Novak, Daniel/0000-0001-6996-9344; Bustamante, John/0000-0002-4855-9896; Orozco-Duque, Andres/0000-0001-8582-8015; Kremen, Vaclav/0000-0001-9844-7617; Ugarte, Juan Pablo/0000-0001-8008-3528	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia [121056933647]; Programa de Formacion de Investigadores Francisco Jose de Caldas; Ministry of Education, Youth and Sports of the Czech Republic [MSM6840770012]; Czech Science Foundation [P103/11/P106]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia; Programa de Formacion de Investigadores Francisco Jose de Caldas; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	JPU, CT, and JB were partially supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia (www.colciencias.gov.co), project # 121056933647; AO was supported by the Programa de Formacion de Investigadores Francisco Jose de Caldas (www.colciencias.gov.co); VK and DN were partially supported by research project # MSM6840770012 Interdisciplinary Biomedical Engineering Research II from the Ministry of Education (www.msmt.cz), Youth and Sports of the Czech Republic, and VK was partially supported by post-doctoral research project GACR # P103/11/P106 of the Czech Science Foundation (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz R, 2010, BIOMED SIGNAL PROCES, V5, P1, DOI 10.1016/j.bspc.2009.11.001; Anier A, 2012, BRIT J ANAESTH, V109, P928, DOI 10.1093/bja/aes312; Berenfeld O, 2011, CIRC-ARRHYTHMIA ELEC, V4, P426, DOI 10.1161/CIRCEP.111.964841; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Ciaccio EJ, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-4; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; de Bakker JMT, 2010, CIRC-ARRHYTHMIA ELEC, V3, P204, DOI 10.1161/CIRCEP.109.904763; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; Grzeda R, 2009, NIH PUBLIC ACCESS, V6, P1475; Gupta Anoop Kumar, 2002, Indian Pacing Electrophysiol J, V2, P20; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; HOEKSTRA BPT, 1995, J CARDIOVASC ELECTR, V6, P419, DOI 10.1111/j.1540-8167.1995.tb00416.x; Hunter RJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P622, DOI 10.1161/CIRCEP.111.962928; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jadidi AS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P32, DOI 10.1161/CIRCEP.111.964197; Jalife J, 1998, J CARDIOVASC ELECTR, V9, pS2; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Konings KTS, 1997, CIRCULATION, V95, P1231; Kremen V, 2009, IEEE ENG MED BIO, P2502, DOI 10.1109/IEMBS.2009.5335161; Kremen V, 2008, PHYSIOL MEAS, V29, P1371, DOI 10.1088/0967-3334/29/12/002; Kremen V, 2008, THESIS CZECH TU PRAG; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Nademanee K, 2010, J CARDIOL, V55, P1, DOI 10.1016/j.jjcc.2009.11.002; Narayan SM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P58, DOI 10.1161/CIRCEP.111.977264; Narayan SM, 2012, HEART RHYTHM, V9, P1436, DOI 10.1016/j.hrthm.2012.03.055; Narayan SM, 2012, J CARDIOVASC ELECTR, V23, P447, DOI 10.1111/j.1540-8167.2012.02332.x; Navoret N, 2013, IEEE T BIO-MED ENG, V60, P1975, DOI 10.1109/TBME.2013.2247402; Navoret N, 2012, COMPUT CARDIOL CONF, V39, P893; Navoret N, 2010, IEEE ENG MED BIO, P3249, DOI 10.1109/IEMBS.2010.5627235; NOVAK D, 2009, C P ANN INT C IEEE E, P1812; Orozco-Duque A, 2013, COMPUT CARDIOL CONF, V40, P903; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1992, P NATL ACAD SCI USA, V89, P4432, DOI 10.1073/pnas.89.10.4432; Reddy V, 2009, CARDIOL CLIN, V27, P201, DOI 10.1016/j.ccl.2008.10.002; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROBERGE FA, 1986, CIRC RES, V58, P461, DOI 10.1161/01.RES.58.4.461; Scherr D, 2007, HEART RHYTHM, V4, P1013, DOI 10.1016/j.hrthm.2007.04.021; Schilling C., 2012, ANAL ATRIAL ELECTROG, V17; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; Umapathy K, 2008, HEART RHYTHM, V5, P1029, DOI 10.1016/j.hrthm.2008.03.022; Van Wagoner DR, 2003, PACE, V26, P1572; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	48	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e0114577	10.1371/journal.pone.0114577	http://dx.doi.org/10.1371/journal.pone.0114577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489858	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300053
J	Uscher-Pines, L; Mulcahy, A; Maurer, J; Harris, K				Uscher-Pines, Lori; Mulcahy, Andrew; Maurer, Jurgen; Harris, Katherine			The Relationship between Influenza Vaccination Habits and Location of Vaccination	PLOS ONE			English	Article							SEASONAL INFLUENZA	Objectives: Although use of non-medical settings for vaccination such as retail pharmacies has grown in recent years, little is known about how various settings are used by individuals with different vaccination habits. We aimed to assess the relationship between repeated, annual influenza vaccination and location of vaccination. Study Design: We conducted a cross-sectional survey of 4,040 adults in 2010. Methods: We fielded a nationally representative survey using an online research panel operated by Knowledge Networks. The completion rate among sampled panelists was 73%. Results: 39% of adults reported that they have never received a seasonal influenza vaccination. Compared to those who were usually or always vaccinated from year to year, those who sometimes or rarely received influenza vaccinations were significantly more likely to be vaccinated in a medical setting in 2009-2010. Conclusions: Results indicate that while medical settings are the dominant location for vaccination overall, they play an especially critical role in serving adults who do not regularly receive vaccinations. By exploring vaccination habits, we can more appropriately choose among interventions designed to encourage the initiation vs. maintenance of desired behaviors.	[Uscher-Pines, Lori; Mulcahy, Andrew] RAND Corp, Arlington, VA 22202 USA; [Maurer, Jurgen] Univ Lausanne, Lausanne, Switzerland; [Harris, Katherine] IMPAQ Int, Washington, DC USA	RAND Corporation; University of Lausanne; American Institutes for Research	Uscher-Pines, L (corresponding author), RAND Corp, Arlington, VA 22202 USA.	luscherp@rand.org		/0000-0002-3923-677X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was supported by GlaxoSmithKline. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed here are solely those of the authors and do not represent those of RAND or	Accessed 2011 Jun 17, 2013, INCR AD VACC STRAT L; [Anonymous], 2009, KNOWLEDGEPANEL FACT; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P781; Centers for Disease Control and Prevention, 2012, FIN STAT LEV INFL VA; Centers for Disease Control and Prevention, 2012, REC INFL VACC TRENDS; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Dennis M, 2010, KNOWLEDGEPANEL DESIG; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris KM, 2012, BLUEPRINT IMPROVING; Knowledge Networks, 2009, OV KNOWLEDGEPANEL ST; Lin CJ, 2010, VACCINE, V28, P7706, DOI 10.1016/j.vaccine.2010.07.009; Lu PJ, 2013, AM J EPIDEMIOL, V178, P1478, DOI 10.1093/aje/kwt158; Mamelund SE, 2011, VACCINE, V29, P9441, DOI 10.1016/j.vaccine.2011.10.035; Maurer J, 2011, PREV MED, V52, P459, DOI 10.1016/j.ypmed.2011.03.016; National Vaccine Advisory Committee, 2011, AD IMM COMPL CHALL R; Nichol KL, 1997, INFECT CONT HOSP EP, V18, P189; Nowalk Mary Patricia, 2010, J Healthc Qual, V32, P35; Postema A S, 2000, MMWR Recomm Rep, V49, P1; Uscher-Pines L, 2011, AM J PUBLIC HEALTH, V101, P1252, DOI 10.2105/AJPH.2011.300133; Wiley KE, 2013, MED J AUSTRALIA, V198, P373, DOI 10.5694/mja12.11849	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114863	10.1371/journal.pone.0114863	http://dx.doi.org/10.1371/journal.pone.0114863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490092	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300086
J	Guzman, JM; Luckenbach, JA; Yamamoto, Y; Swanson, P				Guzman, Jose M.; Luckenbach, J. Adam; Yamamoto, Yoji; Swanson, Penny			Expression Profiles of Fsh-Regulated Ovarian Genes during Oogenesis in Coho Salmon	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MESSENGER-RNA EXPRESSION; TISSUE GROWTH-FACTOR; TROUT ONCORHYNCHUS-MYKISS; SECONDARY OOCYTE GROWTH; GRANULOSA-CELLS; RAINBOW-TROUT; STEROIDOGENIC ENZYMES; IN-VITRO; GONADOTROPIN RECEPTORS	The function of follicle-stimulating hormone (Fsh) during oogenesis in fishes is poorly understood. Using coho salmon as a fish model, we recently identified a suite of genes regulated by Fsh in vitro and involved in ovarian processes mostly unexplored in fishes, like cell proliferation, differentiation, survival or extracellular matrix (ECM) remodeling. To better understand the role of these Fsh-regulated genes during oocyte growth in fishes, we characterized their mRNA levels at discrete stages of the ovarian development in coho salmon. While most of the transcripts were expressed at low levels during primary growth (perinucleolus stage), high expression of genes associated with cell proliferation (pim1, pcna, and mcm4) and survival (ddit4l) was found in follicles at this stage. The transition to secondary oocyte growth (cortical alveolus and lipid droplet stage ovarian follicles) was characterized by a marked increase in the expression of genes related to cell survival (clu1, clu2 and ivns1abpa). Expression of genes associated with cell differentiation and growth (wt2l and adh8l), growth factor signaling (inha), steroidogenesis (cyp19a1a) and the ECM (col1a1, col1a2 and dcn) peaked in vitellogenic follicles, showing a strong and positive correlation with transcripts for fshr. Other genes regulated by Fsh and associated with ECM function (ctgf, wapl and fn1) and growth factor signaling (bmp16 and smad5l) peaked in maturing follicles, along with increases in steroidogenesis-related gene transcripts. In conclusion, ovarian genes regulated by Fsh showed marked differences in their expression patterns during oogenesis in coho salmon. Our results suggest that Fsh regulates different ovarian processes at specific stages of development, likely through interaction with other intra- or extra-ovarian factors.	[Guzman, Jose M.; Luckenbach, J. Adam; Yamamoto, Yoji; Swanson, Penny] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA; [Luckenbach, J. Adam; Swanson, Penny] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Yamamoto, Yoji] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Yamamoto, Yoji] Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan	National Oceanic Atmospheric Admin (NOAA) - USA; Washington State University; University of Washington; University of Washington Seattle; Tokyo University of Marine Science & Technology	Guzman, JM (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA.	jose.guzman-jimenez@noaa.gov	Yamamoto, Yoji/O-1958-2014	Yamamoto, Yoji/0000-0002-9628-6706	NOAA Fisheries; National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2007-35203-18088]; Fundacion Alfonso Martin Escudero (Spain); National Academy of Sciences (US)	NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Fundacion Alfonso Martin Escudero (Spain); National Academy of Sciences (US)	This research was partially funded by NOAA Fisheries and by National Research Initiative Competitive Grant no. 2007-35203-18088 from the USDA National Institute of Food and Agriculture to PS, and postdoctoral fellowships from the Fundacion Alfonso Martin Escudero (Spain) and The National Academy of Sciences (US) to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASEM EK, 1992, ACTA ENDOCRINOL-COP, V127, P466, DOI 10.1530/acta.0.1270466; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Campbell B, 2006, BIOL REPROD, V75, P34, DOI 10.1095/biolreprod.105.049494; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chang B, 2009, CELL CYCLE, V8, P780, DOI 10.4161/cc.8.5.7887; Chun SY, 1999, BIOL REPROD, V60, P365, DOI 10.1095/biolreprod60.2.365; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Coffman MA, 2000, BIOL REPROD, V62, P928, DOI 10.1095/biolreprod62.4.928; Dasmahapatra AK, 2005, COMP BIOCHEM PHYS B, V140, P657, DOI 10.1016/j.cbpc.2005.01.007; Davies B, 1999, GEN COMP ENDOCR, V115, P155, DOI 10.1006/gcen.1999.7301; Deloffre LAM, 2012, GENE, V506, P69, DOI 10.1016/j.gene.2012.06.047; Garcia-Lopez A, 2011, COMP BIOCHEM PHYS A, V160, P374, DOI 10.1016/j.cbpa.2011.07.006; Garczynski MA, 1997, BIOL REPROD, V57, P856, DOI 10.1095/biolreprod57.4.856; Ge W, 2005, MOL CELL ENDOCRINOL, V237, P1, DOI 10.1016/j.mce.2005.03.012; Gen K, 2001, BIOL REPROD, V65, P1186, DOI 10.1095/biolreprod65.4.1186; Gomez JM, 1999, GEN COMP ENDOCR, V113, P413, DOI 10.1006/gcen.1998.7222; Grieshaber NA, 2003, ENDOCRINOLOGY, V144, P29, DOI 10.1210/en.2002-220477; Harlow CR, 2007, J ENDOCRINOL, V192, P41, DOI 10.1677/joe.1.06689; Horiguchi M, 2008, ZOOL SCI, V25, P937, DOI 10.2108/zsj.25.937; HSU SY, 1995, MOL ENDOCRINOL, V9, P1356, DOI 10.1210/me.9.10.1356; Huet C, 1997, BIOL REPROD, V56, P1025, DOI 10.1095/biolreprod56.4.1025; Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; KAMADA S, 1992, HORM RES, V37, P141, DOI 10.1159/000182299; Kim DJ, 2005, GEN COMP ENDOCR, V141, P282, DOI 10.1016/j.ygcen.2005.01.001; Kitano H, 2011, GEN COMP ENDOCR, V172, P268, DOI 10.1016/j.ygcen.2011.03.012; Kobayashi T, 2008, GEN COMP ENDOCR, V156, P595, DOI 10.1016/j.ygcen.2008.02.010; Korfsmeier KH, 2002, ACTA HISTOCHEM, V104, P73, DOI 10.1078/0065-1281-00632; Kumar RS, 2000, BIOL REPROD, V63, P1676, DOI 10.1095/biolreprod63.6.1676; Kusakabe M, 2002, ENDOCRINOLOGY, V143, P2062, DOI 10.1210/en.143.6.2062; Lankford SE, 2010, GEN COMP ENDOCR, V166, P250, DOI 10.1016/j.ygcen.2009.09.007; Layman LC, 2000, MOL CELL ENDOCRINOL, V161, P9, DOI 10.1016/S0303-7207(99)00217-8; Layman LC, 2000, SEMIN REPROD MED, V18, P5, DOI 10.1055/s-2000-13470; Le Menn Francoise, 2007, P1; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Levi L, 2008, BIOL REPROD, V79, P570, DOI 10.1095/biolreprod.107.066548; Li CW, 2011, BIOL REPROD, V85, P977, DOI 10.1095/biolreprod.111.092239; Logan KA, 2003, BIOL REPROD, V68, P635, DOI 10.1095/biolreprod.102.008946; Lubzens E, 2003, MOL ASPECTS MED, V24, P441, DOI 10.1016/S0098-2997(03)00040-2; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Luckenbach JA, 2013, MOL CELL ENDOCRINOL, V366, P38, DOI 10.1016/j.mce.2012.11.015; Luckenbach JA, 2011, GEN COMP ENDOCR, V171, P52, DOI 10.1016/j.ygcen.2010.12.016; Luckenbach JA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-2; Lyman-Gingerich Jamie, 2007, P141, DOI 10.1007/978-1-4020-6235-3_6; Mahon MG, 1999, J BIOL CHEM, V274, P4036, DOI 10.1074/jbc.274.7.4036; Makanji Y, 2011, VITAM HORM, V85, P299, DOI 10.1016/B978-0-12-385961-7.00014-7; Matsubara H, 2003, FISHERIES SCI, V69, P979, DOI 10.1046/j.1444-2906.2003.00716.x; Moles G, 2012, GEN COMP ENDOCR, V176, P70, DOI 10.1016/j.ygcen.2011.12.029; Montserrat N, 2004, GEN COMP ENDOCR, V137, P123, DOI 10.1016/j.ygcen.2004.02.011; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Nakamura I, 2005, GEN COMP ENDOCR, V144, P224, DOI 10.1016/j.ygcen.2005.06.004; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Picha ME, 2012, GEN COMP ENDOCR, V177, P220, DOI 10.1016/j.ygcen.2012.04.017; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Polzonetti-Magni AM, 2004, INT REV CYTOL, V239, P1, DOI 10.1016/S0074-7696(04)39001-7; Poon SK, 2009, REPRODUCTION, V138, P709, DOI 10.1530/REP-09-0198; Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Rimon E, 2004, INT J ONCOL, V24, P1325; Rocha A, 2009, GEN COMP ENDOCR, V162, P265, DOI 10.1016/j.ygcen.2009.03.023; SAKAI N, 1994, FEBS LETT, V350, P309, DOI 10.1016/0014-5793(94)00795-0; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Spicer LJ, 2007, BIOL REPROD, V77, P18, DOI 10.1095/biolreprod.106.058230; SRIVASTAVA RK, 1994, J EXP ZOOL, V270, P263, DOI 10.1002/jez.1402700305; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; SWANSON P, 1991, BIOL REPROD, V44, P29, DOI 10.1095/biolreprod44.1.29; Thomas FH, 2005, ENDOCRINOLOGY, V146, P941, DOI 10.1210/en.2004-0826; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; TYLER CR, 1991, GEN COMP ENDOCR, V84, P291, DOI 10.1016/0016-6480(91)90052-8; Wandji SA, 2000, ENDOCRINOLOGY, V141, P2648, DOI 10.1210/en.141.7.2648; Wang YJ, 2003, BIOL REPROD, V69, P1998, DOI 10.1095/biolreprod.103.020826; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wu HJ, 2008, NEPHROLOGY, V13, P607, DOI 10.1111/j.1440-1797.2008.00961.x; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Yamamoto Y, 2011, GEN COMP ENDOCR, V172, P331, DOI 10.1016/j.ygcen.2011.03.017; Yamamoto Y, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-52; Zhu GY, 2012, GEN COMP ENDOCR, V178, P314, DOI 10.1016/j.ygcen.2012.06.018; Zippo A, 2004, BLOOD, V103, P4536, DOI 10.1182/blood-2003-11-3827; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1; Zwain I, 2000, EXP CELL RES, V257, P101, DOI 10.1006/excr.2000.4885	86	24	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114176	10.1371/journal.pone.0114176	http://dx.doi.org/10.1371/journal.pone.0114176			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485989	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600044
J	Pedas, P; Stokholm, MS; Hegelund, JN; Ladegard, AH; Schjoerring, JK; Husted, S				Pedas, Pai; Stokholm, Michaela Schiller; Hegelund, Josefine Nymark; Ladegard, Anne Hald; Schjoerring, Jan Kofod; Husted, Soren			Golgi Localized Barley MTP8 Proteins Facilitate Mn Transport	PLOS ONE			English	Article							METAL-NICOTIANAMINE TRANSPORTER; AFFINITY MANGANESE UPTAKE; ARABINOSYLTRANSFERASE ACTIVITY; GENOTYPIC DIFFERENCES; ARABIDOPSIS-THALIANA; SECRETORY PATHWAY; CA2+/MN2+ PUMP; IRON; GROWTH; IDENTIFICATION	Many metabolic processes in plants are regulated by manganese (Mn) but limited information is available on the molecular mechanisms controlling cellular Mn homeostasis. In this study, a yeast assay was used to isolate and characterize two genes, MTP8.1 and MTP8.2, which encode membrane-bound proteins belonging to the cation diffusion facilitator (CDF) family in the cereal species barley (Hordeum vulgare). Transient expression in onion epidermal cells showed that MTP8.1 and MTP8.2 proteins fused to the green fluorescent protein (GFP) are localized to Golgi. When heterologously expressed in yeast, MTP8.1 and MTP8.2 were found to be Mn transporters catalysing Mn efflux in a similar manner as the Golgi localized endogenous yeast protein Pmr1p. The level of MTP8.1 transcripts in barley roots increased with external Mn supply ranging from deficiency to toxicity, while MTP8.2 transcripts decreased under the same conditions, indicating non-overlapping functions for the two genes. In barley leaves, the expression of both MTP8 genes declined in response to toxic Mn additions to the roots suggesting a role in ensuring proper delivery of Mn to Golgi. Based on the above we suggest that barley MTP8 proteins are involved in Mn loading to the Golgi apparatus and play a role in Mn homeostasis by delivering Mn to Mn-dependent enzymes and/or by facilitating Mn efflux via secretory vesicles. This study highlights the importance of MTP transporters in Mn homeostasis and is the first report of Golgi localized Mn2+ transport proteins in a monocot plant species.	[Pedas, Pai; Stokholm, Michaela Schiller; Hegelund, Josefine Nymark; Ladegard, Anne Hald; Schjoerring, Jan Kofod; Husted, Soren] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Plant & Soil Sci Lab, Copenhagen, Denmark	University of Copenhagen	Pedas, P (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Plant & Soil Sci Lab, Copenhagen, Denmark.	pp@plen.ku.dk	Pedas, Pai/G-3494-2014; Schjoerring, Jan K./A-5387-2009; Hegelund, Josefine Nymark/N-4732-2014; Schjoerring, Jan K./M-4044-2019; Stokholm, Michaela S/B-4593-2017; Husted, Søren/H-4649-2014	Pedas, Pai/0000-0001-6733-7300; Schjoerring, Jan K./0000-0002-2852-3298; Hegelund, Josefine Nymark/0000-0002-5663-9503; Schjoerring, Jan K./0000-0002-2852-3298; Stokholm, Michaela S/0000-0003-3092-0281; Husted, Søren/0000-0003-2020-1902	Ministry of Science, Technology and Innovation [274-06-0325]; Danish Ministry of Science, Innovation and Higher Education (Research Council grant) [DSF-10-093498-NUTRIEFFICIENT]	Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Danish Ministry of Science, Innovation and Higher Education (Research Council grant)	This work was supported financially by grants from The Ministry of Science, Technology and Innovation (contract 274-06-0325) and the Danish Ministry of Science, Innovation and Higher Education (Research Council grant DSF-10-093498-NUTRIEFFICIENT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Baldwin TC, 2001, PLANT CELL, V13, P2283, DOI 10.1105/tpc.13.10.2283; BOWLER C, 1991, EMBO J, V10, P1723, DOI 10.1002/j.1460-2075.1991.tb07696.x; Burnell J.N., 1988, MANGANESE SOILS PLAN, P125, DOI DOI 10.1007/978-94-009-2817-6_10; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Chen ZH, 2013, J EXP BOT, V64, P4375, DOI 10.1093/jxb/ert243; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hebbern CA, 2005, PLANT SOIL, V272, P233, DOI 10.1007/s11104-004-5048-9; Hebbern CA, 2009, PHYSIOL PLANTARUM, V135, P307, DOI 10.1111/j.1399-3054.2008.01188.x; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Jensen MK, 2007, PLANT MOL BIOL, V65, P137, DOI 10.1007/s11103-007-9204-5; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Marschner H, 1995, MINERAL NUTR HIGHER, P325; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nunan KJ, 2003, PLANT PHYSIOL, V132, P331, DOI 10.1104/pp.102.019406; ONO T, 1992, SCIENCE, V258, P1335, DOI 10.1126/science.258.5086.1335; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Pearson JN, 1997, ANN BOT-LONDON, V80, P803, DOI 10.1006/anbo.1997.0523; Pedas P, 2005, PLANT PHYSIOL, V139, P1411, DOI 10.1104/pp.105.067561; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittman JK, 2004, PLANT MOL BIOL, V56, P959, DOI 10.1007/s11103-004-6446-3; Pittman JK, 2005, NEW PHYTOL, V167, P733, DOI 10.1111/j.1469-8137.2005.01453.x; Porchia AC, 2002, PLANT PHYSIOL, V130, P432, DOI 10.1104/pp.003400; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Rengel Z, 2000, MET IONS BIOL SYST, V37, P57; Reuter D.J., 1997, PLANT ANAL INTERPRET, P83; Reyes F, 2008, CURR OPIN PLANT BIOL, V11, P244, DOI 10.1016/j.pbi.2008.03.008; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Sasaki A, 2011, PLANT PHYSIOL, V157, P1832, DOI 10.1104/pp.111.186031; Schaaf G, 2002, PLANT BIOLOGY, V4, P612, DOI 10.1055/s-2002-35432; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WHITE AR, 1993, BIOCHEM J, V294, P231, DOI 10.1042/bj2940231; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Yang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083990; Zeng W, 2008, PLANT PHYSIOL, V147, P78, DOI 10.1104/pp.107.115576	60	44	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113759	10.1371/journal.pone.0113759	http://dx.doi.org/10.1371/journal.pone.0113759			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486417	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600024
J	Singh, AK; Menendez-Conejero, R; Martin, CS; van Raaij, MJ				Singh, Abhimanyu K.; Menendez-Conejero, Rosa; Martin, Carmen San; van Raaij, Mark J.			Crystal Structure of the Fibre Head Domain of the Atadenovirus Snake Adenovirus 1	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; C-TERMINAL DOMAIN; CRYSTALLOGRAPHIC STRUCTURE; BACTERIOPHAGE-T4 FIBRITIN; 1.7-ANGSTROM RESOLUTION; CELLULAR RECEPTOR; GENE-THERAPY; DESMOGLEIN 2; COILED-COIL; SIALIC-ACID	Adenoviruses are non-enveloped icosahedral viruses with trimeric fibre proteins protruding from their vertices. There are five known genera, from which only Mastadenoviruses have been widely studied. Apart from studying adenovirus as a biological model system and with a view to prevent or combat viral infection, there is a major interest in using adenovirus for vaccination, cancer therapy and gene therapy purposes. Adenoviruses from the Atadenovirus genus have been isolated from squamate reptile hosts, ruminants and birds and have a characteristic gene organization and capsid morphology. The carboxy-terminal virus-distal fibre head domains are likely responsible for primary receptor recognition. We determined the high-resolution crystal structure of the Snake Adenovirus 1 (SnAdV-1) fibre head using the multi-wavelength anomalous dispersion (MAD) method. Despite the absence of significant sequence homology, this Atadenovirus fibre head has the same beta-sandwich propeller topology as other adenovirus fibre heads. However, it is about half the size, mainly due to much shorter loops connecting the betastrands. The detailed structure of the SnAdV-1 fibre head and other animal adenovirus fibre heads, together with the future identification of their natural receptors, may lead to the development of new strategies to target adenovirus vectors to cells of interest.	[Singh, Abhimanyu K.; Menendez-Conejero, Rosa; Martin, Carmen San; van Raaij, Mark J.] CSIC, CNB, Dept Estruct Macromol, Madrid, Spain; [Singh, Abhimanyu K.; Menendez-Conejero, Rosa; Martin, Carmen San; van Raaij, Mark J.] CSIC, CNB, NanoBiomed Initiat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	van Raaij, MJ (corresponding author), CSIC, CNB, Dept Estruct Macromol, Madrid, Spain.	mjvanraaij@cnb.csic.es	Singh, Abhimanyu K./C-2243-2019; van Raaij, Mark J/B-3678-2009; San Martín, Carmen/A-4074-2010; Singh, Abhimanyu K./U-5881-2019	Singh, Abhimanyu K./0000-0002-9998-020X; van Raaij, Mark J/0000-0002-4781-1375; San Martín, Carmen/0000-0001-9799-175X; Singh, Abhimanyu K./0000-0002-9998-020X	Spanish Ministry of Economy and Competitiveness [BFU2011-24843, BFU2010-16382, BFU2013-41249-P]; Spanish Ministry of Health and Social Protection [FIS2011-16090-E]; La Caixa; Instituto de Salud Carlos III of Spain	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Health and Social Protection; La Caixa(La Caixa Foundation); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III)	This research was sponsored by grants BFU2011-24843 (Mark J. van Raaij), BFU2010-16382 (Carmen San Martin) and BFU2013-41249-P (Carmen San Martin) from the Spanish Ministry of Economy and Competitiveness and the BioFiViNet network, grant number FIS2011-16090-E from the Spanish Ministry of Health and Social Protection (Carmen San Martin and Mark J. van Raaij). Abhimanyu K. Singh is a recipient of a predoctoral fellowship from La Caixa. Rosa Menendez-Conejero held a predoctoral fellowship from the Instituto de Salud Carlos III of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000; Bachtarzi H, 2008, EXPERT OPIN DRUG DEL, V5, P1231, DOI [10.1517/17425240802507636, 10.1517/17425240802507636 ]; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Calvo PG, 2005, J MOL BIOL, V354, P137, DOI 10.1016/j.jmb.2005.09.034; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; El Bakkouri M, 2008, VIROLOGY, V378, P169, DOI 10.1016/j.virol.2008.05.011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Guardado-Calvo P, 2009, J GEN VIROL, V90, P672, DOI 10.1099/vir.0.008276-0; Guardado-Calvo P, 2007, J GEN VIROL, V88, P2407, DOI 10.1099/vir.0.82845-0; Guardado-Calvo P, 2010, J VIROL, V84, P10558, DOI 10.1128/JVI.00997-10; Harrach B., 2011, VIRUS TAXONOMY CLASS, P95; HESS M, 1995, J MOL BIOL, V252, P379, DOI 10.1006/jmbi.1995.0504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JUHASZ A, 1993, ARCH VIROL, V130, P429, DOI 10.1007/BF01309671; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Loser P, 1999, GENE THER MOL BIOL, V4, P33; McConnell MJ, 2004, HUM GENE THER, V15, P1022, DOI 10.1089/hum.2004.15.1022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mitraki A, 2006, ADV PROTEIN CHEM, V73, P97, DOI 10.1016/S0065-3233(06)73004-2; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Pantelic RS, 2008, J VIROL, V82, P7346, DOI 10.1128/JVI.00764-08; Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008; Penzes JJ, 2014, J VIROL, V88, P11304, DOI 10.1128/JVI.00306-14; Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190; Philipson L, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P1; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Martin CS, 2012, VIRUSES-BASEL, V4, P847, DOI 10.3390/v4050847; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Seiradake E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000277; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Singh AK, 2013, ACTA CRYSTALLOGR F, V69, P1374, DOI 10.1107/S1744309113029308; Singh AK, 2013, ACTA CRYSTALLOGR F, V69, P1135, DOI 10.1107/S174430911302397X; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HJ, 2013, J VIROL, V87, P11346, DOI 10.1128/JVI.01825-13; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	59	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114373	10.1371/journal.pone.0114373	http://dx.doi.org/10.1371/journal.pone.0114373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486282	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600049
J	Jia, TQ; Wei, DF; Meng, S; Allan, AC; Zeng, LH				Jia, Tianqi; Wei, Danfeng; Meng, Shan; Allan, Andrew C.; Zeng, Lihui			Identification of Regulatory Genes Implicated in Continuous Flowering of Longan (Dimocarpus longan L.)	PLOS ONE			English	Article							LOCUS-T; POTASSIUM CHLORATE; CIRCADIAN CLOCK; AMBIENT-TEMPERATURE; FLORAL INITIATION; ARABIDOPSIS; TIME; TRANSCRIPTION; GIBBERELLIN; PROTEIN	Longan (Dimocarpus longan L.) is a tropical/subtropical fruit tree of significant economic importance in Southeast Asia. However, a lack of transcriptomic and genomic information hinders research on longan traits, such as the control of flowering. In this study, high-throughput RNA sequencing (RNA-Seq) was used to investigate differentially expressed genes between a unique longan cultivar 'Sijimi'(S) which flowers throughout the year and a more typical cultivar 'Lidongben'(L) which flowers only once in the season, with the aim of identifying candidate genes associated with continuous flowering. 36,527 and 40,982 unigenes were obtained by de novo assembly of the clean reads from cDNA libraries of L and S cultivars. Additionally 40,513 unigenes were assembled from combined reads of these libraries. A total of 32,475 unigenes were annotated by BLAST search to NCBI non-redundant protein (NR), Swiss-Prot, Clusters of Orthologous Groups (COGs) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Of these, almost fifteen thousand unigenes were identified as significantly differentially expressed genes (DEGs) by using Reads Per kb per Million reads (RPKM) method. A total of 6,415 DEGs were mapped to 128 KEGG pathways, and 8,743 DEGs were assigned to 54 Gene Ontology categories. After blasting the DEGs to public sequence databases, 539 potential flowering-related DEGs were identified. In addition, 107 flowering-time genes were identified in longan, their expression levels between two longan samples were compared by RPKM method, of which the expression levels of 15 were confirmed by real-time quantitative PCR. Our results suggest longan homologues of SHORT VEGETATIVE PHASE (SVP), GIGANTEA (GI), F-BOX 1 (FKF1) and EARLY FLOWERING 4 (ELF4) may be involved this flowering trait and ELF4 may be a key gene. The identification of candidate genes related to continuous flowering will provide new insight into the molecular process of regulating flowering time in woody plants.	[Jia, Tianqi; Wei, Danfeng; Meng, Shan; Zeng, Lihui] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China; [Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Auckland, New Zealand	Fujian Agriculture & Forestry University; New Zealand Institute for Plant & Food Research Ltd	Zeng, LH (corresponding author), Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China.	lhzeng@hotmail.com	Allan, Andrew C/L-3253-2016	Allan, Andrew C/0000-0003-1944-7067	National Natural Science Foundation of P. R. China [30971989]; Plant & Food Research Limited	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Plant & Food Research Limited	This work was supported by the National Natural Science Foundation of P. R. China (No. 30971989). Andrew C. Allan is an employee of The New Zealand Institute for Plant & Food Research Limited. He received support in the form of salary from Plant & Food Research Limited, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abou-Elwafa SF, 2011, J EXP BOT, V62, P3359, DOI 10.1093/jxb/erq321; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Benjamini Y, 2001, ANN STAT, V29, P1165; Bergonzi S, 2013, SCIENCE, V340, P1094, DOI 10.1126/science.1234116; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Brunner AM, 2004, NEW PHYTOL, V164, P43, DOI 10.1111/j.1469-8137.2004.01165.x; Chen Hu, 2010, Genomics and Applied Biology, V29, P288; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Ding L, 2013, ARABIDOPSIS PLANT PH, V163, P1243; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Goldberg-Moeller R, 2013, PLANT SCI, V198, P46, DOI 10.1016/j.plantsci.2012.09.012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hegele M, 2008, EUR J HORTIC SCI, V73, P49; Heller WP, 2014, TROP PLANT BIOL, V7, P19, DOI 10.1007/s12042-013-9134-0; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim Y, 2012, MOL PLANT, V5, P678, DOI 10.1093/mp/sss005; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Lin YL, 2013, PLANT PHYSIOL BIOCH, V66, P20, DOI 10.1016/j.plaphy.2013.02.002; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028516; Marquardt S, 2006, J EXP BOT, V57, P3379, DOI 10.1093/jxb/erl073; Matsumoto TK, 2006, PLANT SCI, V170, P500, DOI 10.1016/j.plantsci.2005.09.016; Matsumoto TK, 2007, HORTTECHNOLOGY, V17, P296, DOI 10.21273/HORTTECH.17.3.296; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mizuno T, 2014, PLANT CELL PHYSIOL, V55, P958, DOI 10.1093/pcp/pcu030; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Nakagawa M, 2012, SCI HORTIC-AMSTERDAM, V139, P108, DOI 10.1016/j.scienta.2012.03.005; Peng J, 2010, ACTA HORTIC, V863, P249, DOI 10.17660/ActaHortic.2010.863.32; Pillitteri LJ, 2004, PLANT PHYSIOL, V135, P1540, DOI 10.1104/pp.103.036178; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Potchanasin P, 2009, SCI HORTIC-AMSTERDAM, V122, P312, DOI 10.1016/j.scienta.2009.06.007; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Sringarm K, 2009, SCI HORTIC-AMSTERDAM, V122, P295, DOI 10.1016/j.scienta.2008.11.031; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Susawaengsup C, 2011, TALANTA, V85, P897, DOI 10.1016/j.talanta.2011.04.073; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Winterhagen P, 2013, PLANT PHYSIOL BIOCH, V71, P184, DOI 10.1016/j.plaphy.2013.07.013; Wu SH, 2010, ACTA HORTIC, V863, P37; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshida R, 2009, NEW PHYTOL, V182, P838, DOI 10.1111/j.1469-8137.2009.02809.x; Zawaski C, 2011, PLANTA, V234, P1285, DOI 10.1007/s00425-011-1485-x; Zhang JZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-63; Zhou CM, 2013, SCIENCE, V340, P1097, DOI 10.1126/science.1234340; Zhu J, 2013, J PLANT GENET RESOUR, V14, P61	69	20	27	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114568	10.1371/journal.pone.0114568	http://dx.doi.org/10.1371/journal.pone.0114568			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479005	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200106
J	Kawamoto, R; Ninomiya, D; Hasegawa, Y; Kasai, Y; Kusunoki, T; Ohtsuka, N; Kumagi, T; Abe, M				Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Kumagi, Teru; Abe, Masanori			Mildly Elevated Serum Bilirubin Levels Are Negatively Associated with Carotid Atherosclerosis among Elderly Persons	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; GILBERTS-SYNDROME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEART-DISEASE; RENAL-DISEASE; RISK-FACTOR; URIC-ACID	Serum bilirubin may have a beneficial role in preventing oxidative changes in atherosclerosis. Limited information is available on whether serum total bilirubin is an independent confounding factor for carotid atherosclerosis {for example, intima-media thickness (IMT), plaque} measured noninvasively by B-mode ultrasonography only among elderly persons. The study subjects were 325 men aged 79 +/- 8 (mean +/- standard deviation) years and 509 women aged 81 +/- 8 years that were enrolled consecutively from patients aged >= 60 years in the medical department. Carotid IMT and plaque were derived via B-mode ultrasonography. Multiple linear regression analysis showed that in men age (beta=0.199, p=0.002), smoking status (beta=0.154, p=0.006), GGT (beta=-0.139, p=0.039), and GGT (beta=-0.133, p=0.022) were significantly and independently associated with carotid IMT, and in women age (beta=0.186, p<0.001), systolic blood pressure (beta=0.104, p=0.046), diastolic blood pressure (beta=-0.148, p=0.004), prevalence of antihypertensive medication (beta=0.126, p=0.004), fasting plasma glucose (beta=0.135, p=0.003), GGT (beta=-0.104, p=0.032), estimated glomerular filtration rate, serum bilirubin (beta=-0.119, p=0.006), and prevalence of cardiovascular disease (CVD) (beta=0.103, p=0.017) were also independently associated with carotid IMT. The odds ratios (ORs) {95% confidence interval (CI)} of increasing serum bilirubin category were negatively associated with carotid IMT >= 1.0 mm and plaque in both genders. Compared to subjects with a serum bilirubin of Quartile-1, the multivariate-OR (95% CI) of carotid plaque was 0.25 (0.11-0.57) in the Quartile-4 male group, and 0.41 (0.21-0.78) in the Quartile-2 female group, 0.51 (0.26-0.98) in the Quartile-3 female group, and 0.46 (0.24-0.89) in the Quartile-4 female group. Our data demonstrated an independently negative association between serum bilirubin and carotid atherosclerosis in both genders.	[Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kumagi, Teru; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime, Japan; [Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Seiyo City, Ehime, Japan	Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime, Japan.	rykawamo@m.ehime.ca.jp	Kumagi, Teru/AAS-7427-2021	Kumagi, Teru/0000-0002-2292-7750	Foundation for Development of Community	Foundation for Development of Community	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2012). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Bulmer AC, 2013, PROG LIPID RES, V52, P193, DOI 10.1016/j.plipres.2012.11.001; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Dekker D, 2011, ARTERIOSCL THROM VAS, V31, P458, DOI 10.1161/ATVBAHA.110.211789; Demirkol S, 2013, ANGIOLOGY       0127; Djousse L, 2003, AM J CARDIOL, V91, P485, DOI 10.1016/S0002-9149(02)03256-3; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; FELSHER BF, 1975, GASTROENTEROLOGY, V69, P42; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Huang SS, 2010, HEART, V96, P1227, DOI 10.1136/hrt.2009.192393; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Ishizaka N, 2001, STROKE, V32, P581, DOI 10.1161/01.STR.32.2.580-b; Jiang SM, 2012, CHINESE MED J-PEKING, V125, P2649, DOI 10.3760/cma.j.issn.0366-6999.2012.15.002; Kalkan GY, 2014, ANGIOLOGY, V65, P308, DOI 10.1177/0003319713507627; Kang SJ, 2014, ANN MED, V46, P138, DOI 10.3109/07853890.2014.895588; Kao TW, 2012, INTERN MED J, V42, P1199, DOI 10.1111/j.1445-5994.2011.02620.x; Kawamoto R, 2005, J ATHEROSCLER THROMB, V12, P143, DOI 10.5551/jat.12.143; Kawamoto R, 2005, INTERNAL MED, V44, P787, DOI 10.2169/internalmedicine.44.787; Kawamoto R, 2007, J ATHEROSCLER THROMB, V14, P78, DOI 10.5551/jat.14.78; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Madhavan M, 1997, ATHEROSCLEROSIS, V131, P107, DOI 10.1016/S0021-9150(97)06088-7; Mayer M, 2000, CLIN CHEM, V46, P1723; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pae HO, 2006, ATHEROSCLEROSIS, V187, P274, DOI 10.1016/j.atherosclerosis.2005.09.010; Park BH, 2012, ENDOCRINOL METAB, V27, P126, DOI 10.3803/EnM.2012.27.2.126; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; Sidhu PS, 1997, BRIT J RADIOL, V70, P85, DOI 10.1259/bjr.70.829.9059301; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Takayama S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-2; Tanaka M, 2009, ATHEROSCLEROSIS, V206, P287, DOI 10.1016/j.atherosclerosis.2009.02.010; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Vitek L, 2006, CEREBROVASC DIS, V21, P408, DOI 10.1159/000091966; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x	42	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114281	10.1371/journal.pone.0114281	http://dx.doi.org/10.1371/journal.pone.0114281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479598	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200065
J	Norback, D; Lampa, E; Engvall, K				Norback, Dan; Lampa, Erik; Engvall, Karin			Asthma, Allergy and Eczema among Adults in Multifamily Houses in Stockholm (3-HE Study) - Associations with Building Characteristics, Home Environment and Energy Use for Heating	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; RESPIRATORY SYMPTOMS; MITE ALLERGEN; HEALTH-RISKS; F 1; INDOOR; PREVALENCE; FORMALDEHYDE; ENDOTOXIN; EXPOSURE	Risk factors for asthma, allergy and eczema were studied in a stratified random sample of adults in Stockholm. In 2005, 472 multifamily buildings (10,506 dwellings) were invited (one subject/dwelling) and 7,554 participated (73%). Associations were analyzed by multiple logistic regression, adjusting for gender, age, smoking, country of birth, income and years in the dwelling. In total, 11% had doctor's diagnosed asthma, 22% doctor's diagnosed allergy, 23% pollen allergy and 23% eczema. Doctor's diagnosed asthma was more common in dwellings with humid air (OR=1.74) and mould odour (OR=1.79). Doctor's diagnosed allergy was more common in buildings with supply exhaust air ventilation as compared to exhaust air only (OR=1.45) and was associated with redecoration (OR=1.48) and mould odour (OR=2.35). Pollen allergy was less common in buildings using more energy for heating (OR=0.75) and was associated with humid air (OR=1.76) and mould odour (OR=2.36). Eczema was more common in larger buildings (OR 1.07) and less common in buildings using more energy for heating (OR=0.85) and was associated with water damage (OR=1.47), humid air (OR=1.73) and mould odour (OR=2.01). Doctor's diagnosed allergy was less common in buildings with management accessibility both in the neighbourhood and in larger administrative divisions, as compared to management in the neighbourhood only (OR=0.49; 95% CI 0.29-0.82). Pollen allergy was less common if the building maintenance was outsourced (OR=0.67; 95% CI 0.51-0.88). Eczema was more common when management accessibility was only at the division level (OR=1.49; 95% CI 1.06-2.11). In conclusions, asthma, allergy or eczema were more common in buildings using less energy for heating, in larger buildings and in dwellings with redecorations, mould odour, dampness and humid air. There is a need to reduce indoor chemical emissions and to control dampness. Energy saving may have consequences for allergy and eczema. More epidemiological studies are needed on building management organization.	[Norback, Dan; Lampa, Erik; Engvall, Karin] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden	Uppsala University	Norback, D (corresponding author), Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden.	dan.norback@medsci.uu.se		Norback, Dan/0000-0002-5174-6668	Swedish Asthma and Allergy Association's Research Foundation [22012041-K]; Swedish Research Council FORMAS [294-2008-80, 244-2010-277]; Swedish Property Foundation (FORMAS) [244-2008-80]; Property Federation in Stockholm (FORMAS) [244-2008-80]; City of Stockholm (FORMAS) [244-2008-80]; Fortum corporation (FORMAS) [244-2008-80]; FORMAS [294-2008-80]	Swedish Asthma and Allergy Association's Research Foundation; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Property Foundation (FORMAS)(Swedish Research Council Formas); Property Federation in Stockholm (FORMAS); City of Stockholm (FORMAS); Fortum corporation (FORMAS); FORMAS(Swedish Research Council Formas)	The study was supported by grants from The Swedish Asthma and Allergy Association's Research Foundation (contract 22012041-K), The Swedish Research Council FORMAS (contracts 294-2008-80 and 244-2010-277), The Swedish Property Foundation (FORMAS contract 244-2008-80), The Property Federation in Stockholm (FORMAS contract 244-2008-80), The City of Stockholm (FORMAS contract 244-2008-80) and the Fortum corporation (FORMAS contract 244-2008-80). The contract 294-2008-80 with FORMAS included requested co-sponsorship by the organizations or companies mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breysse J, 2011, PUBLIC HEALTH REP, V126, P64, DOI 10.1177/00333549111260S110; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, P573, DOI 10.1289/ehp.02110s4573; Ekerljung L, 2010, INT J TUBERC LUNG D, V14, P764; Engvall K, 2001, INT J TUBERC LUNG D, V5, P468; Engvall K, 2010, METHODS QUALITY ASSU; Engvall K, 2014, INDOOR AIR, V14, P23; Eriksson J, 2012, CLIN RESPIR J, V6, P159, DOI 10.1111/j.1752-699X.2011.00269.x; Fabian MP, 2014, J ALLERGY CLIN IMMUN, V133, P77, DOI 10.1016/j.jaci.2013.06.003; Gordian ME, 2010, INT J ENV RES PUB HE, V7, P3051, DOI 10.3390/ijerph7083051; Harrell FE, 2001, REGRESSION MODELING; Harrop J, 2007, CLIN EXP ALLERGY, V37, P526, DOI 10.1111/j.1365-2222.2007.02679.x; Herr CEW, 2004, INT ARCH OCC ENV HEA, V77, P90, DOI 10.1007/s00420-003-0489-7; Hirsch T, 2000, ALLERGY, V55, P79, DOI 10.1034/j.1398-9995.2000.00250.x; Howden-Chapman P, 2011, INT J PUBLIC HEALTH, V56, P583, DOI 10.1007/s00038-011-0287-z; Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249; Jie Y, 2011, J FORMOS MED ASSOC, V110, P555, DOI 10.1016/j.jfma.2011.07.003; Liu LQ, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-34; Moniruzzaman S, 2012, INT J ENVIRON HEAL R, V22, P22, DOI 10.1080/09603123.2011.588322; Nguyen T, 2010, PUBLIC HEALTH REP, V125, P877, DOI 10.1177/003335491012500615; NORBACK D, 1995, OCCUP ENVIRON MED, V52, P388, DOI 10.1136/oem.52.6.388; Peden D, 2010, J ALLERGY CLIN IMMUN, V125, pS150, DOI 10.1016/j.jaci.2009.10.073; Quansah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047526; Radon K, 2006, OCCUP ENVIRON MED, V63, P73, DOI 10.1136/oem.2004.017616; Ronmark EP, 2012, BRIT J DERMATOL, V166, P1301, DOI 10.1111/j.1365-2133.2012.10904.x; Sahlberg B, 2012, INDOOR AIR, V22, P331, DOI 10.1111/j.1600-0668.2012.00766.x; Sahlberg B, 2010, SCAND J PUBLIC HEALT, V38, P232, DOI 10.1177/1403494809350517; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Sobottka A, 1996, TOXICOL LETT, V88, P365, DOI 10.1016/0378-4274(96)03763-0; Spertini F, 2010, ALLERGY, V65, P623, DOI 10.1111/j.1398-9995.2009.02230.x; Sun Y, 2009, INDOOR AIR, V19, P174, DOI 10.1111/j.1600-0668.2008.00577.x; Takaoka M, 2011, INDOOR BUILT ENVIRON, V20, P369, DOI 10.1177/1420326X11403194; The National Board of Housing Building and Planning (Boverket), 2009, REG DAT EN DECL FORM; The Swedish Council for Building Research, 1996, EN BOOK A RES PRES K; Thomson H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008657.pub2; Thomson NC, 2007, CURR ALLERGY ASTHM R, V7, P303, DOI 10.1007/s11882-007-0045-8; THORNTON EW, 1994, NATURE, V372, P327, DOI 10.1038/372327a0; WHO, WHO GUID IND AIR QUA; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Wilson Jonathan, 2014, Energy Efficiency, V7, P151, DOI 10.1007/s12053-013-9216-8; Zock JP, 2007, AM J RESP CRIT CARE, V176, P735, DOI 10.1164/rccm.200612-1793OC	41	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112960	10.1371/journal.pone.0112960	http://dx.doi.org/10.1371/journal.pone.0112960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479551	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200013
J	Romani, C; Calza, S; Todeschini, P; Tassi, RA; Zanotti, L; Bandiera, E; Sartori, E; Pecorelli, S; Ravaggi, A; Santin, AD; Bignotti, E				Romani, Chiara; Calza, Stefano; Todeschini, Paola; Tassi, Renata A.; Zanotti, Laura; Bandiera, Elisabetta; Sartori, Enrico; Pecorelli, Sergio; Ravaggi, Antonella; Santin, Alessandro D.; Bignotti, Eliana			Identification of Optimal Reference Genes for Gene Expression Normalization in a Wide Cohort of Endometrioid Endometrial Carcinoma Tissues	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; HOUSEKEEPING GENES; RT-PCR; RNA; QUANTIFICATION; CELL	Accurate normalization is a primary component of a reliable gene expression analysis based on qRT-PCR technique. While the use of one or more reference genes as internal controls is commonly accepted as the most appropriate normalization strategy, many qPCR-based published studies still contain data poorly normalized and reference genes arbitrarily chosen irrespective of the particular tissue and the specific experimental design. To date, no validated reference genes have been identified for endometrial cancer tissues. In this study, 10 normalization genes (GAPDH, B2M, ACTB, POLR2A, UBC, PPIA, HPRT1, GUSB, TBP, H3F3A) belonging to different functional and abundance classes in various tissues and used in different studies, were analyzed to determine their applicability. In total, 100 endometrioid endometrial cancer samples, which were carefully balanced according to their tumor grade, and 29 normal endometrial tissues were examined using SYBR Green Real-Time RT-PCR. The expression stability of candidate reference genes was determined and compared by means of geNorm and NormFinder softwares. Both algorithms were in agreement in identifying GAPDH, H3F3A, PPIA, and HPRT1 as the most stably expressed genes, only differing in their ranking order. Analysis performed on the expression levels of all candidate genes confirm HPRT1 and PPIA as the most stably expressed in the study groups regardless of sample type, to be used alone or better in combination. As the stable expression of HPRT1 and PPIA between normal and tumor endometrial samples fulfill the basic requirement of a reference gene to be used for normalization purposes, HPRT1 expression showed significant differences between samples from low-grade and high-grade tumors. In conclusion, our results recommend the use of PPIA as a single reference gene to be considered for improved reliability of normalization in gene expression studies involving endometrial tumor samples at different tumor degrees.	[Romani, Chiara; Todeschini, Paola; Tassi, Renata A.; Zanotti, Laura; Bandiera, Elisabetta; Sartori, Enrico; Pecorelli, Sergio; Ravaggi, Antonella; Bignotti, Eliana] Univ Brescia, Div Gynecol Oncol, Angelo Nocivelli Inst Mol Med, Brescia, Italy; [Calza, Stefano] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Calza, Stefano] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Santin, Alessandro D.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA	University of Brescia; University of Brescia; Karolinska Institutet; Yale University	Romani, C (corresponding author), Univ Brescia, Div Gynecol Oncol, Angelo Nocivelli Inst Mol Med, Brescia, Italy.	cromani76@gmail.com	Calza, Stefano/AAM-9790-2021; Romani, Chiara/AAB-9920-2022; Ravaggi, Antonella/K-5585-2016	Calza, Stefano/0000-0003-4996-7995; Romani, Chiara/0000-0001-7916-2704; Ravaggi, Antonella/0000-0003-4661-9979; Zanotti, Laura/0000-0002-0471-7127	Istituto Superiore di Sanita' (Programma Italia-USA Oncoproteomica), Rome, Italy [527/B4/4]; National Institutes of Health [R01 CA154460-01, U01 CA176067-01A1]; Honorable Tina Brozman Foundation; Deborah Bunn Alley Ovarian Cancer Research Foundation; Guido Berlucchi Research Foundation; NATIONAL CANCER INSTITUTE [U01CA176067, R01CA154460] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	Istituto Superiore di Sanita' (Programma Italia-USA Oncoproteomica), Rome, Italy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honorable Tina Brozman Foundation; Deborah Bunn Alley Ovarian Cancer Research Foundation; Guido Berlucchi Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the Istituto Superiore di Sanita' (Programma Italia-USA Oncoproteomica 527/B4/4), Rome, Italy, to SP and in part by R01 CA154460-01 and U01 CA176067-01A1 grants from the National Institutes of Health, the Honorable Tina Brozman Foundation, the Deborah Bunn Alley Ovarian Cancer Research Foundation, and the Guido Berlucchi Research Foundation to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2014, R LANG ENV STAT COMP; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Creasman WT, 2004, GYNECOL ONCOL, V95, P593, DOI 10.1016/j.ygyno.2004.08.019; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dijkstra JR, 2014, MOL ONCOL       0102, V2; Felix AS, 2010, CANCER CAUSE CONTROL, V21, P1851, DOI 10.1007/s10552-010-9612-8; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hevir N, 2011, MOL CELL ENDOCRINOL, V331, P158, DOI 10.1016/j.mce.2010.09.011; Huber PJ, 2009, WILEY SERIES PROBABI; Lefever S, 2009, NUCLEIC ACI IN PRESS; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Meuer S.C., 2001, RAPID CYCLE REAL TIM; Mueller O, 2004, RNA INTEGRITY NUMBER; Piyamongkol W, 2003, MOL HUM REPROD, V9, P411, DOI 10.1093/molehr/gag051; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; SCHUIRMANN DL, 1981, BIOMETRICS, V37, P617; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; US Food and Drug Administration (FDA), 1992, GUID STAT PROC BIOE; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellek S., 2003, TESTING STAT HYPOTHE	32	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113781	10.1371/journal.pone.0113781	http://dx.doi.org/10.1371/journal.pone.0113781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473950	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500091
J	Shemesh, II; Rozen-Zvi, B; Kalechman, Y; Gafter, U; Sredni, B				Shemesh, Itay Israel; Rozen-Zvi, Benaya; Kalechman, Yona; Gafter, Uzi; Sredni, Benjamin			AS101 Prevents Diabetic Nephropathy Progression and Mesangial Cell Dysfunction: Regulation of the AKT Downstream Pathway	PLOS ONE			English	Article							HIGH GLUCOSE; PHOSPHOINOSITIDE 3-KINASE; KIDNEY-DISEASE; TGF-BETA; IMMUNOMODULATOR AS101; RENAL HYPERTROPHY; GROWTH; FIBROSIS; GLOMERULOSCLEROSIS; PHOSPHORYLATION	Diabetic nephropathy (DN) is characterized by proliferation of mesangial cells, mesangial expansion, hypertrophy and extracellular matrix accumulation. Previous data have cross-linked PKB (AKT) to TGF beta induced matrix modulation. The nontoxic compound AS101 has been previously shown to favorably affect renal pathology in various animal models and inhibits AKTactivity in leukemic cells. Here, we studied the pharmacological properties of AS101 against the progression of rat DN and high glucose-induced mesangial dysfunction. In-vivo administration of AS101 to Streptozotocin injected rats didn't decreased blood glucose levels but ameliorated kidney hypotrophy, proteinuria and albuminuria and downregulated cortical kidney phosphorylation of AKT, GSK3 beta and SMAD3. AS101 treatment of primary rat glomerular mesangial cells treated with high glucose significantly reduced their elevated proliferative ability, as assessed by XTT assay and cell cycle analysis. This reduction was associated with decreased levels of p-AKT, increased levels of PTEN and decreased p-GSK3 beta and p-FoxO3a expression. Pharmacological inhibition of PI3K, mTORC1 and SMAD3 decreased HG-induced collagen accumulation, while inhibition of GSK3 beta did not affect its elevated levels. AS101 also prevented HG-induced cell growth correlated to mTOR and (rp) S6 dephosphorylation. Thus, pharmacological inhibition of the AKT downstream pathway by AS101 has clinical potential in alleviating the progression of diabetic nephropathy.	[Shemesh, Itay Israel; Kalechman, Yona; Sredni, Benjamin] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Safdie Inst AIDS & Immunol Res, Ramat Gan, Israel; [Rozen-Zvi, Benaya; Gafter, Uzi] Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel; [Rozen-Zvi, Benaya; Gafter, Uzi] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Bar Ilan University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shemesh, II (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Safdie Inst AIDS & Immunol Res, Ramat Gan, Israel.	Itay.sh4@gmail.com; Benjamin.Sredni@biu.ac.il	rozen-zvi, benaya/AAR-4812-2021		Safdie Institute for AIDS and Immunology Research; Milton and Lois Shiffman Global Research Program; Dave and Florence Muskovitz Chair in Cancer Research; Comet Walerstein Cancer Research Program; Dorsha Wallman Cancer Research Endowment; Frida Stollman Cancer Memorial Fund	Safdie Institute for AIDS and Immunology Research; Milton and Lois Shiffman Global Research Program; Dave and Florence Muskovitz Chair in Cancer Research; Comet Walerstein Cancer Research Program; Dorsha Wallman Cancer Research Endowment; Frida Stollman Cancer Memorial Fund	This work was partly supported by: The Safdie Institute for AIDS and Immunology Research; The Milton and Lois Shiffman Global Research Program; The Dave and Florence Muskovitz Chair in Cancer Research; The Comet Walerstein Cancer Research Program; The Dorsha Wallman Cancer Research Endowment and the Frida Stollman Cancer Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaad KO, 2007, J CLIN PATHOL, V60, P18, DOI 10.1136/jcp.2005.035592; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Choudhury D, 2010, DISCOV MED, V10, P406; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Goldfarb S, 2001, Trans Am Clin Climatol Assoc, V112, P27; Goldfarb S., 2001, T AM CLIN CLIMAT ASS, V112, P33; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Ho C, 2012, AM J MED SCI, V344, P374, DOI 10.1097/MAJ.0b013e31824369c5; James LR, 2010, AM J PHYSIOL-ENDOC M, V298, pE210, DOI 10.1152/ajpendo.00232.2009; Jeong SI, 2012, FOOD CHEM TOXICOL, V50, P1045, DOI 10.1016/j.fct.2011.11.028; Kalechman Y, 2004, J BIOL CHEM, V279, P24724, DOI 10.1074/jbc.M312006200; Kalechman Y, 2003, J AM SOC NEPHROL, V14, P620, DOI 10.1097/01.ASN.0000053415.29636.4F; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Layani-Bazar A, 2014, CANCER RES, V74, P3092, DOI 10.1158/0008-5472.CAN-13-2159; LEEHEY DJ, 1995, DIABETES, V44, P929, DOI 10.2337/diabetes.44.8.929; Li XF, 2001, P NATL ACAD SCI USA, V98, P14416, DOI 10.1073/pnas.251547198; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Lu Q, 2013, EXP PHYSIOL, V98, P934, DOI 10.1113/expphysiol.2012.068361; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ricupero DA, 2001, AM J PHYSIOL-CELL PH, V281, pC99, DOI 10.1152/ajpcell.2001.281.1.C99; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Schellhase KG, 2005, FAM MED, V37, P125; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Schiffer M, 2000, KIDNEY INT, V58, pS45, DOI 10.1046/j.1523-1755.2000.07708.x; Sharma K, 2000, CYTOKINE GROWTH F R, V11, P115, DOI 10.1016/S1359-6101(99)00035-0; Sheu ML, 2004, MOL PHARMACOL, V66, P187, DOI 10.1124/mol.66.1.187; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang WX, 2012, J NEPHROL, V25, P1023, DOI 10.5301/jn.5000089; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; WOLF G, 1992, KIDNEY INT, V42, P647, DOI 10.1038/ki.1992.330; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wu D, 2009, AM J PHYSIOL-RENAL, V297, pF822, DOI 10.1152/ajprenal.00054.2009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu F, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/289327; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	54	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114287	10.1371/journal.pone.0114287	http://dx.doi.org/10.1371/journal.pone.0114287			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474550	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500009
J	Shrinet, J; Nandal, UK; Adak, T; Bhatnagar, RK; Sunil, S				Shrinet, Jatin; Nandal, Umesh Kumar; Adak, Tridibes; Bhatnagar, Raj K.; Sunil, Sujatha			Inference of the Oxidative Stress Network in Anopheles stephensi upon Plasmodium Infection	PLOS ONE			English	Article							RNA-SEQ; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MIDGUT; IMMUNITY; REDOX; GAMBIAE; SYSTEM; THIOREDOXIN; ANNOTATION	Ookinete invasion of Anopheles midgut is a critical step for malaria transmission; the parasite numbers drop drastically and practically reach a minimum during the parasite's whole life cycle. At this stage, the parasite as well as the vector undergoes immense oxidative stress. Thereafter, the vector undergoes oxidative stress at different time points as the parasite invades its tissues during the parasite development. The present study was undertaken to reconstruct the network of differentially expressed genes involved in oxidative stress in Anopheles stephensi during Plasmodium development and maturation in the midgut. Using high throughput next generation sequencing methods, we generated the transcriptome of the An. stephensi midgut during Plasmodium vinckei petteri oocyst invasion of the midgut epithelium. Further, we utilized large datasets available on public domain on Anopheles during Plasmodium ookinete invasion and Drosophila datasets and arrived upon clusters of genes that may play a role in oxidative stress. Finally, we used support vector machines for the functional prediction of the unannotated genes of An. stephensi. Integrating the results from all the different data analyses, we identified a total of 516 genes that were involved in oxidative stress in An. stephensi during Plasmodium development. The significantly regulated genes were further extracted from this gene cluster and used to infer an oxidative stress network of An. stephensi. Using system biology approaches, we have been able to ascertain the role of several putative genes in An. stephensi with respect to oxidative stress. Further experimental validations of these genes are underway.	[Shrinet, Jatin; Bhatnagar, Raj K.; Sunil, Sujatha] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Nandal, Umesh Kumar] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Adak, Tridibes] Natl Inst Malaria Res, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Amsterdam; Academic Medical Center Amsterdam; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sunil, S (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi, India.	sujatha@icgeb.res.in	SHRINET, JATIN/P-9088-2014	SHRINET, JATIN/0000-0002-4274-613X	Ramanujan fellowship, Department of Science and Technology, Government of India;  [SR/S2/RJN-53/2009]	Ramanujan fellowship, Department of Science and Technology, Government of India; 	SS is a recipient of Ramanujan fellowship, Department of Science and Technology, Government of India, and their support is duly acknowledged. The study was funded through grant number "SR/S2/RJN-53/2009". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ AMM, 1991, REV I MED TROP, V33, P421, DOI [10.1590/S0036-46651991000600001, 10.1590/S0036-46651991000600013]; Andrews S., 2010, REFERENCE SOURCE; Beutler B, 2008, CURR TOP MICROBIOL, V321, P3; Brandt SM, 2008, GENETICS, V180, P1671, DOI 10.1534/genetics.108.089748; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Clark TM, 2005, TISSUE CELL, V37, P457, DOI 10.1016/j.tice.2005.08.001; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Duran-Bedolla J., 2013, OXID ANTIOXID MED SC, V2, P93, DOI [10.5455/oams.130413.rv.007, DOI 10.5455/OAMS.130413.RV.007, DOI 10.5455/0AMS.130413.RV.007]; Forst CV, 2006, INFECTIOUS DIS INFOR, P123; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gostner JM, 2013, REDOX REP, V18, P88, DOI 10.1179/1351000213Y.0000000044; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Huang Y, 2006, BIOINFORMATICS, V26, P680; HUNT NH, 1990, BLOOD CELLS, V16, P499; Hunt NH, 1989, BLOOD CELLS, V16, P527; Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jomova K, 2012, J MICROBIOLOGY BIOTE, V1; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kogenaru S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-629; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DD, 2001, ADV NEUR IN, V13, P556; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lehane M. J., 1996, BIOL INSECT MIDGUT; Linksvayer TA, 2012, J EXP ZOOL PART B, V318B, P159, DOI 10.1002/jez.b.22001; Martinez-Cruz O, INVERTEBRATES MITOCH; Mohien CU, 2013, MOL CELL PROTEOMICS, V12, P120, DOI 10.1074/mcp.M112.019596; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nepveu F, 2013, FUTURE MED CHEM, V5, P1993, DOI [10.4155/FMC.13.159, 10.4155/fmc.13.159]; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Niissalo A., 2007, CYTOSCAPE ITS PLUGIN; Nubel E, 2009, PROTEOMICS, V9, P2408, DOI 10.1002/pmic.200800632; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Seyres D, 2012, BRIEF FUNCT GENOMICS, V11, P366, DOI 10.1093/bfgp/els028; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripoli G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r11; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Yan JZ, 2009, GENESIS, V47, P196, DOI 10.1002/dvg.20483; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649	65	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114461	10.1371/journal.pone.0114461	http://dx.doi.org/10.1371/journal.pone.0114461			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474020	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500031
J	Ye, RS; Yang, WL; Yuan, YM; Deng, XQ				Ye, Rensong; Yang, Wenlan; Yuan, Yiming; Deng, Xingqi			The CC Genotype of the Delta-Sarcoglycan Gene Polymorphism rs13170573 Is Associated with Obstructive Sleep Apnea in the Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; GLYCOPROTEIN COMPLEX; JAPANESE PATIENTS; VASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTOR; METAANALYSIS; DYSFUNCTION	Obstructive sleep apnea (OSA) is a highly heterogeneous sleep disorder, and increasing evidence suggests that genetic factors play a role in the etiology of OSA. Airway muscle dysfunction might promote pharyngeal collapsibility, mutations or single nucleotide polymorphisms (SNPs) in the delta-sarcoglycan (SCGD) gene associated with muscle dysfunction. To evaluate if SCGD gene SNPs are associated with OSA, 101 individuals without OSA and 97 OSA patients were recruited randomly. The genotype distributions of SNPs (rs157350, rs7715464, rs32076, rs13170573 and rs1835919) in case and control populations were evaluated. The GG, GC and CC genotypes of rs13170573 in control and OSA groups were 51.5% and 37.1%, 36.6% and 35.1%, and 11.9% and 27.8%, respectively. Significantly fewer OSA patients possessed the GG genotype and significantly more possessed the CC genotype compared with controls. Further multivariate logistic regression analysis showed that the CC genotype was an independent risk factor for OSA, with an odds ratio (OR) of 2.17 (95% confidence interval [CI]: 1.19-6.01). Other factors, such as age >= 50 years, male gender, body mass index (BMI) >= 25 kg/m(2), low-density lipoprotein cholesterol (LDL-C) level >= 3.33 mg/dL, smoking and hypertension, were also independent risk factors for OSA in our multivariate logistic regression model.	[Ye, Rensong] Jiangsu Univ, Affiliated Shanghai Peoples Hosp 8, Dept Internal Med, Shanghai, Peoples R China; [Deng, Xingqi] Ctr Hosp Minhang Dist, Dept Emergency Med, Shanghai, Peoples R China; [Yang, Wenlan] Tongji Univ, Affiliated Shanghai Pulm Hosp, Dept Resp Med, Shanghai 200092, Peoples R China; [Yuan, Yiming] Sichuan Univ, Affiliated West China Hosp, Dept Gerontol, Chengdu 610064, Peoples R China	Jiangsu University; Tongji University; Sichuan University	Deng, XQ (corresponding author), Ctr Hosp Minhang Dist, Dept Emergency Med, Shanghai, Peoples R China.	dxq2000@hotmail.com						Abboud F, 2014, J CLIN INVEST, V124, P1454, DOI 10.1172/JCI70420; Badorff C, 2004, MED MICROBIOL IMMUN, V193, P121, DOI 10.1007/s00430-003-0189-7; Bailey EF, 2006, J APPL PHYSIOL, V101, P609, DOI 10.1152/japplphysiol.00204.2006; Chockalingam PS, 2002, AM J PHYSIOL-CELL PH, V283, pC500, DOI 10.1152/ajpcell.00529.2001; Choi JB, 2006, SLEEP, V29, P1531, DOI 10.1093/sleep/29.12.1531; Date M, 2000, AM J CARDIOL, V85, P1315, DOI 10.1016/S0002-9149(00)00762-1; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Duchna H-W, 2006, Pneumologie, V60, P568, DOI 10.1055/s-2006-944248; Eng L, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-18; Fava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115; GUILLEMINAULT C, 1988, CHEST, V93, P104, DOI 10.1378/chest.93.1.104; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hightower CM, 2013, J NEUROCHEM, V127, P750, DOI 10.1111/jnc.12346; Honda T, 2007, CIRC J, V71, P1263, DOI 10.1253/circj.71.1263; Jordan AS, 2002, J APPL PHYSIOL, V93, P2129, DOI 10.1152/japplphysiol.00135.2002; Kawada T, 2002, P NATL ACAD SCI USA, V99, P901, DOI 10.1073/pnas.022641799; Kendzerska T, 2014, SLEEP MED REV, V18, P49, DOI 10.1016/j.smrv.2013.01.003; Larkin EK, 2008, ANN HUM GENET, V72, P762, DOI 10.1111/j.1469-1809.2008.00472.x; Lee Won, 2008, Expert Rev Respir Med, V2, P349, DOI 10.1586/17476348.2.3.349; Lopez-Jimenez F, 2008, CHEST, V133, P793, DOI 10.1378/chest.07-0800; Lurie A, 2011, ADV CARDIOL, V46, P1, DOI 10.1159/000327660; Ordonez-Razo RM, 2010, GENET TEST MOL BIOMA, V14, P237, DOI 10.1089/gtmb.2009.0147; Muzumdar H, 2012, SLEEP, V35, P1311, DOI 10.5665/sleep.2094; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Ordonez-Razo RM, 2012, GENET TEST MOL BIOMA, V16, P855, DOI 10.1089/gtmb.2011.0343; Ovchinsky A, 2002, ARCH OTOLARYNGOL, V128, P815, DOI 10.1001/archotol.128.7.815; Palmer LJ, 2004, AM J RESP CRIT CARE, V169, P1314, DOI 10.1164/rccm.200304-493OC; Palmer LJ, 2003, AM J HUM GENET, V72, P340, DOI 10.1086/346064; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Relf BL, 2010, J SLEEP RES, V19, P349, DOI 10.1111/j.1365-2869.2009.00797.x; Resnick HE, 1999, BRIT MED J, V318, P531, DOI 10.1136/bmj.318.7182.531; Riha RL, 2009, EUR RESPIR J, V33, P646, DOI 10.1183/09031936.00151008; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Sanchez-Garcia S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-2; Sankri-Tarbichi Abdul Ghani, 2012, Avicenna J Med, V2, P3, DOI 10.4103/2231-0770.94803; Sasaki N, 2013, ANESTHESIOLOGY, V118, P961, DOI 10.1097/ALN.0b013e318288834f; Savas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012601; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sleiman P, 2011, SLEEP, V34, P1449, DOI 10.5665/sleep.1366; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Towbin JA, 2001, J ELECTROCARDIOL, V34, P151, DOI 10.1054/jelc.2001.28859; Varvarigou V, 2011, SLEEP, V34, P1461, DOI 10.5665/sleep.1376; Wheeler MT, 2002, HUM MOL GENET, V11, P2147, DOI 10.1093/hmg/11.18.2147; Wicklund MP, 2014, NEUROL CLIN, V32, P729, DOI 10.1016/j.ncl.2014.04.005; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099	49	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114160	10.1371/journal.pone.0114160	http://dx.doi.org/10.1371/journal.pone.0114160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474115	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500119
J	Boban, M; Ljungdahl, PO; Foisner, R				Boban, Mirta; Ljungdahl, Per O.; Foisner, Roland			Atypical Ubiquitylation in Yeast Targets Lysine-less Asi2 for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PEROXISOMAL IMPORT RECEPTOR; NUCLEAR-MEMBRANE PROTEIN; COMPLEX CLASS-I; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; UBIQUITIN LIGASE; MAT-ALPHA-2 REPRESSOR; DOWN-REGULATION	Proteins are typically targeted for proteasomal degradation by the attachment of a polyubiquitin chain to epsilon-amino groups of lysine residues. Non-lysine ubiquitylation of proteasomal substrates has been considered an atypical and rare event limited to complex eukaryotes. Here we report that a fully functional lysine-less mutant of an inner nuclear membrane protein in yeast, Asi2, is polyubiquitylated and targeted for proteasomal degradation. Efficient degradation of lysine-free Asi2 requires E3-ligase Doa10 and E2 enzymes Ubc6 and Ubc7, components of the endoplasmic reticulum-associated degradation pathway. Together, our data suggest that non-lysine ubiquitylation may be more prevalent than currently considered.	[Boban, Mirta; Foisner, Roland] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria; [Ljungdahl, Per O.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-S-10691 Stockholm, Sweden	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Stockholm University	Foisner, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	roland.foisner@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019; Ljungdahl, Per O/M-5258-2013	Ljungdahl, Per O/0000-0002-6625-3540; Foisner, Roland/0000-0003-4734-4647	Swedish Research Council [2011-5925]; Austrian Science Fund [FWF P23805-B20]; EMBO Long-Term Fellowship; Austrian Science Fund (FWF) [P 23805] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Swedish Research Council Grant 2011-5925 (to P. O. L.), Austrian Science Fund Grant FWF P23805-B20 (to R. F.), and an EMBO Long-Term Fellowship (to M. B.).	Andreasson C, 2004, YEAST, V21, P193, DOI 10.1002/yea.1052; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Boban M, 2014, J CELL SCI, V127, P3603, DOI 10.1242/jcs.153163; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Ciechanover A, 2007, ANN NY ACAD SCI, V1116, P1, DOI 10.1196/annals.1402.078; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Domingues C, 2012, CELL DEATH DIFFER, V19, P470, DOI 10.1038/cdd.2011.116; Forsberg H, 2001, GENETICS, V158, P973; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Liu XQ, 2013, J BIOL CHEM, V288, P7230, DOI 10.1074/jbc.M112.424911; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; McBratney S, 2002, GENETICS, V162, P567; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; SIKORSKI RS, 1989, GENETICS, V122, P19; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	44	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2489	2495		10.1074/jbc.M114.600593	http://dx.doi.org/10.1074/jbc.M114.600593			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492870	Green Published, hybrid			2022-12-26	WOS:000348588000050
J	Hughes, S; Wilkinson, H; Gilbert, SPR; Kishida, M; Ding, SS; Woollard, A				Hughes, Samantha; Wilkinson, Henry; Gilbert, Sophie P. R.; Kishida, Marcia; Ding, Siyu Serena; Woollard, Alison			The C. elegans TPR Containing Protein, TRD-1, Regulates Cell Fate Choice in the Developing Germ Line and Epidermis	PLOS ONE			English	Article							SEX-DETERMINATION GENE; RNA-BINDING PROTEIN; CAENORHABDITIS-ELEGANS; TETRATRICOPEPTIDE REPEAT; ASYMMETRIC DIVISION; DEPENDENT CONTROL; MITOTIC REGION; STEM-CELLS; SPERMATOGENESIS; HERMAPHRODITE	Correct cell fate choice is crucial in development. In post-embryonic development of the hermaphroditic Caenorhabitis elegans, distinct cell fates must be adopted in two diverse tissues. In the germline, stem cells adopt one of three possible fates: mitotic cell cycle, or gamete formation via meiosis, producing either sperm or oocytes. In the epidermis, the stem cell-like seam cells divide asymmetrically, with the daughters taking on either a proliferative (seam) or differentiated (hypodermal or neuronal) fate. We have isolated a novel conserved C. elegans tetratricopeptide repeat containing protein, TRD-1, which is essential for cell fate determination in both the germline and the developing epidermis and has homologs in other species, including humans (TTC27). We show that trd-1(RNAi) and mutant animals have fewer seam cells as a result of inappropriate differentiation towards the hypodermal fate. In the germline, trd-1 RNAi results in a strong masculinization phenotype, as well as defects in the mitosis to meiosis switch. Our data suggests that trd-1 acts downstream of tra-2 but upstream of fem-3 in the germline sex determination pathway, and exhibits a constellation of phenotypes in common with other Mog (masculinization of germline) mutants. Thus, trd-1 is a new player in both the somatic and germline cell fate determination machinery, suggestive of a novel molecular connection between the development of these two diverse tissues.	[Hughes, Samantha; Wilkinson, Henry; Gilbert, Sophie P. R.; Kishida, Marcia; Ding, Siyu Serena; Woollard, Alison] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Woollard, A (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	alison.woollard@bioch.ox.ac.uk	Ding, Serena/AAM-2834-2020	Ding, Serena/0000-0002-8590-3908; Hughes, Samantha/0000-0001-8447-2563; Wilkinson, Henry Charles/0000-0001-7810-8300	Association for International Cancer Research Grants [08-0458, 12-0028]; Wellcome Trust; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1106660] Funding Source: researchfish; Worldwide Cancer Research [12-0028] Funding Source: researchfish	Association for International Cancer Research Grants; Wellcome Trust(Wellcome TrustEuropean Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Worldwide Cancer Research	This work was funded by the Association for International Cancer Research Grants 08-0458 and 12-0028 to AW and SH (http://www.aicr.org.uk) and a Wellcome Trust Studentship to SSD (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachorik JL, 2005, P NATL ACAD SCI USA, V102, P10893, DOI 10.1073/pnas.0504593102; BARTON MK, 1987, GENETICS, V115, P107; Belfiore M, 2004, DEVELOPMENT, V131, P2935, DOI 10.1242/dev.01154; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BRENNER S, 1974, GENETICS, V77, P71; Byrd DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088372; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DONIACH T, 1986, GENETICS, V114, P53; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Ellis R, 2007, SEX DETERMINATION GE; ELLIS RE, 1995, GENETICS, V139, P561; Ellis RE, 2014, SEMIN CELL DEV BIOL, V29, P17, DOI 10.1016/j.semcdb.2014.04.005; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Gallegos M, 1998, EMBO J, V17, P6337, DOI 10.1093/emboj/17.21.6337; GRAHAM PL, 1993, DEV GENET, V14, P471, DOI 10.1002/dvg.1020140608; GRAHAM PL, 1993, GENETICS, V133, P919; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; Hughes S, 2013, BIOL OPEN, V2, P718, DOI 10.1242/bio.20134549; Kagoshima H, 2007, DEVELOPMENT, V134, P3905, DOI 10.1242/dev.008276; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kasturi P, 2010, DEV BIOL, V344, P593, DOI 10.1016/j.ydbio.2010.05.009; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Koh K, 2001, DEVELOPMENT, V128, P2867; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Matus DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000654; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Nimmo R, 2008, DEV BIOL, V313, P492, DOI 10.1016/j.ydbio.2007.11.002; Puoti A, 1999, MOL CELL BIOL, V19, P2189; Puoti A, 2001, EMBO REP, V2, P899, DOI 10.1093/embo-reports/kve209; Rybarska A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000494; Sawa H, 2012, CURR TOP DEV BIOL, V101, P55, DOI 10.1016/B978-0-12-394592-1.00003-X; SCHEDL T, 1988, GENETICS, V119, P43; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Thompson BE, 2005, DEVELOPMENT, V132, P3471, DOI 10.1242/dev.01921; Worrall LJ, 2008, BBA-PROTEINS PROTEOM, V1784, P496, DOI 10.1016/j.bbapap.2007.12.003; Zanetti S, 2011, DEV BIOL, V354, P232, DOI 10.1016/j.ydbio.2011.04.001; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	41	6	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114998	10.1371/journal.pone.0114998	http://dx.doi.org/10.1371/journal.pone.0114998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493563	Green Published, gold			2022-12-26	WOS:000346611400088
J	Knutson, SK; Warholic, NM; Johnston, LD; Klaus, CR; Wigle, TJ; Iwanowicz, D; Littlefield, BA; Porter-Scott, M; Smith, JJ; Moyer, MP; Copeland, RA; Pollock, RM; Kuntz, KW; Raimondi, A; Keilhack, H				Knutson, Sarah K.; Warholic, Natalie M.; Johnston, L. Danielle; Klaus, Christine R.; Wigle, Tim J.; Iwanowicz, Dorothy; Littlefield, Bruce A.; Porter-Scott, Margaret; Smith, Jesse J.; Moyer, Mikel P.; Copeland, Robert A.; Pollock, Roy M.; Kuntz, Kevin W.; Raimondi, Alejandra; Keilhack, Heike			Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; PROTEIN METHYLTRANSFERASES; SELECTIVE-INHIBITION; MOLECULAR SUBTYPES; SOMATIC MUTATIONS; DRUG DISCOVERY; MECHANISMS; CANCER; RESISTANCE; APOPTOSIS	Patients with non-Hodgkin lymphoma (NHL) are treated today with a cocktail of drugs referred to as CHOP (Cyclophosphamide, Hydroxyldaunorubicin, Oncovin, and Prednisone). Subsets of patients with NHL of germinal center origin bear oncogenic mutations in the EZH2 histone methyltransferase. Clinical testing of the EZH2 inhibitor EPZ-6438 has recently begun in patients. We report here that combining EPZ-6438 with CHOP in preclinical cell culture and mouse models results in dramatic synergy for cell killing in EZH2 mutant germinal center NHL cells. Surprisingly, we observe that much of this synergy is due to Prednisolone - a glucocorticoid receptor agonist (GRag) component of CHOP. Dramatic synergy was observed when EPZ-6438 is combined with Prednisolone alone, and a similar effect was observed with Dexamethasone, another GRag. Remarkably, the anti-proliferative effect of the EPZ-6438+GRag combination extends beyond EZH2 mutant-bearing cells to more generally impact germinal center NHL. These preclinical data reveal an unanticipated biological intersection between GR-mediated gene regulation and EZH2-mediated chromatin remodeling. The data also suggest the possibility of a significant and practical benefit of combining EZH2 inhibitors and GRag that warrants further investigation in a clinical setting.	[Knutson, Sarah K.; Warholic, Natalie M.; Johnston, L. Danielle; Klaus, Christine R.; Wigle, Tim J.; Iwanowicz, Dorothy; Porter-Scott, Margaret; Smith, Jesse J.; Moyer, Mikel P.; Copeland, Robert A.; Pollock, Roy M.; Kuntz, Kevin W.; Raimondi, Alejandra; Keilhack, Heike] Epizyme Inc, Res & Dev, Cambridge, MA 02139 USA; [Littlefield, Bruce A.] Eisai Inc, Oncol, Andover, MA USA	Eisai Co Ltd	Keilhack, H (corresponding author), Epizyme Inc, Res & Dev, Cambridge, MA 02139 USA.	hkeilhack@epizyme.com			Eisai Inc.	Eisai Inc.(Eisai Co Ltd)	This work was funded by Eisai Inc. through collaboration between Epizyme and Eisai. The funding entity had no input in study design, data collection and analysis and decision to publish. The funders were not involved in the preparation of the manuscript, but did review and approve it.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Barrett-Lee PJ, 2009, ANN ONCOL, V20, P816, DOI 10.1093/annonc/mdn728; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Copeland RA, 2013, ONCOGENE, V32, P939, DOI 10.1038/onc.2012.552; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Furusawa C, 2012, SCIENCE, V338, P215, DOI 10.1126/science.1224311; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; George AA, 2009, INT J BIOCHEM CELL B, V41, P214, DOI 10.1016/j.biocel.2008.09.019; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Maxwell SA, 2013, EXP BIOL MED, V238, P971, DOI 10.1177/1535370213498985; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nastoupil LJ, 2012, ONCOLOGY-NY, V26, P488; Niitsu N, 2010, INT J HEMATOL, V92, P231, DOI 10.1007/s12185-010-0666-x; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Rutz HP, 2004, CANCER BIOL THER, V3, P715, DOI 10.4161/cbt.3.8.966; Rutz HP, 2002, LANCET, V360, P1969, DOI 10.1016/S0140-6736(02)11922-2; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Van Bogaert T, 2010, CYTOKINE GROWTH F R, V21, P275, DOI 10.1016/j.cytogfr.2010.04.003; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wigle TJ, 2013, CURR OPIN CHEM BIOL, V17, P369, DOI 10.1016/j.cbpa.2013.03.035	42	52	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e111840	10.1371/journal.pone.0111840	http://dx.doi.org/10.1371/journal.pone.0111840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493630	Green Published, gold, Green Submitted			2022-12-26	WOS:000346611400005
J	Heckt, T; Bickert, T; Jeschke, A; Seitz, S; Schulze, J; Ito, WD; Zimmermann, W; Amling, M; Schinke, T; Horst, AK; Keller, J				Heckt, Timo; Bickert, Thomas; Jeschke, Anke; Seitz, Sebastian; Schulze, Jochen; Ito, Wulf D.; Zimmermann, Wolfgang; Amling, Michael; Schinke, Thorsten; Horst, Andrea Kristina; Keller, Johannes			Increased Osteoclastogenesis in Mice Lacking the Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1	PLOS ONE			English	Article							DIFFERENTIATION; DEFICIENCY; RECEPTOR; PHYSIOLOGY; CYTOKINE; LIGAND	Alterations in bone remodeling are a major public health issue, as therapeutic options for widespread bone disorders such as osteoporosis and tumor-induced osteolysis are still limited. Therefore, a detailed understanding of the regulatory mechanism governing bone cell differentiation in health and disease are of utmost clinical importance. Here we report a novel function of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a member of the immunoglobulin superfamily involved in inflammation and tumorigenesis, in the physiologic regulation of bone remodeling. Assessing the expression of all members of the murine Ceacam family in bone tissue and marrow, we found CEACAM1 and CEACAM10 to be differentially expressed in both bone-forming osteoblasts and bone-resorbing osteoclasts. While Ceacam10-deficient mice displayed no alteration in structural bone parameters, static histomorphometry demonstrated a reduced trabecular bone mass in mice lacking CEACAM1. Furthermore, cellular and dynamic histomorphometry revealed an increased osteoclast formation in Ceacam1-deficient mice, while osteoblast parameters and the bone formation rate remained unchanged. In line with these findings, we detected accelerated osteoclastogenesis in Ceacam1-deficient bone marrow cells, while osteoblast differentiation, as determined by mineralization and alkaline phosphatase assays, was not affected. Therefore, our results provide in vivo and in vitro evidence for a physiologic role of CEACAM1 in the regulation of osteoclastogenesis.	[Heckt, Timo; Jeschke, Anke; Seitz, Sebastian; Schulze, Jochen; Amling, Michael; Schinke, Thorsten; Keller, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany; [Bickert, Thomas; Horst, Andrea Kristina] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, D-20246 Hamburg, Germany; [Ito, Wulf D.] Cardiovasc Ctr Oberallgau Kempten, D-87509 Immenstadt, Germany; [Zimmermann, Wolfgang] Univ Munich, Klinikum Grosshadern, LIFE Ctr, Tumor Immunol Lab, D-81377 Munich, Germany; [Horst, Andrea Kristina] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Keller, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany.	j.keller@uke.de		Keller, Johannes/0000-0002-8925-7288	Deutsche Forschungsgemeinschaft [SPP1468]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SPP1468 IMMUNOBONE - Project SCHI 504/7-2 and IT13-3 - http://www.immunobone.de/ - TS WDI AKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Bickert T, 2012, ARTERIOSCL THROM VAS, V32, P2566, DOI 10.1161/ATVBAHA.112.300015; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Chen LF, 2012, IMMUNITY, V37, P930, DOI 10.1016/j.immuni.2012.07.016; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Finkenzeller D, 2003, MOL CELL BIOL, V23, P272, DOI 10.1128/MCB.23.1.272-279.2003; Goltzman D, 2001, J CLIN INVEST, V107, P1219, DOI 10.1172/JCI13073; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Horst AK, 2009, BLOOD, V113, P6726, DOI 10.1182/blood-2008-10-184556; Huang S, 2010, BONE, V46, P1138, DOI 10.1016/j.bone.2009.12.020; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Ludewig P, 2013, CIRC RES, V113, P1013, DOI 10.1161/CIRCRESAHA.113.301207; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Michigami T, 2000, BLOOD, V96, P1953, DOI 10.1182/blood.V96.5.1953.h8001953_1953_1960; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; ROODMAN GD, 1995, BONE, V17, pS57, DOI 10.1016/8756-3282(95)00179-H; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	33	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114360	10.1371/journal.pone.0114360	http://dx.doi.org/10.1371/journal.pone.0114360			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490771	gold, Green Submitted, Green Published			2022-12-26	WOS:000347515300031
J	Lin, J; Reilly, MP; Terembula, K; Wilson, FP				Lin, Jennie; Reilly, Muredach P.; Terembula, Karen; Wilson, F. Perry			Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; RISK-FACTOR; PREDICTIVE-VALUE; CALCIFICATION; ABNORMALITIES; MORTALITY; PATHOPHYSIOLOGY	Background: CKD, an independent risk factor for CV disease, increases mortality in T2DM. Treating modifiable CV risk factors decreases mortality in diabetics with microalbuminuria, but the role of early CV prevention in diabetics with mild CKD by GFR criteria alone remains unclear. The purpose of this study was to probe whether T2DM patients with mild GFR impairment have atherogenic lipid profiles compared to diabetic counterparts with normal renal function. Methods: In the Penn Diabetes Heart Study (PDHS), a single-center observational cohort of T2DM patients without clinical CVD, cross-sectional analyses were performed for directly measured lipid fractions in 1852 subjects with eGFR. 60 mL/min/1.73 m(2) determined by the CKD-EPI equation (n=1852). Unadjusted and multivariable analyses of eGFR association with log-transformed lipid parameters in incremental linear and logistic regression models (with eGFR 90 mL/min/1.73 m(2) as a cut-point) were performed. Results: Mild GFR impairment (eGFR 60-90 mL/min/1.73 m(2), median urinary ACR 5.25 mg/g) was associated with higher log-transformed Lp(a) values (OR 1.17, p=0.005) and with clinically atherogenic Lp(a) levels above 30 mg/dL (OR 1.35, p=0.013) even after full adjustment for demographics, medications, metabolic parameters, and albuminuria. Logistic regression demonstrated a trend towards significance between worse kidney function and apoB (p=0.17) as well as apoC-III (p=0.067) in the fully adjusted model. Conclusions: Elevated Lp(a) levels have a robust association with mild GFR impairment in type 2 diabetics independent of race, insulin resistance, and albuminuria.	[Lin, Jennie] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Reilly, Muredach P.; Terembula, Karen] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Wilson, F. Perry] Yale Univ, Sch Med, Dept Med, Sect Nephrol,Program Appl Translat Res, New Haven, CT 06510 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Yale University	Lin, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	linjenn@mail.med.upenn.edu		Reilly, Muredach/0000-0002-3035-9386; Lin, Jennie/0000-0002-9328-6700; Wilson, Francis Perry/0000-0002-2633-2412	National Institute of Diabetes and Digestive and Kidney Diseases [T32-DK00700640, K23-DK097201]; National Heart, Lung and Blood Institute [K24-HL107643]; Clinical and Translational Science Award from the National Center for Research Resources [UL1RR024134]; Diabetes and Endocrine Research Center award [P20-DK 019525]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL107643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK097201, T32DK007006, P30DK019525] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Clinical and Translational Science Award from the National Center for Research Resources; Diabetes and Endocrine Research Center award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases: T32-DK00700640, JL. K23-DK097201, FPW; National Heart, Lung and Blood Institute: K24-HL107643, MPR; Clinical and Translational Science Award (UL1RR024134) from the National Center for Research Resources and a Diabetes and Endocrine Research Center award (P20-DK 019525) awarded to the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Anderson JL, 2013, AM J CARDIOL, V112, P799, DOI 10.1016/j.amjcard.2013.05.009; [Anonymous], 2014, KIDNEY INT, V85, P1303, DOI DOI 10.1038/KI.2014.31; Attman PO, 2011, NEPHROL DIAL TRANSPL, V26, P2572, DOI 10.1093/ndt/gfq762; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; Attman PO, 1998, NEPHROL DIAL TRANSPL, V13, P2833, DOI 10.1093/ndt/13.11.2833; ATTMAN PO, 1993, AM J KIDNEY DIS, V21, P573, DOI 10.1016/S0272-6386(12)80030-8; Chan DC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0309-9; Chan DT, 2009, J LIPID RES, V50, P2524, DOI 10.1194/jlr.P900003-JLR200; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Boer IH, 2008, ATHEROSCLEROSIS, V197, P407, DOI 10.1016/j.atherosclerosis.2007.06.018; Dohi T, 2011, NEPHROL DIAL TRANSPL, V26, P2906, DOI 10.1093/ndt/gfq820; ELOSUA R, 2014, TACG, P15, DOI DOI 10.2147/TACG.S35301; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Holzmann MJ, 2012, ANN MED, V44, P262, DOI 10.3109/07853890.2010.532153; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Jacobson TA, 2013, MAYO CLIN PROC, V88, P1294, DOI 10.1016/j.mayocp.2013.09.003; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; Keane WF, 2013, J ATHEROSCLER THROMB, V20, P123, DOI 10.5551/jat.12849; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Kronenberg F, 1997, J LIPID RES, V38, P1755; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Lamprea-Montealegre JA, 2013, ARTERIOSCL THROM VAS, V33, P652, DOI 10.1161/ATVBAHA.112.300624; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lilly SM, 2013, ATHEROSCLEROSIS, V230, P17, DOI 10.1016/j.atherosclerosis.2013.06.004; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Martin SS, 2011, AM J CARDIOL, V107, P393, DOI 10.1016/j.amjcard.2010.09.033; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mulvey CK, 2014, DIABETES CARE, V37, P124, DOI 10.2337/dc12-1880; Nakamura T, 2011, ATHEROSCLEROSIS, V218, P163, DOI 10.1016/j.atherosclerosis.2011.04.040; *NAT KIDN FDN, 2012, YAJKD, V60, P850, DOI DOI 10.1053/J.AJKD.2012.07.005; O'Donoghue ML, 2014, J AM COLL CARDIOL, V63, P520, DOI 10.1016/j.jacc.2013.09.042; Ooi EMM, 2011, J LIPID RES, V52, P794, DOI 10.1194/jlr.M011163; Pennell P, 2006, CLIN NEPHROL, V66, P336; Qasim AN, 2013, ATHEROSCLEROSIS, V226, P419, DOI 10.1016/j.atherosclerosis.2012.11.011; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Reilly MP, 2004, J CLIN ENDOCR METAB, V89, P3872, DOI 10.1210/jc.2003-031676; Rosas S, 2008, AM J NEPHROL, V28, P361, DOI 10.1159/000112225; Samuelsson O, 1996, NEPHROL DIAL TRANSPL, V11, P2237, DOI 10.1093/oxfordjournals.ndt.a027142; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sechi LA, 1999, KIDNEY INT, V56, P1049, DOI 10.1046/j.1523-1755.1999.00621.x; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Uhlig K, 2005, AM J KIDNEY DIS, V45, P28, DOI 10.1053/j.ajkd.2004.08.043; Virani SS, 2012, CIRCULATION, V125, P241, DOI 10.1161/CIRCULATIONAHA.111.045120; Wang XW, 2012, CARDIORENAL MED, V2, P57, DOI 10.1159/000335509; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Willey JZ, 2011, AM HEART J, V161, P886, DOI 10.1016/j.ahj.2011.01.018	54	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114397	10.1371/journal.pone.0114397	http://dx.doi.org/10.1371/journal.pone.0114397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490096	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300036
J	Ericsson, A; Turner, N; Hansson, GI; Wallenius, K; Oakes, ND				Ericsson, Anette; Turner, Nigel; Hansson, Goran I.; Wallenius, Kristina; Oakes, Nicholas D.			Pharmacological PPAR alpha Activation Markedly Alters Plasma Turnover of the Amino Acids Glycine, Serine and Arginine in the Rat	PLOS ONE			English	Article							INDIRECT CALORIMETRY; LIVER-REGENERATION; METABOLISM; AGONIST; MICE; INCREASES; REVERSES; EXCHANGE; MUSCLE; MODEL	The current study extends previously reported PPAR alpha agonist WY 14,643 (30 mmol/kg/day for 4 weeks) effects on circulating amino acid concentrations in rats fed a 48% saturated fat diet. Steady-state tracer experiments were used to examine in vivo kinetic mechanisms underlying altered plasma serine, glycine and arginine levels. Urinary urea and creatinine excretion were measured to assess whole-body amino acid catabolism. WY 14,643 treated animals demonstrated reduced efficiency to convert food consumed to body weight gain while liver weight was increased compared to controls. WY 14,643 raised total amino acid concentration (38%), largely explained by glycine, serine and threonine increases. H-3-glycine, C-14-serine and C-14-arginine tracer studies revealed elevated rates of appearance (R-a) for glycine (45.5 +/- 5.8 versus 17.4 +/- 2.7 mu mol/kg/min) and serine (21.0 +/- 1.4 versus 12.0 +/- 1.0) in WY 14,643 versus control. Arginine was substantially decreased (-62%) in plasma with estimated R-a reduced from 3.1 +/- 0.3 to 1.2 +/- 0.2 mu mol/kg/min in control versus WY 14,643. Nitrogen excretion over 24 hours was unaltered. Hepatic arginase activity was substantially decreased by WY 14,643 treatment. In conclusion, PPAR alpha agonism potently alters metabolism of several specific amino acids in the rat. The changes in circulating levels of serine, glycine and arginine reflected altered fluxes into the plasma rather than changes in clearance or catabolism. This suggests that PPAR alpha has an important role in modulating serine, glycine and arginine de novo synthesis.	[Ericsson, Anette; Hansson, Goran I.; Wallenius, Kristina; Oakes, Nicholas D.] AstraZeneca R&D, Dept Biosci, Molndal, Sweden; [Turner, Nigel] Garvan Inst Med Res, Sydney, NSW, Australia; [Turner, Nigel] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia	AstraZeneca; Garvan Institute of Medical Research; University of New South Wales Sydney	Ericsson, A (corresponding author), AstraZeneca R&D, Dept Biosci, Molndal, Sweden.	Anette.E.Ericsson@astrazeneca.com	Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328; Wallenius, Kristina/0000-0002-3231-2733	AstraZeneca; Australian Research Council Future Fellowship	AstraZeneca(AstraZeneca); Australian Research Council Future Fellowship(Australian Research Council)	AstraZeneca is the funder of all work. Co-authors Anette Ericsson, Goran I. Hansson, Kristina Wallenius and Nicholas D. Oakes are employed by AstraZeneca R&D Molndal. Nigel Turner is supported by an Australian Research Council Future Fellowship. The funder, AstraZeneca, provided support in the form of salaries for authors AE, GIH, KW and NDO, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The decision to publish was made by an internal AstraZeneca review of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alhonen L, 2002, BIOCHEM J, V362, P149, DOI 10.1042/0264-6021:3620149; Bjorndal B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066926; Carrillo MC, 1996, MECH AGEING DEV, V91, P55, DOI 10.1016/0047-6374(96)01779-4; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Cunningham Michael L, 2007, Toxic Rep Ser, P1; De Souza AT, 2006, TOXICOL SCI, V92, P578, DOI 10.1093/toxsci/kfl019; Dejong CHC, 1998, CLIN SCI, V95, P409, DOI 10.1042/CS19980002; DISTEFANO JJ, 1982, AM J PHYSIOL, V243, pR1, DOI 10.1152/ajpregu.1982.243.1.R1; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Evoy D, 1998, NUTRITION, V14, P611, DOI 10.1016/S0899-9007(98)00005-7; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; GEYER JW, 1971, ANAL BIOCHEM, V39, P412, DOI 10.1016/0003-2697(71)90431-3; Guelzim N, 2011, AMINO ACIDS, V41, P969, DOI 10.1007/s00726-010-0797-7; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kim H, 2003, DIABETES, V52, P1770, DOI 10.2337/diabetes.52.7.1770; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Linz W, 2009, ACTA PHARMACOL SIN, V30, P935, DOI 10.1038/aps.2009.58; Luiking YC, 2004, CRIT CARE MED, V32, P2135, DOI 10.1097/01.CCM.0000142939.81045.A0; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Rose ML, 1997, CHEM RES TOXICOL, V10, P1198, DOI 10.1021/tx970079u; Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006; van de Poll MCG, 2004, AM J CLIN NUTR, V79, P185; Wallenius K, 2013, PPAR RES, V2013, DOI 10.1155/2013/305347; WATERLOW JC, 1981, BRIT MED BULL, V37, P5, DOI 10.1093/oxfordjournals.bmb.a071676; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113328	10.1371/journal.pone.0113328	http://dx.doi.org/10.1371/journal.pone.0113328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486018	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600019
J	Fronkova, E; Klocperk, A; Svaton, M; Novakova, M; Kotrova, M; Kayserova, J; Kallna, T; Keslova, P; Votava, F; Vinohradska, H; Freiberger, T; Mejstrikova, E; Trka, J; Sediva, A				Fronkova, Eva; Klocperk, Adam; Svaton, Mlchael; Novakova, Michaela; Kotrova, Mlchaela; Kayserova, Jana; Kallna, Tomas; Keslova, Petra; Votava, Felix; Vinohradska, Hana; Freiberger, Tomas; Mejstrikova, Ester; Trka, Jan; Sediva, Anna			The TREC/KREC Assay for the Diagnosis and Monitoring of Patients with DiGeorge Syndrome	PLOS ONE			English	Article							T-CELL-RECEPTOR; MINIMAL RESIDUAL DISEASE; DELETION SYNDROME; THYMIC OUTPUT; IMMUNODEFICIENCY; PROLIFERATION; REPERTOIRES	DiGeorge syndrome (DGS) presents with a wide spectrum of thymic pathologies. Nationwide neonatal screening programs of lymphocyte production using T-cell recombination excision circles (TREC) have repeatedly identified patients with DGS. We tested what proportion of DGS patients could be identified at birth by combined TREC and kappa-deleting element recombination circle (KREC) screening. Furthermore, we followed TREC/KREC levels in peripheral blood (PB) to monitor postnatal changes in lymphocyte production. Methods: TREC/KREC copies were assessed by quantitative PCR (qPCR) and were related to the albumin control gene in dry blood spots (DBSs) from control (n=56), severe immunodeficiency syndrome (SCID, n=10) and DGS (n=13) newborns. PB was evaluated in DGS children (n=32), in diagnostic samples from SCID babies (n=5) and in 91 controls. Results: All but one DGS patient had TREC levels in the normal range at birth, albeit quantitative TREC values were significantly lower in the DGS cohort. One patient had slightly reduced KREC at birth. Postnatal DGS samples revealed reduced TREC numbers in 5 of 32 (16%) patients, whereas KREC copy numbers were similar to controls. Both TREC and KREC levels showed a more pronounced decrease with age in DGS patients than in controls (p<0.0001 for both in a linear model). DGS patients had higher percentages of NK cells at the expense of T cells (p<0.0001). The patients with reduced TREC levels had repeated infections in infancy and developed allergy and/or autoimmunity, but they were not strikingly different from other patients. In 12 DGS patients with paired DBS and blood samples, the TREC/KREC levels were mostly stable or increased and showed similar kinetics in respective patients. Conclusions: The combined TREC/KREC approach with correction via control gene identified 1 of 13 (8%) of DiGeorge syndrome patients at birth in our cohort. The majority of patients had TREC/KREC levels in the normal range.	[Fronkova, Eva; Svaton, Mlchael; Novakova, Michaela; Kotrova, Mlchaela; Kallna, Tomas; Keslova, Petra; Mejstrikova, Ester; Trka, Jan] Charles Univ Prague, Sch Med 2, Dept Paediat Haematol Oncol, CLIP, Prague, Czech Republic; [Fronkova, Eva; Klocperk, Adam; Svaton, Mlchael; Novakova, Michaela; Kotrova, Mlchaela; Kayserova, Jana; Kallna, Tomas; Keslova, Petra; Mejstrikova, Ester; Trka, Jan; Sediva, Anna] Charles Univ Prague, Sch Med 2, Dept Immunol, Prague, Czech Republic; [Klocperk, Adam; Kayserova, Jana; Sediva, Anna] Univ Hosp Motol, Prague, Czech Republic; [Votava, Felix] Charles Univ Prague, Sch Med 3, Dept Pediat, Prague, Czech Republic; [Votava, Felix] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic; [Vinohradska, Hana] Masaryk Univ, Fac Med, Children Hosp, Dept Clin Biochem, Brno, Czech Republic; [Freiberger, Tomas] Masaryk Univ, Dept Clin Immunol & Allergol, Fac Med, Brno, Czech Republic; [Freiberger, Tomas] Cent European Inst Technol, Brno, Czech Republic; [Freiberger, Tomas] Ctr Cardiovasc Surg & Transplantat, Mol Genet Lab, Brno, Czech Republic	Charles University Prague; Charles University Prague; Motol University Hospital; Charles University Prague; University Hospital Vinohrady; Masaryk University Brno; Masaryk University Brno	Sediva, A (corresponding author), Charles Univ Prague, Sch Med 2, Dept Immunol, Prague, Czech Republic.	anna.sediva@fnmotol.cz	Freiberger, Tomas/D-8421-2011; Sediva, Anna/AAE-2774-2019; Kalina, Tomas/AAC-6655-2019; Kalina, Tomas/C-1078-2009; Svaton, Michael/AAB-3869-2019; Trka, Jan/Y-4820-2019; Klocperk, Adam/L-6185-2017; Kalina, Tomas/AAE-5036-2019; Sediva, Anna/J-5904-2017	Freiberger, Tomas/0000-0001-6532-7053; Sediva, Anna/0000-0001-7730-2304; Kalina, Tomas/0000-0003-4475-2872; Klocperk, Adam/0000-0002-1526-4557; Kalina, Tomas/0000-0003-4475-2872; Novakova, Michaela/0000-0003-2964-5956; Kotrova, Michaela/0000-0001-5394-1072	Czech Science Foundation (GACR) Centre of Excellence [P302/12/G101]; Internal Grant Agency of the Ministry of Health of the Czech Republic [IGA MZCR NT/13287-4/2012]; Ministry of Health of the Czech Republic (MH CZ-DRO), University Hospital Motol, Prague, Czech Republic [00064203]; L'Oreal for Women in Science Fellowship; Science Development Program at Charles University in Prague, PRVOUK [P31]	Czech Science Foundation (GACR) Centre of Excellence; Internal Grant Agency of the Ministry of Health of the Czech Republic; Ministry of Health of the Czech Republic (MH CZ-DRO), University Hospital Motol, Prague, Czech Republic; L'Oreal for Women in Science Fellowship; Science Development Program at Charles University in Prague, PRVOUK	Funding: Support was provided by the Czech Science Foundation (GACR) Centre of Excellence, P302/12/G101, http://www.gacr.cz/en/, (EF, JT); Internal Grant Agency of the Ministry of Health of the Czech Republic, IGA MZCR NT/13287-4/2012, http://iga.mzcr.cz/publicWeb/ (AS); Ministry of Health of the Czech Republic (MH CZ-DRO), University Hospital Motol, Prague, Czech Republic, 00064203, http://www.mzcr.cz/ (AS); L'Oreal for Women in Science Fellowship in 2013, http://www.prozenyvevede.cz (EF); Science Development Program at Charles University in Prague, PRVOUK P31. http://ips.fsv.cuni.cz/IPSENG-53.html (FV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SP, 2014, J CLIN IMMUNOL, V34, P323, DOI 10.1007/s10875-014-0007-6; Borte S, 2011, ANN NY ACAD SCI, V1246, P118, DOI 10.1111/j.1749-6632.2011.06350.x; Cancrini C, 2005, J CLIN IMMUNOL, V25, P265, DOI 10.1007/s10875-005-4085-3; Chinn IK, 2013, CLIN EXP IMMUNOL, V173, P140, DOI 10.1111/cei.12088; Davies EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00322; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Framme JL, 2014, J CLIN IMMUNOL, V34, P514, DOI 10.1007/s10875-014-0002-y; Fronkova E, 2008, BONE MARROW TRANSPL, V42, P187, DOI 10.1038/bmt.2008.122; Gennery AR, 2012, CELL MOL LIFE SCI, V69, P17, DOI 10.1007/s00018-011-0842-z; Janda A, 2007, PEDIATR TRANSPLANT, V11, P441, DOI 10.1111/j.1399-3046.2007.00702.x; JUNKER AK, 1995, J PEDIATR-US, V127, P231, DOI 10.1016/S0022-3476(95)70300-4; Kamae C, 2013, J ALLERGY CLIN IMMUN, V131, P1437, DOI 10.1016/j.jaci.2012.10.059; Kelly Brian T, 2013, Clin Epidemiol, V5, P363, DOI 10.2147/CLEP.S48890; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; Lima K, 2010, CLIN EXP IMMUNOL, V161, P98, DOI 10.1111/j.1365-2249.2010.04152.x; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Patel K, 2012, J PEDIATR-US, V161, P950, DOI 10.1016/j.jpeds.2012.06.018; Pierdominici M, 2003, CLIN EXP IMMUNOL, V132, P323, DOI 10.1046/j.1365-2249.2003.02134.x; Pongers-Willemse MJ, 1998, LEUKEMIA, V12, P2006, DOI 10.1038/sj.leu.2401246; Sediva A, 2005, MED SCI MONITOR, V11; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; van Zelm MC, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00012; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458	25	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114514	10.1371/journal.pone.0114514	http://dx.doi.org/10.1371/journal.pone.0114514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485546	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600065
J	Wu, CT; Lai, JN; Tsai, YT				Wu, Chien-Tung; Lai, Jung-Nien; Tsai, Yueh-Ting			The Prescription Pattern of Chinese Herbal Products That Contain Dang-Qui and Risk of Endometrial Cancer among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; SURGICAL ADJUVANT BREAST; PROJECT NSABP B-14; ALTERNATIVE MEDICINE; THERAPY; PREVENTION; CARCINOMA; METHYLTRANSFERASE; COMPLEMENTARY; TRIALS	Purpose: The increased practice of traditional Chinese medicine worldwide has raised concerns regarding herb-drug interactions. We analyzed the usage of Chinese herbal products containing dang-qui and investigated whether dang-qui therapy increases endometrial cancer risk among tamoxifen-treated breast cancer survivors in Taiwan. Methods: All patients newly diagnosed with invasive breast cancer who received tamoxifen treatment from January 1, 1998, to December 31, 2008 were selected from the National Health Insurance Research Database. The usage, frequency of service and type of Chinese herbal products containing dang-qui prescribed across the 31,970 survivors were evaluated. Logistic regression method was employed to estimate the odds ratios for utilization of Chinese herbal products containing dang-qui. Cox proportional hazard regression was performed to calculate the hazard ratio of endometrial cancer associated with dang-qui use within the cohort. Results: Almost one in two study subjects had used dang-qui. Among 31,938 tamoxifen-treated breast cancer survivors, 157 cases of subsequent endometrial cancer were identified. The hazard ratio for development of endometrial cancer among breast cancer survivors aged 20-79 years who had taken dang-qui after tamoxifen treatment was decreased compared to survivors who had never used dang-qui (HR: 0.61, 95% CI: 0.44-0.84). To minimise potential confounding factors, women with breast cancer in the reproductive age were excluded from further analysis, and the negative relationship between dang-qui consumption and subsequent endometrial cancer among breast cancer survivors aged 55-79 years was still observed, although not significantly (HR: 0.74, 95% CI: 0.46-1.17). Conclusions: Dang-qui consumption is common among breast cancer survivors aged 20-79 years and seems decrease the risk of subsequent endometrial cancer after less than a cumulative dose of 7,500 mg of tamoxifen treatment.	[Wu, Chien-Tung; Lai, Jung-Nien; Tsai, Yueh-Ting] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Lai, Jung-Nien] Taipei City Hosp, Dept Chinese Med, Yangming Branch, Taipei, Taiwan; [Wu, Chien-Tung; Lai, Jung-Nien; Tsai, Yueh-Ting] Taiwan Assoc Tradit Chinese Med Family, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital	Tsai, YT (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	kareny@ms10.hinet.net			National Science Council [NSC-102WFA2200187]; National Research Institutes of Chinese Medicine [NRICM-10002]; Ministry of Health and Welfare	National Science Council(Ministry of Science and Technology, Taiwan); National Research Institutes of Chinese Medicine; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	The study was partially supported by the National Science Council (NSC-102WFA2200187), the National Research Institutes of Chinese Medicine (NRICM-10002), and the Ministry of Health and Welfare (http://www.mohw.gov.tw/EN/Ministry/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1991, J NATL CANCER I, V83, P1013, DOI 10.1093/jnci/83.14.1013; [Anonymous], 2013, LIST 100 UN FORM; Bergman L, 2000, LANCET, V356, P881, DOI 10.1016/S0140-6736(00)02677-5; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; BUSH TL, 1993, EPIDEMIOL REV, V15, P233, DOI 10.1093/oxfordjournals.epirev.a036110; Centers for Disease Control and Prevention, 2013, INT CLASS DIS; Chen Ming-Chen, 2013, J Tradit Complement Med, V3, P256, DOI 10.4103/2225-4110.119734; Clarke M, 1998, LANCET, V351, P1451; COOK LS, 1995, J NATL CANCER I, V87, P1359, DOI 10.1093/jnci/87.18.1359; Curtis RE, 2004, JNCI-J NATL CANCER I, V96, P70, DOI 10.1093/jnci/djh007; Curtis RE, 1996, J NATL CANCER I, V88, P832, DOI 10.1093/jnci/88.12.832; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Department of Chinese Medicine and Pharmacy Ministry of Health and Welfare, 2014, LIST 21 MOST IMP ANC; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; FORNANDER T, 1989, LANCET, V1, P117; Gelmon K, 2000, LANCET, V356, P868, DOI 10.1016/S0140-6736(00)02670-2; HARDELL L, 1988, LANCET, V2, P1432; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Kuo CC, 2007, INT J CANCER, V121, P2293, DOI 10.1002/ijc.22927; Lai JN, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/697893; Lai JN, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/891893; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; LOVE RR, 1994, J NATL CANCER I, V86, P1025, DOI 10.1093/jnci/86.13.1025; Mignotte H, 1998, INT J CANCER, V76, P325, DOI 10.1002/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X; NAYFIELD SG, 1991, J NATL CANCER I, V83, P1450, DOI 10.1093/jnci/83.20.1450; Rakovitch E, 2005, BREAST CANCER RES TR, V90, P139, DOI 10.1007/s10549-004-3779-1; Reyes-Gibby CC, 2008, LANCET ONCOL, V9, P777, DOI 10.1016/S1470-2045(08)70197-9; Rubino C, 2003, BRIT J CANCER, V89, P840, DOI 10.1038/sj.bjc.6601138; RUTQVIST LE, 1995, J NATL CANCER I, V87, P645, DOI 10.1093/jnci/87.9.645; Sasco AJ, 1996, LANCET, V347, P761, DOI 10.1016/S0140-6736(96)90111-7; SUNDERLAND MC, 1991, J CLIN ONCOL, V9, P1283, DOI 10.1200/JCO.1991.9.7.1283; Swerdlow AJ, 2005, JNCI-J NATL CANCER I, V97, P375, DOI 10.1093/jnci/dji057; Tagliaferri M, 2001, SEMIN ONCOL, V28, P121, DOI 10.1053/sonc.2001.20749; VANLEEUWEN FE, 1994, LANCET, V343, P448, DOI 10.1016/S0140-6736(94)92692-1; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r	36	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113887	10.1371/journal.pone.0113887	http://dx.doi.org/10.1371/journal.pone.0113887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485843	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600029
J	Shen, JY; Zhou, CL; Zhu, S; Shi, WQ; Hu, MS; Fu, XW; Wang, CD; Wang, YC; Zhang, Q; Yu, Y				Shen, Junye; Zhou, Chuanli; Zhu, Shien; Shi, Wenqing; Hu, Maishun; Fu, Xiangwei; Wang, Chuduan; Wang, Yachun; Zhang, Qin; Yu, Ying			Comparative Transcriptome Analysis Reveals Early Pregnancy-Specific Genes Expressed in Peripheral Blood of Pregnant Sows	PLOS ONE			English	Article							PROSTAGLANDIN SYNTHESIS; MATERNAL RECOGNITION; EMBRYO IMPLANTATION; MESSENGER-RNA; ENDOMETRIUM; DIAGNOSIS; TIME; SWINE; LEUKOCYTES	Early and accurate diagnosis of pregnancy is important for effective management of an economical pig farm. Besides the currently available methods used in early diagnosis of sows, circulating nucleic acids in peripheral blood may contain some early pregnancy-specific molecular markers. For the first time, microarray analysis of peripheral blood from pregnant sows versus non-pregnant sows identified 127 up-regulated and 56 down-regulated genes at day 14 post-insemination. Gene Ontology annotation grouped the total differently expressed genes into 3 significantly enriched terms, cell surface receptor linked signal transduction, G-protein coupled receptor protein signaling pathway and regulation of vesicle-mediated transport. Signaling pathway analysis revealed the only one significantly changed pathway was arachidonic acid metabolism. Of the differently expressed genes, nine (including LPAR3, RXFP4, GALP, CBR1, CBR2, GPX6, USP18, LHB and NR5A1) were found to exert function related to early pregnancy processes. This study provides a clue that differentially abundant RNAs in maternal peripheral blood can help to identify the molecular markers of early pregnancy in pigs.	[Shen, Junye; Zhou, Chuanli; Wang, Chuduan; Wang, Yachun; Zhang, Qin; Yu, Ying] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China; [Shen, Junye; Zhou, Chuanli; Zhu, Shien; Hu, Maishun; Fu, Xiangwei; Wang, Chuduan; Wang, Yachun; Zhang, Qin; Yu, Ying] China Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Shi, Wenqing] Anim Husb & Vet Stn Beijing, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Yu, Y (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China.	yuying@cau.edu.cn	Deng, Shou-Long/GWV-0452-2022		Beijing Municipal Bureau of Agriculture R D Program [20100222]; Kunming Bureau of science and technology Key Program [09H130302]; Key Development of New Transgenic Breeds Programs [2009ZX08009-146B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]	Beijing Municipal Bureau of Agriculture R D Program; Kunming Bureau of science and technology Key Program; Key Development of New Transgenic Breeds Programs; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Beijing Municipal Bureau of Agriculture R & D Program (grant number 20100222, 2010), Kunming Bureau of science and technology Key Program (grant number 09H130302, 2011), Key Development of New Transgenic Breeds Programs (grant number 2009ZX08009-146B, 2009) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1191). The funders had no role in study design and data analysis, decision to publish, or preparation of the manuscript.	Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Chen Y, 2000, BRIT J CANCER, V82, P2000; Chiu RWK, 2006, CLIN CHEM, V52, P313, DOI 10.1373/clinchem.2005.059691; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Gifford CA, 2008, BIOL REPROD, V79, P518, DOI 10.1095/biolreprod.108.069468; Gifford CA, 2007, J DAIRY SCI, V90, P274, DOI 10.3168/jds.S0022-0302(07)72628-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung ECW, 2009, J CLIN PATHOL, V62, P308, DOI 10.1136/jcp.2007.048470; Kaczmarek MM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103564; Kauffman AS, 2005, HORM BEHAV, V48, P141, DOI 10.1016/j.yhbeh.2005.01.010; Klein C, 2010, BIOL REPROD, V83, P102, DOI 10.1095/biolreprod.109.081612; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee FY, 2011, DEV CELL, V21, P315, DOI 10.1016/j.devcel.2011.06.028; Markowska-Daniel I., 2009, Zycie Weterynaryjne, V84, P794; Mayer J, 2013, THERIOGENOLOGY, V79, P173, DOI 10.1016/j.theriogenology.2012.09.024; Miller GM, 2003, J SWINE HEALTH PROD, V11, P233; Mistry HD, 2012, AM J OBSTET GYNECOL, V206, P21, DOI 10.1016/j.ajog.2011.07.034; Mlynarczuk J, 2013, ANIM REPROD SCI; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Nitta A, 2011, REPRODUCTION, V142, P879, DOI 10.1530/REP-11-0157; Ostrup E, 2011, REPROD FERT DEVELOP, V23, P964, DOI 10.1071/RD11140; Ostrup E, 2010, BIOL REPROD, V83, P277, DOI 10.1095/biolreprod.109.082321; Poon LLM, 2000, CLIN CHEM, V46, P1832; Port JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-503; Purohit G., 2010, WEBMEDCENTRAL REPROD, V1, DOI 10.9754/journal.wmc.2010.001305; Quan K, 2011, AFR J BIOTECHNOL, V10, P9710; Raymond F, 2009, J CLIN MICROBIOL, V47, P743, DOI 10.1128/JCM.01297-08; Ren QA, 2010, INT J MOL SCI, V11, P2322, DOI 10.3390/ijms11062322; Sedrak M, 2011, GENET TEST MOL BIOMA, V15, P627, DOI 10.1089/gtmb.2010.0263; Silvertown JD, 2010, REGUL PEPTIDES, V159, P44, DOI 10.1016/j.regpep.2009.09.007; Vigano P, 2003, PLACENTA, V24, pS56, DOI 10.1016/S0143-4004(03)00137-1; Waclawik A, 2011, REPRODUCTION, V142, P389, DOI 10.1530/REP-11-0033; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Williams SI, 2008, CAN VET J, V49, P269; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zhang H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-45; Ziecik AJ, 2002, DOMEST ANIM ENDOCRIN, V23, P265, DOI 10.1016/S0739-7240(02)00162-5	38	8	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114036	10.1371/journal.pone.0114036	http://dx.doi.org/10.1371/journal.pone.0114036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479131	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200040
J	Chakraborty, M; McGreal, EP; Williams, A; Davies, PL; Powell, W; Abdulla, S; Voitenok, NN; Hogwood, J; Gray, E; Spiller, B; Chambers, RC; Kotecha, S				Chakraborty, Mallinath; McGreal, Eamon P.; Williams, Andrew; Davies, Philip L.; Powell, Wendy; Abdulla, Salima; Voitenok, Nikolai N.; Hogwood, John; Gray, Elaine; Spiller, Brad; Chambers, Rachel C.; Kotecha, Sailesh			Role of Serine Proteases in the Regulation of Interleukin-8(77) during the Development of Bronchopulmonary Dysplasia in Preterm Ventilated Infants	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; RESPIRATORY-DISTRESS SYNDROME; NEUTROPHIL CHEMOTACTIC FACTOR; BRONCHOALVEOLAR LAVAGE FLUID; TERMINAL SEQUENCE; TISSUE FACTOR; AMINO-ACID; IN-VITRO; ELASTASE; INHIBITORS	Rationale: The chemokine interleukin-8 is implicated in the development of bronchopulmonary dysplasia in preterm infants. The 77-amino acid isoform of interleukin-8 (interleukin-8(77)) is a less potent chemoattractant than other shorter isoforms. Although interleukin-8(77) is abundant in the preterm circulation, its regulation in the preterm lung is unknown. Objectives: To study expression and processing of pulmonary interleukin-8(77) in preterm infants who did and did not develop bronchopulmonary dysplasia. Methods: Total interleukin-8 and interleukin-8(77) were measured in bronchoalveolar lavage fluid from preterm infants by immunoassay. Neutrophil serine proteases were used to assess processing. Neutrophil chemotaxis assays and degranulation of neutrophil matrix metalloproteinase-9 were used to assess interleukin-8 function. Main Results: Peak total interleukin-8 and interleukin-8(77) concentrations were increased in infants who developed bronchopulmonary dysplasia compared to those who did not. Shorter forms of interleukin-8 predominated in the preterm lung (96.3% No-bronchopulmonary dysplasia vs 97.1% bronchopulmonary dysplasia, p>0.05). Preterm bronchoalveolar lavage fluid significantly converted exogenously added interleukin-8(77) to shorter isoforms (p, 0.001). Conversion was greater in bronchopulmonary dysplasia infants (p<0.05). This conversion was inhibited by alpha-1 antitrypsin and antithrombin III (p<0.01). Purified neutrophil serine proteases efficiently converted interleukin-8(77) to shorter isoforms in a time- and dose-dependent fashion; shorter interleukin-8 isoforms were primarily responsible for neutrophil chemotaxis (p<0.001). Conversion by proteinase-3 resulted in significantly increased interleukin-8 activity in vitro (p<0.01). Conclusions: Shorter, potent, isoforms interleukin-8 predominate in the preterm lung, and are increased in infants developing bronchopulmonary dysplasia, due to conversion of interleukin-8(77) by neutrophil serine proteases and thrombin. Processing of interleukin-8 provides an attractive therapeutic target to prevent development of bronchopulmonary dysplasia.	[Chakraborty, Mallinath; McGreal, Eamon P.; Davies, Philip L.; Powell, Wendy; Abdulla, Salima; Spiller, Brad; Kotecha, Sailesh] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales; [Williams, Andrew; Chambers, Rachel C.] UCL, Rayne Inst, Ctr Inflammat & Tissue Repair, London, England; [Voitenok, Nikolai N.] Fund Mol Haematol & Immunol, Moscow, Russia; [Hogwood, John; Gray, Elaine] Natl Inst Biol Stand & Controls, Div Haematol, Potters Bar, Herts, England	Cardiff University; University of London; King's College London; University College London; National Institute for Biological Standards & Control	Kotecha, S (corresponding author), Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales.	kotechas@cardiff.ac.uk	Spiller, Owen Brad/AAC-2474-2020	Spiller, Owen Brad/0000-0002-9117-6911; Chakraborty, Mallinath/0000-0002-1721-6532; Chambers, Rachel/0000-0003-1370-9417; Kotecha, Sailesh/0000-0003-3535-7627	Sparks, The Children's Medical Research Charity; Arriva Pharmaceuticals	Sparks, The Children's Medical Research Charity; Arriva Pharmaceuticals	This work was supported by Sparks, The Children's Medical Research Charity (http://www.sparks.org.uk/) and by Arriva Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok O, 2006, AM J RESP CRIT CARE, V173, P318, DOI 10.1164/rccm.200503-425OC; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Bacon K, 2003, CYTOKINE, V21, P48, DOI 10.1016/S1043-4666(02)00493-3; Beeton ML, 2011, EUR RESPIR J, V37, P1424, DOI 10.1183/09031936.00037810; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Cederqvist K, 2001, PEDIATRICS, V108, P686, DOI 10.1542/peds.108.3.686; Chakraborty M, 2010, PAEDIATR RESPIR REV, V11, P162, DOI 10.1016/j.prrv.2010.03.002; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Davies PL, 2010, THORAX, V65, P246, DOI 10.1136/thx.2009.116061; de Blic J, 2000, EUR RESPIR J, V15, P217; De Dooy J, 2007, PEDIATR PULM, V42, P193, DOI 10.1002/ppul.20511; DETMERS PA, 1991, J IMMUNOL, V147, P4211; Dik WA, 2003, PEDIATR PULM, V35, P34, DOI 10.1002/ppul.10219; Ekekezie II, 2004, PEDIATRICS, V113, P1709, DOI 10.1542/peds.113.6.1709; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; Goodman RB, 1998, AM J PHYSIOL-LUNG C, V275, pL87, DOI 10.1152/ajplung.1998.275.1.L87; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; GREGORY H, 1988, BIOCHEM BIOPH RES CO, V151, P883, DOI 10.1016/S0006-291X(88)80364-4; HASLETT C, 1985, AM J PATHOL, V119, P101; HEBERT CA, 1990, J IMMUNOL, V145, P3033; Hilgendorff A, 2011, AM J RESP CRIT CARE, V184, P537, DOI 10.1164/rccm.201012-2010OC; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kambas K, 2011, J IMMUNOL, V186, P6568, DOI 10.4049/jimmunol.1003756; Konrad FM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/740987; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Leavell KJ, 1997, J LEUKOCYTE BIOL, V61, P361, DOI 10.1002/jlb.61.3.361; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Leverence JT, 2011, CHEM-BIOL INTERACT, V189, P72, DOI 10.1016/j.cbi.2010.09.026; Lipinski S, 2011, HAMOSTASEOLOGIE, V31, P94, DOI 10.5482/ha-1134; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Maheshwari A, 2009, CYTOKINE, V46, P12, DOI 10.1016/j.cyto.2008.12.022; McGreal EP, 2010, BBA-MOL BASIS DIS, V1802, P649, DOI 10.1016/j.bbadis.2010.04.005; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; Mortier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023913; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Munshi UK, 1997, PEDIATR PULM, V24, P331; NAKAGAWA H, 1991, FEBS LETT, V282, P412, DOI 10.1016/0014-5793(91)80526-9; Nashkevich NN, 2002, J IMMUNOL METHODS, V270, P37, DOI 10.1016/S0022-1759(02)00279-X; NOURSHARGH S, 1992, J IMMUNOL, V148, P106; OGDEN BE, 1984, AM REV RESPIR DIS, V130, P817; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; SCHRODER JM, 1990, J IMMUNOL, V144, P2223; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; SPEER CP, 1993, PEDIATRICS, V91, P794; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Sveger T, 2002, ACTA PAEDIATR, V91, P934, DOI 10.1080/080352502760272614; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; VANDAMME J, 1989, EUR J BIOCHEM, V181, P337; VANDAMME J, 1988, J EXP MED, V167, P1364, DOI 10.1084/jem.167.4.1364; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; YOSHIMURA T, 1989, MOL IMMUNOL, V26, P87	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114524	10.1371/journal.pone.0114524	http://dx.doi.org/10.1371/journal.pone.0114524			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474412	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500044
J	Huang, Y; Furtmuller, GJ; Tong, DD; Zhu, S; Lee, WPA; Brandacher, G; Kang, JU				Huang, Yong; Furtmueller, Georg J.; Tong, Dedi; Zhu, Shan; Lee, W. P. Andrew; Brandacher, Gerald; Kang, Jin U.			MEMS-Based Handheld Fourier Domain Doppler Optical Coherence Tomography for Intraoperative Microvascular Anastomosis Imaging	PLOS ONE			English	Article							PROBE; 3D	Purpose: To demonstrate the feasibility of a miniature handheld optical coherence tomography (OCT) imager for real time intraoperative vascular patency evaluation in the setting of super-microsurgical vessel anastomosis. Methods: A novel handheld imager Fourier domain Doppler optical coherence tomography based on a 1.3-mm central wavelength swept source for extravascular imaging was developed. The imager was minimized through the adoption of a 2.4-mm diameter microelectromechanical systems (MEMS) scanning mirror, additionally a 12.7-mm diameter lens system was designed and combined with the MEMS mirror to achieve a small form factor that optimize functionality as a handheld extravascular OCT imager. To evaluate in-vivo applicability, super-microsurgical vessel anastomosis was performed in a mouse femoral vessel cut and repair model employing conventional interrupted suture technique as well as a novel non-suture cuff technique. Vascular anastomosis patency after clinically successful repair was evaluated using the novel handheld OCT imager. Results: With an adjustable lateral image field of view up to 1.5 mm by 1.5 mm, high-resolution simultaneous structural and flow imaging of the blood vessels were successfully acquired for BALB/C mouse after orthotopic hind limb transplantation using a non-suture cuff technique and BALB/C mouse after femoral artery anastomosis using a suture technique. We experimentally quantify the axial and lateral resolution of the OCT to be 12.6 mm in air and 17.5 mm respectively. The OCT has a sensitivity of 84 dB and sensitivity roll-off of 5.7 dB/mm over an imaging range of 5 mm. Imaging with a frame rate of 36 Hz for an image size of 1000(lateral) x 512(axial) pixels using a 50,000 A-lines per second swept source was achieved. Quantitative vessel lumen patency, lumen narrowing and thrombosis analysis were performed based on acquired structure and Doppler images. Conclusions: A miniature handheld OCT imager that can be used for intraoperative evaluation of microvascular anastomosis was successfully demonstrated.	[Huang, Yong; Kang, Jin U.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Furtmueller, Georg J.; Tong, Dedi; Zhu, Shan; Lee, W. P. Andrew; Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Vascularized Composite Allotransplantat VCA Lab, Dept Plast & Reconstruct Surg, Baltimore, MD 21205 USA; [Tong, Dedi] Beijing Jishuitan Hosp, Dept Hand Surg, Beijing 10035, Peoples R China; [Zhu, Shan] Peking Union Med Coll, Beijing, Peoples R China; [Zhu, Shan] Chinese Acad Med Sci, Dept Plast & Reconstruct Surg, Plast Surg Hosp, Beijing, Peoples R China	Johns Hopkins University; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS	Huang, Y (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	yhuang60@jhu.edu; brandacher@jhmi.edu	Furtmüller, Georg J/D-8119-2019; Brandacher, Gerald/L-7540-2016	Furtmüller, Georg J/0000-0001-8286-0968; Brandacher, Gerald/0000-0001-7790-441X; Huang, Yong/0000-0002-7031-9709	NIH/NEI [5R01EY021540-03]; Yong Huang acknowledges China Scholarship Council (CSC); NATIONAL EYE INSTITUTE [R01EY021540] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Yong Huang acknowledges China Scholarship Council (CSC); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH/NEI 5R01EY021540-03. Yong Huang acknowledges China Scholarship Council (CSC) for partial support for his PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN CY, 1994, PLAST RECONSTR SURG, V93, P1481, DOI 10.1097/00006534-199406000-00022; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Huang Y, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.111404; Huang Y, 2012, BIOMED OPT EXPRESS, V3, P2162, DOI 10.1364/BOE.3.002162; Huo L, 2010, OPT EXPRESS, V18, P14375, DOI 10.1364/OE.18.014375; Jung W, 2011, IEEE T BIO-MED ENG, V58, P741, DOI 10.1109/TBME.2010.2096816; Liang CP, 2011, OPT EXPRESS, V19, P26283, DOI 10.1364/OE.19.026283; Lu CD, 2014, BIOMED OPT EXPRESS, V5, P293, DOI 10.1364/BOE.5.000293; Martins PN, 2007, MICROSURG, V27, P678, DOI 10.1002/micr.20431; Rothwell Ann, 2011, J Perioper Pract, V21, P73; Sucher R, 2010, TRANSPLANTATION, V90, P1374, DOI 10.1097/TP.0b013e3181ff4fc3; Sun CR, 2012, BIOMED OPT EXPRESS, V3, P1404, DOI 10.1364/BOE.3.001404; Tao YKK, 2010, OPT LETT, V35, P3315, DOI 10.1364/OL.35.003315; Wang DL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086005; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926	16	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114215	10.1371/journal.pone.0114215	http://dx.doi.org/10.1371/journal.pone.0114215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474742	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500002
J	Pruthvi, V; Narasimhan, R; Nataraja, KN				Pruthvi, Vittal; Narasimhan, Rama; Nataraja, Karaba N.			Simultaneous Expression of Abiotic Stress Responsive Transcription Factors, AtDREB2A, AtHB7 and AtABF3 Improves Salinity and Drought Tolerance in Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; ENHANCES TOLERANCE; TRANSGENIC RICE; GENE-EXPRESSION; SALT TOLERANCE; ARABIDOPSIS; OVEREXPRESSION; PLANTS; PROTEINS; COLD	Drought, salinity and extreme temperatures are the most common abiotic stresses, adversely affecting plant growth and productivity. Exposure of plants to stress activates stress signalling pathways that induce biochemical and physiological changes essential for stress acclimation. Stress tolerance is governed by multiple traits, and importance of a few traits in imparting tolerance has been demonstrated. Under drought, traits linked to water mining and water conservation, water use efficiency and cellular tolerance (CT) to desiccation are considered to be relevant. In this study, an attempt has been made to improve CT in drought hardy crop, peanut (Arachis hypogaea L., cv. TMV2) by co-expressing stress-responsive transcription factors (TFs), AtDREB2A, AtHB7 and AtABF3, associated with downstream gene expression. Transgenic plants simultaneously expressing these TFs showed increased tolerance to drought, salinity and oxidative stresses compared to wild type, with an increase in total plant biomass. The transgenic plants exhibited improved membrane and chlorophyll stability due to enhanced reactive oxygen species scavenging and osmotic adjustment by proline synthesis under stress. The improvement in stress tolerance in transgenic lines were associated with induced expression of various CT related genes like AhGlutaredoxin, AhAldehyde reductase, AhSerine threonine kinase like protein, AhRbx1, AhProline amino peptidase, AhHSP70, AhDIP and AhLea4. Taken together the results indicate that co-expression of stress responsive TFs can activate multiple CT pathways, and this strategy can be employed to improve abiotic stress tolerance in crop plants.	[Pruthvi, Vittal; Narasimhan, Rama; Nataraja, Karaba N.] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India	University of Agricultural Sciences Bangalore	Nataraja, KN (corresponding author), Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India.	nataraja_karaba@yahoo.com		Nataraja, Karaba N./0000-0002-9766-3622	Department of Biotechnology (DBT), Ministry of Science and technology, Government of India	Department of Biotechnology (DBT), Ministry of Science and technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from Department of Biotechnology (DBT), Ministry of Science and technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Asif MA, 2011, MOL BIOTECHNOL, V49, P250, DOI 10.1007/s12033-011-9399-1; Babitha KC, 2013, TRANSGENIC RES, V22, P327, DOI 10.1007/s11248-012-9645-8; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bhatnagar-Mathur P, 2007, PLANT CELL REP, V26, P2071, DOI 10.1007/s00299-007-0406-8; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; CALKINS JB, 1990, CRYOBIOLOGY, V27, P194, DOI 10.1016/0011-2240(90)90012-S; Cheng YJ, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-30; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Rolla AAD, 2014, TRANSGENIC RES, V23, P75, DOI 10.1007/s11248-013-9723-6; de Ronde JA, 2004, EUPHYTICA, V138, P123, DOI 10.1023/B:EUPH.0000046806.68554.5b; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Hamidou F, 2012, J AGRON CROP SCI; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Heatley ME, 1996, IN VITRO CELL DEV-PL, V32, P115; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Inostroza-Blancheteau C, 2013, PLANT BIOLOGY, V15, P1013, DOI 10.1111/j.1438-8677.2012.00722.x; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Lai SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025090; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Lee YH, 1998, PLANT MOL BIOL, V37, P377, DOI 10.1023/A:1006084305012; Li YJ, 2013, PLANT BIOTECHNOL J, V11, P747, DOI 10.1111/pbi.12066; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv SL, 2009, PLANTA, V229, P899, DOI 10.1007/s00425-008-0880-4; Mahmood T, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue1-fulltext-1; Mishra KB, 2012, PLANT SCI, V182, P79, DOI 10.1016/j.plantsci.2011.03.022; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Naika M, 2013, PLANT CELL PHYSIOL, V54, pE8, DOI 10.1093/pcp/pcs185; Nataraja KN, 1999, PHOTOSYNTHETICA, V36, P89, DOI 10.1023/A:1007070820925; Oh SJ, 2007, PLANT BIOTECHNOL J, V5, P646, DOI 10.1111/j.1467-7652.2007.00272.x; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Parvathi MS, 2013, J PLANT BIOCHEM BIOT, V22, P193, DOI 10.1007/s13562-012-0135-0; Ponsamuel J, 1998, PLANT CELL REP, V17, P373, DOI 10.1007/s002990050409; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pruthvi V, 2013, PHYSIOL MOL BIOL PLA, V19, P277, DOI 10.1007/s12298-012-0156-0; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Re DA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-150; Saini R, 2003, PLANT CELL REP, V21, P851, DOI 10.1007/s00299-003-0574-0; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Shekhawat UKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075506; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vanjildorj E, 2005, PLANT CELL TISS ORG, V83, P41, DOI 10.1007/s11240-005-3800-3; Vemanna RS, 2013, MOL BIOTECHNOL, V53, P129, DOI 10.1007/s12033-012-9499-6; Xiao BZ, 2007, THEOR APPL GENET, V115, P35, DOI 10.1007/s00122-007-0538-9; Xu J, 2013, PLANT PHYSIOL, V161, P1517, DOI 10.1104/pp.112.212803; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yokotani N, 2013, J PLANT RES, V126, P131, DOI 10.1007/s10265-012-0501-y; Yu LH, 2013, PLANT PHYSIOL, V162, P1378, DOI 10.1104/pp.113.217596; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zou C, 2011, P NATL ACAD SCI USA, V108, P14992, DOI 10.1073/pnas.1103202108	74	42	49	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111152	10.1371/journal.pone.0111152	http://dx.doi.org/10.1371/journal.pone.0111152			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474740	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500062
J	Siddiqi, S; Foo, JN; Vu, A; Azim, S; Silver, DL; Mansoor, A; Tay, SKH; Abbasi, S; Hashmi, AH; Janjua, J; Khalid, S; Tai, ES; Yeo, GW; Khor, CC				Siddiqi, Saima; Foo, Jia Nee; Vu, Anthony; Azim, Saad; Silver, David L.; Mansoor, Atika; Tay, Stacey Kiat Hong; Abbasi, Sumiya; Hashmi, Asraf Hussain; Janjua, Jamal; Khalid, Sumbal; Tai, E. Shyong; Yeo, Gene W.; Khor, Chiea Chuen			A Novel Splice-Site Mutation in ALS2 Establishes the Diagnosis of Juvenile Amyotrophic Lateral Sclerosis in a Family with Early Onset Anarthria and Generalized Dystonias	PLOS ONE			English	Article							REVEALS; LINKAGE; DISEASE; TOOL	The diagnosis of childhood neurological disorders remains challenging given the overlapping clinical presentation across subgroups and heterogeneous presentation within subgroups. To determine the underlying genetic cause of a severe neurological disorder in a large consanguineous Pakistani family presenting with severe scoliosis, anarthria and progressive neuromuscular degeneration, we performed genome-wide homozygosity mapping accompanied by whole-exome sequencing in two affected first cousins and their unaffected parents to find the causative mutation. We identified a novel homozygous splice-site mutation (c.3512+1G>A) in the ALS2 gene (NM_020919.3) encoding alsin that segregated with the disease in this family. Homozygous loss-of-function mutations in ALS2 are known to cause juvenile-onset amyotrophic lateral sclerosis (ALS), one of the many neurological conditions having overlapping symptoms with many neurological phenotypes. RT-PCR validation revealed that the mutation resulted in exon-skipping as well as the use of an alternative donor splice, both of which are predicted to cause loss-of-function of the resulting proteins. By examining 216 known neurological disease genes in our exome sequencing data, we also identified 9 other rare nonsynonymous mutations in these genes, some of which lie in highly conserved regions. Sequencing of a single proband might have led to mis-identification of some of these as the causative variant. Our findings established a firm diagnosis of juvenile ALS in this family, thus demonstrating the use of whole exome sequencing combined with linkage analysis in families as a powerful tool for establishing a quick and precise genetic diagnosis of complex neurological phenotypes.	[Siddiqi, Saima; Mansoor, Atika; Hashmi, Asraf Hussain] Inst Biomed & Genet Engn, Islamabad, Pakistan; [Foo, Jia Nee; Khor, Chiea Chuen] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Vu, Anthony; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Vu, Anthony; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Azim, Saad] Ali Med Ctr, Islamabad, Pakistan; [Silver, David L.; Tai, E. Shyong] Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore, Singapore; [Tay, Stacey Kiat Hong; Khor, Chiea Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 117595, Singapore; [Abbasi, Sumiya; Khalid, Sumbal] Int Islamic Univ, Islamabad, Pakistan; [Janjua, Jamal] Coll Phys & Surg CPSP, Islamabad, Pakistan; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Natl Univ Hosp Syst, Singapore 117595, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Natl Univ Hosp Syst, Singapore 117548, Singapore; [Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; National University of Singapore; International Islamic University, Pakistan; National University of Singapore; National University of Singapore; National University of Singapore	Foo, JN (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	foojn@gis.a-star.edu.sg	Tay, Stacey/E-7029-2015; Yeo, Gene/AAE-7676-2019; Foo, Jia Nee/D-6069-2014; Siddiqi, Saima/AAJ-6584-2021	Tay, Stacey/0000-0002-3077-4184; Yeo, Gene/0000-0002-0799-6037; Foo, Jia Nee/0000-0001-9899-2308; Tai, E Shyong/0000-0003-2929-8966; /0000-0001-5751-1432; Silver, David/0000-0002-7289-9890	Government of Pakistan funding; National Institute of Health [HG004659, NS075449, U54HG007005]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659, U54HG007005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	Government of Pakistan funding; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The sample collection and clinical work was supported by Government of Pakistan funding to IBGE. The genetic analysis was supported by the Agency for Science, Technology and Research, Singapore (to C.C.K.). A.V. and G.W.Y. were supported by grants from the National Institute of Health (HG004659, NS075449 and U54HG007005) and G.W.Y. is an Alfred P. Sloan Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bird TD, 1993, GENEREVIEWSTM; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Sheerin UM, 2014, NEUROLOGY, V82, P1065, DOI 10.1212/WNL.0000000000000254; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Trojsi Francesca, 2013, Acta Myol, V32, P23; Verma A, 2013, MUSCLE NERVE, V47, P330, DOI 10.1002/mus.23673; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	20	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113258	10.1371/journal.pone.0113258	http://dx.doi.org/10.1371/journal.pone.0113258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474699	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500080
J	Okata, T; Toyoda, K; Okamoto, A; Miyata, T; Nagatsuka, K; Minematsu, K				Okata, Takuya; Toyoda, Kazunori; Okamoto, Akira; Miyata, Toshiyuki; Nagatsuka, Kazuyuki; Minematsu, Kazuo			Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; WARFARIN	Objectives: In Japan, low-dose rivaroxaban [15 mg QD/10 mg QD for creatinine clearance of 30-49 mL/min] was approved for clinical use in NVAF patients partly because of its unique pharmacokinetics in Japanese subjects. The aim of the study was to determine the anticoagulation intensity of rivaroxaban and its determinant factors in Japanese stroke patients. Methods: Consecutive stroke patients with NVAF admitted between July 2012 and December 2013 were studied. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and estimated plasma concentration of rivaroxaban (C-riv) based on an anti-factor Xa chromogenic assay were measured just before and 4 and 9 h after administration at the steady state level of rivaroxaban. Determinant factors for C-riv were explored using a linear mixed-model approach. Results: Of 110 patients (37 women, 75+/-9 years old), 59 took 15 mg QD of rivaroxaban and 51 took 10 mg QD. C-riv at 4 h was 186 ng/mL for patients taking 15 mg QD and 147 ng/mL for those taking 10 mg QD. Both PT and aPTT were positively correlated with C-riv. C-riv was 72% lower at 4 h in 15 patients receiving crushed tablets than in the other patients, and tablet crushing was significantly associated with lower C-riv (adjusted estimate -0.43, 95% CI -0.60 to -0.26) after multivariate-adjustment. Conclusion: The anticoagulation effects of rivaroxaban in the acute stroke setting for Japanese NVAF patients were relatively low as compared with those in the ROCKET-AF and J-ROCKET AF trials. Tablet crushing, common in dysphagic patients, decreased C-riv.	[Okata, Takuya; Toyoda, Kazunori; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Osaka, Japan; [Okamoto, Akira] Natl Cerebral & Cardiovasc Ctr, Dept Clin Chem, Osaka, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka, Japan; [Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Toyoda, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Osaka, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	National Cerebral and Cardiovascular Center [23-4-3, 25-6-4]	National Cerebral and Cardiovascular Center(National Cerebral & Cardiovascular Center - Japan)	The present study was supported by Intramural Research Funds (23-4-3, 25-6-4) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, XAR PACK INS; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dyke CK, 2002, CIRCULATION, V105, P2385, DOI 10.1161/01.CIR.0000016351.12759.52; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Kaneko M, 2013, DRUG METAB PHARMACOK, V28, P321, DOI 10.2133/dmpk.DMPK-12-RG-109; LANGE N, 1989, J AM STAT ASSOC, V84, P241, DOI 10.2307/2289869; Moore KT, 2012, ACCP ANN M; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Samama MM, 2012, THROMB HAEMOSTASIS, V107, P379, DOI 10.1160/TH11-06-0391; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Samama MM, 2002, PATHOPHYSIOL HAEMO T, V32, P218, DOI 10.1159/000073570; Tanigawa T, 2013, DRUG METAB PHARMACOK, V28, P59, DOI 10.2133/dmpk.DMPK-12-RG-034; Toyoda K, 2013, CONTRIB NEPHROL, V179, P1, DOI 10.1159/000346944; Toyoda K, 2012, NEUROLOGY, V78, P1898, DOI 10.1212/WNL.0b013e318259e29f	19	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113641	10.1371/journal.pone.0113641	http://dx.doi.org/10.1371/journal.pone.0113641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25479967	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400071
J	Sun, C; Yu, D; Ye, WD; Liu, C; Gu, SP; Sinsheimer, NR; Song, ZC; Li, XH; Chen, C; Song, YN; Wang, SS; Schrader, L; Chen, YP				Sun, Cheng; Yu, Diankun; Ye, Wenduo; Liu, Chao; Gu, Shuping; Sinsheimer, Nathan R.; Song, Zhongchen; Li, Xihai; Chen, Chun; Song, Yingnan; Wang, Shusheng; Schrader, Laura; Chen, YiPing			The Short Stature Homeobox 2 (Shox2)-bone Morphogenetic Protein (BMP) Pathway Regulates Dorsal Mesenchymal Protrusion Development and Its Temporary Function as a Pacemaker during Cardiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINOATRIAL NODE; ATRIOVENTRICULAR SEPTATION; CARDIAC DEVELOPMENT; DEVELOPING HEART; CHANNEL HCN4; MOUSE HEART; EXPRESSION; MICE; CELLS; SHOX2	The atrioventricular (AV) junction plays a critical role in chamber septation and transmission of cardiac conduction pulses. It consists of structures that develop from embryonic dorsal mesenchymal protrusion (DMP) and the embryonic AV canal. Despite extensive studies on AV junction development, the genetic regulation of DMP development remains poorly understood. In this study we present evidence that Shox2 is expressed in the developing DMP. Intriguingly, this Shox2-expressing domain possesses a pacemaker-specific genetic profile including Hcn4 and Tbx3. This genetic profile leads to nodal-like electrophysiological properties, which is gradually silenced as the AV node becomes matured. Phenotypic analyses of Shox2(-/-) mice revealed a hypoplastic and defectively differentiated DMP, likely attributed to increased apoptosis, accompanied by dramatically reduced expression of Bmp4 and Hcn4, ectopic activation of Cx40, and an aberrant pattern of action potentials. Interestingly, conditional deletion of Bmp4 or inhibition of BMP signaling by overexpression of Noggin using a Shox2-Cre allele led to a similar DMP hypoplasia and down-regulation of Hcn4, whereas activation of a transgenic Bmp4 allele in Shox2(-/-) background attenuated DMP defects. Moreover, the lack of Hcn4 expression in the DMP of mice carrying Smad4 conditional deletion and direct binding of pSmad1/5/8 to the Hcn4 regulatory region further confirm the Shox2-BMP genetic cascade in the regulation of DMP development. Our results reveal that Shox2 regulates DMP fate and development by controlling BMP signaling through the Smad-dependent pathway to drive tissue growth and to induce Hcn4 expression and suggest a temporal pacemaking function for the DMP during early cardiogenesis.	[Sun, Cheng; Yu, Diankun; Ye, Wenduo; Liu, Chao; Gu, Shuping; Sinsheimer, Nathan R.; Song, Zhongchen; Li, Xihai; Chen, Chun; Song, Yingnan; Wang, Shusheng; Schrader, Laura; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Tulane University	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, 6823 St Charles Ave, New Orleans, LA 70118 USA.	ychen@tulane.edu	Chen, Chun/AAR-8041-2020; Schrader, Laura/ABH-4854-2020; Yu, Diankun/AFO-0203-2022	Schrader, Laura/0000-0003-3355-1194; Chen, Chun/0000-0002-6957-0103; Yu, Diankun/0000-0002-1390-7985	National Institutes of Health [R01 DE17792]; American Heart Association [13PRE13750003]; Fujian Normal University of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fujian Normal University of China; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE17792 (to Y. C.).; Supported by an American Heart Association Predoctoral Fellowship 13PRE13750003.; Supported by a fellowship from Fujian Normal University of China.	Aanhaanen WTJ, 2010, CIRC RES, V107, P728, DOI 10.1161/CIRCRESAHA.110.222992; ARGUELLO C, 1986, J MOL CELL CARDIOL, V18, P499, DOI 10.1016/S0022-2828(86)80915-4; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Binder G, 2011, HORM RES PAEDIAT, V75, P81, DOI 10.1159/000324105; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Briggs LE, 2013, CIRC RES, V112, P1420, DOI 10.1161/CIRCRESAHA.112.300821; Chen BY, 2009, J MOL CELL CARDIOL, V47, P706, DOI 10.1016/j.yjmcc.2009.07.007; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Espinoza-Lewis RA, 2011, DEV BIOL, V356, P359, DOI 10.1016/j.ydbio.2011.05.663; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Frank DU, 2012, P NATL ACAD SCI USA, V109, pE154, DOI 10.1073/pnas.1115165109; Hahurij ND, 2008, CIRCULATION, V117, P2850, DOI 10.1161/CIRCULATIONAHA.107.756288; Hall J. E., 2011, GUYTON HALL TXB MED; HANCOX JC, 1993, AM J PHYSIOL, V265, pH755, DOI 10.1152/ajpheart.1993.265.2.H755; He FL, 2014, DEV BIOL, V391, P170, DOI 10.1016/j.ydbio.2014.04.013; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kulessa H, 2002, GENESIS, V32, P66, DOI 10.1002/gene.10032; Kuratomi S, 2007, BIOCHEM BIOPH RES CO, V353, P67, DOI 10.1016/j.bbrc.2006.11.119; Kuratomi S, 2009, CARDIOVASC RES, V83, P682, DOI 10.1093/cvr/cvp171; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Mahtab EAF, 2009, DEV DYNAM, V238, P183, DOI 10.1002/dvdy.21819; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Massague J, 2000, GENE DEV, V14, P627; McGuire MA, 1996, CIRCULATION, V94, P571, DOI 10.1161/01.CIR.94.3.571; Munshi NV, 2012, CIRC RES, V110, P1525, DOI 10.1161/CIRCRESAHA.111.260026; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Semina EV, 1998, HUM MOL GENET, V7, P415, DOI 10.1093/hmg/7.3.415; Sheng XY, 2011, CIRC-ARRHYTHMIA ELEC, V4, P936, DOI 10.1161/CIRCEP.111.964056; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Sun C, 2013, GENESIS, V51, P515, DOI 10.1002/dvg.22397; Vedantham V, 2013, DEV BIOL, V373, P149, DOI 10.1016/j.ydbio.2012.10.017; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Wessels A, 1996, CIRC RES, V78, P110, DOI 10.1161/01.RES.78.1.110; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhang YM, 2002, CIRCULATION, V106, P1294, DOI 10.1161/01.CIR.0000027585.05868.67; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zipes DP., 2018, CARDIAC ELECTROPHYSI, V7	53	20	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2007	2023		10.1074/jbc.M114.619007	http://dx.doi.org/10.1074/jbc.M114.619007			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488669	hybrid, Green Published			2022-12-26	WOS:000348588000009
J	Yang, JX; Zhang, N; Wang, HW; Gao, P; Yang, QP; Wen, QP				Yang, Jing-Xian; Zhang, Nan; Wang, Han-Wei; Gao, Peng; Yang, Qing-Ping; Wen, Qing-Ping			CXCR4 Receptor Overexpression in Mesenchymal Stem Cells Facilitates Treatment of Acute Lung Injury in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BONE-MARROW; STROMAL CELLS; PROMOTING MIGRATION; KI-67 PROTEIN; THERAPY; EXPRESSION; INFLAMMATION; PATHOGENESIS; LESTR/FUSIN	Novel therapeutic regimens for tissue renewal incorporate mesenchymal stem cells (MSCs) as they differentiate into a variety of cell types and are a stem cell type that is easy to harvest and to expand in vitro. However, surface chemokine receptors, such as CXCR4, which are involved in the mobilization of MSCs, are expressed only on the surface of a small proportion of MSCs, and the lack of CXCR4 expression may underlie the low efficiency of homing of MSCs toward tissue damage, which results in a poor curative effect. Here, a rat CXCR4 expressing lentiviral vector was constructed and introduced into MSCs freshly prepared from rat bone marrow. The influence of CXCR4 expression on migration, proliferation, differentiation, and paracrine effects of MSCs was examined in vitro. The in vivo properties of CXCR4-MSCs were also investigated in a model of acute lung injury in rats induced by lipopolysaccharide. Expression of CXCR4 in MSCs significantly enhanced the chemotactic and paracrine characteristics of the cells in vitro but did not affect self-renewal or differentiation into alveolar and vascular endothelial cells. In vivo, CXCR4 improved MSC homing and colonization of damaged lung tissue, and furthermore, the transplanted CXCR4-MSCs suppressed the development of acute lung injury in part by modulating levels of inflammatory molecules and the neutrophil count. These results indicated that efficient mobilization of MSCs to sites of tissue injury may be due to CXCR4, and therefore, increased expression of CXCR4 may improve their therapeutic potential in the treatment of diseases where tissue damage develops.	[Yang, Jing-Xian; Zhang, Nan; Yang, Qing-Ping] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China; [Zhang, Nan] China Med Univ, Sch Pharm, Shenyang 110013, Peoples R China; [Wang, Han-Wei; Wen, Qing-Ping] Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Peoples R China; [Gao, Peng] Dalian Med Univ, Dept Anesthesiol, Dalian 116044, Peoples R China	Liaoning University of Traditional Chinese Medicine; China Medical University; Dalian Medical University; Dalian Medical University	Wen, QP (corresponding author), Dalian Med Univ, Dept Anesthesiol, Dalian 116044, Peoples R China.	wenqp050607@gmail.com			Natural Science Fund of China [81273923]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Fund of China (no. 81273923).	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bosma KJ, 2010, DRUGS, V70, P1255, DOI 10.2165/10898570-000000000-00000; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Du ZY, 2013, LIVER TRANSPLANT, V19, P215, DOI 10.1002/lt.23577; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hariprashad A, 2013, JAAPA-J AM ACAD PHYS, V26, P23, DOI 10.1097/01.JAA.0000433867.15142.5d; Hayes Mairead, 2012, F1000 Med Rep, V4, P2, DOI 10.3410/M4-2; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hu Y, 2012, J MOL NEUROSCI, V48, P127, DOI 10.1007/s12031-012-9784-7; Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803; Ke F, 2014, STEM CELLS, V32, P2799, DOI 10.1002/stem.1763; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Liang ZX, 2011, CHINESE MED J-PEKING, V124, P2715, DOI 10.3760/cma.j.issn.0366-6999.2011.17.027; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Miller AC, 2014, CRIT CARE MED, V42, P413, DOI 10.1097/CCM.0b013e3182a645e5; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Petty JM, 2007, J IMMUNOL, V178, P8148, DOI 10.4049/jimmunol.178.12.8148; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Rahmanzadeh R, 2007, CELL PROLIFERAT, V40, P422, DOI 10.1111/j.1365-2184.2007.00433.x; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Spieth PM, 2014, CURR OPIN CRIT CARE, V20, P113, DOI 10.1097/MCC.0000000000000056; Sung SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071637; Tai Wen-Lin, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P283; Villar J, 2014, CURR OPIN CRIT CARE, V20, P3, DOI 10.1097/MCC.0000000000000057; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; Yang JX, 2012, ACTA NEUROPATHOL, V124, P491, DOI 10.1007/s00401-012-0989-1; Yang JX, 2010, AM J PATHOL, V177, P1989, DOI 10.2353/ajpath.2010.091203; Yang JX, 2009, J CLIN INVEST, V119, P3678, DOI 10.1172/JCI37914; Zhang P, 2013, ONCOL REP, V30, P1753, DOI 10.3892/or.2013.2619; Zhao J, 2011, AM J PHYSIOL-LUNG C, V301, pL547, DOI 10.1152/ajplung.00058.2011; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504	52	90	96	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1994	2006		10.1074/jbc.M114.605063	http://dx.doi.org/10.1074/jbc.M114.605063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492872	Green Published, hybrid			2022-12-26	WOS:000348588000008
J	Deng, XD; Yang, JH; Wu, XX; Li, YJ; Fei, XW				Deng, Xiaodong; Yang, Jinghao; Wu, Xiaoxia; Li, YaJun; Fei, Xiaowen			A C2H2 Zinc Finger Protein FEMU2 Is Required for fox1 Expression in Chlamydomonas reinhardtii	PLOS ONE			English	Article							ALGA CHLAMYDOMONAS-REINHARDTII; DEFICIENCY-RESPONSIVE ELEMENT; DNA-BINDING SPECIFICITY; IRON-UPTAKE; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; MULTICOPPER OXIDASE; METAL TRANSPORTER	Chlamydomonas reinhardtii fox1 gene encodes a ferroxidase that is involved in cellular Fe uptake and highly induced during Fe deficient conditions. In an effort to identify fox1 promoter regulatory elements, an insertional library was generated in a transgenic Chlamydomonas strain (2A38) harboring an arylsulfatase (ARS) reporter gene driven by the fox1 promoter. Mutants with a defective response to low iron conditions were selected for further study. Among these, a strain containing a disrupted femu2 gene was identified. Activation of the fox1 promoter by the femu2 gene product was confirmed by silencing the femu2 gene using RNA interference. In three femu2 RNAi transgenic lines (IR3, IR6, and IR7), ARS reporter gene activities declined by 84.3%, 86.4%, and 88.8%, respectively under Fe deficient conditions. Furthermore, RT-PCR analysis of both the femu2 mutant and the RNAi transgenic lines showed significantly decreased transcript abundance of the endogenous fox1 gene under Fe deficient conditions. Amino acid sequence analysis of the femu2 gene product identified three potential C2H2 zinc finger (ZF) motifs and a nuclear localization study suggests that FEMU2 is localized to the nucleus. In addition, a potential FEMU2 binding site ((G/T) TTGG(G/T)(G/T)T) was identified using PCR-mediated random binding site selection. Taken together, this evidence suggests that FEMU2 is involved in up-regulation of the fox1 gene in Fe deficient cells.	[Deng, Xiaodong; Yang, Jinghao; Wu, Xiaoxia; Li, YaJun] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Peoples R China; [Fei, Xiaowen] Hainan Med Coll, Sch Sci, Haikou 571101, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan Medical University	Fei, XW (corresponding author), Hainan Med Coll, Sch Sci, Haikou 571101, Peoples R China.	feixw2000@hotmail.com	fei, xiaowen/GRJ-8141-2022; Deng, Xiaodong/AAF-3261-2019	Deng, Xiaodong/0000-0002-6938-1214	National Natural Science Foundation of China [31160050, 31360051]; Major Technology Project of Hainan [ZDZX2013023-1]; National Nonprofit Institute Research Grants [CATAS-ITBB110507, 130305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Technology Project of Hainan; National Nonprofit Institute Research Grants	This work was supported by the National Natural Science Foundation of China (31160050, 31360051), the Major Technology Project of Hainan (ZDZX2013023-1), and the National Nonprofit Institute Research Grants (CATAS-ITBB110507, 130305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; DAVIES JP, 1992, NUCLEIC ACIDS RES, V20, P2959, DOI 10.1093/nar/20.12.2959; DAVIES JP, 1994, MOL CELL BIOL, V14, P5165, DOI 10.1128/MCB.14.8.5165; DEHOSTOS EL, 1988, J CELL BIOL, V106, P29, DOI 10.1083/jcb.106.1.29; Deng X, 2007, EUKARYOT CELL, V6, P2163, DOI 10.1128/EC.00324-07; Deng XD, 2011, BIOMASS BIOENERG, V35, P1811, DOI 10.1016/j.biombioe.2011.01.005; Dent RM, 2005, PLANT PHYSIOL, V137, P545, DOI 10.1104/pp.104.055244; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Ellis PD, 2002, BIOCHEM J, V364, P547, DOI 10.1042/BJ20020269; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Fei XW, 2007, PLANT CELL PHYSIOL, V48, P1496, DOI 10.1093/pcp/pcm110; Fei XW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/790247; Fei XW, 2009, J BIOCHEM, V146, P157, DOI 10.1093/jb/mvp056; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Herbik A, 2002, PLANT PHYSIOL, V130, P2039, DOI 10.1104/pp.013060; Hutners H, 1946, J BACTERIOL, V52, P213; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Ling HQ, 2002, P NATL ACAD SCI USA, V99, P13938, DOI 10.1073/pnas.212448699; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Martin KM, 2000, BIOCHEM J, V345, P529, DOI 10.1042/0264-6021:3450529; Martin KM, 2003, BIOCHEM J, V375, P457, DOI 10.1042/BJ20030870; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; OKUMURA N, 1994, PLANT MOL BIOL, V25, P705, DOI 10.1007/BF00029608; Osada S, 1996, J BIOL CHEM, V271, P3891; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rubinelli P, 2002, PLANTA, V215, P1, DOI 10.1007/s00425-001-0711-3; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Song A, 2002, J BIOL CHEM, V277, P30055, DOI 10.1074/jbc.M204278200; Stacey MG, 1999, PLANT CELL, V11, P349, DOI 10.1105/tpc.11.3.349; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; Vert G, 2001, PLANT J, V26, P181, DOI 10.1046/j.1365-313x.2001.01018.x; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26	66	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112977	10.1371/journal.pone.0112977	http://dx.doi.org/10.1371/journal.pone.0112977			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485540	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600013
J	Chen, B; Zheng, JX; Zeng, YY; Li, BF; Xie, B; Zheng, JH; Zhou, J; Zhang, WM				Chen, Bei; Zheng, Jingxian; Zeng, Yunyun; Li, Baofeng; Xie, Bo; Zheng, Jihua; Zhou, Juan; Zhang, Weimin			Sequence-Dependent Antiproliferative Effects of Gefitinib and Docetaxel on Non-Small Cell Lung Cancer (NSCLC) Cells and the Possible Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; SYNERGISTIC INTERACTION; DETERMINES RESPONSE; ERLOTINIB; CHEMOTHERAPY; COMBINATION; EGFR; MULTICENTER; CARBOPLATIN	Purpose: Recent clinical trials showed that the sequential combination of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy could prolong the PFS and/or OS of advanced non-small cell lung cancer (NSCLC) patients with EGFR mutation. The aim of present study was to assess the optimal combination sequence and to explore its possible mechanism. Methods: PC-9 cells and A549 cells, the lung adenocarcinoma cells with mutant and wide-type EGFR respectively, were treated with docetaxel/gefitinib alone or in different combination schedules. The EGFR and K-ras gene status was determined by qPCR-HRM technique. Cell proliferation was detected by MTT assay. The expression and phosphorylation of EGFR, ERK, Akt and IGF-1R were detected by western blot. Cell cycle distribution was observed by flow cytometry. Results: Only sequential administration of docetaxel followed by gefitinib (D -> G) induced significant synergistic effect in both cell lines (Combination Index<0.9). The reverse sequence (G -> D) resulted in an antagonistic interaction in both cell lines (CI>1.1), whereas the concurrent administration (D+G) showed additive (0.9<CI<1.1)-synergistic effect in PC-9 cells and antagonistic-additive effect in A549 cells. Mechanism studies showed that docetaxel-induced phosphorylation of EGFR and ERK was repressed by subsequently used gefitinib, but not by concurrent exposure of gefitinib. The gefitinib-repressed phosphorylation of EGFR and ERK was reversed neither by concurrent nor by subsequent administration of docetaxel. D+G reinforced their inhibition on the phosphorylation of IGF-1R in PC-9 cells. Conclusions: The cytotoxic drugs followed by EGFR-TKIs may be the optimal combination for antiproliferative effects in EGFR-mutant NSCLC cells, and the phosphorylation of EGFR and ERK might contribute to this effect.	[Chen, Bei; Zheng, Jingxian; Zeng, Yunyun; Li, Baofeng; Xie, Bo; Zheng, Jihua; Zhou, Juan; Zhang, Weimin] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Oncol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital	Zhang, WM (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Oncol, Guangzhou, Guangdong, Peoples R China.	wmzhang79@126.com		Chen, Bei/0000-0003-2553-3279	National Natural Science Foundation of China [81172225, 81101821, 81000819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81172225, 81101821 and 81000819) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger W, 2012, LUNG CANCER, V77, P2, DOI 10.1016/j.lungcan.2011.12.014; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Cheng H, 2011, CANCER CHEMOTH PHARM, V67, P637, DOI 10.1007/s00280-010-1347-4; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giovannetti E, 2008, MOL PHARMACOL, V73, P1290, DOI 10.1124/mol.107.042382; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Jiang YW, 2014, J CANCER RES CLIN, V140, P1087, DOI 10.1007/s00432-014-1671-x; Kanda S, 2013, J CLIN ONCOL S, V31; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Kuiper JL, 2013, LUNG CANCER, V80, P102, DOI 10.1016/j.lungcan.2012.12.024; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Morelli MP, 2005, ANN ONCOL, V16, P61, DOI 10.1093/annonc/mdi910; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Takeda K, 2010, J CLIN ONCOL, V28, P753, DOI 10.1200/JCO.2009.23.3445; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Van Schaeybroeck S, 2005, CLIN CANCER RES, V11, P7480, DOI 10.1158/1078-0432.CCR-05-0328; Van Schaeybroeck S, 2006, MOL CANCER THER, V5, P1154, DOI 10.1158/1535-7163.MCT-05-0446; Wu JD, 2006, CLIN CANCER RES, V12, P6153, DOI 10.1158/1078-0432.CCR-06-0443; Wu YL, 2013, LANCET ONCOL, V14, P777, DOI 10.1016/S1470-2045(13)70254-7; Xue MZ, 2012, CURR PHARM DESIGN, V18, P2901, DOI 10.2174/138161212800672723; Yamada T, 2013, ONCOGENE, V32, P4427, DOI 10.1038/onc.2012.446; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1	29	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114074	10.1371/journal.pone.0114074	http://dx.doi.org/10.1371/journal.pone.0114074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474307	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500112
J	Csapo, P; Raab, M				Csapo, Peter; Raab, Markus			"Hand down, Man down.'' Analysis of Defensive Adjustments in Response to the Hot Hand in Basketball Using Novel Defense Metrics	PLOS ONE			English	Article							BEHAVIOR	The hot-hand phenomenon, according to which a player's performance is significantly elevated during certain phases relative to the expected performance based on the player's base rate, has left many researchers and fans in basketball puzzled: The vast majority of players, coaches and fans believe in its existence but statistical evidence supporting this belief has been scarce. It has frequently been argued that the hot hand in basketball is unobservable because of strategic adjustments and defensive interference of the opposing team. We use a dataset with novel metrics, such as the number of defenders and the defensive intensity for each shot attempt, which enable us to directly measure defensive pressure. First, we examine how the shooting percentage of NBA players changes relative to the attributes of each metric. We find that it is of lesser importance by how many defenders a player is guarded but that defensive intensity, e.g., whether a defender raises his hand when his opponent shoots, has a larger impact on shot difficulty. Second, we explore how the underlying metrics and shooting accuracy change as a function of streak length. Our results indicate that defensive pressure and shot difficulty increase (decrease) during hot (cold) streaks, so that defenders seem to behave according to the hot-hand belief and try to force hot players into more difficult shots. However, we find that shooting percentages of presumably hot players do not increase and that shooting performance is not related to streakiness, so that the defenders' hot-hand behavior cannot be considered ecologically rational. Therefore, we are unable to find evidence in favor of the hot-hand effect even when accounting for defensive pressure.	[Csapo, Peter; Raab, Markus] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Raab, Markus] London S Bank Univ, Sch Appl Sci, London, England	German Sport University Cologne; London South Bank University	Csapo, P (corresponding author), German Sport Univ Cologne, Inst Psychol, Cologne, Germany.	peter.csapo@whu.edu	Raab, Markus/B-4919-2009	Raab, Markus/0000-0001-6546-1666	Jurgen Manchot Foundation	Jurgen Manchot Foundation	This research was supported by the Jurgen Manchot Foundation (http://www.manchot.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RM, 1992, PERCEPT MOTOR SKILL, V74, P934, DOI 10.2466/pms.1992.74.3.934; Aharoni G, 2012, APPL ECON, V44, P2309, DOI 10.1080/00036846.2011.564141; ALAMAR B, 2011, ANALYTICS MAGAZINE; Arkes J, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1198; Attali Y, 2013, PSYCHOL SCI, V24, P1151, DOI 10.1177/0956797612468452; Bar-Eli M, 2006, PSYCHOL SPORT EXERC, V7, P525, DOI 10.1016/j.psychsport.2006.03.001; Bocskocsky A, 2014, HEAT CHECK NEW EVIDE; Burns BD, 2004, COGNITIVE PSYCHOL, V48, P295, DOI 10.1016/j.cogpsych.2003.07.003; Carlson KA, 2007, ORGAN BEHAV HUM DEC, V104, P113, DOI 10.1016/j.obhdp.2007.03.004; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Gula B, 2004, J SPORT EXERCISE PSY, V26, P167, DOI 10.1123/jsep.26.1.167; Iso-Ahola SE, 2014, REV GEN PSYCHOL, V18, P19, DOI 10.1037/a0036406; Neiman T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1580; Raab M, 2012, J EXP PSYCHOL-APPL, V18, P81, DOI 10.1037/a0025951; Skinner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030776; Smith G, 2003, PSYCHON B REV, V10, P753, DOI 10.3758/BF03196542; Willer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049807; Yaari G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024532; 2014, NBA YEAR BY YEAR LEA	19	18	18	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114184	10.1371/journal.pone.0114184	http://dx.doi.org/10.1371/journal.pone.0114184			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474443	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000346382500122
J	Gomila, M; Prince-Manzano, C; Svensson-Stadler, L; Busquets, A; Erhard, M; Martinez, DL; Lalucat, J; Moore, ERB				Gomila, Margarita; Prince-Manzano, Claudia; Svensson-Stadler, Liselott; Busquets, Antonio; Erhard, Marcel; Martinez, Deny L.; Lalucat, Jorge; Moore, Edward R. B.			Genotypic and Phenotypic Applications for the Differentiation and Species-Level Identification of Achromobacter for Clinical Diagnoses	PLOS ONE			English	Article							AD-HOC-COMMITTEE; CYSTIC-FIBROSIS; SP-NOV.; ROUTINE IDENTIFICATION; DENITRIFICANS RUGER; XYLOSOXIDANS; SAMPLES; RECLASSIFICATION; INFECTIONS; PIECHAUDII	The Achromobacter is a genus in the family Alcaligenaceae, comprising fifteen species isolated from different sources, including clinical samples. The ability to detect and correctly identify Achromobacter species, particularly A. xylosoxidans, and differentiate them from other phenotypically similar and genotypically related Gram-negative, aerobic, non-fermenting species is important for patients with cystic fibrosis (CF), as well as for nosocomial and other opportunistic infections. Traditional phenotypic profile-based analyses have been demonstrated to be inadequate for reliable identifications of isolates of Achromobacter species and genotypic-based assays, relying upon comparative 16S rRNA gene sequence analyses are not able to insure definitive identifications of Achromobacter species, due to the inherently conserved nature of the gene. The uses of alternative methodologies to enable high-resolution differentiation between the species in the genus are needed. A comparative multi-locus sequence analysis (MLSA) of four selected 'house-keeping' genes (atpD, gyrB, recA, and rpoB) assessed the individual gene sequences for their potential in developing a reliable, rapid and cost-effective diagnostic protocol for Achromobacter species identifications. The analysis of the type strains of the species of the genus and 46 strains of Achromobacter species showed congruence between the cluster analyses derived from the individual genes. The MLSA gene sequences exhibited different levels of resolution in delineating the validly published Achromobacter species and elucidated strains that represent new genotypes and probable new species of the genus. Our results also suggested that the recently described A. spritinus is a later heterotypic synonym of A. marplatensis. Strains were analyzed, using whole-cell Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight mass spectrometry (MALDI-TOF MS), as an alternative phenotypic profile-based method with the potential to support the identifications determined by the genotypic DNA sequence-based MLSA. The MALDI-TOF MS data showed good accordance in strain groupings and identifications by the MLSA data.	[Gomila, Margarita; Prince-Manzano, Claudia; Busquets, Antonio; Martinez, Deny L.; Lalucat, Jorge] Univ Balearic Isl, Dept Biol, Palma De Mallorca, Islas Baleares, Spain; [Svensson-Stadler, Liselott; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Culture Collect Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Erhard, Marcel] RIPAC LAB GmbH, Potsdam, Germany; [Lalucat, Jorge] CSIC UIB, Mediterranean Inst Adv Studies IMEDEA, Palma De Mallorca, Islas Baleares, Spain	Universitat de les Illes Balears; University of Gothenburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Gomila, M (corresponding author), Univ Balearic Isl, Dept Biol, Palma De Mallorca, Islas Baleares, Spain.	marga.gomila@uib.es	Gomila, Margarita/H-3314-2015; Lalucat, Jorge/K-1127-2014; Busquets Bisbal, Antonio/K-9206-2014	Gomila, Margarita/0000-0001-8725-190X; Lalucat, Jorge/0000-0002-8350-6087; Moore, Edward/0000-0001-7693-924X; Busquets Bisbal, Antonio/0000-0002-2793-1388	University of the Balearic Islands - Spanish Ministry of Education, Culture and Sports through the International Excellence Campus Program; Spanish Ministry of Education and Science, Jose Castillejo Program; FEMS Research Fellowship [2009-1]; Vastra Gotaland Region (Sweden) [ALFGBG-210591, VGFOUREG-157801, VGFOUREG-232981]; Spanish MINECO [CGL2011-24318]; Consolider [CSD2009-00006]	University of the Balearic Islands - Spanish Ministry of Education, Culture and Sports through the International Excellence Campus Program; Spanish Ministry of Education and Science, Jose Castillejo Program(German Research Foundation (DFG)); FEMS Research Fellowship; Vastra Gotaland Region (Sweden); Spanish MINECO(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Margarita Gomila is the recipient of a postdoctoral contract from the University of the Balearic Islands funded by the Spanish Ministry of Education, Culture and Sports through the International Excellence Campus Program. Margarita Gomila was supported for exchange to the CCUG through fellowships from the Spanish Ministry of Education and Science, by means of the Jose Castillejo Program (2008) and from a FEMS Research Fellowship 2009-1. This work was supported also by funding from Vastra Gotaland Region (Sweden) projects ALFGBG-210591, VGFOUREG-157801 and VGFOUREG-232981, and from Spanish MINECO, through projects CGL2011-24318 and Consolider CSD2009-00006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amoureux L, 2013, APPL ENVIRON MICROB, V79, P7142, DOI 10.1128/AEM.02293-13; Barrado L, 2013, J CLIN MICROBIOL, V51, P1927, DOI 10.1128/JCM.00494-13; Blumel S, 2001, INT J SYST EVOL MICR, V51, P1867, DOI 10.1099/00207713-51-5-1867; Busse HJ, 2005, BERGEYS MANUAL SYSTE, P658, DOI DOI 10.1007/0-387-29298-5_; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1825, DOI 10.1099/ijs.0.02609-0; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1819, DOI 10.1099/ijs.0.02698-0; DAMATO RF, 1988, J CLIN MICROBIOL, V26, P2425, DOI 10.1128/JCM.26.11.2425-2426.1988; De Baets F, 2014, PEDIATR PULM, V49, P414, DOI 10.1002/ppul.22864; De Baets F, 2007, J CYST FIBROS, V6, P75, DOI 10.1016/j.jcf.2006.05.011; DELEY J, 1986, INT J SYST BACTERIOL, V36, P405, DOI 10.1099/00207713-36-3-405; Duggan JM, 1996, CLIN INFECT DIS, V23, P569, DOI 10.1093/clinids/23.3.569; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez-Olmos A, 2012, J CYST FIBROS, V11, P59, DOI 10.1016/j.jcf.2011.09.001; Gomila M, 2007, APPL ENVIRON MICROB, V73, P3787, DOI 10.1128/AEM.02934-06; Gomila M, 2011, INT J SYST EVOL MICR, V61, P2231, DOI 10.1099/ijs.0.025304-0; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Hansen CR, 2013, J CYST FIBROS, V12, P609, DOI 10.1016/j.jcf.2013.05.004; Jacquier H, 2011, EUR J CLIN MICROBIOL, V30, P1579, DOI 10.1007/s10096-011-1263-5; JUKES T H, 1969, P21; Kallow W, 2010, MASS SPECTROMETRY MI, P255; Kersters K., 1984, BERGEYS MANUAL SYSTE, P361; KIREDJIAN M, 1986, INT J SYST BACTERIOL, V36, P282, DOI 10.1099/00207713-36-2-282; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Liu LX, 2002, J CLIN MICROBIOL, V40, P1210, DOI 10.1128/JCM.40.4.1210-1213.2002; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Ridderberg W, 2012, J CLIN MICROBIOL, V50, P2688, DOI 10.1128/JCM.00728-12; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; SPEAR JB, 1988, J CLIN MICROBIOL, V26, P598, DOI 10.1128/JCM.26.3.598-599.1988; Spilker T, 2013, J CYST FIBROS, V12, P298, DOI 10.1016/j.jcf.2012.10.002; Spilker T, 2012, J CLIN MICROBIOL, V50, P3010, DOI 10.1128/JCM.00814-12; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tayeb LA, 2008, RES MICROBIOL, V159, P169, DOI 10.1016/j.resmic.2007.12.005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandamme P, 2013, SYST APPL MICROBIOL, V36, P474, DOI 10.1016/j.syapm.2013.06.005; Vandamme P, 2013, SYST APPL MICROBIOL, V36, P1, DOI 10.1016/j.syapm.2012.10.003; Vu-Thien H, 1998, EUR J CLIN MICROBIOL, V17, P724, DOI 10.1007/s100960050168; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Yabuuchi E, 1998, MICROBIOL IMMUNOL, V42, P429, DOI 10.1111/j.1348-0421.1998.tb02306.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Ziemke F, 1998, INT J SYST BACTERIOL, V48, P179, DOI 10.1099/00207713-48-1-179	45	22	22	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114356	10.1371/journal.pone.0114356	http://dx.doi.org/10.1371/journal.pone.0114356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474264	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500024
J	Mukherjee, D; Royce, SG; Alexander, JA; Buckley, B; Isukapalli, SS; Bandera, EV; Zarbl, H; Georgopoulos, PG				Mukherjee, Dwaipayan; Royce, Steven G.; Alexander, Jocelyn A.; Buckley, Brian; Isukapalli, Sastry S.; Bandera, Elisa V.; Zarbl, Helmut; Georgopoulos, Panos G.			Physiologically-Based Toxicokinetic Modeling of Zearalenone and Its Metabolites: Application to the Jersey Girl Study	PLOS ONE			English	Article							MYCOTOXIN ZEARALENONE; AROMATIC HYDROXYLATION; ORAL BIOAVAILABILITY; IN-VITRO; RAT; EXPOSURE; ZERANOL; BIOTRANSFORMATION; URINE; GLUCURONIDATION	Zearalenone (ZEA), a fungal mycotoxin, and its metabolite zeranol (ZAL) are known estrogen agonists in mammals, and are found as contaminants in food. Zeranol, which is more potent than ZEA and comparable in potency to estradiol, is also added as a growth additive in beef in the US and Canada. This article presents the development and application of a Physiologically-Based Toxicokinetic (PBTK) model for ZEA and ZAL and their primary metabolites, zearalenol, zearalanone, and their conjugated glucuronides, for rats and for human subjects. The PBTK modeling study explicitly simulates critical metabolic pathways in the gastrointestinal and hepatic systems. Metabolic events such as dehydrogenation and glucuronidation of the chemicals, which have direct effects on the accumulation and elimination of the toxic compounds, have been quantified. The PBTK model considers urinary and fecal excretion and biliary recirculation and compares the predicted biomarkers of blood, urinary and fecal concentrations with published in vivo measurements in rats and human subjects. Additionally, the toxicokinetic model has been coupled with a novel probabilistic dietary exposure model and applied to the Jersey Girl Study (JGS), which involved measurement of mycoestrogens as urinary biomarkers, in a cohort of young girls in New Jersey, USA. A probabilistic exposure characterization for the study population has been conducted and the predicted urinary concentrations have been compared to measurements considering inter-individual physiological and dietary variability. The in vivo measurements from the JGS fall within the high and low predicted distributions of biomarker values corresponding to dietary exposure estimates calculated by the probabilistic modeling system. The work described here is the first of its kind to present a comprehensive framework developing estimates of potential exposures to mycotoxins and linking them with biologically relevant doses and biomarker measurements, including a systematic characterization of uncertainties in exposure and dose estimation for a vulnerable population.	[Mukherjee, Dwaipayan; Royce, Steven G.; Alexander, Jocelyn A.; Buckley, Brian; Isukapalli, Sastry S.; Bandera, Elisa V.; Zarbl, Helmut; Georgopoulos, Panos G.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Mukherjee, Dwaipayan; Royce, Steven G.; Alexander, Jocelyn A.; Isukapalli, Sastry S.; Zarbl, Helmut; Georgopoulos, Panos G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Mukherjee, Dwaipayan; Georgopoulos, Panos G.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ USA; [Georgopoulos, Panos G.] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Georgopoulos, PG (corresponding author), Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.	panosg@ccl.rutgers.edu	Bandera, Elisa V/M-4169-2014; Mukherjee, Dwaipayan/AAN-6736-2020	Bandera, Elisa V/0000-0002-8789-2755; Mukherjee, Dwaipayan/0000-0002-3918-3188	National Institute of Environmental Health Sciences [P30E5S005022]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by National Institute of Environmental Health Sciences Grant P30E5S005022 (http://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN R S, 1983, Regulatory Toxicology and Pharmacology, V3, P9, DOI 10.1016/0273-2300(83)90046-6; Bandera EV, 2011, SCI TOTAL ENVIRON, V409, P5221, DOI 10.1016/j.scitotenv.2011.09.029; Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053; Beef Checkoff, 2009, TECHNICAL REPORT; BIEHL ML, 1993, TOXICOL APPL PHARM, V121, P152, DOI 10.1006/taap.1993.1140; BORIES GF, 1991, DRUG METAB DISPOS, V19, P140; Coffey R, 2009, FOOD CONTROL, V20, P239, DOI 10.1016/j.foodcont.2008.05.011; COMAS AP, 1982, LANCET, V1, P1299; Cubitt HE, 2009, PHARM RES-DORDR, V26, P1073, DOI 10.1007/s11095-008-9823-9; DERODRIGUEZ CAS, 1985, J PEDIATR-US, V107, P393, DOI 10.1016/S0022-3476(85)80513-8; DIXON SN, 1986, J VET PHARMACOL THER, V9, P353, DOI 10.1111/j.1365-2885.1986.tb00055.x; EU Directorate-GeneralXXIV, 1999, TECHNICAL REPORT; European Food Safety Authority (EFSA), 1975, EFSA J, V9; FARA GM, 1979, LANCET, V2, P295; Fink-Gremmels J, 2008, FOOD ADDIT CONTAM A, V25, P172, DOI 10.1080/02652030701823142; FitzGerald MP, 2002, AM J OBSTET GYNECOL, V187, P1384, DOI 10.1067/mob.2002.126865; FITZPATRICK DW, 1988, J ENVIRON SCI HEAL B, V23, P343, DOI 10.1080/03601238809372610; Fleck Stefanie C, 2012, Mycotoxin Res, V28, P267, DOI 10.1007/s12550-012-0143-x; Georgopoulos PG, 2006, J TOXICOL ENV HEAL B, V9, P457, DOI 10.1080/10937400600755929; Georgopoulos PG, 2014, RISK ANAL; Haritova AM, 2010, VET J, V185, P278, DOI 10.1016/j.tvjl.2009.06.007; Hildebrand A, 2010, TOXICOL LETT, V192, P379, DOI 10.1016/j.toxlet.2009.11.014; Johnson R, 2010, TECHNICAL REPORT; KIESSLING KH, 1978, ACTA PHARMACOL TOX, V43, P285; Kleinova M, 2002, J AGR FOOD CHEM, V50, P4769, DOI 10.1021/jf020160p; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Liu Suling, 2004, Breast J, V10, P514, DOI 10.1111/j.1075-122X.2004.21410.x; Malekinejad H, 2005, VET RES, V36, P799, DOI 10.1051/vetres:2005034; Malekinejad H, 2006, VET J, V172, P96, DOI 10.1016/j.tvjl.2005.03.004; Mallis LM, 2003, J CHROMATOGR B, V796, P71, DOI 10.1016/j.jchromb.2003.08.003; Massart F, 2008, J PEDIATR-US, V152, P690, DOI 10.1016/j.jpeds.2007.10.020; MIGDALOF BH, 1983, XENOBIOTICA, V13, P209, DOI 10.3109/00498258309052257; Miles CO, 1996, J AGR FOOD CHEM, V44, P3244, DOI 10.1021/jf9601325; Pearson MA, 2009, J EXPO SCI ENV EPID, V19, P336, DOI 10.1038/jes.2008.48; Pfeiffer E, 2013, MYCOTOXIN RES, V29, P177, DOI 10.1007/s12550-013-0165-z; Pfeiffer E, 2010, MOL NUTR FOOD RES, V54, P1468, DOI 10.1002/mnfr.200900524; Pfeiffer E, 2009, MOL NUTR FOOD RES, V53, P1123, DOI 10.1002/mnfr.200800584; Poulin P, 2002, J PHARM SCI, V91; Ramos AJ, 1996, INT J PHARMACEUT, V128, P129, DOI 10.1016/0378-5173(95)04239-3; Schaut A, 2008, J APPL TOXICOL, V28, P966, DOI 10.1002/jat.1362; SCHOENTAL R, 1983, LANCET, V1, P537; Sewell H, 1993, G2090 U MISS; Shephard GS, 2013, FOOD CHEM TOXICOL, V62, P217, DOI 10.1016/j.fct.2013.08.040; Shin BS, 2009, J TOXICOL ENV HEAL A, V72, P1406, DOI 10.1080/15287390903212774; Shin BS, 2009, J TOXICOL ENV HEAL A, V72, P1395, DOI 10.1080/15287390903212741; Skopp G, 2002, FORENSIC SCI INT, V126, P17, DOI 10.1016/S0379-0738(02)00023-3; So MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096404; Tangni EK, 2009, SCI TOTAL ENVIRON, V407, P4411, DOI 10.1016/j.scitotenv.2008.10.060; Tangni EK, 2007, J SCI FOOD AGR, V87, P1263, DOI 10.1002/jsfa.2838; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Videmann B, 2008, FOOD CHEM TOXICOL, V46, P3279, DOI 10.1016/j.fct.2008.07.011; Wang YL, 2008, ENVIRON RES, V107, P139, DOI 10.1016/j.envres.2008.01.008; Warth B, 2013, TOXICOL LETT, V220, P88, DOI 10.1016/j.toxlet.2013.04.012; World Health Organization, 2000, TECHNICAL REPORT; Zollner P, 2002, J AGR FOOD CHEM, V50, P2494, DOI 10.1021/jf0113631	55	23	23	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113632	10.1371/journal.pone.0113632	http://dx.doi.org/10.1371/journal.pone.0113632			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474635	Green Published, gold			2022-12-26	WOS:000346382500088
J	Yang, HJ; Wahlmuller, FC; Sarg, B; Furtmuller, M; Geiger, M				Yang, Hanjiang; Wahlmueller, Felix Christof; Sarg, Bettina; Furtmueller, Margareta; Geiger, Margarethe			A plus -Helix of Protein C Inhibitor (PCI) Is a Cell-penetrating Peptide That Mediates Cell Membrane Permeation of PCI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Permeabilization; Cell-penetrating Peptide (CPP); Nuclear Translocation; Peptides; Serpin; Protein C Inhibitor; Testisin	TESTICULAR GERM-CELLS; SERINE-PROTEASE; IN-VITRO; EXPRESSION; PLASMA; TESTISIN; BINDING; SERPIN; LOCALIZATION; RECOGNITION	Background: Extracellular protein C inhibitor (PCI) can cross the cellular plasma membrane. Results: Testisin (fluid-phase and cell membrane-anchored) cleaves PCI close to its N terminus. N-terminally truncated PCI can no longer be internalized by cells. Conclusion: Testisin removes helix A+, a cell-penetrating peptide, which mediates cell membrane permeation of PCI. Significance: Testisin or other proteases could regulate PCI internalization by removing its N terminus. Protein C inhibitor (PCI) is a serpin with broad protease reactivity. It binds glycosaminoglycans and certain phospholipids that can modulate its inhibitory activity. PCI can penetrate through cellular membranes via binding to phosphatidylethanolamine. The exact mechanism of PCI internalization and the intracellular role of the serpin are not well understood. Here we showed that testisin, a glycosylphosphatidylinositol-anchored serine protease, cleaved human PCI and mouse PCI (mPCI) at their reactive sites as well as at sites close to their N terminus. This cleavage was observed not only with testisin in solution but also with cell membrane-anchored testisin on U937 cells. The cleavage close to the N terminus released peptides rich in basic amino acids. Synthetic peptides corresponding to the released peptides of human PCI (His(1)-Arg(11)) and mPCI (Arg(1)-Ala(18)) functioned as cell-penetrating peptides. Because intact mPCI but not testisin-cleaved mPCI was internalized by Jurkat T cells, a truncated mPCI mimicking testisin-cleaved mPCI was created. The truncated mPCI lacking 18 amino acids at the N terminus was not taken up by Jurkat T cells. Therefore our model suggests that testisin or other proteases could regulate the internalization of PCI by removing its N terminus. This may represent one of the mechanisms regulating the intracellular functions of PCI.	[Yang, Hanjiang; Wahlmueller, Felix Christof; Furtmueller, Margareta; Geiger, Margarethe] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Sarg, Bettina] Med Univ Innsbruck, Div Clin Biochem, Bioctr, A-6020 Innsbruck, Austria	Medical University of Vienna; Medical University of Innsbruck	Geiger, M (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Schwarzspanierstr 17, A-1090 Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Furtmuller, Margareta/0000-0002-2572-6401; Geiger, Margarethe/0000-0003-2021-5319	Austria Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) [P22792-B11]; Austrian Science Fund (FWF) [P 22792] Funding Source: researchfish	Austria Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austria Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) Grant P22792-B11 (to M. G.).	Asanuma K, 2007, INT J CANCER, V121, P955, DOI 10.1002/ijc.22773; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083/jcb.200707165; Bijsmans ITGW, 2011, MODERN PATHOL, V24, P463, DOI 10.1038/modpathol.2010.214; Brenner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057243; Cao Y, 2003, PROSTATE, V57, P196, DOI 10.1002/pros.10296; ECKE S, 1992, J BIOL CHEM, V267, P7048; ECKE S, 1992, ANN NY ACAD SCI, V667, P84, DOI 10.1111/j.1749-6632.1992.tb51601.x; Elisen MGLM, 1996, THROMB HAEMOSTASIS, V75, P760; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; Fortenberry YM, 2010, BBA-GEN SUBJECTS, V1800, P580, DOI 10.1016/j.bbagen.2010.03.003; Furtmueller M., 2011, J THROMB HAEMOST SS2, V9; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; GEIGER M, 1989, BLOOD, V74, P722; GEIGER M, 1991, J BIOL CHEM, V266, P11851; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Hayashi T, 2007, J THROMB HAEMOST, V5, P1477, DOI 10.1111/j.1538-7836.2007.02594.x; He SP, 1999, MOL HUM REPROD, V5, P513, DOI 10.1093/molehr/5.6.513; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Inoue M, 1998, BIOCHEM BIOPH RES CO, V252, P307, DOI 10.1006/bbrc.1998.9645; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Meijers JCM, 2011, SEMIN THROMB HEMOST, V37, P349, DOI 10.1055/s-0031-1276583; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; PRIGLINGER U, 1994, J BIOL CHEM, V269, P14705; Prohaska TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039262; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Samani FS, 2014, CYTOTECHNOLOGY, V66, P555, DOI 10.1007/s10616-013-9609-8; Shigemasa K, 2000, J SOC GYNECOL INVEST, V7, P358, DOI 10.1016/S1071-5576(00)00086-1; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Sokolikova B., 2011, J THROMB HAEMOST SS2, V9; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Tang T, 2005, CANCER RES, V65, P868; Uhrin P, 2000, J CLIN INVEST, V106, P1531, DOI 10.1172/JCI10768; Wahlmuller FC, 2014, THROMB HAEMOSTASIS, V111, P41, DOI 10.1160/TH13-06-0478; Wakita T, 2004, INT J CANCER, V108, P516, DOI 10.1002/ijc.11594; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; ZHENG XL, 1994, AM J PHYSIOL, V267, pC466, DOI 10.1152/ajpcell.1994.267.2.C466	47	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3081	3091		10.1074/jbc.M114.581736	http://dx.doi.org/10.1074/jbc.M114.581736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25488662	Green Published, hybrid			2022-12-26	WOS:000349310700044
J	Colussi, F; Sorensen, TH; Alasepp, K; Kari, J; Cruys-Bagger, N; Windahl, MS; Olsen, JP; Borch, K; Westh, P				Colussi, Francieli; Sorensen, Trine H.; Alasepp, Kadri; Kari, Jeppe; Cruys-Bagger, Nicolaj; Windahl, Michael S.; Olsen, Johan P.; Borch, Kim; Westh, Peter			Probing Substrate Interactions in the Active Tunnel of a Catalytically Deficient Cellobiohydrolase (Cel7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE-BINDING DOMAIN; TRICHODERMA-REESEI CELLOBIOHYDROLASES; HEAT-CAPACITY CHANGES; CRYSTAL-STRUCTURES; FREE-ENERGY; MICROCRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; GLYCOSIDE HYDROLASES; CELLULASES; PROTEIN	Cellobiohydrolases break down cellulose sequentially by sliding along the crystal surface with a single cellulose strand threaded through the catalytic tunnel of the enzyme. This so-called processive mechanism relies on a complex pattern of enzyme-substrate interactions, which need to be addressed in molecular descriptions of processivity and its driving forces. Here, we have used titration calorimetry to study interactions of cellooligosaccharides (COS) and a catalytically deficient variant (E212Q) of the enzyme Cel7A from Trichoderma reesei. This enzyme has similar to 10 glucopyranose subsites in the catalytic tunnel, and using COS ligands with a degree of polymerization (DP) from 2 to 8, different regions of the tunnel could be probed. For COS ligands with a DP of 2-3 the binding constants were around 10(5) M-1, and for longer ligands (DP 5-8) this value was similar to 10(7) M-1. Within each of these groups we did not find increased affinity as the ligands got longer and potentially filled more subsites. On the contrary, we found a small but consistent affinity loss as DP rose from 6 to 8, particularly at the higher investigated temperatures. Other thermodynamic functions (Delta H, Delta S, and Delta C-p) decreased monotonously with both temperature and DP. Combined interpretation of these thermodynamic results and previously published structural data allowed assessment of an affinity profile along the length axis of the active tunnel.	[Colussi, Francieli; Sorensen, Trine H.; Alasepp, Kadri; Kari, Jeppe; Cruys-Bagger, Nicolaj; Windahl, Michael S.; Olsen, Johan P.; Westh, Peter] Roskilde Univ, NSM, Res Unit Funct Biomat, DK-4000 Roskilde, Denmark; [Windahl, Michael S.; Borch, Kim] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Roskilde University; Novozymes	Westh, P (corresponding author), Roskilde Univ, NSM, Res Unit Funct Biomat, 1 Univ Vej,Bldg 28, DK-4000 Roskilde, Denmark.	pwesth@ruc.dk	Olsen, Johan/A-5599-2016; Kari, Jeppe/AAP-6649-2021; Westh, Peter/AAR-9731-2021; Colussi, Francieli/J-9166-2016	Olsen, Johan/0000-0002-1383-8318; Kari, Jeppe/0000-0003-3792-3856; Westh, Peter/0000-0002-6185-0637; Windahl, Michael Skovbo/0000-0002-0572-3115; Colussi, Francieli/0000-0002-4392-767X; Sorensen, Trine Holst/0000-0002-2045-7580	Danish Council for Strategic Research; Program Commission on Sustainable Energy and Environment Grant [21 04-07-0028, 11-116772]; Carlsberg Foundation [2013-01-0208]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Program Commission on Sustainable Energy and Environment Grant; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Danish Council for Strategic Research, Program Commission on Sustainable Energy and Environment Grant 21 04-07-0028 and 11-116772 (to P. W.) and by Carlsberg Foundation Grant 2013-01-0208 (to P. W.).	Alasepp K, 2014, LANGMUIR, V30, P7134, DOI 10.1021/la500161e; Baranauskiene L, 2009, INT J MOL SCI, V10, P2752, DOI 10.3390/ijms10062752; Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w; Baumann MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-45; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Bommarius AS, 2014, CURR OPIN BIOTECH, V29, P139, DOI 10.1016/j.copbio.2014.04.007; Borch K., 2014, WIPO patent, Patent No. 2014138672; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; CABANI S, 1981, J SOLUTION CHEM, V10, P563, DOI 10.1007/BF00646936; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; CLARKE ECW, 1966, T FARADAY SOC, V62, P539, DOI 10.1039/tf9666200539; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; COSTAS M, 1994, J CHEM SOC FARADAY T, V90, P1513, DOI 10.1039/ft9949001513; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Ducros VMA, 2003, CHEM BIOL, V10, P619, DOI 10.1016/S1074-5521(03)00143-1; Gallicchio E, 2000, J PHYS CHEM B, V104, P6271, DOI 10.1021/jp0006274; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guo J, 2013, BIOMACROMOLECULES, V14, P1268, DOI 10.1021/bm300810t; Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kern M, 2013, P NATL ACAD SCI USA, V110, P10189, DOI 10.1073/pnas.1301502110; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Koga Y, 2013, PHYS CHEM CHEM PHYS, V15, P14548, DOI 10.1039/c3cp51650d; LIN LN, 1991, BIOCHEMISTRY-US, V30, P11660, DOI 10.1021/bi00114a008; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mattinen ML, 1997, FEBS LETT, V407, P291, DOI 10.1016/S0014-5793(97)00356-6; Mayes HB, 2014, J AM CHEM SOC, V136, P1008, DOI 10.1021/ja410264d; Momeni M. H., 2014, THESIS SWEDISH U AGR; NIDETZKY B, 1994, ENZYME MICROB TECH, V16, P43, DOI 10.1016/0141-0229(94)90108-2; Nielsen AD, 2000, BBA-PROTEIN STRUCT M, V1479, P321, DOI 10.1016/S0167-4838(00)00012-1; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Parkkinen T, 2008, PROTEIN SCI, V17, P1383, DOI 10.1110/ps.034488.108; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Pellegrini VOA, 2014, LANGMUIR, V30, P12602, DOI 10.1021/la5024423; Schonbeck C, 2014, J INCL PHENOM MACRO, V78, P351, DOI 10.1007/s10847-013-0305-2; Schonbeck C, 2012, ANAL CHEM, V84, P2305, DOI 10.1021/ac202842s; Srisodsuk M, 1997, J BIOTECHNOL, V57, P49, DOI 10.1016/S0168-1656(97)00088-6; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	56	33	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2444	2454		10.1074/jbc.M114.624163	http://dx.doi.org/10.1074/jbc.M114.624163			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477511	Green Published, hybrid			2022-12-26	WOS:000348588000046
J	Lahti, M; Eriksson, JG; Heinonen, K; Kajantie, E; Lahti, J; Wahlbeck, K; Tuovinen, S; Pesonen, AK; Mikkonen, M; Osmond, C; Raikkonen, K				Lahti, Marius; Eriksson, Johan G.; Heinonen, Kati; Kajantie, Eero; Lahti, Jari; Wahlbeck, Kristian; Tuovinen, Soile; Pesonen, Anu-Katriina; Mikkonen, Maiju; Osmond, Clive; Raikkonen, Katri			Maternal Grand Multiparity and the Risk of Severe Mental Disorders in Adult Offspring	PLOS ONE			English	Article							HOSPITAL DISCHARGE REGISTER; BIRTH COHORT; OBSTETRIC COMPLICATIONS; PERINATAL CIRCUMSTANCES; NEONATAL OUTCOMES; PRETERM INFANTS; FOLLOW-UP; SCHIZOPHRENIA; VALIDITY; FINLAND	Background: Previous studies have shown that maternal grand multiparity may predict an increased risk of mental disorders in young adult offspring, but whether such effects persist throughout adulthood remains unknown. The current study examined if maternal grand multiparity predicts the risks of severe mental disorders, suicides, suicide attempts and dementias throughout adult life. Methods: Our study sample comprised 13243 Helsinki Birth Cohort Study 1934-1944 participants (6905 men and 6338 women). According to hospital birth records, 341 offspring were born to grand multiparous mothers. From Finnish national hospital discharge and causes of death registers, we identified 1682 participants diagnosed with mental disorders during 1969-2010. Results: Maternal grand multiparity predicted significantly increased risks of mood disorders (Hazard Ratio=1.64, p=0.03), non-psychotic mood disorders (Hazard Ratio=2.02, p=0.002), and suicide attempts (Hazard Ratio=3.94, p=0.01) in adult offspring. Furthermore, women born to grand multiparous mothers had significantly increased risks of any severe mental disorder (Hazard Ratio=1.79, p=0.01), non-psychotic substance use disorders (Hazard Ratio=2.77, p=0.02) schizophrenia, schizotypal and delusional disorders (Hazard Ratio=2.40, p=0.02), mood disorders (Hazard Ratio=2.40, p=0.002), non-psychotic mood disorders (Hazard Ratio=2.91, p<0.001), and suicide attempts (Hazard Ratio=5.05, p=0.01) in adulthood. The effects of maternal grand multiparity on offspring psychopathology risk were independent of maternal age and body mass index at childbirth, and of year of birth, sex, childhood socioeconomic position, and birth weight of the offspring. In contrast, no significant effects were found among men. Conclusions: Women born to grand multiparous mothers are at an increased risk of severe mental disorders and suicide attempts across adulthood. Our findings may inform the development of preventive interventions for mental disorders.	[Lahti, Marius; Heinonen, Kati; Lahti, Jari; Tuovinen, Soile; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Eriksson, Johan G.; Kajantie, Eero; Wahlbeck, Kristian; Mikkonen, Maiju] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Wahlbeck, Kristian] Finnish Assoc Mental Hlth, Helsinki, Finland; [Osmond, Clive] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Vaasa Central Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Southampton	Lahti, M (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	marius.lahti@helsinki.fi	Lahti, Jari/P-7987-2018; Lahti, Jari/P-2283-2019; Wahlbeck, Kristian/F-8394-2011; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Pesonen, Anu-Katriina/0000-0002-0662-6261; Wahlbeck, Kristian/0000-0003-3754-3933; Raikkonen, Katri/0000-0003-3124-3470; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Tuovinen, Soile/0000-0001-5410-0611; Eriksson, Johan/0000-0002-2516-2060; Heinonen, Kati/0000-0002-1262-5599; Osmond, Clive/0000-0002-9054-4655	Academy of Finland [261661, 140278, 135132, 132614, 129911, 129457]; University of Helsinki; Finnish Foundation of Cardiovascular Research; Finnish Diabetes Research Foundation; Finnish Medical Society; Finska Lakaresallskapet; National Doctoral Programme of Psychology; Paivikki and Sakari Sohlberg Foundation; Juho Vainio Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Signe and Ane Gyllenberg Foundation; Jalmari and Rauha Ahokas Foundation; Emil Aaltonen Foundation; Finnish Ministry of Education; Finnish Foundation for Paediatric Research	Academy of Finland(Academy of Finland); University of Helsinki; Finnish Foundation of Cardiovascular Research; Finnish Diabetes Research Foundation; Finnish Medical Society; Finska Lakaresallskapet; National Doctoral Programme of Psychology; Paivikki and Sakari Sohlberg Foundation; Juho Vainio Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Signe and Ane Gyllenberg Foundation; Jalmari and Rauha Ahokas Foundation; Emil Aaltonen Foundation; Finnish Ministry of Education; Finnish Foundation for Paediatric Research	This study was supported by grants from the Academy of Finland (grant numbers 261661, 140278, 135132, 132614, 129911, and 129457), University of Helsinki, the Finnish Foundation of Cardiovascular Research, the Finnish Diabetes Research Foundation, the Finnish Medical Society, Finska Lakaresallskapet, the National Doctoral Programme of Psychology, the Paivikki and Sakari Sohlberg Foundation, the Juho Vainio Foundation, the Yrjo Jahnsson Foundation, Samfundet Folkhalsan, the Signe and Ane Gyllenberg Foundation, the Jalmari and Rauha Ahokas Foundation, the Emil Aaltonen Foundation, the Finnish Ministry of Education and the Finnish Foundation for Paediatric Research. The funders were not involved in the conduct of the study or in the collection, management, analysis or interpretation of the data.	Alaraisanen A, 2012, SOC PSYCH PSYCH EPID, V47, P1783, DOI 10.1007/s00127-012-0479-8; Aliyu MH, 2005, OBSTET GYNECOL, V105, P1045, DOI 10.1097/01.AOG.0000157444.74674.75; Bai J, 2002, AM J OBSTET GYNECOL, V186, P274, DOI 10.1067/mob.2002.119639; Bjorngaard JH, 2013, AM J EPIDEMIOL, V177, P638, DOI 10.1093/aje/kwt014; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Ekeus C, 2006, PSYCHOL MED, V36, P269, DOI 10.1017/S0033291705006549; Fazel S, 2012, J PERS DISORD, V26, P737, DOI 10.1521/pedi.2012.26.5.737; Johnson JG, 2001, ARCH GEN PSYCHIAT, V58, P453, DOI 10.1001/archpsyc.58.5.453; Kapusta ND, 2011, ARCH GEN PSYCHIAT, V68, P1050, DOI 10.1001/archgenpsychiatry.2011.66; Kemppainen L, 2000, SOC PSYCH PSYCH EPID, V35, P104, DOI 10.1007/s001270050191; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Keskinen E, 1966, SCHIZOPHR RES, V145, P56; Kieseppa T, 2000, ACTA NEUROPSYCHIATR, V12, P106, DOI 10.1017/S0924270800035535; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Lawson DW, 2009, EVOL HUM BEHAV, V30, P170, DOI 10.1016/j.evolhumbehav.2008.12.001; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Morgan Z, 2012, SOC PSYCH PSYCH EPID, V47, P1707, DOI 10.1007/s00127-012-0481-1; Niederkrotenthaler T, 2012, EUR J EPIDEMIOL, V27, P729, DOI 10.1007/s10654-012-9724-4; Nordhov SM, 2012, PEDIATRICS, V129, pE9, DOI 10.1542/peds.2011-0248; Paananen R, 2013, J EPIDEMIOL COMMUN H, V67, P1025, DOI 10.1136/jech-2013-202768; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pihlajamaa J, 2008, NORD J PSYCHIAT, V62, P198, DOI 10.1080/08039480801983596; POIKOLAINEN K, 1983, DRUG ALCOHOL DEPEN, V12, P315, DOI 10.1016/0376-8716(83)90002-9; Raikkonen K, 2011, J PSYCHIATR RES, V45, P332, DOI 10.1016/j.jpsychires.2010.07.003; Riordan DV, 2012, SOC PSYCH PSYCH EPID, V47, P975, DOI 10.1007/s00127-011-0405-5; Roman H, 2004, OBSTET GYNECOL, V103, P1294, DOI 10.1097/01.AOG.0000127426.95464.85; Ruusunen A, 2014, J AFFECT DISORDERS, V159, P1, DOI 10.1016/j.jad.2014.01.020; Solomon A, 2014, ALZHEIMERS DEMENT, V10, P303, DOI 10.1016/j.jalz.2013.03.004; Spencer-Smith MM, 2012, PEDIATRICS, V130, P1094, DOI 10.1542/peds.2012-0426; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Suvisaari JM, 2013, SCHIZOPHRENIA BULL, V39, P1056, DOI 10.1093/schbul/sbs109; Teguete I, 2012, ACTA OBSTET GYN SCAN, V91, P580, DOI 10.1111/j.1600-0412.2012.01372.x; Yasmeen S, 2005, J MATERN-FETAL NEO M, V17, P277, DOI 10.1080/14767050500123798	33	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114679	10.1371/journal.pone.0114679	http://dx.doi.org/10.1371/journal.pone.0114679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493431	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000346611400066
J	Ali, TY; Pipkin, FB; Khan, RN				Ali, Tayyba Y.; Pipkin, Fiona Broughton; Khan, Raheela N.			The Effect of pH and Ion Channel Modulators on Human Placental Arteries	PLOS ONE			English	Article							DOMAIN K+ CHANNELS; POTASSIUM CHANNELS; FETOPLACENTAL VASOCONSTRICTION; VASCULAR-RESISTANCE; INTRACELLULAR PH; BLOOD-FLOW; TREK-1; LOCALIZATION; STIMULATION; EXPRESSION	Chorionic plate arteries (CPA) are located at the maternofetal interface where they are able to respond to local metabolic changes. Unlike many other types of vasculature, the placenta lacks nervous control and requires autoregulation for controlling blood flow. The placental circulation, which is of low-resistance, may become hypoxic easily leading to fetal acidosis and fetal distress however the role of the ion channels in these circumstances is not well-understood. Active potassium channel conductances that are subject to local physicochemical modulation may serve as pathways through which such signals are transduced. The aim of this study was to investigate the modulation of CPA by pH and the channels implicated in these responses using wire myography. CPA were isolated from healthy placentae and pre-contracted with U46619 before testing the effects of extracellular pH using 1 M lactic acid over the pH range 7.4 - 6.4 in the presence of a variety of ion channel modulators. A change from pH 7.4 to 7.2 produced a 29 +/- 3% (n=9) relaxation of CPA which increased to 61 +/- 4% at the lowest pH of 6.4. In vessels isolated from placentae of women with pre-eclampsia (n=6), pH responses were attenuated. L-methionine increased the relaxation to 67 +/- 7% (n=6; p<0.001) at pH 6.4. Similarly the TASK 1/3 blocker zinc chloride (1 mM) gave a maximum relaxation of 72 +/- 5% (n=8; p<0.01) which compared with the relaxation produced by the TREK-1 opener riluzole (75 +/- 5%; n=6). Several other modulators induced no significant changes in vascular responses. Our study confirmed expression of several ion channel subtypes in CPA with our results indicating that extracellular pH within the physiological range has an important role in controlling vasodilatation in the human term placenta.	[Ali, Tayyba Y.; Pipkin, Fiona Broughton; Khan, Raheela N.] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Div Med Sci & Grad Entry Med, Derby DE22 3DT, England	University of Nottingham	Khan, RN (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Div Med Sci & Grad Entry Med, Uttoxeter Rd, Derby DE22 3DT, England.	raheela.khan@nottingham.ac.uk		Khan, Raheela N/0000-0002-6034-269X	British Heart Foundation [FS/05/049]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation; FS/05/049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 1990, J HYPERTENS, V8, P197, DOI 10.1097/00004872-199003000-00001; Aalkjaer C, 1997, ACTA PHYSIOL SCAND, V161, P557, DOI 10.1046/j.1365-201X.1997.00263.x; ALLEN J, 1987, BRIT J ANAESTH, V59, P1273, DOI 10.1093/bja/59.10.1273; Ashworth JR, 1999, HYPERTENS PREGNANCY, V18, P57, DOI 10.3109/10641959909009611; Bai XL, 2005, J SOC GYNECOL INVEST, V12, P77, DOI 10.1016/j.jsgi.2004.08.004; Baker SA, 2008, BRIT J PHARMACOL, V153, P1259, DOI 10.1038/sj.bjp.0707690; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Bobrow CS, 1999, ARCH DIS CHILD-FETAL, V80, pF246, DOI 10.1136/fn.80.3.F246; Brereton MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057451; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chanrachakul B, 2004, AM J PHYSIOL-CELL PH, V287, pC1747, DOI 10.1152/ajpcell.00236.2004; Chavez RA, 1999, J BIOL CHEM, V274, P7887, DOI 10.1074/jbc.274.12.7887; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; Dabertrand F, 2012, CIRC RES, V110, P285, DOI 10.1161/CIRCRESAHA.111.258145; Divya CS, 2006, MOL CARCINOGEN, V45, P320, DOI 10.1002/mc.20170; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Duprat F, 2000, MOL PHARMACOL, V57, P906; Enyeart JA, 2008, BIOCHEM BIOPH RES CO, V370, P623, DOI 10.1016/j.bbrc.2008.04.001; Gruss M, 2004, MOL PHARMACOL, V66, P530; Hampl V, 2002, AM J PHYSIOL-HEART C, V283, pH2440, DOI 10.1152/ajpheart.01033.2001; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hoeldtke NJ, 1997, AM J OBSTET GYNECOL, V177, P1088, DOI 10.1016/S0002-9378(97)70020-6; Horiuchi T, 2002, STROKE, V33, P844, DOI 10.1161/hs0302.104112; HOWARD RB, 1987, AM J OBSTET GYNECOL, V157, P1261, DOI 10.1016/S0002-9378(87)80307-1; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Hussain AS, 1997, CAN J PHYSIOL PHARM, V75, P807, DOI 10.1139/cjpp-75-7-807; Ishizaka H, 1996, CIRC RES, V78, P50, DOI 10.1161/01.RES.78.1.50; Jakoubek V, 2006, PLACENTA, V27, P1030, DOI 10.1016/j.placenta.2005.10.006; Jakoubek V, 2008, AM J PHYSIOL-HEART C, V294, pH1638, DOI 10.1152/ajpheart.01120.2007; Kang D, 2005, J PHYSIOL-LONDON, V564, P103, DOI 10.1113/jphysiol.2004.081059; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kleiner-Assaf A, 1999, AM J PHYSIOL-HEART C, V276, pH2204, DOI 10.1152/ajpheart.1999.276.6.H2204; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Larcombe-McDouall JB, 1998, PFLUG ARCH EUR J PHY, V435, P810, DOI 10.1007/s004240050588; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Li XT, 2006, CARDIOVASC RES, V69, P86, DOI 10.1016/j.cardiores.2005.08.018; Magloire H, 2003, J DENT RES, V82, P542, DOI 10.1177/154405910308200711; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Malin GL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1471; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Mills TA, 2009, FREE RADICAL BIO MED, V47, P159, DOI 10.1016/j.freeradbiomed.2009.04.019; MYATT L, 1992, PLACENTA, V13, P329, DOI 10.1016/0143-4004(92)90057-Z; Omo-Aghoja L, 2014, ANN MED HEALTH SCI R, V4, P8, DOI 10.4103/2141-9248.126602; PARRATT J, 1994, LANCET, V344, P717, DOI 10.1016/S0140-6736(94)92209-8; Poston L, 1997, EXP PHYSIOL, V82, P377, DOI 10.1113/expphysiol.1997.sp004033; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Terrenoire C, 2001, CIRC RES, V89, P336, DOI 10.1161/hh1601.094979; Wareing M, 2002, PLACENTA, V23, P400, DOI 10.1053/plac.2002.0825; Wareing M, 2006, AM J PHYSIOL-REG I, V291, pR437, DOI 10.1152/ajpregu.00040.2006; WRAY S, 1990, J PHYSIOL-LONDON, V423, P411, DOI 10.1113/jphysiol.1990.sp018030; YANG JM, 1995, ACTA OBSTET GYN SCAN, V74, P419, DOI 10.3109/00016349509024402	63	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114405	10.1371/journal.pone.0114405	http://dx.doi.org/10.1371/journal.pone.0114405			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490401	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300038
J	Hammerl, JA; Jackel, C; Alter, T; Janzcyk, P; Stingl, K; Knuver, MT; Hertwig, S				Hammerl, Jens A.; Jaeckel, Claudia; Alter, Thomas; Janzcyk, Pawel; Stingl, Kerstin; Knuever, Marie Theres; Hertwig, Stefan			Reduction of Campylobacter jejuni in Broiler Chicken by Successive Application of Group II and Group III Phages	PLOS ONE			English	Article							BACTERIOPHAGE; COLI; COLONIZATION; INFECTION; PATHOGENS; EFFICACY; SURFACE; SKIN	Background: Bacteriophage treatment is a promising tool to reduce Campylobacter in chickens. Several studies have been published where group II or group III phages were successfully applied. However, these two groups of phages are different regarding their host ranges and host cell receptors. Therefore, a concerted activity of group II and group III phages might enhance the efficacy of a treatment and decrease the number of resistant bacteria. Results: In this study we have compared the lytic properties of some group II and group III phages and analysed the suitability of various phages for a reduction of C. jejuni in broiler chickens. We show that group II and group III phages exhibit different kinetics of infection. Two group III and one group II phage were selected for animal experiments and administered in different combinations to three groups of chickens, each containing ten birds. While group III phage CP14 alone reduced Campylobacter counts by more than 1 log(10) unit, the concomitant administration of a second group III phage (CP81) did not yield any reduction, probably due to the development of resistance induced by this phage. One group of chickens received phage CP14 and, 24 hours later, group II phage CP68. In this group of animals, Campylobacter counts were reduced by more than 3 log10 units. Conclusion: The experiments illustrated that Campylobacter phage cocktails have to be carefully composed to achieve the best results.	[Hammerl, Jens A.; Jaeckel, Claudia; Janzcyk, Pawel; Stingl, Kerstin; Knuever, Marie Theres; Hertwig, Stefan] Bundesinst Risikobewertung, Berlin, Germany; [Alter, Thomas] Free Univ Berlin, Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin	Hertwig, S (corresponding author), Bundesinst Risikobewertung, Berlin, Germany.	stefan.hertwig@bfr.bund.de	Alter, Thomas/J-4810-2014; Hammerl, Jens Andre/Y-6406-2018	Hammerl, Jens Andre/0000-0002-6930-4358; Stingl, Kerstin/0000-0002-8338-717X; Alter, Thomas/0000-0002-6048-5666	Federal Office for Agriculture and Food ("Bundesanstalt fur Landwirtschaft und Ernahrung" project: CAMPYQUANT) [2816100107]	Federal Office for Agriculture and Food ("Bundesanstalt fur Landwirtschaft und Ernahrung" project: CAMPYQUANT)	The work of JAH was supported by a grant of the German Federal Office for Agriculture and Food ("Bundesanstalt fur Landwirtschaft und Ernahrung" project: CAMPYQUANT, No. 2816100107); http://www.ble.de/EN/00_Home/homepage_node.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atterbury RJ, 2003, APPL ENVIRON MICROB, V69, P6302, DOI 10.1128/AEM.69.10.6302-6306.2003; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carvalho CM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-232; Conlan AJK, 2011, J R SOC INTERFACE, V8, P1720, DOI 10.1098/rsif.2011.0125; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Coward C, 2006, APPL ENVIRON MICROB, V72, P4638, DOI 10.1128/AEM.00184-06; Eberle KN, 2012, POULTRY SCI, V91, P255, DOI 10.3382/ps.2011-01414; ECDC, 2013, ANN EP REP 2012 ANN; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053899; Ghareeb K, 2012, POULTRY SCI, V91, P1825, DOI 10.3382/ps.2012-02168; Gibbens JC, 2001, PREV VET MED, V48, P85, DOI 10.1016/S0167-5877(00)00189-6; Goode D, 2003, APPL ENVIRON MICROB, V69, P5032, DOI 10.1128/AEM.69.8.5032-5036.2003; Hammerl JA, 2012, J VIROL, V86, P8896, DOI 10.1128/JVI.01252-12; Hammerl JA, 2011, J VIROL, V85, P8597, DOI 10.1128/JVI.00395-11; Hansen VM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-90; Hertwig S, 2013, BERL MUNCH TIERARZTL, V126, P357, DOI 10.2376/0005-9366-126-357; Humphrey T. J., 2000, Microbiology Today, V27, P10; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Javed MA, 2014, ARCH VIROL, V159, P181, DOI 10.1007/s00705-013-1788-2; Kittler S, 2013, APPL ENVIRON MICROB, V79, P7525, DOI 10.1128/AEM.02703-13; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Loc-Carrillo CM, 2004, THESIS U NOTTINGHAM; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Orquera Stefanie, 2012, J Mol Genet Med, V6, P273; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Sails AD, 1998, J MED MICROBIOL, V47, P123, DOI 10.1099/00222615-47-2-123; Sambrook J., 2001, MOL CLONING LAB MANU; Scott AE, 2007, ENVIRON MICROBIOL, V9, P2341, DOI 10.1111/J.1462-2920.2007.01351.x; Shane SM, 2000, REV SCI TECH OIE, V19, P376, DOI 10.20506/rst.19.2.1224; Siringan P, 2011, APPL ENVIRON MICROB, V77, P3320, DOI 10.1128/AEM.02704-10; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002	34	46	49	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114785	10.1371/journal.pone.0114785	http://dx.doi.org/10.1371/journal.pone.0114785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490713	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300080
J	Jones, CN; Moore, M; Dimisko, L; Alexander, A; Ibrahim, A; Hassell, BA; Warren, HS; Tompkins, RG; Fagan, SP; Irimia, D				Jones, Caroline N.; Moore, Molly; Dimisko, Laurie; Alexander, Andrew; Ibrahim, Amir; Hassell, Bryan A.; Warren, H. Shaw; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel			Spontaneous Neutrophil Migration Patterns during Sepsis after Major Burns	PLOS ONE			English	Article							CHEMOTAXIS; GRADIENTS; INJURY; INTERLEUKIN-6; PROCALCITONIN; EXPRESSION; INFECTION; RESPONSES; KINETICS; SURVIVAL	Finely tuned to respond quickly to infections, neutrophils have amazing abilities to migrate fast and efficiently towards sites of infection and inflammation. Although neutrophils ability to migrate is perturbed in patients after major burns, no correlations have yet been demonstrated between altered migration and higher rate of infections and sepsis in these patients when compared to healthy individuals. To probe if such correlations exist, we designed microfluidic devices to quantify the neutrophil migration phenotype with high precision. Inside these devices, moving neutrophils are confined in channels smaller than the neutrophils and forced to make directional decisions at bifurcations and around posts. We employed these devices to quantify neutrophil migration across 18 independent parameters in 74 blood samples from 13 patients with major burns and 3 healthy subjects. Blinded, retrospective analysis of clinical data and neutrophil migration parameters revealed that neutrophils isolated from blood samples collected during sepsis migrate spontaneously inside the microfluidic channels. The spontaneous neutrophil migration is a unique phenotype, typical for patients with major burns during sepsis and often observed one or two days before the diagnosis of sepsis is confirmed. The spontaneous neutrophil migration phenotype is rare in patients with major burns in the absence of sepsis, and is not encountered in healthy individuals. Our findings warrant further studies of neutrophils and their utility for early diagnosing and monitoring sepsis in patients after major burns.	[Jones, Caroline N.; Moore, Molly; Dimisko, Laurie; Alexander, Andrew; Ibrahim, Amir; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Jones, Caroline N.; Moore, Molly; Dimisko, Laurie; Alexander, Andrew; Ibrahim, Amir; Warren, H. Shaw; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Jones, Caroline N.; Dimisko, Laurie; Hassell, Bryan A.; Irimia, Daniel] BioMEMS Resource Ctr, Ctr Engn Med & Surg Serv, Boston, MA USA; [Jones, Caroline N.; Ibrahim, Amir; Warren, H. Shaw; Irimia, Daniel] Shriners Hosp Children, Boston, MA USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Dept Med, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Irimia, D (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	dirimia@mgh.harvard.edu	Irimia, Daniel/A-4095-2008; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Hassell, Bryan/0000-0002-2946-439X; xiao, wenzhong/0000-0003-4944-6380; Dimisko, Laurie/0000-0002-4974-8250	Kidder Burn Critical Care Fellowship; National Institutes of Health [GM007035, GM092804, EB002503]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007035, R24GM102656, R01GM092804, U54GM062119] Funding Source: NIH RePORTER	Kidder Burn Critical Care Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MM was the recipient of the Kidder Burn Critical Care Fellowship. CNJ has been supported by an institutional training grant from the National Institutes of Health: GM007035. This research has been supported through research grants from the National Institutes of Health GM092804 and EB002503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f; Anand D, 2014, J CRIT CARE; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BJERKNES R, 1990, BLOOD CELLS, V16, P127; BJERKNES R, 1989, BURNS, V15, P77, DOI 10.1016/0305-4179(89)90133-2; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; D'Avignon LC, 2010, BURNS, V36, P773, DOI 10.1016/j.burns.2009.11.007; Danikas DD, 2008, CLIN EXP IMMUNOL, V154, P87, DOI 10.1111/j.1365-2249.2008.03737.x; DECHALAIN TMB, 1994, BURNS, V20, P416, DOI 10.1016/0305-4179(94)90033-7; Fan H, 2014, RENAL FAILURE, V36, P1399, DOI 10.3109/0886022X.2014.945184; Fitrolaki DM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-31; Fjaertoft G, 2007, SCAND J INFECT DIS, V39, P525, DOI 10.1080/00365540601113693; Fournier PE, 2013, NAT REV MICROBIOL, V11, P574, DOI 10.1038/nrmicro3068; Gong YL, 2014, BURNS, V40, P402, DOI 10.1016/j.burns.2013.07.010; Hamza B, 2014, INTEGR BIOL-UK, V6, P175, DOI 10.1039/c3ib40175h; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hietbrink F, 2013, SHOCK, V40, P21, DOI 10.1097/SHK.0b013e318295a40a; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Irimia D, 2009, BIOPHYS J, V96, P3897, DOI 10.1016/j.bpj.2008.12.3967; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jeschke MG, 2013, INT J BURNS TRAUMA, V3, P137; Karzai W, 1997, INFECTION, V25, P329, DOI 10.1007/BF01740811; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; KIM Y, 1989, BURNS, V15, P93, DOI 10.1016/0305-4179(89)90137-X; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Kuster H, 1998, LANCET, V352, P1271, DOI 10.1016/S0140-6736(98)08148-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Martensson J, 2010, INTENS CARE MED, V36, P1333, DOI 10.1007/s00134-010-1887-4; Oberhoffer M, 1999, CRIT CARE MED, V27, P1814, DOI 10.1097/00003246-199909000-00018; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Pascual C, 1998, CRIT CARE MED, V26, P705, DOI 10.1097/00003246-199804000-00019; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Sackmann EK, 2012, BLOOD, V120, pE45, DOI 10.1182/blood-2012-03-416453; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]; SOLOMKIN JS, 1984, ANN SURG, V200, P742, DOI 10.1097/00000658-198412000-00012; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; WARDEN GD, 1975, ANN SURG, V181, P363, DOI 10.1097/00000658-197503000-00019; WARDEN GD, 1974, J CLIN INVEST, V54, P1001, DOI 10.1172/JCI107815; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	52	50	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114509	10.1371/journal.pone.0114509	http://dx.doi.org/10.1371/journal.pone.0114509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489947	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300044
J	Bond, MR; Ghosh, SK; Wang, P; Hanover, JA				Bond, Michelle R.; Ghosh, Salil K.; Wang, Peng; Hanover, John A.			Conserved Nutrient Sensor O-GlcNAc Transferase Is Integral to C. elegans Pathogen-Specific Immunity	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BETA-CATENIN; SIGNALING PATHWAY; INNATE IMMUNITY; STRESS-RESPONSE; LIFE-SPAN; MODEL; ACTIVATION; GLYCOSYLATION; GLCNACYLATION	Discriminating pathogenic bacteria from bacteria used as a food source is key to Caenorhabidits elegans immunity. Using mutants defective in the enzymes of O-linked N-acetylglucosamine (O-GlcNAc) cycling, we examined the role of this nutrient-sensing pathway in the C. elegans innate immune response. Genetic analysis showed that deletion of O-GlcNAc transferase (ogt-1) yielded animals hypersensitive to the human pathogen S. aureus but not to P. aeruginosa. Genetic interaction studies revealed that nutrient-responsive OGT-1 acts through the conserved beta-catenin (BAR-1) pathway and in concert with p38 MAPK (PMK-1) to modulate the immune response to S. aureus. Moreover, whole genome transcriptional profiling revealed that O-GlcNAc cycling mutants exhibited deregulation of unique stress-and immune-responsive genes. The participation of nutrient sensor OGT-1 in an immunity module evolutionarily conserved from C. elegans to humans reveals an unexplored nexus between nutrient availability and a pathogen-specific immune response.	[Bond, Michelle R.; Hanover, John A.] NIDDK, NIH, Bethesda, MD 20892 USA; [Ghosh, Salil K.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Wang, Peng] Medstar Georgetown Univ Hosp, Dept Pathol, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Food & Drug Administration (FDA); Georgetown University	Hanover, JA (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NIDDK intramural funds (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060103, ZIADK060102, ZIADK060101] Funding Source: NIH RePORTER	NIDDK intramural funds (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK intramural funds (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Bogaerts A, 2010, DEV COMP IMMUNOL, V34, P690, DOI 10.1016/j.dci.2010.02.003; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; BRENNER S, 1974, GENETICS, V77, P71; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Cheung AL, 1998, INFECT IMMUN, V66, P5988, DOI 10.1128/IAI.66.12.5988-5993.1998; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Ha JR, 2014, EXP CELL RES, V321, P153, DOI 10.1016/j.yexcr.2013.11.021; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kneass ZT, 2004, J BIOL CHEM, V279, P45759, DOI 10.1074/jbc.M407911200; Kong C, 2014, BIOL OPEN, V3, P644, DOI 10.1242/bio.20148334; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li JJ, 2012, INT J MOL MED, V30, P157, DOI 10.3892/ijmm.2012.954; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; Natarajan L, 2001, GENETICS, V159, P159; Olivier-Van Stichelen S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.36; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Pattee PA, 1990, GENETIC PHYS MAPPING; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pukkila-Worley R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002733; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Sahu SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038200; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Simonsen KT, 2012, VIRULENCE, V3, P477, DOI 10.4161/viru.21906; Studencka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002940; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sun JR, 2012, EMBO REP, V13, P855, DOI 10.1038/embor.2012.100; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; WANG BB, 1993, CELL, V74, P29, DOI 10.1016/0092-8674(93)90292-X; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	61	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113231	10.1371/journal.pone.0113231	http://dx.doi.org/10.1371/journal.pone.0113231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474640	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500079
J	Bugide, S; David, D; Nair, A; Kannan, N; Samanthapudi, VSK; Prabhakar, J; Manavathi, B				Bugide, S.; David, D.; Nair, A.; Kannan, N.; Samanthapudi, V. S. K.; Prabhakar, J.; Manavathi, B.			Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics	ONCOGENE			English	Article							CALPAIN-MEDIATED PROTEOLYSIS; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; KINASE FAK; MICROTUBULE; CANCER; MOTILITY; SRC; INTEGRINS; SURVIVAL	The scaffolding protein, hematopoietic PBX-interacting protein (HPIP/PBXIP1), regulates cell migration necessary for cancer cell dissemination. However, the mechanism that governs this process remains unknown. We show here that HPIP expression is associated with stages of breast cancer where cell dissemination results in poor patient outcome. Our investigation finds a novel association of HPIP with focal adhesion kinase (FAK) regulating FA dynamics. Interestingly, this interaction that led to activation of FAK protein was mediated by the C-terminal domain of HPIP and not the typical integrin-binding motif. Further, short hairpin RNA-mediated knockdown of FAK expression significantly reduced HPIP-induced cell migration indicating participation of FAK pathway. Live-cell time-lapse imaging and biochemical analysis further established the role of HPIP in microtubule-induced FA disassembly. We also found that HPIP-mediated MAPK activation led to phosphorylation and subsequent activation of calpain2, and the activated calpain2 in turn proteolyses FA protein, talin. Interestingly, HPIP is also proteolysed by calpain2 in breast cancer cells. The proteolysis of HPIP and talin by calpain2, and the activation of calapin2 by HPIP-mediated MAPK phosphorylation, is a novel regulatory axis to modulate the cell migration signal. Together, we have determined HPIP as a novel activator of FAK and a new substrate of calpain2. These molecular interactions between HPIP and FAK, and HPIP and calpain2 regulate cell adhesion and migration through modulation of FA dynamics.	[Bugide, S.; Samanthapudi, V. S. K.; Manavathi, B.] Univ Hyderabad, Sch Life Sci, Dept Biochem, Mol & Cellular Oncol Lab, Hyderabad 500046, Telangana, India; [David, D.; Nair, A.] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India; [Kannan, N.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Prabhakar, J.] Reg Canc Ctr, Thiruvananthapuram, Kerala, India	University of Hyderabad; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); British Columbia Cancer Agency	Manavathi, B (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Mol & Cellular Oncol Lab, Hyderabad 500046, Telangana, India.	manavathibsl@uohyd.ernet.in	Bugide, Suresh/AAD-6053-2022	Manavathi, Bramanandam/0000-0002-1797-398X; Kannan, Nagarajan/0000-0002-8825-2178	Department of Biotechnology (DBT), India [BT/01/IYBA/2009, BT/PR11114/BRB/10/635/2008, BT-BRB-TF-4-2013]; Department of Science and Technology (DST), India [SB/SO/BB/013/2013]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India))	We are grateful to Dr Elaine Fuchs, Rockefeller University, New York, for providing pBABE-FAK, DsRed2-zyxin and pEGFP-paxillin constructs, and Dr Sam Aparicio, British Columbia Cancer Agency, Vancouver, Canada, for providing pGIPz-FAKshRNA clones. This work was supported by Department of Biotechnology (DBT), India Grant Nos: BT/01/IYBA/2009, BT/PR11114/BRB/10/635/2008 and BT-BRB-TF-4-2013, and Department of Science and Technology (DST), Grant Nos: SB/SO/BB/013/2013, India (to BM). SB is Senior Research Fellow, Council for Scientific and Industrial Research, India (CSIR), India. The authors also acknowledge DBT-CREBB, UGC-PURSE, DST-FIST and UOH-SAP-CAS for providing the research facilities at University of Hyderabad.	Abramovich C, 2000, J BIOL CHEM, V275, P26172, DOI 10.1074/jbc.M001323200; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Golubovskaya VM, 2010, ANTI-CANCER AGENT ME, V10, P735; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Manavathi B, 2012, J BIOL CHEM, V287, P5600, DOI 10.1074/jbc.M111.289843; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagano M, 2010, J BIOL CHEM, V285, P21013, DOI 10.1074/jbc.M110.106443; OWENS LV, 1995, CANCER RES, V55, P2752; Panetti TS, 2002, FRONT BIOSCI-LANDMRK, V7, pD143, DOI 10.2741/panetti; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ritt M, 2013, J BIOL CHEM, V288, P8875, DOI 10.1074/jbc.M112.421164; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Scolz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051259; Sieg DJ, 1999, J CELL SCI, V112, P2677; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang XH, 2008, BBA-MOL CELL RES, V1783, P1220, DOI 10.1016/j.bbamcr.2008.01.026; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265	42	22	26	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4601	4612		10.1038/onc.2014.389	http://dx.doi.org/10.1038/onc.2014.389			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25486428				2022-12-26	WOS:000360189300006
J	Hijmans, BS; Tiemann, CA; Grefhorst, A; Boesjes, M; van Dijk, TH; Tietge, UJF; Kuipers, F; van Riel, NAW; Groen, AK; Oosterveer, MH				Hijmans, Brenda S.; Tiemann, Christian A.; Grefhorst, Aldo; Boesjes, Marije; van Dijk, Theo H.; Tietge, Uwe J. F.; Kuipers, Folkert; van Riel, Natal A. W.; Groen, Albert K.; Oosterveer, Maaike H.			A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation	FASEB JOURNAL			English	Article						computational modeling; T0901317; fatty liver; FFA flux; VLDL metabolism	FATTY-ACIDS; LXR-ALPHA; LIPID-ACCUMULATION; SIGNALING PATHWAYS; TRANSFER PROTEIN; PLASMA; CHOLESTEROL; METABOLISM; GAMMA; HEPATOBILIARY	Liver X receptor (LXR) agonists exert potent antiatherosclerotic actions but simultaneously induce excessive triglyceride (TG) accumulation in the liver. To obtain a detailed insight into the underlying mechanism of hepatic TG accumulation, we used a novel computational modeling approach called analysis of dynamic adaptations in parameter trajectories (ADAPT). We revealed that both input and output fluxes to hepatic TG content are considerably induced on LXR activation and that in the early phase of LXR agonism, hepatic steatosis results from only a minor imbalance between the two. It is generally believed that LXR-induced hepatic steatosis results from increased de novo lipogenesis (DNL). In contrast, ADAPT predicted that the hepatic influx of free fatty acids is the major contributor to hepatic TG accumulation in the early phase of LXR activation. Qualitative validation of this prediction showed a 5-fold increase in the contribution of plasma palmitate to hepatic monounsaturated fatty acids on acute LXR activation, whereas DNL was not yet significantly increased. This study illustrates that complex effects of pharmacological intervention can be translated into distinct patterns of metabolic regulation through state-of-the-art mathematical modeling.	[Hijmans, Brenda S.; Boesjes, Marije; Tietge, Uwe J. F.; Kuipers, Folkert; Groen, Albert K.; Oosterveer, Maaike H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [van Dijk, Theo H.; Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Tiemann, Christian A.; van Riel, Natal A. W.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Tiemann, Christian A.; van Riel, Natal A. W.; Groen, Albert K.] Univ Amsterdam, Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Grefhorst, Aldo] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Groen, Albert K.] Univ Groningen, Groningen Ctr Syst Biol, Groningen, Netherlands	University of Groningen; University of Groningen; Eindhoven University of Technology; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Oosterveer, MH (corresponding author), Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Pediat Lab, POB 30-001, NL-9700 RB Groningen, Netherlands.	m.h.oosterveer@umcg.nl	oosterveer, maaike h/C-3374-2013; van Riel, Natal/J-5319-2013	van Riel, Natal/0000-0001-9375-4730; Kuipers, Folkert/0000-0003-2518-737X	Top Institute Pharma [T2-110]; European Union, FP7-HEALTH [305707]; Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation	Top Institute Pharma; European Union, FP7-HEALTH; Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	The authors thank Y. Paalvast for contributions to the revision of this manuscript. The authors thank V. W. Bloks, H. Havinga, and T. Bos for scientific discussion and excellent technical assistance. This research was funded by Top Institute Pharma (Grant T2-110) and the European Union, FP7-HEALTH (Grant 305707) and performed within the framework of the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (Grant 01C-104), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation, and Dutch Kidney Foundation. Ppar gamma<SUP>hep-/-</SUP> mice were kindly provided by Dr. J. W. Jonker (University Medical Center Groningen).	Archer A, 2014, AM J PHYSIOL-ENDOC M, V306, pE494, DOI 10.1152/ajpendo.00410.2013; Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Dib L, 2014, J LIPID RES, V55, P247, DOI 10.1194/jlr.M043422; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; DURAN M, 1988, CLIN CHEM, V34, P548; ELOVSON J, 1988, J LIPID RES, V29, P1461; FIDGE NH, 1974, CLIN CHIM ACTA, V52, P15, DOI 10.1016/0009-8981(74)90383-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRASER R, 1970, J LIPID RES, V11, P60; Gao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065641; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HELLERSTEIN MK, 1992, AM J PHYSIOL, V263, pE988; HOVING EB, 1988, J CHROMATOGR-BIOMED, V434, P395, DOI 10.1016/S0378-4347(88)80006-9; Hultin M, 1996, J LIPID RES, V37, P1022; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang XC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1634, DOI 10.2741/jiang1; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Macfarlane DP, 2011, AM J PHYSIOL-ENDOC M, V300, pE402, DOI 10.1152/ajpendo.00331.2010; Martins IJ, 1996, J LIPID RES, V37, P2696; Matsusue K, 2014, FEBS LETT, V588, P2277, DOI 10.1016/j.febslet.2014.05.012; MUSKIET FAJ, 1983, J CHROMATOGR, V278, P231, DOI 10.1016/S0378-4347(00)84782-9; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Oosterveer MH, 2010, PROG LIPID RES, V49, P343, DOI 10.1016/j.plipres.2010.03.002; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Peng DC, 2010, ATHEROSCLEROSIS, V208, P126, DOI 10.1016/j.atherosclerosis.2009.07.016; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Plosch T, 2006, AM J PHYSIOL-GASTR L, V291, pG414, DOI 10.1152/ajpgi.00557.2005; Quinet EM, 2009, J LIPID RES, V50, P2358, DOI 10.1194/jlr.M900037-JLR200; Rao R, 1997, BIOCHEMISTRY-US, V36, P3645, DOI 10.1021/bi962776b; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shetty S, 2012, ENDOCRINOLOGY, V153, P113, DOI 10.1210/en.2011-1339; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Takazawa T, 2009, J BIOL CHEM, V284, P30049, DOI 10.1074/jbc.M109.047993; Tao H, 2010, AM J PHYSIOL-ENDOC M, V298, pE68, DOI 10.1152/ajpendo.00367.2009; Tiemann CA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003166; Tiemann CA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-174; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Torres DM, 2012, SEMIN LIVER DIS, V32, P30, DOI 10.1055/s-0032-1306424; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; Weedon-Fekjaer MS, 2010, J LIPID RES, V51, P1886, DOI 10.1194/jlr.M004978; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200	53	18	18	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1153	1164		10.1096/fj.14-254656	http://dx.doi.org/10.1096/fj.14-254656			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25477282	Green Submitted			2022-12-26	WOS:000354115000005
J	Overstreet, JM; Samarakoon, R; Cardona-Grau, D; Goldschmeding, R; Higgins, PJ				Overstreet, Jessica M.; Samarakoon, Rohan; Cardona-Grau, Diana; Goldschmeding, Roel; Higgins, Paul J.			Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-beta 1 in orchestrating profibrotic responses	FASEB JOURNAL			English	Article						kidney fibrosis; p53; ROS; NOX	URETERAL OBSTRUCTION; TARGET GENES; LUNG INJURY; FIBROSIS; ACTIVATION; SMAD; P53; MECHANISMS; REQUIRES; DISEASE	Effective therapy to prevent organ fibrosis, which is associated with more than half of all mortalities, remains elusive. Involvement of tumor suppressor ataxia telangiectasia mutated (ATM) in the TGF-beta 1 pathway related to renal fibrosis is largely unknown. ATM activation (pATM(Ser1981)) increased 4-fold in the tubulointerstitial region of the unilateral ureteral obstruction-injured kidney in mice correlating with SMAD3 and p53(Ser15) phosphorylation and elevated levels of p22(phox) subunit of the NADPH oxidases (NOXs), and fibrotic markers, plasminogen activator inhibitor-1 (PAI-1), and fibronectin, when compared to contralateral (contra) or sham controls. In fact, ATM is rapidly phosphorylated at Ser(1981) by TGF-beta 1 stimulation. Stable silencing and pharmacologic inhibition of ATM ablated TGF-beta 1-induced p53 activation (>95%) and subsequent PAI-1, fibronectin, connective tissue growth factor, and p21 expression in human kidney 2 (HK-2) tubular epithelial cells and normal rat kidney-49 fibroblasts (NRK-49F). ATM or p53 depletion in HK-2 cells, moreover, bypassed TGF-beta 1-mediated cytostasis evident in control short hairpin RNA-expressing HK-2 cells. Interestingly, stable silencing of NOX subunits, p22(phox) and p47(phox), in HK-2 cells blocked TGF-beta 1-induced pATM(Ser1981) (>90%) and target gene induction via p53-dependent mechanisms. Furthermore, NRK-49F fibroblast proliferation triggered by conditioned media from TGF-beta 1-stimulated, control vector-transfected HK-2 cells decreased (similar to 50%) when exposed to conditioned media from ATM-deficient, TGF-beta 1-treated HK-2 cells. Thus, TGF-b1 promotes NOX-dependent ATM activation leading to p53-mediated fibrotic gene reprogramming and growth arrest in HK-2 cells. Furthermore, TGF-beta 1/ATM-initiated paracrine factor secretion by dysfunctional renal epithelium promotes interstitial fibroblast growth, suggesting a role of tubular ATM in mediating epithelial-mesenchymal cross-talk highlighting the translational benefit of targeting the NOX/ATM/p53 axis in renal fibrosis.	[Overstreet, Jessica M.; Samarakoon, Rohan; Higgins, Paul J.] Albany Med Coll, Ctr Cell Biol & Canc Res, 47 New Scotland Ave, Albany, NY 12208 USA; [Cardona-Grau, Diana] Albany Med Coll, Div Urol, Albany, NY 12208 USA; [Goldschmeding, Roel] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Albany Medical College; Utrecht University; Utrecht University Medical Center	Higgins, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, 47 New Scotland Ave, Albany, NY 12208 USA.	higginp@mail.amc.edu			U.S. National Institutes of Health National Institute of General Medical Sciences Grant [GM057242]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of General Medical Sciences Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health National Institute of General Medical Sciences Grant GM057242 (to P.J.H.). J.M.O., R.S., and P.J.H. conceived and designed the experiments. J.M.O., R.S., and D.C.-G. performed the experiments. J.M.O. and R.S. analyzed the data. R.G. contributed key reagents/materials. J.M.O., R.S., and P.J.H. wrote the paper. The authors declare no conflicts of interest.	Anglicheau D, 2012, TRANSPLANTATION, V93, P1136, DOI 10.1097/TP.0b013e31824ef181; Aoshiba K, 2013, EXP TOXICOL PATHOL, V65, P1053, DOI 10.1016/j.etp.2013.04.001; Boder E, 1985, Kroc Found Ser, V19, P1; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Kortlever RM, 2008, J BIOL CHEM, V283, P24308, DOI 10.1074/jbc.M803341200; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee Chun Geun, 2006, Proc Am Thorac Soc, V3, P418, DOI 10.1513/pats.200602-017AW; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ying Y, 2014, J AM SOC NEPHROL, V25, P2707, DOI 10.1681/ASN.2013121270; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902; Zieg J, 2011, NEPHROLOGY, V16, P595, DOI 10.1111/j.1440-1797.2011.01459.x	28	24	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1258	1268		10.1096/fj.14-262527	http://dx.doi.org/10.1096/fj.14-262527			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25480384	Green Published			2022-12-26	WOS:000354115000014
J	Zulliger, R; Naash, MI; Rajala, RVS; Molday, RS; Azadi, S				Zulliger, Rahel; Naash, Muna I.; Rajala, Raju V. S.; Molday, Robert S.; Azadi, Seifollah			Impaired Association of Retinal Degeneration-3 with Guanylate Cyclase-1 and Guanylate Cyclase-activating Protein-1 Leads to Leber Congenital Amaurosis-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR CELLS; GENETIC-HETEROGENEITY; RETINITIS-PIGMENTOSA; MUTATION ANALYSIS; TRAFFICKING; ROD; LOCALIZATION; SEGMENTS; BINDING; MODEL	One-fifth of all cases of Leber congenital amaurosis are type 1 (LCA1). LCA1 is a severe form of retinal dystrophy caused by loss-of-function mutations in guanylate cyclase 1 (GC1), a key member of the phototransduction cascade involved in modulating the photocurrents. Although GC1 has been studied for some time, the mechanisms responsible for its regulation and membrane targeting are not fully understood. We reported earlier that retinal degeneration 3 (RD3) protein interacts with GC1 and promotes its targeting to the photoreceptor outer segments (POS). Here, we extend our studies to show a direct association between RD3 and guanylate cyclase activating protein 1 (GCAP1). Furthermore, we demonstrate that this functional interaction is important for GC1 targeting to POS. We also show that most LCA1-causing mutations in GC1 result in lost GC1 interaction with RD3 or GC1 being targeted to the plasma membrane. Our data suggest that GC1, GCAP1, and RD3 form a complex in the endoplasmic reticulum that targets GC1 to POS. Interruption of this assembly is likely the underlying mechanism for a subset of LCA1. This study offers insights for the development of therapeutic strategies to treat this severe form of blindness.	[Zulliger, Rahel; Naash, Muna I.; Rajala, Raju V. S.; Azadi, Seifollah] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.; Azadi, Seifollah] Dean McGee Eye Inst, Oklahoma City, OK 73104 USA; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of British Columbia	Azadi, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	sazadi@ouhsc.edu			National Institutes of Health from NEI [EY010609, EY000871]; Knights Templar Eye Foundation [C5067001, C5067002]; NATIONAL EYE INSTITUTE [R56EY010609, R01EY010609, R55EY010609, R01EY002422, R01EY000871] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants EY010609 (to M. I. N.) and EY000871 (to R. R.) from NEI. This work was also supported by was supported by Knights Templar Eye Foundation Grants C5067001 and C5067002 (to S. A.).	Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Chen YB, 2013, INVEST OPHTH VIS SCI, V54, P4351, DOI 10.1167/iovs.13-11606; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deretic D, 1998, EYE, V12, P526, DOI 10.1038/eye.1998.141; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Duda T, 1999, BIOCHEMISTRY-US, V38, P509, DOI 10.1021/bi9824137; Duda T, 2002, MOL CELL BIOCHEM, V230, P129, DOI 10.1023/A:1014296124514; El-Shanti H, 1999, J MED GENET, V36, P862; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; GARBERS DL, 1988, COLD SPRING HARB SYM, V53, P993, DOI 10.1101/SQB.1988.053.01.114; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; KAPLAN J, 1990, HUM GENET, V85, P635; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Koch KW, 2002, ADV EXP MED BIOL, V514, P349; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Lu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078274; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Perrault Isabelle, 2005, Hum Mutat, V25, P222, DOI 10.1002/humu.9304; Perrault I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051622; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Sokal I, 1999, BIOCHEMISTRY-US, V38, P1387, DOI 10.1021/bi982512k; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Tucker CL, 2004, MOL VIS, V10, P297; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	45	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3488	3499		10.1074/jbc.M114.616656	http://dx.doi.org/10.1074/jbc.M114.616656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25477517	hybrid, Green Published			2022-12-26	WOS:000349456000023
J	Hong, KW; Jeong, SW; Chung, M; Cho, SB				Hong, Kyung-Won; Jeong, Seok Won; Chung, Myungguen; Cho, Seong Beom			Association between Expression Quantitative Trait Loci and Metabolic Traits in Two Korean Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIPOPROTEIN-LIPASE GENE; BLOOD-PRESSURE; HERITABILITY; DISEASE; RISK; SNPS	Most genome-wide association studies consider genes that are located closest to single nucleotide polymorphisms (SNPs) that are highly significant for those studies. However, the significance of the associations between SNPs and candidate genes has not been fully determined. An alternative approach that used SNPs in expression quantitative trait loci (eQTL) was reported previously for Crohn's disease; it was shown that eQTL-based preselection for follow-up studies was a useful approach for identifying risk loci from the results of moderately sized GWAS. In this study, we propose an approach that uses eQTL SNPs to support the functional relationships between an SNP and a candidate gene in a genome-wide association study. The genome-wide SNP genotypes and 10 biochemical measures (fasting glucose levels, BUN, serum albumin levels, AST, ALT, gamma GTP, total cholesterol, HDL cholesterol, triglycerides, and LDL cholesterol) were obtained from the Korean Association Resource (KARE) consortium. The eQTL SNPs were isolated from the SNP dataset based on the RegulomeDB eQTL-SNP data from the ENCODE projects and two recent eQTL reports. A total of 25,658 eQTL SNPs were tested for their association with the 10 metabolic traits in 2 Korean populations (Ansung and Ansan). The proportion of phenotypic variance explained by eQTL and non-eQTL SNPs showed that eQTL SNPs were more likely to be associated with the metabolic traits genetically compared with non-eQTL SNPs. Finally, via a meta-analysis of the two Korean populations, we identified 14 eQTL SNPs that were significantly associated with metabolic traits. These results suggest that our approach can be expanded to other genome-wide association studies.	[Hong, Kyung-Won; Jeong, Seok Won; Chung, Myungguen; Cho, Seong Beom] KCDC, Natl Inst Hlth, Ctr Genome Sci, Div Biomed Informat, Cheongwon Gun, South Korea; [Chung, Myungguen] Hanyang Univ, Div Mol & Life Sci, Seoul 133791, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Hanyang University	Cho, SB (corresponding author), KCDC, Natl Inst Hlth, Ctr Genome Sci, Div Biomed Informat, Cheongwon Gun, South Korea.	sbcho@korea.kr			Korean Genome Analysis Project [4845-301, 2013-NG72001-00]; Korean Biobank Project [4851-307, KBP-2013-000]; Center for Disease Control and Prevention, Republic of Korea	Korean Genome Analysis Project; Korean Biobank Project; Center for Disease Control and Prevention, Republic of Korea	The genotypes and epidemiological traits were provided with biospecimens and data from Korean Genome Analysis Project (4845-301, 2013-NG72001-00), the Korean Genome and Epidemiology Study (4851-302), and the Korean Biobank Project (4851-307, KBP-2013-000). These were supported by the Center for Disease Control and Prevention, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cheng Hsing-Hsien, 1999, Acta Paediatrica Sinica, V40, P225; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; GILLARD BK, 1989, J IMMUNOL, V142, P3826; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Hong KW, 2011, J HUM GENET, V56, P205, DOI 10.1038/jhg.2010.167; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Jee SH, 2002, YONSEI MED J, V43, P160, DOI 10.3349/ymj.2002.43.2.160; Jee Sun Ha, 2005, Korean Circulation Journal, V35, P233; Kang TW, 2010, HUM MOL GENET, V19, P3672, DOI 10.1093/hmg/ddq281; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Ko KP, 2011, ANN EPIDEMIOL, V21, P42, DOI 10.1016/j.annepidem.2010.10.006; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Liang LM, 2013, GENOME RES, V23, P716, DOI 10.1101/gr.142521.112; Lippi G, 2008, INTERNAL MED, V47, P705, DOI 10.2169/internalmedicine.47.0810; Maglione V, 2010, J NEUROSCI, V30, P4072, DOI 10.1523/JNEUROSCI.6348-09.2010; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rueedi R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004132; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schrimpe-Rutledge AC, 2012, J PROTEOME RES, V11, P3520, DOI 10.1021/pr3002996; Sung J, 2009, J CLIN ENDOCR METAB, V94, P4946, DOI 10.1210/jc.2009-1268; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang XL, 2014, J MED GENET, V51, P319, DOI 10.1136/jmedgenet-2013-102045; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Williams SM, 2011, ANN HUM GENET, V75, P348, DOI 10.1111/j.1469-1809.2011.00640.x; Wung SF, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-19; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114128	10.1371/journal.pone.0114128	http://dx.doi.org/10.1371/journal.pone.0114128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493549	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400032
J	Daniel, J; Sirakova, T; Kolattukudy, P				Daniel, Jaiyanth; Sirakova, Tatiana; Kolattukudy, Pappachan			An Acyl-CoA Synthetase in Mycobacterium tuberculosis Involved in Triacylglycerol Accumulation during Dormancy	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; TRANSPORT; ACTIVATION; PREFERENCE; PROTEINS; INSIGHTS; REVEALS; CLONING; FAMILY	Latent infection with dormant Mycobacterium tuberculosis is one of the major reasons behind the emergence of drug-resistant strains of the pathogen worldwide. In its dormant state, the pathogen accumulates lipid droplets containing triacylglycerol synthesized from fatty acids derived from host lipids. In this study, we show that Rv1206 (FACL6), which is annotated as an acyl-CoA synthetase and resembles eukaryotic fatty acid transport proteins, is able to stimulate fatty acid uptake in E. coli cells. We show that purified FACL6 displays acyl-coenzyme A synthetase activity with a preference towards oleic acid, which is one of the predominant fatty acids in host lipids. Our results indicate that the expression of FACL6 protein in Mycobacterium tuberculosis is significantly increased during in vitro dormancy. The facl6-deficient Mycobacterium tuberculosis mutant displayed a diminished ability to synthesize acyl-coenzyme A in cell-free extracts. Furthermore, during in vitro dormancy, the mutant synthesized lower levels of intracellular triacylglycerol from exogenous fatty acids. Complementation partially restored the lost function. Our results suggest that FACL6 modulates triacylglycerol accumulation as the pathogen enters dormancy by activating fatty acids.	[Daniel, Jaiyanth; Sirakova, Tatiana; Kolattukudy, Pappachan] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Daniel, Jaiyanth] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA	State University System of Florida; University of Central Florida; Purdue University System; Indiana University Purdue University Fort Wayne	Daniel, J (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	danielj@ipfw.edu		Daniel, Jaiyanth/0000-0002-3605-687X	National Institutes of Health [AI46582, AI35272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035272, R01AI046582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI46582 and AI35272 from the National Institutes of Health to PK. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; Dirusso CC, 2008, BBA-MOL CELL BIOL L, V1781, P135, DOI 10.1016/j.bbalip.2008.01.002; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; GINSBURGH CL, 1984, J BIOL CHEM, V259, P8437; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Melton EM, 2013, BIOCHEM BIOPH RES CO, V440, P743, DOI 10.1016/j.bbrc.2013.09.137; Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Sirakova TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051641; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	41	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114877	10.1371/journal.pone.0114877	http://dx.doi.org/10.1371/journal.pone.0114877			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490545	Green Published, gold			2022-12-26	WOS:000347515300089
J	Jia, XH; Zhou, XH; Luo, YQ; Xue, K; Xue, X; Xu, X; Yang, YH; Wu, LY; Zhou, JZ				Jia, Xiaohong; Zhou, Xuhui; Luo, Yiqi; Xue, Kai; Xue, Xian; Xu, Xia; Yang, Yuanhe; Wu, Liyou; Zhou, Jizhong			Effects of Substrate Addition on Soil Respiratory Carbon Release Under Long-Term Warming and Clipping in a Tallgrass Prairie	PLOS ONE			English	Article							CYCLE FEEDBACK; NITROGEN MINERALIZATION; INTERANNUAL VARIABILITY; LITTER DECOMPOSITION; ORGANIC-CARBON; CLIMATE; TEMPERATURE; RESPONSES; BIOMASS; LABILE	Regulatory mechanisms of soil respiratory carbon (C) release induced by substrates (i.e., plant derived substrates) are critical for predicting ecosystem responses to climate change, but the mechanisms are not well understood. In this study, we sampled soils from a long-term field manipulative experiment and conducted a laboratory incubation to explore the role of substrate supply in regulating the differences in soil C release among the experimental treatments, including control, warming, clipping, and warming plus clipping. Three types of substrates (glucose, C-3 and C-4 plant materials) were added with an amount equal to 1% of soil dry weight under the four treatments. We found that the addition of all three substrates significantly stimulated soil respiratory C release in all four warming and clipping treatments. In soils without substrate addition, warming significantly stimulated soil C release but clipping decreased it. However, additions of glucose and C-3 plant materials (C-3 addition) offset the warming effects, whereas C-4 addition still showed the warming-induced stimulation of soil C release. Our results suggest that long-term warming may inhibit microbial capacity for decomposition of C-3 litter but may enhance it for decomposition of C-4 litter. Such warming-induced adaptation of microbial communities may weaken the positive C-cycle feedback to warming due to increased proportion of C-4 species in plant community and decreased litter quality. In contrast, clipping may weaken microbial capacity for warming-induced decomposition of C-4 litter but may enhance it for C-3 litter. Warming- and clipping-induced shifts in microbial metabolic capacity may be strongly associated with changes in plant species composition and could substantially influence soil C dynamics in response to global change.	[Jia, Xiaohong] Chinese Acad Forestry, Inst Desertificat Studies, Beijing 100091, Peoples R China; [Jia, Xiaohong; Xue, Xian] Chinese Acad Sci, Cold & Arid Regions Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou 730000, Peoples R China; [Jia, Xiaohong; Luo, Yiqi; Xue, Kai; Xue, Xian; Xu, Xia; Yang, Yuanhe; Wu, Liyou; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Xuhui] Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn,Minist Educ, Shanghai 200433, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University of Oklahoma System; University of Oklahoma - Norman; Fudan University	Zhou, XH (corresponding author), Fudan Univ, Inst Biodivers Sci, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn,Minist Educ, Shanghai 200433, Peoples R China.	zxuhui14@fudan.edu.cn	Zhou, Xuhui/H-4332-2011; 吴, 昊/AAB-1620-2020; Yang, Yuanhe/D-1448-2011; Zhou, Xuhui/O-5727-2019	Zhou, Xuhui/0000-0002-2038-9901; Xue, Kai/0000-0002-5990-4448	Chinese National Natural Science Foundation [41171077, 31370489, 40801002, 41371093, 41471096]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Pujiang Program [12PJ1401400]; "Thousand Young Talents" Program in China; US National Science Foundation (NSF) [DEB 0078325, DEB 0743778]; Terrestrial Carbon Program at the Office of Science (BER); Department of Energy [DEFG02-006ER64319]; Midwestern Regional Center of the National Institute for Climatic Change Research (NICCR) at Michigan Technological University [DE-FC02-06ER64158]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Pujiang Program; "Thousand Young Talents" Program in China; US National Science Foundation (NSF)(National Science Foundation (NSF)); Terrestrial Carbon Program at the Office of Science (BER)(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Midwestern Regional Center of the National Institute for Climatic Change Research (NICCR) at Michigan Technological University	This study was financially supported by the Chinese National Natural Science Foundation (41171077, 31370489, 40801002, 41371093, and 41471096), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, 2012 Shanghai Pujiang Program (12PJ1401400), and the "Thousand Young Talents" Program in China, as well as the US National Science Foundation (NSF) under DEB 0078325 and DEB 0743778, by the Terrestrial Carbon Program at the Office of Science (BER), the Department of Energy (Grants No.: DEFG02-006ER64319), and the Midwestern Regional Center of the National Institute for Climatic Change Research (NICCR) at Michigan Technological University under Award No.: DE-FC02-06ER64158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADU JK, 1978, SOIL BIOL BIOCHEM, V10, P117, DOI 10.1016/0038-0717(78)90081-0; Agren GI, 2000, AMBIO, V29, P55, DOI 10.1639/0044-7447(2000)029[0055:TDOOSO]2.0.CO;2; Alef K., 1995, METHODS APPL SOIL MI, P214, DOI [10.1016/B978-012513840-6/50020-3, DOI 10.1016/B978-012513840-6/50020-3]; Ayres E, 2006, SOIL BIOL BIOCHEM, V38, P183, DOI 10.1016/j.soilbio.2005.04.018; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; Billings SA, 2013, GLOBAL CHANGE BIOL, V19, P90, DOI 10.1111/gcb.12029; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conen F, 2006, BIOGEOSCIENCES, V3, P515, DOI 10.5194/bg-3-515-2006; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dalias P, 2001, SOIL BIOL BIOCHEM, V33, P1049, DOI 10.1016/S0038-0717(01)00009-8; Edenhofer O., 2014, CONTRIBUTION WORKING; Eliasson PE, 2005, GLOBAL CHANGE BIOL, V11, P167, DOI 10.1111/j.1365-2486.2004.00878.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Franzluebbers AJ, 2001, SOIL BIOL BIOCHEM, V33, P1103, DOI 10.1016/S0038-0717(01)00016-5; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Glinski J., 1985, Soil aeration and its role for plants.; Gray T. R. G., 1976, Symposium, Society for General Microbiology, P327; GRAY T. R. G., 1971, Microbial productivity in soil., P255; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Ito A, 2002, ECOL MODEL, V151, P143, DOI 10.1016/S0304-3800(01)00473-2; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; Jenny H., 1980, The soil resource.; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MATIN A, 1992, J APPL BACTERIOL, V73, pS49, DOI 10.1111/j.1365-2672.1992.tb03624.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Mertens S, 2001, ECOSYSTEMS, V4, P226, DOI 10.1007/s10021-001-0006-3; NEELY CL, 1991, SOIL BIOL BIOCHEM, V23, P947, DOI 10.1016/0038-0717(91)90175-J; Nguyen C, 2001, SOIL BIOL BIOCHEM, V33, P53, DOI 10.1016/S0038-0717(00)00114-0; Niu SL, 2010, ECOLOGY, V91, P3261, DOI 10.1890/09-1634.1; PAJARI B, 1995, PLANT SOIL, V168, P563, DOI 10.1007/BF00029369; Paul EA, 1998, ASSESSMENT METHODS S, P193; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; SAKAMOTO K, 1994, BIOL FERT SOILS, V17, P39, DOI 10.1007/BF00418670; Saleska SR, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001573; SCHLESER GH, 1982, Z NATURFORSCH A, V37, P287, DOI 10.1515/zna-1982-0316; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Sorensen PL, 2008, SOIL BIOL BIOCHEM, V40, P2344, DOI 10.1016/j.soilbio.2008.05.013; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; USDA, 1979, SOIL SURV MCCLAIN CO; Waldrop MP, 2004, BIOGEOCHEMISTRY, V67, P235, DOI 10.1023/B:BIOG.0000015321.51462.41; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Xia JY, 2013, GLOBAL CHANGE BIOL, V19, P2104, DOI 10.1111/gcb.12172; Xu X, 2012, GLOBAL CHANGE BIOL, V18, P1648, DOI 10.1111/j.1365-2486.2012.02651.x; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Ziegler SE, 2013, SOIL BIOL BIOCHEM, V60, P23, DOI 10.1016/j.soilbio.2013.01.001; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	60	4	5	6	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114203	10.1371/journal.pone.0114203	http://dx.doi.org/10.1371/journal.pone.0114203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490701	gold, Green Published			2022-12-26	WOS:000347515300020
J	Wan, XG; Cruts, B; Jensen, HJ				Wan, Xiaogeng; Cruts, Bjorn; Jensen, Henrik Jeldtoft			The Causal Inference of Cortical Neural Networks during Music Improvisations	PLOS ONE			English	Article							GENERATION	We present an EEG study of two music improvisation experiments. Professional musicians with high level of improvisation skills were asked to perform music either according to notes (composed music) or in improvisation. Each piece of music was performed in two different modes: strict mode and "let-go" mode. Synchronized EEG data was measured from both musicians and listeners. We used one of the most reliable causality measures: conditional Mutual Information from Mixed Embedding (MIME), to analyze directed correlations between different EEG channels, which was combined with network theory to construct both intra-brain and cross-brain networks. Differences were identified in intra-brain neural networks between composed music and improvisation and between strict mode and "let-go" mode. Particular brain regions such as frontal, parietal and temporal regions were found to play a key role in differentiating the brain activities between different playing conditions. By comparing the level of degree centralities in intra-brain neural networks, we found a difference between the response of musicians and the listeners when comparing the different playing conditions.	[Wan, Xiaogeng; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Wan, Xiaogeng; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Ctr Complex Sci, London, England; [Cruts, Bjorn] Brainmarker BV, Gulpen, Netherlands	Imperial College London; Imperial College London	Jensen, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	h.jensen@imperial.ac.uk						Babiloni C, 2011, CORTEX, V47, P1082, DOI 10.1016/j.cortex.2011.05.006; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Beudel M, 2009, CEREB CORTEX, V19; Bhattacharya J, 2005, SIGNAL PROCESS, V85; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Cruts B, 2012, REPORT STAT ANAL EEG; de Manzano O, 2012, NEUROIMAGE, V63, P272, DOI 10.1016/j.neuroimage.2012.06.024; de Manzano O, 2012, NEUROIMAGE, V59, P772, DOI 10.1016/j.neuroimage.2011.07.016; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Dolan David., 2013, MUSIC PERFORMANCE RE, V6, P1; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Hennig H, 2012, PHYS TODAY, V65, P64, DOI 10.1063/PT.3.1650; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; Kawasaki M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01692; Larson MG, 2008, CIRCULATION, V117, P115, DOI 10.1161/CIRCULATIONAHA.107.654335; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Takahashi DY, 2010, BIOL CYBERN, V103, P463, DOI 10.1007/s00422-010-0410-x; Takahashi DY, 2010, 32 ANN INT C IEEE EM; Vlachos I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016207; Vuust P, 2000, POLYRYTMIK OGMETRIK; Vuust P., 2008, COGN SEMIOT, V2008, P134, DOI [10.3726/81606_134, DOI 10.3726/81606_134]	29	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e112776	10.1371/journal.pone.0112776	http://dx.doi.org/10.1371/journal.pone.0112776			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489852	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300003
J	Haggar, FA; Pereira, G; Preen, D; Holman, CD; Einarsdottir, K				Haggar, Fatima A.; Pereira, Gavin; Preen, David; Holman, C. D'Arcy; Einarsdottir, Kristjana			Adverse Obstetric and Perinatal Outcomes following Treatment of Adolescent and Young Adult Cancer: A Population-Based Cohort Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHILDHOOD-CANCER; PREGNANCY OUTCOMES; REPRODUCTIVE OUTCOMES; PLACENTAL ABRUPTION; FEMALE SURVIVORS; PRETERM BIRTH; WILMS-TUMOR; FERTILITY	Objective: To investigate obstetric and perinatal outcomes among female survivors of adolescent and young adult (AYA) cancers and their offspring. Methods: Using multivariate analysis of statewide linked data, outcomes of all first completed pregnancies (n=1894) in female survivors of AYA cancer diagnosed in Western Australia during the period 1982-2007 were compared with those among females with no cancer history. Comparison pregnancies were matched by maternal age-group, parity and year of delivery. Results: Compared with the non-cancer group, female survivors of AYA cancer had an increased risk of threatened abortion (adjusted relative risk 2.09, 95% confidence interval 1.51-2.74), gestational diabetes (2.65, 2.08-3.57), pre-eclampsia (1.32, 1.04-1.87), post-partum hemorrhage (2.83, 1.92-4.67), cesarean delivery (2.62, 2.22-3.04), and maternal postpartum hospitalization >5 days (3.01, 1.72-5.58), but no excess risk of threatened preterm delivery, antepartum hemorrhage, premature rupture of membranes, failure of labor to progress or retained placenta. Their offspring had an increased risk of premature birth (<37 weeks: 1.68, 1.21-2.08), low birth weight (<2500 g: 1.51, 1.23-2.12), fetal growth restriction (3.27, 2.45-4.56), and neonatal distress indicated by low Apgar score (<7) at 1 minute (2.83, 2.28-3.56), need for resuscitation (1.66, 1.27-2.19) or special care nursery admission (1.44, 1.13-1.78). Congenital abnormalities and perinatal deaths (intrauterine or <= 7 days of birth) were not increased among offspring of survivors. Conclusion: Female survivors of AYA cancer have moderate excess risks of adverse obstetric and perinatal outcomes arising from subsequent pregnancies that may require additional surveillance or intervention.	[Haggar, Fatima A.] Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada; [Haggar, Fatima A.; Preen, David; Holman, C. D'Arcy] Univ Western Australia, Sch Populat Hlth, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [Pereira, Gavin; Einarsdottir, Kristjana] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Pereira, Gavin] Yale Univ, Sch Med, Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA	University of Ottawa; Ottawa Hospital Research Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia; Yale University	Haggar, FA (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Dept Surg, Ottawa, ON, Canada.	fhaggar@toh.on.ca	Pereira, Gavin/D-7136-2014; Einarsdóttir, Kristjana/E-8337-2011; Preen, David/H-5663-2014	Pereira, Gavin/0000-0003-3740-8117; Einarsdóttir, Kristjana/0000-0003-4931-7650; Preen, David/0000-0002-2982-2169	Cancer Council Western Australia; University of Western Australia; NHMRC Early Career Fellowship grant [1052236]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Cancer Council Western Australia(Cancer Council Western Australia); University of Western Australia; NHMRC Early Career Fellowship grant(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Cancer Council Western Australia and The University of Western Australia. GP received funding from a NHMRC Early Career Fellowship grant 1052236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Ananth CV, 1999, JAMA-J AM MED ASSOC, V282, P1646, DOI 10.1001/jama.282.17.1646; Apgar V, CURR RES ANESTH ANAL, V1, P260; Australian Bureau of Statistics, 2010, BIRTHS AUSTR 2009; Australian Bureau of Statistics, 2006, DROP; Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335; Barr RD, 2011, CANCER-AM CANCER SOC, V117, P2245, DOI 10.1002/cncr.26052; Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Blumenfeld Z, 1999, J SOC GYNECOL INVEST, V6, P229, DOI 10.1016/S1071-5576(99)00028-3; Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; BYRNE J, 1988, MED PEDIATR ONCOL, V16, P233, DOI 10.1002/mpo.2950160403; Chiarelli AM, 2000, EPIDEMIOLOGY, V11, P161, DOI 10.1097/00001648-200003000-00013; Chiarelli AM, 1996, AM J EPIDEMIOL, V143, P83; Chow SM, 2004, INT J RADIAT ONCOL, V59, P992, DOI 10.1016/j.ijrobp.2003.12.023; Clark H, 2007, OBSTET GYNECOL, V110, P849, DOI 10.1097/01.AOG.0000284458.53303.1c; Critchley Hilary O D, 2005, J Natl Cancer Inst Monogr, P64; Critchley Hilary O D, 2002, Hum Fertil (Camb), V5, P61, DOI 10.1080/1464727022000198942; Diehl V, 2003, NEW ENGL J MED, V348, P2386, DOI 10.1056/NEJMoa022473; Garcia-Enguidanos A, 2002, EUR J OBSTET GYN R B, V102, P111, DOI 10.1016/S0301-2115(01)00613-3; GLODE LM, 1981, LANCET, V1, P1132; Green DM, 2010, J CLIN ONCOL, V28, P2824, DOI 10.1200/JCO.2009.27.2922; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; GREEN DM, 1989, CANCER-AM CANCER SOC, V64, P2335, DOI 10.1002/1097-0142(19891201)64:11<2335::AID-CNCR2820641124>3.0.CO;2-7; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Green DN, 2002, AM J OBSTET GYNECOL, V187, P1070, DOI 10.1067/mob.2002.126643; HAWKINS MM, 1989, INT J CANCER, V43, P399, DOI 10.1002/ijc.2910430309; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Howlader N, 2011, SEER CANC STAT REV 1; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Link K, 2004, J CLIN ENDOCR METAB, V89, P5003, DOI 10.1210/jc.2004-0126; LITTLEY MD, 1989, Q J MED, V70, P145; Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475; Lumley J, 2003, BJOG-INT J OBSTET GY, V110, P3, DOI 10.1016/S1470-0328(03)00011-9; Madanat-Harjuoja LM, 2013, ACTA ONCOL, V52, P1152, DOI 10.3109/0284186X.2012.758870; Madanat-Harjuoja LM, 2010, INT J CANCER, V127, P1669, DOI 10.1002/ijc.25157; Magelssen H, 2008, HUM REPROD, V23, P178, DOI 10.1093/humrep/dem362; Mauldin JG, 2001, SEMIN PERINATOL, V25, P215, DOI 10.1053/sper.2001.26419; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mueller BA, 2009, ARCH PEDIAT ADOL MED, V163, P879, DOI 10.1001/archpediatrics.2009.112; Percy C., 1990, INT CLASSIFICATION D; Reulen RC, 2009, CANCER EPIDEM BIOMAR, V18, P2239, DOI 10.1158/1055-9965.EPI-09-0287; SAS Inc, 2009, SAS SOFTW VERS 9 2; Schover Leslie R, 2005, J Natl Cancer Inst Monogr, P2; SEER, 2008, SEER AD YOUNG AD SIT; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; STANLEY FJ, 1994, PAEDIATR PERINAT EP, V8, P433, DOI 10.1111/j.1365-3016.1994.tb00482.x; Stensheim H, 2013, INT J CANCER, V133, P2696, DOI 10.1002/ijc.28292; Szabo I, 1996, Early Pregnancy, V2, P233; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; Threlfall T, 2010, CANC INCIDENCE MORTA; US National Cancer Institute Lance Armstrong Foundation, 2007, CLOS GAP STRAT PLAN; Wo JY, 2009, INT J RADIAT ONCOL, V73, P1304, DOI 10.1016/j.ijrobp.2008.12.016	55	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113292	10.1371/journal.pone.0113292	http://dx.doi.org/10.1371/journal.pone.0113292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485774	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600016
J	Pandya, D; Mariani, M; McHugh, M; Andreoli, M; Sieber, S; He, S; Dowell-Martino, C; Fiedler, P; Scambia, G; Ferlini, C				Pandya, Deep; Mariani, Marisa; McHugh, Mark; Andreoli, Mirko; Sieber, Steven; He, Shiquan; Dowell-Martino, Candice; Fiedler, Paul; Scambia, Giovanni; Ferlini, Cristiano			Herpes Virus MicroRNA Expression and Significance in Serous Ovarian Cancer	PLOS ONE			English	Article							INTERFERON; CHEMOTHERAPY; METABOLISM; MECHANISMS; SIGNATURES; CARCINOMA; THERAPY; SIMPLEX; MIRNA	Serous ovarian cancer (SEOC) is the deadliest gynecologic malignancy. MicroRNAs (miRNAs) are a class of small noncoding RNAs which regulate gene expression and protein translation. MiRNAs are also encoded by viruses with the intent of regulating their own genes and those of the infected cells. This is the first study assessing viral miRNAs in SEOC. MiRNAs sequencing data from 487 SEOC patients were downloaded from the TCGA website and analyzed through in-house sequencing pipeline. To cross-validate TCGA analysis, we measured the expression of miR-H25 by quantitative immunofluorescence in an additional cohort of 161 SEOC patients. Gene, miRNA expression, and cytotoxicity assay were performed on multiple ovarian cancer cell lines transfected with miR-H25 and miR-BART7. Outcome analysis was performed using multivariate Cox and Kaplan-Meier method. Viral miRNAs are more expressed in SEOC than in normal tissues. Moreover, Herpetic viral miRNAs (miR-BART7 from EBV and miR-H25 from HSV-2) are significant and predictive biomarkers of outcome in multivariate Cox analysis. MiR-BART7 correlates with resistance to first line chemotherapy and early death, whereas miR-H25 appears to impart a protective effect and long term survival. Integrated analysis of gene and viral miRNAs expression suggests that miR-BART7 induces directly cisplatin-resistance, while miR-H25 alters RNA processing and affects the expression of noxious human miRNAs such as miR-143. This is the first investigation linking viral miRNA expression to ovarian cancer outcome. Viral miRNAs can be useful to develop biomarkers for early diagnosis and as a potential therapeutic tool to reduce SEOC lethality.	[Pandya, Deep; Mariani, Marisa; McHugh, Mark; Andreoli, Mirko; Sieber, Steven; He, Shiquan; Dowell-Martino, Candice; Fiedler, Paul; Ferlini, Cristiano] Danbury Hosp Res Inst, Danbury, CT 06810 USA; [Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Gynecol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ferlini, C (corresponding author), Danbury Hosp Res Inst, Danbury, CT 06810 USA.	cristiano.ferlini@danhosp.org			AIRC (Associazione Italiana Ricerca sul Cancro) [IG11975]; Associazione OPPO e le sue stanze ONLUS; Ruth C. Donovan Cancer Research Program	AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Associazione OPPO e le sue stanze ONLUS; Ruth C. Donovan Cancer Research Program	Funding: This work was partially supported by a grant from AIRC (Associazione Italiana Ricerca sul Cancro, IG11975), Associazione OPPO e le sue stanze ONLUS, by the Ruth C. Donovan Cancer Research Program and by a liberal donation from Mr. and Mrs. Ruggles. This work is dedicated to Monica DeFeo who lost her courageous battle against cancer at the young age of 53. Sponsors of the study did not have any role in the study conception and management.	[Anonymous], 2012, CANCER DISCOV, V2, P1068, DOI 10.1158/2159-8290.CD-NB2012-129; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benencia F, 2005, HUM GENE THER, V16, P765, DOI 10.1089/hum.2005.16.765; Benencia F, 2008, CANCER BIOL THER, V7, P1194, DOI 10.4161/cbt.7.8.6216; Berek Jonathan S, 2003, J Clin Oncol, V21, p168s, DOI 10.1200/JCO.2003.01.517; Brooks PJ, 2014, ENVIRON MOL MUTAGEN, V55, P77, DOI 10.1002/em.21824; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chan JYW, 2012, ANTICANCER RES, V32, P3201; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Chen B, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-228; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; De Donato M, 2012, J CELL PHYSIOL, V227, P1034, DOI 10.1002/jcp.22813; Einav U, 2005, ONCOGENE, V24, P6367, DOI 10.1038/sj.onc.1208797; Ford JL, 2013, ANN EPIDEMIOL, V23, P275, DOI 10.1016/j.annepidem.2013.02.008; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; McMartin KE, 2012, CLIN TOXICOL, V50, P375, DOI 10.3109/15563650.2012.683197; Miles Gregory D, 2012, BMC Res Notes, V5, P164, DOI 10.1186/1756-0500-5-164; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Nakamori M, 2003, CLIN CANCER RES, V9, P2727; Nowak M, 2010, SCAND J IMMUNOL, V71, P91, DOI 10.1111/j.1365-3083.2009.02350.x; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459	37	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114750	10.1371/journal.pone.0114750	http://dx.doi.org/10.1371/journal.pone.0114750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485872	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600095
J	Hu, Y; Huo, ZH; Liu, CM; Liu, SG; Zhang, N; Yin, KL; Qi, L; Ma, X; Xia, HF				Hu, Yi; Huo, Zheng-Hao; Liu, Chun-Mei; Liu, Shi-Guo; Zhang, Ning; Yin, Kun-Lun; Qi, Lu; Ma, Xu; Xia, Hong-Fei			Functional Study of One Nucleotide Mutation in Pri-MiR-125a Coding Region which Related to Recurrent Pregnancy Loss	PLOS ONE			English	Article							EXPRESSION; MIFEPRISTONE; PROLIFERATION; APOPTOSIS; MICRORNAS; ALTER	MicroRNAs (miRNAs) are short non-coding RNAs which modulate gene expression by binding to complementary segments present in the 3'UTR of the mRNAs of protein coding genes. MiRNAs play very important roles in maintaining normal human body physiology conditions, meanwhile, abnormal miRNA expressions have been found related to many human diseases spanning from psychiatric disorders to malignant cancers. Recently, emerging reports have indicated that disturbed miRNAs expression contributed to the pathogenesis of recurrent pregnancy loss (RPL). In this study, we identified a new mutation site (+29A>G, position relative to pre-miR-125a) by scanning pri-miR-125a coding region in 389 Chinese Han RPL patients. This site was co-existed with two polymorphisms (rs12976445 and rs41275794) in patients heterogeneously and changed the predicted secondary structures of pri-miR-125a. Subsequent in vitro analysis indicated that the A>G mutation reduced mature miR-125a expression, and further led to less efficient inhibition of verified target genes. Functional analysis showed that mutant pri-mir-125a can enhance endometrial stromal cells (ESCs) invasive capacity and increase the sensitivity of ESCs cells to mifepristone. Moreover, we further analyzed the possible molecular mechanism by RIP-chip assay and found that mutant pri-mir-125a disturbed the expression of miR-125a targetome, the functions of which includes embryonic development, cell proliferation, migration and invasion. These data suggest that A>G mutation in pri-miR-125a coding region contributes to the genetic predisposition to RPL by disordering the production of miR-125a, which consequently meddled in gene regulatory network between mir-125a and mRNA.	[Hu, Yi; Liu, Chun-Mei; Zhang, Ning; Yin, Kun-Lun; Qi, Lu; Ma, Xu; Xia, Hong-Fei] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China; [Zhang, Ning; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Hu, Yi] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Huo, Zheng-Hao] Ningxia Med Univ, Sch Basic Med Sci, Dept Biotechnol, Ningxia, Peoples R China; [Liu, Shi-Guo] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Microbiology, CAS; Ningxia Medical University; Qingdao University	Ma, X (corresponding author), Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China.	genetic@263.net.cn; hongfeixia@126.com		Hu, Yi/0000-0002-5432-1438	Natural Science Foundation of China [81370720, 81301446]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from Natural Science Foundation of China (No. 81370720 and No. 81301446). Website: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KH, 2007, TRENDS MOL MED, V13, P310, DOI 10.1016/j.molmed.2007.05.005; CHARD T, 1991, BAILLIERE CLIN OB GY, V5, P179, DOI 10.1016/S0950-3552(05)80077-X; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Hoy AM, 2012, BIOCHEM SOC T, V40, P886, DOI 10.1042/BST20120019; Hu Y, 2011, RNA BIOL, V8, P861, DOI 10.4161/rna.8.5.16034; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Li AM, 2005, FERTIL STERIL, V84, P202, DOI 10.1016/j.fertnstert.2005.01.126; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mahajan DK, 1997, FERTIL STERIL, V68, P967, DOI 10.1016/S0015-0282(97)00189-1; Minas V, 2007, MOL HUM REPROD, V13, P663, DOI 10.1093/molehr/gam054; Narvekar N, 2004, J CLIN ENDOCR METAB, V89, P2491, DOI 10.1210/jc.2003-031945; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	19	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114781	10.1371/journal.pone.0114781	http://dx.doi.org/10.1371/journal.pone.0114781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479352	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200128
J	Kumar, CS; Kumar, S				Kumar, Chandra Shekhar; Kumar, Sachin			Species Based Synonymous Codon Usage in Fusion Protein Gene of Newcastle Disease Virus	PLOS ONE			English	Article							CLEAVAGE-ACTIVATION SITE; ESCHERICHIA-COLI; F-PROTEIN; SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC CLEAVAGE; VIRAL REPLICATION; SEQUENCE; BIAS; VIRULENCE; PATHOGENICITY	Newcastle disease is highly pathogenic to poultry and many other avian species. However, the Newcastle disease virus (NDV) has also been reported from many non-avian species. The NDV fusion protein (F) is a major determinant of its pathogenicity and virulence. The functionalities of F gene have been explored for the development of vaccine and diagnostics against NDV. Although the F protein is well studied but the codon usage and its nucleotide composition from NDV isolated from different species have not yet been explored. In present study, we have analyzed the factors responsible for the determination of codon usage in NDV isolated from four major avian host species. The F gene of NDV is analyzed for its base composition and its correlation with the bias in codon usage. Our result showed that random mutational pressure is responsible for codon usage bias in F protein of NDV isolates. Aromaticity, GC3s, and aliphatic index were not found responsible for species based synonymous codon usage bias in F gene of NDV. Moreover, the low amount of codon usage bias and expression level was further confirmed by a low CAI value. The phylogenetic analysis of isolates was found in corroboration with the relatedness of species based on codon usage bias. The relationship between the host species and the NDV isolates from the host does not represent a significant correlation in our study. The present study provides a basic understanding of the mechanism involved in codon usage among species.	[Kumar, Chandra Shekhar; Kumar, Sachin] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Kumar, S (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	sachinku@iitg.ernet.in		Kumar, Chandra Shekhar/0000-0002-1469-3018; Paraskevis, Dimitrios/0000-0001-6167-7152	department of biotechnology [NER-BPMC/2013/134]; department of science and technology [IFA-LSBM-34]; board of research on nuclear sciences [2012/20/37B/06/BRNS]	department of biotechnology; department of science and technology(Department of Science & Technology (India)); board of research on nuclear sciences	The NDV research in our laboratory is currently supported by the department of biotechnology (NER-BPMC/2013/134), the department of science and technology (IFA-LSBM-34), and the board of research on nuclear sciences (2012/20/37B/06/BRNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 1998, NEWCASTLE DIS OTHER; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Cao Hong-wei, 2014, Indian Journal of Virology, V25, P132, DOI 10.1007/s13337-013-0175-7; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Cornax I, 2013, J GEN VIROL, V94, P1189, DOI 10.1099/vir.0.048579-0; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamb R. A, 2005, VIRUS TAXONOMY CLASS, P655; Liu XD, 2010, ARCH VIROL, V155, P685, DOI 10.1007/s00705-010-0631-2; LLOYD AT, 1992, NUCLEIC ACIDS RES, V20, P5289, DOI 10.1093/nar/20.20.5289; MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1995, MICROBIOL IMMUNOL, V39, P1; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Pollock DD, 2000, MOL BIOL EVOL, V17, P1776, DOI 10.1093/oxfordjournals.molbev.a026278; Rao YS, 2011, DNA RES, V18, P499, DOI 10.1093/dnares/dsr035; Reyes A, 1998, MOL BIOL EVOL, V15, P499, DOI 10.1093/oxfordjournals.molbev.a025949; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; SAKAGUCHI T, 1994, J GEN VIROL, V75, P2821, DOI 10.1099/0022-1317-75-10-2821; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; Samal S, 2013, J VIROL, V87, P10083, DOI 10.1128/JVI.01446-13; Samal S, 2012, J VIROL, V86, P2501, DOI 10.1128/JVI.06380-11; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; Sharma B, 2012, ARCH VIROL, V157, P1565, DOI 10.1007/s00705-012-1317-8; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Wakamatsu N, 2006, AVIAN DIS, V50, P483, DOI 10.1637/7515-020706R.1; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-146; Zhang YQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-174	42	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114754	10.1371/journal.pone.0114754	http://dx.doi.org/10.1371/journal.pone.0114754			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479071	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200124
J	van den Bogert, B; Meijerink, M; Zoetendal, EG; Wells, JM; Kleerebezem, M				van den Bogert, Bartholomeus; Meijerink, Marjolein; Zoetendal, Erwin G.; Wells, Jerry M.; Kleerebezem, Michiel			Immunomodulatory Properties of Streptococcus and Veillonella Isolates from the Human Small Intestine Microbiota	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; TIGHT JUNCTION PROTEINS; PATCH DENDRITIC CELLS; GUT MICROBIOTA; LACTOBACILLUS-PLANTARUM; LY6C(HI) MONOCYTES; GENOME SEQUENCE; ORAL TOLERANCE; IMMUNE-SYSTEM; IN-VIVO	The human small intestine is a key site for interactions between the intestinal microbiota and the mucosal immune system. Here we investigated the immunomodulatory properties of representative species of commonly dominant small-intestinal microbial communities, including six streptococcal strains (four Streptococcus salivarius, one S. equinus, one S. parasanguinis) one Veillonella parvula strain, one Enterococcus gallinarum strain, and Lactobacillus plantarum WCFS1 as a bench mark strain on human monocyte-derived dendritic cells. The different streptococci induced varying levels of the cytokines IL-8, TNF-alpha, and IL-12p70, while the V. parvula strain showed a strong capacity to induce IL-6. E. gallinarum strain was a potent inducer of cytokines and TLR2/6 signalling. As Streptococcus and Veillonella can potentially interact metabolically and frequently co-occur in ecosystems, immunomodulation by pair-wise combinations of strains were also tested for their combined immunomodulatory properties. Strain combinations induced cytokine responses in dendritic cells that differed from what might be expected on the basis of the results obtained with the individual strains. A combination of (some) streptococci with Veillonella appeared to negate IL-12p70 production, while augmenting IL-8, IL-6, IL-10, and TNF-alpha responses. This suggests that immunomodulation data obtained in vitro with individual strains are unlikely to adequately represent immune responses to mixtures of gut microbiota communities in vivo. Nevertheless, analysing the immune responses of strains representing the dominant species in the intestine may help to identify immunomodulatory mechanisms that influence immune homeostasis.	[van den Bogert, Bartholomeus; Zoetendal, Erwin G.; Kleerebezem, Michiel] TIFN, Wageningen, Netherlands; [van den Bogert, Bartholomeus; Zoetendal, Erwin G.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Meijerink, Marjolein; Wells, Jerry M.; Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6700 AP Wageningen, Netherlands; [Kleerebezem, Michiel] NIZO Food Res BV, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Kleerebezem, M (corresponding author), TIFN, Wageningen, Netherlands.	michiel.kleerebezem@wur.nl	Kleerebezem, Michiel/AAT-2078-2021	Meijerink, Martijn/0000-0002-1500-7294; Kleerebezem, Michiel/0000-0001-8552-2235	Top Institute Food and Nutrition, Wageningen, The Netherlands; Netherlands Bioinformatics Centre (NBIC)	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government); Netherlands Bioinformatics Centre (NBIC)	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands and by The Netherlands Bioinformatics Centre (NBIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Benyacoub J, 2005, J NUTR, V135, P1171, DOI 10.1093/jn/135.5.1171; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Egland PG, 2004, P NATL ACAD SCI USA, V101, P16917, DOI 10.1073/pnas.0407457101; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ivanov II, 2010, MUCOSAL IMMUNOL, V3, P209, DOI 10.1038/mi.2010.3; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kelly D, 2012, IMMUNOL REV, V245, P27, DOI 10.1111/j.1600-065X.2011.01079.x; KIYONO H, 1982, J EXP MED, V155, P605, DOI 10.1084/jem.155.2.605; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lelouard H, 2010, GASTROENTEROLOGY, V138, P173, DOI 10.1053/j.gastro.2009.09.051; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Meijerink M, 2012, FEMS IMMUNOL MED MIC, V65, P488, DOI 10.1111/j.1574-695X.2012.00981.x; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nagano Y, 2012, CURR OPIN IMMUNOL, V24, P392, DOI 10.1016/j.coi.2012.05.007; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Smelt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047244; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Surana NK, 2012, IMMUNOL REV, V245, P13, DOI 10.1111/j.1600-065X.2011.01075.x; Tanaka K, 2004, HISTOL HISTOPATHOL, V19, P907, DOI 10.14670/HH-19.907; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van den Bogert B, 2013, GENOME ANNOUNC, V1; Van den Bogert B, 2011, HDB MOL MICROBIAL EC, VII, P170; Van den Bogert B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083418; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; YAMAZAKI S, 1985, IMMUNOLOGY, V56, P43; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	59	85	107	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114277	10.1371/journal.pone.0114277	http://dx.doi.org/10.1371/journal.pone.0114277			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479553	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907200064
J	Nie, G; Wang, T; Lu, SJ; Liu, WQ; Li, YL; Lei, JH				Nie, Ge; Wang, Ting; Lu, Shengjun; Liu, Wenqi; Li, Yonglong; Lei, Jiahui			Detection of Clonorchis sinensis Circulating Antigen in Sera from Chinese Patients by Immunomagnetic Bead ELISA Based on IgY	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SCHISTOSOMA-JAPONICUM; CYSTEINE PROTEINASE; CAPTURE ELISA; PCR ASSAY; INFECTION; DIAGNOSIS; SERODIAGNOSIS; EXPRESSION; SAMPLES	Background: Clonorchiasis, caused by Clonorchis sinensis, is widely distributed in Southeast Asia including China. Clonorchiasis is included in control programs of neglected tropical diseases by World Health Organization (WHO) because it is one of the major health problems in most endemic areas. Diagnosis of clonorchiasis plays a key role in the control programs. However, so far, there is no satisfactory method for clonorchiasis because of low sensitivity, poor practicality and high false positivity of available diagnostic tools. Methodology/Principal Findings: We developed an immunomagnetic bead enzyme-linked immunosorbent assay (ELISA) based on IgY (egg yolk immunoglobulin) against cysteine proteinase of C. sinensis for detection of circulating antigen in serum samples of patients infected with C. sinensis. The polyclonal IgY, coated with magnetic beads, was used as a capture antibody and a monoclonal IgG labeled with horseradish peroxidase as a detection antibody in the IgY-based immunomagnetic bead ELISA system (IgY-IMB-ELISA). The results showed that the sensitivity of IgY-IMB-ELISA was 93.3% (14 of 15) in cases of heavy infection (5000 to 9999 eggs per gram feces, i.e, EPG 5000-9999), 86.7% (13 of 15) in cases of moderate infection (EPG 1000-4999) and 75.0% (9 of 12) in cases of light infection (EPG,1000) of clonorchiasis. Together 36 of total 42 (85.7%) serum samples of human clonorchiasis gave a positive reaction. There was a significant correlation between ELISA optical density and egg counts (EPG) with a correlation coefficient of 0.83 in total 42 patients. There were no positive results in patients with trichinosis (n=10) or cysticercosis (n=10). Cross-reactivity was 6.7% (2 of 30) with schistosomiasis japonica and 10.0% (3 of 30) with paragonimiasis, respectively. No positive reaction was found in 20 healthy persons. Conclusions: Our findings suggest that IgY-IMB-ELISA appears to be a sensitive and specific assay for detection of circulating antigen in human clonorchiasis.	[Nie, Ge; Wang, Ting; Lu, Shengjun; Liu, Wenqi; Li, Yonglong; Lei, Jiahui] Huazhong Univ Sci & Technol, Dept Parasitol, Sch Basic Med, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Lei, JH (corresponding author), Huazhong Univ Sci & Technol, Dept Parasitol, Sch Basic Med, Tongji Med Coll, Wuhan 430074, Peoples R China.	leijiahui@hust.edu.cn	Lei, Jiahui/HGV-0100-2022		Development Program of China (973 program) [2010CB530000]	Development Program of China (973 program)(National Basic Research Program of China)	This work was supported by Development Program of China (973 program; No. 2010CB530000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chen YT, 1984, CHIN J INFECT DIS, V2, P88; Conlan JV, 2009, TROP ANIM HEALTH PRO, V41, P913, DOI 10.1007/s11250-008-9279-2; da Silva WD, 2010, VET IMMUNOL IMMUNOP, V135, P173, DOI 10.1016/j.vetimm.2009.12.011; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Gessler F, 2006, DIAGN MICR INFEC DIS, V56, P225, DOI 10.1016/j.diagmicrobio.2006.04.014; Han S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046977; HONG S-T, 1988, Korean Journal of Parasitology, V26, P1, DOI 10.3347/kjp.1988.26.1.1; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000312; Huang MJ, 1994, BEIJING MED J, V16, P11; Huang SY, 2012, PARASITOL INT, V61, P187, DOI 10.1016/j.parint.2011.07.010; Johansen MV, 2010, ADV PARASIT, V73, P171, DOI 10.1016/S0065-308X(10)73007-4; Juliarena M, 2007, VET RES COMMUN, V31, P43, DOI 10.1007/s11259-006-3422-1; Keiser J, 2010, CURR OPIN INFECT DIS, V23, P513, DOI 10.1097/QCO.0b013e32833de06a; Kessel M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008194; Kim JH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001339; Lee JJ, 2012, KOREAN J PARASITOL, V50, P207, DOI 10.3347/kjp.2012.50.3.207; Lee JS, 2006, VACCINE, V24, P2358, DOI 10.1016/j.vaccine.2005.11.062; Lei JH, 2011, AM J TROP MED HYG, V85, P1054, DOI 10.4269/ajtmh.2011.11-0051; Lei JH, 2009, ACTA TROP, V111, P39, DOI 10.1016/j.actatropica.2009.02.012; LESLIE GA, 1969, J EXP MED, V130, P1337, DOI 10.1084/jem.130.6.1337; Li Shunyu, 2004, Parasitol Res, V93, P36, DOI 10.1007/s00436-004-1097-5; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Luo JM, 1992, CHIN J ZOONOSES, V8, P27; Lv XL, 2012, PARASITOL RES, V110, P2211, DOI 10.1007/s00436-011-2751-3; Marcos LA, 2008, CURR OPIN INFECT DIS, V21, P523, DOI 10.1097/QCO.0b013e32830f9818; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; Nagano I, 2004, CLIN DIAGN LAB IMMUN, V11, P411, DOI 10.1128/CDLI.11.2.411-416.2004; Ohnishi T, 2000, J IMMUNOL METHODS, V244, P163, DOI 10.1016/S0022-1759(00)00252-0; Pei FuQuan, 2004, Journal of Tropical Medicine (Guangzhou), V4, P10; Qian MB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001377; Qiao T, 2012, PARASITOL RES, V111, P1497, DOI 10.1007/s00436-012-2986-7; Rahman SMM, 2012, PARASITOL INT, V61, P203, DOI 10.1016/j.parint.2011.08.006; Safarik Ivo, 2004, Biomagn Res Technol, V2, P7, DOI 10.1186/1477-044X-2-7; SITHITHAWORN P, 1991, PARASITOLOGY, V102, P277, DOI 10.1017/S0031182000062594; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Teixeira CF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000073; Toledo R, 2012, EUR J CLIN MICROBIOL, V31, P1705, DOI 10.1007/s10096-011-1515-4; Wang Cheng-zu, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P193; Zhang YueQing, 1995, Chinese Journal of Parasitic Disease Control, V8, P51; Zhao QP, 2004, CLIN DIAGN LAB IMMUN, V11, P814, DOI 10.1128/CDLI.11.4.814-817.2004	42	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113208	10.1371/journal.pone.0113208	http://dx.doi.org/10.1371/journal.pone.0113208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474577	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500078
J	Stepanian, A; Alcais, A; de Prost, D; Tsatsaris, V; Dreyfus, M; Treluyer, JM; Mandelbrot, L				Stepanian, Alain; Alcais, Alexandre; de Prost, Dominique; Tsatsaris, Vassilis; Dreyfus, Michel; Treluyer, Jean-Marc; Mandelbrot, Laurent		ECLAXIR Study Grp	Highly Significant Association between Two Common Single Nucleotide Polymorphisms in CORIN Gene and Preeclampsia in Caucasian Women	PLOS ONE			English	Article							SERINE-PROTEASE; HYPERTENSION; ALLELE	Preeclampsia is a frequent medical complication during pregnancy. Corin, a serine protease which activates pro-atrial natriuretic peptide, has recently been shown to be involved in the pathophysiology of preeclampsia. The aim of this study was to search for CORIN gene variations and their association to preeclampsia in Caucasian and African women. Our study population was composed of 571 pregnant women (295 with preeclampsia and 276 normotensive controls) matched for maternal and gestational age, and ethnic origin. The 22 exons of the CORIN gene were sequenced in a discovery sample (n=260), where 31 single nucleotide polymorphisms were identified. In a replication sample (n=311), 4 single nucleotide polymorphisms were tested. Two minor alleles (C for rs2271036 and G for rs2271037) were significantly associated to preeclampsia. Adjusted odds ratios [95% confidence interval] were 2.5 [1.2-3.8] (p=0.007) and 2.3 [1.5-3.5] (p=1.3 x 10(-4)), respectively. These associations were ethnic-specific, as only found in the Caucasian of subjects (odds ratio=3.5 [1.8-6.6], p=1.1 x 10(-4); odds ratio=3.1 [1.7-5.8], p=2.1 x 10(-4), for each single nucleotide polymorphism, respectively). The two single nucleotide polymorphisms are in almost perfect linkage disequilibrium (r(2)=0.93). No specific association was found with severe preeclampsia, early-onset preeclampsia nor fetal growth retardation. In conclusion, this is the first report of a highly significant association between these two single nucleotide polymorphisms in CORIN gene and preeclampsia. Our findings further support the probability of a critical role of corin in preeclamspia pathophysiology at the uteroplacental interface.	[Stepanian, Alain] Hop Lariboisiere, Serv Hematol Biol, F-75475 Paris, France; [Alcais, Alexandre] INSERM, Lab Human Genet Infect Dis, Necker Branch, U1163,Imagine Inst, Paris, France; [Alcais, Alexandre; Treluyer, Jean-Marc] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Alcais, Alexandre] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [de Prost, Dominique] Hop Louis Mourier, AP HP, Serv Hematol Biol & Transfus, F-92701 Colombes, France; [de Prost, Dominique] INSERM, Unite 770, F-94275 Le Kremlin Bicetre, France; [Tsatsaris, Vassilis] Hop Port Royal, AP HP, Serv Gynecol Obstet, Paris, France; [Tsatsaris, Vassilis] Univ Paris 05, INSERM, Unite 767, Paris, France; [Tsatsaris, Vassilis; Treluyer, Jean-Marc; Mandelbrot, Laurent] Dept Hosp Univ Risque & Grossesse, Paris, France; [Tsatsaris, Vassilis] Fondat PremUP, Paris, France; [Dreyfus, Michel] CHU Clemenceau, Unite Gynecol Obstet & Med Reprod, Caen, France; [Alcais, Alexandre; Treluyer, Jean-Marc] INSERM CIC P0901, Paris, France; [de Prost, Dominique; Mandelbrot, Laurent] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mandelbrot, Laurent] Hop Louis Mourier, AP HP, Serv Gynecol Obstet, F-92701 Colombes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite	Mandelbrot, L (corresponding author), Dept Hosp Univ Risque & Grossesse, Paris, France.	laurent.mandelbrot@lmr.aphp.fr	treluyer, Jean-Marc/F-8036-2010; Mandelbrot, Laurent/AAD-3554-2019; Alcais, Alexandre/J-5882-2017	Mandelbrot, Laurent/0000-0002-5883-7597; Alcais, Alexandre/0000-0002-1012-2226; Stepanian, Alain/0000-0002-2942-0901	regional Programme Hospitalier de Recherche Clinique [P020925]; Assistance Publique-Hopitaux de Paris (Contrat d'Initiation a la Recherche Clinique) [08078]	regional Programme Hospitalier de Recherche Clinique; Assistance Publique-Hopitaux de Paris (Contrat d'Initiation a la Recherche Clinique)	This work was supported by a research grant from the regional Programme Hospitalier de Recherche Clinique, #P020925, and a grant from Assistance Publique-Hopitaux de Paris (Contrat d'Initiation a la Recherche Clinique, #08078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Anselem O, 2011, INT J GYNECOL OBSTET, V115, P153, DOI 10.1016/j.ijgo.2011.06.012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Buurma AJ, 2013, HUM REPROD UPDATE, V19, P289, DOI 10.1093/humupd/dms060; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Jebbink J, 2012, BBA-MOL BASIS DIS, V1822, P1960, DOI 10.1016/j.bbadis.2012.08.004; Kaitu'u-Lino TJ, 2013, HUM REPROD, V28, P1172, DOI 10.1093/humrep/det028; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Poston Lucilla, 2006, Pharmacol Rep, V58 Suppl, P69; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Salomon LJ, 2007, ULTRASOUND OBST GYN, V29, P550, DOI 10.1002/uog.4019; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Stepanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006192; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097	26	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113176	10.1371/journal.pone.0113176	http://dx.doi.org/10.1371/journal.pone.0113176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474356	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500076
J	Wollman, I; Fritz, C; Poitevineau, J; McAdams, S				Wollman, Indiana; Fritz, Claudia; Poitevineau, Jacques; McAdams, Stephen			Investigating the Role of Auditory and Tactile Modalities in Violin Quality Evaluation	PLOS ONE			English	Article							VIBRATION SENSATION; PIANO PERFORMANCE; FEEDBACK; ACOUSTICS; COORDINATION	The role of auditory and tactile modalities involved in violin playing and evaluation was investigated in an experiment employing a blind violin evaluation task under different conditions: i) normal playing conditions, ii) playing with auditory masking, and iii) playing with vibrotactile masking. Under each condition, 20 violinists evaluated five violins according to criteria related to violin playing and sound characteristics and rated their overall quality and relative preference. Results show that both auditory and vibrotactile feedback are important in the violinists' evaluations but that their relative importance depends on the violinist, the violin and the type of evaluation (different criteria ratings or preference). In this way, the overall quality ratings were found to be accurately predicted by the rating criteria, which also proved to be perceptually relevant to violinists, but were poorly correlated with the preference ratings; this suggests that the two types of ratings (overall quality vs preference) may stem from different decision-making strategies. Furthermore, the experimental design confirmed that violinists agree more on the importance of criteria in their overall evaluation than on their actual ratings for different violins. In particular, greater agreement was found on the importance of criteria related to the sound of the violin. Nevertheless, this study reveals that there are fundamental differences in the way players interpret and evaluate each criterion, which may explain why correlating physical properties with perceptual properties has been challenging so far in the field of musical acoustics.	[Wollman, Indiana; Fritz, Claudia; Poitevineau, Jacques] Univ Paris 06, Sorbonne Univ, CNRS, UMR 7190,Inst Jean le Rond, F-75015 Paris, France; [McAdams, Stephen] McGill Univ, Schulich Sch Mus, Montreal, PQ H3A 1E3, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Sorbonne Universite; McGill University	Wollman, I (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, UMR 7190,Inst Jean le Rond, F-75015 Paris, France.	wollman@lam.jussieu.fr	McAdams, Stephen/GQB-0225-2022; Fritz, Claudia/E-9260-2019	McAdams, Stephen/0000-0002-6744-9035	Canadian Natural Sciences and Engineering Research Council [RGPIN 312774-2010]; Canada Research Chairs Program [950-223484]; UPMC-Ministry of Higher Education and Research, France	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); UPMC-Ministry of Higher Education and Research, France	This work was supported in part by grants from the Canadian Natural Sciences and Engineering Research Council (# RGPIN 312774-2010) and the Canada Research Chairs Program (#950-223484) to SM. IW was a recipient of a PhD fellowship from UPMC-Ministry of Higher Education and Research, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKENFELT A, 1992, MUSIC PERCEPT, V9, P311; Baader AP, 2005, COGNITIVE BRAIN RES, V23, P436, DOI 10.1016/j.cogbrainres.2004.11.008; Banton LJ, 1995, PSYCHOL MUSIC, V23, P3, DOI DOI 10.1177/0305735695231001; Bissinger G, 2004, ACTA ACUST UNITED AC, V90, P590; Bissinger G, 2008, J ACOUST SOC AM, V124, P1764, DOI 10.1121/1.2956478; Dunnwald H, 1991, J CATGUT ACOUSTICAL, P1; Finney SA, 1997, MUSIC PERCEPT, V15, P153; Florens J-L, 2004, 5 INT GEST WORKSH, P487; Fritz C, 2012, P NATL ACAD SCI USA, V109, P760, DOI 10.1073/pnas.1114999109; Fritz C, 2010, J ACOUST SOC AM, V127, P513, DOI 10.1121/1.3266684; Fulford R, 2012, P 12 INT C MUS PERC, P335; Galembo Alexander, 2001, P INT WORKSH HUM SUP, P257; GATES A, 1974, PERCEPT PSYCHOPHYS, V16, P105, DOI 10.3758/BF03203260; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Gordon E.E., 1993, LEARNING SEQUENCES M, V6th; Hollerbach JM, 1990, VISUAL COGNITION ACT, P213; Hsee CK, 1999, PSYCHOL BULL, V125, P576, DOI 10.1037/0033-2909.125.5.576; Hutchins C. M., 1985, J CATGUT ACOUST SOC, V44, P12; Keele S.W., 1973, ATTENTION HUMAN PERF; Keller PE, 2010, MUSIC PERCEPT, V28, P27, DOI 10.1525/MP.2010.28.1.27; Lashley K.S., 1951, PROBLEM SERIAL ORDER, V21; Lecoutre B, 1992, PAC PROGRAMME ANAL C; Marshall K. D., 1986, J CATGUT ACOUST SOC, V45, P28; MARSHALL KD, 1985, J ACOUST SOC AM, V77, P695, DOI 10.1121/1.392338; Nichols C, 2002, ORGAN SOUND, V7, P215, DOI DOI 10.1017/S135577180200211X; Pfordresher P. Q., 2006, ADV COGN PSYCHOL, V2, P183, DOI [10.2478/v10053-008-0054-8, DOI 10.2478/V10053-008-0054-8]; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Rouanet H, 2000, NEW WAYS STAT METHOD; Saitis C, 2013, P STOCKH MUS AC C ST, P123; Saitis C, 2012, J ACOUST SOC AM, V132, P4002, DOI 10.1121/1.4765081; Shliesser HF, 1968, PERCEPT MOTOR SKILL, V26, P275; Sinclair S., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P463, DOI 10.1109/WHC.2011.5945530; VERRILLO RT, 1962, J ACOUST SOC AM, V34, P1768, DOI 10.1121/1.1909124; VERRILLO RT, 1992, MUSIC PERCEPT, V9, P281; Weisenberger JM, 2008, BLACKWELL HDB SENSAT; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wills R., 2007, P 8 WORLD SCI ENG AC, P1; Woodhouse J, 1998, ACUSTICA, V84, P947	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112552	10.1371/journal.pone.0112552	http://dx.doi.org/10.1371/journal.pone.0112552			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474036	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500073
J	Thaler, R; Sturmlechner, I; Spitzer, S; Riester, SM; Rumpler, M; Zwerina, J; Klaushofer, K; van Wijnen, AJ; Varga, F				Thaler, Roman; Sturmlechner, Ines; Spitzer, Silvia; Riester, Scott M.; Rumpler, Monika; Zwerina, Jochen; Klaushofer, Klaus; van Wijnen, Andre J.; Varga, Franz			Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis	FASEB JOURNAL			English	Article						osteoblast; osteoclast; osteocyte; osteogenesis	GROWTH-FACTOR-BETA; ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; SAA PROTEIN; MATRIX METALLOPROTEINASE-13; DIETARY-CHOLESTEROL; PARATHYROID-HORMONE; ADIPOSE-TISSUE	Serum amyloid A (A-SAA/Saa3) was shown before to affect osteoblastic metabolism. Here, using RT-quantitative PCR and/or immunoblotting, we show that expression of mouse Saa3 and human SAA1 and SAA2 positively correlates with increased cellular maturation toward the osteocyte phenotype. Expression is not detected in C3H10T1/2 embryonic fibroblasts but is successively higher in preosteoblastic MC3T3-E1 cells, late osteoblastic MLO-A5 cells, and MLO-Y4 osteocytes, consistent with findings using primary bone cells from newborn mouse calvaria. Recombinant Saa3 protein functionally inhibits osteoblast differentiation as reflected by reductions in the expression of osteoblast markers and decreased mineralization in newborn mouse calvaria. Yet, Saa3 protein enhances osteoclastogenesis in mouse macrophages/monocytes based on the number of multinucleated and tartrate-resistant alkaline phosphatase-positive cells and Calcr mRNA expression. Depletion of Saa3 in MLO osteocytes results in the loss of the mature osteocyte phenotype. Recombinant osteocalcin, which is reciprocally regulated with Saa3 at the osteoblast/osteocyte transition, attenuates Saa3 expression in MLO-Y4 osteocytes. Mechanistically, Saa3 produced by MLO-Y4 osteocytes is integrated into the extracellular matrix of MC3T3-E1 osteoblasts, where it associates with the P2 purinergic receptor P2rx7 to stimulate Mmp13 expression via the P2rx7/MAPK/ERK/activator protein 1 axis. Our data suggest that Saa3 may function as an important coupling factor in bone development and homeostasis.	[Thaler, Roman; Sturmlechner, Ines; Spitzer, Silvia; Rumpler, Monika; Zwerina, Jochen; Klaushofer, Klaus; Varga, Franz] Hanusch Hosp, Trauma Ctr Meidling, Ludwig Boltzmann Inst Osteol, Dept Med 1,Wiener Gebietskrankenkasse & Allgemein, A-1140 Vienna, Austria; [Thaler, Roman; Riester, Scott M.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Thaler, Roman; Riester, Scott M.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem, Rochester, MN 55905 USA; [Thaler, Roman; Riester, Scott M.; van Wijnen, Andre J.] Mayo Clin, Dept Mol Biol, Rochester, MN 55905 USA	Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic	van Wijnen, AJ (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu; franz.varga@osteologie.at	Riester, Scott M/K-7032-2015; van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Sturmlechner, Ines/0000-0003-1272-5618	Fonds zur Foerderung der Wissenschaftlichen Forschung (The Austrian Science Fund) [P24370-B19]; Wiener Gebietskrankenkasse (Social Health Insurance Vienna); Allgemeine Unfallversicherungsanstalt (Austrian Social Insurance for Occupational Risks); U.S. National Institutes of Health [R01-AR049069]; Center for Regenerative Medicine at Mayo Clinic; Patrick J. Kelly Research Fellowship award; Austrian Science Fund (FWF) [P 24370] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	Fonds zur Foerderung der Wissenschaftlichen Forschung (The Austrian Science Fund); Wiener Gebietskrankenkasse (Social Health Insurance Vienna); Allgemeine Unfallversicherungsanstalt (Austrian Social Insurance for Occupational Risks); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Regenerative Medicine at Mayo Clinic; Patrick J. Kelly Research Fellowship award; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank their colleagues at Mayo Clinic for support and stimulating discussions. They are especially grateful to Florian Haider and David Neidhart (LBIO, Vienna, Austria), Eric Lewallen, Amel Dudakovic, Emily Camilleri, Jennifer Westendorf, and David Deyle (Mayo Clinic) for stimulating discussions. They also thank Dr. Masayoshi Kumegawa (Meikai University, Urayasu, Chiba, Japan) and Dr. Lynda Bonewald (University of Missouri-Kansas City, Kansas, MI, USA) for generously providing cell lines and Dr. PhilippScherer (University of Texas, Southwestern, Dallas, TX, USA) for providing a mouse Saa3 antibody. This study was supported by the Fonds zur Foerderung der Wissenschaftlichen Forschung (The Austrian Science Fund) Project P24370-B19, the Wiener Gebietskrankenkasse (Social Health Insurance Vienna), and the Allgemeine Unfallversicherungsanstalt (Austrian Social Insurance for Occupational Risks). Additional support was provided by U.S. National Institutes of Health Grant R01-AR049069 (to A.J.v.W.), as well as intramural grants from the Center for Regenerative Medicine at Mayo Clinic and a Patrick J. Kelly Research Fellowship award (to S.M.R.).	Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; Bellido T, 2014, CALCIFIED TISSUE INT, V94, P25, DOI 10.1007/s00223-013-9774-y; BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Boumah CE, 2005, PROG NUCLEIC ACID RE, V80, P287, DOI 10.1016/S0079-6603(05)80007-8; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Chung TF, 2000, AMYLOID, V7, P105, DOI 10.3109/13506120009146246; Connolly M, 2011, ANN RHEUM DIS, V70, P1296, DOI 10.1136/ard.2010.142240; Cunnane G, 2001, CURR OPIN RHEUMATOL, V13, P67, DOI 10.1097/00002281-200101000-00011; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Del Fattore Andrea, 2012, Front Biosci (Elite Ed), V4, P2302; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200; Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Katayama T, 2007, INT HEART J, V48, P45, DOI 10.1536/ihj.48.45; Komori Toshihisa, 2014, J Bone Metab, V21, P55, DOI 10.11005/jbm.2014.21.1.55; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Kumon Y, 1997, J RHEUMATOL, V24, P14; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; Li XL, 2006, ANN NY ACAD SCI, V1068, P26, DOI 10.1196/annals.1346.006; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MORRIS AG, 1981, J GEN VIROL, V53, P39, DOI 10.1099/0022-1317-53-1-39; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Paschalis EP, 2011, BONE, V49, P1232, DOI 10.1016/j.bone.2011.08.027; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; PreciadoPatt L, 1996, J IMMUNOL, V156, P1189; Price Joanna S, 2011, Curr Osteoporos Rep, V9, P76, DOI 10.1007/s11914-011-0050-7; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; RYGG M, 1993, BIOCHIM BIOPHYS ACTA, V1216, P402, DOI 10.1016/0167-4781(93)90007-Z; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Sommer G, 2008, J CELL BIOCHEM, V104, P2241, DOI 10.1002/jcb.21782; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Sun DH, 2013, STEM CELLS, V31, P1170, DOI 10.1002/stem.1356; Syberg S, 2012, J OSTEOPOROS, V2012, DOI DOI 10.1155/2012/637986; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Thaler R, 2011, J CELL PHYSIOL, V226, P2505, DOI 10.1002/jcp.22595; Thaler R, 2013, FASEB J, V27, P446, DOI 10.1096/fj.12-208058; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; WALKER PR, 1977, J CELL PHYSIOL, V93, P89; Wesselius A, 2011, FRONT BIOSCI-LANDMRK, V16, P2572, DOI 10.2741/3873; WESTERMARK GT, 1990, AM J PATHOL, V137, P377; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yamada T, 2000, SCAND J IMMUNOL, V52, P7; Zerega B, 2004, MATRIX BIOL, V23, P35, DOI 10.1016/j.matbio.2004.02.002	70	22	23	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1344	1359		10.1096/fj.14-265512	http://dx.doi.org/10.1096/fj.14-265512			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25491310	Green Published			2022-12-26	WOS:000354115000021
J	Saitoh, Y; Fujikake, N; Okamoto, Y; Popiel, HA; Hatanaka, Y; Ueyama, M; Suzuki, M; Gaumer, S; Murata, M; Wada, K; Nagai, Y				Saitoh, Yuji; Fujikake, Nobuhiro; Okamoto, Yuma; Popiel, H. Akiko; Hatanaka, Yusuke; Ueyama, Morio; Suzuki, Mari; Gaumer, Sebastien; Murata, Miho; Wada, Keiji; Nagai, Yoshitaka			p62 Plays a Protective Role in the Autophagic Degradation of Polyglutamine Protein Oligomers in Polyglutamine Disease Model Flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; IN-VITRO; DROSOPHILA; EXPANSIONS; EXPRESSION; MECHANISM; TAU; NEURODEGENERATION	Oligomer formation and accumulation of pathogenic proteins are key events in the pathomechanisms of many neurodegenerative diseases, such as Alzheimer disease, ALS, and the polyglutamine (polyQ) diseases. The autophagy-lysosome degradation system may have therapeutic potential against these diseases because it can degrade even large oligomers. Although p62/sequestosome 1 plays a physiological role in selective autophagy of ubiquitinated proteins, whether p62 recognizes and degrades pathogenic proteins in neurodegenerative diseases has remained unclear. In this study, to elucidate the role of p62 in such pathogenic conditions in vivo, we used Drosophila models of neurodegenerative diseases. We found that p62 predominantly co-localizes with cytoplasmic polyQ protein aggregates in the MJDtr-Q78 polyQ disease model flies. Loss of p62 function resulted in significant exacerbation of eye degeneration in these flies. Immunohistochemical analyses revealed enhanced accumulation of cytoplasmic aggregates by p62 knockdown in the MJDtr-Q78 flies, similarly to knockdown of autophagy-related genes (Atgs). Knockdown of both p62 and Atgs did not show any additive effects in the MJDtr-Q78 flies, implying that p62 function is mediated by autophagy. Biochemical analyses showed that loss of p62 function delays the degradation of the MJDtr-Q78 protein, especially its oligomeric species. We also found that loss of p62 function exacerbates eye degeneration in another polyQ disease fly model as well as in ALS model flies. We therefore conclude that p62 plays a protective role against polyQ-induced neurodegeneration, by the autophagic degradation of polyQ protein oligomers in vivo, indicating its therapeutic potential for the polyQ diseases and possibly for other neurodegenerative diseases.	[Saitoh, Yuji; Fujikake, Nobuhiro; Okamoto, Yuma; Popiel, H. Akiko; Hatanaka, Yusuke; Ueyama, Morio; Suzuki, Mari; Wada, Keiji; Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Saitoh, Yuji; Murata, Miho] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo 1878551, Japan; [Saitoh, Yuji; Murata, Miho] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Chuo Ku, Chiba 2608670, Japan; [Gaumer, Sebastien] Univ Versailles St Quentin En Yvelines, Lab Genet & Biol Cellulaire, Ecole Prat Hautes Etud, EA4589, F-78035 Versailles, France; [Nagai, Yoshitaka] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Chiba University; UDICE-French Research Universities; Universite Paris Saclay; Japan Science & Technology Agency (JST)	Nagai, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.	nagai@ncnp.go.jp	Saitoh, Yuji/AAC-9090-2020	Saitoh, Yuji/0000-0002-0919-429X; Ueyama, Morio/0000-0002-2950-7361	Japan Society for the Promotion of Science (JSPS), Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Health Labor Sciences Research Grants for Research on Development of New Drugs from the Ministry of Health, Labor, and Welfare, Japan; Research Committee for Ataxic Diseases from the Ministry of Health, Labor, and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25110741] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labor Sciences Research Grants for Research on Development of New Drugs from the Ministry of Health, Labor, and Welfare, Japan; Research Committee for Ataxic Diseases from the Ministry of Health, Labor, and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (to Y. N.) from the Japan Society for the Promotion of Science (JSPS), Japan; by Grants-in-Aid for Scientific Research on Priority Areas (Proteolysis) (to Y. N.) and on Innovative Areas (Synapse and Neurocircuit Pathology) (to Y. N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Health Labor Sciences Research Grants for Research on Development of New Drugs and the Research Committee for Ataxic Diseases (to Y. N.) from the Ministry of Health, Labor, and Welfare, Japan; and by a grant from Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (to Y. N.).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Doi H, 2013, J NEUROSCI, V33, P7710, DOI 10.1523/JNEUROSCI.3021-12.2013; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Menzies FM, 2015, CELL DEATH DIFFER, V22, P433, DOI 10.1038/cdd.2014.151; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Roman G, 2002, GENESIS, V34, P127, DOI 10.1002/gene.10133; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sontag EM, 2012, J HUNTINGTONS DIS, V1, P119, DOI 10.3233/JHD-2012-129004; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Takahashi T, 2008, HUM MOL GENET, V17, P345, DOI 10.1093/hmg/ddm311; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; WYERS F, 1995, J VIROL, V69, P4463, DOI 10.1128/JVI.69.7.4463-4470.1995; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113	45	40	40	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1442	1453		10.1074/jbc.M114.590281	http://dx.doi.org/10.1074/jbc.M114.590281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25480790	hybrid, Green Published			2022-12-26	WOS:000348056400014
J	Li, C; Lin, Y; Huang, YY; Liu, XX; Liang, SL				Li, Cheng; Lin, Ying; Huang, Yuanyuan; Liu, Xiaoxiao; Liang, Shuli			Citrobacter amalonaticus Phytase on the Cell Surface of Pichia pastoris Exhibits High pH Stability as a Promising Potential Feed Supplement	PLOS ONE			English	Article							HEAT-STABLE PHYTASE; ESCHERICHIA-COLI; GENE CLONING; YEAST; EXPRESSION; WALL; CONSTRUCTION; PROTEINS; ACID; PERFORMANCE	Phytase expressed and anchored on the cell surface of Pichia pastoris avoids the expensive and time-consuming steps of protein purification and separation. Furthermore, yeast cells with anchored phytase can be used as a whole-cell biocatalyst. In this study, the phytase gene of Citrobacter amalonaticus was fused with the Pichia pastoris glycosylphosphatidylinositol (GPI)-anchored glycoprotein homologue GCW61. Phytase exposed on the cell surface exhibits a high activity of 6413.5 U/g, with an optimal temperature of 60 degrees C. In contrast to secreted phytase, which has an optimal pH of 5.0, phytase presented on the cell surface is characterized by an optimal pH of 3.0. Moreover, our data demonstrate that phytase anchored on the cell surface exhibits higher pH stability than its secreted counterpart. Interestingly, our in vitro digestion experiments demonstrate that phytase attached to the cell surface is a more efficient enzyme than secreted phytase.	[Li, Cheng; Lin, Ying; Huang, Yuanyuan; Liu, Xiaoxiao; Liang, Shuli] S China Univ Technol, Sch Biosci & Bioengn, Guangdong Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology	Liang, SL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangdong Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China.	shuli@scut.edu.cn	Li, Cheng/AAV-3966-2021	Ying, Lin/0000-0001-8686-7868	National Science and Technology Support Program of China [2013BAD10B01]	National Science and Technology Support Program of China	The research was granted by the National Science and Technology Support Program of China (Project No. 2013BAD10B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104221; Augspurger NR, 2003, J ANIM SCI, V81, P474; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Duquesne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095128; Fernandez-Murga ML, 2008, J BACTERIOL, V190, P3018, DOI 10.1128/JB.01831-07; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; Georgiev D, 2013, EMIR J FOOD AGR, V25, P342, DOI 10.9755/ejfa.v25i5.13633; Graf E., 1983, Journal of the American Oil Chemists' Society, V60, P1861; Greiner R, 2007, PROTEIN J, V26, P577, DOI 10.1007/s10930-007-9100-5; Hamada K, 1998, J BIOL CHEM, V273, P26946, DOI 10.1074/jbc.273.41.26946; Harnpicharnchai P, 2010, FEMS MICROBIOL LETT, V302, P8, DOI 10.1111/j.1574-6968.2009.01811.x; Jorquera M, 2008, MICROBES ENVIRON, V23, P182, DOI 10.1264/jsme2.23.182; Kaur P, 2010, J BIOTECHNOL, V149, P8, DOI 10.1016/j.jbiotec.2010.06.017; KOBORI H, 1992, PROTOPLASMA, V167, P193, DOI 10.1007/BF01403383; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717; LEIDICH SD, 1994, J BIOL CHEM, V269, P10193; Liang XX, 2013, BIOTECHNOL LETT, V35, P367, DOI 10.1007/s10529-012-1085-2; Liu JH, 2001, ENZYME MICROB TECH, V28, P582, DOI 10.1016/S0141-0229(00)00349-5; Luo HY, 2007, CURR MICROBIOL, V55, P185, DOI 10.1007/s00284-006-0586-4; Mo AY, 2005, BIOTECHNOL BIOPROC E, V10, P576, DOI 10.1007/BF02932297; NELSON TS, 1971, J NUTR, V101, P1289, DOI 10.1093/jn/101.10.1289; Pasamontes L, 1997, APPL ENVIRON MICROB, V63, P1696, DOI 10.1128/AEM.63.5.1696-1700.1997; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Promdonkoy P, 2009, FEMS MICROBIOL LETT, V290, P18, DOI 10.1111/j.1574-6968.2008.01399.x; Rodriguez E, 2000, BIOCHEM BIOPH RES CO, V268, P373, DOI 10.1006/bbrc.2000.2121; SCHREUDER MP, 1993, YEAST, V9, P399, DOI 10.1002/yea.320090410; Sebastian S, 1996, POULTRY SCI, V75, P1516, DOI 10.3382/ps.0751516; Shim JH, 2007, J AGR FOOD CHEM, V55, P4735, DOI 10.1021/jf070217d; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Su GD, 2010, BIOTECHNOL LETT, V32, P1131, DOI 10.1007/s10529-010-0270-4; Su GD, 2010, APPL MICROBIOL BIOT, V86, P1493, DOI 10.1007/s00253-009-2382-0; Tanino T, 2006, BIOTECHNOL PROGR, V22, P989, DOI 10.1021/bp060133+; Tomschy A, 2002, APPL ENVIRON MICROB, V68, P1907, DOI 10.1128/AEM.68.4.1907-1913.2002; Ueda M, 2000, J BIOSCI BIOENG, V90, P125, DOI 10.1263/jbb.90.125; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; Wang QJ, 2007, BIOTECHNOL LETT, V29, P1561, DOI 10.1007/s10529-007-9430-6; Wang Y, 2007, CURR MICROBIOL, V55, P65, DOI 10.1007/s00284-006-0613-5; Wodzinski RJ, 1996, ADV APPL MICROBIOL, V42, P263, DOI 10.1016/S0065-2164(08)70375-7; Wu TH, 2014, J BIOTECHNOL, V175, P1, DOI 10.1016/j.jbiotec.2014.01.034; Zhang L, 2013, APPL ENVIRON MICROB; ZHOU JR, 1995, CRIT REV FOOD SCI, V35, P495, DOI 10.1080/10408399509527712; Zyla K, 2000, POULTRY SCI, V79, P66, DOI 10.1093/ps/79.1.66; Zyla K, 1999, J SCI FOOD AGR, V79, P1841, DOI 10.1002/(SICI)1097-0010(199910)79:13&lt;1841::AID-JSFA463&gt;3.0.CO;2-G	44	9	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114728	10.1371/journal.pone.0114728	http://dx.doi.org/10.1371/journal.pone.0114728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490768	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300071
J	Razavi, M; Fournier, S; Shepard, DS; Ritter, G; Strickler, GK; Stason, WB				Razavi, Moaven; Fournier, Stephen; Shepard, Donald S.; Ritter, Grant; Strickler, Gail K.; Stason, William B.			Effects of Lifestyle Modification Programs on Cardiac Risk Factors	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CLINICAL CARDIOLOGY SUBCOMMITTEE; SECONDARY PREVENTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; METABOLISM SUBCOMMITTEE; REHABILITATION; STATEMENT; EXERCISE	Medicare conducted a payment demonstration to evaluate the effectiveness of two intensive lifestyle modification programs in patients with symptomatic coronary artery disease: the Dr. Dean Ornish Program for Reversing Heart Disease (Ornish) and Cardiac Wellness Program of the Benson-Henry Mind Body Institute. This report describes the changes in cardiac risk factors achieved by each program during the active intervention year and subsequent year of follow-up. The demonstration enrolled 580 participants who had had an acute myocardial infarction, had undergone coronary artery bypass graft surgery or percutaneous coronary intervention within 12 months, or had documented stable angina pectoris. Of these, 98% completed the intense 3-month intervention, 71% the 12-month intervention, and 56% an additional follow-up year. Most cardiac risk factors improved significantly during the intense intervention period in both programs. Favorable changes in cardiac risk factors and functional cardiac capacity were maintained or improved further at 12 and 24 months in participants with active follow-up. Multivariable regressions found that risk-factor improvements were positively associated with abnormal baseline values, Ornish program participation for body mass index and systolic blood pressure, and with coronary artery bypass graft surgery. Expressed levels of motivation to lose weight and maintain weight loss were significant independent predictors of sustained weight loss (p = 0.006). Both lifestyle modification programs achieved well-sustained reductions in cardiac risk factors.	[Razavi, Moaven; Fournier, Stephen; Shepard, Donald S.; Ritter, Grant; Strickler, Gail K.; Stason, William B.] Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02454 USA	Brandeis University	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, Waltham, MA 02454 USA.	shepard@brandeis.edu	Deschepper, Reginald/B-8103-2013	Deschepper, Reginald/0000-0002-4222-3945	Centers for Medicare & Medicaid Services (CMS) [500-95-0060, 500-02-0012-MDBU]; Centers for Disease Control [7R01 DP000339-03]; National Institute on General Medical Sciences [P20GM103644]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services (CMS); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Centers for Medicare & Medicaid Services (CMS, http://cms.hhs.gov/) under contract number 500-95-0060, Task Order 02 to Brandeis University (DSS) and number 500-02-0012-MDBU to the Delmarva Foundation for Medical Care (DSS) (http://www.delmarvafoundation.org/). The analysis received additional support from grant 7R01 DP000339-03 from the Centers for Disease Control (http://www.cdc.gov/) to the Benson-Henry Institute for Mind Body Medicine (WBS) and grant P20GM103644 from the National Institute on General Medical Sciences (http://www.nigms.nih.gov) to the University of Vermont (DSS). The funders had no role in study design (though approved by CMS), data collection and analysis, decision to publish, or preparation of the manuscript.	Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Centers for Medicare and Medicaid Services (CMS) Cardiac rehabilitation programs, 2014, MED NAT COV DET MA 1; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Delmarva Foundation, 2001, HCFA MED LIF MOD PRO; GOULD KL, 1995, JAMA-J AM MED ASSOC, V274, P894, DOI 10.1001/jama.274.11.894; Jolliffe J, 2001, COCHRANE REV COCHRAN, V1; Kip K, 2008, J AM COLL CARDIOL, V51; Kubilius R, 2012, MED LITH, V48, P116; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; MASAREI JRL, 1984, AM J CLIN NUTR, V40, P468, DOI 10.1093/ajcn/40.3.468; Morrin L, 2000, J Cardiopulm Rehabil, V20, P115, DOI 10.1097/00008483-200003000-00005; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Roger VL, 2012, HEART DIS STROKE STA; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Wenger N. K, 1995, AHCPR PUB	24	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114772	10.1371/journal.pone.0114772	http://dx.doi.org/10.1371/journal.pone.0114772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490202	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300077
J	Zhang, B; Tao, H; Wei, BX; Jin, ZY; Xu, XM; Tian, YQ				Zhang, Bao; Tao, Han; Wei, Benxi; Jin, Zhengyu; Xu, Xueming; Tian, Yaoqi			Characterization of Different Substituted Carboxymethyl Starch Microgels and Their Interactions with Lysozyme	PLOS ONE			English	Article							LINKED HIGH AMYLOSE; CONTROLLED-RELEASE; PARTICLES; HYDROGELS; MECHANISM; KINETICS	A carboxymethyl starch (CMS) microgel system was prepared for the control of uptaking and releasing proteins (lysozyme). The physicochemical properties of microgels in various degrees of substitution (DS) were determined by thermal gravimetric analysis (TGA), swelling degree, and rheological analysis. The microgel particle size mostly ranged from 25 mm to 45 mm. The result obtained from the TGA studies indicated that carboxymethylation decreased the thermal stability of starch, but crosslinking increased the thermal stability of CMS. The CMS microgels showed typical pH sensitivity, and the swelling degree of microgel increased with the increasing of DS and pH, because of the large amounts of carboxyl group ionization. The samples (2.25%) could behave as viscoelastic solids since the storage modulus was larger than the loss modulus over the entire frequency range. The protein uptake increased with increasing pH and DS at low salt concentration. The optimal pH shifted to lower pH with increasing ionic strength. The saturated protein uptake decreased with increasing ionic strength at each pH. The protein was easily released from the microgel with high pH and high salt concentration.	[Zhang, Bao; Wei, Benxi; Jin, Zhengyu; Tian, Yaoqi] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Zhang, Bao; Tao, Han; Wei, Benxi; Jin, Zhengyu; Xu, Xueming] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China; [Jin, Zhengyu; Xu, Xueming] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Jin, ZY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	jinlab2008@yahoo.com; yqtian@jiangnan.edu.cn	Tian, Yaoqi/E-7493-2010	Tian, Yaoqi/0000-0001-5693-8872	National Natural Science Foundation of China [31230057]; Key Technology R&D Program for the 12th Five-Year Plan [2012BAD37B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program for the 12th Five-Year Plan	This work was supported by the National Natural Science Foundation of China (No. 31230057) and the Key Technology R&D Program for the 12th Five-Year Plan (No. 2012BAD37B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7; Capek P, 2010, J THERM ANAL CALORIM, V99, P667, DOI 10.1007/s10973-009-0194-1; Cury BSF, 2009, INT J PHARMACEUT, V371, P8, DOI 10.1016/j.ijpharm.2008.12.010; Eichenbaum GM, 2001, MACROMOLECULES, V34, P6526, DOI 10.1021/ma0124892; Guan Y, 2011, SOFT MATTER, V7, P6375, DOI 10.1039/c0sm01541e; Hansson P, 2012, J PHYS CHEM B, V116, P10964, DOI 10.1021/jp306121h; Hirsch JB, 2002, CEREAL CHEM, V79, P102, DOI 10.1094/CCHEM.2002.79.1.102; Johansson C, 2009, J PHYS CHEM B, V113, P6183, DOI 10.1021/jp900706k; Karg M, 2009, CURR OPIN COLLOID IN, V14, P438, DOI 10.1016/j.cocis.2009.08.002; Lawal OS, 2007, STARCH-STARKE, V59, P224, DOI 10.1002/star.200600594; Lenaerts V, 1998, J CONTROL RELEASE, V53, P225, DOI 10.1016/S0168-3659(97)00256-3; Li X, 2010, CARBOHYD POLYM, V80, P768, DOI 10.1016/j.carbpol.2009.12.025; Li Y, 2012, FOOD HYDROCOLLOID, V28, P28, DOI 10.1016/j.foodhyd.2011.11.011; Li Y, 2011, SOFT MATTER, V7, P10377, DOI 10.1039/c1sm06072d; Li Y, 2009, BIOMACROMOLECULES, V10, P1931, DOI 10.1021/bm900337n; Liu J, 2012, FOOD CHEM, V133, P1196, DOI 10.1016/j.foodchem.2011.05.061; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Mocanu G, 2004, EUR POLYM J, V40, P283, DOI 10.1016/j.eurpolymj.2003.09.019; Muhammad K, 2000, CARBOHYD POLYM, V42, P85, DOI 10.1016/S0144-8617(99)00120-4; Mulhbacher J, 2001, J CONTROL RELEASE, V76, P51, DOI 10.1016/S0168-3659(01)00425-4; Ramazani-Harandi MJ, 2006, POLYM TEST, V25, P470, DOI 10.1016/j.polymertesting.2006.01.011; Rudnik E, 2006, J THERM ANAL CALORIM, V85, P267, DOI 10.1007/s10973-005-7274-7; Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2; Schachschal S, 2010, MACROMOLECULES, V43, P4331, DOI 10.1021/ma100184h; Tan BH, 2010, POLYMER, V51, P3238, DOI 10.1016/j.polymer.2010.04.059; Wang JP, 2001, J AM CHEM SOC, V123, P11284, DOI 10.1021/ja016610w	26	20	20	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114634	10.1371/journal.pone.0114634	http://dx.doi.org/10.1371/journal.pone.0114634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490774	Green Submitted, gold, Green Published			2022-12-26	WOS:000347515300061
J	Jee, DY; do Han, K; Kim, EC				Jee, Donghyun; do Han, Kyung; Kim, Eun Chul			Inverse Association between High Blood 25-Hydroxyvitamin D Levels and Diabetic Retinopathy in a Representative Korean Population	PLOS ONE			English	Article								Purpose: To investigate the association between 25-hydroxyvitamin D and diabetic retinopathy (DR). Methods: A population-based cross-sectional study using a nation-wide, systemically stratified, multistage, clustered sampling method included a total of 18,363 subjects aged >= 40 years who participated in the Korean National Health and Nutrition Examination Survey during 2008-2012. All participants participated in standardized interviews, blood 25-hydroxyvitamin D level evaluations, and comprehensive ophthalmic examinations. Seven standard retinal fundus photographs were obtained from both eyes after pupil dilatation. DR was graded according to the modified Airlie House classification system. Results: The blood 25-hydroxyvitamin D levels were 19.2 ng/mL in men and 17.9 ng/mL in women. After adjusting for potential confounders, including age, sex, diabetes duration, hemoglobin A1c levels, and hypertension, the odds ratios (OR) for any DR and proliferative DR among men decreased significantly in the highest blood 25-hydroxyvitamin D level quintile relative to the lowest quintile (OR, 0.37; 95% confidence interval [CI], 0.18-0.76; P for trend =0.004 and OR, 0.15; 95% CI, 0.03-0.83; P for trend =0.043). Conclusions: This study provides the first epidemiologic findings of the inverse relationships of blood 25-hydroxyvitamin D levels with any DR and proliferative DR only in men. Considering anti-angiogenic and anti-fibrotic action of vitamin D, further studies including longitudinal and interventional analysis are warranted.	[Jee, Donghyun; Kim, Eun Chul] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Jee, Donghyun] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [do Han, Kyung] Catholic Univ Korea, Coll Med, Dept Prevent Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Harvard University; Harvard T.H. Chan School of Public Health; Catholic University of Korea	Jee, DY (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	donghyunjee@catholic.ac.kr							0	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e115199	10.1371/journal.pone.0115199	http://dx.doi.org/10.1371/journal.pone.0115199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485770	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600110
J	Norwood, Z; Nyholm, E; Otanicar, T; Johnsson, F				Norwood, Zack; Nyholm, Emil; Otanicar, Todd; Johnsson, Filip			A Geospatial Comparison of Distributed Solar Heat and Power in Europe and the US	PLOS ONE			English	Article							PERFORMANCE; COLLECTORS; SYSTEMS	The global trends for the rapid growth of distributed solar heat and power in the last decade will likely continue as the levelized cost of production for these technologies continues to decline. To be able to compare the economic potential of solar technologies one must first quantify the types and amount of solar resource that each technology can utilize; second, estimate the technological performance potential based on that resource; and third, compare the costs of each technology across regions. In this analysis, we have performed the first two steps in this process. We use physical and empirically validated models of a total of 8 representative solar system types: non-tracking photovoltaics, 2d-tracking photovoltaics, high concentration photovoltaics, flat-plate thermal, evacuated tube thermal, concentrating trough thermal, concentrating solar combined heat and power, and hybrid concentrating photovoltaic/thermal. These models are integrated into a simulation that uses typical meteorological year weather data to create a yearly time series of heat and electricity production for each system over 12,846 locations in Europe and 1,020 locations in the United States. Through this simulation, systems composed of various permutations of collector-types and technologies can be compared geospatially and temporally in terms of their typical production in each location. For example, we see that silicon solar cells show a significant advantage in yearly electricity production over thin-film cells in the colder climatic regions, but that advantage is lessened in regions that have high average irradiance. In general, the results lead to the conclusion that comparing solar technologies across technology classes simply on cost per peak watt, as is usually done, misses these often significant regional differences in annual performance. These results have implications for both solar power development and energy systems modeling of future pathways of the electricity system.	[Norwood, Zack; Nyholm, Emil; Johnsson, Filip] Chalmers Tekn Hogskola, Gothenburg, Sweden; [Otanicar, Todd] Univ Tulsa, Dept Mech Engn, Tulsa, OK 74104 USA	Chalmers University of Technology; University of Tulsa	Norwood, Z (corresponding author), Chalmers Tekn Hogskola, Gothenburg, Sweden.	donkey@berkeley.edu		Otanicar, Todd/0000-0002-4579-6183; Johnsson, Filip/0000-0003-3106-5379	research program Pathways to Sustainable European Energy Systems; Chalmers Energy Initiative; E.ON	research program Pathways to Sustainable European Energy Systems; Chalmers Energy Initiative; E.ON	This work is financed by the research program Pathways to Sustainable European Energy Systems, E.ON, and the Chalmers Energy Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burroughs S, 2013, 2941 PSEL SAND NAT L; Chang TP, 2009, SOL ENERGY, V83, P1274, DOI 10.1016/j.solener.2009.02.009; Coventry JS, 2005, SOL ENERGY, V78, P211, DOI 10.1016/j.solener.2004.03.014; DEVOS A, 1980, J PHYS D APPL PHYS, V13, P839, DOI 10.1088/0022-3727/13/5/018; Dincertco, 2011, EV TUB COLL SKY 8CPC; Duffie JA, 2013, SOLAR ENGINEERING OF THERMAL PROCESSES, 4TH EDITION, P1, DOI 10.1002/9781118671603; Eurostat, 2013, BUILD ROADS OTH ART; Fischer S, 2004, SOL ENERGY, V76, P117, DOI 10.1016/j.solener.2003.07.021; Huld T, 2011, SOL ENERG MAT SOL C, V95, P3359, DOI 10.1016/j.solmat.2011.07.026; Huld T, 2010, SOL ENERGY, V84, P324, DOI 10.1016/j.solener.2009.12.002; Institut fur Solartechnik, 2013, CONC COLL POL 1800; International Energy Agency, 2013, EN BAL; Jacobson MZ, 2011, ENERG POLICY, V39, P1154, DOI 10.1016/j.enpol.2010.11.040; Jiang Y, 2010, P 2010 IEEE INT S IE; Kalogirou SA, 2006, ENERG CONVERS MANAGE, V47, P3368, DOI 10.1016/j.enconman.2006.01.012; Kalogirou SA, 2004, PROG ENERG COMBUST, V30, P231, DOI 10.1016/j.pecs.2004.02.001; King DL, 2004, PHOT ARR PERF MOD; Lemmon E.W., 2013, NIST REFERENCE FLUID, DOI 10.18434/T4/1502528; Marion W, 2008, USERS MANUAL TMY3 DA, DOI [10.1093/oxfordjournals.aob.a088087, DOI 10.1093/OXFORDJOURNALS.AOB.A088087]; Masson G., 2013, GLOBAL MARKET OUTLOO; Norwood Z, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044016; Otanicar TP, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4811095; Otanicar T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3514590; Otanicar TP, 2011, J SOL ENERG-T ASME, V133, DOI 10.1115/1.4003679; PV Performance Modeling Collaborative, 2012, PHYS MOD IAM; Quaschning V, 2004, SOL ENERGY, V77, P171, DOI 10.1016/j.solener.2004.04.011; REINDL DT, 1990, SOL ENERGY, V45, P1, DOI 10.1016/0038-092X(91)90123-E; Remund Jan, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy, P4388; Skoplaki E, 2009, SOL ENERGY, V83, P614, DOI 10.1016/j.solener.2008.10.008; The MathWorks Inc, 2014, MATLAB REL 2014A; THEUNISSEN PH, 1985, SOL ENERGY, V35, P311, DOI 10.1016/0038-092X(85)90139-2; Wiginton LK, 2010, COMPUT ENVIRON URBAN, V34, P345, DOI 10.1016/j.compenvurbsys.2010.01.001	32	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112442	10.1371/journal.pone.0112442	http://dx.doi.org/10.1371/journal.pone.0112442			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474632	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500070
J	Ramakrishnan, K; Okkema, PG				Ramakrishnan, Kalpana; Okkema, Peter G.			Regulation of C-elegans Neuronal Differentiation by the ZEB-Family Factor ZAG-1 and the NK-2 Homeodomain Factor CEH-28	PLOS ONE			English	Article							SMAD-INTERACTING PROTEIN-1; CAENORHABDITIS-ELEGANS; TRANSCRIPTION-FACTOR; HIRSCHSPRUNG-DISEASE; CORNEAL-DYSTROPHY; NERVOUS-SYSTEM; DNA-BINDING; GENE; EXPRESSION; MUTATIONS	The C. elegans pharyngeal neuron M4 is a multi-functional cell that acts as a cholinergic motor neuron to stimulate peristaltic pharyngeal muscle contraction and as a neuroendocrine cell secreting neuropeptides and growth factors to affect other cells both inside and outside the pharynx. The conserved transcription factors ZAG-1 and CEH-28 are co-expressed in M4 through most of development, and here we examine how these factors contribute to M4 differentiation. We find ZAG-1 functions upstream of CEH-28 in a branched pathway to activate expression of different sets of M4 differentiation markers. CEH-28 activates expression of the growth factor genes dbl-1 and egl-17, and the neuropeptide genes flp-5 and flp-2, while ZAG-1 activates expression of the serotonin receptor ser-7, as well as expression of ceh-28 and its downstream targets. Other markers of M4 differentiation are expressed normally in both zag-1 and ceh-28 mutants, including the neuropeptide gene flp-21 and the acetylcholine biosynthetic gene unc-17. Unlike ceh-28 mutants, zag-1 mutants completely lack peristaltic muscle contractions resulting from broader defects in M4 differentiation. Despite these defects, neither ZAG-1 nor CEH-28 are terminal selectors of the M4 phenotype, and we suggest they function in a hierarchy to regulate different aspects of M4 differentiation.	[Ramakrishnan, Kalpana; Okkema, Peter G.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Okkema, PG (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	okkema@uic.edu			National Institutes of Health grant [R01 GM82865]; University of Illinois at Chicago's College of Liberal Arts and Sciences; Research Open Access Publishing Fund; State of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082865] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago's College of Liberal Arts and Sciences; Research Open Access Publishing Fund; State of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a grant from the National Institutes of Health grant R01 GM82865 (http://www.nih.gov/), the University of Illinois at Chicago's College of Liberal Arts and Sciences and the Research Open Access Publishing Fund (http://www.uic.edu/), and the State of Illinois (https://www.illinois.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chen XY, 2014, J NEUROSCI, V34, P6522, DOI 10.1523/JNEUROSCI.0022-14.2014; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; Cui MX, 2003, DEV BIOL, V257, P104, DOI 10.1016/S0012-1606(03)00033-2; Dillner NB, 2004, DNA CELL BIOL, V23, P25, DOI 10.1089/104454904322745907; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gheldof A, 2012, CELL MOL LIFE SCI, V69, P2527, DOI 10.1007/s00018-012-0935-3; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Hu F, 2010, BBA-MOL BASIS DIS, V1802, P301, DOI 10.1016/j.bbadis.2009.12.002; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Layden MJ, 2006, DEV BIOL, V291, P253, DOI 10.1016/j.ydbio.2005.12.009; Lewis J.A., 1995, BASIC CULTURE METHOD, V48, P4; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Mello C, 1995, CAENORHABDITIS ELEGA, P451; Papaioannou S, 2005, J NEUROBIOL, V65, P304, DOI 10.1002/neu.20201; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; RAIZEN DM, 1995, GENETICS, V141, P1365; Ramakrishnan K, 2014, DEV BIOL, V390, P149, DOI 10.1016/j.ydbio.2014.03.015; Ray P, 2008, DEV NEUROBIOL, V68, P421, DOI 10.1002/dneu.20599; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Song BM, 2012, J NEUROSCI, V32, P1920, DOI 10.1523/JNEUROSCI.2064-11.2012; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Tomassy GS, 2013, NEURON, V77, P1, DOI 10.1016/j.neuron.2012.12.026; van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vogler G, 2008, DEV BIOL, V319, P78, DOI 10.1016/j.ydbio.2008.04.008; Wacker I, 2003, DEVELOPMENT, V130, P3795, DOI 10.1242/dev.00570; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; WATANABE Y, 1993, J BIOCHEM-TOKYO, V114, P849, DOI 10.1093/oxfordjournals.jbchem.a124267; Winner B, 2014, HUM MOL GENET	50	10	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113893	10.1371/journal.pone.0113893	http://dx.doi.org/10.1371/journal.pone.0113893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474681	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500098
J	Stein, J; Luppa, M; Ruzanska, U; Sikorski, C; Konig, HH; Riedel-Heller, SG				Stein, Janine; Luppa, Melanie; Ruzanska, Ulrike; Sikorski, Claudia; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Measuring Negative Attitudes towards Overweight and Obesity in the German Population - Psychometric Properties and Reference Values for the German Short Version of the Fat Phobia Scale (FPS)	PLOS ONE			English	Article							DIETETICS STUDENTS; WEIGHT BIAS; STIGMA; REJECTION; UPDATE	Objective: Obesity is one of the leading public health problems worldwide. Obese individuals are often stigmatized and the psychosocial consequences of overweight and obesity are the subject of current research. To detect stigmatizing attitudes towards obese people, the Fat Phobia Scale (FPS) was developed in the USA in the early nineties. In addition, the 14-item short form of the FPS was constructed. The FPS belongs to the most commonly used instruments for measuring negative attitudes towards obese people because of its good psychometric properties. For the recently developed German short form of the FPS, however, the comprehensive investigation of the psychometric properties and the determination of reference values are still pending. Thus, the main objectives of this study were the evaluation of the psychometric quality of the scale as well as the calculation of reference values. Methods: The study was based on a representative survey in the German general population. A sample of 1,657 subjects (18-94 years) was assessed via structured telephone interviews including the 14-item German version of the FPS. Descriptive statistics and inference-statistical analyses were conducted. Reference values in terms of percentage ranks were calculated. Results: Substantial evidence for the reliability and validity of the German short version of the FPS was found. This study, for the first time in Germany, provides age-specific reference values for the German short form of the FPS allowing the interpretation of individual test scores. Conclusion: Facing the far-reaching consequences of experienced stigmatization of obese individuals, these study results provide an important basis for further studies aiming at the investigation of negative attitudes towards overweight and obesity.	[Stein, Janine; Luppa, Melanie; Ruzanska, Ulrike; Sikorski, Claudia; Riedel-Heller, Steffi G.] Univ Leipzig, Fac Med, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Ruzanska, Ulrike] Univ Leipzig, Inst Psychol, Fac Biosci Pharm & Psychol, D-04109 Leipzig, Germany; [Sikorski, Claudia] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr IFB Adipos Dis, D-04109 Leipzig, Germany; [Koenig, Hans-Helmut] Univ Hamburg, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany	Leipzig University; Leipzig University; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stein, J (corresponding author), Univ Leipzig, Fac Med, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Janine.Stein@medizin.uni-leipzig.de	König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021	König, Hans-Helmut/0000-0001-5711-6862; Gisch, Ulrike/0000-0002-5431-1221	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]; German Research Foundation (DFG); Leipzig University	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Berryman DE, 2006, J AM DIET ASSOC, V106, P1678, DOI 10.1016/j.jada.2006.07.016; Bogardus ES, 1933, SOCIOL SOC RES, V17, P271; Chen EY, 2005, OBES RES, V13, P1393, DOI 10.1038/oby.2005.168; Harkness J. A., 2003, CROSS CULTURAL SURVE; Harkness JA, 2008, EUROPEAN SOCIAL SURV, P1; Hayran Osman, 2013, J Allied Health, V42, P147; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; International Obesity Task Force, 2011, ANN REPORT; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Larson MG, 2008, CIRCULATION, V117, P115, DOI 10.1161/CIRCULATIONAHA.107.654335; Latner JD, 2005, OBES RES, V13, P1226, DOI 10.1038/oby.2005.145; LINK BG, 1987, AM J SOCIOL, V92, P1461, DOI 10.1086/228672; LINK BG, 1987, AM SOCIOL REV, V52, P96, DOI 10.2307/2095395; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Maske UE, 2013, PSYCHIAT PRAX, V40, P207, DOI 10.1055/s-0033-1343103; McClure KJ, 2011, J HEALTH COMMUN, V16, P359, DOI 10.1080/10810730.2010.535108; Morrison T.G., 2009, HDB ASSESSMENT METHO, P79; O'Brien KS, 2013, INT J OBESITY, V37, P455, DOI 10.1038/ijo.2012.52; O'Brien KS, 2008, OBESITY, V16, pS87, DOI 10.1038/oby.2008.456; Pantenburg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048113; Pettigrew TF, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P262, DOI 10.1002/9780470773963.ch16; Poon MY, 2009, J CLIN NURS, V18, P2355, DOI 10.1111/j.1365-2702.2008.02709.x; Poustchi Y, 2013, FAM MED, V45, P345; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Puhl R, 2009, J AM DIET ASSOC, V109, P438, DOI 10.1016/j.jada.2008.11.034; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; ROBINSON BE, 1993, INT J EAT DISORDER, V14, P467, DOI 10.1002/1098-108X(199312)14:4&lt;467::AID-EAT2260140410&gt;3.0.CO;2-J; Sikorski C, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0046924; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Wolf Corri, 2010, J Physician Assist Educ, V21, P37; World Health Organization, 2008, GLOB HLTH OBS GHO OV; Wotzel H, 2014, PSYCHIAT PRAXIS; YUKER HE, 1995, HDB ASSESSMENT METHO, P81	39	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114641	10.1371/journal.pone.0114641	http://dx.doi.org/10.1371/journal.pone.0114641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6MB	25474195	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500051
J	Sundberg, JP; Stearns, TM; Joh, J; Proctor, M; Ingle, A; Silva, KA; Dadras, SS; Jenson, AB; Ghim, SJ				Sundberg, John P.; Stearns, Timothy M.; Joh, Joongho; Proctor, Mary; Ingle, Arvind; Silva, Kathleen A.; Dadras, Soheil S.; Jenson, A. Bennett; Ghim, Shin-je			Immune Status, Strain Background, and Anatomic Site of Inoculation Affect Mouse Papillomavirus (MmuPV1) Induction of Exophytic Papillomas or Endophytic Trichoblastomas	PLOS ONE			English	Article							MASTOMYS-NATALENSIS PAPILLOMAVIRUS; HAMSTER ORAL PAPILLOMAVIRUS; BASAL-CELL CARCINOMA; GENE-EXPRESSION; LANCEOLATE-HAIR; SENCAR MICE; STEM-CELLS; SKIN; INFECTION; UBIQUITIN	Papillomaviruses (PVs) induce papillomas, premalignant lesions, and carcinomas in a wide variety of species. PVs are classified first based on their host and tissue tropism and then their genomic diversities. A laboratory mouse papillomavirus, MmuPV1 (formerly MusPV), was horizontally transmitted within an inbred colony of NMRI-Foxn1(nu)/Foxn1(nu) (nude; T cell deficient) mice of an unknown period of time. A ground-up, filtered papilloma inoculum was not capable of infecting C57BL/6J wild-type mice; however, immunocompetent, alopecic, S/RV/Cri-ba/ba (bare) mice developed small papillomas at injection sites that regressed. NMRI-Foxn1(nu) and B6.Cg-Foxn1(nu), but not NU/J-Foxn1(nu), mice were susceptible to MmuPV1 infection. B6 congenic strains, but not other congenic strains carrying the same allelic mutations, lacking B- and T-cells, but not B-cells alone, were susceptible to infection, indicating that mouse strain and T-cell deficiency are critical to tumor formation. Lesions initially observed were exophytic papillomas around the muzzle, exophytic papillomas on the tail, and condylomas of the vaginal lining which could be induced by separate scarification or simultaneous scarification of MmuPV1 at all four sites. On the dorsal skin, locally invasive, poorly differentiated tumors developed with features similar to human trichoblastomas. Transcriptome analysis revealed significant differences between the normal skin in these anatomic sites and in papillomas versus trichoblastomas. The primarily dysregulated genes involved molecular pathways associated with cancer, cellular development, cellular growth and proliferation, cell morphology, and connective tissue development and function. Although trichoepitheliomas are benign, aggressive tumors, few of the genes commonly associated with basal cell carcinoma or squamous cells carcinoma were highly dysregulated.	[Sundberg, John P.; Stearns, Timothy M.; Silva, Kathleen A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Joh, Joongho; Proctor, Mary; Jenson, A. Bennett; Ghim, Shin-je] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Ingle, Arvind] Tata Mem Hosp, Kharghar, Navi Mumbai, India; [Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Dermatol & Genet Dev Biol, Farmington, CT USA	Jackson Laboratory; University of Louisville; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Connecticut	Sundberg, JP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org		Stearns, Timothy/0000-0002-5533-6076	University of Louisville Clinical and Translational Science Pilot Grant Program; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	University of Louisville Clinical and Translational Science Pilot Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Louisville Clinical and Translational Science Pilot Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine K, 2005, J CELL BIOCHEM, V95, P763, DOI 10.1002/jcb.20487; Battistella M, 2013, AM J DERMATOPATHOL; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Binder RL, 1997, MOL CARCINOGEN, V20, P151, DOI 10.1002/(SICI)1098-2744(199709)20:1<151::AID-MC17>3.0.CO;2-0; Binder RL, 1998, CANCER RES, V58, P4314; Bonnez W, 1998, J VIROL, V72, P5256, DOI 10.1128/JVI.72.6.5256-5261.1998; Carney H C, 1990, J Vet Diagn Invest, V2, P294; Chen J, 2008, J INVEST DERMATOL, V128, P270, DOI 10.1038/sj.jid.5701038; Cladel NM, 2013, J VIROL, V87, P9391, DOI 10.1128/JVI.00777-13; Conti C, 1996, PATHOBIOLOGY AGING M; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; da Silva-Diz V, 2013, ONCOGENE, V32, P3732, DOI 10.1038/onc.2012.375; De Vico G, 2011, ANAL QUANT CYTOL, V33, P151; Folster-Holst R, 1999, BRIT J DERMATOL, V140, P1139; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fosbrink M, 2005, EXP MOL PATHOL, V78, P116, DOI 10.1016/j.yexmp.2004.11.001; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldschmidt MH, 2002, TUMORS DOMESTIC ANIM, P58; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Handisurya A, 2013, J VIROL, V87, P13214, DOI 10.1128/JVI.02162-13; Handisurya A, 2012, VIROLOGY, V433, P385, DOI 10.1016/j.virol.2012.08.035; Harel S, 2012, J INVEST DERMATOL, V132, P2315, DOI 10.1038/jid.2012.291; HogenEsch H, 1999, PATHOBIOLOGY, V67, P45, DOI 10.1159/000028050; Ingle A, 2011, VET PATHOL, V48, P500, DOI 10.1177/0300985810377186; Ito T, 2013, EUR J DERMATOL, V23, P277, DOI 10.1684/ejd.2013.1961; Iwasaki T, 1997, J GEN VIROL, V78, P1087, DOI 10.1099/0022-1317-78-5-1087; Joh J, 2012, EXP MOL PATHOL, V93, P416, DOI 10.1016/j.yexmp.2012.07.001; Joh J, 2011, J GEN VIROL, V92, P692, DOI 10.1099/vir.0.026138-0; Katoh H, 2012, NEOPLASIA, V14, P559, DOI 10.1593/neo.12330; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; KREIDER JW, 1986, J VIROL, V59, P369, DOI 10.1128/JVI.59.2.369-376.1986; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; Lin K, 2010, J FORMOS MED ASSOC, V109, P4, DOI 10.1016/S0929-6646(10)60017-4; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Maeda H, 2005, J INT MED RES, V33, P647, DOI 10.1177/147323000503300606; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; McCarthy N, 2007, NAT REV CANCER, V7, P404, DOI 10.1038/nrc2156; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Meyer B, 2004, DIFFERENTIATION, V72, P541, DOI 10.1111/j.1432-0436.2004.07209007.x; Mikaelian I, 2004, TOXICOL PATHOL, V32, P181, DOI 10.1080/01926230490274335; Montagutelli X, 1996, J INVEST DERMATOL, V107, P20, DOI 10.1111/1523-1747.ep12297438; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nafz J, 2007, J GEN VIROL, V88, P2670, DOI 10.1099/vir.0.82955-0; Nancarrow DJ, 2008, CANC RES, V68; Osio A, 2013, AM J DERMATOPATH, V35, P284, DOI 10.1097/DAD.0b013e3182631622; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Petry IB, 2010, CLIN CANCER RES, V16, P451, DOI 10.1158/1078-0432.CCR-09-1617; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; RANDELIA HP, 1961, GENET RES, V2, P283, DOI 10.1017/S0016672300000756; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2006, VET MICROBIOL, V117, P267, DOI 10.1016/j.vetmic.2006.06.010; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roop D, 2008, NAT GENET, V40, P1040, DOI 10.1038/ng0908-1040; Ross PL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-69; Schafer K, 2010, J VIROL METHODS, V163, P216, DOI 10.1016/j.jviromet.2009.09.020; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schirren CG, 1997, AM J DERMATOPATH, V19, P341, DOI 10.1097/00000372-199708000-00005; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schulz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047164; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; Segrelles C, 2014, STEM CELLS; Sharif M, 2006, J VET MED A, V53, P352, DOI 10.1111/j.1439-0442.2006.00834.x; Sher RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023498; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sundberg J. P., 2012, COMP ANATOMY HISTOLO, P433; Sundberg JP, 2000, VET PATHOL, V37, P1, DOI 10.1354/vp.37-1-1; SUNDBERG JP, 1990, CARCINOGENESIS, V11, P341, DOI 10.1093/carcin/11.2.341; SUNDBERG JP, 1988, VET PATHOL, V25, P356, DOI 10.1177/030098588802500504; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; Sundberg JP, 2000, EXP DERMATOL, V9, P206, DOI 10.1034/j.1600-0625.2000.009003206.x; Sundberg JP, 1996, HUMAN PAPILLOMAVIRUS, P47; Sundberg JP., 1994, HDB MOUSE MUTATIONS, P57; TAN CH, 1994, VIROLOGY, V198, P534, DOI 10.1006/viro.1994.1064; Tomlins C, 2010, CARCINOGENESIS, V31, P2155, DOI 10.1093/carcin/bgq200; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; Van Doorslaer K, 2007, J GEN VIROL, V88, P1484, DOI 10.1099/vir.0.82615-0; Van Doorslaer K, 2011, TRENDS MICROBIOL, V19, P49, DOI 10.1016/j.tim.2010.11.004; VANRANST M, 1992, NUCLEIC ACIDS RES, V20, P2889, DOI 10.1093/nar/20.11.2889; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Weber F, 2001, BRIT J DERMATOL, V144, P1044, DOI 10.1046/j.1365-2133.2001.04196.x; White AC, 2014, NAT CELL BIOL, V16, P99, DOI 10.1038/ncb2889; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; WU H, 2003, ANAL GENE EXPRESSION; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zakrzewska K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-309; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167	90	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113582	10.1371/journal.pone.0113582	http://dx.doi.org/10.1371/journal.pone.0113582			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474466	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500086
J	Tong, WC; Tribe, RM; Smith, R; Taggart, MJ				Tong, Wing-Chiu; Tribe, Rachel M.; Smith, Roger; Taggart, Michael J.			Computational Modeling Reveals Key Contributions of KCNQ and hERG Currents to the Malleability of Uterine Action Potentials Underpinning Labor	PLOS ONE			English	Article							GO-RELATED GENES; POTASSIUM CHANNELS; K+-CHANNEL; FUNCTIONAL-CHARACTERIZATION; SPLICE VARIANT; KV7 CHANNELS; EXPRESSION; MYOMETRIUM; INACTIVATION; DEPENDENCE	The electrical excitability of uterine smooth muscle cells is a key determinant of the contraction of the organ during labor and is manifested by spontaneous, periodic action potentials (APs). Near the end of term, APs vary in shape and size reflecting an ability to change the frequency, duration and amplitude of uterine contractions. A recent mathematical model quantified several ionic features of the electrical excitability in uterine smooth muscle cells. It replicated many of the experimentally recorded uterine AP configurations but its limitations were evident when trying to simulate the long-duration bursting APs characteristic of labor. A computational parameter search suggested that delayed rectifying K+ currents could be a key model component requiring improvement to produce the longer-lasting bursting APs. Of the delayed rectifying K+ currents family it is of interest that KCNQ and hERG channels have been reported to be gestationally regulated in the uterus. These currents exhibit features similar to the broadly defined uterine I-K1 of the original mathematical model. We thus formulated new quantitative descriptions for several I-KCNQ and I-hERG. Incorporation of these currents into the uterine cell model enabled simulations of the long-lasting bursting APs. Moreover, we used this modified model to simulate the effects of different contributions of IKCNQ and IhERG on AP form. Our findings suggest that the alterations in expression of hERG and KCNQ channels can potentially provide a mechanism for fine tuning of AP forms that lends a malleability for changing between plateau-like and long-lasting bursting-type APs as uterine cells prepare for parturition.	[Tong, Wing-Chiu; Taggart, Michael J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Tribe, Rachel M.] Kings Hlth Partners, London, England; [Smith, Roger] Univ Newcastle, Hunter Med Res Inst, New Lambton, NSW, Australia	Newcastle University - UK; University of London; King's College London; University of London; King's College London; Hunter Medical Research Institute; University of Newcastle	Taggart, MJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	michael.taggart@ncl.ac.uk		Smith, Roger/0000-0003-4720-0280; Taggart, Michael/0000-0002-9981-2783; Tribe, Rachel/0000-0003-3675-9978	UK Medical Research Council [G0900525, G1100243]; Bioinformatics Training Fellowship [G0902091]; MRC [G0900525, G0902091, G1100243] Funding Source: UKRI; Medical Research Council [G0902091, G1100243, G0900525] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bioinformatics Training Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (G0900525, G1100243, www.mrc.ac.uk) including a Bioinformatics Training Fellowship to WCT (G0902091). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2006, J MEMBRANE BIOL, V211, P115, DOI 10.1007/s00232-006-0010-9; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bentzen BH, 2006, NEUROPHARMACOLOGY, V51, P1068, DOI 10.1016/j.neuropharm.2006.07.001; Blom SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008251; BOYLE MB, 1987, SCIENCE, V235, P1221, DOI 10.1126/science.2434999; BOYLE MB, 1987, NATURE, V330, P373, DOI 10.1038/330373a0; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Ermentrout G. B., 2002, SIMULATING ANAL ANIM; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gao ZB, 2008, J BIOL CHEM, V283, P22649, DOI 10.1074/jbc.M802426200; Gibor G, 2004, J GEN PHYSIOL, V124, P83, DOI 10.1085/jgp.200409068; Goldbeter A, 2012, FEBS LETT, V586, P2955, DOI 10.1016/j.febslet.2012.07.041; Greenwood IA, 2009, J PHYSIOL-LONDON, V587, P2313, DOI 10.1113/jphysiol.2009.171272; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Inoue Y, 1999, CAN J PHYSIOL PHARM, V77, P447, DOI 10.1139/cjpp-77-6-447; Jensen HS, 2007, BIOPHYS J, V92, P2747, DOI 10.1529/biophysj.106.101287; Khan RN, 1997, AM J PHYSIOL-CELL PH, V273, pC1721, DOI 10.1152/ajpcell.1997.273.5.C1721; Knock GA, 1999, J PHYSIOL-LONDON, V518, P769, DOI 10.1111/j.1469-7793.1999.0769p.x; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Larsen AP, 2011, BIOPHYS J, V101, P818, DOI 10.1016/j.bpj.2011.06.034; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; London B, 1997, CIRC RES, V81, P870; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; Parkington HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5108; Peretz A, 2002, J PHYSIOL-LONDON, V545, P751, DOI 10.1113/jphysiol.2002.028381; Pervolaraki E, 2013, BIOSYSTEMS, V112, P63, DOI 10.1016/j.biosystems.2013.03.012; Pusch M, 2001, J PHYSIOL-LONDON, V533, P135, DOI 10.1111/j.1469-7793.2001.0135b.x; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roura-Ferrer M, 2009, CELL PHYSIOL BIOCHEM, V24, P325, DOI 10.1159/000257425; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Seebohm G, 2001, BRIT J PHARMACOL, V134, P1647, DOI 10.1038/sj.bjp.0704421; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Sharp GC, 2013, MOL HUM REPROD, V19, P711, DOI 10.1093/molehr/gat043; Shoeb F, 2003, J BIOL CHEM, V278, P2503, DOI 10.1074/jbc.M208525200; Soh H, 2010, MOL PHARMACOL, V78, P1088, DOI 10.1124/mol.110.066100; Su TR, 2009, ACTA PHARMACOL SIN, V30, P1220, DOI 10.1038/aps.2009.117; Taggart MJ, 1998, J PHYSIOL-LONDON, V509, P315, DOI 10.1111/j.1469-7793.1998.315bn.x; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Varro A, 2011, BRIT J PHARMACOL, V164, P14, DOI 10.1111/j.1476-5381.2011.01367.x; Wang SM, 1996, FEBS LETT, V389, P167, DOI 10.1016/0014-5793(96)00570-4; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; WILDE DW, 1988, BIOL REPROD, V38, P836, DOI 10.1095/biolreprod38.4.836; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2008, BIOCHEM BIOPH RES CO, V371, P741, DOI 10.1016/j.bbrc.2008.04.129; Yeung SYM, 2007, AM J PHYSIOL-CELL PH, V292, pC468, DOI 10.1152/ajpcell.00142.2006; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Young RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065110; Zhang ST, 2003, J PHYSIOL-LONDON, V548, P691, DOI 10.1113/jphysiol.2003.039198	53	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114034	10.1371/journal.pone.0114034	http://dx.doi.org/10.1371/journal.pone.0114034			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474527	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500105
J	Zhang, XM; Yamaoka, K; Sonomoto, K; Kaneko, H; Satake, M; Yamamoto, Y; Kondo, M; Zhao, JD; Miyagawa, I; Yamagata, K; Fukuyo, S; Okada, Y; Tanaka, Y				Zhang, Xiangmei; Yamaoka, Kunihiro; Sonomoto, Koshiro; Kaneko, Hiroaki; Satake, Makoto; Yamamoto, Yuka; Kondo, Masahiro; Zhao, Jidong; Miyagawa, Ippei; Yamagata, Kaoru; Fukuyo, Shunsuke; Okada, Yosuke; Tanaka, Yoshiya			Local Delivery of Mesenchymal Stem Cells with Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold Suppress Arthritis in Rats	PLOS ONE			English	Article							REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; BONE-MARROW; CLINICAL-APPLICATIONS; IMMUNE TOLERANCE; DIFFERENTIATION; TRANSPLANTATION; INDUCTION	Mesenchymal stem cells (MSC) have been used recently for the treatment of autoimmune diseases in murine animal models due to the immunoregulatory capacity. Current utilization of MSC requires cells in certain quantity with multiple courses of administration, leading to limitation in clinical usage. Here we efficiently treated collagen-induced arthritis rats with a single local implantation with reduced number of MSC (2 similar to 20% of previous studies) with nano-fiber poly-lactic-co-glycolic acid (nano-fiber) scaffold. MSC seeded on nano-fiber scaffold suppressed arthritis and bone destruction due to inhibition of systemic inflammatory reaction and immune response by suppressing T cell proliferation and reducing anti-type II collagen antibody production. In vivo tracing of MSC demonstrated that these cells remained within the scaffold without migrating to other organs. Meanwhile, in vitro culture of MSC with nano-fiber scaffold significantly increased TGF-beta 1 production. These results indicate an efficient utilization of MSC with the scaffold for destructive joints in rheumatoid arthritis by a single and local inoculation. Thus, our data may serve as a new strategy for MSC-based therapy in inflammatory diseases and an alternative delivery method for bone destruction treatment.	[Zhang, Xiangmei; Yamaoka, Kunihiro; Sonomoto, Koshiro; Kondo, Masahiro; Zhao, Jidong; Miyagawa, Ippei; Yamagata, Kaoru; Fukuyo, Shunsuke; Okada, Yosuke; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan; [Kaneko, Hiroaki; Satake, Makoto; Yamamoto, Yuka] Teijin Ltd, Integrat Technol Res Inst, Tokyo, Japan; [Kondo, Masahiro] Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 1, Yokohama, Kanagawa, Japan	University of Occupational & Environmental Health - Japan; Teijin Limited; Mitsubishi Tanabe Pharma Corporation	Tanaka, Y (corresponding author), Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan.	tanaka@med.uoeh-u.ac.jp	Okada, Yosuke/AAT-3173-2020; Miyagawa, Ippei/AHB-0789-2022		Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan; UOEH Grant for Advanced Research; Grants-in-Aid for Scientific Research [25860821] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan); UOEH Grant for Advanced Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Research Grants-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan and UOEH Grant for Advanced Research. Hiroaki Kaneko, Makoto Satake and Yuka Yamamoto are employees of the Teijin Limited. Masahiro Kondo is employee of the Mitsubishi Tanabe Pharma Corporation. Teijin Limited and Mitsubishi Tanabe Pharma Corporation provided support in the form of salaries for authors HK, MS, YY and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Behrens F, 2007, ANN RHEUM DIS, V66, P1151, DOI 10.1136/ard.2006.068320; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Davies JE, 2010, ORGANOGENESIS, V6, P161, DOI 10.4161/org.6.3.12392; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Kondo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079463; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; Liang J, 2009, MULT SCLER J, V15, P644, DOI 10.1177/1352458509104590; Liang J, 2012, CLIN RHEUMATOL, V31, P157, DOI 10.1007/s10067-011-1816-0; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; MacDonald GIA, 2011, ARTHRITIS RHEUM-US, V63, P2547, DOI 10.1002/art.30474; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309; Papadopoulou A, 2012, ANN RHEUM DIS, V71, P1733, DOI 10.1136/annrheumdis-2011-200985; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ra JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-181; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schurgers E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2939; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Sun LY, 2007, LUPUS, V16, P121, DOI 10.1177/0961203306075793; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; THORBECKE GJ, 1992, P NATL ACAD SCI USA, V89, P7375, DOI 10.1073/pnas.89.16.7375; Toyokawa N, 2010, ARTHROSCOPY, V26, P375, DOI 10.1016/j.arthro.2009.08.006; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Zheng ZH, 2008, RHEUMATOLOGY, V47, P22, DOI 10.1093/rheumatology/kem284	41	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114621	10.1371/journal.pone.0114621	http://dx.doi.org/10.1371/journal.pone.0114621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474102	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500050
J	Seifert, W; Kuhnisch, J; Maritzen, T; Lommatzsch, S; Hennies, HC; Bachmann, S; Horn, D; Haucke, V				Seifert, Wenke; Kuehnisch, Jirko; Maritzen, Tanja; Lommatzsch, Stefanie; Hennies, Hans Christian; Bachmann, Sebastian; Horn, Denise; Haucke, Volker			Cohen Syndrome-associated Protein COH1 Physically and Functionally Interacts with the Small GTPase RAB6 at the Golgi Complex and Directs Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBRAL-CORTEX; MEMBRANE TRAFFICKING; MUTATIONAL SPECTRUM; GENE; TRANSPORT; NEURONS; HETEROGENEITY; GLYCOSYLATION; LOCALIZATION; HOMEOSTASIS	Postnatal microcephaly, intellectual disability, and progressive retinal dystrophy are major features of autosomal recessive Cohen syndrome, which is caused by mutations in the gene COH1 (VPS13B). We have recently identified COH1 as a Golgi-enriched scaffold protein that contributes to the structural maintenance and function of the Golgi complex. Here, we show that association of COH1 with the Golgi complex depends on the small GTPase RAB6. RNAi-mediated knockdown of RAB6A/A' prevents the localization of COH1 to the Golgi complex. Expression of the constitutively inactive RAB6_T27N mutant led to an increased solubilization of COH1 from lipid membrane preparations. Co-IP experiments confirmed the physical interaction of COH1 with RAB6 that preferentially occurred with the constitutively active RAB6_Q72L mutants. Depletion of COH1 in primary neurons negatively interfered with neurite outgrowth, indicating a causal link between the integrity of the Golgi complex and axonal outgrowth. We conclude that COH1 is a RAB6 effector protein and that reduced brain size in Cohen syndrome patients likely results from impaired COH1 function at the Golgi complex, causing decreased neuritogenesis.	[Seifert, Wenke; Lommatzsch, Stefanie; Bachmann, Sebastian] Charite, Inst Vegetat Anat, D-10115 Berlin, Germany; [Kuehnisch, Jirko; Horn, Denise] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Kuehnisch, Jirko] Max Planck Inst Mol Genet FG Dev & Dis, D-14195 Berlin, Germany; [Maritzen, Tanja; Haucke, Volker] Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany; [Hennies, Hans Christian] Univ Cologne, CCG, D-50931 Cologne, Germany; [Hennies, Hans Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hennies, Hans Christian] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Cologne; University of Cologne; Medical University of Innsbruck	Seifert, W (corresponding author), Charite, Inst Vegetat Anat, Charitepl 1, D-10117 Berlin, Germany.	wenke.seifert@charite.de	Seifert, Wenke/B-8772-2011; Kühnisch, Jirko/L-7761-2013; Kühnisch, Jirko/M-3744-2019; Hennies, Hans C/G-9424-2014	Kühnisch, Jirko/0000-0003-4744-5421; Hennies, Hans C/0000-0001-7210-2389; Haucke, Volker/0000-0003-3119-6993; Maritzen, Tanja/0000-0003-4993-0340; Seifert, Wenke/0000-0003-1432-9862	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to T. M., V. H., and W. S.).	Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; COHEN MM, 1973, J PEDIATR-US, V83, P280; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hennies HC, 2004, AM J HUM GENET, V75, P138, DOI 10.1086/422219; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Kivitie-Kallio S, 1998, NEUROPEDIATRICS, V29, P298, DOI 10.1055/s-2007-973581; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubbehusen J, 2010, HUM MOL GENET, V19, P3623, DOI 10.1093/hmg/ddq278; Majeed W, 2014, TRAFFIC, V15, P630, DOI 10.1111/tra.12167; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Mochida GH, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014779; Park J. S., J CELL SCI, V125, P3004; Park J. S., EUKARYOT CELL, V12, P1530; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Redding K, 1996, MOL CELL BIOL, V16, P6208; Rosnoblet C, 2013, GLYCOCONJUGATE J, V30, P23, DOI 10.1007/s10719-012-9389-y; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Seifert W, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039867; Seifert W, 2011, J BIOL CHEM, V286, P37665, DOI 10.1074/jbc.M111.267971; Seifert W, 2009, HUM MUTAT, V30, pE404, DOI 10.1002/humu.20886; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	38	55	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3349	3358		10.1074/jbc.M114.608174	http://dx.doi.org/10.1074/jbc.M114.608174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25492866	hybrid, Green Published			2022-12-26	WOS:000349456000013
J	Asuthkar, S; Elustondo, PA; Demirkhanyan, L; Sun, X; Baskaran, P; Velpula, KK; Thyagarajan, B; Pavlov, EV; Zakharian, E				Asuthkar, Swapna; Elustondo, Pia A.; Demirkhanyan, Lusine; Sun, Xiaohui; Baskaran, Padmamalini; Velpula, Kiran Kumar; Thyagarajan, Baskaran; Pavlov, Evgeny V.; Zakharian, Eleonora			The TRPM8 Protein Is a Testosterone Receptor I. BIOCHEMICAL EVIDENCE FOR DIRECT TRPM8-TESTOSTERONE INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen; Calcium Channel; Ion Channel; Testosterone; Transient Receptor Potential Channels (TRP Channels); Cold and Menthol Receptor TRPM8; Transient Receptor Potential Melastatin 8 Channel	PROSTATE-CANCER; MEDULLOBLASTOMA CELLS; COLD; CHANNEL; EXPRESSION; MENTHOL; TRP-P8; IDENTIFICATION; SURVIVAL; GENE	Background: TRPM8 channels are highly expressed in prostate tissues, where the role of this cold receptor is not well understood. Results: Testosterone directly interacts with the TRPM8 protein. Conclusion: TRPM8 is a testosterone receptor. Significance: TRPM8 channels may be implicated in various physiological processes regulated by androgens. The transient receptor potential ion channel of the melastatin subfamily, TRPM8, is a major cold receptor in the peripheral nervous system. Along with the sensory neurons, the TRPM8 protein is highly expressed in the prostate epithelial cells, and this expression is regulated by androgens. Here we investigated the expression and intracellular localization of the TRPM8 channel in relationship to androgens. We performed experiments using human prostate tissues obtained from healthy individuals and patients with prostate cancer at various stages of the disease as well as in cultured cells. Using an immunohistochemistry approach, we detected an intensive colocalization pattern of the TRPM8 protein with endogenous androgens in all tissues tested, suggesting possible interactions. Co-immunoprecipitation experiments performed using cultured prostate epithelial cells, prostate cancer cells, and HEK-293 cells stably expressing TRPM8 further confirmed direct binding of the steroid hormone, testosterone, to the TRPM8 protein. Applications of picomolar concentrations of testosterone to the primary human prostate cells, endogenously expressing TRPM8, elicited Ca2+ responses and channel currents, and those were inhibited in the presence of TRPM8 antagonist, N-(2-aminoethyl)-N-(4-(benzyloxy)-3-methoxybenzyl)thiophene-2-carboxamide hydrochloride. These results indicate that the TRPM8 channel is physically associated with testosterone and suggest that, in addition to a genomic role, testosterone plays a role in direct regulation of the TRPM8 channel function.	[Asuthkar, Swapna; Demirkhanyan, Lusine; Sun, Xiaohui; Velpula, Kiran Kumar; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Elustondo, Pia A.; Pavlov, Evgeny V.] Dalhousie Univ, Halifax, NS B3H 4R2, Canada; [Baskaran, Padmamalini; Thyagarajan, Baskaran] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY 82071 USA; [Pavlov, Evgeny V.] NYU, Coll Dent, Dept Basic Sci, New York, NY 10010 USA	University of Illinois System; University of Illinois Peoria; Dalhousie University; University of Wyoming; New York University	Zakharian, E (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	zakharel@uic.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855; Baskaran, Padmamalini/0000-0001-8851-1486	National Institutes of Health [R01GM098052, 8P20GM103432-12]; Heart and Stroke Foundation of Canada [G-13-0003008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098052, P20GM103432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM098052 (to E. Z.). This work was also supported by Heart and Stroke Foundation of Canada Grant G-13-0003008 (to E. P.) and by the pilot project support from the National Institutes of Health Grant 8P20GM103432-12 (to B. T.).	Asuthkar S, 2014, ONCOGENE, V33, P1922, DOI 10.1038/onc.2013.151; Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Fuessel S, 2003, INT J ONCOL, V23, P221; Henshall SM, 2003, CANCER RES, V63, P4196; Kiessling A, 2003, PROSTATE, V56, P270, DOI 10.1002/pros.10265; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morgentaler A, 2006, EUR UROL, V50, P935, DOI 10.1016/j.eururo.2006.06.034; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Tsavaler L, 2001, CANCER RES, V61, P3760; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146	25	65	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2659	2669		10.1074/jbc.M114.610824	http://dx.doi.org/10.1074/jbc.M114.610824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25480783	hybrid, Green Published			2022-12-26	WOS:000349310700011
J	Glencross, DK; Coetzee, LM; Cassim, N				Glencross, Deborah K.; Coetzee, Lindi M.; Cassim, Naseem			An Integrated Tiered Service Delivery Model (ITSDM) Based on Local CD4 Testing Demands Can Improve Turn-Around Times and Save Costs whilst Ensuring Accessible and Scalable CD4 Services across a National Programme	PLOS ONE			English	Article							SOUTH-AFRICA; CARE; HIV; ENUMERATION; INITIATION; SYSTEM; BLOOD; RATES	Background: The South African National Health Laboratory Service (NHLS) responded to HIV treatment initiatives with two-tiered CD4 laboratory services in 2004. Increasing programmatic burden, as more patients access anti-retroviral therapy (ART), has demanded extending CD4 services to meet increasing clinical needs. The aim of this study was to review existing services and develop a service-model that integrated laboratory-based and point-of-care testing (POCT), to extend national coverage, improve local turn-around/(TAT) and contain programmatic costs. Methods: NHLS Corporate Data Warehouse CD4 data, from 60-70 laboratories and 4756 referring health facilities was reviewed for referral laboratory workload, respective referring facility volumes and related TAT, from 2009-2012. Results: An integrated tiered service delivery model (ITSDM) is proposed. Tier-1/POCT delivers CD4 testing at single health-clinics providing ART in hard-to-reach areas (<5 samples/day). Laboratory-based testing is extended with Tier-2/POC-Hubs (processing <= 30-40 CD4 samples/day), consolidating POCT across 8-10 health-clinics with other HIV-related testing and Tier-3/'community' laboratories, serving <= 40 health-clinics, processing <= 150 samples/day. Existing Tier-4/'regional' laboratories serve <= 100 facilities and process,350 samples/day; Tier-5 are high-volume 'metro'/centralized laboratories (>350-1500 tests/day, serving >= 200 health-clinics). Tier-6 provides national support for standardisation, harmonization and quality across the organization. Conclusion: The ITSDM offers improved local TAT by extending CD4 services into rural/remote areas with new Tier-3 or Tier-2/POC-Hub services installed in existing community laboratories, most with developed infrastructure. The advantage of lower laboratory CD4 costs and use of existing infrastructure enables subsidization of delivery of more expensive POC services, into hard-to-reach districts without reasonable access to a local CD4 laboratory. Full ITSDM implementation across 5 service tiers ( as opposed to widespread implementation of POC testing to extend service) can facilitate sustainable 'full service coverage' across South Africa, and save>than R125 million in HIV/AIDS programmatic costs. ITSDM hierarchical parental-support also assures laboratory/POC management, equipment maintenance, quality control and on-going training between tiers.	[Glencross, Deborah K.; Coetzee, Lindi M.] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa; [Glencross, Deborah K.; Coetzee, Lindi M.; Cassim, Naseem] NHLS, Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Glencross, DK (corresponding author), Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa.	debbie.glencross@nhls.ac.za	Cassim, Naseem/AFU-5522-2022; Cassim, Naseem/GLR-4911-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X				Beckman Coulter International, 2014, FLOW CYT; Beckman Coulter International, 2014, BECKM COULT FLOW CYT; Bornheimer S, 2013, DEV BD FACSPRESTO IN; Cassim N, 2014, PLOS ONE IN PRESS; Cassim N, 2012, AFR SOC LAB MED 1 IN; Cassim N, 2014, AFR SOC LAB MED 1 IN; Coetzee LM, 2014, 8 HIV INT M 2014 5 9; Coetzee LM, 2012, COST ANAL MOBILE LAB; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fajardo E, 2014, AIDS; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Glencross DK, 2012, AFR SOC LAB MED 1 IN; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lawrie D, 2010, CYTOM PART B-CLIN CY, V78B, P201, DOI 10.1002/cyto.b.20520; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Massambu C, 2009, AM J CLIN PATHOL, V131, P861, DOI 10.1309/AJCP3ZAAFUPCIXIG; 'Medecins Sans Frontiers' SA, 2013, NEW ROOTS S AFR CHAL; National Department of Health, 2011, NAT STRAT PLAN HIV S; National Department of Health, 2013, POINT CAR TEST POS P; National Department of Health, 2012, NAT HLTH CAR FAC BAS; National Department of Health, 2003, OP PLAN COMPR HIV AI; National Department of Health, 2013, PROGR UPD NAT STRAT; National Department of Health, 2012, NAT HLTH INS PRES NH; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health, 2013, UPD NAT STRAT PLAN H; National Department of Health, 2008, POL GUID IMPL PMTCT; National Health Laboratory Services, 2013, NAT HLTH LAB SERV AN; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P359, DOI 10.1309/AJCPY5ASUEJYQ5RK; Scott LE, 2005, CYTOM PART B-CLIN CY, V67B, P31, DOI 10.1002/cyto.b.20066; Smith H, 2012, GEOGRAPHIC LOCATION; South African National AIDS Council, SANAC PROGR REP NAT; STATSSA-Statistics SA, 2013, MIDY POP EST 2013 PR; STATSSA-Statistics SA, 2011, MIDY POP EST 2011 PR; World Health Organisation, 2002, WHO EM SCAL UP ANT T; World Health Organization, 2008, CONS TECHN OP REC CL	41	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114727	10.1371/journal.pone.0114727	http://dx.doi.org/10.1371/journal.pone.0114727			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490718	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300070
J	Vaziri, ND; Liu, SM; Lau, WL; Khazaeli, M; Nazertehrani, S; Farzaneh, SH; Kieffer, DA; Adams, SH; Martin, RJ				Vaziri, Nosratola D.; Liu, Shu-Man; Lau, Wei Ling; Khazaeli, Mahyar; Nazertehrani, Sohrab; Farzaneh, Seyed H.; Kieffer, Dorothy A.; Adams, Sean H.; Martin, Roy J.			High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease	PLOS ONE			English	Article							GUT BACTERIAL TRANSLOCATION; IMPAIRS BARRIER FUNCTION; STAGE RENAL-DISEASE; INTESTINAL MICROBIOTA; INDOLIC COMPOUNDS; TIGHT JUNCTION; MICROINFLAMMATION; FAILURE; UREMIA	Inflammation is a major mediator of CKD progression and is partly driven by altered gut microbiome and intestinal barrier disruption, events which are caused by: urea influx in the intestine resulting in dominance of urease-possessing bacteria; disruption of epithelial barrier by urea-derived ammonia leading to endotoxemia and bacterial translocation; and restriction of potassium-rich fruits and vegetables which are common sources of fermentable fiber. Restriction of these foods leads to depletion of bacteria that convert indigestible carbohydrates to short chain fatty acids which are important nutrients for colonocytes and regulatory T lymphocytes. We hypothesized that a high resistant starch diet attenuates CKD progression. Male Sprague Dawley rats were fed a chow containing 0.7% adenine for 2 weeks to induce CKD. Rats were then fed diets supplemented with amylopectin (low-fiber control) or high fermentable fiber (amylose maize resistant starch, HAM-RS2) for 3 weeks. CKD rats consuming low fiber diet exhibited reduced creatinine clearance, interstitial fibrosis, inflammation, tubular damage, activation of NF kappa B, upregulation of pro-inflammatory, pro-oxidant, and pro-fibrotic molecules; impaired Nrf2 activity, down-regulation of antioxidant enzymes, and disruption of colonic epithelial tight junction. The high resistant starch diet significantly attenuated these abnormalities. Thus high resistant starch diet retards CKD progression and attenuates oxidative stress and inflammation in rats. Future studies are needed to explore the impact of HAM-RS2 in CKD patients.	[Vaziri, Nosratola D.; Liu, Shu-Man; Lau, Wei Ling; Khazaeli, Mahyar; Nazertehrani, Sohrab; Farzaneh, Seyed H.] Univ Calif Irvine, Div Nephrol, Irvine, CA 92717 USA; [Kieffer, Dorothy A.; Adams, Sean H.; Martin, Roy J.] Univ Calif Davis, Grad Grp Nutr Biol, Sacramento, CA 95817 USA; [Kieffer, Dorothy A.; Adams, Sean H.; Martin, Roy J.] Univ Calif Davis, Dept Nutr, Sacramento, CA 95817 USA; [Kieffer, Dorothy A.; Adams, Sean H.] USDA ARS, Western Human Nutr Res Ctr, Obes & Metab Res Unit, Davis, CA USA	University of California System; University of California Irvine; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Vaziri, ND (corresponding author), Univ Calif Irvine, Div Nephrol, Irvine, CA 92717 USA.	ndvaziri@uci.edu	Liu, Shuman/C-1218-2015; Lau, Wei Ling/AAE-4397-2020; ADAMS, SEAN/N-9262-2018	ADAMS, SEAN/0000-0002-9515-2319	USDA-ARS Project [5306-51530-019-00]; Danish Council for Strategic Research; ARS [ARS-0426492] Funding Source: Federal RePORTER	USDA-ARS Project; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported in part by intramural USDA-ARS Project 5306-51530-019-00 (SHA) and the Danish Council for Strategic Research (RJM). USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminzadeh MA, 2012, TRANSL RES, V160, P309, DOI 10.1016/j.trsl.2012.03.003; Baer DJ, 2014, J NUTR, V144, P1023, DOI 10.3945/jn.113.185298; Birt DF, 2013, ADV NUTR, V4, P587, DOI 10.3945/an.113.004325; Bossola M, 2009, CLIN J AM SOC NEPHRO, V4, P379, DOI 10.2215/CJN.03490708; Charrier JA, 2013, OBESITY, V21, P2350, DOI 10.1002/oby.20362; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Hendrikx TK, 2009, NEPHROL DIAL TRANSPL, V24, P1969, DOI 10.1093/ndt/gfp005; Kalmokoff M, 2013, J APPL MICROBIOL, V114, P1516, DOI 10.1111/jam.12157; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Keenan MJ, 2012, J NUTRIGENET NUTRIGE, V5, P26, DOI 10.1159/000335319; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Murtagh FEM, 2007, ADV CHRONIC KIDNEY D, V14, P82, DOI 10.1053/j.ackd.2006.10.001; Sakurai H, 1996, BBA-MOL BASIS DIS, V1316, P132, DOI 10.1016/0925-4439(96)00022-1; Shen L, 2011, MOL NUTR FOOD RES, V55, P1499, DOI 10.1002/mnfr.201000605; Shi K, 2014, DIGESTIVE D IN PRESS; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Vaziri ND, 2002, HYPERTENSION, V39, P135, DOI 10.1161/hy0102.100540; Vaziri ND, 2013, AM J NEPHROL, V38, P99, DOI 10.1159/000353764; Vaziri ND, 2013, AM J NEPHROL, V37, P1, DOI 10.1159/000345969; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, AM J NEPHROL, V36, P438, DOI 10.1159/000343886; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Vaziri ND, 2012, J RENAL NUTR, V22, P149, DOI 10.1053/j.jrn.2011.10.020; Vidrine K, 2014, OBESITY, V22, P344, DOI 10.1002/oby.20501; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang FQ, 2012, DIGEST DIS SCI, V57, P2856, DOI 10.1007/s10620-012-2242-0; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Wutzke KD, 2013, ISOT ENVIRON HEALT S, V49, P464, DOI 10.1080/10256016.2013.804519; Younes H, 1999, AM J KIDNEY DIS, V33, P633, DOI 10.1016/S0272-6386(99)70213-1; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	35	188	199	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114881	10.1371/journal.pone.0114881	http://dx.doi.org/10.1371/journal.pone.0114881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490712	Green Published, gold			2022-12-26	WOS:000347515300090
J	Winkler, MA; Dib, C; Ljubimov, AV; Saghizadeh, M				Winkler, Michael A.; Dib, Christian; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh			Targeting miR-146a to Treat Delayed Wound Healing in Human Diabetic Organ-Cultured Corneas	PLOS ONE			English	Article							STEM-CELL DEFICIENCY; C-MET GENE; BASEMENT-MEMBRANE; INTEGRIN ALTERATIONS; MICRORNA; INFLAMMATION; EXPRESSION; CANCER; DIFFERENTIATION; PROLIFERATION	Limbal epithelial stem cells (LESC) residing at the corneal periphery are largely responsible for maintaining corneal optical transparency by continuously supplying new corneal epithelial cells, which mature during their radial migration to the central cornea. Diabetes mellitus (DM) affects all the structures of the eye including the cornea. Frequent epithelial erosions, delayed wound healing, and microbial infections are common alterations of the diabetic eye that can result in vision loss. MicroRNAs (miRNAs) are short non-coding oligonucleotides that regulate gene expression by repressing translation. Our purpose was to understand the role of miR-146a in the human limbal versus central corneal epithelial compartment in normal and pathological conditions such as diabetes mellitus. Using quantitative real-time PCR (QPCR) we found miR-146a enrichment in the limbal corneal compartment. This miRNA was also expressed at higher levels in the diabetic vs. normal limbus. Cell migration and wound closure were significantly delayed in normal and diabetic primary limbal epithelial cells (LEC) transfected with miR-146a. Cells treated with miR-146a had decreased levels of phosphorylated (activated) p38 and EGFR, mediators of epithelial wound healing. Conversely, inhibition of miR-146a significantly enhanced cell migration in both normal and diabetic primary LEC and in diabetic organ-cultured corneas by nearly 40% vs. scrambled miRNA control, accompanied by increased phosphorylated signaling intermediates. Transfection of miR-146a in cultured LEC resulted in an increased immunoreactivity for putative LEC markers Frizzled-7 and K15, whereas inhibition of miR-146a decreased their expressions. These data suggest that miR-146a plays a role in LEC maintenance at the corneal periphery, and its expression is downregulated during their migration towards the central cornea and accompanying terminal differentiation. Furthermore, abnormal miR-146a upregulation may be an important mechanism of delayed wound healing in the diabetic cornea.	[Winkler, Michael A.; Dib, Christian; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Dept Biomed Sci, Eye Program, Los Angeles, CA 90048 USA; [Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Dib, Christian; Ljubimov, Alexander V.; Saghizadeh, Mehrnoosh] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saghizadeh, M (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Dept Biomed Sci, Eye Program, Los Angeles, CA 90048 USA.	ghiamm@cshs.org	Ljubimov, Alexander V/E-5883-2013; Ljubimov, Alexander/CAE-9130-2022	Ljubimov, Alexander/0000-0003-2398-5319	NIH [R21 EY022771, R01 EY13431]; Cedars-Sinai Regenerative Medicine Institute grants; NATIONAL EYE INSTITUTE [R01EY025377, R01EY013431, R21EY022771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Regenerative Medicine Institute grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH R21 EY022771, R01 EY13431, and Cedars-Sinai Regenerative Medicine Institute grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2014, CANCER LETT, V351, P134, DOI 10.1016/j.canlet.2014.05.013; Amitai-Lange A., 2014, STEM CELLS; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cavallerano J, 1992, Optom Clin, V2, P93; Cezar-de-Mello PFT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003099; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060317; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chous PA, 2003, DIABETIC EYE DIS, P87; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; HANNA C, 1961, ARCH OPHTHALMOL-CHIC, V65, P695; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Huang YQ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-142; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079926; Kabosova A, 2003, EXP EYE RES, V77, P211, DOI 10.1016/S0014-4835(03)00111-8; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kreidberg Jordan A, 2000, CURR OPIN CELL BIOL, V12, P548; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Lehrer MS, 1998, J CELL SCI, V111, P2867; Li Jun, 2010, Chinese Medical Sciences Journal, V25, P65, DOI 10.1016/S1001-9294(10)60024-7; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim P, 2009, SEMIN OPHTHALMOL, V24, P139, DOI 10.1080/08820530902801478; Lin DH, 2013, INVEST OPHTH VIS SCI, V54, P6167, DOI 10.1167/iovs.12-11577; Liu JJ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0092-7; Ljubimov AV, 1998, J HISTOCHEM CYTOCHEM, V46, P1033, DOI 10.1177/002215549804600907; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Saghizadeh M, 2001, AM J PATHOL, V158, P723, DOI 10.1016/S0002-9440(10)64015-1; Saghizadeh M, 2013, INVEST OPHTH VIS SCI, V54, P8172, DOI 10.1167/iovs.13-13233; Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632; Saghizadeh M, 2011, MOL VIS, V17, P2177; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Saghizadeh M, 2010, BRAIN RES BULL, V81, P262, DOI 10.1016/j.brainresbull.2009.10.007; Sanchez-Thorin JC, 1998, INT OPHTHALMOL CLIN, V38, P19, DOI 10.1097/00004397-199838020-00004; Sareen D, 2014, STEM CELL TRANSL MED, V3, P1002, DOI 10.5966/sctm.2014-0076; Schultz R O, 1981, Trans Am Ophthalmol Soc, V79, P180; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; United States Government, 2014, CHILDR FAM INC FACT; Wang BS, 2014, GENET MOL RES, V13, P5426, DOI 10.4238/2014.July.24.22; Wang Q, 2014, INVEST OPHTH VIS SCI, V55, P3986, DOI 10.1167/iovs.13-13076; Wei H, 2014, ENDOCR J; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yan YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080029; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	58	52	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114692	10.1371/journal.pone.0114692	http://dx.doi.org/10.1371/journal.pone.0114692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490205	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300067
J	Liaw, YW; Lin, CY; Lai, YS; Yang, TC; Wang, CJ; Whang-Peng, J; Liu, LF; Lin, CP; Nieh, S; Lu, SC; Hwang, JL				Liaw, Yi-Wei; Lin, Chi-Yu; Lai, Yu-Sheng; Yang, Tzu-Chung; Wang, Chau-Jong; Whang-Peng, Jacqueline; Liu, Leroy F.; Lin, Chia-Po; Nieh, Shin; Lu, Shao-Chun; Hwang, Jaulang			A Vaccine Targeted at CETP Alleviates High Fat and High Cholesterol Diet-Induced Atherosclerosis and Non-Alcoholic Steatohepatitis in Rabbit	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CORONARY-HEART-DISEASE; LIVER-DISEASE; CARDIOVASCULAR RISK; INHIBITION; METABOLISM; FC; INFLAMMATION	Low HDL-C levels are associated with atherosclerosis and non-alcoholic steatohepatitis, and increased levels may reduce the risk of these diseases. Inhibition of cholesteryl ester transfer protein (CETP) activity is considered a promising strategy for increasing HDL-C levels. Since CETP is a self-antigen with low immunogenicity, we developed a novel CETP vaccine (Fc-CETP6) to overcome the low immunogenicity of CETP and for long-term inhibition of CETP activity. The vaccine consists of a rabbit IgG Fc domain for antigen delivery to antigen-presenting cells fused to a linear array of 6 repeats of a CETP epitope to efficiently activate B cells. Rabbits were fed a high fat/cholesterol (HFC) diet to induce atherosclerosis and NASH, and immunized with Fc-CETP6 vaccine. The Fc-CETP6 vaccine successfully elicited anti-CETP antibodies and lowered plasma CETP activity. The levels of plasma HDL-C and ApoA-I were higher, and plasma ox-LDL lower, in the Fc-CETP6-immunized rabbits as compared to the unimmunized HFC diet-fed rabbits. Pathological analyses revealed less lipid accumulation and inflammation in the aorta and liver of the Fc-CETP6-immunized rabbits. These results show that the Fc-CETP6 vaccine efficiently elicited antibodies against CETP and reduced susceptibility to both atherosclerosis and steatohepatitis induced by the HFC diet. Our findings suggest that the Fc-CETP6 vaccine may improve atherosclerosis and NASH and has high potential for clinical use.	[Liaw, Yi-Wei; Hwang, Jaulang] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Lai, Yu-Sheng; Yang, Tzu-Chung; Lu, Shao-Chun] Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan; [Lin, Chi-Yu] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Whang-Peng, Jacqueline] Taipei Med Univ, Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Lin, Chia-Po] Bur Food & Drug Anal, Dept Hlth, Div Drug Biol, Taipei, Taiwan; [Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Liaw, Yi-Wei; Lin, Chi-Yu; Hwang, Jaulang] Taipei Med Univ, Coll Med, Dept Biochem, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Defense Medical Center; Chung Shan Medical University; Taipei Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Defense Medical Center; Taipei Medical University	Lu, SC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, Taipei 10764, Taiwan.	lsc@ntu.edu.tw; jaulangh@TMU.edu.tw		Liu, Leroy/0000-0001-9396-763X	National Health Research Institutes of Taiwan [NHRI-EX101-10153SI, NHRI-EX102-10153SI]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This study was supported by research grants NHRI-EX101-10153SI (http://goo.gl/bx7Wul) and NHRI-EX102-10153SI (http://goo.gl/w3824A) from the National Health Research Institutes of Taiwan. Dr. Shao-Chun Lu and Dr. Jaulang Hwang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Barter PJ, 2012, J LIPID RES, V53, P1755, DOI 10.1194/jlr.R024075; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; BLAKE WL, 1994, BIOCHEM BIOPH RES CO, V205, P1257, DOI 10.1006/bbrc.1994.2800; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Brousseau ME, 2009, J LIPID RES, V50, P1456, DOI 10.1194/jlr.P800037-JLR200; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Buyssens N, 1996, HEPATOLOGY, V24, P939; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Chang PY, 2004, J LIPID RES, V45, P2116, DOI 10.1194/jlr.M400229-JLR200; Cheng AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033917; Chiang HL, 2012, VACCINE, V30, P7573, DOI 10.1016/j.vaccine.2012.10.041; Clark RW, 2006, J LIPID RES, V47, P537, DOI 10.1194/jlr.M500349-JLR200; Davidson MH, 2003, ATHEROSCLEROSIS, V169, P113, DOI 10.1016/S0021-9150(03)00137-0; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOSSELIN EJ, 1992, J IMMUNOL, V149, P3477; Honey K, 2007, J CLIN INVEST, V117, P282, DOI 10.1172/JCI31253; Hsu CT, 2000, CANCER RES, V60, P3701; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lucero D, 2011, CLIN CHIM ACTA, V412, P587, DOI 10.1016/j.cca.2010.12.012; Musunuru K, 2010, LIPIDS, V45, P907, DOI 10.1007/s11745-010-3408-1; Navab M, 2005, TRENDS CARDIOVAS MED, V15, P158, DOI 10.1016/j.tcm.2005.05.008; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Nicholls SJ, 2008, CIRCULATION, V118, P2506, DOI 10.1161/CIRCULATIONAHA.108.790733; Ogawa T, 2010, AM J PATHOL, V177, P153, DOI 10.2353/ajpath.2010.090895; Ota H, 2006, J VET MED SCI, V68, P1179, DOI 10.1292/jvms.68.1179; Patel S, 2010, ATHEROSCLEROSIS, V212, P392, DOI 10.1016/j.atherosclerosis.2010.05.035; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Qi GF, 2004, VACCINE, V22, P3187, DOI 10.1016/j.vaccine.2004.01.060; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Rhainds D, 2012, FUTUR CARDIOL, V8, P513, DOI [10.2217/FCA.12.25, 10.2217/fca.12.25]; Rittershaus CW, 2000, ARTERIOSCL THROM VAS, V20, P2106, DOI 10.1161/01.ATV.20.9.2106; Smith JD, 2010, CURR OPIN INVEST DR, V11, P989; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; TALL AR, 1986, J LIPID RES, V27, P361; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	45	26	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e111529	10.1371/journal.pone.0111529	http://dx.doi.org/10.1371/journal.pone.0111529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486007	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600006
J	Ogoma, SB; Ngonyani, H; Simfukwe, ET; Mseka, A; Moore, J; Maia, MF; Moore, SJ; Lorenz, LM				Ogoma, Sheila B.; Ngonyani, Hassan; Simfukwe, Emmanuel T.; Mseka, Antony; Moore, Jason; Maia, Marta F.; Moore, Sarah J.; Lorenz, Lena M.			The Mode of Action of Spatial Repellents and Their Impact on Vectorial Capacity of Anopheles gambiae sensu stricto	PLOS ONE			English	Article							MOSQUITOS DIPTERA; ATTRACTION; BEHAVIOR; PROVINCE; INSECTS; RANGE; BAITS; NETS; PUSH	Malaria vector control relies on toxicity of insecticides used in long lasting insecticide treated nets and indoor residual spraying. This is despite evidence that sub-lethal insecticides reduce human-vector contact and malaria transmission. The impact of sub-lethal insecticides on host seeking and blood feeding of mosquitoes was measured. Taxis boxes distinguished between repellency and attraction inhibition of mosquitoes by measuring response of mosquitoes towards or away from Transfluthrin coils and humans. Protective effective distance of coils and long-term effects on blood feeding were measured in the semi-field tunnel and in a Peet Grady chamber. Laboratory reared pyrethroid susceptible Anopheles gambiae sensu stricto mosquitoes were used. In the taxis boxes, a higher proportion of mosquitoes (67%-82%) were activated and flew towards the human in the presence of Transfluthrin coils. Coils did not hinder attraction of mosquitoes to the human. In the semi-field Tunnel, coils placed 0.3 m from the human reduced feeding by 86% (95% CI [0.66; 0.95]) when used as a "bubble'' compared to 65% (95% CI [0.51; 0.76]) when used as a "point source''. Mosquitoes exposed to coils inside a Peet Grady chamber were delayed from feeding normally for 12 hours but there was no effect on free flying and caged mosquitoes exposed in the semi-field tunnel. These findings indicate that airborne pyrethroids minimize human-vector contact through reduced and delayed blood feeding. This information is useful for the development of target product profiles of spatial repellent products that can be used to complement mainstream malaria vector control tools.	[Ogoma, Sheila B.; Ngonyani, Hassan; Simfukwe, Emmanuel T.; Mseka, Antony; Moore, Jason; Maia, Marta F.; Moore, Sarah J.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Bagamoyo, Tanzania; [Ogoma, Sheila B.; Moore, Jason; Lorenz, Lena M.] London Sch Hyg & Trop Med, London WC1, England; [Maia, Marta F.; Moore, Sarah J.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Maia, Marta F.; Moore, Sarah J.] Univ Basel, Basel, Switzerland	Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Ogoma, SB (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Bagamoyo, Tanzania.	sogoma@ihi.or.tz	Moore, Sarah J/HGE-7143-2022; Maia, Marta/I-6003-2019	Moore, Sarah J/0000-0002-0938-6654; Maia, Marta/0000-0003-3302-5610	Bill and Melinda Gates Foundation [51431]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation with the grant number: 51431. The grant was awarded to SJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bernier U.R., 2006, INSECT REPELLENTS PR, P77; Bernier UR, 2005, J MED ENTOMOL, V42, P306, DOI 10.1603/0022-2585(2005)042[0306:COCASR]2.0.CO;2; Bernier UR, 2007, INSECT REPELLENTS PR, P77; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bugoro H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-287; CHADWICK PR, 1975, B ENTOMOL RES, V65, P97, DOI 10.1017/S0007485300005800; Chavasse DC, 1996, T ROY SOC TROP MED H, V90, P493, DOI 10.1016/S0035-9203(96)90291-6; Cohnstaedt LW, 2011, J VECTOR ECOL, V36, P395, DOI 10.1111/j.1948-7134.2011.00180.x; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; dellaTorre A, 1997, GENETICS, V146, P239; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Dickens JC, 2013, PESTICIDE BIOCH PHYS; Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; GILLIES MT, 1970, B ENTOMOL RES, V60, P225, DOI 10.1017/S000748530004075X; GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill N, 2007, BMJ-BRIT MED J, V335, P1001; KENNEDY JS, 1947, B ENTOMOL RES, V37, P593, DOI 10.1017/S0007485300030091; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kitau J, 2010, J AM MOSQUITO CONTR, V26, P287, DOI 10.2987/09-5979.1; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; KNOLS BGJ, 1993, MED VET ENTOMOL, V7, P161, DOI 10.1111/j.1365-2915.1993.tb00670.x; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lorenz LM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-131; Lucas JR, 2007, J AM MOSQUITO CONTR, V23, P47, DOI 10.2987/8756-971X(2007)23[47:ULAFTO]2.0.CO;2; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; MILLER JE, 1994, J MED ENTOMOL, V31, P114, DOI 10.1093/jmedent/31.1.114; Mita T, 2003, AM J TROP MED HYG, V68, P413, DOI 10.4269/ajtmh.2003.68.413; Obermayr U, 2012, J MED ENTOMOL, V49, P1387, DOI 10.1603/ME12084; Ogoma SB, 2012, PARASIT VECTORS; Ogoma SB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-131; Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-287; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; WHOPES, 2009, GUID EFF TEST MOSQ R; Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2; Winney R., 1975, Pyrethrum Post, V13, P17	46	42	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e110433	10.1371/journal.pone.0110433	http://dx.doi.org/10.1371/journal.pone.0110433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485850	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000346907600004
J	Fajardo, J; Lessmann, J; Bonaccorso, E; Devenish, C; Munoz, J				Fajardo, Javier; Lessmann, Janeth; Bonaccorso, Elise; Devenish, Christian; Munoz, Jesus			Combined Use of Systematic Conservation Planning, Species Distribution Modelling, and Connectivity Analysis Reveals Severe Conservation Gaps in a Megadiverse Country (Peru)	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; HABITAT AVAILABILITY; RESERVE SELECTION; SAMPLE-SIZE; AREAS; SENSITIVITY; PERFORMANCE; PREDICTION; SOFTWARE; ECUADOR	Conservation planning is crucial for megadiverse countries where biodiversity is coupled with incomplete reserve systems and limited resources to invest in conservation. Using Peru as an example of a megadiverse country, we asked whether the national system of protected areas satisfies biodiversity conservation needs. Further, to complement the existing reserve system, we identified and prioritized potential conservation areas using a combination of species distribution modeling, conservation planning and connectivity analysis. Based on a set of 2,869 species, including mammals, birds, amphibians, reptiles, butterflies, and plants, we used species distribution models to represent species' geographic ranges to reduce the effect of biased sampling and partial knowledge about species' distributions. A site-selection algorithm then searched for efficient and complementary proposals, based on the above distributions, for a more representative system of protection. Finally, we incorporated connectivity among areas in an innovative post-hoc analysis to prioritize those areas maximizing connectivity within the system. Our results highlight severe conservation gaps in the Coastal and Andean regions, and we propose several areas, which are not currently covered by the existing network of protected areas. Our approach helps to find areas that contribute to creating a more representative, connected and efficient network.	[Fajardo, Javier] Univ Extremadura, Ctr Univ Merida, Merida, Spain; [Fajardo, Javier; Munoz, Jesus] Real Jardin Botan RJB CSIC, Madrid, Spain; [Lessmann, Janeth; Bonaccorso, Elise; Munoz, Jesus] Univ Tecnol Indoamer, Ctr Biodiversidad & Cambio Climat, Quito, Ecuador; [Bonaccorso, Elise] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Devenish, Christian] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Manchester M15 6BH, Lancs, England; [Devenish, Christian] Ctr Ornitol & Biodiversidad CORBIDI, Lima, Peru	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Kansas; Manchester Metropolitan University	Fajardo, J (corresponding author), Univ Extremadura, Ctr Univ Merida, Merida, Spain.	javierfajnolla@gmail.com	Munoz, Jesus/B-7809-2008; Lessmann, Janeth/M-1524-2017; Fajardo, Javier/AAG-7278-2020	Lessmann, Janeth/0000-0002-1502-625X; Fajardo, Javier/0000-0002-0990-9718; Devenish, Christian/0000-0002-5249-0844	CRUE-CEPYME; ATECMA; Ministry of Economy and Competitiveness of Spain [CGL2012-38624-C02-02]; Universidad Tecnologica Indoamerica	CRUE-CEPYME; ATECMA; Ministry of Economy and Competitiveness of Spain(Spanish Government); Universidad Tecnologica Indoamerica	CRUE-CEPYME grants with the cooperation of ATECMA funded JF to perform this study. JM is currently supported by grant CGL2012-38624-C02-02 of the Ministry of Economy and Competitiveness of Spain. The involvement of JL and EB was supported by Universidad Tecnologica Indoamerica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Angulo Pratolongo F, 2009, BIRDLIFE CONSERVATIO, V16, P307; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Ardron J. A., 2008, MARXAN GOOD PRACTICE; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Carvalho SB, 2010, BIOL CONSERV, V143, P426, DOI 10.1016/j.biocon.2009.11.010; Centro de Datos para la Conservacion Universidad Nacional Agraria La Molina The Natural Conservancy, 2006, PLANIFICACION PARA L; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Delgado-Jaramillo M, 2013, THESIS; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J., 2009, SPATIAL CONSERVATION, P70; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Fernandez-Baca J, 2007, PRIORITIES FOR COAST, P45; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Game ET, 2008, MARXAN USER MANUAL F; Gaston KJ, 2003, CONSERV BIOL, V17, P188, DOI 10.1046/j.1523-1739.2003.01268.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2012, IUCN RED LIST THREAT; Jenkins CN, 2013, PNAS, V110, P1; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Lessmann J, 2014, ECOL EVOL, V4, P2410, DOI 10.1002/ece3.1102; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maddock A, 1999, BIODIVERS CONSERV, V8, P603, DOI 10.1023/A:1008819015819; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mateo RG, 2008, THESIS; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Nakandakari A, 2012, THESIS; Noss R.F., 2006, CONNECTIVITY CONSERV, P587, DOI [10.1017/CBO9780511754821.026, DOI 10.1017/CBO9780511754821.026]; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Possingham H. P., 2006, PRINCIPLES BIOL CONS, P507; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Ridgely R. S., 2012, BIRD SPECIES DISTRIB; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez LO, 2000, AMBIO, V29, P329, DOI 10.1639/0044-7447(2000)029[0329:BDOPDP]2.0.CO;2; Rodriguez LO, 1996, DIVERSIDAD BIOLOGICA; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Sanchez-Cordero Victor, 2005, Biodiversity Informatics, V2, P11; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Schulenberg T.S., 2007, BIRDS PERU REVISED U, P18; SERNANP, 2009, PLAN DIRECTOR DE LAS; SERNANP, 2012, LISTADO DE AREAS PRO; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Underwood JG, 2010, CONSERV BIOL, V24, P162, DOI 10.1111/j.1523-1739.2009.01303.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Velazquez-Tibata J, 2012, REGIONAL ENV CHANGE, V13, P14; Veliz Rosas C, 2008, ZONAS ARIDAS, V12, P36; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Whitehouse JF, 1992, IVTH WORLD CONGRESS; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	77	66	71	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114367	10.1371/journal.pone.0114367	http://dx.doi.org/10.1371/journal.pone.0114367			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479411	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200079
J	Hamaoka, BY; Ghosh, P				Hamaoka, Brent Y.; Ghosh, Partho			Structure of the Essential Plasmodium Host Cell Traversal Protein SPECT1	PLOS ONE			English	Article							HELIX-HELIX PACKING; MEMBRANE-ATTACK; SPOROZOITE; BINDING; FAMILY; DOMAIN	Host cell traversal by Plasmodium, the protozoan cause of malaria, is an essential part of this parasite's virulence. In this process, the parasite enters a host cell through a parasite-induced pore, traverses the host cell, and then exits the host cell. Two P. berghei proteins, SPECT1 and SPECT2, are required for host cell traversal by the sporozoite form of the parasite. In the absence of either, no pore formation is observed. While SPECT2 has sequence homology to pore-forming proteins, SPECT1 has no homology to proteins of known structure or function. Here we present the 2.75 angstrom resolution structure of a slightly truncated version of P. berghei SPECT1. The structure reveals that the protein forms a four-helix bundle, with the rare feature of having all of these helices in parallel or antiparallel alignment. Also notable is the presence of a large, conserved, hydrophobic internal cavity in the protein, which may constitute a ligand-binding site or be indicative of partial instability in SPECT1, or both. The structure of SPECT1 will make possible targeted mutagenesis experiments aimed at understanding its mechanism of action in host cell traversal.	[Hamaoka, Brent Y.; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pghosh@ucsd.edu			National Institutes of Health (NIH) [T32 CA0092523]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) T32 CA0092523 (BYH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Bowie JU, 1997, NAT STRUCT BIOL, V4, P915, DOI 10.1038/nsb1197-915; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FENG YQ, 1991, BIOCHEMISTRY-US, V30, P10150, DOI 10.1021/bi00106a011; FENG YQ, 1994, NAT STRUCT BIOL, V1, P30, DOI 10.1038/nsb0194-30; Formaglio P, 2014, PARASITOL INT, V63, P237, DOI 10.1016/j.parint.2013.07.009; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Garg S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2725; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Greenwood AI, 2006, CHEM PHYS LIPIDS, V143, P1, DOI 10.1016/j.chemphyslip.2006.04.002; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; KAMTEKAR S, 1995, FASEB J, V9, P1013, DOI 10.1096/fasebj.9.11.7649401; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEDERER F, 1981, J MOL BIOL, V148, P427, DOI 10.1016/0022-2836(81)90185-6; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Mali Sonja, 2008, Morbidity and Mortality Weekly Report, V57, P24; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; Otwinowski Z, METHODS ENZYMOLOGY, P307; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Tavares J, 2013, J EXP MED, V210, P905, DOI 10.1084/jem.20121130; VANDERBERG JP, 1990, J PROTOZOOL, V37, P528, DOI 10.1111/j.1550-7408.1990.tb01260.x; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Walther D, 1998, PROTEINS, V33, P457, DOI 10.1002/(SICI)1097-0134(19981201)33:4<457::AID-PROT1>3.0.CO;2-L; Walther D, 1996, J MOL BIOL, V255, P536, DOI 10.1006/jmbi.1996.0044; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x	38	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114685	10.1371/journal.pone.0114685	http://dx.doi.org/10.1371/journal.pone.0114685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479287	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200111
J	Jian, Y; Silvestri, S; Brown, J; Hickman, R; Marani, M				Jian, Yun; Silvestri, Sonia; Brown, Jeff; Hickman, Rick; Marani, Marco			The Temporal Spectrum of Adult Mosquito Population Fluctuations: Conceptual and Modeling Implications	PLOS ONE			English	Article							CULISETA MELANURA DIPTERA; CULEX MOSQUITOS; TIME-SERIES; ABUNDANCE; HABITATS; TEMPERATURE; VARIABILITY; DYNAMICS; PREDICT; DESIGN	An improved understanding of mosquito population dynamics under natural environmental forcing requires adequate field observations spanning the full range of temporal scales over which mosquito abundance fluctuates in natural conditions. Here we analyze a 9-year daily time series of uninterrupted observations of adult mosquito abundance for multiple mosquito species in North Carolina to identify characteristic scales of temporal variability, the processes generating them, and the representativeness of observations at different sampling resolutions. We focus in particular on Aedes vexans and Culiseta melanura and, using a combination of spectral analysis and modeling, we find significant population fluctuations with characteristic periodicity between 2 days and several years. Population dynamical modelling suggests that the observed fast fluctuations scales (2 days-weeks) are importantly affected by a varying mosquito activity in response to rapid changes in meteorological conditions, a process neglected in most representations of mosquito population dynamics. We further suggest that the range of time scales over which adult mosquito population variability takes place can be divided into three main parts. At small time scales (indicatively 2 days-1 month) observed population fluctuations are mainly driven by behavioral responses to rapid changes in weather conditions. At intermediate scales (1 to several month) environmentally-forced fluctuations in generation times, mortality rates, and density dependence determine the population characteristic response times. At longer scales (annual to multi-annual) mosquito populations follow seasonal and inter-annual environmental changes. We conclude that observations of adult mosquito populations should be based on a sub-weekly sampling frequency and that predictive models of mosquito abundance must include behavioral dynamics to separate the effects of a varying mosquito activity from actual changes in the abundance of the underlying population.	[Jian, Yun; Silvestri, Sonia; Marani, Marco] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Brown, Jeff; Hickman, Rick] Brunswick Cty Govt, Mosquito Control Dept, Brunswick, NC 28422 USA; [Marani, Marco] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; [Marani, Marco] Univ Padua, Dept Civil Architectural & Environm Engn, Padua, Italy	Duke University; Duke University; University of Padua	Marani, M (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	marco.marani@duke.edu	Marani, Marco/F-9451-2016	Marani, Marco/0000-0002-1493-6913; SILVESTRI, SONIA/0000-0002-5114-8633	Nicholas School of the Environment	Nicholas School of the Environment	The authors acknowledge support by the Nicholas School of the Environment (graduate support to YJ, and funding to MM and SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MOSQUITOES THEIR CON; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Brunswick County Government, 2011, MOSQ CONTR; Buckner E., 2012, FEATURED CREATURES; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Chadee DD, 2014, ACTA TROP, V132, pS86, DOI 10.1016/j.actatropica.2013.09.019; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chuang TW, 2012, REMOTE SENS ENVIRON, V125, P147, DOI 10.1016/j.rse.2012.07.018; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Clements AN., 1992, BIOL MOSQUITOES DEV; Crans WJ, 2013, AEDES VEXANS MEIGEN; Crans WJ, 2013, CULISETA MELANURA CO; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Deyle ER, 2013, P NATL ACAD SCI USA, V110, P6430, DOI 10.1073/pnas.1215506110; Ermert V., 2011, MALARIA J, V10; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Hart EM, 2011, OIKOS, V120, P1227, DOI 10.1111/j.1600-0706.2011.18707.x; Horsfall W. R., 1973, BIONOMICS EMBRYOLOGY; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Jian Y, 2014, ECOL MODEL, V272, P301, DOI 10.1016/j.ecolmodel.2013.10.019; Kantz H., 2004, NONLINEAR TIME SERIE; MacKenzie D.I., 2005, OCCUPANCY ESTIMATION; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahmood F, 1997, J AM MOSQUITO CONTR, V13, P92; Mahmood F, 1998, J MED ENTOMOL, V35, P980, DOI 10.1093/jmedent/35.6.980; Mahmood F, 1998, J MED ENTOMOL, V35, P1007, DOI 10.1093/jmedent/35.6.1007; MALONEY JM, 1976, MOSQ NEWS, V36, P190; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; Nadeem K, 2012, OIKOS, V121, P1656, DOI 10.1111/j.1600-0706.2011.20010.x; Polansky L, 2010, ECOLOGY, V91, P1506, DOI 10.1890/08-2159.1; Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P105; Reisen WK, 1999, J AM MOSQUITO CONTR, V15, P24; Reisen WK, 2000, J AM MOSQUITO CONTR, V16, P13; REISEN WK, 1987, J AM MOSQUITO CONTR, V3, P601; Royle J. A., 2008, HIERARCHICAL MODELIN; Russell TL, 2011, P ROY SOC B-BIOL SCI, V278, P3142, DOI 10.1098/rspb.2011.0153; Sanford MR, 2011, PLOS ONE, V6; Shaman J, 2002, EMERG INFECT DIS, V8, P6; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Shaman J, 2011, J MED ENTOMOL, V48, P867, DOI 10.1603/ME10269; Shumway R.H., 2006, TIME SERIES ANAL ITS; Shumway RH, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7865-3; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; TRPIS M, 1970, CAN ENTOMOL, V102, P1048, DOI 10.4039/Ent1021048-8; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; Yang GJ, 2008, POPUL ECOL, V50, P293, DOI 10.1007/s10144-008-0082-8; Yang GJ, 2008, ECOL APPL, V18, P2028, DOI 10.1890/07-1209.1; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]	56	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114301	10.1371/journal.pone.0114301	http://dx.doi.org/10.1371/journal.pone.0114301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478861	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200069
J	Shioji, S; Imai, S; Ando, K; Kumagai, K; Matsusue, Y				Shioji, Suguru; Imai, Shinji; Ando, Kosei; Kumagai, Kousuke; Matsusue, Yoshitaka			Extracellular and Intracellular Mechanisms of Mechanotransduction in Three-Dimensionally Embedded Rat Chondrocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN ARTICULAR CHONDROCYTES; COLLAGEN-INDUCED ARTHRITIS; N-TERMINAL KINASE; GENE-EXPRESSION; PROTEOGLYCAN SYNTHESIS; CARTILAGE DESTRUCTION; UP-REGULATION; ATDC5 CELLS; IN-VIVO	Purpose: Articular cartilage homeostasis involves modulation of chondrocyte matrix synthesis in response to mechanical stress (MS). We studied extracellular and intracellular mechanotransduction pathways mediating this response. Methods: We first confirmed rapid up-regulation of the putative chondro-protective cytokine, interleukin (IL)-4, as an immediate response to MS. We then studied the role of IL-4 by investigating responses to exogenous IL-4 or a specific IL-4 inhibitor, combined with MS. Next we investigated the intracellular second messengers. Since chondrocyte phenotype alters according to the extracellular environment, we characterized the response to mechanotransduction in 3-dimensionally embedded chondrocytes. Results: Expression of aggrecan and type II collagen was significantly up-regulated by exogenous IL-4 whereas MS-induced matrix synthesis was inhibited by an IL-4 blocker. Further, MS-induced matrix synthesis was completely blocked by a p38 MAPK inhibitor, while it was only partially blocked by inhibitors of other putative second messengers. Conclusion: IL-4 mediates an extracellular pathway of mechanotransduction, perhaps via an autocrine/paracrine loop, while p38 mediates an intracellular pathway prevalent only in a 3-dimensional environment.	[Shioji, Suguru; Imai, Shinji; Ando, Kosei; Kumagai, Kousuke; Matsusue, Yoshitaka] Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 52021, Japan	Shiga University of Medical Science	Shioji, S (corresponding author), Shiga Univ Med Sci, Dept Orthoped Surg, Otsu, Shiga 52021, Japan.	sshioji@bella.shiga-med.acjp			Japan Society for the Promotion of Science [22500457]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#22500457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2009, ACTA ORTHOP, V80, P724, DOI 10.3109/17453670903413111; Badger AM, 1998, J IMMUNOL, V161, P467; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bobick BE, 2006, EXP CELL RES, V312, P1079, DOI 10.1016/j.yexcr.2005.12.028; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chai DH, 2010, OSTEOARTHR CARTILAGE, V18, P249, DOI 10.1016/j.joca.2009.09.002; Chaipinyo K, 2004, J ORTHOP RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Eckstein F, 1999, ANAT EMBRYOL, V200, P419, DOI 10.1007/s004290050291; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Joosten LAB, 1997, ARTHRITIS RHEUM, V40, P249, DOI 10.1002/art.1780400209; Jorgensen C, 1998, IMMUNOLOGY, V93, P518; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kong DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069403; KORVER THV, 1992, J RHEUMATOL, V19, P905; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Lubberts E, 1999, J IMMUNOL, V163, P4546; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Millward-Sadler SJ, 2006, OSTEOARTHR CARTILAGE, V14, P991, DOI 10.1016/j.joca.2006.03.013; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x; Rai MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025749; Ridley SH, 1997, J IMMUNOL, V158, P3165; Saito T, 2013, OSTEOARTHR CARTILAGE, V21, P165, DOI 10.1016/j.joca.2012.09.003; Salter DM, 2001, CLIN ORTHOP RELAT R, pS49; Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.3.CO;2-B; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou Y, 2007, OSTEOARTHR CARTILAGE, V15, P884, DOI 10.1016/j.joca.2007.02.001	39	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114327	10.1371/journal.pone.0114327	http://dx.doi.org/10.1371/journal.pone.0114327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479057	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200073
J	Bouquie, R; Wainstein, L; Pilet, P; Mussini, JM; Deslandes, G; Clouet, J; Dailly, E; Jolliet, P; Victorri-Vigneau, C				Bouquie, Regis; Wainstein, Laura; Pilet, Paul; Mussini, Jean-Marie; Deslandes, Guillaume; Clouet, Johann; Dailly, Eric; Jolliet, Pascale; Victorri-Vigneau, Caroline			Crushed and Injected Buprenorphine Tablets: Characteristics of Princeps and Generic Solutions	PLOS ONE			English	Article							DERMATITIS NICOLAUS-SYNDROME; PARTICULATE MATTER; INFUSION PHLEBITIS; LIVEDO; FILTRATION; AUSTRALIA; DIVERSION	Self-injection of high-dose buprenorphine is responsible for well-described complications. In 2011, we have been alerted by unusual but serious cutaneous complication among injection buprenorphine users. A prospective data collection identified 30 cases of necrotic cutaneous lesions after injection of filtered buprenorphine solution, among which 25 cases occurred following injection of buprenorphine generics. The main goal of our study was to put forward particularities that could explain the cutaneous complications, by qualitatively and quantitatively confronting particles present in Subutex and generics solutions. We used the same protocol that injected-buprenorphine users: generic or subutex tablets were crushed in sterile water and filtered through 2 filters commonly used (cotton-pad and sterifilt). Solutions were analyzed by laser granulometry, flow cytometry and scanning electron microscopy. We have highlighted the wide variation of the quantity and the size of the particles present in solution between the two drugs after cotton-pad filtration. The proportion of particles <10 mu m is systematically higher in the generic solutions than with Subutex. All of the insoluble particles found in generic solutions contain silica, whereas non-organic element was to be identified in the insoluble particles of Subutex. One skin biopsy obtained from one patient who developed a necrotic lesion after intravenous injection of filtrated solution of buprenorphine generic, shows non-organic elements. Identification of particles in situ enables us to confirm the presence of silica in the biopsy. Actually the monitoring of patient receiving generic of buprenorphine must be strengthened.	[Bouquie, Regis; Wainstein, Laura; Deslandes, Guillaume] CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France; [Bouquie, Regis; Jolliet, Pascale; Victorri-Vigneau, Caroline] Univ Nantes, EA Biostat Pharmacoepidemiol & Mesures Subject Sa, Nantes, France; [Pilet, Paul] Univ Nantes, INSERM, UMR 791, Lab Ingn Osteoarticulaire & Dent LIOAD, Nantes, France; [Pilet, Paul] CHU Nantes, Pole Hosp Univ 4, F-44035 Nantes 01, France; [Mussini, Jean-Marie] CHU Nantes, Anat Pathol Lab, F-44035 Nantes 01, France; [Clouet, Johann] Univ Nantes, INSERM, Unite Mixte Rech Sante UMRS 791, Lab Ingen Osteoarticulaire & Dent LIOAD, Nantes, France; [Clouet, Johann] CHU Nantes, Pole Hosp Univ 7, Pharm Cent, F-44035 Nantes 01, France; [Dailly, Eric; Jolliet, Pascale] CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France; [Dailly, Eric] Univ Nantes, EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Victorri-Vigneau, Caroline] CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France	Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; CHU de Nantes	Bouquie, R (corresponding author), CHU Nantes, Serv Pharmacol Clin, F-44035 Nantes 01, France.	regis.bouquie@chu-nantes.fr	Paul, Pilet/A-3755-2015; Clouet, Johann/P-1358-2014; Jolliet, pascale/L-9026-2015; Victorri Vigneau, Caroline/L-9030-2015	Victorri-Vigneau, Caroline/0000-0002-3745-2532; Dailly, Eric/0000-0002-5400-335X; Pascale, JOLLIET/0000-0003-0191-9249				ABRAHAM JL, 1980, ENVIRON RES, V21, P94, DOI 10.1016/0013-9351(80)90011-0; *AC NAT PHARM, 2011, SEANC THEM MAT PREM; Bellot B, 2014, ARCH PEDIATRIE, V21, P377, DOI 10.1016/j.arcped.2014.01.016; BOLLINGER RO, 1978, AM J HOSP PHARM, V35, P312, DOI 10.1093/ajhp/35.3.312; Brecheteau F, 2013, J SEX MED, V10, P2866, DOI 10.1111/jsm.12282; BREWSTER D, 1981, J PHARM PHARMACOL, V33, P500, DOI 10.1111/j.2042-7158.1981.tb13848.x; Cherasse A, 2003, JOINT BONE SPINE, V70, P390, DOI 10.1016/S1297-319X(03)00137-4; Corazza M, 2001, J EUR ACAD DERMATOL, V15, P585, DOI 10.1046/j.1468-3083.2001.00320.x; DAVIS NM, 1970, AM J HOSP PHARM, V27, P822, DOI 10.1093/ajhp/27.10.822; DELUCA PP, 1975, AM J HOSP PHARM, V32, P1001, DOI 10.1093/ajhp/32.10.1001; DRESSLER FA, 1989, AM J CARDIOL, V64, P909, DOI 10.1016/0002-9149(89)90841-2; EVANS WE, 1976, AM J HOSP PHARM, V33, P1160, DOI 10.1093/ajhp/33.11.1160; Gaudez C, 2003, REV NEUROL-FRANCE, V159, P571; Gayken J, 2006, J BURN CARE RES, V27, P541, DOI 10.1097/01.BCR.0000225917.09339.03; Glaizal M, 2011, THERAPIE, V66, P545, DOI 10.2515/therapie/2011069; Grau D, 2010, NOUV REV FR, P188; Guarneri C, 2010, AM J CLIN DERMATOL, V11, P51, DOI 10.2165/1153426-S0-000000000-00000; GUYTON AC, 1997, HUM PHYSIOL MECH DIS; HAHN HH, 1969, ARCH INTERN MED, V123, P656, DOI 10.1001/archinte.123.6.656; Hornez E, 2010, ANN CHIR PLAST ESTH, V55, P159, DOI 10.1016/j.anplas.2008.12.004; Jenkinson RA, 2005, ADDICTION, V100, P197, DOI 10.1111/j.1360-0443.2004.00958.x; Just PA, 2007, AM J DERMATOPATH, V29, P72, DOI 10.1097/01.dad.0000211508.67736.d4; Kienast AK, 2008, CLIN EXP DERMATOL, V33, P555, DOI 10.1111/j.1365-2230.2008.02861.x; Kim SK, 2012, ARCH PLAST SURG-APS, V39, P249, DOI 10.5999/aps.2012.39.3.249; Marangi GF, 2010, J DERMATOL, V37, P488, DOI 10.1111/j.1346-8138.2010.00864.x; Modzelewska I, 1980, Wiad Lek, V33, P231; Nayci Sillan, 2013, Indian Dermatol Online J, V4, P152, DOI 10.4103/2229-5178.110642; Perli Daniel, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007785; Potier A, 2007, ANN DERMATOL VENER, V134, P148, DOI 10.1016/S0151-9638(07)91607-5; Rahimi-Movaghar A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007775.pub2; Roux P, 2011, DRUG ALCOHOL REV, V30, P287, DOI 10.1111/j.1465-3362.2011.00285.x; Ruffieux P, 1996, DERMATOLOGY, V193, P368, DOI 10.1159/000246298; Schneider P, 2010, ARCH DERMATOL, V146, P208, DOI 10.1001/archdermatol.2009.372; SCHROEDER HG, 1976, AM J HOSP PHARM, V33, P543, DOI 10.1093/ajhp/33.6.543; Scott J, 2005, J SUBST USE, V10, P293, DOI DOI 10.1080/14659890412331319425; STANDRING S, 2008, GRAYS ANATOMY ANATOM, P127; *TIPH CAN, RAPP 2010 DONN REC R; Wainstein L, 2015, BRIT J DERMATOL, V172, P1412, DOI 10.1111/bjd.13503; Winstock AR, 2008, INT J DRUG POLICY, V19, P450, DOI 10.1016/j.drugpo.2007.03.002; Zaragoza J, 2013, ANN DERMATOL VENER, V140, P713, DOI 10.1016/j.annder.2013.07.009	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113991	10.1371/journal.pone.0113991	http://dx.doi.org/10.1371/journal.pone.0113991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474108	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500101
J	Safarzoda, S; Bahlai, CA; Fox, AF; Landis, DA				Safarzoda, Shahlo; Bahlai, Christine A.; Fox, Aaron F.; Landis, Douglas A.			The Role of Natural Enemy Foraging Guilds in Controlling Cereal Aphids in Michigan Wheat	PLOS ONE			English	Article							SCHIZAPHIS-GRAMINUM RONDANI; RHOPALOSIPHUM-PADI L; WINTER-WHEAT; BIOLOGICAL-CONTROL; GENERALIST PREDATORS; GREENBUGS HOMOPTERA; SEASONAL ABUNDANCE; BEETLE COLEOPTERA; YIELD LOSSES; PEST	Insect natural enemies (predators and parasitoids) provide important ecosystem services by suppressing populations of insect pests in many agricultural crops. However, the role of natural enemies against cereal aphids in Michigan winter wheat (Triticum aestivum L.) is largely unknown. The objectives of this research were to characterize the natural enemy community in wheat fields and evaluate the role of different natural enemy foraging guilds (foliar-foraging versus ground-dwelling predators) in regulating cereal aphid population growth. We investigated these objectives during the spring and summer of 2012 and 2013 in four winter wheat fields on the Michigan State University campus farm in East Lansing, Michigan. We monitored and measured the impact of natural enemies by experimentally excluding or allowing their access to wheat plants infested with Rhopalosiphum padi (L.) and Sitobion avenae (F.) (Hemiptera: Aphidae). Our results indicate that the natural enemy community in the wheat fields consisted mostly of foliar-foraging and ground-dwelling predators with relatively few parasitoids. In combination, these natural enemy groups were very effective at reducing cereal aphid populations. We also investigated the role of each natural enemy foraging guild (foliar-foraging versus ground-dwelling predators) independently. Overall, our results suggest that, in combination, natural enemies can almost completely halt early-season aphid population increase. Independently, ground-dwelling predators were more effective at suppressing cereal aphid populations than foliar-foraging predators under the conditions we studied. Our results differ from studies in Europe and the US Great Plains where foliar foraging predators and parasitoids are frequently more important cereal aphid natural enemies.	[Safarzoda, Shahlo; Bahlai, Christine A.; Fox, Aaron F.; Landis, Douglas A.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Michigan State University	Bahlai, CA (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	cbahlai@msu.edu	Landis, Douglas A./L-7991-2019; Bahlai, Christie/L-5500-2019	Bahlai, Christie/0000-0002-8937-8709	United States Agency for International Development (USAID) [EPP-A-00-0400016-00]; Michigan State University's College of Agriculture and Natural Resources, Graduate School, Office of International Studies and Programs, Department of Entomology, AgBioResearch; USDA National Institute of Food and Agriculture	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Michigan State University's College of Agriculture and Natural Resources, Graduate School, Office of International Studies and Programs, Department of Entomology, AgBioResearch; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Support for this study was provided by the United States Agency for International Development (USAID) Cooperative Agreement No: EPP-A-00-0400016-00 for the IPM Innovation Lab managed by Virginia Tech and with a sub-award to Michigan State University (http://www.usaid.gov/). Partial support was provided by Michigan State University's College of Agriculture and Natural Resources, Graduate School, Office of International Studies and Programs, Department of Entomology ( http://www.ent.msu.edu/), AgBioResearch (http://agbioresearch.msu.edu/), and the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsuhaibani AM, 1996, ARAB GULF J SCI RES, V14, P405; Banken JAO, 1998, J ECON ENTOMOL, V91, P1, DOI 10.1093/jee/91.1.1; BASEDOW T, 1985, PESTIC SCI, V16, P325, DOI 10.1002/ps.2780160404; Brewer MJ, 2004, ANNU REV ENTOMOL, V49, P219, DOI 10.1146/annurev.ento.49.061802.123149; BROWN KC, 1983, ENVIRON ENTOMOL, V12, P1747, DOI 10.1093/ee/12.6.1747; CHAMBERS RJ, 1986, ANN APPL BIOL, V108, P219, DOI 10.1111/j.1744-7348.1986.tb07644.x; CHAMBERS RJ, 1983, J APPL ECOL, V20, P209, DOI 10.2307/2403387; Chapin JW, 2001, J ECON ENTOMOL, V94, P410, DOI 10.1603/0022-0493-94.2.410; CHIVERTON PA, 1986, ANN APPL BIOL, V109, P49, DOI 10.1111/j.1744-7348.1986.tb03183.x; Clement SL, 2004, J KANSAS ENTOMOL SOC, V77, P165, DOI 10.2317/0311.19.1; CORDEIRO GM, 1993, J ROY STAT SOC B MET, V55, P661; DiFonzo C, 2007, QUESTIONS ANSWERS AP; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; EDWARDS CA, 1979, J APPL ECOL, V16, P811, DOI 10.2307/2402855; Elliott NC, 1999, LANDSCAPE ECOL, V14, P239, DOI 10.1023/A:1008002528345; ELLIOTT NC, 1990, ENVIRON ENTOMOL, V19, P1320, DOI 10.1093/ee/19.5.1320; ELLIOTT NC, 1991, CAN ENTOMOL, V123, P13, DOI 10.4039/Ent12313-1; EVANS EW, 1992, J KANSAS ENTOMOL SOC, V65, P30; Fiedler AK, 2007, ENVIRON ENTOMOL, V36, P751, DOI 10.1603/0046-225X(2007)36[751:AOMNPT]2.0.CO;2; FLICKINGER EL, 1991, J WILDLIFE DIS, V27, P265, DOI 10.7589/0090-3558-27.2.265; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Giles KL, 2003, J ECON ENTOMOL, V96, P975, DOI 10.1603/0022-0493-96.3.975; GRIFFITHS E, 1985, ECOL ENTOMOL, V10, P181, DOI 10.1111/j.1365-2311.1985.tb00547.x; Hein G., 2006, INSECTICIDES CONTROL; KIECKHEFER RW, 1992, AGRON J, V84, P180, DOI 10.2134/agronj1992.00021962008400020011x; KIECKHEFER RW, 1988, J ECON ENTOMOL, V81, P317, DOI 10.1093/jee/81.1.317; KRAUSS J, 2011, PLOS ONE, V6; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Larsson H, 2005, CROP PROT, V24, P397, DOI 10.1016/j.cropro.2004.08.011; Lee JH, 2005, ENVIRON ENTOMOL, V34, P115, DOI 10.1603/0046-225X-34.1.115; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; Losey JE, 1999, ECOL APPL, V9, P378, DOI 10.1890/1051-0761(1999)009[0378:FFSPTC]2.0.CO;2; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Miller T.D., 1999, GROWTH STAGES WHEAT; Mohamed AH, 2000, ENVIRON ENTOMOL, V29, P360, DOI 10.1603/0046-225X(2000)029[0360:AAEOPA]2.0.CO;2; Ostman O, 2001, BASIC APPL ECOL, V2, P365, DOI 10.1078/1439-1791-00072; Ostman O, 2003, ECOL ECON, V45, P149, DOI 10.1016/S0921-8009(03)00007-7; PIKE KS, 1985, J ECON ENTOMOL, V78, P676, DOI 10.1093/jee/78.3.676; R Core Team, 2021, R LANGUAGE ENV STAT; Reisig DD, 2012, J ECON ENTOMOL, V105, P1612, DOI 10.1603/EC12124; RICE ME, 1988, ENVIRON ENTOMOL, V17, P836, DOI 10.1093/ee/17.5.836; Schmidt MH, 2004, ENTOMOL EXP APPL, V113, P87, DOI 10.1111/j.0013-8703.2004.00205.x; Schmidt MH, 2003, P ROY SOC B-BIOL SCI, V270, P1905, DOI 10.1098/rspb.2003.2469; Shufran RA, 1997, J ECON ENTOMOL, V90, P1106, DOI 10.1093/jee/90.5.1106; Shufran RA, 1996, J ECON ENTOMOL, V89, P46, DOI 10.1093/jee/89.1.46; Sivakoff FS, 2012, BIOL CONTROL, V63, P296, DOI 10.1016/j.biocontrol.2012.09.008; Straub CS, 2008, BIOL CONTROL, V45, P225, DOI 10.1016/j.biocontrol.2007.05.013; Swinton SM, 2006, AM J AGR ECON, V88, P1160, DOI 10.1111/j.1467-8276.2006.00927.x; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; TEETES GL, 1975, J ECON ENTOMOL, V68, P214, DOI 10.1093/jee/68.2.214; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; VICKERMAN GP, 1979, B ENTOMOL RES, V69, P1, DOI 10.1017/S0007485300017855; WILES JA, 1992, PESTIC SCI, V36, P263, DOI 10.1002/ps.2780360313; Wise K., 2011, MANAGING WHEAT GROWT	56	15	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114230	10.1371/journal.pone.0114230	http://dx.doi.org/10.1371/journal.pone.0114230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473951	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500004
J	Salvemini, M; Arunkumar, KP; Nagaraju, J; Sanges, R; Petrella, V; Tomar, A; Zhang, HY; Zheng, WW; Saccone, G				Salvemini, Marco; Arunkumar, Kallare P.; Nagaraju, Javaregowda; Sanges, Remo; Petrella, Valeria; Tomar, Archana; Zhang, Hongyu; Zheng, Weiwei; Saccone, Giuseppe			De Novo Assembly and Transcriptome Analysis of the Mediterranean Fruit Fly Ceratitis capitata Early Embryos	PLOS ONE			English	Article							INTERGENIC NONCODING RNAS; SEX DETERMINATION; TRANSFORMER GENE; ANASTREPHA-SUSPENSA; DROSOPHILA-HYDEI; CHROMOSOME; EXPRESSION; INSECTS; SEQUENCE; VECTOR	The agricultural pest Ceratitis capitata, also known as the Mediterranean fruit fly or Medfly, belongs to the Tephritidae family, which includes a large number of other damaging pest species. The Medfly has been the first non-drosophilid fly species which has been genetically transformed paving the way for designing genetic-based pest control strategies. Furthermore, it is an experimentally tractable model, in which transient and transgene-mediated RNAi have been successfully used. We applied Illumina sequencing to total RNA preparations of 8-10 hours old embryos of C. capitata, This developmental window corresponds to the blastoderm cellularization stage. In summary, we assembled 42,614 transcripts which cluster in 26,319 unique transcripts of which 11,045 correspond to protein coding genes; we identified several hundreds of long ncRNAs; we found an enrichment of transcripts encoding RNA binding proteins among the highly expressed transcripts, such as CcTRA-2, known to be necessary to establish and, most likely, to maintain female sex of C. capitata. Our study is the first de novo assembly performed for Ceratitis capitata based on Illumina NGS technology during embryogenesis and it adds novel data to the previously published C. capitata EST databases. We expect that it will be useful for a variety of applications such as gene cloning and phylogenetic analyses, as well as to advance genetic research and biotechnological applications in the Medfly and other related Tephritidae.	[Salvemini, Marco; Petrella, Valeria; Saccone, Giuseppe] Univ Naples Federico II, Dept Biol, Naples, Italy; [Arunkumar, Kallare P.; Nagaraju, Javaregowda; Tomar, Archana] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Sanges, Remo] Stn Zool Anton Dohrn, Naples, Italy; [Zhang, Hongyu; Zheng, Weiwei] Huazhong Agr Univ, Coll Plant Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Zhang, Hongyu; Zheng, Weiwei] Huazhong Agr Univ, Coll Plant Sci & Technol, Inst Urban & Hort Pests, Wuhan, Peoples R China	University of Naples Federico II; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Stazione Zoologica Anton Dohrn di Napoli; Huazhong Agricultural University; Huazhong Agricultural University	Salvemini, M (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	marco.salvemini@unina.it; hongyu.zhang@mail.hzau.edu.cn	Sanges, Remo/M-9814-2019; saccone, giuseppe/F-8627-2013; Salvemini, Marco/AAJ-5560-2021	Sanges, Remo/0000-0002-5047-9713; saccone, giuseppe/0000-0002-9835-3693; SALVEMINI, Marco/0000-0003-2297-9267; Tomar, Archana/0000-0001-5752-7020	Ministero dell'Universita e della Ricerca	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	Ministero dell'Universita e della Ricerca Grant to GS (PRIN2012). University of Naples Federico II/Fondazione Compagnia di Sanpaolo Grant to MS (STAR2014). Taskforce Project Grant from Department of Biotechnology, Government of India to KPA and JN.	Akbari OS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03954; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bolger MA, 2014, BIOINFORMATICS; Bopp D, 2014, SEX DEV, V8, P20, DOI 10.1159/000356458; Bopp D, 1996, DEVELOPMENT, V122, P971; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; Carey JR, 2011, EXP GERONTOL, V46, P404, DOI 10.1016/j.exger.2010.09.009; Carvalho AB, 2013, GENOME RES, V23, P1894, DOI 10.1101/gr.156034.113; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; CLINE TW, 1978, GENETICS, V90, P683; Crisanti A, 2013, PATHOG GLOB HEALTH, V107, P458, DOI 10.1179/2047772413Z.000000000174; Criscione F, 2013, INSECT MOL BIOL, V22, P433, DOI 10.1111/imb.12034; Dafa'alla T, 2010, J GENET, V89, P301, DOI 10.1007/s12041-010-0041-y; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Diamantidis AD, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.33; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Evans JD, 2013, J HERED, V104, P595, DOI 10.1093/jhered/est050; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; FRANZ G, 1991, NUCLEIC ACIDS RES, V19, P6646, DOI 10.1093/nar/19.23.6646; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Gabrieli P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-12; Gao G, 2014, GENOME RES, V24, P629, DOI 10.1101/gr.165837.113; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; Heffer A, 2013, ANNU REV ENTOMOL, V58, P161, DOI 10.1146/annurev-ento-120811-153601; Hokanson KE, 2014, TRANSGENIC RES, V23, P1057, DOI 10.1007/s11248-013-9769-5; Intra J, 2011, J INSECT PHYSIOL, V57, P452, DOI 10.1016/j.jinsphys.2011.01.007; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; KLASSEN W, 1994, FRUIT FLIES AND THE STERILE INSECT TECHNIQUE, P3; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koukidou M, 2014, SEX DEV, V8, P127, DOI 10.1159/000357203; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemke S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-278; Li BN, 2009, J ECON ENTOMOL, V102, P1781, DOI 10.1603/029.102.0508; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Z, 2009, NUCLEIC ACIDS RES, V37, P4308, DOI 10.1093/nar/gkp334; LOUKERIS TG, 1995, SCIENCE, V270, P2002, DOI 10.1126/science.270.5244.2002; MALACRIDA A, 1992, BIOCHEM GENET, V30, P35, DOI 10.1007/BF00554426; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; MARCHINI D, 1995, J BIOL CHEM, V270, P6199, DOI 10.1074/jbc.270.11.6199; Martinez-Barnetche J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-207; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morrison NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050922; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaraju J, 2010, J GENET, V89, P269, DOI 10.1007/s12041-010-0051-9; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Nirmala X, 2013, GENE, V517, P212, DOI 10.1016/j.gene.2012.12.012; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Ogaugwu CE, 2013, INSECT BIOCHEM MOLEC, V43, P1, DOI 10.1016/j.ibmb.2012.10.010; Pane A, 2002, DEVELOPMENT, V129, P3715; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Patel KR, 2012, PLOS ONE, V7; Peel AD, 2008, PHILOS T R SOC B, V363, P1539, DOI 10.1098/rstb.2007.2244; Robinson AS, 2002, GENETICA, V116, P5, DOI 10.1023/A:1020951407069; Saccone G, 2011, GENETICA, V139, P99, DOI 10.1007/s10709-010-9503-7; Saccone G, 1998, DEVELOPMENT, V125, P1495; Salvemini M, 2006, INSECT MOL BIOL, V15, P341, DOI 10.1111/j.1365-2583.2006.00651.x; Salvemini M, 2010, J GENET, V89, P287, DOI 10.1007/s12041-010-0040-z; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P51, DOI 10.1016/j.ibmb.2011.10.007; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Scolari F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046812; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shukla JN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00948; Siciliano P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085523; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; Topalis P, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-16; Vannini L, 2010, ARCH INSECT BIOCHEM, V75, P92, DOI 10.1002/arch.20382; Verhulst EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063618; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Vicoso B, 2013, NATURE, V499, P332, DOI 10.1038/nature12235; Walker JJ, 2000, GENETICS, V155, P191; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Wimmer EA, 2013, CURR BIOL, V23, pR453, DOI 10.1016/j.cub.2013.03.058; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhou Jianfeng, 2010, Recent Pat DNA Gene Seq, V4, P192, DOI 10.2174/187221510794751622; ZWIEBEL LJ, 1995, SCIENCE, V270, P2005, DOI 10.1126/science.270.5244.2005	102	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114191	10.1371/journal.pone.0114191	http://dx.doi.org/10.1371/journal.pone.0114191			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474564	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500123
J	Su, JJ; Liang, HW; Yao, WY; Wang, N; Zhang, SY; Yan, X; Feng, H; Pang, WJ; Wang, YB; Wang, XL; Fu, Z; Liu, YQ; Zhao, CH; Zhang, JF; Zhang, CY; Zen, K; Chen, X; Wang, YL				Su, Jiaojiao; Liang, Hongwei; Yao, Weiyan; Wang, Nan; Zhang, Suyang; Yan, Xin; Feng, Hui; Pang, Wenjing; Wang, Yanbo; Wang, Xueliang; Fu, Zhen; Liu, Yanqing; Zhao, Chihao; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Chen, Xi; Wang, Yalei			MiR-143 and MiR-145 Regulate IGF1R to Suppress Cell Proliferation in Colorectal Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; I RECEPTOR; GROWTH; METASTASIS; EXPRESSION; PREDICTION; ONCOMIRS	Insulin-like growth factor 1 receptor (IGF1R) is a transmembrane receptor that is activated by insulin-like growth factor 1 (IGF-1) and by a related hormone called IGF-2. It belongs to the large class of tyrosine kinase receptors and plays an important role in colorectal cancer etiology and progression. In this study, we used bioinformatic analyses to search for miRNAs that potentially target IGF1R. We identified specific target sites for miR-143 and miR-145 (miR-143/145) in the 3'-untranslated region (3 '-UTR) of the IGF1R gene. These miRNAs are members of a cluster of miRNAs that have been reported to exhibit tumor suppressor activity. Consistent with the bioinformatic analyses, we identified an inverse correlation between miR-143/145 levels and IGF1R protein levels in colorectal cancer tissues. By overexpressing miR-143/145 in Caco2, HT29 and SW480 colorectal cancer cells, we experimentally validated that miR-143/145 directly recognizes the 3'-UTR of the IGF1R transcript and regulates IGF1R expression. Furthermore, the biological consequences of the targeting of IGF1R by miR-143/145 were examined by cell proliferation assays in vitro. We demonstrated that the repression of IGF1R by miR-143/145 suppressed the proliferation of Caco2 cells. Taken together, our findings provide evidence for a role of the miR-143/145 cluster as a tumor suppressor in colorectal cancer through the inhibition of IGF1R translation.	[Su, Jiaojiao; Feng, Hui; Wang, Yalei] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei 230022, Anhui, Peoples R China; [Liang, Hongwei; Wang, Nan; Zhang, Suyang; Wang, Yanbo; Wang, Xueliang; Fu, Zhen; Liu, Yanqing; Zhao, Chihao; Zhang, Junfeng; Zhang, Chen-Yu; Zen, Ke; Chen, Xi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Yao, Weiyan; Pang, Wenjing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Yan, Xin] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China	Anhui Medical University; Nanjing University; Shanghai Jiao Tong University; Nanjing University; Nanjing University	Chen, X (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	xichen@nju.edu.cn; alei416@163.com			National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81101330, 31271378, 81250044]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2014CB542300), the National Natural Science Foundation of China (Nos. 81101330, 31271378 and 81250044) and the Natural Science Foundation of Jiangsu Province (Nos. BK2011013 and BK2012014).	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Bauer KM, 2012, J PROTEOME RES, V11, P4744, DOI 10.1021/pr300600r; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Davies M, 2006, INT J COLORECTAL DIS, V21, P201, DOI 10.1007/s00384-005-0776-8; Dong XQ, 2010, GASTROENTEROLOGY, V139, P464, DOI 10.1053/j.gastro.2010.04.042; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esposito DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036190; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kokki I, 2013, CROAT MED J, V54, P532, DOI 10.3325/cmj.2013.54.532; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZJ, 2013, WORLD J GASTROENTERO, V19, P7788, DOI 10.3748/wjg.v19.i43.7788; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Michael MZ, 2003, MOL CANCER RES, V1, P882; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Wang SH, 2009, INT J ONCOL, V34, P1461, DOI 10.3892/ijo_00000275; Zhang R, 2013, J INT MED RES, V41, P1228, DOI 10.1177/0300060513487631; Zhu Z, 2014, FEBS LETT; Zumsteg A, 2012, MOL CANCER RES, V10, P800, DOI 10.1158/1541-7786.MCR-11-0522	39	77	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114420	10.1371/journal.pone.0114420	http://dx.doi.org/10.1371/journal.pone.0114420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474488	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500026
J	Weinmayr, G; Forastiere, F; Buchele, G; Jaensch, A; Strachan, DP; Nagel, G				Weinmayr, Gudrun; Forastiere, Francesco; Buechele, Gisela; Jaensch, Andrea; Strachan, David P.; Nagel, Gabriele		ISAAC Phase Two Study Grp	Overweight/Obesity and Respiratory and Allergic Disease in Children: International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION; NATIONAL-HEALTH; OBESITY; ATOPY; ASSOCIATION; SYMPTOMS; SEX; SENSITIZATION; INFECTIONS	Background: Childhood obesity and asthma are increasing worldwide. A possible link between the two conditions has been postulated. Methods: Cross-sectional studies of stratified random samples of 8-12-year-old children (n=10 652) (16 centres in affluent and 8 centres in non-affluent countries) used the standardized methodology of ISAAC Phase Two. Respiratory and allergic symptoms were ascertained by parental questionnaires. Tests for allergic disease were performed. Height and weight were measured, and overweight and obesity were defined according to international definitions. Prevalence rates and prevalence odds ratios were calculated. Results: Overweight (odds ratio=1.14, 95%-confidence interval: 0.98; 1.33) and obesity (odds ratio=1.67, 95%-confidence interval: 1.25; 2.21) were related to wheeze. The relationship was stronger in affluent than in non-affluent centres. Similar results were found for cough and phlegm, rhinitis and eczema but the associations were mostly driven by children with wheeze. There was a clear association of overweight and obesity with airways obstruction (change in FEV1/FVC, -0.90, 95%-confidence interval: -1.33%; -0.47%, for overweight and -2.46%, 95%-confidence interval: -3.84%; -1.07%, for obesity) whereas the results for the other objective markers, including atopy, were null. Conclusions: Our data from a large international child population confirm that there is a strong relation of body mass index with wheeze especially in affluent countries. Moreover, body mass index is associated with an objective marker of airways obstruction (FEV1/FVC) but no other objective markers of respiratory and allergic disorders.	[Weinmayr, Gudrun; Buechele, Gisela; Jaensch, Andrea; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Forastiere, Francesco] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England	Ulm University; University of London	Weinmayr, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gudrun.weinmayr@uni-ulm.de	Martínez-Gimeno, Antonio/A-9416-2010; De sario, Manuela/K-1932-2016; Di Domenicantonio, Riccardo/H-7867-2018; Ellwood, Philippa/G-7555-2015; KHUBCHANDANI, RAJU/AAI-9871-2020; Papadopoulou, Athina/AAR-6407-2020; EL Sharif, Nuha/AAB-1863-2019; Forastiere, Francesco/J-9067-2016; Nagel, Gabriele/C-3635-2012; Pitrez, Paulo/A-3040-2011	Martínez-Gimeno, Antonio/0000-0003-4051-1860; De sario, Manuela/0000-0002-1117-2735; Di Domenicantonio, Riccardo/0000-0002-9726-0786; Ellwood, Philippa/0000-0002-1994-4023; KHUBCHANDANI, RAJU/0000-0003-0294-119X; EL Sharif, Nuha/0000-0001-6410-4720; Forastiere, Francesco/0000-0002-9162-5684; Nagel, Gabriele/0000-0001-6185-8535; kuyucu, semanur/0000-0003-1999-6496; williams, hywel/0000-0002-5646-3093; Nilsson, Lennart/0000-0002-5680-6367; STEIN, RENATO/0000-0003-0269-0757; Pitrez, Paulo/0000-0001-7319-1133; Lund, Eiliv/0000-0002-8071-8711; Pearce, Neil/0000-0002-9938-7852; Garcia-Marcos, Luis/0000-0002-0925-3851	Fifth Framework Program of European Commission [QLK4-CT-1999-01288]; Almeria: Fondo de Investigacion Sanitaria [00/1092E]; Ankara*: Scientific and Technical Research council of Turkey [SPAG-2237]; Treatment and Research Foundation of Turkey for Allergy, Asthma and Immunology; Research Foundation of Hacettepe University Faculty of Medicine; Athens: the Thorax Foundation Research Centre, Greece; Cartagena: Fondo de Investigacion Sanitaria [00/1092E]; Creteil: French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale (INSERM) [IDS 337/4D001D, 737/69480]; Ministere de l'Emploi et de la Solidarite [227/7HL02D]; Mutuelle Generale de l'Education Nationale [257/8PL01F]; Agence de l'Environnement et de la Maitrise de l'Energie ADEME/PRIMEQUAL 96 [FJ012B]; Dresden: German Ministry of Education and Research [01 EE 9411-3]; Hastings: Health Research Council of New Zealand, Asthma and Respiratory Foundation of New Zealand; Hawkes Bay Medical Research Foundation; Kintampo*: Linkoping: the Swedish Foundation for Health Care Sciences and Allergy Research; Madrid: Fondo de Investigacion Sanitaria [00/1092E]; Mumbai*: Jaslok Hospital & Research Centre; Munich: German Ministry of Education and Research [01 EE 9411-3]; Ostersund: the Swedish Foundation for Health Care Sciences and Allergy Research; Pichincha province: Wellcome Trust; Porto Alegre: Rudolf und Clothilde Eberhardt Foundation, Ulm, Germany; Ramallah: Al-Quds University, Directorate General for International Cooperation and Belgian Technical Cooperation; Riga*; Rome: Lazio Regional Health Authority; Tallinn*; Tbilisi*; Thessaloniki: the Thorax Foundation Research Centre, Greece; Tirana*; Utrecht: Dutch Ministries of the Environment, of Health and of Transport, Rotterdam, the Netherlands; Valencia: Fondo de Investigacion Sanitaria [00/1092E]; West Sussex: South Thames National Health Service Regional Research and Development [SPGS 573]	Fifth Framework Program of European Commission; Almeria: Fondo de Investigacion Sanitaria; Ankara*: Scientific and Technical Research council of Turkey; Treatment and Research Foundation of Turkey for Allergy, Asthma and Immunology; Research Foundation of Hacettepe University Faculty of Medicine; Athens: the Thorax Foundation Research Centre, Greece; Cartagena: Fondo de Investigacion Sanitaria; Creteil: French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale (INSERM); Ministere de l'Emploi et de la Solidarite; Mutuelle Generale de l'Education Nationale; Agence de l'Environnement et de la Maitrise de l'Energie ADEME/PRIMEQUAL 96; Dresden: German Ministry of Education and Research; Hastings: Health Research Council of New Zealand, Asthma and Respiratory Foundation of New Zealand; Hawkes Bay Medical Research Foundation; Kintampo*: Linkoping: the Swedish Foundation for Health Care Sciences and Allergy Research; Madrid: Fondo de Investigacion Sanitaria; Mumbai*: Jaslok Hospital & Research Centre; Munich: German Ministry of Education and Research; Ostersund: the Swedish Foundation for Health Care Sciences and Allergy Research; Pichincha province: Wellcome Trust; Porto Alegre: Rudolf und Clothilde Eberhardt Foundation, Ulm, Germany; Ramallah: Al-Quds University, Directorate General for International Cooperation and Belgian Technical Cooperation; Riga*; Rome: Lazio Regional Health Authority; Tallinn*; Tbilisi*; Thessaloniki: the Thorax Foundation Research Centre, Greece; Tirana*; Utrecht: Dutch Ministries of the Environment, of Health and of Transport, Rotterdam, the Netherlands; Valencia: Fondo de Investigacion Sanitaria; West Sussex: South Thames National Health Service Regional Research and Development	Coordination and central laboratory analyses of the European centres were funded by the Fifth Framework Program of European Commission, [grant number QLK4-CT-1999-01288]; Funding of local studies: Almeria: Fondo de Investigacion Sanitaria (grant code 00/1092E); Ankara*: Scientific and Technical Research council of Turkey (grant code SPAG-2237), Treatment and Research Foundation of Turkey for Allergy, Asthma and Immunology, and the Research Foundation of Hacettepe University Faculty of Medicine; Athens: the Thorax Foundation Research Centre, Greece; Cartagena: Fondo de Investigacion Sanitaria (grant code 00/1092E). Creteil: French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale (INSERM) (grant codes IDS 337/4D001D and 737/69480), Ministere de l'Emploi et de la Solidarite (grant code 227/7HL02D), Mutuelle Generale de l'Education Nationale (grant code 257/8PL01F) and Agence de l'Environnement et de la Maitrise de l'Energie ADEME/PRIMEQUAL 96 (grant code FJ012B); Dresden: German Ministry of Education and Research (01 EE 9411-3); Hastings: Health Research Council of New Zealand, Asthma and Respiratory Foundation of New Zealand, and Hawkes Bay Medical Research Foundation; Kintampo*: Linkoping: the Swedish Foundation for Health Care Sciences and Allergy Research; Madrid: Fondo de Investigacion Sanitaria (grant code 00/1092E); Mumbai*: Jaslok Hospital & Research Centre; Munich: German Ministry of Education and Research (01 EE 9411-3); Ostersund: the Swedish Foundation for Health Care Sciences and Allergy Research; Pichincha province: Wellcome Trust; Porto Alegre: Rudolf und Clothilde Eberhardt Foundation, Ulm, Germany; Ramallah: Al-Quds University, Directorate General for International Cooperation and Belgian Technical Cooperation; Riga*; Rome: Lazio Regional Health Authority; Tallinn*; Tbilisi*; Thessaloniki: the Thorax Foundation Research Centre, Greece; Tirana*; Utrecht: Dutch Ministries of the Environment, of Health and of Transport, Rotterdam, the Netherlands; Valencia: Fondo de Investigacion Sanitaria (grant code 00/1092E); West Sussex: South Thames National Health Service Regional Research and Development project SPGS 573. *: centres supported, at least in part, by European members of the ISAAC Steering Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; CHAMBLESS LE, 1985, COMMUN STAT-THEOR M, V14, P1377, DOI 10.1080/03610928508828982; Chatzi L, 2007, PEDIAT ALLERG IMM-UK, V18, P480, DOI 10.1111/j.1399-3038.2007.00596.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Groot EP, 2010, EUR RESPIR J, V36, P671, DOI 10.1183/09031936.00185709; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P406, DOI 10.1093/aje/kwg175; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hancox RJ, 2005, AM J RESP CRIT CARE, V171, P440, DOI 10.1164/rccm.200405-623OC; Jensen ME, 2014, PEDIATR RES, V75, P93, DOI 10.1038/pr.2013.181; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; Mai XM, 2003, ACTA PAEDIATR, V92, P1144, DOI 10.1080/08035250310005666; Matricardi PM, 2007, CLIN EXP ALLERGY, V37, P476, DOI 10.1111/j.1365-2222.2007.02664.x; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Mitchell EA, 2013, CLIN EXP ALLERGY, V43, P73, DOI 10.1111/cea.12024; Murray CS, 2011, CLIN EXP ALLERGY, V41, P78, DOI 10.1111/j.1365-2222.2010.03598.x; Nagel G, 2009, EUR RESPIR J, V33, P993, DOI 10.1183/09031936.00075708; Nagel G, 2012, PEDIAT ALLERG IMM-UK, V23, P737, DOI 10.1111/pai.12007; Nagel G, 2010, THORAX, V65, P516, DOI 10.1136/thx.2009.128256; PISTELLI R, 1992, EUR RESPIR J, V5, P463; Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c; Scholtens S, 2010, INT J OBESITY, V34, P606, DOI 10.1038/ijo.2009.194; Sin DD, 2008, THORAX, V63, P1018, DOI 10.1136/thx.2007.086819; Tantisira KG, 2001, RESP RES, V2, P324, DOI 10.1186/rr81; Visness CM, 2010, J ASTHMA, V47, P822, DOI 10.3109/02770903.2010.489388; von Hertzen LC, 2004, ALLERGY, V59, P124, DOI 10.1046/j.1398-9995.2003.00433.x; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Weinmayr G, 2013, CLIN EXP ALLERGY, V43, P762, DOI 10.1111/cea.12107; Weinmayr G, 2013, CLIN EXP ALLERGY, V43, P223, DOI 10.1111/cea.12035; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wickens K, 2005, THORAX, V60, P7, DOI 10.1136/thx.2002.001529	36	75	75	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113996	10.1371/journal.pone.0113996	http://dx.doi.org/10.1371/journal.pone.0113996			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474308	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500103
J	Wu, H; Zheng, J; Deng, J; Zhang, L; Li, N; Li, W; Li, F; Lu, J; Zhou, Y				Wu, H.; Zheng, J.; Deng, J.; Zhang, L.; Li, N.; Li, W.; Li, F.; Lu, J.; Zhou, Y.			LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophageal cancer and prognosis	ONCOGENE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; LONG NONCODING RNA; SUSCEPTIBILITY LOCI; LUNG-CANCER; GENE; CHINESE; PROLIFERATION; TRANSCRIPTION; METASTASIS	Long intergenic noncoding RNAs (lincRNAs) have critical regulatory roles in cancer biology; however, the contributions of lincRNAs to esophageal squamous cell carcinoma (ESCC) have been infrequently explored. The aim of this study was to explore the contribution of lincRNAs, located at ESCC susceptibility loci identified by genome-wide association studies, to the risk and prognosis of ESCC. The associations between lincRNAs and the risk and prognosis of ESCC were analyzed in 358 diagnosed patients from eastern China, and the findings were validated in 326 additional patients from southern China. Functional relevance of lincRNAs was further examined by biochemical assays. We found that lincRNA-uc002yug.2 was commonly overexpressed in ESCC compared with paired peritumoral tissue in eastern and southern Chinese populations. The expression levels of lincRNA-uc002yug.2 in ESCC might be a prognostic factor for survival. Moreover, lincRNA-uc002yug.2 promoted a combination of RUNX1 and alternative splicing (AS) factors in the nucleus to produce more RUNX1 alpha, the short isoform and inhibitor of RUNX1, and reduce CEBP alpha (CCAAT/enhancer-binding protein-alpha) gene expression, thereby promoting ESCC progression. These results indicated that lincRNA-uc002yug.2 might involve in AS of RUNX1/AML1 and serve as a predictor for esophageal cancer and prognosis.	[Wu, H.; Zheng, J.; Deng, J.; Li, N.; Li, W.; Li, F.; Zhou, Y.] Soochow Univ, Coll Med, Dept Genet, Suzhou 215123, Peoples R China; [Zhang, L.] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou 215123, Peoples R China; [Lu, J.] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China	Soochow University - China; Soochow University - China; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhou, Y (corresponding author), Soochow Univ, Coll Med, Dept Genet, Renai Rd 199,Bldg 401,Room 1418, Suzhou 215123, Peoples R China.	zhouyifeng@suda.edu.cn		Zhang, Liyuan/0000-0002-7469-1743	National Scientific Foundation of China [81001278, 81171895, 81472630, 81072366]; Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Natural Science Foundation [BK2011297]; Jiangsu Province Science and Technology Support Program [BE2012648]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20101561]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Natural Science Foundation; Jiangsu Province Science and Technology Support Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by the National Scientific Foundation of China grants 81001278, 81171895, 81472630 and 81072366; a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Provincial Natural Science Foundation (No. BK2011297); Jiangsu Province Science and Technology Support Program (No. BE2012648) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (No. 20101561).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Girard N, 2013, P NATL ACAD SCI USA, V110, P13522, DOI 10.1073/pnas.1310067110; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jin GF, 2012, AM J HUM GENET, V91, P928, DOI 10.1016/j.ajhg.2012.09.009; Kumar M, 2013, INT J CANCER, V132, P2032, DOI 10.1002/ijc.27880; Kuwano H, 2005, SURG TODAY, V35, P7, DOI 10.1007/s00595-004-2885-3; Liu X, 2009, LEUKEMIA, V23, P739, DOI 10.1038/leu.2008.350; Luco RF, 2011, CURR OPIN GENET DEV, V21, P366, DOI 10.1016/j.gde.2011.03.004; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057013; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; St Kapranov P, 2010, BMC BIOL, V8, P149; Sun M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-68; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; Szumilo Justyna, 2009, Pol Merkur Lekarski, V26, P82; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu C, 2013, NAT GENET, V45, P632, DOI 10.1038/ng.2638; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Yamabuki T, 2006, INT J ONCOL, V28, P1375; Yang Howard H., 2008, V141, P23; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021	45	48	50	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4723	4734		10.1038/onc.2014.400	http://dx.doi.org/10.1038/onc.2014.400			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25486427				2022-12-26	WOS:000360931500006
J	Sanyal, N; Arentson, BW; Luo, M; Tanner, JJ; Becker, DF				Sanyal, Nikhilesh; Arentson, Benjamin W.; Luo, Min; Tanner, John J.; Becker, Donald F.			First Evidence for Substrate Channeling between Proline Catabolic Enzymes A VALIDATION OF DOMAIN FUSION ANALYSIS FOR PREDICTING PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE GAMMA-SEMIALDEHYDE; PYRROLINE-5-CARBOXYLIC ACID; STRUCTURAL-CHARACTERIZATION; SALMONELLA-TYPHIMURIUM; DEHYDROGENASE DOMAIN; CRYSTAL-STRUCTURE; METABOLISM; INTERMEDIATE; DEGRADATION; FLAVOENZYME	Proline dehydrogenase (PRODH) and Delta(1)-pyrroline-5-carboxylate (P5C) dehydrogenase (P5CDH) catalyze the four-electron oxidation of proline to glutamate via the intermediates P5C and L-glutamate-gamma-semialdehyde (GSA). In Gram-negative bacteria, PRODH and P5CDH are fused together in the bifunctional enzyme proline utilizationA(PutA) whereas in other organisms PRODH and P5CDH are expressed as separate monofunctional enzymes. Substrate channeling has previously been shown for bifunctional PutAs, but whether the monofunctional enzymes utilize an analogous channeling mechanism has not been examined. Here, we report the first evidence of substrate channeling in a PRODH-P5CDH two-enzyme pair. Kinetic data for the coupled reaction of PRODH and P5CDH from Thermus thermophilus are consistent with a substrate channeling mechanism, as the approach to steady-state formation of NADH does not fit a nonchanneling two-enzyme model. Furthermore, inactive P5CDH and PRODH mutants inhibit NADH production and increase trapping of the P5C intermediate in coupled assays of wild-type PRODH-P5CDH enzyme pairs, indicating that the mutants disrupt PRODH-P5CDH channeling interactions. A dissociation constant of 3 mu M was estimated for a putative PRODH-P5CDH complex by surface plasmon resonance (SPR). Interestingly, P5CDH binding to PRODH was only observed when PRODH was immobilized with the top face of its (beta alpha)(8) barrel exposed. Using the known x-ray crystal structures of PRODH and P5CDH from T. thermophilus, a model was built for a proposed PRODH-P5CDH enzyme channeling complex. The structural model predicts that the core channeling pathway of bifunctional PutA enzymes is conserved in monofunctional PRODH-P5CDH enzyme pairs.	[Sanyal, Nikhilesh; Arentson, Benjamin W.; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Luo, Min; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Nebraska System; University of Nebraska Lincoln; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Becker, DF (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dbecker3@unl.edu		Tanner, John/0000-0001-8314-113X	National Institutes of Health [GM065546, P30GM103335]; Hatch Act; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM065546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065546 and P30GM103335 and is a contribution of the University of Nebraska Agricultural Research Division, supported in part by funds provided through the Hatch Act.	Arentson BW, 2014, BIOCHEMISTRY-US, V53, P5150, DOI 10.1021/bi5007404; Baker P, 2012, BIOCHEMISTRY-US, V51, P4558, DOI 10.1021/bi300407y; Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Curtis J, 2004, PLANT PHYSIOL, V136, P3313, DOI 10.1104/pp.104.044024; EKENA K, 1990, MOL GEN GENET, V220, P492, DOI 10.1007/BF00391761; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Geck MK, 1999, BIOCHEMISTRY-US, V38, P8032, DOI 10.1021/bi983029c; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Monteoliva MI, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-21; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; James CL, 2002, BIOCHEMISTRY-US, V41, P3726, DOI 10.1021/bi0159074; Johnson K. A., 1913, BIOCHEMISTRY-US, V50, P8264; KOHL DH, 1988, P NATL ACAD SCI USA, V85, P2036, DOI 10.1073/pnas.85.7.2036; Krishnan N, 2008, INFECT IMMUN, V76, P3037, DOI 10.1128/IAI.01737-07; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Liu W, 2012, BIOFACTORS, V38, P398, DOI 10.1002/biof.1036; Luo M, 2013, J MOL BIOL, V425, P3106, DOI 10.1016/j.jmb.2013.05.027; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Michaelis L, 1913, BIOCHEM Z, V49, P333; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; Moses S, 2012, J BACTERIOL, V194, P745, DOI 10.1128/JB.06380-11; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Nishimura A, 2012, FEBS LETT, V586, P2411, DOI 10.1016/j.febslet.2012.05.056; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048; Pang SS, 2014, CELL METAB, V19, P221, DOI 10.1016/j.cmet.2013.12.005; Pemberton TA, 2014, BIOCHEMISTRY-US, V53, P1350, DOI 10.1021/bi500048b; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRERE PA, 1990, FEBS LETT, V268, P360, DOI 10.1016/0014-5793(90)81286-W; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Surber MW, 1998, ARCH BIOCHEM BIOPHYS, V354, P281, DOI 10.1006/abbi.1998.0697; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P16158, DOI 10.1021/bi991741j; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; Yadid I, 2013, P NATL ACAD SCI USA, V110, pE2182, DOI 10.1073/pnas.1214052110; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhao H, 2013, CHEM COMMUN, V49, P4444, DOI 10.1039/c3cc41437j	58	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2225	2234		10.1074/jbc.M114.625483	http://dx.doi.org/10.1074/jbc.M114.625483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492892	Green Published, hybrid			2022-12-26	WOS:000348588000026
J	Bacarizo, J; Martinez-Rodriguez, S; Martin-Garcia, JM; Andujar-Sanchez, M; Ortiz-Salmeron, E; Neira, JL; Camara-Artigas, A				Bacarizo, Julio; Martinez-Rodriguez, Sergio; Manuel Martin-Garcia, Jose; Andujar-Sanchez, Montserrat; Ortiz-Salmeron, Emilia; Luis Neira, Jose; Camara-Artigas, Ana			Electrostatic Effects in the Folding of the SH3 Domain of the c-Src Tyrosine Kinase: pH-Dependence in 3D-Domain Swapping and Amyloid Formation	PLOS ONE			English	Article							TRANSITION-STATE ENSEMBLE; CRYSTALLOGRAPHIC STRUCTURE; GLOBULAR-PROTEINS; BETA-STRANDS; IDENTIFICATION; FIBRIL; AGGREGATION; MECHANISM; DYNAMICS; DIMER	The SH3 domain of the c-Src tyrosine kinase (c-Src-SH3) aggregates to form intertwined dimers and amyloid fibrils at mild acid pHs. In this work, we show that a single mutation of residue Gln128 of this SH3 domain has a significant effect on: (i) its thermal stability; and (ii) its propensity to form amyloid fibrils. The Gln128Glu mutant forms amyloid fibrils at neutral pH but not at mild acid pH, while Gln128Lys and Gln128Arg mutants do not form these aggregates under any of the conditions assayed. We have also solved the crystallographic structures of the wild-type (WT) and Gln128Glu, Gln128Lys and Gln128Arg mutants from crystals obtained at different pHs. At pH 5.0, crystals belong to the hexagonal space group P6(5)22 and the asymmetric unit is formed by one chain of the protomer of the c-Src-SH3 domain in an open conformation. At pH 7.0, crystals belong to the orthorhombic space group P2(1)2(1)2(1), with two molecules at the asymmetric unit showing the characteristic fold of the SH3 domain. Analysis of these crystallographic structures shows that the residue at position 128 is connected to Glu106 at the diverging beta-turn through a cluster of watermolecules. Changes in this hydrogen-bond network lead to the displacement of the c-Src-SH3 distal loop, resulting also in conformational changes of Leu100 that might be related to the binding of proline rich motifs. Our findings show that electrostatic interactions and solvation of residues close to the folding nucleation site of the c-Src-SH3 domain might play an important role during the folding reaction and the amyloid fibril formation.	[Bacarizo, Julio; Martinez-Rodriguez, Sergio; Manuel Martin-Garcia, Jose; Andujar-Sanchez, Montserrat; Ortiz-Salmeron, Emilia; Camara-Artigas, Ana] Univ Almeria, Res Ctr Agr & Food Biotechnol BITAL, Dept Chem & Phys, Almeria 04120, Spain; [Martinez-Rodriguez, Sergio] Univ Granada, Fac Sci, Dept Phys Chem, E-18071 Granada, Spain; [Manuel Martin-Garcia, Jose] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Luis Neira, Jose] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; [Luis Neira, Jose] Biocomputat & Complex Syst Phys Inst, Zaragoza 50009, Spain	Universidad de Almeria; University of Granada; Arizona State University; Arizona State University-Tempe; Universidad Miguel Hernandez de Elche	Camara-Artigas, A (corresponding author), Univ Almeria, Res Ctr Agr & Food Biotechnol BITAL, Dept Chem & Phys, Agrifood Campus Int Excellence CeiA3, Almeria 04120, Spain.	acamara@ual.es	MARTIN GARCIA, JOSE MANUEL/GQA-3160-2022; Sánchez, montserrat Andújar/H-1377-2015; Neira, Jose/ABF-4210-2021; Garcia, Jose Manuel Martin/V-2043-2018; Ortiz-Salmerón, Emilia/H-1381-2015; Camara-Artigas, Ana/M-2252-2019; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; MARTIN GARCIA, JOSE MANUEL/AAB-6838-2020	MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Sánchez, montserrat Andújar/0000-0002-8726-998X; Garcia, Jose Manuel Martin/0000-0002-4558-3858; Ortiz-Salmerón, Emilia/0000-0002-7125-218X; Camara-Artigas, Ana/0000-0003-2197-726X; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858	Spanish Ministry of Science and Innovation and Ministry of Economy and Competitiveness; FEDER [(EU): BIO2009-13261-C02-01/02, BIO2012-39922-C02-01/02, CTQ2013-4493, CSD2008-00005, (EU): P09-CVI-5063, (EU): Prometeo 2013/018]; Andalusian Regional Government (Spain); Valentian Regional Government (Spain); European Synchrotron Radiation Facility (ESRF), Grenoble, France: BAG [MX-1406, MX-1541]; ALBA (Barcelona, Spain) [2012010072, 2012100378]	Spanish Ministry of Science and Innovation and Ministry of Economy and Competitiveness; FEDER(European Commission); Andalusian Regional Government (Spain); Valentian Regional Government (Spain); European Synchrotron Radiation Facility (ESRF), Grenoble, France: BAG; ALBA (Barcelona, Spain)	This research was funded by the Spanish Ministry of Science and Innovation and Ministry of Economy and Competitiveness and FEDER (EU): BIO2009-13261-C02-01/02 (ACA); BIO2012-39922-C02-01/02 (ACA); CTQ2013-4493 (JLN) and CSD2008-00005 (JLN); Andalusian Regional Government (Spain) and FEDER (EU): P09-CVI-5063 (ACA); and Valentian Regional Government (Spain) and FEDER (EU): Prometeo 2013/018 (JLN). Data collection was supported by European Synchrotron Radiation Facility (ESRF), Grenoble, France: BAG proposals MX-1406 (ACA) and MX-1541 (ACA); and ALBA (Barcelona, Spain) proposals 2012010072 (ACA) and 2012100378 (ACA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Ahn HC, 2006, PROTEIN SCI, V15, P2552, DOI 10.1110/ps.062154306; Bacarizo J, 2013, ACTA CRYSTALLOGR D, V69, P756, DOI 10.1107/S0907444913001522; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayro MJ, 2011, J AM CHEM SOC, V133, P13967, DOI 10.1021/ja203756x; Bayro MJ, 2010, BIOCHEMISTRY-US, V49, P7474, DOI 10.1021/bi100864t; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Camara-Artigas A, 2014, J STRUCT BIOL, V186, P195, DOI 10.1016/j.jsb.2014.02.007; Camara-Artigas A, 2009, FEBS LETT, V583, P749, DOI 10.1016/j.febslet.2009.01.036; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Di Nardo AA, 2003, J MOL BIOL, V333, P641, DOI 10.1016/j.jmb.2003.08.035; Ding F, 2005, J MOL BIOL, V350, P1035, DOI 10.1016/j.jmb.2005.05.017; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Domenech R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069307; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Gnanakaran S, 2003, BIOPHYS J, V84, P1548, DOI 10.1016/S0006-3495(03)74966-2; Grantcharova VP, 1997, BIOCHEMISTRY-US, V36, P15685, DOI 10.1021/bi971786p; Grantcharova VP, 2001, J MOL BIOL, V306, P555, DOI 10.1006/jmbi.2000.4352; Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Guo WH, 2003, BIOPHYS J, V85, P61, DOI 10.1016/S0006-3495(03)74454-3; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Kishan KVR, 2001, PROTEIN SCI, V10, P1046, DOI 10.1110/ps.50401; Klimov DK, 2002, J MOL BIOL, V317, P721, DOI 10.1006/jmbi.2002.5453; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Martin-Garcia JM, 2007, FEBS LETT, V581, P1701, DOI 10.1016/j.febslet.2007.03.059; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Morel B, 2006, J MOL BIOL, V356, P453, DOI 10.1016/j.jmb.2005.11.062; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907; Newcomer ME, 2002, CURR OPIN STRUC BIOL, V12, P48, DOI 10.1016/S0959-440X(02)00288-9; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Rousseau F, 2006, J MOL BIOL, V363, P496, DOI 10.1016/j.jmb.2006.07.061; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Ruzafa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049690; van der Wel PCA, 2012, PRION, V6, P211, DOI 10.4161/pri.18987; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU H, 1993, FEBS LETT, V324, P87, DOI 10.1016/0014-5793(93)81538-B; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x	77	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113224	10.1371/journal.pone.0113224	http://dx.doi.org/10.1371/journal.pone.0113224			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490095	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300006
J	Drwal, MN; Marinello, J; Manzo, SG; Wakelin, LPG; Capranico, G; Griffith, R				Drwal, Malgorzata N.; Marinello, Jessica; Manzo, Stefano G.; Wakelin, Laurence P. G.; Capranico, Giovanni; Griffith, Renate			Novel DNA Topoisomerase II alpha Inhibitors from Combined Ligand- and Structure-Based Virtual Screening	PLOS ONE			English	Article							ANTITUMOR AGENTS; POTENT INHIBITORS; 4-BETA-ARYLAMINO DERIVATIVES; GENETIC ALGORITHM; CYTOTOXIC AGENTS; CLEAVAGE; ANALOGS; 4'-O-DEMETHYLEPIPODOPHYLLOTOXIN; PODOPHYLLOTOXIN; CAMPTOTHECIN	DNA topoisomerases are enzymes responsible for the relaxation of DNA torsional strain, as well as for the untangling of DNA duplexes after replication, and are important cancer drug targets. One class of topoisomerase inhibitors, "poisons'', binds to the transient enzyme-DNA complex which occurs during the mechanism of action, and inhibits the religation of DNA. This ultimately leads to the accumulation of DNA double strand breaks and cell death. Different types of topoisomerases occur in human cells and several poisons of topoisomerase I and II are widely used clinically. However, their use is compromised by a variety of side effects. Recent studies confirm that the inhibition of the alpha-isoform of topoisomerase II is responsible for the cytotoxic effect, whereas the inhibition of the beta-isoform leads to development of adverse drug reactions. Thus, the discovery of agents selective for topoisomerase II alpha is an important strategy for the development of topoisomerase II poisons with improved clinical profiles. Here, we present a computer-aided drug design study leading to the identification of structurally novel topoisomerase IIa poisons. The study combines ligand-and structure-based drug design methods including pharmacophore models, homology modelling, docking, and virtual screening of the National Cancer Institute compound database. From the 8 compounds identified from the computational work, 6 were tested for their capacity to poison topoisomerase II in vitro: 4 showed selective inhibitory activity for the alpha-over the beta-isoform and 3 of these exhibited cytotoxic activity. Thus, our study confirms the applicability of computer-aided methods for the discovery of novel topoisomerase II poisons, and presents compounds which could be investigated further as selective topoisomerase II alpha inhibitors.	[Drwal, Malgorzata N.; Wakelin, Laurence P. G.; Griffith, Renate] UNSW Australia, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Marinello, Jessica; Manzo, Stefano G.; Capranico, Giovanni] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy	University of New South Wales Sydney; University of Bologna	Griffith, R (corresponding author), UNSW Australia, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	r.griffith@unsw.edu.au	Griffith, Renate/A-3584-2015; Drwal, Malgorzata/B-6461-2015; Capranico, Giovanni/K-1678-2014	Griffith, Renate/0000-0001-7739-5686; Capranico, Giovanni/0000-0002-8708-6454; Marinello, Jessica/0000-0002-2356-869X	University of New South Wales, Australia; University International Postgraduate Award (UIPA); Translational Cancer Research Network (TCRN) Australia	University of New South Wales, Australia; University International Postgraduate Award (UIPA); Translational Cancer Research Network (TCRN) Australia	MD acknowledges financial assistance from the University of New South Wales, Australia, in providing a PhD scholarship in the form of a University International Postgraduate Award (UIPA), as well as the Translational Cancer Research Network (TCRN) Australia for providing a Postgraduate Research Scholarship Top-up in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auzanneau C, 2012, MOL PHARMACOL, V82, P134, DOI 10.1124/mol.111.077537; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; BAGULEY BC, 1995, CANCER CHEMOTH PHARM, V36, P244, DOI 10.1007/BF00685854; Bastow KF, 1997, BIOORGAN MED CHEM, V5, P1481, DOI 10.1016/S0968-0896(97)00102-8; BEERS SA, 1988, J NAT PROD, V51, P901, DOI 10.1021/np50059a014; Beretta GL, 2008, TOP CURR CHEM, V283, P1, DOI 10.1007/128_2007_3; Bertozzi D, 2014, MOL CANCER THER, V13, P239, DOI 10.1158/1535-7163.MCT-13-0729; Bertozzi D, 2011, CELL CYCLE, V10, P3189, DOI 10.4161/cc.10.18.17183; Binaschi M, 2000, CANCER RES, V60, P3770; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Capranico G, 1998, BBA-GENE STRUCT EXPR, V1400, P185, DOI 10.1016/S0167-4781(98)00135-3; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Chang JY, 2000, BIOCHEM PHARMACOL, V59, P497, DOI 10.1016/S0006-2952(99)00363-9; CHANG JY, 1991, CANCER RES, V51, P1755; DEISABELLA P, 1995, NUCLEIC ACIDS RES, V23, P223, DOI 10.1093/nar/23.2.223; DRAKE FH, 1987, J BIOL CHEM, V262, P16739; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Drwal MN, 2013, J COMPUT AID MOL DES, V27, P1037, DOI 10.1007/s10822-013-9695-x; Drwal Malgorzata N, 2013, Drug Discov Today Technol, V10, pe395, DOI 10.1016/j.ddtec.2013.02.002; Drwal MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025150; Finlay GJ, 1996, EUR J CANCER, V32A, P708, DOI 10.1016/0959-8049(95)00604-4; HSIANG YH, 1989, MOL PHARMACOL, V36, P371; HU H, 1992, J MED CHEM, V35, P866, DOI 10.1021/jm00083a009; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keller PA, 2000, J MOL GRAPH MODEL, V18, P235, DOI 10.1016/S1093-3263(00)00028-0; LEE KH, 1989, J NAT PROD, V52, P606, DOI 10.1021/np50063a021; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Petronzi C, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-24; POMMIER Y, 1991, J MOL BIOL, V222, P909, DOI 10.1016/0022-2836(91)90585-T; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi Q, 2001, BIOORGAN MED CHEM, V9, P2999, DOI 10.1016/S0968-0896(01)00206-1; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURSTON LS, 1989, J MED CHEM, V32, P604, DOI 10.1021/jm00123a016; THURSTON LS, 1986, J MED CHEM, V29, P1547, DOI 10.1021/jm00158a042; Tumiatti V, 2009, J MED CHEM, V52, P7873, DOI 10.1021/jm901131m; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG ZQ, 1992, J MED CHEM, V35, P871, DOI 10.1021/jm00083a010; WANG ZQ, 1993, PHARMACEUT RES, V10, P343, DOI 10.1023/A:1018923902760; WANG ZQ, 1990, J MED CHEM, V33, P2660, DOI 10.1021/jm00171a050; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; Wu CC, 2013, NUCLEIC ACIDS RES, V41, P10630, DOI 10.1093/nar/gkt828; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xiao ZY, 2004, J MED CHEM, V47, P5140, DOI 10.1021/jm030609l; Xiao ZY, 2004, BIOORGAN MED CHEM, V12, P3339, DOI 10.1016/j.bmc.2004.03.067; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; ZHANG YL, 1992, J NAT PROD, V55, P1100, DOI 10.1021/np50086a011; ZHOU XM, 1991, J MED CHEM, V34, P3346, DOI 10.1021/jm00116a001; ZHOU XM, 1993, PHARMACEUT RES, V10, P214, DOI 10.1023/A:1018978525533; Zhu XK, 1999, J MED CHEM, V42, P2441, DOI 10.1021/jm990055f	55	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114904	10.1371/journal.pone.0114904	http://dx.doi.org/10.1371/journal.pone.0114904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489853	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300093
J	Serfas, BG; Buttner, OB; Florack, A				Serfas, Benjamin G.; Buettner, Oliver B.; Florack, Arnd			Eyes Wide Shopped: Shopping Situations Trigger Arousal in Impulsive Buyers	PLOS ONE			English	Article							PUPIL; TEMPTATION; RESOURCES	The present study proposes arousal as an important mechanism driving buying impulsiveness. We examined the effect of buying impulsiveness on arousal in non-shopping and shopping contexts. In an eye- tracking experiment, we measured pupil dilation while participants viewed and rated pictures of shopping scenes and non-shopping scenes. The results demonstrated that buying impulsiveness is closely associated with arousal as response to viewing pictures of shopping scenes. This pertained for hedonic shopping situations as well as for utilitarian shopping situations. Importantly, the effect did not emerge for non-shopping scenes. Furthermore, we demonstrated that arousal of impulsive buyers is independent from cognitive evaluation of scenes in the pictures.	[Serfas, Benjamin G.; Buettner, Oliver B.; Florack, Arnd] Univ Vienna, Dept Appl Psychol Work Educ & Econ, Vienna, Austria; [Buettner, Oliver B.] Zeppelin Univ, Dept Econ Sci, Friedrichshafen, Germany	University of Vienna; Zeppelin University	Serfas, BG (corresponding author), Univ Vienna, Dept Appl Psychol Work Educ & Econ, Vienna, Austria.	benjamin.serfas@univie.ac.at	Florack, Arnd/A-9137-2008; Serfas, Benjamin G/E-3070-2014; Buttner, Oliver/E-3022-2014	Florack, Arnd/0000-0001-9906-0043; Serfas, Benjamin G/0000-0003-4358-6139; Buttner, Oliver/0000-0001-5037-1895	Marie Curie FP7 Integration Grant within the 7th European Union Framework Program [FP7-PEOPLE-2011-CIG 293577]	Marie Curie FP7 Integration Grant within the 7th European Union Framework Program	This work was supported by a Marie Curie FP7 Integration Grant within the 7th European Union Framework Program to Oliver B. Buttner (FP7-PEOPLE-2011-CIG 293577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Bijleveld E, 2009, PSYCHOL SCI, V20, P1313, DOI 10.1111/j.1467-9280.2009.02443.x; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Buttner OB, 2014, EUR J MARKETING, V48, P1026, DOI 10.1108/EJM-04-2012-0210; Buttner OB, 2014, SOC PSYCHOL PERS SCI, V5, P343, DOI 10.1177/1948550613494024; ELLIOTT R, 1970, J PERS SOC PSYCHOL, V14, P166, DOI 10.1037/h0028686; Faber RJ, 2004, J CONSUM RES, P537; Groeppel-Klein A, 2005, BRAIN RES BULL, V67, P428, DOI 10.1016/j.brainresbull.2005.06.012; Hubert M, 2013, PSYCHOL MARKET, V30, P861, DOI 10.1002/mar.20651; Lang P.J., 2008, A8 U FLOR; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pine KJ, 2011, PERS INDIV DIFFER, V50, P74, DOI 10.1016/j.paid.2010.08.026; Rook DW, 1995, J CONSUM RES, V22, P305, DOI 10.1086/209452; ROOK DW, 1987, J CONSUM RES, V14, P189, DOI 10.1086/209105; Tice DM, 2001, J PERS SOC PSYCHOL, V80, P53, DOI 10.1037//0022-3514.80.1.53; Tsukayama E, 2012, EUR J PERSONALITY, V26, P318, DOI 10.1002/per.841; Verplanken B, 2001, EUR J PERSONALITY, V15, pS71, DOI 10.1002/per.423; Vohs KD, 2007, J CONSUM RES, V33, P537, DOI 10.1086/510228; Zahn TP, 1996, PSYCHOPHYSIOLOGY, V33, P731, DOI 10.1111/j.1469-8986.1996.tb02369.x	21	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114593	10.1371/journal.pone.0114593	http://dx.doi.org/10.1371/journal.pone.0114593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25489955	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300054
J	Bogenschutz, NL; Rodriguez, J; Tsukiyama, T				Bogenschutz, Naomi L.; Rodriguez, Jairo; Tsukiyama, Toshio			Initiation of DNA Replication from Non-Canonical Sites on an Origin-Depleted Chromosome	PLOS ONE			English	Article							SACCHAROMYCES; YEAST; IDENTIFICATION; STABILITY	Eukaryotic DNA replication initiates from multiple sites on each chromosome called replication origins (origins). In the budding yeast Saccharomyces cerevisiae, origins are defined at discrete sites. Regular spacing and diverse firing characteristics of origins are thought to be required for efficient completion of replication, especially in the presence of replication stress. However, a S. cerevisiae chromosome III harboring multiple origin deletions has been reported to replicate relatively normally, and yet how an origin-deficient chromosome could accomplish successful replication remains unknown. To address this issue, we deleted seven well-characterized origins from chromosome VI, and found that these deletions do not cause gross growth defects even in the presence of replication inhibitors. We demonstrated that the origin deletions do cause a strong decrease in the binding of the origin recognition complex. Unexpectedly, replication profiling of this chromosome showed that DNA replication initiates from non-canonical loci around deleted origins in yeast. These results suggest that replication initiation can be unexpectedly flexible in this organism.	[Bogenschutz, Naomi L.; Rodriguez, Jairo; Tsukiyama, Toshio] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Bogenschutz, Naomi L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Bogenschutz, Naomi L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Tsukiyama, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.	ttsukiya@fhcrc.org	Rodriguez Lumbiarres, Jairo/E-7944-2018	Rodriguez Lumbiarres, Jairo/0000-0002-6844-974X	NSF [DGE-0718124, GM078259]; Spanish Ministerio de Educacion y Ciencia; National Science Foundation Graduate Research Fellowship Program [DGE-0718124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078259] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Spanish Ministerio de Educacion y Ciencia(Spanish Government); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by NSF DGE-0718124 for NB, and GM078259 for TT. JR was supported in part by a fellowship from the Spanish Ministerio de Educacion y Ciencia. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-0718124. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberis M, 2010, CURR GENOMICS, V11, P199, DOI 10.2174/138920210791110942; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; Dershowitz A, 2007, MOL CELL BIOL, V27, P4652, DOI 10.1128/MCB.01246-06; Diffley JFX, 2010, COLD SPRING HARBOR S; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hawkins M, 2013, CELL REP, V5, P1132, DOI 10.1016/j.celrep.2013.10.014; Kasinathan S, 2014, NAT METHODS, V11, P203, DOI [10.1038/NMETH.2766, 10.1038/nmeth.2766]; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Lindstrom KC, 2006, MOL CELL BIOL, V26, P6117, DOI 10.1128/MCB.00642-06; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rodriguez J, 2013, GENE DEV, V27, P74, DOI 10.1101/gad.202978.112; Royce TE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-186; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Siow CC, 2012, NUCLEIC ACIDS RES, V40, pD682, DOI 10.1093/nar/gkr1091; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Theis JF, 2007, GENETICS, V177, P1445, DOI 10.1534/genetics.107.074690; Theis JF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001227; THOMAS BJ, 1989, GENETICS, V123, P725; van Brabant AJ, 2001, MOL CELL, V7, P705, DOI 10.1016/S1097-2765(01)00216-7; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Viggiani CJ, 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1101/03.PR0T5385; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	32	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114545	10.1371/journal.pone.0114545	http://dx.doi.org/10.1371/journal.pone.0114545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486280	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600075
J	Cai, Q; Wang, B; Coling, D; Zuo, J; Fang, J; Yang, S; Vera, K; Hu, BH				Cai, Qunfeng; Wang, Bo; Coling, Donald; Zuo, Jian; Fang, Jie; Yang, Shiming; Vera, Krystal; Hu, Bo Hua			Reduction in Noise-Induced Functional Loss of the Cochleae in Mice with Pre-Existing Cochlear Dysfunction Due to Genetic Interference of Prestin	PLOS ONE			English	Article							INDUCED HEARING-LOSS; OUTER HAIR-CELLS; LOW-DOSE KANAMYCIN; KNOCKOUT MICE; MOTOR PROTEIN; SALICYLATE; PROTECTION; EXPOSURE; THRESHOLD; ELECTROMOTILITY	Various cochlear pathologies, such as acoustic trauma, ototoxicity and age-related degeneration, cause hearing loss. These pre-existing hearing losses can alter cochlear responses to subsequent acoustic overstimulation. So far, the knowledge on the impacts of pre-existing hearing loss caused by genetic alteration of cochlear genes is limited. Prestin is the motor protein expressed exclusively in outer hair cells in the mammalian cochlea. This motor protein contributes to outer hair cell motility. At present, it is not clear how the interference of prestin function affects cochlear responses to acoustic overstimulation. To address this question, a genetic model of prestin dysfunction in mice was created by inserting an internal ribosome entry site (IRES)-CreERT2-FRT-Neo-FRT cassette into the prestin locus after the stop codon. Homozygous mice exhibit a threshold elevation of auditory brainstem responses with large individual variation. These mice also display a threshold elevation and a shift of the input/output function of the distortion product otoacoustic emission, suggesting a reduction in outer hair cell function. The disruption of prestin function reduces the threshold shifts caused by exposure to a loud noise at 120 dB (sound pressure level) for 1 h. This reduction is positively correlated with the level of pre-noise cochlear dysfunction and is accompanied by a reduced change in Cdh1 expression, suggesting a reduction in molecular responses to the acoustic overstimulation. Together, these results suggest that prestin interference reduces cochlear stress responses to acoustic overstimulation.	[Cai, Qunfeng; Coling, Donald; Vera, Krystal; Hu, Bo Hua] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA; [Wang, Bo; Yang, Shiming] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otolaryngol & Head & Neck Surg, Beijing, Peoples R China; [Zuo, Jian; Fang, Jie] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chinese People's Liberation Army General Hospital; St Jude Children's Research Hospital	Hu, BH (corresponding author), SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA.	bhu@buffalo.edu			National Institutes of Health (NIH) [R01DC010154, 2R01DC006471]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010154, R21DC013879, R01DC006471] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Financial support was provided by National Institutes of Health (NIH) (R01DC010154, to Bo Hua Hu), (2R01DC006471, to Jian Zuo), (http://www.nih.gov); and American Lebanese Syrian Associated Charities (ALSAC) (to Jian Zuo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman C, 2008, AUDIOL NEURO-OTOL, V13, P266, DOI 10.1159/000115436; BANCROFT BR, 1991, HEARING RES, V54, P20, DOI 10.1016/0378-5955(91)90132-S; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cai Q, 2013, LARYNGOSCOPE, V123; Cai QF, 2013, J NEUROSCI METH, V219, P240, DOI 10.1016/j.jneumeth.2013.08.010; Cai QF, 2012, NEUROBIOL DIS, V45, P723, DOI 10.1016/j.nbd.2011.10.018; CAMPO P, 1991, HEARING RES, V55, P195, DOI 10.1016/0378-5955(91)90104-H; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Chen GD, 2002, HEARING RES, V172, P186, DOI 10.1016/S0378-5955(02)00582-8; Cheng J, 2011, AM J HUM GENET, V89, P56, DOI 10.1016/j.ajhg.2011.05.027; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Dallos P, 2008, CURR OPIN NEUROBIOL, V18, P370, DOI 10.1016/j.conb.2008.08.016; DIELER R, 1991, J NEUROCYTOL, V20, P637, DOI 10.1007/BF01187066; Fang J, 2012, GENESIS, V50, P124, DOI 10.1002/dvg.20810; Fechter Laurence D., 2002, Noise Health, V4, P49; Fernandez EA, 2010, JARO-J ASSOC RES OTO, V11, P235, DOI 10.1007/s10162-009-0204-9; Hakuba N, 2000, J NEUROSCI, V20, P8750; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hu BH, 2002, HEARING RES, V172, P1, DOI 10.1016/S0378-5955(01)00361-6; Hu BH, 2012, J NEUROSCI, V32, P14927, DOI 10.1523/JNEUROSCI.1588-12.2012; Hu BH, 2010, J NEUROSCI RES, V88, P1812, DOI 10.1002/jnr.22333; HUMES LE, 1984, J ACOUST SOC AM, V76, P1318, DOI 10.1121/1.391447; Kozel PJ, 2002, HEARING RES, V164, P231, DOI 10.1016/S0378-5955(01)00420-8; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; LEBO CP, 1972, LARYNGOSCOPE, V82, P1399, DOI 10.1288/00005537-197208000-00002; Li HZ, 2009, NOISE HEALTH, V11, P26, DOI 10.4103/1463-1741.45310; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; McFadden Sandra L., 2001, Noise Health, V3, P49; Miller JM, 1998, SCAND AUDIOL, V27, P53; Ohlemiller KK, 2011, HEARING RES, V280, P141, DOI 10.1016/j.heares.2011.05.007; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PUEL JL, 1988, HEARING RES, V37, P65, DOI 10.1016/0378-5955(88)90078-0; RAJAN R, 1988, J NEUROPHYSIOL, V60, P549, DOI 10.1152/jn.1988.60.2.549; REITER ER, 1995, J NEUROPHYSIOL, V73, P506, DOI 10.1152/jn.1995.73.2.506; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; SHONE G, 1991, HEARING RES, V56, P173, DOI 10.1016/0378-5955(91)90167-8; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; SPONGR VP, 1992, ARCH OTOLARYNGOL, V118, P157; SUBRAMANIAM M, 1993, HEARING RES, V65, P234, DOI 10.1016/0378-5955(93)90216-N; SUN JC, 1994, LARYNGOSCOPE, V104, P1251; VOLDRICH L, 1979, ARCH OHREN NASEN KEH, V222, P169, DOI 10.1007/BF00456312; WHITLON DS, 1993, J NEUROCYTOL, V22, P1030, DOI 10.1007/BF01235747; WOODFORD CM, 1978, ANN OTO RHINOL LARYN, V87, P117, DOI 10.1177/000348947808700119; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng XY, 1997, HEARING RES, V104, P191, DOI 10.1016/S0378-5955(96)00187-6; Zhu YH, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-26	50	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113990	10.1371/journal.pone.0113990	http://dx.doi.org/10.1371/journal.pone.0113990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486270	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600034
J	Nienhouse, V; Gao, X; Dong, QF; Nelson, DE; Toh, E; McKinley, K; Schreckenberger, P; Shibata, N; Fok, CS; Mueller, ER; Brubaker, L; Wolfe, AJ; Radek, KA				Nienhouse, Vanessa; Gao, Xiang; Dong, Qunfeng; Nelson, David E.; Toh, Evelyn; McKinley, Kathleen; Schreckenberger, Paul; Shibata, Noriko; Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda; Wolfe, Alan J.; Radek, Katherine A.			Interplay between Bladder Microbiota and Urinary Antimicrobial Peptides: Mechanisms for Human Urinary Tract Infection Risk and Symptom Severity	PLOS ONE			English	Article							INVASIVE BACTERIAL-INFECTION; SQUAMOUS-CELL CARCINOMAS; PELVIC FLOOR DISORDERS; HUMAN BETA-DEFENSIN-1; POSTMENOPAUSAL WOMEN; PSORIASIN S100A7; INNATE IMMUNITY; RIBONUCLEASE 7; HUMAN SKIN; DEFENSE	Resident bacterial communities (microbiota) and host antimicrobial peptides (AMPs) are both essential components of normal host innate immune responses that limit infection and pathogen induced inflammation. However, their interdependence has not been investigated in the context of urinary tract infection (UTI) susceptibility. Here, we explored the interrelationship between the urinary microbiota and host AMP responses as mechanisms for UTI risk. Using prospectively collected day of surgery (DOS) urine specimens from female pelvic floor surgery participants, we report that the relative abundance and/or frequency of specific urinary microbiota distinguished between participants who did or did not develop a post-operative UTI. Furthermore, UTI risk significantly correlated with both specific urinary microbiota and beta-defensin AMP levels. Finally, urinary AMP hydrophobicity and protease activity were greater in participants who developed UTI, and correlated positively with both UTI risk and pelvic floor symptoms. These data demonstrate an interdependency between the urinary microbiota, AMP responses and symptoms, and identify a potential mechanism for UTI risk. Assessment of bacterial microbiota and host innate immune AMP responses in parallel may identify increased risk of UTI in certain populations.	[Nienhouse, Vanessa; Radek, Katherine A.] Loyola Univ Chicago, Burn & Shock Trauma Res Inst, Div Hlth Sci, Maywood, IL 60660 USA; [Nienhouse, Vanessa; Shibata, Noriko; Wolfe, Alan J.; Radek, Katherine A.] Loyola Univ Chicago, Dept Microbiol & Immunol, Div Hlth Sci, Maywood, IL USA; [Nienhouse, Vanessa; Schreckenberger, Paul; Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda; Wolfe, Alan J.; Radek, Katherine A.] Loyola Univ Chicago, Stritch Sch Med, Div Hlth Sci, Maywood, IL USA; [Nienhouse, Vanessa; Schreckenberger, Paul; Shibata, Noriko; Wolfe, Alan J.; Radek, Katherine A.] Loyola Univ Chicago, Infect Dis & Immunol Res Inst, Div Hlth Sci, Maywood, IL USA; [Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda] Loyola Univ Chicago, Div Female Pelv Med & Reconstruct Surg, Div Hlth Sci, Dept Obstet Gynecol, Maywood, IL USA; [McKinley, Kathleen; Schreckenberger, Paul] Loyola Univ Chicago, Dept Pathol, Div Hlth Sci, Maywood, IL USA; [Fok, Cynthia S.; Mueller, Elizabeth R.; Brubaker, Linda] Loyola Univ Chicago, Dept Urol, Div Hlth Sci, Maywood, IL USA; [Radek, Katherine A.] Loyola Univ Chicago, Dept Surg, Div Hlth Sci, Maywood, IL USA; [Nelson, David E.; Toh, Evelyn] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Gao, Xiang; Dong, Qunfeng] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Gao, Xiang; Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Radek, KA (corresponding author), Loyola Univ Chicago, Burn & Shock Trauma Res Inst, Div Hlth Sci, Maywood, IL 60660 USA.	kradek1@luc.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Toh, Evelyn/0000-0003-2932-4060	Loyola University Chicago Stritch School of Medicine Research Funding Committee; Marion and Ralph C. Falk Medical Research Trust; Indiana University Foundation	Loyola University Chicago Stritch School of Medicine Research Funding Committee; Marion and Ralph C. Falk Medical Research Trust; Indiana University Foundation	This study was funded by the Loyola University Chicago Stritch School of Medicine Research Funding Committee and the Marion and Ralph C. Falk Medical Research Trust for KAR, AJW and LB. This study was also funded by the Indiana University Foundation for DEN.	Arao S, 1999, J CLIN MICROBIOL, V37, P553, DOI 10.1128/JCM.37.3.553-557.1999; Barber MD, 2006, AM J OBSTET GYNECOL, V194, P1492, DOI 10.1016/j.ajog.2006.01.076; Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Brown JS, 2001, OBSTET GYNECOL, V98, P1045, DOI 10.1016/S0029-7844(01)01630-1; Brubaker L, 2014, INT UROGYNECOL J, V25, P1179, DOI 10.1007/s00192-013-2325-2; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Clausen ML, 2013, BRIT J DERMATOL, V169, P587, DOI 10.1111/bjd.12419; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Fok CS, 2013, J UROLOGY, V189, P1721, DOI 10.1016/j.juro.2012.11.167; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Foxman B, 2001, J CLIN EPIDEMIOL, V54, P710, DOI 10.1016/S0895-4356(00)00352-8; Gallo RL, 2003, CURR ALLERGY ASTHM R, V3, P402, DOI 10.1007/s11882-003-0074-x; GANZ T, 1993, BLOOD, V82, P641; Ganz T, 2001, J INFECT DIS, V183, pS41, DOI 10.1086/318838; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Khassawneh M, 2010, PEDIATR NEPHROL, V25, P1377, DOI 10.1007/s00467-010-1473-6; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Mahajan ST, 2006, AM J OBSTET GYNECOL, V194, P722, DOI 10.1016/j.ajog.2005.08.043; Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Nielsen KL, 2014, INFECT IMMUN, V82, P1572, DOI 10.1128/IAI.01393-13; Nizet V, 2003, SCAND J INFECT DIS, V35, P670, DOI 10.1080/00365540310015629; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Oottamasathien S, 2011, J UROLOGY, V186, P1684, DOI 10.1016/j.juro.2011.03.099; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Ostergaard M, 1999, ELECTROPHORESIS, V20, P349; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Pham T, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.010; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Siddiqui H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-205; Spencer JD, 2011, KIDNEY INT, V80, P175, DOI 10.1038/ki.2011.109; Spencer JD, 2013, KIDNEY INT, V83, P615, DOI 10.1038/ki.2012.410; Spencer JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031712; Stamm WE, 1999, CLIN INFECT DIS, V28, P723, DOI 10.1086/515209; Stothard DR, 1998, INFECT IMMUN, V66, P3618, DOI 10.1128/IAI.66.8.3618-3625.1998; Sturm PDJ, 2006, J CLIN MICROBIOL, V44, P652, DOI 10.1128/JCM.44.2.652-654.2006; Sutkin G, 2010, INT UROGYNECOL J, V21, P955, DOI 10.1007/s00192-010-1137-x; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Vartivarian SE, 1996, ARCH INTERN MED, V156, P433, DOI 10.1001/archinte.156.4.433; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolf R, 2006, J INVEST DERMATOL, V126, P1600, DOI 10.1038/sj.jid.5700210; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wu JM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.046; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	70	71	74	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114185	10.1371/journal.pone.0114185	http://dx.doi.org/10.1371/journal.pone.0114185			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486068	gold, Green Published			2022-12-26	WOS:000346907600045
J	Price, CTD; Abu Kwaik, Y				Price, Christopher T. D.; Abu Kwaik, Yousef			The Transcriptome of Legionella pneumophila-Infected Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; HOST-CELL DEATH; INTRACELLULAR REPLICATION; GLUTAMATE TRANSPORTERS; CONTAINING PHAGOSOME; ARGININE TRANSPORT; MOUSE MACROPHAGES; PROTEIN-SYNTHESIS; IFN-GAMMA	Background: Legionella pneumophila is an intracellular bacterial pathogen that invades and replicates within alveolar macrophages through injection of,300 effector proteins by its Dot/Icm type IV translocation apparatus. The bona fide F-box protein, AnkB, is a nutritional virulence effector that triggers macrophages to generate a surplus of amino acids, which is essential for intravacuolar proliferation. Therefore, the ankB mutant represents a novel genetic tool to determine the transcriptional response of human monocyte-derived macrophages (hMDMs) to actively replicating L. pneumophila. Methodology/Principal Findings: Here, we utilized total human gene microarrays to determine the global transcriptional response of hMDMs to infection by wild type or the ankB mutant of L. pneumophila. The transcriptomes of hMDMs infected with either actively proliferating wild type or non-replicative ankB mutant bacteria were remarkably similar. The transcriptome of infected hMDMs was predominated by up-regulation of inflammatory pathways (IL-10 anti-inflammatory, interferon signaling and amphoterin signaling), anti-apoptosis, and down-regulation of protein synthesis pathways. In addition, L. pneumophila modulated diverse metabolic pathways, particularly those associated with bio-active lipid metabolism, and SLC amino acid transporters expression. Conclusion/Significance: Taken together, the hMDM transcriptional response to L. pneumophila is independent of intra-vacuolar replication of the bacteria and primarily involves modulation of the immune response and metabolic as well as nutritional pathways.	[Price, Christopher T. D.; Abu Kwaik, Yousef] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA; [Abu Kwaik, Yousef] Univ Louisville, Ctr Predict Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Price, CTD (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	christopher.price@louisville.edu; abukwaik@louisville.edu		Abu Kwaik, Yousef/0000-0002-2119-2078	National Institute of Allergy and Infectious Diseases [R01AI069321, R21AI107978]; Commonwealth of Kentucky Research Challenge Trust Fund; National Institutes of Health [2P20GM103436-14, 1P30GM106396-01]; J. G. Brown Cancer Center at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107978, R01AI069321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396, P20GM103436] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Commonwealth of Kentucky Research Challenge Trust Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. G. Brown Cancer Center at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The YAK lab is supported by Public Health Service Awards R01AI069321 and R21AI107978 from the National Institute of Allergy and Infectious Diseases and by the Commonwealth of Kentucky Research Challenge Trust Fund. Part of this work was performed at the University of Louisville Genomics Facility, which is supported by the National Institutes of Health: 2P20GM103436-14, NIH: 1P30GM106396-01 and the J. G. Brown Cancer Center at the University of Louisville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zant A, 2005, INFECT IMMUN, V73, P5339, DOI 10.1128/IAI.73.9.5339-5349.2005; Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Archer KA, 2010, INFECT IMMUN, V78, P2477, DOI 10.1128/IAI.00243-10; Asrat S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004229; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Barry DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029046; Barry KC, 2013, J IMMUNOL, V190, P6329, DOI 10.4049/jimmunol.1300100; Bartfeld S, 2009, CELL MICROBIOL, V11, P1638, DOI 10.1111/j.1462-5822.2009.01354.x; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Belyi Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00076; Berger UV, 2006, ANAT EMBRYOL, V211, P595, DOI 10.1007/s00429-006-0109-x; Boon JY, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00064; BRIELAND JK, 1995, INFECT IMMUN, V63, P3253, DOI 10.1128/IAI.63.9.3253-3258.1995; Bruckert WM, 2014, INFECT IMMUN, V82, P72, DOI 10.1128/IAI.01079-13; Canadien V, 2005, J IMMUNOL, V174, P2471, DOI 10.4049/jimmunol.174.5.2471; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen Y, 2010, DIAGN MICR INFEC DIS, V66, P253, DOI 10.1016/j.diagmicrobio.2009.11.001; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Degtyar E, 2009, CELL MICROBIOL, V11, P1219, DOI 10.1111/j.1462-5822.2009.01328.x; Deng JC, 2001, INFECT IMMUN, V69, P6382, DOI 10.1128/IAI.69.10.6382-6390.2001; Derre I, 2004, INFECT IMMUN, V72, P6221, DOI 10.1128/IAI.72.11.6221-6229.2004; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diehl N, 2013, VIRUSES-BASEL, V5, P3192, DOI 10.3390/v5123192; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Fortier A, 2011, IMMUNOBIOLOGY, V216, P1274, DOI 10.1016/j.imbio.2011.06.008; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; Franco IS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002546; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Sans-Fons MG, 2013, J INFECT DIS, V207, P1684, DOI 10.1093/infdis/jit084; Guo ZH, 2014, MICROBES INFECT, V16, P225, DOI 10.1016/j.micinf.2013.11.007; Haneburger I, 2014, CURR TOP MICROBIOL, V376, P155, DOI 10.1007/82_2013_341; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; Hoffmann C, 2014, CELL MICROBIOL, V16, P1034, DOI 10.1111/cmi.12256; Hubber A, 2014, CURR TOP MICROBIOL, V376, P227, DOI 10.1007/82_2013_343; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Ivanov SS, 2014, CURR TOP MICROBIOL, V376, P135, DOI 10.1007/82_2013_344; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Lomma M, 2010, CELL MICROBIOL, V12, P1272, DOI 10.1111/j.1462-5822.2010.01467.x; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00036; Luo ZQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00031; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; MCCUSKER KT, 1991, INFECT IMMUN, V59, P240, DOI 10.1128/IAI.59.1.240-246.1991; McHugh SL, 2000, J LEUKOCYTE BIOL, V67, P863, DOI 10.1002/jlb.67.6.863; Molmeret M, 2004, CELL MICROBIOL, V6, P33, DOI 10.1046/j.1462-5822.2003.00335.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Neild AL, 2003, IMMUNITY, V18, P813, DOI 10.1016/S1074-7613(03)00140-7; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Park DR, 1996, J IMMUNOL, V157, P2528; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2014, ENVIRON MICROBIOL, V16, P350, DOI 10.1111/1462-2920.12290; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00131; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00122; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; Rimaniol AC, 2001, AM J PHYSIOL-CELL PH, V281, pC1964, DOI 10.1152/ajpcell.2001.281.6.C1964; Rimaniol AC, 2000, J IMMUNOL, V164, P5430, DOI 10.4049/jimmunol.164.10.5430; Rolando M, 2014, TRENDS CELL BIOL; Santic M, 2005, INFECT IMMUN, V73, P3166, DOI 10.1128/IAI.73.5.3166-3171.2005; Schmeck B, 2007, EUR RESPIR J, V29, P25, DOI 10.1183/09031936.00141005; Schunder E, 2014, J BIOL CHEM; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Shin S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000220; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Stavrou S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004145; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Tachado SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003324; Tateda K, 1998, CLIN DIAGN LAB IMMUN, V5, P401, DOI 10.1128/CDLI.5.3.401-403.1998; Tattoli I, 2012, BIOL OPEN, V1, P1215, DOI 10.1242/bio.20122840; Viner R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002988; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yoshizawa S, 2005, INFECT IMMUN, V73, P2709, DOI 10.1128/IAI.73.5.2709-2717.2005; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	100	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114914	10.1371/journal.pone.0114914	http://dx.doi.org/10.1371/journal.pone.0114914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485627	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600105
J	Hua, X; Tan, SN; Bandara, HMHN; Fu, YJ; Liu, SG; Smyth, HDC				Hua, Xin; Tan, Shengnan; Bandara, H. M. H. N.; Fu, Yujie; Liu, Siguo; Smyth, Hugh D. C.			Externally Controlled Triggered-Release of Drug from PLGA Micro and Nanoparticles	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; PSEUDOMONAS-AERUGINOSA; POLYVINYL-ALCOHOL; IN-VITRO; CANDIDA-ALBICANS; NANOSPHERES; FIELD; CIPROFLOXACIN; MICROSPHERES; DELIVERY	Biofilm infections are extremely hard to eradicate and controlled, triggered and controlled drug release properties may prolong drug release time. In this study, the ability to externally control drug release from micro and nanoparticles was investigated. We prepared micro/nanoparticles containing ciprofloxacin (CIP) and magnetic nanoparticles encapsulated in poly (lactic-co-glycolic acid) PLGA. Both micro/nanoparticles were observed to have narrow size distributions. We investigated and compared their passive and externally triggered drug release properties based on their different encapsulation structures for the nano and micro systems. In passive release studies, CIP demonstrated a fast rate of release in first 2 days which then slowed and sustained release for approximately 4 weeks. Significantly, magnetic nanoparticles containing systems all showed ability to have triggered drug release when exposed to an external oscillating magnetic field (OMF). An experiment where the OMF was turned on and off also confirmed the ability to control the drug release in a pulsatile manner. The magnetically triggered release resulted in a 2-fold drug release increase compared with normal passive release. To confirm drug integrity following release, the antibacterial activity of released drug was evaluated in Pseudomonas aeruginosa biofilms in vitro. CIP maintained its antimicrobial activity after encapsulation and triggered release.	[Hua, Xin; Liu, Siguo] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China; [Tan, Shengnan; Fu, Yujie] Northeast Forestry Univ, State Engn Lab Bioresource Ecoutilizat, Harbin, Peoples R China; [Bandara, H. M. H. N.; Smyth, Hugh D. C.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Forestry University - China; University of Texas System; University of Texas Austin	Liu, SG (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China.	siguo_liu@yahoo.com.cn; hugh.smyth@austin.utexas.edu	Bandara, Nihal/O-7287-2014	Bandara, Nihal/0000-0001-7652-2030; Smyth, Hugh/0000-0002-6582-5869	National Heart, Lung, and Blood Institute of the National Institutes of Health [R33HL092812-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092812] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The National Heart, Lung, and Blood Institute of the National Institutes of Health under R33HL092812-03 provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4; Araujo J, 2009, COLLOID SURFACE B, V72, P48, DOI 10.1016/j.colsurfb.2009.03.028; Arnold MM, 2007, J CONTROL RELEASE, V121, P100, DOI 10.1016/j.jconrel.2007.05.039; Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Blum JS, 2008, J CONTROL RELEASE, V129, P66, DOI 10.1016/j.jconrel.2008.04.002; Chiang WL, 2012, SMALL, V8, P3584, DOI 10.1002/smll.201201743; Cirpanli Y, 2005, J MICROENCAPSUL, V22, P877, DOI 10.1080/02652040500273878; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Fernandez-Pacheco R, 2007, J MAGN MAGN MATER, V311, P318, DOI 10.1016/j.jmmm.2006.11.192; Gorner T, 1999, J CONTROL RELEASE, V57, P259, DOI 10.1016/S0168-3659(98)00121-7; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; Hergt R, 2006, J PHYS-CONDENS MAT, V18, pS2919, DOI 10.1088/0953-8984/18/38/S26; Hickey AJ, 2007, J PHARM SCI-US, V96, P1282, DOI 10.1002/jps.20916; Hilger I, 2002, ACAD RADIOL, V9, P198, DOI 10.1016/S1076-6332(03)80171-X; Hu SH, 2011, CHEM COMMUN, V47, P1776, DOI 10.1039/c0cc03998e; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jin Y, 2004, ARCH ORAL BIOL, V49, P789, DOI 10.1016/j.archoralbio.2004.04.011; Kini S, 2011, IEEE T MAGN, V47, P2882, DOI 10.1109/TMAG.2011.2158403; Lee SC, 1999, J CONTROL RELEASE, V59, P123, DOI 10.1016/S0168-3659(98)00185-0; Mahmoudi M, 2009, J PHYS CHEM C, V113, P9573, DOI 10.1021/jp9001516; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mao ZW, 2005, J CONTROL RELEASE, V104, P193, DOI 10.1016/j.jconrel.2005.02.005; McCarthy JR, 2007, NANOMEDICINE-UK, V2, P153, DOI 10.2217/17435889.2.2.153; McGill SL, 2009, IEEE T NANOBIOSCI, V8, P33, DOI 10.1109/TNB.2009.2017292; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Page-Clisson ME, 1998, J CONTROL RELEASE, V56, P23, DOI 10.1016/S0168-3659(98)00065-0; PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X; Peng XH, 2008, INT J NANOMED, V3, P311; Petri-Fink A, 2005, BIOMATERIALS, V26, P2685, DOI 10.1016/j.biomaterials.2004.07.023; Pierce GE, 2005, J IND MICROBIOL BIOT, V32, P309, DOI 10.1007/s10295-005-0225-2; Pradhan P, 2010, J CONTROL RELEASE, V142, P108, DOI 10.1016/j.jconrel.2009.10.002; Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2; RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6; Roca AG, 2012, IEEE T MAGN, V48, P4054, DOI 10.1109/TMAG.2012.2201459; Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X; Shen JM, 2013, ACS APPL MATER INTER, V5, P7014, DOI 10.1021/am401277s; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Subramani K, 2009, CURR NANOSCI, V5, P135, DOI 10.2174/157341309788185406; Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X; WOOD DM, 2006, COCHRANE DB SYST REV, V1; Xu CJ, 2009, J AM CHEM SOC, V131, P15346, DOI 10.1021/ja905938a; Yin JH, 2006, INT J PHARMACEUT, V314, P46, DOI 10.1016/j.ijpharm.2006.01.047; Young JI, 2003, INT J PHARM, V259, P79, DOI 10.1016/S0378-5173(03)00207-2	45	33	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114271	10.1371/journal.pone.0114271	http://dx.doi.org/10.1371/journal.pone.0114271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479357	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200061
J	Wan, X; Xia, WK; Gendoo, Y; Chen, W; Sun, WJ; Sun, D; Cao, CC				Wan, Xin; Xia, Wenkai; Gendoo, Yasser; Chen, Wen; Sun, Wenjin; Sun, Dong; Cao, Changchun			Upregulation of Stromal Cell-Derived Factor 1 (SDF-1) is Associated with Macrophage Infiltration in Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							KIDNEY INJURY; ISCHAEMIA/REPERFUSION INJURY; CHEMOKINE RECEPTORS; SIGNAL-TRANSDUCTION; EXPRESSION; REPAIR; CXCR4; ANGIOGENESIS; RECRUITMENT; INVOLVEMENT	Background: Stromal cell-derived factor-1(SDF-1) is a chemotactic and angiogenic factor that mediates the repair of various tissues. As macrophages are important contributors to ischemic kidney injury, we examine the role of SDF-1 in a rodent model of ischemia-reperfusion (I/R) injury. Methods: Male wild-type (WT) (C57BL/6) mice were subjected to bilateral I/R injury or sham operation in the presence or absence of macrophage depletion (liposomal clodronate [0.2 ml/20-25 g body weight i.p.]). Macrophage accumulation was assessed by immunohistochemistry. Tissue levels of SDF-1 (ELISA) and SDF-1 mRNA expression (real-time PCR) were measured. The cellular location of SDF-1 was assessed using immunohistochemical staining. Results: Immunofluorescence staining of renal tissue sections confirmed macrophage depletion by liposomal clodronate. SDF-1 production was elevated in response to I/R injury and was significantly increased upon macrophage depletion. SDF-1 positive cells initially appeared initially in the cortex, and subsequently diffused to the outer medulla after I/R injury. Conclusions: Our study demonstrates that SDF-1 is significantly upregulated during renal I/R. We hypothesize that SDF-1 upregulation may be an important macrophage effector mechanism during I/R injury.	[Wan, Xin; Xia, Wenkai; Gendoo, Yasser; Sun, Wenjin; Sun, Dong; Cao, Changchun] Nanjing Med Univ, Nanjing Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Chen, Wen] Nanjing Med Univ, Nanjing Hosp 1, Dept Thorac & Cardiovasc Surg, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Cao, CC (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China.	caochangchun@njmu.edu.cn			National Natural Science Foundation of China [81370797]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Project supported by the National Natural Science Foundation of China (Grant No. 81370797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Grone HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134957; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Lai PH, 2008, GRAEF ARCH CLIN EXP, V246, P1707, DOI 10.1007/s00417-008-0907-3; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; Oliver JA, 2012, AM J PHYSIOL-RENAL, V302, pF1362, DOI 10.1152/ajprenal.00202.2011; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pillarisetti K, 2001, CLONING RELATIVE EXP; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SABBAHY ME, 2011, WILEY INTERDISCIPLIN, V3, P606; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vinuesa E, 2008, J PATHOL, V214, P104, DOI 10.1002/path.2259; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	32	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114564	10.1371/journal.pone.0114564	http://dx.doi.org/10.1371/journal.pone.0114564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478952	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200105
J	Zhao, CH; Qi, JZ; Tao, WX; He, L; Xu, W; Chan, J; Deng, ZX				Zhao, Chunhua; Qi, Jianzhao; Tao, Weixing; He, Lei; Xu, Wei; Chan, Jason; Deng, Zixin			Characterization of Biosynthetic Genes of Ascamycin/Dealanylascamycin Featuring a 5 '-O-Sulfonamide Moiety in Streptomyces sp. JCM9888	PLOS ONE			English	Article							PEPTIDYL NUCLEOSIDE ANTIBIOTICS; HETEROLOGOUS EXPRESSION; SELECTIVE TOXICITY; PACIDAMYCIN GROUP; BOND FORMATION; CLUSTER; NUCLEOCIDIN; ASCAMYCIN; IDENTIFICATION; SULFOTRANSFERASE	Ascamycin (ACM) and dealanylascamycin (DACM) are nucleoside antibiotics elaborated by Streptomyces sp. JCM9888. The later shows broad spectrum inhibition activity to various gram-positive and gram-negative bacteria, eukaryotic Trypanosoma and is also toxic to mice, while ascamycin is active against very limited microorganisms, such as Xanthomonas. Both compounds share an unusual 5'-O-sulfonamide moiety which is attached to an adenosine nucleoside. In this paper, we first report on the 30 kb gene cluster (23 genes, acmA to acmW) involved in the biosynthesis of these two antibiotics and a biosynthetic assembly line was proposed. Of them, six genes (AcmABGKIW) are hypothetical genes involved in 5'-O-sulfonamide formation. Two flavin adenine dinucleotide (FAD)-dependent chlorinase genes acmX and acmY were characterized which are significantly remote from acmA-W and postulated to be required for adenine C2-halogenation. Notably gene disruption of acmE resulted in a mutant which could only produce dealanylascamycin but was blocked in its ability to biosynthesize ascamycin, revealing its key role of conversion of dealanylascamycin to ascamycin.	[Zhao, Chunhua; Qi, Jianzhao; Tao, Weixing; He, Lei; Xu, Wei; Deng, Zixin] Wuhan Univ, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, Wuhan 430071, Peoples R China; [Zhao, Chunhua; Qi, Jianzhao; Tao, Weixing; He, Lei; Xu, Wei; Deng, Zixin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China; [Chan, Jason] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China	Wuhan University; Wuhan University; Hong Kong University of Science & Technology	Zhao, CH (corresponding author), Wuhan Univ, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, 185 East Lake Rd, Wuhan 430071, Peoples R China.	zhaochunhua@whu.edu.cn; zxdeng@sjtu.edu.cn	Qi, Jianzhao/ABF-3423-2021	Qi, Jianzhao/0000-0003-1418-873X; Chan, K K Jason/0000-0002-7472-7232; Xu, Wei/0000-0003-0653-7805	973 Program, Ministry of Science and Technology, China [2009CB118901, 2012CB721002]; National Natural Science Foundation of China	973 Program, Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge grants from the 973 Program (2009CB118901, 2012CB721002), Ministry of Science and Technology, China, and the National Natural Science Foundation of China. CZ is a recipient of China postdoctoral training project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruntner C, 1999, MOL GEN GENET, V262, P102; Butler A, 2009, NATURE, V460, P848, DOI 10.1038/nature08303; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Chen WQ, 2009, J BIOL CHEM, V284, P10627, DOI 10.1074/jbc.M807534200; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; Cone MC, 2003, CHEMBIOCHEM, V4, P821, DOI 10.1002/cbic.200300583; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; FLORINI JR, 1966, J BIOL CHEM, V241, P1091; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; ISONO K, 1984, J ANTIBIOT, V37, P670, DOI 10.7164/antibiotics.37.670; JAFFE JJ, 1970, EXP PARASITOL, V28, P535, DOI 10.1016/0014-4894(70)90121-9; Jia XY, 2006, CHEM BIOL, V13, P575, DOI 10.1016/j.chembiol.2006.03.008; Kalan L, 2013, CHEM BIOL, V20, P1214, DOI 10.1016/j.chembiol.2013.09.006; Kaysser L, 2010, J BIOL CHEM, V285, P12684, DOI 10.1074/jbc.M109.094490; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KIRST HA, 1985, J ANTIBIOT, V38, P575, DOI 10.7164/antibiotics.38.575; KOBASHI K, 1986, ARCH BIOCHEM BIOPHYS, V245, P537, DOI 10.1016/0003-9861(86)90247-X; LACALLE RA, 1992, EMBO J, V11, P785, DOI 10.1002/j.1460-2075.1992.tb05112.x; Li JN, 2011, METAB ENG, V13, P336, DOI 10.1016/j.ymben.2011.01.002; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; MORTON GO, 1969, J AM CHEM SOC, V91, P1535, DOI 10.1021/ja01034a046; Niu GQ, 2013, CHEM BIOL, V20, P34, DOI 10.1016/j.chembiol.2012.10.017; OSADA H, 1986, J ANTIBIOT, V39, P286, DOI 10.7164/antibiotics.39.286; OSADA H, 1985, ANTIMICROB AGENTS CH, V27, P230, DOI 10.1128/AAC.27.2.230; OSADA H, 1986, BIOCHEM J, V233, P459, DOI 10.1042/bj2330459; Rackham EJ, 2010, CHEMBIOCHEM, V11, P1700, DOI 10.1002/cbic.201000200; Sambrook J., 2001, MOL CLONING LAB MANU; SHUMAN DA, 1970, J AM CHEM SOC, V92, P3434, DOI 10.1021/ja00714a035; SHUMAN DA, 1969, J AM CHEM SOC, V91, P3391, DOI 10.1021/ja01040a062; Sudo T, 1996, BIOCHEM J, V319, P99, DOI 10.1042/bj3190099; TAKAHASHI E, 1982, J ANTIBIOT, V35, P939, DOI 10.7164/antibiotics.35.939; Tang XY, 2013, NAT CHEM BIOL, V9, P610, DOI [10.1038/NCHEMBIO.1310, 10.1038/nchembio.1310]; Ubukata M, 1985, Nucleic Acids Symp Ser, P81; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Walsh CT, 2011, ACS CHEM BIOL, V6, P1000, DOI 10.1021/cb200284p; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; Wu J, 2012, CHEMBIOCHEM, V13, P1613, DOI 10.1002/cbic.201200173; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Zhang GY, 2012, APPL ENVIRON MICROB, V78, P2393, DOI 10.1128/AEM.07185-11; Zhang WJ, 2011, P NATL ACAD SCI USA, V108, P12249, DOI 10.1073/pnas.1109539108; Zhang WJ, 2010, P NATL ACAD SCI USA, V107, P16828, DOI 10.1073/pnas.1011557107	46	19	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114722	10.1371/journal.pone.0114722	http://dx.doi.org/10.1371/journal.pone.0114722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479601	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200116
J	Guo, MX; Wang, RC; Wang, J; Hua, K; Wang, YM; Liu, XQ; Yao, SG				Guo, Mingxin; Wang, Ruci; Wang, Juan; Hua, Kai; Wang, Yueming; Liu, Xiaoqiang; Yao, Shanguo			ALT1, a Snf2 Family Chromatin Remodeling ATPase, Negatively Regulates Alkaline Tolerance through Enhanced Defense against Oxidative Stress in Rice	PLOS ONE			English	Article							IRON-DEFICIENCY CHLOROSIS; ARABIDOPSIS-THALIANA; SALT TOLERANCE; DROUGHT RESISTANCE; ACID SYNTHESIS; GENE; AVAILABILITY; TRANSPORTER; ACTIVATION; EXPRESSION	Alkaline salt stress adversely affects rice growth, productivity and grain quality. However, the mechanism underlying this process remains elusive. We characterized here an alkaline tolerant mutant, alt1 in rice. Map-based cloning revealed that alt1 harbors a mutation in a chromatin remodeling ATPase gene. ALT1-RNAi transgenic plants under different genetic background mimicked the alt1 phenotype, exhibiting tolerance to alkaline stress in a transcript dosage-dependent manner. The predicted ALT1 protein belonged to the Ris1 subgroup of the Snf2 family and was localized in the nucleus, and transcription of ALT1 was transiently suppressed after alkaline treatment. Although the absorption of several metal ions maintained well in the mutant under alkaline stress, expression level of the genes involved in metal ions homeostasis was not altered in the alt1 mutant. Classification of differentially expressed abiotic stress related genes, as revealed by microarray analysis, found that the majority (50/78) were involved in ROS production, ROS scavenging, and DNA repair. This finding was further confirmed by that alt1 exhibited lower levels of H2O2 under alkaline stress and tolerance to methyl viologen treatment. Taken together, these results suggest that ALT1 negatively functions in alkaline tolerance mainly through the defense against oxidative damage, and provide a potential two-step strategy for improving the tolerance of rice plants to alkaline stress.	[Guo, Mingxin; Wang, Ruci; Wang, Juan; Hua, Kai; Wang, Yueming; Liu, Xiaoqiang; Yao, Shanguo] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Guo, Mingxin; Wang, Ruci; Wang, Juan; Hua, Kai; Wang, Yueming; Liu, Xiaoqiang; Yao, Shanguo] Chinese Acad Sci, Natl Plant Gene Res Ctr, Inst Genet & Dev Biol, Beijing, Peoples R China; [Guo, Mingxin; Wang, Juan; Hua, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, SG (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China.	sgyao@genetics.ac.cn		Guo, Mingxin/0000-0002-7764-1194	Chinese Academy of Sciences [KSCX2-YW-N-079]; Hundred Talents Program of Chinese Academy of Sciences [KSCX2-YW-076]; National "973" Program [2013CBA01405]; State Key Laboratory of Plant Genomics	Chinese Academy of Sciences(Chinese Academy of Sciences); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National "973" Program(National Basic Research Program of China); State Key Laboratory of Plant Genomics	This work was supported by grants from Chinese Academy of Sciences (KSCX2-YW-N-079), Hundred Talents Program of Chinese Academy of Sciences (KSCX2-YW-076), National "973" Program (2013CBA01405) and State Key Laboratory of Plant Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar HUR, 2008, ENVIRON EXP BOT, V63, P224, DOI 10.1016/j.envexpbot.2007.10.018; Bashir K, 2007, PLANT MOL BIOL, V65, P277, DOI 10.1007/s11103-007-9216-1; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Charlson DV, 2005, CROP SCI, V45, P2394, DOI 10.2135/cropsci2004.0510; Cordoba-Canero D, 2011, PLANT J, V68, P693, DOI 10.1111/j.1365-313X.2011.04720.x; Deng ZY, 2007, PLANT MOL BIOL, V65, P31, DOI 10.1007/s11103-007-9195-2; Du H, 2010, PLANT PHYSIOL, V154, P1304, DOI 10.1104/pp.110.163741; Duan YF, 2010, NEW PHYTOL, V186, P681, DOI 10.1111/j.1469-8137.2010.03207.x; FAO/AGL, 2000, EXT CAUS SALT AFF SO; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gao P, 2011, MOL BIOL REP, V38, P237, DOI 10.1007/s11033-010-0100-8; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Garg Bharti, 2012, Physiology and Molecular Biology of Plants, V18, P217, DOI 10.1007/s12298-012-0117-7; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomez-Galera S, 2012, PLANT PHYSIOL BIOCH, V53, P46, DOI 10.1016/j.plaphy.2012.01.009; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu YF, 2013, PLANT PHYSIOL BIOCH, V70, P33, DOI 10.1016/j.plaphy.2013.05.001; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kim SG, 2009, PHYSIOL PLANTARUM, V138, P1; Kim SY, 2005, J BIOCHEM MOL BIOL, V38, P218; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Kobayashi T, 2010, P JPN ACAD B-PHYS, V86, P900, DOI 10.2183/pjab.86.900; Kobayashi T, 2008, RICE, V1, P144, DOI 10.1007/s12284-008-9011-x; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Li CR, 2013, PLANT CELL ENVIRON, V36, P775, DOI 10.1111/pce.12013; Lin S, 1997, MOL BREEDING, V3, P219, DOI 10.1023/A:1009637320805; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Lu XD, 2008, CELL RES, V18, P589, DOI 10.1038/cr.2008.44; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mlynarova L, 2007, PLANT J, V51, P874, DOI 10.1111/j.1365-313X.2007.03185.x; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; O'Rourke JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-476; Ogawa D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1279; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Qi DL, 2008, J GENET GENOMICS, V35, P299, DOI 10.1016/S1673-8527(08)60043-0; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; Schmidt R, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27540; Shao T, 2011, PLANT PHYSIOL, V156, P1386, DOI 10.1104/pp.111.177428; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; TUSEN DD, 2010, THEOR APPL GENET, V121, P229; Wang S, 2011, DNA REPAIR, V10, P620, DOI 10.1016/j.dnarep.2011.04.009; Yamaguchi K, 2012, PLANT J, V70, P389, DOI 10.1111/j.1365-313X.2011.04874.x; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yang YQ, 2010, PLANT CELL, V22, P1313, DOI 10.1105/tpc.109.069609; Zhang X, 2013, J INTEGR PLANT BIOL, V55, P262, DOI 10.1111/jipb.12013; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x; Zhao CF, 2012, PLANTA, V236, P1165, DOI 10.1007/s00425-012-1667-1	62	21	28	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e112515	10.1371/journal.pone.0112515	http://dx.doi.org/10.1371/journal.pone.0112515			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473841	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500072
J	Palagani, A; Op de Beeck, K; Naulaerts, S; Diddens, J; Chirumamilla, CS; Van Camp, G; Laukens, K; Heyninck, K; Gerlo, S; Mestdagh, P; Vandesompele, J; Vanden Berghe, W				Palagani, Ajay; Op de Beeck, Ken; Naulaerts, Stefan; Diddens, Jolien; Chirumamilla, Chandra Sekhar; Van Camp, Guy; Laukens, Kris; Heyninck, Karen; Gerlo, Sarah; Mestdagh, Pieter; Vandesompele, Joke; Vanden Berghe, Wim			Ectopic MicroRNA-150-5p Transcription Sensitizes Glucocorticoid Therapy Response in MM1S Multiple Myeloma Cells but Fails to Overcome Hormone Therapy Resistance in MM1R Cells	PLOS ONE			English	Article							LIGAND-INDEPENDENT ACTIVATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; C-MYB; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; CANCER-CELLS; NONCODING RNA; RECEPTOR; MIR-150	Glucocorticoids (GCs) selectively trigger cell death in the multiple myeloma cell line MM1S which express NR3C1/Glucocorticoid Receptor (GR) protein, but fail to kill MM1R cells which lack GR protein. Given recent demonstrations of altered microRNA profiles in a diverse range of haematological malignancies and drug resistance, we characterized GC inducible mRNA and microRNA transcription profiles in GC sensitive MM1S as compared to GC resistant MM1R cells. Transcriptome analysis revealed that GCs regulate expression of multiple genes involved in cell cycle control, cell organization, cell death and immunological disease in MM1S cells, which remain unaffected in MM1R cells. With respect to microRNAs, mir-150-5p was identified as the most time persistent GC regulated microRNA, out of 5 QPCR validated microRNAs (mir-26b, mir-125a-5p, mir-146-5p, mir-150-5p, and mir-184), which are GC inducible in MM1S but not in MM1R cells. Functional studies further revealed that ectopic transfection of a synthetic mir-150-5p mimics GR dependent gene expression changes involved in cell death and cell proliferation pathways. Remarkably, despite the gene expression changes observed, overexpression of mir-150-5p in absence of GCs did not trigger significant cytotoxicity in MM1S or MM1R cells. This suggests the requirement of additional steps in GC induced cell death, which can not be mimicked by mir-150-5p overexpression alone. Interestingly, a combination of mir-150-5p transfection with low doses GC in MM1S cells was found to sensitize therapy response, whereas opposite effects could be observed with a mir-150-5p specific antagomir. Although mir-150-5p overexpression did not substantially change GR expression levels, it was found that mir-150-5p evokes GR specific effects through indirect mRNA regulation of GR interacting transcription factors and hormone receptors, GR chaperones, as well as various effectors of unfolded protein stress and chemokine signalling. Altogether GC-inducible mir-150-5p adds another level of regulation to GC specific therapeutic responses in multiple myeloma.	[Palagani, Ajay; Diddens, Jolien; Chirumamilla, Chandra Sekhar; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signalling PPES, B-2020 Antwerp, Belgium; [Palagani, Ajay; Heyninck, Karen; Vanden Berghe, Wim] Univ Ghent, Dept Physiol, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium; [Op de Beeck, Ken; Van Camp, Guy] Univ Antwerp, Dept Biomed Sci, Ctr Med Genet, B-2020 Antwerp, Belgium; [Op de Beeck, Ken] Univ Antwerp, Univ Antwerp Hosp, Dept Med Oncol, Lab Canc Res & Clin Oncol, B-2020 Antwerp, Belgium; [Naulaerts, Stefan; Laukens, Kris] Univ Antwerp, Biomed Informat Res Ctr Antwerp Biomina, B-2020 Antwerp, Belgium; [Naulaerts, Stefan; Laukens, Kris] Univ Antwerp Hosp, Antwerp, Belgium; [Naulaerts, Stefan; Laukens, Kris] Univ Antwerp, Dept Math & Comp Sci, Adv Database Res & Modelling ADReM, B-2020 Antwerp, Belgium; [Gerlo, Sarah] VIB UGent, Dept Med Prot Res, Ghent, Belgium; [Mestdagh, Pieter; Vandesompele, Joke] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium	University of Antwerp; Ghent University; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital	Vanden Berghe, W (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signalling PPES, B-2020 Antwerp, Belgium.	wim.vandenberghe@ua.ac.be	de Beeck, Ken Op/J-5248-2016; Vanden Berghe, Wim/HGE-4696-2022; Laukens, Kris/V-1121-2018; Palagani, Ajay/ABG-9147-2020; Berghe, Wim Vanden/S-6425-2018; Van Camp, Guy/F-3386-2013; Vandesompele, Jo/W-3411-2018	de Beeck, Ken Op/0000-0001-5527-6838; Laukens, Kris/0000-0002-8217-2564; Berghe, Wim Vanden/0000-0003-0161-7355; Van Camp, Guy/0000-0001-5105-9000; Vandesompele, Jo/0000-0001-6274-0184; Naulaerts, Stefan/0000-0002-1880-6374; Mestdagh, Pieter/0000-0001-7821-9684	Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT, Belgium); Multiple Myeloma Research Foundation (MMRF, US); FWO; NOI/DOCPRO (UA) research grants	Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT, Belgium); Multiple Myeloma Research Foundation (MMRF, US); FWO(FWO); NOI/DOCPRO (UA) research grants	Research has been supported by the Strategic Basic Research (SBO) grant of the Agency for Innovation by Science and Technology (IWT, Belgium), the Multiple Myeloma Research Foundation (MMRF, US), FWO and NOI/DOCPRO (UA) research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; Almanza G, 2013, P NATL ACAD SCI USA, V110, P20182, DOI 10.1073/pnas.1311145110; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Baghdassarian N, 1998, EXP CELL RES, V240, P263, DOI 10.1006/excr.1998.3942; Bao L, 2013, LEUKEMIA RES, V37, P1083, DOI 10.1016/j.leukres.2013.06.002; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beck IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069115; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Bladh LG, 2005, MOL ENDOCRINOL, V19, P632, DOI 10.1210/me.2004-0294; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Chen SH, 2013, CANCER SCI, V104, P826, DOI 10.1111/cas.12156; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Das I, 2013, J EXP MED, V210, P1201, DOI 10.1084/jem.20121268; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; De Iudicibus S, 2011, WORLD J GASTROENTERO, V17, P1095, DOI 10.3748/wjg.v17.i9.1095; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Gay F, 2010, AM J HEMATOL, V85, P664, DOI 10.1002/ajh.21777; Geng CD, 2011, MOL ENDOCRINOL, V25, P44, DOI 10.1210/me.2010-0249; Gentleman R, 2005, BIOINFORMATICS COMPU, p[xix, 473]; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Granes F, 2004, EUR J IMMUNOL, V34, P2781, DOI 10.1002/eji.200425154; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Gross KL, 2011, MOL ENDOCRINOL, V25, P1087, DOI 10.1210/me.2010-0051; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Grugan KD, 2008, J STEROID BIOCHEM, V110, P244, DOI 10.1016/j.jsbmb.2007.11.003; Han TT, 2014, CANCER BIOL THER, V15, P3, DOI 10.4161/cbt.26607; Hattori T, 2013, NAGOYA J MED SCI, V75, P81; He Y, 2014, ONCOGENE, V33, P3887, DOI 10.1038/onc.2013.346; He Y, 2013, ONCOGENE; Hong YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069926; Hu AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060452; Ishmael FT, 2011, J IMMUNOL, V186, P1189, DOI 10.4049/jimmunol.1001794; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; Kastrinakis NG, 2000, ANN ONCOL, V11, P1217, DOI 10.1023/A:1008331714186; Kfir-Erenfeld S, 2014, CANCER IMMUNOL IMMUN, V63, P37, DOI 10.1007/s00262-013-1477-8; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Korde N, 2011, BLOOD, V117, P5573, DOI 10.1182/blood-2011-01-270140; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kullmann MK, 2013, CELL CYCLE, V12, P2625, DOI 10.4161/cc.25622; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Li J, 2013, J BIOL CHEM, V288, P23586, DOI 10.1074/jbc.M113.489302; Li XJ, 2013, BR J CANC; Liang KL, 2013, BLOOD, V121, P4265, DOI 10.1182/blood-2012-12-471300; Lu SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040676; Manoharan P, 2014, J BIOL CHEM; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Murray MY, 2013, CELL CYCLE, V12, P2144, DOI 10.4161/cc.25251; Nicholson L, 2010, LEUKEMIA RES, V34, P1366, DOI 10.1016/j.leukres.2009.12.014; Niesvizky R, 2008, BLOOD, V111, P1101, DOI 10.1182/blood-2007-05-090258; Obexer P, 2009, J BIOL CHEM, V284, P30933, DOI 10.1074/jbc.M109.051441; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Polman JAE, 2012, ENDOCRINOLOGY, V153, P4317, DOI 10.1210/en.2012-1255; Pore SK, 2013, BIOMATERIALS, V34, P6804, DOI 10.1016/j.biomaterials.2013.05.054; Protiva P, 2008, INT J CANCER, V123, P687, DOI 10.1002/ijc.23515; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Robertson S, 2013, STEROIDS, V78, P182, DOI 10.1016/j.steroids.2012.10.016; Rolland-Turner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054135; Rossi A, 2013, BLOOD, V121, P1982, DOI 10.1182/blood-2012-08-448563; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez-Vega B, 2006, MOL CANCER THER, V5, P3062, DOI 10.1158/1535-7163.MCT-06-0344; Sarvaiya PJ, 2012, MOL CELL ENDOCRINOL, V361, P124, DOI 10.1016/j.mce.2012.03.024; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Sengul A, 2013, PHYSIOL RES, V62, P221, DOI 10.33549/physiolres.932410; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suttana W, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-99; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Tessel Michael A., 2011, Hormones & Cancer, V2, P182, DOI 10.1007/s12672-011-0072-8; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang J, 2013, INT J CLIN EXP PATHO, V6, P2366; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	93	48	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113842	10.1371/journal.pone.0113842	http://dx.doi.org/10.1371/journal.pone.0113842			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474406	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500095
J	Fujii, S; Matsumoto, S; Nojima, S; Morii, E; Kikuchi, A				Fujii, S.; Matsumoto, S.; Nojima, S.; Morii, E.; Kikuchi, A.			Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target	ONCOGENE			English	Article							GASTRIC-CANCER; SIGNALING PATHWAYS; EXCHANGE FACTORS; TUMOR-CELLS; WNT; BINDING; ACTIVATION; INVASION; FAMILY; GROWTH	We recently demonstrated that expression of ADP-ribosylation factor (ARF)-like 4c (Arl4c) induced by a combination of Wnt/beta-catenin and epidermal growth factor/Ras signaling in normal epithelial cells grown in three-dimensional culture promotes cellular migration and proliferation, resulting in formation of tube-like structures, suggesting the involvement of Arl4c in epithelial morphogenesis. It is conceivable that there could be a common mechanism between epithelial morphogenesis and carcinogenesis. Therefore the current study was conducted to investigate whether Arl4c might be involved in tumorigenesis. Immunohistochemical analyses of tissue specimens obtained from colorectal and lung cancer patients revealed that Arl4c was not observed in non-tumor regions but was strongly expressed at high frequencies in tumor lesions. Inhibition of Wnt/beta-catenin or Ras/mitogen-activated protein kinase signaling reduced Arl4c mRNA levels in HCT116 colorectal cancer cells and A549 lung cancer cells. Knockdown of Arl4c inhibited Rac activity and also prevented nuclear localization of yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) in these cancer cells. Arl4c-depleted cancer cells consistently showed decreased migration, invasion and proliferation capabilities both in vitro and in vivo. Furthermore, direct injection of Arl4c small interfering RNA (siRNA) into HCT116 cell-derived tumors (in vivo treatment with siRNA) inhibited tumor growth in immunodeficient mice. These results suggest that Arl4c is involved in tumorigenesis and might represent a novel therapeutic target for suppressing proliferation and invasion of colorectal and lung cancer cells.	[Fujii, S.; Matsumoto, S.; Kikuchi, A.] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; [Fujii, S.] Osaka Univ, IPBS, Inst Acad Initiat, Suita, Osaka 5650871, Japan; [Nojima, S.; Morii, E.] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kikuchi, A (corresponding author), Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akikuchi@molbiobc.med.osaka-u.ac.jp			Ministry of Education, Science and Culture of Japan [25250018, 26861547, 25860211, 23112004]; Uehara Memorial Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	We thank Dr Y Shintani and Dr K Shojima for valuable discussions regarding Arl4c expression and their technical assistance. We also thank Dr T Kobayashi, Dr W Yasui and Dr K Matsumoto for donating cells. This work was supported by Grants-in-Aid for Scientific Research to AK (2013-2014) (No. 25250018), SF (2014) (No. 26861547) and SM (2013-2014) (No. 25860211) and for Scientific Research on Innovative Areas to AK (2011-2014) (No. 23112004) from the Ministry of Education, Science and Culture of Japan and by grants from the Uehara Memorial Foundation.	Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Engel T, 2004, FEBS LETT, V566, P241, DOI 10.1016/j.febslet.2004.04.048; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gon H, 2013, MOL BIOL CELL, V24, P3764, DOI 10.1091/mbc.E13-07-0357; Hanaki H, 2012, MOL CANCER THER, V11, P298, DOI 10.1158/1535-7163.MCT-11-0682; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kagawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083629; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Matsumoto S, 2014, EMBO J, V33, P702, DOI 10.1002/embj.201386942; Matsumoto S, 2010, EMBO J, V29, P1192, DOI 10.1038/emboj.2010.26; McCormick F, 1999, TRENDS BIOCHEM SCI, V24, pM53, DOI 10.1016/S0968-0004(99)01480-2; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mori M, 2001, MODERN PATHOL, V14, P72, DOI 10.1038/modpathol.3880259; Nieto MA, 2013, SCIENCE, V342; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wei SM, 2009, BIOCHEM BIOPH RES CO, V384, P352, DOI 10.1016/j.bbrc.2009.04.125; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200	46	45	47	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 10	2015	34	37					4834	4844		10.1038/onc.2014.402	http://dx.doi.org/10.1038/onc.2014.402			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CR0YP	25486429				2022-12-26	WOS:000361050000004
J	Kim, IK; Stegeman, RA; Brosey, CA; Ellenberger, T				Kim, In-Kwon; Stegeman, Roderick A.; Brosey, Chris A.; Ellenberger, Tom			A Quantitative Assay Reveals Ligand Specificity of the DNA Scaffold Repair Protein XRCC1 and Efficient Disassembly of Complexes of XRCC1 and the Poly(ADP-ribose) Polymerase 1 by Poly(ADP-ribose) Glycohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; BINDING-PROTEINS; DAMAGE; DOMAINS; UBIQUITINATION; METABOLISM; INHIBITORS; STABILITY; LENGTH; SITES	The posttranslational modification of proteins with poly(ADP-ribose) (PAR) regulates protein-protein interactions in DNA repair, gene expression, chromatin structure, and cell fate determination. The PAR polymerase PARP1 binds to damaged chromatin and synthesizes PAR chains to signal DNA damage and recruit the DNA repair scaffold, XRCC1. Pharmacological blockade of PARP1 enzymatic activity impairs XRCC1-dependent repair of DNA damage and selectively kills cancer cells lacking other DNA repair functions. As such, PARP inhibitors are promising new therapies for repair-deficient tumors such as BRCA mutated breast cancers. Although the XRCC1-PARP1 complex is relevant to the proposed therapeutic mechanism of PARP inhibitors, the physical makeup and dynamics of this complex are not well characterized at the molecular level. Here we describe a fluorescence-based, real-time assay that quantitatively monitors interactions between PARylated PARP1 and XRCC1. Using this assay, we show that the PAR posttranslational modification by itself is a high affinity ligand for XRCC1, requiring a minimum chain length of 7 ADP-ribose units in the oligo(ADP-ribose) ligand for a stable interaction with XRCC1. This discrete binding interface enables the PAR glycohydrolase (PARG) to completely disassemble the PARP1-XRCC1 complex without assistance from a mono(ADP-ribose) glycohydrolase. Our quantitative, real-time assay of PAR-dependent protein-protein interactions and PAR turnover by PARG is an excellent tool for high-throughput screening to identify pharmacological modulators of PAR metabolism that may be useful therapeutic alternatives to PARP inhibitors.	[Kim, In-Kwon; Stegeman, Roderick A.; Brosey, Chris A.; Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Kim, IK (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	inkwon@biochem.wustl.edu; tome@biochem.wustl.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R01GM052504]; Structural Cell Biology of DNA Repair Program [P01 CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Cell Biology of DNA Repair Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM052504 (to T. E.) and by the Structural Cell Biology of DNA Repair Program (Grant P01 CA92584 to John Tainer, The Scripps Research Institute).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P443, DOI 10.1038/nrm3601; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; HATAKEYAMA K, 1986, J BIOL CHEM, V261, P4902; He JX, 2010, ACTA PHARMACOL SIN, V31, P1172, DOI 10.1038/aps.2010.103; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Lakowicz J. R., 2007, PRINCIPLES FLUORESCE, P86; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Liu C, 2013, NUCLEIC ACIDS RES, V41, P1698, DOI 10.1093/nar/gks1278; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Parsons JL, 2010, DNA REPAIR, V9, P835, DOI 10.1016/j.dnarep.2010.04.008; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Tan ES, 2012, ANAL BIOCHEM, V428, P126, DOI 10.1016/j.ab.2012.06.015; Telli Melinda L, 2010, Clin Adv Hematol Oncol, V8, P629; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P1; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wei LZ, 2013, J CELL SCI, V126, P4414, DOI 10.1242/jcs.128272; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Zaja R, 2013, BIOMOLECULES, V3, P1, DOI 10.3390/biom3010001	36	39	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3775	3783		10.1074/jbc.M114.624718	http://dx.doi.org/10.1074/jbc.M114.624718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25477519	hybrid, Green Published			2022-12-26	WOS:000349456000048
J	Lin, PH; Duann, P; Komazaki, S; Park, KH; Li, HC; Sun, MZ; Sermersheim, M; Gumpper, K; Parrington, J; Galione, A; Evans, AM; Zhu, MX; Ma, JJ				Lin, Pei-Hui; Duann, Pu; Komazaki, Shinji; Park, Ki Ho; Li, Haichang; Sun, Mingzhai; Sermersheim, Mathew; Gumpper, Kristyn; Parrington, John; Galione, Antony; Evans, A. Mark; Zhu, Michael X.; Ma, Jianjie			Lysosomal Two-pore Channel Subtype 2 (TPC2) Regulates Skeletal Muscle Autophagic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR; CALCIUM; NAADP; DEGRADATION; MECHANISMS; PROTEASES; PATHWAYS; DISEASE; FUSION; FLUX	Postnatal skeletal muscle mass is regulated by the balance between anabolic protein synthesis and catabolic protein degradation, and muscle atrophy occurs when protein homeostasis is disrupted. Autophagy has emerged as critical in clearing dysfunctional organelles and thus in regulating protein turnover. Here we show that endolysosomal two-pore channel subtype 2 (TPC2) contributes to autophagy signaling and protein homeostasis in skeletal muscle. Muscles derived from Tpcn2(-/-) mice exhibit an atrophic phenotype with exacerbated autophagy under starvation. Compared with wild types, animals lacking TPC2 demonstrated an enhanced autophagy flux characterized by increased accumulation of autophagosomes upon combined stress induction by starvation and colchicine treatment. In addition, deletion of TPC2 in muscle caused aberrant lysosomal pH homeostasis and reduced lysosomal protease activity. Association between mammalian target of rapamycin and TPC2 was detected in skeletal muscle, allowing for appropriate adjustments to cellular metabolic states and subsequent execution of autophagy. TPC2 therefore impacts mammalian target of rapamycin reactivation during the process of autophagy and contributes to maintenance of muscle homeostasis.	[Lin, Pei-Hui; Duann, Pu; Park, Ki Ho; Li, Haichang; Sun, Mingzhai; Sermersheim, Mathew; Gumpper, Kristyn; Ma, Jianjie] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan; [Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University System of Ohio; Ohio State University; Saitama Medical University; University of Oxford; University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston	Lin, PH (corresponding author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.	pei-hui.lin@osumc.edu; jianjie.ma@osumc.edu	Li, Haichang/AAL-6132-2020; Sun, Mingzhai/B-4945-2012; Park, Ki Ho/N-8153-2017; Gumpper, Kristyn/AAD-7637-2019	Li, Haichang/0000-0001-9784-6480; Park, Ki Ho/0000-0002-6193-9826; Gumpper, Kristyn/0000-0003-2704-1868; Galione, Antony/0000-0002-4132-7646	National Institutes of Health [R01AR61385, R01AG028856, R01GM081658]; British Heart Foundation [RG/12/14/29885]; Ohio State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614, R01AG028856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Ohio State University(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR61385 and R01AG028856 (to J. M.) and R01GM081658 (to M. X. Z.). This work was also supported by British Heart Foundation Program Grant RG/12/14/29885 (to A. M. E.) and an Ohio State University intramural Lockwood Early Career Development Award (to P. H. L.).	Amoasii L, 2012, CURR TOP MICROBIOL, V362, P209, DOI 10.1007/978-94-007-5025-8_10; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chen Y, 2013, EXP CELL RES, V319, P142, DOI 10.1016/j.yexcr.2012.09.004; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; DiCiccio JE, 2011, J GEN PHYSIOL, V137, P385, DOI 10.1085/jgp.201110596; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Fetalvero KM, 2013, MOL CELL BIOL, V33, P98, DOI 10.1128/MCB.01075-12; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hamasaki M, 2013, CURR OPIN CELL BIOL, V25, P455, DOI 10.1016/j.ceb.2013.03.004; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kayala KMN, 2012, BRAIN RES, V1489, P8, DOI 10.1016/j.brainres.2012.10.036; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; PAVLATH GK, 1994, J CELL BIOL, V127, P1923, DOI 10.1083/jcb.127.6.1923; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Pyo JO, 2013, DIABETES METAB J, V37, P333, DOI 10.4093/dmj.2013.37.5.333; Rennie MJ, 2004, ANNU REV PHYSIOL, V66, P799, DOI 10.1146/annurev.physiol.66.052102.134444; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Tjondrokoesoemo A, 2013, J BIOL CHEM, V288, P2103, DOI 10.1074/jbc.M112.425975; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zois CE, 2011, AUTOPHAGY, V7, P1371, DOI 10.4161/auto.7.11.16664; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	53	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3377	3389		10.1074/jbc.M114.608471	http://dx.doi.org/10.1074/jbc.M114.608471			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25480788	Green Published, hybrid			2022-12-26	WOS:000349456000015
J	Chayka, O; D'Acunto, CW; Middleton, O; Arab, M; Sala, A				Chayka, Olesya; D'Acunto, Cosimo Walter; Middleton, Odette; Arab, Maryann; Sala, Arturo			Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; C-MYC; RECQ HELICASES; N-MYC; DRIVEN TUMORIGENESIS; FUNCTIONAL GENOMICS; PROLIFERATION; KINASE; CANCER; BIOINFORMATICS	The MYC family of transcription factors consists of three well characterized members, c-MYC, L-MYC, and MYCN, deregulated in the majority of human cancers. In neuronal tumors such as neuroblastoma, MYCN is frequently activated by gene amplification, and reducing its expression by RNA interference has been shown to promote growth arrest and apoptosis of tumor cells. From a clinical perspective, RNA interference is not yet a viable option, and small molecule inhibitors of transcription factors are difficult to develop. We therefore planned to identify, at the global level, the genes interacting functionally with MYCN required to promote fitness of tumor cells facing oncogenic stress. To find genes whose inactivation is synthetically lethal to MYCN, we implemented a genome-wide approach in which we carried out a drop-out shRNA screen using a whole genome library that was delivered into isogenic neuroblastoma cell lines expressing or not expressing MYCN. After the screen, we selected for in-depth analysis four shRNAs targeting AHCY, BLM, PKMYT1, and CKS1B. These genes were chosen because they are directly regulated by MYC proteins, associated with poor prognosis of neuroblastoma patients, and inhibited by small molecule compounds. Mechanistically, we found that BLM and PKMYT1 are required to limit oncogenic stress and promote stabilization of the MYCN protein. Cocktails of small molecule inhibitors of CKS1B, AHCY, BLM, and PKMYT1 profoundly affected the growth of all neuroblastoma cell lines but selectively caused death of MYCN-amplified cells. Our findings suggest that drugging the MYCN network is a promising avenue for the treatment of high risk, neuroblastic cancers.	[Chayka, Olesya; Arab, Maryann; Sala, Arturo] Brunel Univ, Brunel Inst Canc Genet & Pharmacogen, Uxbridge UB8 3PH, Middx, England; [Chayka, Olesya; D'Acunto, Cosimo Walter; Middleton, Odette; Sala, Arturo] UCL, Inst Child Hlth, London WC1N 1EH, England	Brunel University; University of London; University College London	Sala, A (corresponding author), Brunel Univ, Brunel Inst Canc Genet & Pharmacogen, Uxbridge UB8 3PH, Middx, England.	arturo.sala@brunel.ac.uk		Sala, Arturo/0000-0002-2841-7866	SPARKS; Neuroblastoma Society	SPARKS; Neuroblastoma Society	This work was supported by grants from SPARKS and the Neuroblastoma Society (to A. S.).	Aubry S, 2000, DNA CELL BIOL, V19, P353, DOI 10.1089/10445490050043326; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bahmanyar M, 2013, LEUKEMIA RES, V37, P1726, DOI 10.1016/j.leukres.2013.09.025; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burkhart CA, 2003, J NATL CANCER I, V95, P1394, DOI 10.1093/jnci/djg045; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Cermelli S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014209; Chanthery Y.H., 2012, SCI TRANSL MED, V4, pra3; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez-Sanchez ME, 2009, MOL CELL BIOL, V29, P6182, DOI 10.1128/MCB.00973-09; FLEXNER CW, 1992, LANCET, V339, P438, DOI 10.1016/0140-6736(92)90133-N; Fowler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Nguyen GH, 2013, CHEM BIOL, V20, P55, DOI 10.1016/j.chembiol.2012.10.016; Gualdrini F, 2010, ONCOTARGET, V1, P278; He S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00001; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Horowitz DP, 2008, CANCER BIOL THER, V7, P1783, DOI 10.4161/cbt.7.11.6779; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Komarova NL, 2013, NATURE, V499, P291, DOI 10.1038/499291a; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Lee SW, 2014, APMIS, V122, P206, DOI 10.1111/apm.12136; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mao FJ, 2010, CANCER RES, V70, P6548, DOI 10.1158/0008-5472.CAN-10-0475; Martinsson-Ahlzen HS, 2008, MOL CELL BIOL, V28, P5698, DOI 10.1128/MCB.01833-07; MAYERS DL, 1995, P NATL ACAD SCI USA, V92, P215, DOI 10.1073/pnas.92.1.215; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Perier RC, 1999, NUCLEIC ACIDS RES, V27, P307, DOI 10.1093/nar/27.1.307; Potapova TA, 2011, MOL BIOL CELL, V22, P1191, DOI 10.1091/mbc.E10-07-0599; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Rohe A, 2012, BIOORG MED CHEM LETT, V22, P1219, DOI 10.1016/j.bmcl.2011.11.064; Sankar N, 2009, J BIOL CHEM, V284, P15193, DOI 10.1074/jbc.M900776200; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seki M, 2008, CELL CYCLE, V7, P2472, DOI 10.4161/cc.7.16.6462; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soucek L, 2002, CANCER RES, V62, P3507; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhao X, 2013, LEUKEMIA, V27, P2341, DOI 10.1038/leu.2013.94	66	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2198	2212		10.1074/jbc.M114.624056	http://dx.doi.org/10.1074/jbc.M114.624056			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477524	Green Published, hybrid			2022-12-26	WOS:000348588000024
J	Matevossian, A; Resh, MD				Matevossian, Arnnine; Resh, Marilyn D.			Membrane Topology of Hedgehog Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TOPOLOGY; PREDICTION; PALMITOYLATION; GHRELIN; ACCURACY; REGIONS; RANGE	Hedgehog acyltransferase (Hhat) is a multipass transmembrane enzyme that mediates the covalent attachment of the 16-carbon fatty acid palmitate to the N-terminal cysteine of Sonic Hedgehog (Shh). Palmitoylation of Shh by Hhat is critical for short and long range signaling. Knowledge of the topological organization of Hhat transmembrane helices would enhance our understanding of Hhat-mediated Shh palmitoylation. Bioinformatics analysis of transmembrane domains within human Hhat using 10 different algorithms resulted in highly consistent predictions in the C-terminal, but not in the N-terminal, region of Hhat. To empirically determine the topology of Hhat, we designed and exploited Hhat constructs containing either terminal or 12 different internal epitope tags. We used selective permeabilization coupled with immunofluorescence as well as a protease protection assay to demonstrate that Hhat contains 10 transmembrane domains and 2 re-entrant loops. The invariant His and highly conserved Asp residues within the membrane-bound O-acyltransferase (MBOAT) homology domain are segregated on opposite sides of the endoplasmic reticulum membrane. The localization of His-379 on the lumenal membrane surface is consistent with a role for this invariant residue in catalysis. Analysis of the activity and stability of the Hhat constructs revealed that the C-terminal MBOAT domain is especially sensitive to manipulation. Moreover, there was remarkable similarity in the overall topological organization of Hhat and ghrelin O-acyltransferase, another MBOAT family member. Knowledge of the topological organization of Hhat could serve as an important tool for further design of selective Hhat inhibitors.	[Matevossian, Arnnine; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	reshm@mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966, CA186957]; Cycle for Survival, Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [R21CA186957, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cycle for Survival, Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57966 and CA186957. This work was also supported by Cycle for Survival, Memorial Sloan Kettering Cancer Center.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Konitsiotis AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089899; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Petrova E, 2015, ONCOGENE, V34, P263, DOI 10.1038/onc.2013.575; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	30	36	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2235	2243		10.1074/jbc.M114.625764	http://dx.doi.org/10.1074/jbc.M114.625764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488661	Green Published, hybrid			2022-12-26	WOS:000348588000027
J	Oberhettinger, P; Leo, JC; Linke, D; Autenrieth, IB; Schutz, MS				Oberhettinger, Philipp; Leo, Jack C.; Linke, Dirk; Autenrieth, Ingo B.; Schuetz, Monika S.			The Inverse Autotransporter Intimin Exports Its Passenger Domain via a Hairpin Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; BACTERIAL OUTER-MEMBRANE; YERSINIA-ENTEROCOLITICA; 2-PARTNER SECRETION; BETA-DOMAIN; PROTEINS; BAMA; TRANSLOCATION; BIOGENESIS; TRANSPORT	Autotransporter proteins comprise a large family of virulence factors that consist of a beta-barrel translocation unit and an extracellular effector or passenger domain. The beta-barrel anchors the protein to the outer membrane of Gram-negative bacteria and facilitates the transport of the passenger domain onto the cell surface. By inserting an epitope tag into the N terminus of the passenger domain of the inverse autotransporter intimin, we generated a mutant defective in autotransport. Using this stalled mutant, we could show that (i) at the time point of stalling, the beta-barrel appears folded; (ii) the stalled autotransporter is associated with BamA and SurA; (iii) the stalled intimin is decorated with large amounts of SurA; (iv) the stalled autotransporter is not degraded by periplasmic proteases; and (v) inverse autotransporter passenger domains are translocated by a hairpin mechanism. Our results suggest a function for the BAM complex not only in insertion and folding of the beta-barrel but also for passenger translocation.	[Oberhettinger, Philipp; Autenrieth, Ingo B.; Schuetz, Monika S.] Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, D-72076 Tubingen, Germany; [Leo, Jack C.; Linke, Dirk] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oslo	Schutz, MS (corresponding author), Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Elfriede Aulhorn Str 6, D-72076 Tubingen, Germany.	monika.schuetz@med.uni-tuebingen.de	Linke, Dirk/F-9147-2010; Leo, Jack/HHS-7710-2022; Leo, Jack C./F-2177-2011	Linke, Dirk/0000-0003-3150-6752; Leo, Jack C./0000-0002-7066-7527	German Research Council (DFG) [SFB 766]; FEMS; Fortune program [F1433253]; TUFF of the University Clinics Tubingen [E05003231]; German Center for Infection Research (DZIF)	German Research Council (DFG)(German Research Foundation (DFG)); FEMS; Fortune program; TUFF of the University Clinics Tubingen; German Center for Infection Research (DZIF)	This work was supported by grants from the German Research Council (DFG) within the SFB 766 (to M. S., I. B. A., and D. L.), a FEMS Advanced Fellowship (to J. C. L.), the Fortune program F1433253 (to P. O.), the TUFF program E05003231 of the University Clinics Tubingen (to M. S.), and the German Center for Infection Research (DZIF) (to M. S. and I. B. A.).	Adams TM, 2005, J BACTERIOL, V187, P522, DOI 10.1128/JB.187.2.522-533.2005; Adu-Bobie J, 1998, INFECT IMMUN, V66, P5643, DOI 10.1128/IAI.66.12.5643-5649.1998; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; Grosskinsky U, 2007, J BACTERIOL, V189, P9011, DOI 10.1128/JB.00985-07; Ieva R, 2008, MOL MICROBIOL, V67, P188, DOI 10.1111/j.1365-2958.2007.06048.x; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jacob-Dubuisson F, 2013, RES MICROBIOL, V164, P583, DOI 10.1016/j.resmic.2013.03.009; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kang'ethe W, 2013, J BIOL CHEM, V288, P35028, DOI 10.1074/jbc.M113.515635; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; Lehr U, 2010, MOL MICROBIOL, V78, P932, DOI 10.1111/j.1365-2958.2010.07377.x; Leo JC, 2015, MOL MICROBIOL, V95, P80, DOI 10.1111/mmi.12840; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Maurer J, 1999, J BACTERIOL, V181, P7014, DOI 10.1128/JB.181.22.7014-7020.1999; Mikula KM, 2012, J BACTERIOL, V194, P827, DOI 10.1128/JB.05322-11; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Oberhettinger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047069; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Paramasivam N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-510; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schutz M, 2010, INFECT IMMUN, V78, P2677, DOI 10.1128/IAI.01350-09; Shahid SA, 2012, NAT METHODS, V9, P1212, DOI [10.1038/NMETH.2248, 10.1038/nmeth.2248]; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Touze T, 2004, MOL MICROBIOL, V51, P73, DOI 10.1046/j.1365-2958.2003.03830.x; Tsai JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014403; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x	51	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1837	1849		10.1074/jbc.M114.604769	http://dx.doi.org/10.1074/jbc.M114.604769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25488660	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000348056400048
J	Hui, SSC; Hui, GPS; Xie, YJ				Hui, Stanley Sai-Chuen; Hui, Grace Pui-Sze; Xie, Yao Jie			Association between Physical Activity Knowledge and Levels of Physical Activity in Chinese Adults with Type 2 Diabetes	PLOS ONE			English	Article							NATIONAL-HEALTH; LEISURE-TIME; LIFE-STYLE; US ADULTS; EXERCISE; DIET; PREVENTION; MELLITUS; RECOMMENDATIONS; PREDICTORS	Background: Physical activity (PA) is an important treatment regimen for diabetes. The purposes of this study were to evaluate people's knowledge of how exercise influences wellbeing (termed "PA knowledge'' or "knowledge of PA'' in this paper) and the resulting association with levels of PA in Chinese adults with Type 2 diabetes, and to identify the valuable demographic and lifestyle factors that possibly influence the association between PA knowledge and level of PA. Methods: Two hundred and fifty-eight adults with Type 2 diabetes completed an interviewer-administered survey at a diabetes clinic in Hong Kong. Data on demographics, lifestyle factors and diabetes-related medical indicators were obtained. A 20-item questionnaire was developed to measure PA-related knowledge (one point scored for each correct answer; aggregate score up to 20 points). level of PA was measured by the International Physical Activity Questionnaire. Results: The proportions of correct answers to each question ranged from 19.4 to 90.7%. Compared with poorly educated participants, those with university education level and above had PA knowledge scores 1.7 points higher (14.3 vs. 12.6, P<0.05). Younger, female, and obese participants were more likely to have lower level of PA (all P<0.05). After adjustment for age, gender, (BMI) and education level, the odds of having a moderate-to-high level of PA was 19% greater with 1 unit increase in PA knowledge score [95% confidence interval (CI): 1.09-1.29; P<0.001], this association was strongest in participants with tertiary education level or above [odds ratio (OR): 1.35; 95% CI: 1.03-1.77; P<0.05]. Conclusions: PA knowledge was positively associated with level of PA. Education level significantly influenced the association between PA knowledge and level of PA, leading to the suggestion of vulnerable groups to target for PA improvement in the face of diabetes.	[Hui, Stanley Sai-Chuen; Xie, Yao Jie] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Hong Kong, Peoples R China; [Hui, Grace Pui-Sze] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; United Christian Hospital	Hui, SSC (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Hong Kong, Peoples R China.	hui2162@cuhk.edu.hk	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; HUI, Stanley Sai-chuen/0000-0002-2462-4622				Bandura A., 1986, SOCIAL FDN THOUGHT A; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Department of Health of HKSAR, 2009, LEV PHYS ACT 2009; DISHMAN RK, 1985, PUBLIC HEALTH REP, V100, P158; DISHMAN RK, 1990, EXERCISE, FITNESS, AND HEALTH, P75; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; FORD ES, 1995, DIABETES CARE, V18, P27, DOI 10.2337/diacare.18.1.27; Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706; Hong Kong Sports Development Board, 1999, SPORTS PART SURV 199; Hui SSC, 2001, J AGING PHYS ACTIV, V9, P372, DOI 10.1123/japa.9.4.372; International Diabetes Federation, 2013, IDF DIAB ALT; International Obesity Task Force, 2000, AS PAC PERSP RED OB; Kandula NR, 2005, ANN EPIDEMIOL, V15, P257, DOI 10.1016/j.annepidem.2004.06.006; Kelly Cynthia W, 2007, AAOHN J, V55, P253; Kirk AF, 2007, DIABETIC MED, V24, P809, DOI 10.1111/j.1464-5491.2007.02190.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krug L M, 1991, Diabetes Educ, V17, P185, DOI 10.1177/014572179101700314; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Macfarlane DJ, 2007, J SCI MED SPORT, V10, P45, DOI 10.1016/j.jsams.2006.05.003; Mitchell R, 1994, Asia Pac J Public Health, V7, P218; Morrow JR, 2004, RES Q EXERCISE SPORT, V75, P231, DOI 10.1080/02701367.2004.10609156; Mynarski W, 2012, DIABETES RES CLIN PR, V98, P46, DOI 10.1016/j.diabres.2012.05.024; Nelson KM, 2002, DIABETES, V51, pA61; Ohta T, 1999, J AGING PHYS ACTIV, V7, P231, DOI 10.1123/japa.7.3.231; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; RK D, 1994, ADV EXERCISE ADHEREN, P1; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; VEGA WA, 1987, PREV MED, V16, P696, DOI 10.1016/0091-7435(87)90052-1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhao G, 2008, DIABETIC MED, V25, P221, DOI 10.1111/j.1464-5491.2007.02332.x	35	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115098	10.1371/journal.pone.0115098	http://dx.doi.org/10.1371/journal.pone.0115098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9YP	25493559	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400095
J	Paskin, TR; Jellies, J; Bacher, J; Beane, WS				Paskin, Taylor R.; Jellies, John; Bacher, Jessica; Beane, Wendy S.			Planarian Phototactic Assay Reveals Differential Behavioral Responses Based on Wavelength	PLOS ONE			English	Article							ULTRAVIOLET VISION; DUGESIA-TIGRINA; LIGHT; REGENERATION; BRAIN; HEAD; EYE; AVOIDANCE; RADIATION; SYSTEMS	Planarians are free-living aquatic flatworms that possess a well-documented photophobic response to light. With a true central nervous system and simple cerebral eyes (ocelli), planarians are an emerging model for regenerative eye research. However, comparatively little is known about the physiology of their photoreception or how their behavior is affected by various wavelengths. Most phototactic studies have examined planarian behavior using white light. Here, we describe a novel planarian behavioral assay to test responses to small ranges of visible wavelengths (red, blue, green), as well as ultraviolet (UV) and infrared (IR) which have not previously been examined. Our data show that planarians display behavioral responses across a range of wavelengths. These responses occur in a hierarchy, with the shortest wavelengths (UV) causing the most intense photophobic responses while longer wavelengths produce no effect (red) or an apparent attraction (IR). In addition, our data reveals that planarian photophobia is comprised of both a general photophobic response (that drives planarians to escape the light source regardless of wavelength) and wavelength-specific responses that encompass specific behavioral reactions to individual wavelengths. Our results serve to improve the understanding of planarian phototaxis and suggest that behavioral studies performed with white light mask a complex behavioral interaction with the environment.	[Paskin, Taylor R.; Jellies, John; Bacher, Jessica; Beane, Wendy S.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA	Western Michigan University	Beane, WS (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	wendy.beane@wmich.edu		Beane, Wendy/0000-0002-3762-1025	Western Michigan University; Faculty Research and Creative Activities Award from the Office of the Vice President for Research at Western Michigan University [W2013-007]	Western Michigan University; Faculty Research and Creative Activities Award from the Office of the Vice President for Research at Western Michigan University	This work was supported by a start-up grant from Western Michigan University to WB and a Faculty Research and Creative Activities Award from the Office of the Vice President for Research at Western Michigan University (W2013-007) to JJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2010, COLD SPRING HARB PER, V2; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Aksoy V, 2012, VISION RES, V67, P28, DOI 10.1016/j.visres.2012.06.013; AREES EA, 1986, PHYSIOL BEHAV, V36, P445, DOI 10.1016/0031-9384(86)90313-6; Asano Y, 1998, J EXP BIOL, V201, P1263; Beane WS, 2012, STEM CELLS DEV, V21, P2085, DOI 10.1089/scd.2011.0605; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Beane WS, 2013, DEVELOPMENT, V140, P313, DOI 10.1242/dev.086900; Bowmaker JK, 1995, PROG RETIN EYE RES, V15, P1; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; CARPENTER KS, 1974, CELL TISSUE RES, V148, P143; Dasheiff BD, 2002, ECOTOX ENVIRON SAFE, V53, P196, DOI 10.1006/eesa.2002.2227; Davidson C, 2011, PERCEPTION, V40, P743, DOI 10.1068/p6949; de Souza SC, 2005, J PHOTOCH PHOTOBIO B, V80, P203, DOI 10.1016/j.jphotobiol.2005.05.002; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Elliott SA, 2013, WIRES DEV BIOL, V2, P301, DOI 10.1002/wdev.82; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; GREBE E, 1991, B ENVIRON CONTAM TOX, V46, P866, DOI 10.1007/BF01689731; Hargreaves B, 2003, UV EFFECTS AQUATIC O, P61; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; JACOBS GH, 1992, AM ZOOL, V32, P544; Jellies J, 2014, J COMP PHYSIOL A, P1; Jellies J, 2014, J EXP BIOL, V217, P974, DOI 10.1242/jeb.094243; Jellies J, 2012, J COMP PHYSIOL A, V198, P567, DOI 10.1007/s00359-012-0730-5; JONES FRH, 1971, ANIM BEHAV, V19, P269; Kalafatic M, 2006, FOLIA BIOL, V54, P3; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Matsumoto T, 2005, FISHERIES SCI, V71, P350, DOI 10.1111/j.1444-2906.2005.00971.x; McConnell JV, 1965, SPEC PUBL WORM RUN D; Nakazawa M, 2003, MOL BIOL EVOL, V20, P784, DOI 10.1093/molbev/msg086; NOLTE J, 1972, J GEN PHYSIOL, V59, P167, DOI 10.1085/jgp.59.2.167; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; Orii H, 1998, HYDROBIOLOGIA, V383, P183, DOI 10.1023/A:1003495928829; Osburn C, 2003, UV EFFECTS AQUATIC O, P187; Parker G. H., 1900, AM J PHYSIOL, V4, P373; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pra D, 2005, MUTAT RES-GEN TOX EN, V585, P79, DOI 10.1016/j.mrgentox.2005.04.002; Reddien PW, 2013, DEVELOPMENT, V140, P951, DOI 10.1242/dev.080499; REYNIERSE JH, 1967, J COMP PHYSIOL PSYCH, V63, P366, DOI 10.1037/h0024360; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Shcherbakov D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064429; Shcherbakov D, 2012, ZOOLOGY, V115, P233, DOI 10.1016/j.zool.2012.01.005; Shomrat T, 2013, J EXP BIOL, V216, P3799, DOI 10.1242/jeb.087809; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; Stevenson CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015310; Takano T, 2007, DEV GROWTH DIFFER, V49, P383, DOI 10.1111/j.1440-169x.2007.00936.x; Taliaferro WH, 1920, J EXP ZOOL, V31, P59; Umesono Y, 2011, EUR J NEUROSCI, V34, P863, DOI 10.1111/j.1460-9568.2011.07819.x; Van Wolfswinkel JC, 2014, CELL STEM CELL; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wu HPP, 2011, J PHOTOCH PHOTOBIO B, V102, P156, DOI 10.1016/j.jphotobiol.2010.11.003; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zukauskas A, 2009, IEEE J SEL TOP QUANT, V15, P1189, DOI 10.1109/JSTQE.2009.2019113	61	34	34	3	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114708	10.1371/journal.pone.0114708	http://dx.doi.org/10.1371/journal.pone.0114708			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493551	Green Submitted, Green Published, gold			2022-12-26	WOS:000346611400067
J	Akram, S; Englitz, B; Elhilali, M; Simon, JZ; Shamma, SA				Akram, Sahar; Englitz, Bernhard; Elhilali, Mounya; Simon, Jonathan Z.; Shamma, Shihab A.			Investigating the Neural Correlates of a Streaming Percept in an Informational-Masking Paradigm	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; COCKTAIL PARTY; SELECTIVE ATTENTION; NEURONAL RESPONSES; REPETITION RATE; REPRESENTATION; MECHANISMS; SOUND; SPEECH; SEGREGATION	Humans routinely segregate a complex acoustic scene into different auditory streams, through the extraction of bottom-up perceptual cues and the use of top-down selective attention. To determine the neural mechanisms underlying this process, neural responses obtained through magnetoencephalography (MEG) were correlated with behavioral performance in the context of an informational masking paradigm. In half the trials, subjects were asked to detect frequency deviants in a target stream, consisting of a rhythmic tone sequence, embedded in a separate masker stream composed of a random cloud of tones. In the other half of the trials, subjects were exposed to identical stimuli but asked to perform a different task-to detect tone-length changes in the randobuildup of the normalized neural responses was significantly faster, mirroring the accelerated buildup of the streaming percepts. Our data thus support close links between the perceptual and neural consequences of the auditory stream segregation.m cloud of tones. In order to verify that the normalized neural response to the target sequence served as an indicator of streaming, we correlated neural responses with behavioral performance under a variety of stimulus parameters (target tone rate, target tone frequency, and the "protection zone", that is, the spectral area with no tones around the target frequency) and attentional states (changing task objective while maintaining the same stimuli). In all conditions that facilitated target/masker streaming behaviorally, MEG normalized neural responses also changed in a manner consistent with the behavior. Thus, attending to the target stream caused a significant increase in power and phase coherence of the responses in recording channels correlated with an increase in the behavioral performance of the listeners. Normalized neural target responses also increased as the protection zone widened and as the frequency of the target tones increased. Finally, when the target sequence rate increased, the	[Akram, Sahar; Englitz, Bernhard; Shamma, Shihab A.] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Akram, Sahar; Englitz, Bernhard; Simon, Jonathan Z.; Shamma, Shihab A.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; [Simon, Jonathan Z.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Elhilali, Mounya] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Englitz, Bernhard; Shamma, Shihab A.] Ecole Normale Super, Dept Etud Cognit, F-75231 Paris, France; [Englitz, Bernhard] Donders Inst Brain Cognit & Behav, Dept Neurophysiol, Nijmegen, Netherlands	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Radboud University Nijmegen	Akram, S (corresponding author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	sakram@umd.edu	Elhilali, Mounya/A-3396-2010; Englitz, Bernhard/K-7636-2018; Simon, Jonathan Z/A-8196-2008	Elhilali, Mounya/0000-0003-2597-738X; Englitz, Bernhard/0000-0001-9106-0356; Simon, Jonathan Z/0000-0003-0858-0698	National Institutes of Health [1R01AG036424]; NATIONAL INSTITUTE ON AGING [R01AG036424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The funding for this work is provided by National Institutes of Health Grant number 1R01AG036424 (http://www.nih.gov/) to ME and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett EL, 2011, J NEUROPHYSIOL, V106, P849, DOI 10.1152/jn.00559.2010; Bidet-Caulet A, 2007, J NEUROSCI, V27, P9252, DOI 10.1523/JNEUROSCI.1402-07.2007; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bregman AS, 2000, PERCEPT PSYCHOPHYS, V62, P626, DOI 10.3758/BF03212114; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Efron B., 1994, INTRO BOOTSTRAP; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; Elhilali M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000129; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Fisher N., 1995, STAT ANAL CIRCULAR D; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Fishman YI, 2012, J NEUROPHYSIOL, V107, P2366, DOI 10.1152/jn.01010.2011; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Kay S, 1993, ESTIMATION THEORY FU, P465; Kidd G, 2003, J ACOUST SOC AM, V114, P2835, DOI 10.1121/1.1621864; KIDD G, 1995, J ACOUST SOC AM, V98, P1977, DOI 10.1121/1.414459; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Kowalski N, 1996, J NEUROPHYSIOLOGY, V76; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Micheyl C, 2007, HEARING - FROM SENSORY PROCESSING TO PERCEPTION, P267, DOI 10.1007/978-3-540-73009-5_29; Micheyl C, 2010, JARO-J ASSOC RES OTO, V11, P709, DOI 10.1007/s10162-010-0227-2; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paltoglou AE, 2009, HEARING RES, V257, P106, DOI 10.1016/j.heares.2009.08.007; PHILLIPS DP, 1989, J ACOUST SOC AM, V85, P2537, DOI 10.1121/1.397748; Schreiner CE, 1996, J NEUROPHYSIOL, V75, P1283, DOI 10.1152/jn.1996.75.3.1283; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Simon JZ, 2005, J NEUROSCI METH, V149, P64, DOI 10.1016/j.jneumeth.2005.05.005; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Steinschneider M, 2013, HEARING RES, V305, P57, DOI 10.1016/j.heares.2013.05.013; Teki S, 2013, ELIFE, V2, DOI 10.7554/eLife.00699; Tiitinen H, 1997, PROG NEURO-PSYCHOPH, V21, P751, DOI 10.1016/S0278-5846(97)00077-8; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; Vliegen J, 1999, J ACOUST SOC AM, V106, P938, DOI 10.1121/1.427140; Xiang JJ, 2010, J NEUROSCI, V30, P12084, DOI 10.1523/JNEUROSCI.0827-10.2010	51	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114427	10.1371/journal.pone.0114427	http://dx.doi.org/10.1371/journal.pone.0114427			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490720	Green Published, gold			2022-12-26	WOS:000347515300040
J	Braun, DL; Kouyos, R; Oberle, C; Grube, C; Joos, B; Fellay, J; McLaren, PJ; Kuster, H; Gunthard, HF				Braun, Dominique L.; Kouyos, Roger; Oberle, Corinna; Grube, Christina; Joos, Beda; Fellay, Jacques; McLaren, Paul J.; Kuster, Herbert; Guenthard, Huldrych F.			A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOCIETY-USA PANEL; EARLY ANTIRETROVIRAL THERAPY; VIROLOGICAL SET-POINT; VIRAL LOAD; CLINICAL-MANIFESTATIONS; INDEPENDENT PREDICTORS; INFECTED PATIENTS; TYPE-1 INFECTION; AIDS	Objective: Best long-term practice in primary HIV-1 infection (PHI) remains unknown for the individual. A risk-based scoring system associated with surrogate markers of HIV-1 disease progression could be helpful to stratify patients with PHI at highest risk for HIV-1 disease progression. Methods: We prospectively enrolled 290 individuals with well-documented PHI in the Zurich Primary HIV-1 Infection Study, an open-label, non-randomized, observational, single-center study. Patients could choose to undergo early antiretroviral treatment (eART) and stop it after one year of undetectable viremia, to go on with treatment indefinitely, or to defer treatment. For each patient we calculated an a priori defined "Acute Retroviral Syndrome Severity Score'' (ARSSS), consisting of clinical and basic laboratory variables, ranging from zero to ten points. We used linear regression models to assess the association between ARSSS and log baseline viral load (VL), baseline CD4(+) cell count, and log viral setpoint (sVL) (i.e. VL measured >= 90 days after infection or treatment interruption). Results: Mean ARSSS was 2.89. CD4(+) cell count at baseline was negatively correlated with ARSSS (p=0.03, n=289), whereas HIV-RNA levels at baseline showed a strong positive correlation with ARSSS (p<0.001, n=290). In the regression models, a 1-point increase in the score corresponded to a 0.10 log increase in baseline VL and a CD4(+) cell count decline of 12/mu l, respectively. In patients with PHI and not undergoing eART, higher ARSSS were significantly associated with higher sVL (p=0.029, n=64). In contrast, in patients undergoing eART with subsequent structured treatment interruption, no correlation was found between sVL and ARSSS (p=0.28, n=40). Conclusion: The ARSSS is a simple clinical score that correlates with the best-validated surrogate markers of HIV-1 disease progression. In regions where ART is not universally available and eART is not standard this score may help identifying patients who will profit the most from early antiretroviral therapy.	[Braun, Dominique L.; Kouyos, Roger; Oberle, Corinna; Grube, Christina; Joos, Beda; Kuster, Herbert; Guenthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Fellay, Jacques; McLaren, Paul J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Fellay, Jacques; McLaren, Paul J.] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Fellay, Jacques; McLaren, Paul J.] Univ Lausanne, Lausanne, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Braun, DL (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	dominique.braun@usz.ch; huldrych.guenthard@usz.ch	Kouyos, Roger/ABB-2291-2021; gunthard, huldrych f/F-1724-2011; Joos, Beda/D-5547-2009; Fellay, Jacques/A-6681-2009; Kouyos, Roger/G-6226-2014	Kouyos, Roger/0000-0002-9220-8348; gunthard, huldrych f/0000-0002-1142-6723; Joos, Beda/0000-0002-3082-8875; Fellay, Jacques/0000-0002-8240-939X; Kouyos, Roger/0000-0002-9220-8348; Kuster, Herbert/0000-0001-6873-0091; Braun, Dominique Laurent/0000-0003-4036-1030; McLaren, Paul/0000-0001-6019-7018	Swiss National Science Foundation [324730-130865, PZ00P3-142411]; University of Zurich's Clinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study''; University Hospital of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich's Clinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study''; University Hospital of Zurich	This work was supported by the Swiss National Science Foundation [grant #324730-130865 to HFG, grant #PZ00P3-142411 to RK] and by the University of Zurich's Clinical Research Priority Program (CRPP) "Viral infectious diseases: Zurich Primary HIV Infection Study'' to HFG and by the matching fund program of the University Hospital of Zurich to DLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the other authors, no funding was declared.	Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Mata-Marin JA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-181; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; BOUFASSA F, 1995, J INFECT DIS, V171, P1190, DOI 10.1093/infdis/171.5.1190; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; COOPER DA, 1985, LANCET, V1, P537; Daar ES, 2008, CURR OPIN HIV AIDS, V3, P10, DOI 10.1097/COH.0b013e3282f2e295; Dana J, 2004, J EDUC BEHAV STAT, V29, P317, DOI 10.3102/10769986029003317; Desquilbet L, 2004, AIDS, V18, P2361; DORRUCCI M, 1995, AIDS, V9, P597, DOI 10.1097/00002030-199506000-00011; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Finster M, 2005, ANESTHESIOLOGY, V102, P855, DOI 10.1097/00000542-200504000-00022; FOX R, 1987, AIDS, V1, P35; Ghosn J, 2012, JAIDS-J ACQ IMM DEF, V60, pE112, DOI 10.1097/QAI.0b013e31825b6fde; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Hoen B, 2005, JAIDS-J ACQ IMM DEF, V40, P307, DOI 10.1097/01.qai.0000182628.66713.31; Hofer CB, 2000, J ACQ IMMUN DEF SYND, V25, P188, DOI 10.1097/00126334-200010010-00014; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; KEET IPM, 1993, AIDS, V7, P51, DOI 10.1097/00002030-199301000-00008; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Lodi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078642; LOES SKD, 1993, CLIN INFECT DIS, V17, P59, DOI 10.1093/clinids/17.1.59; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rieder P, 2011, CLIN INFECT DIS, V53, P1271, DOI 10.1093/cid/cir725; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rieg G, 2007, AIDS RES HUM RETROV, V23, P1257, DOI 10.1089/aid.2006.0311; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; TINDALL B, 1988, ARCH INTERN MED, V148, P945, DOI 10.1001/archinte.148.4.945; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Vanhems P, 2002, JAIDS-J ACQ IMM DEF, V31, P318, DOI 10.1097/00126334-200211010-00007; Vanhems P, 1998, CLIN INFECT DIS, V26, P323, DOI 10.1086/516289; von Wyl V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027463	57	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114111	10.1371/journal.pone.0114111	http://dx.doi.org/10.1371/journal.pone.0114111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490090	Green Published, Green Accepted, gold			2022-12-26	WOS:000347515300016
J	Ohta, T; Ido, A; Kusano, K; Miura, C; Miura, T				Ohta, Takashi; Ido, Atsushi; Kusano, Kie; Miura, Chiemi; Miura, Takeshi			A Novel Polysaccharide in Insects Activates the Innate Immune System in Mouse Macrophage RAW264 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; UDP-L-RHAMNOSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; NITRIC-OXIDE; BOMBYX-MORI; D-GLUCOSE; DROSOPHILA; RECOGNITION; LARVAE	A novel water-soluble polysaccharide was identified in the pupae of the melon fly Bactrocera cucurbitae) as a molecule that activates the mammalian innate immune response. We attempted to purify this innate immune activator using nitric oxide NO) production in mouse RAW264 macrophages as an indicator of immunostimulatory activity. A novel acidic polysaccharide was identified, which we named "dipterose'', with a molecular weight of 1.01 x 10(6) and comprising nine monosaccharides. Dipterose was synthesized in the melon fly itself at the pupal stage. The NO-producing activity of dipterose was approximately equal to that of lipopolysaccharide, a potent immunostimulator. Inhibition of Toll-like receptor 4 TLR4) led to the suppression of NO production by dipterose. Furthermore, dipterose induced the expression of proinflammatory cytokines and interferon beta (IFN beta) and promoted the activation of nuclear factor kappa B (NF-kappa B) in macrophages, indicating that it stimulates the induction of various cytokines in RAW264 cells via the TLR4 signaling pathway. Our results thus suggest that dipterose activates the innate immune response against various pathogenic microorganisms and viral infections. This is the first identification of an innate immune-activating polysaccharide from an animal.	[Ohta, Takashi; Ido, Atsushi; Kusano, Kie; Miura, Chiemi; Miura, Takeshi] Ehime Univ, Southern Ehime Fisheries Res Ctr, Res Grp Reprod Physiol, Ainan, Ehime, Japan	Ehime University	Miura, T (corresponding author), Ehime Univ, Southern Ehime Fisheries Res Ctr, Res Grp Reprod Physiol, Ainan, Ehime, Japan.	miutake@agr.ehime-u.ac.jp	Ido, Atsushi/AAW-6077-2021	Ido, Atsushi/0000-0002-8266-4438	Japan Science and Technology Agency (JST); Japan Science and Technology Agency [AS2113025E]; Japan Society for the Promotion of Science; Bussan Biotech Co., LTD	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bussan Biotech Co., LTD	This work was supported by the Japan Science and Technology Agency (JST), A-step start-up venture program (#AS2113025E) from the Japan Science and Technology Agency (http://www.jst.go.jp), Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (http://kaken.nii.ac.jp/), and Bussan Biotech Co., LTD (http://bussan-bio.co.jp/). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akiyama N, 2000, ANTICANCER RES, V20, P357; Akiyama T, 2011, FOOD HYG SAFE SCI, V52, P40, DOI 10.3358/shokueishi.52.40; Aksoy S, 1997, INSECT MOL BIOL, V6, P183, DOI 10.1111/j.1365-2583.1997.tb00086.x; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; BARANYOVITS FLC, 1978, ENDEAVOUR, V2, P85, DOI 10.1016/0160-9327(78)90061-3; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; BOURTZIS K, 2008, INSECT SYMBIOSIS, V3, P384; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Han SB, 2003, INT IMMUNOPHARMACOL, V3, P1301, DOI 10.1016/S1567-5769(03)00118-8; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hirose Y, 2013, J NAT PROD, V76, P554, DOI 10.1021/np300713c; Huis A.V., 2013, EDIBLE INSECTS FUTUR, P187; Ikan R, 1999, NATURALLY OCCURRING; Imamura M, 1999, ARCH INSECT BIOCHEM, V40, P88, DOI 10.1002/(SICI)1520-6327(1999)40:2&lt;88::AID-ARCH3&gt;3.0.CO;2-B; Ishii A, 2007, IMMUNOGENETICS, V59, P281, DOI 10.1007/s00251-007-0193-y; KAMSTEEG J, 1978, FEBS LETT, V91, P281, DOI 10.1016/0014-5793(78)81192-2; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liwanag AJM, 2012, PLANT CELL, V24, P5024, DOI 10.1105/tpc.112.106625; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Satyavathi VV, 2014, CELL SIGNAL, V26, P1753, DOI 10.1016/j.cellsig.2014.02.024; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Schuhmann B, 2003, ARCH INSECT BIOCHEM, V53, P125, DOI 10.1002/arch.10091; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang J, 2010, INT J BIOL MACROMOL, V46, P389, DOI 10.1016/j.ijbiomac.2010.02.007; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xiaoming C, 2010, FOREST INSECTSAS FOO; Yang Ping, 2004, Journal of Insect Biotechnology and Sericology, V73, P7; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060781; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	53	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114823	10.1371/journal.pone.0114823	http://dx.doi.org/10.1371/journal.pone.0114823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490773	gold, Green Submitted, Green Published			2022-12-26	WOS:000347515300081
J	Woodard, GE; Ji, Y; Christopherson, GT; Wolcott, KM; Hall, DJ; Jackson, WM; Nesti, LJ				Woodard, Geoffrey E.; Ji, Youngmi; Christopherson, Gregory T.; Wolcott, Karen M.; Hall, David J.; Jackson, Wesley M.; Nesti, Leon J.			Characterization of Discrete Subpopulations of Progenitor Cells in Traumatic Human Extremity Wounds	PLOS ONE			English	Article							STEM-CELLS; MUSCLE; INJURY; EXPRESSION; CD34; DIFFERENTIATION; FIBROCYTES; BONE	Here we show that distinct subpopulations of cells exist within traumatic human extremity wounds, each having the ability to differentiate into multiple cells types in vitro. A crude cell suspension derived from traumatized muscle was positively sorted for CD29, CD31, CD34, CD56 or CD91. The cell suspension was also simultaneously negatively sorted for either CD45 or CD117 to exclude hematopoietic stem cells. These subpopulations varied in terms their total numbers and their abilities to grow, migrate, differentiate and secrete cytokines. While all five subpopulations demonstrated equal abilities to undergo osteogenesis, they were distinct in their ability to undergo adipogenesis and vascular endotheliogenesis. The most abundant subpopulations were CD29+ and CD34+, which overlapped significantly. The CD29+ and CD34+ cells had the greatest proliferative and migratory capacity while the CD56+ subpopulation produced the highest amounts of TGFSS1 and TGFSS2. When cultured under endothelial differentiation conditions the CD29+ and CD34+ cells expressed VE-cadherin, Tie2 and CD31, all markers of endothelial cells. These data indicate that while there are multiple cell types within traumatized muscle that have osteogenic differentiation capacity and may contribute to bone formation in post-traumatic heterotopic ossification (HO), the major contributory cell types are CD29+ and CD34+, which demonstrate endothelial progenitor cell characteristics.	[Woodard, Geoffrey E.; Jackson, Wesley M.; Nesti, Leon J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Ji, Youngmi; Christopherson, Gregory T.; Hall, David J.; Nesti, Leon J.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Wolcott, Karen M.] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Nesti, Leon J.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed Surg, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center	Woodard, GE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA.	gew232000@gmail.com; leonnesti@gmail.com			Military Amputee Research Program at Walter Reed Army Medical Center [P05-A011]; Comprehensive Neurosciences Program [CNP-2008-CR01]; Defense Medical Research and Development Program [D10_1_AR_J5_920]; NIH Intramural Research Program [Z01 AR41131]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041131] Funding Source: NIH RePORTER	Military Amputee Research Program at Walter Reed Army Medical Center; Comprehensive Neurosciences Program; Defense Medical Research and Development Program; NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support was provided by the Military Amputee Research Program at Walter Reed Army Medical Center (P05-A011), the Comprehensive Neurosciences Program (CNP-2008-CR01), the Defense Medical Research and Development Program (D10_1_AR_J5_920) and the NIH Intramural Research Program (Z01 AR41131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aini H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037728; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; ARO HT, 1991, APMIS, V99, P482, DOI 10.1111/j.1699-0463.1991.tb05179.x; Bareja A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090398; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Chen D, 2013, J THROMB HAEMOST, V11, P963, DOI 10.1111/jth.12198; Chen HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097476; Cuenca-Lopez MD, 2008, CELL MOL BIOL, V54, P40, DOI 10.1170/T829; Davis TA, 2013, BONE, V56, P119, DOI 10.1016/j.bone.2013.05.016; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doornberg Job N, 2014, J Bone Joint Surg Am, V96, pe36, DOI 10.2106/JBJS.M.00388; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; FINA L, 1990, BLOOD, V75, P2417; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Hald ES, 2014, TRANSL STROKE RES, V5, P385, DOI 10.1007/s12975-013-0300-3; Hall S, 1997, J ANAT, V190, P57, DOI 10.1046/j.1469-7580.1997.19010057.x; Hildebrand KA, 2004, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000122664.95703.79; Iorio Richard, 2002, J Am Acad Orthop Surg, V10, P409; Jackson WM, 2009, J TISSUE ENG REGEN M, V3, P129, DOI 10.1002/term.149; Jackson WM, 2011, J ORTHOP RES, V29, P1613, DOI 10.1002/jor.21354; Jackson WM, 2011, J CELL MOL MED, V15, P2377, DOI 10.1111/j.1582-4934.2010.01225.x; Ji YM, 2012, ADV EXP MED BIOL, V720, P39, DOI 10.1007/978-1-4614-0254-1_4; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kimura S, 2012, NEPHRON CLIN PRACT, V121, pC16, DOI 10.1159/000341374; Landry PS, 2000, J TRAUMA, V48, P479, DOI 10.1097/00005373-200003000-00018; Lei Y, 2014, EXP CELL RES, V323, P198, DOI 10.1016/j.yexcr.2014.01.011; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Mackie AR, 2011, TEX HEART I J, V38, P474; Massa M, 2005, J CLIN ONCOL, V23, P5688, DOI 10.1200/JCO.2005.09.021; Masuda H, 2013, TRENDS CARDIOVAS MED, V23, P99, DOI 10.1016/j.tcm.2012.09.007; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Mu XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016699; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Oishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056641; Ostrovidov S, 2014, TISSUE ENG B; Otis G, 1883, MED SURG HIST CIVIL; Peterson LT, 1944, J BONE JOINT SURG, V26, P635; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; Sellheyer K, 2010, HAUTARZT, V61, P429, DOI 10.1007/s00105-010-1919-6; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Sueblinvong Viranuj, 2014, Adv Biosci Biotechnol, V5, P19; Uchida N, 2001, J CLIN INVEST, V108, P1071, DOI 10.1172/JCI13297; Verloop RE, 2009, EUR CYTOKINE NETW, V20, P207, DOI 10.1684/ecn.2009.0174; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zhang ST, 2013, HISTOL HISTOPATHOL, V28, P725, DOI 10.14670/HH-28.725	56	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114318	10.1371/journal.pone.0114318	http://dx.doi.org/10.1371/journal.pone.0114318			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490403	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300028
J	Barug, D; Goorden, S; Herruer, M; Muller, M; Brohet, R; de Winter, P				Barug, Daan; Goorden, Susan; Herruer, Martien; Muller, Moira; Brohet, Richard; de Winter, Peter			Reference Values for Interleukin-6 and Interleukin-8 in Cord Blood of Healthy Term Neonates and Their Association with Stress-Related Perinatal Factors	PLOS ONE			English	Article							DIAGNOSTIC MARKERS; SEPSIS; INFECTION; IL-6	Background: Automated interleukin assays are promising diagnostic aids for early-onset neonatal sepsis, however, reference values for healthy term neonates are incompletely known. The goal of this study is to determine reference values for interleukin-6 (IL-6) and interleukin-8 (IL-8) in cord blood of healthy term neonates. Methods and Findings: Women were recruited from April 2012 to August 2012. IL-6 and IL-8 levels were measured using an automated immunometric assay (Immulite) in cord blood of 93 healthy term newborns, 60 of them were born via vaginal delivery and 33 by elective caesarean section (ECS). A mean value for IL-8 of 8.1 +/- 3.0 pg/mL was found in cord blood of healthy term neonates, which apply to both vaginal delivery and ECS. Regarding IL-6, two values apply. For vaginal delivery, a median value of 3.3 pg/mL (range, <2 to 9.53 pg/mL) was found, while for ECS, a median value of <2 pg/mL (range, <2 to 48 pg/mL) applies. Conclusions: We propose a reference value of <14.1 pg/mL for IL-8 (mean + 2SD), applying to vaginally delivered and ECS-delivered healthy term newborns. From a clinical point of view, we also propose one reference value for IL-6 to be applied to vaginally delivered and ECS-delivered healthy term newborns, which is <10.2 pg/mL (97.5th percentile total group). These values have to be validated in larger cohorts of neonates, inclusive of those with and without early-onset neonatal sepsis.	[Barug, Daan; de Winter, Peter] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands; [Goorden, Susan; Herruer, Martien] Atal Medial Med Diagnost Ctr, Hoofddorp, Netherlands; [Muller, Moira] Spaarne Hosp, Dept Obstet & Gynaecol, Hoofddorp, Netherlands; [Brohet, Richard] Spaarne Hosp, Res Ctr Linnaeus Inst, Hoofddorp, Netherlands	Spaarne Hospital; Spaarne Hospital; Spaarne Hospital	Barug, D (corresponding author), Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands.	daantjebarug@gmail.com	De Winter, P/N-4317-2019	de Winter, Peter/0000-0002-8476-5312				Abbas A., 2010, CELL MOL IMMUNOL, V6th ed., P267; Arnon S, 2008, CURR OPIN INFECT DIS, V21, P223, DOI 10.1097/QCO.0b013e3282fa15dd; Benitz WE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.4.e41; Cernada M, 2012, ACTA PAEDIATR, V101, pe203, DOI 10.1111/j.1651-2227.2011.02577.x; Dollner H, 2001, BIOL NEONATE, V80, P41, DOI 10.1159/000047118; Fan Y, 2012, WORLD J PEDIATR, V8, P101, DOI 10.1007/s12519-012-0347-3; Franz AR, 2004, PEDIATRICS, V114, P1, DOI 10.1542/peds.114.1.1; Goetzl L, 2002, AM J OBSTET GYNECOL, V187, P834, DOI 10.1067/mob.2002.127135; Haque Khalid N, 2005, Pediatr Crit Care Med, V6, pS45, DOI 10.1097/01.PCC.0000161946.73305.0A; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Krueger M, 2001, BIOL NEONATE, V80, P118, DOI 10.1159/000047130; Kurt ANC, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/31397; Mehr SS, 2001, AM J PERINAT, V18, P313, DOI 10.1055/s-2001-17857; Mishra UK, 2006, ARCH DIS CHILD-FETAL, V91, pF208, DOI 10.1136/adc.2004.064188; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Ng PC, 2004, ARCH DIS CHILD-FETAL, V89, pF229, DOI 10.1136/adc.2002.023838; Polin RA, 2003, J PEDIATR-US, V143, P3, DOI 10.1016/S0022-3476(03)00271-3; Santana C, 2001, ACTA PAEDIATR, V90, P1176, DOI 10.1080/080352501317061602; Schulpis KH, 2008, CLIN CHEM LAB MED, V46, P1624, DOI 10.1515/CCLM.2008.305; TasciA Y, 2006, EUR J OBSTET GYN R B, V128, P34, DOI 10.1016/j.ejogrb.2005.11.049; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687	21	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114109	10.1371/journal.pone.0114109	http://dx.doi.org/10.1371/journal.pone.0114109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485809	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600042
J	Tolstikov, V; Nikolayev, A; Dong, S; Zhao, G; Kuo, MS				Tolstikov, Vladimir; Nikolayev, Alexander; Dong, Sucai; Zhao, Genshi; Kuo, Ming-Shang			Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; MASS-SPECTROMETRY; NAD BIOSYNTHESIS; PHARMACOLOGICAL INHIBITION; PROFILING PROCEDURES; GAS-CHROMATOGRAPHY; COLORECTAL-CANCER; GASTRIC-CANCER; STRESS; FK866	Nicotinamide phosphoribosyltransferase (NAMPT) plays an important role in cellular bioenergetics. It is responsible for converting nicotinamide to nicotinamide adenine dinucleotide, an essential molecule in cellular metabolism. NAMPT has been extensively studied over the past decade due to its role as a key regulator of nicotinamide adenine dinucleotide-consuming enzymes. NAMPT is also known as a potential target for therapeutic intervention due to its involvement in disease. In the current study, we used a global mass spectrometry-based metabolomic approach to investigate the effects of FK866, a small molecule inhibitor of NAMPT currently in clinical trials, on metabolic perturbations in human cancer cells. We treated A2780 (ovarian cancer) and HCT-116 (colorectal cancer) cell lines with FK866 in the presence and absence of nicotinic acid. Significant changes were observed in the amino acids metabolism and the purine and pyrimidine metabolism. We also observed metabolic alterations in glycolysis, the citric acid cycle (TCA), and the pentose phosphate pathway. To expand the range of the detected polar metabolites and improve data confidence, we applied a global metabolomics profiling platform by using both non-targeted and targeted hydrophilic (HILIC)-LCMS and GC-MS analysis. We used Ingenuity Knowledge Base to facilitate the projection of metabolomics data onto metabolic pathways. Several metabolic pathways showed differential responses to FK866 based on several matches to the list of annotated metabolites. This study suggests that global metabolomics can be useful tool in pharmacological studies of the mechanism of action of drugs at a cellular level.	[Tolstikov, Vladimir; Nikolayev, Alexander; Kuo, Ming-Shang] Eli Lilly & Co, Lilly Res Labs, Discovery Chem & Technol, Indianapolis, IN 46285 USA; [Dong, Sucai; Zhao, Genshi] Eli Lilly & Co, Lilly Res Labs, Canc Signaling & Metab, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly	Kuo, MS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Discovery Chem & Technol, 893 S Delaware St, Indianapolis, IN 46285 USA.	kuo_ming-shang@lilly.com	Tolstikov, Vladimir/P-2465-2019	Tolstikov, Vladimir/0000-0002-0445-884X	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was supported by Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Galli U, 2008, CHEMMEDCHEM, V3, P771, DOI 10.1002/cmdc.200700311; Galli U, 2013, J MED CHEM, V56, P6279, DOI 10.1021/jm4001049; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kirkland JB, 2009, CURR PHARM DESIGN, V15, P3, DOI 10.2174/138161209787185823; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tolstikov V, 2013, ASMS MINN MN; Tong L., 2008, U.S. Patent, Patent No. 0020413; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zou W, 2009, ALGORITHMS, V2, DOI 10.3390/a2020638	48	60	60	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114019	10.1371/journal.pone.0114019	http://dx.doi.org/10.1371/journal.pone.0114019			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486521	Green Published, gold			2022-12-26	WOS:000346907600036
J	Wang, HT; Han, YF; Chan, YS; He, JF				Wang, Haitao; Han, Yi-Fan; Chan, Ying-Shing; He, Jufang			Stimulus-Specific Adaptation at the Synapse Level In Vitro	PLOS ONE			English	Article							INFERIOR COLLICULUS; AUDITORY-CORTEX; NEURONS; PLASTICITY; MECHANISMS; NETWORKS; BLOCKADE; BRAIN	Stimulus-specific adaptation (SSA) is observed in many brain regions in humans and animals. SSA of cortical neurons has been proposed to accumulate through relays in ascending pathways. Here, we examined SSA at the synapse level using whole-cell patch-clamp recordings of primary cultured cortical neurons of the rat. First, we found that cultured neurons had high firing capability with 100-Hz current injection. However, neuron firing started to adapt to repeated electrically activated synaptic inputs at 10 Hz. Next, to activate different dendritic inputs, electrical stimulations were spatially separated. Cultured neurons showed similar SSA properties in the oddball stimulation paradigm compared to those reported in vivo. Single neurons responded preferentially to a deviant stimulus over repeated, standard stimuli considering both synapse-driven spikes and excitatory postsynaptic currents (EPSCs). Compared with two closely placed stimulating electrodes that activated highly overlapping dendritic fields, two separately placed electrodes that activated less overlapping dendritic fields elicited greater SSA. Finally, we used glutamate puffing to directly activate postsynaptic glutamate receptors. Neurons showed SSA to two separately placed puffs repeated at 10 Hz. Compared with EPSCs, GABAa receptor-mediated inhibitory postsynaptic currents showed weaker SSA. Heterogeneity of the synaptic inputs was critical for producing SSA, with glutamate receptor desensitization participating in the process. Our findings suggest that postsynaptic fatigue contributes largely to SSA at low frequencies.	[Wang, Haitao; He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Haitao; He, Jufang] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Haitao; He, Jufang] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Han, Yi-Fan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Ying-Shing] Univ Hong Kong, Fac Med, Dept Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Hong Kong Polytechnic University; Hong Kong Polytechnic University; University of Hong Kong; University of Hong Kong	Wang, HT (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	wang_haitao@gibh.ac.cn; jufanghe@cityu.edu.hk	Wang, Haitao/GYV-1262-2022	Wang, Haitao/0000-0002-2436-113X; Han, Yifan/0000-0002-5833-069X; Chan, Ying Shing/0000-0002-6228-1595; HE, Jufang/0000-0002-4288-5957	Hong Kong Research Grants Council [561111, 561212, 561410, CRF09/9, T13-607/12R]; National Key Basic Research Program of China [2012CB966300, 2013CB530900]; National Science Foundation of China [31371114, 31300901]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the Hong Kong Research Grants Council (561111, 561212, 561410, CRF09/9, T13-607/12R), National Key Basic Research Program of China (2012CB966300, 2013CB530900), and National Science Foundation of China (31371114, 31300901). The authors also appreciate the donations from Charlie Lee Foundation and Fong Shu Fook Tong Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abolafia JM, 2011, CEREB CORTEX, V21, P977, DOI 10.1093/cercor/bhq163; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2011, J NEUROSCI, V31, P17306, DOI 10.1523/JNEUROSCI.1915-11.2011; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Ayala YA, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00119; Beck O, 2005, J NEUROPHYSIOL, V94, P363, DOI 10.1152/jn.01287.2004; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boynton GM, 2003, J NEUROSCI, V23, P8781; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Duque D, 2014, J PHYSIOL-LONDON, V592, P729, DOI 10.1113/jphysiol.2013.261941; Escera C, 2014, PSYCHOPHYSIOLOGY, V51, P111, DOI 10.1111/psyp.12156; Eytan D, 2003, J NEUROSCI, V23, P9349; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hershenhoren I, 2014, J NEUROSCI, V34, P3303, DOI 10.1523/JNEUROSCI.2166-13.2014; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; Luo JL, 2010, J BIOL CHEM, V285, P19947, DOI 10.1074/jbc.M110.111286; Malmierca MS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00111; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Mann ZF, 2011, HEARING RES, V276, P2, DOI 10.1016/j.heares.2011.01.011; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Perez-Gonzalez D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034297; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Thomas JM, 2012, HEARING RES, V291, P34, DOI 10.1016/j.heares.2012.06.004; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Varela JA, 1997, J NEUROSCI, V17, P7926; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Wang LY, 1998, J PHYSIOL-LONDON, V509, P183, DOI 10.1111/j.1469-7793.1998.183bo.x; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yu XJ, 2009, J NEUROPHYSIOL, V101, P980, DOI 10.1152/jn.91130.2008; Zhao L, 2011, NEUROSCIENCE, V181, P163, DOI 10.1016/j.neuroscience.2011.01.060; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114537	10.1371/journal.pone.0114537	http://dx.doi.org/10.1371/journal.pone.0114537			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486252	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600073
J	Hellebuyck, T; Van Steendam, K; Deforce, D; Blooi, M; Van Nieuwerburgh, F; Bullaert, E; Ducatelle, R; Haesebrouck, F; Pasmans, F; Martel, A				Hellebuyck, Tom; Van Steendam, Katleen; Deforce, Dieter; Blooi, Mark; Van Nieuwerburgh, Filip; Bullaert, Evelien; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank; Martel, An			Autovaccination Confers Protection against Devriesea agamarum Associated Septicemia but Not Dermatitis in Bearded Dragons (Pogona vitticeps)	PLOS ONE			English	Article							ANTIBODY-RESPONSES; HERPESVIRUS; TORTOISES; ANTIGEN; SURFACE; TURTLE	Devrieseasis caused by Devriesea agamarum is a highly prevalent disease in captive desert lizards, resulting in severe dermatitis and in some cases mass mortality. In this study, we assessed the contribution of autovaccination to devrieseasis control by evaluating the capacity of 5 different formalin-inactivated D. agamarum vaccines to induce a humoral immune response in bearded dragons (Pogona vitticeps). Each vaccine contained one of the following adjuvants: CpG, incomplete Freund's, Ribi, aluminium hydroxide, or curdlan. Lizards were administrated one of the vaccines through subcutaneous injection and booster vaccination was given 3 weeks after primo-vaccination. An indirect ELISA was developed and used to monitor lizard serological responses. Localized adverse effects following subcutaneous immunization were observed in all but the Ribi adjuvanted vaccine group. Following homologous experimental challenge, the incomplete Freund's as well as the Ribi vaccine were observed to confer protection in bearded dragons against the development of D. agamarum associated septicemia but not against dermatitis. Subsequently, two-dimensional gelelectrophoresis followed by immunoblotting and mass spectrometry was conducted with serum obtained from 3 lizards that showed seroconversion after immunisation with the Ribi vaccine. Fructose-bisphosphate aldolase and aldo-keto reductase of D. agamarum reacted with serum from the latter lizards. Based on the demonstrated seroconversion and partial protection against D. agamarum associated disease following the use of formalin-inactivated vaccines as well as the identification of target antigens in Ribi vaccinated bearded dragons, this study provides promising information towards the development of a vaccination strategy to control devrieseasis in captive lizard collections.	[Hellebuyck, Tom; Blooi, Mark; Bullaert, Evelien; Ducatelle, Richard; Haesebrouck, Freddy; Pasmans, Frank; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van Steendam, Katleen; Deforce, Dieter; Van Nieuwerburgh, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Blooi, Mark] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium	Ghent University; Ghent University	Hellebuyck, T (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Tom.Hellebuyck@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Haesebrouck, Freddy/0000-0002-1709-933X; Deforce, Dieter LD/0000-0002-0635-661X				Ambrosius H, 1972, C INSERM PHYL ONT ST, P135; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Cooper EL, 1988, BIOL REPTILIA, P298; D'Costa SS, 2000, BIOCHEM BIOPH RES CO, V278, P826, DOI 10.1006/bbrc.2000.3884; DEEB BJ, 1992, J IMMUNOL METHODS, V152, P105, DOI 10.1016/0022-1759(92)90093-9; Devloo R, 2011, VET MICROBIOL, V150, P297, DOI 10.1016/j.vetmic.2011.01.029; Fiebig H, 1973, Allerg Immunol (Leipz), V19, P248; Hellebuyck T, 2011, LETT APPL MICROBIOL, V52, P28, DOI 10.1111/j.1472-765X.2010.02962.x; Hellebuyck T, 2009, VET MICROBIOL, V139, P189, DOI 10.1016/j.vetmic.2009.05.003; Hellebuyck T, 2009, VET MICROBIOL, V134, P267, DOI 10.1016/j.vetmic.2008.08.021; HERBST LH, 1995, VET IMMUNOL IMMUNOP, V46, P317, DOI 10.1016/0165-2427(94)05360-5; Jacobson ER, 2002, SEMIN AVIAN EXOT PET, V11, P33, DOI 10.1053/saep.2002.28239; JACOBSON ER, 1991, J ZOO WILDLIFE MED, V22, P184; Lapidus A, 2009, STAND GENOMIC SCI, V1, P3, DOI 10.4056/sigs.492; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Lock BA, 2003, AM J VET RES, V64, P388, DOI 10.2460/ajvr.2003.64.388; Marschang RE, 2001, DEUT TIERARZTL WOCH, V108, P376; Martel A, 2008, INT J SYST EVOL MICR, V58, P2206, DOI 10.1099/ijs.0.65478-0; Origgi FC, 2004, VET PATHOL, V41, P50, DOI 10.1354/vp.41-1-50; Pasmans F, 2002, VET MICROBIOL, V87, P315, DOI 10.1016/S0378-1135(02)00081-0; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SALANITRO SK, 1973, COPEIA, P504; Salway J.G., 2017, METABOLISM GLANCE; Van Steendam K, 2013, INT J LEGAL MED, V127, P287, DOI 10.1007/s00414-012-0747-x; Van Steendam K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3070; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	27	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113084	10.1371/journal.pone.0113084	http://dx.doi.org/10.1371/journal.pone.0113084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479609	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200015
J	Hsieh, YH; Wu, JH; Fang, J; Yang, Y; Lou, J				Hsieh, Ying-Hen; Wu, Jianhong; Fang, Jian; Yang, Yong; Lou, Jie			Quantification of Bird-to-Bird and Bird-toHuman Infections during 2013 Novel H7N9 Avian Influenza Outbreak in China	PLOS ONE			English	Article							PANDEMIC INFLUENZA; REPRODUCTION NUMBER; PERSON TRANSMISSION; VIRUS; STRATEGIES; EPIDEMIC; SPREAD; DENGUE	From February to May, 2013, 132 human avian influenza H7N9 cases were identified in China resulting in 37 deaths. We developed a novel, simple and effective compartmental modeling framework for transmissions among (wild and domestic) birds as well as from birds to human, to infer important epidemiological quantifiers, such as basic reproduction number for bird epidemic, bird-to-human infection rate and turning points of the epidemics, for the epidemic via human H7N9 case onset data and to acquire useful information regarding the bird-to-human transmission dynamics. Estimated basic reproduction number for infections among birds is 4.10 and the mean daily number of human infections per infected bird is 3.16*10(-5) [3.08*10(-5), 3.23*10(-5)]. The turning point of 2013 H7N9 epidemic is pinpointed at April 16 for bird infections and at April 9 for bird-to-human transmissions. Our result reveals very low level of bird-to-human infections, thus indicating minimal risk of widespread bird-to-human infections of H7N9 virus during the outbreak. Moreover, the turning point of the human epidemic, pinpointed at shortly after the implementation of full-scale control and intervention measures initiated in early April, further highlights the impact of timely actions on ending the outbreak. This is the first study where both the bird and human components of an avian influenza epidemic can be quantified using only the human case data.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan; [Wu, Jianhong; Fang, Jian; Yang, Yong] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Wu, Jianhong; Fang, Jian] York Univ, Ctr Dis Modelling, Toronto, ON M3J 2R7, Canada; [Fang, Jian] Harbin Inst Technol, Dept Math, Harbin 150006, Peoples R China; [Lou, Jie] Shanghai Univ, Dept Math, Shanghai, Peoples R China	China Medical University Taiwan; China Medical University Taiwan; York University - Canada; York University - Canada; Harbin Institute of Technology; Shanghai University	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	hsieh@mail.cmu.edu.tw	Wu, Jian/AAU-5221-2020; Hsieh, Ying-Hen/E-9685-2010; Fang, Jian/AAK-7981-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Science Council, Taiwan; Natural Science Foundation of China; International Development Research Centre; Canada Research Chair Program; Natural Sciences and Engineering Research Council of Canada	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Development Research Centre; Canada Research Chair Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding support came from the National Science Council, Taiwan (YHH), the Natural Science Foundation of China (JF and JL), the International Development Research Centre (JW), the Canada Research Chair Program (JW), and the Natural Sciences and Engineering Research Council of Canada (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusto FB, 2010, DISCRETE CONT DYN-B, V13, P1, DOI 10.3934/dcdsb.2009.13.1; ANDERSON R M, 1991; [Anonymous], 2013, HUM INF INFL A H7N9; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2004, EMERG INFECT DIS, V10, P201, DOI 10.3201/eid1002.030515; Hsieh YH, 2009, SERIES CONT APPL MAT, V11, P216, DOI DOI 10.1142/9789814261265_; Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66; Iwami S, 2007, MATH BIOSCI, V207, P1, DOI 10.1016/j.mbs.2006.08.001; Kucharski Adam, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.e1473d9bfc99d080ca242139a06c455f; Le Menach A, 2006, P ROY SOC B-BIOL SCI, V273, P2467, DOI 10.1098/rspb.2006.3609; Liu R, 2008, MATH MODEL NAT PHENO, V3, P161, DOI 10.1051/mmnp:2008048; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Ministry of Agriculture of the People's Republic of China, 2013, NO H7N9 VIR FOUND PO; National Health and Family Planning Commission, 2013, NEWS B; Nishiura H, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-30; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang XS, 2012, J THEOR BIOL, V313, P12, DOI 10.1016/j.jtbi.2012.07.024; World Health Organization, 2014, 17 WHO; Wu H, 2013, N ENGL J MED; Wu J, 2008, MATH EPIDEMIOLOGY; Xiao Y, 2014, J THEORETI BIOL, V3521, P3525; Xinhua News Agency, 2013, XINHAUNET NEWS; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2	33	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111834	10.1371/journal.pone.0111834	http://dx.doi.org/10.1371/journal.pone.0111834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479054	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000346907200005
J	Leiherer, A; Muendlein, A; Rein, P; Saely, CH; Kinz, E; Vonbank, A; Fraunberger, P; Drexel, H				Leiherer, Andreas; Muendlein, Axel; Rein, Philipp; Saely, Christoph H.; Kinz, Elena; Vonbank, Alexander; Fraunberger, Peter; Drexel, Heinz			Genome-Wide Association Study Reveals a Polymorphism in the Podocyte Receptor RANK for the Decline of Renal Function in Coronary Patients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CELL CARCINOMA; VASCULAR CALCIFICATION; POPULATION; ATHEROSCLEROSIS; ANGIOGRAPHY; MECHANISMS; CREATININE; EXPRESSION	Impaired kidney function is a significant health problem and a major concern in clinical routine and is routinely determined by decreased glomerular filtration rate (GFR). In contrast to single assessment of a patients' kidney function providing only limited information on patients' health, serial measurements of GFR clearly improves the validity of diagnosis. The decline of kidney function has recently been reported to be predictive for mortality and vascular events in coronary patients. However, it has not been investigated for genetic association in GWA studies. This study investigates for the first time the association of cardiometabolic polymorphisms with the decline of estimated GFR during a 4 year follow up in 583 coronary patients, using the Cardio-Metabo Chip. We revealed a suggestive association with 3 polymorphisms, surpassing genome-wide significance (p=4.0 e-7). The top hit rs17069906 (p=5.6 e-10) is located within the genomic region of RANK, recently demonstrated to be an important player in the adaptive recovery response in podocytes and suggested as a promising therapeutic target in glomerular diseases.	[Leiherer, Andreas; Muendlein, Axel; Rein, Philipp; Saely, Christoph H.; Kinz, Elena; Vonbank, Alexander; Drexel, Heinz] VIVIT, Feldkirch, Austria; [Rein, Philipp; Saely, Christoph H.; Vonbank, Alexander; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Leiherer, Andreas; Saely, Christoph H.; Kinz, Elena; Fraunberger, Peter; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Leiherer, Andreas; Fraunberger, Peter] Med Cent Labs, Feldkirch, Austria; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Drexel, H (corresponding author), VIVIT, Feldkirch, Austria.	vivit@lkhf.at	Muendlein, Axel/AAS-5313-2021; Leiherer, Andreas/X-5539-2019	Leiherer, Andreas/0000-0003-3776-5704; Muendlein, Axel/0000-0002-5582-4125; Vonbank, Alexander/0000-0001-5648-5623	Land Vorarlberg; College of Physicians in Vorarlberg	Land Vorarlberg; College of Physicians in Vorarlberg	This study was supported by grants from the "Land Vorarlberg" and the "College of Physicians in Vorarlberg", but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 1987, AM J PHYSIOL, V253, pF783; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ANGLARD P, 1991, CANCER RES, V51, P1071; Bharti AC, 2004, APOPTOSIS, V9, P677, DOI 10.1023/B:APPT.0000045780.10463.c6; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; DREXEL H, 1994, CIRCULATION, V90, P2230, DOI 10.1161/01.CIR.90.5.2230; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Gayrard N, 2008, ARCH PATHOL LAB MED, V132, P965, DOI 10.1043/1543-2165(2008)132[965:CSORET]2.0.CO;2; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Goek ON, 2012, AM J KIDNEY DIS, V60, P197, DOI 10.1053/j.ajkd.2012.01.014; Hadaczek P, 1998, CANCER RES, V58, P2946; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Liu SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041331; Liu YW, 2011, FRONT BIOSCI-LANDMRK, V16, P1302, DOI 10.2741/3790; Malliga DE, 2011, WIEN MED WOCHENSCHR, V161, P565, DOI 10.1007/s10354-011-0022-7; Mogensen Mette Sloth, 2012, Frontiers in Genetics, V3, P225, DOI 10.3389/fgene.2012.00225; Moore LE, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.14; Muendlein A, 2012, CLIN CHIM ACTA, V413, P287, DOI 10.1016/j.cca.2011.10.008; Murata K, 2011, CLIN J AM SOC NEPHRO, V6, P1963, DOI 10.2215/CJN.02300311; Ndip A, 2014, DIABETOLOGIA; Okumura H, 2009, CANCER SCI, V100, P1145, DOI 10.1111/j.1349-7006.2009.01168.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rebholz CM, 2014, NEPHROL DIAL TRANSPL; Rein P, 2014, AM J CARDIOL, V113, P215, DOI 10.1016/j.amjcard.2013.08.032; Rein P, 2010, ATHEROSCLEROSIS, V211, P348, DOI 10.1016/j.atherosclerosis.2010.02.031; Risch L, 2007, CLIN CHIM ACTA, V378, P71, DOI 10.1016/j.cca.2006.10.015; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Saely CH, 2006, EUR J CLIN INVEST, V36, P91, DOI 10.1111/j.1365-2362.2006.01604.x; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SMEETS DFCM, 1986, HUM GENET, V72, P215, DOI 10.1007/BF00291880; Strefford JC, 2005, CANCER GENET CYTOGEN, V159, P1, DOI 10.1016/j.cancergencyto.2004.09.020; Toma MI, 2008, NEOPLASIA, V10, P634, DOI 10.1593/neo.08160; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z	42	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114240	10.1371/journal.pone.0114240	http://dx.doi.org/10.1371/journal.pone.0114240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478860	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200052
J	Lian, YL; Xu, MY; Zhong, YM; Yang, YQ; Chen, FR; Guo, J				Lian, Yingli; Xu, Meiying; Zhong, Yuming; Yang, Yongqiang; Chen, Fanrong; Guo, Jun			Ammonia Oxidizers in a Pilot-Scale Multilayer Rapid Infiltration System for Domestic Wastewater Treatment	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; NITRITE ACCUMULATION; NITROGEN REMOVAL; ARCHAEA; BACTERIA; SOIL; NITRIFICATION; TEMPERATURE; SEQUENCE	A pilot-scale multilayer rapid infiltration system (MRIS) for domestic wastewater treatment was established and efficient removal of ammonia and chemical oxygen demand (COD) was achieved in this study. The microbial community composition and abundance of ammonia oxidizers were investigated. Efficient biofilms of ammonia oxidizers in the stationary phase (packing material) was formed successfully in the MRIS without special inoculation. DGGE and phylogenetic analyses revealed that proteobacteria dominated in the MRIS. Relative abundance of ammonia-oxidizing archaea (AOA) and ammonia-oxidizing bacteria (AOB) showed contrary tendency. In the flowing phase (water effluent), AOA diversity was significantly correlated with the concentration of dissolve oxygen (DO), NO3-N and NH3-N. AOB abundance was significantly correlated with the concentration of DO and chemical oxygen demand (COD). NH3-N and COD were identified as the key factors to shape AOB community structure, while no variable significantly correlated with that of AOA. AOA might play an important role in the MRIS. This study could reveal key environmental factors affecting the community composition and abundance of ammonia oxidizers in the MRIS.	[Lian, Yingli] S China Univ Technol, Sch Biol Sci & Engn, Guangzhou 510006, Guangdong, Peoples R China; [Lian, Yingli; Xu, Meiying; Zhong, Yuming; Guo, Jun] Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China; [Yang, Yongqiang; Chen, Fanrong] Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou 510640, Guangdong, Peoples R China	South China University of Technology; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS	Xu, MY (corresponding author), Guangdong Inst Microbiol, Guangzhou 510070, Guangdong, Peoples R China.	xumy@gdim.cn	Xu, Meiying/AAM-1646-2020; Yang, Yongqiang/S-2732-2019		The Chinese Academy of Sciences [KZCX2-YW-JC105]; Chinese National Programs for High Technology Research and Development (863 Program) [2011AA060904]; Natural Science Foundation of Guangdong Province, China [9351007002000001]	The Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Programs for High Technology Research and Development (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This study was partly funded by innovative Program of The Chinese Academy of Sciences (KZCX2-YW-JC105), the Chinese National Programs for High Technology Research and Development (863 Program) (2011AA060904). The assistance from the Teamwork Project of the Natural Science Foundation of Guangdong Province, China (9351007002000001) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, STANDARD METHODS EXA; Auset M, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003611; BOCK E, 1995, ARCH MICROBIOL, V163, P16, DOI 10.1007/BF00262198; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Boyle-Yarwood SA, 2008, ENVIRON MICROBIOL, V10, P2956, DOI 10.1111/j.1462-2920.2008.01600.x; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gieseke A, 2006, APPL ENVIRON MICROB, V72, P4283, DOI 10.1128/AEM.00241-06; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; JONES RD, 1980, MICROB ECOL, V6, P339, DOI 10.1007/BF02010496; Kim DJ, 2006, BIORESOURCE TECHNOL, V97, P459, DOI 10.1016/j.biortech.2005.03.032; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koops HP, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P778, DOI 10.1007/0-387-30745-1_36; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lenz M, 2009, APPL MICROBIOL BIOT, V83, P377, DOI 10.1007/s00253-009-1915-x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mohanakrishnan J, 2011, APPL MICROBIOL BIOT, V91, P1647, DOI 10.1007/s00253-011-3330-3; Mota C, 2005, APPL ENVIRON MICROB, V71, P8565, DOI 10.1128/AEM.71.12.8565-8572.2005; Nicol GW, 2006, TRENDS MICROBIOL, V14, P207, DOI 10.1016/j.tim.2006.03.004; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Park SJ, 2007, J MICROBIOL, V45, P113; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Ruiz G, 2003, WATER RES, V37, P1371, DOI 10.1016/S0043-1354(02)00475-X; Schmidt I, 2003, FEMS MICROBIOL REV, V27, P481, DOI 10.1016/S0168-6445(03)00039-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; Wendroth O., 2004, VADOSE ZONE J, V3, P1057, DOI [10.2136/vzj2004.1057, DOI 10.2136/VZJ2004.1057]; Yoo K, 1999, WATER RES, V33, P145	38	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114723	10.1371/journal.pone.0114723	http://dx.doi.org/10.1371/journal.pone.0114723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479611	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200117
J	Miyaso, H; Nakamura, N; Naito, M; Hirai, S; Matsuno, Y; Itoh, M; Mori, C				Miyaso, Hidenobu; Nakamura, Noriko; Naito, Munekazu; Hirai, Shuichi; Matsuno, Yoshiharu; Itoh, Masahiro; Mori, Chisato			Early Postnatal Exposure to a Low Dose of Decabromodiphenyl Ether Affects Expression of Androgen and Thyroid Hormone Receptor-Alpha and Its Splicing Variants in Mouse Sertoli Cells	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; MESSENGER-RNA; GENE-EXPRESSION; DIPHENYL ETHER; DEVELOPMENTAL EXPOSURE; DEVELOPING LEYDIG; IN-VIVO; TESTIS; SPERMATOGENESIS; BDE-209	Decabromodiphenyl ether (decaBDE) adversely affects reproduction and development. Our previous study showed that postnatal exposure to a low dose of decaBDE (0.025 mg/kg body weight/day) by subcutaneous injection on postnatal days (PNDs) 1 through 5 leads to reductions in testicular size and number of Sertoli cells and sperm, while higher dose of decaBDE (2.5 mg/kg body weight/day) had no significant differences about these. In the present study, we examined the molecular mechanism of these effects on mouse testes following postnatal exposure to a low decaBDE dose. We hypothesized that postnatal exposure to decaBDE may alter levels of serum thyroid hormones (THs) and testosterone, or the level of TH receptor alpha (Thra) transcripts and its splicing variants and androgen receptor (Ar) in Sertoli cells, adversely affecting spermatogenesis. To test this hypothesis, we examined serum TH and testosterone levels and the levels of transcripts of the Ar, Thra and its splicing variants, and Thra splicing factors (Hnrnpa1, Srsf1, and Hnrnph1) with qPCR in isolated mouse Sertoli cells exposed postnatally to decaBDE (0.025, 0.25, and 2.5 mg/kg). Levels of serum testosterone and transcripts encoding Ar, Thra, and its variant, Thra1, declined significantly in Sertoli cells of mice exposed to 0.025 mg decaBDE/kg. No significant differences in serum TH level or Thra2, Hnrnph1, or Srsf1 transcript levels were observed between control and decaBDE-exposed mice. However, the Thra1:Thra2 and Hnrnpa1:Srsf1 ratios were altered in Sertoli cells of mice exposed to 0.025 mg decaBDE/kg but not in cells exposed to 0.25 or 2.5 mg decaBDE/kg. These results indicate that postnatal exposure to a low dose of decaBDE on PNDs 1 through 5 lowers the testosterone level and the levels of Ar and Thra transcripts in Sertoli cells, accompanied by an imbalance in the ratios of Thra splicing variants, resulting in smaller testicular size and impaired spermatogenesis.	[Miyaso, Hidenobu; Matsuno, Yoshiharu; Mori, Chisato] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Miyaso, Hidenobu; Matsuno, Yoshiharu; Mori, Chisato] Chiba Univ, Grad Sch Med, Dept Bioenvironm Med, Chiba, Japan; [Nakamura, Noriko] Marshall Univ, Joan C Edwards Sch Med, Dept Pharmacol Physiol & Toxicol, Huntington, WV USA; [Naito, Munekazu] Aichi Med Univ, Dept Anat, Nagakute, Aichi, Japan; [Hirai, Shuichi; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan	Chiba University; Chiba University; Marshall University; Aichi Medical University; Tokyo Medical University	Mori, C (corresponding author), Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan.	cmori@faculty.chiba-u.jp	HIRAI, SHUICHI/AAQ-6081-2020	Miyaso, Hidenobu/0000-0003-2212-1500	JSPS KAKENHI [20241016, 24710069]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI (grant numbers 20241016 and 24710069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambepola NK, 1998, J ENDOCRINOL, V156, P43, DOI 10.1677/joe.0.1560043; Auwerx J, 1999, CELL, V97, P161; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Fagman H, 2006, DEV DYNAM, V235, P444, DOI 10.1002/dvdy.20653; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hanamura A, 1998, RNA, V4, P430; Hastings ML, 2001, RNA, V7, P859, DOI 10.1017/S1355838201002084; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Jannini EA, 2000, J CLIN ENDOCR METAB, V85, P3453, DOI 10.1210/jc.85.9.3453; JOYCE KL, 1993, J ANDROL, V14, P448; Kim TH, 2009, J TOXICOL ENV HEAL A, V72, P1296, DOI 10.1080/15287390903320742; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Lee E, 2010, J TOXICOL SCI, V35, P535, DOI 10.2131/jts.35.535; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; McDonald TA, 2002, CHEMOSPHERE, V46, P745, DOI 10.1016/S0045-6535(01)00239-9; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Miyaso H, 2012, J TOXICOL SCI, V37, P987, DOI 10.2131/jts.37.987; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Noyes PD, 2013, ENVIRON SCI TECHNOL, V47, P10012, DOI 10.1021/es402650x; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; Ortega FJ, 2009, OBESITY, V17, P2134, DOI 10.1038/oby.2009.110; Rao JN, 2003, J ENDOCRINOL INVEST, V26, P435, DOI 10.1007/BF03345199; ROMERT P, 1973, Z ANAT ENTWICKLUNGS, V139, P319, DOI 10.1007/BF00519971; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SHAN LX, 1995, ENDOCRINOLOGY, V136, P3856, DOI 10.1210/en.136.9.3856; Shan LX, 1997, ENDOCRINOLOGY, V138, P1259, DOI 10.1210/en.138.3.1259; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Thijssen-Timmer DC, 2006, J MOL ENDOCRINOL, V37, P251, DOI 10.1677/jme.1.01914; Timmer DC, 2003, J ENDOCRINOL, V179, P217, DOI 10.1677/joe.0.1790217; Tseng LH, 2008, CHEMOSPHERE, V70, P640, DOI 10.1016/j.chemosphere.2007.06.078; Tseng LH, 2006, TOXICOLOGY, V224, P33, DOI 10.1016/j.tox.2006.04.003; Tseng LH, 2013, ENVIRON TOXICOL, V28, P380, DOI 10.1002/tox.20729; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Zhai Jin-Xia, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P294	40	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114487	10.1371/journal.pone.0114487	http://dx.doi.org/10.1371/journal.pone.0114487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479311	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200094
J	Suzuki, H; Oku, H; Horie, T; Morishita, S; Tonari, M; Oku, K; Okubo, A; Kida, T; Mimura, M; Fukumoto, M; Kojima, S; Takai, S; Ikeda, T				Suzuki, Hiroyuki; Oku, Hidehiro; Horie, Taeko; Morishita, Seita; Tonari, Masahiro; Oku, Kazuma; Okubo, Akiko; Kida, Teruyo; Mimura, Masashi; Fukumoto, Masanori; Kojima, Shota; Takai, Shinji; Ikeda, Tsunehiko			Changes in Expression of Aquaporin-4 and Aquaporin-9 in Optic Nerve after Crushing in Rats	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; DIABETIC-RETINOPATHY; WATER TRANSPORT; BRAIN EDEMA; GLIAL-CELLS; INJURY; KIR4.1; MICE; REGENERATION; SURVIVAL	The purpose of this study was to determine the temporal and spatial changes in the expression of AQP4 and AQP9 in the optic nerve after it is crushed. The left optic nerves of rats were either crushed (crushed group) or sham operated (sham group), and they were excised before, and at 1, 2, 4, 7, and 14 days later. Four optic nerves were pooled for each time point in both groups. The expression of AQP4 and AQP9 was determined by western blot analyses. Immunohistochemistry was used to determine the spatial expression of AQP4, AQP9, and GFAP in the optic nerve. Optic nerve edema was determined by measuring the water content in the optic nerve. The barrier function of the optic nerve vessels was determined by the extravasated Evans blue dye on days 7 and 14. The results showed that the expression of AQP4 was increased on day 1 but the level was significantly lower than that in the sham group on days 4 and 7 (P<0.05). In contrast, the expression of AQP9 gradually increased, and the level was significantly higher than that in the sham group on days 7 and 14 (P<0.05, Tukey-Kramer). The down-regulation of AQP4 was associated with crush-induced optic nerve edema, and the water content of the nerve was significantly increased by 4.3% in the crushed optic nerve from that of the untouched fellow nerve on day 7. The expression of AQP4 and GFAP was reduced at the crushed site where AQP4-negative and AQP9-positive astrocytes were present. The barrier function was impaired at the crushed site on days 7 and 14, restrictedly where AQP4-negative and AQP9-positive astrocytes were present. The presence of AQP9-positive astrocytes at the crushed site may counteract the metabolic damage but this change did not fully compensate for the barrier function defect.	[Suzuki, Hiroyuki; Oku, Hidehiro; Horie, Taeko; Morishita, Seita; Tonari, Masahiro; Oku, Kazuma; Okubo, Akiko; Kida, Teruyo; Mimura, Masashi; Fukumoto, Masanori; Kojima, Shota; Takai, Shinji; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Osaka, Japan	Osaka Medical College	Oku, H (corresponding author), Osaka Med Coll, Dept Ophthalmol, Osaka, Japan.	hidehirooku@aol.com	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219; Mimura, Masashi/0000-0002-2396-5636	Japanese Ministry of Education [25462763]	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Japanese Ministry of Education Grant 25462763 (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bosco A, 2005, INVEST OPHTH VIS SCI, V46, P3869, DOI 10.1167/iovs.05-0385; Cui B, 2012, EXP EYE RES, V98, P37, DOI 10.1016/j.exer.2012.02.013; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Dibaj P, 2007, J NEUROCHEM, V103, P2620, DOI 10.1111/j.1471-4159.2007.04979.x; Dibas A, 2007, PHARMACOL RES, V55, P378, DOI 10.1016/j.phrs.2007.01.021; Dibas A, 2010, MOL VIS, V16, P330; Fukuda M, 2010, EXP EYE RES, V90, P17, DOI 10.1016/j.exer.2009.09.003; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hollborn M, 2012, CURR EYE RES, V37, P524, DOI 10.3109/02713683.2012.658133; Hollborn M, 2011, CURR EYE RES, V36, P850, DOI 10.3109/02713683.2011.593108; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kurimoto T, 2006, NEUROREPORT, V17, P1525, DOI 10.1097/01.wnr.0000234749.80936.54; Li XM, 2014, NEUROL SCI; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Miki A, 2013, AM J PATHOL, V182, P1727, DOI 10.1016/j.ajpath.2013.01.027; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Naka M, 2010, INVEST OPHTH VIS SCI, V51, P4618, DOI 10.1167/iovs.09-4712; Nielsen S, 1997, J NEUROSCI, V17, P171; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Qin YW, 2012, INVEST OPHTH VIS SCI, V53, P3047, DOI 10.1167/iovs.11-9154; Qin YW, 2009, EXP EYE RES, V89, P741, DOI 10.1016/j.exer.2009.06.020; Ransom BR, 1997, GLIA, V21, P134; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schey KL, 2014, BBA-GEN SUBJECTS, V1840, P1513, DOI 10.1016/j.bbagen.2013.10.037; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Yang MH, 2013, BIOSCI REP, V33; Zhang Y, 2011, J INT MED RES, V39, P464, DOI 10.1177/147323001103900214; Zhou JP, 2008, NEUROREPORT, V19, P1, DOI 10.1097/WNR.0b013e3282f2b4eb; Zickler P, 2010, CELL PHYSIOL BIOCHEM, V26, P483, DOI 10.1159/000320571	39	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114694	10.1371/journal.pone.0114694	http://dx.doi.org/10.1371/journal.pone.0114694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479407	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200113
J	Wiman, NG; Walton, VM; Shearer, PW; Rondon, SI				Wiman, Nik G.; Walton, Vaughn M.; Shearer, Peter W.; Rondon, Silvia I.			Electronically Monitored Labial Dabbing and Stylet 'Probing' Behaviors of Brown Marmorated Stink Bug, Halyomorpha halys, in Simulated Environments	PLOS ONE			English	Article							HILARIS HEMIPTERA-PENTATOMIDAE; FEEDING-ACTIVITY; HOMALODISCA-COAGULATA; HETEROPTERA; DAMAGE; PENETRATION; DURATION; GROWTH; TEMPERATURE; MORPHOLOGY	Brown marmorated stink bug, Halyomorpha halys (Stal), (Hemiptera: Pentatomidae) is an invasive polyphagous agricultural and urban nuisance pest of Asian origin that is becoming widespread in North America and Europe. Despite the economic importance of pentatomid pests worldwide, their feeding behavior is poorly understood. Electronically monitored insect feeding (EMIF) technology is a useful tool in studies of feeding behavior of Hemiptera. Here we examined H. halys feeding behavior using an EMIF system designed for high throughput studies in environmental chambers. Our objectives were to quantify feeding activity by monitoring proboscis contacts with green beans, including labial dabbing and stylet penetration of the beans, which we collectively define as 'probes'. We examined frequency and duration of 'probes' in field-collected H. halys over 48 hours and we determined how environmental conditions could affect diel and seasonal periodicity of ` probing' activity. We found differences in 'probing' activity between months when the assays were conducted. These differences in activity may have reflected different environmental conditions, and they also coincide with what is known about the phenology of H. halys. While a substantial number of ` probes' occurred during scotophase, including some of the longest mean 'probe' durations, activity was either lower or similar to '[probing' activity levels during photophase on average. We found that temperature had a significant impact on H. halys probing' behavior and may influence periodicity of activity. Our data suggest that the minimal temperature at which 'probing' of H. halys occurs is between 3.5 and 6.1 degrees C (95% CI), and that ` probing' does not occur at temperatures above 26.5 to 29.6 degrees C (95% CI). We estimated that the optimal temperature for ` probing' is between 16 and 17 degrees C.	[Wiman, Nik G.; Walton, Vaughn M.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Shearer, Peter W.] Oregon State Univ, Mid Columbia Agr Res & Extens Ctr, Hood River, OR 97031 USA; [Rondon, Silvia I.] Oregon State Univ, Hermiston Agr Res & Extens Ctr, Hermiston, OR USA	Oregon State University; Oregon State University; Oregon State University	Wiman, NG (corresponding author), Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA.	nik.wiman@oregonstate.edu	Wiman, Nik/J-4998-2019; Rondon, Silvia I./A-7033-2011; Rondon, Silvia I/AAC-4676-2021	Wiman, Nik/0000-0003-0890-5050; Rondon, Silvia I./0000-0002-7819-6934; 	USDA-NIFA Specialty Crops Research Initiative Award [201151181-30937]	USDA-NIFA Specialty Crops Research Initiative Award	Work supported by USDA-NIFA Specialty Crops Research Initiative Award 201151181-30937 (http://www.nifa.usda. gov/fo/specialtycropresearchinitiative.cfm) with funding going to VW, PS, and SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APRIYANTO D, 1989, J KANSAS ENTOMOL SOC, V62, P392; Backus E.A., 1985, P163; Backus EA, 2005, ANN ENTOMOL SOC AM, V98, P787, DOI 10.1603/0013-8746(2005)098[0787:SPBAHC]2.0.CO;2; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Backus Elaine A., 2000, P1; Baptist BA, 1941, Q J MICROSC SCI, V83, P91; Boethel DJ, 2000, J ECON ENTOMOL, V93, P707, DOI 10.1603/0022-0493-93.3.707; BOWLING CC, 1979, J ECON ENTOMOL, V72, P259, DOI 10.1093/jee/72.2.259; BOWLING CC, 1980, J ECON ENTOMOL, V73, P1, DOI 10.1093/jee/73.1.1; Brown MW, 2003, J AGR URBAN ENTOMOL, V20, P193; Bundy CS, 2012, SOUTHWEST ENTOMOL, V37, P411, DOI 10.3958/059.037.0317; *CABI, 2014, HAL HAL BROWN MARM S; CERVANTES F, 2014, P HEM PLANT INT S, P40; Chapman R.F., 1998, INSECTS STRUCTURE FU; Chesley LC, 1934, BIOL BULL-US, V66, P330, DOI 10.2307/1537386; COBBEN R H, 1978, Mededelingen Landbouwhogeschool Wageningen, V78, P5; COHEN AC, 1993, J INSECT PHYSIOL, V39, P823, DOI 10.1016/0022-1910(93)90114-7; COOP L, IPPC SYNTHESIS ANAL; Corpuz L. R., 1969, Philippine Entomologist, V1, P225; Depieri RA, 2011, NEOTROP ENTOMOL, V40, P197, DOI 10.1590/S1519-566X2011000200007; Esquivel JF, 2010, SOUTHWEST ENTOMOL, V35, P457, DOI 10.3958/059.035.0332; HAYE T, 2014, J PEST SCI, V87, P1, DOI DOI 10.1007/S10340-014-0560-Z.; Hedstrom CS., 2014, THESIS OREGON STATE; HOLLAY ME, 1987, ANN ENTOMOL SOC AM, V80, P212, DOI 10.1093/aesa/80.2.212; Hori K, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P11; HORI K, 1975, COMP BIOCHEM PHYSIOL, V50, P145, DOI 10.1016/0305-0491(75)90314-4; Huang TI, 2014, ARTHROPOD-PLANT INTE, V8, P89, DOI 10.1007/s11829-014-9289-0; Huang TI, 2013, J ECON ENTOMOL, V106, P1726, DOI 10.1603/EC13048; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; KASHIN P, 1966, J INSECT PHYSIOL, V12, P281, DOI 10.1016/0022-1910(66)90143-0; KASHIN P, 1965, NATURE, V208, P462, DOI 10.1038/208462a0; KESTER KM, 1984, ENTOMOL EXP APPL, V35, P75, DOI 10.1007/BF00343462; Krupke CH, 2006, ANN ENTOMOL SOC AM, V99, P169, DOI 10.1603/0013-8746(2006)099[0169:DPOECH]2.0.CO;2; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; LESKEY TC, 2012, PSYCHE STUTTG, V2012; LOCKWOOD JA, 1986, J ENTOMOL SCI, V21, P175, DOI 10.18474/0749-8004-21.2.175; LYE BH, 1988, J ECON ENTOMOL, V81, P189, DOI 10.1093/jee/81.1.189; MADHUSUDHAN VV, 1994, ANN APPL BIOL, V124, P405, DOI 10.1111/j.1744-7348.1994.tb04146.x; Martinson HM, 2013, ANN ENTOMOL SOC AM, V106, P47, DOI 10.1603/AN12088; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; McPherson JE., 2000, FLA ENTOMOL; Medrano EG, 2011, SOUTHWEST ENTOMOL, V36, P233, DOI 10.3958/059.036.0302; Medrano EG, 2009, CURR MICROBIOL, V59, P405, DOI 10.1007/s00284-009-9452-5; MILES PW, 1969, ENTOMOL EXP APPL, V12, P736, DOI 10.1007/BF00297100; Mitchell PL, 2004, NEOTROP ENTOMOL, V33, P519, DOI 10.1590/S1519-566X2004000500001; *NAT INSTR, 2009, DAQ M SER NI USB 621; *NAT INSTR, 2009, NI USB 621X SPEC; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Nielsen AL, 2011, ENVIRON ENTOMOL, V40, P231, DOI 10.1603/EN10187; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; PALUMBO JC, 2010, PLANT HLTH PROG; PANIZZI A, 2000, STINK BUGS PENTATOMI; Panizzi Antonio, 1995, Anais da Sociedade Entomologica do Brasil, V24, P437; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Peiffer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088483; R Core Team, 2021, R LANGUAGE ENV STAT; Ruberson JR, 2013, APPL ENTOMOL ZOOL, V48, P3, DOI 10.1007/s13355-012-0146-2; RYAN JA, 2012, XTS EXTENSIBLE TIME; SEVACHERIAN V, 1975, ANN ENTOMOL SOC AM, V68, P557, DOI 10.1093/aesa/68.3.557; Shearer PW, 1996, ENVIRON ENTOMOL, V25, P599, DOI 10.1093/ee/25.3.599; SHEARER PW, 2014, PACIFIC NW INSECT MA; SIMMONS AM, 1988, J ECON ENTOMOL, V81, P812, DOI 10.1093/jee/81.3.812; Son Y, 2012, ENVIRON ENTOMOL, V41, P1215, DOI 10.1603/EN11319; Suiter DR, 2010, J INTEGR PEST MANAG, V1, DOI 10.1603/IPM10009; Tjallingii W.F., 1988, P95; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; WALKER GP, 2000, P S 19 INT C ENT BEI; Watanabe Mamoru, 1994, Japanese Journal of Sanitary Zoology, V45, P311; Williams L, 2005, ARCH INSECT BIOCHEM, V58, P84, DOI 10.1002/arch.20035; Wiman NG, 2015, J PEST SCI, V88, P37, DOI 10.1007/s10340-014-0582-6; WOODSIDE AM, 1950, B VA AGR EXP STN, V435; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	78	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113514	10.1371/journal.pone.0113514	http://dx.doi.org/10.1371/journal.pone.0113514			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474148	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500083
J	Vadlamani, G; Thomas, MD; Patel, TR; Donald, LJ; Reeve, TM; Stetefeld, J; Standing, KG; Vocadlo, DJ; Mark, BL				Vadlamani, Grishma; Thomas, Misty D.; Patel, Trushar R.; Donald, Lynda J.; Reeve, Thomas M.; Stetefeld, Joerg; Standing, Kenneth G.; Vocadlo, David J.; Mark, Brian L.			The beta-Lactamase Gene Regulator AmpR Is a Tetramer That Recognizes and Binds the D-Ala-D-Ala Motif of Its Repressor UDP-N-acetylmuramic Acid (MurNAc)-pentapeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Mass Spectrometry (MS); Peptidoglycan; Small Angle X-ray Scattering (SAXS); Transcription; AmpC beta-Lactamase; AmpR; LysR-type Transcriptional Regulator	LYSR-TYPE REGULATOR; PSEUDOMONAS-AERUGINOSA; TRANSCRIPTIONAL REGULATOR; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENTEROBACTER-CLOACAE; MASS-SPECTROMETER; STRUCTURAL BASIS; ACTIVATION; INDUCTION	Background: Peptidoglycan metabolites regulate AmpR-mediated control of ampC -lactamase expression. Results: AmpR binds DNA as a tetramer and interacts with up to four copies of its repressor UDP-MurNAc-pentapeptide via its d-Ala-d-Ala motif. Conclusion: d-Ala-d-Ala recognition supports 1,6-anhydroMurNAc-pentapeptide as an AmpR activator, probably through competitive binding with UDP-MurNAc-pentapeptide. Significance: Understanding how peptidoglycan metabolites modulate AmpR provides insight into how -lactam classes differentially induce ampC expression. Inducible expression of chromosomal AmpC -lactamase is a major cause of -lactam antibiotic resistance in the Gram-negative bacteria Pseudomonas aeruginosa and Enterobacteriaceae. AmpC expression is induced by the LysR-type transcriptional regulator (LTTR) AmpR, which activates ampC expression in response to changes in peptidoglycan (PG) metabolite levels that occur during exposure to -lactams. Under normal conditions, AmpR represses ampC transcription by binding the PG precursor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide. When exposed to -lactams, however, PG catabolites (1,6-anhydroMurNAc-peptides) accumulate in the cytosol, which have been proposed to competitively displace UDP-MurNAc-pentapeptide from AmpR and convert it into an activator of ampC transcription. Here we describe the molecular interactions between AmpR (from Citrobacter freundii), its DNA operator, and repressor UDP-MurNAc-pentapeptide. Non-denaturing mass spectrometry revealed AmpR to be a homotetramer that is stabilized by DNA containing the T-N-11-A LTTR binding motif and revealed that it can bind four repressor molecules in an apparently stepwise manner. A crystal structure of the AmpR effector-binding domain bound to UDP-MurNAc-pentapeptide revealed that the terminal d-Ala-d-Ala motif of the repressor forms the primary contacts with the protein. This observation suggests that 1,6-anhydroMurNAc-pentapeptide may convert AmpR into an activator of ampC transcription more effectively than 1,6-anhydroMurNAc-tripeptide (which lacks the d-Ala-d-Ala motif). Finally, small angle x-ray scattering demonstrates that the AmpRDNA complex adopts a flat conformation similar to the LTTR protein AphB and undergoes only a slight conformational change when binding UDP-MurNAc-pentapeptide. Modeling the AmpRDNA tetramer bound to UDP-MurNAc-pentapeptide predicts that the UDP-MurNAc moiety of the repressor participates in modulating AmpR function.	[Vadlamani, Grishma; Thomas, Misty D.; Reeve, Thomas M.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Patel, Trushar R.; Donald, Lynda J.; Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Standing, Kenneth G.] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Simon Fraser University	Mark, BL (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.	brian.mark@umanitoba.ca	Stetefeld, Joerg/H-7630-2017; Patel, Trushar R/F-2776-2011; Vocadlo, David J/E-5508-2014; Patel, Trushar R./AAB-6250-2020	Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R/0000-0003-0627-2923; Vocadlo, David J/0000-0001-6897-5558; Patel, Trushar R./0000-0003-0627-2923; Vadlamani, Grishma/0000-0002-4198-6967; Mark, Brian/0000-0002-7344-1355	Canadian Institutes of Health Research (CIHR) [MOP-97818]; Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council; CIHR; University of Saskatchewan; Manitoba Research Chair award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; CIHR(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Manitoba Research Chair award	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-97818 and Cystic Fibrosis Canada grants (to B. L. M. and D. J. V.). The Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council, the CIHR, and the University of Saskatchewan.Recipient of a Manitoba Research Chair award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akakura R, 2002, J BIOL CHEM, V277, P5866, DOI 10.1074/jbc.M110555200; Alanazi AM, 2013, ACTA CRYSTALLOGR D, V69, P1995, DOI 10.1107/S0907444913017320; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Balasubramanian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034067; Balcewich MD, 2010, J MOL BIOL, V400, P998, DOI 10.1016/j.jmb.2010.05.040; BISHOP RE, 1993, EUR J BIOCHEM, V213, P405, DOI 10.1111/j.1432-1033.1993.tb17775.x; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Cheng QM, 2000, J BACTERIOL, V182, P4836, DOI 10.1128/JB.182.17.4836-4840.2000; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Devesse L, 2011, MOL MICROBIOL, V81, P354, DOI 10.1111/j.1365-2958.2011.07673.x; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; DONALD LJ, 2006, CELL BIOL LAB HDB, P457; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ezezika OC, 2007, ACTA CRYSTALLOGR F, V63, P361, DOI 10.1107/S1744309107019185; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; HOLTJE JV, 1994, FEMS MICROBIOL LETT, V122, P159, DOI 10.1111/j.1574-6968.1994.tb07159.x; HONORE N, 1986, EMBO J, V5, P3709, DOI 10.1002/j.1460-2075.1986.tb04704.x; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1995, MOL MICROBIOL, V15, P553, DOI 10.1111/j.1365-2958.1995.tb02268.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Juan C, 2006, ANTIMICROB AGENTS CH, V50, P1780, DOI 10.1128/AAC.50.5.1780-1787.2006; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Kaneko K, 2005, J CLIN MICROBIOL, V43, P2955, DOI 10.1128/JCM.43.6.2955-2958.2005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; KORAT B, 1991, MOL MICROBIOL, V5, P675, DOI 10.1111/j.1365-2958.1991.tb00739.x; Kozlovski VI, 2011, INT J MASS SPECTROM, V308, P118, DOI 10.1016/j.ijms.2011.08.009; Kuga A, 2000, ANTIMICROB AGENTS CH, V44, P561, DOI 10.1128/AAC.44.3.561-567.2000; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Loboda AV, 2000, RAPID COMMUN MASS SP, V14, P1047, DOI 10.1002/1097-0231(20000630)14:12<1047::AID-RCM990>3.0.CO;2-E; Lossl P, 2014, J AM SOC MASS SPECTR, V25, P906, DOI 10.1007/s13361-014-0874-3; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Momany C, 2012, MOL MICROBIOL, V83, P453, DOI 10.1111/j.1365-2958.2011.07960.x; Monferrer D, 2010, MOL MICROBIOL, V75, P1199, DOI 10.1111/j.1365-2958.2010.07043.x; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; ORR A, 1995, BIOTECHNIQUES, V19, P204; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PARSEK MR, 1994, J BIOL CHEM, V269, P11279; Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Porrua O, 2007, MOL MICROBIOL, V66, P410, DOI 10.1111/j.1365-2958.2007.05927.x; Ruangprasert A, 2010, J MOL BIOL, V404, P568, DOI 10.1016/j.jmb.2010.09.053; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Serdyuk I. N., 2007, METHODS MOL BIOPHYSI, P21; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor JL, 2012, MOL MICROBIOL, V83, P457, DOI 10.1111/j.1365-2958.2011.07919.x; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2002, J BACTERIOL, V184, P4233, DOI 10.1128/JB.184.15.4233-4239.2002; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Zhou XH, 2010, J MOL BIOL, V396, P1012, DOI 10.1016/j.jmb.2009.12.033	67	46	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2630	2643		10.1074/jbc.M114.618199	http://dx.doi.org/10.1074/jbc.M114.618199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25480792	Green Published, hybrid			2022-12-26	WOS:000349310700009
J	Shah, N; Colbert, KN; Enos, MD; Herschlag, D; Weis, WI				Shah, Niket; Colbert, Karen N.; Enos, Michael D.; Herschlag, Daniel; Weis, William I.			Three alpha SNAP and 10 ATP Molecules Are Used in SNARE Complex Disassembly by N-ethylmaleimide-sensitive Factor (NSF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN NSF; VESICULAR TRANSPORT; BACTERIOPHAGE-T4 FIBRITIN; ATTACHMENT PROTEINS; MEMBRANE-FUSION; DOMAIN; PARTICLES; STIMULATION	The fusion of intracellular membranes is driven by the formation of a highly stable four-helix bundle of SNARE proteins embedded in the vesicle and target membranes. N-Ethylmaleimide sensitive factor recycles SNAREs after fusion by binding to the SNARE complex through an adaptor protein, alpha SNAP, and using the energy of ATP hydrolysis to disassemble the complex. Although only a single molecule of alpha SNAP binds to a soluble form of the SNARE complex, we find that three molecules of alpha SNAP are used for SNARE complex disassembly. We describe an engineered alpha SNAP trimer that supports more efficient SNARE complex disassembly than monomeric alpha SNAP. Using the trimerized alpha SNAP, we find that N-ethylmaleimide-sensitive factor hydrolyzes 10 ATP molecules on average to disassemble a single SNARE complex.	[Shah, Niket; Colbert, Karen N.; Enos, Michael D.; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Shah, Niket; Colbert, Karen N.; Enos, Michael D.; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Enos, Michael/0000-0003-3208-7043	National Institutes of Health [R01 GM64798, R01 MH58570, T32 GM007276]; Canadian Institutes of Health Research Postdoctoral Fellowship; Stanford University Dean's Postdoctoral Fellowship; United States National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064798, T32GM007276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Stanford University Dean's Postdoctoral Fellowship; United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM64798 (to D. H.) and R01 MH58570 (to W. I. W.).; Supported by a Canadian Institutes of Health Research Postdoctoral Fellowship and a Stanford University Dean's Postdoctoral Fellowship.; Supported by a graduate fellowship from the United States National Science Foundation.; Supported by National Institutes of Health Training Grant T32 GM007276.	Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Buxbaum E, 1999, EUR J BIOCHEM, V265, P54, DOI 10.1046/j.1432-1327.1999.00643.x; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 2002, BIOCHEMISTRY-US, V41, P530, DOI 10.1021/bi015632s; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; MORGAN A, 1994, J BIOL CHEM, V269, P29347; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Papanikolopoulou K, 2004, J BIOL CHEM, V279, P8991, DOI 10.1074/jbc.M311791200; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1998, FEBS LETT, V423, P113, DOI 10.1016/S0014-5793(98)00072-6; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286	33	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2175	2188		10.1074/jbc.M114.620849	http://dx.doi.org/10.1074/jbc.M114.620849			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25492864	Green Published, hybrid			2022-12-26	WOS:000348588000022
J	Chen, L; Xu, M; Li, GY; Cai, WX; Zhou, JX				Chen, Lu; Xu, Ming; Li, Gui-Yun; Cai, Wei-Xin; Zhou, Jian-Xin			Incidence, Risk Factors and Consequences of Emergence Agitation in Adult Patients after Elective Craniotomy for Brain Tumor: A Prospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; DELIRIUM; ANESTHESIA; PAIN; SEDATION; OUTCOMES; DYSFUNCTION; EXTUBATION; SURGERY	Emergence agitation is a frequent complication that can have serious consequences during recovery from general anesthesia. However, agitation has been poorly investigated in patients after craniotomy. In this prospective cohort study, adult patients were enrolled after elective craniotomy for brain tumor. The sedation-agitation scale was evaluated during the first 12 hours after surgery. Agitation developed in 35 of 123 patients (29%). Of the agitated patients, 28 (80%) were graded as very and dangerously agitated. By multivariate stepwise logistic regression analysis, independent predictors for agitation included male sex, history of long-term use of anti-depressant drugs or benzodiazepines, frontal approach of the operation, method and duration of anesthesia and presence of endotracheal intubation. Total intravenous anesthesia and balanced anesthesia with short duration were protective factors. Emergence agitation was associated with self-extubation (8.6% vs 0%, P=50.005). Sedatives were administered more in agitated patients than non-agitated patients (85.7% vs 6.8%, P<0.001). In conclusion, emergence agitation was a frequent complication in patients after elective craniotomy for brain tumors. The clarification of risk factors could help to identify the high-risk patients, and then to facilitate the prevention and treatment of agitation. For patients undergoing craniotomy, greater attention should be paid to those receiving a frontal approach for craniotomy and those anesthetized under balanced anesthesia with long duration. More researches are warranted to elucidate whether total intravenous anesthesia could reduce the incidence of agitation after craniotomy.	[Chen, Lu; Xu, Ming; Li, Gui-Yun; Cai, Wei-Xin; Zhou, Jian-Xin] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Dept Crit Care Med, Beijing 100050, Peoples R China	Capital Medical University	Zhou, JX (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Dept Crit Care Med, Beijing 100050, Peoples R China.	zhoujx.cn@gmail.com	Chen, Lu/AAH-1632-2020	Chen, Lu/0000-0002-7512-1865				Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bruder N, 1999, J NEUROSURG ANESTH, V11, P282, DOI 10.1097/00008506-199910000-00009; Bruder Nicolas J, 2002, Curr Opin Anaesthesiol, V15, P477, DOI 10.1097/00001503-200210000-00001; Cai YH, 2013, J INT MED RES, V41, P208, DOI 10.1177/0300060513475964; Citerio G, 2012, EUR J ANAESTH, V29, P371, DOI 10.1097/EJA.0b013e32835422db; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gottschalk A, 2007, J NEUROSURG, V106, P210, DOI 10.3171/jns.2007.106.2.210; Himmelseher S, 2001, Curr Opin Anaesthesiol, V14, P483, DOI 10.1097/00001503-200110000-00004; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; Kim YS, 2012, KOREAN J ANESTHESIOL, V63, P48, DOI 10.4097/kjae.2012.63.1.48; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Liang C, 2014, J ANESTH; Liu GY, 2014, GENET MOL RES, V13, P9285, DOI 10.4238/2014.January.24.9; Manninen PH, 1999, CAN J ANAESTH, V46, P7, DOI 10.1007/BF03012507; Mordhorst C, 2010, J NEUROSURG ANESTH, V22, P202, DOI 10.1097/ANA.0b013e3181df0600; Nair S, 2011, BRIT J NEUROSURG, V25, P100, DOI 10.3109/02688697.2010.534199; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Radtke FM, 2010, MINERVA ANESTESIOL, V76, P394; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Rose D. Keith, 1996, Canadian Journal of Anaesthesia, V43, pR116; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Senanarong V, 2004, DEMENT GERIATR COGN, V17, P14, DOI 10.1159/000074080; Sessler CN, 2008, CRIT CARE, V12, DOI 10.1186/cc6148; Silverstein JH, 2007, ANESTHESIOLOGY, V106, P622, DOI 10.1097/00000542-200703000-00026; Tate JA, 2012, QUAL HEALTH RES, V22, P157, DOI 10.1177/1049732311421616; van den Boogaard M, 2012, INT J NURS STUD, V49, P775, DOI 10.1016/j.ijnurstu.2011.11.016; Vonder Haar C, 2013, BEHAV BRAIN RES, V240, P153, DOI 10.1016/j.bbr.2012.11.029; Whitlock EL, 2011, MINERVA ANESTESIOL, V77, P448; Woods JC, 2004, INTENS CARE MED, V30, P1066, DOI 10.1007/s00134-004-2193-9; Yu A, 2013, CRIT CARE MED, V41, P2002, DOI 10.1097/CCM.0b013e31828e96c0; Yu DH, 2010, CAN J ANESTH, V57, P843, DOI 10.1007/s12630-010-9338-9	31	23	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114239	10.1371/journal.pone.0114239	http://dx.doi.org/10.1371/journal.pone.0114239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493435	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400038
J	Gao, YJ; Yang, HW				Gao, YingJie; Yang, HongWei			A High-Order, Symplectic, Finite-Difference Time-Domain Scheme for Bioelectromagnetic Applications within the Mother/Fetus Model	PLOS ONE			English	Article							MAXWELLS EQUATIONS; ELECTROMAGNETIC-RADIATION; ABSORPTION RATE; SAR; INTEGRATORS; SCATTERING; DECOMPOSITION; PENETRATION	An explicit high-order, symplectic, finite-difference time-domain (SFDTD) scheme is applied to a bioelectromagnetic simulation using a simple model of a pregnant woman and her fetus. Compared to the traditional FDTD scheme, this scheme maintains the inherent nature of the Hamilton system and ensures energy conservation numerically and a high precision. The SFDTD scheme is used to predict the specific absorption rate (SAR) for a simple model of a pregnant female woman (month 9) using radio frequency (RF) fields from 1.5 Tand 3 T MRI systems (operating at approximately 64 and 128 MHz, respectively). The results suggest that by using a plasma protective layer under the 1.5 T MRI system, the SAR values for the pregnant woman and her fetus are significantly reduced. Additionally, for a 90 degree plasma protective layer, the SAR values are approximately equal to the 120 degree layer and the 180 degree layer, and it is reduced relative to the 60 degree layer. This proves that using a 90 degree plasma protective layer is the most effective and economical angle to use.	[Gao, YingJie; Yang, HongWei] Nanjing Agr Univ, Coll Sci, Dept Phys, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, HW (corresponding author), Nanjing Agr Univ, Coll Sci, Dept Phys, Nanjing, Jiangsu, Peoples R China.	phd_hwyang@aliyun.com						ANDERSON N, 1983, INT J ELECTRON, V54, P861, DOI 10.1080/00207218308938781; Chen YC, 2005, MULTIRESOLUTION TIME; Chin SA, 1997, PHYS LETT A, V226, P344, DOI 10.1016/S0375-9601(97)00003-0; Colak OH, 2008, MICROW OPT TECHN LET, V50, P1958, DOI 10.1002/mop.23535; Diot S, 2012, 1 ECCOMAS YOUNG INV, P24; Fang J., 1989, TIME DOMAIN FINITE D; Georgakopoulos SV, 2002, IEEE ANTENN PROPAG M, V44, P92, DOI 10.1109/MAP.2002.1003639; Georgakopoulos SV, 2002, IEEE ANTENN PROPAG M, V44, P134, DOI 10.1109/74.997945; Hirata A, 2011, PHYS MED BIOL, V56, P4091, DOI 10.1088/0031-9155/56/13/022; Hirono T, 1997, IEEE MICROW GUIDED W, V7, P279, DOI 10.1109/75.622539; Hirono T, 2001, IEEE T MICROW THEORY, V49, P1640, DOI 10.1109/22.942578; IEC Standard, 2004, MED EQ 2, P2; Kainz W, 2003, PHYS MED BIOL, V48, P2551, DOI 10.1088/0031-9155/48/15/319; Krumpholz M, 1996, IEEE T MICROW THEORY, V44, P555, DOI 10.1109/22.491023; Massoudi H, 1979, IEEE T MICROW THEORY, V27, P3251; Nakamura T, 1998, ELECTRON COMM JPN 1, V81, P71, DOI 10.1002/(SICI)1520-6424(199810)81:10<71::AID-ECJA8>3.0.CO;2-S; Nakamura T, 1998, ELECTRON COMM JPN 1, V81, P1, DOI 10.1002/(SICI)1520-6424(199810)81:10<1::AID-ECJA1>3.0.CO;2-D; Peter MC, 2011, COMMUNICATIONS APPL, V6, P1; Saidi F, 2008, MICROW OPT TECHN LET, V50, P1501, DOI 10.1002/mop.23406; Sha WEI, 2008, IEEE T ANTENN PROPAG, V56, P493, DOI 10.1109/TAP.2007.915444; Shao ZH, 2003, J COMPUT PHYS, V189, P427, DOI 10.1016/S0021-9991(03)00226-2; Shao ZH, 2003, IEEE T MICROW THEORY, V51, P856, DOI 10.1109/TMTT.2003.808627; SUZUKI M, 1992, PHYS LETT A, V165, P387, DOI 10.1016/0375-9601(92)90335-J; Togashi T, 2008, IEEE T MICROW THEORY, V56, P554, DOI 10.1109/TMTT.2007.914625; Turkel E, 1997, IEEE ANTENNAS AND PROPAGATION SOCIETY INTERNATIONAL SYMPOSIUM 1997, VOLS 1-4, P2156, DOI 10.1109/APS.1997.625395; Yano M, 2001, ELECTRON COMM JPN 1, V84, P57, DOI 10.1002/1520-6424(200104)84:4<57::AID-ECJA7>3.0.CO;2-J; YOSHIDA H, 1990, PHYS LETT A, V150, P262, DOI 10.1016/0375-9601(90)90092-3; Zhai PW, 2005, APPL OPTICS, V44, P1650, DOI 10.1364/AO.44.001650	28	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114425	10.1371/journal.pone.0114425	http://dx.doi.org/10.1371/journal.pone.0114425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493433	Green Published, Green Submitted, gold			2022-12-26	WOS:000346611400045
J	Kisonaite, M; Zubriene, A; Capkauskaite, E; Smirnov, A; Smirnoviene, J; Kairys, V; Michailoviene, V; Manakova, E; Grazulis, S; Matulis, D				Kisonaite, Migle; Zubriene, Asta; Capkauskaite, Edita; Smirnov, Alexey; Smirnoviene, Joana; Kairys, Visvaldas; Michailoviene, Vilma; Manakova, Elena; Grazulis, Saulius; Matulis, Daumantas			Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; FUNCTIONAL-GROUP CONTRIBUTIONS; LIGAND-BINDING; INHIBITORS; ENTHALPY; MODEL; NONADDITIVITY; COMPENSATION; RECOGNITION; PROTEINS	The early stage of drug discovery is often based on selecting the highest affinity lead compound. To this end the structural and energetic characterization of the binding reaction is important. The binding energetics can be resolved into enthalpic and entropic contributions to the binding Gibbs free energy. Most compound binding reactions are coupled to the absorption or release of protons by the protein or the compound. A distinction between the observed and intrinsic parameters of the binding energetics requires the dissection of the protonation/deprotonation processes. Since only the intrinsic parameters can be correlated with molecular structural perturbations associated with complex formation, it is these parameters that are required for rational drug design. Carbonic anhydrase (CA) isoforms are important therapeutic targets to treat a range of disorders including glaucoma, obesity, epilepsy, and cancer. For effective treatment isoform-specific inhibitors are needed. In this work we investigated the binding and protonation energetics of sixteen [(2-pyrimidinylthio)acetyl]benzenesulfonamide CA inhibitors using isothermal titration calorimetry and fluorescent thermal shift assay. The compounds were built by combining four sulfonamide headgroups with four tailgroups yielding 16 compounds. Their intrinsic binding thermodynamics showed the limitations of the functional group energetic additivity approach used in fragment-based drug design, especially at the level of enthalpies and entropies of binding. Combined with high resolution crystal structural data correlations were drawn between the chemical functional groups on selected inhibitors and intrinsic thermodynamic parameters of CA-inhibitor complex formation.	[Kisonaite, Migle; Zubriene, Asta; Capkauskaite, Edita; Smirnov, Alexey; Smirnoviene, Joana; Michailoviene, Vilma; Matulis, Daumantas] Vilnius State Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, LT-02241 Vilnius, Lithuania; [Kairys, Visvaldas] Vilnius State Univ, Inst Biotechnol, Dept Bioinformat, LT-02241 Vilnius, Lithuania; [Manakova, Elena; Grazulis, Saulius] Vilnius State Univ, Inst Biotechnol, Dept Prot DNA Interact, LT-02241 Vilnius, Lithuania	Vilnius University; Vilnius University; Vilnius University	Matulis, D (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Biothermodynam & Drug Design, Graiciuno 8, LT-02241 Vilnius, Lithuania.	matulis@ibt.lt	Smirnov, Alexey/AAB-2521-2020; Gražulis, Saulius/J-9056-2015; Smirnovienė, Joana/AAE-9067-2020; Kairys, Visvaldas/K-9893-2013; Matulis, Daumantas/F-9367-2010	Smirnov, Alexey/0000-0001-5361-8232; Gražulis, Saulius/0000-0002-7928-5218; Kairys, Visvaldas/0000-0002-5427-0175; Kisonaite, Migle/0000-0002-1348-154X; Matulis, Daumantas/0000-0002-6178-6276; Smirnoviene, Joana/0000-0001-5503-4775; Capkauskaite, Edita/0000-0003-4335-2981	Research Council of Lithuania [LIG-09/2012]; FP7-REGPOT-1 grant "MoBiLi'' [245721, TD0905, CM0804]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); FP7-REGPOT-1 grant "MoBiLi''	This research was funded by a grant from the Research Council of Lithuania (LIG-09/2012). Authors thank FP7-REGPOT-2009-1 grant "MoBiLi'' agreement No.: 245721, and the COST projects TD0905 and CM0804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2013, J ENZYM INHIB MED CH, V28, P267, DOI 10.3109/14756366.2012.737323; Alterio V, 2012, CHEM REV, V112, P4421, DOI 10.1021/cr200176r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Baranauskiene L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-12; Baranauskiene L, 2010, J ENZYM INHIB MED CH, V25, P863, DOI 10.3109/14756360903571685; Baum B, 2010, J MOL BIOL, V397, P1042, DOI 10.1016/j.jmb.2010.02.007; Biela A, 2012, CHEMMEDCHEM, V7, P1423, DOI 10.1002/cmdc.201200206; Capkauskaite E, 2013, BIOORGAN MED CHEM, V21, P6937, DOI 10.1016/j.bmc.2013.09.029; Capkauskaite E, 2012, EUR J MED CHEM, V51, P259, DOI 10.1016/j.ejmech.2012.02.050; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Domsic JF, 2008, J BIOL CHEM, V283, P30766, DOI 10.1074/jbc.M805353200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Garbett NC, 2012, EXPERT OPIN DRUG DIS, V7, P299, DOI 10.1517/17460441.2012.666235; Gitto R, 2010, J MED CHEM, V53, P2401, DOI 10.1021/jm9014026; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hassan MI, 2013, BIOORGAN MED CHEM, V21, P1570, DOI 10.1016/j.bmc.2012.04.044; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Jogaite V, 2013, BIOORGAN MED CHEM, V21, P1431, DOI 10.1016/j.bmc.2012.10.016; Kemp MM, 2012, BIOORGAN MED CHEM, V20, P1979, DOI 10.1016/j.bmc.2011.11.071; KHALIFAH RG, 1993, BIOCHEMISTRY-US, V32, P3058, DOI 10.1021/bi00063a017; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Klinger AL, 2006, J MED CHEM, V49, P3496, DOI 10.1021/jm058279n; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lopez M, 2010, J MED CHEM, V53, P2913, DOI 10.1021/jm901888x; Morkunaite V, 2015, J ENZYM INHIB MED CH, V30, P204, DOI 10.3109/14756366.2014.908291; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsson TSG, 2011, PROTEIN SCI, V20, P1607, DOI 10.1002/pro.692; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pilipuityte V, 2015, J MOL RECOGNIT, V28, P166, DOI 10.1002/jmr.2404; Reynolds CH, 2011, ACS MED CHEM LETT, V2, P433, DOI 10.1021/ml200010k; Rogez-Florent T, 2014, J MOL RECOGNIT, V27, P46, DOI 10.1002/jmr.2330; Ruben AJ, 2006, CHEM BIOL DRUG DES, V67, P2, DOI 10.1111/j.1747-0285.2005.00314.x; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Sudzius J, 2010, BIOORGAN MED CHEM, V18, P7413, DOI 10.1016/j.bmc.2010.09.011; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Whitesides GM, 2005, Q REV BIOPHYS, V38, P385, DOI 10.1017/S0033583506004240; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zubrien A, 2014, J ENZYM INHIB MED CH, V29, P124, DOI 10.3109/14756366.2012.757223	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114106	10.1371/journal.pone.0114106	http://dx.doi.org/10.1371/journal.pone.0114106			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493428	gold, Green Published, Green Submitted			2022-12-26	WOS:000346611400031
J	Shivaprakash, KN; Ramesha, BT; Shaanker, RU; Dayanandan, S; Ravikanth, G				Shivaprakash, K. Nagaraju; Ramesha, B. Thimmappa; Shaanker, Ramanan Uma; Dayanandan, Selvadurai; Ravikanth, Gudasalamani			Genetic Structure, Diversity and Long Term Viability of a Medicinal Plant, Nothapodytes nimmoniana Graham. (Icacinaceae), in Protected and Non-Protected Areas in the Western Ghats Biodiversity Hotspot	PLOS ONE			English	Article							TROPICAL TREE; FRAGMENTED POPULATIONS; MICROSATELLITE MARKERS; ALLELIC RICHNESS; AMERICAN GINSENG; BOTTLENECK; PROGRAM; FOREST; INDIA; FLOW	Background and Question: The harvesting of medicinal plants from wild sources is escalating in many parts of the world, compromising the long-term survival of natural populations of medicinally important plants and sustainability of sources of raw material to meet pharmaceutical industry needs. Although protected areas are considered to play a central role in conservation of plant genetic resources, the effectiveness of protected areas for maintaining medicinal plant populations subject to intense harvesting pressure remain largely unknown. We conducted genetic and demographic studies of Nothapodytes nimmoniana Graham, one of the extensively harvested medicinal plant species in the Western Ghats biodiversity hotspot, India to assess the effectiveness of protected areas in long-term maintenance of economically important plant species. Methodology/Principal Findings: The analysis of adults and seedlings of N. nimmoniana in four protected and four non-protected areas using 7 nuclear microsatellite loci revealed that populations that are distributed within protected areas are subject to lower levels of harvesting and maintain higher genetic diversity (H-e=0.816, H-o=0.607, A=18.857) than populations in adjoining non-protected areas (H-e=0.781, H-o=0.511, A=15.571). Furthermore, seedlings in protected areas had significantly higher observed heterozygosity (H-o=0.630) and private alleles as compared to seedlings in adjoining non-protected areas (H-o=0.426). Most populations revealed signatures of recent genetic bottleneck. The prediction of long-term maintenance of genetic diversity using BOTTLESIM indicated that current population sizes of the species are not sufficient to maintain 90% of present genetic diversity for next 100 years. Conclusions/Significance: Overall, these results highlight the need for establishing more protected areas encompassing a large number of adult plants in the Western Ghats to conserve genetic diversity of economically and medicinally important plant species.	[Shivaprakash, K. Nagaraju; Ramesha, B. Thimmappa; Shaanker, Ramanan Uma] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Shivaprakash, K. Nagaraju; Ramesha, B. Thimmappa; Shaanker, Ramanan Uma; Ravikanth, Gudasalamani] Univ Agr Sci, Sch Ecol & Conservat, Bangalore, Karnataka, India; [Shivaprakash, K. Nagaraju] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Shivaprakash, K. Nagaraju] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Shaanker, Ramanan Uma; Dayanandan, Selvadurai; Ravikanth, Gudasalamani] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India; [Shivaprakash, K. Nagaraju; Dayanandan, Selvadurai] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada	University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore; Concordia University - Canada; Concordia University - Canada	Shivaprakash, KN (corresponding author), Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India.	shiva216nagaraju@gmail.com; gravikanth@atree.org	G, Ravikanth/AAI-5668-2020	G, Ravikanth/0000-0002-9399-8580; Uma Shaanker, Ramanan/0000-0003-3100-7654	Department of Biotechnology, India; NSERC-Canada; Canadian Commonwealth Scholarships Program	Department of Biotechnology, India(Department of Biotechnology (DBT) India); NSERC-Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Commonwealth Scholarships Program	The work was supported by the following: Department of Biotechnology, India; NSERC-Canada; and Canadian Commonwealth Scholarships Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich PR, 1998, MOL ECOL, V7, P933, DOI 10.1046/j.1365-294x.1998.00396.x; Andrianoelina O, 2009, ANN BOT-LONDON, V104, P1231, DOI 10.1093/aob/mcp231; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Christine O, 2009, INT J FORESTRY RES; Chung MG, 2000, HEREDITY, V85, P490, DOI 10.1046/j.1365-2540.2000.00781.x; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cruse-Sanders JM, 2004, J HERED, V95, P309, DOI 10.1093/jhered/esh046; Dayanandan S, 1999, MOL ECOL, V8, P1585, DOI 10.1046/j.1365-294x.1999.00735.x; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Ganeshaiah KN, 1998, ECON BOT, V52, P316, DOI 10.1007/BF02862150; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gowda HCH, 2002, CURR SCI INDIA, V83, P1077; Guidugli MC, 2010, GENET MOL BIOL, V33, P131, DOI 10.1590/S1415-47572010000100022; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hundertmark KJ, 2010, CONSERV GENET, V11, P139, DOI 10.1007/s10592-009-0013-z; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kareem VKA, 2011, PLANT GENET RESOUR-C, V9, P506, DOI 10.1017/S1479262111000803; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kumar R, 2000, 100 RED LISTED MED P, P261; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lee CT, 2002, BIOL CONSERV, V104, P107, DOI 10.1016/S0006-3207(01)00159-8; Lemes MR, 2003, MOL ECOL, V12, P2845; Leroux SJ, 2010, BIOL CONSERV, V143, P609, DOI 10.1016/j.biocon.2009.11.018; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Loiselle BA, 1995, BIOTROPICA, V27, P487, DOI 10.2307/2388962; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nageswara Rao M, 2010, BIOREMEDIATION BIODI, V4, P69; Nageswara Rao M, 2001, FOREST GENETIC RESOU, P49; Nantel P, 1996, CONSERV BIOL, V10, P608, DOI 10.1046/j.1523-1739.1996.10020608.x; Ng KKS, 2006, TREE GENET GENOMES, V2, P121, DOI 10.1007/s11295-006-0035-3; Novick RR, 2003, MOL ECOL, V12, P2885, DOI 10.1046/j.1365-294X.2003.01951.x; NWDC (National Wildlife Database Centre), 1999, 1999 WILD LIF I INDI; Pearce F, 1997, NEW SCI, V15, P6; Pimbert M. P., 1997, SOCIAL CHANGE CONSER; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Ramesha BT, 2008, J CHROMATOGR SCI, V46, P362, DOI 10.1093/chromsci/46.4.362; Ramesha BT, 2007, J GENET, V86, P9, DOI 10.1007/s12041-007-0002-2; Ramesha BT, 2008, MOL ECOLOGY RESOURCE, V8, P365; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Ravikanth G, 2009, MANAGEMENT UTILIZATI, P53; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Savolainen O., 2000, Forest conservation genetics: principles and practice, P91, DOI 10.1079/9780851995045.0091; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; Shaanker R. Uma, 2008, P197, DOI 10.1007/978-3-540-74603-4_10; Shaanker RU, 2004, ENVIRON CONSERV, V31, P242, DOI 10.1017/S0376892904001596; Sharma MV, 2011, J PLANT ECOL, V4, P259, DOI 10.1093/jpe/rtq029; Sharma MV, 2010, CURR SCI INDIA, V99, P1444; Sheldon J.W., 1997, ADV EC BOT, VXII; Shivaprakash KN, 2011, THESIS U AGR SCI BAN; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SLATKIN M, 1995, GENETICS, V139, P457; Sork VL, 1999, TRENDS ECOL EVOL, V14, P219, DOI 10.1016/S0169-5347(98)01585-7; Tadwalkar MD, 2012, TROP ECOL, V53, P53; Thapa S, 2010, FOREST ECOL MANAG, V259, P641, DOI 10.1016/j.foreco.2009.11.023; Ved DK, 1997, AMRUTH, V1, P2; VRIJENHOEK RC, 1985, SCIENCE, V229, P400, DOI 10.1126/science.229.4711.400; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White GM, 1999, MOL ECOL, V8, P1899, DOI 10.1046/j.1365-294x.1999.00790.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Yamazaki Y, 2003, PHYTOCHEMISTRY, V62, P461, DOI 10.1016/S0031-9422(02)00543-5; Zucchi MI, 2003, GENET MOL BIOL, V26, P449, DOI 10.1590/S1415-47572003000400008	77	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e112769	10.1371/journal.pone.0112769	http://dx.doi.org/10.1371/journal.pone.0112769			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493426	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000346611400010
J	Burlakova, LE; Tulumello, BL; Karatayev, AY; Krebs, RA; Schloesser, DW; Paterson, WL; Griffith, TA; Scott, MW; Crail, T; Zanatta, DT				Burlakova, Lyubov E.; Tulumello, Brianne L.; Karatayev, Alexander Y.; Krebs, Robert A.; Schloesser, Donald W.; Paterson, Wendy L.; Griffith, Traci A.; Scott, Mariah W.; Crail, Todd; Zanatta, David T.			Competitive Replacement of Invasive Congeners May Relax Impact on Native Species: Interactions among Zebra, Quagga, and Native Unionid Mussels	PLOS ONE			English	Article							FRESH-WATER MUSSELS; LAKE ST-CLAIR; DREISSENA-POLYMORPHA PALLAS; GREAT-LAKES; COASTAL WETLAND; NORTH-AMERICA; LAWRENCE-RIVER; BIOCHEMICAL-COMPOSITION; BIVALVES UNIONIDAE; AMBLEMA PLICATA	Determining when and where the ecological impacts of invasive species will be most detrimental and whether the effects of multiple invaders will be superadditive, or subadditive, is critical for developing global management priorities to protect native species in advance of future invasions. Over the past century, the decline of freshwater bivalves of the family Unionidae has been greatly accelerated by the invasion of Dreissena. The purpose of this study was to evaluate the current infestation rates of unionids by zebra (Dreissena polymorpha) and quagga (D. rostriformis bugensis) mussels in the lower Great Lakes region 25 years after they nearly extirpated native unionids. In 2011-2012, we collected infestation data for over 4000 unionids from 26 species at 198 nearshore sites in lakes Erie, Ontario, and St. Clair, the Detroit River, and inland Michigan lakes and compared those results to studies from the early 1990s. We found that the frequency of unionid infestation by Dreissena recently declined, and the number of dreissenids attached to unionids in the lower Great Lakes has fallen almost ten-fold since the early 1990s. We also found that the rate of infestation depends on the dominant Dreissena species in the lake: zebra mussels infested unionids much more often and in greater numbers. Consequently, the proportion of infested unionids, as well as the number and weight of attached dreissenids were lower in waterbodies dominated by quagga mussels. This is the first large-scale systematic study that revealed how minor differences between two taxonomically and functionally related invaders may have large consequences for native communities they invade.	[Burlakova, Lyubov E.; Tulumello, Brianne L.; Karatayev, Alexander Y.; Paterson, Wendy L.] SUNY Buffalo, Great Lakes Ctr, Buffalo, NY 14260 USA; [Burlakova, Lyubov E.] SUNY Buffalo, Res Fdn, Off Sponsored Programs, Buffalo, NY USA; [Krebs, Robert A.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Schloesser, Donald W.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA; [Paterson, Wendy L.; Griffith, Traci A.; Scott, Mariah W.; Zanatta, David T.] Cent Michigan Univ, Inst Great Lakes Res, Dept Biol, Mt Pleasant, MI 48859 USA; [Crail, Todd] Univ Toledo, Lake Erie Ctr, Dept Environm Sci, Toledo, OH 43606 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Cleveland State University; United States Department of the Interior; United States Geological Survey; Central Michigan University; University System of Ohio; University of Toledo	Burlakova, LE (corresponding author), SUNY Buffalo, Great Lakes Ctr, Buffalo, NY 14260 USA.	burlakle@buffalostate.edu	Zanatta, David/AAR-6797-2020	Zanatta, David/0000-0002-3174-071X; Krebs, Robert/0000-0003-3384-5870; Burlakova, Lyubov/0000-0002-2995-919X	U.S. Fish and Wildlife Service (US FWS) via the Great Lakes Fish and Wildlife Restoration Act (GLFWRA) [30191-A-G152]; NSF URM award [0731582]; Research Foundation of SUNY	U.S. Fish and Wildlife Service (US FWS) via the Great Lakes Fish and Wildlife Restoration Act (GLFWRA); NSF URM award; Research Foundation of SUNY	Funding support came from the U.S. Fish and Wildlife Service (US FWS) via the Great Lakes Fish and Wildlife Restoration Act (GLFWRA, project #30191-A-G152). Support for B. Tulumello was also provided by an NSF URM award #0731582 to C. M. Pennuto (SUNY Buffalo State), and L. Burlakova was supported in part by Research Foundation of SUNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, conclusions, or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the view of GLFWRA, NSF, USGS, or SUNY RF.	Allen DC, 2009, J N AM BENTHOL SOC, V28, P93, DOI 10.1899/07-170.1; ARTER HE, 1989, AQUAT SCI, V51, P87, DOI 10.1007/BF00879296; Baker SM, 2008, AM MIDL NAT, V160, P20, DOI 10.1674/0003-0031(2008)160[20:ZMDPAT]2.0.CO;2; Baker SM, 1997, CAN J FISH AQUAT SCI, V54, P512, DOI 10.1139/cjfas-54-3-512; Baker SM, 2000, AM MIDL NAT, V143, P443, DOI 10.1674/0003-0031(2000)143[0443:PSABCO]2.0.CO;2; Baldwin BS, 2002, CAN J FISH AQUAT SCI, V59, P680, DOI 10.1139/F02-043; bij de Vaate A G Van der Velde R S E W Leuven K C M Heiler, 2014, QUAGGA ZEBRA MUSSELS, V2, P83, DOI [10.1201/b15437-11, DOI 10.1201/B15437-11]; Bodis E, 2014, BIOL INVASIONS, V16, P1373, DOI 10.1007/s10530-013-0575-z; BOGAN AE, 1993, AM ZOOL, V33, P599; Bogan AE, 2008, HYDROBIOLOGIA, V595, P139, DOI 10.1007/s10750-007-9011-7; Bowers R, 2005, HYDROBIOLOGIA, V545, P93, DOI 10.1007/s10750-005-2212-z; Bowers R, 2004, AM MIDL NAT, V151, P286, DOI 10.1674/0003-0031(2004)151[0286:EOHOUU]2.0.CO;2; Bowers RW, 2007, WETLANDS, V27, P203, DOI 10.1672/0277-5212(2007)27[203:FPOZMA]2.0.CO;2; Burlakova LE, 2000, INT REV HYDROBIOL, V85, P529, DOI 10.1002/1522-2632(200011)85:5/6<529::AID-IROH529>3.3.CO;2-F; Carlton JT, 2008, J GREAT LAKES RES, V34, P770, DOI 10.3394/0380-1330-34.4.770; Casper AF, 2010, J GREAT LAKES RES, V36, P184, DOI 10.1016/j.jglr.2009.10.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claxton WT, 1998, CAN J ZOOL, V76, P1269, DOI 10.1139/cjz-76-7-1269; Conn DB, 1993, 3RD P INT ZEBR MUSS, P223; Crail TD, 2011, J GREAT LAKES RES, V37, P199, DOI 10.1016/j.jglr.2010.12.006; Cummings KS, 1992, INHS MANUAL, V5; Diggins TP, 2004, BIOL INVASIONS, V6, P83, DOI 10.1023/B:BINV.0000010124.00582.d3; Dussart GBJ, 1966, LIMNOLOGIE; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fuller P, 2014, NONINDIGENOUS AQUATI; GILLIS PL, 1994, CAN J ZOOL, V72, P1260; Goodrich C, 1932, OCCAS PAP MUS ZOOL U, V238, P8; Gorley C.K., 2006, GETTING STARTED PRIM; Graf Daniel L., 2002, Occasional Papers on Mollusks Museum of Comparative Zoology Harvard University, V6, P175; GRIFFITHS RW, 1991, CAN J FISH AQUAT SCI, V48, P1381, DOI 10.1139/f91-165; Haag WR, 2012, NORTH AMERICAN FRESHWATER MUSSELS: NATURAL HISTORY, ECOLOGY, AND CONSERVATION, P1, DOI 10.1017/CBO9781139048217; HAAG WR, 1993, CAN J FISH AQUAT SCI, V50, P13, DOI 10.1139/f93-002; Hayes Keith R., 2003, P382; HEBERT PDN, 1989, CAN J FISH AQUAT SCI, V46, P1587, DOI 10.1139/f89-202; HEBERT PDN, 1991, CAN J ZOOL, V69, P405, DOI 10.1139/z91-063; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Hollandsworth D, 2011, AM MIDL NAT, V166, P369, DOI 10.1674/0003-0031-166.2.369; HUNTER RD, 1992, NAUTILUS, V106, P60; Karatayev AY, 2014, J GREAT LAKES RES, V40, P550, DOI 10.1016/j.jglr.2014.04.010; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Karatayev AY, 2010, J SHELLFISH RES, V29, P975, DOI 10.2983/035.029.0432; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Karatayev AY, 1998, J SHELLFISH RES, V17, P1219; Karatayev AY, 1997, J SHELLFISH RES, V16, P187; Karatayev AY, 2014, QUAGGA ZEBRA MUSSELS, P695; Karatayev VA, 2013, J GREAT LAKES RES, V39, P622, DOI 10.1016/j.jglr.2013.09.007; Keller RP, 2007, CONSERV BIOL, V21, P191, DOI 10.1111/j.1523-1739.2006.00563.x; Koehl MAR, 1996, ANNU REV ECOL SYST, V27, P501, DOI 10.1146/annurev.ecolsys.27.1.501; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; LEWANDOWSKI K, 1976, Polskie Archiwum Hydrobiologii, V23, P409; Lozano SJ, 2011, STATUS MACROINVERTEB, P1; Lucy F.E., 2014, QUAGGA ZEBRA MUSSELS, V2nd ed., P623; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; MACKIE GL, 1991, HYDROBIOLOGIA, V219, P251, DOI 10.1007/BF00024759; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGoldrick DJ, 2009, J GREAT LAKES RES, V35, P137, DOI 10.1016/j.jglr.2008.11.007; Metcalfe-Smith JL, 1998, J GREAT LAKES RES, V24, P845, DOI 10.1016/S0380-1330(98)70866-4; Mills EL, 2003, CAN J FISH AQUAT SCI, V60, P471, DOI 10.1139/F03-033; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Nalepa TF, 1996, J GREAT LAKES RES, V22, P354, DOI 10.1016/S0380-1330(96)70961-9; NALEPA TF, 1991, J GREAT LAKES RES, V17, P214, DOI 10.1016/S0380-1330(91)71358-0; NALEPA TF, 1994, CAN J FISH AQUAT SCI, V51, P2227, DOI 10.1139/f94-225; Nichols S. Jerrine, 1997, Journal of Shellfish Research, V16, P346; Nichols SJ, 1999, CAN J ZOOL, V77, P423, DOI 10.1139/cjz-77-3-423; Nichols SJ, 1997, NATURE, V389, P921, DOI 10.1038/40039; Patterson MWR, 2005, J GREAT LAKES RES, V31, P223, DOI 10.1016/S0380-1330(05)70316-6; Pennuto CM, 2012, J GREAT LAKES RES, V38, P161, DOI 10.1016/j.jglr.2012.04.002; Peyer SM, 2010, J EXP BIOL, V213, P2602, DOI 10.1242/jeb.042549; Peyer SM, 2009, J EXP BIOL, V212, P2026, DOI 10.1242/jeb.028688; Protasov Alexander A., 1994, Archiwum Rybactwa Polskiego, V2, P257; Rauschert ESJ, 2012, ECOL APPL, V22, P1413, DOI 10.1890/11-2107.1; RICCIARDI A, 1995, CAN J FISH AQUAT SCI, V52, P1449, DOI 10.1139/f95-140; Ricciardi A, 1996, CAN J FISH AQUAT SCI, V53, P1434, DOI 10.1139/cjfas-53-6-1434; Ricciardi A, 1995, CAN J FISH AQUAT SCI, V52, P2695, DOI 10.1139/f95-858; SCHLOESSER D W, 1991, Journal of Shellfish Research, V10, P355; Schloesser Don W., 1999, Northeastern Naturalist, V6, P341, DOI 10.2307/3858274; Schloesser DW, 2006, AM MIDL NAT, V155, P307, DOI 10.1674/0003-0031(2006)155[307:EOFMBU]2.0.CO;2; Schloesser DW, 1996, AM ZOOL, V36, P300; SCHLOESSER DW, 1994, CAN J FISH AQUAT SCI, V51, P2234, DOI 10.1139/f94-226; Schloesser DW, 1998, AM MIDL NAT, V140, P299, DOI 10.1674/0003-0031(1998)140[0299:IOZAQM]2.0.CO;2; SEBESTYEN O, 1938, VERH INT VER LIMNOL, V8, P169; Sherman JJ, 2013, J GREAT LAKES RES, V39, P201, DOI 10.1016/j.jglr.2013.03.001; Silayeva A. A., 2005, VESTNIK TYUMENSKOGO, V5, P112; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sousa R, 2011, FRESHWATER BIOL, V56, P867, DOI 10.1111/j.1365-2427.2010.02532.x; Spoo A, 2008, PEARLY MUSSELS PENNS; Strayer D. L., 2014, QUAGGA ZEBRA MUSSELS, P71; Strayer DL, 2007, J N AM BENTHOL SOC, V26, P111, DOI 10.1899/0887-3593(2007)26[111:EOZMDP]2.0.CO;2; Strayer DL, 2004, BIOSCIENCE, V54, P429, DOI 10.1641/0006-3568(2004)054[0429:CPOPMN]2.0.CO;2; Strayer DL, 1996, FRESHWATER BIOL, V36, P771; Strayer DL, 1999, J N AM BENTHOL SOC, V18, P74, DOI 10.2307/1468010; Strayer DL, 1997, NY STATE MUS MEM, V26; TUCKER JK, 1994, J FRESHWATER ECOL, V9, P129, DOI 10.1080/02705060.1994.9664439; Ward JM, 2007, DIVERS DISTRIB, V13, P155, DOI 10.1111/j.1472-4642.2007.00336.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Watkins JM, 2007, J GREAT LAKES RES, V33, P642, DOI 10.3394/0380-1330(2007)33[642:EFREOD]2.0.CO;2; Watters G.T., 2009, FRESHWATER MUSSELS O; Yang SA, 2011, AM NAT, V177, P110, DOI 10.1086/657433; Zanatta DT, 2002, J GREAT LAKES RES, V28, P479, DOI 10.1016/S0380-1330(02)70599-6; Zanatta DT, NE NAT IN PRESS; Zar J. H., 2010, BIOSTAT ANAL, V5th	102	27	30	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114926	10.1371/journal.pone.0114926	http://dx.doi.org/10.1371/journal.pone.0114926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490103	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300096
J	Grady, A; Bryant, J; Carey, M; Paul, C; Sanson-Fisher, R				Grady, Alice; Bryant, Jamie; Carey, Mariko; Paul, Chris; Sanson-Fisher, Rob			Enablers of the Implementation of Tissue Plasminogen Activator in Acute Stroke Care: A Cross-Sectional Survey	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; EVIDENCE-BASED GUIDELINES; EMERGENCY; THROMBOLYSIS; IMPROVE	Objective: To assess emergency physicians' perceptions of individual and system enablers to the use of tissue Plasminogen Activator in acute stroke. Method: Australian fellows and trainees of Australasian College for Emergency Medicine completed a 57-item online survey assessing enablers to implementation of evidence-based practice across six domains: knowledge, skills, modelling, monitoring, feedback, and maintenance. Demographic and workplace characteristics were obtained. Descriptive statistics were calculated to describe demographic and workplace characteristics of responders, and survey responses. Each domain received an overall score (%) based on the number of responders agreeing with all items within the domain. Results: A total of 429 (13%) Australasian College for Emergency Medicine members responded. 17.7% of respondents reported they and/or their workplace met all knowledge-related enablers, however only 2.3% had all skill-related enablers in place. Of respondents who decide which patients receive tissue Plasminogen Activator treatment, 18.1% agreed that all maintenance-related enablers are in place at their hospital, compared to 6.6% for those who do not decide which patients receive tissue Plasminogen Activator treatment. None of the respondents had all items in place cross all domains. Conclusions: Even when allowing for the low response rate, it seems likely there is a lack of individual and system enablers supporting the implementation of best-practice stroke care in a number of Australian hospitals. Quality improvement programs could target all domains, particularly the skills-training and feedback emergency physicians receive, to aid implementation of tissue Plasminogen Activator treatment for acute stroke.	[Grady, Alice; Bryant, Jamie; Carey, Mariko; Paul, Chris; Sanson-Fisher, Rob] Univ Newcastle, Prior Res Ctr Hlth Behav, Hunter Med Res Inst, Callaghan, NSW 2308, Australia	Hunter Medical Research Institute; University of Newcastle	Grady, A (corresponding author), Univ Newcastle, Prior Res Ctr Hlth Behav, Hunter Med Res Inst, Callaghan, NSW 2308, Australia.	alice.grady@newcastle.edu.au	Bryant, Jamie/G-8000-2013; CAREY, MARIKO/ABC-2842-2021	Bryant, Jamie/0000-0001-9378-5852; CAREY, MARIKO/0000-0002-0549-1115; Sanson-Fisher, Rob/0000-0001-6022-2949	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: CP and RSF have received a financial contribution from Boehringer Ingelheim towards an National Health and Medical Research Council-funded trial. AG, JB and MC have no competing interests to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asch SM, 2005, MED CARE, V43, P667, DOI 10.1097/01.mlr.0000167182.72251.a1; BANDURA A, 1986, SOC FDN THOUGHT ACTI; Bartlett J, 2002, INT J QUAL HEALTH C, V14, P463, DOI 10.1093/intqhc/14.6.463; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Carey M, 2009, INT J QUAL HEALTH C, V21, P37, DOI 10.1093/intqhc/mzn049; Couzigou C, 2005, J HOSP INFECT, V59, P197, DOI 10.1016/j.jhin.2004.09.013; Durieux P, 2000, JAMA-J AM MED ASSOC, V283, P2816, DOI 10.1001/jama.283.21.2816; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Gleitman H., 1991, PSYCHOLOGY; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Grol R, 2005, IMPROVING PATIENT CA, P1; Grol R., 2005, IMPROV PATIENT CARE, V41, P57; Hamidon BB, 2007, J CLIN NEUROSCI, V14, P831, DOI 10.1016/j.jocn.2006.03.029; Intercollegiate Stroke Working Party, 2011, NAT SENT STROK AUD; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Marinopoulos Spyridon S, 2007, Evid Rep Technol Assess (Full Rep), P1; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Stroke Foundation, 2013, NAT STROK AUD AC SER; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Schwamm LH, 2013, CIRC-CARDIOVASC QUAL, V6, P543, DOI 10.1161/CIRCOUTCOMES.111.000303; Shiffman Richard N, 2005, BMC Med Inform Decis Mak, V5, P23, DOI 10.1186/1472-6947-5-23; Slade D, 2008, DISCOURSE COMMUN, V2, P271, DOI 10.1177/1750481308091910; van Wijngaarden JDH, 2009, STROKE, V40, P3390, DOI 10.1161/STROKEAHA.109.559492; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7	33	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114778	10.1371/journal.pone.0114778	http://dx.doi.org/10.1371/journal.pone.0114778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490546	Green Published, gold			2022-12-26	WOS:000347515300079
J	Zhu, YQ; Zhou, SL; Gao, G; Zou, HX; Lei, L				Zhu, Youqing; Zhou, Shilin; Gao, Gui; Zou, Huanxin; Lei, Lin			Extended Emitter Target Tracking Using GM-PHD Filter	PLOS ONE			English	Article							MULTITARGET TRACKING	If equipped with several radar emitters, a target will produce more than one measurement per time step and is denoted as an extended target. However, due to the requirement of all possible measurement set partitions, the exact probability hypothesis density filter for extended target tracking is computationally intractable. To reduce the computational burden, a fast partitioning algorithm based on hierarchy clustering is proposed in this paper. It combines the two most similar cells to obtain new partitions step by step. The pseudo-likelihoods in the Gaussian-mixture probability hypothesis density filter can then be computed iteratively. Furthermore, considering the additional measurement information from the emitter target, the signal feature is also used in partitioning the measurement set to improve the tracking performance. The simulation results show that the proposed method can perform better with lower computational complexity in scenarios with different clutter densities.	[Zhu, Youqing; Zhou, Shilin; Gao, Gui; Zou, Huanxin; Lei, Lin] Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Zhu, YQ (corresponding author), Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China.	zhu_youqing@163.com						Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Gilholm K, 2005, PROC SPIE, V5913, DOI 10.1117/12.618730; Granstrom K., 2010, 2010 13 INT C INFORM, P1, DOI DOI 10.1109/ICIF.2010.5711885; Granstrom K, 2012, IEEE T AERO ELEC SYS, V48, P3268, DOI 10.1109/TAES.2012.6324703; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Li WL, 2014, SIGNAL PROCESS, V94, P48, DOI 10.1016/j.sigpro.2013.06.012; Li WL, 2013, SIGNAL PROCESS, V93, P86, DOI 10.1016/j.sigpro.2012.06.030; Li WL, 2011, SIGNAL PROCESS, V91, P1036, DOI 10.1016/j.sigpro.2010.08.004; Liu J, 2005, IEEE T PATTERN ANAL, V27, P1185, DOI 10.1109/TPAMI.2005.166; Mahler R, 2009, FUSION: 2009 12TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION, VOLS 1-4, P915; Mahler RPS, 2003, IEEE T AERO ELEC SYS, V39, P1152, DOI 10.1109/TAES.2003.1261119; Orguner U., 2011, 14 INT C INFORM FUSI, P65; Panta K, 2009, IEEE T AERO ELEC SYS, V45, P1003, DOI 10.1109/TAES.2009.5259179; Schuhmacher D, 2008, IEEE T SIGNAL PROCES, V56, P3447, DOI 10.1109/TSP.2008.920469; Shieh CS, 2002, IEEE T ANTENN PROPAG, V50, P1120, DOI 10.1109/TAP.2002.801387; Spezio AE, 2002, IEEE T MICROW THEORY, V50, P633, DOI 10.1109/22.989948; Vo BN, 2006, IEEE T SIGNAL PROCES, V54, P4091, DOI 10.1109/TSP.2006.881190; Vo BN, 2005, IEEE T AERO ELEC SYS, V41, P1224, DOI 10.1109/TAES.2005.1561884; Yin JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085884; Zhang YQ, 2013, SIGNAL PROCESS, V93, P2975, DOI 10.1016/j.sigpro.2013.04.006; Zhou XL, 2014, SIGNAL PROCESS, V94, P650, DOI 10.1016/j.sigpro.2013.08.002	22	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114317	10.1371/journal.pone.0114317	http://dx.doi.org/10.1371/journal.pone.0114317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490206	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300027
J	He, YY; Chen, ZY; Liu, XL; Wang, CW; Lu, W				He, Yuyong; Chen, Zhiyu; Liu, Xiaolan; Wang, Chengwei; Lu, Wei			Influence of Trace Elements Mixture on Bacterial Diversity and Fermentation Characteristics of Liquid Diet Fermented with Probiotics under Air-Tight Condition	PLOS ONE			English	Article							LACTIC ACID PRODUCTION; COMPOSITE ANTIMICROBIAL PEPTIDES; BACILLUS-SUBTILIS SPORES; GROWTH-PERFORMANCE; FEED; SUPPLEMENTATION; MICROBIOTA; TOXICITY; IODINE; ZINC	Cu2+, Zn2+, Fe2+ and I- are often supplemented to the diet of suckling and early weaning piglets, but little information is available regarding the effects of different Cu2+, Zn2+, Fe2+ and I- mixtures on bacteria growth, diversity and fermentation characteristics of fermented liquid diet for piglets. Pyrosequencing was performed to investigate the effect of Cu2+, Zn2+, Fe2+ and I- mixtures on the diversity, growth and fermentation characteristics of bacteria in the liquid diet fermented with Bacillus subtilis and Enterococcus faecalis under air-tight condition. Results showed that the mixtures of Cu2+, Zn2+, Fe2+ and I- at different concentrations promoted Bacillus growth, increased bacterial diversity and lactic acid production and lowered pH to about 5. The importance of Cu2+, Zn2+, Fe2+ and I- is different for Bacillus growth with the order Zn2+. Fe2+. Cu2+. I- in a 21-d fermentation and Cu2+. I-. Fe2+. Zn2+ in a 42-d fermentation. Cu2+, Zn2+, Fe2+ and I- is recommended at a level of 150, 60, 150 and 0.6 mg/kg respectively for the production of fermented liquid diet with Bacillus subtilis. The findings improve our understanding of the influence of trace elements on liquid diet fermentation with probiotics and support the proper use of trace elements in the production of fermented liquid diet for piglets.	[He, Yuyong; Chen, Zhiyu; Liu, Xiaolan; Lu, Wei] Jiangxi Agr Univ, Jiangxi Prov Key Lab Anim Nutr, Nanchang, Peoples R China; [Wang, Chengwei] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Science & Technology Normal University	Lu, W (corresponding author), Jiangxi Agr Univ, Jiangxi Prov Key Lab Anim Nutr, Nanchang, Peoples R China.	lw20030508@163.com			Program for Key Science & Technology in Jiangxi Province [20121BBF60032, 20132BBF60039]	Program for Key Science & Technology in Jiangxi Province	This research was funded by Program for Key Science & Technology in Jiangxi Province (20121BBF60032, 20132BBF60039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; BLOOMFIELD SF, 1994, J APPL BACTERIOL, V76, P492, DOI 10.1111/j.1365-2672.1994.tb01107.x; BOYAVAL P, 1989, LAIT, V69, P87, DOI 10.1051/lait:198927; Budhavaram NK, 2009, BIORESOURCE TECHNOL, V100, P5966, DOI 10.1016/j.biortech.2009.01.080; Canibe N, 2007, ANIM FEED SCI TECH, V134, P108, DOI 10.1016/j.anifeedsci.2006.05.005; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Djukic-Vukovic AP, 2012, FOOD CHEM, V134, P1038, DOI 10.1016/j.foodchem.2012.03.011; EDWARDS JL, 1965, APPL MICROBIOL, V13, P851, DOI 10.1128/AEM.13.6.851-857.1965; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gao T, 2012, BIORESOURCE TECHNOL, V121, P105, DOI 10.1016/j.biortech.2012.06.108; Geary TM, 1999, J SCI FOOD AGR, V79, P633, DOI 10.1002/(SICI)1097-0010(19990315)79:4&lt;633::AID-JSFA231&gt;3.0.CO;2-L; Guan S, 2011, WORLD MYCOTOXIN J, V4, P413, DOI 10.3920/WMJ2011.1290; Guan S, 2011, J FOOD AGRIC ENVIRON, V9, P163; Hojberg O, 2003, APPL ENVIRON MICROB, V69, P408, DOI 10.1128/AEM.69.1.408-418.2003; Hyronimus B, 1998, J APPL MICROBIOL, V85, P42, DOI 10.1046/j.1365-2672.1998.00466.x; Jin B, 2001, J CHEM TECHNOL BIOT, V76, P1041, DOI 10.1002/jctb.486; Lee AJ, 2011, INT J FOOD SCI TECH, V46, P1494, DOI 10.1111/j.1365-2621.2011.02644.x; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Michelson T, 2006, ENZYME MICROB TECH, V39, P861, DOI 10.1016/j.enzmictec.2006.01.015; Mikkelsen L. L., 2000, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V70, P919; Missotten JAM, 2010, ARCH ANIM NUTR, V64, P437, DOI 10.1080/1745039X.2010.512725; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Naughton PJ, 2001, BERL MUNCH TIERARZTL, V114, P378; Ohara H, 1996, J FERMENT BIOENG, V81, P272, DOI 10.1016/0922-338X(96)82222-7; Otludil B, 2005, BIOTECHNOL BIOTEC EQ, V19, P105, DOI [10.1080/13102818.2005.10817199, DOI 10.1080/13102818.2005.10817199]; Rathnayake I.V.N., 2010, INT J ENV ENG, V2, P191, DOI [10.5281/zenodo.1071334., DOI 10.5281/ZENODO.1071334]; Robina Ali, 2012, International Journal of Veterinary Science, V1, P98; Romero-Garcia S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-23; Russell JB, 1998, ADV MICROB PHYSIOL, V39, P205; Russell PJ, 1996, J SCI FOOD AGR, V72, P8, DOI 10.1002/(SICI)1097-0010(199609)72:1&lt;8::AID-JSFA646&gt;3.0.CO;2-K; Scholten RHJ, 2002, J ANIM SCI, V80, P1179; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Spilimbergo S., 2003, Innovative Food Science & Emerging Technologies, V4, P161, DOI 10.1016/S1466-8564(02)00089-9; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van Winsen RL, 2001, APPL ENVIRON MICROB, V67, P3071, DOI 10.1128/AEM.67.7.3071-3076.2001; Wang SP, 2011, J FOOD AGRIC ENVIRON, V9, P181; Watanabe K, 2009, WORLD J MICROB BIOT, V25, P803, DOI 10.1007/s11274-008-9952-7; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069502; Xiao H, 2013, J ANIM SCI, V91, P4750, DOI 10.2527/jas.2013-6427; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Zhao D, 2013, APPL MICROBIOL BIOT, V97, P2173, DOI 10.1007/s00253-012-4043-y; Zhao X, 2013, APPL MICROBIOL BIOT, V97, P6477, DOI 10.1007/s00253-013-4970-2	48	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114218	10.1371/journal.pone.0114218	http://dx.doi.org/10.1371/journal.pone.0114218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486254	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600047
J	Wilberts, BL; Arruda, PH; Kinyon, JM; Frana, TS; Wang, C; Magstadt, DR; Madson, DM; Patience, JF; Burrough, ER				Wilberts, Bailey L.; Arruda, Paulo H.; Kinyon, Joann M.; Frana, Tim S.; Wang, Chong; Magstadt, Drew R.; Madson, Darin M.; Patience, John F.; Burrough, Eric R.			Investigation of the Impact of Increased Dietary Insoluble Fiber through the Feeding of Distillers Dried Grains with Solubles (DDGS) on the Incidence and Severity of Brachyspira-Associated Colitis in Pigs	PLOS ONE			English	Article							SWINE-DYSENTERY; SERPULINA-HYODYSENTERIAE; EXPERIMENTAL-INFECTION; GROWING PIGS; EXPRESSION; HAMPSONII; IDENTIFICATION; DIGESTIBILITY; FERMENTATION; INOCULATION	Diet has been implicated as a major factor impacting clinical disease expression of swine dysentery and Brachyspira hyodysenteriae colonization. However, the impact of diet on novel pathogenic strongly beta-hemolytic Brachyspira spp. including "B. hampsonii" has yet to be investigated. In recent years, distillers dried grains with solubles (DDGS), a source of insoluble dietary fiber, has been increasingly included in diets of swine. A randomized complete block experiment was used to examine the effect of increased dietary fiber through the feeding of DDGS on the incidence of Brachyspira-associated colitis in pigs. One hundred 4-week-old pigs were divided into five groups based upon inocula (negative control, Brachyspira intermedia, Brachyspira pilosicoli, B. hyodysenteriae or "B. hampsonii'') and fed one of two diets containing no (diet 1) or 30% (diet 2) DDGS. The average days to first positive culture and days post inoculation to the onset of clinical dysentery in the B. hyodysenteriae groups was significantly shorter for diet 2 when compared to diet 1 (P=0.04 and P=0.0009, respectively). A similar difference in the average days to first positive culture and days post inoculation to the onset of clinical dysentery was found when comparing the "B. hampsonii'' groups. In this study, pigs receiving 30% DDGS shed on average one day prior to and developed swine dysentery nearly twice as fast as pigs receiving 0% DDGS. Accordingly, these data suggest a reduction in insoluble fiber through reducing or eliminating DDGS in swine rations should be considered an integral part of any effective disease elimination strategy for swine dysentery.	[Wilberts, Bailey L.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA 50011 USA; [Arruda, Paulo H.; Kinyon, Joann M.; Frana, Tim S.; Wang, Chong; Magstadt, Drew R.; Madson, Darin M.; Burrough, Eric R.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Patience, John F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University	Burrough, ER (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, 1600 S 16th St, Ames, IA 50011 USA.	burrough@iastate.edu	Patience, john F./A-2935-2009; Wang, Chong/AAI-3796-2020	Wang, Chong/0000-0003-4489-4344; Burrough, Eric/0000-0003-4747-9189	Innovative Swine Industry Enhancement Grant Program	Innovative Swine Industry Enhancement Grant Program	Funding: This work was supported by a grant from the Innovative Swine Industry Enhancement Grant Program administered by the Iowa Attorney General's Office. The funding source had no involvement in data collection, analysis and interpretation of data, writing the report, and decision to submit the article for publication.	Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Burrough ER, 2012, J VET DIAGN INVEST, V24, P1025, DOI 10.1177/1040638712457927; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DREAU D, 1994, J ANIM SCI, V72, P2090, DOI 10.2527/1994.7282090x; Durmic Z, 2000, J APPL MICROBIOL, V89, P678, DOI 10.1046/j.1365-2672.2000.01166.x; Hampson DJ, 2012, DIS SWINE, P680; Hansen CF, 2010, J ANIM SCI, V88, P3327, DOI 10.2527/jas.2009-2719; Hansen CF, 2011, BRIT J NUTR, V106, P1506, DOI 10.1017/S000711451100208X; HARRIS DL, 1972, VET MED SM ANIM CLIN, V67, P61; Huisman J., 1991, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V61, P901; Kennedy MJ, 1996, VET MICROBIOL, V49, P21, DOI 10.1016/0378-1135(95)00174-3; Kirkwood RN, 2000, SWINE HEALTH PROD, V8, P73; Klose V, 2010, J APPL MICROBIOL, V108, P1271, DOI 10.1111/j.1365-2672.2009.04521.x; Leser TD, 2000, APPL ENVIRON MICROB, V66, P3290, DOI 10.1128/AEM.66.8.3290-3296.2000; Lindecrona RH, 2003, ANIM SCI, V76, P81, DOI 10.1017/S1357729800053340; Molbak L, 2007, J APPL MICROBIOL, V103, P1853, DOI 10.1111/j.1365-2672.2007.03430.x; Montagne L, 2004, NUTR REV, V62, P105, DOI [10.1301/nr.2004.mar.105-114, 10.1111/j.1753-4887.2004.tb00031.x]; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Pluske JR, 1998, J NUTR, V128, P1737, DOI 10.1093/jn/128.10.1737; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Rubin JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057146; SchmidtWittig U, 1996, ANN NUTR METAB, V40, P343, DOI 10.1159/000177936; Siba PM, 1996, EPIDEMIOL INFECT, V116, P207, DOI 10.1017/S0950268800052456; Thomsen LE, 2007, VET MICROBIOL, V119, P152, DOI 10.1016/j.vetmic.2006.09.004; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; Urriola PE, 2010, J ANIM SCI, V88, P2373, DOI 10.2527/jas.2009-2227; Urriola PE, 2010, J ANIM SCI, V88, P1454, DOI 10.2527/jas.2009-2162; Warneke HL, 2014, J VET DIAGN INVEST, V26, P635, DOI 10.1177/1040638714541114; Wilberts BL, 2014, VET PATHOL, V51, P1096, DOI 10.1177/0300985813516646; Zijlstra RT, 2012, J ANIM SCI, V90, P49, DOI 10.2527/jas.53718	33	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114741	10.1371/journal.pone.0114741	http://dx.doi.org/10.1371/journal.pone.0114741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485776	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600094
J	Bartolo, I; Zakovic, S; Martin, F; Palladino, C; Carvalho, P; Camacho, R; Thamm, S; Clemente, S; Taveira, N				Bartolo, Ines; Zakovic, Suzana; Martin, Francisco; Palladino, Claudia; Carvalho, Patricia; Camacho, Ricardo; Thamm, Sven; Clemente, Sofia; Taveira, Nuno			HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESOURCE-LIMITED SETTINGS; RITONAVIR-BASED REGIMENS; NON-B INFECTIONS; ANTIRETROVIRAL TREATMENT; SUBTYPE C; VIROLOGICAL RESPONSE; NAIVE INDIVIDUALS; GENETIC DIVERSITY; SOUTH-AFRICA	Objectives: To assess HIV-1 diversity, transmission dynamics and prevalence of transmitted drug resistance (TDR) in Angola, five years after ART scale-up. Methods: Population sequencing of the pol gene was performed on 139 plasma samples collected in 2009 from drug-naive HIV-1 infected individuals living in Luanda. HIV-1 subtypes were determined using phylogenetic analysis. Drug resistance mutations were identified using the Calibrated Population Resistance Tool (CPR). Transmission networks were determined using phylogenetic analysis of all Angolan sequences present in the databases. Evolutionary trends were determined by comparison with a similar survey performed in 2001. Results: 47.1% of the viruses were pure subtypes (all except B), 47.1% were recombinants and 5.8% were untypable. The prevalence of subtype A decreased significantly from 2001 to 2009 (40.0% to 10.8%, P=0.0019) while the prevalence of unique recombinant forms (URFs) increased > 2-fold (40.0% to 83.1%, P < 0.0001). The most frequent URFs comprised untypable sequences with subtypes H (U/H, n=7, 10.8%), A (U/A, n=6, 9.2%) and G (G/U, n=4, 6.2%). Newly identified U/H recombinants formed a highly supported monophyletic cluster suggesting a local and common origin. TDR mutation K103N was found in one (0.7%) patient (1.6% in 2001). Out of the 364 sequences sampled for transmission network analysis, 130 (35.7%) were part of a transmission network. Forty eight transmission clusters were identified; the majority (56.3%) comprised sequences sampled in 2008-2010 in Luanda which is consistent with a locally fuelled epidemic. Very low genetic distance was found in 27 transmission pairs sampled in the same year, suggesting recent transmission events. Conclusions: Transmission of drug resistant strains was still negligible in Luanda in 2009, five years after the scale-up of ART. The dominance of small and recent transmission clusters and the emergence of new URFs are consistent with a rising HIV-1 epidemics mainly driven by heterosexual transmission.	[Bartolo, Ines; Martin, Francisco; Palladino, Claudia; Taveira, Nuno] Univ Lisbon, Fac Farm, Ctr Patogenese Mol, Unidade Retrovius & Infeccoes Associadas, P-1699 Lisbon, Portugal; [Bartolo, Ines; Martin, Francisco; Palladino, Claudia; Taveira, Nuno] Univ Lisbon, Fac Farm, Inst Invest Medicamento iMed ULisboa, P-1699 Lisbon, Portugal; [Bartolo, Ines; Zakovic, Suzana; Martin, Francisco; Taveira, Nuno] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, Monte De Caparica, Portugal; [Carvalho, Patricia; Camacho, Ricardo] Hosp Egas Moniz, Ctr Hosp Lisboa Ocidental, Mol Biol Lab, Lisbon, Portugal; [Camacho, Ricardo] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Thamm, Sven] Abbott GmbH & Co KG, Wiesbaden, Germany; [Clemente, Sofia] Hosp Divina Providencia, Serv Doencas Infecciosas, Luanda, Angola	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade de Lisboa; KU Leuven; ABBOTT GMBH & CO. KG	Taveira, N (corresponding author), Univ Lisbon, Fac Farm, Ctr Patogenese Mol, Unidade Retrovius & Infeccoes Associadas, P-1699 Lisbon, Portugal.	ntaveira@ff.ul.pt	iMed.ULisboa, EEPHIV/B-4222-2014; Taveira, Nuno C/A-6252-2014; Carvalho, Patrícia Sousa Vindeirinho Albuquerque/HCI-2410-2022; Bártolo, Inês/A-7477-2014; Camacho, Ricardo J/I-7629-2012; Palladino, Claudia/E-2523-2014	Taveira, Nuno C/0000-0003-0176-5585; Bártolo, Inês/0000-0002-2022-8921; Camacho, Ricardo J/0000-0002-9129-3237; Palladino, Claudia/0000-0002-8148-0928	Fundacao para a Ciencia e Tecnologia (FCT), Portugal ["PTDC/SAU-FAR/115290/2009", "PTDC/SAU-EPI/122400/2010", SFRH/BPD/76225/2011, SFRH/BD/87488/2012, SFRH/BPD/77448/2011]; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union; European Union studentship from the Erasmus Mundus Masters in Forensic Sciences; Fundação para a Ciência e a Tecnologia [PTDC/SAU-EPI/122400/2010, PTDC/SAU-FAR/115290/2009] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union; European Union studentship from the Erasmus Mundus Masters in Forensic Sciences; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT) http://www.fct.pt), Portugal, (grants "PTDC/SAU-FAR/115290/2009" and "PTDC/SAU-EPI/122400/2010"), and by Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), from the European Union. Ines Bartolo was supported by a post-doc fellowship (SFRH/BPD/76225/2011) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. Suzana Zakovic was supported by a European Union studentship from the Erasmus Mundus Masters in Forensic Sciences (http://forensicerasmusmundus.blogs.lincoln.ac.uk/). Francisco Martin was supported by a PhD fellowship (SFRH/BD/87488/2012) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. Claudia Palladino was supported by a post-doc fellowship (SFRH/BPD/77448/2011) from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis A., 2005, Infection Genetics and Evolution, V5, P231, DOI 10.1016/j.meegid.2004.07.007; Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Castelbranco EPAF, 2010, AIDS RES HUM RETROV, V26, P1313, DOI 10.1089/aid.2010.0111; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Bartolo I, 2005, AIDS RES HUM RETROV, V21, P306, DOI 10.1089/aid.2005.21.306; Bartolo I, 2012, GENETIC DIVERSITY IN MICROORGANISMS, P171; Bartolo I, 2009, ANTIMICROB AGENTS CH, V53, P3156, DOI 10.1128/AAC.00110-09; Bartolo I, 2009, JAIDS-J ACQ IMM DEF, V51, P323, DOI 10.1097/QAI.0b013e3181a24906; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Catumbela E, 2013, LANCET, V382, P17; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; de Meyer S, 2008, AIDS RES HUM RETROV, V24, P379, DOI 10.1089/aid.2007.0173; Djoko CF, 2011, AIDS RES HUM RETROV, V27, P323, DOI 10.1089/aid.2010.0201; FAghokeng A, 2009, ANTIVIR THER, V14, P401; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2006, AIDS REV, V8, P98; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Instituto Nacional de Luta Contra a SIDA - Angola, 2010, UNGASS 2010 REL PROG; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; Kempf DJ, 2002, ANTIVIR THER, V7, P165; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitner T., 2000, AIDS REV, V2, P241; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Los Alamos Sequence Database, 2014, LOS AL SEQ DAT; Mahnke YD, 2013, AIDS, V27, P697, DOI 10.1097/QAD.0b013e32835ce2e9; Ministerio da Saude de Angola, 2009, B EP VIH SIDA; Afonso JM, 2012, INFECT GENET EVOL, V12, P1458, DOI 10.1016/j.meegid.2012.05.005; Nwobegahay J, 2012, J MED VIROL, V84, P1839, DOI 10.1002/jmv.23348; Pellegrin I, 2006, ANTIVIR THER, V11, P421; Pellegrin I, 2007, ANTIMICROB AGENTS CH, V51, P1473, DOI 10.1128/AAC.00481-06; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poveda E, 2007, J ANTIMICROB CHEMOTH, V60, P885, DOI 10.1093/jac/dkm276; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stanford HIV Drug Resistance Database, 2014, STANF HIV DRUG RES D; Sullivan PS, 2012, AIDS, V26, P175, DOI 10.1097/QAD.0b013e32834ed8c8; van Westen GJP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002899; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; WHO, 2010, ANT THER HIV INF AD; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11	63	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113626	10.1371/journal.pone.0113626	http://dx.doi.org/10.1371/journal.pone.0113626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479241	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907200025
J	Bohon, KS; Wiest, MC				Bohon, Kaitlin S.; Wiest, Michael C.			Role of Medio-Dorsal Frontal and Posterior Parietal Neurons during Auditory Detection Performance in Rats	PLOS ONE			English	Article							SUBJECTIVE SENSORY EXPERIENCE; PREFRONTAL CORTEX; SUSTAINED ATTENTION; CORTICAL AREAS; TACTILE PERCEPTION; VISUAL-PERCEPTION; CONSCIOUSNESS; MECHANISMS; HUMANS; MEMORY	To further characterize the role of frontal and parietal cortices in rat cognition, we recorded action potentials simultaneously from multiple sites in the medio-dorsal frontal cortex and posterior parietal cortex of rats while they performed a two-choice auditory detection task. We quantified neural correlates of task performance, including response movements, perception of a target tone, and the differentiation between stimuli with distinct features (different pitches or durations). A minority of units-15% in frontal cortex, 23% in parietal cortex-significantly distinguished hit trials (successful detections, response movement to the right) from correct rejection trials (correct leftward response to the absence of the target tone). Estimating the contribution of movement-related activity to these responses suggested that more than half of these units were likely signaling correct perception of the auditory target, rather than merely movement direction. In addition, we found a smaller and mostly not overlapping population of units that differentiated stimuli based on task-irrelevant details. The detection-related spiking responses we observed suggest that correlates of perception in the rat are sparsely represented among neurons in the rat's frontal-parietal network, without being concentrated preferentially in frontal or parietal areas.	[Bohon, Kaitlin S.; Wiest, Michael C.] Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA	Wellesley College	Wiest, MC (corresponding author), Wellesley Coll, Neurosci Program, Wellesley, MA 02181 USA.	mwiest@wellesley.edu	Wiest, Michael/ABC-8101-2020		National Science Foundation Integrative Organismal Systems [1121689]	National Science Foundation Integrative Organismal Systems	MCW's work was supported by National Science Foundation Integrative Organismal Systems grant 1121689 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Broussard J, 2006, NEUROSCIENCE, V143, P407, DOI 10.1016/j.neuroscience.2006.08.030; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; de Lafuente V, 2006, P NATL ACAD SCI USA, V103, P14266, DOI 10.1073/pnas.0605826103; DESMEDT JE, 1994, NEUROSCI LETT, V168, P126, DOI 10.1016/0304-3940(94)90432-4; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Hromadka T, 2007, HEARING RES, V229, P180, DOI 10.1016/j.heares.2007.01.002; Jaegle A, 2014, J COGNITIVE NEUROSCI, V26, P422, DOI 10.1162/jocn_a_00494; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; Lafuente Vd, 2006, P NATL ACAD SCI USA, V103, P14266; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Meier P, 2011, J VIS, V11, P22; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nakamura K, 1999, J NEUROPHYSIOL, V82, P2503, DOI 10.1152/jn.1999.82.5.2503; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Nienborg H, 2012, ANNU REV NEUROSCI, V35, P463, DOI 10.1146/annurev-neuro-062111-150403; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Posner MI, 2012, NEUROIMAGE, V61, P450, DOI 10.1016/j.neuroimage.2011.12.040; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; REEP RL, 1994, EXP BRAIN RES, V100, P67; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rees G, 2013, ANN NY ACAD SCI, V1296, P4, DOI 10.1111/nyas.12257; Ro T, 2004, J COGNITIVE NEUROSCI, V16, P24, DOI 10.1162/089892904322755520; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008	42	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114064	10.1371/journal.pone.0114064	http://dx.doi.org/10.1371/journal.pone.0114064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479194	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200041
J	Li, W; Long, JA; Watts, LT; Jiang, Z; Shen, Q; Li, YX; Duong, TQ				Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.			A Quantitative MRI Method for Imaging Blood-Brain Barrier Leakage in Experimental Traumatic Brain Injury	PLOS ONE			English	Article							REPERFUSION INJURY; MODEL SELECTION; PATLAK PLOTS; RAT MODEL; GD-DTPA; PERMEABILITY; STROKE; PARAMETERS; DIFFUSION; BREAKDOWN	Blood-brain barrier (BBB) disruption is common following traumatic brain injury (TBI). Dynamic contrast enhanced (DCE) MRI can longitudinally measure the transport coefficient K-trans which reflects BBB permeability. K-trans measurements however are not widely used in TBI research because it is generally considered to be noisy and possesses low spatial resolution. We improved spatiotemporal resolution and signal sensitivity of K-trans MRI in rats by using a high-sensitivity surface transceiver coil. To overcome the signal drop off profile of the surface coil, a pre-scan module was used to map the flip angle (B-1 field) and magnetization (M-0) distributions. A series of T-1-weighted gradient echo images were acquired and fitted to the extended Kety model with reversible or irreversible leakage, and the best model was selected using F-statistics. We applied this method to study the rat brain one hour following controlled cortical impact (mild to moderate TBI), and observed clear depiction of the BBB damage around the impact regions, which matched that outlined by Evans Blue extravasation. Unlike the relatively uniform T-2 contrast showing cerebral edema, K-trans shows a pronounced heterogeneous spatial profile in and around the impact regions, displaying a nonlinear relationship with T-2. This improved K-trans MRI method is also compatible with the use of high-sensitivity surface coil and the high-contrast two-coil arterial spin-labeling method for cerebral blood flow measurement, enabling more comprehensive investigation of the pathophysiology in TBI.	[Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Li, Wei; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Li, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	liw5@uthscsa.edu; duongt@uthscsa.edu	Watts, Lora Talley/A-2724-2012; Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Watts, Lora Talley/0000-0002-2337-1504; Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827; jiang, zhao/0000-0002-8192-9908	NIH/NINDS [R01 NS45879, UL1 TR001119, TL1TR001119, KL2 TR001118]; NIH/NINDS via the Clinical Translational Science Awards (CTSA) [TL1TR001119, UL1TR001119, 8UL1TR000149]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120, TL1TR001119, KL2TR001118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045879] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NINDS via the Clinical Translational Science Awards (CTSA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported in part by grants from NIH/NINDS R01 NS45879 (TQD), UL1 TR001119 (WL), TL1TR001119 (JAL), and KL2 TR001118 (LTW) via the Clinical Translational Science Awards (CTSA, parent grant UL1TR001119, 8UL1TR000149, and TL1TR001119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1998, ACT NEUR S, V71, P104; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Durukan A, 2009, BRAIN RES, V1280, P158, DOI 10.1016/j.brainres.2009.05.025; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Jiang Z, 2014, NEUROSCI LETT, V566, P298, DOI 10.1016/j.neulet.2014.02.066; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Nagaraja TN, 2010, MAGN RESON MED, V63, P1502, DOI 10.1002/mrm.22339; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts P. S., 2010, SIGNAL, V500, P400; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Yankeelov TE, 2007, MAGN RESON MED, V57, P353, DOI 10.1002/mrm.21131	26	23	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114173	10.1371/journal.pone.0114173	http://dx.doi.org/10.1371/journal.pone.0114173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478693	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200050
J	Postler, TS; Bixby, JG; Desrosiers, RC; Yuste, E				Postler, Thomas S.; Bixby, Jacqueline G.; Desrosiers, Ronald C.; Yuste, Eloisa			Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41	PLOS ONE			English	Article							HIV-1 ENVELOPE GLYCOPROTEIN; CELL-SURFACE EXPRESSION; TYROSINE-BASED SIGNAL; NEUTRALIZATION SENSITIVITY; CLATHRIN ADAPTER; TYPE-1 MATRIX; TRANSMEMBRANE PROTEINS; MACROPHAGE TROPISM; ENV INCORPORATION; DILEUCINE MOTIF	Previous studies have shown that truncation of the cytoplasmic-domain sequences of the simian immunodeficiency virus (SIV) envelope glycoprotein (Env) just prior to a potential intracellular-trafficking signal of the sequence YIHF can strongly increase Env protein expression on the cell surface, Env incorporation into virions and, at least in some contexts, virion infectivity. Here, all 12 potential intracellular-trafficking motifs (YXX Phi or LL/LI/IL) in the gp41 cytoplasmic domain (gp41CD) of SIVmac239 were analyzed by systematic mutagenesis. One single and 7 sequential combination mutants in this cytoplasmic domain were characterized. Cell-surface levels of Env were not significantly affected by any of the mutations. Most combination mutations resulted in moderate 3- to 8-fold increases in Env incorporation into virions. However, mutation of all 12 potential sites actually decreased Env incorporation into virions. Variant forms with 11 or 12 mutated sites exhibited 3-fold lower levels of inherent infectivity, while none of the other single or combination mutations that were studied significantly affected the inherent infectivity of SIVmac239. These minor effects of mutations in trafficking motifs form a stark contrast to the strong increases in cell-surface expression and Env incorporation which have previously been reported for large truncations of gp41CD. Surprisingly, mutation of potential trafficking motifs in gp41CD of SIVmac316, which differs by only one residue from gp41CD of SIVmac239, effectively recapitulated the increases in Env incorporation into virions observed with gp41CD truncations. Our results indicate that increases in Env surface expression and virion incorporation associated with truncation of SIVmac239 gp41CD are not fully explained by loss of consensus trafficking motifs.	[Postler, Thomas S.; Bixby, Jacqueline G.; Desrosiers, Ronald C.; Yuste, Eloisa] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, New England Primate Res Ctr, Southborough, MA 01772 USA	Harvard University	Yuste, E (corresponding author), Inst Invest Biomed August Pi & Sunyer, AIDS Res Unit, Barcelona, Spain.	EYUSTE@clinic.ub.es	Yuste, Eloisa/R-9493-2019	Yuste, Eloisa/0000-0002-9484-9974; Postler, Thomas/0000-0002-3558-9084	National Institutes of Health [5RO1AI025328, RR00168]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant 5RO1AI025328 from the National Institutes of Health (www.nih.gov) to RCD and by base grant RR00168 from the National Institutes of Health (www.nih.gov) to the New England Primate Research Center (Harvard Medical School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Bhakta SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-37; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2000, TRAFFIC, V1, P661, DOI 10.1034/j.1600-0854.2000.010810.x; Breed MW, 2013, J VIROL, V87, P1528, DOI 10.1128/JVI.01928-12; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen BK, 2012, IMMUNOL RES, V54, P133, DOI 10.1007/s12026-012-8320-8; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cole KS, 2001, VIROLOGY, V290, P59; Day JR, 2004, J VIROL, V78, P1069, DOI 10.1128/JVI.78.3.1069-1079.2004; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Fultz PN, 2001, J VIROL, V75, P278, DOI 10.1128/JVI.75.1.278-291.2001; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Hallenberger S, 1997, J VIROL, V71, P1036, DOI 10.1128/JVI.71.2.1036-1045.1997; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; HIRSCH VM, 1989, NATURE, V341, P573, DOI 10.1038/341573a0; Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; Kuiken C, 2009, 0903280 LAUR THEOR B; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; MAMMANO F, 1995, J VIROL, V69, P3824, DOI 10.1128/JVI.69.6.3824-3830.1995; Manrique JM, 2001, AIDS RES HUM RETROV, V17, P1615, DOI 10.1089/088922201753342022; Marcon L, 1997, AIDS RES HUM RETROV, V13, P441, DOI 10.1089/aid.1997.13.441; Means RE, 1997, J VIROL, V71, P7895, DOI 10.1128/JVI.71.10.7895-7902.1997; Mori K, 2000, J VIROL, V74, P10852, DOI 10.1128/JVI.74.22.10852-10859.2000; MORI K, 1992, J VIROL, V66, P2067, DOI 10.1128/JVI.66.4.2067-2075.1992; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; RITTER GD, 1993, VIROLOGY, V197, P255, DOI 10.1006/viro.1993.1586; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; ROWELL JF, 1995, J IMMUNOL, V155, P473; Sauter MM, 1996, J CELL BIOL, V132, P795, DOI 10.1083/jcb.132.5.795; SPIES CP, 1994, J VIROL, V68, P585, DOI 10.1128/JVI.68.2.585-591.1994; SPIES CP, 1994, VIROLOGY, V203, P8, DOI 10.1006/viro.1994.1449; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; VERONESE FD, 1989, J VIROL, V63, P1416, DOI 10.1128/JVI.63.3.1416-1419.1989; West JT, 2002, J VIROL, V76, P3338, DOI 10.1128/JVI.76.7.3338-3349.2002; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Yuste E, 2005, J VIROL, V79, P12455, DOI 10.1128/JVI.79.19.12455-12463.2005; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; ZINGLER K, 1993, J VIROL, V67, P2824, DOI 10.1128/JVI.67.5.2824-2831.1993	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114753	10.1371/journal.pone.0114753	http://dx.doi.org/10.1371/journal.pone.0114753			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479017	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907200123
J	Welford, RWD; Garzotti, M; Lourenco, CM; Mengel, E; Marquardt, T; Reunert, J; Amraoui, Y; Kolb, SA; Morand, O; Groenen, P				Welford, Richard W. D.; Garzotti, Marco; Lourenco, Charles Marques; Mengel, Eugen; Marquardt, Thorsten; Reunert, Janine; Amraoui, Yasmina; Kolb, Stefan A.; Morand, Olivier; Groenen, Peter			Plasma Lysosphingomyelin Demonstrates Great Potential as a Diagnostic Biomarker for Niemann-Pick Disease Type C in a Retrospective Study	PLOS ONE			English	Article							DRIED BLOOD SPOTS; GLOBOTRIAOSYLSPHINGOSINE	Niemann-Pick disease type C (NP-C) is a devastating, neurovisceral lysosomal storage disorder which is characterised by variable manifestation of visceral signs, progressive neuropsychiatric deterioration and premature death, caused by mutations in the NPC1 and NPC2 genes. Due to the complexity of diagnosis and the availability of an approved therapy in the EU, improved detection of NP-C may have a huge impact on future disease management. At the cellular level dysfunction or deficiency of either the NPC1 or NPC2 protein leads to a complex intracellular endosomal/lysosomal trafficking defect, and organ specific patterns of sphingolipid accumulation. Lysosphingolipids have been shown to be excellent biomarkers of sphingolipidosis in several enzyme deficient lysosomal storage disorders. Additionally, in a recent study the lysosphingolipids, lysosphingomyelin (SPC) and glucosylsphingosine (GlcSph), appeared to be elevated in the plasma of three adult NP-C patients. In order to investigate the clinical utility of SPC and GlcSph as diagnostic markers, an in-depth fit for purpose biomarker assay validation for measurement of these biomarkers in plasma by liquid chromatography-tandem mass spectrometry was performed. Plasma SPC and GlcSph are stable and can be measured accurately, precisely and reproducibly. In a retrospective analysis of 57 NP-C patients and 70 control subjects, median plasma SPC and GlcSph were significantly elevated in NP-C by 2.8-fold and 1.4-fold respectively. For miglustat-naive NP-C patients, aged 2-50 years, the area under the ROC curve was 0.999 for SPC and 0.776 for GlcSph. Plasma GlcSph did not correlate with SPC levels in NP-C patients. The data indicate excellent potential for the use of lysosphingomyelin in NP-C diagnosis, where it could be used to identify NP-C patients for confirmatory genetic testing.	[Welford, Richard W. D.; Garzotti, Marco; Kolb, Stefan A.; Morand, Olivier; Groenen, Peter] Actel Pharmaceut Ltd, Allschwil, Switzerland; [Lourenco, Charles Marques] Hosp Clin Ribeirao Preto, Sao Paulo, Brazil; [Mengel, Eugen; Amraoui, Yasmina] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Paediat & Adolescent Med, Dept Lysosomal Storage Disorder, D-55122 Mainz, Germany; [Marquardt, Thorsten; Reunert, Janine] Klin Kinder & Jugendmed, Munster, Germany	Actelion Pharmaceuticals Ltd; Johannes Gutenberg University of Mainz	Welford, RWD (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	richard.welford@actelion.com			Actelion Pharmaceuticals	Actelion Pharmaceuticals	The study was funded by Actelion Pharmaceuticals. The funders (senior management and board) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Bauer P, 2013, HUM MOL GENET, V22, P4349, DOI 10.1093/hmg/ddt284; Chuang WL, 2014, MOL GENET METAB, V111, P209, DOI 10.1016/j.ymgme.2013.11.012; Chuang WL, 2013, CLIN CHIM ACTA, V419, P73, DOI 10.1016/j.cca.2013.01.017; CROCKER AC, 1961, J NEUROCHEM, V7, P69, DOI 10.1111/j.1471-4159.1961.tb13499.x; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; European Medicines Agency (EMA), 2011, EMEACHMPEWP192217200; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Fast Douglas M, 2009, AAPS J, V11, P238, DOI 10.1208/s12248-009-9100-9; Houghton R, 2009, BIOANALYSIS, V1, P1365, DOI [10.4155/bio.09.139, 10.4155/BIO.09.139]; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Johnson B, 2013, ANN LAB MED, V33, P274, DOI 10.3343/alm.2013.33.4.274; Kodama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029074; Lin N, 2014, J LIPID RES, V55, P338, DOI 10.1194/jlr.D044024; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Mengel E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-166; Patterson MC, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-12; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Rolfs A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079732; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Stampfer M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-35; Stevenson L, 2013, BIOANALYSIS, V5, P2903, DOI 10.4155/bio.13.238; U.S. FDA, 1998, GUIDANCE IND BIOANAL; van Karnebeek CD, 2014, MOL GENET METAB; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Wijburg FA, 2012, NEUROLOGY, V78, P1560, DOI 10.1212/WNL.0b013e3182563b82; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zhang HW, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-82	32	60	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114669	10.1371/journal.pone.0114669	http://dx.doi.org/10.1371/journal.pone.0114669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479233	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200110
J	Qi, J; Yang, ZY				Qi, Jin; Yang, Zhiyong			Learning Dictionaries of Sparse Codes of 3D Movements of Body Joints for Real-Time Human Activity Understanding	PLOS ONE			English	Article							ACTION RECOGNITION; DEFICITS; VISION; HMM	Real-time human activity recognition is essential for human-robot interactions for assisted healthy independent living. Most previous work in this area is performed on traditional two-dimensional (2D) videos and both global and local methods have been used. Since 2D videos are sensitive to changes of lighting condition, view angle, and scale, researchers begun to explore applications of 3D information in human activity understanding in recently years. Unfortunately, features that work well on 2D videos usually don't perform well on 3D videos and there is no consensus on what 3D features should be used. Here we propose a model of human activity recognition based on 3D movements of body joints. Our method has three steps, learning dictionaries of sparse codes of 3D movements of joints, sparse coding, and classification. In the first step, space-time volumes of 3D movements of body joints are obtained via dense sampling and independent component analysis is then performed to construct a dictionary of sparse codes for each activity. In the second step, the space-time volumes are projected to the dictionaries and a set of sparse histograms of the projection coefficients are constructed as feature representations of the activities. Finally, the sparse histograms are used as inputs to a support vector machine to recognize human activities. We tested this model on three databases of human activities and found that it outperforms the state-of-the-art algorithms. Thus, this model can be used for real-time human activity recognition in many applications.	[Qi, Jin; Yang, Zhiyong] Georgia Regents Univ, Brain & Behav Discovery Inst, James & Jean Culver Vis Discovery Inst, Dept Ophthalmol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Yang, ZY (corresponding author), Georgia Regents Univ, Brain & Behav Discovery Inst, James & Jean Culver Vis Discovery Inst, Dept Ophthalmol, Augusta, GA 30912 USA.	zhyang@gru.edu						Aggarwal JK, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1922649.1922653; [Anonymous], P 21 ACM INT C MULT, DOI DOI 10.1145/2502081.2502099; Bengio Yoshua, 2007, P ADV NEUR INF PROC, P153; CAMPBELL LW, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P624, DOI 10.1109/ICCV.1995.466880; Camplani M, 2012, P SOC PHOTO-OPT INS, V8290; Cook DJ, 2005, SMART ENV TECHNOLOGI, P1; Das B, 2012, PERS UBIQUIT COMPUT, V16, P859, DOI 10.1007/s00779-011-0445-6; Dollar P., 2005, Proceedings. 2nd Joint IEEE International Workshop on Visual Surveillance and Performance Evaluation of Tracking and Surveillance (VS-PETS) (IEEE Cat. No. 05EX1178), P65; Farias ST, 2006, ALZ DIS ASSOC DIS, V20, P217, DOI 10.1097/01.wad.0000213849.51495.d9; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Jalal A, 2011, LECT NOTES COMPUT SC, V6719, P25, DOI 10.1007/978-3-642-21535-3_4; Jhuang HH, 2013, IEEE I CONF COMP VIS, P3192, DOI 10.1109/ICCV.2013.396; Jia XF, 2012, INT C PATT RECOG, P3001; JOHANSSON G, 1975, SCI AM, V232, P76, DOI 10.1038/scientificamerican0675-76; Kaushik P, 2008, METHOD INFORM MED, V47, P203, DOI 10.3414/ME9111; Klaser A., 2008, BMVC, V275, P1; Koppula HS, 2013, INT J ROBOT RES, V32, P951, DOI 10.1177/0278364913478446; Laptev I, 2005, INT J COMPUT VISION, V64, P107, DOI 10.1007/s11263-005-1838-7; Le Q.V., 2011, NEURIPS, P1017; Lei JN, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P208; Li WB, 2010, 2010 THE 3RD INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND INDUSTRIAL APPLICATION (PACIIA2010), VOL I, P9, DOI 10.1109/cvprw.2010.5543273; Lu Xia, 2012, IEEE COMP SOC C COMP, P20, DOI DOI 10.1109/CVPRW.2012.6239233; Lv F, 2006, LECT NOTES COMPUT SC, V3954, P359; Mao Ye, 2013, Time-Of-Flight and Depth Imaging. Sensors, Algorithms and Applications. Dagstuhl 2012 Seminar on Time-of-Flight Imaging and GCPR 2013 Workshop on Imaging New Modalities: LNCS 8200, P149, DOI 10.1007/978-3-642-44964-2_8; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Mualler M., 2006, P 2006 ACM SIGGRAPH, P137; Ngiam J, ICML, P265; Ni BB, 2012, LECT NOTES COMPUT SC, V7573, P173, DOI 10.1007/978-3-642-33709-3_13; Ni BB, 2013, IEEE T CYBERNETICS, V43, P1383, DOI 10.1109/TCYB.2013.2276433; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Oreifej O, 2013, PROC CVPR IEEE, P716, DOI 10.1109/CVPR.2013.98; Piyathilaka L, 2013, C IND ELECT APPL, P567; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Reisberg B, 2001, INT PSYCHOGERIATR, V13, P163, DOI 10.1017/S1041610201007566; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; Shotton J., 2013, MACH LEARN COMPUT VI, V411, P119, DOI DOI 10.1007/978-3-642-28661-2_5; Sung J., 2011, P 16 AAAI C PLAN ACT, P47; Sung JY, 2012, IEEE INT CONF ROBOT, P842, DOI 10.1109/ICRA.2012.6224591; Vedaldi A, 2012, IEEE T PATTERN ANAL, V34, P480, DOI 10.1109/TPAMI.2011.153; Vieira Antonio W., 2012, Progress in Pattern Recognition, Image Analysis, ComputerVision, and Applications. Proceedings 17th Iberoamerican Congress, CIARP 2012, P252, DOI 10.1007/978-3-642-33275-3_31; Wadley VG, 2008, AM J GERIAT PSYCHIAT, V16, P416, DOI 10.1097/JGP.0b013e31816b7303; Wang J, 2014, IEEE T PATTERN ANAL, V36, P914, DOI 10.1109/TPAMI.2013.198; Wang J, 2012, LECT NOTES COMPUT SC, V7573, P872, DOI 10.1007/978-3-642-33709-3_62; Wang J, 2012, PROC CVPR IEEE, P1290, DOI 10.1109/CVPR.2012.6247813; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Yang XD, 2014, J VIS COMMUN IMAGE R, V25, P2, DOI 10.1016/j.jvcir.2013.03.001; Yao A, 2012, INT J COMPUT VISION, V100, P16, DOI 10.1007/s11263-012-0532-9; Zhang C., 2012, J COMPUTER VISION IM, V2; Zhang H., 2011, INTELLIGENT ROBOTS S, P2044, DOI DOI 10.1109/IROS.2011.6094489; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046686	52	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114147	10.1371/journal.pone.0114147	http://dx.doi.org/10.1371/journal.pone.0114147			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473850	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500117
J	Schmickl, T; Karsai, I				Schmickl, Thomas; Karsai, Istvan			Sting, Carry and Stock: How Corpse Availability Can Regulate De-Centralized Task Allocation in a Ponerine Ant Colony	PLOS ONE			English	Article							DIVISION-OF-LABOR; NEST CONSTRUCTION BEHAVIOR; HONEY-BEES; SELF-ORGANIZATION; MODEL; WORK; RECRUITMENT; OPTIMIZATION; HYMENOPTERA; POLYETHISM	We develop a model to produce plausible patterns of task partitioning in the ponerine ant Ectatomma ruidum based on the availability of living prey and prey corpses. The model is based on the organizational capabilities of a "common stomach'' through which the colony utilizes the availability of a natural (food) substance as a major communication channel to regulate the income and expenditure of the very same substance. This communication channel has also a central role in regulating task partitioning of collective hunting behavior in a supply & demand-driven manner. Our model shows that task partitioning of the collective hunting behavior in E. ruidum can be explained by regulation due to a common stomach system. The saturation of the common stomach provides accessible information to individual ants so that they can adjust their hunting behavior accordingly by engaging in or by abandoning from stinging or transporting tasks. The common stomach is able to establish and to keep stabilized an effective mix of workforce to exploit the prey population and to transport food into the nest. This system is also able to react to external perturbations in a de-centralized homeostatic way, such as to changes in the prey density or to accumulation of food in the nest. In case of stable conditions the system develops towards an equilibrium concerning colony size and prey density. Our model shows that organization of work through a common stomach system can allow Ectatomma ruidum to collectively forage for food in a robust, reactive and reliable way. The model is compared to previously published models that followed a different modeling approach. Based on our model analysis we also suggest a series of experiments for which our model gives plausible predictions. These predictions are used to formulate a set of testable hypotheses that should be investigated empirically in future experimentation.	[Schmickl, Thomas] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Karsai, Istvan] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	University of Graz; East Tennessee State University	Karsai, I (corresponding author), E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	karsai@etsu.edu		Schmickl, Thomas/0000-0001-8598-7462	European Union [270382]; EU-FET [601074]; FWF (Austrian Science Fund) [P23943-N13]; East Tennessee State University [RDC 12-005M]	European Union(European Commission); EU-FET; FWF (Austrian Science Fund)(Austrian Science Fund (FWF)); East Tennessee State University	TS is supported by the following grants: European Union-Information and Communication Technologies projects EU-ICT 'CoCoRo', no. 270382 and EU-FET 'ASSISI_bf', no. 601074 (http://cordis.europa.eu/fp7/ict/); FWF (Austrian Science Fund) 'REBODIMENT', no. P23943-N13 (http://www.fwf.ac.at/en/). IK was supported by East Tennessee State University Research Development Grant no. RDC 12-005M (http://www.etsu.edu/research/rdc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBOGBA C, 1992, INSECT SOC, V39, P455, DOI 10.1007/BF01240629; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Anderson C, 2001, ANIM BEHAV, V62, P634; BERNSTEIN RA, 1975, ECOLOGY, V56, P213, DOI 10.2307/1935314; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Bonabeau E, 1998, B MATH BIOL, V60, P753, DOI 10.1006/bulm.1998.0041; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; BREED MD, 1990, OECOLOGIA, V84, P117, DOI 10.1007/BF00665604; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Cassill DL, 1999, BEHAV ECOL SOCIOBIOL, V45, P301, DOI 10.1007/s002650050565; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Dechaume-Moncharmont FX, 2005, P ROY SOC B-BIOL SCI, V272, P1689, DOI 10.1098/rspb.2005.3137; DEJEAN A, 1987, SOCIOBIOLOGY, V13, P119; DEJEAN A, 1993, J ETHOL, V11, P43, DOI 10.1007/BF02350005; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Detrain C, 2002, BIOL BULL, V202, P286; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; EBERLEIN RL, 1992, EUR J OPER RES, V59, P216, DOI 10.1016/0377-2217(92)90018-5; Forrester J.W., 1961, IND DYNAMICS; Forrester J.W., 1969, URBAN DYNAMICS; Forrester J. W., 1973, WORLD DYNAMICS; Forrester JW., 1968, PRINCIPLES SYSTEMS; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gordon DM, 2002, COMPLEXITY, V8, P43, DOI [10.1002/cplx.10048, DOI 10.1002/CPLX.10048]; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Hamann H, 2013, B MATH BIOL, V75, P1181, DOI 10.1007/s11538-013-9851-4; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; Jeanne RL, 1996, ANIM BEHAV, V52, P473, DOI 10.1006/anbe.1996.0191; Jeanson R, 2007, BEHAV ECOL SOCIOBIOL, V62, P289, DOI 10.1007/s00265-007-0464-5; Johnson BR, 2008, NATURWISSENSCHAFTEN, V95, P523, DOI 10.1007/s00114-008-0354-3; Johnson BR, 2009, AM NAT, V174, P537, DOI 10.1086/605373; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 1998, P NATL ACAD SCI USA, V95, P8665, DOI 10.1073/pnas.95.15.8665; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; Karsai I, 2011, ECOL MODEL, V222, P447, DOI 10.1016/j.ecolmodel.2010.11.002; Labella TH, 2006, ACM T AUTON ADAP SYS, V1, P4, DOI 10.1145/1152934.1152936; Lachaud J.-P., 1990, Actes des Colloques Insectes Sociaux, V6, P151; Lachaud J.-P., 1987, Experientia Supplementum (Basel), V54, P197; Lachaud J. P., 1984, FOLIA ENTOMOL MEX, V61, P159; Lachaud J.-P., 1990, FOLIA ENTOMOL GICA M, V78, P241; LACHAUD JP, 1985, SOCIOBIOLOGY, V11, P133; LACHAUD JP, 1994, ENTOMOL EXP APPL, V72, P145, DOI 10.1007/BF02383549; Oster G.F., 1978, Monographs in Population Biology, pi; Plowright R.C., 1988, P419; PRATT SC, 1989, ETHOLOGY, V81, P313; Ratnieks FLW, 1999, INSECT SOC, V46, P95, DOI 10.1007/s000400050119; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; Schatz B, 1998, ACT COLLOQ INSECT S, V12, P19; Schatz B, 1999, SOCIOBIOLOGY, V34, P605; Schatz B, 1997, BEHAV ECOL SOCIOBIOL, V40, P337, DOI 10.1007/s002650050350; Schatz B, 1996, INSECT SOC, V43, P111, DOI 10.1007/BF01242563; SCHATZ B, 1995, SOCIOBIOLOGY, V26, P269; Schmickl T, 2008, AUTON ROBOT, V25, P171, DOI 10.1007/s10514-007-9073-4; Schmickl T, 2008, MATH COMP MODEL DYN, V14, P101, DOI 10.1080/13873950701846662; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Schmickl T, 2008, ARTIF LIFE, VXI, P529; Schmickl T, 2008, LECT NOTES ARTIF INT, V5040, P383; Schmickl T, 2007, LECT NOTES COMPUT SC, V4433, P144; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; Schmickl T, 2009, ROBOT AUTON SYST, V57, P913, DOI 10.1016/j.robot.2009.06.002; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Stein W., 2005, SIGSAM Bulletin, V39, P61, DOI 10.1145/1101884.1101889; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Sumpter DJT, 2003, BEHAV ECOL SOCIOBIOL, V53, P131, DOI 10.1007/s00265-002-0549-0; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Thenius R, 2005, LECT NOTES ARTIF INT, V3690, P246; Thenius R, 2008, CONNECT SCI, V20, P193, DOI 10.1080/09540090802091982; Thenius R, 2006, LECT NOTES COMPUT SC, V4095, P725; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Theraulaz G, 2002, J THEOR BIOL, V215, P481, DOI 10.1006/jtbi.2001.2518; TOFTS C, 1993, B MATH BIOL, V55, P891, DOI 10.1007/BF02460691; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Volterra V., 1928, Journal du Conseil Copenhague, P3; Volterra V, 1931, LECONS THEORIE MATH; Wedde HF, 2006, J SYST ARCHITECT, V52, P461, DOI 10.1016/j.sysarc.2006.02.005	88	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e114611	10.1371/journal.pone.0114611	http://dx.doi.org/10.1371/journal.pone.0114611			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493558	Green Submitted, Green Published, gold			2022-12-26	WOS:000346611400060
J	Alshbool, FZ; Mohan, S				Alshbool, Fatima Z.; Mohan, Subburaman			Differential Expression of Claudin Family Members during Osteoblast and Osteoclast Differentiation: Cldn-1 Is a Novel Positive Regulator of Osteoblastogenesis	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; EPITHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; COLON-CANCER; STEM-CELLS; BONE; OCCLUDIN; PATHWAY; MOUSE	Claudins (Cldns), a family of 27 transmembrane proteins, represent major components of tight junctions. Aside from functioning as tight junctions, Cldns have emerging roles as regulators of cell proliferation and differentiation. While Cldns are known to be expressed and have important functions in various tissues, their expression and function in bone cells is ill-defined. In this study, the expression of Cldns was examined during osteoblast and osteoclast differentiation. The expression of Cldn-1, -7, -11, and -15 was downregulated during early stages of osteoclast differentiation, whereas Cldn-6 was upregulated. Moreover, the expression of several Cldns increased 3-7 fold in fully differentiated osteoclasts. As for osteoblasts, the expression of several Cldns was found to increase more than 10-fold during differentiation, with some peaking at early, and others at late stages. By contrast, only expression of Cldn-12, and -15 decreased during osteoblast differentiation. In subsequent studies, we focused on the role of Cldn-1 in osteoblasts as its expression was increased by more than 10 fold during osteoblast differentiation and was found to be regulated by multiple osteoregulatory agents including IGF-1 and Wnt3a. We evaluated the consequence of lentiviral shRNA-mediated knockdown of Cldn-1 on osteoblast proliferation and differentiation using MC3T3-E1 mouse osteoblasts. Cldn-1 knockdown caused a significant reduction in MC3T3-E1 cell proliferation and ALP activity. Accordingly, expression levels of cyclinD1 and ALP mRNA levels were reduced in Cldn-1 shRNA knockdown cells. We next determined if Cldn-1 regulates the expression of Runx-2 and osterix, master transcription factors of osteoblast differentiation, and found that their levels were reduced significantly as a consequence of Cldn-1 knockdown. Moreover, knocking down Cldn-1 reduced beta-catenin level. In conclusion, the expression of Cldn family members during bone cell differentiation is complex and involves cell type and differentiation stage-dependent regulation. In addition, Cldn-1 is a positive regulator of osteoblast proliferation and differentiation.	[Alshbool, Fatima Z.; Mohan, Subburaman] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Med, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92354 USA; [Alshbool, Fatima Z.] Loma Linda Univ, Dept Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Mohan, S (corresponding author), Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.	Subburaman.Mohan@va.gov			National Institutes of Health [R01-AR031062]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant (R01-AR031062 to SM). They have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuazza G, 2006, AM J PHYSIOL-RENAL, V291, pF1132, DOI 10.1152/ajprenal.00063.2006; Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Alshbool FZ, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.200; Alshbool FZ, 2014, ENDOCRINOLOGY, P1173; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Bhat AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037174; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Breiderhoff T, 2012, P NATL ACAD SCI USA, V109, P14241, DOI 10.1073/pnas.1203834109; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593; Dempster David W, 2011, Am J Manag Care, V17 Suppl 6, pS164; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Fujita H, 2011, J ALLERGY CLIN IMMUN, V127, P1612, DOI 10.1016/j.jaci.2011.03.039; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Govoni KE, 2006, GROWTH HORM IGF RES, V16, P49, DOI 10.1016/j.ghir.2005.10.001; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Hatakeyama N, 2008, CELL TISSUE RES, V334, P243, DOI 10.1007/s00441-008-0690-9; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hong YH, 2005, BIOSCI BIOTECH BIOCH, V69, P2117, DOI 10.1271/bbb.69.2117; Hoshino M, 2008, ORAL DIS, V14, P606, DOI 10.1111/j.1601-0825.2007.01427.x; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Linares GR, 2012, J BONE MINER RES, V27, P1553, DOI 10.1002/jbmr.1600; Linares GR, 2011, AM J PHYSIOL-ENDOC M, V301, pE40, DOI 10.1152/ajpendo.00065.2011; Linares GR, 2009, BONE, V44, P795, DOI 10.1016/j.bone.2009.01.003; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Luo Y, 2011, INVEST OPHTH VIS SCI, V52, P7556, DOI 10.1167/iovs.11-7185; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Pope JL, 2013, GUT; Prele CM, 2003, EXP CELL RES, V282, P24, DOI 10.1006/excr.2002.5668; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; SOARES AMV, 1992, J ANAT, V181, P345; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wang LL, 2012, CELL RES, V22, P1082, DOI 10.1038/cr.2012.77; WEINGER JM, 1974, CALC TISS RES, V14, P15, DOI 10.1007/BF02060280; Wongdee K, 2008, HISTOCHEM CELL BIOL, V130, P79, DOI 10.1007/s00418-008-0419-6; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114357	10.1371/journal.pone.0114357	http://dx.doi.org/10.1371/journal.pone.0114357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479235	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200076
J	Kuhn, KA; Manieri, NA; Liu, TC; Stappenbeck, TS				Kuhn, Kristine A.; Manieri, Nicholas A.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.			IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; INTERLEUKIN-6 RECEPTOR; CLINICAL-RELEVANCE; RANDOMIZED-TRIAL; COLON-CANCER; MOUSE MODEL; CELLS	IL-6 is a pleiotropic cytokine often associated with inflammation. Inhibition of this pathway has led to successful treatment of rheumatoid arthritis, but one unforeseen potential complication of anti-IL-6 therapy is bowel perforation. Within the intestine, IL-6 has been shown to prevent epithelial apoptosis during prolonged inflammation. The role of IL-6 in the intestine during an initial inflammatory insult is unknown. Here, we evaluate the role of IL-6 at the onset of an inflammatory injury. Using two murine models of bowel injury - wound by biopsy and bacterial triggered colitis - we demonstrated that IL-6 is induced soon after injury by multiple cell types including intraepithelial lymphocytes. Inhibition of IL-6 resulted in impaired wound healing due to decreased epithelial proliferation. Using intestinal tissue obtained from patients who underwent surgical resection of the colon due to traumatic perforation, we observed cells with detectable IL-6 within the area of perforation and not at distant sites. Our data demonstrate the important role of IL-6 produced in part by intraepithelial lymphocytes at the onset of an inflammatory injury for epithelial proliferation and wound repair.	[Kuhn, Kristine A.; Manieri, Nicholas A.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Kuhn, Kristine A.] Washington Univ, Sch Med, Dept Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	stappenb@wustl.edu		Liu, Ta-Chiang/0000-0002-2800-9360; Manieri, Nicholas/0000-0002-5648-5989	Pfizer; National Institutes of Health (NIH) [DK071619]; Crohns and Colitis Foundation of America Genetics Consortium; W.M. Keck Foundation for research in molecular medicine; American College of Rheumatology Research Foundation; NIH [T32 AR007279]; National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [P30DK052574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK071619] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America Genetics Consortium; W.M. Keck Foundation for research in molecular medicine; American College of Rheumatology Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Pfizer, the National Institutes of Health (NIH) (DK071619), and the Crohns and Colitis Foundation of America Genetics Consortium (TSS). KAK was supported by the W.M. Keck Foundation for research in molecular medicine, the American College of Rheumatology Research Foundation, and an NIH training grant (T32 AR007279). The Washington University Digestive Disease Research Core Center is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) (P30DK052574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Gout T, 2011, CLIN RHEUMATOL, V30, P1471, DOI 10.1007/s10067-011-1827-x; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Kitamura K, 2004, J LEUKOCYTE BIOL, V76, P1111, DOI 10.1189/jlb.0604328; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Manieri NA, 2012, GASTROENTEROLOGY, V143, P110, DOI 10.1053/j.gastro.2012.03.037; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Reinisch W, 1999, AM J GASTROENTEROL, V94, P2156; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; STARNES HF, 1990, J IMMUNOL, V145, P4185; SUZUKI Y, 1990, LIFE SCI, V47, P2193, DOI 10.1016/0024-3205(90)90149-L; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; WOODROOFE C, 1992, DNA CELL BIOL, V11, P587, DOI 10.1089/dna.1992.11.587	33	154	154	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114195	10.1371/journal.pone.0114195	http://dx.doi.org/10.1371/journal.pone.0114195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478789	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200051
J	Rao, A; Padhy, D				Rao, Aparna; Padhy, Debananda			Pattern of Pseudoexfoliation Deposits on the Lens and Their Clinical Correlation-Clinical Study and Review of Literature	PLOS ONE			English	Article							EXFOLIATION SYNDROME; FLUORESCEIN ANGIOGRAPHY; IRIS	Purpose: To study the clinical correlates of pattern of deposits over the lens in patients with pseudoexfoliation syndrome (PXF) or pseudoexfoliation glaucoma. Methods: This retrospective observational study screened 346 patients with PXF seen in glaucoma clinic of a tertiary hospital from 2011-2013. Details like pattern of deposits, location on the lens surface and pupillary abnormalities in slit lamp photographs and their correlation with clinical and demographic variables, were analysed. Results: A total of 84 eyes of 42 patients with bilateral PXF were included for the study. Glaucoma was seen in 30 eyes with baseline IOP of 24+3.8 mm Hg. Comparing the type of deposits, namely classical (n=39 eyes), radial pigmentary (RP) form (n=39 eyes) and combined classical and radial pigmentary (CR) forms (n=6 eyes) of deposits, pupillary ruff atrophy was common in all forms while poor dilatation was rare in the RP type (n=5 vs n=25 in classical forms, p<0.001). Mean deviation (MD) was worse in the classical and CR form as compared to RP type with the latter presenting much earlier, 43 +/- 3.2 years vs 48 +/- 4.1 years in CR and 56 +/- 5.7 years in classical form, p<0.001. The baseline IOP in the RP group (18 +/- 2.3 mm Hg) was significantly lower than the other two forms (CR 20 +/- 3.2 mm Hg, classical 28 +/- 2.3 mm Hg), p<0.001, with only 2 eyes on anti-glaucoma drugs at presentation. Conclusion: Pattern of exfoliation deposits may indicate the stage and severity of the disease process in evolution with the RP representing an earlier/less severe form of pseudoexfoliation syndrome.	[Rao, Aparna; Padhy, Debananda] LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India	L. V. Prasad Eye Institute	Rao, A (corresponding author), LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India.	aparna@lvpei.org		rao, Aparna/0000-0001-8120-8740				ASANO N, 1995, OPHTHALMOLOGY, V102, P1279, DOI 10.1016/S0161-6420(95)30873-1; BARTHOLOMEW RS, 1971, BRIT J OPHTHALMOL, V55, P693, DOI 10.1136/bjo.55.10.693; BERTELSEN TI, 1969, ACTA OPHTHALMOL, V47, P476; BROOKS AMV, 1983, BRIT J OPHTHALMOL, V67, P249, DOI 10.1136/bjo.67.4.249; BROOKS AMV, 1987, OPHTHALMOLOGY, V94, P1090; CARPEL EF, 1988, AM J OPHTHALMOL, V105, P692, DOI 10.1016/0002-9394(88)90073-6; Cobb CJ, 2004, BRIT J OPHTHALMOL, V88, P1002, DOI 10.1136/bjo.2003.031732; DARK AJ, 1990, BRIT J OPHTHALMOL, V74, P717, DOI 10.1136/bjo.74.12.717; DARK AJ, 1977, BRIT J OPHTHALMOL, V61, P462, DOI 10.1136/bjo.61.7.462; LAYDEN WE, 1974, AM J OPHTHALMOL, V78, P835, DOI 10.1016/0002-9394(74)90307-9; Mitchell P, 1997, AM J OPHTHALMOL, V124, P685, DOI 10.1016/S0002-9394(14)70908-0; Naumann GOH, 1998, OPHTHALMOLOGY, V105, P951, DOI 10.1016/S0161-6420(98)96020-1; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Parodi MB, 2008, EYE, V22, P49, DOI 10.1038/sj.eye.6702602; Parodi MB, 1999, EUR J OPHTHALMOL, V9, P284; Parodi MB, 2000, ACTA OPHTHALMOL SCAN, V78, P437, DOI 10.1034/j.1600-0420.2000.078004437.x; PRINCE AM, 1986, OPHTHALMOLOGY, V93, P803; PRINCE AM, 1987, ARCH OPHTHALMOL-CHIC, V105, P1076; PUSKA P, 1995, ACTA OPHTHALMOL SCAN, V73, P226; Rao Aparna, 2012, J Ophthalmic Vis Res, V7, P197; Rao A, 2012, SEMIN OPHTHALMOL, V27, P1, DOI 10.3109/08820538.2011.626356; Repo LP, 1996, GRAEF ARCH CLIN EXP, V234, P171, DOI 10.1007/BF00462029; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Ritch R, 2001, CURR OPIN OPHTHALMOL, V12, P124, DOI 10.1097/00055735-200104000-00008; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; TAYLOR HR, 1979, T OPHTHAL SOC UK, V99, P302; TETSUMOTO K, 1992, GRAEF ARCH CLIN EXP, V230, P252, DOI 10.1007/BF00176300; Vannas A, 1969, Acta Ophthalmol Suppl, V105, P1; Vesti E, 2000, PROG RETIN EYE RES, V19, P345, DOI 10.1016/S1350-9462(99)00019-1	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113329	10.1371/journal.pone.0113329	http://dx.doi.org/10.1371/journal.pone.0113329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478872	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200018
J	Sun, J; Sun, K; Chen, S; Yao, LP; Zhang, YQ				Sun, Jing; Sun, Kun; Chen, Sun; Yao, Liping; Zhang, Yuqi			A New Scoring System for Spontaneous Closure Prediction of Perimembranous Ventricular Septal Defects in Children	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; DOPPLER-ECHOCARDIOGRAPHY; ANEURYSM; QUANTITATION; CHILDHOOD; RISK	Background: Perimembranous ventricular septal defect (PMVSD) is a congenital heart aberration, which is surgically treated by patch or device closure, but also can heal without operation as spontaneous closure (SC). Methods: We analyzed data from 1873 PMVSD patients admitted to our hospital during September 2001 and December 2009, in order to establish a Cox regression model for PMVSD SC probability prediction (derivative cohort). Initial contact age, ventricular septal defect (VSD) diameter, shunt flow, aneurysmal tissue of the ventricular membranous septum (ATVMS) development, associated complications, and left ventricular end-diastolic dimension (LVDD) were analyzed for correlations with SC. The derived scoring system based on the coefficients of the model was developed and applied to another cohort with 382 PMVSD patients to evaluate the validity for SC probability forecast (validation cohort). Results: Multivariate Cox regression analysis revealed that SC of PMVSD was associated with age at first contact, defect size, diffuse shunt flow, ATVMS formation, associated complication, as well as increased LVDD, which were used to establish a new scoring system. The area under the receiver operating characteristic (ROC) curve of our predictive scaling was 0.831 (95% CI 0.804-.0858, p<0.001) in the derivative cohort. The scoring system also accurately predicted SC with an area under the ROC curve of 0.863 (95% CI 0.785-0.941, p<0.001) in the validation cohort. Conclusion: Our scoring system using factors affecting SC can predict the probability of SC in PMVSD patients.	[Sun, Jing; Sun, Kun; Chen, Sun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Pediat Heart Ctr, Shanghai 200092, Peoples R China; [Yao, Liping] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Echocardiog, Shanghai 200092, Peoples R China; [Zhang, Yuqi] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat Cardiol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Pediat Heart Ctr, Shanghai 200092, Peoples R China.	sunkun@xinhuamed.com.cn			National Basic Research Program of China [2010CB529501]; National Natural Science Foundation of China [81070134/30772349]; Shanghai Municipal Health Bureau [2013ZYJB0016]; Shanghai Science and Technology Committee [12JC1406600]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	We acknowledge financial support provided by a grant from the National Basic Research Program of China (2010CB529501), the grants from the National Natural Science Foundation of China (81070134/30772349), a grant from Shanghai Municipal Health Bureau (2013ZYJB0016), and the major key project for fundamental research from Shanghai Science and Technology Committee (12JC1406600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butera Gianfranco, 2006, Expert Rev Cardiovasc Ther, V4, P671, DOI 10.1586/14779072.4.5.671; Demirag M Kemal, 2003, Asian Cardiovasc Thorac Ann, V11, P213; Deng HY, 2006, ZHONG GUO LIN CHUANG, V17, P301; Eroglu AG, 2003, PEDIATR CARDIOL, V24, P31, DOI 10.1007/s00246-002-1345-3; FREEDOM RM, 1974, CIRCULATION, V49, P375, DOI 10.1161/01.CIR.49.2.375; Gabriel HM, 2002, J AM COLL CARDIOL, V39, P1066, DOI 10.1016/S0735-1097(02)01706-0; George B, 2014, J NUCL CARDIOL, V21, P686, DOI 10.1007/s12350-014-9908-2; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; IGNASZEWSKI AP, 1994, CAN J CARDIOL, V10, P67; King, 1999, Curr Treat Options Cardiovasc Med, V1, P311, DOI 10.1007/s11936-999-0026-4; Lin MH, 2001, J FORMOS MED ASSOC, V100, P539; Minette MS, 2006, CIRCULATION, V114, P2190, DOI 10.1161/CIRCULATIONAHA.106.618124; Miyake T, 2004, PEDIATR INT, V46, P135, DOI 10.1046/j.1442-200x.2004.01858.x; Mo X, 2001, JIANGSU MED J, V27, P81; NUGENT EW, 1977, CIRCULATION, V56, P82; OMOTO R, 1984, JPN HEART J, V25, P325; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sciomer S, 2007, PULM PHARMACOL THER, V20, P135, DOI 10.1016/j.pupt.2006.03.008; SHIRALI GS, 1995, AM HEART J, V130, P1228, DOI 10.1016/0002-8703(95)90147-7; SOTO B, 1980, BRIT HEART J, V43, P332; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; VANDENHEUVEL F, 1995, BRIT HEART J, V73, P49; Welton MG, 2001, PROGR PEDIAT CARDIOL, V14, P125; Wu MH, 2006, PEDIATRICS, V117, pE262, DOI 10.1542/peds.2005-1255; Zhao QM, 2013, ACTA PAEDIATR, V102, P397, DOI 10.1111/apa.12170; Zhuang J, 1999, Zhonghua Wai Ke Za Zhi, V37, P241	26	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113822	10.1371/journal.pone.0113822	http://dx.doi.org/10.1371/journal.pone.0113822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479616	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200032
J	Wawrousek, K; Noble, S; Korlach, J; Chen, J; Eckert, C; Yu, JP; Maness, PC				Wawrousek, Karen; Noble, Scott; Korlach, Jonas; Chen, Jin; Eckert, Carrie; Yu, Jianping; Maness, Pin-Ching			Genome Annotation Provides Insight into Carbon Monoxide and Hydrogen Metabolism in Rubrivivax gelatinosus	PLOS ONE			English	Article							FE-ONLY HYDROGENASE; IRON-SULFUR PROTEIN; RHODOSPIRILLUM-RUBRUM; PHYSIOLOGICAL CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATOR; TOLERANT HYDROGENASE; OXIDATION PATHWAY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DEHYDROGENASE	We report here the sequencing and analysis of the genome of the purple non-sulfur photosynthetic bacterium Rubrivivax gelatinosus CBS. This microbe is a model for studies of its carboxydotrophic life style under anaerobic condition, based on its ability to utilize carbon monoxide (CO) as the sole carbon substrate and water as the electron acceptor, yielding CO2 and H-2 as the end products. The CO-oxidation reaction is known to be catalyzed by two enzyme complexes, the CO dehydrogenase and hydrogenase. As expected, analysis of the genome of Rx. gelatinosus CBS reveals the presence of genes encoding both enzyme complexes. The CO-oxidation reaction is CO-inducible, which is consistent with the presence of two putative CO-sensing transcription factors in its genome. Genome analysis also reveals the presence of two additional hydrogenases, an uptake hydrogenase that liberates the electrons in H-2 in support of cell growth, and a regulatory hydrogenase that senses H-2 and relays the signal to a two-component system that ultimately controls synthesis of the uptake hydrogenase. The genome also contains two sets of hydrogenase maturation genes which are known to assemble the catalytic metallocluster of the hydrogenase NiFe active site. Collectively, the genome sequence and analysis information reveals the blueprint of an intricate network of signal transduction pathways and its underlying regulation that enables Rx. gelatinosus CBS to thrive on CO or H-2 in support of cell growth.	[Wawrousek, Karen; Eckert, Carrie; Yu, Jianping; Maness, Pin-Ching] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA; [Noble, Scott] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA; [Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA; [Chen, Jin] Michigan State Univ, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA	University of Wyoming; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Michigan State University	Maness, PC (corresponding author), Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.	pinching.maness@nrel.gov	; ECKERT, CARRIE/V-8199-2017	Yu, Jianping/0000-0003-0466-3197; Wawrousek, Karen/0000-0002-0764-703X; ECKERT, CARRIE/0000-0003-4201-2926	U.S. Department of Energy Fuel Cell Technologies Office; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG02-91ER20021]; University of Wyoming	U.S. Department of Energy Fuel Cell Technologies Office(United States Department of Energy (DOE)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); University of Wyoming	This work was supported by the U.S. Department of Energy Fuel Cell Technologies Office (to SN, CE, JY, and PCM), Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy award number DE-FG02-91ER20021 (to JC), and the University of Wyoming start-up funds (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1980, BIOCHIM BIOPHYS ACTA, V594, P105, DOI 10.1016/0304-4173(80)90007-5; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bashir A, 2012, NAT BIOTECHNOL, V30, P701, DOI 10.1038/nbt.2288; BONAM D, 1987, J BIOL CHEM, V262, P2980; BONAM D, 1984, J BACTERIOL, V159, P693, DOI 10.1128/JB.159.2.693-699.1984; BONAM D, 1989, J BACTERIOL, V171, P3102, DOI 10.1128/jb.171.6.3102-3107.1989; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CHAMPINE JE, 1987, J BACTERIOL, V169, P4784, DOI 10.1128/jb.169.10.4784-4789.1987; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Elsen S, 2003, J BACTERIOL, V185, P7111, DOI 10.1128/JB.185.24.7111-7119.2003; ENSIGN SA, 1991, J BIOL CHEM, V266, P18395; Forzi L, 2005, FEBS J, V272, P4741, DOI 10.1111/j.1742-4658.2005.04889.x; Fox JD, 1996, J BACTERIOL, V178, P1515, DOI 10.1128/jb.178.6.1515-1524.1996; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; Fritsch J, 2014, J BIOL CHEM, V289, P7982, DOI 10.1074/jbc.M113.544668; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hu PS, 2012, J BACTERIOL, V194, P3262, DOI 10.1128/JB.00515-12; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Kerby RL, 2008, J BACTERIOL, V190, P3336, DOI 10.1128/JB.00033-08; Kerby RL, 2011, J BACTERIOL, V193, P774, DOI 10.1128/JB.00794-10; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kunkel A, 1998, EUR J BIOCHEM, V252, P467, DOI 10.1046/j.1432-1327.1998.2520467.x; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lenz O, 1998, P NATL ACAD SCI USA, V95, P12474, DOI 10.1073/pnas.95.21.12474; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Manes PC, 2001, APPL MICROBIOL BIOT, V57, P751, DOI 10.1007/s00253-001-0828-0; Maness PC, 2005, APPL ENVIRON MICROB, V71, P2870, DOI 10.1128/AEM.71.6.2870-2874.2005; Maness PC, 2002, INT J HYDROGEN ENERG, V27, P1407, DOI 10.1016/S0360-3199(02)00107-6; Maness PC, 2002, APPL ENVIRON MICROB, V68, P2633, DOI 10.1128/AEM.68.6.2633-2636.2002; MANESS PC, 1994, APPL BIOCHEM BIOTECH, V45-6, P395, DOI 10.1007/BF02941814; Nagashima S, 2012, J BACTERIOL, V194, P3541, DOI 10.1128/JB.00511-12; Nikolskaya AN, 2002, NUCLEIC ACIDS RES, V30, P2453, DOI 10.1093/nar/30.11.2453; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Pelzmann A, 2009, J BIOL CHEM, V284, P9578, DOI 10.1074/jbc.M805354200; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Singer SW, 2006, BBA-BIOENERGETICS, V1757, P1582, DOI 10.1016/j.bbabio.2006.10.003; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; Tang KH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00165; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; UFFEN RL, 1983, J BACTERIOL, V155, P956, DOI 10.1128/JB.155.3.956-965.1983; Vanzin G, 2010, APPL ENVIRON MICROB, V76, P3715, DOI 10.1128/AEM.02753-09; Vignais PM, 2005, BIOCHEM SOC T, V33, P28, DOI 10.1042/BST0330028; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Watt RK, 1999, J BACTERIOL, V181, P4554, DOI 10.1128/JB.181.15.4554-4560.1999; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065	62	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114551	10.1371/journal.pone.0114551	http://dx.doi.org/10.1371/journal.pone.0114551			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479613	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200100
J	Neal-McKinney, JM; Samuelson, DR; Eucker, TP; Nissen, MS; Crespo, R; Konkel, ME				Neal-McKinney, Jason M.; Samuelson, Derrick R.; Eucker, Tyson P.; Nissen, Mark S.; Crespo, Rocio; Konkel, Michael E.			Reducing Campylobacter jejuni Colonization of Poultry via Vaccination	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; HUMAN EPITHELIAL-CELLS; CECAL COLONIZATION; BROILER-CHICKENS; FLAGELLIN GENES; C. JEJUNI; IDENTIFICATION; FIBRONECTIN; SALMONELLA; INFECTION	Campylobacter jejuni is a leading bacterial cause of human gastrointestinal disease worldwide. While C. jejuni is a commensal organism in chickens, case-studies have demonstrated a link between infection with C. jejuni and the consumption of foods that have been cross-contaminated with raw or undercooked poultry. We hypothesized that vaccination of chickens with C. jejuni surface-exposed colonization proteins (SECPs) would reduce the ability of C. jejuni to colonize chickens, thereby reducing the contamination of poultry products at the retail level and potentially providing a safer food product for consumers. To test our hypothesis, we injected chickens with recombinant C. jejuni peptides from CadF, FlaA, FlpA, CmeC, and a CadF-FlaA-FlpA fusion protein. Seven days following challenge, chickens were necropsied and cecal contents were serially diluted and plated to determine the number of C. jejuni per gram of material. The sera from the chickens were also analyzed to determine the concentration and specificity of antibodies reactive against the C. jejuni SECPs. Vaccination of chickens with the CadF, FlaA, and FlpA peptides resulted in a reduction in the number of C. jejuni in the ceca compared to the non-vaccinated C. jejuni-challenged group. The greatest reduction in C. jejuni colonization was observed in chickens injected with the FlaA, FlpA, or CadF-FlaA-FlpA fusion proteins. Vaccination of chickens with different SECPs resulted in the production of C. jejuni-specific IgY antibodies. In summary, we show that the vaccination of poultry with individual C. jejuni SECPs or a combination of SECPs provides protection of chickens from C. jejuni colonization.	[Neal-McKinney, Jason M.; Samuelson, Derrick R.; Eucker, Tyson P.; Nissen, Mark S.; Konkel, Michael E.] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Crespo, Rocio] Washington State Univ, Coll Vet Med, Avian Hlth & Food Safety Lab, Pullman, WA 99164 USA	Washington State University; Washington State University	Konkel, ME (corresponding author), Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA.	konkel@vetmed.wsu.edu	Samuelson, Derrick/AAR-4230-2021; Samuelson, Derrick/AAC-9132-2019	Samuelson, Derrick/0000-0002-5356-1413; Konkel, Michael/0000-0002-8950-0903; Crespo, Rocio/0000-0002-6286-1004	United States Department of Agriculture, National Institute of Food and Agriculture [2011-67015-30772]; National Institutes of General Medical Sciences Training Grant [T32GM083864, T32GM008336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336, T32GM083864] Funding Source: NIH RePORTER	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of General Medical Sciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds awarded to MEK from the United States Department of Agriculture, National Institute of Food and Agriculture (Award Number 2011-67015-30772) (www.nifa.usda.gov). DRS was partially supported by the National Institutes of General Medical Sciences Training Grant #T32GM083864 (www.nigms.nih.gov). TPE was partially supported by National Institutes of General Medical Sciences Training Grant #T32GM008336 (www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar VF, 2013, FOODBORNE PATHOG DIS, V10, P435, DOI 10.1089/fpd.2012.1302; Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905; Allen VM, 2008, BRIT POULTRY SCI, V49, P233, DOI 10.1080/00071660802094206; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Annamalai T, 2013, POULTRY SCI, V92, P2201, DOI 10.3382/ps.2012-03004; [Anonymous], J VACCINES VACCIN; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Baffoni L, 2012, INT J FOOD MICROBIOL, V157, P156, DOI 10.1016/j.ijfoodmicro.2012.04.024; Bahrndorff S, 2013, EMERG INFECT DIS, V19, P425, DOI 10.3201/eid1903.111593; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Boysen L, 2009, J FOOD PROTECT, V72, P497, DOI 10.4315/0362-028X-72.3.497; Buckley AM, 2010, VACCINE, V28, P1094, DOI 10.1016/j.vaccine.2009.10.018; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; Connerton PL, 2011, J APPL MICROBIOL, V111, P255, DOI 10.1111/j.1365-2672.2011.05012.x; Cox JM, 2010, J APPL MICROBIOL, V108, P745, DOI 10.1111/j.1365-2672.2009.04456.x; DOYLE MP, 1992, CAMPLYLOBACTER JEJUNI, P45; Dupuis L, 2006, ANN NY ACAD SCI, V1081, P202, DOI 10.1196/annals.1373.024; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fischer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078543; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Havelaar AH, 2007, RISK ANAL, V27, P831, DOI 10.1111/j.1539-6924.2007.00926.x; Hermans D, 2012, POULTRY SCI, V91, P1733, DOI 10.3382/ps.2011-02106; Hermans D, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-27; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Janez N, 2013, J MICROBIOL METH, V95, P68, DOI 10.1016/j.mimet.2013.06.024; Konkel ME, 2005, MOL MICROBIOL, V57, P1022, DOI 10.1111/j.1365-2958.2005.04744.x; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KONKEL ME, 1992, INFECT IMMUN, V60, P4945, DOI 10.1128/IAI.60.11.4945-4949.1992; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Laniewski P, 2014, WORLD J MICROB BIOT, V30, P281, DOI 10.1007/s11274-013-1447-5; Larson CL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.65; Layton SL, 2011, CLIN VACCINE IMMUNOL, V18, P449, DOI 10.1128/CVI.00379-10; Lehner Y, 2014, CURR MICROBIOL, V69, P240, DOI 10.1007/s00284-014-0575-y; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Meredith H, 2013, INT J FOOD MICROBIOL, V166, P309, DOI 10.1016/j.ijfoodmicro.2013.07.005; Metcalf JH, 2011, POULTRY SCI, V90, P494, DOI 10.3382/ps.2010-00891; MOROOKA T, 1985, J GEN MICROBIOL, V131, P1973; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Musavian HS, 2014, INT J FOOD MICROBIOL, V176, P23, DOI 10.1016/j.ijfoodmicro.2014.02.001; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Nagel GM, 2013, INT J FOOD MICROBIOL, V165, P281, DOI 10.1016/j.ijfoodmicro.2013.05.016; Nair DVT, 2014, POULTRY SCI, V93, P2636, DOI 10.3382/ps.2013-03858; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Newell DG, 2011, APPL ENVIRON MICROB, V77, P8605, DOI 10.1128/AEM.01090-10; NEWELL DG, 1986, J HYG-CAMBRIDGE, V96, P131, DOI 10.1017/S0022172400065906; PALERMO MS, 1991, CLIN IMMUNOL IMMUNOP, V58, P343, DOI 10.1016/0090-1229(91)90125-T; PAVLOVSKIS OR, 1991, INFECT IMMUN, V59, P2259, DOI 10.1128/IAI.59.7.2259-2264.1991; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; Robyn J, 2013, POULTRY SCI, V92, P1408, DOI 10.3382/ps.2012-02863; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Rowan NJ, 2007, J FOOD PROTECT, V70, P2805, DOI 10.4315/0362-028X-70.12.2805; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Schroder W, 1997, FEMS MICROBIOL LETT, V150, P141, DOI 10.1016/S0378-1097(97)00111-0; Schwerer B, 2002, MICROBES INFECT, V4, P373, DOI 10.1016/S1286-4579(02)01550-2; Shoaf-Sweeney KD, 2008, APPL ENVIRON MICROB, V74, P6867, DOI 10.1128/AEM.01097-08; Skanseng B, 2010, J APPL MICROBIOL, V109, P1265, DOI 10.1111/j.1365-2672.2010.04766.x; STERN NJ, 1992, CAMPLYLOBACTER JEJUNI, P49; Theoret JR, 2012, CLIN VACCINE IMMUNOL, V19, P1426, DOI 10.1128/CVI.00151-12; van Gerwe T, 2010, VET MICROBIOL, V143, P314, DOI 10.1016/j.vetmic.2009.11.029; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wagenaar JA, 2013, CLIN INFECT DIS, V57, P1600, DOI 10.1093/cid/cit555; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	75	49	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114254	10.1371/journal.pone.0114254	http://dx.doi.org/10.1371/journal.pone.0114254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474206	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500006
J	Parenti, R; Cardile, V; Graziano, ACE; Parenti, C; Venuti, A; Bertuccio, MP; Lo Furno, D; Magro, G				Parenti, Rosalba; Cardile, Venera; Graziano, Adriana Carol Eleonora; Parenti, Carmela; Venuti, Assunta; Bertuccio, Maria Paola; Lo Furno, Debora; Magro, Gaetano			Wilms' Tumor Gene 1 (WT1) Silencing Inhibits Proliferation of Malignant Peripheral Nerve Sheath Tumor sNF96.2 Cell Line	PLOS ONE			English	Article							PROTEIN WT1; SUPPRESSOR WT1; TRANSCRIPTIONAL REGULATION; MAMMALIAN TARGET; DOWN-REGULATION; GROWTH-FACTOR; UP-REGULATION; IN-VITRO; EXPRESSION; CANCER	Wilms' tumor gene 1 (WT1) plays complex roles in tumorigenesis, acting as tumor suppressor gene or an oncogene depending on the cellular context. WT1 expression has been variably reported in both benign and malignant peripheral nerve sheath tumors (MPNSTs) by means of immunohistochemistry. The aim of the present study was to characterize its potential pathogenetic role in these relatively uncommon malignant tumors. Firstly, immunohistochemical analyses in MPNST sNF96.2 cell line showed strong WT1 staining in nuclear and perinuclear areas of neoplastic cells. Thus, we investigated the effects of silencing WT1 by RNA interference. Through Western Blot analysis and proliferation assay we found that WT1 knockdown leads to the reduction of cell growth in a time- and dose-dependent manner. siWT1 inhibited proliferation of sNF96.2 cell lines likely by influencing cell cycle progression through a decrease in the protein levels of cyclin D1 and inhibition of Akt phosphorylation compared to the control cells. These results indicate that WT1 knockdown attenuates the biological behavior of MPNST cells by decreasing Akt activity, demonstrating that WT1 is involved in the development and progression of MPNSTs. Thus, WT1 is suggested to serve as a potential therapeutic target for MPNSTs.	[Parenti, Rosalba; Cardile, Venera; Graziano, Adriana Carol Eleonora; Lo Furno, Debora] Univ Catania, Physiol Sect, Dept Biomed & Biotechnol Sci, I-95125 Catania, Italy; [Parenti, Carmela] Univ Catania, Pharmacol & Toxicol Sect, Dept Drug Sci, I-95125 Catania, Italy; [Venuti, Assunta; Bertuccio, Maria Paola] Nerviano Med Sci Srl, Business Unit Oncol, I-20014 Nerviano Milano, Italy; [Magro, Gaetano] Univ Catania, Azienda Osped Univ Policlin Vittorio Emanuele Ana, Dept GF Ingrassia, I-95125 Catania, Italy	University of Catania; University of Catania; Nerviano Medical Sciences S.r.l; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania	Parenti, R (corresponding author), Univ Catania, Physiol Sect, Dept Biomed & Biotechnol Sci, I-95125 Catania, Italy.	parenti@unict.it	Parenti, Carmela/AAH-6439-2021; loreto, carla/AAC-2711-2019; Graziano, Adriana C E/J-9952-2016; Parenti, Rosalba/AAS-5489-2020; Bertuccio, Maria Paola/K-9814-2016; Furno, Debora Lo/P-1667-2019; Parenti, Rosalba/ABC-5780-2020; Venuti, Assunta/AFA-2281-2022	Graziano, Adriana C E/0000-0003-1652-9577; Bertuccio, Maria Paola/0000-0002-0644-8418; Furno, Debora Lo/0000-0002-1971-8990; Parenti, Rosalba/0000-0002-1614-4696; Venuti, Assunta/0000-0001-5438-1724; Magro, Gaetano Giuseppe/0000-0003-3244-6827; CARDILE, Venera/0000-0001-9902-3736	Ricerca e Competitivita, ASSE I [PON 01_02418F1]	Ricerca e Competitivita, ASSE I	The authors Venuti A and Bertuccio MP were supported by a grant under the project PON 01_02418F1 "Ricerca e Competitivita 2007-2013'', ASSE I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar EM, 1996, ONCOGENE, V12, P1005; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpentieri DF, 2002, MODERN PATHOL, V15, P1080, DOI 10.1097/01.MP.0000028646.03760.6B; Carroll SL, 2012, ACTA NEUROPATHOL, V123, P321, DOI 10.1007/s00401-011-0928-6; Chen MY, 2011, J NEURO-ONCOL, V103, P87, DOI 10.1007/s11060-010-0374-7; Chen ZX, 2001, INT J HEMATOL, V73, P39, DOI 10.1007/BF02981901; Clark AJ, 2010, J NEUROSURG, V112, P18, DOI 10.3171/2008.11.JNS08368; Dudnakova T, 2010, ONCOGENE, V29, P1085, DOI 10.1038/onc.2009.444; Ellisen LW, 2002, INT J HEMATOL, V76, P110, DOI 10.1007/BF02982572; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Fieber LA, 2003, NEUROBIOL DIS, V13, P136, DOI 10.1016/S0969-9961(03)00031-7; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Grobmyer SR, 2008, J SURG ONCOL, V97, P340, DOI 10.1002/jso.20971; Hartkamp J, 2008, BIOCHEM SOC T, V36, P629, DOI 10.1042/BST0360629; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hohenstein P, 2006, HUM MOL GENET, V15, pR196, DOI 10.1093/hmg/ddl196; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Inagaki Takuya, 2011, Jikeikai Medical Journal, V58, P95; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Jomgeow T, 2006, CANCER SCI, V97, P259, DOI 10.1111/j.1349-7006.2006.00169.x; Katz D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001227; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Koesters R, 2004, INT J CANCER, V109, P385, DOI 10.1002/ijc.11721; Lee PR, 2004, NEURON GLIA BIOL, V1, P135, DOI 10.1017/S1740925X04000274; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Li YW, 2004, ONCOGENE, V23, P1146, DOI 10.1038/sj.onc.1207068; Liu XW, 2001, J BIOL CHEM, V276, P5068, DOI 10.1074/jbc.M008776200; Loeb DM, 2001, CANCER RES, V61, P921; Loeb DM, 2006, CELL CYCLE, V5, P1249, DOI 10.4161/cc.5.12.2807; Loeb DM, 2002, J BIOL CHEM, V277, P19627, DOI 10.1074/jbc.M201336200; Lovell MA, 2003, BRAIN RES, V983, P84, DOI 10.1016/S0006-8993(03)03032-4; Magro G, 2014, ACTA HISTOCHEM, V116, P905, DOI 10.1016/j.acthis.2014.03.001; Mahzouni Parvin, 2013, Adv Biomed Res, V2, P33, DOI 10.4103/2277-9175.108772; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Menke AL, 1998, INT REV CYTOL, V181, P151, DOI 10.1016/S0074-7696(08)60418-0; MIWA H, 1992, LEUKEMIA, V6, P405; Nakatsuka S, 2006, MODERN PATHOL, V19, P804, DOI 10.1038/modpathol.3800588; Navakanit Ruxapon, 2007, Journal of the Medical Association of Thailand, V90, P2416; Nik SA, 2005, INT J CANCER, V114, P202, DOI 10.1002/ijc.20717; Niksic M, 2004, HUM MOL GENET, V13, P463, DOI 10.1093/hmg/ddh040; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Oji Y, 2004, CANCER SCI, V95, P583, DOI 10.1111/j.1349-7006.2004.tb02490.x; Oue T, 2011, J PEDIATR SURG, V46, P2233, DOI 10.1016/j.jpedsurg.2011.09.004; Ouyang WM, 2007, J CELL BIOCHEM, V101, P969, DOI 10.1002/jcb.21279; Parenti R, 2014, ACTA HISTOCHEM, V116, P48, DOI 10.1016/j.acthis.2013.05.003; Parenti R, 2013, ACTA HISTOCHEM, V115, P70, DOI 10.1016/j.acthis.2012.04.006; Park HJ, 2013, INT J ONCOL, V42, P657, DOI 10.3892/ijo.2012.1751; Roberts SGE, 2006, BIOCHEM SOC SYMP, V73, P191; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Rong Y, 2006, CANCER RES, V66, P8049, DOI 10.1158/0008-5472.CAN-06-1172; Salvatorelli L, 2011, PATHOLOGICA, V103, P186; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Schittenhelm J, 2010, CANCER BIOMARK, V7, P73, DOI 10.3233/CBM-2010-0149; Singh A, 2012, PATHOL ONCOL RES, V18, P383, DOI 10.1007/s12253-011-9456-x; Spurlock G, 2010, J CANCER RES CLIN, V136, P1869, DOI 10.1007/s00432-010-0846-3; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Tatsumi N, 2008, INT J ONCOL, V32, P701; Tuna M, 2005, ONCOGENE, V24, P1648, DOI 10.1038/sj.onc.1208345; Ueda T, 2003, CANCER SCI, V94, P271, DOI 10.1111/j.1349-7006.2003.tb01432.x; Upadhyaya M, 2011, FRONT BIOSCI-LANDMRK, V16, P937, DOI 10.2741/3727; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Wagner N, 2002, CELL GROWTH DIFFER, V13, P297; Wagner N, 2008, PFLUG ARCH EUR J PHY, V455, P839, DOI 10.1007/s00424-007-0340-1; Wang JF, 2011, J PEDIATR SURG, V46, P326, DOI 10.1016/j.jpedsurg.2010.11.011; Wang X, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-114; Weiss SW, 2008, ENZINGER WEISSS SOFT, P903; Wilm B, 2010, INT J MOL EPIDEMIOL, V1, P75; Wu J, 2014, ONCOGENE, V33, P173, DOI 10.1038/onc.2012.579; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068837; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Zamora-Avila DE, 2009, CANCER GENE THER, V16, P892, DOI 10.1038/cgt.2009.35; Zamora-Avila DE, 2007, MELANOMA RES, V17, P341, DOI 10.1097/CMR.0b013e3282efd3ae; Zapata-Benavides P, 2002, BIOCHEM BIOPH RES CO, V295, P784, DOI 10.1016/S0006-291X(02)00751-9; Zapata-Benavides P, 2012, ONCOL LETT, V3, P751, DOI 10.3892/ol.2012.578; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	83	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114333	10.1371/journal.pone.0114333	http://dx.doi.org/10.1371/journal.pone.0114333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474318	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500016
J	Duval, C; Cohen, C; Chagnoleau, C; Flouret, V; Bourreau, E; Bernerd, F				Duval, Christine; Cohen, Catherine; Chagnoleau, Corinne; Flouret, Virginie; Bourreau, Emilie; Bernerd, Francoise			Key Regulatory Role of Dermal Fibroblasts in Pigmentation as Demonstrated Using a Reconstructed Skin Model: Impact of Photo-Aging	PLOS ONE			English	Article							STEM-CELL FACTOR; HEPATOCYTE GROWTH-FACTOR; NORMAL HUMAN MELANOCYTES; SUN EXPOSURE; HYPERPIGMENTATION; MORPHOGENESIS; KERATINOCYTES; EXPRESSION; MECHANISM; HORMONE	To study cutaneous pigmentation in a physiological context, we have previously developed a functional pigmented reconstructed skin model composed of a melanocyte-containing epidermis grown on a dermal equivalent comprising living fibroblasts. The present studies, using the same model, aimed to demonstrate that dermal fibroblasts influence skin pigmentation up to the macroscopic level. The proof of principle was performed with pigmented skins differing only in the fibroblast component. First, the in vitro system was reconstructed with or without fibroblasts in order to test the global influence of the presence of this cell type. We then assessed the impact of the origin of the fibroblast strain on the degree of pigmentation using fetal versus adult fibroblasts. In both experiments, impressive variation in skin pigmentation at the macroscopic level was observed and confirmed by quantitative parameters related to skin color, melanin content and melanocyte numbers. These data confirmed the responsiveness of the model and demonstrated that dermal fibroblasts do indeed impact the degree of skin pigmentation. We then hypothesized that a physiological state associated with pigmentary alterations such as photo-aging could be linked to dermal fibroblasts modifications that accumulate over time. Pigmentation of skin reconstructed using young unexposed fibroblasts (n=3) was compared to that of tissues containing natural photo-aged fibroblasts (n=3) which express a senescent phenotype. A stimulation of pigmentation in the presence of the natural photo-aged fibroblasts was revealed by a significant increase in the skin color (decrease in Luminance) and an increase in both epidermal melanin content and melanogenic gene expression, thus confirming our hypothesis. Altogether, these data demonstrate that the level of pigmentation of the skin model is influenced by dermal fibroblasts and that natural photo-aged to fibroblasts can contribute to the hyperpigmentation that is associated with photoaging.	[Duval, Christine; Cohen, Catherine; Chagnoleau, Corinne; Flouret, Virginie; Bourreau, Emilie; Bernerd, Francoise] LOreal Res & Innovat, Aulnay Sous Bois, France	L'Oreal Group	Duval, C (corresponding author), LOreal Res & Innovat, Aulnay Sous Bois, France.	cduval@rd.loreal.com			L'Oreal Research Innovation	L'Oreal Research Innovation	The authors received no specific funding for this work. L'Oreal Research & Innovation provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; Bastiaens M, 2004, PIGM CELL RES, V17, P225, DOI 10.1111/j.1600-0749.2004.00131.x; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; BREATHNACH AS, 1991, PIGM CELL RES, V4, P71, DOI 10.1111/j.1600-0749.1991.tb00318.x; BUFFEY JA, 1994, BRIT J DERMATOL, V131, P836, DOI 10.1111/j.1365-2133.1994.tb08586.x; Cardinali G, 2009, EUR J DERMATOL, V19, P469, DOI 10.1684/ejd.2009.0724; Cario-Andre M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x; Castanet J, 1997, ARCH DERMATOL, V133, P1296, DOI 10.1001/archderm.133.10.1296; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Chung H, 2014, J BIOL CHEM, V289, P21751, DOI 10.1074/jbc.M113.541177; CIE, 1986, COL, P29; Duval C, 2001, PIGM CELL RES, V14, P348, DOI 10.1034/j.1600-0749.2001.140506.x; Duval C, 2012, TISSUE ENG PART C-ME, V18, P947, DOI [10.1089/ten.tec.2011.0676, 10.1089/ten.TEC.2011.0676]; Enomoto A, 2011, AM J PATHOL, V178, P679, DOI 10.1016/j.ajpath.2010.10.021; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; Hedley SJ, 1997, PIGM CELL RES, V10, P54, DOI 10.1111/j.1600-0749.1997.tb00466.x; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HOLZLE E, 1992, BRIT J DERMATOL, V127, P48, DOI 10.1111/j.1365-2133.1992.tb16989.x; Imokawa G, 1998, BIOCHEM J, V330, P1235, DOI 10.1042/bj3301235; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kawabata K, 2014, SKIN RES TECHNOL, V20, P155, DOI 10.1111/srt.12099; Kihira C, 1999, J DERMATOL SCI, V20, P72, DOI 10.1016/S0923-1811(98)00077-2; Kim E, 2013, CANCER RES, V73, P6874, DOI 10.1158/0008-5472.CAN-13-1720; Kovacs D, 2010, BRIT J DERMATOL, V163, P1020, DOI 10.1111/j.1365-2133.2010.09946.x; Lavker Robert M., 1995, P123; Marionnet C, 2006, EXP DERMATOL, V15, P625, DOI 10.1111/j.1600-0625.2006.00454.x; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V176, P45, DOI 10.1016/0006-291X(91)90887-D; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Mildner M, 2007, J INVEST DERMATOL, V127, P2637, DOI 10.1038/sj.jid.5700938; Monestier S, 2006, BRIT J DERMATOL, V154, P438, DOI 10.1111/j.1365-2133.2005.06996.x; Nakazawa K, 1997, PIGM CELL RES, V10, P382, DOI 10.1111/j.1600-0749.1997.tb00696.x; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Nouveau-Richard S, 2005, J DERMATOL SCI, V40, P187, DOI 10.1016/j.jdermsci.2005.06.006; Okazaki M, 2005, SCAND J PLAST RECONS, V39, P339, DOI 10.1080/02844310500300362; Okazaki M, 2003, BRIT J DERMATOL, V148, P689, DOI 10.1046/j.1365-2133.2003.05283.x; Ortonne JP, 2008, J INVEST DERM SYMP P, V13, P10, DOI 10.1038/jidsymp.2008.7; Pouyani T, 2012, IN VITRO CELL DEV-AN, V48, P493, DOI 10.1007/s11626-012-9541-9; Ramelet AA, 2009, EXP GERONTOL, V44, P208, DOI 10.1016/j.exger.2008.11.004; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Scott G, 1997, J INVEST DERMATOL, V108, P147, DOI 10.1111/1523-1747.ep12332650; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shin J, 2012, J EUR ACAD DERMATOL, V26, P1577, DOI 10.1111/j.1468-3083.2011.04223.x; Shishido E, 2001, J INVEST DERMATOL, V117, P627, DOI 10.1046/j.0022-202x.2001.01440.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Souto Luís Ricardo Martinhão, 2006, Sao Paulo Med. J., V124, P71, DOI 10.1590/S1516-31802006000200005; SWOPE VB, 1991, J INVEST DERMATOL, V96, P180, DOI 10.1111/1523-1747.ep12460991; Varani J, 2004, J INVEST DERMATOL, V122, P1471, DOI 10.1111/j.0022-202X.2004.22614.x; Wlaschek M, 2001, J PHOTOCH PHOTOBIO B, V63, P41, DOI 10.1016/S1011-1344(01)00201-9; Yaar M, 1995, Adv Dermatol, V10, P63; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yamamoto T, 2001, BRIT J DERMATOL, V144, P199, DOI 10.1046/j.1365-2133.2001.03983.x; Zuliani T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070408	64	65	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114182	10.1371/journal.pone.0114182	http://dx.doi.org/10.1371/journal.pone.0114182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490395	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300018
J	Handa, H; Usuba, A; Maddula, S; Baumbach, JI; Mineshita, M; Miyazawa, T				Handa, Hiroshi; Usuba, Ayano; Maddula, Sasidhar; Baumbach, Joerg Ingo; Mineshita, Masamichi; Miyazawa, Teruomi			Exhaled Breath Analysis for Lung Cancer Detection Using Ion Mobility Spectrometry	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; CANINE SCENT DETECTION; BIOMARKERS; DIAGNOSIS; ARRAY; CONDENSATE; MUTATIONS; PROFILES; AIR	Background: Conventional methods for lung cancer detection including computed tomography (CT) and bronchoscopy are expensive and invasive. Thus, there is still a need for an optimal lung cancer detection technique. Methods: The exhaled breath of 50 patients with lung cancer histologically proven by bronchoscopic biopsy samples (32 adenocarcinomas, 10 squamous cell carcinomas, 8 small cell carcinomas), were analyzed using ion mobility spectrometry (IMS) and compared with 39 healthy volunteers. As a secondary assessment, we compared adenocarcinoma patients with and without epidermal growth factor receptor (EGFR) mutation. Results: A decision tree algorithm could separate patients with lung cancer including adenocarcinoma, squamous cell carcinoma and small cell carcinoma. One hundred-fifteen separated volatile organic compound (VOC) peaks were analyzed. Peak-2 noted as n-Dodecane using the IMS database was able to separate values with a sensitivity of 70.0% and a specificity of 89.7%. Incorporating a decision tree algorithm starting with n-Dodecane, a sensitivity of 76% and specificity of 100% was achieved. Comparing VOC peaks between adenocarcinoma and healthy subjects, n-Dodecane was able to separate values with a sensitivity of 81.3% and a specificity of 89.7%. Fourteen patients positive for EGFR mutation displayed a significantly higher n-Dodecane than for the 14 patients negative for EGFR (p<0.01), with a sensitivity of 85.7% and a specificity of 78.6%. Conclusion: In this prospective study, VOC peak patterns using a decision tree algorithm were useful in the detection of lung cancer. Moreover, n-Dodecane analysis from adenocarcinoma patients might be useful to discriminate the EGFR mutation.	[Handa, Hiroshi; Usuba, Ayano; Mineshita, Masamichi; Miyazawa, Teruomi] St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan; [Maddula, Sasidhar] BioMedicalCtr, B&S Analyt, Dortmund, Germany; [Baumbach, Joerg Ingo] Reutlingen Univ, Fac Appl Chem, Reutlingen, Germany	Saint Marianna University	Miyazawa, T (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Resp & Infect Dis, Kawasaki, Kanagawa, Japan.	miyazawat@marianna-u.ac.jp			Japan Society for Promotion of Science [20410061, 24800068]; Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) [SFB 876]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich)(German Research Foundation (DFG))	This study was supported by the Japan Society for Promotion of Science and by Grants-in-Aid for Scientific Research (20410061, 24800068). Dr. Baumbach was supported by Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) SFB 876 "Providing Information by Resource-Constrained Analysis'', project TB1 "Resource-Constrained Analysis of Spectrometry Data''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader S, 2006, J CHEMOMETR, V20, P128, DOI 10.1002/cem.998; Baumbach JI, 2011, INT J ION MOBIL SPEC, V14, P159, DOI 10.1007/s12127-011-0078-5; Baumbach JI, 2006, ANAL BIOANAL CHEM, V384, P1059, DOI 10.1007/s00216-005-3397-8; Bodeker B, 2010, INT J ION MOBIL SPEC, V13, P177, DOI 10.1007/s12127-010-0044-7; Bodeker B, 2009, INT J ION MOBIL SPEC, V12, P103, DOI 10.1007/s12127-009-0024-y; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P89, DOI 10.1007/s12127-008-0013-6; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P83, DOI 10.1007/s12127-008-0012-7; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P77, DOI 10.1007/s12127-008-0011-8; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Bunkowski A, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046001; Bunkowski A, 2010, INT J ION MOBIL SPEC, V13, P141, DOI 10.1007/s12127-010-0052-7; Chen X, 2005, MEAS SCI TECHNOL, V16, P1535, DOI 10.1088/0957-0233/16/8/001; Darwiche K, 2011, LUNG, V189, P445, DOI 10.1007/s00408-011-9324-1; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Fink T, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027104; GORDON SM, 1985, CLIN CHEM, V31, P1278; Hauschild AC, 2012, GENET MOL RES, V11, P2733, DOI 10.4238/2012.July.10.17; Hauschild AC, 2012, METABOLITES, V2, P733, DOI 10.3390/metabo2040733; Hauschild AC, 2013, METABOLITES, V3, P277, DOI 10.3390/metabo3020277; Junger M, 2010, ANAL BIOANAL CHEM, V396, P471, DOI 10.1007/s00216-009-3168-z; Kreuer S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05423; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Maddula S, 2012, INT J ION MOBIL SPEC, V15, P79, DOI 10.1007/s12127-012-0089-x; Maddula S, 2009, ANAL BIOANAL CHEM, V394, P791, DOI 10.1007/s00216-009-2758-0; Mazzone PJ, 2010, EUR RESPIR MONOGR, P130, DOI 10.1183/1025448x.00018709; Mazzone PJ, 2007, THORAX, V62, P565, DOI 10.1136/thx.2006.072892; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Nana-Sinkam SP, 2013, CHEST, V143, pE30, DOI 10.1378/chest.12-2346; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Paradiso A, 2008, EUR RESPIR J, V32, P1126, DOI 10.1183/09031936.00083008; Peng G, 2008, NANO LETT, V8, P3631, DOI 10.1021/nl801577u; Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Saijo N, 2010, JPN J CLIN ONCOL, V40, pi7, DOI 10.1093/jjco/hyq121; Smolinska A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027105; Westhoff M, 2007, J PHYSIOL PHARMACOL, V58, P739; Westhoff M, 2011, INT J ION MOBIL SPEC, V14, P139, DOI 10.1007/s12127-011-0081-x; Westhoff M, 2009, THORAX, V64, P744, DOI 10.1136/thx.2008.099465; Westhoff M, 2010, INT J ION MOBIL SPEC, V13, P131, DOI 10.1007/s12127-010-0049-2; Zhang D, 2011, LUNG CANCER, V73, P379, DOI 10.1016/j.lungcan.2011.05.018	43	70	76	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114555	10.1371/journal.pone.0114555	http://dx.doi.org/10.1371/journal.pone.0114555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490772	Green Published, gold			2022-12-26	WOS:000347515300051
J	Khalek, WA; Cortade, F; Ollendorff, V; Lapasset, L; Tintignac, L; Chabi, B; Wrutniak-Cabello, C				Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Lapasset, Laure; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal			SIRT3, a Mitochondrial NAD(+)-Dependent Deacetylase, Is Involved in the Regulation of Myoblast Differentiation	PLOS ONE			English	Article							INHIBITS SKELETAL MYOGENESIS; KAPPA-B; CALORIE RESTRICTION; MUSCLE; EXPRESSION; BIOGENESIS; SIRTUINS; OXYGEN; MYOD; RESPIRATION	Sirtuin 3 (SIRT3), one of the seven mammalian sirtuins, is a mitochondrial NAD(+)-dependent deacetylase known to control key metabolic pathways. SIRT3 deacetylases and activates a large number of mitochondrial enzymes involved in the respiratory chain, in ATP production, and in both the citric acid and urea cycles. We have previously shown that the regulation of myoblast differentiation is tightly linked to mitochondrial activity. Since SIRT3 modulates mitochondrial activity, we decide to address its role during myoblast differentiation. For this purpose, we first investigated the expression of endogenous SIRT3 during C2C12 myoblast differentiation. We further studied the impact of SIRT3 silencing on both the myogenic potential and the mitochondrial activity of C2C12 cells. We showed that SIRT3 protein expression peaked at the onset of myoblast differentiation. The inhibition of SIRT3 expression mediated by the stable integration of SIRT3 short inhibitory RNA (SIRT3shRNA) in C2C12 myoblasts, resulted in: 1) abrogation of terminal differentiation - as evidenced by a marked decrease in the myoblast fusion index and a significant reduction of Myogenin, MyoD, Sirtuin 1 and Troponin T protein expression - restored upon MyoD overexpression; 2) a decrease in peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and citrate synthase protein expression reflecting an alteration of mitochondrial density; and 3) an increased production of reactive oxygen species (ROS) mirrored by the decreased activity of manganese superoxide dismutase (MnSOD). Altogether our data demonstrate that SIRT3 mainly regulates myoblast differentiation via its influence on mitochondrial activity.	[Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Lapasset, Laure; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] Univ Montpellier I, F-34000 Montpellier, France; [Khalek, Waed Abdel; Cortade, Fabienne; Ollendorff, Vincent; Lapasset, Laure; Tintignac, Lionel; Chabi, Beatrice; Wrutniak-Cabello, Chantal] Univ Montpellier 2, Montpellier, France; [Lapasset, Laure] IGMM, Inst Genet Mol Montpellier, CNRS UMR5535, Montpellier, France; [Tintignac, Lionel] Univ Basel, Biozentrum, Basel, Switzerland	INRAE; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Basel	Wrutniak-Cabello, C (corresponding author), INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	wrutniak@supagro.inra.fr	Chabi, Beatrice/AAI-6545-2020	Chabi, Beatrice/0000-0002-5604-5668	Institut National de la Recherche Agronomique (INRA); INRA; Ecole Doctorale CBS2	Institut National de la Recherche Agronomique (INRA); INRA; Ecole Doctorale CBS2	This study was supported by funds from the Institut National de la Recherche Agronomique (INRA). WAK was a recipient of doctoral fellowship financed by INRA and Ecole Doctorale CBS2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Laguerre M, 2011, J PHARM PHARMACOL, V63, P531, DOI 10.1111/j.2042-7158.2010.01216.x; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wharton DC., 1967, METHOD ENZYMOL, P245; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhong L, 2011, CELL METAB, V13, P621, DOI 10.1016/j.cmet.2011.05.004	46	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114388	10.1371/journal.pone.0114388	http://dx.doi.org/10.1371/journal.pone.0114388			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489948	gold, Green Published			2022-12-26	WOS:000347515300034
J	Cai, JY; Gong, R; Yan, FJ; Yu, CJ; Liu, L; Wang, W; Lin, Y; Guo, MX; Li, WX; Huang, Z				Cai, Jinyang; Gong, Rui; Yan, Fengjuan; Yu, Chunjie; Liu, Lu; Wang, Wei; Lin, Yi; Guo, Mingxiong; Li, Wenxin; Huang, Zan			ZNF300 Knockdown Inhibits Forced Megakaryocytic Differentiation by Phorbol and Erythrocytic Differentiation by Arabinofuranosyl Cytidine in K562 Cells	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; ERYTHROLEUKEMIC CELLS; COREPRESSOR KAP-1; N-COR; ARA-C; GENES; IDENTIFICATION; CONTRIBUTES; REPRESSION; INDUCTION	Previously, we reported that ZNF300 might play a role in leukemogenesis. In this study, we further investigated the function of ZNF300 in K562 cells undergoing differentiation. We found that ZNF300 upregulation in K562 cells coincided with megakaryocytic differentiation induced by phorbol-12-myristate-13-acetate (PMA) or erythrocytic differentiation induced by cytosine arabinoside (Ara-C), respectively. To further test whether ZNF300 upregulation promoted differentiation, we knocked down ZNF300 and found that ZNF300 knockdown effectively abolished PMA-induced megakaryocytic differentiation, evidenced by decreased CD61 expression. Furthermore, Ara-C-induced erythrocytic differentiation was also suppressed in ZNF300 knockdown cells with decreased c-globin expression and CD235a expression. These observations suggest that ZNF300 may be a critical factor controlling distinct aspects of K562 cells. Indeed, ZNF300 knockdown led to increased cell proliferation. Consistently, ZNF300 knockdown cells exhibited an increased percentage of cells at S phase accompanied by decreased percentage of cells at G0/G1 and G2/M phase. Increased cell proliferation was further supported by the increased expression of cell proliferation marker PCNA and the decreased expression of cell cycle regulator p15 and p27. In addition, MAPK/ERK signaling was significantly suppressed by ZNF300 knockdown. These findings suggest a potential mechanism by which ZNF300 knockdown may impair megakaryocytic and erythrocytic differentiation.	[Cai, Jinyang; Wang, Wei; Li, Wenxin] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Cai, Jinyang; Yan, Fengjuan; Yu, Chunjie; Liu, Lu; Wang, Wei; Lin, Yi; Guo, Mingxiong; Li, Wenxin; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Gong, Rui] Hubei Entry Exit Inspect & Quarantine Bur PR Chin, Hubei Int Travel Healthcare Ctr, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; z-huang@whu.edu.cn	LIN, YI/AAC-3335-2020; Cai, Jinyang/HCH-0290-2022	LIN, YI/0000-0001-8209-1185; Liu, Lu/0000-0001-7984-6671; Cai, Jinyang/0000-0002-7385-8281; Yu, Chunjie/0000-0003-2161-3394; Huang, Zan/0000-0001-5623-6950; Wang, Wei/0000-0001-7429-1013	National Natural Science Foundation of China [81070406, 31371481]; Ph.D. Programs Foundation of Ministry of Education of China [20110141110016]; New Century Excellent Talents in University (NCET) of Ministry of Education of China [NCET-12-0422]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); New Century Excellent Talents in University (NCET) of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (Grant Nos. 81070406 and 31371481 to ZH), Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20110141110016 to ZH), and New Century Excellent Talents in University (NCET) of Ministry of Education of China (NCET-12-0422 to ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brzezianska E, 2011, FRONT BIOSCI-LANDMRK, V16, P422, DOI 10.2741/3696; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Ferguson LR, 2007, CELL MOL LIFE SCI, V64, P3105, DOI 10.1007/s00018-007-7303-8; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gou DM, 2004, BBA-GENE STRUCT EXPR, V1676, P203, DOI 10.1016/j.bbaexp.2003.11.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; LUISIDELUCA C, 1984, J CLIN INVEST, V74, P821, DOI 10.1172/JCI111498; Mark C, 1999, DNA CELL BIOL, V18, P381, DOI 10.1089/104454999315277; Nolte F, 2008, ANN HEMATOL, V87, P777, DOI 10.1007/s00277-008-0502-z; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Qiu HL, 2008, CELL MOL BIOL LETT, V13, P391, DOI 10.2478/s11658-008-0005-x; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Takagaki K, 2005, GENES CELLS, V10, P97, DOI 10.1111/j.1365-2443.2005.00821.x; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; WANDA PE, 1989, LEUKEMIA RES, V13, P683, DOI 10.1016/0145-2126(89)90057-X; Wang T, 2012, J CELL MOL MED, V16, P1134, DOI 10.1111/j.1582-4934.2011.01388.x; Wang W, 2013, CELL MOL LIFE SCI, V70, P3947, DOI 10.1007/s00018-013-1359-4; Wang W, 2012, J BIOL CHEM, V287, P42856, DOI 10.1074/jbc.M112.399923; Xu JH, 2010, LEUKEMIA RES, V34, P1636, DOI 10.1016/j.leukres.2010.04.009; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72	36	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114768	10.1371/journal.pone.0114768	http://dx.doi.org/10.1371/journal.pone.0114768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485965	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600096
J	Lee, JC; Park, BK; Choung, S; Kim, JM; Joung, KH; Lee, JH; Kim, KS; Kim, HJ; Jeong, JW; Dal Rhee, S; Ku, BJ				Lee, Jun Choul; Park, Byung Kil; Choung, Sorim; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; Kim, Koon Soon; Kim, Hyun Jin; Jeong, Jae-Wook; Dal Rhee, Sang; Ku, Bon Jeong			Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GENE; MUTATION	Mitogen-inducible gene 6 (Mig-6) is a negative feedback inhibitor of epidermal growth factor receptor (EGFR) signaling. We previously found that Mig-6 plays a critical role in the regulation of cholesterol homeostasis and in bile acid synthesis. In this study, we investigated the effects of EGFR inhibition to identify a potential new treatment target for hypercholesterolemia. We used a mouse model with conditional ablation of the Mig-6 gene in the liver (Alb(cre/+) Mig-6(f/f); Mig-6(d/d)) to effectively investigate the role of Mig-6 in the regulation of liver function. Mig-6(d/d) mice were treated with either the EGFR inhibitor gefitinib or statin for 6 weeks after administration of a high-fat or standard diet. We then compared lipid profiles and other parameters among each group of mice. After a high-fat diet, Mig-6(d/d) mice showed elevated serum levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides and glucose, characteristics resembling hypercholesterolemia in diabetic patients. We observed decreases in serum levels of lipids and glucose in high-fat-diet-fed Mig-6(d/d) mice after 6 weeks of treatment with gefitinib or statin. Furthermore gefitinib-treated mice showed significantly greater decreases in serum levels of total, HDL and LDL cholesterol compared with statin-treated mice. Taken together, these results suggest that EGFR inhibition is effective for the treatment of hypercholesterolemia in high-fat-diet-fed Mig-6(d/d) mice, and our findings provide new insights into the development of possible treatment targets for hypercholesterolemia via modulation of EGFR inhibition.	[Lee, Jun Choul; Choung, Sorim; Kim, Ji Min; Joung, Kyong Hye; Lee, Ju Hee; Kim, Koon Soon; Kim, Hyun Jin; Ku, Bon Jeong] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea; [Lee, Jun Choul] Daejeon Vet Hosp, Dept Internal Med, Taejon, South Korea; [Park, Byung Kil; Dal Rhee, Sang] Chungnam Natl Univ, Grad Sch New Drug Dev & Discovery, Dept Drug Dev & Discovery, Taejon, South Korea; [Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Dal Rhee, Sang] Korea Res Inst Chem Technol, Res Ctr Drug Discovery Technol, Div Drug Discovery Res, Taejon, South Korea	Chungnam National University; Chungnam National University; Michigan State University; Korea Research Institute of Chemical Technology (KRICT)	Dal Rhee, S (corresponding author), Chungnam Natl Univ, Grad Sch New Drug Dev & Discovery, Dept Drug Dev & Discovery, Taejon, South Korea.	sdrhee@krict.re.kr; bonjeong@cnu.ac.kr		Lee, Ju Hee/0000-0001-5976-7175; Kim, Hyun Jin/0000-0002-6760-4963; Ku, Bon Jeong/0000-0002-3414-8949	National Research Foundation of Korea (NRF) grant - Korean Government [NRF-2013R1A1A2004719]; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) grant - Korean Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2013R1A1A2004719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; Bhatnagar D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a993; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chen YC, 2013, MOL ENDOCRINOL, V27, P162, DOI 10.1210/me.2012-1174; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jin N, 2007, GENESIS, V45, P716, DOI 10.1002/dvg.20348; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Ku BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042915; Lee HY, 2014, CIRC J, V78, P281, DOI 10.1253/circj.CJ-13-1494; Lim S, 2013, INT J CARDIOL, V167, P1696, DOI 10.1016/j.ijcard.2012.10.037; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Nagashima T, 2009, FEBS J, V276, P5239, DOI 10.1111/j.1742-4658.2009.07220.x; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Reschke M, 2010, HEPATOLOGY, V51, P1383, DOI 10.1002/hep.23428; Santos RD, 2014, CURR OPIN LIPIDOL, V25, P183, DOI 10.1097/MOL.0000000000000073; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Wong RWC, 2003, CELL MOL LIFE SCI, V60, P113, DOI 10.1007/s000180300007; Zhang YW, 2007, CELL CYCLE, V6, P507, DOI 10.4161/cc.6.5.3928	27	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114782	10.1371/journal.pone.0114782	http://dx.doi.org/10.1371/journal.pone.0114782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486251	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600099
J	Muthusamy, V; Hossain, F; Thirunavukkarasu, N; Choudhary, M; Saha, S; Bhat, JS; Prasanna, BM; Gupta, HS				Muthusamy, Vignesh; Hossain, Firoz; Thirunavukkarasu, Nepolean; Choudhary, Mukesh; Saha, Supradip; Bhat, Jayant S.; Prasanna, Boddupalli M.; Gupta, Hari S.			Development of beta-Carotene Rich Maize Hybrids through Marker-Assisted Introgression of beta-carotene hydroxylase Allele	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; GENETIC-VARIATION; BLAST RESISTANCE; BIOFORTIFICATION; ACCUMULATION; VARIABILITY; PROVITAMIN; INBREDS; LOCUS; TOOLS	Development of vitamin A-rich cereals can help in alleviating the widespread problem of vitamin A deficiency. We report here significant enhancement of kernel beta-carotene in elite maize genotypes through accelerated marker-assisted backcross breeding. A favourable allele (543 bp) of the beta-carotene hydroxylase (crtRB1) gene was introgressed in the seven elite inbred parents, which were low (1.4 mu g/g) in kernel beta-carotene, by using a crtRB1-specific DNA marker for foreground selection. About 90% of the recurrent parent genome was recovered in the selected progenies within two backcross generations. Concentration of beta-carotene among the crtRB1-introgressed inbreds varied from 8.6 to 17.5 mu g/g - a maximum increase up to 12.6-fold over recurrent parent. The reconstituted hybrids developed from improved parental inbreds also showed enhanced kernel beta-carotene as high as 21.7 mu g/g, compared to 2.6 mu g/g in the original hybrid. The reconstituted hybrids evaluated at two locations possessed similar grain yield to that of original hybrids. These beta-carotene enriched high yielding hybrids can be effectively utilized in the maize biofortification programs across the globe.	[Muthusamy, Vignesh; Hossain, Firoz; Thirunavukkarasu, Nepolean; Choudhary, Mukesh; Prasanna, Boddupalli M.; Gupta, Hari S.] Indian Agr Res Inst, Div Genet, ICAR, New Delhi 110012, India; [Saha, Supradip] Indian Agr Res Inst, Div Agr Chem, ICAR, New Delhi 110012, India; [Bhat, Jayant S.] Indian Agr Res Inst, ICAR, Reg Res Ctr, Dharwad, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Gupta, HS (corresponding author), Borlaug Inst South Asia, New Delhi, India.	hsgupta.53@gmail.com	Muthusamy, Vignesh/AAB-6224-2022; Muthusamy, Vignesh/AAU-5785-2020; Choudhary, Mukesh/AAS-7109-2021; Research, ICAR-Indian Institute of Maize/ABC-7039-2020; Saha, Supradip/X-9912-2019; Saha, Supradip/F-4103-2012	Muthusamy, Vignesh/0000-0003-3169-890X; Saha, Supradip/0000-0002-6655-4001; Boddupalli, Prasanna/0000-0002-5761-2273	Department of Biotechnolgy, Government of India	Department of Biotechnolgy, Government of India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnolgy, Government of India under the Project "Development of micronutrient enriched maize through molecular breeding''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; [Anonymous], 2009, WHO GLOBAL DATABASE; AOAC, 1965, OFFICIAL METHODS ANA, V10 th, P744; Atlin GN, 2011, PL BRED RE, V34, P83; Babu R, 2005, THEOR APPL GENET, V111, P888, DOI 10.1007/s00122-005-0011-6; Babu R., 2014, GENOMICS PLANT GENET, V2, DOI [10.1007/978-94-007-7575-6_21, DOI 10.1007/978-94-007-7575-6_21]; Babu R, 2013, THEOR APPL GENET, V126, P389, DOI 10.1007/s00122-012-1987-3; Bjarnason M, 1992, PLANT BREEDING REV, P181; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; BUCKNER B, 1990, PLANT CELL, V2, P867, DOI 10.1105/tpc.2.9.867; Chander S, 2008, J AGR FOOD CHEM, V56, P6506, DOI 10.1021/jf7037967; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Danson JW, 2006, AFR J BIOTECHNOL, V5, P2417; Egesel CO, 2003, CROP SCI, V43, P818, DOI 10.2135/cropsci2003.0818; Farre G., 2013, HDB FOOD FORTIFICATI, V1, P335; Gupta HS, 2009, CURR SCI INDIA, V96, P230; Gupta HS, 2013, PLANT BREEDING, V132, P77, DOI 10.1111/pbr.12009; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hernandez H.H., 1969, CIMMYT RES B, V13; Jelena V, 2008, GENETIKA, V40, P145, DOI DOI 10.2298/GENSR0802145V; Koide Y, 2011, FIELD CROP RES, V123, P19, DOI 10.1016/j.fcr.2011.04.005; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Mangelsdorf PC, 1926, GENETICS, V11, P423; Menkir A, 2008, FOOD CHEM, V109, P521, DOI 10.1016/j.foodchem.2008.01.002; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Naidoo R, 2012, MOL BREEDING, V30, P1207, DOI 10.1007/s11032-012-9709-8; Naqvi S, 2009, P NATL ACAD SCI USA, V106, P7762, DOI 10.1073/pnas.0901412106; Neuffer MG, 1997, MUTANTS MAIZE; Ortiz-Monasterio JI, 2007, J CEREAL SCI, V46, P293, DOI 10.1016/j.jcs.2007.06.005; Perez-Massot E, 2013, GENES NUTR, V8, P29, DOI 10.1007/s12263-012-0315-5; Ribaut JM, 1998, TRENDS PLANT SCI, V3, P236, DOI 10.1016/S1360-1385(98)01240-0; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Shiri M. R., 2013, Crop Breeding Journal, V3, P107; Singh VK, 2012, FIELD CROP RES, V128, P8, DOI 10.1016/j.fcr.2011.12.003; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Vasal S K., 2001, P 7 E S AFR REG MAI, P3; Vignesh M, 2013, J PLANT BIOCHEM BIOT, V22, P401, DOI 10.1007/s13562-012-0168-4; Vignesh M, 2012, INDIAN J GENET PL BR, V72, P189; Wong JC, 2004, THEOR APPL GENET, V108, P349, DOI 10.1007/s00122-003-1436-4; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang W, 2004, PLANT MOL BIOL REP, V22, P361, DOI 10.1007/BF02772679; Zhang XC, 2012, THEOR APPL GENET, V125, P235, DOI 10.1007/s00122-012-1828-4; Zhu CF, 2008, P NATL ACAD SCI USA, V105, P18232, DOI 10.1073/pnas.0809737105	48	100	102	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113583	10.1371/journal.pone.0113583	http://dx.doi.org/10.1371/journal.pone.0113583			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486271	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600022
J	Shevchenko, V; Gushchin, I; Polovinkin, V; Round, E; Borshchevskiy, V; Utrobin, P; Popov, A; Balandin, T; Buldt, G; Gordeliy, V				Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Round, Ekaterina; Borshchevskiy, Valentin; Utrobin, Petr; Popov, Alexander; Balandin, Taras; Bueldt, Georg; Gordeliy, Valentin			Crystal Structure of Escherichia coli-Expressed Haloarcula marismortui Bacteriorhodopsin I in the Trimeric Form	PLOS ONE			English	Article							PROTEIN-STRUCTURE; DARK-ADAPTATION; RHODOPSIN II; MEMBRANE; CHAIN; PROTEORHODOPSIN; REFINEMENT; ELECTRON; PUMP	Bacteriorhodopsins are a large family of seven-helical transmembrane proteins that function as light-driven proton pumps. Here, we present the crystal structure of a new member of the family, Haloarcula marismortui bacteriorhodopsin I (HmBRI) D94N mutant, at the resolution of 2.5 angstrom. While the HmBRI retinal-binding pocket and proton donor site are similar to those of other archaeal proton pumps, its proton release region is extended and contains additional water molecules. The protein's fold is reinforced by three novel inter-helical hydrogen bonds, two of which result from double substitutions relative to Halobacterium salinarum bacteriorhodopsin and other similar proteins. Despite the expression in Escherichia coli and consequent absence of native lipids, the protein assembles as a trimer in crystals. The unique extended loop between the helices D and E of HmBRI makes contacts with the adjacent protomer and appears to stabilize the interface. Many lipidic hydrophobic tail groups are discernible in the membrane region, and their positions are similar to those of archaeal isoprenoid lipids in the crystals of other proton pumps, isolated from native or native-like sources. All these features might explain the HmBRI properties and establish the protein as a novel model for the microbial rhodopsin proton pumping studies.	[Shevchenko, Vitaly; Round, Ekaterina; Borshchevskiy, Valentin; Balandin, Taras; Gordeliy, Valentin] Res Ctr Julich GmbH, Inst Complex Syst ICS Struct Biochem 6, Julich, Germany; [Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Utrobin, Petr; Bueldt, Georg; Gordeliy, Valentin] Moscow Inst Phys & Technol, Lab Adv Studies Membrane Prot, Dolgoprudnyi, Russia; [Gushchin, Ivan; Polovinkin, Vitaly; Utrobin, Petr; Gordeliy, Valentin] Univ Grenoble Alpes, IBS, Grenoble, France; [Gushchin, Ivan; Polovinkin, Vitaly; Utrobin, Petr; Gordeliy, Valentin] CNRS, IBS, Grenoble, France; [Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] CEA Grenoble, IBS, F-38054 Grenoble, France; [Popov, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Gordeliy, V (corresponding author), Res Ctr Julich GmbH, Inst Complex Syst ICS Struct Biochem 6, Julich, Germany.	valentin.gordeliy@ibs.fr	Borshchevskiy, Valentin I./F-2287-2014; Gushchin, Ivan/AAO-8829-2020; Gushchin, Ivan/K-9197-2015; Popov, Alexander/A-8827-2008; Utrobin, Petr/O-9252-2015; Polovinkin, Vitaly/G-6627-2017; Gordeliy, Valentin I/J-3636-2013; Buldt, Georg/K-5345-2013; Shevchenko, Vitaly/F-2956-2014	Borshchevskiy, Valentin I./0000-0003-4398-9712; Gushchin, Ivan/0000-0002-5348-6070; Gushchin, Ivan/0000-0002-5348-6070; Polovinkin, Vitaly/0000-0002-3630-5565; Gordeliy, Valentin I/0000-0001-5782-5896; Popov, Alexander/0000-0002-3058-8912	ANR France; CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; BMBF (PhoNa - Photonic Nanomaterials); RFBR [13-04-91320, 12-04-31290]; Russian state Program for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science; Fondation Nanosciences	ANR France(French National Research Agency (ANR)); CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement(French Atomic Energy Commission); BMBF (PhoNa - Photonic Nanomaterials)(Federal Ministry of Education & Research (BMBF)); RFBR(Russian Foundation for Basic Research (RFBR)); Russian state Program for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science; Fondation Nanosciences	The work was supported by the program "Chaires d'excellence" edition 2008 of ANR France and CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement. Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials). The work was supported by RFBR (research projects 13-04-91320 and 12-04-31290) and the Russian state Program for enhancing the competitiveness of MIPT among the world's leading research and education centers of the Ministry of education and science. The work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). VP is deeply thankful to Fondation Nanosciences for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Borshchevskiy V, 2010, ACTA CRYSTALLOGR D, V66, P26, DOI 10.1107/S0907444909042838; Borshchevskiy VI, 2011, J MOL BIOL, V409, P813, DOI 10.1016/j.jmb.2011.04.038; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DENCHER NA, 1983, BIOCHEMISTRY-US, V22, P1323, DOI 10.1021/bi00275a002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; GERWERT K, BIOCHIMICA ET BIOPHY; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; Hirai T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005769; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; IHARA K, 1994, BIOPHYS J, V67, P1187, DOI 10.1016/S0006-3495(94)80587-9; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; REYNOLDS JA, 1977, P NATL ACAD SCI USA, V74, P2803, DOI 10.1073/pnas.74.7.2803; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeda K, 1998, J MOL BIOL, V283, P463, DOI 10.1006/jmbi.1998.2103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Wang T, 2013, STRUCTURE, V21, P290, DOI 10.1016/j.str.2012.12.018; WICKSTRAND C, BIOCHIMICA ET BIOPHY; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Zhang J, 2013, PROTEINS, V81, P1585, DOI 10.1002/prot.24316	49	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112873	10.1371/journal.pone.0112873	http://dx.doi.org/10.1371/journal.pone.0112873			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479443	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200012
J	Tazoe, T; Endoh, T; Kitamura, T; Ogata, T				Tazoe, Toshiki; Endoh, Takashi; Kitamura, Taku; Ogata, Toru			Polarity Specific Effects of Transcranial Direct Current Stimulation on Interhemispheric Inhibition	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; LATENCY AFFERENT INHIBITION; THETA-BURST-STIMULATION; TRANSCALLOSAL INHIBITION; INTRACORTICAL CIRCUITS; BRAIN-STIMULATION; EXCITABILITY; HEMISPHERE; PATHWAYS; RECOVERY	Transcranial direct current stimulation (tDCS) has been used as a useful interventional brain stimulation technique to improve unilateral upper-limb motor function in healthy humans, as well as in stroke patients. Although tDCS applications are supposed to modify the interhemispheric balance between the motor cortices, the tDCS after-effects on interhemispheric interactions are still poorly understood. To address this issue, we investigated the tDCS after-effects on interhemispheric inhibition (IHI) between the primary motor cortices (M1) in healthy humans. Three types of tDCS electrode montage were tested on separate days; anodal tDCS over the right M1, cathodal tDCS over the left M1, bilateral tDCS with anode over the right M1 and cathode over the left M1. Single-pulse and paired-pulse transcranial magnetic stimulations were given to the left M1 and right M1 before and after tDCS to assess the bilateral corticospinal excitabilities and mutual direction of IHI. Regardless of the electrode montages, corticospinal excitability was increased on the same side of anodal stimulation and decreased on the same side of cathodal stimulation. However, neither unilateral tDCS changed the corticospinal excitability at the unstimulated side. Unilateral anodal tDCS increased IHI from the facilitated side M1 to the unchanged side M1, but it did not change IHI in the other direction. Unilateral cathodal tDCS suppressed IHI both from the inhibited side M1 to the unchanged side M1 and from the unchanged side M1 to the inhibited side M1. Bilateral tDCS increased IHI from the facilitated side M1 to the inhibited side M1 and attenuated IHI in the opposite direction. Sham-tDCS affected neither corticospinal excitability nor IHI. These findings indicate that tDCS produced polarity-specific after-effects on the interhemispheric interactions between M1 and that those after-effects on interhemispheric interactions were mainly dependent on whether tDCS resulted in the facilitation or inhibition of the M1 sending interhemispheric volleys.	[Tazoe, Toshiki; Endoh, Takashi; Kitamura, Taku; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan; [Tazoe, Toshiki] Japan Soc Promot Sci, Tokyo, Japan; [Endoh, Takashi] Uekusa Gakuen Univ, Fac Child Dev & Educ, Chiba, Japan; [Kitamura, Taku] Shibaura Inst Technol, Div Funct Control Syst, Grad Sch Engn & Sci, Saitama, Japan	Japan Society for the Promotion of Science; Shibaura Institute of Technology	Tazoe, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan.	Tot12@pitt.edu	Ogata, Toru/ADC-3560-2022	Ogata, Toru/0000-0001-9011-8640	 [23.10759];  [24700612]	; 	This research was supported by Grants-in-Aid for Research Fellow of the Japan Society for the Promotion of Science to TT (#23.10759) and by Grants-in-Aids for Young Scientist B to TE (#24700612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bradnam LV, 2012, CEREB CORTEX, V22, P2662, DOI 10.1093/cercor/bhr344; Bradnam LV, 2011, J NEUROPHYSIOL, V105, P2582, DOI 10.1152/jn.01084.2010; CATSMANBERREVOETS CE, 1980, EXP BRAIN RES, V39, P433; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2012, J NEURAL TRANSM, V119, P1499, DOI 10.1007/s00702-012-0845-4; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fregni F, 2005, NEUROREPORT, V16, P1551, DOI 10.1097/01.wnr.0000177010.44602.5e; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Gilio F, 2003, J PHYSIOL-LONDON, V551, P563, DOI 10.1113/jphysiol.2003.044313; Hinder MR, 2010, EXP BRAIN RES, V205, P423, DOI 10.1007/s00221-010-2379-z; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kang Eun Kyoung, 2011, Exp Transl Stroke Med, V3, P4, DOI 10.1186/2040-7378-3-4; Kidgell DJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-64; Kim DY, 2010, AM J PHYS MED REHAB, V89, P879, DOI 10.1097/PHM.0b013e3181f70aa7; Kobayashi M, 2009, EUR J NEUROSCI, V29, P833, DOI 10.1111/j.1460-9568.2009.06628.x; Kukaswadia S, 2005, J PHYSIOL-LONDON, V563, P915, DOI 10.1113/jphysiol.2004.080010; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lee H, 2007, J PHYSIOL-LONDON, V580, P1021, DOI 10.1113/jphysiol.2006.126011; Li JY, 2013, J NEUROPHYSIOL, V109, P659, DOI 10.1152/jn.01044.2011; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; Mahmoudi H, 2011, DISABIL REHABIL, V33, P1383, DOI 10.3109/09638288.2010.532283; Mordillo-Mateos L, 2012, BRAIN STIMUL, V5, P214, DOI 10.1016/j.brs.2011.05.001; Nelson AJ, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-31; NETZ J, 1995, EXP BRAIN RES, V104, P527; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; O'Shea J, 2014, NEUROIMAGE, V85, P924, DOI 10.1016/j.neuroimage.2013.05.096; Pal PK, 2005, J NEUROPHYSIOL, V94, P1668, DOI 10.1152/jn.01306.2004; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Roche N, 2012, CLIN NEUROPHYSIOL, V123, P1027, DOI 10.1016/j.clinph.2011.09.011; Roche N, 2009, J PHYSIOL-LONDON, V587, P5653, DOI 10.1113/jphysiol.2009.177550; Scelzo E, 2011, NEUROSCI LETT, V498, P167, DOI 10.1016/j.neulet.2011.05.007; Sehm B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00183; Shin HW, 2011, NEUROREPORT, V22, P166, DOI 10.1097/WNR.0b013e3283439511; Suppa A, 2008, J PHYSIOL-LONDON, V586, P4489, DOI 10.1113/jphysiol.2008.156596; Tazoe T, 2014, J NEUROSCI, V34, P13924, DOI 10.1523/JNEUROSCI.1648-14.2014; Tazoe T, 2013, J NEUROSCI, V33, P16178, DOI 10.1523/JNEUROSCI.2638-13.2013; Tazoe T, 2013, EUR J NEUROSCI, V37, P96, DOI 10.1111/ejn.12026; Tremblay S, 2013, NEUROREPORT, V24, P46, DOI 10.1097/WNR.0b013e32835c36b8; Trompetto C, 2003, CLIN NEUROPHYSIOL, V114, P2181, DOI 10.1016/S1388-2457(03)00213-X; Tsutsumi R, 2014, J NEUROPHYSIOL, V111, P26, DOI 10.1152/jn.00515.2013; Tsutsumi R, 2012, J NEUROPHYSIOL, V108, P1130, DOI 10.1152/jn.00300.2012; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075; Zimerman M, 2012, STROKE, V43, P2185, DOI 10.1161/STROKEAHA.111.645382	62	53	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114244	10.1371/journal.pone.0114244	http://dx.doi.org/10.1371/journal.pone.0114244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478912	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200053
J	Grady, JP; Murphy, JL; Blakely, EL; Haller, RG; Taylor, RW; Turnbull, DM; Tuppen, HAL				Grady, John P.; Murphy, Julie L.; Blakely, Emma L.; Haller, Ronald G.; Taylor, Robert W.; Turnbull, Doug M.; Tuppen, Helen A. L.			Accurate Measurement of Mitochondrial DNA Deletion Level and Copy Number Differences in Human Skeletal Muscle	PLOS ONE			English	Article							REAL-TIME PCR; INDIVIDUAL CELLS; DISEASE; QUANTIFICATION; SINGLE; MTDNA; DEPLETION; ASSAY	Accurate and reliable quantification of the abundance of mitochondrial DNA (mtDNA) molecules, both wild-type and those harbouring pathogenic mutations, is important not only for understanding the progression of mtDNA disease but also for evaluating novel therapeutic approaches. A clear understanding of the sensitivity of mtDNA measurement assays under different experimental conditions is therefore critical, however it is routinely lacking for most published mtDNA quantification assays. Here, we comprehensively assess the variability of two quantitative Taqman real-time PCR assays, a widely-applied MT-ND1/MT-ND4 multiplex mtDNA deletion assay and a recently developed MT-ND1/B2M singleplex mtDNA copy number assay, across a range of DNA concentrations and mtDNA deletion/copy number levels. Uniquely, we provide a specific guide detailing necessary numbers of sample and real-time PCR plate replicates for accurately and consistently determining a given difference in mtDNA deletion levels and copy number in homogenate skeletal muscle DNA.	[Grady, John P.; Murphy, Julie L.; Blakely, Emma L.; Taylor, Robert W.; Turnbull, Doug M.; Tuppen, Helen A. L.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Haller, Ronald G.] VA North Texas Med Ctr, Dallas, TX USA; [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX USA	Newcastle University - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Tuppen, HAL (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helen.tuppen@ncl.ac.uk		Tuppen, Helen/0000-0001-8762-0824; Turnbull, Doug/0000-0002-8878-9901; Grady, John/0000-0001-9667-3872	Wellcome Trust Centre for Mitochondrial Research [906919]; National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS) [RO1-AR050597]; Medical Research Council [G0700718, MR/K000608/1, MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10187] Funding Source: researchfish; MRC [MR/K000608/1, MR/K006312/1, G0700718] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050597] Funding Source: NIH RePORTER	Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Wellcome Trust Centre for Mitochondrial Research (906919; www.wellcome.ac.uk) and the National Institutes of Health (National Institute of Arthritis, Musculoskeletal and Skin Diseases, NIAMS, RO1-AR050597 to RGH; www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Balakrishnan VS, 2010, CLIN J AM SOC NEPHRO, V5, P996, DOI 10.2215/CJN.09141209; Blackwood JK, 2010, BIOCHEM BIOPH RES CO, V393, P740, DOI 10.1016/j.bbrc.2010.02.072; BRUGGER RM, 1969, AM STAT, V23, P32; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149; Krishnan KJ, 2007, ANAL BIOCHEM, V370, P127, DOI 10.1016/j.ab.2007.06.024; Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110; Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067; Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005; Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; Rotig A, 2009, BBA-MOL BASIS DIS, V1792, P1103, DOI 10.1016/j.bbadis.2009.06.009; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sochivko DG, 2013, DOKL BIOCHEM BIOPHYS, V449, P105, DOI 10.1134/S1607672913020154; Spendiff S, 2013, HUM MOL GENET, V22, P4739, DOI 10.1093/hmg/ddt327; Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282; Venegas V, 2012, METHODS MOL BIOL, V837, P327, DOI 10.1007/978-1-61779-504-6_22; Wong LJC, 2003, J MED GENET, V40; Zhang GJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-173	31	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114462	10.1371/journal.pone.0114462	http://dx.doi.org/10.1371/journal.pone.0114462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474153	gold, Green Submitted, Green Published			2022-12-26	WOS:000346382500032
J	Kortekaas, KE; Meijer, CA; Hinnen, JW; Dalman, RL; Xu, BH; Hamming, JF; Lindeman, JH				Kortekaas, Kim E.; Meijer, C. Arnoud; Hinnen, Jan Willem; Dalman, Ronald L.; Xu, Baohui; Hamming, Jaap F.; Lindeman, Jan H.			ACE Inhibitors Potently Reduce Vascular Inflammation, Results of an Open Proof-Of-Concept Study in the Abdominal Aortic Aneurysm	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; NF-KAPPA-B; RABBIT MODEL; EXPRESSION; MACROPHAGES; RAT; MATRIX-METALLOPROTEINASE-9; ATHEROSCLEROSIS; METAANALYSIS; DEGRADATION	Background: Independent of their blood pressure lowering effect, ACE inhibitors are thought to reduce vascular inflammation. The clinical relevance of this effect is unclear with the current knowledge. Abdominal aortic aneurysms (AAA) are characterized by a broad, non-specific inflammatory response, and thus provide a clinical platform to evaluate the anti-inflammatory potential of ACE inhibitors. Methods and Results: Eleven patients scheduled for open AAA repair received ramipril (5 mg/day) during 2-4 weeks preceding surgery. Aortic wall samples were collected during surgery, and compared to matched samples obtained from a biobank. An anti-inflammatory potential was evaluated in a comprehensive analysis that included immunohistochemistry, mRNA and protein analysis. A putative effect of ACE inhibitors on AAA growth was tested separately by comparing 18-month growth rate of patients on ACE inhibitors (n=82) and those not taking ACE inhibitors (n=204). Ramipril reduces mRNA expression of multiple pro-inflammatory cytokines such as IL-1 beta, IL-6, IL-8, TNF-alpha, Interferon-gamma, and MCP-1, as well as aortic wall IL-8 and MCP-1 (P=0.017 and 0.008, respectively) protein content. The is followed by clear effects on cell activation that included a shift towards anti-inflammatory macrophage (M2) subtype. Evaluation of data from the PHAST cohort did not indicate an effect of ACE inhibitors on 18-month aneurysm progression (mean difference at 18 months: -0.24 mm (95% CI: -0.90-0.45, P=NS). Conclusions: ACE inhibition quenches multiple aspects of vascular inflammation in AAA. However, this does not translate into reduced aneurysm growth.	[Kortekaas, Kim E.; Meijer, C. Arnoud; Hinnen, Jan Willem; Hamming, Jaap F.; Lindeman, Jan H.] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands; [Kortekaas, Kim E.; Dalman, Ronald L.; Xu, Baohui] Stanford Med Sch, Div Vasc Surg, Stanford, CA USA; [Hinnen, Jan Willem] Jeroen Bosch Ziekenhuis, Dept Vasc Surg, Shertogenbosch, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Stanford University; Jeroen Bosch Ziekenhuis	Lindeman, JH (corresponding author), Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands.	lindeman@lumc.nl		Meijer, Arnoud/0000-0001-5521-1575; Xu, Baohui/0000-0002-2857-7464	National Heart, Lung and Blood Institute [1R21HL112122-01]; ZonMw (The Netherlands Organization for Health Research and Development) [40-41200-98-052]; NutsOhra Fund [0701-061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112122] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ZonMw (The Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government); NutsOhra Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the authors institutions. Additional support was obtained through grant from the National Heart, Lung and Blood Institute (1R21HL112122-01) (RLD). The PHAST study is supported by grants from ZonMw (The Netherlands Organization for Health Research and Development) grant 40-41200-98-052 www.zonmw.nl, and NutsOhra Fund (project 0701-061, http://www.stichtingnutsohra.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; BENDER N, 1990, CLIN PHYSIOL BIOCH, V8, P44; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; da Cunha V, 2005, ATHEROSCLEROSIS, V178, P9, DOI 10.1016/j.atherosclerosis.2004.08.023; Di Raimondo D, 2012, CURR PHARM DESIGN, V18, P4385, DOI 10.2174/138161212802481282; Elewaut D, 1999, J IMMUNOL, V163, P1457; Ferrari R, 2009, DRUGS, V69, P265, DOI 10.2165/00003495-200969030-00003; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; Goeman JJ, 2011, STAT SCI, V26, P584; Hackam DG, 2006, LANCET, V368, P659, DOI 10.1016/S0140-6736(06)69250-7; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Hernandez-Presa MA, 1998, AM J PATHOL, V153, P1825, DOI 10.1016/S0002-9440(10)65697-0; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Kowalewski R, 2006, J VASC RES, V43, P95, DOI 10.1159/000089790; Krysiak R, 2008, PHARMACOL REP, V60, P514; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lederle FA, 2013, ANN INTERN MED, V159, P852, DOI 10.7326/0003-4819-159-12-201312170-00012; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; Lindeman JHN, 2008, CLIN SCI, V114, P687, DOI 10.1042/CS20070352; Lindeman JHN, 2011, CIRCULATION, V124, pE463, DOI 10.1161/CIRCULATIONAHA.110.008573; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Luoma JS, 1998, ARTERIOSCL THROM VAS, V18, P157, DOI 10.1161/01.ATV.18.2.157; McMillan WD, 1999, J VASC SURG, V29, P122, DOI 10.1016/S0741-5214(99)70363-0; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; OSBORNEPELLEGRIN MJ, 1994, INT J EXP PATHOL, V75, P179; Rizas KD, 2009, CARDIOL REV, V17, P201, DOI 10.1097/CRD.0b013e3181b04698; Ruiz-Ortega M, 2000, NEPHROL DIAL TRANSPL, V15, P561, DOI 10.1093/ndt/15.5.561; Schmeisser A, 2004, BIOCHEM BIOPH RES CO, V325, P532, DOI 10.1016/j.bbrc.2004.10.059; Soehnlein O, 2005, J VASC RES, V42, P399, DOI 10.1159/000087340; Sweeting MJ, 2010, J VASC SURG, V52, P1, DOI 10.1016/j.jvs.2010.02.264; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Thompson SG, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17410; van der Meij E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053882; Watanabe T, 2006, ANN VASC SURG, V20, P317, DOI 10.1007/s10016-006-9038-7; Wilmink ABM, 2002, J VASC SURG, V36, P751, DOI 10.1067/mva.2002.126550; Xiong F, 2014, J SURG RES, V189, P166, DOI 10.1016/j.jss.2014.01.057; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yoshimura K, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/648167; ZWADLO G, 1987, EXP CELL BIOL, V55, P295	42	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111952	10.1371/journal.pone.0111952	http://dx.doi.org/10.1371/journal.pone.0111952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474105	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500065
J	Petersen, SB; Olsen, SF; Molgaard, C; Granstrom, C; Cohen, A; Vestergaard, P; Strom, M				Petersen, Sesilje Bondo; Olsen, Sjurdur Frodi; Molgaard, Christian; Granstrom, Charlotta; Cohen, Arieh; Vestergaard, Peter; Strom, Marin			Maternal Vitamin D Status and Offspring Bone Fractures: Prospective Study over Two Decades in Aarhus City, Denmark	PLOS ONE			English	Article							MINERAL CONTENT; PREGNANCY; MASS; ASSOCIATION; CHILDHOOD; CHILDREN; EPIDEMIOLOGY; SERUM; DIET	Background: Studies investigating the association between maternal vitamin D status and offspring bone mass measured by dual-energy X-ray absorptiometry (DXA) during childhood have shown conflicting results. Purpose: We used occurrence of bone fractures up to the age of 18 as a measure reflecting offspring bone mass and related that to maternal vitamin D status. Methods: The Danish Fetal Origins 1988 Cohort recruited 965 pregnant women during 1988-89 at their 30th gestation week antenatal midwife visit. A blood sample was drawn and serum was stored, which later was analyzed for the concentration of 25-hydroxyvitamin D (25(OH)D) by the liquid chromatography coupled with a tandem mass spectrometric method (LC-MS/MS). Outcome was diagnosis of first time bone fractures extracted from the Danish National Patient Register. Results: Vitamin D status was available for 850 women. The median (5th-95th percentile) 25(OH)D was 76.2 (23.0-152.1) nmol/l. During follow up 294 children were registered with at least one bone fracture diagnosis. Multivariable Cox regression models using age as the underlying time scale indicated no overall association between maternal vitamin D status and first time bone fractures. However, there was a significantly increased hazard ratio (HR) during childhood for those who had maternal blood drawn in Dec/Jan/Feb compared with Jun/Jul/Aug (HR: 1.75, 95% CI: 1.11-2.74). Adjustment for vitamin D status strengthened this association (1.82, 1.12-2.97), which indicated a potential seasonal impact on offspring fractures independent of maternal vitamin D status. In a sensitivity analysis we found a borderline significant inverse association between continuous concentrations of 25(OH)D and offspring forearm fractures (P=0.054). Conclusion: Overall, our results did not substantiate an association between maternal vitamin D status and offspring bone fractures. Further studies on this subject are needed, but the study populations must be large enough to allow for subdivision of fractures.	[Petersen, Sesilje Bondo; Olsen, Sjurdur Frodi; Granstrom, Charlotta; Strom, Marin] Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark; [Molgaard, Christian] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Cohen, Arieh] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Vestergaard, Peter] Aalborg Univ Hosp, Dept Endocrinol, Aalborg, Denmark; [Vestergaard, Peter] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Statens Serum Institut; University of Copenhagen; Statens Serum Institut; Aalborg University; Aalborg University Hospital; Aalborg University	Petersen, SB (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.	ssp@ssi.dk	Petersen, Steffen b/E-8727-2015; Mølgaard, Christian/D-2052-2014	Petersen, Steffen b/0000-0002-0739-2751; Mølgaard, Christian/0000-0002-5311-9457; Olsen, Sjurdur/0000-0003-3017-7096; Strom, Marin/0000-0003-1926-6610	Danish Council for Strategic Research [09-067124]; Novo Nordic Foundation	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordic Foundation(Novo Nordisk Foundation)	Supported by the Danish Council for Strategic Research (09-067124, Center for Fetal Programming) (SFO) and the Novo Nordic Foundation (SFO). No personal benefits in any form have been received or will be received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen Bo, 2012, Front Endocrinol (Lausanne), V3, P2, DOI 10.3389/fendo.2012.00002; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2010, RATIONEL FARMAK 0606; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Clark EM, 2006, PEDIATRICS, V117, pE291, DOI 10.1542/peds.2005-1404; Clark EM, 2006, J BONE MINER RES, V21, P1489, DOI 10.1359/JBMR.060601; Cole ZA, 2009, J BONE MINER RES, V24, P663, DOI 10.1359/JBMR.081212; Cooper C, 2005, RHEUMATOLOGY, V44, P36, DOI 10.1093/rheumatology/kei060; Cooper C, 2009, ADV EXP MED BIOL, V639, P217, DOI 10.1007/978-1-4020-8749-3_16; Dam H, 1998, ACTA PSYCHIAT SCAND, V97, P1, DOI 10.1111/j.1600-0447.1998.tb09954.x; Ford L, 2013, METHODS MOL BIOL, V1065, P245, DOI 10.1007/978-1-62703-616-0_16; Institute of Medicine IOM, 2011, DIEAT REF RANG CALC; Ioannou C, 2012, J CLIN ENDOCR METAB, V97, pE2070, DOI 10.1210/jc.2012-2538; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Jensen CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053059; Kimball S, 2008, CRIT REV CL LAB SCI, V45, P339, DOI [10.1080/10408360802165295, 10.1080/10408360802165295 ]; Lapillonne A, 2000, ACTA PAEDIATR, V89, P772, DOI 10.1080/080352500750043620; Lawlor DA, 2013, LANCET, V382, P767, DOI 10.1016/S0140-6736(13)61830-9; Lawlor DA, 2013, LANCET, V381, P2176, DOI 10.1016/S0140-6736(12)62203-X; LISSNER D, 1981, CLIN CHEM, V27, P773; Lucas RM, 2008, NUTR REV, V66, P710, DOI 10.1111/j.1753-4887.2008.00126.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mathison DJ, 2010, PEDIATR EMERG CARE, V26, P594, DOI 10.1097/PEC.0b013e3181eb838d; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Pitukcheewanont P, 2013, PEDIATR ENDOCR REV P, V10, P318; Prasad M, 2010, PUBLIC HEALTH NUTR, V13, P939, DOI 10.1017/S1368980010001138; Ryan LM, 2010, CURR OPIN ENDOCRINOL, V17, P530, DOI 10.1097/MED.0b013e32833e9c8b; Sayers A, 2009, J CLIN ENDOCR METAB, V94, P765, DOI 10.1210/jc.2008-2146; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Streym SV, 2013, EUR J CLIN NUTR, V67, P1022, DOI 10.1038/ejcn.2013.152; Swart KMA, 2013, CURR OSTEOPOROS REP, V11, P213, DOI 10.1007/s11914-013-0155-2; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Tobias JH, 2005, OSTEOPOROSIS INT, V16, P1731, DOI 10.1007/s00198-005-1912-6; Vestergaard P, 2002, AM J EPIDEMIOL, V156, P1, DOI 10.1093/aje/kwf007; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	36	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114334	10.1371/journal.pone.0114334	http://dx.doi.org/10.1371/journal.pone.0114334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474409	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500017
J	Umetsu, D; Dunst, S; Dahmann, C				Umetsu, Daiki; Dunst, Sebastian; Dahmann, Christian			An RNA Interference Screen for Genes Required to Shape the Anteroposterior Compartment Boundary in Drosophila Identifies the Eph Receptor	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; LINEAGE RESTRICTION; IMAGINAL DISCS; CELL AFFINITY; WING DISC; HINDBRAIN; HEDGEHOG; EXPRESSION; ZEBRAFISH; MAINTENANCE	The formation of straight compartment boundaries separating groups of cells with distinct fates and functions is an evolutionarily conserved strategy during animal development. The physical mechanisms that shape compartment boundaries have recently been further elucidated, however, the molecular mechanisms that underlie compartment boundary formation and maintenance remain poorly understood. Here, we report on the outcome of an RNA interference screen aimed at identifying novel genes involved in maintaining the straight shape of the anteroposterior compartment boundary in Drosophila wing imaginal discs. Out of screening 3114 transgenic RNA interference lines targeting a total of 2863 genes, we identified a single novel candidate that interfered with the formation of a straight anteroposterior compartment boundary. Interestingly, the targeted gene encodes for the Eph receptor tyrosine kinase, an evolutionarily conserved family of signal transducers that has previously been shown to be important for maintaining straight compartment boundaries in vertebrate embryos. Our results identify a hitherto unknown role of the Eph receptor tyrosine kinase in Drosophila and suggest that Eph receptors have important functions in shaping compartment boundaries in both vertebrate and insect development.	[Umetsu, Daiki; Dahmann, Christian] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Dunst, Sebastian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Dahmann, C (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	christian.dahmann@tu-dresden.de	Dahmann, Christian/B-5841-2017	Dunst, Sebastian/0000-0002-3414-1640	EMBO long-term fellowship; Deutsche Forschungsgemeinschaft [DA586/8-1, DA586/10-1, DA586/14-1]	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the EMBO long-term fellowship (to DU) and the Deutsche Forschungsgemeinschaft (DA586/8-1, DA586/10-1, and DA586/14-1 to CD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; BECKER N, 1994, MECH DEVELOP, V47, P3, DOI 10.1016/0925-4773(94)90091-4; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Blair SS, 2003, NATURE, V424, P379, DOI 10.1038/424379a; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Blair SS, 1997, DEVELOPMENT, V124, P4053; Bossing T, 2002, DEVELOPMENT, V129, P4205; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Fritsch C, 2003, MECH DEVELOP, V120, P949, DOI 10.1016/S0925-4773(03)00083-2; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; HAY BA, 1994, DEVELOPMENT, V120, P2121; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010; Klein Thomas, 2008, V420, P253, DOI 10.1007/978-1-59745-583-1_15; Lage PIZ, 2003, DEVELOPMENT, V130, P4683, DOI 10.1242/dev.00680; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Langenberg T, 2005, DEVELOPMENT, V132, P3209, DOI 10.1242/dev.01862; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Martin AC, 2010, NAT CELL BIOL, V12, P5, DOI 10.1038/ncb0110-5; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; Monier B, 2011, CELL MOL LIFE SCI, V68, P1897, DOI 10.1007/s00018-011-0668-8; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; NIETO MA, 1992, DEVELOPMENT, V116, P1137; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schlichting K, 2005, DEV BIOL, V279, P142, DOI 10.1016/j.ydbio.2004.12.008; Scully AL, 1999, MOL CELL NEUROSCI, V13, P337, DOI 10.1006/mcne.1999.0752; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Umetsu D, 2014, CURR BIOL, V24, P1798, DOI 10.1016/j.cub.2014.06.052; Umetsu D, 2010, FLY, V4, P241, DOI 10.4161/fly.4.3.12173; Vegh M, 2003, GENETICS, V163, P1427; Vincent JP, 2009, CURR BIOL, V19, pR1028, DOI 10.1016/j.cub.2009.10.030; Vincent JP, 1998, INT J DEV BIOL, V42, P311; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Xu QL, 1995, DEVELOPMENT, V121, P4005	65	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114340	10.1371/journal.pone.0114340	http://dx.doi.org/10.1371/journal.pone.0114340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473846	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500021
J	Watanobe, H; Furutani, T; Nihei, M; Sakuma, Y; Yanai, R; Takahashi, M; Sato, H; Sagawa, F				Watanobe, Hajime; Furutani, Tomoyuki; Nihei, Masahiko; Sakuma, Yu; Yanai, Rie; Takahashi, Miyuki; Sato, Hideo; Sagawa, Fumihiko			The Thyroid Status of Children and Adolescents in Fukushima Prefecture Examined during 20-30 Months after the Fukushima Nuclear Power Plant Disaster: A Cross-Sectional, Observational Study	PLOS ONE			English	Article							EXPOSED IN-UTERO; CHERNOBYL ACCIDENT; CANCER INCIDENCE; I-131; THYROGLOBULIN; TIME; RADIATION; BYELARUS; DISEASES; FALLOUT	Background: A possible increase in thyroid cancer in the young represents the most critical health problem to be considered after the nuclear accident in Fukushima, Japan (March 2011), which is an important lesson from the Chernobyl disaster (April 1986). Although it was reported that childhood thyroid cancer had started to increase 3-5 yr after the Chernobyl accident, we speculate that the actual period of latency might have been shorter than reported, considering the delay in initiating thyroid surveillance in the then Soviet Union and also the lower quality of ultrasonographic testing in the 1980s. Our primary objectives in the present study were to identify any possible thyroid abnormality in young Fukushima citizens at a relatively early timepoint (20-30 months) after the accident, and also to strive to find a possible relationship among thyroid ultrasonographic findings, thyroid-relevant biochemical markers, and iodine-131 ground deposition in the locations of residence where they stayed during very early days after the accident. Methods and Findings: This is a cross-sectional study. We targeted the Fukushima residents who were 18 yr old or younger (including fetuses) at the time of the accident. Our examinations comprised a questionnaire, thyroid ultrasonography, thyroid-related blood tests, and urinary iodine measurement. We analyzed a possible relationship among thyroid ultrasonographic findings (1,137 subjects), serum hormonal data (731 subjects), urinary iodine concentrations (770 subjects), and iodine-131 ground deposition (1,137 subjects). We did not find any significant relationship among these indicators, and no participant was diagnosed to contract thyroid cancer. Conclusions: At the timepoint of 20-30 months after the accident, we did not confirm any discernible deleterious effects of the emitted radioactivity on the thyroid of young Fukushima residents. This is the first report in English detailing the thyroid status of young Fukushima residents after the nuclear disaster.	[Watanobe, Hajime; Nihei, Masahiko; Sakuma, Yu; Sagawa, Fumihiko] Radiat Countermeasures Res Inst Earthquake Disast, Hirata, Fukushima, Japan; [Watanobe, Hajime] Kasukabe Kousei Hosp, Kasukabe, Saitama, Japan; [Furutani, Tomoyuki] Keio Univ, Fac Policy Management, Fujisawa, Kanagawa, Japan; [Nihei, Masahiko; Sakuma, Yu; Sagawa, Fumihiko] Hirata Cent Clin, Hirata, Fukushima, Japan; [Yanai, Rie; Takahashi, Miyuki; Sato, Hideo; Sagawa, Fumihiko] Hirata Cent Hosp, Hirata, Fukushima, Japan	Keio University	Watanobe, H (corresponding author), Radiat Countermeasures Res Inst Earthquake Disast, Hirata, Fukushima, Japan.	hajime.watanobe@kenkyujyo.net						[Anonymous], 2013, REP UN SCI COMM EFF; [Anonymous], 2010, REP UN SCI COMM EFF; Cardis E, 2005, JNCI-J NATL CANCER I, V97, P724, DOI 10.1093/jnci/dji129; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Hatch M, 2009, J CLIN ENDOCR METAB, V94, P899, DOI 10.1210/jc.2008-2049; Heidenreich WF, 1999, RADIAT RES, V151, P617, DOI 10.2307/3580038; Hou XL, 2009, ANAL CHIM ACTA, V632, P181, DOI 10.1016/j.aca.2008.11.013; Imaizumi M, 2008, J CLIN ENDOCR METAB, V93, P1641, DOI 10.1210/jc.2008-0042; Japan Atomic Energy Agency, HEADQ FUK PARTN OP; Kamada N, 2012, J ENVIRON RADIOACTIV, V110, P84, DOI 10.1016/j.jenvrad.2012.02.007; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Kirichenko VA, 2012, BIOSECUR BIOTERROR, V10, P314, DOI 10.1089/bsp.2012.0019; Krivoruchko K, 2011, SPATIAL STAT DATA AN; Likhtarov I, 2014, HEALTH PHYS, V106, P370, DOI 10.1097/HP.0b013e31829f3096; Muramatsu Y, 2015, J ENVIRON RADIOACTIV, V139, P344, DOI 10.1016/j.jenvrad.2014.05.007; NEDVECKAITE T, 1993, J RADIOAN NUCL CH AR, V174, P43, DOI 10.1007/BF02040331; NIKIFOROV Y, 1994, CANCER-AM CANCER SOC, V74, P748, DOI 10.1002/1097-0142(19940715)74:2<748::AID-CNCR2820740231>3.0.CO;2-H; NOGUCHI H, 1988, J ENVIRON RADIOACTIV, V7, P65, DOI 10.1016/0265-931X(88)90042-2; Nuclear Regulation Authority Ministry of the Environment, 2012, RES RES DISTR RAD SU; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Spencer CA, 2004, J CLIN ENDOCR METAB, V89, P3702, DOI 10.1210/jc.2004-0986; The Japan Society of Clinical Oncology, 2010, GUID DIAGN TREAT THY; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; Torii T, 2013, HEALTH PHYS, V105, P192, DOI 10.1097/HP.0b013e318294444e; United Nations, 2011, REP UN SCI COMM EFF, VII; Vejbjerg P, 2009, EUR J ENDOCRINOL, V161, P475, DOI 10.1530/EJE-09-0262; WHO/UNICEF/ICCIDD, 2007, ASS IOD DEF DIS MON; World Health Organization, 1999, GUID IOD PROPH FOLL; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105; Zanzonico PB, 2000, HEALTH PHYS, V78, P660, DOI 10.1097/00004032-200006000-00008; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	33	10	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113804	10.1371/journal.pone.0113804	http://dx.doi.org/10.1371/journal.pone.0113804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474311	gold, Green Published, Green Submitted			2022-12-26	WOS:000346382500094
J	Martin-Villar, E; Borda-d'Agua, B; Carrasco-Ramirez, P; Renart, J; Parsons, M; Quintanilla, M; Jones, GE				Martin-Villar, E.; Borda-d'Agua, B.; Carrasco-Ramirez, P.; Renart, J.; Parsons, M.; Quintanilla, M.; Jones, G. E.			Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IN-VIVO; EXTRACELLULAR-MATRIX; REGULATES COFILIN; TUMOR-METASTASIS; PA2.26 ANTIGEN; ORAL-CANCER; TGF-BETA; INVASION; PODOSOMES	Invadopodia are actin-rich cell membrane projections used by invasive cells to penetrate the basement membrane. Control of invadopodia stability is critical for efficient degradation of the extracellular matrix (ECM); however, the underlying molecular mechanisms remain poorly understood. Here, we uncover a new role for podoplanin, a transmembrane glycoprotein closely associated with malignant progression of squamous cell carcinomas (SCCs), in the regulation of invadopodia-mediated matrix degradation. Podoplanin downregulation in SCC cells impairs invadopodia stability, thereby reducing the efficiency of ECM degradation. We report podoplanin as a novel component of invadopodia-associated adhesion rings, where it clusters prior to matrix degradation. Early podoplanin recruitment to invadopodia is dependent on lipid rafts, whereas ezrin/moesin proteins mediate podoplanin ring assembly. Finally, we demonstrate that podoplanin regulates invadopodia maturation by acting upstream of the ROCK-LIMK-Cofilin pathway through the control of RhoC GTPase activity. Thus, podoplanin has a key role in the regulation of invadopodia function in SCC cells, controlling the initial steps of cancer cell invasion.	[Martin-Villar, E.; Carrasco-Ramirez, P.; Renart, J.; Quintanilla, M.] Inst Invest Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain; [Martin-Villar, E.; Borda-d'Agua, B.; Parsons, M.; Jones, G. E.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of London; King's College London	Martin-Villar, E (corresponding author), Inst Invest Biomed Alberto Sols CSIC UAM, Arturo Duperier 4, Madrid 28029, Spain.	emvillar@iib.uam.es; gareth.jones@kcl.ac.uk	Martin-Villar, Ester/F-1982-2016; Renart, Jaime/B-7661-2009; Jones, Gareth E/H-2282-2012; Quintanilla, Miguel/K-9293-2017; Parsons, Maddy/B-2203-2013	Martin-Villar, Ester/0000-0003-2910-2345; Renart, Jaime/0000-0001-6620-3706; Jones, Gareth E/0000-0001-5879-3048; Parsons, Maddy/0000-0002-2021-8379; Quintanilla, Miguel/0000-0002-2124-7657	Cancer Research UK [C7125/A9926, A13651]; Medical Research Council [G0401026]; Spanish Ministry of Economy and Competitiveness [SAF 2010-19152/SAF2013-46183R]; Community of Madrid [S2010/BMD-2359]; Fundacion Cientifica Asociacion Espanola Contra el Cancer (AECC); MRC [G1100041, G0401026] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Community of Madrid(Comunidad de Madrid); Fundacion Cientifica Asociacion Espanola Contra el Cancer (AECC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Professor Anne Ridley for critical advice and help with ERM, and Rho GTPase siRNAs; Dr Yolanda Calle for her support and helpful suggestions; Drs Asier Jayo and Patricia Costa for help with LIMK studies, technical advice and critical discussions on this work and Dr David Sarrio for critical reading of the manuscript. This work has been funded by grants from Cancer Research UK (C7125/A9926; A13651) to GEJ and EM-V, the Medical Research Council (G0401026) to GEJ and from the Spanish Ministry of Economy and Competitiveness (SAF 2010-19152/SAF2013-46183R) and Community of Madrid (S2010/BMD-2359, SkinModel-CM) to MQ. EM-V is currently a recipient of a Postdoctoral Research Contract from Fundacion Cientifica Asociacion Espanola Contra el Cancer (AECC).	Antelmi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075113; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Beaty BT, 2014, J CELL BIOL, V205, P737, DOI 10.1083/jcb.201312046; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Beaty BT, 2014, EUR J CELL BIOL, DOI [10.1016/ j. ejcb. 2014. 07. 003, DOI 10.1016/J.EJCB.2014.07.003)]; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Fernandez-Munoz B, 2011, INT J BIOCHEM CELL B, V43, P886, DOI 10.1016/j.biocel.2011.02.010; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hagedorn EJ, 2014, J CELL BIOL, V204, P1209, DOI 10.1083/jcb.201312098; Hagedorn EJ, 2013, J CELL BIOL, V201, P903, DOI 10.1083/jcb.201301091; Honma M, 2012, J DERMATOL SCI, V65, P134, DOI 10.1016/j.jdermsci.2011.11.011; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Hwang YS, 2012, CARCINOGENESIS, V33, P2135, DOI 10.1093/carcin/bgs258; Inoue H, 2012, TUMOR BIOL, V33, P183, DOI 10.1007/s13277-011-0261-7; Kawaguchi H, 2008, J CLIN ONCOL, V26, P354, DOI 10.1200/JCO.2007.13.4072; Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Paz H, 2014, ONCOGENE, V33, P4193, DOI 10.1038/onc.2013.393; Pignatelli J, 2012, J CELL BIOL, V197, P421, DOI 10.1083/jcb.201108143; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Scholl FG, 1999, J CELL SCI, V112, P4601; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Suzuki H, 2008, FEBS LETT, V582, P341, DOI 10.1016/j.febslet.2007.12.028; Toll A, 2012, J AM ACAD DERMATOL, V67, P1310, DOI 10.1016/j.jaad.2012.03.007; Tsuneki M, 2013, LAB INVEST, V93, P921, DOI 10.1038/labinvest.2013.86; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamaguchi H, 2010, ONCOTARGET, V1, P320; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Yurrita MM, 2014, INT J BIOCHEM CELL B, V46, P68, DOI 10.1016/j.biocel.2013.11.016; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690	55	52	57	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4531	4544		10.1038/onc.2014.388	http://dx.doi.org/10.1038/onc.2014.388			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25486435	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000360189200012
J	Ost, M; Keipert, S; van Schothorst, EM; Donner, V; van der Stelt, I; Kipp, AP; Petzke, KJ; Jove, M; Pamplona, R; Portero-Otin, M; Keijer, J; Klaus, S				Ost, Mario; Keipert, Susanne; van Schothorst, Evert M.; Donner, Verena; van der Stelt, Inge; Kipp, Anna P.; Petzke, Klaus-Juergen; Jove, Mariona; Pamplona, Reinald; Portero-Otin, Manuel; Keijer, Jaap; Klaus, Susanne			Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux	FASEB JOURNAL			English	Article						amino acid metabolism; metabolic reprogramming; mitochondrial myopathy; oxidative stress tolerance; polyamines	UNCOUPLING PROTEIN-1 EXPRESSION; UBIQUITIN-PROTEASOME PATHWAY; HUMAN SKELETAL-MUSCLE; ANTIOXIDANT DEFENSE; GENE-EXPRESSION; RECEPTOR-GAMMA; MOUSE MODEL; CATHEPSIN-L; KEY ROLE; METABOLISM	Recent studies on mouse and human skeletal muscle (SM) demonstrated the important link between mitochondrial function and the cellular metabolic adaptation. To identify key compensatory molecular mechanisms in response to chronic mitochondrial distress, we analyzed mice with ectopic SM respiratory uncoupling in uncoupling protein 1 transgenic (UCP1-TG) mice as model of muscle-specific compromised mitochondrial function. Here we describe a detailed metabolic reprogramming profile associated with mitochondrial perturbations in SM, triggering an increased protein turnover and amino acid metabolism with induced biosynthetic serine/1-carbon/glycine pathway and the longevity-promoting polyamine spermidine as well as the trans-sulfuration pathway. This is related to an induction of NADPH-generating pathways and glutathione metabolism as an adaptive mitohormetic response and defense against increased oxidative stress. Strikingly, consistent muscle retrograde signaling profiles were observed in acute stress states such as muscle cell starvation and lipid overload, muscle regeneration, and heart muscle inflammation, but not in response to exercise. We provide conclusive evidence for a key compensatory stress-signaling network that preserves cellular function, oxidative stress tolerance, and survival during conditions of increased SM mitochondrial distress, a metabolic reprogramming profile so far only demonstrated for cancer cells and heart muscle.	[Ost, Mario; Keipert, Susanne; Donner, Verena; Kipp, Anna P.; Petzke, Klaus-Juergen; Klaus, Susanne] German Inst Human Nutr, Potsdam, Germany; [van Schothorst, Evert M.; van der Stelt, Inge; Keijer, Jaap] Wageningen Univ, Human & Anim Physiol, NL-6700 AP Wageningen, Netherlands; [Jove, Mariona; Pamplona, Reinald; Portero-Otin, Manuel] Univ Lleida, Biomed Res Inst, Lleida, Spain	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Wageningen University & Research; Universitat de Lleida	Klaus, S (corresponding author), German Inst Human Nutr, Inst Ernahrungsforsch Potsdam Rehbrucke, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	klaus@dife.de	Jové, Mariona/M-9104-2016; Portero-Otin, Manuel/B-7122-2009; Keipert, Susanne/V-2464-2017; Klaus, Susanne/P-9299-2018; Pamplona, Reinald/A-7359-2010; Keijer, Jaap/J-8089-2013	Jové, Mariona/0000-0001-5577-6162; Portero-Otin, Manuel/0000-0002-1823-0299; Keipert, Susanne/0000-0002-6618-7379; Klaus, Susanne/0000-0001-8726-185X; Pamplona, Reinald/0000-0003-4337-6107; Ost, Mario/0000-0002-1811-2049; Coleman, Verena/0000-0003-3045-4620; Kipp, Anna Patricia/0000-0002-3307-1038; van Schothorst, Evert/0000-0002-3036-5903; Keijer, Jaap/0000-0002-9720-7491	European Union [244995]; Leibniz Society [SAW-2013-FBN-3]; Spanish Ministry of Economy and Competitiveness [PI13/00584, PI11/01532]; Generalitat of Catalounya [2014SGR168]	European Union(European Commission); Leibniz Society; Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat of Catalounya	This research received funding from the European Union's Seventh Framework Program FP7 2007-2013 under Grant Agreement 244995 (BIOCLAIMS Project) and from the Leibniz Society (SAW-2013-FBN-3) as well as grants from the Spanish Ministry of Economy and Competitiveness (PI13/00584, PI11/01532) and the Generalitat of Catalounya (2014SGR168). The authors thank A. Sylvester, A. Voigt, I. Walter, C. Borchert, S. Deubel, L. Duivenvoorde, and A. Bunschoten for excellent technical assistance.	Adjeitey CNK, 2013, AM J PHYSIOL-ENDOC M, V305, pE405, DOI 10.1152/ajpendo.00057.2013; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brigelius-Flohe R, 2002, METHOD ENZYMOL, V347, P101; Brooks NE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00099; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Deval C, 2001, BIOCHEM J, V360, P143, DOI 10.1042/0264-6021:3600143; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Duivenvoorde LPM, 2011, J MOL ENDOCRINOL, V47, P81, DOI 10.1530/JME-11-0001; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ellinger JJ, 2011, J BIOMOL NMR, V49, P221, DOI 10.1007/s10858-011-9481-9; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Ham DJ, 2014, CLIN NUTR, V33, P448, DOI 10.1016/j.clnu.2013.06.013; Hoevenaars FPM, 2012, GENES NUTR, V7, P399, DOI 10.1007/s12263-011-0262-6; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Keipert S, 2013, AM J PHYSIOL-ENDOC M, V304, pE495, DOI 10.1152/ajpendo.00518.2012; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Keipert S, 2011, AGING CELL, V10, P122, DOI 10.1111/j.1474-9726.2010.00648.x; Keipert S, 2010, BBA-BIOENERGETICS, V1797, P324, DOI 10.1016/j.bbabio.2009.11.008; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lehti TM, 2006, AM J PHYSIOL-ENDOC M, V290, pE900, DOI 10.1152/ajpendo.00444.2005; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Macpherson PCD, 2011, J CELL BIOCHEM, V112, P2149, DOI 10.1002/jcb.23136; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102435; Minois N, 2014, GERONTOLOGY, V60, P319, DOI 10.1159/000356748; Neschen S, 2008, PHYSIOL GENOMICS, V33, P333, DOI 10.1152/physiolgenomics.00226.2007; Ost M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094689; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Shi Y, 2013, AM J PHYSIOL-REG I, V304, pR343, DOI 10.1152/ajpregu.00139.2012; Silva JM, 2009, NEUROBIOL DIS, V34, P357, DOI 10.1016/j.nbd.2009.02.005; Stack C, 2014, HUM MOL GENET, V23, P3716, DOI 10.1093/hmg/ddu080; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Tedeschi PM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.393; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Van der Meer-Van Kraaij C, 2003, FASEB J, V17, P1277, DOI 10.1096/fj.02-1036com; van Helden YGJ, 2010, CELL MOL LIFE SCI, V67, P2039, DOI 10.1007/s00018-010-0341-7; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; VANHALL G, 1995, J PHYSIOL-LONDON, V489, P251, DOI 10.1113/jphysiol.1995.sp021047; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025881; WAALKES TP, 1957, J LAB CLIN MED, V50, P733; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Wikoff WR, 2008, J CLIN INVEST, V118, P2661, DOI 10.1172/JCI34138; Yamazaki Y, 2010, BIOCHEM J, V427, P171, DOI 10.1042/BJ20091346; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200	77	45	45	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1314	1328		10.1096/fj.14-261503	http://dx.doi.org/10.1096/fj.14-261503			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25491309				2022-12-26	WOS:000354115000019
J	Hou, Q; He, WJ; Hao, HJ; Han, QW; Chen, L; Dong, L; Liu, JJ; Li, X; Zhang, YJ; Ma, YZ; Han, WD; Fu, XB				Hou, Qian; He, Wen-Jun; Hao, Hao-Jie; Han, Qing-Wang; Chen, Li; Dong, Liang; Liu, Jie-Jie; Li, Xiang; Zhang, Ya-Jing; Ma, Ying-Zhi; Han, Wei-Dong; Fu, Xiao-Bing			The Four-Herb Chinese Medicine ANBP Enhances Wound Healing and Inhibits Scar Formation via Bidirectional Regulation of Transformation Growth Factor Pathway	PLOS ONE			English	Article							RABBIT EAR; RAT SKIN; REPAIR; FIBROSIS; MECHANISMS; REGENERATION; INFLAMMATION; FIBROBLASTS; EXPRESSION; CELLS	The four-herb Chinese medicine ANBP is a pulverized mixture of four herbs including Agrimonia Eupatoria (A), Nelumbo Nucifera Gaertn (N), Boswellia Carteri (B) and Pollen Typhae Angustifoliae (P). The combination of the four herbs was first described in Chinese canonical medicine about 2000 years ago for treatment of various trauma disorders, such as hemostasis, antiinflammatory, analgesia, and wound healing, etc. However, the precise mechanisms of ANBP are still unclear. In our study, using rabbit ear hypertrophic scar models of full-thickness skin defect, we showed that local ANBP treatment not only significantly enhanced wound healing by relieving inflammation, increasing formation of granulation tissue and accelerating re-epithelialization, but also reduced scar formation by decreasing collagen production, protuberant height and volume of scars, and increasing collagen maturity. We demonstrated that these effects of ANBP are associated with transforming growth factor (TGF)-beta 1-mediated signalling pathways through Smad-dependent pathways. ANBP treatment significantly increased expression of TGF-beta 1 and Smad2/3 mRNA at the early stage of wound healing, and led to markedly decrease expression of TGF-beta 1 and Smad2/3 compared with the control group after 14 days post-wounding. Taken together, our results defined a bidirectional regulation role of ANBP for TGF-beta 1/Smad pathway in promoting wound healing and alleviating scar formation, which may be an effective therapy for human wounds at the earliest stage.	[Hou, Qian; He, Wen-Jun; Hao, Hao-Jie; Han, Qing-Wang; Chen, Li; Dong, Liang; Liu, Jie-Jie; Li, Xiang; Zhang, Ya-Jing; Ma, Ying-Zhi; Han, Wei-Dong; Fu, Xiao-Bing] Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med, Beijing, Peoples R China; [Hou, Qian] Chinese PLA 148th Hosp, Dept Internal Med, Zibo, Peoples R China; [Fu, Xiao-Bing] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Wound Healing & Cell Biol Lab, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Han, WD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med, Beijing, Peoples R China.	hanwdrsw69@yahoo.com; fuxiaobing@vip.sina.com	Hao, Haojie/D-6982-2013		National Basic Science and Development Program (973 Programme) [2012CB518103, 2012CB518105]; 863 Projects of Ministry of Science and Technology of China [2013AA020105, 2012AA020502]; National Natural Science Foundation of China [81121004, 81230041, 31100705, 30901564, 81101883]; China Postdoctoral Science Foundation [2013M542517]; Beijing Novel Program [2008B53, 2009A038]; Science and Technology Project of Hunan Provincial Science and Technology Department [2012FJ3012]; Scientific Research Project of Traditional Chinese Medicine in Hunan Province [2012111]	National Basic Science and Development Program (973 Programme)(National Basic Research Program of China); 863 Projects of Ministry of Science and Technology of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Novel Program(Beijing Municipal Science & Technology Commission); Science and Technology Project of Hunan Provincial Science and Technology Department; Scientific Research Project of Traditional Chinese Medicine in Hunan Province	This research was supported in part by the National Basic Science and Development Program (973 Programme, 2012CB518103 and 2012CB518105), the 863 Projects of Ministry of Science and Technology of China (2013AA020105 and 2012AA020502), the National Natural Science Foundation of China (81121004, 81230041, 31100705, 30901564, and 81101883), the China Postdoctoral Science Foundation (2013M542517), the Beijing Novel Program (2008B53, 2009A038), the Science and Technology Project of Hunan Provincial Science and Technology Department (2012FJ3012) and the Scientific Research Project of Traditional Chinese Medicine in Hunan Province (2012111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENTO EP, 1991, CIBA F SYMP, V157, P115; Colwell AS, 2005, PLAST RECONSTR SURG, V116, P1387, DOI 10.1097/01.prs.0000182343.99694.28; Colwell AS, 2005, ADV BIOCHEM ENG BIOT, V93, P83, DOI 10.1007/b99972; Colwell AS, 2003, FRONT BIOSCI-LANDMRK, V8, pS1240, DOI 10.2741/1183; Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hou Q, 2011, CANCER SCI, V102, P1287, DOI 10.1111/j.1349-7006.2011.01933.x; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kim JJ, 2012, J ETHNOPHARMACOL, V140, P213, DOI 10.1016/j.jep.2011.12.035; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Li P, 2011, J PATHOL, V223, P659, DOI 10.1002/path.2831; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; Liu X, 2005, J TRAUMA, V59, P682, DOI 10.1097/01.ta.0000177674.55388.40; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Ohkura N, 2012, BLOOD COAGUL FIBRIN, V23, P254, DOI 10.1097/MBC.0b013e3283504148; Pugazhenthi K, 2008, J PINEAL RES, V44, P387, DOI 10.1111/j.1600-079X.2007.00541.x; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; SHAH M, 1995, J CELL SCI, V108, P985; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tilton Robert, 2010, Chin Med, V5, P30, DOI 10.1186/1749-8546-5-30; Wolcott R D, 2008, J Wound Care, V17, P333; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Xie JL, 2008, WOUND REPAIR REGEN, V16, P576, DOI 10.1111/j.1524-475X.2008.00405.x; Ye M, 2007, RAPID COMMUN MASS SP, V21, P3593, DOI 10.1002/rcm.2832	30	24	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e112274	10.1371/journal.pone.0112274	http://dx.doi.org/10.1371/journal.pone.0112274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489732	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300002
J	Jacot, TA; Nelson, A; Thurman, A; Kashuba, ADM; Archer, DF; Doncel, GF				Jacot, Terry A.; Nelson, Ashley; Thurman, Andrea; Kashuba, Angela D. M.; Archer, David F.; Doncel, Gustavo F.			Development of a Composite Measure of Product Adherence, Protocol Compliance, and Semen Exposure Using DNA and Protein Biomarkers for Topical HIV Prevention Studies	PLOS ONE			English	Article							DYE STAIN ASSAY; PREEXPOSURE PROPHYLAXIS; BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; RIBOSOMAL-RNA; IDENTIFICATION; WOMEN; GEL; INFECTION; TRIALS	Background: Poor and inconsistent use of study products has hindered clinical HIV prevention studies. It is important to be able to monitor product adherence and protocol compliance in order to determine microbicide efficacy and safety more accurately. Current methods for monitoring adherence are subjective, non-specific, or invasive. Herein, we present a composite, objective measure of product adherence and protocol compliance to assess vaginal insertion, semen exposure and drug expulsion utilizing DNA, protein, and drug isolated directly from returned, vaginally used gel applicators. Methods: DNA, vaginal cells, and residual tenofovir were isolated from vaginally inserted applicators. Vaginal and semen biomarkers were amplified using a multiplex PCR to determine vaginal insertion. Vaginal cells were fixed followed by cytokeratin 4 immunocytochemistry to confirm DNA assessment of vaginal insertion. Tenofovir was extracted and quantitated through LC-MS/MS. Results: DNA isolated from vaginally inserted applicators were positive for vaginal bacteria DNA and the control eukaryotic gene, amelogenin, while manually handled, "sham'', applicators were negative for both. Semen exposure was independently determined by simultaneous amplification of one or both Y-chromosomal genes, SRY and TSPY4. Vaginal insertion determination by DNA analysis was further confirmed by positive cytokeratin 4 (CK4) immunocytochemistry of vaginal cells remaining on the gel applicators. On the contrary, sham applicators provided very few cells when swabbed, and they were all negative for CK4. CK4 was not found in epidermal cells from the hand. Drug expulsion was detected through quantitation of residual gel present on the surface of returned applicators. Sham applicators had no detectable tenofovir. Conclusion: Utilizing a composite, triple marker based panel of DNA, protein, and drug present on the surface of returned vaginal gel applicators, it is possible to determine, objectively and non-invasively, product adherence, protocol compliance, and semen exposure in microbicide trials.	[Jacot, Terry A.; Nelson, Ashley; Thurman, Andrea; Archer, David F.; Doncel, Gustavo F.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA; [Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Kashuba, Angela D. M.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA	Eastern Virginia Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jacot, TA (corresponding author), Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA.	jacotta@evms.edu			American people through the United States Agency for International Development (USAID) [GPO-A-00-08-00005-00]; National Institutes of Health NICHD HIV/AIDS IAA [Y1-HD-0083, RO1 HD 07 2705-01, P30 AI50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institutes of Health NICHD HIV/AIDS IAA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under Cooperative agreement GPO-A-00-08-00005-00 to CONRAD, Eastern Virginia Medical School. The views expressed by the authors do not necessarily reflect the view of USAID or the United States Government. This work was also supported by the National Institutes of Health NICHD HIV/AIDS IAA #Y1-HD-0083 (GD), RO1 HD 07 2705-01 (GD), P30 AI50410 (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, LEGAL MED-TOKYO, V14, P160, DOI 10.1016/j.legalmed.2012.01.005; [Anonymous], 2013, WHO HIV AIDS FACT SH; Austin MN, 2009, SEX TRANSM DIS, V36, P368, DOI 10.1097/OLQ.0b013e3181972397; Benschop CCG, 2012, INT J LEGAL MED, V126, P303, DOI 10.1007/s00414-011-0660-8; Fleming RI, 2010, FORENSIC SCI INT-GEN, V4, P311, DOI 10.1016/j.fsigen.2009.11.008; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gallo MF, 2007, INT J STD AIDS, V18, P33, DOI 10.1258/095646207779949899; Gengiah TN, 2014, AIDS BEHAV, V18, P833, DOI 10.1007/s10461-014-0750-y; Halpern V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003784; Hanson E, 2012, FORENSIC SCI INT-GEN, V6, P548, DOI 10.1016/j.fsigen.2012.01.004; Hemmerling A, 2012, SEX TRANSM DIS, V39, P710, DOI 10.1097/OLQ.0b013e3182641f08; Honda K, 1999, J FORENSIC SCI, V44, P868; Jacot TA, 2013, CONTRACEPTION, V88, P387, DOI 10.1016/j.contraception.2012.11.022; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Katzen LL, 2011, SEX TRANSM DIS, V38, P1050, DOI 10.1097/OLQ.0b013e31822e6160; Keller MJ, 2013, SEX TRANSM DIS, V40, P939, DOI 10.1097/OLQ.0000000000000040; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Marazzo J, 2013, PREEXPOSURE PROPHYLA; Mauck CK, 2008, JAIDS-J ACQ IMM DEF, V49, P64, DOI 10.1097/QAI.0b013e318183a917; Moench TR, 2012, SEX TRANSM DIS, V39, P335, DOI 10.1097/OLQ.0b013e31824790bb; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schulz MM, 2010, J FORENSIC SCI, V55, P492, DOI 10.1111/j.1556-4029.2009.01071.x; Schwartz JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025974; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Song YL, 2000, FEMS MICROBIOL LETT, V187, P167, DOI 10.1016/S0378-1097(00)00196-8; Thurman AR, 2014, SEX TRANSM IN PRESS; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2013, SEX TRANSM DIS, V40, P950, DOI 10.1097/OLQ.0000000000000053; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Virkler K, 2009, FORENSIC SCI INT, V188, P1, DOI 10.1016/j.forsciint.2009.02.013; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	37	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114368	10.1371/journal.pone.0114368	http://dx.doi.org/10.1371/journal.pone.0114368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489736	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300032
J	Sun, YY; Pan, J; Mao, SD; Jin, JP				Sun, Yuanyuan; Pan, Jing; Mao, Shudan; Jin, Jieping			IL-17/miR-192/IL-17Rs Regulatory Feedback Loop Facilitates Multiple Myeloma Progression	PLOS ONE			English	Article							KAPPA-B ACTIVATION; T-CELLS; CANCER; IL-17; MICROENVIRONMENT; INTERLEUKIN-17; PROLIFERATION; ANGIOGENESIS; METASTASIS; EXPRESSION	Multiple myeloma (MM) is a clonal plasma cell disorder which constitutes the second most common hematological malignancy, and remains an incurable tumor with poor survival. Recently, interleukin-17 (IL-17), produced locally in the tumor microenvironment, has been reported to play a crucial role in tumor immunity. In this study, we determined that exposure of MM cells to IL-17 had various promotive influences on different aspects of tumor progression. IL-17 significantly induced cell proliferation, inhibited cellular apoptosis, repressed cell adhesion to fibronectin and collagen I, and facilitated cell migration. Exposure to IL-17 also resulted in epithelial-mesenchymal transition (EMT), as evidenced by repression of the epithelial marker E-cadherin, and induction of the mesenchymal marker Vimentin, and EMT transcription factors Snail and Slug. Further experiments showed that IL-17 activated the oncogenic p65 transcription factor, which directly repressed the miR-192 gene via binding to the miR-192 promoter. Loss of miR-192 in MM cells can mimic the effects of IL-17, and was required for the above oncogenic effects of IL-17 on MM. Furthermore, we found that miR-192, and its homologous miR-215 directly targeted the 39-untranslated regions of IL-17Rs, including IL-17RA and RE mRNA. By examining bone marrow specimens derived from MM patients, a negative correlation between miR-192 expression and IL-17 or IL-17RA expression was observed. Also, IL-17 was negatively correlated with E-cadherin and positively with Vimentin. Taken together, our study provides evidence that the IL-17/miR-192/IL-17Rs regulatory feedback loop is manifest in MM and might represent a promising and efficient prognostic marker and therapeutic target for MM.	[Sun, Yuanyuan; Pan, Jing; Mao, Shudan; Jin, Jieping] Liaoning Med Univ, Affiliated Hosp 1, Dept Hematol, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Jin, JP (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Hematol, Jinzhou, Liaoning, Peoples R China.	yihaidaohang@163.com			Foundation of Science and Technology Agency in Liaoning Province [2012225019]	Foundation of Science and Technology Agency in Liaoning Province	This work was supported by the Foundation of Science and Technology Agency in Liaoning Province (2012225019, Research on regulation of IL-17 on myeloma). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang SH, 2014, P NATL ACAD SCI USA, V111, P5664, DOI 10.1073/pnas.1319051111; Das Roy L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2345; Dogini DB, 2014, GENET MOL BIOL, V37, P285, DOI 10.1590/S1415-47572014000200014; Feng SP, 2011, NUCLEIC ACIDS RES, V39, P6669, DOI 10.1093/nar/gkr232; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Girardin A, 2013, INT J CANCER, V132, P1842, DOI 10.1002/ijc.27855; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huston Alissa, 2006, Future Oncol, V2, P371, DOI 10.2217/14796694.2.3.371; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Li LQ, 2013, CLIN IMMUNOL, V148, P246, DOI 10.1016/j.clim.2013.05.003; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Ludwig Heinz, 2004, Clin Adv Hematol Oncol, V2, P233; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; Omrane I, 2014, IMMUNOL LETT, V158, P189, DOI 10.1016/j.imlet.2014.01.002; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Prabhala RH, 2010, BLOOD, V115, P5385, DOI 10.1182/blood-2009-10-246660; Ribatti D, 2014, ADV EXP MED BIOL, V816, P361, DOI 10.1007/978-3-0348-0837-8_14; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Song XN, 2013, LEUKEMIA RES, V37, P1094, DOI 10.1016/j.leukres.2013.06.022; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Umansky V, 2013, CANCER MICROENVIRON, V6, P169, DOI 10.1007/s12307-012-0126-7; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu LL, 2004, WORLD J GASTROENTERO, V10, P3255, DOI 10.3748/wjg.v10.i22.3255	34	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114647	10.1371/journal.pone.0114647	http://dx.doi.org/10.1371/journal.pone.0114647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489847	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300063
J	Dong, Y; Zhang, T; Li, JJ; Deng, HY; Song, YJ; Zhai, D; Peng, Y; Lu, XL; Liu, MY; Zhao, YX; Yi, ZF				Dong, Yanmin; Zhang, Tao; Li, Jingjie; Deng, Huayun; Song, Yajuan; Zhai, Dong; Peng, Yi; Lu, Xiaoling; Liu, Mingyao; Zhao, Yongxiang; Yi, Zhengfang			Oridonin Inhibits Tumor Growth and Metastasis through Anti-Angiogenesis by Blocking the Notch Signaling	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; ENDOTHELIAL-CELLS; ACTIN DYNAMICS; BREAST-CANCER; DELTA-NOTCH; IN-VITRO; PHASE-I; APOPTOSIS; ACTIVATION; CADHERIN	While significant progress has been made in understanding the anti-inflammatory and anti-proliferative effects of the natural diterpenoid component Oridonin on tumor cells, little is known about its effect on tumor angiogenesis or metastasis and on the underlying molecular mechanisms. In this study, Oridonin significantly suppressed human umbilical vascular endothelial cells (HUVECs) proliferation, migration, and apillary-like structure formation in vitro. Using aortic ring assay and mouse corneal angiogenesis model, we found that Oridonin inhibited angiogenesis ex vivo and in vivo. In our animal experiments, Oridonin impeded tumor growth and metastasis. Immunohistochemistry analysis further revealed that the expression of CD31 and vWF protein in xenografts was remarkably decreased by the Oridonin. Furthermore, Oridonin reinforced endothelial cell-cell junction and impaired breast cancer cell transendothelial migration. Mechanistically, Oridonin not only down-regulated Jagged2 expression and Notch1 activity but also decreased the expression of their target genes. In conclusion, our results demonstrated an original role of Oridonin in inhibiting tumor angiogenesis and propose a mechanism. This study also provides new evidence supporting the central role of Notch in tumor angiogenesis and suggests that Oridonin could be a potential drug candidate for angiogenesis related diseases.	[Dong, Yanmin; Zhang, Tao; Li, Jingjie; Deng, Huayun; Song, Yajuan; Zhai, Dong; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Dong, Yanmin; Zhang, Tao; Li, Jingjie; Deng, Huayun; Song, Yajuan; Zhai, Dong; Liu, Mingyao; Yi, Zhengfang] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Peng, Yi; Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, Nanning 530021, Guangxi, Peoples R China	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Guangxi Medical University	Zhao, YX (corresponding author), Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, 22 Shuang Yong Rd, Nanning 530021, Guangxi, Peoples R China.	yongxiangzhao@126.com; zfyi@bio.ecnu.edu.cn	lu, xl/HDO-8340-2022	Liu, Mingyao/0000-0001-7339-5048	Major State Basic Research Development Program of China [2015CB910400]; National Natural Science Foundation of China [81272463, 81472788, 81330049]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1128]; Innovation Program of Shanghai Municipal Education Commission [13zz034]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was partially supported by Major State Basic Research Development Program of China (2015CB910400). National Natural Science Foundation of China (81272463, 81472788, 81330049). Program for Changjiang Scholars and Innovative Research Team in University (IRT1128). Innovation Program of Shanghai Municipal Education Commission (13zz034). The Science and Technology Commission of Shanghai Municipality (11DZ2260300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Dai FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052162; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Gao F, 2010, INT J LAB HEMATOL, V32, pE114, DOI 10.1111/j.1751-553X.2009.01147.x; Garcia A, 2012, HISTOL HISTOPATHOL, V27, P151, DOI 10.14670/HH-27.151; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Kang N, 2010, J NAT PROD, V73, P1058, DOI 10.1021/np9008199; Kang N, 2010, CANCER LETT, V294, P147, DOI 10.1016/j.canlet.2010.01.032; Kiec-Wilk B, 2010, J PHYSIOL PHARMACOL, V61, P217; Krop I, 2012, J CLIN ONCOL, V30, P2307, DOI 10.1200/JCO.2011.39.1540; Lai L, 2012, BRIT J PHARMACOL, V165, P1084, DOI 10.1111/j.1476-5381.2011.01532.x; Lechertier T, 2004, ANTICANCER RES, V24, P4011; Liu H, 2014, TUMOUR BIOL; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Longo N, 2001, BLOOD, V98, P3717, DOI 10.1182/blood.V98.13.3717; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Meade-Tollin LC, 2004, J NAT PROD, V67, P2, DOI 10.1021/np0304114; Mierke CT, 2008, J BIOPHYS, V2008; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pihan GA, 1998, CANCER RES, V58, P3974; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shi W, 2006, J MAMMARY GLAND BIOL, V11, P41, DOI 10.1007/s10911-006-9011-7; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Zabel BA, 2001, MOL CANCER, V10, P73; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhang T, 2014, NEOPLASIA, V16, P665, DOI 10.1016/j.neo.2014.07.009; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhang XL, 2011, INT J CANCER, V129, P2502, DOI 10.1002/ijc.25909; Zhou GB, 2007, BLOOD, V109, P3441, DOI 10.1182/blood-2006-06-032250	48	46	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113830	10.1371/journal.pone.0113830	http://dx.doi.org/10.1371/journal.pone.0113830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485753	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600028
J	Knitlova, J; Hajkova, V; Voska, L; Elsterova, J; Obrova, B; Melkova, Z				Knitlova, Jarmila; Hajkova, Vera; Voska, Ludek; Elsterova, Jana; Obrova, Barbora; Melkova, Zora			Development of Eczema Vaccinatum in Atopic Mouse Models and Efficacy of MVA Vaccination against Lethal Poxviral Infection	PLOS ONE			English	Article							SMALLPOX VACCINE; IMMUNE-RESPONSE; VIRUS ANKARA; DENDRITIC CELLS; PROTEIN-KINASE; ANIMAL-MODELS; UNITED-STATES; SKIN-LESIONS; NC/NGA MICE; DERMATITIS	Smallpox vaccine based on live, replicating vaccinia virus (VACV) is associated with several potentially serious and deadly complications. Consequently, a new generation of vaccine based on non-replicating Modified vaccinia virus Ankara (MVA) has been under clinical development. MVA seems to induce good immune responses in blood tests, but it is impossible to test its efficacy in vivo in human. One of the serious complications of the replicating vaccine is eczema vaccinatum (EV) occurring in individuals with atopic dermatitis (AD), thus excluding them from all preventive vaccination schemes. In this study, we first characterized and compared development of eczema vaccinatum in different mouse strains. Nc/Nga, Balb/c and C57BI/6J mice were epicutaneously sensitized with ovalbumin (OVA) or saline control to induce signs of atopic dermatitis and subsequently trans-dermally (t.d.) immunized with VACV strain Western Reserve (WR). Large primary lesions occurred in both mock- and OVA-sensitized Nc/Nga mice, while they remained small in Balb/c and C57BI/6J mice. Satellite lesions developed in both mock-and OVA-sensitized Nc/Nga and in OVA-sensitized Balb/c mice with the rate 40-50%. Presence of mastocytes and eosinophils was the highest in Nc/Nga mice. Consequently, we have chosen Nc/Nga mice as a model of AD/EV and tested efficacy of MVA and Dryvax vaccinations against a lethal intra-nasal (i.n.) challenge with WR, the surrogate of smallpox. Inoculation of MVA intra-muscularly (i.m.) or t.d. resulted in no lesions, while inoculation of Dryvax t.d. yielded large primary and many satellite lesions similar to WR. Eighty three and 92% of mice vaccinated with a single dose of MVA i.m. or t.d., respectively, survived a lethal i.n. challenge with WR without any serious illness, while all Dryvax-vaccinated animals survived. This is the first formal prove of protective immunity against a lethal poxvirus challenge induced by vaccination with MVA in an atopic organism.	[Knitlova, Jarmila; Hajkova, Vera; Elsterova, Jana; Obrova, Barbora; Melkova, Zora] Charles Univ Prague, Fac Med 1, Dept Immunol & Microbiol, Prague 12800 2, Czech Republic; [Voska, Ludek] Inst Clin & Expt Med, Dept Clin & Transplant Pathol, Prague 14021 4, Czech Republic	Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM)	Melkova, Z (corresponding author), Charles Univ Prague, Fac Med 1, Dept Immunol & Microbiol, Studnickova 7, Prague 12800 2, Czech Republic.	zmelk@LF1.cuni.cz	Hájková, Věra/J-7185-2017; Knitlova, Jarmila/AAG-1338-2021; Melkova, Zora/J-4209-2017	Hájková, Věra/0000-0002-2274-4858; Knitlova, Jarmila/0000-0003-4607-4497; Melkova, Zora/0000-0002-9709-2110	Agency of Charles University [100307, PRVOUK-P24/LF1/3]; European Regional Development Fund [CZ.1.05/1.1.00/02.0109]	Agency of Charles University; European Regional Development Fund(European Commission)	This work was supported by Grant Agency of Charles University - project No. 100307 (http://www.cuni.cz/UK-1673. html) (JK); Charles University - project No. PRVOUK-P24/LF1/3 (http://www.cuni.cz/UK-4157. html) (ZM); and European Regional Development Fund -project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec'' (CZ.1.05/1.1.00/02.0109) ((http://www. biocev.eu/en/about/project-in-numbers/) (ZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2011, J MOL BIOL, V413, P973, DOI 10.1016/j.jmb.2011.09.025; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Artenstein AW, 2008, REV MED VIROL, V18, P217, DOI 10.1002/rmv.571; Baixeras E, 1998, VIRUS RES, V58, P107, DOI 10.1016/S0168-1702(98)00105-1; Barchichat S, 2002, VIRUS RES, V90, P243, DOI 10.1016/S0168-1702(02)00200-9; Becker Y, 2003, VIRUS GENES, V27, P269, DOI 10.1023/A:1026399916888; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Gutermutha J, 2004, INT ARCH ALLERGY IMM, V135, P262, DOI 10.1159/000082099; Guzman E, 2012, J VIROL, V86, P5452, DOI 10.1128/JVI.00264-12; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Kalbacova M, 2008, VIRUS RES, V135, P53, DOI 10.1016/j.virusres.2008.02.007; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kawakami Yuko, 2007, Allergol Int, V56, P403, DOI 10.2332/allergolint.O-07-486; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kutinova L, 1996, VACCINE, V14, P1045, DOI 10.1016/0264-410X(96)00008-4; KUTINOVA L, 1995, VACCINE, V13, P487, DOI 10.1016/0264-410X(94)00019-J; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liskova J, 2011, VIRUS RES, V160, P40, DOI 10.1016/j.virusres.2011.05.005; Mamessier E, 2005, REV MAL RESPIR, V22, P305, DOI 10.1019/200539977; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Matsumoto M, 1999, J IMMUNOL, V162, P1056; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Miljkovic Z, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-37; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Nemeckova S, 2001, ACTA VIROL, V45, P243; Oyoshi MK, 2012, J INVEST DERMATOL, V132, P1299, DOI 10.1038/jid.2011.409; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Rager KJ, 1998, J VIROL, V72, P1171, DOI 10.1128/JVI.72.2.1171-1176.1998; Reed JL, 2012, CLIN INFECT DIS, V54, P832, DOI 10.1093/cid/cir952; Scott JE, 2007, J ALLERGY CLIN IMMUN, V120, P1382, DOI 10.1016/j.jaci.2007.08.004; Shiohara T, 2004, J DERMATOL SCI, V36, P1, DOI 10.1016/j.jdermsci.2004.02.013; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Townsend MB, 2012, J VIROL; Vestergaard C, 2000, MOL MED TODAY, V6, P209, DOI 10.1016/S1357-4310(00)01683-X; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; von Sonnenburg F, 2014, VACCINE, V32, P5696, DOI 10.1016/j.vaccine.2014.08.022; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wertheimer ER, 2012, VACCINE, V30, P985, DOI 10.1016/j.vaccine.2011.12.049; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yagi R, 2002, J IMMUNOL, V168, P2020, DOI 10.4049/jimmunol.168.4.2020	55	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114374	10.1371/journal.pone.0114374	http://dx.doi.org/10.1371/journal.pone.0114374			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486419	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600050
J	Liu, Y; Yu, JT; Wang, HF; Hao, XK; Yang, YF; Jiang, T; Zhu, XC; Cao, L; Zhang, DQ; Tan, L				Liu, Ying; Yu, Jin-Tai; Wang, Hui-Fu; Hao, Xiao-Ke; Yang, Yu-Fen; Jiang, Teng; Zhu, Xi-Chen; Cao, Lei; Zhang, Dao-Qiang; Tan, Lan			Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; LEWY BODIES; BRAIN; EXPRESSION; GENE; SUSCEPTIBILITY; EPIDEMIOLOGY; DEMENTIA; VOLUME; NM23	Recently, a large meta-analysis of five genome wide association studies (GWAS) identified a novel locus (rs2718058) adjacent to NME8 that played a preventive role in Alzheimer's disease (AD). However, this link between the single nucleotide polymorphism (SNP) rs2718058 and the pathology of AD have not been mentioned yet. Therefore, this study assessed the strength of association between the NME8 rs2718058 genotypes and AD-related measures including the cerebrospinal fluid (CSF) amyloid beta, tau, P-tau concentrations, neuroimaging biomarkers and cognitive performance, in a large cohort from Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used information of a total of 719 individuals, including 211 normal cognition (NC), 346 mild cognitive impairment (MCI) and 162 AD. Although we didn't observe a positive relationship between rs2718058 and AD, it was significantly associated with several AD related endophenotypes. Among the normal cognitively normal participants, the minor allele G carriers showed significantly associated with higher CDRSB score than A allele carriers (P=0.021). Occipital gyrus atrophy were significantly associated with NME8 genotype status (P=0.002), with A allele carriers has more atrophy than the minor allele G carriers in AD patients; lateral ventricle (both right and left) cerebral metabolic rate for glucose (CMRgl) were significantly associated with NME8 genotype (P<0.05), with GA genotype had higher metabolism than GG and AA genotypes in MCI group; the atrophic right hippocampus in 18 months is significantly different between the three group, with GG and AA genotypes had more hippocampus atrophy than GA genotypes in the whole group. Together, our results are consistent with the direction of previous research, suggesting that NME8 rs2718058 appears to play a role in lowering the brain neurodegeneration.	[Liu, Ying; Yu, Jin-Tai; Tan, Lan] Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China; [Yu, Jin-Tai; Tan, Lan] Qingdao Univ, Qingdao Municipal Hosp, Sch Med, Dept Neurol, Qingdao, Peoples R China; [Yu, Jin-Tai; Wang, Hui-Fu; Zhu, Xi-Chen; Cao, Lei; Tan, Lan] Nanjing Med Univ, Qingdao Municipal Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Hao, Xiao-Ke; Zhang, Dao-Qiang] Nanjing Univ Aeronaut & Astronaut, Dept Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Yang, Yu-Fen] Air Beijing Dongjiao Lane Community Hlth, Beijing, Peoples R China; [Jiang, Teng] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Dalian Medical University; Qingdao Municipal Hospital; Qingdao Municipal Hospital; Qingdao University; Nanjing Medical University; Nanjing University of Aeronautics & Astronautics; Nanjing Medical University	Yu, JT (corresponding author), Dalian Med Univ, Qingdao Municipal Hosp, Dept Neurol, Qingdao, Peoples R China.	yu-jintai@163.com; dr.tanlan@163.com	Yu, Jin-Tai/HDL-7766-2022	Yu, Jin-Tai/0000-0002-7686-0547	ADNI (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Bio-Clinica, Inc; Biogen Idec Inc; Bristol-Myers Squibb Co, F. HoffmannLaRoche Ltd and Genetech, Inc; GE Healthcare; Innogenetics, NV; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development LLC; Medpace, Inc; Merck Co, Inc; Meso Scale Diagnostics, LLC; NeuroRx Research; Novartis Pharmaceuticals, Co, Pfizer, Inc; Piramal Imaging; Servier; Synarc Inc; Takeda Pharmaceutical Co; ADNI clinical sites in Canada; National Natural Science Foundation of China [81171209, 81371406, 81000544]; Jiangsu Natural Science Foundation for Distinguished Young Scholar [BK20130034]; NATIONAL INSTITUTE ON AGING [U24AG021886, U01AG024904] Funding Source: NIH RePORTER	ADNI (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Bio-Clinica, Inc; Biogen Idec Inc(Biogen); Bristol-Myers Squibb Co, F. HoffmannLaRoche Ltd and Genetech, Inc(Bristol-Myers Squibb); GE Healthcare(General ElectricGE Healthcare); Innogenetics, NV; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development LLC; Medpace, Inc; Merck Co, Inc(Merck & Company); Meso Scale Diagnostics, LLC; NeuroRx Research; Novartis Pharmaceuticals, Co, Pfizer, Inc; Piramal Imaging; Servier(Servier); Synarc Inc; Takeda Pharmaceutical Co(Takeda Pharmaceutical Company Ltd); ADNI clinical sites in Canada; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation for Distinguished Young Scholar; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing was funded by ADNI (National Institutes of Health U01 AG024904). ADNI is funded by the National Institute on Aging; the National Institute of Biomedical Imaging and Bioengineering; the Alzheimer's Association; the Alzheimer's Drug Discovery Foundation; Bio-Clinica, Inc; Biogen Idec Inc; Bristol-Myers Squibb Co, F. HoffmannLaRoche Ltd and Genetech, Inc; GE Healthcare; Innogenetics, NV; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development LLC; Medpace, Inc; Merck & Co, Inc; Meso Scale Diagnostics, LLC; NeuroRx Research; Novartis Pharmaceuticals, Co, Pfizer, Inc; Piramal Imaging; Servier; Synarc Inc; and Takeda Pharmaceutical Co. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private-sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization was the Northern California Institute for Research and Education, and the study was coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Natural Science Foundation of China (81171209, 81371406, 81000544) and Jiangsu Natural Science Foundation for Distinguished Young Scholar (No. BK20130034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford JW, 2011, J ALZHEIMERS DIS, V27, P885, DOI 10.3233/JAD-2011-110950; Ashford JW, 2011, J ALZHEIMERS DIS, V26, P1, DOI 10.3233/JAD-2011-0073; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; CALIGO MA, 1995, INT J CANCER, V60, P837, DOI 10.1002/ijc.2910600619; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Erten-Lyons D, 2010, ALZHEIMERS DEMENT, V6, P118, DOI 10.1016/j.jalz.2009.05.663; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; Jiang T, 2012, J ALZHEIMERS DIS, V31, P475, DOI 10.3233/JAD-2012-120640; Kantarci K, 2012, NEUROBIOL AGING, V33, P2091, DOI 10.1016/j.neurobiolaging.2011.09.024; KEIM D, 1992, J CLIN INVEST, V89, P919, DOI 10.1172/JCI115672; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kim SH, 2002, BIOCHEM BIOPH RES CO, V296, P970; Kremen WS, 2012, NEUROBIOL AGING, V33, P1, DOI 10.1016/j.neurobiolaging.2010.02.007; Lahiri DK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-68; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lebedev AV, 2013, J NEUROL, V260, P1104, DOI 10.1007/s00415-012-6768-z; Migliaccio R, 2012, ALZHEIMERS DEMENT, V8, pe71; Migliaccio Raffaella, 2012, Alzheimers Dement, V8, pS78, DOI 10.1016/j.jalz.2012.04.010; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; MOURAD N, 1966, J BIOL CHEM, V241, P271; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Raamana PR, 2014, FRONTIERS NEUROLOGY, V5; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	29	12	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114777	10.1371/journal.pone.0114777	http://dx.doi.org/10.1371/journal.pone.0114777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486118	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600098
J	Simonetta, F; Gestermann, N; Bloquet, S; Bourgeois, C				Simonetta, Federico; Gestermann, Nicolas; Bloquet, Stephane; Bourgeois, Christine			Interleukin-7 Optimizes FOXP3+CD4+Regulatory T Cells Reactivity to Interleukin-2 by Modulating CD25 Expression	PLOS ONE			English	Article							HOMEOSTATIC PROLIFERATION; CD127 EXPRESSION; IL-2 RECEPTOR; CUTTING EDGE; FOXP3; TRANSCRIPTION; STIMULATION; LYMPHOPENIA; MAINTENANCE; INDUCTION	The vast majority of Foxp3 regulatory T cells (Treg) exhibits constitutive expression of CD25 (IL-2R alpha), which allows the constitution of the high affinity IL-2R alpha beta gamma receptor, ensuring efficient IL-2 binding by Treg. Maintenance of CD25 expression at Treg surface depends on both cell intrinsic factors and environmental stimuli such as IL-2 itself. Whether other factors can participate to maintenance of CD25 expression in vivo is at present unknown. In the present work we demonstrated that IL-7, a gamma-chain cytokine exerting a crucial role in T cell development and homeostasis, is able and necessary to sustain the expression of high levels of CD25 at Treg surface. We demonstrated that, during in vitro cultures performed in the absence of IL-2, IL-7 is able to sustain CD25 expression at Treg surface through a transcriptional mechanism. By studying mice in which IL-7 signaling is either genetically impaired or increased and by employing adoptive transfer murine models, we demonstrated that IL-7 is necessary for sustained expression of CD25 at Treg surface in vivo. To ascertain the biological impact of IL-7 mediated modulation of CD25 expression, we demonstrated that IL-7 modulation of CD25 expression at Treg surface affected their ability to efficiently bind IL-2 and transduce IL-2 signaling. Finally, we demonstrated that IL-7 dependent modulation of CD25 associated with potentiated IL-2 induced expansion of Treg in vivo. Collectively, our results identify IL-7 as a necessary factor contributing to sustained CD25 expression at Treg surface in vivo thereby affecting their ability to efficiently react to IL-2.	[Simonetta, Federico; Gestermann, Nicolas; Bourgeois, Christine] INSERM, U1012, Le Kremlin Bicetre, France; [Simonetta, Federico; Gestermann, Nicolas; Bourgeois, Christine] Univ Paris Sud, U1012, Le Kremlin Bicetre, France; [Simonetta, Federico] Univ Hosp Geneva, Dept Med Specialties, Div Hematol, Geneva, Switzerland; [Bloquet, Stephane] Univ Paris Sud, Fac Med Paris Sud, Animalerie Centrale, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bourgeois, C (corresponding author), INSERM, U1012, Le Kremlin Bicetre, France.	christine.bourgeois@u-psud.fr	Bourgeois, Christine/L-5944-2018; Simonetta, Federico/CAH-2436-2022; Bourgeois, Christine/ABA-1432-2021	Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Simonetta, Federico/0000-0002-0399-689X	Agence Nationale de la recherche contre le SIDA et les hepatites virales (ANRS); Fondation de France; Fondation pour la recherche medicale (FRM)	Agence Nationale de la recherche contre le SIDA et les hepatites virales (ANRS)(ANRS); Fondation de France(Fondation de France); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Agence Nationale de la recherche contre le SIDA et les hepatites virales (ANRS) and Fondation de France. Federico Simonetta was also supported by the Fondation pour la recherche medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Amado IF, 2013, J EXP MED, V210, P2707, DOI 10.1084/jem.20122759; ARMITAGE RJ, 1990, J IMMUNOL, V144, P938; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Bosco N, 2006, J IMMUNOL, V177, P5014, DOI 10.4049/jimmunol.177.8.5014; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Camperio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048303; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; COSTELLO R, 1993, IMMUNOLOGY, V80, P451; Cozzo C, 2003, J IMMUNOL, V171, P5678, DOI 10.4049/jimmunol.171.11.5678; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Dupont G, 2014, CYTOKINE, V69, P146, DOI 10.1016/j.cyto.2014.05.021; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; GRABSTEIN KH, 1990, J IMMUNOL, V144, P3015; Gratz IK, 2013, J IMMUNOL, V190, P4483, DOI 10.4049/jimmunol.1300212; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kennedy-Nasser AA, 2014, CLIN CANCER RES, V20, P2215, DOI 10.1158/1078-0432.CCR-13-3205; Kim GY, 2012, J IMMUNOL, V188, P5859, DOI 10.4049/jimmunol.1102328; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; MORRISSEY PJ, 1989, J EXP MED, V169, P707, DOI 10.1084/jem.169.3.707; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; O'Gorman WE, 2009, J IMMUNOL, V183, P332, DOI 10.4049/jimmunol.0900691; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Raynor J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00161; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Simonetta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036596; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	54	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113314	10.1371/journal.pone.0113314	http://dx.doi.org/10.1371/journal.pone.0113314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485946	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600018
J	Kim, H; Keum, DJ; Kwak, JW; Chung, HS; Bae, H				Kim, Hyunseong; Keum, Dong June; Kwak, Jung Won; Chung, Hwan-Suck; Bae, Hyunsu			Bee Venom Phospholipase A2 Protects against Acetaminophen-Induced Acute Liver Injury by Modulating Regulatory T Cells and IL-10 in Mice	PLOS ONE			English	Article							NITRIC-OXIDE; INDUCED HEPATOTOXICITY; A(2) SUPERFAMILY; HEPATIC-INJURY; TOLERANCE; INTERLEUKIN-10; DAMAGE; MOUSE; RAT; INFLAMMATION	The aim of this study was to investigate the protective effects of phospholipase A2 (PLA2) from bee venom against acetaminophen-induced hepatotoxicity through CD4(+)CD25(+)Foxp3(+) T cells (Treg) in mice. Acetaminophen (APAP) is a widely used antipyretic and analgesic, but an acute or cumulative overdose of acetaminophen can cause severe hepatic failure. Tregs have been reported to possess protective effects in various liver diseases and kidney toxicity. We previously found that bee venom strongly increased the Treg population in splenocytes and subsequently suppressed immune disorders. More recently, we found that the effective component of bee venom is PLA2. Thus, we hypothesized that PLA2 could protect against liver injury induced by acetaminophen. To evaluate the hepatoprotective effects of PLA2, C57BL/6 mice or interleukin-10-deficient (IL-10(-/-)) mice were injected with PLA2 once a day for five days and sacrificed 24 h (h) after acetaminophen injection. The blood sera were collected 0, 6, and 24 h after acetaminophen injection for the analysis of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). PLA2-injected mice showed reduced levels of serum AST, ALT, proinflammatory cytokines, and nitric oxide (NO) compared with the PBS-injected control mice. However, IL-10 was significantly increased in the PLA2-injected mice. These hepatic protective effects were abolished in Treg-depleted mice by antibody treatment and in IL-10 (/) mice. Based on these findings, it can be concluded that the protective effects of PLA2 against acetaminophen-induced hepatotoxicity can be mediated by modulating the Treg and IL-10 production.	[Kim, Hyunseong; Keum, Dong June; Kwak, Jung Won; Chung, Hwan-Suck; Bae, Hyunsu] Kyung Hee Univ, Dept Physiol, Coll Korean Med, Seoul 130701, South Korea; [Bae, Hyunsu] Kyung Hee Univ, Inst Korean Med, Seoul 130701, South Korea	Kyung Hee University; Kyung Hee University	Chung, HS (corresponding author), Kyung Hee Univ, Dept Physiol, Coll Korean Med, 1 Hoeki Dong, Seoul 130701, South Korea.	sock21@hanmail.net; hbae@khu.ac.kr	Bae, Hyunsu/ABH-6248-2020	Bae, Hyunsu/0000-0002-0299-3582	Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST) [2009-0063466]	Korea Science and Engineering Foundation (KOSEF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorea Science and Engineering FoundationKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2009-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedda S, 2003, J HEPATOL, V39, P765, DOI 10.1016/S0168-8278(03)00325-8; Bleibel W, 2007, DIGEST DIS SCI, V52, P2463, DOI 10.1007/s10620-006-9472-y; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Choi MS, 2013, CYTOKINE, V61, P256, DOI 10.1016/j.cyto.2012.10.005; Chung ES, 2012, BRAIN BEHAV IMMUN, V26, P1322, DOI 10.1016/j.bbi.2012.08.013; Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Darwish SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079284; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DUDLER T, 1995, J IMMUNOL, V155, P2605; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Ito Y, 2004, AM J PHYSIOL-GASTR L, V286, pG60, DOI 10.1152/ajpgi.00217.2003; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jeong JK, 2011, INT J MOL MED, V28, P867, DOI 10.3892/ijmm.2011.730; Kim H, 2013, EVID BASED; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Kuo PC, 1997, J PHARMACOL EXP THER, V282, P1072; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Lee WM, 2008, HEPATOL RES, V38, pS3, DOI 10.1111/j.1872-034X.2008.00419.x; LIU J, 1993, J PHARMACOL EXP THER, V266, P1607; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; Louis H, 1997, GASTROENTEROLOGY, V112, P935, DOI 10.1053/gast.1997.v112.pm9041256; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Monti MC, 2006, CHEMBIOCHEM, V7, P971, DOI 10.1002/cbic.200500454; Nguyen K, 2012, J HEPATOL, V56, P626, DOI 10.1016/j.jhep.2011.09.014; Olaleye MT, 2008, EXP TOXICOL PATHOL, V59, P319, DOI 10.1016/j.etp.2007.10.003; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Patterson AD, 2012, HEPATOLOGY, V56, P281, DOI 10.1002/hep.25645; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572; Speletas M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/827565; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang AY, 2010, WORLD J GASTROENTERO, V16, P384, DOI 10.3748/wjg.v16.i3.384; Wang WH, 2010, WORLD J GASTROENTERO, V16, P5502, DOI 10.3748/wjg.v16.i43.5502; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Whyte IM, 2007, CURR MED RES OPIN, V23, P2359, DOI 10.1185/030079907X219715; Yin H, 2010, HEPATOLOGY, V51, P1007, DOI 10.1002/hep.23476; Zhao HX, 2003, ANTIMICROB AGENTS CH, V47, P965, DOI 10.1128/AAC.47.3.965-971.2003; Zhao XM, 2012, TOXICOL LETT, V214, P69, DOI 10.1016/j.toxlet.2012.08.005	50	28	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114726	10.1371/journal.pone.0114726	http://dx.doi.org/10.1371/journal.pone.0114726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478691	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200118
J	Markman, S				Markman, Shai			Parental Self-Feeding Effects on Parental Care Levels and Time Allocation in Palestine Sunbirds	PLOS ONE			English	Article							ORANGE-TUFTED SUNBIRD; NITROGEN REQUIREMENTS; FOOD SUPPLEMENTATION; STURNUS-VULGARIS; DIET; CURRENCIES; LIMITATION; FITNESS; POLLEN; NECTAR	The trade-off between parents feeding themselves and their young is an important life history problem that can be considered in terms of optimal behavioral strategies. Recent studies on birds have tested how parents allocate the food between themselves and their young. Until now the effect of food consumption by parent birds on their food delivery to their young as well as other parental activities has rarely been studied. I have previously shown that parent Palestine sunbirds (Nectarinia osea) will consume nectar and liquidized arthropods from artificial feeders. However, they will only feed their young with whole arthropods. This provided a unique opportunity to experimentally manipulate the food eaten by parents independent of that fed to their offspring. Here, I hypothesized that parents invest in their current young according to the quality of food that they themselves consume. Breeding pairs with two or three nestlings were provided with feeders containing water (control), sucrose solution (0.75 mol) or liquidized mealworms mixed with sucrose solution (0.75 mol). As food quality in feeders increased (from water up to liquidized mealworms mixed with sucrose solution): 1) Parents (especially females) increased their food delivery of whole arthropod prey to their young. 2) Only males increased their nest guarding effort. Nestling food intake and growth rate increased with increasing food quality of parents and decreasing brood size. These results imply that increasing the nutrient content of foods consumed by parent sunbirds allow them to increase the rate at which other foods are delivered to their young and to increase the time spent on other parental care activities.	Univ Haifa, Dept Biol & Environm, Tivon, Israel	University of Haifa	Markman, S (corresponding author), Univ Haifa, Dept Biol & Environm, Tivon, Israel.	markmans@research.haifa.ac.il			Israel Science Foundation [1338/11]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation number 1338/11 awarded to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Beauchamp G, 1991, BEHAV ECOL, V2, P21, DOI 10.1093/beheco/2.1.21; Bell G.P., 1990, Studies in Avian Biology, P416; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BRICE AT, 1992, COMP BIOCHEM PHYS A, V101, P151, DOI 10.1016/0300-9629(92)90643-5; CARLSON A, 1985, ANIM BEHAV, V33, P664, DOI 10.1016/S0003-3472(85)80090-7; Crook SL, 2009, WATERBIRDS, V32, P548, DOI 10.1675/063.032.0408; Dawson RD, 2002, BEHAV ECOL SOCIOBIOL, V52, P43, DOI 10.1007/s00265-002-0486-y; Gill F. B., 1990, ORNITHOLOGY; GOLDSTEIN H, 1988, ARDEA, V76, P169; GREIGSMITH PW, 1988, IBIS, V130, P1, DOI 10.1111/j.1474-919X.1988.tb00950.x; Harrison C., 1975, FIELD GUIDE NESTS EG; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; HOUSTON AI, 1987, J THEOR BIOL, V124, P251, DOI 10.1016/S0022-5193(87)80115-7; Ilmonen P, 1999, OIKOS, V86, P79, DOI 10.2307/3546571; KACELNIK A, 1990, J ANIM ECOL, V59, P655, DOI 10.2307/4887; Kokko H, 1998, P ROY SOC B-BIOL SCI, V265, P1871, DOI 10.1098/rspb.1998.0515; KREBS JR, 1985, J ANIM ECOL, V54, P459, DOI 10.2307/4491; Litzow MA, 2002, OECOLOGIA, V132, P286, DOI 10.1007/s00442-002-0945-1; Markman S, 1996, ANIM BEHAV, V52, P437, DOI 10.1006/anbe.1996.0188; MARKMAN S, 1995, ANIM BEHAV, V50, P655, DOI 10.1016/0003-3472(95)80127-8; Markman S, 2004, J ANIM ECOL, V73, P747, DOI 10.1111/j.0021-8790.2004.00847.x; Markman S, 1999, AUK, V116, P257, DOI 10.2307/4089476; Markman S, 2002, P ROY SOC B-BIOL SCI, V269, P1931, DOI 10.1098/rspb.2002.2118; Martinez del Rio Carlos, 1994, P103, DOI 10.1017/CBO9780511661716.009; McNamara JM, 1997, AM NAT, V150, P603, DOI 10.1086/286084; Nahari N, 1980, THESIS TEL AVIV U; PATON DC, 1982, AUST J ECOL, V7, P279, DOI 10.1111/j.1442-9993.1982.tb01506.x; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; PYKE GH, 1980, AUST J ECOL, V5, P343, DOI 10.1111/j.1442-9993.1980.tb01258.x; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; RICHARDSON KC, 1990, AUST J ZOOL, V38, P581, DOI 10.1071/ZO9900581; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Roxburgh L, 2000, PHYSIOL BIOCHEM ZOOL, V73, P638, DOI 10.1086/317747; Roxburgh L, 2000, THESIS BEN GURION U; Santangeli A, 2012, ANIM BEHAV, V83, P1115, DOI 10.1016/j.anbehav.2012.02.002; Smiseth PT, 2003, BEHAV ECOL, V14, P793, DOI 10.1093/beheco/arg083; Sofaer HR, 2013, BEHAV ECOL, V24, P698, DOI 10.1093/beheco/ars212; Sokal RR, 1997, BIOMETRY; SONERUD GA, 1989, ORNIS SCAND, V20, P69, DOI 10.2307/3676711; Stephens D.W., 1986, pi; Stephens David W., 2007, FORAGING; STILES FG, 1971, SCIENCE, V173, P818, DOI 10.1126/science.173.3999.818; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Thompson AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0558; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; van Tets IG, 2000, AUK, V117, P826, DOI 10.1642/0004-8038(2000)117[0826:PATNRO]2.0.CO;2; WELHAM CVJ, 1993, ECOLOGY, V74, P1893, DOI 10.2307/1939946; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28; Ydenberg RC, 1994, ECOSCIENCE, V1, P1; Zanette L, 2006, ECOLOGY, V87, P2459, DOI 10.1890/0012-9658(2006)87[2459:FAPAEP]2.0.CO;2; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; Zar JH, 1996, BIOSTATISTIACL ANAL	53	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113890	10.1371/journal.pone.0113890	http://dx.doi.org/10.1371/journal.pone.0113890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474620	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500097
J	Zhang, XH; Zhang, L; Cheng, X; Guo, YX; Sun, XH; Chen, G; Li, HM; Li, PC; Lu, XH; Tian, ML; Qin, JB; Zhou, H; Jin, GH				Zhang, Xinhua; Zhang, Lei; Cheng, Xiang; Guo, Yuxiu; Sun, Xiaohui; Chen, Geng; Li, Haoming; Li, Pengcheng; Lu, Xiaohui; Tian, Meiling; Qin, Jianbing; Zhou, Hui; Jin, Guohua			IGF-1 Promotes Brn-4 Expression and Neuronal Differentiation of Neural Stem Cells via the PI3K/Akt Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; PROGENITOR CELLS; TRANSCRIPTION FACTOR; HIPPOCAMPAL-NEURONS; SUBVENTRICULAR ZONE; MAMMALIAN TARGET; PC12 CELLS; INSULIN	Our previous studies indicated that transcription factor Brn-4 is upregulated in the surgically denervated hippocampus in vivo, promoting neuronal differentiation of hippocampal neural stem cells (NSCs) in vitro. The molecules mediating Brn-4 upregulation in the denervated hippocampus remain unknown. In this study we examined the levels of insulin-like growth factor-1 (IGF-1) in hippocampus following denervation. Surgical denervation led to a significant increase in IGF-1 expression in vivo. We also report that IGF-1 treatment on NSCs in vitro led to a marked acceleration of Brn-4 expression and cell differentiation down neuronal pathways. The promotion effects were blocked by PI3K-specific inhibitor (LY294002), but not MAPK inhibitor (PD98059); levels of phospho-Akt were increased by IGF-1 treatment. In addition, inhibition of IGF-1 receptor (AG1024) and mTOR (rapamycin) both attenuated the increased expression of Brn-4 induced by IGF-1. Together, the results demonstrated that upregulation of IGF-1 induced by hippocampal denervation injury leads to activation of the PI3K/Akt signaling pathway, which in turn gives rise to upregulation of the Brn-4 and subsequent stem cell differentiation down neuronal pathways.	[Zhang, Xinhua; Zhang, Lei; Cheng, Xiang; Chen, Geng; Li, Haoming; Tian, Meiling; Qin, Jianbing; Jin, Guohua] Nantong Univ, Dept Anat, Nantong, Jiangsu, Peoples R China; [Guo, Yuxiu; Li, Pengcheng; Zhou, Hui] Nantong Univ, Affiliated Hosp, Dept Pediat, Nantong, Jiangsu, Peoples R China; [Sun, Xiaohui] Nantong Rehibilitat Hosp Agings, Vasculocardiol Dept, Nantong, Jiangsu, Peoples R China; [Lu, Xiaohui] Nantong Univ, Affiliated Hosp, Dept Stomatol, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University	Zhou, H (corresponding author), Nantong Univ, Affiliated Hosp, Dept Pediat, Nantong, Jiangsu, Peoples R China.	jguohua@ntu.edu.cn; nthuihui@126.com	Li, Hao/GPS-9834-2022	Zhang, Xin-hua/0000-0002-5702-6733	National Natural Science Foundation of China [31171038]; Jiangsu Natural Science Foundation [BK2011385]; Jiangsu Natural College Foundation [11KJB180008, 13KJB310010]; National Training Programs of Innovation and Entrepreneurship for Undergraduates [201210304031]; Grant of Nantong University for Innovation Talent; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Natural College Foundation; National Training Programs of Innovation and Entrepreneurship for Undergraduates; Grant of Nantong University for Innovation Talent; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (Grant 31171038), Jiangsu Natural Science Foundation (BK2011385), Jiangsu Natural College Foundation (11KJB180008, 13KJB310010), the Grant of Nantong University for Innovation Talent, National Training Programs of Innovation and Entrepreneurship for Undergraduates (201210304031), and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Aberg MAI, 2000, J NEUROSCI, V20, P2896; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Colucci-D'Amato L, 2006, NEUROL SCI, V27, P266, DOI 10.1007/s10072-006-0682-z; Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x; DEPABLO F, 1995, TRENDS NEUROSCI, V18, P143, DOI 10.1016/0166-2236(95)93892-2; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Heumann Rolf, 1994, Current Opinion in Neurobiology, V4, P668, DOI 10.1016/0959-4388(94)90008-6; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kalluri HSG, 2007, EUR J NEUROSCI, V25, P1041, DOI 10.1111/j.1460-9568.2007.05336.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; MARSH HN, 1993, J NEUROSCI, V13, P4281; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Murray PS, 2011, INT J PEPTIDES, V2011; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; Schreiber J, 1997, J BIOL CHEM, V272, P32286, DOI 10.1074/jbc.272.51.32286; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sekulic A, 2000, CANCER RES, V60, P3504; Shi JH, 2010, NEUROSCI RES, V67, P8, DOI 10.1016/j.neures.2010.01.007; Shimazaki T, 1999, EMBO J, V18, P444, DOI 10.1093/emboj/18.2.444; Sung SM, 2007, NEUROCHEM RES, V32, P1932, DOI 10.1007/s11064-007-9390-1; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Wang HT, 2012, NEUROSCI LETT, V516, P105, DOI 10.1016/j.neulet.2012.03.068; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhang H, 2011, NEUROCHEM RES, V36, P49, DOI 10.1007/s11064-010-0260-x; Zhang XH, 2007, NEUROSCI LETT, V414, P115, DOI 10.1016/j.neulet.2006.07.078; Zhang XH, 2009, HIPPOCAMPUS, V19, P176, DOI 10.1002/hipo.20498; Zou LQ, 2010, INT J NEUROSCI, V120, P192, DOI 10.3109/00207450903464579	55	36	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113801	10.1371/journal.pone.0113801	http://dx.doi.org/10.1371/journal.pone.0113801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474202	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500093
J	Golden, D; Cantley, LG				Golden, D.; Cantley, L. G.			Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; HEREDITARY LYMPHEDEMA; FORKHEAD BOX; CK2; TRANSITION; PHOSPHORYLATION; LOCALIZATION; CANCER; DOMAIN; CELLS	Nuclear Foxc2 is a transcriptional regulator of mesenchymal transformation during developmental epithelial-mesenchymal transition (EMT) and has been associated with EMT in malignant epithelia. Our laboratory has shown that in normal epithelial cells Foxc2 is maintained in the cytoplasm where it promotes an epithelial phenotype. The Foxc2 amino terminus has a consensus casein kinase 2 (CK2) phosphorylation site at serine 124, and we now show that CK2 associates with Foxc2 and phosphorylates this site in vitro. Knockdown or inhibition of the CK2 alpha/alpha a' kinase subunit in epithelial cells causes de novo accumulation of Foxc2 in the nucleus. Mutation of serine 124 to leucine promotes constitutive nuclear localization of Foxc2 and expression of mesenchymal genes, whereas an S124D phosphomimetic leads to constitutive cytoplasmic localization and epithelial maintenance. In malignant breast cancer cells, the CK2 beta regulatory subunit is downregulated and FOXC2 is found in the nucleus, correlating with an increase in a-smooth muscle actin (SMA) expression. Restoration of CK2 beta expression in these cells results in cytoplasmic localization of Foxc2, decreased alpha-SMA expression and reduced cell migration and invasion. In contrast, knockdown of CK2 beta in normal breast epithelial cells leads to FOXC2 nuclear localization, decreased E-cadherin expression, increased alpha-SMA and vimentin expression, and enhanced cell migration and invasion. Based on these findings, we propose that Foxc2 is functionally maintained in the cytoplasm of normal epithelial cells by CK2 alpha/alpha'-mediated phosphorylation at serine 124, which is dependent on proper targeting of the holoenzyme via the CK2 beta regulatory subunit.	[Golden, D.] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Cantley, L. G.] Yale Univ, Sch Med, Dept Internal Med, Sect Nephrol, Haven, CT USA	University of Connecticut; Yale University	Golden, D (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, 263 Farmington Ave,MC 3501, Farmington, CT 06030 USA.	dgolden@uchc.edu		Golden, Diana/0000-0002-1080-9175	NIH [DK65109]; DG [DK094589]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007276, R01DK065109, F32DK094589] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DG; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH awards to LGC (DK65109) and DG (DK094589).	Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Bard JBL, 2008, DEV DYNAM, V237, P2748, DOI 10.1002/dvdy.21652; Barrett RMA, 2011, CELL CYCLE, V10, P538, DOI 10.4161/cc.10.3.14758; Berry FB, 2005, HUM MOL GENET, V14, P2619, DOI 10.1093/hmg/ddi295; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Schwindling SL, 2004, ONCOGENE, V23, P4155, DOI 10.1038/sj.onc.1207566; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; von Knethen A, 2010, J CELL SCI, V123, P192, DOI 10.1242/jcs.055475; WALLIN A, 1992, LAB INVEST, V66, P474; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331	28	22	24	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4702	4712		10.1038/onc.2014.395	http://dx.doi.org/10.1038/onc.2014.395			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25486430	Green Accepted			2022-12-26	WOS:000360931500004
J	Etheridge, T; Rahman, M; Gaffney, CJ; Shaw, D; Shephard, F; Magudia, J; Solomon, DE; Milne, T; Blawzdziewicz, J; Constantin-Teodosiu, D; Greenhaff, PL; Vanapalli, SA; Szewczyk, NJ				Etheridge, Timothy; Rahman, Mizanur; Gaffney, Christopher J.; Shaw, Debra; Shephard, Freya; Magudia, Jignesh; Solomon, Deepak E.; Milne, Thomas; Blawzdziewicz, Jerzy; Constantin-Teodosiu, Dumitru; Greenhaff, Paul L.; Vanapalli, Siva A.; Szewczyk, Nathaniel J.			The integrin-adhesome is required to maintain muscle structure, mitochondrial ATP production, and movement forces in Caenorhabditis elegans	FASEB JOURNAL			English	Article						dystrophy; mitochondria; calpain; focal adhesion	GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; CALPAIN 3; PROTEIN; GENE; LOCOMOTION; KINASE; LOCALIZATION; COSTAMERES; COMPONENTS	The integrin-adhesome network, which contains >150 proteins, is mechano-transducing and located at discreet positions along the cell-cell and cell-extracellular matrix interface. A small subset of the integrin-adhesome is known to maintain normal muscle morphology. However, the importance of the entire adhesome for muscle structure and function is unknown. We used RNA interference to knock down 113 putative Caenorhabditis elegans homologs constituting most of the mammalian adhesome and 48 proteins known to localize to attachment sites in C. elegans muscle. In both cases, we found >90% of components were required for normal muscle mitochondrial structure and/or proteostasis vs. empty vector controls. Approximately half of these, mainly proteins that physically interact with each other, were also required for normal sarcomere and/or adhesome structure. Next we confirmed that the dystrophy observed in adhesome mutants associates with impaired maximal mitochondrial ATP production (P < 0.01), as well as reduced probability distribution of muscle movement forces compared with wild-type animals. Our results show that the integrin-adhesome network as a whole is required for maintaining both muscle structure and function and extend the current understanding of the full complexities of the functional adhesome in vivo.	[Etheridge, Timothy] Univ Exeter, Dept Sport & Hlth Sci, Coll Life & Environm Sci, Exeter EX1 2LU, Devon, England; [Shaw, Debra] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX1 2LU, Devon, England; [Rahman, Mizanur; Solomon, Deepak E.; Vanapalli, Siva A.] Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA; [Blawzdziewicz, Jerzy] Texas Tech Univ, Dept Engn Mech, Lubbock, TX 79409 USA; [Gaffney, Christopher J.; Shaw, Debra; Magudia, Jignesh; Milne, Thomas; Constantin-Teodosiu, Dumitru; Greenhaff, Paul L.; Szewczyk, Nathaniel J.] Univ Nottingham, Sch Life Sci & Med, Med Res Council, Arthrit Res UK Ctr Musculoskeletal Ageing Res, Nottingham, England; [Shephard, Freya] Univ Nottingham, Sch Vet Med & Sci, Nottingham, Leics, England	University of Exeter; University of Exeter; Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; University of Nottingham	Etheridge, T (corresponding author), Univ Exeter, Dept Sport & Hlth Sci, Coll Life & Environm Sci, St Lukes Campus, Exeter EX1 2LU, Devon, England.	t.etheridge@exeter.ac.uk		Greenhaff, Paul/0000-0003-4403-0490; Gaffney, Christopher/0000-0001-7990-2792; Szewczyk, Nathaniel/0000-0003-4425-9746; Etheridge, Timothy/0000-0002-3588-8711; Constantin-Teodosiu, Dumitru/0000-0002-8448-5564	Medical Research Council [G0801271]; U.S. National Institutes of Health [AR-054342]; University of Nottingham; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054342] Funding Source: NIH RePORTER; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; MRC [G0801271, MR/K00414X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nottingham; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council Grant G0801271 and U.S. National Institutes of Health Grant AR-054342. C.G. is in receipt of a University of Nottingham doctoral training fellowship. Mitochondrial ATP production measurements were funded by the University of Nottingham.	ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BRENNER S, 1974, GENETICS, V77, P71; Crossland H, 2013, AM J PHYSIOL-ENDOC M, V305, pE183, DOI 10.1152/ajpendo.00541.2012; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Ermolova N, 2011, HUM MOL GENET, V20, P3331, DOI 10.1093/hmg/ddr239; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Etheridge T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002471; Fisher K, 2013, BIOL OPEN, V2, P1354, DOI 10.1242/bio.20136007; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fluck M, 1999, AM J PHYSIOL-CELL PH, V277, pC152, DOI 10.1152/ajpcell.1999.277.1.C152; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Ghanbari A, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/9/095009; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hoehndorf R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060847; Johari S, 2013, LAB CHIP, V13, P1699, DOI 10.1039/c3lc41403e; Klossner S, 2009, EUR J APPL PHYSIOL, V106, P389, DOI 10.1007/s00421-009-1032-7; Koller A, 2005, ELECTROPHORESIS, V26, P2470, DOI 10.1002/elps.200500024; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2009, HUM MOL GENET, V18, P3194, DOI 10.1093/hmg/ddp257; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lecroisey C, 2007, J MUSCLE RES CELL M, V28, P79, DOI 10.1007/s10974-007-9104-y; Lehmann S, 2012, GENES-BASEL, V3, P686, DOI 10.3390/genes3040686; Lehmann S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-71; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mackey AL, 2008, J APPL PHYSIOL, V105, P1620, DOI 10.1152/japplphysiol.90952.2008; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Meissner B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019937; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Moerman Donald G, 2006, WormBook, P1; Moulder GL, 2010, J MOL BIOL, V403, P516, DOI 10.1016/j.jmb.2010.08.055; Nahabedian JF, 2012, METHODS, V56, P95, DOI 10.1016/j.ymeth.2011.11.005; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ojima K, 2010, J CLIN INVEST, V120, P2672, DOI 10.1172/JCI40658; Ono K, 2003, J CELL SCI, V116, P2073, DOI 10.1242/jcs.00421; Piekny AJ, 2000, GENETICS, V156, P1671; Plenefisch JD, 2000, DEVELOPMENT, V127, P1197; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Rogalski TM, 2003, GENETICS, V163, P905; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Shephard F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024686; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Ugural AC, 2003, ADV STRENGTH APPL EL; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang HV, 2008, J CELL BIOL, V180, P1037, DOI 10.1083/jcb.200707175; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Xu XJ, 2007, EXP CELL RES, V313, P2465, DOI 10.1016/j.yexcr.2007.03.017; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zdinak LA, 1997, J CELL BIOCHEM, V67, P143, DOI 10.1002/(SICI)1097-4644(19971001)67:1<143::AID-JCB15>3.3.CO;2-F	57	20	21	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1235	1246		10.1096/fj.14-259119	http://dx.doi.org/10.1096/fj.14-259119			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25491313	Green Published, hybrid			2022-12-26	WOS:000354115000012
J	Shih, DM; Yu, JM; Vergnes, L; Dali-Youcef, N; Champion, MD; Devarajan, A; Zhang, PX; Castellani, LW; Brindley, DN; Jamey, C; Auwerx, J; Reddy, ST; Ford, DA; Reue, K; Lusis, AJ				Shih, Diana M.; Yu, Janet M.; Vergnes, Laurent; Dali-Youcef, Nassim; Champion, Matthew D.; Devarajan, Asokan; Zhang, Peixiang; Castellani, Lawrence W.; Brindley, David N.; Jamey, Carole; Auwerx, Johan; Reddy, Srinivasa T.; Ford, David A.; Reue, Karen; Lusis, Aldons J.			PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosis	FASEB JOURNAL			English	Article						bile acid; cholesterol; hyperlipidemia; mitochondria; mitochondria-associated membrane	TANDEM MASS-SPECTROMETRY; HIGH-DENSITY LIPOPROTEIN; HUMAN SERUM PARAOXONASE; BILE-ACID METABOLISM; OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM; DEFICIENT MICE; SCAVENGER RECEPTOR; BIOLOGICAL SAMPLES; HEPATIC STEATOSIS	We report the engineering and characterization of paraoxonase-3 knockout mice (Pon3KO). The mice were generally healthy but exhibited quantitative alterations in bile acid metabolism and a 37% increased body weight compared to the wild-type mice on a high fat diet. PON3 was enriched in the mitochondria-associated membrane fraction of hepatocytes. PON3 deficiency resulted in impaired mitochondrial respiration, increased mitochondrial superoxide levels, and increased hepatic expression of inflammatory genes. PON3 deficiency did not influence atherosclerosis development on an apolipoprotein E null hyperlipidemic background, but it did lead to a significant 60% increase in atherosclerotic lesion size in Pon3KO mice on the C57BL/6J background when fed a cholate-cholesterol diet. On the diet, the Pon3KO had significantly increased plasma intermediate-density lipoprotein/LDL cholesterol and bile acid levels. They also exhibited significantly elevated levels of hepatotoxicity markers in circulation, a 58% increase in gallstone weight, a 40% increase in hepatic cholesterol level, and increased mortality. Furthermore, Pon3KO mice exhibited decreased hepatic bile acid synthesis and decreased bile acid levels in the small intestine compared with wild-type mice. Our study suggests a role for PON3 in the metabolism of lipid and bile acid as well as protection against atherosclerosis, gallstone disease, and obesity.	[Shih, Diana M.; Castellani, Lawrence W.; Reddy, Srinivasa T.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Yu, Janet M.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Zhang, Peixiang; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Devarajan, Asokan; Reddy, Srinivasa T.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Dali-Youcef, Nassim] Illkirch & Hop Univ Strasbourg, IGBMC, Strasbourg, France; [Jamey, Carole] Univ Strasbourg, Toxicol Lab, Strasbourg, France; [Champion, Matthew D.; Ford, David A.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Champion, Matthew D.; Ford, David A.] St Louis Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63104 USA; [Brindley, David N.] Univ Alberta, Edmonton, AB, Canada; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, Lausanne, Switzerland	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Saint Louis University; Saint Louis University; University of Alberta; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Shih, DM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, 10833 Conte Ave,A2-237 CHS, Los Angeles, CA 90095 USA.	dshih@mednet.ucla.edu	Auwerx, Johan/ABE-9307-2021; DALI-YOUCEF, Nassim/O-2549-2016; Ford, David/D-1819-2018	DALI-YOUCEF, Nassim/0000-0001-6958-1331; vergnes, laurent/0000-0002-8804-589X; Ford, David/0000-0002-0029-1560; Auwerx, Johan/0000-0002-5065-5393	U.S. National Institutes of Health (NIH) [HL030568-26A1, R01 HL074214, RR019232]; National Center for Research Resources [S10RR026744, NIH P01 HL028481, 2 RO1 HL71776]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026744, S10RR019232] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071776, P01HL028481, R01HL074214, P01HL030568] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Yu-Rong Xia, Yi-Shou Shi, Yonghong Meng, Judy Wu, Xu-Ping Wang, Zhiqiang Zhou, and Sarada Charugundla for excellent technical support. This study was supported by the following grants: U.S. National Institutes of Health (NIH) HL030568-26A1 (to A.J.L. and D.M.S.), and R01 HL074214 and RR019232 (to D.A.F.); National Center for Research Resources S10RR026744 and NIH P01 HL028481 (to K.R.), and 2 RO1 HL71776 (to S.T.R. and D.M.S.).	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Argmann C. A., 2006, CURRENT PROTOCOLS MO; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowden JA, 2011, ANAL BIOCHEM, V417, P202, DOI 10.1016/j.ab.2011.06.015; Costa LG, 1999, CHEM-BIOL INTERACT, V119, P429, DOI 10.1016/S0009-2797(99)00055-1; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Davis RA, 2002, J LIPID RES, V43, P533; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; FOLCH J, 1957, J BIOL CHEM, V226, P497; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Hung YC, 2006, FEBS LETT, V580, P849, DOI 10.1016/j.febslet.2005.12.102; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Kassel KM, 2011, AM J PATHOL, V179, P2278, DOI 10.1016/j.ajpath.2011.07.015; Kempster SL, 2012, AM J PHYSIOL-ENDOC M, V302, pE103, DOI 10.1152/ajpendo.00357.2011; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702; Lu SY, 2010, DNA CELL BIOL, V29, P407, DOI 10.1089/dna.2010.1024; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; MACKNESS MI, 1988, BIOCHEM J, V250, P539, DOI 10.1042/bj2500539; Mardones P, 2001, J LIPID RES, V42, P170; Martin LJ, 2012, CIRC RES, V111, P516, DOI 10.1161/CIRCRESAHA.112.276667; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ng CJ, 2006, J BIOL CHEM, V281, P29491, DOI 10.1074/jbc.M605379200; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Reddy ST, 2001, ARTERIOSCL THROM VAS, V21, P542, DOI 10.1161/01.ATV.21.4.542; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rosenblat M, 2003, ARTERIOSCL THROM VAS, V23, P468, DOI 10.1161/01.ATV.0000059385.95664.4D; Rothem L, 2007, FREE RADICAL BIO MED, V43, P730, DOI 10.1016/j.freeradbiomed.2007.05.003; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schweikert EM, 2012, CELL DEATH DIFFER, V19, P1549, DOI 10.1038/cdd.2012.35; Shih DM, 2007, CIRC RES, V100, P1200, DOI 10.1161/01.RES.0000264499.48737.69; Shih DM, 2010, ADV EXP MED BIOL, V660, P73, DOI 10.1007/978-1-60761-350-3_8; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Stoltz DA, 2009, J BIOL CHEM, V284, P35564, DOI 10.1074/jbc.M109.051706; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wang N, 1996, J BIOL CHEM, V271, P8837, DOI 10.1074/jbc.271.15.8837; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yang K, 2008, ADIPOSE TISSUE PROTO; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yao PM, 2001, J BIOL CHEM, V276, P42468, DOI 10.1074/jbc.M101419200; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	66	29	32	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1185	1197		10.1096/fj.14-260570	http://dx.doi.org/10.1096/fj.14-260570			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25477283	Green Published			2022-12-26	WOS:000354115000008
J	Raval, KK; Tao, R; White, BE; De Lange, WJ; Koonce, CH; Yu, JY; Kishnani, PS; Thomson, JA; Mosher, DF; Ralphe, JC; Kamp, TJ				Raval, Kunil K.; Tao, Ran; White, Brent E.; De lange, Willem J.; Koonce, Chad H.; Yu, Junying; Kishnani, Priya S.; Thomson, James A.; Mosher, Deane F.; Ralphe, John C.; Kamp, Timothy J.			Pompe Disease Results in a Golgi-based Glycosylation Deficit in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cardiomyopathy; Golgi; Induced Pluripotent Stem Cell (iPSC); Lysosomal Glycoprotein; N-linked Glycosylation; Tissue Engineering; Pompe Disease	LYSOSOMAL MEMBRANE-GLYCOPROTEINS; ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; CONGENITAL DISORDERS; CHANNEL ACTIVITY; MANNOSIDASE-II; MOUSE MODEL; DYSTROGLYCAN; COMPLEX; CARDIOMYOPATHY	Background: How the absence of lysosomal enzyme acid -glucosidase causes hypertrophic cardiomyopathy in Pompe disease is unknown. Results: Pompe patient-induced pluripotent stem cell-derived cardiomyocytes have normal autophagic and contractile function but exhibit a deficit of Golgi-based protein glycosylation. Conclusion: Loss of the lysosomal glycogen hydrolyzing ability results in protein glycosylation deficits. Significance: Malfunctioning proteins due to misglycosylation may contribute to the pathophysiology of Pompe cardiomyopathy. Infantile-onset Pompe disease is an autosomal recessive disorder caused by the complete loss of lysosomal glycogen-hydrolyzing enzyme acid -glucosidase (GAA) activity, which results in lysosomal glycogen accumulation and prominent cardiac and skeletal muscle pathology. The mechanism by which loss of GAA activity causes cardiomyopathy is poorly understood. We reprogrammed fibroblasts from patients with infantile-onset Pompe disease to generate induced pluripotent stem (iPS) cells that were differentiated to cardiomyocytes (iPSC-CM). Pompe iPSC-CMs had undetectable GAA activity and pathognomonic glycogen-filled lysosomes. Nonetheless, Pompe and control iPSC-CMs exhibited comparable contractile properties in engineered cardiac tissue. Impaired autophagy has been implicated in Pompe skeletal muscle; however, control and Pompe iPSC-CMs had comparable clearance rates of LC3-II-detected autophagosomes. Unexpectedly, the lysosome-associated membrane proteins, LAMP1 and LAMP2, from Pompe iPSC-CMs demonstrated higher electrophoretic mobility compared with control iPSC-CMs. Brefeldin A induced disruption of the Golgi in control iPSC-CMs reproduced the higher mobility forms of the LAMPs, suggesting that Pompe iPSC-CMs produce LAMPs lacking appropriate glycosylation. Isoelectric focusing studies revealed that LAMP2 has a more alkaline pI in Pompe compared with control iPSC-CMs due largely to hyposialylation. MALDI-TOF-MS analysis of N-linked glycans demonstrated reduced diversity of multiantennary structures and the major presence of a trimannose complex glycan precursor in Pompe iPSC-CMs. These data suggest that Pompe cardiomyopathy has a glycan processing abnormality and thus shares features with hypertrophic cardiomyopathies observed in the congenital disorders of glycosylation.	[Raval, Kunil K.; Tao, Ran; White, Brent E.; Koonce, Chad H.; Mosher, Deane F.; Kamp, Timothy J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA; [Raval, Kunil K.; Kamp, Timothy J.] WiCell Inst, Madison, WI 53719 USA; [De lange, Willem J.; Ralphe, John C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA; [Yu, Junying] Cellular Dynam Int, Madison, WI 53711 USA; [Thomson, James A.; Kamp, Timothy J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; [Thomson, James A.] Morgridge Inst Res, Madison, WI 53715 USA; [Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Kishnani, Priya S.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; Duke University	Kamp, TJ (corresponding author), Univ Wisconsin, Dept Med, 8459 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	tjk@medicine.wisc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876; De Lange, Willem/0000-0001-7296-8924	National Institutes of Health [U01 HL099773, P41GM10349010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773, R01HL107367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490, T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 HL099773 (to T. J. K. and J. A. T.) and by National Institutes of Health-funded Research Resource for Biomedical Glycomics (National Institutes of Health Grant P41GM10349010 to Parastoo Azadi at the Complex Carbohydrate Research Center).	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Ausems MGEM, 1996, CLIN GENET, V49, P325; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; Carchon HA, 2004, CLIN CHEM, V50, P101, DOI 10.1373/clinchem.2003.021568; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; Chen CA, 2011, J CARD FAIL, V17, P930, DOI 10.1016/j.cardfail.2011.07.011; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; Chen LR, 2009, J PEDIATR-US, V155, P271, DOI 10.1016/j.jpeds.2009.03.015; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cohen MW, 1997, J CELL BIOL, V136, P1047, DOI 10.1083/jcb.136.5.1047; de Lange WJ, 2011, CIRC RES, V109, P8, DOI 10.1161/CIRCRESAHA.111.242354; De Lange WJ, 2013, J GEN PHYSIOL, V142, P241, DOI 10.1085/jgp.201311018; Duplomb L, 2014, HUM MOL GENET, V23, P2391, DOI 10.1093/hmg/ddt630; Ednie AR, 2013, J MOL CELL CARDIOL, V59, P117, DOI 10.1016/j.yjmcc.2013.02.013; ELICES MJ, 1990, CARBOHYD RES, V203, P109, DOI 10.1016/0008-6215(90)80050-D; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FERMINI B, 1991, AM J PHYSIOL, V260, pH735, DOI 10.1152/ajpheart.1991.260.3.H735; Footitt EJ, 2009, J INHERIT METAB DIS, V32, pS313, DOI 10.1007/s10545-009-1262-1; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gehrmann J, 2003, CARDIOL YOUNG, V13, P345, DOI 10.1017/S1047951103000702; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hayee B, 2011, GLYCOBIOLOGY, V21, P914, DOI 10.1093/glycob/cwr023; Ikeda Y, 2000, J BIOCHEM, V128, P609, DOI 10.1093/oxfordjournals.jbchem.a022793; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Isaac EL, 2000, EXP CELL RES, V254, P204, DOI 10.1006/excr.1999.4755; Kabaeva Z, 2011, HUM MOL GENET, V20, P3346, DOI 10.1093/hmg/ddr240; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kapusta L, 2013, HEART FAIL REV, V18, P187, DOI 10.1007/s10741-012-9302-6; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knaapen MWM, 1997, ANAT RECORD, V248, P233; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Marengo FD, 1998, J MOL CELL CARDIOL, V30, P127, DOI 10.1006/jmcc.1997.0579; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Marquardt T, 2003, EUR J PEDIATR, V162, P359, DOI 10.1007/s00431-002-1136-0; McDowell R, 2008, GENET MED, V10, P758, DOI 10.1097/GIM.0b013e318183722f; Meikle PJ, 1997, CLIN CHEM, V43, P1325; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Nabi IR, 1998, GLYCOBIOLOGY, V8, P947, DOI 10.1093/glycob/8.9.947; Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52; Norring SA, 2013, FASEB J, V27, P622, DOI 10.1096/fj.12-214387; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; POST JA, 1992, AM J PHYSIOL, V263, pH147, DOI 10.1152/ajpheart.1992.263.1.H147; POUS C, 1994, EUR J BIOCHEM, V219, P1073, DOI 10.1111/j.1432-1033.1994.tb18590.x; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317; Raben N, 2010, MOL GENET METAB, V101, P324, DOI 10.1016/j.ymgme.2010.08.001; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rahman SA, 2014, J PROTEOME RES, V13, P1167, DOI 10.1021/pr401043r; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Sparks S., 1993, CONGENITAL MUSCULAR; Sparks S. E., 2005, CONGENITAL DISORDERS; SZUMILO T, 1987, BIOCHEMISTRY-US, V26, P5498, DOI 10.1021/bi00391a043; Takikita S, 2009, MOL GENET METAB, V96, P208, DOI 10.1016/j.ymgme.2008.12.012; Taylor KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056181; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wopereis S, 2003, CLIN CHEM, V49, P1839, DOI 10.1373/clinchem.2003.022541; Xu S, 2010, J APPL PHYSIOL, V108, P1383, DOI 10.1152/japplphysiol.01253.2009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	88	59	59	0	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3121	3136		10.1074/jbc.M114.628628	http://dx.doi.org/10.1074/jbc.M114.628628			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25488666	Green Published, hybrid			2022-12-26	WOS:000349310700047
J	Chen, T; Kocinsky, HS; Cha, BY; Murtazina, R; Yang, JB; Tse, CM; Singh, V; Cole, R; Aronson, PS; de Jonge, H; Sarker, R; Donowitz, M				Chen, Tiane; Kocinsky, Hetal S.; Cha, Boyoung; Murtazina, Rakhilya; Yang, Jianbo; Tse, C. Ming; Singh, Varsha; Cole, Robert; Aronson, Peter S.; de Jonge, Hugo; Sarker, Rafiquel; Donowitz, Mark			Cyclic GMP Kinase II (cGKII) Inhibits NHE3 by Altering Its Trafficking and Phosphorylating NHE3 at Three Required Sites IDENTIFICATION OF A MULTIFUNCTIONAL PHOSPHORYLATION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; ACUTE ACTIVATION; BASAL ACTIVITY; PROTEIN; CAMP; NHERF2; BINDS; STIMULATION; ISOFORM; MULTIPLE	The epithelial brush-border Na+/H+ exchanger NHE3 is acutely inhibited by cGKII/cGMP, but how cGKII inhibits NHE3 is unknown. This study tested the hypothesis that cGMP inhibits NHE3 by phosphorylating it and altering its membrane trafficking. Studies were carried out in PS120/NHERF2 and in Caco-2/Bbe cells overexpressing HA-NHE3 and cGKII, and in mouse ileum. NHE3 activity was measured with 2',7'-bis(carboxyethyl)-S-(and 6) carboxyfluorescein acetoxy methylester/fluorometry. Surface NHE3 was determined by cell surface biotinylation. Identification of NHE3 phosphorylation sites was by iTRAQ/LC-MS/MS with TiO2 enrichment and immunoblotting with specific anti-phospho-NHE3 antibodies. cGMP/cGKII rapidly inhibited NHE3, which was associated with reduced surface NHE3. cGMP/cGKII increased NHE3 phosphorylation at three sites (rabbit Ser(554), Ser(607), and Ser(663), equivalent to mouse Ser(552), Ser(605), and Ser(659)), all of which had to be present at the same time for cGMP to inhibit NHE3. NHE3-Ser(663) phosphorylation was not necessary for cAMP inhibition of NHE3. Dexamethasone (4 h) stimulated wild type NHE3 activity and increased surface expression but failed to stimulate NHE3 activity or increase surface expression when NHE3 was mutated to either S663A or S663D. We conclude that 1) cGMP inhibition of NHE3 is associated with phosphorylation of NHE3 at Ser(554), Ser(607), and Ser(663), all of which are necessary for cGMP/cGKII to inhibitNHE3.2) Dexamethasone stimulates NHE3 by phosphorylation of a single site, Ser(663). The requirement for three phosphorylation sites in NHE3 for cGKII inhibition, and for phos-phorylation of one of these sites for dexamethasone stimulation of NHE3, is a unique example of regulation by phosphorylation.	[Chen, Tiane; Cha, Boyoung; Murtazina, Rakhilya; Yang, Jianbo; Tse, C. Ming; Singh, Varsha; Sarker, Rafiquel; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Chen, Tiane; Cha, Boyoung; Murtazina, Rakhilya; Yang, Jianbo; Tse, C. Ming; Singh, Varsha; Sarker, Rafiquel; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Cole, Robert] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Kocinsky, Hetal S.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Aronson, Peter S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [de Jonge, Hugo] Erasmus MC, GI Div, NL-3015 CN Rotterdam, Netherlands	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Yale University; Yale University; Erasmus University Rotterdam; Erasmus MC	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA.	rndonowit@jhmi.edu	yang, jian/HIK-0188-2022		National Institutes of Health NIDDK [R01-DK26523, R01-DK61765, P01-DK072084, P30-DK89502]; Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, R01DK061765, R01DK026523, P01DK072084, P01DK017433] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hopkins Digestive Diseases Basic and Translational Research Core Center; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants R01-DK26523, R01-DK61765, P01-DK072084, and P30-DK89502, The Hopkins Digestive Diseases Basic and Translational Research Core Center, and the Hopkins Center for Epithelial Disorders.	ANDERSON JM, 1989, J CELL BIOL, V109, P1047, DOI 10.1083/jcb.109.3.1047; AZARANI A, 1995, J BIOL CHEM, V270, P23166, DOI 10.1074/jbc.270.39.23166; Bacic D, 2003, KIDNEY INT, V64, P2133, DOI 10.1046/j.1523-1755.2003.00308.x; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Harada K, 2010, J BIOL CHEM, V285, P24044, DOI 10.1074/jbc.M109.072553; Hayashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055623; He PJ, 2011, MOL BIOL CELL, V22, P3812, DOI 10.1091/mbc.E11-04-0328; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Kocinsky HS, 2005, AM J PHYSIOL-RENAL, V289, pF249, DOI 10.1152/ajprenal.00082.2004; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; Muller U, 2002, J NEUROSCI, V22, P8739; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Vaandrager AB, 1997, GASTROENTEROLOGY, V112, P437, DOI 10.1053/gast.1997.v112.pm9024297; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Vaandrager AB, 1997, J BIOL CHEM, V272, P4195, DOI 10.1074/jbc.272.7.4195; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; WIEPRECHT M, 1994, BIOCHEM J, V297, P241, DOI 10.1042/bj2970241; XU RF, 1995, J CELL PHYSIOL, V165, P30, DOI 10.1002/jcp.1041650105; Yip JW, 1997, J BIOL CHEM, V272, P18473, DOI 10.1074/jbc.272.29.18473; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753; Zizak M, 2012, J BIOL CHEM, V287, P13442, DOI 10.1074/jbc.M111.307256	43	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1952	1965		10.1074/jbc.M114.590174	http://dx.doi.org/10.1074/jbc.M114.590174			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25480791	hybrid, Green Published			2022-12-26	WOS:000348588000005
J	Ogawa, M; Sawaguchi, S; Kawai, T; Nadano, D; Matsuda, T; Yagi, H; Kato, K; Furukawa, K; Okajima, T				Ogawa, Mitsutaka; Sawaguchi, Shogo; Kawai, Takami; Nadano, Daita; Matsuda, Tsukasa; Yagi, Hirokazu; Kato, Koichi; Furukawa, Koichi; Okajima, Tetsuya			Impaired O-Linked N-Acetylglucosaminylation in the Endoplasmic Reticulum by Mutated Epidermal Growth Factor (EGF) Domain-specific O-Linked N-Acetylglucosamine Transferase Found in Adams-Oliver Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTER; EXTRACELLULAR DOMAIN; GLCNAC MODIFICATION; MOLECULAR-CLONING; NOTCH RECEPTORS; UDP-GLCNAC; ALPHA-DYSTROGLYCAN; INSULIN-RESISTANCE; MANIC FRINGE; MUTATIONS	Epidermal growth factor (EGF) domain-specific O-linked N-acetylglucosamine (EOGT) is an endoplasmic reticulum (ER)-resident O-linkedN-acetylglucosamine (O-GlcNAc) transferase that acts on EGF domain-containing proteins such as Notch receptors. Recently, mutations in EOGT have been reported in patients with Adams-Oliver syndrome (AOS). Here, we have characterized enzymatic properties of mouse EOGT and EOGT mutants associated with AOS. Simultaneous expression of EOGT with Notch1 EGF repeats in human embryonic kidney 293T (HEK293T) cells led to immunoreactivity with the CTD110.6 antibody in the ER. Consistent with the GlcNAc modification in the ER, the enzymatic properties of EOGT are distinct from those of Golgi-resident GlcNAc transferases; the pH optimum of EOGT ranges from 7.0 to 7.5, and the K-m value for UDP N-acetylglucosamine (UDP-GlcNAc) is 25 mu M. Despite the relatively low K-m value for UDP-GlcNAc, EOGT-catalyzed GlcNAcylation depends on the hexosamine pathway, as revealed by the increased O-GlcNAcylation of Notch1 EGF repeats upon supplementation with hexosamine, suggesting differential regulation of the luminal UDP-GlcNAc concentration in the ER and Golgi. As compared with wild-type EOGT, O-GlcNAcylation in the ER is nearly abolished in HEK293T cells exogenously expressing EOGT variants associated with AOS. Introduction of the W207S mutation resulted in degradation of the protein via the ubiquitin-proteasome pathway, although the stability and ER localization of EOGTR377Q were not affected. Importantly, the interaction between UDPGlcNAc and EOGTR377Q was impaired without adversely affecting the acceptor substrate interaction. These results suggest that impaired glycosyltransferase activity in mutant EOGT proteins and the consequent defective O-GlcNAcylation in the ER constitute the molecular basis for AOS.	[Ogawa, Mitsutaka; Sawaguchi, Shogo; Kawai, Takami; Furukawa, Koichi; Okajima, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan; [Ogawa, Mitsutaka] Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama, Shiga 5260829, Japan; [Nadano, Daita; Matsuda, Tsukasa] Nagoya Univ, Dept Appl Mol Biosci, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Nagoya University; Nagoya University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Okajima, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	tokajima@med.nagoya-u.ac.jp	Yagi, Hirokazu/ABH-6151-2020; Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X; Kato, Koichi/0000-0001-7187-9612; Yagi, Hirokazu/0000-0001-9296-0225	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Takeda Foundation; Astellas Foundation; Grants-in-Aid for Scientific Research [25670140] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation(Takeda Science Foundation (TSF)); Astellas Foundation(Astellas Pharmaceuticals); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Challenging Exploratory Research (to T.O.) from the Japan Society for the Promotion of Science, a Grant-in-aid for Scientific Research on Innovative Areas (to T.O., H. Y., and K. K.) from the Ministry of Education, Culture, Sports, Science and Technology, and a Grant-in-aid from the Takeda Foundation and the Astellas Foundation (T.O.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Csala M, 2007, BBA-BIOMEMBRANES, V1768, P1325, DOI 10.1016/j.bbamem.2007.03.009; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hoffmann BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032762; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Miura Y, 2012, BBA-GEN SUBJECTS, V1820, P1678, DOI 10.1016/j.bbagen.2012.06.013; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; Ogawa Mitsutaka, 2014, World J Biol Chem, V5, P224, DOI 10.4331/wjbc.v5.i2.224; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Ogawa M, 2012, BBA-GEN SUBJECTS, V1820, P24, DOI 10.1016/j.bbagen.2011.10.011; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rampal R, 2005, J BIOL CHEM, V280, P32133, DOI 10.1074/jbc.M506104200; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sakaidani Y, 2010, METHOD ENZYMOL, V480, P355, DOI 10.1016/S0076-6879(10)80016-3; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stittrich AB, 2014, AM J HUM GENET, V95, P275, DOI 10.1016/j.ajhg.2014.07.011; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Tashima Y, 2014, J BIOL CHEM, V289, P11132, DOI 10.1074/jbc.M113.492512; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Trembath R. C, 2011, AM J HUM GENET, V88, P574; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; Yagi H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03288; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	54	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2137	2149		10.1074/jbc.M114.598821	http://dx.doi.org/10.1074/jbc.M114.598821			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25488668	hybrid, Green Published			2022-12-26	WOS:000348588000019
J	Lee, DJ; Bahn, YS; Kim, HJ; Chung, SY; Kang, HA				Lee, Dong-Jik; Bahn, Yong-Sun; Kim, Hong-Jin; Chung, Seung-Yeon; Kang, Hyun Ah			Unraveling the Novel Structure and Biosynthetic Pathway of O-Linked Glycans in the Golgi Apparatus of the Human Pathogenic Yeast Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; SCHIZOSACCHAROMYCES-POMBE; PICHIA-PASTORIS; FUNCTIONAL-CHARACTERIZATION; MANNOSYL GLYCANS; GENE FAMILY; GLYCOSYLATION; MANNOSYLTRANSFERASE	Cryptococcus neoformans is an encapsulated basidiomycete causing cryptococcosis in immunocompromised humans. The cell surface mannoproteins of C. neoformans were reported to stimulate the host T-cell response and to be involved in fungal pathogenicity; however, their O-glycan structure is uncharacterized. In this study, we performed a detailed structural analysis of the O-glycans attached to cryptococcal mannoproteins using HPLC combined with exoglycosidase treatment and showed that the major C. neoformans O-glycans were short manno-oligosaccharides that were connected mostly by alpha 1,2-linkages but connected by an alpha 1,6-linkage at the third mannose residue. Comparison of the O-glycan profiles from wild-type and uxs1 Delta mutant strains strongly supports the presence of minor O-glycans carrying a xylose residue. Further analyses of C. neoformans mutant strains identified three mannosyltransferase genes involved in O-glycan extensions in the Golgi. C. neoformans KTR3, the only homolog of the Saccharomyces cerevisiae KRE2/MNT1 family genes, was shown to encode an alpha 1,2-mannosyltransferase responsible for the addition of the second mannose residue via an alpha 1,2-linkage to the major O-glycans. C. neoformans HOC1 and HOC3, homologs of the Saccharomyces cerevisiae OCH1 family genes, were shown to encode alpha 1,6-mannosyltransferases that can transfer the third mannose residue, via an alpha 1,6-linkage, to minor O-glycans containing xylose and to major O-glycans without xylose, respectively. Moreover, the C. neoformans ktr3 Delta mutant strain, which displayed increased sensitivity to SDS, high salt, and high temperature, showed attenuated virulence in a mouse model of cryptococcosis, suggesting that the extended structure of O-glycans is required for cell integrity and full pathogenicity of C. neoformans.	[Lee, Dong-Jik; Chung, Seung-Yeon; Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea; [Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea	Chung Ang University; Chung Ang University; Yonsei University	Kang, HA (corresponding author), Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Seoul 156756, South Korea.	hyunkang@cau.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752	National Research Foundation of Korea from the Korea Ministry of Education and Science Technology [NRF-2012-0001150, NRF-2013R1A1A2A10063473]	National Research Foundation of Korea from the Korea Ministry of Education and Science Technology(Ministry of Education (MOE), Republic of Korea)	This work is supported by National Research Foundation of Korea Grants NRF-2012-0001150 and NRF-2013R1A1A2A10063473 from the Korea Ministry of Education and Science Technology.	Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Baker LG, 2011, EUKARYOT CELL, V10, P1264, DOI 10.1128/EC.05138-11; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Biondo C, 2006, FEMS YEAST RES, V6, P645, DOI 10.1111/j.1567-1364.2006.00043.x; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Diaz-Jimenez DF, 2012, BIOCHEM BIOPH RES CO, V419, P77, DOI 10.1016/j.bbrc.2012.01.131; Duman JG, 1998, BIOTECHNOL APPL BIOC, V28, P39; Endo T, 1999, BBA-GEN SUBJECTS, V1473, P237, DOI 10.1016/S0304-4165(99)00182-8; Fernandez-Alvarez A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002563; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gentzsch M, 1997, GLYCOBIOLOGY, V7, P481, DOI 10.1093/glycob/7.4.481; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; GRAHAM TR, 1994, J CELL BIOL, V127, P667, DOI 10.1083/jcb.127.3.667; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; HAUSLER A, 1992, P NATL ACAD SCI USA, V89, P6846, DOI 10.1073/pnas.89.15.6846; Ikeda Y, 2009, FEMS YEAST RES, V9, P115, DOI 10.1111/j.1567-1364.2008.00458.x; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Kim MW, 2006, J BIOL CHEM, V281, P6261, DOI 10.1074/jbc.M508507200; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mansour MK, 2004, INFECT IMMUN, V72, P1746, DOI 10.1128/IAI.72.3.1746-1754.2004; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; MOORE TDE, 1993, MOL CELL BIOL, V13, P1962, DOI 10.1128/MCB.13.3.1962; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Neiman AM, 1997, GENETICS, V145, P637; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Park JN, 2012, J BIOL CHEM, V287, P19501, DOI 10.1074/jbc.M112.354209; Park JN, 2011, APPL ENVIRON MICROB, V77, P1187, DOI 10.1128/AEM.02323-10; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reilly MC, 2011, J BIOL CHEM, V286, P26888, DOI 10.1074/jbc.M111.262162; Romero PA, 1999, GLYCOBIOLOGY, V9, P1045, DOI 10.1093/glycob/9.10.1045; Schutzbach J, 2007, CARBOHYD RES, V342, P881, DOI 10.1016/j.carres.2007.01.002; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Wozniak Karen L., 2009, V470, P71, DOI 10.1007/978-1-59745-204-5_7; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723; Yoko-O T, 1998, EUR J BIOCHEM, V257, P630, DOI 10.1046/j.1432-1327.1998.2570630.x; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Zhou H, 2007, EUKARYOT CELL, V6, P2260, DOI 10.1128/EC.00261-07; Ziegler FD, 1999, GLYCOBIOLOGY, V9, P497, DOI 10.1093/glycob/9.5.497	54	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1861	1873		10.1074/jbc.M114.607705	http://dx.doi.org/10.1074/jbc.M114.607705			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25477510	Green Published, hybrid			2022-12-26	WOS:000348056400050
J	Gunzenhauser, J; Wyss, R; Manley, S				Gunzenhaeuser, Julia; Wyss, Romain; Manley, Suliana			A Quantitative Approach to Evaluate the Impact of Fluorescent Labeling on Membrane-Bound HIV-Gag Assembly by Titration of Unlabeled Proteins	PLOS ONE			English	Article							CELL; LOCALIZATION; VISUALIZATION; PARTICLES	The assembly process of the human immunodeficiency virus 1 (HIV-1) is driven by the viral polyprotein Gag. Fluorescence imaging of Gag protein fusions is widely performed and has revealed important information on viral assembly. Gag fusion proteins are commonly co-transfected with an unlabeled form of Gag to prevent labeling artifacts such as morphological defects and decreased infectivity. Although viral assembly is widely studied on individual cells, the efficiency of the co-transfection rescue has never been tested at the single cell level. Here, we first develop a methodology to quantify levels of unlabeled to labeled Gag in single cells using a fluorescent reporter protein for unlabeled Gag and fluorescence correlation spectroscopy. Using super-resolution imaging based on photoactivated localization microscopy (PALM) combined with molecular counting we then study the nanoscale morphology of Gag clusters as a function of unlabeled to labeled Gag ratios in single cells. We show that for a given co-transfection ratio, individual cells express a wide range of protein ratios, necessitating a quantitative read-out for the expression of unlabeled Gag. Further, we show that monomerically labeled Gag assembles into membrane-bound clusters that are morphologically indistinguishable from mixtures of unlabeled and labeled Gag.	[Gunzenhaeuser, Julia; Manley, Suliana] Ecole Polytech Fed Lausanne, Lab Expt Biophys, Lausanne, Switzerland; [Wyss, Romain] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne; Ecole Polytechnique Federale de Lausanne	Manley, S (corresponding author), Ecole Polytech Fed Lausanne, Lab Expt Biophys, Lausanne, Switzerland.	suliana.manley@epfl.ch	Manley, Suliana/D-3818-2012	Manley, Suliana/0000-0002-4755-4778	European Community [243016-PALMassembly]	European Community(European Commission)	European Community's Seventh Framework Programme 243016-PALMassembly, SM JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Charette SJ, 2010, J IMMUNOL METHODS, V353, P148, DOI 10.1016/j.jim.2009.12.007; Chen RH, 1999, AM J PHYSIOL-RENAL, V276, pF777, DOI 10.1152/ajprenal.1999.276.5.F777; Chen Y, 2009, BIOPHYS J, V96, P1961, DOI 10.1016/j.bpj.2008.10.067; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Goedhart J., 2011, PLOS ONE, V6; Gonzalez G, 2011, PLOS ONE, V6; Gunzenhauser J, 2012, NANO LETT, V12, P4705, DOI 10.1021/nl3021076; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Larson DR, 2005, P NATL ACAD SCI USA, V102, P15453, DOI 10.1073/pnas.0504812102; Lehmann M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002456; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Malkusch S, 2012, HISTOCHEM CELL BIOL, P1; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Materna SC, 2005, FEMS MICROBIOL LETT, V243, P29, DOI 10.1016/j.femsle.2004.11.035; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Starr TE, 2002, J PHYS CHEM B, V106, P2365, DOI 10.1021/jp012689f; Stirnnagel K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-45; Voelkel C, 2010, P NATL ACAD SCI USA, V107, P7805, DOI 10.1073/pnas.0914517107; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2014	9	12							e115095	10.1371/journal.pone.0115095	http://dx.doi.org/10.1371/journal.pone.0115095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9YP	25493438	Green Submitted, gold, Green Published			2022-12-26	WOS:000346611400094
J	Esfahani, ZG; Valizadeh, A				Esfahani, Zahra Ghasemi; Valizadeh, Alireza			Zero-Lag Synchronization Despite Inhomogeneities in a Relay System	PLOS ONE			English	Article							PHASE-RESETTING CURVES; CAT VISUAL-CORTEX; NEURONAL OSCILLATIONS; NETWORKS; MODULATION; MODEL; MECHANISM; RESPONSES; DYNAMICS; FEEDBACK	A novel proposal for the zero-lag synchronization of the delayed coupled neurons, is to connect them indirectly via a third relay neuron. In this study, we develop a Poincare map to investigate the robustness of the synchrony in such a relay system against inhomogeneity in the neurons and synaptic parameters. We show that when the inhomogeneity does not violate the symmetry of the system, synchrony is maintained and in some cases inhomogeneity enhances synchrony. On the other hand if the inhomogeneity breaks the symmetry of the system, zero lag synchrony can not be preserved. In this case we give analytical results for the phase lag of the spiking of the neurons in the stable state.	[Esfahani, Zahra Ghasemi; Valizadeh, Alireza] Inst Adv Studies Basic Sci, Zanjan, Iran	Institute for Advanced Studies in Basic Sciences (IASBS)	Valizadeh, A (corresponding author), Inst Adv Studies Basic Sci, Zanjan, Iran.	valizade@iasbs.ac.ir	Valizadeh, Alireza/R-7972-2019; Valizadeh, Alireza/AAQ-1581-2020	Valizadeh, Alireza/0000-0001-5101-8567; 				Achuthan S, 2009, J NEUROSCI, V29, P5218, DOI 10.1523/JNEUROSCI.0426-09.2009; Ariaratnam JT, 2001, PHYS REV LETT, V86, P4278, DOI 10.1103/PhysRevLett.86.4278; Banerjee R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.027201; Barbour B, 2007, TRENDS NEUROSCI, V30, P622, DOI 10.1016/j.tins.2007.09.005; Bayati M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011925; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; BRAIMAN Y, 1995, NATURE, V378, P465, DOI 10.1038/378465a0; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G., 2006, RHYTHMS BRAIN; Canavier C.C., 2006, SCHOLARPEDIA, V1, P1332, DOI [10.4249/scholarpedia.1332, DOI 10.4249/SCHOLARPEDIA.1332, DOI 10.4249/SCH0LARPE-DIA.1332]; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; D'Huys O, 2010, SPIE PHOTONICS EUROP; Englert A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.114102; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Ermentrout B, 2001, NEURAL COMPUT, V13, P1285, DOI 10.1162/08997660152002861; Ermentrout GB, 2012, NEURAL COMPUT, V24, P3111, DOI 10.1162/NECO_a_00370; Ermentrout GB, 2012, SPR SER COMPUT NEURO, V6, P207, DOI 10.1007/978-1-4614-0739-3_9; Ermentrout GB, 2010, MATH FDN NEUROSCIENC, V64; Ernst U, 1998, PHYS REV E, V57, P2150, DOI 10.1103/PhysRevE.57.2150; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Fischer I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.123902; Flunkert V, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.254101; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goel P, 2002, PHYSICA D, V163, P191, DOI 10.1016/S0167-2789(01)00374-8; Gollo LL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003548; Gollo LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017756; Gollo LL, 2010, NEUROIMAGE, V52, P947, DOI 10.1016/j.neuroimage.2009.11.058; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Hansel D, 2012, SPR SER COMPUT NEURO, V6, P361, DOI 10.1007/978-1-4614-0739-3_15; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Karbowski J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031902; Lu WL, 2004, IEEE T CIRCUITS-I, V51, P2491, DOI 10.1109/TCSI.2004.838308; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MURPHY JT, 1985, CAN J NEUROL SCI, V12, P11, DOI 10.1017/S0317167100046527; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nowotny T, 2003, J NEUROSCI, V23, P9776; Panchuk A, 2013, INT J BIFURCATION CH, V23; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Sadeghi S, 2014, J COMPUT NEUROSCI, V36, P55, DOI 10.1007/s10827-013-0461-9; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; Teramae J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.204103; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 1999, FAST OSCILLATIONS CO; Tsodyks M, 2000, J NEUROSCI, V20; Vaadia E., 1992, INFORM PROCESSING CO, P81; Valizadeh A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144520; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Vicente R, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066202; Viriyopase A, 2012, FRONTIERS COMPUTATIO, V6; Wang XJ, 1996, J NEUROSCI, V16, P6402; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Woodman MM, 2011, J COMPUT NEUROSCI, V31, P401, DOI 10.1007/s10827-011-0315-2; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Young CK, 2009, CEREB CORTEX, V19, P24, DOI 10.1093/cercor/bhn055	76	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e112688	10.1371/journal.pone.0112688	http://dx.doi.org/10.1371/journal.pone.0112688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486522	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600011
J	Falcon, CR; Masih, D; Gatti, G; Sanchez, MC; Motran, CC; Cervi, L				Falcon, Cristian R.; Masih, Diana; Gatti, Gerardo; Cecilia Sanchez, Maria; Motran, Claudia C.; Cervi, Laura			Fasciola hepatica Kunitz Type Molecule Decreases Dendritic Cell Activation and Their Ability to Induce Inflammatory Responses	PLOS ONE			English	Article							ANTIGENS; MATURATION; TH17	The complete repertoire of proteins with immunomodulatory activity in Fasciola hepatica (Fh) has not yet been fully described. Here, we demonstrated that Fh total extract (TE) reduced LPS-induced DC maturation, and the DC ability to induce allogeneic responses. After TE fractionating, a fraction lower than 10 kDa (F<10 kDa) was able to maintain the TE properties to modulate the DC pro-and anti-inflammatory cytokine production induced by LPS. In addition, TE or F<10 kDa treatment decreased the ability of immature DC to stimulate the allogeneic responses and induced a novo allogeneic CD4+CD25+Foxp3+ T cells. In contrast, treatment of DC with T/L or F<10 kDa plus LPS (F<10/L) induced a regulatory IL-27 dependent mechanism that diminished the proliferative and Th1 and Th17 allogeneic responses. Finally, we showed that a Kunitz type molecule (Fh-KTM), present in F<10 kDa, was responsible for suppressing pro-inflammatory cytokine production in LPS-activated DC, by printing tolerogenic features on DC that impaired their ability to induce inflammatory responses. These results suggest a modulatory role for this protein, which may be involved in the immune evasion mechanisms of the parasite.	[Falcon, Cristian R.] Natl Univ Cordoba, Dept Biol Chem, Fac Chem Sci, CIQUIBIC CONICET, Cordoba, Argentina; [Masih, Diana; Gatti, Gerardo; Cecilia Sanchez, Maria; Motran, Claudia C.; Cervi, Laura] Natl Univ Cordoba, Dept Clin Biochem, Fac Chem Sci, CIQUIBIC CONICET, Cordoba, Argentina; [Gatti, Gerardo] Fdn Advancement Med, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Cervi, L (corresponding author), Natl Univ Cordoba, Dept Biol Chem, Fac Chem Sci, CIQUIBIC CONICET, Cordoba, Argentina.	lcervi@fcq.unc.edu.ar	Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901	FONCyT PICT	FONCyT PICT(ANPCyTFONCyT)	Funding: Funding provided by FONCyT PICT 2005. Categoria I. Temas Abiertos. 32027 Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozas SE, 1995, MOL BIOCHEM PARASIT, V74, P19, DOI 10.1016/0166-6851(95)02478-6; Carranza F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040356; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Cervi L, 2004, VET IMMUNOL IMMUNOP, V97, P97, DOI 10.1016/j.vetimm.2003.08.015; Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; Falcon C, 2010, VET IMMUNOL IMMUNOP, V137, P36, DOI 10.1016/j.vetimm.2010.04.007; Falcon CR, 2012, J INFECT DIS, V205, P506, DOI 10.1093/infdis/jir606; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; LaCourse EJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001666; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Mascanfroni I, 2008, FASEB J, V22, P1032, DOI 10.1096/fj.07-8652com; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Robinson MW, 2013, INT J PARASITOL, V43, P283, DOI 10.1016/j.ijpara.2012.11.004; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Schierack P, 2003, INFECT IMMUN, V71, P2422, DOI 10.1128/IAI.71.5.2422-2429.2003; Shigetomi H, 2010, INFLAMM RES, V59, P679, DOI 10.1007/s00011-010-0205-5; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803	25	35	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114505	10.1371/journal.pone.0114505	http://dx.doi.org/10.1371/journal.pone.0114505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486609	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600064
J	Herdegen, S; Conte, C; Kamal, S; Calin-Jageman, RJ; Calin-Jageman, IE				Herdegen, Samantha; Conte, Catherine; Kamal, Saman; Calin-Jageman, Robert J.; Calin-Jageman, Irina E.			Immediate and Persistent Transcriptional Correlates of Long-Term Sensitization Training at Different CNS Loci in Aplysia californica	PLOS ONE			English	Article							SITE-SPECIFIC SENSITIZATION; NEURONS INNERVATING TAIL; SIPHON-WITHDRAWAL REFLEX; SENSORY NEURONS; SYNAPTIC FACILITATION; PROTEIN-SYNTHESIS; MESSENGER-RNA; GILL-WITHDRAWAL; MEMORY; EXPRESSION	Repeated noxious stimulation produces long-term sensitization of defensive withdrawal reflexes in Aplysia californica, a form of long-term memory that requires changes in both transcription and translation. Previous work has identified 10 transcripts which are rapidly up-regulated after long-term sensitization training in the pleural ganglia. Here we use quantitative PCR to begin examining how these transcriptional changes are expressed in different CNS loci related to defensive withdrawal reflexes at 1 and 24 hours after long-term sensitization training. Specifically, we sample from a) the sensory wedge of the pleural ganglia, which exclusively contains the VC nociceptor cell bodies that help mediate input to defensive withdrawal circuits, b) the remaining pleural ganglia, which contain withdrawal interneurons, and c) the pedal ganglia, which contain many motor neurons. Results from the VC cluster show different temporal patterns of regulation: 1) rapid but transient up-regulation of Aplysia homologs of C/EBP, C/EBP gamma, and CREB1, 2) delayed but sustained up-regulation of BiP, Tolloid/BMP-1, and sensorin, 3) rapid and sustained up-regulation of Egr, GlyT2, VPS36, and an uncharacterized protein (LOC101862095), and 4) an unexpected lack of regulation of Aplysia homologs of calmodulin (CaM) and reductase-related protein (RRP). Changes in the remaining pleural ganglia mirror those found in the VC cluster at 1 hour but with an attenuated level of regulation. Because these samples had almost no expression of the VC-specific transcript sensorin, our data suggests that sensitization training likely induces transcriptional changes in either defensive withdrawal interneurons or neurons unrelated to defensive withdrawal. In the pedal ganglia, we observed only a rapid but transient increase in Egr expression, indicating that long-term sensitization training is likely to induce transcriptional changes in motor neurons but raising the possibility of different transcriptional endpoints in this cell type.	[Herdegen, Samantha; Conte, Catherine; Kamal, Saman; Calin-Jageman, Robert J.; Calin-Jageman, Irina E.] Dominican Univ, Neurosci Program, River Forest, IL 60305 USA		Calin-Jageman, IE (corresponding author), Dominican Univ, Neurosci Program, River Forest, IL 60305 USA.	rcalinjageman@dom.edu; icalinjageman@dom.edu	Calin-Jageman, Robert/K-1311-2019	Calin-Jageman, Robert/0000-0002-9837-6529; Calin-Jageman, Irina/0000-0002-2529-4223	Tellabs Foundation; National Institutes of Health [R15MH090998-01]; Jared-Beach Scholarship program; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH090998] Funding Source: NIH RePORTER	Tellabs Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jared-Beach Scholarship program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This work was supported by a grant from the Tellabs Foundation (http://www.tellabs.com/) and by National Institutes of Health Grant R15MH090998-01 (http://www.nih.gov/). In addition, Catherine Conte's work on this project was supported through the generosity of the Jared-Beach Scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TW, 2012, CURR BIOL, V22, pR705, DOI 10.1016/j.cub.2012.08.011; Abramson C. I., 1994, PRIMER INVERTEBRATE; Acheampong A, 2012, LEARN MEMORY, V19, P159, DOI 10.1101/lm.024638.111; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Antzoulatos EG, 2007, J NEUROSCI, V27, P676, DOI 10.1523/JNEUROSCI.4025-06.2007; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047378; BRUNET JF, 1991, SCIENCE, V252, P856, DOI 10.1126/science.1840700; BUONOMANO DV, 1992, BRAIN RES, V577, P147, DOI 10.1016/0006-8993(92)90548-N; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; CLEARY LJ, 1995, LEARN MEMORY, V2, P133, DOI 10.1101/lm.2.3-4.133; Cyriac A, 2013, NEUROBIOL LEARN MEM, V102, P43, DOI 10.1016/j.nlm.2013.03.008; DUBUC B, 1991, J EXP BIOL, V156, P315; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Esdin J, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00181; FREDMAN SM, 1979, BRAIN RES BULL, V4, P393, DOI 10.1016/S0361-9230(79)80017-9; Frost L, 1997, J NEUROSCI, V17, P2900; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; HAWKINS RD, 1984, PSYCHOL REV, V91, P375, DOI 10.1037/0033-295X.91.3.375; HENING WA, 1979, BRAIN RES, V179, P231, DOI 10.1016/0006-8993(79)90441-4; Herdegen S, 2014, NEUROBIOL LEARN MEM, V116, P27, DOI 10.1016/j.nlm.2014.07.009; Hermitte G, 1999, NEUROBIOL LEARN MEM, V71, P34, DOI 10.1006/nlme.1998.3858; HICKIE C, 1995, J NEUROPHYSIOL, V74, P307, DOI 10.1152/jn.1995.74.1.307; Hickie C, 1997, EUR J NEUROSCI, V9, P627, DOI 10.1111/j.1460-9568.1997.tb01411.x; Holmes G, 2015, LEARN MEMORY, V22, P11, DOI 10.1101/lm.036970.114; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Illich PA, 1997, J NEUROSCI, V17, P459, DOI 10.1523/JNEUROSCI.17-01-00459.1997; Jung K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-288; Korzus E, 2003, ACTA BIOCHIM POL, V50, P775; Krontiris-Litowitz J, 1999, J COMP PHYSIOL A, V185, P181, DOI 10.1007/s003590050376; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; Lee YS, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-3; Levenson J, 1999, J NEUROSCI, V19, P8094; Liu QR, 1997, J NEUROSCI, V17, P755; Liu RY, 2008, J NEUROSCI, V28, P1970, DOI 10.1523/JNEUROSCI.3848-07.2008; Liu RY, 2011, J NEUROSCI, V31, P6871, DOI 10.1523/JNEUROSCI.5071-10.2011; Liu RY, 2011, LEARN MEMORY, V18, P245, DOI 10.1101/lm.2112111; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; Marinesco S, 2004, J NEUROPHYSIOL, V92, P2468, DOI 10.1152/jn.00209.2004; MONTAROLO P, 1986, SCIENCE; RAYPORT SG, 1983, J NEUROPHYSIOL, V49, P864, DOI 10.1152/jn.1983.49.4.864; RAYPORT SG, 1986, J NEUROSCI, V6, P759; Sangha S, 2003, J EXP BIOL, V206, P1605, DOI 10.1242/jeb.00301; Schacher S, 2000, J NEUROBIOL, V45, P152, DOI 10.1002/1097-4695(20001115)45:3<152::AID-NEU3>3.0.CO;2-0; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; Shields-Johnson ME, 2013, LEARN MEMORY, V20, P1, DOI 10.1101/lm.028084.112; Simmons J. P., 2012, DIALOGUE OFFICIAL NE, V26, P4, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun ZY, 2001, J NEUROBIOL, V46, P41, DOI 10.1002/1097-4695(200101)46:1<41::AID-NEU4>3.0.CO;2-R; Sutton MA, 2004, J NEUROSCI, V24, P3600, DOI 10.1523/JNEUROSCI.1134-03.2004; TRITT SH, 1980, J NEUROPHYSIOL, V43, P581, DOI 10.1152/jn.1980.43.3.581; Wainwright ML, 2004, J NEUROPHYSIOL, V92, P2628, DOI 10.1152/jn.00335.2004; Wainwright ML, 2002, J NEUROSCI, V22, P4132, DOI 10.1523/JNEUROSCI.22-10-04132.2002; Walters ET, 2009, BRAIN BEHAV EVOLUT, V74, P206, DOI 10.1159/000258667; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1522, DOI 10.1152/jn.1983.50.6.1522; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; Walters ET, 2004, J COMP NEUROL, V471, P219, DOI 10.1002/cne.20042; WALTERS ET, 1987, J NEUROSCI, V7, P400; Watanabe H, 2005, NEUROBIOL LEARN MEM, V83, P151, DOI 10.1016/j.nlm.2004.11.003; WOOLF CJ, 1991, TRENDS NEUROSCI, V14, P74, DOI 10.1016/0166-2236(91)90024-O; XU YL, 1994, J NEUROSCI, V14, P3565; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zwartjes RE, 1998, LEARN MEMORY, V4, P478, DOI 10.1101/lm.4.6.478	73	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114481	10.1371/journal.pone.0114481	http://dx.doi.org/10.1371/journal.pone.0114481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486125	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600059
J	Polonsky, JA; Martinez-Pino, I; Nackers, F; Chonzi, P; Manangazira, P; Van Herp, M; Maes, P; Porten, K; Luquero, FJ				Polonsky, Jonathan A.; Martinez-Pino, Isabel; Nackers, Fabienne; Chonzi, Prosper; Manangazira, Portia; Van Herp, Michel; Maes, Peter; Porten, Klaudia; Luquero, Francisco J.			Descriptive Epidemiology of Typhoid Fever during an Epidemic in Harare, Zimbabwe, 2012	PLOS ONE			English	Article							POINT PATTERN-ANALYSIS; RISK-FACTORS; ENVIRONMENTAL-FACTORS; KELANTAN; AREA	Background: Typhoid fever remains a significant public health problem in developing countries. In October 2011, a typhoid fever epidemic was declared in Harare, Zimbabwe - the fourth enteric infection epidemic since 2008. To orient control activities, we described the epidemiology and spatiotemporal clustering of the epidemic in Dzivaresekwa and Kuwadzana, the two most affected suburbs of Harare. Methods: A typhoid fever case-patient register was analysed to describe the epidemic. To explore clustering, we constructed a dataset comprising GPS coordinates of case-patient residences and randomly sampled residential locations (spatial controls). The scale and significance of clustering was explored with Ripley K functions. Cluster locations were determined by a random labelling technique and confirmed using Kulldorff's spatial scan statistic. Principal Findings: We analysed data from 2570 confirmed and suspected case-patients, and found significant spatiotemporal clustering of typhoid fever in two non-overlapping areas, which appeared to be linked to environmental sources. Peak relative risk was more than six times greater than in areas lying outside the cluster ranges. Clusters were identified in similar geographical ranges by both random labelling and Kulldorff's spatial scan statistic. The spatial scale at which typhoid fever clustered was highly localised, with significant clustering at distances up to 4.5 km and peak levels at approximately 3.5 km. The epicentre of infection transmission shifted from one cluster to the other during the course of the epidemic. Conclusions: This study demonstrated highly localised clustering of typhoid fever during an epidemic in an urban African setting, and highlights the importance of spatiotemporal analysis for making timely decisions about targetting prevention and control activities and reinforcing treatment during epidemics. This approach should be integrated into existing surveillance systems to facilitate early detection of epidemics and identify their spatial range.	[Polonsky, Jonathan A.; Martinez-Pino, Isabel; Nackers, Fabienne; Porten, Klaudia; Luquero, Francisco J.] Epictr, Paris, France; [Martinez-Pino, Isabel] European Ctr Dis Prevent & Control, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Chonzi, Prosper] Harare City Hlth Dept, Minist Hlth & Child Welf, Harare, Zimbabwe; [Manangazira, Portia] Epidemiol & Dis Control Directorate, Minist Hlth & Child Welf, Harare, Zimbabwe; [Van Herp, Michel; Maes, Peter] Medecins Sans Frontieres Operat Ctr Brussels, Brussels, Belgium	European Centre for Disease Prevention & Control	Polonsky, JA (corresponding author), Epictr, Paris, France.	jonathan.polonsky@epicentre.msf.org	Nackers, Fabienne/X-6615-2019	Nackers, Fabienne/0000-0001-9870-1910; Polonsky, Jonathan/0000-0002-8634-4255				Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Carlos HA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-39; Chonzi Prosper, 2012, Morbidity and Mortality Weekly Report, V61, P435; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Diggle P.J., 1995, BERNOULLI, V1, DOI [10.2307/3318678, DOI 10.2307/3318678, 10.1002/sim.4780142106]; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Enachescu D, 2009, BIOCYBERN BIOMED ENG, V29, P19; Fernandez MAL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-442; Fernandez MAL, 2011, T ROY SOC TROP MED H, V105, P38, DOI 10.1016/j.trstmh.2010.10.001; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Hinman Sarah E, 2006, Int J Health Geogr, V5, P13, DOI 10.1186/1476-072X-5-13; Kariuki S, 2008, J INFECT DEV COUNTR, V2, P443, DOI 10.3855/jidc.159; Kelsall JE, 1998, J ROY STAT SOC C-APP, V47, P559, DOI 10.1111/1467-9876.00128; Khan MI, 2012, EPIDEMIOL INFECT, V140, P665, DOI 10.1017/S0950268811000938; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Luquero FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019005; Mason PR, 2009, J INFECT DEV COUNTR, V3, P148, DOI 10.3855/jidc.62; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; R Core Team, 2016, R FDN STAT COMP; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Safian N, 2008, MED J INDONES, V17, P175; Shah SA, 2012, SAINS MALAYS, V41, P911; Shi X, 2010, INT J GEOGR INF SCI, V24, P643, DOI 10.1080/13658810902950625; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051823; Toprak D, 2008, INT ARCH PHOTOGRAMM, V37, P1367; Tran HH, 2005, T ROY SOC TROP MED H, V99, P819, DOI 10.1016/j.trstmh.2005.05.007; United Nations Department of Economic and Social Affairs Population Division, 2009, WORLD POP PROSP 2008; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; Waller LA., 2009, SAGE HDB SPATIAL ANA, P299, DOI [https://dx.doi.org/10.4135/9780857020130.n16, DOI 10.4135/9780857020130.N16]; Wheeler DC, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-13; WHO-WORLD HEALTH ORGANIZATION, 2012, REP AD HOC CONS TYPH; World Health Organization Ministry of Health & Child Welfare Zimbabwe, 2012, ZIMBABWE WKLY EPIDEM, V48, P1; World Health Organization Ministry of Health & Child Welfare Zimbabwe, 2010, ZIMBABWE WKLY EPIDEM, V28, P1; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114702	10.1371/journal.pone.0114702	http://dx.doi.org/10.1371/journal.pone.0114702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486292	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600088
J	Zulkifley, MA; Mustafa, MM; Hussain, A; Mustapha, A; Ramli, S				Zulkifley, Mohd Asyraf; Mustafa, Mohd Marzuki; Hussain, Aini; Mustapha, Aouache; Ramli, Suzaimah			Robust Identification of Polyethylene Terephthalate (PET) Plastics through Bayesian Decision	PLOS ONE			English	Article							BOTTLES; SYSTEM	Recycling is one of the most efficient methods for environmental friendly waste management. Among municipal wastes, plastics are the most common material that can be easily recycled and polyethylene terephthalate (PET) is one of its major types. PET material is used in consumer goods packaging such as drinking bottles, toiletry containers, food packaging and many more. Usually, a recycling process is tailored to a specific material for optimal purification and decontamination to obtain high grade recyclable material. The quantity and quality of the sorting process are limited by the capacity of human workers that suffer from fatigue and boredom. Several automated sorting systems have been proposed in the literature that include using chemical, proximity and vision sensors. The main advantages of vision based sensors are its environmentally friendly approach, non-intrusive detection and capability of high throughput. However, the existing methods rely heavily on deterministic approaches that make them less accurate as the variations in PET plastic waste appearance are too high. We proposed a probabilistic approach of modeling the PET material by analyzing the reflection region and its surrounding. Three parameters are modeled by Gaussian and exponential distributions: color, size and distance of the reflection region. The final classification is made through a supervised training method of likelihood ratio test. The main novelty of the proposed method is the probabilistic approach in integrating various PET material signatures that are contaminated by stains under constant lighting changes. The system is evaluated by using four performance metrics: precision, recall, accuracy and error. Our system performed the best in all evaluation metrics compared to the benchmark methods. The system can be further improved by fusing all neighborhood information in decision making and by implementing the system in a graphics processing unit for faster processing speed.	[Zulkifley, Mohd Asyraf; Mustafa, Mohd Marzuki; Hussain, Aini; Mustapha, Aouache] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia; [Ramli, Suzaimah] Univ Pertahanan Nas Malaysia, Fac Def Sci & Technol, Dept Comp Sci, Kuala Lumpur 57000, Malaysia	Universiti Kebangsaan Malaysia; Universiti Pertahanan Nasional Malaysia	Zulkifley, MA (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia.	asyraf@eng.ukm.my	Mustapha, AOUACHE/AFK-0820-2022; Zulkifley, Mohd Asyraf/AAZ-3652-2020; Ramli, Suzaimah/GSD-2541-2022; Mustapha, AOUACHE/AAF-7777-2022; mustafa, marzuki/AHA-9319-2022; Hussain, A./D-6915-2017	Hussain, A./0000-0001-7347-7879; Mustapha, AOUACHE/0000-0003-1629-1183; Zulkifley, Mohd Asyraf/0000-0002-4010-3990	Ministry of Science and Technology Malaysia [06-01-02-SF1005]; Universiti Kebangsaan Malaysia [DPP-2014-009]	Ministry of Science and Technology Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia	Funding: This study was funded by the Ministry of Science and Technology Malaysia (06-01-02-SF1005) and Universiti Kebangsaan Malaysia (DPP-2014-009). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcala JM, 2004, MEAS SCI TECHNOL, V15, P371, DOI 10.1088/0957-0233/15/2/009; Bartolome L, 2012, RECENT DEV CHEM RECY, P65; Dahmus JB, 2007, ENVIRON SCI TECHNOL, V41, P7543, DOI 10.1021/es062254b; EEA, 2008, BETT MAN MUN WAST WI; Graham B, 2008, REV OPTICAL TECHNOLO; House B. W., 2011, IEEE INT S SUST SYST, P1, DOI DOI 10.1109/ISSST.2011.5936845; Nikles DE, 2005, MACROMOL MATER ENG, V290, P13, DOI 10.1002/mame.200400186; Park CH, 2008, ENVIRON SCI TECHNOL, V42; Picon A, 2009, IEEE T IND INFORM, V5, P483, DOI 10.1109/TII.2009.2031238; Ramli S., 2010, P 6 INT SIGN PROC IT, P1; Safavi SM, 2010, WASTE MANAGE, V30, P2216, DOI 10.1016/j.wasman.2010.06.023; Scavino Edgar, 2009, Journal of Computer Sciences, V5, P711, DOI 10.3844/jcssp.2009.711.716; Shahbudin S., 2010, 6 INT C SIGN PROC IT, P1, DOI DOI 10.1109/CSPA.2010.5545265; Tachwali Y, 2007, RESOUR CONSERV RECY, V52, P266, DOI 10.1016/j.resconrec.2007.03.008; Takahashi Y, 2008, ENVIRON SCI TECHNOL, V42; van den Broek WHAM, 1998, ANAL CHIM ACTA, V361, P161, DOI 10.1016/S0003-2670(98)00012-9; Wahab D. A., 2006, American Journal of Applied Sciences, V3, P1924, DOI 10.3844/ajassp.2006.1924.1928; Zhang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110159; Zhang H, 2014, WASTE MANAGE, V34, P987, DOI 10.1016/j.wasman.2013.07.015; Zulkifley MA, 2013, IEEE IMAGE PROC, P3162, DOI 10.1109/ICIP.2013.6738651; Zulkifley MA, 2012, EXPERT SYST APPL, V39, P12319, DOI 10.1016/j.eswa.2012.03.004; Zulkifley MA, 2010, INT CONF COMP SCI, P131, DOI 10.1109/ICCSIT.2010.5565166	23	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114518	10.1371/journal.pone.0114518	http://dx.doi.org/10.1371/journal.pone.0114518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485630	Green Submitted, gold, Green Published			2022-12-26	WOS:000346907600066
J	Cui, YC; Li, K; Tian, Y; Yuan, WM; Peng, P; Yang, JZ; Zhang, BJ; Zhang, HD; Wu, AL; Tang, Y				Cui, Yong-Chun; Li, Kai; Tian, Yi; Yuan, Wei-Min; Peng, Peng; Yang, Jian-Zhong; Zhang, Bao-Jie; Zhang, Hui-Dong; Wu, Ai-Li; Tang, Yue			A Pig Model of Ischemic Mitral Regurgitation Induced by Mitral Chordae Tendinae Rupture and Implantation of an Ameroid Constrictor	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; VENA CONTRACTA; QUANTIFICATION; MANAGEMENT; PATHOLOGY; REPAIR; VALVE	A miniature pig model of ischemic mitral regurgitation (IMR) was developed by posterior mitral chordae tendinae rupture and implantation of an ameroid constrictor. A 2.5-mm ameroid constrictor was placed around the left circumflex coronary artery (LCX) of male Tibetan miniature pigs to induce ischemia, while the posterior mitral chordae tendinae was also ruptured. X-ray coronary angiography, ECG analysis, echocardiography, and magnetic resonance imaging (MRI) were used to evaluate heart structure and function in pigs at baseline and one, two, four and eight weeks after the operation. Blood velocity of the mitral regurgitation was found to be between medium and high levels. Angiographic analyses revealed that the LCX closure was 10-20% at one week, 30-40% at two weeks and 90-100% at four weeks subsequent ameroid constrictor implantation. ECG analysis highlighted an increase in the diameter of the left atria (LA) at two weeks post-operation as well as ischemic changes in the left ventricle (LV) and LA wall at four weeks post-operation. Echocardiography and MRI further detected a gradual increase in LA and LV volumes from two weeks post-operation. LV end diastolic and systolic volumes as well as LA end diastolic and systolic volume were also significantly higher in pig hearts post-operation when compared to baseline. Pathological changes were observed in the heart, which included scar tissue in the ischemic central area of the LV. Transmission electron microscopy highlighted the presence of contraction bands and edema surrounding the ischemia area, including inflammatory cell infiltration within the ischemic area. We have developed a pig dmodel of IMR using the posterior mitral chordae tendineae rupture technique and implantation of an ameroid constrictor. The pathological features of this pig IMR model were found to mimic the natural history and progression of IMR in patients.	[Cui, Yong-Chun; Li, Kai; Tian, Yi; Yuan, Wei-Min; Peng, Peng; Yang, Jian-Zhong; Zhang, Bao-Jie; Zhang, Hui-Dong; Wu, Ai-Li; Tang, Yue] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis,Beijing Municipal Ke, Beijing 100037, Peoples R China; [Cui, Yong-Chun; Li, Kai; Tian, Yi; Yuan, Wei-Min; Peng, Peng; Yang, Jian-Zhong; Zhang, Bao-Jie; Zhang, Hui-Dong; Wu, Ai-Li; Tang, Yue] Peking Union Med Coll, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Tang, Y (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis,Beijing Municipal Ke, Beijing 100037, Peoples R China.; Tang, Y (corresponding author), Peking Union Med Coll, Beijing 100037, Peoples R China.	tangyue1226@vip.sina.com	Cui, Yong/AAF-9300-2020; Tian, Yi/AFQ-7590-2022		Beijing Science and Technology Committee [Z101107052210004]; Natural Science Foundation of China [81370190]	Beijing Science and Technology Committee; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is sponsored by the Beijing Science and Technology Committee (Project No: Z101107052210004) and Natural Science Foundation of China (Project No: 81370190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP SP, 1966, PATHOL VET, V3, P137, DOI 10.1177/030098586600300203; Borger MA, 2006, ANN THORAC SURG, V81, P1153, DOI 10.1016/j.athoracsur.2005.08.080; Borger MA, 2012, CIRCULATION, V126, P2674, DOI 10.1161/CIRCULATIONAHA.112.147777; Bouma W, 2010, EUR J CARDIO-THORAC, V37, P170, DOI 10.1016/j.ejcts.2009.07.008; Boyd JH, 2013, CIRC J, V77, P1952, DOI 10.1253/circj.CJ-13-0743; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eisenman Arie, 2006, Expert Rev Cardiovasc Ther, V4, P509, DOI 10.1586/14779072.4.4.509; FEHSKE W, 1994, AM J CARDIOL, V73, P268, DOI 10.1016/0002-9149(94)90232-1; Grigioni F, 2001, CIRCULATION, V103, P1759, DOI 10.1161/01.CIR.103.13.1759; GUTHRIE RB, 1976, MINN MED, V59, P637; Hammersting C, 2013, INTERNIST, V54, P39, DOI 10.1007/s00108-012-3093-7; Hammerstingl C, 2013, DER INTERNIST, V54, P49; Hammerstingl C, 2013, DER INTERNIST, V54, P42; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; HICKEY MS, 1988, CIRCULATION, V78, P51; Huang L, 2008, CHIN J COMP MED, V18, P23; Huang WL, 2013, CHINESE MED J-PEKING, V126, P1766, DOI 10.3760/cma.j.issn.0366-6999.20123171; Khanna D, 2004, ECHOCARDIOGR-J CARD, V21, P737, DOI 10.1111/j.0742-2822.2004.40027.x; Lamas GA, 1997, CIRCULATION, V96, P827; Lancellotti P, 2005, EUR HEART J, V26, P1528, DOI 10.1093/eurheartj/ehi189; Lancellotti P, 2003, CIRCULATION, V108, P447; Leroux AA, 2012, J HEART VALVE DIS, V21, P416; Levine RA, 2005, CIRCULATION, V112, P745, DOI 10.1161/CIRCULATIONAHA.104.486720; Lin JH, 1999, CONTEMP TOP LAB ANIM, V38, P36; Lukacs E, 2013, CAN J PHYSIOL PHARM, V91, P617, DOI 10.1139/cjpp-2012-0410; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Markert Michael, 2009, Journal of Pharmacological and Toxicological Methods, V60, P79, DOI 10.1016/j.vascn.2008.12.004; Nahas K, 2002, COMPARATIVE MED, V52, P258; Robb JD, 2011, EUR J CARDIO-THORAC, V40, P1501, DOI 10.1016/j.ejcts.2011.02.079; Schirmer SH, 2014, J AM COLL CARDIOL, V63, P1916, DOI 10.1016/j.jacc.2013.10.073; Schnurer C, 2011, J CARDIOVASC SURG, V52, P105; Shakil O, 2012, J CARDIOTHOR VASC AN, V26, P756, DOI [10.1053/j.jvca.2012.01.041, 10.1053/j.jvca.2012.03.007]	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111689	10.1371/journal.pone.0111689	http://dx.doi.org/10.1371/journal.pone.0111689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479001	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200004
J	Koyanagi, A; Garin, N; Olaya, B; Ayuso-Mateos, JL; Chatterji, S; Leonardi, M; Koskinen, S; Tobiasz-Adamczyk, B; Haro, JM				Koyanagi, Ai; Garin, Noe; Olaya, Beatriz; Luis Ayuso-Mateos, Jose; Chatterji, Somnath; Leonardi, Matilde; Koskinen, Seppo; Tobiasz-Adamczyk, Beata; Maria Haro, Josep			Chronic Conditions and Sleep Problems among Adults Aged 50 years or over in Nine Countries: A Multi-Country Study	PLOS ONE			English	Article							CHRONIC DISEASES; OLDER-ADULTS; MENTAL-HEALTH; INSOMNIA; PREVALENCE; ASSOCIATION; COMPLAINTS; DISORDERS; DIAGNOSIS; RISK	Background: Data on the association between chronic conditions or the number of chronic conditions and sleep problems in low- or middle-income countries is scarce, and global comparisons of these associations with high-income countries have not been conducted. Methods: Data on 42116 individuals 50 years and older from nationally-representative samples of the Collaborative Research on Ageing in Europe (Finland, Poland, Spain) and the World Health Organization's Study on Global Ageing and Adult Health (China, Ghana, India, Mexico, Russia, South Africa) conducted between 2011-2012 and 2007-2010 respectively were analyzed. Results: The association between nine chronic conditions (angina, arthritis, asthma, chronic lung disease, depression, diabetes, hypertension, obesity, and stroke) and self-reported severe/extreme sleep problems in the past 30 days was estimated by logistic regression with multiple variables. The age-adjusted prevalence of sleep problems ranged from 2.8% (China) to 17.0% (Poland). After adjustment for confounders, angina (OR 1.75-2.78), arthritis (OR 1.39-2.46), and depression (OR 1.75-5.12) were significantly associated with sleep problems in the majority or all of the countries. Sleep problems were also significantly associated with: asthma in Finland, Spain, and India; chronic lung disease in Poland, Spain, Ghana, and South Africa; diabetes in India; and stroke in China, Ghana, and India. A linear dose-dependent relationship between the number of chronic conditions and sleep problems was observed in all countries. Compared to no chronic conditions, the OR (95% CI) for 1,2,3, and >= 4 chronic conditions was 1.41 (1.09-1.82), 2.55 (1.99-3.27), 3.22 (2.52-4.11), and 7.62 (5.88-9.87) respectively in the overall sample. Conclusions: Identifying co-existing sleep problems among patients with chronic conditions and treating them simultaneously may lead to better treatment outcome. Clinicians should be aware of the high risk for sleep problems among patients with multimorbidity. Future studies are needed to elucidate the best treatment options for comorbid sleep problems especially in developing country settings.	[Koyanagi, Ai; Garin, Noe; Olaya, Beatriz; Maria Haro, Josep] Fundacio St Joan de Deu, Res & Dev Unit, Barcelona, Spain; [Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Koyanagi, Ai; Garin, Noe; Olaya, Beatriz; Luis Ayuso-Mateos, Jose; Maria Haro, Josep] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Inst Salud Carlos III, Barcelona, Spain; [Luis Ayuso-Mateos, Jose] Inst Invest Sanitaria Princesa IP, Madrid, Spain; [Chatterji, Somnath] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Leonardi, Matilde] IRCCS Fdn, Neurol Inst Carlo Besta, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Koskinen, Seppo] Natl Inst Hlth & Welf, Helsinki, Finland; [Tobiasz-Adamczyk, Beata] Jagiellonian Univ, Coll Med, Dept Med Sociol, Krakow, Poland	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Barcelona; World Health Organization; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Finland National Institute for Health & Welfare; Jagiellonian University; Collegium Medicum Jagiellonian University	Koyanagi, A (corresponding author), Fundacio St Joan de Deu, Res & Dev Unit, Parc Sanitari St Joan de Deu, Barcelona, Spain.	a.koyanagi@pssjd.org	Koyanagi, Ai/D-3833-2018; Olaya, Beatriz/AAB-1952-2020; CHATTERJI, Somnath/ABE-6832-2020; leonardi, matilde/J-9997-2018; Haro, Josep Maria/D-1423-2011	Koyanagi, Ai/0000-0002-9565-5004; Olaya, Beatriz/0000-0003-2046-3929; leonardi, matilde/0000-0003-0552-8923; Haro, Josep Maria/0000-0002-3984-277X; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X; Garin, Noe/0000-0002-1559-9453	Miguel Servet; United States National Institute on Aging's Division of Behavioral and Social Research [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479]; World Health Organization's Department of Health Statistics and Information Systems; European Community [223071]; Instituto de Salud Carlos III-FIS [PS09/00295, PS09/01845]; Spanish Ministry of Science and Innovation ACI-Promociona [ACI2009-1010]; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	Miguel Servet; United States National Institute on Aging's Division of Behavioral and Social Research; World Health Organization's Department of Health Statistics and Information Systems; European Community(European Commission); Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation ACI-Promociona(Ministry of Science and Innovation, Spain (MICINN)); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ai Koyanagi's work was supported by the Miguel Servet contract by CIBERSAM. WHO's Study on Global AGEing and Adult Health is supported by the United States National Institute on Aging's Division of Behavioral and Social Research through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479) and the World Health Organization's Department of Health Statistics and Information Systems. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 223071 (COURAGE in Europe), from the Instituto de Salud Carlos III-FIS research grants number PS09/00295 and PS09/01845, and from the Spanish Ministry of Science and Innovation ACI-Promociona (ACI2009-1010). The study was also supported by the Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III. The views expressed in this paper are those of the author(s) and do not necessarily represent the views or policies of the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NIH Consens State Sci Statements, V22, P1; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Becker P. M., 2014, CURR MED RES OPIN; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chennaoui M, 2014, SLEEP MED REV; Coryell VT, 2013, INT HEART J, V54, P258, DOI 10.1536/ihj.54.258; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; D'Aniello GE, 2014, J NEUROL SCI, V338, P191, DOI 10.1016/j.jns.2014.01.005; Depner CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0507-z; Di Milia L, 2013, SLEEP MED, V14, P319, DOI 10.1016/j.sleep.2012.12.007; Ferre A, 2013, NEUROLOGIA, V28, P103, DOI 10.1016/j.nrl.2010.09.016; Garcia AD, 2008, CLIN GERIATR MED, V24, P27, DOI 10.1016/j.cger.2007.08.008; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Ghodse H, 2003, BRIT J PSYCHIAT, V183, P15, DOI 10.1192/bjp.183.1.15; GISLASON T, 1987, ACTA MED SCAND, V221, P475; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Gureje O, 2007, SOC PSYCH PSYCH EPID, V42, P495, DOI 10.1007/s00127-007-0183-2; Gureje O, 2011, SLEEP, V34, P965, DOI 10.5665/SLEEP.1138; Iyer S Ramnathan, 2012, J Assoc Physicians India, V60, P42; Kinsella K, 2009, INT POPULATION REPOR; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Levesque JF, 2013, INT J PUBLIC HEALTH, V58, P435, DOI 10.1007/s00038-013-0446-5; Louie GH, 2011, ARTHRIT CARE RES, V63, P247, DOI 10.1002/acr.20362; Manini Todd, 2011, Curr Aging Sci, V4, P184; McCrae CS, 2009, AM J MANAG CARE, V15, pS14; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; McNamara JPH, 2014, PSYCHOL HEALTH MED, V19, P410, DOI 10.1080/13548506.2013.832782; Meng L, 2013, HYPERTENS RES, V36, P985, DOI 10.1038/hr.2013.70; MONANE M, 1992, J CLIN PSYCHIAT, V53, P23; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Institute of Health, 2005, NIH STAT OF THE SCI; Neubauer DN, 2009, AM J MANAG CARE, V15, pS24; Newman AB, 1997, J AM GERIATR SOC, V45, P1; Ohayon MM, 2014, J PSYCHIATR RES, V54, P79, DOI 10.1016/j.jpsychires.2014.02.023; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; PHILLIPS BA, 1987, CHEST, V91, P29, DOI 10.1378/chest.91.1.29; Phillips B, 2007, J CLIN SLEEP MED, V3, P489; Plantinga L, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110244; Pollak C P, 1991, J Geriatr Psychiatry Neurol, V4, P204, DOI 10.1177/089198879100400405; POOLEWILSON PA, 1983, POSTGRAD MED J, V59, P11; Power JD, 2005, ARTHRIT RHEUM-ARTHR, V53, P911, DOI 10.1002/art.21584; Raggi A, 2013, CLIN PSYCHOL PSYCHOT; Reid KJ, 2006, AM J GERIAT PSYCHIAT, V14, P860, DOI 10.1097/01.JGP.0000206164.56404.ba; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Roth Thomas, 2009, Prim Care Companion J Clin Psychiatry, V11, P292, DOI 10.4088/PCC.08m00749bro; Roth T, 2009, AM J MANAG CARE, V15, pS6; Santos-Silva R, 2010, SLEEP MED, V11, P520, DOI 10.1016/j.sleep.2009.12.011; Schubert CR, 2002, SLEEP, V25, P889; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1; Spiegelhalder K, 2010, NAT SCI SLEEP, V2, P71; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Stone KL, 2014, J AM GERIATR SOC, V62, P299, DOI 10.1111/jgs.12649; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Sundbom F, 2013, ALLERGY, V68, P213, DOI 10.1111/all.12079; Tjepkema Michael, 2005, Health Rep, V17, P9; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Vitiello MV, 2009, J CLIN SLEEP MED, V5, P355; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675	66	112	115	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114742	10.1371/journal.pone.0114742	http://dx.doi.org/10.1371/journal.pone.0114742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25478876	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200120
J	Pacheco, MTF; Berra, CM; Morais, KLP; Sciani, JM; Branco, VG; Bosch, RV; Chudzinski-Tavassi, AM				Pacheco, Mario T. F.; Berra, Carolina M.; Morais, Katia L. P.; Sciani, Juliana M.; Branco, Vania G.; Bosch, Rosemary V.; Chudzinski-Tavassi, Ana M.			Dynein Function and Protein Clearance Changes in Tumor Cells Induced by a Kunitz-Type Molecule, Amblyomin-X	PLOS ONE			English	Article							PROTEASOME; CANCER; AUTOPHAGY; LOCALIZATION; PROGRESSION; INHIBITOR; RECEPTORS; PATHWAY; COMPLEX; AMBRA1	Amblyomin-X is a Kunitz-type recombinant protein identified from the transcriptome of the salivary glands of the tick Amblyomma cajennense and has anti-coagulant and antitumoral activity. The supposed primary target of this molecule is the proteasome system. Herein, we elucidated intracellular events that are triggered by Amblyomin-X treatment in an attempt to provide new insight into how this serine protease inhibitor, acting on the proteasome, could be comparable with known proteasome inhibitors. The collective results showed aggresome formation after proteasome inhibition that appeared to occur via the non-exclusive ubiquitin pathway. Additionally, Amblyomin-X increased the expression of various chains of the molecular motor dynein in tumor cells, modulated specific ubiquitin linkage signaling and inhibited autophagy activation by modulating mTOR, LC3 and AMBRA1 with probable dynein involvement. Interestingly, one possible role for dynein in the mechanism of action of Amblyomin-X was in the apoptotic response and its crosstalk with autophagy, which involved the factor Bim; however, we observed no changes in the apoptotic response related to dynein in the experiments performed. The characteristics shared among Amblyomin-X and known proteasome inhibitors included NF-kappa B blockage and nascent polypeptide-dependent aggresome formation. Therefore, our study describes a Kunitz-type protein that acts on the proteasome to trigger distinct intracellular events compared to classic known proteasome inhibitors that are small-cell-permeable molecules. In investigating the experiments and literature on Amblyomin-X and the known proteasome inhibitors, we also found differences in the structures of the molecules, intracellular events, dynein involvement and tumor cell type effects. These findings also reveal a possible new target for Amblyomin-X, i.e., dynein, and may serve as a tool for investigating tumor cell death associated with proteasome inhibition.	[Pacheco, Mario T. F.; Berra, Carolina M.; Morais, Katia L. P.; Sciani, Juliana M.; Branco, Vania G.; Bosch, Rosemary V.; Chudzinski-Tavassi, Ana M.] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Morais, Katia L. P.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil	Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP)	Chudzinski-Tavassi, AM (corresponding author), Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil.	ana.chudzinski@butantan.gov.br	Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Berra, Carolina/O-1180-2013; Chudzinski-Tavassi, Ana M./I-4167-2012; Sciani, Juliana Mozer/B-6990-2012; Chudzinski-Tavassi, Ana M/X-3772-2018	Berra, Carolina/0000-0002-8964-4499; Sciani, Juliana Mozer/0000-0001-7213-206X; Morais, Katia/0000-0001-8877-5887	Sao Paulo Research Foundation (FAPESP) [2011/05969-4, CAT/CEPID 1998/14307-9, CETICs 2013/07467-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by grants provided by the Sao Paulo Research Foundation (FAPESP; processes 2011/05969-4, CAT/CEPID 1998/14307-9, and CETICs 2013/07467-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi EM, 2012, BIOMED PHARMACOTHER, V66, P64, DOI 10.1016/j.biopha.2011.11.015; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Batista IFC, 2010, ARCH BIOCHEM BIOPHYS, V493, P151, DOI 10.1016/j.abb.2009.10.009; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Cenci S, 2012, JLB, V92, P1; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chuzinski-Tavassi AM, 2010, TOXICON, P1145; Clippinger AJ, 2012, GENE DEV, V26, P2015, DOI 10.1101/gad.196147.112; Cohen S, 2006, BIOCHEM BIOPH RES CO, V345, P7, DOI 10.1016/j.bbrc.2006.04.036; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; DONATI MB, 1984, HAEMOSTASIS, V14, P422; Dorsey BD, 2008, J MED CHEM, V51, P1068, DOI 10.1021/jm7010589; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Fimia GM, 2011, AUTOPHAGY, V7, P115, DOI 10.4161/auto.7.1.14071; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Jain S, 2011, CORE EVID, V6, P43, DOI 10.2147/CE.S13838; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Luo SQ, 2012, MOL CELL, V47, P359, DOI 10.1016/j.molcel.2012.05.040; Manasanch EE, 2017, NAT REV CLIN ONCOL, V14, P417, DOI [10.1007/s12079-011-0121-7, 10.1038/nrclinonc.2016.206]; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shrum CK, 2008, PNAS, V106, P2647; Tan SC, 2011, MOL BIOL CELL, V22, P467, DOI 10.1091/mbc.E10-02-0129; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Venere M, 2013, CANCER CELL, V23, P135, DOI 10.1016/j.ccr.2013.01.020; Ventura JS, 2013, BIOMED PHARMACOTHER, V67, P192, DOI 10.1016/j.biopha.2012.11.009; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501	45	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e111907	10.1371/journal.pone.0111907	http://dx.doi.org/10.1371/journal.pone.0111907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479096	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200006
J	Schaefer, K; Brown, N; Kaye, PM; Lacey, CJ				Schaefer, Katrein; Brown, Najmeeyah; Kaye, Paul M.; Lacey, Charles J.			Cervico-Vaginal Immunoglobulin G Levels Increase Post-Ovulation Independently of Neutrophils	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; FEMALE REPRODUCTIVE-TRACT; MENSTRUAL-CYCLE; GENITAL-TRACT; HUMAN ENDOMETRIUM; ESTROUS-CYCLE; POLYMORPHONUCLEAR LEUKOCYTES; VAGINAL IMMUNIZATION; SECRETORY COMPONENT; MUCOSAL IMMUNITY	The prevalence of sexually transmitted infections (STIs) is often higher in females than in males. Although the reproductive cycle profoundly modulates local immunity in the female reproductive tract (FRT) system, significant gaps in our knowledge of the immunobiology of the FRT still exist. An intriguing and frequently observed characteristic of the FRT is the predominant presence of immunoglobulin (Ig) G in cervico-vaginal secretions. We show here that in the mouse, IgG accumulation was enhanced approximately 5-fold post-ovulation, and was accompanied by an influx of neutrophils into the FRT. To determine whether these two events were causally related, we performed short-term neutrophil depletion experiments at individual stages throughout the estrous cycle. Our results demonstrate that neutrophils were not necessary for cycle-dependent tissue remodeling and cycle progression and that cycle-dependent IgG accumulation occurred independent of neutrophils. We thus conclude that neutrophil influx and IgG accumulation are independent events that occur in the FRT during the reproductive cycle.	[Kaye, Paul M.] Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Kaye, PM (corresponding author), Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	paul.kaye@york.ac.uk		Kaye, Paul/0000-0002-8796-4755	EC; UK Medical Research Council [G1000230]; EUROPRISE Studentship [REE0031-0708-26]; Medical Research Council [G1000230] Funding Source: researchfish; MRC [G1000230] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUROPRISE Studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by an EC FP6 grant for the European HIV Enterprise (EUROPRISE; to CJL; http://ec.europa.eu) and the UK Medical Research Council (G1000230 to PMK; http://www.mrc.ac.uk). KS was supported by an EUROPRISE Studentship (REE0031-0708-26; http://www.europrise.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Arici A, 1998, J CLIN ENDOCR METAB, V83, P1783, DOI 10.1210/jc.83.5.1783; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; BOUVET JP, 1994, INFECT IMMUN, V62, P3957, DOI 10.1128/IAI.62.9.3957-3961.1994; Brannstrom M, 1999, EUR J OBSTET GYN R B, V83, P213, DOI 10.1016/S0301-2115(99)00003-2; Cauci S, 2003, MOL HUM REPROD, V9, P53, DOI 10.1093/molehr/gag003; CHIPPERFIELD EJ, 1972, CLIN EXP IMMUNOL, V11, P219; CHIPPERFIELD EJ, 1975, INFECT IMMUN, V11, P215, DOI 10.1128/IAI.11.2.215-221.1975; CHODIRKER WB, 1963, SCIENCE, V142, P1080, DOI 10.1126/science.142.3595.1080; Chua Felix, 2006, Proc Am Thorac Soc, V3, P424, DOI 10.1513/pats.200603-078AW; Cobo ER, 2011, AM J TROP MED HYG, V85, P667, DOI 10.4269/ajtmh.2011.11-0123; Criss AK, 2012, NAT REV MICROBIOL, V10, P178, DOI 10.1038/nrmicro2713; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; CRITCHLEY HOD, 1994, HUM REPROD, V9, P1406, DOI 10.1093/oxfordjournals.humrep.a138719; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DIYACOVO L, 1977, EXPERIENTIA, V33, P392; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; HOCINI H, 1995, SCAND J IMMUNOL, V42, P269, DOI 10.1111/j.1365-3083.1995.tb03653.x; HURLIMANN J, 1978, VIRCHOWS ARCH A, V377, P211, DOI 10.1007/BF00426931; Jaeger BN, 2012, J EXP MED, V209, P565, DOI 10.1084/jem.20111908; Johansson M, 2003, CURR OPIN INFECT DIS, V16, P43, DOI 10.1097/00001432-200302000-00008; JUNGI TW, 1977, AM J PHYSIOL, V233, pR59, DOI 10.1152/ajpregu.1977.233.1.R59; Kaushic C, 2011, J REPROD IMMUNOL, V88, P204, DOI 10.1016/j.jri.2010.12.004; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Kutteh WH, 1998, AIDS RES HUM RETROV, V14, pS51; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Lindqvist M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020448; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; Milligan GN, 1999, J VIROL, V73, P6380, DOI 10.1128/JVI.73.8.6380-6386.1999; Milligan GN, 2001, J REPROD IMMUNOL, V49, P49, DOI 10.1016/S0165-0378(00)00080-2; Monteiro EF, 2005, SEX TRANSM INFECT, V81, P41, DOI 10.1136/sti.2004.009431; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; RACHMAN F, 1983, J REPROD FERTIL, V69, P17, DOI 10.1530/jrf.0.0690017; Rank RG, 2011, INFECT IMMUN, V79, P3291, DOI 10.1128/IAI.00200-11; Roig de Vargas-Linares, 1971, Acta Physiol Lat Am, V21, P158; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Salamonsen LA, 1999, J REPROD IMMUNOL, V44, P1; Sasaki S, 2009, BIOCHEM BIOPH RES CO, V382, P35, DOI 10.1016/j.bbrc.2009.02.112; Shang L, 2014, J IMMUNOL, V193, P277, DOI 10.4049/jimmunol.1400417; Shen L, 2004, CELL IMMUNOL, V230, P23, DOI 10.1016/j.cellimm.2004.08.004; Shrier LA, 2003, J ADOLESCENT HEALTH, V32, P183, DOI 10.1016/S1054-139X(02)00536-0; Sonoda Y, 1998, J IMMUNOL, V160, P6159; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; USALA SJ, 1989, J REPROD MED, V34, P292; Willis C, 2003, HUM REPROD, V18, P1173, DOI 10.1093/humrep/deg231; WIRA CR, 1977, NATURE, V268, P534, DOI 10.1038/268534a0; WIRA CR, 1980, ENDOCRINOLOGY, V106, P1020, DOI 10.1210/endo-106-3-1020; WIRA CR, 1985, BIOL REPROD, V32, P90, DOI 10.1095/biolreprod32.1.90; Wira CR, 2002, ENDOCRINOLOGY, V143, P2872, DOI 10.1210/en.143.8.2872; WIRA CR, 1987, J IMMUNOL, V138, P4159; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; WUTTKE W, 1993, HUM REPROD, V8, P141, DOI 10.1093/humrep/8.suppl_2.141; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114824	10.1371/journal.pone.0114824	http://dx.doi.org/10.1371/journal.pone.0114824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479383	Green Accepted, Green Published, gold			2022-12-26	WOS:000346907200129
J	Chen, NT; Chen, MJ; Guo, CY; Chen, KT; Su, HJ				Chen, Nai-Tzu; Chen, Mu-Jean; Guo, Chao-Yu; Chen, Kow-Tong; Su, Huey-Jen			Precipitation Increases the Occurrence of Sporadic Legionnaires' Disease in Taiwan	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; FLOWER SHOW; RISK; RAINFALL; OUTBREAK; SURVEILLANCE; NETHERLANDS; MORTALITY; SURVIVAL; HUMIDITY	Legionnaires' disease (LD) is an acute form of pneumonia, and changing weather is considered a plausible risk factor. Yet, the relationship between weather and LD has rarely been investigated, especially using long-term daily data. In this study, daily data was used to evaluate the impacts of precipitation, temperature, and relative humidity on LD occurrence in Taiwan from 1995-2011. A time-stratified 2:1 matched-period case-crossover design was used to compare each case with self-controlled data using a conditional logistic regression analysis, and odds ratios (ORs) for LD occurrence was estimated. The city, gender and age were defined as a stratum for each matched set to modify the effects. For lag day- 0 to 15, the precipitation at lag day-11 significantly affected LD occurrence (p<0.05), and a 2.5% (95% CIs=0.3-4.7%) increased risk of LD occurrence was associated with every 5-mm increase in precipitation. In addition, stratified analyses further showed that positive associations of precipitation with LD incidence were only significant in male and elderly groups and during the warm season ORs=1.023-1.029). However, such an effect was not completely linear. Only precipitations at 21-40 (OR=1.643 (95% CIs=1.074-2.513)) and 61-80 mm (OR=2.572 (1.106-5.978)) significantly increased the risk of LD occurrence. Moreover, a negative correlation between mean temperature at an 11-day lag and LD occurrence was also found (OR=0.975 (0.953-0.996)). No significant association between relative humidity and LD occurrence was identified (p>0.05). In conclusion, in warm, humid regions, an increase of daily precipitation is likely to be a critical weather factor triggering LD occurrence where the risk is found particularly significant at an 11-day lag. Additionally, precipitation at 21-40 and 61-80 mm might make LD occurrence more likely.	[Chen, Nai-Tzu; Chen, Mu-Jean; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Mu-Jean] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Miaoli, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Coll Med, Inst Publ Hlth, Taipei 112, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Coll Med, Dept Publ Hlth, Taipei 112, Taiwan; [Chen, Kow-Tong] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University	Su, HJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw		Guo, Chao-Yu/0000-0002-9066-9933	Taiwan National Science Council [NSC102-2621-M-006-001, NSC101-2625-M-006-009, NSC101-2621-M-006-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This supplement received financial support from the Taiwan National Science Council (NSC102-2621-M-006-001, NSC101-2625-M-006-009, NSC101-2621-M-006-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherholt TB, 1998, J AM WATER WORKS ASS, V90, P66; BERENDT RF, 1980, J INFECT DIS, V141, P689, DOI 10.1093/infdis/141.5.689; Casati S, 2009, CLIN MICROBIOL INFEC, V15, P571, DOI 10.1111/j.1469-0691.2009.02742.x; Conza L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002428; Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176; Dominguez A, 2009, INT J TUBERC LUNG D, V13, P407; Figueiras A, 2005, EPIDEMIOLOGY, V16, P239, DOI 10.1097/01.ede.0000152915.58564.d3; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Garcia-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061036; HAMBLETON P, 1983, J HYG-CAMBRIDGE, V90, P451, DOI 10.1017/S0022172400029090; Heath CH, 1996, EUR J CLIN MICROBIOL, V15, P286, DOI 10.1007/BF01695659; HELMS CM, 1984, AM J MED SCI, V288, P2, DOI 10.1097/00000441-198407000-00001; Hicks LA, 2007, EPIDEMIOL INFECT, V135, P811, DOI 10.1017/S0950268806007552; Hong PY, 2013, APPL ENVIRON MICROB, V79, P2620, DOI 10.1128/AEM.03760-12; Jones TF, 2003, CLIN INFECT DIS, V37, P1292, DOI 10.1086/379017; Joseph CA, 2010, EUROSURVEILLANCE, V15, P9; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P181, DOI 10.1017/S095026880800099X; Krojgaard LH, 2011, EUROSURVEILLANCE, V16, P11; Lettinga KD, 2002, EMERG INFECT DIS, V8, P1448, DOI 10.3201/eid0812.020035; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; Ng V, 2008, ECOHEALTH, V5, P482, DOI 10.1007/s10393-009-0218-0; Pravinkumar SJ, 2010, EUROSURVEILLANCE, V15, P4; Richardson HY, 2009, WATER RES, V43, P2159, DOI 10.1016/j.watres.2009.02.035; Ricketts KD, 2009, EPIDEMIOL INFECT, V137, P1003, DOI 10.1017/S095026880800157X; Rivera JM, 2009, INFECT CONT HOSP EP, V30, P306, DOI 10.1086/595981; Sakamoto R, 2009, EMERG INFECT DIS, V15, P1295, DOI 10.3201/eid1508.090317; Ferre MRS, 2009, EUR J CLIN MICROBIOL, V28, P153, DOI 10.1007/s10096-008-0603-6; Travis TC, 2012, INT J MICROBIOL, V2012	28	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114337	10.1371/journal.pone.0114337	http://dx.doi.org/10.1371/journal.pone.0114337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474539	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500018
J	Feriche, B; Garcia-Ramos, A; Calderon-Soto, C; Drobnic, F; Bonitch-Gongora, JG; Galilea, PA; Riera, J; Padial, P				Feriche, Belen; Garcia-Ramos, Amador; Calderon-Soto, Carmen; Drobnic, Franchek; Bonitch-Gongora, Juan G.; Galilea, Pedro A.; Riera, Joan; Padial, Paulino			Effect of Acute Exposure to Moderate Altitude on Muscle Power: Hypobaric Hypoxia vs. Normobaric Hypoxia	PLOS ONE			English	Article							UPPER-BODY MOVEMENTS; EXERCISE PERFORMANCE; SKELETAL-MUSCLE; ADAPTATIONS; STRENGTH; OXYGENATION; ACTIVATION; KINEMATICS; RESPONSES; KINETICS	When ascending to a higher altitude, changes in air density and oxygen levels affect the way in which explosive actions are executed. This study was designed to compare the effects of acute exposure to real or simulated moderate hypoxia on the dynamics of the force-velocity relationship observed in bench press exercise. Twenty-eight combat sports athletes were assigned to two groups and assessed on two separate occasions: G1 (n=17) in conditions of normoxia (N1) and hypobaric hypoxia (HH) and G2 (n=11) in conditions of normoxia (N2) and normobaric hypoxia (NH). Individual and complete force-velocity relationships in bench press were determined on each assessment day. For each exercise repetition, we obtained the mean and peak velocity and power shown by the athletes. Maximum power (P-max) was recorded as the highest P-mean obtained across the complete force-velocity curve. Our findings indicate a significantly higher absolute load linked to P-max (similar to 3%) and maximal strength (1RM) (similar to 6%) in G1 attributable to the climb to altitude (P<0.05). We also observed a stimulating effect of natural hypoxia on Pmean and P-peak in the middle-high part of the curve (>= 60 kg; P<0.01) and a 7.8% mean increase in barbell displacement velocity (P<0.001). No changes in any of the variables examined were observed in G2. According to these data, we can state that acute exposure to natural moderate altitude as opposed to simulated normobaric hypoxia leads to gains in 1RM, movement velocity and power during the execution of a force-velocity curve in bench press.	[Feriche, Belen; Garcia-Ramos, Amador; Bonitch-Gongora, Juan G.; Padial, Paulino] Univ Granada, Dept Phys Educ & Sport, Granada, Spain; [Calderon-Soto, Carmen] High Sport Council, High Performance Ctr Sierra Nevada, Granada, Spain; [Drobnic, Franchek; Galilea, Pedro A.; Riera, Joan] High Sport Council, Ctr Alt Rendiment, Dept Sport Physiol, Grp Invest Rendiment & Salut Esportista Alt Nivel, Barcelona, Spain	University of Granada	Feriche, B (corresponding author), Univ Granada, Dept Phys Educ & Sport, Granada, Spain.	mbelen@ugr.es	Bonitch-Góngora, Juan/AAG-5406-2020; Feriche, Belén/K-2783-2012; Ramos, Amador Garcia/S-6982-2016; Bonitch-Góngora, Juan/P-8233-2019	Feriche, Belén/0000-0002-3933-6041; Ramos, Amador Garcia/0000-0003-0608-8755; Bonitch-Góngora, Juan/0000-0003-0083-0138; Galilea, Pedro/0000-0002-4163-3125; Padial, Paulino/0000-0002-0847-7378	Ministry of education, culture and Sport of Spain [14/UPB10/07]	Ministry of education, culture and Sport of Spain	This study has been supported by a Grant from the Ministry of education, culture and Sport of Spain, Reference 14/UPB10/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; [Anonymous], 2014, THE J; [Anonymous], 2006, ARCH MED DEPORT; Billaut F, 2012, SPORTS MED, V42, P751, DOI 10.2165/11634050-000000000-00000; Bonetti DL, 2009, SPORTS MED, V39, P107, DOI 10.2165/00007256-200939020-00002; Chawla S, 2014, RESONANCE, V19, P538, DOI 10.1007/s12045-014-0057-3; Cronin JB, 2003, J STRENGTH COND RES, V17, P148; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; ELLIOTT BC, 1989, MED SCI SPORT EXER, V21, P450; FERRETTI G, 1990, INT J SPORTS MED, V11, pS31, DOI 10.1055/s-2007-1024851; Fiori G, 2000, AM J PHYS ANTHROPOL, V113, P47, DOI 10.1002/1096-8644(200009)113:1<47::AID-AJPA5>3.0.CO;2-K; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Hahn AG, 2001, SPORTS MED, V31, P533, DOI 10.2165/00007256-200131070-00008; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kon M, 2012, J STRENGTH COND RES, V26, P611, DOI 10.1519/JSC.0b013e3182281c69; Levine BD, 2008, SCAND J MED SCI SPOR, V18, P76, DOI 10.1111/j.1600-0838.2008.00835.x; MERCADE JJ, 2006, PROCEEDINGS OF THE 1, P148; MERCADE JJ, 2013, PROCEEDINGS OF THE 1, P817; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; NARICI MV, 1995, EUR J APPL PHYSIOL O, V70, P213, DOI 10.1007/BF00238566; Newton RU, 1996, J APPL BIOMECH, V12, P31, DOI 10.1123/jab.12.1.31; Newton RU, 1997, EUR J APPL PHYSIOL O, V75, P333, DOI 10.1007/s004210050169; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; PERONNET F, 1991, J APPL PHYSIOL, V70, P399, DOI 10.1152/jappl.1991.70.1.399; Raguso CA, 2004, CURR OPIN CLIN NUTR, V7, P411, DOI 10.1097/01.mco.0000134372.78438.09; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Scott BR, 2015, J STRENGTH COND RES, V29, P807, DOI 10.1519/JSC.0000000000000680; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9	31	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114072	10.1371/journal.pone.0114072	http://dx.doi.org/10.1371/journal.pone.0114072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474104	Green Published, gold			2022-12-26	WOS:000346382500110
J	Urriola-Munoz, P; Lagos-Cabre, R; Moreno, RD				Urriola-Munoz, Paulina; Lagos-Cabre, Raul; Moreno, Ricardo D.			A Mechanism of Male Germ Cell Apoptosis Induced by Bisphenol-A and Nonylphenol Involving ADAM17 and p38 MAPK Activation	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; PUBERTAL RAT TESTES; TNF-ALPHA; BINDING AFFINITIES; DIRECT EXPOSURE; POTENTIAL ROLE; SERTOLI-CELLS; P-NONYLPHENOL; SEMEN QUALITY; UP-REGULATION	Germ cell apoptosis regulation is pivotal in order to maintain proper daily sperm production. Several reports have shown that endocrine disruptors such as Bisphenol-A (BPA) and Nonylphenol (NP) induce germ cell apoptosis along with a decrease in sperm production. Given their ubiquitous distribution in plastic products used by humans it is important to clarify their mechanism of action. TACE/ADAM17 is a widely distributed extracellular metalloprotease and participates in the physiological apoptosis of germ cells during spermatogenesis. The aims of this work were: 1) to determine whether BPA and NP induce ADAM17 activation; and 2) to study whether ADAM17 and/or ADAM10 are involved in germ cell apoptosis induced by BPA and NP in the pubertal rat testis. A single dose of BPA or NP (50 mg/kg) induces germ cell apoptosis in 21-day-old male rats, which was prevented by a pharmacological inhibitor of ADAM17, but not by an inhibitor of ADAM10. In vitro, we showed that BPA and NP, at similar concentrations to those found in human samples, induce the shedding of exogenous and endogenous (TNF-alpha) ADAM17 substrates in primary rat Sertoli cell cultures and TM4 cell line. In addition, pharmacological inhibitors of metalloproteases and genetic silencing of ADAM17 prevent the shedding induced in vitro by BPA and NP. Finally, we showed that in vivo BPA and NP induced early activation (phosphorylation) of p38 MAPK and translocation of ADAM17 to the cell surface. Interestingly, the inhibition of p38 MAPK prevents germ cell apoptosis and translocation of ADAM17 to the cell surface. These results show for the first time that xenoestrogens can induce activation of ADAM17 at concentrations similar to those found in human samples, suggesting a mechanism by which they could imbalance para/juxtacrine cell-to-cell-communication and induce germ cell apoptosis.	[Urriola-Munoz, Paulina; Lagos-Cabre, Raul; Moreno, Ricardo D.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Moreno, RD (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Alameda 340, Santiago, Chile.	rmoreno@bio.puc.cl	Moreno, Ricardo R/C-6802-2011	Moreno, Ricardo/0000-0002-7499-5501; Urriola-Munoz, Paulina/0000-0002-2492-2240	Chilean research council (FONDECYT) [1110778]; CONICYT	Chilean research council (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by a grant from the Chilean research council (FONDECYT) Grant number 1110778 to RDM (http://www.conicyt.cl/fondecyt/). RLC and PUM are PhD fellows from CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Braun JM, 2011, CURR OPIN PEDIATR, V23, P233, DOI 10.1097/MOP.0b013e3283445675; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Choi MS, 2014, J APPL TOXICOL, V34, P628, DOI 10.1002/jat.2886; Christova Y, 2013, EMBO REP, V14, P884, DOI 10.1038/embor.2013.128; Codelia VA, 2008, MOL REPROD DEV, V75, P881, DOI 10.1002/mrd.20822; Daidoji T, 2003, DRUG METAB DISPOS, V31, P993, DOI 10.1124/dmd.31.8.993; de Jager C, 1999, ANDROLOGIA, V31, P107, DOI 10.1046/j.1439-0272.1999.00246.x; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Feng HL, 1999, FERTIL STERIL, V71, P85, DOI 10.1016/S0015-0282(98)00401-4; Gong Y, 2006, REPROD TOXICOL, V22, P623, DOI 10.1016/j.reprotox.2006.04.019; Gong Y, 2009, TOXICOL LETT, V186, P84, DOI 10.1016/j.toxlet.2009.01.010; Gong Y, 2008, TOXICOL LETT, V183, P10, DOI 10.1016/j.toxlet.2008.08.011; Grady R, 2012, CURR UROL REP, V13, P307, DOI 10.1007/s11934-012-0261-1; Hall KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031600; Han SW, 2009, J TOXICOL ENV HEAL A, V72, P1463, DOI 10.1080/15287390903212972; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012; Inoue K, 2002, J CHROMATOGR B, V773, P97, DOI 10.1016/S1570-0232(02)00101-0; Jenkins LK, 2007, REPROD FERT DEVELOP, V19, P461, DOI 10.1071/RD06079; Ji GX, 2009, HUM REPROD, V24, P2439, DOI 10.1093/humrep/dep223; Jin PP, 2013, J BIOMED RES, V27, P135, DOI 10.7555/JBR.27.20120076; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Lee J, 2010, N-S ARCH PHARMACOL, V382, P51, DOI 10.1007/s00210-010-0527-4; Li YJ, 2009, TOXICOL SCI, V108, P427, DOI 10.1093/toxsci/kfp024; Liu C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.203; Lizama C, 2012, J CELL PHYSIOL, V227, P829, DOI 10.1002/jcp.22795; Lizama C, 2011, BBA-MOL CELL RES, V1813, P120, DOI 10.1016/j.bbamcr.2010.08.003; Lizama C, 2010, REPRODUCTION, V140, P305, DOI 10.1530/REP-10-0104; Lizama C, 2009, J CELL PHYSIOL, V221, P296, DOI 10.1002/jcp.21868; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; McClusky LM, 2007, TOXICOL SCI, V95, P249, DOI 10.1093/toxsci/kfl141; Moreno RD, 2006, CELL TISSUE RES, V325, P533, DOI 10.1007/s00441-006-0186-4; Nakamura D, 2010, TOXICOL LETT, V194, P16, DOI 10.1016/j.toxlet.2010.02.002; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Nassar N, 2007, ARCH DIS CHILD, V92, P580, DOI 10.1136/adc.2006.112862; Nelson CP, 2005, J UROLOGY, V174, P1573, DOI 10.1097/01.ju.0000179249.21944.7e; Obama T, 2014, AM J HYPERTENS; Ortiz RJ, 2009, MOL HUM REPROD, V15, P363, DOI 10.1093/molehr/gap024; Peiretti F, 2003, EXP CELL RES, V285, P278, DOI 10.1016/S0014-4827(03)00052-1; Phillips KP, 2008, J TOXICOL ENV HEAL B, V11, P188, DOI 10.1080/10937400701873472; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Qian WY, 2014, TOXICOLOGY, V324, P27, DOI 10.1016/j.tox.2014.06.001; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Salian S, 2009, TOXICOLOGY, V265, P56, DOI 10.1016/j.tox.2009.09.012; Satoh K, 2001, J HEALTH SCI, V47, P495, DOI 10.1248/jhs.47.495; Schlondorff J, 1999, J CELL SCI, V112, P3603; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Urriola-Munoz P, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-31; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wang C, 2014, ENV TOXICOL; Weikert S, 2004, INT J ANDROL, V27, P161, DOI 10.1111/j.1365-2605.2004.00467.x; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Yan Y, 2009, CELL BIOL INT, V33, P158, DOI 10.1016/j.cellbi.2008.10.008; Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200; Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122; Zhang YH, 2009, J PEDIATR-US, V155, P500, DOI 10.1016/j.jpeds.2009.04.007	68	54	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e113793	10.1371/journal.pone.0113793	http://dx.doi.org/10.1371/journal.pone.0113793			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474107	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500092
J	Zhao, TT; Compton, SG; Yang, YJ; Wang, R; Chen, Y				Zhao, Ting-Ting; Compton, Stephen G.; Yang, Yong-Jiang; Wang, Rong; Chen, Yan			Phenological Adaptations in Ficus tikoua Exhibit Convergence with Unrelated Extra-Tropical Fig Trees	PLOS ONE			English	Article							FLOWERING PHENOLOGY; HOST SANCTIONS; POLLINATION; CONSEQUENCES; MUTUALISM; WASPS; EVOLUTION; PATTERNS; DIVERSITY; SELECTION	Flowering phenology is central to the ecology and evolution of most flowering plants. In highly-specific nursery pollination systems, such as that involving fig trees (Ficus species) and fig wasps (Agaonidae), any mismatch in timing has serious consequences because the plants must balance seed production with maintenance of their pollinator populations. Most fig trees are found in tropical or subtropical habitats, but the dioecious Chinese Ficus tikoua has a more northerly distribution. We monitored how its fruiting phenology has adapted in response to a highly seasonal environment. Male trees (where fig wasps reproduce) had one to three crops annually, whereas many seed-producing female trees produced only one fig crop. The timing of release of Ceratosolen fig wasps from male figs in late May and June was synchronized with the presence of receptive figs on female trees, at a time when there were few receptive figs on male trees, thereby ensuring seed set while allowing remnant pollinator populations to persist. F. tikoua phenology has converged with those of other (unrelated) northern Ficus species, but there are differences. Unlike F. carica in Europe, all F. tikoua male figs contain male flowers, and unlike F. pumila in China, but like F. carica, it is the second annual generation of adult wasps that pollinate female figs. The phenologies of all three temperate fig trees generate annual bottlenecks in the size of pollinator populations and for female F. tikoua also a shortage of fig wasps that results in many figs failing to be pollinated.	[Zhao, Ting-Ting; Yang, Yong-Jiang; Chen, Yan] Mianyang Normal Univ, Coll Life Sci & Biotechnol, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang 621000, Sichuan, Peoples R China; [Compton, Stephen G.; Wang, Rong] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Mianyang Teachers' College; University of Leeds; Rhodes University	Chen, Y (corresponding author), Mianyang Normal Univ, Coll Life Sci & Biotechnol, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang 621000, Sichuan, Peoples R China.	goose_01@163.com		Compton, Stephen/0000-0002-1247-8058	Natural Science Foundation of China [31270387]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (31270387) to YC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; Aizen MA, 2003, ECOLOGY, V84, P2613, DOI 10.1890/02-0521; Armbruster WS, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu003; Bain A, 2014, ACTA OECOL, V57, P124, DOI 10.1016/j.actao.2013.10.004; Berg C.C., 2005, FLORA MALESIANA 1; BRONSTEIN JL, 1988, ECOLOGY, V69, P207, DOI 10.2307/1943176; BRONSTEIN JL, 1990, ECOLOGY, V71, P2145, DOI 10.2307/1938628; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chang X-S, 1998, FLORA REIPUBLICAE PO; Chen Y, 2012, MOL ECOL, V21, P1687, DOI 10.1111/j.1365-294X.2012.05491.x; Chen Y, 2011, BIOCHEM SYST ECOL, V39, P441, DOI 10.1016/j.bse.2011.06.006; COMPTON SG, 1994, BIOTROPICA, V26, P180, DOI 10.2307/2388807; Compton SG, 2010, BIOL LETTERS, V6, P838, DOI 10.1098/rsbl.2010.0389; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; GALIL J, 1968, NEW PHYTOL, V67, P745, DOI 10.1111/j.1469-8137.1968.tb05497.x; GRAFEN A, 1991, P ROY SOC B-BIOL SCI, V245, P73, DOI 10.1098/rspb.1991.0090; Greeff JM, 2002, OIKOS, V96, P386, DOI 10.1034/j.1600-0706.2002.960221.x; Harrison RD, 2003, OIKOS, V100, P628, DOI 10.1034/j.1600-0706.2003.11829.x; Hauser TP, 2000, HEREDITAS, V132, P95, DOI 10.1111/j.1601-5223.2000.00095.x; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Jander KC, 2012, ECOL LETT, V15, P1362, DOI 10.1111/j.1461-0248.2012.01857.x; Jander KC, 2010, P ROY SOC B-BIOL SCI, V277, P1481, DOI 10.1098/rspb.2009.2157; Jousselin E, 2001, ECOL LETT, V4, P151, DOI 10.1046/j.1461-0248.2001.00209.x; Kang H, 2004, J PLANT BIOL, V47, P348, DOI 10.1007/BF03030550; KJELLBERG F, 1987, EVOLUTION, V41, P693, DOI 10.1111/j.1558-5646.1987.tb05846.x; KJELLBERG F, 1988, P K NED AKAD C BIOL, V91, P117; KJELLBERG F, 1989, EXPERIENTIA, V45, P653, DOI 10.1007/BF01975682; Kjellberg F, 2001, P ROY SOC B-BIOL SCI, V268, P1113, DOI 10.1098/rspb.2001.1633; KJELLBERG F, 1990, BIOL INVASIONS EUROP, P371; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097783; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Patel A, 1996, J ECOL, V84, P667, DOI 10.2307/2261330; Patel A, 1997, J TROP ECOL, V13, P681, DOI 10.1017/S0266467400010865; R Development Core Team, 2012, R LANG ENV STAT COMP; Raja S, 2008, SYMBIOSIS, V45, P25; Rathcke B., 1983, P305; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Ronsted N, 2008, SYMBIOSIS, V45, P45; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Smith CM, 1996, J BIOGEOGR, V23, P477, DOI 10.1111/j.1365-2699.1996.tb00009.x; Suleman N, 2011, PLANT SYST EVOL, V296, P245, DOI 10.1007/s00606-011-0491-6; Tarachai Y, 2008, SYMBIOSIS, V45, P29; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Tzeng HY, 2006, BOT STUD, V47, P307; VALDEYRON G, 1979, EVOLUTION, V33, P673, DOI 10.1111/j.1558-5646.1979.tb04720.x; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; Whipple AV, 2009, J EVOLUTION BIOL, V22, P793, DOI 10.1111/j.1420-9101.2009.01690.x; Zhao R, 2010, THESIS E CHINA NORMA	55	10	11	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114344	10.1371/journal.pone.0114344	http://dx.doi.org/10.1371/journal.pone.0114344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474008	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500022
J	Chen, Z; Li, MT; Xu, D; Yang, H; Li, J; Zhao, JL; Zhang, HH; Han, SM; Xu, T; Zeng, XF				Chen, Zhen; Li, Meng-Tao; Xu, Dong; Yang, Hong; Li, Jing; Zhao, Jiu-Liang; Zhang, Heng-Hui; Han, Shao-Mei; Xu, Tao; Zeng, Xiao-Feng			Protein-Losing Enteropathy in Systemic Lupus Erythematosus: 12 Years Experience from a Chinese Academic Center	PLOS ONE			English	Article							CLASSIFICATION CRITERIA; GASTROENTEROPATHY; DIAGNOSIS; DIARRHEA; DISEASE; PATIENT; EDEMA	Objective: Protein-losing enteropathy (PLE) is a complication in some systemic lupus erythematosus (SLE) patients that is often misdiagnosed. With this study, we provide insight into clinical characteristics, laboratory characteristics, diagnostic tests, risk factors, treatment, and prognosis of the disease. Methods: A retrospective, case-control study was performed in 44 patients with SLE-related PLE (PLE group) and 88 patients with active SLE (control group) admitted to our care from January 2000-January 2012. Risk factors for SLE-related PLE were examined, and we analyzed the accuracy of single and combined laboratory characteristics in discriminating SLE-related PLE from active SLE. Serum albumin and C3 levels were measured as outcome during and after treatment with corticosteroids and immunosuppressive agents. Results: The PLE group had lower mean serum albumin and 24-hour urine protein levels, higher mean total plasma cholesterol levels, and greater frequencies of anti-SSA and SSB seropositivity compared with the control group. Anti-SSA seropositivity, hypoalbuminemia, and hypercholesterolemia were independent risk factors for SLE-related PLE. The simultaneous presence of serum albumin (<22 g/l) and 24-hour urine protein (<0.8 g/24 h) had high specificity, positive predictive value, negative predictive value, and positive likelihood ratio, a low negative likelihood ratio and no significant reduction in sensitivity. High dosage of glucocorticosteroid combined with cyclophosphomide were mostly prescribed for SLE-related PLE. Conclusion: SLE-related PLE should be considered when an SLE patient presents with generalized edema, anti-SSA antibody seropositivity, hypercholesterolemia, severe hypoalbuminemia, and low 24-hour urine protein levels. Aggressive treatment for lupus might improve prognosis.	[Chen, Zhen; Li, Meng-Tao; Xu, Dong; Li, Jing; Zhao, Jiu-Liang; Zeng, Xiao-Feng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Chen, Zhen; Li, Meng-Tao; Xu, Dong; Yang, Hong; Li, Jing; Zhao, Jiu-Liang; Han, Shao-Mei; Xu, Tao; Zeng, Xiao-Feng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Zhen; Li, Meng-Tao; Xu, Dong; Li, Jing; Zhao, Jiu-Liang; Zeng, Xiao-Feng] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China; [Yang, Hong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing 100730, Peoples R China; [Zhang, Heng-Hui] Peking Univ, Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China; [Han, Shao-Mei; Xu, Tao] Chinese Acad Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	zengxfpumc@gmail.com	Jiuliang, Zhao/AAW-5669-2020; meng, li/GVT-2063-2022	Jiuliang, Zhao/0000-0001-9308-2858; 	Chinese National Key Technology RD Program; Ministry of Science and Technology [2008BAI59B02, 2012AA02A513]; Chinese National High Technology Research and Development Program; Research Special Fund for Public Welfare Industry of Health, Ministry of Health [201202004]; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' Ministry of Science and Technology [2012ZX09303006-002]	Chinese National Key Technology RD Program(National Key Technology R&D Program); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); Research Special Fund for Public Welfare Industry of Health, Ministry of Health; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' Ministry of Science and Technology	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02), the Chinese National High Technology Research and Development Program, the Ministry of Science and Technology (2012AA02A513), the Research Special Fund for Public Welfare Industry of Health, Ministry of Health (201202004), and the National Major Scientific and Technological Special Project for "Significant New Drugs Development'' Ministry of Science and Technology (2012ZX09303006-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mogairen SM, 2011, RHEUMATOL INT, V31, P995, DOI 10.1007/s00296-011-1827-9; Aoki T, 2002, J GASTROENTEROL, V37, P204, DOI 10.1007/s005350200022; Awazawa R, 2012, J DERMATOL, V39, P454, DOI 10.1111/j.1346-8138.2011.01404.x; Carneiro FOAA, 2012, LUPUS, V21, P445, DOI 10.1177/0961203311425523; Chang JM, 2002, CLIN NEPHROL, V57, P392; Chau TN, 2011, DIGESTION, V84, P199, DOI 10.1159/000327914; Chiu NT, 2001, RADIOLOGY, V219, P86, DOI 10.1148/radiology.219.1.r01ap2986; de Castro GRW, 2005, RHEUMATOL INT, V25, P135, DOI 10.1007/s00296-004-0483-8; Gattorno M, 2002, EUR J PEDIATR, V161, P84, DOI 10.1007/s00431-001-0868-6; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gornisiewicz M, 2001, LUPUS, V10, P835, DOI 10.1191/096120301701548472; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hung J, 2006, NEPHROL DIAL TRANSPL, V21, P2027, DOI 10.1093/ndt/gfl043; Khalesi M, 2013, ACTA GASTRO-ENT BELG, V76, P413; Kim YG, 2008, LUPUS, V17, P575, DOI 10.1177/0961203307087407; Law ST, 2012, LUPUS, V21, P840, DOI 10.1177/0961203312438113; Lee CK, 2002, J RHEUMATOL, V29, P1330; Mok CC, 2006, RHEUMATOLOGY, V45, P425, DOI 10.1093/rheumatology/kei164; Oh DCT, 2006, LUPUS, V15, P102, DOI 10.1191/0961203306lu2251cr; Ossandon A, 2002, LUPUS, V11, P465, DOI 10.1191/0961203302lu233xx; Park JM, 2004, YONSEI MED J, V45, P923, DOI 10.3349/ymj.2004.45.5.923; Parodi A, 2009, ARTHRITIS RHEUM-US, V60, P3388, DOI 10.1002/art.24883; Peng SL, 2009, KELLEYS TXB RHEUMATO, P748; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Rajendiran A, 2012, INTERNAL MED, V51, P3131, DOI 10.2169/internalmedicine.51.8518; Ratnayake Eranda C, 2012, Int Arch Med, V5, P1, DOI 10.1186/1755-7682-5-1; Takenaka H, 2012, J CLIN GASTROENTEROL, V46, P575, DOI 10.1097/MCG.0b013e31823832ac; Tian XP, 2010, WORLD J GASTROENTERO, V16, P2971, DOI 10.3748/wjg.v16.i24.2971; Tsao YT, 2010, AM J EMERG MED, V28; Turkcapar Nuran, 2006, Turk J Gastroenterol, V17, P226; Umar SB, 2010, AM J GASTROENTEROL, V105, P43, DOI 10.1038/ajg.2009.561; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wang YF, 2008, CLIN RHEUMATOL, V27, P1325, DOI 10.1007/s10067-008-0929-6; Wu CC, 2004, NEPHROL DIAL TRANSPL, V19, P2149, DOI 10.1093/ndt/gfh226; Xu D, 2010, LUPUS, V19, P866, DOI 10.1177/0961203310365883; Yazici Y, 2002, LUPUS, V11, P119, DOI 10.1191/0961203302lu152cr; Zheng WJ, 2007, JCR-J CLIN RHEUMATOL, V13, P313, DOI 10.1097/RHU.0b013e31815bf9c6	37	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114684	10.1371/journal.pone.0114684	http://dx.doi.org/10.1371/journal.pone.0114684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490025	Green Submitted, Green Published, gold			2022-12-26	WOS:000347515300065
J	Dong, BL; Li, DS; Li, RY; Chen, SCA; Liu, WH; Liu, W; Chen, LQ; Chen, Y; Zhang, X; Tong, ZS; Xia, Y; Xia, P; Wang, Y; Duan, YQ				Dong, Bilin; Li, Dongsheng; Li, Ruoyu; Chen, Sharon C. -A.; Liu, Weihuang; Liu, Wei; Chen, Liuqing; Chen, Yao; Zhang, Xu; Tong, Zhongsheng; Xia, Yun; Xia, Ping; Wang, Yan; Duan, Yiqun			A Chitin-Like Component on Sclerotic Cells of Fonsecaea pedrosoi Inhibits Dectin-1-Mediated Murine Th17 Development by Masking beta-Glucans	PLOS ONE			English	Article							HOST-DEFENSE; CHROMOBLASTOMYCOSIS; RECEPTOR; INFECTION; IMMUNITY; FORMS; RECOGNITION; CYTOKINES; AGENT; FUNGI	Fonsecaea pedrosoi (F. pedrosoi), a major agent of chromoblastomycosis, has been shown to be recognized primarily by C-type lectin receptors (CLRs) in a murine model of chromoblastomycosis. Specifically, the beta-glucan receptor, Dectin-1, mediates Th17 development and consequent recruitment of neutrophils, and is evidenced to have the capacity to bind to saprophytic hyphae of F. pedrosoi in vitro. However, when embedded in tissue, most etiological agents of chromoblastomycosis including F. pedrosoi will transform into the sclerotic cells, which are linked to the greatest survival of melanized fungi in tissue. In this study, using immunocompetent and athymic (nu/nu) murine models infected subcutaneously or intraperitoneally with F. pedrosoi, we demonstrated that T lymphocytes play an active role in the resolution of localized footpad infection, and there existed a significantly decreased expression of Th17-defining transcription factor Ror gamma t and inefficient recruitment of neutrophils in chronically infected spleen where the inoculated mycelium of F. pedrosoi transformed into the sclerotic cells. We also found that Dectin-1-expressing histocytes and neutrophils participated in the enclosure of transformed sclerotic cells in the infectious foci. Furthermore, we induced the formation of sclerotic cells in vitro, and evidenced a significantly decreased binding capacity of human or murine-derived Dectin-1 to the induced sclerotic cells in comparison with the saprophytic mycelial forms. Our analysis of beta-glucans-masking components revealed that it is a chitin-like component, but not the mannose moiety on the sclerotic cells, that interferes with the binding of beta-glucans by human or murine Dectin-1. Notably, we demonstrated that although Dectin-1 contributed to the development of IL-17A-producing CD3+CD4+ murine splenocytes upon in vitro-stimulation by saprophytic F. pedrosoi, the masking effect of chitin components partly inhibited Dectin-1-mediated Th17 development upon in vitro-stimulation by induced sclerotic cells. Therefore, these findings extend our understanding of the chronicity of chromoblastomycosis.	[Dong, Bilin; Li, Dongsheng; Chen, Liuqing; Chen, Yao; Zhang, Xu; Tong, Zhongsheng; Xia, Yun; Xia, Ping; Duan, Yiqun] 1 Hosp Wuhan, Ctr Infect Skin Dis, Dept Dermatol, Wuhan, Peoples R China; [Li, Ruoyu] Peking Univ, Res Ctr Med Mycol, Beijing 100871, Peoples R China; [Chen, Sharon C. -A.] Univ Sydney, Westmead Hosp, ICPMR Pathol W, Ctr Infect Dis & Microbiol,Lab Serv, Westmead, NSW 2145, Australia; [Liu, Weihuang] Wuhan Univ, Med Res Ctr, Wuhan 430072, Peoples R China; [Liu, Wei; Wang, Yan] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	Peking University; University of Sydney; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Tong, ZS (corresponding author), 1 Hosp Wuhan, Ctr Infect Skin Dis, Dept Dermatol, Wuhan, Peoples R China.	zhongshengtong1970@126.com; augustusdong@126.com			National Natural Science Foundation of China [81301376]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by grants from National Natural Science Foundation of China (NO: 81301376, BD), http://isisn.nsfc.gov.cn/egrantweb/contract/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO L, 1986, European Journal of Epidemiology, V2, P243, DOI 10.1007/BF00419488; Alviano DS, 2003, RES MICROBIOL, V154, P689, DOI 10.1016/j.resmic.2003.09.002; Ameen M, 2009, CLIN EXP DERMATOL, V34, P849, DOI 10.1111/j.1365-2230.2009.03415.x; Bonifaz A, 2001, MYCOSES, V44, P1, DOI 10.1046/j.1439-0507.2001.00613.x; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BUTTERFIELD W, 1976, MYCOPATHOLOGIA, V58, P59, DOI 10.1007/BF00493594; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; De Hoog GS, 2000, MED MYCOL, V38, P243, DOI 10.1080/mmy.38.s1.243.250; Gartner BN, 2005, EMBO J, V24, P1277; Gimenes VMF, 2005, MICROBES INFECT, V7, P708, DOI 10.1016/j.micinf.2005.01.006; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Jamil A, 2012, MED MYCOL, V50, P99, DOI 10.3109/13693786.2011.571295; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Laan M, 1999, J IMMUNOL, V162, P2347; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050589; Li DS, 2012, AM J DERMATOPATH, V34, P813, DOI 10.1097/DAD.0b013e318252f956; Machado AP, 2011, MYCOSES, V54, P202, DOI 10.1111/j.1439-0507.2009.01792.x; Martinez RL, 2007, CLIN DERMATOL, V25, P188, DOI 10.1016/j.clindermatol.2006.05.007; Ogawa MM, 2003, INT J DERMATOL, V42, P622, DOI 10.1046/j.1365-4362.2003.01814.x; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santos ALS, 2007, FEMS MICROBIOL REV, V31, P570, DOI 10.1111/j.1574-6976.2007.00077.x; SILVA M, 1957, MYCOLOGIA, V49, P318, DOI 10.2307/3755682; Teixeira de Sousa Mda G, 2006, SCAND J IMMUNOL, V64, P595; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Wang H, 2013, CELL BIOCHEM BIOPHYS, V67, P599, DOI 10.1007/s12013-013-9547-2; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wozniak KL, 2006, INFECT IMMUN, V74, P3817, DOI 10.1128/IAI.00317-06	34	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114113	10.1371/journal.pone.0114113	http://dx.doi.org/10.1371/journal.pone.0114113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490199	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300017
J	Howe, SE; Konjufca, VH				Howe, Savannah E.; Konjufca, Vjollca H.			Protein-Coated Nanoparticles Are Internalized by the Epithelial Cells of the Female Reproductive Tract and Induce Systemic and Mucosal Immune Responses	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; GENITAL-TRACT; VACCINE DEVELOPMENT; ANTIBODY-RESPONSES; INTRAVAGINAL IMMUNIZATION; 1-INFECTED INDIVIDUALS; VAGINAL IMMUNIZATION; VIRUS; INFECTION; WOMEN	The female reproductive tract (FRT) includes the oviducts (fallopian tubes), uterus, cervix and vagina. A layer of columnar epithelium separates the endocervix and uterus from the outside environment, while the vagina is lined with stratified squamous epithelium. The mucosa of the FRT is exposed to antigens originating from microflora, and occasionally from infectious microorganisms. Whether epithelial cells (ECs) of the FRT take up (sample) the lumen antigens is not known. To address this question, we examined the uptake of 20-40 nm nanoparticles (NPs) applied vaginally to mice which were not treated with hormones, epithelial disruptors, or adjuvants. We found that 20 and 40 nm NPs are quickly internalized by ECs of the upper FRT and within one hour could be observed in the lymphatic ducts that drain the FRT, as well as in the ileac lymph nodes (ILNs) and the mesenteric lymph nodes (MLNs). Chicken ovalbumin (Ova) conjugated to 20 nm NPs (NP-Ova) when administered vaginally reaches the internal milieu in an immunologically relevant form; thus vaginal immunization of mice with NP-Ova induces systemic IgG to Ova antigen. Most importantly, vaginal immunization primes the intestinal mucosa for secretion of sIgA. Sub-cutaneous (s.c) boosting immunization with Ova in complete Freund's adjuvant (CFA) further elevates the systemic (IgG1 and IgG2c) as well as mucosal (IgG1 and sIgA) antibody titers. These findings suggest that the modes of antigen uptake at mucosal surfaces and pathways of antigen transport are more complex than previously appreciated.	[Howe, Savannah E.; Konjufca, Vjollca H.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Konjufca, VH (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	vjollca@micro.siu.edu		Konjufca, Vjollca/0000-0002-7736-5097	Southern Illinois University	Southern Illinois University	This work was supported by the start up funds provided to Vjollca Konjufca by Southern Illinois University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Ballou B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051995; Bienenstock J, 1978, Adv Exp Med Biol, V107, P53; Chachu KA, 2008, J VIROL, V82, P6610, DOI 10.1128/JVI.00141-08; Cu Y, 2011, J CONTROL RELEASE, V156, P258, DOI 10.1016/j.jconrel.2011.06.036; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; CUFF CF, 1990, J VIROL, V64, P1256, DOI 10.1128/JVI.64.3.1256-1263.1990; Dorrell L, 2000, AIDS, V14, P1117, DOI 10.1097/00002030-200006160-00008; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gebert A, 1996, INT REV CYTOL, V167, P91, DOI 10.1016/S0074-7696(08)61346-7; Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003; Howe SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086656; Hunter Z, 2011, VACCINE, V29, P4584, DOI 10.1016/j.vaccine.2011.04.051; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Lewis DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025165; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Marks E, 2011, EUR J IMMUNOL, V41, P2642, DOI 10.1002/eji.201041297; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Mestecky J, 2005, AM J REPROD IMMUNOL, V53, P208, DOI 10.1111/j.1600-0897.2005.00267.x; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Mestecky J, 2009, J REPROD IMMUNOL, V83, P196, DOI 10.1016/j.jri.2009.07.005; Nag P, 2004, J INFECT DIS, V190, P1970, DOI 10.1086/425582; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; OWENS RB, 1974, J NATL CANCER I, V52, P1375, DOI 10.1093/jnci/52.4.1375; Raux M, 1999, AIDS RES HUM RETROV, V15, P1365, DOI 10.1089/088922299310070; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Russell MW, 2002, MICROBES INFECT, V4, P667, DOI 10.1016/S1286-4579(02)01585-X; Schafer F, 2002, GUT, V50, P608, DOI 10.1136/gut.50.5.608; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schleiss MR, 2000, VIRAL IMMUNOL, V13, P155, DOI 10.1089/vim.2000.13.155; Skurnick JH, 2002, J INFECT DIS, V185, P428, DOI 10.1086/338830; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Wegmann F, 2011, HUM VACCINES, V7, P982, DOI 10.4161/hv.7.9.16505; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334; Youngman KR, 2002, J IMMUNOL, V168, P2173, DOI 10.4049/jimmunol.168.5.2173	45	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114601	10.1371/journal.pone.0114601	http://dx.doi.org/10.1371/journal.pone.0114601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490456	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300058
J	Jin, CN; Liu, M; Sun, JP; Fang, F; Wen, YN; Yu, CM; Lee, APW				Jin, Chun-Na; Liu, Ming; Sun, Jing-Ping; Fang, Fang; Wen, Yong-Na; Yu, Cheuk-Man; Lee, Alex Pui-Wai			The Prevalence and Prognosis of Resistant Hypertension in Patients with Heart Failure	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; SYSTOLIC BLOOD-PRESSURE; LEFT-VENTRICULAR HYPERTROPHY; LEVELS PREDICT SURVIVAL; UNITED-STATES; ATRIAL-FIBRILLATION; CLINICAL-FEATURES; HIGH-RISK; MORTALITY; OUTCOMES	Background: Resistant hypertension is associated with adverse clinical outcome in hypertensive patients. However, the prognostic significance of resistant hypertension in patients with heart failure remains uncertain. Methods and Results: The 1 year survival and heart failure re-hospitalization rate of 1288 consecutive patients admitted to a university hospital for either newly diagnosed heart failure or an exacerbation of prior chronic heart failure was analyzed. Resistant hypertension was defined as uncontrolled blood pressure (>140/90 mmHg) despite being compliant with an antihypertensive regimen that includes 3 or more drugs (including a diuretic). A total of 176 (13.7%) heart failure patients had resistant hypertension. There was no difference in all cause mortality, cardiovascular mortality, and heart failure related re-hospitalization between patients with versus without resistant hypertension. Diabetes [hazard ratio=1.62, 95% confidence interval=1.13-2.34; P=0.010] and serum sodium >139 mmol/L (hazard ratio=1.54, 95% confidence interval=1.06-2.23; P=0.024) were independently associated with resistant hypertension. Patients with resistant hypertension had a relatively higher survival rate (86.9% vs. 83.8%), although the difference was not significant (log-rank x(2)=1.00, P=0.317). In patients with reduced ejection fraction, heart failure related re-hospitalization was significantly lower in patients with resistant hypertension (45.8% vs. 59.1%, P=0.050). Conclusions: Resistant hypertension appears to be not associated with adverse clinical outcome in patients with heart failure, in fact may be a protective factor for reduced heart failure related re-hospitalization in patients with reduced ejection fraction.	[Jin, Chun-Na; Liu, Ming; Sun, Jing-Ping; Fang, Fang; Wen, Yong-Na; Yu, Cheuk-Man; Lee, Alex Pui-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,Div Cardiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Lee, APW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut,Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	alexpwlee@cuhk.edu.hk	Yu, Cheuk-man/P-3747-2015; Lee, Alex Pui-Wai/E-9217-2013; Fang, Fang/B-9912-2017	Lee, Alex Pui-Wai/0000-0002-4120-155X; Fang, Fang/0000-0002-4023-2928				Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Anand IS, 2007, J AM COLL CARDIOL, V49, P32, DOI 10.1016/j.jacc.2006.04.109; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Badheka AO, 2011, AM J CARDIOL, V108, P1283, DOI 10.1016/j.amjcard.2011.06.045; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bisognano JD, 2009, J CARD FAIL, V15, pS63, DOI 10.1016/j.cardfail.2009.06.191; Brophy JM, 2004, AM J MED, V116, P300, DOI 10.1016/j.amjmed.2003.09.035; Buiciuc O, 2011, J CARD FAIL, V17, P907, DOI 10.1016/j.cardfail.2011.08.002; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cygankiewicz I, 2009, AM J CARDIOL, V103, P1003, DOI 10.1016/j.amjcard.2008.11.061; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019; De Blois J, 2010, J CARD FAIL, V16, P225, DOI 10.1016/j.cardfail.2009.12.002; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Goldberg RJ, 2007, ARCH INTERN MED, V167, P490, DOI 10.1001/archinte.167.5.490; Grigorian-Shamagian L, 2008, J CARD FAIL, V14, P561, DOI 10.1016/j.cardfail.2008.03.006; Gupta AK, 2011, J HYPERTENS, V29, P2004, DOI 10.1097/HJH.0b013e32834a8a42; Harjola VP, 2010, EUR J HEART FAIL, V12, P239, DOI 10.1093/eurjhf/hfq002; Hawkins NM, 2007, HEART, V93, P59, DOI 10.1136/hrt.2005.083949; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Kwon BJ, 2010, EUR J HEART FAIL, V12, P1339, DOI 10.1093/eurjhf/hfq157; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee TT, 2006, AM HEART J, V151, P76, DOI 10.1016/j.ahj.2005.03.009; Linssen GCM, 2011, EUR J HEART FAIL, V13, P1111, DOI 10.1093/eurjhf/hfr066; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; McAdam-Marx C, 2009, CLIN THER, V31, P1116, DOI 10.1016/j.clinthera.2009.05.007; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; Nunez J, 2010, EUR J HEART FAIL, V12, P38, DOI 10.1093/eurjhf/hfp176; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Persson H, 2007, J AM COLL CARDIOL, V49, P687, DOI 10.1016/j.jacc.2006.08.062; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Pulignano G, 2002, AM HEART J, V143, P45, DOI 10.1067/mhj.2002.119608; Raphael CE, 2009, HEART, V95, P56, DOI 10.1136/hrt.2007.134973; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Writing Group M, 2012, CIRCULATION, V125, pe2	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114958	10.1371/journal.pone.0114958	http://dx.doi.org/10.1371/journal.pone.0114958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490405	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300098
J	Tolle, F; Wilke, J; Wengel, J; Mayer, G				Tolle, Fabian; Wilke, Julian; Wengel, Jesper; Mayer, Gunter			By-Product Formation in Repetitive PCR Amplification of DNA Libraries during SELEX	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; RNA; ARTIFACTS; SELECTION; APTAMERS; LIGANDS; BIAS; LNA	The selection of nucleic acid aptamers is an increasingly important approach to generate specific ligands binding to virtually any molecule of choice. However, selection-inherent amplification procedures are prone to artificial by-product formation that prohibits the enrichment of target-recognizing aptamers. Little is known about the formation of such by-products when employing nucleic acid libraries as templates. We report on the formation of two different forms of by-products, named ladder-and non-ladder-type observed during repetitive amplification in the course of in vitro selection experiments. Based on sequence information and the amplification behaviour of defined enriched nucleic acid molecules we suppose a molecular mechanism through which these amplification by-products are built. Better understanding of these mechanisms might help to find solutions minimizing by-product formation and improving the success rate of aptamer selection.	[Tolle, Fabian; Wilke, Julian; Mayer, Gunter] Univ Bonn, LIMES Inst, Bonn, Germany; [Wengel, Jesper] Univ Southern Denmark, Dept Phys Chem & Pharm, Nucle Acid Ctr, Odense M, Denmark	University of Bonn; University of Southern Denmark	Mayer, G (corresponding author), Univ Bonn, LIMES Inst, Bonn, Germany.	gmayer@uni-bonn.de		Tolle, Fabian/0000-0002-4221-0167; Wengel, Jesper/0000-0001-9835-1009	Deutsche Forschungsgemeinschaft (DFG) [Ma 3442/4.1]; European Research Concil under the European Union's Seventh Framework program (FP7)/ERC [268776]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Concil under the European Union's Seventh Framework program (FP7)/ERC	Funded by Deutsche Forschungsgemeinschaft to G.M. (DFG Ma 3442/4.1). J.W. acknowledge support from the European Research Concil under the European Union's Seventh Framework program (FP7/2007-2013)/ERC Grant agreement no. 268776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Avci-Adali M, 2010, MOLECULES, V15, P1, DOI 10.3390/molecules15010001; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Kalle E, 2013, J MICROBIOL METH, V95, P285, DOI 10.1016/j.mimet.2013.09.014; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Koshkin AA, 1998, TETRAHEDRON LETT, V39, P4381, DOI 10.1016/S0040-4039(98)00706-0; Marshall KA, 1999, J MOL EVOL, V49, P656, DOI 10.1007/PL00006586; Mayer G, 2008, RNA, V14, P524, DOI 10.1261/rna.821908; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Muller J, 2009, CHEM BIOL, V16, P442, DOI 10.1016/j.chembiol.2009.03.007; Musheev MU, 2006, ANAL CHIM ACTA, V564, P91, DOI 10.1016/j.aca.2005.09.069; Plaxco KW, 2011, TRENDS BIOTECHNOL, V29, P1, DOI 10.1016/j.tibtech.2010.10.005; Raddatz M. S., 2008, ANGEW CHEM, V120, P5268, DOI DOI 10.1002/ANGE.200800216; Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029; Shao KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024910; Svobodova M, 2012, ANAL BIOANAL CHEM, V404, P835, DOI 10.1007/s00216-012-6183-4; Tolle F, 2013, CHEM SCI, V4, P60, DOI 10.1039/c2sc21510a; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	22	54	56	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114693	10.1371/journal.pone.0114693	http://dx.doi.org/10.1371/journal.pone.0114693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490402	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300068
J	Xia, JY; Veselenak, RL; Gorder, SR; Bourne, N; Milligan, GN				Xia, Jingya; Veselenak, Ronald L.; Gorder, Summer R.; Bourne, Nigel; Milligan, Gregg N.			Virus-Specific Immune Memory at Peripheral Sites of Herpes Simplex Virus Type 2 (HSV-2) Infection in Guinea Pigs	PLOS ONE			English	Article							CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; ANTIBODY-SECRETING CELLS; FEMALE GENITAL-TRACT; SENSORY GANGLIA; B-CELLS; MICE; REACTIVATION; REINFECTION; RESPONSES	Despite its importance in modulating HSV-2 pathogenesis, the nature of tissue-resident immune memory to HSV-2 is not completely understood. We used genital HSV-2 infection of guinea pigs to assess the type and location of HSV-specific memory cells at peripheral sites of HSV-2 infection. HSV-specific antibody-secreting cells were readily detected in the spleen, bone marrow, vagina/cervix, lumbosacral sensory ganglia, and spinal cord of previously-infected animals. Memory B cells were detected primarily in the spleen and to a lesser extent in bone marrow but not in the genital tract or neural tissues suggesting that the HSV-specific antibody-secreting cells present at peripheral sites of HSV-2 infection represented persisting populations of plasma cells. The antibody produced by these cells isolated from neural tissues of infected animals was functionally relevant and included antibodies specific for HSV-2 glycoproteins and HSV-2 neutralizing antibodies. A vigorous IFN-gamma-secreting T cell response developed in the spleen as well as the sites of HSV-2 infection in the genital tract, lumbosacral ganglia and spinal cord following acute HSV-2 infection. Additionally, populations of HSV-specific tissue-resident memory T cells were maintained at these sites and were readily detected up to 150 days post HSV-2 infection. Unlike the persisting plasma cells, HSV-specific memory T cells were also detected in uterine tissue and cervicothoracic region of the spinal cord and at low levels in the cervicothoracic ganglia. Both HSV-specific CD4(+) and CD8(+) resident memory cell subsets were maintained long-term in the genital tract and sensory ganglia/spinal cord following HSV-2 infection. Together these data demonstrate the long-term maintenance of both humoral and cellular arms of the adaptive immune response at the sites of HSV-2 latency and virus shedding and highlight the utility of the guinea pig infection model to investigate tissue-resident memory in the setting of HSV-2 latency and spontaneous reactivation.	[Xia, Jingya; Veselenak, Ronald L.; Bourne, Nigel; Milligan, Gregg N.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gorder, Summer R.; Bourne, Nigel; Milligan, Gregg N.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Bourne, Nigel; Milligan, Gregg N.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Milligan, GN (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	gnmillig@utmb.edu			John Sealy Memorial Endowment Fund Research Pilot Grant; National Institutes of Health [AI105962]; Sealy Center for Vaccine Development Pre-doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105962] Funding Source: NIH RePORTER	John Sealy Memorial Endowment Fund Research Pilot Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development Pre-doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was funded by a John Sealy Memorial Endowment Fund Research Pilot Grant (GNM) and by grant AI105962 from the National Institutes of Health (NB). JX was supported by a Sealy Center for Vaccine Development Pre-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bourne N, 1999, ANTIVIR RES, V40, P139, DOI 10.1016/S0166-3542(98)00055-2; BROWN ZA, 1987, NEW ENGL J MED, V317, P1246, DOI 10.1056/NEJM198711123172002; COOK ML, 1973, INFECT IMMUN, V7, P272, DOI 10.1128/IAI.7.2.272-288.1973; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; ESIRI MM, 1980, CLIN EXP IMMUNOL, V40, P42; Held K, 2012, J NEUROVIROL, V18, P62, DOI 10.1007/s13365-011-0067-9; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; HULL HF, 1984, J PEDIATR-US, V104, P211, DOI 10.1016/S0022-3476(84)80994-4; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Johansson M, 2003, CURR OPIN INFECT DIS, V16, P43, DOI 10.1097/00001432-200302000-00008; Johnson AJ, 2008, J VIROL, V82, P9678, DOI 10.1128/JVI.01159-08; KLEIN RJ, 1980, J GEN VIROL, V49, P401, DOI 10.1099/0022-1317-49-2-401; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; KOELLE DM, 1994, J INFECT DIS, V169, P956, DOI 10.1093/infdis/169.5.956; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; KOELLE DM, 1994, J VIROL, V68, P2803, DOI 10.1128/JVI.68.5.2803-2810.1994; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Liu T, 1996, J VIROL, V70, P264, DOI 10.1128/JVI.70.1.264-271.1996; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; MCBRIDE BW, 1988, VACCINE, V6, P414, DOI 10.1016/0264-410X(88)90141-7; MCKENDALL RR, 1979, INFECT IMMUN, V23, P305, DOI 10.1128/IAI.23.2.305-311.1979; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Milligan GN, 2005, J VIROL, V79, P11537, DOI 10.1128/JVI.79.17.11537-11540.2005; MILLIGAN GN, 1995, VIROLOGY, V206, P234, DOI 10.1016/S0042-6822(95)80038-7; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Milligan GN, 1998, J IMMUNOL, V160, P6093; Ohashi M, 2011, J VIROL, V85, P3030, DOI 10.1128/JVI.02426-10; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Parr EL, 1998, J REPROD IMMUNOL, V38, P15, DOI 10.1016/S0165-0378(97)00081-8; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; Schafer H, 2007, J IMMUNOL METHODS, V328, P106, DOI 10.1016/j.jim.2007.08.012; Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; SIMMONS A, 1985, J VIROL, V53, P944, DOI 10.1128/JVI.53.3.944-948.1985; STANBERRY LR, 1986, J INFECT DIS, V153, P1055, DOI 10.1093/infdis/153.6.1055; Tang VA, 2010, J REPROD IMMUNOL, V87, P39, DOI 10.1016/j.jri.2010.06.155; Tschen SI, 2006, EUR J IMMUNOL, V36, P603, DOI 10.1002/eji.200535123; Tschen SI, 2002, J IMMUNOL, V168, P2922, DOI 10.4049/jimmunol.168.6.2922; Valencia Frances, 2013, Methods Mol Biol, V1030, P315, DOI 10.1007/978-1-62703-484-5_24; van Velzen M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003547; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Walsh PN, 2013, J IMMUNOL METHODS, V394, P84, DOI 10.1016/j.jim.2013.05.007; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2013, NATURE, V497, P494, DOI 10.1038/nature12110	55	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114652	10.1371/journal.pone.0114652	http://dx.doi.org/10.1371/journal.pone.0114652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485971	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907600083
J	Bagchi, S; Vlaeminck, SE; Sauder, LA; Mosquera, M; Neufeld, JD; Boon, N				Bagchi, Samik; Vlaeminck, Siegfried E.; Sauder, Laura A.; Mosquera, Mariela; Neufeld, Josh D.; Boon, Nico			Temporal and Spatial Stability of Ammonia-Oxidizing Archaea and Bacteria in Aquarium Biofilters	PLOS ONE			English	Article							WATER TREATMENT-PLANT; PHYLOGENETIC DIVERSITY; ACTIVATED-SLUDGE; FRESH-WATER; NITRIFICATION; COMMUNITY; SYSTEMS; ANAMMOX; NICHE; SOILS	Nitrifying biofilters are used in aquaria and aquaculture systems to prevent accumulation of ammonia by promoting rapid conversion to nitrate via nitrite. Ammonia-oxidizing archaea (AOA), as opposed to ammonia-oxidizing bacteria (AOB), were recently identified as the dominant ammonia oxidizers in most freshwater aquaria. This study investigated biofilms from fixed-bed aquarium biofilters to assess the temporal and spatial dynamics of AOA and AOB abundance and diversity. Over a period of four months, ammonia-oxidizing microorganisms from six freshwater and one marine aquarium were investigated at 4-5 time points. Nitrogen balances for three freshwater aquaria showed that active nitrification by aquarium biofilters accounted for >= 81-86% of total nitrogen conversion in the aquaria. Quantitative PCR (qPCR) for bacterial and thaumarchaeal ammonia monooxygenase (amoA) genes demonstrated that AOA were numerically dominant over AOB in all six freshwater aquaria tested, and contributed all detectable amoA genes in three aquarium biofilters. In the marine aquarium, however, AOB outnumbered AOA by three to five orders of magnitude based on amoA gene abundances. A comparison of AOA abundance in three carrier materials (fine sponge, rough sponge and sintered glass or ceramic rings) of two three-media freshwater biofilters revealed preferential growth of AOA on fine sponge. Denaturing gel gradient electrophoresis (DGGE) of thaumarchaeal 16S rRNA genes indicated that community composition within a given biofilter was stable across media types. In addition, DGGE of all aquarium biofilters revealed low AOA diversity, with few bands, which were stable over time. Nonmetric multidimensional scaling (NMDS) based on denaturing gradient gel electrophoresis (DGGE) fingerprints of thaumarchaeal 16S rRNA genes placed freshwater and marine aquaria communities in separate clusters. These results indicate that AOA are the dominant ammonia-oxidizing microorganisms in freshwater aquarium biofilters, and that AOA community composition within a given aquarium is stable over time and across biofilter support material types.	[Bagchi, Samik; Vlaeminck, Siegfried E.; Mosquera, Mariela; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol LabMET, B-9000 Ghent, Belgium; [Sauder, Laura A.; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Ghent University; University of Waterloo	Boon, N (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol LabMET, Coupure Links 653, B-9000 Ghent, Belgium.	Nico.Boon@UGent.be	Vlaeminck, Siegfried E./B-4203-2014; Boon, Nico/B-4083-2011; Bagchi, Samik/C-1396-2010	Vlaeminck, Siegfried E./0000-0002-2596-8857; Boon, Nico/0000-0002-7734-3103; Bagchi, Samik/0000-0001-9477-2818	Flemish Government [1F2B8M/JDW/2010-2011/10-BTL-IND-01]; Research Foundation Flanders (FWO-Vlaanderen); Natural Sciences and Engineering Council of Canada (NSERC)	Flemish Government(European Commission); Research Foundation Flanders (FWO-Vlaanderen)(FWO); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.B. was supported by a scholarship from the Flemish Government (1F2B8M/JDW/2010-2011/10-BTL-IND-01) on a bilateral cultural cooperation program; S.E.V. was supported as a postdoctoral fellow from the Research Foundation Flanders (FWO-Vlaanderen); and L.S. and J.D.N. were supported by the Natural Sciences and Engineering Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RJE, 2013, ISME J, V7, P1620, DOI 10.1038/ismej.2013.35; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Bernhard AE, 2005, ENVIRON MICROBIOL, V7, P1289, DOI 10.1111/j.1462-2920.2005.00808.x; Bouskill NJ, 2012, ENVIRON MICROBIOL, V14, P714, DOI 10.1111/j.1462-2920.2011.02623.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brown MN, 2013, FEMS MICROBIOL ECOL, V83, P17, DOI 10.1111/j.1574-6941.2012.01448.x; El-Shafai SA, 2004, AQUACULTURE, V232, P117, DOI 10.1016/S0044-8486(03)00516-7; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Foesel BU, 2008, FEMS MICROBIOL ECOL, V63, P192, DOI 10.1111/j.1574-6941.2007.00418.x; Geets J, 2007, APPL MICROBIOL BIOT, V75, P211, DOI 10.1007/s00253-006-0805-8; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Grommen R, 2005, FEMS MICROBIOL ECOL, V52, P1, DOI 10.1016/j.femsec.2004.10.001; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Hovanec TA, 1996, APPL ENVIRON MICROB, V62, P2888, DOI 10.1128/AEM.62.8.2888-2896.1996; Kasuga I, 2010, WATER RES, V44, P5039, DOI 10.1016/j.watres.2010.07.015; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Limpiyakorn T, 2013, APPL MICROBIOL BIOT, V97, P1425, DOI 10.1007/s00253-012-4650-7; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Pedersen LF, 2009, AQUACULTURE, V296, P246, DOI 10.1016/j.aquaculture.2009.08.021; Pitcher A, 2011, ISME J, V5, P1896, DOI 10.1038/ismej.2011.60; Sakami T, 2012, MAR GENOM, V7, P27, DOI 10.1016/j.margen.2012.04.006; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Sauder LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023281; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Urakawa H, 2008, APPL ENVIRON MICROB, V74, P894, DOI 10.1128/AEM.01529-07; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; Vlaeminck SE, 2011, ENVIRON MICROBIOL, V13, P283, DOI 10.1111/j.1462-2920.2010.02345.x; Vlaeminck SE, 2010, APPL ENVIRON MICROB, V76, P900, DOI 10.1128/AEM.02337-09; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Yool A, 2007, NATURE, V447, P999, DOI 10.1038/nature05885	41	28	28	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113515	10.1371/journal.pone.0113515	http://dx.doi.org/10.1371/journal.pone.0113515			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479061	Green Published, gold			2022-12-26	WOS:000346907200022
J	Gmehlin, D; Fuermaier, ABM; Walther, S; Debelak, R; Rentrop, M; Westermann, C; Sharma, A; Tucha, L; Koerts, J; Tucha, O; Weisbrod, M; Aschenbrenner, S				Gmehlin, Dennis; Fuermaier, Anselm B. M.; Walther, Stephan; Debelak, Rudolf; Rentrop, Mirjam; Westermann, Celina; Sharma, Anuradha; Tucha, Lara; Koerts, Janneke; Tucha, Oliver; Weisbrod, Matthias; Aschenbrenner, Steffen			Intraindividual Variability in Inhibitory Function in Adults with ADHD - An Ex-Gaussian Approach	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME VARIABILITY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BORDERLINE PERSONALITY-DISORDER; RESPONSE-INHIBITION; PERFORMANCE; CHILDREN; MODEL; TASK; DISTRACTIBILITY	Objective: Attention deficit disorder (ADHD) is commonly associated with inhibitory dysfunction contributing to typical behavioral symptoms like impulsivity or hyperactivity. However, some studies analyzing intraindividual variability (IIV) of reaction times in children with ADHD (cADHD) question a predominance of inhibitory deficits. IIV is a measure of the stability of information processing and provides evidence that longer reaction times (RT) in inhibitory tasks in cADHD are due to only a few prolonged responses which may indicate deficits in sustained attention rather than inhibitory dysfunction. We wanted to find out, whether a slowing in inhibitory functioning in adults with ADHD (aADHD) is due to isolated slow responses. Methods: Computing classical RT measures (mean RT, SD), ex-Gaussian parameters of IIV (which allow a better separation of reaction time (mu), variability (sigma) and abnormally slow responses (tau) than classical measures) as well as errors of omission and commission, we examined response inhibition in a wellestablished GoNogo task in a sample of aADHD subjects without medication and healthy controls matched for age, gender and education. Results: We did not find higher numbers of commission errors in aADHD, while the number of omissions was significantly increased compared with controls. In contrast to increased mean RT, the distributional parameter mu did not document a significant slowing in aADHD. However, subjects with aADHD were characterized by increased IIV throughout the entire RT distribution as indicated by the parameters sigma and tau as well as the SD of reaction time. Moreover, we found a significant correlation between tau and the number of omission errors. Conclusions: Our findings question a primacy of inhibitory deficits in aADHD and provide evidence for attentional dysfunction. The present findings may have theoretical implications for etiological models of ADHD as well as more practical implications for neuropsychological testing in aADHD.	[Gmehlin, Dennis; Rentrop, Mirjam; Westermann, Celina; Aschenbrenner, Steffen] SRH Klinikum, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany; [Weisbrod, Matthias] SRH Klinikum, Dept Psychiat, Karlsbad, Germany; [Weisbrod, Matthias; Aschenbrenner, Steffen] SudWestAkad Neuropsychol SWAN, Heidelberg, Germany; [Walther, Stephan; Sharma, Anuradha; Weisbrod, Matthias] Heidelberg Univ, Dept Child & Adolescent Psychiat, Sect Expt Psychopathol & Neurophysiol, D-69115 Heidelberg, Germany; [Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Debelak, Rudolf] Schuhfried GmbH, Modling, Austria	Ruprecht Karls University Heidelberg; University of Groningen	Gmehlin, D (corresponding author), SRH Klinikum, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany.	dennis.gmehlin@kkl.srh.de	Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840; Debelak, Rudolf/0000-0001-8900-2106; Sharma, Anuradha/0000-0002-6372-2890				Adams ZW, 2011, PSYCHOL ASSESSMENT, V23, P427, DOI 10.1037/a0022112; *AM PSYCH ASS, 2000, DSM 4; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2006, ATTENTION DEFICIT HY; Bellgrove MA, 2004, NEUROPSYCHOLOGIA, V42, P1910, DOI 10.1016/j.neuropsychologia.2004.05.007; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Buzy WM, 2009, CHILD NEUROPSYCHOL, V15, P441, DOI 10.1080/09297040802646991; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Coghill DR, 2013, PSYCHOL MED, P1, DOI DOI 10.1017/S0033291713002547; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; Epstein JN, 2007, J CHILD PSYCHOL PSYC, V48, P899, DOI 10.1111/j.1469-7610.2007.01761.x; Epstein JN, 2010, J INT NEUROPSYCH SOC, V16, P138, DOI 10.1017/S1355617709991111; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Fisher T, 2011, CLIN NEUROPHYSIOL, V122, P2390, DOI 10.1016/j.clinph.2011.05.010; Gooch D, 2012, DEV NEUROPSYCHOL, V37, P453, DOI 10.1080/87565641.2011.650809; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; Hautzinger M, 2011, BECK DEPRESSIONS INV; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Kaiser S., 2012, MANUAL RESPONSE INHI; Kaiser S, 2008, BRAIN COGNITION, V66, P73, DOI 10.1016/j.bandc.2007.05.007; Karalunas SL, 2013, J ABNORM CHILD PSYCH, V41, P837, DOI 10.1007/s10802-013-9715-2; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Kollins SH, 2009, DRUG ALCOHOL DEPEN, V100, P169, DOI 10.1016/j.drugalcdep.2008.09.019; Kooistra L, 2010, J NEURAL TRANSM, V117, P655, DOI 10.1007/s00702-010-0374-y; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; Lampe K, 2007, PSYCHOL MED, V37, P1717, DOI 10.1017/S0033291707000517; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Margraf J, 2011, BECK ANGST INVENTAR; Matzke D, 2009, PSYCHON B REV, V16, P798, DOI 10.3758/PBR.16.5.798; Pazvantoglu O, 2012, J INT NEUROPSYCH SOC, V18, P819, DOI 10.1017/S1355617712000574; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rentrop M, 2010, PSYCHIAT RES, V178, P27, DOI 10.1016/j.psychres.2010.04.009; Rosler M., 2008, HOMBURGER ADHS SKALE; Schweiger A, 2007, J CLIN EXP NEUROPSYC, V29, P100, DOI 10.1080/13803390500519738; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; Vadala R, 2011, FUNCT NEUROL, V26, P117; Valko L, 2010, J NEURAL TRANSM, V117, P1213, DOI 10.1007/s00702-010-0473-9; van Lieshout M, 2013, CLIN PSYCHOL REV, V33, P539, DOI 10.1016/j.cpr.2013.02.003; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Verte S, 2005, DEV PSYCHOPATHOL, V17, P415, DOI 10.1017/S0954579405050200; Wagenmakers EJ, 2007, PSYCHOL REV, V114, P830, DOI 10.1037/0033-295X.114.3.830; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Williams BR, 2007, J CLIN EXP NEUROPSYC, V29, P277, DOI 10.1080/13803390600678020; Wodka EL, 2007, J CLIN EXP NEUROPSYC, V29, P345, DOI 10.1080/13803390600678046	54	41	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e112298	10.1371/journal.pone.0112298	http://dx.doi.org/10.1371/journal.pone.0112298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX4MS	25479234	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200008
J	Kaiser, ML; Duncan, FD; Brooke, BD				Kaiser, Maria L.; Duncan, Frances D.; Brooke, Basil D.			Embryonic Development and Rates of Metabolic Activity in Early and Late Hatching Eggs of the Major Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							DIPTERA-CULICIDAE; AEDES-AEGYPTI; TIME; TEMPERATURE; RESISTANCE; SURVIVAL; DESICCATION; ALBITARSIS; SELECTION; PERIOD	Anopheles gambiae eggs generally hatch at the completion of embryo development; two-three days post oviposition. However, staggered or delayed hatching has been observed whereby a single batch of eggs shows marked variation in time-to-hatch, with some eggs hatching 18 days post oviposition or later. The mechanism enabling delayed hatch has not been clearly elucidated but is likely mediated by environmental and genetic factors that either induce diapause or slow embryo development. This study aimed to compare metabolic activity and embryonic development between eggs collected from sub-colonies of the baseline Anopheles gambiae GAH colony previously selected for early or late time-to-hatch. Egg batches from early and late hatch sub-colonies as well as from the baseline colony were monitored for hatching. For both time-to-hatch selected sub-colonies and the baseline colony the majority of eggs hatched on day two post oviposition. Nevertheless, eggs produced by the late hatch sub-colony showed a significantly longer mean time to hatch than those produced by the early hatch sub-colony. The overall proportions that hatched were similar for all egg batches. CO2 output between eggs from early and late hatch sub-colonies showed significant differences only at 3 and 7 days post oviposition where eggs from the early hatch and the late hatch sub-colony were more metabolically active, respectively. No qualitative differences were observed in embryo development between the sub-colonies. It is concluded that all viable embryos develop to maturity at the same rate and that a small proportion then enter a state of diapause enabling them to hatch later. As it has previously been shown that it is possible to at least partially select for late hatch, this characteristic is likely to involve genetic as well as environmental factors. Delayed hatching in An. gambiae is likely an adaptation to maximise reproductive output despite the increased risk of desiccation in an unstable aquatic environment.	[Kaiser, Maria L.; Brooke, Basil D.] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Kaiser, Maria L.; Brooke, Basil D.] NHLS, Ctr Opportunist Trop & Hosp Infect, Natl Inst Communicable Dis, Johannesburg, South Africa; [Duncan, Frances D.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Brooke, BD (corresponding author), Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa.	basilb@nicd.ac.za		Duncan, Frances/0000-0002-0145-8190; Brooke, Basil/0000-0002-8857-1304	Medical Research Council of South Africa; National Research Foundation; Open Society Foundation	Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation; Open Society Foundation	This project was supported by a grant to BDB from the Medical Research Council of South Africa (www.mrc.ac.za). The project was additionally funded by a National Research Foundation award to FDD. MLK was supported by a bursary from the Open Society Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P105; Clements AN, 2000, BIOL MOSQUITOES, P45; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Darrow EM, 1949, J AM HYG, V50, P207; de Carvalho SCG, 2002, MEM I OSWALDO CRUZ, V97, P1117, DOI 10.1590/S0074-02762002000800009; Deane M. P., 1943, AMER JOUR TROP MED, V23, P95; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Ebrahimi B, 2014, J MED ENTOMOL, V51, P580, DOI 10.1603/ME13100; GILLETT J. D., 1955, Bulletin of Entomological Research, V46, P255, DOI 10.1017/S0007485300030893; Gillies M.T., 1987, PUBLICATION S AFRICA, V55; Gillies MT, 1968, ANOPHELINAE AFRICA S, V54; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Impoinvil DE, 2007, J AM MOSQUITO CONTR, V23, P124, DOI 10.2987/8756-971X(2007)23[124:CTATPE]2.0.CO;2; Kaiser ML, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-360; Kambule IN, 2011, PHYSIOL ENTOMOL, V36, P299, DOI 10.1111/j.1365-3032.2011.00792.x; Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4; Lehmann T, 2006, INFECT GENET EVOL, V6, P410, DOI 10.1016/j.meegid.2006.01.007; LEONARD DE, 1968, J ECON ENTOMOL, V61, P596, DOI 10.1093/jee/61.3.596; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Monnerat AT, 2002, MEM I OSWALDO CRUZ, V97, P589, DOI 10.1590/S0074-02762002000400026; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Perez MH, 2013, J INSECT PHYSIOL, V59, P318, DOI 10.1016/j.jinsphys.2012.12.007; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Roberts DM, 2001, MED VET ENTOMOL, V15, P215, DOI 10.1046/j.0269-283x.2001.00303.x; Rozeboom LE, 1934, AM J HYG, V20, P496, DOI 10.1093/oxfordjournals.aje.a118088; Shililu JI, 2004, J AM MOSQUITO CONTR, V20, P243; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Tripet F, 2003, AM J TROP MED HYG, V68, P1; TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; Vargas HCM, 2014, J INSECT PHYSIOL, V62, P54, DOI 10.1016/j.jinsphys.2014.02.001; Vinogradova E.B., 2007, DIAPAUSE AQUATIC INV, P83, DOI DOI 10.1007/978-1-4020-5680-2_5; Warkentin KM, 2011, INTEGR COMP BIOL, V51, P14, DOI 10.1093/icb/icr017; WILKINSON RN, 1978, J MED ENTOMOL, V14, P666, DOI 10.1093/jmedent/14.6.666; Woods HA, 2005, J EXP BIOL, V208, P1297, DOI 10.1242/jeb.01525; Woods HA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P594, DOI 10.1086/322169; Yaro AS, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-19	38	6	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114381	10.1371/journal.pone.0114381	http://dx.doi.org/10.1371/journal.pone.0114381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479444	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200080
J	Liu, PH; Zhang, H; Liu, C; Wang, XF; Chen, L; Qin, CL				Liu, Peihong; Zhang, Hua; Liu, Chao; Wang, Xiaofang; Chen, Li; Qin, Chunlin			Inactivation of Fam20C in Cells Expressing Type I Collagen Causes Periodontal Disease in Mice	PLOS ONE			English	Article							OSTEOSCLEROTIC BONE DYSPLASIA; SIBLING PROTEINS; MARFAN-SYNDROME; RAINE SYNDROME; NULL MICE; PERIOSTIN; GENE; MUTATIONS; LIGAMENT; DENTIN	Background: FAM20C is a kinase that phosphorylates secretory proteins. Previous studies have shown that FAM20C plays an essential role in the formation and mineralization of bone, dentin and enamel. The present study analyzed the loss-of-function effects of FAM20C on the health of mouse periodontal tissues. Methods: By crossbreeding 2.3 kb Col 1a1-Cre mice with Fam20C(fl/fl) mice, we created 2.3 kb Col 1a1-Cre; Fam20C(fl/fl) (cKO) mice, in which Fam20C was inactivated in the cells that express Type I collagen. We analyzed the periodontal tissues in the cKO mice using X-ray radiography, histology, scanning electron microscopy and immunohistochemistry approaches. Results: The cKO mice underwent a remarkable loss of alveolar bone and cementum, along with inflammation of the periodontal ligament and formation of periodontal pockets. The osteocytes and lacuno-canalicular networks in the alveolar bone of the cKO mice showed dramatic abnormalities. The levels of bone sialoprotein, osteopontin, dentin matrix protein 1 and dentin sialoprotein were reduced in the Fam20C-deficient alveolar bone and/or cementum, while periostin and fibrillin-1 were decreased in the periodontal ligament of the cKO mice. Conclusion: Loss of Fam20C function leads to periodontal disease in mice. The reduced levels of bone sialoprotein, osteopontin, dentin matrix protein 1, dentin sialoprotein, periostin and fibrillin-1 may contribute to the periodontal defects in the Fam20C-deficient mice.	[Liu, Peihong] Harbin Med Univ, Sch Stomatol, Dept Periodont, Harbin 150001, Heilongjiang, Peoples R China; [Liu, Peihong; Zhang, Hua; Liu, Chao; Wang, Xiaofang; Qin, Chunlin] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Liu, Peihong; Zhang, Hua; Liu, Chao; Wang, Xiaofang; Qin, Chunlin] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX USA; [Chen, Li] Harbin Med Univ, Affiliated Hosp 1, Longjiang Scholar Lab, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harbin Medical University	Chen, L (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Longjiang Scholar Lab, Harbin 150001, Heilongjiang, Peoples R China.	chenlidentist@163.com; cqin@bcd.tamhsc.edu		Zhang, Hua/0000-0002-6789-9343; Wang, Xiaofang/0000-0002-7370-7192	National Natural Science Foundation of China [81171744]; U.S. National Institutes of Health [DE022549]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022549] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Natural Science Foundation of China (Grant No. 81171744), and the U.S. National Institutes of Health Grant DE022549 (to CQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh FK, 2013, AM J MED GENET A, V161, P3155, DOI 10.1002/ajmg.a.36160; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Foster BL, 2013, J DENT RES, V92, P166, DOI 10.1177/0022034512469026; Foster BL, 2012, INT J ORAL SCI, V4, P119, DOI 10.1038/ijos.2012.57; Ganburged G, 2010, CELL TISSUE RES, V341, P381, DOI 10.1007/s00441-010-1021-5; Gibson MP, 2013, J PERIODONTAL RES, V48, P221, DOI 10.1111/j.1600-0765.2012.01523.x; Hao JJ, 2007, J BIOL CHEM, V282, P15357, DOI 10.1074/jbc.M701547200; Huang BZ, 2008, EUR J ORAL SCI, V116, P104, DOI 10.1111/j.1600-0722.2008.00522.x; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; MCFARLAND RJ, 1995, ANN NY ACAD SCI, V760, P327, DOI 10.1111/j.1749-6632.1995.tb44649.x; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; PAGE RC, 1981, J PERIODONTOL, V52, P477, DOI 10.1902/jop.1981.52.9.477; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Romanos GE, 2014, J CELL PHYSIOL, V229, P1, DOI 10.1002/jcp.24407; Sawada T, 2006, J HISTOCHEM CYTOCHEM, V54, P1095, DOI 10.1369/jhc.5A6905.2006; Shiga M, 2008, CELL TISSUE RES, V331, P461, DOI 10.1007/s00441-007-0528-x; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Simpson MA, 2009, CLIN GENET, V75, P271, DOI 10.1111/j.1399-0004.2008.01118.x; Sire JY, 2007, CELLS TISSUES ORGANS, V186, P25, DOI 10.1159/000102679; Suda N, 2009, J EXP ZOOL PART B, V312B, P503, DOI 10.1002/jez.b.21278; SUN Y, 2010, HEALTH TECHNOL ASSES, V14, P1033, DOI DOI 10.1369/JHC.2010.956771; Tagliabracci VS, 2013, TRENDS BIOCHEM SCI, V38, P121, DOI 10.1016/j.tibs.2012.11.008; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Takeyari S, 2014, BONE, V67, P56, DOI 10.1016/j.bone.2014.06.026; WANG XF, 2010, HEALTH TECHNOL ASSES, V14, P957, DOI DOI 10.1369/JHC.2010.9565651; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Ye L, 2008, J DENT RES, V87, P624, DOI 10.1177/154405910808700708; Zhang B, 2010, ORAL DIS, V16, P453, DOI 10.1111/j.1601-0825.2010.01656.x	38	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114396	10.1371/journal.pone.0114396	http://dx.doi.org/10.1371/journal.pone.0114396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479552	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200081
J	Wei, T; Li, DS; Marcial, D; Khan, M; Lin, MH; Snape, N; Ghildyal, R; Harrich, D; Spann, K				Wei, Ting; Li, Dongsheng; Marcial, Daneth; Khan, Moshin; Lin, Min-Hsuan; Snape, Natale; Ghildyal, Reena; Harrich, David; Spann, Kirsten			The Eukaryotic Elongation Factor 1A Is Critical for Genome Replication of the Paramyxovirus Respiratory Syncytial Virus	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; FACTOR-I; MATRIX PROTEIN; INFECTED-CELLS; VIRAL-RNA; EF-TU; TRANSLATION; ALPHA; INTERACTS; COMPLEX	The eukaryotic translation factor eEF1A assists replication of many RNA viruses by various mechanisms. Here we show that down-regulation of eEF1A restricts the expression of viral genomic RNA and the release of infectious virus, demonstrating a biological requirement for eEF1A in the respiratory syncytial virus (RSV) life cycle. The key proteins in the replicase/transcriptase complex of RSV; the nucleocapsid (N) protein, phosphoprotein (P) and matrix (M) protein, all associate with eEF1A in RSV infected cells, although N is the strongest binding partner. Using individually expressed proteins, N, but not P or M bound to eEF1A. This study demonstrates a novel interaction between eEF1A and the RSV replication complex, through binding to N protein, to facilitate genomic RNA synthesis and virus production.	[Wei, Ting; Li, Dongsheng; Marcial, Daneth; Khan, Moshin; Lin, Min-Hsuan; Harrich, David] Queensland Inst Med Res Berghofer, Herston, Qld, Australia; [Marcial, Daneth; Snape, Natale; Spann, Kirsten] Univ Queensland, Clin Med Virol Ctr, Herston, Qld, Australia; [Marcial, Daneth; Khan, Moshin; Snape, Natale; Spann, Kirsten] Childrens Hlth Queensland, Sir Albert Sakzewski Virus Res Ctr, Herston, Qld, Australia; [Ghildyal, Reena] Univ Canberra, Ctr Res Therapeut Solut, Canberra, ACT 2601, Australia; [Harrich, David; Spann, Kirsten] Australian Infect Dis Res Ctr, St Lucia, Qld, Australia	University of Queensland; University of Canberra	Harrich, D (corresponding author), Queensland Inst Med Res Berghofer, Herston, Qld, Australia.	David.Harrich@qimr.edu.au; K.Spann@uq.edu.au	Lin, Min-Hsuan/ABA-3334-2020; Spann, Kirsten/B-4524-2013; Harrich, David/H-6668-2016	Spann, Kirsten/0000-0003-0567-8382; Harrich, David/0000-0003-3690-0150; Ghildyal, Reena/0000-0002-3147-4976; Lin, Min-Hsuan/0000-0001-7074-6041	Australian National Health and Medical Research Council [1065121]; Australian Infectious Diseases Research Centre project; Australian National Health and Medical Research Council; Australian Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Infectious Diseases Research Centre project; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This study was funded by the Australian National Health and Medical Research Council Project Grant #1065121 to DH and KS (https://www.nhmrc.gov.au/); Australian Infectious Diseases Research Centre project grant to KS and DH (www.aidrc.org.au/); Australian National Health and Medical Research Council Biomedical Early Career Development Fellowship to TW; and Australian Research Council Future Fellowship to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Collins CL, 2002, J INFECTION, V45, P10, DOI 10.1053/jinf.2001.1016; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Collins PL, 2007, FIELDS VIROLOGY, P1601; Das T, 1998, P NATL ACAD SCI USA, V95, P1449, DOI 10.1073/pnas.95.4.1449; Dreher TW, 1999, J BIOL CHEM, V274, P666, DOI 10.1074/jbc.274.2.666; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Ghildyal R, 2002, J GEN VIROL, V83, P753, DOI 10.1099/0022-1317-83-4-753; Ghildyal R, 2006, FEMS MICROBIOL REV, V30, P692, DOI 10.1111/j.1574-6976.2006.00025.x; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Johnson CM, 2001, J GEN VIROL, V82, P2935, DOI 10.1099/0022-1317-82-12-2935; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kou YH, 2006, J BIOMED SCI, V13, P861, DOI 10.1007/s11373-006-9104-8; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nishikiori M, 2006, J VIROL, V80, P8459, DOI 10.1128/JVI.00545-06; Perrin KM, 2012, PEDIATRICS, V129, P55, DOI 10.1542/peds.2010-2991; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Sasvari Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002438; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Sikora D, 2009, VIROLOGY, V390, P71, DOI 10.1016/j.virol.2009.04.022; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Ulloa L, 1998, VIRUS RES, V53, P13, DOI 10.1016/S0168-1702(97)00121-4; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; Yamaji Y, 2006, VIROLOGY, V347, P100, DOI 10.1016/j.virol.2005.11.031; Yamaji Y, 2010, ARCH VIROL, V155, P263, DOI 10.1007/s00705-009-0571-x	35	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114447	10.1371/journal.pone.0114447	http://dx.doi.org/10.1371/journal.pone.0114447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479059	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200090
J	Domina, M; Cariccio, VL; Benfatto, S; D'Aliberti, D; Venza, M; Borgogni, E; Castellino, F; Biondo, C; D'Andrea, D; Grassi, L; Tramontano, A; Teti, G; Felici, F; Beninati, C				Domina, Maria; Cariccio, Veronica Lanza; Benfatto, Salvatore; D'Aliberti, Deborah; Venza, Mario; Borgogni, Erica; Castellino, Flora; Biondo, Carmelo; D'Andrea, Daniel; Grassi, Luigi; Tramontano, Anna; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen-Specific Libraries	PLOS ONE			English	Article							NEXT-GENERATION; PHAGE DISPLAY; VACCINES; GP120; REPERTOIRE; SELECTION; EPITOPES; STRATEGY; NADA	There is a need for techniques capable of identifying the antigenic epitopes targeted by polyclonal antibody responses during deliberate or natural immunization. Although successful, traditional phage library screening is laborious and can map only some of the epitopes. To accelerate and improve epitope identification, we have employed massive sequencing of phage-displayed antigen-specific libraries using the Illumina MiSeq platform. This enabled us to precisely identify the regions of a model antigen, the meningococcal NadA virulence factor, targeted by serum antibodies in vaccinated individuals and to rank hundreds of antigenic fragments according to their immunoreactivity. We found that next generation sequencing can significantly empower the analysis of antigen-specific libraries by allowing simultaneous processing of dozens of library/serum combinations in less than two days, including the time required for antibody-mediated library selection. Moreover, compared with traditional plaque picking, the new technology (named Phage-based Representation OF Immuno-Ligand Epitope Repertoire or PROFILER) provides superior resolution in epitope identification. PROFILER seems ideally suited to streamline and guide rational antigen design, adjuvant selection, and quality control of newly produced vaccines. Furthermore, this method is also susceptible to find important applications in other fields covered by traditional quantitative serology.	[Domina, Maria; Cariccio, Veronica Lanza; Benfatto, Salvatore; D'Aliberti, Deborah; Biondo, Carmelo; Teti, Giuseppe; Beninati, Concetta] Univ Messina, SPGMB Dept, Messina, Italy; [Venza, Mario] Univ Messina, SSMCSO Dept, Messina, Italy; [Borgogni, Erica; Castellino, Flora] Novartis Vaccines & Diagnost, Siena, Italy; [D'Andrea, Daniel; Grassi, Luigi; Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, Rome, Italy; [Teti, Giuseppe; Beninati, Concetta] Charybdis Vaccines Srl, Messina, Italy; [Felici, Franco] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy	University of Messina; University of Messina; Novartis; Sapienza University Rome; University of Molise	Teti, G (corresponding author), Univ Messina, SPGMB Dept, Messina, Italy.	gteti@unime.it	D'Andrea, Daniel/G-3014-2018; Tramontano, anna/D-5378-2009; Biondo, Carmelo/AAA-3391-2019; Domina, Maria/K-7883-2016; Felici, Franco/H-5693-2012; Grassi, Luigi/E-5877-2011	Tramontano, anna/0000-0002-5610-3338; Felici, Franco/0000-0003-2205-5195; Domina, Maria/0000-0002-0445-8356; Grassi, Luigi/0000-0002-6308-7540; D'Andrea, Daniel/0000-0002-7843-3856; Benfatto, Salvatore/0000-0003-4439-3136; BENINATI, Concetta/0000-0001-8305-1337	CLUSTER MEDINTECH [CTN01_00177_962865]; PANLab [PON a3_00166]; King Abdullah University of Science and Technology [KUK I1-012-43]; Progetti di Ricerca di Rilevante Interesse Nazionale [20108XYHJS]; Flagship EPIGEN	CLUSTER MEDINTECH; PANLab; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Progetti di Ricerca di Rilevante Interesse Nazionale; Flagship EPIGEN	Funding for this work came from CLUSTER MEDINTECH (Project CTN01_00177_962865), PANLab (PON a3_00166), King Abdullah University of Science and Technology (Award KUK I1-012-43), Progetti di Ricerca di Rilevante Interesse Nazionale (20108XYHJS), and the Flagship EPIGEN. All funding for this project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FK, 2012, VACCINE, V30, P922, DOI 10.1016/j.vaccine.2011.11.089; Bagnoli F, 2011, OMICS, V15, P545, DOI 10.1089/omi.2010.0127; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Busse CE, 2013, EUR J IMMUNOL; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; Chong L, 2001, SCIENCE, V292, P446, DOI 10.1126/science.1060677; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Durbin R., 1999, BIOL SEQUENCE ANAL P; Felici F, 1996, METHOD ENZYMOL, V267, P116; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Heyduk E, 2014, ANAL BIOCHEM, V464, P73, DOI 10.1016/j.ab.2014.07.014; Holtappels R, 2005, BIF FUTURA, V20, p[157, 157]; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kimura A, 2011, CLIN VACCINE IMMUNOL, V18, P483, DOI 10.1128/CVI.00304-10; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Mathonet P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00265; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; McLaughlin ME, 2013, METHOD ENZYMOL, V523, P327, DOI 10.1016/B978-0-12-394292-0.00015-1; Mehr R, 2012, IMMUNOL LETT, V148, P11, DOI 10.1016/j.imlet.2012.08.002; Minenkova O, 2003, INT J CANCER, V106, P534, DOI 10.1002/ijc.11269; Nara PL, 1998, VACCINE, V16, P1780, DOI 10.1016/S0264-410X(98)00168-6; PAIGE CJ, 1989, FASEB J, V3, P1818, DOI 10.1096/fasebj.3.7.2497040; Pantophlet R, 2003, TRENDS MOL MED, V9, P468, DOI 10.1016/j.molmed.2003.09.001; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pejchal R, 2010, CURR PHARM DESIGN, V16, P3744, DOI 10.2174/138161210794079173; PIZZI E, 1995, BIOPOLYMERS, V36, P675, DOI 10.1002/bip.360360513; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Stalhammar-Carlemalm M, 2007, CELL HOST MICROBE, V2, P427, DOI 10.1016/j.chom.2007.10.003; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Tavano R, 2011, J BACTERIOL, V193, P107, DOI 10.1128/JB.00430-10; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114159	10.1371/journal.pone.0114159	http://dx.doi.org/10.1371/journal.pone.0114159			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473968	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500118
J	Zhang, YJ; Guo, SL; Liu, QF; Jiang, JS				Zhang, Yanjun; Guo, Shengli; Liu, Qingfang; Jiang, Jishao			Influence of Soil Moisture on Litter Respiration in the Semiarid Loess Plateau	PLOS ONE			English	Article							BELOW-GROUND LITTER; ABOVEGROUND LITTER; CO2 EFFLUX; RHIZOSPHERE RESPIRATION; TEMPERATURE-DEPENDENCE; FOREST ECOSYSTEMS; ORGANIC-MATTER; WATER-CONTENT; DECOMPOSITION; CARBON	Understanding the response mechanisms of litter respiration to soil moisture in water-limited semi-arid regions is of vital importance to better understanding the interplay between ecological processes and the local carbon cycle. In situ soil respiration was monitored during 2010-2012 under various conditions (normal litter, no litter, and double litter treatments) in a 30-year-old artificial black locust plantation (Robinia pseudoacacia L.) on the Loess Plateau. Litter respiration with normal and double litter treatments exhibited similar seasonal variation, with the maximum value obtained in summer (0.57 and 1.51 mmol m(-2) s(-1) under normal and double litter conditions, respectively) and the minimum in spring (0.27 and 0.69 mu mol m(-2) s(-1) under normal and double litter conditions, respectively). On average, annual cumulative litter respiration was 115 and 300 g C m(-2) y-(1) under normal and double litter conditions, respectively. Using a soil temperature of 17 degrees C as the critical point, the relationship between litter respiration and soil moisture was found to follow quadratic functions well, whereas the determination coefficient was much greater at high soil temperature than at low soil temperature (33-35% vs. 2224%). Litter respiration was significantly higher in 2010 and 2012 than in 2011 under both normal litter (132-165 g C m(-2) y(-1) vs. 48 g C m(-2) y(-1)) and double litter (389-418 g C m(-2) y(-1) vs. 93 g C m(-2) y(-1)) conditions. Such significant interannual variations were largely ascribed to the differences in summer rainfall. Our study demonstrates that, apart from soil temperature, moisture	[Zhang, Yanjun; Guo, Shengli] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Peoples R China; [Guo, Shengli; Jiang, Jishao] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Guo, Shengli; Jiang, Jishao] Minist Water Resource, Yangling, Peoples R China; [Guo, Shengli; Liu, Qingfang] Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Guo, SL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dry Land Farming Loess, Yangling, Peoples R China.	slguo@ms.iswc.ac.cn			National Natural Science Foundation of China [41071338]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by the National Natural Science Foundation of China (Grant No. 41071338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro M, 2009, SOIL BIOL BIOCHEM, V41, P594, DOI 10.1016/j.soilbio.2008.12.021; Balogh J, 2011, SOIL BIOL BIOCHEM, V43, P1006, DOI 10.1016/j.soilbio.2011.01.017; Berryman EM, 2014, CAN J FOREST RES, V44, P432, DOI 10.1139/cjfr-2013-0334; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Chen ST, 2010, AGR FOREST METEOROL, V150, P590, DOI 10.1016/j.agrformet.2010.02.004; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; [邓琦 DENG Qi], 2007, [地球科学进展, Advance in Earth Sciences], V22, P976; Ge X., 2013, ACTA ECOL SIN, V33, P102, DOI [10.1016/j.chnaes.2013.01.006, DOI 10.1016/J.CHNAES.2013.01.006]; Goebes P, 2013, EGU GEN ASS C, P7565; Hibbard KA, 2005, BIOGEOCHEMISTRY, V73, P29, DOI 10.1007/s10533-004-2946-0; Jiang H, 2013, BIOGEOSCIENCES, V10, P3963, DOI 10.5194/bg-10-3963-2013; Jongen M, 2013, PLANT SOIL, P1; Kavvadias VA, 2001, FOREST ECOL MANAG, V144, P113, DOI 10.1016/S0378-1127(00)00365-0; Kim H, 2005, PHYTON-ANN REI BOT A, V45, P385; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Liang N, 2010, BIOGEOSCIENCES, V7, P3447, DOI 10.5194/bg-7-3447-2010; [刘迎春 LIU Yingchun], 2011, [生态学报, Acta Ecologica Sinica], V31, P4277; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Nadelhoffer K.J., 2004, FORESTS TIME ENV CON, P300, DOI DOI 10.1890/0012-9623-96.3.492; Palviainen M, 2004, PLANT SOIL, V259, P123, DOI 10.1023/B:PLSO.0000020938.78215.bd; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rey A, 2011, SOIL BIOL BIOCHEM, V43, P393, DOI 10.1016/j.soilbio.2010.11.007; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Sayer EJ, 2006, FOREST ECOL MANAG, V229, P285, DOI 10.1016/j.foreco.2006.04.007; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Shiels AB, 2006, BIOTROPICA, V38, P348, DOI 10.1111/j.1744-7429.2006.00140.x; Subke JA, 2004, OECOLOGIA, V139, P551, DOI 10.1007/s00442-004-1540-4; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Wang QK, 2013, AGR FOREST METEOROL, V178, P152, DOI 10.1016/j.agrformet.2013.04.021; Wang YD, 2009, ASIA-PAC J ATMOS SCI, V45, P137; Wilson TB, 2014, AGR FOREST METEOROL, V192, P42, DOI 10.1016/j.agrformet.2014.02.005; Xu S, 2013, BIOGEOSCIENCES, V10, P7423, DOI 10.5194/bg-10-7423-2013; Yan WD, 2013, CHINESE SCI BULL, V58, P750, DOI 10.1007/s11434-012-5474-7; Zheng FL., 2013, RESTORATION DEV DEGR, P77; Zhou P, 2013, ENVIRON EARTH SCI, V68, P633, DOI 10.1007/s12665-012-1766-0; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010; Zhu B, 2013, SOIL BIOL BIOCHEM, V63, P89, DOI 10.1016/j.soilbio.2013.03.027; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1338, DOI 10.1016/j.soilbio.2009.02.023	47	7	10	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114558	10.1371/journal.pone.0114558	http://dx.doi.org/10.1371/journal.pone.0114558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474633	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500046
J	Song, GJ; Leslie, KL; Barrick, S; Mamonova, T; Fitzpatrick, JM; Drombosky, KW; Peyser, N; Wang, B; Pellegrini, M; Bauer, PM; Friedman, PA; Mierke, DF; Bisello, A				Song, Gyun Jee; Leslie, Kristen L.; Barrick, Stacey; Mamonova, Tatyana; Fitzpatrick, Jeremy M.; Drombosky, Kenneth W.; Peyser, Noah; Wang, Bin; Pellegrini, Maria; Bauer, Philip M.; Friedman, Peter A.; Mierke, Dale F.; Bisello, Alessandro			Phosphorylation of Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) by Akt Promotes Stability and Mitogenic Function of S-phase Kinase-associated Protein-2 (Skp2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Cell Proliferation; PDZ Domain; Phosphorylation; Vascular Smooth Muscle Cells; EBP50; Skp2; nherf; nherf1	MUSCLE-CELL PROLIFERATION; UBIQUITIN-MEDIATED DEGRADATION; SUBCELLULAR-LOCALIZATION; CYTOPLASMIC LOCALIZATION; DEPENDENT REGULATION; NEOINTIMA FORMATION; LIGASE; RECEPTOR; COMPLEX; CYCLE	Background: The PDZ scaffolding protein EBP50 promotes Akt-dependent cell proliferation through the S-phase kinase associated protein-2 Skp2. Results: Akt phosphorylates threonine 156 of EBP50, allosterically promoting the binding of Skp2 to the first PDZ domain of EBP50. Conclusion: The interaction with EBP50 regulates the localization and stability of Skp2 and promotes cell proliferation. Significance: These studies define a regulatory mechanism contributing to Akt-dependent cell proliferation. The regulation of the cell cycle by the ubiquitin-proteasome system is dependent on the activity of E3 ligases. Skp2 (S-phase kinase associated protein-2) is the substrate recognition subunit of the E3 ligase that ubiquitylates the cell cycle inhibitors p21(cip1) and p27(kip1) thus promoting cell cycle progression. Increased expression of Skp2 is frequently observed in diseases characterized by excessive cell proliferation, such as cancer and neointima hyperplasia. The stability and cellular localization of Skp2 are regulated by Akt, but the molecular mechanisms underlying these effects remain only partly understood. The scaffolding protein Ezrin-Binding Phosphoprotein of 50 kDa (EBP50) contains two PDZ domains and plays a critical role in the development of neointimal hyperplasia. Here we report that EBP50 directly binds Skp2 via its first PDZ domain. Moreover, EBP50 is phosphorylated by Akt on Thr-156 within the second PDZ domain, an event that allosterically promotes binding to Skp2. The interaction with EBP50 causes cytoplasmic localization of Skp2, increases Skp2 stability and promotes proliferation of primary vascular smooth muscle cells. Collectively, these studies define a novel regulatory mechanism contributing to aberrant cell growth and highlight the importance of scaffolding function of EBP50 in Akt-dependent cell proliferation.	[Song, Gyun Jee; Leslie, Kristen L.; Barrick, Stacey; Mamonova, Tatyana; Drombosky, Kenneth W.; Peyser, Noah; Wang, Bin; Friedman, Peter A.; Bisello, Alessandro] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Song, Gyun Jee] Kungpook Natl Univ, Sch Med, Brain Sci & Engn Inst, Dept Pharmacol, Taegu 702701, South Korea; [Pellegrini, Maria; Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College	Bisello, A (corresponding author), Univ Pittsburgh, Sch Med, E1358 BST,200 Lothrop St, Pittsburgh, PA 15260 USA.	alb138@pitt.edu	Barrick, Stacey/J-1595-2015; Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412; Wang, Bin/0000-0002-5396-6111; Peyser, Noah/0000-0003-4529-8325; Barrick, Stacey/0000-0002-4837-3741	National Institutes of Health [S10 RR-025085, R01-DK069998, UL1 RR024153, UL1TR000005]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2061607]; Pilot Project Program in Hemostasis and Vascular Biology; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Pilot Project Program in Hemostasis and Vascular Biology; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants S10 RR-025085 (to D. F. M.) and R01-DK069998 (to P. A. F.), and by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education [2013R1A1A2061607]. This work was also supported by a Pilot Project Program in Hemostasis and Vascular Biology (to A. B.) supported by grants from the Institute for Transfusion Medicine and the Hemophilia Society of Western Pennsylvania and the National Institutes of Health through Grant Numbers UL1 RR024153 and UL1TR000005.	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Bond M, 2006, CARDIOVASC RES, V69, P198, DOI 10.1016/j.cardiores.2005.08.020; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bond M, 2011, FRONT BIOSCI-LANDMRK, V16, P1517, DOI 10.2741/3802; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Leslie KL, 2013, J BIOL CHEM, V288, P36426, DOI 10.1074/jbc.M113.483339; Li JQ, 2004, INT J ONCOL, V25, P87; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Shigemasa K, 2003, CLIN CANCER RES, V9, P1756; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Song GJ, 2012, J MOL CELL CARDIOL, V53, P809, DOI 10.1016/j.yjmcc.2012.08.022; Song GJ, 2012, ARTERIOSCL THROM VAS, V32, P33, DOI 10.1161/ATVBAHA.111.235200; Song GJ, 2010, J MOL CELL CARDIOL, V49, P1012, DOI 10.1016/j.yjmcc.2010.08.025; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang HB, 2010, CELL CYCLE, V9, P1021, DOI 10.4161/cc.9.5.10916; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200; Zhu CQ, 2004, CLIN CANCER RES, V10, P1984, DOI 10.1158/1078-0432.CCR-03-0470	38	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2879	2887		10.1074/jbc.M114.609768	http://dx.doi.org/10.1074/jbc.M114.609768			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25492869	Green Published, hybrid			2022-12-26	WOS:000349310700028
J	Bajardi, P; Paolotti, D; Vespignani, A; Eames, K; Funk, S; Edmunds, WJ; Turbelin, C; Debin, M; Colizza, V; Smallenburg, R; Koppeschaar, C; Franco, AO; Faustino, V; Carnahan, A; Rehn, M; Merletti, F; Douwes, J; Firestone, R; Richiardi, L				Bajardi, Paolo; Paolotti, Daniela; Vespignani, Alessandro; Eames, Ken; Funk, Sebastian; Edmunds, W. John; Turbelin, Clement; Debin, Marion; Colizza, Vittoria; Smallenburg, Ronald; Koppeschaar, Carl; Franco, Ana O.; Faustino, Vitor; Carnahan, AnnaSara; Rehn, Moa; Merletti, Franco; Douwes, Jeroen; Firestone, Ridvan; Richiardi, Lorenzo			Association between Recruitment Methods and Attrition in Internet-Based Studies	PLOS ONE			English	Article							INFLUENZA-LIKE-ILLNESS; HEALTH COMMUNICATION; BIRTH COHORT; BEHAVIOR; PARTICIPANTS; NETHERLANDS; EXPERIENCE; PATTERNS; MEDIA; BIAS	Internet-based systems for epidemiological studies have advantages over traditional approaches as they can potentially recruit and monitor a wider range of individuals in a relatively inexpensive fashion. We studied the association between communication strategies used for recruitment (offline, online, face-to-face) and follow-up participation in nine Internet-based cohorts: the Influenzanet network of platforms for influenza surveillance which includes seven cohorts in seven different European countries, the Italian birth cohort Ninfea and the New Zealand birth cohort ELF. Follow-up participation varied from 43% to 89% depending on the cohort. Although there were heterogeneities among studies, participants who became aware of the study through an online communication campaign compared with those through traditional offline media seemed to have a lower follow-up participation in 8 out of 9 cohorts. There were no clear differences in participation between participants enrolled face-to-face and those enrolled through other offline strategies. An Internet-based campaign for Internet-based epidemiological studies seems to be less effective than an offline one in enrolling volunteers who keep participating in follow-up questionnaires. This suggests that even for Internet-based epidemiological studies an offline enrollment campaign would be helpful in order to achieve a higher participation proportion and limit the cohort attrition.	[Bajardi, Paolo] Univ Turin, Dept Vet Sci, Computat Epidemiol Grp, GECO, Turin, Italy; [Bajardi, Paolo; Paolotti, Daniela; Vespignani, Alessandro; Colizza, Vittoria] ISI Fdn, Turin, Italy; [Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Vespignani, Alessandro] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Eames, Ken; Funk, Sebastian; Edmunds, W. John] London Sch Hyg & Trop Med, London WC1, England; [Turbelin, Clement; Debin, Marion; Colizza, Vittoria] Inst Natl St Rech Med, UMR S 707, Paris, France; [Turbelin, Clement; Debin, Marion; Colizza, Vittoria] Univ Paris 06, UMR S 707, Paris, France; [Smallenburg, Ronald; Koppeschaar, Carl] Aquistointer BV, Amsterdam, Netherlands; [Franco, Ana O.; Faustino, Vitor] Inst Gulbenkian Cincia, Oeiras, Portugal; [Carnahan, AnnaSara; Rehn, Moa] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Dept Med Sci, Turin, Italy; [Merletti, Franco; Richiardi, Lorenzo] CPO Piemonte, Turin, Italy; [Douwes, Jeroen; Firestone, Ridvan] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand	University of Turin; Northeastern University; Harvard University; University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Public Health Agency of Sweden; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; Massey University	Bajardi, P (corresponding author), Univ Turin, Dept Vet Sci, Computat Epidemiol Grp, GECO, Turin, Italy.	paolo.bajardi@isi.it	Bajardi, Paolo/AAE-2416-2022; Firestone, Riz/AAU-2414-2021; Paolotti, Daniela/K-5740-2016; richiardi, lorenzo/J-3480-2018	Bajardi, Paolo/0000-0001-8865-4495; Firestone, Riz/0000-0003-2834-8044; Paolotti, Daniela/0000-0003-1356-3470; DEBIN, Marion/0000-0002-5146-7642; Colizza, Vittoria/0000-0002-2113-2374; richiardi, lorenzo/0000-0003-0316-9402; de Oliveira Franco, Ana Isabel/0000-0002-9195-965X; Funk, Sebastian/0000-0002-2842-3406; Douwes, Jeroen/0000-0003-3599-4036; Vespignani, Alessandro/0000-0003-3419-4205	EC-ICT IP EPIWORK [231807]; European Research Council [n.ERC-2007-Stg204863]; ISI Foundation; ANR [ANR-12-MONU-0018]; Career Development Fellowship; National Institute for Health Research; Institut de Veille Sanitaire; Compagnia di San Paolo; Piedmont Region; Health Research Council of New Zealand; Massey University; Master in Epidemiology of the University of Turin and Compagnia di San Paolo; Medical Research Council [MR/K021680/1] Funding Source: researchfish; MRC [MR/K021680/1] Funding Source: UKRI	EC-ICT IP EPIWORK; European Research Council(European Research Council (ERC)European Commission); ISI Foundation; ANR(French National Research Agency (ANR)); Career Development Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); Institut de Veille Sanitaire; Compagnia di San Paolo(Compagnia di San Paolo); Piedmont Region(Regione Piemonte); Health Research Council of New Zealand(Health Research Council of New Zealand); Massey University; Master in Epidemiology of the University of Turin and Compagnia di San Paolo; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the EC-ICT IP EPIWORK g.a. no. 231807. PB gratefully acknowledges the European Research Council Ideas contract n.ERC-2007-Stg204863 (EPIFOR) and the ISI Foundation that partially funded this work. The work has been partially funded by the ANR contract no. ANR-12-MONU-0018 (HARMSflu) to VC, MD, CT. KE is funded by a Career Development Fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors(s) and not necessarily those of the NHS, the National Institute of Health research or the Department of Health (UK). The GrippeNet.fr study is partially funded by the Institut de Veille Sanitaire. The Ninfea study is partially funded by the Compagnia di San Paolo and the Piedmont Region. The ELF study was partially funded by the Health Research Council of New Zealand and from Massey University. This work has been supported by the Master in Epidemiology of the University of Turin and Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3010; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Cassell MM, 1998, J HEALTH COMMUN, V3, P71; CHAIKEN S, 1983, J PERS SOC PSYCHOL, V45, P241, DOI 10.1037/0022-3514.45.2.241; Dokkum NFB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-176; Eames KT, 2011, EPIDEMIOL INFECT, V12, P1; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Glasgow RE, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e11; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; Kreuter MW, 2004, ANNU REV PUBL HEALTH, V25, P439, DOI 10.1146/annurev.publhealth.25.101802.123000; Mayr A, 2012, J CLIN EPIDEMIOL, V65, P970, DOI 10.1016/j.jclinepi.2012.03.005; Peels DA, 2012, J MED INTERNET RES, V14, P146, DOI 10.2196/jmir.2229; Pizzi C, 2012, J EPIDEMIOL COMMUN H, V66, P976, DOI 10.1136/jech-2011-200065; Richiardi L, 2013, HDB EPIDEMIOLOGY, P439; Richiardi L, 2007, EUR J EPIDEMIOL, V22, P831, DOI 10.1007/s10654-007-9194-2; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1018, DOI 10.1093/ije/dyt103; Richiardi L, 2012, EPIDEMIOLOGY, V23, P175, DOI 10.1097/EDE.0b013e31823b5ee4; Rothman KJ, 2013, INT J EPIDEMIOL, V42; Svensson M, 2012, EUR J EPIDEMIOL, V27, P333, DOI 10.1007/s10654-012-9687-5; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; van Velsen L, 2012, J MED INTERNET RES, V14, P265, DOI 10.2196/jmir.2123; WORCHEL S, 1975, J APPL SOC PSYCHOL, V5, P157, DOI 10.1111/j.1559-1816.1975.tb01305.x	22	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114925	10.1371/journal.pone.0114925	http://dx.doi.org/10.1371/journal.pone.0114925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3YM	25490045	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000347515300095
J	Chen, YW; Tsai, MY; Pan, HB; Tseng, HH; Hung, YT; Chou, CP				Chen, Ya-Wen; Tsai, Meng-Yuan; Pan, Huay-Ben; Tseng, Hui-Hwa; Hung, Yu-Ting; Chou, Chen-Pin			Gadoxetic Acid-Enhanced MRI and Sonoelastography: Non-Invasive Assessments of Chemoprevention of Liver Fibrosis in Thioacetamide-Induced Rats with Sho-Saiko-To	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; CIRRHOSIS; AGENT; MODEL; CARCINOMA; BIOPSY	Background: This study aimed to compare the performance of gadoxetic acid - enhanced magnetic resonance imaging (MRI) and sonoelastography in evaluating chemopreventive effects of Sho-Saiko-To (SST) in thioacetamide (TAA)-induced early liver fibrosis in rats. Materials and Methods: Ten of Sprague-Dawley rats receiving TAA (200 mg/kg of body weight) intraperitoneal injection were divided into three groups: Group 1 (TAA only, n = 3), Group 2 (TAA +0.25 g/kg SST, n = 4) and Group 3 (TAA+ 1 g/kg SST, n = 3). Core needle liver biopsy at week 2 and liver specimens after sacrifice at week 6 confirmed liver fibrosis using histological examinations, including Sirius red staining, Ishak and Metavir scoring systems. Gadoxetic acid-enhanced MRI and shear-wave sonoelastography were employed to evaluate liver fibrosis. The expression of hepatic transporter organic anion transporter 1 (Oatp1), multidrug-resistant protein 2 (Mrp2) and alpha-smooth muscle actin (alpha-Sma) were also analyzed in each group by immunohistochemistry (IHC) and Western blot. Results: According to histological grading by Sirius red staining, Ishak scores of liver fibrosis in Groups 1, 2 and 3 were 3, 2 and 1, respectively. As shown in gadoxetic acid-enhanced MRI, the ratio of relative enhancement was significantly lower in Group 1 (1.87 +/- 0.21) than in Group 2 of low-dose (2.82 +/- 0.25) and Group 3 of high-dose (2.72 +/- 0.12) SST treatment at 10 minutes after gadoxetic acid intravenous injection (p<0.05). Sonoelastography showed that the mean difference before and after experiments in Groups 1, 2 and 3 were 4.66 +/- 0.1, 4.4 +/- 0.57 and 3 +/- 0.4 KPa (p<0.1), respectively. Chemopreventive effects of SST reduced the Mrp2 protein level (p<0.01) but not Oatp1 and alpha-Sma levels. Conclusion: Sonoelastography and gadoxetic acid-enhanced MRI could monitor the treatment effect of SST in an animal model of early hepatic fibrosis.	[Chen, Ya-Wen] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli 350, Taiwan; [Chen, Ya-Wen] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan; [Tsai, Meng-Yuan; Pan, Huay-Ben; Hung, Yu-Ting; Chou, Chen-Pin] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan; [Tsai, Meng-Yuan; Pan, Huay-Ben; Tseng, Hui-Hwa; Chou, Chen-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Pan, Huay-Ben] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 824, Taiwan; [Tseng, Hui-Hwa] Kaohsiung Vet Gen Hosp, Dept Pathol, Kaohsiung 813, Taiwan; [Chou, Chen-Pin] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; I Shou University; Kaohsiung Veterans General Hospital; Fooyin University	Chou, CP (corresponding author), Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan.	r2207759@ms19.hinet.net	Chen, Ya-Wen/B-1100-2010; Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	Ministry of Science and Technology; National Health Research Institutes, Taiwan [NSC 99-2314-B-075B-006-MY3, NSC 102-2320-B-400004, NHRI CA-103-PP-03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants NSC 99-2314-B-075B-006-MY3, NSC 102-2320-B-400004, NHRI CA-103-PP-03 from Ministry of Science and Technology and National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berzigotti A, 2013, J HEPATOL, V59, P180, DOI 10.1016/j.jhep.2012.12.028; Bruck R, 2001, J HEPATOL, V35, P457, DOI 10.1016/S0168-8278(01)00163-5; Chen TM, 2008, INT J EXP PATHOL, V89, P223, DOI 10.1111/j.1365-2613.2008.00576.x; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Deng G, 2011, J ETHNOPHARMACOL, V136, P83, DOI 10.1016/j.jep.2011.04.008; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317; Guardigli M, 2005, J HISTOCHEM CYTOCHEM, V53, P1451, DOI 10.1369/jhc.5A6621.2005; HARANAKA K, 1985, CANCER IMMUNOL IMMUN, V20, P1; Hope TA, 2012, RADIOLOGY, V264, P423, DOI 10.1148/radiol.12112453; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jeong W, 2005, J VET MED SCI, V67, P235, DOI 10.1292/jvms.67.235; Kato M, 1998, J INVEST DERMATOL, V111, P640, DOI 10.1046/j.1523-1747.1998.00341.x; Lee JK, 2011, HEPATOL RES, V41, P825, DOI 10.1111/j.1872-034X.2011.00829.x; Libra A, 2006, J PHARMACOL EXP THER, V319, P809, DOI 10.1124/jpet.106.106591; Malaguarnera G, 2012, WORLD J GASTROENTERO, V18, P2756, DOI 10.3748/wjg.v18.i22.2756; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Ohta T, 2006, ACTA MED OKAYAMA, V60, P77; Pascolo L, 1999, BIOCHEM BIOPH RES CO, V257, P746, DOI 10.1006/bbrc.1999.0454; Perez MJ, 2002, J NUTR, V132, P652, DOI 10.1093/jn/132.4.652; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sporea I, 2012, ULTRASCHALL MED, V33, P550, DOI 10.1055/s-0032-1313011; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Tsuda N, 2011, EUR RADIOL, V21, P2542, DOI 10.1007/s00330-011-2228-x; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Van Montfoort JE, 1999, J PHARMACOL EXP THER, V290, P153; Yamamoto H, 2003, GASTROENTEROLOGY, V125, P556, DOI 10.1016/S0016-5085(03)00904-1; Zech Christoph J, 2007, Magn Reson Med Sci, V6, P43, DOI 10.2463/mrms.6.43; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	36	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114756	10.1371/journal.pone.0114756	http://dx.doi.org/10.1371/journal.pone.0114756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490034	Green Published, Green Submitted, gold			2022-12-26	WOS:000347515300075
J	Deng, B; Fu, LQ; Zhang, XP; Zheng, JJ; Peng, LS; Sun, JD; Zhu, HY; Wang, YB; Li, WF; Wu, XX; Wu, D				Deng, Bin; Fu, Luoqin; Zhang, Xiaoping; Zheng, Jiajia; Peng, Lisha; Sun, Jiandong; Zhu, Haiyan; Wang, Yibing; Li, Weifen; Wu, Xuexiang; Wu, Di			The Denitrification Characteristics of Pseudomonas stutzeri SC221-M and Its Application to Water Quality Control in Grass Carp Aquaculture	PLOS ONE			English	Article							AEROBIC DENITRIFICATION; HETEROTROPHIC NITRIFICATION; BACTERIUM; REMOVAL; AMMONIA; NITRATE; EXPRESSION; MECHANISM; BIOLOGY; GENOME	To reduce ammonium and nitrite in aquaculture water, an isolate of the denitrifying bacterium Pseudomonas stutzeri, SC221-M, was obtained. The effects of various nitrogen and carbon sources, the ratio of carbon to nitrogen and temperature on bacterial growth, denitrification rates and the expression levels of nirS and nosZ in SC221-M were studied. The following conditions were determined to be optimal for growth and denitrification in SC221-M: NaNO2 as the nitrogen source, sodium citrate as the carbon source, a carbon to nitrogen ratio range of 4-8, and a temperature range of 20-35 degrees C. Subsequently, SC221-M and the Bacillus cereus BSC24 strain were selected to generate microbial preparations. The results showed that addition of the microbial preparations decreased various hydrochemical parameters, including total dissolved solids, ammonium, nitrite, total nitrogen and the chemical oxygen demand. Nitrogen removal rates were highest on day 9; the removal rates of BSC24, SC221-M, a mixed preparation and a 3 x mixed preparation were 24.5%, 26.6%, 53.9% and 53.4%, respectively. The mixed preparation (SC221-M+BSC24) was more effective at removing nitrogen than either the SC221-M or BSC24 preparation. Roche 454 pyrosequencing and subsequent analysis indicated that the control and other groups formed separate clusters, and the microbial community structure in the water changed significantly after the addition of microbial preparations. These results indicate that the addition of microbial preparations can improve both the water quality and microbial community structure in an experimental aquaculture system. P. stutzeri strain SC221-M and its related microbial preparations are potential candidates for the regulation of water quality in commercial aquaculture systems.	[Deng, Bin; Fu, Luoqin; Zhang, Xiaoping; Zheng, Jiajia; Peng, Lisha; Sun, Jiandong; Zhu, Haiyan; Wang, Yibing; Li, Weifen] Zhejiang Univ, Coll Anim Sci, Inst Anim Nutr & Feed Sci, Key Lab Mol Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Deng, Bin] Guizhou Inst Technol, Sch Pharmaceut Engn, Guiyang, Peoples R China; [Zhang, Xiaoping] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xuexiang] Guizhou Univ, Coll Anim Sci, Guiyang 550003, Peoples R China; [Wu, Di] Ctr Dis Control & Prevent, Deyang, Peoples R China	Zhejiang University; Guizhou Institute of Technology; Zhejiang University; Guizhou University; Chinese Center for Disease Control & Prevention	Zhang, XP (corresponding author), Zhejiang Univ, Coll Anim Sci, Inst Anim Nutr & Feed Sci, Key Lab Mol Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangxiaoping403@gmail.com; weifenli@zju.edu.cn	zhu, xueqiong/U-1320-2019; Sun, Jiandong/J-1263-2012	Sun, Jiandong/0000-0003-1288-466X	National Basic Research Program, P. R. China (973 Program) [2009CB118705]; Special Fund for Agro-scientific Research in the Public Interest [201203083]; Foundation of Agricultural Science and Technology Support Project of Guizhou Province [3053]	National Basic Research Program, P. R. China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Foundation of Agricultural Science and Technology Support Project of Guizhou Province	This work was supported by National Basic Research Program, P. R. China (973 Program) 2009CB118705, Special Fund for Agro-scientific Research in the Public Interest, 201203083, and Foundation of Agricultural Science and Technology Support Project of Guizhou Province [2010] 3053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARILLO A, 1981, ECOTOX ENVIRON SAFE, V5, P316, DOI 10.1016/0147-6513(81)90006-3; Borges MT, 2008, MICROB ECOL, V55, P107, DOI 10.1007/s00248-007-9256-8; Bosch R, 1999, GENE, V236, P149, DOI 10.1016/S0378-1119(99)00241-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Garcia-Valdes E, 2003, SYST APPL MICROBIOL, V26, P390, DOI 10.1078/072320203322497428; Henderson SL, 2010, APPL ENVIRON MICROB, V76, P2155, DOI 10.1128/AEM.02993-09; Holt JG, 1994, BERGEYS MANUAL DETER, V75, P121; Hu Z, 2013, ENVIRON SCI POLLUT R, V20, P1059, DOI 10.1007/s11356-012-1018-6; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Kim JK, 2005, BIORESOURCE TECHNOL, V96, P1897, DOI 10.1016/j.biortech.2005.01.040; Kim M, 2008, J BIOSCI BIOENG, V106, P498, DOI 10.1263/jbb.106.498; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Liu FJ, 2002, J ENVIRON SCI-CHINA, V14, P339; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mires D, 1995, ISR J AQUACULT-BAMID, V47, P163; Nimrat S, 2012, VET MICROBIOL, V159, P443, DOI 10.1016/j.vetmic.2012.04.029; Pena A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00113-13; Saleh-Lakha S, 2009, APPL ENVIRON MICROB, V75, P5082, DOI 10.1128/AEM.00777-09; Saleh-Lakha S, 2009, APPL ENVIRON MICROB, V75, P3903, DOI 10.1128/AEM.00080-09; Shan H, 2001, APPL MICROBIOL BIOT, V57, P791; Su JJ, 2001, J APPL MICROBIOL, V90, P457, DOI 10.1046/j.1365-2672.2001.01265.x; Szymanski N, 2003, FUTURE DIRECTIONS ON, P347; Tilak KS, 2007, J ENVIRON BIOL, V28, P45; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yu HY, 2011, J BACTERIOL, V193, P3422, DOI 10.1128/JB.05039-11; Zawadzka AM, 2007, BIOMETALS, V20, P145, DOI 10.1007/s10534-006-9022-2; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhang QL, 2012, BIORESOURCE TECHNOL, V108, P35, DOI 10.1016/j.biortech.2011.12.139; Zhang X, 2013, WORLD J MICROB BIOT; Zhang XP, 2013, WORLD J MICROB BIOT, V29, P1645, DOI 10.1007/s11274-013-1327-z; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	32	23	34	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114886	10.1371/journal.pone.0114886	http://dx.doi.org/10.1371/journal.pone.0114886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489740	Green Submitted, gold, Green Published			2022-12-26	WOS:000347515300092
J	Rozycka, M; Wojtas, M; Jakob, M; Stigloher, C; Grzeszkowiak, M; Mazur, M; Ozyhar, A				Rozycka, Miroslawa; Wojtas, Magdalena; Jakob, Michal; Stigloher, Christian; Grzeszkowiak, Mikolaj; Mazur, Maciej; Ozyhar, Andrzej			Intrinsically Disordered and Pliable Starmaker-Like Protein from Medaka (Oryzias latipes) Controls the Formation of Calcium Carbonate Crystals	PLOS ONE			English	Article							MODULATING BIOMINERALIZATION PROTEINS; NACREOUS LAYER FORMATION; ALPHA-HELICAL STRUCTURE; DYE STAINS-ALL; CIRCULAR-DICHROISM; UNSTRUCTURED PROTEINS; POLYELECTROLYTE DOMAINS; PHOSPHORYLATION SITES; PROCAMBARUS-CLARKII; SECONDARY STRUCTURE	Fish otoliths, biominerals composed of calcium carbonate with a small amount of organic matrix, are involved in the functioning of the inner ear. Starmaker (Stm) from zebrafish (Danio rerio) was the first protein found to be capable of controlling the formation of otoliths. Recently, a gene was identified encoding the Starmaker-like (Stm-l) protein from medaka (Oryzias latipes), a putative homologue of Stm and human dentine sialophosphoprotein. Although there is no sequence similarity between Stm-l and Stm, Stm-l was suggested to be involved in the biomineralization of otoliths, as had been observed for Stm even before. The molecular properties and functioning of Stm-l as a putative regulatory protein in otolith formation have not been characterized yet. A comprehensive biochemical and biophysical analysis of recombinant Stm-l, along with in silico examinations, indicated that Stm-l exhibits properties of a coil-like intrinsically disordered protein. Stm-l possesses an elongated and pliable structure that is able to adopt a more ordered and rigid conformation under the influence of different factors. An in vitro assay of the biomineralization activity of Stm-l indicated that Stm-l affected the size, shape and number of calcium carbonate crystals. The functional significance of intrinsically disordered properties of Stm-l and the possible role of this protein in controlling the formation of calcium carbonate crystals is discussed.	[Rozycka, Miroslawa; Wojtas, Magdalena; Jakob, Michal; Ozyhar, Andrzej] Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland; [Stigloher, Christian] Univ Wurzburg, Bioctr, Div Elect Microscopy, D-97070 Wurzburg, Germany; [Grzeszkowiak, Mikolaj] Adam Mickiewicz Univ, Fac Phys, NanoBioMed Ctr, Poznan, Poland; [Grzeszkowiak, Mikolaj] Wroclaw Univ Technol, Fac Chem, Dept Macromol Phys, PL-50370 Wroclaw, Poland; [Mazur, Maciej] Univ Warsaw, Dept Chem, Warsaw, Poland	Wroclaw University of Science & Technology; University of Wurzburg; Adam Mickiewicz University; Wroclaw University of Science & Technology; University of Warsaw	Ozyhar, A (corresponding author), Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.	andrzej.ozyhar@pwr.edu.pl	Różycka, Mirosława/V-4541-2018; Stigloher, Christian/E-4762-2015	Różycka, Mirosława/0000-0002-8008-6689; Stigloher, Christian/0000-0001-6941-2669; OZYHAR, Andrzej/0000-0002-5874-784X; Mazur, Maciej/0000-0002-9197-5553	Polish Ministry of Science and Higher Education for the Faculty of Chemistry of the Wroclaw University of Technology; National Science Centre [NN 204 1200 40]; European Social Fund within the project Development of common PhD studies in nanotechnology-electronics and photovoltaics in Macromolecular Physics Institute of Polish Academy of Science; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Polish Ministry of Science and Higher Education for the Faculty of Chemistry of the Wroclaw University of Technology; National Science Centre(National Science Centre, Poland); European Social Fund within the project Development of common PhD studies in nanotechnology-electronics and photovoltaics in Macromolecular Physics Institute of Polish Academy of Science; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This work was supported by the statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry of the Wroclaw University of Technology. This work was supported in part by the National Science Centre grant NN 204 1200 40. This work was also supported by the European Social Fund within the project Development of common PhD studies in nanotechnology-electronics and photovoltaics in Macromolecular Physics Institute of Polish Academy of Science and at the Faculty of Physics at Adam Mickiewicz University in Poznan. Publication fee was covered by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers G K, 1970, Adv Protein Chem, V24, P343, DOI 10.1016/S0065-3233(08)60245-4; Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Allemand Denis, 2007, P291, DOI 10.1002/9783527619443.ch17; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bajoghli B, 2009, DEV DYNAM, V238, P2860, DOI 10.1002/dvdy.22093; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Batas B, 1997, J CHROMATOGR A, V766, P109, DOI 10.1016/S0021-9673(96)01020-5; Begg GE, 2001, CURR PROTOC PROTEIN; Begg GE, 1999, CURRENT PROTOCOLS PR, P1078; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borelli G, 2003, J EXP BIOL, V206, P2685, DOI 10.1242/jeb.00479; Borelli G, 2001, CALCIFIED TISSUE INT, V69, P356, DOI 10.1007/s00223-001-2016-8; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; Cui ZJ, 2012, AMINO ACIDS, V43, P505, DOI 10.1007/s00726-011-1175-9; Dai LJ, 2008, J NON-CRYST SOLIDS, V354, P1845, DOI 10.1016/j.jnoncrysol.2007.10.022; DEHAEN C, 1987, ANAL BIOCHEM, V166, P235, DOI 10.1016/0003-2697(87)90570-7; Delak K, 2009, BIOCHEMISTRY-US, V48, P3669, DOI 10.1021/bi900113v; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dong A, 1998, ARCH BIOCHEM BIOPHYS, V355, P275, DOI 10.1006/abbi.1998.0718; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; Fujisawa R, 1998, EUR J ORAL SCI, V106, P249, DOI 10.1111/j.1600-0722.1998.tb02183.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; George A, 2005, CELLS TISSUES ORGANS, V181, P232, DOI 10.1159/000091384; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; Guibbolini M, 2006, COMP BIOCHEM PHYS A, V145, P99, DOI 10.1016/j.cbpa.2006.05.003; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Inoue H, 2007, PEPTIDES, V28, P566, DOI 10.1016/j.peptides.2006.12.005; Jayaraman G, 1996, BIOCHEM BIOPH RES CO, V222, P33, DOI 10.1006/bbrc.1996.0693; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kaplon TM, 2008, BIOMACROMOLECULES, V9, P2118, DOI 10.1021/bm800135m; Kaplon TM, 2009, BBA-PROTEINS PROTEOM, V1794, P1616, DOI 10.1016/j.bbapap.2009.07.010; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Keene EC, 2010, CRYST GROWTH DES, V10, P1383, DOI 10.1021/cg901389v; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Kim IW, 2006, CRYST GROWTH DES, V6, P1078, DOI 10.1021/cg060056q; Kim IW, 2004, CRYST GROWTH DES, V4, P1113, DOI 10.1021/cg049919a; Klaning E, 2014, BONE; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liao SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02136; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manon F, 2010, ANONYMOUS INSTRUMENT, P431, DOI [DOI 10.1002/9780470602614CH15, 10.1002/9780470602614.ch15.]; Marin Frederic, 2007, P273, DOI 10.1002/9783527619443.ch16; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Mitrea DM, 2012, BIOCOMPUT-PAC SYM, P152; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Payan P, 1999, AM J PHYSIOL-REG I, V277, pR123, DOI 10.1152/ajpregu.1999.277.1.R123; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSS MD, 1984, PHILOS T ROY SOC B, V304, P445, DOI 10.1098/rstb.1984.0038; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Salvay Andres G, 2012, Methods Mol Biol, V896, P91, DOI 10.1007/978-1-4614-3704-8_6; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TAL M, 1985, J BIOL CHEM, V260, P9976; Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Uversky Vladimir N, 2012, Methods Mol Biol, V896, P179, DOI 10.1007/978-1-4614-3704-8_11; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Walther LE, 2007, J VESTIBUL RES-EQUIL, V17, P89; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weber K, 1972, Methods Enzymol, V26, P3; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Wojtas M, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P3; Wojtas Magdalena, 2012, Methods Mol Biol, V896, P319, DOI 10.1007/978-1-4614-3704-8_21; Wojtas M, 2012, CRYST GROWTH DES, V12, P158, DOI 10.1021/cg200905f; Wustman BA, 2004, BIOPOLYMERS, V74, P363, DOI 10.1002/bip.20086; Wustman BA, 2003, CONNECT TISSUE RES, V44, P10, DOI 10.1080/03008200390152016; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020498; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	125	29	29	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114308	10.1371/journal.pone.0114308	http://dx.doi.org/10.1371/journal.pone.0114308			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490041	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300025
J	Sims, S; Colston, J; Emery, V; Klenerman, P				Sims, Stuart; Colston, Julia; Emery, Vince; Klenerman, Paul			CD73 Is Dispensable for the Regulation of Inflationary CD8(+) T-Cells after Murine Cytomegalovirus Infection and Adenovirus Immunisation	PLOS ONE			English	Article							MEMORY INFLATION; ADENOSINE RECEPTOR; LATENCY; VIRUS	The ecto-5'-nucleotidase (CD73) is expressed by T-cell subsets, myeloid derived suppressive cells and endothelial cells. It works in conjunction with CD39 to regulate the formation and degradation of adenosine in vivo. Adenosine has previously been shown to suppress the proliferation and cytokine secretion of T-cells and recent evidence suggests that inhibition of CD73 has the potential to enhance T-cell directed therapies. Here we utilised a CD73 knockout mouse model to assess the suppressive ability of CD73 on CD8(+) T-cell classical memory and memory "inflation", induced by murine cytomegalovirus (MCMV) infection and adenovirus immunisation. We show that CD73 is dispensable for normal CD8(+) T-cell differentiation and function in both models. Thus CD73 as a suppressor of CD8(+) T-cells is unlikely to play a deterministic role in the generation and functional characteristics of antiviral memory in these settings.	[Sims, Stuart; Colston, Julia; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford, England; [Emery, Vince] Univ Surrey, Dept Microbial & Cellular Sci, Guildford GU2 5XH, Surrey, England	University of Oxford; University of Surrey	Sims, S (corresponding author), Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.	stuart.sims@bsse.ethz.ch; paul.klenerman@ndm.ox.ac.uk	; Emery, Vincent/G-8928-2013	Colston, Julia/0000-0002-3337-2455; klenerman, paul/0000-0003-4307-9161; Emery, Vincent/0000-0001-5893-9756; sims, stuart/0000-0002-6327-0927	Wellcome Trust [MA 091663]; Oxford Martin School	Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Martin School	This work was funded by the Wellcome Trust (MA 091663 and fellowship to Julia Colston) and the Oxford Martin School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bolinger B, 2013, J IMMUNOL, V190, P4162, DOI 10.4049/jimmunol.1202665; Carriere M, 2014, J INFECT DIS, V209, P1321, DOI 10.1093/infdis/jit643; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Gamadia LE, 2004, J IMMUNOL, V172, P6107, DOI 10.4049/jimmunol.172.10.6107; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Humphreys IR, 2010, EUR J IMMUNOL, V40, P2762, DOI 10.1002/eji.200940256; Hutchinson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014646; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kinsey GR, 2012, J AM SOC NEPHROL, V23, P1528, DOI 10.1681/ASN.2012010070; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Lang A, 2009, J IMMUNOL, V183, P8077, DOI 10.4049/jimmunol.0801117; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Marashi SM, 2011, J ALLERGY CLIN IMMUN, V127, P1385, DOI 10.1016/j.jaci.2011.04.001; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Ohta A, 2009, J IMMUNOL, V183, P5487, DOI 10.4049/jimmunol.0901247; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; ROMERO P, 2007, J IMMUNOLOGY; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Swanson PA, 2009, J IMMUNOL, V182, P5198, DOI 10.4049/jimmunol.0900421; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tsuda Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001275; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279	29	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114323	10.1371/journal.pone.0114323	http://dx.doi.org/10.1371/journal.pone.0114323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490556	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300029
J	Jimenez, S; Navarro, V; Moyano, J; Sanchez-Mico, M; Torres, M; Davila, JC; Vizuete, M; Gutierrez, A; Vitorica, J				Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Torres, Manuel; Carlos Davila, Jose; Vizuete, Marisa; Gutierrez, Antonia; Vitorica, Javier			Disruption of Amyloid Plaques Integrity Affects the Soluble Oligomers Content from Alzheimer Disease Brains	PLOS ONE			English	Article							A-BETA OLIGOMERS; MOUSE MODEL; PROTEIN; AGE; ACCUMULATION; PATHOGENESIS; AGGREGATION; PATHOLOGY; DEMENTIA; ISF	The implication of soluble Abeta in the Alzheimer's disease (AD) pathology is currently accepted. In fact, the content of soluble extracellular Abeta species, such as monomeric and/or oligomeric Abeta, seems to correlate with the clinicopathological dysfunction observed in AD patients. However, the nature (monomeric, dimeric or other oligomers), the relative abundance, and the origin (extra-/intraneuronal or plaque-associated), of these soluble species are actually under debate. In this work we have characterized the soluble (defined as soluble in Tris-buffered saline after ultracentrifugation) Abeta, obtained from hippocampal samples of Braak II, Braak III-IV and Braak V-VI patients. Although the content of both Abeta40 and Abeta42 peptides displayed significant increase with pathology progression, our results demonstrated the presence of low, pg/mu g protein, amount of both peptides. This low content could explain the absence (or below detection limits) of soluble Abeta peptides detected by western blots or by immunoprecipitation-western blot analysis. These data were in clear contrast to those published recently by different groups. Aiming to explain the reasons that determine these substantial differences, we also investigated whether the initial homogenization could mobilize Abeta from plaques, using 12-month-old PS1xAPP cortical samples. Our data demonstrated that manual homogenization (using Dounce) preserved the integrity of Abeta plaques whereas strong homogenization procedures (such as sonication) produced a vast redistribution of the Abeta species in all soluble and insoluble fractions. This artifact could explain the dissimilar and somehow controversial data between different groups analyzing human AD samples.	[Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Torres, Manuel; Vizuete, Marisa; Vitorica, Javier] Univ Seville, Fac Farm, Dept Bioquim & Biol Mol, Seville, Spain; [Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Torres, Manuel; Vizuete, Marisa; Vitorica, Javier] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Carlos Davila, Jose; Gutierrez, Antonia] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Fac Ciencias, Dept Biol Celular Gene & Fisiol, E-29071 Malaga, Spain; [Jimenez, Sebastian; Navarro, Victoria; Moyano, Javier; Sanchez-Mico, Maria; Carlos Davila, Jose; Vizuete, Marisa; Gutierrez, Antonia; Vitorica, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidad de Malaga; CIBERNED	Gutierrez, A (corresponding author), Univ Malaga, Inst Invest Biomed Malaga IBIMA, Fac Ciencias, Dept Biol Celular Gene & Fisiol, E-29071 Malaga, Spain.	agutierrez@uma.es; vitorica@us.es	Jimenez, Sebastian Jimenez S/K-6168-2017; Navarro Garrido, Victoria/U-2291-2017; Torres, Manuel/F-7963-2016; Sanchez-Mico, Maria V./A-4234-2019; IBIS, ALZHEIMER/O-9867-2015	Jimenez, Sebastian Jimenez S/0000-0002-9151-7587; Navarro Garrido, Victoria/0000-0002-4385-9697; Torres, Manuel/0000-0002-5076-8486; Sanchez-Mico, Maria V./0000-0001-9156-4327; Davila Cansino, Jose Carlos/0000-0001-7016-288X; Gutierrez Perez, Antonia/0000-0002-6264-6152	Fondo de Investigacion Sanitaria (FIS), from Instituto de Salud Carlos III of Spain [PI12/01431, PI12/01439]; Junta de Andalucia [CTS-2035]; Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED) [PI2010/08, PI2013/01]	Fondo de Investigacion Sanitaria (FIS), from Instituto de Salud Carlos III of Spain; Junta de Andalucia(Junta de Andalucia); Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED)	This work was supported by Fondo de Investigacion Sanitaria (FIS), from Instituto de Salud Carlos III of Spain, through grants PI12/01431 (to AG) and PI12/01439 (to JV), by Junta de Andalucia (collaborative grant CTS-2035 to JV and AG), and by Centro de Investigacion Biomedica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED) (collaborative grants PI2010/08 and PI2013/01 to JV and AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Rijal Upadhaya Ajeet, 2012, Neurobiol Aging, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Rostagno A, 2001, CURRENT PROTOCOLS CE; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005	24	16	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114041	10.1371/journal.pone.0114041	http://dx.doi.org/10.1371/journal.pone.0114041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485545	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907600039
J	Seven, J; Polle, A				Seven, Jasmin; Polle, Andrea			Subcellular Nutrient Element Localization and Enrichment in Ecto- and Arbuscular Mycorrhizas of Field-Grown Beech and Ash Trees Indicate Functional Differences	PLOS ONE			English	Article							TEMPERATE DECIDUOUS FOREST; X-RAY-MICROANALYSIS; PINUS-SYLVESTRIS; POLYPHOSPHATE GRANULES; ECTOMYCORRHIZAL FUNGI; COMMUNITY COMPOSITION; FRAXINUS-EXCELSIOR; FAGUS-SYLVATICA; DIVERSITY; ROOTS	Mycorrhizas are the chief organ for plant mineral nutrient acquisition. In temperate, mixed forests, ash roots (Fraxinus excelsior) are colonized by arbuscular mycorrhizal fungi (AM) and beech roots (Fagus sylvatica) by ectomycorrhizal fungi (EcM). Knowledge on the functions of different mycorrhizal species that coexist in the same environment is scarce. The concentrations of nutrient elements in plant and fungal cells can inform on nutrient accessibility and interspecific differences of mycorrhizal life forms. Here, we hypothesized that mycorrhizal fungal species exhibit interspecific differences in mineral nutrient concentrations and that the differences correlate with the mineral nutrient concentrations of their associated root cells. Abundant mycorrhizal fungal species of mature beech and ash trees in a long-term undisturbed forest ecosystem were the EcM Lactarius subdulcis, Clavulina cristata and Cenococcum geophilum and the AM Glomus sp. Mineral nutrient subcellular localization and quantities of the mycorrhizas were analysed after non-aqueous sample preparation by electron dispersive X-ray transmission electron microscopy. Cenococcum geophilum contained the highest sulphur, Clavulina cristata the highest calcium levels, and Glomus, in which cations and P were generally high, exhibited the highest potassium levels. Lactarius subdulcis-associated root cells contained the highest phosphorus levels. The root cell concentrations of K, Mg and P were unrelated to those of the associated fungal structures, whereas S and Ca showed significant correlations between fungal and plant concentrations of those elements. Our results support profound interspecific differences for mineral nutrient acquisition among mycorrhizas formed by different fungal taxa. The lack of correlation between some plant and fungal nutrient element concentrations may reflect different retention of mineral nutrients in the fungal part of the symbiosis. High mineral concentrations, especially of potassium, in Glomus sp. suggest that the well-known influence of tree species on chemical soil properties may be related to their mycorrhizal associates.	[Seven, Jasmin; Polle, Andrea] Busgen Inst, D-37077 Gottingen, Germany		Polle, A (corresponding author), Busgen Inst, Busgenweg 2, D-37077 Gottingen, Germany.	apolle@gwdg.de		Polle, Andrea/0000-0001-8697-6394	German Science Foundation [GRK 1086]; University of Gottingen; Deutsche Forschungsgemeinschaft;  [INST 186/766-1 FUGG]	German Science Foundation(German Research Foundation (DFG)); University of Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	Funding: This study was financially supported by the German Science Foundation (http://www.dfg.de/) by a grant to the Graduate school GRK 1086 "Die Bedeutung der Biodiversitat fur Stoffkreislaufe und biotische Interaktionen in temperaten Laubwaldern" (project A1) to AP and JS and by grant No. INST 186/766-1 FUGG to AP. The publication fund of the University of Gottingen and the Deutsche Forschungsgemeinschaft supported open access publication of this article (http://www.sub.uni-goettingen.de/elektronisches-publizieren/open-access/open-access-publikationsfonds/) by a grant to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R., 1987, COLOR ATLAS ECTOMYCO; Aponte C, 2013, FOREST ECOL MANAG, V309, P36, DOI 10.1016/j.foreco.2013.05.035; ASHFORD AE, 1986, CAN J BOT, V64, P677, DOI 10.1139/b86-086; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BONFANTE P, 1995, NEW PHYTOL, V130, P3, DOI 10.1111/j.1469-8137.1995.tb01810.x; Bonfante-Fasolo P, 2004, MYCORRHIZAL FUNCTION, P65; Bonneville S, 2011, GEOCHIM COSMOCHIM AC, V75, P6988, DOI 10.1016/j.gca.2011.08.041; Bucking H, 2002, J EXP BOT, V53, P1659, DOI 10.1093/jxb/erf011; Bucking H, 1998, MICRON, V29, P53, DOI 10.1016/S0968-4328(97)00059-0; Bucking H, 2000, NEW PHYTOL, V145, P321, DOI 10.1046/j.1469-8137.2000.00574.x; Bucking H, 2000, NEW PHYTOL, V145, P311, DOI 10.1046/j.1469-8137.2000.00572.x; Chen SL, 2014, MATERIALS, V7, P3160, DOI 10.3390/ma7043160; COLPAERT JV, 1992, NEW PHYTOL, V120, P127, DOI 10.1111/j.1469-8137.1992.tb01065.x; Courty PE, 2008, APPL ENVIRON MICROB, V74, P5792, DOI 10.1128/AEM.01592-08; COX G, 1976, NEW PHYTOL, V77, P371, DOI 10.1111/j.1469-8137.1976.tb01526.x; Dickie IA, 2005, J ECOL, V93, P244, DOI 10.1111/j.1365-2745.2005.00977.x; Ducic T, 2008, MYCORRHIZA, V18, P227, DOI 10.1007/s00572-008-0174-5; Emborg J, 1998, FOREST ECOL MANAG, V106, P83, DOI 10.1016/S0378-1127(97)00299-5; Fernandez CW, 2013, SOIL BIOL BIOCHEM, V65, P141, DOI 10.1016/j.soilbio.2013.05.022; FRANZ F, 1995, NOVA HEDWIGIA, V61, P367; FRITZ E, 1989, SCANNING MICROSCOPY, V3, P517; Fritz E, 2007, MICROSC MICROANAL, V13, P233, DOI 10.1017/S1431927607070420; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; Hagerberg D, 2005, MYCORRHIZA, V15, P387, DOI 10.1007/s00572-004-0344-z; HARLEY JL, 1952, NEW PHYTOL, V51, P56, DOI 10.1111/j.1469-8137.1952.tb06115.x; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Kottke I, 1998, MYCORRHIZA, V7, P267, DOI 10.1007/s005720050191; KOTTKE I, 1995, NEW PHYTOL, V129, P411, DOI 10.1111/j.1469-8137.1995.tb04311.x; Kottke I, 1986, TREES-STRUCT FUNCT, V1, P1, DOI 10.1007/BF00197021; Lang C, 2011, TREE PHYSIOL, V31, P531, DOI 10.1093/treephys/tpr042; Lang C, 2011, MYCORRHIZA, V21, P297, DOI 10.1007/s00572-010-0338-y; Langenbruch C, 2012, PLANT SOIL, V352, P389, DOI 10.1007/s11104-011-1004-7; Leuschner C, 2009, BASIC APPL ECOL, V10, P1, DOI 10.1016/j.baae.2008.06.001; LINGLEE M, 1975, NEW PHYTOL, V75, P551, DOI 10.1111/j.1469-8137.1975.tb01418.x; Marigo G, 2000, TREES-STRUCT FUNCT, V15, P1, DOI 10.1007/s004680000061; McCully ME, 2010, FUNCT PLANT BIOL, V37, P1011, DOI 10.1071/FP10095; Meinen C, 2009, OECOLOGIA, V161, P99, DOI 10.1007/s00442-009-1352-7; Mitchell RJ, 2012, PLANT SOIL, V352, P65, DOI 10.1007/s11104-011-0980-y; Molder A., 2006, WALDOKOLOGIE ONLINE, V3, P83; Olsson PA, 2008, APPL ENVIRON MICROB, V74, P4144, DOI 10.1128/AEM.00376-08; Pena R, 2014, ISME J, V8, P321, DOI 10.1038/ismej.2013.158; Pena R, 2010, APPL ENVIRON MICROB, V76, P1831, DOI 10.1128/AEM.01703-09; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Rineau F, 2010, FUNGAL BIOL-UK, V114, P1007, DOI 10.1016/j.funbio.2010.09.011; Rineau F, 2009, MYCORRHIZA, V19, P493, DOI 10.1007/s00572-009-0249-y; Rumberger MD, 2005, MYCORRHIZA, V15, P307, DOI 10.1007/s00572-005-0350-9; Rumberger MD, 2004, PLANT SOIL, V264, P111, DOI 10.1023/B:PLSO.0000047793.14857.4f; SANDERS FE, 1977, NEW PHYTOL, V78, P257, DOI 10.1111/j.1469-8137.1977.tb04829.x; Scheidegger C, 1998, MYCLORRHIZA STRUCTUR, P205; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Talkner U, 2009, EUR J SOIL SCI, V60, P338, DOI 10.1111/j.1365-2389.2008.01117.x; Talkner U, 2010, PLANT SOIL, V336, P405, DOI 10.1007/s11104-010-0491-2; Taylor Andy F. S., 2005, Mycologist, V19, P102, DOI 10.1017/S0269915X05003034; vanBreemen N, 1997, CAN J FOREST RES, V27, P1110, DOI 10.1139/cjfr-27-7-1110; Wallander H, 2003, FEMS MICROBIOL ECOL, V44, P57, DOI 10.1111/j.1574-6941.2003.tb01090.x; Wang Q, 2011, MYCOL PROG, V10, P323, DOI 10.1007/s11557-010-0705-2	59	18	18	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114672	10.1371/journal.pone.0114672	http://dx.doi.org/10.1371/journal.pone.0114672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486253	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600086
J	Solin, SL; Wang, Y; Mauldin, J; Schultz, LE; Lincow, DE; Brodskiy, PA; Jones, CA; Syrkin-Nikolau, J; Linn, JM; Essner, JJ; Hostetter, JM; Whitley, EM; Cameron, JD; Chou, HH; Severin, AJ; Sakaguchi, DS; McGrail, M				Solin, Staci L.; Wang, Ying; Mauldin, Joshua; Schultz, Laura E.; Lincow, Deborah E.; Brodskiy, Pavel A.; Jones, Crystal A.; Syrkin-Nikolau, Judith; Linn, Jasmine M.; Essner, Jeffrey J.; Hostetter, Jesse M.; Whitley, Elizabeth M.; Cameron, J. Douglas; Chou, Hui-Hsien; Severin, Andrew J.; Sakaguchi, Donald S.; McGrail, Maura			Molecular and Cellular Characterization of a Zebrafish Optic Pathway Tumor Line Implicates Glia-Derived Progenitors in Tumorigenesis	PLOS ONE			English	Article							MULLER GLIA; STEM-CELLS; REGENERATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; SUFFICIENT; TARGET; GROWTH	In this study we describe the molecular and cellular characterization of a zebrafish mutant that develops tumors in the optic pathway. Heterozygous Tg(flk1:RFP) is18 transgenic adults develop tumors of the retina, optic nerve and optic tract. Molecular and genetic mapping demonstrate the tumor phenotype is linked to a high copy number transgene array integrated in the lincRNA gene lincRNAis18/Zv9_00007276 on chromosome 3. TALENs were used to isolate a 147kb deletion allele that removes exons 2-5 of the lincRNAis18 gene. Deletion allele homozygotes are viable and do not develop tumors, indicating loss of function of the lincRNAis18 locus is not the trigger for tumor onset. Optic pathway tumors in the Tg(flk1:RFP) is18 mutant occur with a penetrance of 80-100% by 1 year of age. The retinal tumors are highly vascularized and composed of rosettes of various sizes embedded in a fibrous matrix. Immunohistochemical analysis showed increased expression of the glial markers GFAP and BLBP throughout retinal tumors and in dysplastic optic nerve. We performed transcriptome analysis of pre-tumorous retina and retinal tumor tissue and found changes in gene expression signatures of radial glia and astrocytes (slc1a3), activated glia (atf3, blbp, apoeb), proliferating neural progenitors (foxd3, nestin, cdh2, her9/hes1), and glioma markers (S100 beta, vim). The transcriptome also revealed activation of cAMP, Stat3 and Wnt signal transduction pathways. qRT-PCR confirmed.10-fold overexpression of the Wnt pathway components hbegfa, ascl1a, and insm1a. Together the data indicate Muller glia and/or astrocyte-derived progenitors could contribute to the zebrafish Tg(flk1:RFP) is18 optic pathway tumors.	[Solin, Staci L.; Wang, Ying; Mauldin, Joshua; Schultz, Laura E.; Lincow, Deborah E.; Brodskiy, Pavel A.; Jones, Crystal A.; Syrkin-Nikolau, Judith; Linn, Jasmine M.; Essner, Jeffrey J.; Chou, Hui-Hsien; Sakaguchi, Donald S.; McGrail, Maura] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Hostetter, Jesse M.; Whitley, Elizabeth M.] Iowa State Univ, Dept Vet Pathol, Ames, IA USA; [Cameron, J. Douglas] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN USA; [Severin, Andrew J.] Univ Minnesota, Genome Informat Facil, Off Biotechnol, Minneapolis, MN USA	Iowa State University; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McGrail, M (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	mmcgrail@iastate.edu	McGrail, Maura/AAA-5610-2021	McGrail, Maura/0000-0001-9308-6189; Essner, Jeffrey/0000-0001-8816-3848; Hostetter, Jesse/0000-0002-5555-5121; Brodskiy, Pavel/0000-0002-1951-7734; LINCOW, DEBORAH/0000-0002-3463-5368; Sakaguchi, Donald/0000-0003-4537-0972	Roy J. Carver Charitable Trust [14-14418]; Research to Prevent Blindness; Iowa State University Center for Integrated Animal Genomics; Iowa State University DOE/SULI and CC Research Experience for Undergraduate Programs; Iowa State University IINspire-LSAMP program; Iowa State University Startup funds; NATIONAL CANCER INSTITUTE [R03CA182061] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Iowa State University Center for Integrated Animal Genomics; Iowa State University DOE/SULI and CC Research Experience for Undergraduate Programs; Iowa State University IINspire-LSAMP program; Iowa State University Startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Roy J. Carver Charitable Trust [14-14418 MM], Research to Prevent Blindness [DJC], the Iowa State University Center for Integrated Animal Genomics [JJE, MM, DSS], Iowa State University DOE/SULI and CC Research Experience for Undergraduate Programs [DEL, PAB], Iowa State University IINspire-LSAMP program [CAJ], and Iowa State University Startup funds [MM]. Dr. Cameron is supported in part by an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Neurosciences of the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Banerjee S, 2011, P NATL ACAD SCI USA, V108, P15996, DOI 10.1073/pnas.1019012108; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Blong CC, 2010, J NEUROSCI RES, V88, P1445, DOI 10.1002/jnr.22324; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen YH, 2013, ONCOGENE; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Gallina D, 2014, EXP EYE RES, V123, P121, DOI 10.1016/j.exer.2013.06.019; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Gorsuch RA, 2013, EXP EYE RES; Gorsuch RA, 2014, EXP EYE RES, V123, P131, DOI 10.1016/j.exer.2013.07.012; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ju B, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.10; Kassen SC, 2009, EXP EYE RES, V88, P1051, DOI 10.1016/j.exer.2009.01.007; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Lin NJ, 2012, MOL CANCER RES, V10, P208, DOI 10.1158/1541-7786.MCR-10-0109; McGrail M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018826; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nelson CM, 2012, J COMP NEUROL, V520, P4294, DOI 10.1002/cne.23213; Neve LD, 2012, COMP BIOCHEM PHYS C, V155, P213, DOI 10.1016/j.cbpc.2011.08.006; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Ramachandran R, 2012, NAT CELL BIOL, V14, P1013, DOI 10.1038/ncb2586; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Rodriguez EF, 2011, ACTA NEUROPATHOL, V121, P407, DOI 10.1007/s00401-010-0784-9; Rodriguez FJ, 2013, ANNU REV PATHOL-MECH, V8, P361, DOI 10.1146/annurev-pathol-020712-164009; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Saul KE, 2010, COMP BIOCHEM PHYS A, V155, P172, DOI 10.1016/j.cbpa.2009.10.042; Severin AJ, 2010, PLANT PHYSIOL, V154, P3, DOI 10.1104/pp.110.158949; Shibata T, 1997, J NEUROSCI, V17, P9212; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Sun L, 2014, J CHEM-NY, DOI DOI 10.1155/2014/295149; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	44	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114888	10.1371/journal.pone.0114888	http://dx.doi.org/10.1371/journal.pone.0114888			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485542	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907600104
J	Sun, LY; Zhao, H; Kang, Y; Shen, XD; Cai, ZY; Shen, JY; He, B; Yang, CD				Sun, Ling-Yue; Zhao, Hang; Kang, Yu; Shen, Xue-dong; Cai, Zong-ye; Shen, Jie-yan; He, Ben; Yang, Cheng-de			Two-Dimensional Echocardiography in the Assessment of Long-Term Prognosis in Patients with Pulmonary Arterial Hypertension	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; DOPPLER-ECHOCARDIOGRAPHY; AMERICAN-SOCIETY; VASCULAR-RESISTANCE; HEART-FAILURE; TEI-INDEX; GUIDELINES; RECOMMENDATIONS; VALIDATION; CATHETERIZATION	Objective: To investigate the relationship between cardiac diastolic dysfunction and outcomes in patients with pulmonary arterial hypertension (PAH) and to clarify the potential effect of two-dimensional echocardiography (2D-echo) on prognostic value in patients with PAH. Methods: Patients diagnosed with PAH (as WSPH (World Symposia on Pulmonary Hypertension) classification I) confirmed by right heart catheterization (RHC), received targeted monotherapy or combination therapy. 2D-echo parameters, World Health Organization (WHO) functional classification and 6-minute walking distance (6MWD) were recorded. The clinical prognosis of patients was assessed by the correlation between echo parameters and clinical 6MWD using receiver operating characteristic (ROC) curve analysis. Results: Fifty-eight patients were included. Left and right ventricular diastolic dysfunction (LVDD and RVDD) scores measured by 2D-echo had good correlation with 6MWD at baseline (r(LVDD) = -0.699; r(RVDD) = -0.818, both P<0.001) and at last follow-up (r(LVDD) = -0.701; r(RVDD) = -0.666, both P<0.001). Furthermore, bi-ventricular (LVDD+RVDD) scores measured by 2D-echo had a better correlation with 6MWD at baseline and last follow-up (r=-0.831; r=-0.771, both P<0.001). ROC curve analysis showed that the area under curves (AUCs) for LVDD score, RVDD score and (LVDD+RVDD) scores were 0.823 (P<0.0001), 0.737 (P=0.0002), and 0.825 (P<0.0001), respectively. Compared with ROC analysis of other single parameters, cardiac diastolic function score was more accurate in predicting survival in patients with PAH. Conclusion: LVDD score, RVDD score and (LVDD+RVDD) scores yielded a comprehensive quantitative assessment of LV and RV diastolic function that correlated moderately with clinical functional parameters and might be useful in the assessment of PAH.	[Sun, Ling-Yue; Zhao, Hang; Kang, Yu; Shen, Xue-dong; Cai, Zong-ye; Shen, Jie-yan; He, Ben] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Yang, Cheng-de] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	dr_jyshen@sina.cn	Kang, Yu/K-8894-2019	Kang, Yu/0000-0003-0446-0867; Cai, Zongye/0000-0002-4898-1907				Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Blanchard DG, 2009, JACC-CARDIOVASC IMAG, V2, P143, DOI 10.1016/j.jcmg.2008.10.012; Chapman CB, 2013, ECHOCARDIOGR-J CARD, V30, P1022, DOI 10.1111/echo.12185; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Gabler NB, 2012, CIRCULATION, V126, P349, DOI 10.1161/CIRCULATIONAHA.112.105890; Galie N, 2013, J AM COLL CARDIOL, V62, pD1, DOI 10.1016/j.jacc.2013.10.030; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghio S, 2010, INT J CARDIOL, V140, P272, DOI 10.1016/j.ijcard.2008.11.051; Gopal AS, 2007, J AM SOC ECHOCARDIOG, V20, P445, DOI 10.1016/j.echo.2006.10.027; Hsu VM, 2008, J RHEUMATOL, V35, P458; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Inaba T, 2013, CIRC J, V77, P198, DOI 10.1253/circj.CJ-12-0203; Jurcut R, 2011, J AM SOC ECHOCARDIOG, V24, P1109, DOI 10.1016/j.echo.2011.07.016; Kassem E, 2013, AM HEART J, V165, P1024, DOI 10.1016/j.ahj.2013.02.027; Koestenberger M, 2012, CONGENIT HEART DIS, V7, P250, DOI 10.1111/j.1747-0803.2012.00655.x; Kuehne T, 2005, HEART, V91, P1064, DOI 10.1136/hrt.2004.038265; Mauritz GJ, 2012, CHEST, V141, P935, DOI 10.1378/chest.10-3277; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ogihara Y, 2014, J CARDIOL, V63, P149, DOI 10.1016/j.jjcc.2013.07.002; Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sato T, 2012, J AM SOC ECHOCARDIOG, V25, P280, DOI 10.1016/j.echo.2011.12.012; Sebbag I, 2001, AM J CARDIOL, V88, P1060, DOI 10.1016/S0002-9149(01)01995-6; Shen JY, 1999, RHEUMATOL INT, V18, P147, DOI 10.1007/s002960050074; Straburzynska-Migaj E, 2007, KARDIOL POL, V65, P1049; Tonelli AR, 2012, CHEST, V141, P1457, DOI 10.1378/chest.11-1903; Van Empel VPM, 2014, J CARD FAIL, V20, P98, DOI 10.1016/j.cardfail.2013.12.010; Vitarelli A, 2012, INT J CARDIOVAS IMAG, V28, P1905, DOI 10.1007/s10554-012-0022-8; Wallentin Guron C, 2005, EUR J ECHOCARDIOGR, V6, P419; Yeo TC, 1998, AM J CARDIOL, V81, P1157, DOI 10.1016/S0002-9149(98)00140-4; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	35	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114443	10.1371/journal.pone.0114443	http://dx.doi.org/10.1371/journal.pone.0114443			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25485890	gold, Green Submitted, Green Published			2022-12-26	WOS:000346907600056
J	Karreman, MA; Mercier, L; Schieber, NL; Shibue, T; Schwab, Y; Goetz, JG				Karreman, Matthia A.; Mercier, Luc; Schieber, Nicole L.; Shibue, Tsukasa; Schwab, Yannick; Goetz, Jacky G.			Correlating Intravital Multi-Photon Microscopy to 3D Electron Microscopy of Invading Tumor Cells Using Anatomical Reference Points	PLOS ONE			English	Article							COLLECTIVE INVASION; LIGHT; FLUORESCENCE; ZEBRAFISH; MICROENVIRONMENT; PHOTOOXIDATION; ULTRASTRUCTURE; TOMOGRAPHY; FIXATION; TISSUES	Correlative microscopy combines the advantages of both light and electron microscopy to enable imaging of rare and transient events at high resolution. Performing correlative microscopy in complex and bulky samples such as an entire living organism is a time-consuming and error-prone task. Here, we investigate correlative methods that rely on the use of artificial and endogenous structural features of the sample as reference points for correlating intravital fluorescence microscopy and electron microscopy. To investigate tumor cell behavior in vivo with ultrastructural accuracy, a reliable approach is needed to retrieve single tumor cells imaged deep within the tissue. For this purpose, fluorescently labeled tumor cells were subcutaneously injected into a mouse ear and imaged using two-photon-excitation microscopy. Using near-infrared branding, the position of the imaged area within the sample was labeled at the skin level, allowing for its precise recollection. Following sample preparation for electron microscopy, concerted usage of the artificial branding and anatomical landmarks enables targeting and approaching the cells of interest while serial sectioning through the specimen. We describe here three procedures showing how three-dimensional (3D) mapping of structural features in the tissue can be exploited to accurately correlate between the two imaging modalities, without having to rely on the use of artificially introduced markers of the region of interest. The methods employed here facilitate the link between intravital and nanoscale imaging of invasive tumor cells, enabling correlating function to structure in the study of tumor invasion and metastasis.	[Karreman, Matthia A.; Schieber, Nicole L.; Schwab, Yannick] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Mercier, Luc; Goetz, Jacky G.] INSERM, U1109, MN3T, F-67200 Strasbourg, France; [Mercier, Luc; Goetz, Jacky G.] Univ Strasbourg, F-67000 Strasbourg, France; [Mercier, Luc; Goetz, Jacky G.] Univ Strasbourg, LabEx Medalis, F-67000 Strasbourg, France; [Mercier, Luc; Goetz, Jacky G.] FMTS, F-67000 Strasbourg, France; [Shibue, Tsukasa] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA	European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Massachusetts Institute of Technology (MIT); Whitehead Institute	Schwab, Y (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	schwab@embl.de; jacky.goetz@inserm.fr	GOETZ, Jacky/AAT-1746-2021	GOETZ, Jacky/0000-0003-2842-8116; Karreman, Matthia Andrea/0000-0003-0074-5945; Schwab, Yannick/0000-0001-8027-1836; Schieber, Nicole L./0000-0002-3212-5057	Ligue Contre le Cancer; Inserm; University of Strasbourg; EMBL funds; EMBL Interdisciplinary Post-doctoral fellowship (EIPOD) under Marie Curie Actions (COFUND); INSERM/Region Alsace Ph.D fellowship	Ligue Contre le Cancer(Ligue nationale contre le cancer); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; EMBL funds; EMBL Interdisciplinary Post-doctoral fellowship (EIPOD) under Marie Curie Actions (COFUND); INSERM/Region Alsace Ph.D fellowship(Region Grand-Est)	This work has been supported by research grants from the Ligue Contre le Cancer (JGG), by institutional funding from Inserm and the University of Strasbourg (JGG) and by EMBL funds (YS). MAK is supported by an EMBL Interdisciplinary Post-doctoral fellowship (EIPOD) under Marie Curie Actions (COFUND), and LM is supported by an INSERM/Region Alsace Ph.D fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronskaia AV, 2008, J STRUCT BIOL, V164, P183, DOI 10.1016/j.jsb.2008.07.003; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716; Biel SS, 2003, J MICROSC-OXFORD, V212, P91, DOI 10.1046/j.1365-2818.2003.01227.x; Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/NMETH.1622, 10.1038/nmeth.1622]; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; ELBERS PF, 1966, BIOCHIM BIOPHYS ACTA, V112, P318, DOI 10.1016/0926-6585(66)90330-X; Fein MR, 2013, DIS MODEL MECH, V6, P580, DOI 10.1242/dmm.009282; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; Goetz JG, 2014, CELL REP, V6, P799, DOI 10.1016/j.celrep.2014.01.032; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Griffiths G, 1993, FINE STRUCTURE IMMUN, P60; Handschuh S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-44; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hayat MA, 1993, STAINS CYTOCHEMICAL; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Jimenez N, 2010, J MICROSC-OXFORD, V237, P208, DOI 10.1111/j.1365-2818.2009.03329.x; JONES S, 1982, J CLIN PATHOL, V35, P425, DOI 10.1136/jcp.35.4.425; Karreman MA, 2009, BIOL CELL, V101, P287, DOI 10.1042/BC20080076; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kolotuev I, 2012, METHOD CELL BIOL, V111, P203, DOI 10.1016/B978-0-12-416026-2.00011-X; Kolotuev I, 2010, BIOL CELL, V102, P121, DOI 10.1042/BC20090096; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; KUSHIDA H, 1962, J ELECTRON MICROSC, V11, P135; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Liv N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055707; Lucas MS, 2012, METHOD CELL BIOL, V111, P325, DOI 10.1016/B978-0-12-416026-2.00017-0; Maco B, 2014, NAT PROTOC, V9, P1354, DOI 10.1038/nprot.2014.101; Maco B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057405; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Mascaro ALA, 2013, P NATL ACAD SCI USA, V110, P10824, DOI 10.1073/pnas.1219256110; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Polishchuk RS, 2012, METHOD CELL BIOL, V111, P21, DOI 10.1016/B978-0-12-416026-2.00002-9; RAK JW, 1992, BRIT J CANCER, V65, P641, DOI 10.1038/bjc.1992.138; Ritsma L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004394; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schieber NL, 2010, METHOD CELL BIOL, V96, P425, DOI 10.1016/S0091-679X(10)96018-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024	56	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114448	10.1371/journal.pone.0114448	http://dx.doi.org/10.1371/journal.pone.0114448			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479106	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200091
J	Alpay, F; Zare, Y; Kamalludin, MH; Huang, XX; Shi, XW; Shook, GE; Collins, MT; Kirkpatrick, BW				Alpay, Fazli; Zare, Yalda; Kamalludin, Mamat H.; Huang, Xixia; Shi, Xianwei; Shook, George E.; Collins, Michael T.; Kirkpatrick, Brian W.			Genome-Wide Association Study of Susceptibility to Infection by Mycobacterium avium Subspecies paratuberculosis in Holstein Cattle	PLOS ONE			English	Article							JOHNES-DISEASE; ANTIBODY-RESPONSE; GENETIC-VARIATION; CROHNS-DISEASE; DAIRY HERDS; HERITABILITY; LOCI; PREVALENCE; VARIANTS; PERFORMANCE	Paratuberculosis, or Johne's disease, is a chronic, granulomatous, gastrointestinal tract disease of cattle and other ruminants caused by the bacterium Mycobacterium avium, subspecies paratuberculosis (MAP). Control of Johne's disease is based on programs of testing and culling animals positive for infection with MAP while concurrently modifying management to reduce the likelihood of infection. The current study is motivated by the hypothesis that genetic variation in host susceptibility to MAP infection can be dissected and quantifiable associations with genetic markers identified. For this purpose, a case-control, genome-wide association study was conducted using US Holstein cattle phenotyped for MAP infection using a serum ELISA and/or fecal culture test. Cases included cows positive for either serum ELISA, fecal culture or both. Controls consisted of animals negative for the serum ELISA test or both serum ELISA and fecal culture when both were available. Controls were matched by herd and proximal birth date with cases. A total of 856 cows (451 cases and 405 controls) were used in initial discovery analyses, and an additional 263 cows (159 cases and 104 controls) from the same herds were used as a validation data set. Data were analyzed in a single marker analysis controlling for relatedness of individuals (GRAMMAR-GC) and also in a Bayesian analysis in which multiple marker effects were estimated simultaneously (GenSel). For the latter, effects of non-overlapping 1 Mb marker windows across the genome were estimated. Results from the two discovery analyses were generally concordant; however, discovery results were generally not well supported in analysis of the validation data set. A combined analysis of discovery and validation data sets provided strongest support for SNPs and 1 Mb windows on chromosomes 1, 2, 6, 7, 17 and 29.	[Alpay, Fazli] Uludag Univ, Dept Anim Sci, Fac Vet Med, TR-16059 Bursa, Turkey; [Zare, Yalda; Kamalludin, Mamat H.; Shi, Xianwei; Kirkpatrick, Brian W.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Kamalludin, Mamat H.] Univ Putra Malaysia, Fac Agr, Dept Anim Sci, Upm Serdang, Selangor, Malaysia; [Huang, Xixia] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Shook, George E.; Kirkpatrick, Brian W.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Collins, Michael T.] Univ Wisconsin, Dept Pathobiol Sci, Sch Vet Med, Madison, WI 53706 USA	Uludag University; University of Wisconsin System; University of Wisconsin Madison; Universiti Putra Malaysia; Xinjiang Agricultural University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kirkpatrick, BW (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	bwkirkpa@wisc.edu	Kamalludin, Mamat H/W-1626-2017; Alpay, Fazlı/AAE-4562-2019	Kamalludin, Mamat H/0000-0001-9728-8212; Alpay, Fazlı/0000-0002-3612-1002	United States Department of Agriculture National Institute of Food and Agriculture [2010-65205-20442, 2007-35205-17884]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by grants from United States Department of Agriculture National Institute of Food and Agriculture (grant #2010-65205-20442 and 2007-35205-17884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Brazil JC, 2013, J IMMUNOL, V191, P4804, DOI 10.4049/jimmunol.1301307; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Carter MA, 2011, VET CLIN N AM-FOOD A, V27, P637, DOI 10.1016/j.cvfa.2011.07.010; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; Collins MT, 2006, JAVMA-J AM VET MED A, V229, P1912, DOI 10.2460/javma.229.12.1912; COLLINS MT, 1990, J CLIN MICROBIOL, V28, P2514, DOI 10.1128/JCM.28.11.2514-2519.1990; Collins MT, 2002, CLIN DIAGN LAB IMMUN, V9, P1367, DOI 10.1128/CDLI.9.6.1367-1371.2002; Dargatz DA, 2001, J AM VET MED ASSOC, V219, P497, DOI 10.2460/javma.2001.219.497; ELMGREEN J, 1984, GUT, V25, P737, DOI 10.1136/gut.25.7.737; Fernando R. L., 2008, ANIMAL BREEDING GENE; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Flanders WD, 1996, AM J EPIDEMIOL, V144, P696; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034349; Gomez-Rodriguez J, 2011, FEBS J, V278, P1980, DOI 10.1111/j.1742-4658.2011.08072.x; Gonda MG, 2006, J DAIRY SCI, V89, P1804, DOI 10.3168/jds.S0022-0302(06)72249-4; Groenendaal H, 2003, PREV VET MED, V60, P69, DOI 10.1016/S0167-5877(03)00083-7; Gunnarsson E, 2003, ACTA VET SCAND, V44, P255; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hinger M, 2008, J DAIRY SCI, V91, P3237, DOI 10.3168/jds.2008-1021; Jubb T, 2000, VET MICROBIOL, V77, P423, DOI 10.1016/S0378-1135(00)00327-8; Kennedy DJ, 2000, VET MICROBIOL, V77, P443, DOI 10.1016/S0378-1135(00)00329-1; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kirkpatrick BW, 2010, ANIM GENET; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Koets AP, 2000, J DAIRY SCI, V83, P2702, DOI 10.3168/jds.S0022-0302(00)75164-2; Kosaka Y, 2006, TRENDS IMMUNOL, V27, P453, DOI 10.1016/j.it.2006.08.006; Kupper J, 2012, J DAIRY SCI, V95, P2734, DOI 10.3168/jds.2011-4994; Lee Sang-Yull, 2004, Cancer Immun, V4, P13; Lombard JE, 2013, PREV VET MED, V108, P234, DOI 10.1016/j.prevetmed.2012.08.006; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Meuwissen THE, 2001, GENETICS, V157, P1819; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Momotani E, 2012, JPN J VET RES, V60, pS19; Moon CM, 2013, J GASTROEN HEPATOL, V28, P1588, DOI 10.1111/jgh.12214; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; National Animal Health Monitoring System, 2008, JOHN DIS US DAIR 199; Neibergs HL, 2010, MAMM GENOME, V21, P419, DOI 10.1007/s00335-010-9278-2; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Salzberg SL, 1997, COMP CLASSIFIERS PIT; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Shook GE, 2012, ANIM GENET, V43, P56, DOI 10.1111/j.1365-2052.2012.02349.x; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sweeney RW, 2012, J VET INTERN MED, V26, P1239, DOI 10.1111/j.1939-1676.2012.01019.x; Tharaldsen J, 2003, ACTA VET SCAND, V44, P243; van Hulzen KJE, 2012, J DAIRY SCI, V95, P2740, DOI 10.3168/jds.2011-5005; van Hulzen KJE, 2011, J DAIRY SCI, V94, P992, DOI 10.3168/jds.2010-3472; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764; Zare Y, 2014, J DAIRY SCI; Zare Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088380	65	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e111704	10.1371/journal.pone.0111704	http://dx.doi.org/10.1371/journal.pone.0111704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473852	Green Submitted, gold, Green Published			2022-12-26	WOS:000346382500063
J	Jiang, YF; Lan, XJ; Luo, W; Kong, XC; Qi, PF; Wang, JR; Wei, YM; Jiang, QT; Liu, YX; Peng, YY; Chen, GY; Dai, SF; Zheng, YL				Jiang, Yun-Feng; Lan, Xiu-Jin; Luo, Wei; Kong, Xing-Chen; Qi, Peng-Fei; Wang, Ji-Rui; Wei, Yu-Ming; Jiang, Qian-Tao; Liu, Ya-Xi; Peng, Yuan-Ying; Chen, Guo-Yue; Dai, Shou-Fen; Zheng, You-Liang			Genome-Wide Quantitative Trait Locus Mapping Identifies Multiple Major Loci for Brittle Rachis and Threshability in Tibetan Semi-Wild Wheat (Triticum aestivum ssp tibetanum Shao)	PLOS ONE			English	Article							MAP-BASED ANALYSIS; FREE-THRESHING HABIT; DOMESTICATION GENE-Q; HEXAPLOID WHEATS; COMMON WHEAT; CHROMOSOME LOCATION; AEGILOPS-TAUSCHII; POLYPLOID WHEAT; GLUME TENACITY; WEEDRACE	Tibetan semi-wild wheat (Triticum aestivum ssp. tibetanum Shao) is a semi-wild hexaploid wheat resource that is only naturally distributed in the Qinghai-Tibet Plateau. Brittle rachis and hard threshing are two important characters of Tibetan semi-wild wheat. A whole-genome linkage map of T. aestivum ssp. tibetanum was constructed using a recombinant inbred line population (Q1028 x ZM9023) with 186 lines, 564 diversity array technology markers, and 117 simple sequence repeat markers. Phenotypic data on brittle rachis and threshability, as two quantitative traits, were evaluated on the basis of the number of average spike rachis fragments per spike and percent threshability in 2012 and 2013, respectively. Quantitative trait locus (QTL) mapping performed using inclusive composite interval mapping analysis clearly identified four QTLs for brittle rachis and three QTLs for threshability. However, three loci on 2DS, 2DL, and 5AL showed pleiotropism for brittle rachis and threshability; they respectively explained 5.3%, 18.6%, and 18.6% of phenotypic variation for brittle rachis and 17.4%, 13.2%, and 35.2% of phenotypic variation for threshability. A locus on 3DS showed an independent effect on brittle rachis, which explained 38.7% of the phenotypic variation. The loci on 2DS and 3DS probably represented the effect of Tg and Br1, respectively. The locus on 5AL was in very close proximity to the Q gene, but was different from the predicted q in Tibetan semi-wild wheat. To our knowledge, the locus on 2DL has never been reported in common wheat but was prominent in T. aestivum ssp. tibetanum accession Q1028. It remarkably interacted with the locus on 5AL to affect brittle rachis. Several major loci for brittle rachis and threshability were identified in Tibetan semi-wild wheat, improving the understanding of these two characters and suggesting the occurrence of special evolution in Tibetan semi-wild wheat.	[Jiang, Yun-Feng; Lan, Xiu-Jin; Luo, Wei; Kong, Xing-Chen; Qi, Peng-Fei; Wang, Ji-Rui; Wei, Yu-Ming; Jiang, Qian-Tao; Liu, Ya-Xi; Peng, Yuan-Ying; Chen, Guo-Yue; Dai, Shou-Fen; Zheng, You-Liang] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Zheng, You-Liang] Sichuan Agr Univ, Minist Educ, Key Lab Southwestern Crop Germplasm Utilizat, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zheng, YL (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China.	ylzheng@sicau.edu.cn	Jiang, Qiantao/C-6229-2017	Jiang, Qiantao/0000-0003-3192-3732	State Key Program of National Natural Science of China [31230053]; National Natural Science Foundation of China [30471088, 30370883]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by the State Key Program of National Natural Science of China (Grant No. 31230053) and the National Natural Science Foundation of China (30471088; 30370883) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao WG, 1997, EUPHYTICA, V94, P119, DOI 10.1023/A:1002933608249; Chen QF, 1998, GENET RESOUR CROP EV, V45, P407, DOI 10.1023/A:1008635208146; Chen QF, 1999, GENET RESOUR CROP EV, V46, P543, DOI 10.1023/A:1008738423817; Chen QF, 2001, GENET RESOUR CROP EV, V48, P21, DOI 10.1023/A:1011291914213; DEVOS KM, 1992, THEOR APPL GENET, V84, P567, DOI 10.1007/BF00224153; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Faris JD, 2003, GENETICS, V164, P311; Faris JD, 2002, GENOME, V45, P706, DOI 10.1139/G02-036; Faris JD, 2005, WHEAT INFORM SERV, V100, P129; Faris JD, 2014, GENE, V542, P198, DOI 10.1016/j.gene.2014.03.034; Jantasuriyarat C, 2004, THEOR APPL GENET, V108, P261, DOI 10.1007/s00122-003-1432-8; Kato K, 1999, THEOR APPL GENET, V98, P472, DOI 10.1007/s001220051094; Kato K, 2003, PLANT BREEDING, V122, P489, DOI 10.1111/j.1439-0523.2003.00886.x; Lan Xiu-Jin, 2005, Journal of Applied Genetics, V46, P133; Li Wanlong, 2006, Functional & Integrative Genomics, V6, P300, DOI 10.1007/s10142-005-0015-y; Liu DengCai, 2003, Southwest China Journal of Agricultural Sciences, V16, P32; MacKey J, 1954, NEUTRON XRAY EXPT WH; MURAMATSU M, 1986, CAN J GENET CYTOL, V28, P30, DOI 10.1139/g86-006; Nalam VJ, 2007, THEOR APPL GENET, V116, P135, DOI 10.1007/s00122-007-0653-7; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Sears E.R., 1954, ANEUPLOIDS COMMON WH; Shao Q. Q., 1980, ACTA GENET SIN, V7, P150, DOI DOI 10.1098/RSPB.2009.1015; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Sood S, 2009, THEOR APPL GENET, V119, P341, DOI 10.1007/s00122-009-1043-0; VO JW, 2006, JOINTMAP 4 SOFTW CAL; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang Haiyan, 2007, Journal of Genetics and Genomics, V34, P623, DOI 10.1016/S1673-8527(07)60071-X; Wang J., 2012, USERS MANUAL QTL ICI; Watanabe N, 2006, EUPHYTICA, V151, P63, DOI 10.1007/s10681-006-9128-1; Watanabe N, 2005, EUPHYTICA, V144, P119, DOI 10.1007/s10681-005-5193-0; Watanabe N, 2002, HEREDITAS, V137, P180, DOI 10.1034/j.1601-5223.2002.01609.x; Watanabe N, 2006, J APPL GENET, V47, P93, DOI 10.1007/BF03194606; Wei YM, 2002, GENET RESOUR CROP EV, V49, P327, DOI 10.1023/A:1015544403431; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yoshiya K, 2012, GENET RESOUR CROP EV, V59, P67, DOI 10.1007/s10722-011-9668-7; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108	39	19	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114066	10.1371/journal.pone.0114066	http://dx.doi.org/10.1371/journal.pone.0114066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474652	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500107
J	Reifsnyder, PC; Doty, R; Harrison, DE				Reifsnyder, Peter C.; Doty, Rosalinda; Harrison, David E.			Rapamycin Ameliorates Nephropathy despite Elevating Hyperglycemia in a Polygenic Mouse Model of Type 2 Diabetes, NONcNZO10/LtJ	PLOS ONE			English	Article							GENETICALLY HETEROGENEOUS MICE; EXTENDS LIFE-SPAN; INSULIN-RESISTANCE; SIGNALING PATHWAY; BETA-CELLS; TOR; OBESITY; DIET; HYPERTENSION; METABOLISM	While rapamycin treatment has been reported to have a putatively negative effect on glucose homeostasis in mammals, it has not been tested in polygenic models of type 2 diabetes. One such mouse model, NONcNZO10/LtJ, was treated chronically with rapamycin (14 ppm encapsulated in diet) and monitored for the development of diabetes. As expected, rapamycin treatment accelerated the onset and severity of hyperglycemia. However, development of nephropathy was ameliorated, as both glomerulonephritis and IgG deposition in the subendothelial tuft were markedly reduced. Insulin production and secretion appeared to be inhibited, suppressing the developing hyperinsulinemia present in untreated controls. Rapamycin treatment also reduced body weight gain. Thus, rapamycin reduced some of the complications of diabetes despite elevating hyperglycemia. These results suggest that multiple factors must be evaluated when assessing the benefit vs. hazard of rapamycin treatment in patients that have overt, or are at risk for, type 2 diabetes. Testing of rapamycin in combination with insulin sensitizers is warranted, as such compounds may ameliorate the putative negative effects of rapamycin in the type 2 diabetes environment.	[Reifsnyder, Peter C.; Doty, Rosalinda; Harrison, David E.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Harrison, DE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	david.harrison@jax.org			National Institutes of Health [AG022308]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038560, U01AG022308, R01AG032333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (AG022308 to DEH). http://www.nia.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow AD, 2013, DIABETES, V62, P2674, DOI 10.2337/db13-0106; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; Das A, 2014, J BIOL CHEM, V289, P4145, DOI 10.1074/jbc.M113.521062; Deepa Sathyaseelan S, 2013, J Biochem Pharmacol Res, V1, P114; Duarte JMN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0021899; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Le Bacquer O, 2013, J ENDOCRINOL, V216, P21, DOI 10.1530/JOE-12-0351; Leiter EH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/165327; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reifsnyder PC, 2002, DIABETES, V51, P825, DOI 10.2337/diabetes.51.3.825; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Xun PC, 2013, AM J CLIN NUTR, V98, P1543, DOI 10.3945/ajcn.113.065565; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Zahr E, 2007, TRANSPLANTATION, V84, P1576, DOI 10.1097/01.tp.0000296035.48728.28	28	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114324	10.1371/journal.pone.0114324	http://dx.doi.org/10.1371/journal.pone.0114324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473963	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500013
J	Turner, CR; Miller, DJ; Coyne, KJ; Corush, J				Turner, Cameron R.; Miller, Derryl J.; Coyne, Kathryn J.; Corush, Joel			Improved Methods for Capture, Extraction, and Quantitative Assay of Environmental DNA from Asian Bigheaded Carp (Hypophthalmichthys spp.)	PLOS ONE			English	Article							SILVER CARP; MITOCHONDRIAL-DNA; GREAT-LAKES; PCR ASSAYS; PRESERVATION; DIVERSITY; PLANT; QUANTIFICATION; HYBRIDIZATION; CONSERVATION	Indirect, non-invasive detection of rare aquatic macrofauna using aqueous environmental DNA (eDNA) is a relatively new approach to population and biodiversity monitoring. As such, the sensitivity of monitoring results to different methods of eDNA capture, extraction, and detection is being investigated in many ecosystems and species. One of the first and largest conservation programs with eDNA-based monitoring as a central instrument focuses on Asian bigheaded carp (Hypophthalmichthys spp.), an invasive fish spreading toward the Laurentian Great Lakes. However, the standard eDNA methods of this program have not advanced since their development in 2010. We developed new, quantitative, and more cost-effective methods and tested them against the standard protocols. In laboratory testing, our new quantitative PCR (qPCR) assay for bigheaded carp eDNA was one to two orders of magnitude more sensitive than the existing endpoint PCR assays. When applied to eDNA samples from an experimental pond containing bigheaded carp, the qPCR assay produced a detection probability of 94.8% compared to 4.2% for the endpoint PCR assays. Also, the eDNA capture and extraction method we adapted from aquatic microbiology yielded five times more bigheaded carp eDNA from the experimental pond than the standard method, at a per sample cost over forty times lower. Our new, more sensitive assay provides a quantitative tool for eDNA-based monitoring of bigheaded carp, and the higher-yielding eDNA capture and extraction method we describe can be used for eDNA-based monitoring of any aquatic species.	[Turner, Cameron R.; Miller, Derryl J.; Corush, Joel] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Coyne, Kathryn J.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	University of Notre Dame; University of Delaware	Turner, CR (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	crt343@gmail.com		Coyne, Kathryn/0000-0001-8846-531X; Miller, Derryl/0000-0002-4226-4835; Corush, Joel/0000-0001-8192-4691	Great Lakes Restoration Initiative [FY10-S-T0240-O169-2]; Great Lakes Fishery Trust [2011.1197]; National Science Foundation (NSF) IGERT grant award [0504495]	Great Lakes Restoration Initiative; Great Lakes Fishery Trust; National Science Foundation (NSF) IGERT grant award(National Science Foundation (NSF))	Funding was provided by the Great Lakes Restoration Initiative (FY10-S-T0240-O169-2) and the Great Lakes Fishery Trust (2011.1197). CRT was supported by National Science Foundation (NSF) IGERT grant award #0504495 to the GLOBES graduate training program at the University of Notre Dame. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amberg J. J., 2013, 20131080 US GEOL SUR; [Anonymous], 2014, R LANG ENV STAT COMP; Ballantyne KN, 2008, GENOMICS, V91, P301, DOI 10.1016/j.ygeno.2007.10.016; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bellete B, 2003, J MICROBIOL METH, V55, P213, DOI 10.1016/S0167-7012(03)00141-6; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; CHAPMAN DC, 2011, AFS S BETH MAR US AM, V74; Cooke SL, 2010, FRESHWATER BIOL, V55, P2138, DOI 10.1111/j.1365-2427.2010.02474.x; Coyne KJ, 2005, LIMNOL OCEANOGR-METH, V3, P381, DOI 10.4319/lom.2005.3.381; Coyne KJ, 2001, AQUAT MICROB ECOL, V24, P275, DOI 10.3354/ame024275; CUDDINGTON K, 2013, BIOL INVASIONS, DOI DOI 10.1007/S10530-013-0547; Cudmore B, 2012, 2011114 DFO; de Lipthay JR, 2004, SOIL BIOL BIOCHEM, V36, P1607, DOI 10.1016/j.soilbio.2004.03.011; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dempster EL, 1999, BIOTECHNIQUES, V27, P66, DOI 10.2144/99271bm13; Dimichele Luke J., 1993, Journal of the American Society of Brewing Chemists, V51, P63; DROPPO IG, 2006, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A1506; Ellison SLR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-33; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fusillo R, 2007, ACTA THERIOL, V52, P251, DOI 10.1007/BF03194221; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hamilton KM, 2011, J EUKARYOT MICROBIOL, V58, P446, DOI 10.1111/j.1550-7408.2011.00570.x; Herrera A, 2007, J MICROBIOL METH, V70, P1, DOI 10.1016/j.mimet.2007.04.005; Hetzer A, 2007, EXTREMOPHILES, V11, P605, DOI 10.1007/s00792-007-0073-2; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; HOCHMEISTER MN, 1991, INT J LEGAL MED, V104, P229, DOI 10.1007/BF01369812; HOROWITZ AJ, 1988, CHEM BIOL CHARACTERI, P102, DOI DOI 10.1520/STP26702S; Irons KS, 2007, J FISH BIOL, V71, P258, DOI 10.1111/j.1095-8649.2007.01670.x; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kennedy S, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P1; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kolar C.S., 2007, AM FISHERIES SOC SPE; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lamer JT, 2014, MOL ECOL RESOUR, V14, P79, DOI 10.1111/1755-0998.12152; Lamer JT, 2010, N AM J FISH MANAGE, V30, P1452, DOI 10.1577/M10-053.1; Li SF, 2009, J FISH BIOL, V74, P1787, DOI 10.1111/j.1095-8649.2009.02258.x; Lindquist HDA, 2011, ENVIRONMENTAL MICROBIOLOGY: CURRENT TECHNOLOGY AND WATER APPLICATIONS, P39; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; Liu HZ, 2003, CAN J ZOOL, V81, P1938, DOI [10.1139/z03-169, 10.1139/Z03-169]; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Luna GM, 2006, ENVIRON MICROBIOL, V8, P308, DOI 10.1111/j.1462-2920.2005.00896.x; Martellini A, 2005, WATER RES, V39, P541, DOI 10.1016/j.watres.2004.11.012; McDonald Lyman L., 2004, P11; MIFFLIN TE, 2007, SETTING PCR LAB COLD, V2007, P5, DOI DOI 10.1101/PDB.TOP14; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Mitchell KR, 2008, J IND MICROBIOL BIOT, V35, P1139, DOI 10.1007/s10295-008-0393-y; Nagy ZT, 2010, ORG DIVERS EVOL, V10, P91, DOI 10.1007/s13127-010-0012-4; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Niu C, 2008, AFR J BIOTECHNOL, V7, P2818; OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X; ROGSTAD SH, 1992, TAXON, V41, P701, DOI 10.2307/1222395; Sampson SJ, 2009, BIOL INVASIONS, V11, P483, DOI 10.1007/s10530-008-9265-7; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P494, DOI 10.4319/lo.1972.17.3.0494; Siuda W, 1996, AQUAT MICROB ECOL, V11, P193, DOI 10.3354/ame011193; Stark KDC, 1998, APPL ENVIRON MICROB, V64, P543; STUCK JG, 2012, THESIS E ILLINOIS U; Sun J, 2010, CHIN J OCEANOL LIMN, V28, P315, DOI 10.1007/s00343-010-9285-x; Sutherland WJ, 2013, TRENDS ECOL EVOL, V28, P16, DOI 10.1016/j.tree.2012.10.022; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thomson John A., 2002, Telopea, V9, P755; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; *US ARM CORPS ENG, 2013, INT TECHN REV REP; Widmer F, 1997, MOL ECOL, V6, P1, DOI 10.1046/j.1365-294X.1997.00145.x; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yao Y, 2006, MOL CELL PROBE, V20, P311, DOI 10.1016/j.mcp.2006.03.003; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	84	55	60	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114329	10.1371/journal.pone.0114329	http://dx.doi.org/10.1371/journal.pone.0114329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474207	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500015
J	Zhang, NW; Zhao, JJ; Lens, F; de Visser, J; Menamo, T; Fang, W; Xiao, D; Bucher, J; Basnet, RK; Lin, K; Cheng, F; Wang, XW; Bonnema, G				Zhang, Ningwen; Zhao, Jianjun; Lens, Frederic; de Visser, Joan; Menamo, Temesgen; Fang, Wen; Xiao, Dong; Bucher, Johan; Basnet, Ram Kumar; Lin, Ke; Cheng, Feng; Wang, Xiaowu; Bonnema, Guusje			Morphology, Carbohydrate Composition and Vernalization Response in a Genetically Diverse Collection of Asian and European Turnips (Brassica rapa subsp rapa)	PLOS ONE			English	Article							SUCROSE METABOLIZING ENZYMES; STORAGE ORGAN DEVELOPMENT; RAPHANUS-SATIVUS L; FLOWERING-TIME; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; CAMBIAL ACTIVITY; VAR. RAPA; POTATO; ROOTS	Brassica rapa displays enormous morphological diversity, with leafy vegetables, turnips and oil crops. Turnips (Brassica rapa subsp. rapa) represent one of the morphotypes, which form tubers and can be used to study the genetics underlying storage organ formation. In the present study we investigated several characteristics of an extensive turnip collection comprising 56 accessions from both Asia (mainly Japanese origin) and Europe. Population structure was calculated using data from 280 evenly distributed SNP markers over 56 turnip accessions. We studied the anatomy of turnip tubers and measured carbohydrate composition of the mature turnip tubers of a subset of the collection. The variation in 16 leaf traits, 12 tuber traits and flowering time was evaluated in five independent experiments for the entire collection. The effect of vernalization on flowering and tuber formation was also investigated. SNP marker profiling basically divided the turnip accessions into two subpopulations, with admixture, generally corresponding with geographical origin (Europe or Asia). The enlarged turnip tuber consists of both hypocotyl and root tissue, but the proportion of the two tissues differs between accessions. The ratio of sucrose to fructose and glucose differed among accessions, while generally starch content was low. The evaluated traits segregated in both subpopulations, with leaf shape, tuber colour and number of shoots per tuber explaining most variation between the two subpopulations. Vernalization resulted in reduced flowering time and smaller tubers for the Asian turnips whereas the European turnips were less affected by vernalization.	[Zhang, Ningwen; Zhao, Jianjun; de Visser, Joan; Menamo, Temesgen; Fang, Wen; Xiao, Dong; Bucher, Johan; Basnet, Ram Kumar; Lin, Ke; Bonnema, Guusje] Wageningen UR Plant Breeding, Wageningen, Netherlands; [Cheng, Feng; Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Zhao, Jianjun] Hebei Agr Univ, Hort Coll, Baoding, Peoples R China; [Xiao, Dong] Nanjing Agr Univ, Hort Coll, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Lens, Frederic] Nat Biodivers Ctr, Leiden, Netherlands	Wageningen University & Research; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Hebei Agricultural University; Nanjing Agricultural University; Naturalis Biodiversity Center	Bonnema, G (corresponding author), Wageningen UR Plant Breeding, Wageningen, Netherlands.	Guusje.Bonnema@wur.nl	Lens, Frederic/B-8482-2011; Wang, Xiaowu/L-2579-2019; Menamo, Temesgen/AAI-2042-2019; Cheng, Feng/P-3233-2015	Lens, Frederic/0000-0002-5001-0149; Cheng, Feng/0000-0003-2982-9675; Menamo, Temesgen/0000-0003-4856-3147	Funding PSA program "Genomics of developmental and nutritional traits in Brassica rapa" [08-PSA-BD-02]	Funding PSA program "Genomics of developmental and nutritional traits in Brassica rapa"	The project is funded by Funding PSA program 08-PSA-BD-02 "Genomics of developmental and nutritional traits in Brassica rapa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Axelsson T, 2001, GENOME, V44, P856, DOI 10.1139/gen-44-5-856; Bellin D, 2002, PLANT BIOLOGY, V4, P700, DOI 10.1055/s-2002-37405; Bonnema AB, 2011, GENETICS GENOMICS BR, P81; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; de Candolle A., 1886, ORIGIN CULTIVATED PL, VXLIX, P376; de Souza CRB, 2004, PROTEIN PEPTIDE LETT, V11, P577; Del Carpio DP, 2011, THEOR APPL GENET, V122, P1105, DOI 10.1007/s00122-010-1516-1; ELLIOTT MC, 1986, BIOL PLANTARUM, V28, P1, DOI 10.1007/BF02885310; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GIAQUINTA RT, 1979, PLANT PHYSIOL, V63, P828, DOI 10.1104/pp.63.5.828; GOWERS S, 1988, EUPHYTICA, V37, P275; Grubben G., 2004, PLANT RESOURCES TROP, V61, P108; Gupta AK, 2001, ACTA PHYSIOL PLANT, V23, P31, DOI 10.1007/s11738-001-0019-8; HATCH MD, 1963, PLANT PHYSIOL, V38, P344, DOI 10.1104/pp.38.3.348; Hopkins R, 2008, NEW PHYTOL, V179, P155, DOI 10.1111/j.1469-8137.2008.02447.x; Huaman Z., 1986, SYSTEMATIC BOT MORPH; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Kloosterman B, 2005, PLANT BIOTECHNOL J, V3, P505, DOI 10.1111/j.1467-7652.2005.00141.x; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Lee JG, 2013, J AGR FOOD CHEM, V61, P3984, DOI 10.1021/jf400890p; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lou P, 2007, J EXP BOT, V58, P4005, DOI 10.1093/jxb/erm255; Lu G, 2008, J APPL GENET, V49, P23, DOI 10.1007/BF03195245; Lukaszewska E, 2012, PLANT BIOLOGY, V14, P216, DOI 10.1111/j.1438-8677.2011.00477.x; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Osborn TC, 1997, GENETICS, V146, P1123; Persson K, 2001, HEREDITAS, V134, P43, DOI 10.1111/j.1601-5223.2001.00043.x; PETERSON RL, 1973, CAN J BOT, V51, P475, DOI 10.1139/b73-055; PRAT S, 1990, FEBS LETT, V268, P334, DOI 10.1016/0014-5793(90)81281-R; RICARDO C P P, 1970, Phytochemistry (Oxford), V9, P239, DOI 10.1016/S0031-9422(00)85130-4; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Saito H, 2001, J JPN SOC HORTIC SCI, V70, P629, DOI 10.2503/jjshs.70.629; SALEHUZZAMAN SNIM, 1992, PLANT MOL BIOL, V20, P809, DOI 10.1007/BF00027152; Sharma N, 1998, PLANT GROWTH REGUL, V26, P97, DOI 10.1023/A:1006087729077; SHATTUCK VI, 1991, J AM SOC HORTIC SCI, V116, P818, DOI 10.21273/JASHS.116.5.818; SIRJUCHARRAN G, 1988, ANN BOT-LONDON, V61, P99, DOI 10.1093/oxfordjournals.aob.a087533; Sojikul P, 2010, PHYSIOL PLANTARUM, V140, P189, DOI 10.1111/j.1399-3054.2010.01389.x; TAKAHASHI H, 1994, J JPN SOC HORTIC SCI, V63, P99, DOI 10.2503/jjshs.63.99; Teutonico RA, 1995, THEOR APPL GENET, V91, P1279, DOI 10.1007/BF00220941; TING FST, 1980, ANN BOT-LONDON, V46, P277, DOI 10.1093/oxfordjournals.aob.a085918; TING FST, 1980, ANN BOT-LONDON, V46, P267, DOI 10.1093/oxfordjournals.aob.a085917; Trebbi D, 2009, PHYSIOL PLANTARUM, V135, P84, DOI 10.1111/j.1399-3054.2008.01169.x; Vogl-Lukasser B., 2008, ETHNOBOTANY RES APPL, V5, P305; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Y, 2013, PLANT PHYSIOL BIOCH, V70, P269, DOI 10.1016/j.plaphy.2013.05.041; YELLE S, 1991, PLANT PHYSIOL, V95, P1026, DOI 10.1104/pp.95.4.1026; Yildirim E, 2010, GENET MOL RES, V9, P987, DOI 10.4238/vol9-2gmr786; Zhang P, 2003, PLANTA, V218, P192, DOI 10.1007/s00425-003-1098-0; Zhao JJ, 2010, GENOME, V53, P884, DOI 10.1139/G10-082; Zhao JJ, 2010, J EXP BOT, V61, P1817, DOI 10.1093/jxb/erq048; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	56	86	86	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114241	10.1371/journal.pone.0114241	http://dx.doi.org/10.1371/journal.pone.0114241			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474111	Green Published, gold			2022-12-26	WOS:000346382500005
J	Chen, C; Wang, X; Xiong, X; Liu, Q; Huang, Y; Xu, Q; Hu, J; Ge, G; Ling, K				Chen, C.; Wang, X.; Xiong, X.; Liu, Q.; Huang, Y.; Xu, Q.; Hu, J.; Ge, G.; Ling, K.			Targeting type I. phosphatidylinositol phosphate kinase inhibits breast cancer metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LEPTIN RECEPTOR; TYROSINE KINASE; SPLICE VARIANTS; CELL-MIGRATION; C-MET; GAMMA; EXPRESSION; 5-KINASE; ANGIOGENESIS	Most deaths from breast cancer are caused by metastasis, a complex behavior of cancer cells involving migration, invasion, survival and microenvironment manipulation. Type I. phosphatidylinositol phosphate kinase ( PIPKI gamma) regulates focal adhesion assembly and its phosphorylation at Y639 is critical for cell migration induced by EGF. However, the role of this lipid kinase in tumor metastasis remains unclear. Here we report that PIPKI. is vital for breast cancer metastasis. Y639 of PIPKI gamma can be phosphorylated by stimulation of EGF and hepatocyte growth factor ( HGF), two promoting factors for breast cancer progression. Histological analysis revealed elevated Y639 phosphorylation of PIPKI gamma in invasive ductal carcinoma lesions and suggested a positive correlation with tumor grade. Orthotopically transplanted PIPKI.-depleted breast cancer cells showed substantially reduced growth and metastasis, as well as suppressed expression of multiple genes related to cell migration and microenvironment manipulation. Re-expression of wild-type PIPKI. in PIPKI.-depleted cells restored tumor growth and metastasis, reinforcing the importance of PIPKI gamma in breast cancer progression. Y639-to-F or a kinase-dead mutant of PIPKI gamma could not recover the diminished metastasis in PIPKI gamma-depleted cancer cells, suggesting that Y639 phosphorylation and lipid kinase activity are both required for development of metastasis. Further analysis with in vitro assays indicated that depleting PIPKI gamma inhibited cell proliferation, MMP9 secretion and cell migration and invasion, lending molecular mechanisms for the eliminated cancer progression. These results suggest that PIPKI gamma, downstream of EGF and/or HGF receptor, participates in breast cancer progression from multiple aspects and deserves further studies to explore its potential as a therapeutic target.	[Chen, C.; Huang, Y.; Xu, Q.; Hu, J.; Ling, K.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wang, X.] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA; [Xiong, X.] Oklahoma Univ Med, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA; [Liu, Q.; Ge, G.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Hu, J.] Mayo Clin, Dept Hypertens & Nephrol, Rochester, MN 55905 USA; [Ling, K.] Mayo Clin, Canc Ctr, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Oklahoma System; University of Oklahoma Health Sciences Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Mayo Clinic; Mayo Clinic	Ling, K (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Ctr Canc, Guggenheim 16-04,200 First St SW, Rochester, MN 55905 USA.	ling.kun@mayo.edu			National Cancer Institute [1R01CA149039-01A1]; Susan G Komen for the Cure [KG100902]; NATIONAL CANCER INSTITUTE [R01CA149039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099160, R01DK090038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Daniel Visscher (Mayo Clinic) for scoring the breast cancer tissue microarrays, Dr Wilma Lingle (Mayo Clinic) for providing human breast cancer tissue samples and tissue microarrays, Dr Vijayalakshmi Shridhar (Mayo Clinic) for sharing the 4T1 cells and Dr Kah Whye Peng (Mayo Clinic) for providing the luciferase system. This work was supported by research grants from the National Cancer Institute (1R01CA149039-01A1) and Susan G Komen for the Cure (KG100902).	Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; El Sayegh TY, 2007, MOL BIOL CELL, V18, P3026, DOI 10.1091/mbc.E06-12-1159; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Giudici ML, 2006, FEBS LETT, V580, P6933, DOI 10.1016/j.febslet.2006.11.052; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Keshtgar MRS, 1999, EUR J NUCL MED, V26, P57, DOI 10.1007/s002590050360; Landi L, 2013, CURR OPIN ONCOL, V25, P130, DOI 10.1097/CCO.0b013e32835daf37; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; Macaluso M, 2003, ONCOGENE, V22, P6472, DOI 10.1038/sj.onc.1206955; McMurtry V, 2009, CLIN EXP METASTAS, V26, P197, DOI 10.1007/s10585-008-9231-x; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mulligan AM, 2013, CLIN CANCER RES, V19, P336, DOI 10.1158/1078-0432.CCR-11-3314; Perera CN, 2008, J ENDOCRINOL, V199, P221, DOI 10.1677/JOE-08-0215; Ponzo MG, 2010, CELL CYCLE, V9, P1043, DOI 10.4161/cc.9.6.11033; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xiong XH, 2012, MOL BIOL CELL, V23, P87, DOI 10.1091/mbc.E11-05-0449; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800	50	22	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4635	4646		10.1038/onc.2014.393	http://dx.doi.org/10.1038/onc.2014.393			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25486426	Green Accepted			2022-12-26	WOS:000360189300009
J	Roy, BC; Subramaniam, D; Ahmed, I; Jala, VR; Hester, CM; Greiner, KA; Haribabu, B; Anant, S; Umar, S				Roy, B. C.; Subramaniam, D.; Ahmed, I.; Jala, V. R.; Hester, C. M.; Greiner, K. A.; Haribabu, B.; Anant, S.; Umar, S.			Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2	ONCOGENE			English	Article							HISTONE METHYLTRANSFERASE; BREAST-CANCER; E-CADHERIN; IN-VIVO; CATENIN; PROLIFERATION; REPRESSION; PATHWAY; OVEREXPRESSION; TUMORIGENESIS	The enhancer of zeste homolog-2 (EZH2) represses gene transcription through histone H3 lysine-27-trimethylation (H3K27me3). Citrobacter rodentium (CR) promotes crypt hyperplasia and tumorigenesis by aberrantly regulating Wnt/beta-catenin signaling. We aimed at investigating EZH2's role in epigenetically regulating Wnt/beta-catenin signaling following bacterial infection. NIH: Swiss outbred and Apc(Min/+) mice were infected with CR (10(8) CFU); BLT1(-/)-Apc(Min/+) mice, azoxymethane (AOM)/dextran sodium sulfate (DSS)-treated mice and de-identified human adenocarcinoma samples were the models of colon cancer. Following infection with wild-type but not mutant CR, elevated EZH2 levels in the crypt at days 6 and 12 (peak hyperplasia) coincided with increases in H3K27me3 and beta-catenin levels, respectively. Chromatin immunoprecipitation revealed EZH2 and H3K27me3's occupancy on WIF1 (Wnt inhibitory factor 1) promoter resulting in reduced WIF1 mRNA and protein expression. Following EZH2 knockdown via small interfering RNA or EZH2-inhibitor deazaneplanocin A (Dznep) either alone or in combination with histone deacetylase inhibitor suberoylanilide hydroxamic acid, WIF1 promoter activity increased significantly while the overexpression of EZH2 attenuated WIF1 reporter activity. Ectopic overexpression of SET domain mutant (F681Y) almost completely rescued WIF1 reporter activity and partially rescued WIF1 protein levels, whereas H3K27me3 levels were significantly attenuated suggesting that an intact methyltransferases activity is required for EZH2-dependent effects. Interestingly, although beta-catenin levels were lower in EZH2-knocked down cells, F681Y mutants exhibited only partial reduction in beta-catenin levels. Besides EZH2, increases in miR-203 expression in the crypts at days 6 and 12 post infection correlated with reduced levels of its target WIF1; overexpression of miR-203 in primary colonocytes decreased WIF1 mRNA and protein levels. Elevated levels of EZH2 and beta-catenin with concomitant decrease in WIF1 expression in the polyps of CR-infected Apc(Min/+) mice paralleled changes recorded in BLT1(-/-) Apc(Min/+), AOM/DSS and human adenocarcinomas. Thus, EZH2-induced downregulation of WIF1 expression may partially regulate Wnt/beta-catenin-dependent crypt hyperplasia in response to CR infection.	[Roy, B. C.; Subramaniam, D.; Ahmed, I.; Hester, C. M.; Greiner, K. A.; Anant, S.; Umar, S.] Univ Kansas, Med Ctr, Dept Mol Physiol, Kansas City, KS 66160 USA; [Roy, B. C.; Subramaniam, D.; Ahmed, I.; Hester, C. M.; Greiner, K. A.; Anant, S.; Umar, S.] Univ Kansas, Med Ctr, Dept Integrat Physiol, Kansas City, KS 66160 USA; [Roy, B. C.; Subramaniam, D.; Ahmed, I.; Hester, C. M.; Greiner, K. A.; Anant, S.; Umar, S.] Univ Kansas, Med Ctr, Family Med Res Div, Kansas City, KS 66160 USA; [Jala, V. R.; Haribabu, B.] Univ Kansas, James Graham Brown Canc Ctr, Kansas City, KS 66160 USA; [Jala, V. R.; Haribabu, B.] Univ Kansas, Dept Microbiol & Immunol, Kansas City, KS 66160 USA; [Anant, S.; Umar, S.] Univ Kansas, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas	Umar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, 3901 Rainbow Blvd,4028 Wahl Hall East, Kansas City, KS 66160 USA.	sumar@kumc.edu	Bodduluri, Haribabu/A-2584-2010; Anant, Shrikant/AAF-8020-2020; Jala, Venkatakrishna R/K-7255-2018	Bodduluri, Haribabu/0000-0002-8261-3294; Jala, Venkatakrishna R/0000-0002-4206-7305	National Institutes of Health [R01 CA131413]; University of Kansas Medical Center, Kansas City, KS, USA; NATIONAL CANCER INSTITUTE [R01CA131413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center, Kansas City, KS, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Philip R Hardwidge (Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA) for Citrobacter rodentium mutants. This work was partially supported by the National Institutes of Health Grant R01 CA131413 and start-up funds from the University of Kansas Medical Center, Kansas City, KS, USA.	Ahmed I, 2013, AM J PHYSIOL-GASTR L, V304, pG356, DOI 10.1152/ajpgi.00372.2012; Ahmed I, 2012, INFECT IMMUN, V80, P3107, DOI 10.1128/IAI.00236-12; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; Chandrakesan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079432; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hayashi Y, 2013, GUT, V62, P1536, DOI 10.1136/gutjnl-2011-301625; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Jung HY, 2013, MOL CELL, V52, P193, DOI 10.1016/j.molcel.2013.08.028; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Sellin JH, 2001, CANCER RES, V61, P2899; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Shen L, 2013, ONCOTARGETS THER, V6, P321, DOI 10.2147/OTT.S42453; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Umar S, 2005, ONCOGENE, V24, P6709, DOI 10.1038/sj.onc.1208820; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Umar S, 2012, CURR COLORECT CANC R, V8, P298, DOI 10.1007/s11888-012-0143-4; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003	38	21	22	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4519	4530		10.1038/onc.2014.386	http://dx.doi.org/10.1038/onc.2014.386			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25486432	Green Accepted			2022-12-26	WOS:000360189200011
J	Watanabe, S; Sato, K; Hasegawa, N; Kurihara, T; Matsutani, K; Sanada, K; Hamaoka, T; Fujita, S; Iemitsu, M				Watanabe, Shinya; Sato, Koji; Hasegawa, Natsuki; Kurihara, Toshiyuki; Matsutani, Kenji; Sanada, Kiyoshi; Hamaoka, Takafumi; Fujita, Satoshi; Iemitsu, Motoyuki			Serum C1q as a novel biomarker of sarcopenia in older adults	FASEB JOURNAL			English	Article						aging; fibrosis; skeletal muscle; resistance training	SKELETAL-MUSCLE; SATELLITE CELLS; EXERCISE; AGE; INFLAMMATION; EXPRESSION; RESPONSES; PATHWAY; FRAILTY; HEALTH	Aging-induced elevation in C1q secretion activates the Wnt signaling pathway in muscles, leading to the development of muscle fibrosis. However, the association between serum C1q level and muscle mass and strength remains unclear in humans. The aim of the study was to elucidate whether serum C1q level is associated with aging-and resistance training-induced changes in muscle mass and strength. First, in a cross-sectional study, we investigated the association between serum C1q level and muscle mass and strength in 131 healthy subjects, aged 20-81 yr. Second, in an intervention study, we examined the association between the effects of serum C1q level and muscle mass and strength on 12wk resistance training in 11 healthy older adults (60-81 yr). In the cross-sectional study, serum C1q level increased with aging and was negatively correlated with muscle mass and strength. Furthermore, 12 wk resistance training in older adults reduced the age-associated elevation in serum C1q levels. The training effect of serum C1q level significantly correlated with the change in the cross-sectional area of the thigh (r = -0.703; P < 0.01). Serum C1q level may reflect loss of muscle mass; therefore, C1q may be a novel biomarker of sarcopenia.	[Watanabe, Shinya; Sato, Koji; Hasegawa, Natsuki; Kurihara, Toshiyuki; Matsutani, Kenji; Sanada, Kiyoshi; Hamaoka, Takafumi; Fujita, Satoshi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Ritsumeikan University	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	iemitsu@fc.ritsumei.ac.jp		Sanada, Kiyoshi/0000-0003-3703-4098; WATANABE, SHINYA/0000-0003-1369-9001	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [26282199, 25560378, 22680050]; Grants-in-Aid for Scientific Research [25560378] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI #26282199 and #25560378 to M.I. and #22680050 to S.F.). The authors declare no conflicts of interest.	Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001; Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883; Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Fujita S, 2009, DIABETOLOGIA, V52, P1889, DOI 10.1007/s00125-009-1430-8; Gasier HG, 2011, ACTA PHYSIOL, V201, P381, DOI 10.1111/j.1748-1716.2010.02183.x; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Haddad F, 2002, J APPL PHYSIOL, V93, P394, DOI 10.1152/japplphysiol.01153.2001; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Legoedec J, 1997, MOL IMMUNOL, V34, P735, DOI 10.1016/S0161-5890(97)00093-X; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; PETRY F, 1991, J IMMUNOL, V147, P3988; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2014, FASEB J, V28, P1891, DOI 10.1096/fj.13-245480; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; TENNER AJ, 1986, BIOCHEM J, V233, P451, DOI 10.1042/bj2330451; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	30	36	40	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1003	1010		10.1096/fj.14-262154	http://dx.doi.org/10.1096/fj.14-262154			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25491308				2022-12-26	WOS:000350633000024
J	Nishihara, T; Remacle, AG; Angert, M; Shubayev, I; Shiryaev, SA; Liu, HQ; Dolkas, J; Chernov, AV; Strongin, AY; Shubayev, VI				Nishihara, Tasuku; Remacle, Albert G.; Angert, Mila; Shubayev, Igor; Shiryaev, Sergey A.; Liu, Huaqing; Dolkas, Jennifer; Chernov, Andrei V.; Strongin, Alex Y.; Shubayev, Veronica I.			Matrix Metalloproteinase-14 Both Sheds Cell Surface Neuronal Glial Antigen 2 (NG2) Proteoglycan on Macrophages and Governs the Response to Peripheral Nerve Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; AXONAL REGENERATION; SENSORY AXONS; EXPRESSION; GROWTH; INHIBITION; CLEAVAGE; PROTEIN; PROTEOLYSIS; ACTIVATION	Neuronal glial antigen 2 (NG2) is an integral membrane chondroitin sulfate proteoglycan expressed by vascular pericytes, macrophages (NG2-M phi), and progenitor glia of the nervous system. Herein, we revealed that NG2 shedding and axonal growth, either independently or jointly, depended on the pericellular remodeling events executed by membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP-14). Using purified NG2 ectodomain constructs, individual MMPs, and primary NG2-M phi cultures, we demonstrated for the first time that MMP-14 performed as an efficient and unconventional NG2 sheddase and that NG2-M phi infiltrated into the damaged peripheral nervous system. We then characterized the spatiotemporal relationships among MMP-14, MMP-2, and tissue inhibitor of metalloproteinases-2 in sciatic nerve. Tissue inhibitor of metalloproteinases-2-free MMP-14 was observed in the primary Schwann cell cultures using the inhibitory hydroxamate warhead-based MP-3653 fluorescent reporter. In teased nerve fibers, MMP-14 translocated postinjury toward the nodes of Ranvier and its substrates, laminin and NG2. Inhibition of MMP-14 activity using the selective, function-blocking DX2400 human monoclonal antibody increased the levels of regeneration-associated factors, including laminin, growth-associated protein 43, and cAMP-dependent transcription factor 3, thereby promoting sensory axon regeneration after nerve crush. Concomitantly, DX2400 therapy attenuated mechanical hypersensitivity associated with nerve crush in rats. Together, our findings describe a new model in which MMP-14 proteolysis regulates the extracellular milieu and presents a novel therapeutic target in the damaged peripheral nervous system and neuropathic pain.	[Nishihara, Tasuku; Angert, Mila; Liu, Huaqing; Dolkas, Jennifer; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Nishihara, Tasuku; Angert, Mila; Shubayev, Igor; Liu, Huaqing; Dolkas, Jennifer; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92037 USA; [Remacle, Albert G.; Shiryaev, Sergey A.; Chernov, Andrei V.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Nishihara, Tasuku] Ehime Univ, Dept Anesthesiol & Resuscitol, Toon, Ehime 7910295, Japan	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Sanford Burnham Prebys Medical Discovery Institute; Ehime University	Shubayev, VI (corresponding author), Univ Calif San Diego, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	vshubayev@ucsd.edu	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418	National Institutes of Health [RO1DE022757, UL1 RR031980]; Department of Veterans Affairs [5IO1BX000638]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DE022757 (to V. I. S. and A. Y. S.) and UL1 RR031980 (to University of California, San Diego and A. G. R.). This work was also supported by Department of Veterans Affairs Grant 5IO1BX000638 (to V. I. S.).	Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Court FA, 2011, J NEUROSCI, V31, P12208, DOI 10.1523/JNEUROSCI.0141-11.2011; de Castro R, 2005, EXP NEUROL, V192, P299, DOI 10.1016/j.expneurol.2004.11.027; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Hossain-Ibrahim MK, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-80; Hughes PM, 2002, NEUROSCIENCE, V113, P273, DOI 10.1016/S0306-4522(02)00183-5; Hunanyan AS, 2010, J NEUROSCI, V30, P7761, DOI 10.1523/JNEUROSCI.4659-09.2010; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Kobayashi H, 2008, MOL CELL NEUROSCI, V39, P619, DOI 10.1016/j.mcn.2008.08.008; Krekoski CA, 2002, J NEUROSCI, V22, P10408; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Martin S, 2001, J NEUROSCI, V21, P8119, DOI 10.1523/JNEUROSCI.21-20-08119.2001; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Milward E, 2008, J NEUROIMMUNOL, V193, P140, DOI 10.1016/j.jneuroim.2007.11.001; Morgenstern DA, 2003, MOL CELL NEUROSCI, V24, P787, DOI 10.1016/S1044-7431(03)00245-8; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Onda A, 2001, SPINE, V26, P2186, DOI 10.1097/00007632-200110150-00005; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Remacle AG, 2013, J BIOL CHEM, V288, P20568, DOI 10.1074/jbc.M113.471508; Rezajooi K, 2004, MOL CELL NEUROSCI, V25, P572, DOI 10.1016/j.mcn.2003.10.009; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Schneider S, 2001, J NEUROSCI, V21, P920, DOI 10.1523/JNEUROSCI.21-03-00920.2001; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shiryaev SA, 2011, FEBS J, V278, P3277, DOI 10.1111/j.1742-4658.2011.08244.x; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Tan AM, 2006, J NEUROSCI, V26, P4729, DOI 10.1523/JNEUROSCI.3900-05.2006; Tanaka J, 1998, GLIA, V24, P198, DOI 10.1002/(SICI)1098-1136(199810)24:2<198::AID-GLIA5>3.3.CO;2-S; Tillet E, 1997, J BIOL CHEM, V272, P10769; Ughrin YM, 2003, J NEUROSCI, V23, P175; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	65	38	40	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3693	3707		10.1074/jbc.M114.603431	http://dx.doi.org/10.1074/jbc.M114.603431			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25488667	Green Published, hybrid			2022-12-26	WOS:000349456000041
J	Song, WJ; Song, EAC; Jung, MS; Choi, SH; Baik, HH; Jin, BK; Kim, JH; Chung, SH				Song, Woo-Joo; Song, Eun-Ah Christine; Jung, Min-Su; Choi, Sun-Hee; Baik, Hyung-Hwan; Jin, Byung Kwan; Kim, Jeong Hee; Chung, Sul-Hee			Phosphorylation and Inactivation of Glycogen Synthase Kinase 3 beta (GSK3 beta) by Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-SYNDROME; FUNCTIONAL-LINK; ALZHEIMERS-DISEASE; OBESITY-PRONE; MICE; KINASE-3-BETA; PROTEIN; TAU; CHROMOSOME-21; ADIPOGENESIS	Glycogen synthase kinase 3 beta (GSK3 beta) participates in many cellular processes, and its dysregulation has been implicated in a wide range of diseases such as obesity, type 2 diabetes, cancer, and Alzheimer disease. Inactivation of GSK3 beta by phosphorylation at specific residues is a primary mechanism by which this constitutively active kinase is controlled. However, the regulatory mechanism of GSK3 beta is not fully understood. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) has multiple biological functions that occur as the result of phosphorylation of diverse proteins that are involved in metabolism, synaptic function, and neurodegeneration. Here we show that GSK3 beta directly interacts with and is phosphorylated by Dyrk1A. Dyrk1A-mediated phosphorylation at the Thr(356) residue inhibits GSK3 beta activity. Dyrk1A transgenic (TG) mice are lean and resistant to diet-induced obesity because of reduced fat mass, which shows an inverse correlation with the effect of GSK3 beta on obesity. This result suggests a potential in vivo association between GSK3 beta and Dyrk1A regarding the mechanism underlying obesity. The level of Thr(P)(356)-GSK3 beta was higher in the white adipose tissue of Dyrk1A TG mice compared with control mice. GSK3 beta activity was differentially regulated by phosphorylation at different sites in adipose tissue depending on the type of diet the mice were fed. Furthermore, overexpression of Dyrk1A suppressed the expression of adipogenic proteins, including peroxisome proliferator-activated receptor gamma, in 3T3-L1 cells and in young Dyrk1A TG mice fed a chow diet. Taken together, these results reveal a novel regulatory mechanism for GSK3 beta activity and indicate that overexpression of Dyrk1A may contribute to the obesity-resistant phenotype through phosphorylation and inactivation of GSK3 beta.	[Song, Woo-Joo; Song, Eun-Ah Christine; Baik, Hyung-Hwan; Jin, Byung Kwan; Chung, Sul-Hee] Kyung Hee Univ, Dept Biochem & Mol Biol, Neurodegenerat Control Res Ctr, Sch Med, Seoul 130701, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Seoul 130701, South Korea; [Kim, Jeong Hee] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 130701, South Korea; [Song, Woo-Joo; Song, Eun-Ah Christine; Jung, Min-Su; Choi, Sun-Hee; Chung, Sul-Hee] Inje Univ, Inst Brain Sci & Technol, Pusan 614735, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Inje University	Chung, SH (corresponding author), Kyung Hee Univ, Sch Med, 1 Hoegi Dong, Seoul 130701, South Korea.	sulchung@khu.ac.kr		Kim, Jeong Hee/0000-0002-3884-4503	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A092004]; National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [2011-0014085, 2011-0023401, 2012R1A1A2040129, 2011-0030072, 2012-0000495]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2008-0061888]	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Korea Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea Grant A092004 and by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (Grants 2011-0014085, 2011-0023401, 2012R1A1A2040129, 2011-0030072, and 2012-0000495). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2008-0061888).	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; CHANG S, 1990, AM J PHYSIOL, V259, pR1103, DOI 10.1152/ajpregu.1990.259.6.R1103; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee S, 2013, BIOCHEM PHARMACOL, V85, P965, DOI 10.1016/j.bcp.2012.12.023; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Park JH, 2012, J NEUROCHEM, V122, P1081, DOI 10.1111/j.1471-4159.2012.07861.x; Pearce NJ, 2004, METABOLISM, V53, P1322, DOI 10.1016/j.metabol.2004.05.008; Rachdi L, 2014, DIABETOLOGIA, V57, P960, DOI 10.1007/s00125-014-3174-3; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Steuber-Buchberger P, 2008, GENESIS, V46, P144, DOI 10.1002/dvg.20376; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	37	40	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2321	2333		10.1074/jbc.M114.594952	http://dx.doi.org/10.1074/jbc.M114.594952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25477508	Green Published, hybrid			2022-12-26	WOS:000348588000037
J	Miguez-Burbano, MJ; Quiros, C; Lewis, JE; Espinoza, L; Cook, R; Trainor, AB; Richardson, E; Asthana, D				Miguez-Burbano, Maria Jose; Quiros, Clery; Lewis, John E.; Espinoza, Luis; Cook, Robert; Trainor, Allison B.; Richardson, Erika; Asthana, Deshratn			Gender Differences in the Association of Hazardous Alcohol Use with Hypertension in an Urban Cohort of People Living with HIV in South Florida	PLOS ONE			English	Article							BLOOD-PRESSURE; DRINKING PATTERN; CONSUMPTION; RISK; DISEASE; WINE; PREVALENCE	Objective: Industrialized countries are currently experiencing an epidemic of high blood pressure (HBP) extending to people living with HIV (PLWH). Given the prevalence of hazardous alcohol use (HAU), this study examines the relationship between alcohol consumption and hypertension in PLWH. Including a gender analysis is critical, given the high rates of HAU and HIV among females. Method: We followed PLWH including both HAU and non-HAU (200 each). Participants were assessed twice for body weight, blood pressure, alcohol consumption, and other BP-associated lifestyle factors. High blood pressure (defined as systolic/diastolic blood pressure above 140/90 mmHg and/or treatment of HBP) was the primary outcome. Results: Overall prevalence of hypertension was 38% and higher among HAU compared to non-HAU (42% vs. 34%, p=0.02). Less than half with HBP (42%) were receiving treatment for hypertension. Overall, males had a 50% higher risk of HBP than women (odds ratio: 1.5, 95% CI: 1-2.6, p=0.05). However among HAU, females were twice as likely to suffer HBP as their male counterparts (95% CI: 1-3.9, p=0.02). Those HAU who preferred liquor, versus wine, had higher adjusted mean BP (132.6 +/- 18 vs. 122.3 +/- 14 mm Hg, p=0.05). Additional analyses indicated that consumption of >1 standard drink of liquor or beer/day was associated with HBP. Risk of hypertension was noted in those with daily consumption of >3 glasses of wine. For those reporting,1 drink per day, the odds ratio of having HBP was 0.97 (CI: 0.6-0.99, p=0.05). Factors associated with hypertension in the multivariate model included increased age, gender, BMI, HAU particularly of liquor, and smoking. Conclusions: Excessive hypertension burden in this population and its association with HAU and sub-optimal care indicate the need for preventive and educational intervention in PLWH. Analyses highlight the necessity of gender and type-of-beverage specific approaches.	[Miguez-Burbano, Maria Jose; Quiros, Clery; Richardson, Erika] Florida Int Univ, SISH, Miami, FL 33199 USA; [Lewis, John E.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Espinoza, Luis] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA; [Cook, Robert; Trainor, Allison B.] Univ Florida, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Cook, Robert; Trainor, Allison B.] Univ Florida, Coll Med, Gainesville, FL USA; [Asthana, Deshratn] Univ Miami, Miller Sch Med, Dept Pathol, Dept Psychiat & Behav Sci, Miami, FL 33136 USA	State University System of Florida; Florida International University; University of Miami; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Miami	Miguez-Burbano, MJ (corresponding author), Florida Int Univ, SISH, Miami, FL 33199 USA.	mjmiguez@fiu.edu	Cook, Robert Lewis/ABI-4866-2020	Espinoza, Luis/0000-0003-3279-3116	Southern HIV Alcohol Research Consortium (SHARC) Admin and Research Support Core [U24AA022002]; NIAAA [R01 AA018095]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018095, U24AA022002] Funding Source: NIH RePORTER	Southern HIV Alcohol Research Consortium (SHARC) Admin and Research Support Core; NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Some of the work on this paper was supported the Southern HIV Alcohol Research Consortium (SHARC) Admin and Research Support Core, federal grant number U24AA022002 and also by the NIAAA R01 AA018095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedjonov A, 2013, DRUG ALCOHOL REV, V32, P248, DOI 10.1111/j.1465-3362.2012.00521.x; BULPITT CJ, 1987, J HYPERTENS, V5, P85, DOI 10.1097/00004872-198702000-00012; Celio MA, 2016, ALCOHOL CLIN EXP RES, V40, P638, DOI 10.1111/acer.12988; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow DC, 2003, HIV CLIN TRIALS, V4, P411, DOI 10.1310/5E7Q-PGWB-16UE-J48U; Das S, 2010, J ANTIMICROB CHEMOTH, V65, P386, DOI 10.1093/jac/dkp460; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Djousse L, 2009, REV ESP CARDIOL, V62, P603, DOI 10.1016/S0300-8932(09)71326-0; Doumas M, 2010, AM J CARDIOL, V105, P570, DOI 10.1016/j.amjcard.2009.10.027; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Karatzi KN, 2005, AM J HYPERTENS, V18, P1161, DOI 10.1016/j.amjhyper.2005.03.744; Kearney F, 2010, AGE AGEING, V39, P536, DOI 10.1093/ageing/afq083; Khatlb OMN, 2005, CLIN GUIDELINES MANA; Klatsky AL, 1996, CLIN CHIM ACTA, V246, P91, DOI 10.1016/0009-8981(96)06230-4; Leighton F, 2006, CELL BIOCHEM FUNCT, V24, P291, DOI 10.1002/cbf.1269; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; MacMahon S W, 1984, J Hypertens, V2, P85, DOI 10.1097/00004872-198402000-00015; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Matsumoto C, 2014, J CARDIOPULM REHABIL, V34, P159, DOI 10.1097/HCR.0000000000000042; Miguez MJ, 2012, J AIDS CLIN RES, V3, pe109, DOI [10.4172/2155-6113.1000e109, DOI 10.4172/2155-6113.1000E109]; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Schutte AE, 2012, INT J EPIDEMIOL, V41, P1114, DOI 10.1093/ije/dys106; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Skinner H.A., 1984, ALCOHOL DEPENDENCE S; Stamler J, 2000, ANTIVIR THER, V5, P13; Stranges S, 2004, HYPERTENSION, V44, P813, DOI 10.1161/01.HYP.0000146537.03103.f2; STROGATZ DS, 1991, AM J EPIDEMIOL, V133, P442, DOI 10.1093/oxfordjournals.aje.a115911; TREVISAN M, 1987, INT J EPIDEMIOL, V16, P520, DOI 10.1093/ije/16.4.520	30	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e113122	10.1371/journal.pone.0113122	http://dx.doi.org/10.1371/journal.pone.0113122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490037	Green Published, gold			2022-12-26	WOS:000347515300005
J	Wiik, R; Krovel, AV				Wiik, Ragnhild; Krovel, Anne Vatland			Necessity and Effect of Combating Legionella pneumophila in Municipal Shower Systems	PLOS ONE			English	Article							SEQUENCE-BASED SCHEME; LEGIONNAIRES-DISEASE; BIOFILM FORMATION; LARGE OUTBREAK; WATER-SYSTEMS; FLOW; ENUMERATION; SEROGROUPS; CULTURE; AMEBAS	The objective was to obtain research-based, holistic knowledge about necessity and effect of practiced measures against L. pneumophila in municipal shower systems in Stavanger, Norway. The effects of hot water treatment and membrane-filtering were investigated and compared to no intervention at all. The studies were done under real-world conditions. Additionally, a surveillance pilot study of municipal showers in Stavanger was performed. The validity of high total plate count (TPC) as an indication of L. pneumophila was evaluated. A simplified method, named "dripping method", for detection and quantification of L. pneumophila was developed. The sensitivity of the dripping method is 5 colony-forming units of L. pneumophila/ml. The transference of L. pneumophila from shower water to aerosols was studied. Interviews and observational studies among the stakeholders were done in order to identify patterns of communication and behavior in a Legionella risk perspective. No substantial effects of the measures against L. pneumophila were demonstrated, except for a distally placed membrane filter. No significant positive correlation between TPC and L. pneumophila concentrations were found. L. pneumophila serogroup 2-14 was demonstrated in 21% of the 29 buildings tested in the surveillance pilot. Relatively few cells of L. pneumophila were transferred from shower water to aerosols. Anxiety appeared as the major driving force in the risk governance of Legionella. In conclusion, the risk of acquiring Legionnaires' disease from municipal shower systems is evaluated as low and uncertain. By eliminating ineffective approaches, targeted Legionella risk governance can be practiced. Risk management by surveillance is evaluated as appropriate.	[Wiik, Ragnhild; Krovel, Anne Vatland] IRIS Int Res Inst Stavanger, Stavanger, Norway		Wiik, R (corresponding author), BI Norwegian Business Sch, Stavanger, Norway.	ragnhild.wiik@bi.no			Stavanger municipality, Norway	Stavanger municipality, Norway	The work has been funded by Stavanger municipality, Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra S, 2011, APPL ENVIRON MICROB, V77, P1268, DOI 10.1128/AEM.02225-10; Allegra S, 2008, APPL ENVIRON MICROB, V74, P7813, DOI 10.1128/AEM.01364-08; Alleron L, 2013, WATER RES, V47, P6606, DOI 10.1016/j.watres.2013.08.032; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 62221999E ISO; [Anonymous], 1998, 117311998E ISO; Arnold J., 2010, WORK PSYCHOL UNDERST; Bartram Jamie, 2007, P1; Bentham R, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P465; Berg B.L., 2012, QUALITATIVE RES METH, V8th; Borella P, 2004, EMERG INFECT DIS, V10, P457, DOI 10.3201/eid1003.020707; Boshuizen HC, 2001, J INFECT DIS, V184, P515, DOI 10.1086/322049; BOULANGER CA, 1995, APPL ENVIRON MICROB, V61, P1805, DOI 10.1128/AEM.61.5.1805-1809.1995; Bronn P.S., 2005, CORPORATE COMMUNICAT, P167; Chang CW, 2007, J APPL MICROBIOL, V102, P1636, DOI 10.1111/j.1365-2672.2006.03195.x; CIESIELSKI CA, 1984, APPL ENVIRON MICROB, V48, P984, DOI 10.1128/AEM.48.5.984-987.1984; Conza L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002428; Darelid J, 2002, J HOSP INFECT, V50, P213, DOI 10.1053/jhin.2002.1185; Delgado-Viscogliosi P, 2005, APPL ENVIRON MICROB, V71, P4086, DOI 10.1128/AEM.71.7.4086-4096.2005; Den Boer JW, 2002, EMERG INFECT DIS, V8, P37, DOI 10.3201/eid0801.010176; Ducret A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-3; ECDC (European Centre for Disease Prevention and Control), 2012, SURV REP LEG DIS EUR, DOI [10.2900/62079, DOI 10.2900/62079]; Edelstein Paul H., 2008, P1; Epalle T, 2014, MICROB ECOL IN PRESS; European Working Group for Legionella Infections (EWGLI), 2011, EWGLI TECHN GUID INV; Farhat M, 2010, J APPL MICROBIOL, V108, P1073, DOI 10.1111/j.1365-2672.2009.04541.x; FARRELL ID, 1990, EPIDEMIOL INFECT, V104, P381, DOI 10.1017/S0950268800047397; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Garasen Helge, 2005, Tidsskr Nor Laegeforen, V125, P1791; Ginevra C, 2009, CLIN INFECT DIS, V49, P184, DOI 10.1086/599825; HARPER D, 1988, J HOSP INFECT, V11, P201, DOI 10.1016/0195-6701(88)90188-0; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Helbig JH, 2002, EUR J CLIN MICROBIOL, V21, P710, DOI 10.1007/s10096-002-0820-3; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; HUSSONG D, 1987, BIO-TECHNOL, V5, P947, DOI 10.1038/nbt0987-947; Joseph Carol, 2008, P35; Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4; Leoni E, 2001, J APPL MICROBIOL, V90, P27, DOI 10.1046/j.1365-2672.2001.01178.x; Liu Z, 2006, J APPL MICROBIOL, V101, P437, DOI 10.1111/j.1365-2672.2006.02970.x; Loret J. F., 2005, Journal of Water and Health, V3, P423; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Luck PC, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P15; Lueck Paul Christian, 2008, P19; Madigan MT, 2009, BROCK BIOL MICROORGA; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; Mampel J, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P398; McCabe S, 2011, CLIN MICROBIOL INFEC, V17, P1517, DOI 10.1111/j.1469-0691.2011.03582.x; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Miuetzner S, 1997, AM J INFECT CONTROL, V25, P452, DOI 10.1016/S0196-6553(97)90066-3; Mouchtouri V, 2007, AM J INFECT CONTROL, V35, P623, DOI 10.1016/j.ajic.2007.01.002; Ohata K, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P431; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Olsen CW, 2009, EUR J CLIN MICROBIOL, V28, P817, DOI 10.1007/s10096-008-0697-x; Pettersen JE, 2008, FOREBYGGING LEGIONEL; Pettersen JE, 2012, 118 NORW I PUBL HLTH; Pettersen JE, 2010, 115 NORW I PUBL HLTH; Ratcliff RM, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P359; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reichardt C, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P501; Renn O., 2008, RISK GOVERNANCE; Ricci ML, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P505; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1842, DOI 10.1128/AEM.60.6.1842-1851.1994; Schoen ME, 2011, WATER RES, V45, P5826, DOI 10.1016/j.watres.2011.08.031; Schousboe M, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P477; Singh T, 2005, J HOSP INFECT, V61, P257, DOI 10.1016/j.jhin.2005.05.001; Skulberg KR, 2006, THESIS U OSLO NORWAY; Steinert M, 1998, ZBL BAKT-INT J MED M, V288, P331; Steinert M, 1997, APPL ENVIRON MICROB, V63, P2047, DOI 10.1128/AEM.63.5.2047-2053.1997; Stout JE, 2006, LEGIONELLA: STATE OF THE ART 30 YEARS AFTER ITS RECOGNITION, P469; Stout JE, 2010, AM J INFECT CONTROL, V38, P341, DOI 10.1016/j.ajic.2010.02.002; Strauss A., 1998, BASICS QUALITATIVE R; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; TA AC, 1995, J CLIN MICROBIOL, V33, P2118, DOI 10.1128/JCM.33.8.2118-2123.1995; Garcia MT, 2007, ENVIRON MICROBIOL, V9, P1267, DOI 10.1111/j.1462-2920.2007.01245.x; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; Uzel A, 2010, ENV HLTH PHYS CHEM B; Waines PL, 2011, THESIS U PLYMOUTH UK; Wedege E, 2013, SCAND J INFECT DIS, V45, P59, DOI 10.3109/00365548.2012.710855; West AA, 1992, LEGIONELLA CURRENT S, P201; WHITEHOUSE RLS, 1991, J DENT, V19, P290, DOI 10.1016/0300-5712(91)90075-A; Wiik R, 2011, INDOOR AIR, V21, P328, DOI 10.1111/j.1600-0668.2011.00708.x; Wiik R, 2008, 2008187 IRIS; Wiik R, 1998, RF98029; Yamamoto H, 1996, FEMS MICROBIOL ECOL, V20, P149, DOI 10.1111/j.1574-6941.1996.tb00313.x	86	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114331	10.1371/journal.pone.0114331	http://dx.doi.org/10.1371/journal.pone.0114331			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25490721	gold, Green Published, Green Submitted			2022-12-26	WOS:000347515300030
J	Williams, TC; Blackman, ER; Morrison, SS; Gibas, CJ; Oliver, JD				Williams, Tiffany C.; Blackman, Elliot R.; Morrison, Shatavia S.; Gibas, Cynthia J.; Oliver, James D.			Transcriptome Sequencing Reveals the Virulence and Environmental Genetic Programs of Vibrio vulnificus Exposed to Host and Estuarine Conditions	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MANNOSE-SENSITIVE HEMAGGLUTININ; CYCLIC-DI-GMP; BIOFILM FORMATION; PHENOTYPIC EVALUATION; HUMAN SERUM; IRON; PCR; DIGUANYLATE; ADHERENCE	Vibrio vulnificus is a natural inhabitant of estuarine waters worldwide and is of medical relevance due to its ability to cause grievous wound infections and/or fatal septicemia. Genetic polymorphisms within the virulence-correlated gene (vcg) serve as a primary feature to distinguish clinical (C-) genotypes from environmental (E-) genotypes. C-genotypes demonstrate superior survival in human serum relative to E-genotypes, and genome comparisons have allowed for the identification of several putative virulence factors that could potentially aid C-genotypes in disease progression. We used RNA sequencing to analyze the transcriptome of C-genotypes exposed to human serum relative to seawater, which revealed two divergent genetic programs under these two conditions. In human serum, cells displayed a distinct "virulence profile" in which a number of putative virulence factors were upregulated, including genes involved in intracellular signaling, substrate binding and transport, toxin and exoenzyme production, and the heat shock response. Conversely, the "environmental profile" exhibited by cells in seawater revealed upregulation of transcription factors such as rpoS, rpoN, and iscR, as well as genes involved in intracellular signaling, chemotaxis, adherence, and biofilm formation. This dichotomous genetic switch appears to be largely governed by cyclic-di-GMP signaling, and remarkably resembles the dual life-style of V. cholerae as it transitions from host to environment. Furthermore, we found a "general stress response" module, known as the stressosome, to be upregulated in seawater. This signaling system has been well characterized in Gram-positive bacteria, however its role in V. vulnificus is not clear. We examined temporal gene expression patterns of the stressosome and found it to be upregulated in natural estuarine waters indicating that this system plays a role in sensing and responding to the environment. This study advances our understanding of gene regulation in V. vulnificus, and brings to the forefront a number of previously overlooked genetic networks.	[Williams, Tiffany C.; Oliver, James D.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Blackman, Elliot R.; Morrison, Shatavia S.; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Oliver, JD (corresponding author), Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA.	jdoliver@uncc.edu		Morrison, Shatavia S/0000-0002-4658-5951; Blackman, Eric/0000-0002-9405-8435; Gibas, Cynthia/0000-0002-1288-9543	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture [200903571]; Charlotte Research Institute; Duke University Marine Laboratory Mary Derrickson McCurdy Scholar	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Charlotte Research Institute; Duke University Marine Laboratory Mary Derrickson McCurdy Scholar	TCW was supported by the Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture (award no. 200903571) awarded to JDO. Funding for Illumina sequencing was provided by Charlotte Research Institute awarded to CJG. In situ gene expression studies were funded by Duke University Marine Laboratory Mary Derrickson McCurdy Scholar Award granted to JDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice AF, 2008, INFECT IMMUN, V76, P4019, DOI 10.1128/IAI.00208-08; Aronesty E., 2011, EA UTILS COMMAND LIN; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 2013, MICROBIOL-SGM, V159, P1878, DOI 10.1099/mic.0.067900-0; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bogard RW, 2007, APPL ENVIRON MICROB, V73, P7501, DOI 10.1128/AEM.01551-07; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Efimov V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00393; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gosink KK, 2002, J BACTERIOL, V184, P1767, DOI 10.1128/JB.184.6.1767-1771.2002; Hsiao A, 2008, MOL MICROBIOL, V67, P849, DOI 10.1111/j.1365-2958.2007.06091.x; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jenkins I, 2012, RNA SEQ ANAL EDGER V; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Joseph LA, 2004, J BACTERIOL, V186, P889, DOI 10.1128/JB.186.3.889-893.2004; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Kim HS, 2009, MOL MICROBIOL, V74, P436, DOI 10.1111/j.1365-2958.2009.06875.x; KIM HR, 1993, LIFE SCI, V53, P571, DOI 10.1016/0024-3205(93)90714-E; Kim HY, 2014, FOODBORNE PATHOG DIS, V11, P119, DOI 10.1089/fpd.2013.1581; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Kustusch RJ, 2012, J BACTERIOL, V194, P3250, DOI 10.1128/JB.00155-12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SE, 2000, J BACTERIOL, V182, P3405, DOI 10.1128/JB.182.12.3405-3415.2000; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim JG, 2014, INFECT IMMUN, V82, P569, DOI 10.1128/IAI.01141-13; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Litwin CM, 2001, MICROB PATHOGENESIS, V31, P295, DOI 10.1006/mpat.2001.0472; Liu H, 2013, J BACTERIOL PARASITO, P4; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Marotta C, 2011, CERTIFICATE ANAL PRO; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08; Nielsen AT, 2006, PLOS PATHOG, V2, P933, DOI 10.1371/journal.ppat.0020109; Njoroge J, 2012, INFECT IMMUN, V80, P688, DOI 10.1128/IAI.05921-11; O'Toole R, 1997, MICROBIOL-SGM, V143, P3849, DOI 10.1099/00221287-143-12-3849; Oliver JD, 2006, BIOLOGY OF VIBRIOS, P349; Oliver JD, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P253; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ray VA, 2013, J BACTERIOL, V195, P5402, DOI 10.1128/JB.00689-13; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Rosche TM, 2010, ENV MICROBIOL REP, V2, P128, DOI 10.1111/j.1758-2229.2009.00119.x; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shao CP, 2000, INFECT IMMUN, V68, P3569, DOI 10.1128/IAI.68.6.3569-3573.2000; Smith B, 2006, APPL ENVIRON MICROB, V72, P1445, DOI 10.1128/AEM.72.2.1445-1451.2006; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Spinola SM, 2003, INFECT IMMUN, V71, P7178, DOI 10.1128/IAI.71.12.7178-7182.2003; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Syed KA, 2009, J BACTERIOL, V191, P6555, DOI 10.1128/JB.00949-09; Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Thiaville PC, 2011, INFECT IMMUN, V79, P1194, DOI 10.1128/IAI.01031-10; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Valiente E, 2009, FEMS MICROBIOL ECOL, V69, P16, DOI 10.1111/j.1574-6941.2009.00691.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Warner EB, 2008, FOODBORNE PATHOG DIS, V5, P691, DOI 10.1089/fpd.2008.0120; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999; Whitaker WB, 2014, INFECT IMMUN, V82, P544, DOI 10.1128/IAI.01210-13; Williams TC, 2014, APPL ENVIRON MICROB, V80, P1580, DOI 10.1128/AEM.03811-13; WRIGHT AC, 1991, INFECT IMMUN, V59, P192, DOI 10.1128/IAI.59.1.192-197.1991; WRIGHT AC, 1990, INFECT IMMUN, V58, P1769, DOI 10.1128/IAI.58.6.1769-1773.1990; WRIGHT AC, 1981, INFECT IMMUN, V34, P503, DOI 10.1128/IAI.34.2.503-507.1981; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541	91	29	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2014	9	12							e114376	10.1371/journal.pone.0114376	http://dx.doi.org/10.1371/journal.pone.0114376			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3YM	25489854	Green Published, gold, Green Submitted			2022-12-26	WOS:000347515300033
J	Braunreiter, K; Hamlin, S; Lyman-Gingerich, J				Braunreiter, Kara; Hamlin, Shelby; Lyman-Gingerich, Jamie			Identification and Characterization of a Novel Allele of Caenorhabditis elegans bbs-7	PLOS ONE			English	Article							BIEDL SYNDROME PROTEINS; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; ELEGANS; DISEASE; DEFECTS; COMPLEX; MODEL; BBS6	Primary cilia play a role in the sensation of and response to the surrounding environment. Caenorhabditis elegans (C. elegans) have primary cilia only on the distal tips of some dendrites. In order to better understand the relationship between receptor localization to cilia, cilia structure and cilia function, we have characterized a mutation originally identified in a forward genetic screen for mutants with defective PKD-2 ciliary localization. Through behavioral assays and examination of the structure of cilia in the cil-5 (my13) mutant animals, we have found that my13 disrupts not only receptor localization, but also some cilia-mediated sensory behaviors and cilia structural integrity. We have identified the my13 lesion and found that it is a missense mutation in bbs-7, an ortholog of human BBS-7, a gene known to affect human cilia and to be involved in Bardet-Biedl syndrome. Finally, we show that bbs-7(my13) also affects the glia cells which support the cilia.	[Braunreiter, Kara; Hamlin, Shelby; Lyman-Gingerich, Jamie] Univ Wisconsin, Dept Biol, Eau Claire, WI 54701 USA	University of Wisconsin System	Lyman-Gingerich, J (corresponding author), Univ Wisconsin, Dept Biol, Phillips Hall 330, Eau Claire, WI 54701 USA.	lymangjs@uwec.edu			University of Wisconsin-Eau Claire Office of Research and Sponsored Programs; National Institutes of Health AREA Grant [DK88743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK088743] Funding Source: NIH RePORTER	University of Wisconsin-Eau Claire Office of Research and Sponsored Programs; National Institutes of Health AREA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work provided by the University of Wisconsin-Eau Claire Office of Research and Sponsored Programs (JLG, SH, and KB) and the National Institutes of Health AREA Grant (DK88743) (JLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bae YK, 2008, DEV DYNAM, V237, P2021, DOI 10.1002/dvdy.21531; Bae YK, 2008, FRONT BIOSCI-LANDMRK, V13, P5959, DOI 10.2741/3129; Bae YK, 2006, DEVELOPMENT, V133, P3859, DOI 10.1242/dev.02555; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2005, J AM SOC NEPHROL, V16, P305, DOI 10.1681/ASN.2004080645; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Gakovic M, 2011, HUM MOL GENET, V20, P4840, DOI 10.1093/hmg/ddr423; Gascue C, 2012, J CELL SCI, V125, P362, DOI 10.1242/jcs.089375; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Inglis P. N., 2007, WORMBOOK, P1, DOI [10.1895/wormbook.1.126.2, DOI 10.1895/WORMBOOK.1.126.2]; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Knobel KM, 2008, EXP CELL RES, V314, P825, DOI 10.1016/j.yexcr.2007.10.017; Lee BH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001219; Mok CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002335; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Norris DP, 2012, SCIENCE, V338, P206, DOI 10.1126/science.1230401; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Oikonomou G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001121; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Zhang QH, 2013, J CELL SCI, V126, P2372, DOI 10.1242/jcs.111740	44	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e113737	10.1371/journal.pone.0113737	http://dx.doi.org/10.1371/journal.pone.0113737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486278	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600023
J	Qiao, ZW; Xia, CM; Shen, S; Corwin, FD; Liu, M; Guan, RJ; Grider, JR; Qiao, LY				Qiao, Zhongwei; Xia, Chunmei; Shen, Shanwei; Corwin, Frank D.; Liu, Miao; Guan, Ruijuan; Grider, John R.; Qiao, Li-Ya			Suppression of the PI3K Pathway In Vivo Reduces Cystitis-Induced Bladder Hypertrophy and Restores Bladder Capacity Examined by Magnetic Resonance Imaging	PLOS ONE			English	Article							RAT URINARY-BLADDER; CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; COLLAGEN EXPRESSION; REGULATES COLLAGEN; MESSENGER-RNA; SMOOTH-MUSCLE; AKT; RECEPTORS; PROTEIN; INFLAMMATION	This study utilized magnetic resonance imaging (MRI) to monitor the real-time status of the urinary bladder in normal and diseased states following cyclophosphamide (CYP)-induced cystitis, and also examined the role of the phosphoinositide 3-kinase (PI3K) pathway in the regulation of urinary bladder hypertrophy in vivo. Our results showed that under MRI visualization the urinary bladder wall was significantly thickened at 8 h and 48 h post CYP injection. The intravesical volume of the urinary bladder was also markedly reduced. Treatment of the cystitis animals with a specific PI3K inhibitor LY294002 reduced cystitis-induced bladder wall thickening and enlarged the intravesical volumes. To confirm the MRI results, we performed H&E stain postmortem and examined the levels of type I collagen by real-time PCR and western blot. Inhibition of the PI3K in vivo reduced the levels of type I collagen mRNA and protein in the urinary bladder ultimately attenuating cystitis-induced bladder hypertrophy. The bladder mass calculated according to MRI data was consistent to the bladder weight measured ex vivo under each drug treatment. MRI results also showed that the urinary bladder from animals with cystitis demonstrated high magnetic signal intensity indicating considerable inflammation of the urinary bladder when compared to normal animals. This was confirmed by examination of the pro-inflammatory factors showing that interleukin (IL)-1 alpha, IL-6 and tumor necrosis factor (TNF)alpha levels in the urinary bladder were increased with cystitis. Our results suggest that MRI can be a useful technique in tracing bladder anatomy and examining bladder hypertrophy in vivo during disease development and the PI3K pathway has a critical role in regulating bladder hypertrophy during cystitis.	[Qiao, Zhongwei] Fudan Univ, Childrens Hosp, Div Radiol, Shanghai 200433, Peoples R China; [Xia, Chunmei; Guan, Ruijuan] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China; [Xia, Chunmei; Shen, Shanwei; Liu, Miao; Grider, John R.; Qiao, Li-Ya] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Corwin, Frank D.] Virginia Commonwealth Univ, Sch Med, Dept Radiol, Richmond, VA USA; [Grider, John R.; Qiao, Li-Ya] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Richmond, VA USA	Fudan University; Fudan University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Qiao, LY (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23284 USA.	lqiao2@vcu.edu	Liu, Miao/A-7353-2015	Shen, Shanwei/0000-0002-7701-4406	Shanghai Municipal Medical Guide Project [134119a4100]; Shanghai Municipal Natural Science Foundation [13ZR1403400]; Center for Molecular Imaging at Virginia Commonwealth University; NIH [DK034153, DK077917]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077917, R01DK034153, R56DK034153, R23DK034153] Funding Source: NIH RePORTER	Shanghai Municipal Medical Guide Project; Shanghai Municipal Natural Science Foundation; Center for Molecular Imaging at Virginia Commonwealth University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by grants from Shanghai Municipal Medical Guide Project 134119a4100 to ZWQ; Shanghai Municipal Natural Science Foundation 13ZR1403400 to CMX; Center for Molecular Imaging at Virginia Commonwealth University; NIH DK034153 to JRG; and NIH DK077917 to LYQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas CZ, 2012, AM J PHYSIOL-RENAL, V303, pF1363, DOI 10.1152/ajprenal.00273.2012; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Arms L, 2011, AM J PHYSIOL-RENAL, V301, pF252, DOI 10.1152/ajprenal.00556.2010; Arms L, 2010, AM J PHYSIOL-RENAL, V298, pF589, DOI 10.1152/ajprenal.00628.2009; Aronsson P, 2012, AUTON NEUROSCI-BASIC, V171, P49, DOI 10.1016/j.autneu.2012.10.006; Bitti GT, 2014, RADIOGRAPHICS, V34, P429, DOI 10.1148/rg.342125050; Bjorling DE, 2007, BJU INT, V99, P1523, DOI 10.1111/j.1464-410X.2007.06773.x; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Chang S, 2009, LAB INVEST, V89, P823, DOI 10.1038/labinvest.2009.38; Chung CW, 2010, J BIOL CHEM, V285, P4206, DOI 10.1074/jbc.M109.040444; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; Dinis P, 2004, J NEUROSCI, V24, P11253, DOI 10.1523/JNEUROSCI.2657-04.2004; DOOMS GC, 1986, UROL RADIOL, V8, P156, DOI 10.1007/BF02924099; FISHER MR, 1985, RADIOLOGY, V157, P467, DOI 10.1148/radiology.157.2.4048457; FISHER MR, 1985, RADIOLOGY, V157, P471, DOI 10.1148/radiology.157.2.4048458; GABELLA G, 1990, ANAT EMBRYOL, V182, P409; Girard BM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00020; Gonzalez EJ, 2013, AM J PHYSIOL-RENAL, V305, pF1265, DOI 10.1152/ajprenal.00042.2013; Grover S, 2011, THER ADV UROL, V3, P19, DOI 10.1177/1756287211398255; HANASH KA, 1969, J UROLOGY, V102, P427, DOI 10.1016/S0022-5347(17)62164-5; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Ito K, 2008, N-S ARCH PHARMACOL, V377, P483, DOI 10.1007/s00210-007-0197-z; Jerde TJ, 2000, UROL RES, V28, P269, DOI 10.1007/s002400000114; Kageyama A, 2008, NEUROSCI LETT, V436, P81, DOI 10.1016/j.neulet.2008.02.065; Kay JC, 2013, EXP NEUROL, V250, P366, DOI 10.1016/j.expneurol.2013.10.015; Kay JC, 2013, EXP NEUROL; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Lee HJ, 2012, CELL TRANSPLANT, V21, P959, DOI 10.3727/096368911X627516; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Lv JW, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/358184; Ma Z, 2011, ANN BIOMED ENG, V39, P2287, DOI 10.1007/s10439-011-0324-3; Malley SE, 2002, PHYSIOL GENOMICS, V9, P5, DOI 10.1152/physiolgenomics.00117.2001; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Merriam FV, 2008, NEUROSCI LETT, V445, P130, DOI 10.1016/j.neulet.2008.08.076; Metcalfe PD, 2010, BJU INT, V106, P1686, DOI 10.1111/j.1464-410X.2010.09445.x; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nasrin S, 2013, J UROLOGY, V189, P1123, DOI 10.1016/j.juro.2012.09.054; Piccoli C W, 1990, Top Magn Reson Imaging, V2, P51; Qiao LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081547; Saitoh C, 2008, J UROLOGY, V179, P359, DOI 10.1016/j.juro.2007.08.090; Sun Y, 2014, TISSUE ENG C; Tamada T, 2009, J MAGN RESON IMAGING, V29, P636, DOI 10.1002/jmri.21689; Tang HY, 2002, AM J PHYSIOL-REG I, V282, pR890, DOI 10.1152/ajpregu.0527.2001; Tubaro Andrea, 2005, Rev Urol, V7 Suppl 6, pS35; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vizzard MA, 2001, J CHEM NEUROANAT, V21, P125, DOI 10.1016/S0891-0618(00)00115-0; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wang CC, 2013, TOXICOL SCI, V131, P302, DOI 10.1093/toxsci/kfs270; Wang ZY, 2013, J UROL; Wong-You-Cheong JJ, 2006, RADIOGRAPHICS, V26, P1847, DOI 10.1148/rg.266065126; Yokoyama K, 2012, GRAEF ARCH CLIN EXP, V250, P15, DOI 10.1007/s00417-011-1766-x; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102; Zhang QL, 2012, REGUL PEPTIDES, V177, P73, DOI 10.1016/j.regpep.2012.05.088; Zhao Y, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5173	56	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2014	9	12							e114536	10.1371/journal.pone.0114536	http://dx.doi.org/10.1371/journal.pone.0114536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MX	25486122	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907600072
J	Koch, P; Lohr, HB; Driever, W				Koch, Peter; Loehr, Heiko B.; Driever, Wolfgang			A Mutation in cnot8, Component of the Ccr4-Not Complex Regulating Transcript Stability, Affects Expression Levels of Developmental Regulators and Reveals a Role of Fgf3 in Development of Caudal Hypothalamic Dopaminergic Neurons	PLOS ONE			English	Article							MESSENGER-RNA DECAY; DEVELOPING ZEBRAFISH BRAIN; ISOTOCIN CELL-DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; CATECHOLAMINERGIC SYSTEM; MONOAMINERGIC NEURONS; HOMEODOMAIN PROTEIN; DEADENYLASE COMPLEX; GENETIC-ANALYSIS; CAF1 PROTEINS	While regulation of the activity of developmental control genes at the transcriptional level as well as by specific miRNA-based degradation are intensively studied, little is known whether general cellular mechanisms controlling mRNA decay may contribute to differential stability of mRNAs of developmental control genes. Here, we investigate whether a mutation in the deadenylation dependent mRNA decay pathway may reveal differential effects on developmental mechanisms, using dopaminergic differentiation in the zebrafish brain as model system. In a zebrafish genetic screen aimed at identifying genes controlling dopaminergic neuron development we isolated the m1061 mutation that selectively caused increased dopaminergic differentiation in the caudal hypothalamus, while other dopaminergic groups were not affected. Positional cloning revealed that m1061 causes a premature stop codon in the cnot8 open reading frame. Cnot8 is a component of the Ccr4-Not complex and displays deadenylase activity, which is required for removal of the poly (A) tail in bulk mRNA turnover. Analyses of expression of developmental regulators indicate that loss of Cnot8 activity results in increased mRNA in situ hybridization signal levels for a subset of developmental control genes. We show that in the area of caudal hypothalamic dopaminergic differentiation, mRNA levels for several components of the FGF signaling pathway, including Fgf3, FGF receptors, and FGF target genes, are increased. Pharmacological inhibition of FGF signaling or a mutation in the fgf3 gene can compensate the gain of caudal hypothalamic dopaminergic neurons in cnot8(m1061) mutants, indicating a role for Fgf3 in control of development of this dopaminergic population. The cnot8m1061 mutant phenotype provides an in vivo system to study roles of the Cnot8 deadenylase component of the mRNA decay pathway in vertebrate development. Our data indicate that attenuation of Cnot8 activity differentially affects mRNA levels of developmental control genes.	[Koch, Peter; Loehr, Heiko B.; Driever, Wolfgang] Univ Freiburg, Fac Biol, Inst Biol 1, D-79104 Freiburg, Germany; [Driever, Wolfgang] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Koch, P (corresponding author), Univ Cologne, Inst Pharmacol, Gleuelerstr 24, D-50931 Cologne, Germany.	peter.koch@uk-koeln.de; driever@biologie.uni-freiburg.de		Driever, Wolfgang/0000-0002-9551-9141	DFG [GRK 843]; EC program EU-FP6 IP ZF-MODELS; EC program EU-FP7 IP ZF-HEALTH; EC program FP7 IP mesDANEURODEV; GIF [926-183.1/2006]; Excellence Initiative of the German Federal Government [BIOSS - EXC 294]; Excellence Initiative of the German State Government [BIOSS - EXC 294]	DFG(German Research Foundation (DFG)); EC program EU-FP6 IP ZF-MODELS; EC program EU-FP7 IP ZF-HEALTH; EC program FP7 IP mesDANEURODEV; GIF(German-Israeli Foundation for Scientific Research and Development); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by DFG - GRK 843 "Mechanisms of Neuronal Signal Transduction - from Protein to Network" (PK), by the EC programs EU-FP6 IP ZF-MODELS, EU-FP7 IP ZF-HEALTH, and FP7 IP mesDANEURODEV, by GIF 926-183.1/2006, and the Excellence Initiative of the German Federal and State Governments (BIOSS - EXC 294).	Acampora D, 2000, INT J DEV BIOL, V44, P669; Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Bellipanni G, 2002, MECH DEVELOP, V119, pS215, DOI 10.1016/S0925-4773(03)00119-9; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; Borodovsky N, 2009, DEV DYNAM, V238, P826, DOI 10.1002/dvdy.21894; Bosco A, 2013, DEVELOPMENT, V140, P372, DOI 10.1242/dev.089094; Brown CE, 1996, MOL CELL BIOL, V16, P5744; Brown LA, 1998, ONCOGENE, V17, P93, DOI 10.1038/sj.onc.1201911; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Chen C, 2011, BIOCHEM BIOPH RES CO, V411, P360, DOI 10.1016/j.bbrc.2011.06.148; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Eaton JL, 2007, DEV GENES EVOL, V217, P149, DOI 10.1007/s00427-006-0123-2; Eaton JL, 2006, DEV DYNAM, V235, P2071, DOI 10.1002/dvdy.20848; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Flames N, 2011, ANNU REV NEUROSCI, V34, P153, DOI 10.1146/annurev-neuro-061010-113824; Fritz DT, 2004, CELL BIOCHEM BIOPHYS, V41, P265, DOI 10.1385/CBB:41:2:265; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Giraldez AJ, 2010, CURR OPIN GENET DEV, V20, P369, DOI 10.1016/j.gde.2010.04.003; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Holzschuh J, 2003, J NEUROSCI, V23, P5507; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; KANE DA, 1993, DEVELOPMENT, V119, P447; Kiefer P, 1996, GENE, V168, P211, DOI 10.1016/0378-1119(95)00736-9; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Levkowitz G, 2003, NAT NEUROSCI, V6, P28, DOI 10.1038/nn979; Lillesaar C, 2007, DEV DYNAM, V236, P1072, DOI 10.1002/dvdy.21095; Liu HY, 2001, J BIOL CHEM, V276, P7541, DOI 10.1074/jbc.M009112200; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9; Munchberg SR, 1999, MECH DEVELOP, V88, P233, DOI 10.1016/S0925-4773(99)00179-3; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rohr KB, 2000, MECH DEVELOP, V95, P267, DOI 10.1016/S0925-4773(00)00345-2; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Ryu S, 2006, J NEURAL TRANSM-SUPP, P61; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Thisse B., 2001, EXPRESSION ZEBRAFISH; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf A, 2013, DEVELOPMENT, V140, P1762, DOI 10.1242/dev.085357; Woo K, 1998, DEV BIOL, V197, P283, DOI 10.1006/dbio.1998.8870; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	77	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113829	10.1371/journal.pone.0113829	http://dx.doi.org/10.1371/journal.pone.0113829			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478689	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200033
J	Rahim, S; Minas, T; Hong, SH; Justvig, S; Celik, H; Kont, YS; Han, J; Kallarakal, AT; Kong, YL; Rudek, MA; Brown, ML; Kallakury, B; Toretsky, JA; Uren, A				Rahim, Said; Minas, Tsion; Hong, Sung-Hyeok; Justvig, Sarah; Celik, Haydar; Kont, Yasemin Saygideger; Han, Jenny; Kallarakal, Abraham T.; Kong, Yali; Rudek, Michelle A.; Brown, Milton L.; Kallakury, Bhaskar; Toretsky, Jeffrey A.; Ueren, Aykut			A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model	PLOS ONE			English	Article							ETS TRANSCRIPTION FACTORS; POLY(ADP-RIBOSE) POLYMERASE; EWS-FLI1; PATHWAY; GENES; REARRANGEMENTS; SPECIFICITY; EXPRESSION; CARCINOMA; SARCOMA	Background: The erythroblastosis virus E26 transforming sequences (ETS) family of transcription factors consists of a highly conserved group of genes that play important roles in cellular proliferation, differentiation, migration and invasion. Chromosomal translocations fusing ETS factors to promoters of androgen responsive genes have been found in prostate cancers, including the most clinically aggressive forms. ERG and ETV1 are the most commonly translocated ETS proteins. Over-expression of these proteins in prostate cancer cells results in a more invasive phenotype. Inhibition of ETS activity by small molecule inhibitors may provide a novel method for the treatment of prostate cancer. Methods and Findings: We recently demonstrated that the small molecule YK-4-279 inhibits biological activity of ETV1 in fusion-positive prostate cancer cells leading to decreased motility and invasion in-vitro. Here, we present data from an in-vivo mouse xenograft model. SCID-beige mice were subcutaneously implanted with fusion-positive LNCaP-luc-M6 and fusion-negative PC-3M-luc-C6 tumors. Animals were treated with YK-4-279, and its effects on primary tumor growth and lung metastasis were evaluated. YK-4-279 treatment resulted in decreased growth of the primary tumor only in LNCaP-luc-M6 cohort. When primary tumors were grown to comparable sizes, YK-4-279 inhibited tumor metastasis to the lungs. Expression of ETV1 target genes MMP7, FKBP10 and GLYATL2 were reduced in YK-4-279 treated animals. ETS fusion-negative PC-3M-luc-C6 xenografts were unresponsive to the compound. Furthermore, YK-4-279 is a chiral molecule that exists as a racemic mixture of R and S enantiomers. We established that (S)-YK-4-279 is the active enantiomer in prostate cancer cells. Conclusion: Our results demonstrate that YK-4-279 is a potent inhibitor of ETV1 and inhibits both the primary tumor growth and metastasis of fusion positive prostate cancer xenografts. Therefore, YK-4-279 or similar compounds may be evaluated as a potential therapeutic tool for treatment of human prostate cancer at different stages.	[Rahim, Said; Minas, Tsion; Hong, Sung-Hyeok; Justvig, Sarah; Celik, Haydar; Kont, Yasemin Saygideger; Han, Jenny; Kallarakal, Abraham T.; Kong, Yali; Brown, Milton L.; Kallakury, Bhaskar; Toretsky, Jeffrey A.; Ueren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Rudek, Michelle A.] Univ Baltimore, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21201 USA	Georgetown University; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Baltimore	Uren, A (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	au26@georgetown.edu	Saygideger, Yasemin/E-5089-2018	Saygideger, Yasemin/0000-0003-3293-373X; Celik, Haydar/0000-0003-4314-8438	Department of Defense's Congressionally Directed Medical Research Program [PC111510]; Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH) [P30 CA006973, UL1 RR025005]; Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Shared Instrument Grant) [1S10RR026824-01]; CCSG [P30 CA051008-16]; NATIONAL CANCER INSTITUTE [P30CA006973, R01CA138212, RC4CA156509, R01CA133662, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, S10RR026824] Funding Source: NIH RePORTER	Department of Defense's Congressionally Directed Medical Research Program(United States Department of Defense); Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Shared Instrument Grant); CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	These experiments were primarily supported by a grant from the Department of Defense's Congressionally Directed Medical Research Program (PC111510, PI: Aykut Uren, http://cdmrp.army.mil/). The pharmacokinetic experiments were supported by the Analytical Pharmacology Core of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (NIH grants P30 CA006973 and UL1 RR025005, and the Shared Instrument Grant (1S10RR026824-01), http://grants.nih.gov/grants/oer.htm). Biacore experiments were done at the Genomics and Epigenomics Shared Resource, which is supported by CCSG Grant P30 CA051008-16 (Lou Weiner, PI), http://cancercenters.cancer.gov/grants_funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2007, CANCER RES, V67, P6012; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Barber-Rotenberg JS, 2012, ONCOTARGET, V3, P172; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Gartner EM, 2010, CANCER J, V16, P83, DOI 10.1097/PPO.0b013e3181d78223; Grant TJ, 2012, P NATL ACAD SCI USA, V109, P4503, DOI 10.1073/pnas.1121601109; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hilgard P, 1997, EUR J CANCER, V33, P442; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong SH, 2014, ONCOTARGET, V5, P338, DOI 10.18632/oncotarget.1495; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; KUBINYI H, 1977, J MED CHEM, V20, P625, DOI 10.1021/jm00215a002; Ordonez JL, 2010, ADV ANAT PATHOL, V17, P162, DOI 10.1097/PAP.0b013e3181d98cbf; McConathy Jonathan, 2003, Prim Care Companion J Clin Psychiatry, V5, P70; Patel V, 2002, CANCER RES, V62, P1401; Paulo P, 2012, NEOPLASIA, V14, P600, DOI 10.1593/neo.12600; Rahim S, 2013, AM J TRANSL RES, V5, P254; Rahim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019343; Scatena CD, 2004, PROSTATE, V59, P292, DOI 10.1002/pros.20003; Seo PJ, 2011, TRENDS PLANT SCI, V16, P541, DOI 10.1016/j.tplants.2011.06.001; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109	30	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114260	10.1371/journal.pone.0114260	http://dx.doi.org/10.1371/journal.pone.0114260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479232	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200059
J	Rasmussen, G; Monecke, S; Brus, O; Ehricht, R; Soderquist, B				Rasmussen, Gunloeg; Monecke, Stefan; Brus, Ole; Ehricht, Ralf; Soederquist, Bo			Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus aureus Bacteremia Isolates in Sweden	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; BLOOD-STREAM INFECTIONS; POTENTIAL ASSOCIATIONS; RESISTANT; STRAINS; MORTALITY; VIRULENCE; CLONES; GENE	Staphylococcus aureus is one of the major pathogens that causes bacteremia; therefore, it is important to understand the long-term molecular epidemiology of S. aureus bacteremia infections. In particular, little is known about the population structure of methicillin-sensitive S. aureus (MSSA) compared to that of methicillin-resistant S. aureus. We investigated potential changes in the MSSA molecular epidemiology in Orebro County, Sweden, from 1980 through 2010. 400 MSSA bacteremia isolates, the first 100 isolated each decade from 1980 through 2010, were retrospectively identified and analyzed regarding assignment to clonal complexes (CCs), presence of virulence genes and antibiotic resistant determinants with DNA microarray-based genotyping. 24 different CCs were identified. Most isolates (80%) belonged to 6 predominant lineages. Of those, the number of isolates assigned to CC5 and CC15 increased, and those assigned to CC8, CC25, and CC30 decreased. The most prevalent clone, CC45, did not show a significant change in prevalence during the study period. A change in prevalence was observed for some of the virulence genes, mainly attributed with their association to certain CCs. With the exception of the common blaZ gene (encoding penicillinase), antibiotic resistance genes were only sporadically detected. In conclusion, the MSSA population structure was genetically diverse. We observed decadal changes in assignments to five predominant clones, and corresponding changes in the prevalence of some virulence genes linked to CC affiliation. In light of the restrictive antibiotics prescriptions and extensive infection control procedures in Sweden, antibiotic resistance genes were rarely detected and their prevalence unaffected during the study period.	[Rasmussen, Gunloeg; Soederquist, Bo] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Rasmussen, Gunloeg] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Monecke, Stefan; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Brus, Ole] Orebro Univ Hosp, Clin Epidemiol & Biostat, Orebro, Sweden; [Soederquist, Bo] Orebro Univ Hosp, Dept Lab Med, Clin Microbiol, Orebro, Sweden; [Soederquist, Bo] Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden	Orebro University; Orebro University; Alere; Technische Universitat Dresden; Orebro University; Orebro University; Orebro University	Rasmussen, G (corresponding author), Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden.	gunlog.rasmussen@orebroll.se		Soderquist, Bo/0000-0001-5939-2932	Research Committee of the County Council of Orebro University Hospital	Research Committee of the County Council of Orebro University Hospital	Funding for this study was provided by grants from the Research Committee of the County Council of Orebro University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamot HV, 2012, J CLIN MICROBIOL, V50, P3111, DOI 10.1128/JCM.01352-12; Badiou C, 2008, CLIN MICROBIOL INFEC, V14, P1180, DOI 10.1111/j.1469-0691.2008.02105.x; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Fenner L, 2008, EUR J CLIN MICROBIOL, V27, P623, DOI 10.1007/s10096-008-0463-0; Ferry Tristan, 2005, Curr Infect Dis Rep, V7, P420, DOI 10.1007/s11908-005-0043-8; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Goering RV, 2008, J CLIN MICROBIOL, V46, P2842, DOI 10.1128/JCM.00521-08; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Larsson AK, 2014, EUR J CLIN MICROBIOL, V33, P61, DOI 10.1007/s10096-013-1929-2; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lyytikainen O, 2005, EUR J CLIN MICROBIOL, V24, P399, DOI 10.1007/s10096-005-1345-3; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nulens E, 2008, J CLIN MICROBIOL, V46, P2438, DOI 10.1128/JCM.00808-08; Otsuka T, 2006, BIOCHEM BIOPH RES CO, V346, P1234, DOI 10.1016/j.bbrc.2006.06.038; Petersen PJ, 1999, ANTIMICROB AGENTS CH, V43, P738, DOI 10.1128/AAC.43.4.738; Rasmussen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077477; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Tavares A, 2014, EUR J CLIN MICROBIOL, V33, P423, DOI 10.1007/s10096-013-1972-z; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114276	10.1371/journal.pone.0114276	http://dx.doi.org/10.1371/journal.pone.0114276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479442	Green Published, gold, Green Submitted			2022-12-26	WOS:000346907200063
J	Skeff, MA; Brito, GAC; de Oliveira, MG; Braga, CM; Cavalcante, MM; Baldim, V; Holanda-Afonso, RC; Silva-Boghossian, CM; Colombo, AP; Ribeiro, RA; Moura-Neto, V; Leita, RFC				Skeff, Maria Adriana; Brito, Gerly A. C.; de Oliveira, Marcelo G.; Braga, Cintia M.; Cavalcante, Matheus M.; Baldim, Victor; Holanda-Afonso, Rosenilde C.; Silva-Boghossian, Carina M.; Colombo, Ana Paula; Ribeiro, Ronaldo A.; Moura-Neto, Vivaldo; Leita, Renata F. C.			S-Nitrosoglutathione Accelerates Recovery from 5-Fluorouracil-Induced Oral Mucositis	PLOS ONE			English	Article							NITRIC-OXIDE DONORS; BONE-RESORPTION; EXPERIMENTAL PERIODONTITIS; PORPHYROMONAS-GINGIVALIS; COLLAGEN-SYNTHESIS; IN-VITRO; HYDROGEL; STRESS; BETA; RATS	Introduction: Mucositis induced by anti-neoplastic drugs is an important, dose-limiting and costly side-effect of cancer therapy. Aim: To evaluate the effect of the topical application of S-nitrosoglutathione (GSNO), a nitric oxide donor, on 5-fluorouracil (5-FU)-induced oral mucositis in hamsters. Materials and Methods: Oral mucositis was induced in male hamsters by two intraperitoneal administrations of 5-FU on the first and second days of the experiment (60 and 40 mg/kg, respectively) followed by mechanical trauma on the fourth day. Animals received saline, HPMC or HPMC/GSNO (0.1, 0.5 or 2.0 mM) 1 h prior to the 5-FU injection and twice a day for 10 or 14 days. Samples of cheek pouches were harvested for: histopathological analysis, TNF-alpha and IL-1 beta levels, immunohistochemical staining for iNOS, TNF-alpha, IL-1 beta, Ki67 and TGF-beta RII and a TUNEL assay. The presence and levels of 39 bacterial taxa were analyzed using the Checkerboard DNA-DNA hybridization method. The profiles of NO released from the HPMC/GSNO formulations were characterized using chemiluminescence. Results: The HPMC/GSNO formulations were found to provide sustained release of NO for more than 4 h at concentration-dependent rates of 14 to 80 nmol/mL/h. Treatment with HPMC/GSNO (0.5 mM) significantly reduced mucosal damage, inflammatory alterations and cell death associated with 5-FU-induced oral mucositis on day 14 but not on day 10. HPMC/GSNO administration also reversed the inhibitory effect of 5-FU on cell proliferation on day 14. In addition, we observed that the chemotherapy significantly increased the levels and/or prevalence of several bacterial species. Conclusion: Topical HPMC/GSNO accelerates mucosal recovery, reduces inflammatory parameters, speeds up re-epithelization and decreases levels of periodontopathic species in mucosal ulcers.	[Skeff, Maria Adriana; Holanda-Afonso, Rosenilde C.; Moura-Neto, Vivaldo] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Cell Morphogenesis, Rio De Janeiro, RJ, Brazil; [Skeff, Maria Adriana; Brito, Gerly A. C.; Braga, Cintia M.; Cavalcante, Matheus M.; Leita, Renata F. C.] Univ Fed Ceara, Sch Med, Dept Morphol, Fortaleza, Ceara, Brazil; [Silva-Boghossian, Carina M.; Colombo, Ana Paula] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, RJ, Brazil; [Ribeiro, Ronaldo A.] Univ Fed Ceara, Sch Med, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [de Oliveira, Marcelo G.; Baldim, Victor] Univ Estadual Campinas, UNICAMP, Inst Chem, Campinas, SP, Brazil; [Silva-Boghossian, Carina M.] Univ Grande Rio, Fac Dent, Duque De Caxias, RJ, Brazil; [Moura-Neto, Vivaldo] Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Estadual de Campinas; Universidade do Grande Rio	Leita, RFC (corresponding author), Univ Fed Ceara, Sch Med, Dept Morphol, Fortaleza, Ceara, Brazil.	renata.carvalho@ufc.br	de Castro Brito, Gerly Anne/C-8597-2013; Leitao, Renata/ABF-9158-2020; Moura-Neto, VIVALDO/V-9913-2019; Miranda, Maria ASP/B-9137-2015; de Oliveira, Marcelo/B-4709-2013; Silva-Boghossian, Carina Maciel/G-9440-2012; Colombo, Ana Paula Vieira/B-9188-2019; Leitão, Renata FC/GQI-3555-2022; Brito, Gerly/AHB-3965-2022; Leitao, Renata/ABG-7682-2020	de Castro Brito, Gerly Anne/0000-0002-8214-4379; Moura-Neto, VIVALDO/0000-0002-6266-043X; Miranda, Maria ASP/0000-0002-7504-4732; de Oliveira, Marcelo/0000-0002-9371-9975; Silva-Boghossian, Carina Maciel/0000-0002-4500-4350; Colombo, Ana Paula Vieira/0000-0002-2061-1840; Leitão, Renata FC/0000-0003-0202-771X; Brito, Gerly/0000-0002-8214-4379; Baldim, Victor/0000-0002-3003-7328	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (DINTER UFC-UFRJ/CAPES); National Council for Scientific and Technological Development (CNPq); Nacional Institute of Biomedicine of Brazilian Semiarid (IBISAB); National Institute for Translational Neuroscience (INNT); Rio de Janeiro State Research Foundation (FAPERJ); Sao Paulo Research Foundation (FAPESP); PhD Program on Morphological Sciences (PMC) from the Federal University of Rio de Janeiro (UFRJ); Frauzino Foundation to Cancer Research; CNPq [309390/2011-7, 478380/2011-9]; FAPESP [2008/57560-0]	Brazilian Federal Agency for the Support and Evaluation of Graduate Education (DINTER UFC-UFRJ/CAPES); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nacional Institute of Biomedicine of Brazilian Semiarid (IBISAB); National Institute for Translational Neuroscience (INNT); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PhD Program on Morphological Sciences (PMC) from the Federal University of Rio de Janeiro (UFRJ); Frauzino Foundation to Cancer Research; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants from Brazilian Federal Agency for the Support and Evaluation of Graduate Education (DINTER UFC-UFRJ/CAPES), The National Council for Scientific and Technological Development (CNPq), Nacional Institute of Biomedicine of Brazilian Semiarid (IBISAB), National Institute for Translational Neuroscience (INNT), Rio de Janeiro State Research Foundation (FAPERJ), Sao Paulo Research Foundation (FAPESP), PhD Program on Morphological Sciences (PMC) from the Federal University of Rio de Janeiro (UFRJ) and Frauzino Foundation to Cancer Research. Oliveira MG would like to acknowledge grants from CNPq (project #309390/2011-7) and FAPESP (project #2008/57560-0). Leitao RF would like to acknowledge a grant from CNPq (project #478380/2011-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeu TP, 2007, J EUR ACAD DERMATOL, V21, P629, DOI 10.1111/j.1468-3083.2006.02032.x; Amadeu TP, 2008, J SURG RES, V149, P84, DOI 10.1016/j.jss.2007.10.015; de Menezes AMA, 2012, J PERIODONTOL, V83, P514, DOI 10.1902/jop.2011.110332; Bauer Joseph A., 1998, Wound Repair and Regeneration, V6, P569, DOI 10.1046/j.1524-475X.1998.60609.x; Bayer E A, 1980, Methods Biochem Anal, V26, P1; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boutrin MC, 2012, J BACTERIOL, V194, P1582, DOI 10.1128/JB.06457-11; Cariello AJ, 2013, ARQ BRAS OFTALMOL, V76, P38, DOI 10.1590/S0004-27492013000100011; Cariello AJ, 2012, CLIN OPHTHALMOL, V6, P1907, DOI 10.2147/OPTH.S34830; Cariello AJ, 2010, J ANTIMICROB CHEMOTH, V65, P588, DOI 10.1093/jac/dkp485; Chang AHK, 2014, CHEM RES TOXICOL, V27, P794, DOI 10.1021/tx400462r; COLASANTI M, 1995, J BIOL CHEM, V270, P26731, DOI 10.1074/jbc.270.45.26731; Colombo APV, 2005, J PERIODONTOL, V76, P778, DOI 10.1902/jop.2005.76.5.778; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Dugina V, 2001, J CELL SCI, V114, P3285; Enoch S, 2008, ORAL SURG, V1, P11, DOI DOI 10.1111/J.1752-248X.2007.00005.X; ESTRADA C, 1992, BIOCHEM BIOPH RES CO, V186, P475, DOI 10.1016/S0006-291X(05)80832-0; Eyden B, 2003, SEMIN DIAGN PATHOL, V20, P13, DOI 10.1053/sdia.2003.50004; de Souza GFP, 2006, NITRIC OXIDE-BIOL CH, V15, P209, DOI 10.1016/j.niox.2006.01.011; Georgii JL, 2011, J TISSUE ENG REGEN M, V5, P612, DOI 10.1002/term.353; GERDES J, 1991, AM J PATHOL, V138, P867; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2009, ANTIOXID REDOX SIGN, V11, P725, DOI [10.1089/ars.2008.2155, 10.1089/ARS.2008.2155]; Laheij AMGA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/154532; Laheij AMGA, 2012, SUPPORT CARE CANCER, V20, P3231, DOI 10.1007/s00520-012-1463-2; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Leitao RFC, 2007, CANCER CHEMOTH PHARM, V59, P603, DOI 10.1007/s00280-006-0301-y; Leitao RFC, 2004, J PERIODONTOL, V75, P1227, DOI 10.1902/jop.2004.75.9.1227; Lewis JP, 2012, INFECT IMMUN, V80, P3319, DOI 10.1128/IAI.00561-12; Lima V, 2005, EUR J ORAL SCI, V113, P210, DOI 10.1111/j.1600-0722.2005.00216.x; Luo Yang, 2005, Zhonghua Yi Xue Za Zhi, V85, P2070; Medeiros CACX, 2011, CANCER CHEMOTH PHARM, V67, P1085, DOI 10.1007/s00280-010-1409-7; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Raber-Durlacher JE, 2010, ORAL ONCOL, V46, P452, DOI 10.1016/j.oraloncology.2010.03.012; RALSTON SH, 1995, J BONE MINER RES, V10, P1040; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seabra AB, 2007, BRIT J DERMATOL, V156, P814, DOI 10.1111/j.1365-2133.2006.07718.x; Shukla A, 1999, MOL CELL BIOCHEM, V200, P27, DOI 10.1023/A:1006977513146; SOCRANSKY SS, 1994, BIOTECHNIQUES, V17, P788; Soneja A, 2005, PHARMACOL REP, V57, P108; Sonis S, 1991, Oncology (Williston Park), V5, P11; Sonis S, 1991, ONCOLOGY WILLISTON P, V5, P18; Sonis Stephen T, 2004, J Support Oncol, V2, P21; Sonis ST, 2011, ANTI-CANCER DRUG, V22, P607, DOI 10.1097/CAD.0b013e3283462086; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Vercelino R, 2013, J MATER SCI-MATER M, V24, P2157, DOI 10.1007/s10856-013-4973-7; Wang Y, 2013, J FORMOS MED ASS; Wanstall JC, 2001, BRIT J PHARMACOL, V134, P463, DOI 10.1038/sj.bjp.0704269; Weller R, 2006, NITRIC OXIDE-BIOL CH, V15, P395, DOI 10.1016/j.niox.2006.04.002; Witte MB, 2002, J SURG RES, V105, P35, DOI 10.1006/jsre.2002.6443; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; Ye Y, 2013, CLIN MICROBIOL INFEC, V19, pE559, DOI 10.1111/1469-0691.12287; Zur Eyal, 2012, Int J Pharm Compd, V16, P22	55	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113378	10.1371/journal.pone.0113378	http://dx.doi.org/10.1371/journal.pone.0113378			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25478918	gold, Green Published, Green Submitted			2022-12-26	WOS:000346907200019
J	Van Ha, C; Esfahani, MN; Watanabe, Y; Tran, UT; Sulieman, S; Mochida, K; Van Nguyen, D; Tran, LSP				Van Ha, Chien; Esfahani, Maryam Nasr; Watanabe, Yasuko; Uyen Thi Tran; Suiieman, Saad; Mochida, Keiichi; Van Nguyen, Dong; Tran, Lam-Son Phan			Genome-Wide Identification and Expression Analysis of the CaNAC Family Members in Chickpea during Development, Dehydration and ABA Treatments	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTOR; CICER-ARIETINUM L.; MOLECULAR CHARACTERIZATION; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; STRESS-RESPONSE; WATER-DEFICIT; DROUGHT; ARABIDOPSIS; SEQUENCE	The plant-specific NAC transcription factors (TFs) play important roles in regulation of diverse biological processes, including development, growth, cell division and responses to environmental stimuli. In this study, we identified the members of the NAC TF family of chickpea (Cicer arietinum) and assess their expression profiles during plant development and under dehydration and abscisic acid (ABA) treatments in a systematic manner. Seventy-one CaNAC genes were detected from the chickpea genome, including 8 membrane-bound members of which many might be involved in dehydration responses as judged from published literature. Phylogenetic analysis of the chickpea and well-known stress-related Arabidopsis and rice NACs enabled us to predict several putative stress-related CaNACs. By exploring available transcriptome data, we provided a comprehensive expression atlas of CaNACs in various tissues at different developmental stages. With the highest interest in dehydration responses, we examined the expression of the predicted stress-related and membrane-bound CaNACs in roots and leaves of chickpea seedlings, subjected to well-watered (control), dehydration and ABA treatments, using real-time quantitative PCR (RT-qPCR). Nine-teen of the 23 CaNACs examined were found to be dehydration-responsive in chickpea roots and/or leaves in either ABA-dependent or -independent pathway. Our results have provided a solid foundation for selection of promising tissue-specific and/or dehydration-responsive CaNAC candidates for detailed in planta functional analyses, leading to development of transgenic chickpea varieties with improved productivity under drought.	[Van Ha, Chien; Watanabe, Yasuko; Uyen Thi Tran; Suiieman, Saad; Tran, Lam-Son Phan] RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan; [Van Ha, Chien; Van Nguyen, Dong] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell Technol, Agr Genet Inst, Hanoi 100000, Vietnam; [Esfahani, Maryam Nasr] Lorestan Univ, Dept Biol, Khorramabad, Iran; [Suiieman, Saad] Univ Khartoum, Dept Agron, Fac Agr, Khartoum 13314, Sudan; [Mochida, Keiichi] RIKEN Ctr Sustainable Resource Sci, Biomass Res Platform Team, Biomass Engn Program, Cooperat Div, Yokohama, Kanagawa 2300045, Japan	RIKEN; Lorestan University; University of Khartoum; RIKEN	Tran, LSP (corresponding author), RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	son.tran@riken.jp	Tran, Lam-Son P/A-1346-2009; Mochida, Keiichi/T-2866-2019; Mochida, Keiichi/N-9052-2014	Tran, Lam-Son P/0000-0001-9883-9768; Mochida, Keiichi/0000-0003-1299-0024; Mochida, Keiichi/0000-0003-1299-0024	"International Program Associate" of Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan); Ministry of Agriculture and Rural Development of Vietnam [905/HD-KHCN-CNSH]; Ministry of Science and Technology of Vietnam	"International Program Associate" of Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan); Ministry of Agriculture and Rural Development of Vietnam; Ministry of Science and Technology of Vietnam	CVH is supported by a PhD fellowship from "International Program Associate" of Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan) (http://www.riken.jp/en/careers/programs/ipa/). This work was also supported in part by a grant (Project Code 905/HD-KHCN-CNSH) from the Ministry of Agriculture and Rural Development of Vietnam and the Ministry of Science and Technology of Vietnam to the Research Group of DVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Bampidis VA, 2011, ANIM FEED SCI TECH, V168, P1, DOI 10.1016/j.anifeedsci.2011.04.098; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Esfahani MN, 2014, PLANT J, V79, P964, DOI 10.1111/tpj.12599; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guttikonda SK, 2014, MOL BIOL REP, V41, P7995, DOI 10.1007/s11033-014-3695-3; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim SY, 2007, NUCLEIC ACIDS RES, V35, P203, DOI 10.1093/nar/gkl1068; Kou XH, 2014, PLANT MOL BIOL REP, V32, P501, DOI 10.1007/s11105-013-0655-3; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Lee S, 2014, PLANT SCI, V227, P76, DOI 10.1016/j.plantsci.2014.07.003; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Ngwe T, 2012, ANIM SCI J, V83, P43, DOI 10.1111/j.1740-0929.2011.00916.x; Nuruzzaman M, 2012, MOL GENET GENOMICS, V287, P389, DOI 10.1007/s00438-012-0686-8; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Quach TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084886; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubio LA, 2005, J SCI FOOD AGR, V85, P1313, DOI 10.1002/jsfa.1963; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Satheesh V, 2014, MOL BIOL REP, V41, P7763, DOI 10.1007/s11033-014-3669-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shamsi K, 2010, AFR J BIOTECHNOL, V9, P7; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Voitsik AM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-85; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062	68	22	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114107	10.1371/journal.pone.0114107	http://dx.doi.org/10.1371/journal.pone.0114107			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479253	Green Submitted, Green Published, gold			2022-12-26	WOS:000346907200042
J	Lysenko, LV; Kim, J; Henry, C; Tyrtyshnaia, A; Kohnz, RA; Madamba, F; Simon, GM; Kleschevnikova, NE; Nomura, DK; Ezekowitz, RAB; Kleschevnikov, AM				Lysenko, Larisa V.; Kim, Jeesun; Henry, Cassandra; Tyrtyshnaia, Anna; Kohnz, Rebecca A.; Madamba, Francisco; Simon, Gabriel M.; Kleschevnikova, Natalia E.; Nomura, Daniel K.; Ezekowitz, R. Alan B.; Kleschevnikov, Alexander M.			Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; MOUSE MODEL; ALZHEIMERS-DISEASE; WORKING-MEMORY; SYNAPTIC PLASTICITY; APP EXPRESSION; MOTOR BEHAVIOR; RECEPTOR; DEFICITS; IMPAIRMENT	Genetic alterations or pharmacological treatments affecting endocannabinoid signaling have profound effects on synaptic and neuronal properties and, under certain conditions, may improve higher brain functions. Down syndrome (DS), a developmental disorder caused by triplication of chromosome 21, is characterized by deficient cognition and inevitable development of the Alzheimer disease (AD) type pathology during aging. Here we used JZL184, a selective inhibitor of monoacylglycerol lipase (MAGL), to examine the effects of chronic MAGL inhibition on the behavioral, biochemical, and synaptic properties of aged Ts65Dn mice, a genetic model of DS. In both Ts65Dn mice and their normosomic (2N) controls, JZL184-treatment increased brain levels of 2-arachidonoylglycerol (2-AG) and decreased levels of its metabolites such as arachidonic acid, prostaglandins PGD2, PGE2, PGF alpha, and PGJ2. Enhanced spontaneous locomotor activity of Ts65Dn mice was reduced by the JZL184-treatement to the levels observed in 2N animals. Deficient long-term memory was also improved, while short-term and working types of memory were unaffected. Furthermore, reduced hippocampal long-term potentiation (LTP) was increased in the JZL184-treated Ts65Dn mice to the levels observed in 2N mice. Interestingly, changes in synaptic plasticity and behavior were not observed in the JZL184-treated 2N mice suggesting that the treatment specifically attenuated the defects in the trisomic animals. The JZL184-treatment also reduced the levels of A beta 40 and A beta 42, but had no effect on the levels of full length APP and BACE1 in both Ts65Dn and 2N mice. These data show that chronic MAGL inhibition improves the behavior and brain functions in a DS model suggesting that pharmacological targeting of MAGL may be considered as a perspective new approach for improving cognition in DS.	[Lysenko, Larisa V.; Kim, Jeesun; Madamba, Francisco; Kleschevnikova, Natalia E.; Kleschevnikov, Alexander M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Henry, Cassandra; Simon, Gabriel M.; Ezekowitz, R. Alan B.] Abide Therapeut Inc, San Diego, CA USA; [Tyrtyshnaia, Anna] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia; [Kohnz, Rebecca A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Diego; Far Eastern Federal University; University of California System; University of California Berkeley	Kleschevnikov, AM (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	akleschevnikov@ucsd.edu	Lysenko, Larisa/ABF-2485-2020; Lysenko, Larisa/C-1802-2014	Lysenko, Larisa/0000-0002-0861-2904	Cure Alzheimer's Foundation; LuMind Foundation; Jerome Lejeune Foundation; NIH [5R01NS066072]; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066072] Funding Source: NIH RePORTER	Cure Alzheimer's Foundation; LuMind Foundation; Jerome Lejeune Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by The Cure Alzheimer's Foundation (LVL, JK, FM, AMK); LuMind Foundation (AMK); Jerome Lejeune Foundation (FM, AMK); and NIH 5R01NS066072 (LVL, JK, FM, AMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Aliczki M, 2012, BEHAV PHARMACOL, V23, P348, DOI 10.1097/FBP.0b013e3283564dfa; Alldred MJ, 2014, BRAIN STRUCT FUNCT; Baddeley A, 2007, J INTELL DISABIL RES, V51, P925, DOI 10.1111/j.1365-2788.2007.00979.x; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Beauquis J, 2013, HIPPOCAMPUS; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Best TK, 2012, EXP NEUROL, V233, P749, DOI 10.1016/j.expneurol.2011.11.033; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Carlesimo GA, 1997, NEUROPSYCHOLOGIA, V35, P71, DOI 10.1016/S0028-3932(96)00055-3; Chaouloff F, 2011, PHYSIOLOGY, V26, P76, DOI 10.1152/physiol.00050.2010; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Counts SE, 2011, J CHEM NEUROANAT, V42, P111, DOI 10.1016/j.jchemneu.2011.02.004; Cramer N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/101542; Das I, 2011, DIS MODEL MECH, V4, P596, DOI 10.1242/dmm.007716; Demas GE, 1996, BEHAV BRAIN RES, V82, P85, DOI 10.1016/S0166-4328(97)81111-4; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Edgin JO, 2012, PROG BRAIN RES, V197, P123, DOI 10.1016/B978-0-444-54299-1.00007-8; Ekstein S, 2011, J CHILD NEUROL, V26, P1290, DOI 10.1177/0883073811405201; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Ferguson SA, 2013, BEHAV BRAIN RES, V242, P125, DOI 10.1016/j.bbr.2012.12.055; Fernandez F, 2008, BEHAV BRAIN RES, V188, P233, DOI 10.1016/j.bbr.2007.09.015; Fernandez F, 2007, TRENDS NEUROSCI, V30, P497, DOI 10.1016/j.tins.2007.07.005; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Gagnon LG, 2011, NEUROPSYCHOLOGY, V25, P226, DOI 10.1037/a0020919; GATH A, 1986, BRIT J PSYCHIAT, V149, P156, DOI 10.1192/bjp.149.2.156; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Herault Y, 2012, PROG BRAIN RES, V197, P169, DOI 10.1016/B978-0-444-54299-1.00009-1; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Ikonomovic MD, 1995, HIPPOCAMPUS, V5, P469, DOI 10.1002/hipo.450050509; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 1999, J NEUROSCI, V19, P4544; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Kleschevnikov AM, 2012, PROG BRAIN RES, V197, P199, DOI 10.1016/B978-0-444-54299-1.00010-8; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Kleschevnikov AM, 2012, NEUROBIOL DIS, V45, P683, DOI 10.1016/j.nbd.2011.10.009; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lanfranchi S, 2013, CHILD NEUROPSYCHOL; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P397, DOI 10.1080/09297040902740652; LEJEUNE J., 1959, BULL ACAD NATL MED [PARIS], V143, P256; Lesser JM, 2006, GERIATRICS, V61, P14; Lok K, 2013, J NEUROL SCI, V335, P145, DOI 10.1016/j.jns.2013.09.018; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Martinez-Cue C, 2014, NEUROSCI BIOBEHAV RE; Martinez-Cue C, 2013, J NEUROSCI, V33, P3953, DOI 10.1523/JNEUROSCI.1203-12.2013; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Moreira FA, 2009, BEST PRACT RES CL EN, V23, P133, DOI 10.1016/j.beem.2008.09.003; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Popov VI, 2011, J COMP NEUROL, V519, P1338, DOI 10.1002/cne.22573; Proctor DT, 2010, J ALZHEIMERS DIS, V21, P795, DOI 10.3233/JAD-2010-100090; Reilly TJ, 2011, BEHAV BRAIN RES, V222, P375, DOI 10.1016/j.bbr.2011.04.003; Rodgers SP, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-28; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith GK, 2013, HIPPOCAMPUS; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Thomazeau A, 2014, J NEUROSCI, V34, P1138, DOI 10.1523/JNEUROSCI.2852-13.2014; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Whitney KN, 2012, BEHAV BRAIN RES, V232, P202, DOI 10.1016/j.bbr.2012.03.042; Wirths O, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00373.x; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Zhang SY, 2009, J NEUROSCI, V29, P13222, DOI 10.1523/JNEUROSCI.1710-09.2009	87	40	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114521	10.1371/journal.pone.0114521	http://dx.doi.org/10.1371/journal.pone.0114521			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474204	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500042
J	Ulas, A; Turkoz, FP; Silay, K; Tokluoglu, S; Avci, N; Oksuzoglu, B; Alkis, N				Ulas, Arife; Turkoz, Fatma Paksoy; Silay, Kamile; Tokluoglu, Saadet; Avci, Nilufer; Oksuzoglu, Berna; Alkis, Necati			A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SURVIVAL; NSCLC; SCORE; CHEMOTHERAPY; TRIALS; BIOMARKERS; TISSUES; LDH-5; YOUNG	Purpose: We aimed to establish a laboratory prognostic index (LPI) in advanced non-small cell lung cancer (NSCLC) patients based on hematologic and biochemical parameters and to analyze the predictive value of LPI on NSCLC survival. Patients and Methods: The study retrospectively reviewed 462 patients with advanced NSCLC diagnosed between 2000 and 2010 in a single institution. We developed an LPI that included serum levels of white blood cells (WBC), lactate dehydrogenase (LDH), albumin, calcium, and alkaline phosphatase (ALP), based on the results of a Cox regression analysis. The patients were classified into 3 LPI groups as follows: LPI 0: normal; LPI 1: one abnormal laboratory finding; and LPI 2: at least 2 abnormal laboratory findings. Results: The median follow up period was 44 months; the median overall survival (OS) and median progression-free survival (PFS) were 11 and 6 months, respectively. A multivariate analysis revealed that the following could be used as independent prognostic factors: an Eastern Cooperative Oncology Group performance status score (ECOG PS) >= 2, a high LDH level, serum albumin <3 g/dL, serum calcium>10.5 g/dL, number of metastases >2, presence of liver metastases, malignant pleural effusion, or receiving chemotherapy >= 4 cycles. The 1-year OS rates according to LPI 0, LPI 1, and LPI 2 were 54%, 34%, and 17% (p<0.001), respectively and 6-month PFS rates were 44%, 27%, and 15% (p<0.001), respectively. The LPI was a significant predictor for OS (Hazard Ratio (HR): 1.41; 1.05-1.88, p<0.001) and PFS (HR: 1.48; 1.14-1.93, p<0.001). Conclusion: An LPI is an inexpensive, easily accessible and independent prognostic index for advanced NSCLC and may be helpful in making individualized treatment plans and predicting survival rates when combined with clinical parameters.	[Ulas, Arife] Ankara Ataturk Training & Res Hosp, Dept Med Oncol, Ankara, Turkey; [Turkoz, Fatma Paksoy; Tokluoglu, Saadet; Oksuzoglu, Berna; Alkis, Necati] Ankara Oncol Teaching & Res Hosp, Dept Med Oncol, Ankara, Turkey; [Silay, Kamile] Yildirim Beyazit Univ, Ataturk Res & Training Hosp, Fac Med, Dept Internal Med & Geriatr, Ankara, Turkey; [Avci, Nilufer] Balikesir Govt Hosp, Dept Med Oncol, Balikesir, Turkey	Ankara Ataturk Training & Research Hospital; Dr. Abdurrahman Yurtaslan Oncology Hospital; Ankara Ataturk Training & Research Hospital; Ankara Yildirim Beyazit University; Balikesir Ataturk State Hospital	Ulas, A (corresponding author), Ankara Ataturk Training & Res Hosp, Dept Med Oncol, Ankara, Turkey.	drarifeulas@hotmail.com	Ulas, Arife/HGD-4686-2022	Ulas, Arife/0000-0003-2918-2592				ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618, DOI 10.1200/JCO.1991.9.9.1618; Arinc S, 2009, SOUTH MED J, V102, P1019, DOI 10.1097/SMJ.0b013e3181b66b11; Arrieta O, 2010, BMC CANCER, V10, P1471; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Danner BC, 2010, ANTICANCER RES, V30, P1347; Ferrigno D, 2003, Monaldi Arch Chest Dis, V59, P193; FINKELSTEIN DM, 1986, J CLIN ONCOL, V4, P702, DOI 10.1200/JCO.1986.4.5.702; Forrest LM, 2005, BRIT J CANCER, V92, P1834, DOI 10.1038/sj.bjc.6602591; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Gagnon B, 2013, BRIT J CANCER, V109, P2066, DOI 10.1038/bjc.2013.515; GOLDMAN RD, 1964, CANCER RES, V24, P389; Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551; Hoang T, 2005, J CLIN ONCOL, V23, P175, DOI 10.1200/JCO.2005.04.177; Hotta K, 2007, J THORAC ONCOL, V2, P402, DOI 10.1097/01.JTO.0000268673.95119.c7; Jafri SH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-158; Kasymjanova G, 2010, CURR ONCOL, V17, P52; Kawai H, 2012, WORLD J SURG, V36, P2853, DOI 10.1007/s00268-012-1766-y; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kulesza P, 2011, AM J CLIN PATHOL, V136, P228, DOI 10.1309/AJCPO66OIRULFNLZ; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Mandrekar SJ, 2006, CANCER-AM CANCER SOC, V107, P781, DOI 10.1002/cncr.22049; MUNDY GR, 1988, J CLIN INVEST, V82, P1, DOI 10.1172/JCI113555; Odell WD, 1997, SEMIN ONCOL, V24, P299; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Rosell R, 2002, LUNG CANCER, V38, pS43, DOI 10.1016/S0169-5002(02)00171-X; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; STANLEY KE, 1980, J NATL CANCER I, V65, P25; Subramanian J, 2010, J THORAC ONCOL, V5, P23, DOI 10.1097/JTO.0b013e3181c41e8d; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Trape J, 2012, INT J BIOL MARKER, V27, P257, DOI 10.5301/JBM.2012.9314; Travis W, 2004, WHO CLASSIFICATION T; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Wigren T, 1997, RADIOTHER ONCOL, V44, P9, DOI 10.1016/S0167-8140(97)00087-X	36	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114471	10.1371/journal.pone.0114471	http://dx.doi.org/10.1371/journal.pone.0114471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25474743	Green Submitted, Green Published, gold			2022-12-26	WOS:000346382500038
J	Fan, WN; Zhang, SH; Du, HQ; Sun, XG; Shi, YH; Wang, CZ				Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang			Genome-Wide Identification of Different Dormant Medicago sativa L. MicroRNAs in Response to Fall Dormancy	PLOS ONE			English	Article							SMALL RNAS; ALFALFA VARIETIES; PLANT MICRORNAS; GENE-EXPRESSION; TRUNCATULA; PHYTOCHROME; PATHWAY; ROOTS; CARBOHYDRATE; ANNOTATION	Background: MicroRNAs (miRNAs) are a class of regulatory small RNAs (sRNAs) that regulate gene post-transcriptional expression in plants and animals. Highthroughput sequencing technology is capable of identifying small RNAs in plant species. Alfalfa (Medicago sativa L.) is one of the most widely cultivated perennial forage legumes worldwide, and fall dormancy is an adaptive characteristic related to the biomass production and winter survival in alfalfa. Here, we applied highthroughput sRNA sequencing to identify some miRNAs that were responsive to fall dormancy in standard variety (Maverick and CUF101) of alfalfa. Results: Four sRNA libraries were generated and sequenced from alfalfa leaves in two typical varieties at distinct seasons. Through integrative analysis, we identified 51 novel miRNA candidates of 206 families. Additionally, we identified 28 miRNAs associated with fall dormancy in standard variety (Maverick and CUF101), including 20 known miRNAs and eight novel miRNAs. Both high-throughput sequencing and RT-qPCR confirmed that eight known miRNA members were up-regulated and six known miRNA members were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101). Among the 51 novel miRNA candidates, five miRNAs were up-regulated and three miRNAs were down-regulated in response to fall dormancy in standard variety (Maverick and CUF101), and five of them were confirmed by Northern blot analysis. Conclusion: We identified 20 known miRNAs and eight new miRNA candidates that were responsive to fall dormancy in standard variety (Maverick and CUF101) by high-throughput sequencing of small RNAs from Medicago sativa. Our data provide a useful resource for investigating miRNA-mediated regulatory mechanisms of fall dormancy in alfalfa, and these findings are important for our understanding of the roles played by miRNAs in the response of plants to abiotic stress in general and fall dormancy in alfalfa.	[Fan, Wenna; Zhang, Senhao; Du, Hongqi; Sun, Xiaoge; Shi, Yinghua; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wangcz@henau.edu.cn		Zhang, Senhao/0000-0002-9231-9750	China Forage and Grass Research System [CARS-35]; National Natural Science Foundation of China [31172261]	China Forage and Grass Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by China Forage and Grass Research System (CARS-35) and the National Natural Science Foundation of China (No. 31172261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ariss JJ, 2007, CROP SCI, V47, P2274, DOI 10.2135/cropsci2006.12.0782; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BULA RJ, 1954, AGRON J, V46, P397, DOI 10.2134/agronj1954.00021962004600090001x; CASTONGUAY Y, 1995, CROP SCI, V35, P509, DOI 10.2135/cropsci1995.0011183X003500020038x; Chen L, 2012, PLANT SCI, V184, P14, DOI 10.1016/j.plantsci.2011.11.007; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; Cunningham SM, 1998, J PLANT PHYSIOL, V153, P220, DOI 10.1016/S0176-1617(98)80069-2; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Du H, 2013, ACTA AGRESTIA SINICA, V21, P708; Fairey DT, 1996, CAN J PLANT SCI, V76, P429, DOI 10.4141/cjps96-076; Fan WenNa, 2014, Acta Prataculturae Sinica, V23, P177; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; HEINRICHS D. H., 1960, CANADIAN JOUR PLANT SCI, V40, P638; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lacombe S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-123; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSEN K. L., 1963, CROP SCI, V3, P234, DOI 10.2135/cropsci1963.0011183X000300030018x; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McKenzie J. S., 1988, Alfalfa and alfalfa improvement, P259; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Rimi F, 2014, AGRON J, V106, P1258, DOI 10.2134/agronj13.0495; Samac DA, 2006, CHEM IND-SER, V112, P79; Schneider M, 1984, UNIFOLIATE INTERNODE, P96; Schwab PM, 1996, CROP SCI, V36, P418, DOI 10.2135/cropsci1996.0011183X003600020034x; Sharma R, 2001, CURR SCI INDIA, V80, P178; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SMITH D., 1961, Canadian Journal of Plant Science, V41, P244; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; STOUT DG, 1989, CAN J PLANT SCI, V69, P491, DOI 10.4141/cjps89-060; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Teuber L, 1998, FALL DORMANCY, P2; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Trinh TH, 1998, PLANT CELL REP, V17, P345, DOI 10.1007/s002990050405; Verdonk JC, 2013, BOTANY, V91, P117, DOI 10.1139/cjb-2012-0166; VOLENEC JJ, 1991, PLANT PHYSIOL, V96, P786, DOI 10.1104/pp.96.3.786; Wang CZ, 2008, J PLANT NUTR, V31, P1257, DOI 10.1080/01904160802135027; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang TZ, 2014, PLANT CELL, V18, P2051; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yifen C, 1990, PRATACULTURAL SCI, V7, P60; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	70	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114612	10.1371/journal.pone.0114612	http://dx.doi.org/10.1371/journal.pone.0114612			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473944	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500049
J	Chang, D; Gao, F; Slavney, A; Ma, L; Waldman, YY; Sams, AJ; Billing-Ross, P; Madar, A; Spritz, R; Keinan, A				Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Spritz, Richard; Keinan, Alon			Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI INFECTION; ONLINE MENDELIAN INHERITANCE; INFLAMMATORY-BOWEL-DISEASE; SEX-DIFFERENCES; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; GENDER-DIFFERENCES; QUALITY-CONTROL; CROHNS-DISEASE	Many complex human diseases are highly sexually dimorphic, suggesting a potential contribution of the X chromosome to disease risk. However, the X chromosome has been neglected or incorrectly analyzed in most genome-wide association studies (GWAS). We present tailored analytical methods and software that facilitate X-wide association studies (XWAS), which we further applied to reanalyze data from 16 GWAS of different autoimmune and related diseases (AID). We associated several X-linked genes with disease risk, among which (1) ARHGEF6 is associated with Crohn's disease and replicated in a study of ulcerative colitis, another inflammatory bowel disease (IBD). Indeed, ARHGEF6 interacts with a gastric bacterium that has been implicated in IBD. (2) CENPI is associated with three different AID, which is compelling in light of known associations with AID of autosomal genes encoding centromere proteins, as well as established autosomal evidence of pleiotropy between autoimmune diseases. (3) We replicated a previous association of FOXP3, a transcription factor that regulates T-cell development and function, with vitiligo; and (4) we discovered that C1GALT1C1 exhibits sex-specific effect on disease risk in both IBDs. These and other X-linked genes that we associated with AID tend to be highly expressed in tissues related to immune response, participate in major immune pathways, and display differential gene expression between males and females. Combined, the results demonstrate the importance of the X chromosome in autoimmunity, reveal the potential of extensive XWAS, even based on existing data, and provide the tools and incentive to properly include the X chromosome in future studies.	[Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Chang, Diana; Keinan, Alon] Cornell Univ, Program Computat Biol & Med, Ithaca, NY USA; [Slavney, Andrea; Billing-Ross, Paul; Keinan, Alon] Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY USA; [Ma, Li] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Spritz, Richard] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA	Cornell University; Cornell University; Cornell University; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Anschutz Medical Campus	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	ak735@cornell.edu	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Institutes of Health [R01HG006849]; Ellison Medical Foundation; Edward Mallinckrodt, Jr. Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Edward Mallinckrodt, Jr. Foundation	This work was supported in part by National Institutes of Health Grant R01HG006849. AK was also supported by The Ellison Medical Foundation and the Edward Mallinckrodt, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; ALSGEN C, 2013, NEUROBIOL AGING, V0034; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arbiza L, 2014, AM J HUM GENET, V94, P827, DOI 10.1016/j.ajhg.2014.04.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek HY, 2007, ANN NY ACAD SCI, V1096, P18, DOI 10.1196/annals.1397.065; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Bierut LJ, 2002, ALCOHOL RES HEALTH, V26, P208; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chang D, 2014, BIORXIV; Chang D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003820; Choi BG, 2007, ENDOCRIN METAB CLIN, V36, P365, DOI 10.1016/j.ecl.2007.03.011; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton DG, 2009, GENOME MED, V1, DOI 10.1186/gm110; Conde L, 2013, BRIT J HAEMATOL, V162, P858, DOI 10.1111/bjh.12438; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eguchi K, 2001, INTERNAL MED, V40, P275, DOI 10.2169/internalmedicine.40.275; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamdouch K, 2011, CLIN CHIM ACTA, V412, P2267, DOI 10.1016/j.cca.2011.08.024; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heyer E, 2012, MOL ECOL, V21, P597, DOI 10.1111/j.1365-294X.2011.05406.x; Hindorff L., 2013, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Jacob S, 2002, J PINEAL RES, V33, P186, DOI 10.1034/j.1600-079X.2002.02943.x; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jiang B, 2011, J THEOR BIOL, V277, P67, DOI 10.1016/j.jtbi.2011.01.029; Jin X, 2013, INT J MED SCI, V10, P1479, DOI 10.7150/ijms.6934; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawakami Atsushi, 2002, Medical Electron Microscopy, V35, P1, DOI 10.1007/s007950200000; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kemkemer C, 2009, CHROMOSOME RES, V17, P811, DOI 10.1007/s10577-009-9072-8; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lai F, 1999, NEUROLOGY, V53, P331, DOI 10.1212/WNL.53.2.331; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li N, 2014, EUR REV MED PHARMACO, V18, P78; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Ling Hua, 2009, BMC Proc, V3 Suppl 7, pS57; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohmueller KE, 2010, AM J HUM GENET, V86, P978, DOI 10.1016/j.ajhg.2010.03.021; Loley C, 2011, HUM HERED, V71, P23, DOI 10.1159/000323768; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mason KD, 2013, P NATL ACAD SCI USA, V110, P2599, DOI 10.1073/pnas.1215097110; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Matson DR, 2012, GENE DEV, V26, P542, DOI 10.1101/gad.184184.111; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Moretti S, 2009, HISTOL HISTOPATHOL, V24, P849, DOI 10.14670/HH-24.849; Morrow EH, 2013, EVOL APPL, V6, P1208, DOI 10.1111/eva.12097; Muscat JE, 1996, CANCER RES, V56, P5192; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nelson JL, 1997, RHEUM DIS CLIN N AM, V23, P195, DOI 10.1016/S0889-857X(05)70323-9; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pohanka M, 2013, CENT EUR J MED, V8, P369, DOI 10.2478/s11536-013-0177-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Quintero OL, 2012, J AUTOIMMUN, V38, pJ109, DOI 10.1016/j.jaut.2011.10.003; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Selmi C, 2012, AUTOIMMUN REV, V11, pA531, DOI 10.1016/j.autrev.2011.11.024; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stouffer S.A., 1949, ADJUSTMENT ARMY LIFE; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Terry PD, 2009, INFLAMM BOWEL DIS, V15, P134, DOI 10.1002/ibd.20527; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thornton T, 2012, GENET EPIDEMIOL, V36, P438, DOI 10.1002/gepi.21638; THURNHER M, 1992, EUR J IMMUNOL, V22, P1835, DOI 10.1002/eji.1830220724; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weatherhead SC, 2011, J INVEST DERMATOL, V131, P1916, DOI 10.1038/jid.2011.134; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	165	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113684	10.1371/journal.pone.0113684	http://dx.doi.org/10.1371/journal.pone.0113684			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479423	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200028
J	Chang, YM; Chen, LC; Wang, HY; Chiang, CL; Chang, CT; Chung, YC				Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chiang, Chui-Liang; Chang, Chen-Tien; Chung, Yun-Chin			Characterization of an Acidic Chitinase from Seeds of Black Soybean (Glycine max (L) Merr Tainan No. 3)	PLOS ONE			English	Article							ZEA-MAYS; PURIFICATION	Using 4-methylumbelliferyl-beta-D-N, N', N ''-triacetylchitotrioside (4-MU-GlcNAc(3)) as a substrate, an acidic chitinase was purified from seeds of black soybean (Glycine max Tainan no. 3) by ammonium sulfate fractionation and three successive steps of column chromatography. The purified chitinase was a monomeric enzyme with molecular mass of 20.1 kDa and isoelectric point of 4.34. The enzyme catalyzed the hydrolysis of synthetic substrates p-nitrophenyl N-acetyl chitooligosaccharides with chain length from 3 to 5 (GlcNAc(n), n = 3-5), and pNp-GlcNAc(4) was the most degradable substrate. Using pNp-GlcNAc(4) as a substrate, the optimal pH for the enzyme reaction was 4.0; kinetic parameters K-m and k(cat) were 245 mM and 10.31 min(-1), respectively. This enzyme also showed activity toward CM-chitinRBV, a polymer form of chitin, and N-acetyl chitooligosaccharides, an oligomer form of chitin. The smallest oligomer substrate was an N-acetylglucosamine tetramer. These results suggested that this enzyme was an endo-splitting chitinase with short substrate cleavage activity and useful for biotechnological applications, in particular for the production of N-acetyl chitooligosaccharides.	[Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chang, Chen-Tien; Chung, Yun-Chin] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chiang, Chui-Liang] Cent Taiwan Univ Sci & Technol, Dept Food Sci, Taichung, Taiwan	Providence University - Taiwan; Central Taiwan University Science & Technology	Chang, CT (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	ctchang@pu.edu.tw; ycchun@pu.edu.tw	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Science Council of the Republic of China (Taiwan) [NSC-94-2321-B-126-001]	National Science Council of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China (Taiwan) (NSC-94-2321-B-126-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, APPL MICROBIOL BIOT; [Anonymous], 1999, CHITIN AND CHITINASE; [Anonymous], 2000, ENZYME MICROB TECHNO; BERKELEY RC, 1972, ANAL BIOCHEM, V46, P687, DOI 10.1016/0003-2697(72)90343-0; Chiang Chui-Liang, 2006, Taiwanese Journal of Agricultural Chemistry and Food Science, V44, P207; Chiang CL, 2005, J AGR FOOD CHEM, V53, P7579, DOI 10.1021/jf040472n; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dawson RCM, 1969, DATA BIOCH RES, P483; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hollis T, 1997, ARCH BIOCHEM BIOPHYS, V344, P335, DOI 10.1006/abbi.1997.0225; ISHIGE F, 1991, PLANT CELL PHYSIOL, V32, P681, DOI 10.1093/oxfordjournals.pcp.a078131; Jrudel J, 1989, ANAL BIOCHEM, V178, P62; Koga D, 1999, EXS, V87, P111; Kuo CJ, 2009, BOT STUD, V50, P281; KUROSAKI F, 1989, PHYTOCHEMISTRY, V28, P2989, DOI 10.1016/0031-9422(89)80265-1; Lai LS, 2006, J AGR FOOD CHEM, V54, P8611, DOI 10.1021/jf060888w; LIN ZF, 1992, PROCESS BIOCHEM, V27, P83, DOI 10.1016/0032-9592(92)80014-T; LIU WH, 1968, BIOCHEMISTRY-US, V7, P2886, DOI 10.1021/bi00848a027; MCBRIDE JD, 1993, ELECTROPHORESIS, V14, P165, DOI 10.1002/elps.1150140126; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Park SM, 2002, ENZYME MICROB TECH, V30, P697, DOI 10.1016/S0141-0229(02)00042-X; POWNING RF, 1965, COMP BIOCHEM PHYSIOL, V14, P127, DOI 10.1016/0010-406X(65)90013-7; PUNJA ZK, 1993, J NEMATOL, V25, P526; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; VERBURG JG, 1992, J BIOL CHEM, V267, P3886; WADSWORTH SA, 1984, J AGR FOOD CHEM, V32, P1284, DOI 10.1021/jf00126a018; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; WIRTH SJ, 1990, J MICROBIOL METH, V12, P197, DOI 10.1016/0167-7012(90)90031-Z; Yeboah NA, 1998, PLANT MOL BIOL, V36, P407, DOI 10.1023/A:1005921104288	31	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113596	10.1371/journal.pone.0113596	http://dx.doi.org/10.1371/journal.pone.0113596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25479423	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900053
J	Fan, W; Xu, L; Xie, LC; Yang, DC; Liu, XZ; Zhang, JJ; Li, YR; Yi, CJ				Fan, Wen; Xu, Lei; Xie, Liangcai; Yang, Decai; Liu, Xuezheng; Zhang, Jiajun; Li, Yirong; Yi, Cunjian			Negative Interference by Rheumatoid Factor of Plasma B-Type Natriuretic Peptide in Chemiluminescent Microparticle Immunoassays	PLOS ONE			English	Article							HEART-FAILURE; SERUM; ANTIBODIES; DIAGNOSIS; ARTHRITIS; VALUES; BRAIN; NEED	Background: The chemiluminescent microparticle immunoassay (CMIA) is widely used for the quantitative determination of B-type natriuretic peptide (BNP) in human ethylenediaminetetraacetic acid plasma. Rheumatoid factor (RF) is usually thought to result in a positive interference in immunoassays, but it is not clear whether its presence in plasma can lead to interferences in the CMIA of BNP. Methods: The estimation of BNP recovery was carried out by diluting high-concentration BNP samples with RF-positive or RF-negative plasma at a ratio of 1:9. The diluted samples were then tested using the ARCHITECT i2000 System and ARCHITECT BNP Reagent Kits and the recovery was then calculated. Results: When the RF level ranged from 48 to 1420 IU/mL, the average recovery of BNP was 79.29% and 91.61% in the RF-positive and RF-negative plasma samples, respectively, and was thus significantly lower in the group of RF-positive plasma samples than in the group of RF-negative plasma samples. At a dilution of 1:16, the measured BNP level increased by >36% in six of the seven RF-positive plasma samples. The recovery of BNP increased significantly in the RF-positive plasma samples after pretreatment with IgG-sensitive latex particles. In addition, The BNP recovery was not significantly related to the plasma RF at concentrations ranging from 48 to 2720 IU/mL. Conclusions: Measurement of BNP by CMIA is susceptible to interference from RF leading to predominantly (but not exclusively) lower results. Pretreatment of samples with blocking reagents is advisable prior to the initiation of denying patient's necessary treatment.	[Fan, Wen; Xie, Liangcai; Liu, Xuezheng; Zhang, Jiajun] Jingzhou First Peoples Hosp, Dept Lab Med, Jinzhou, Hubei, Peoples R China; [Xu, Lei; Yang, Decai; Li, Yirong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China; [Yi, Cunjian] Jingzhou First Peoples Hosp, Dept Obstet & Gynecol, Jinzhou, Hubei, Peoples R China	Huazhong University of Science & Technology	Li, YR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Hubei, Peoples R China.	liyirong838@163.com; cunjiany@163.com		Zhang, Senhao/0000-0002-9231-9750	National Natural Science Foundation of China [30970060]; Scientific Research Foundation of the Education Ministry of China [2008890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of the Education Ministry of China	This study was supported by grants 30970060 from the National Natural Science Foundation of China and 2008890 from the Scientific Research Foundation of the Education Ministry of China for Returned Chinese Scholars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Eriksson S, 2003, CLIN CHEM, V49, P1095, DOI 10.1373/49.7.1095; Ismail AAA, 2009, J CLIN PATHOL, V62, P673, DOI 10.1136/jcp.2008.055848; Ismail AAA, 2011, ANN CLIN BIOCHEM, V48, P65, DOI 10.1258/acb.2010.010197; Ismail Y, 2007, CLIN MED, V7, P357, DOI 10.7861/clinmedicine.7-4-357; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Li YR, 2014, LABMEDICINE, V45, P82, DOI 10.1309/LMO7HLI8EODNAZSG; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Marks V, 2002, CLIN CHEM, V48, P2008; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; MOORE TL, 1993, CLIN BIOCHEM, V26, P75, DOI 10.1016/0009-9120(93)90032-2; Norden AGW, 1997, CLIN CHEM, V43, P957; Onuska KD, 2000, CLIN CHEM, V46, P307; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Tsavaris N, 2007, ANN RHEUM DIS, V66, P980, DOI 10.1136/ard.2007.070052; Wieczorek SJ, 2002, AM HEART J, V144, P834, DOI 10.1067/mhj.2002.125623; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080620; Xu L, 2013, CLIN BIOCHEM, V46, P799, DOI 10.1016/j.clinbiochem.2013.03.013; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x	21	20	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105304	10.1371/journal.pone.0105304	http://dx.doi.org/10.1371/journal.pone.0105304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25473944	gold, Green Published, Green Submitted			2022-12-26	WOS:000341106100048
